,mention,obj,prob,pmid
0,Patients,species,0.9927,35355238
1,patients,species,0.9907,35355238
2,patients,species,0.9897,35355238
3,patients,species,0.981,35355238
4,patients,species,0.9863,35355238
5,panitumumab,gene,0.879,35355238
6,patients,species,0.9834,35355238
7,patients,species,0.975,35355238
8,panitumumab,gene,0.7544,35355238
9,patients,species,0.986,35355238
10,Colorectal Cancer,disease,1.0,35351276
11,Metastatic colorectal cancer,disease,1.0,35351276
12,mCRC,disease,1.0,35351276
13,patients,species,0.9785,35351276
14,patients,species,0.99,35351276
15,patients,species,0.9775,35351276
16,Patients,species,0.9346,35351276
17,mCRC,disease,0.9893,35351276
18,KRAS/NRAS/BRAF wild,DNA,0.558,35351276
19,KRAS,gene,0.974,35351276
20,NRAS,gene,0.998,35351276
21,BRAF,gene,0.998,35351276
22,epidermal growth factor receptor,gene,0.998,35351276
23,EGFR,gene,0.9946,35351276
24,panitumumab,gene,0.854,35351276
25,EGFR,gene,0.9863,35351276
26,vascular endothelial growth factor,gene,0.998,35351276
27,VEGF,gene,0.997,35351276
28,EGFR,gene,0.99,35351276
29,right-sided tumors,disease,0.9995,35351276
30,patients,species,0.994,35351276
31,RAS mutations,gene,0.9707,35351276
32,panitumumab,gene,0.906,35351276
33,FOLFOX,drug,0.977,35351276
34,Patients,species,0.9575,35351276
35,BRAF,DNA,0.785,35351276
36,BRAF mutations,gene,0.761,35351276
37,BRAF,gene,0.997,35351276
38,cetuximab,gene,0.6567,35351276
39,BRAF,gene,0.998,35351276
40,encorafenib,drug,0.967,35351276
41,MEK kinase,gene,0.906,35351276
42,binimetinib,drug,0.948,35351276
43,patients,species,0.988,35351276
44,mismatch repair (MMR) deficient tumors,disease,0.928,35351276
45,Lynch syndrome,disease,1.0,35351276
46,FOLFOX,drug,0.946,35351276
47,FOLFIRI,drug,0.838,35351276
48,EGFR,gene,0.9917,35351276
49,patients,species,0.98,35351276
50,cancers,disease,1.0,35332092
51,cancers,disease,1.0,35332092
52,epidermal growth factor receptor,gene,0.9985,35332092
53,EGFR,gene,0.996,35332092
54,tumors,disease,1.0,35332092
55,patients,species,0.928,35332092
56,high-grade glioma,disease,1.0,35332092
57,HGG,disease,1.0,35332092
58,head-and-neck squamous cell carcinoma,disease,1.0,35332092
59,HNSCC,disease,1.0,35332092
60,lung adenocarcinoma,disease,1.0,35332092
61,LAC,disease,1.0,35332092
62,panitumumab,gene,0.969,35332092
63,EGFR,gene,0.9946,35332092
64,claudin-5,gene,0.986,35332092
65,panitumumab,gene,0.9575,35332092
66,tumor,disease,0.9985,35332092
67,tumor,disease,0.998,35332092
68,HGG,disease,1.0,35332092
69,HNSCC,disease,1.0,35332092
70,LAC,disease,1.0,35332092
71,at,DNA,,35332092
72,tumor,disease,1.0,35332092
73,HGG,disease,1.0,35332092
74,EGFR,gene,0.9873,35332092
75,HNSCC,disease,0.9995,35332092
76,LAC,disease,1.0,35332092
77,EGFR,gene,0.988,35332092
78,tumor,disease,0.9995,35332092
79,panitumumab,gene,0.9634,35332092
80,multi-cancer,disease,1.0,35332092
81,EGFR,gene,0.9814,35332092
82,tumor cell,cell_type,0.4797,35332092
83,tumor,disease,0.991,35332092
84,tumor,disease,0.9766,35332092
85,tumor,disease,1.0,35332092
86,tumor,disease,0.9985,35302604
87,cancer,disease,0.8545,35302604
88,tumor,disease,1.0,35302604
89,cancer,disease,0.996,35302604
90,tumor,disease,0.9985,35302604
91,tumor,disease,0.991,35302604
92,patients,species,0.9844,35302604
93,panitumumab,gene,0.9365,35302604
94,epidermal growth factor receptor,gene,0.998,35302604
95,EGFR,gene,0.997,35302604
96,patients,species,0.9756,35302604
97,panitumumab,gene,0.9727,35302604
98,EGFR overexpressing cancer cells,cell_line,0.9053,35302604
99,EGFR,gene,0.9883,35302604
100,cancer,disease,0.517,35302604
101,tumor,disease,0.8975,35302604
102,normal,cell_type,0.665,35302604
103,FLT,drug,0.964,35302604
104,tumor,disease,0.9995,35302604
105,EGFR,gene,0.981,35302604
106,patients,species,0.9844,35302604
107,tumor cell,cell_type,0.4946,35302604
108,tumor,disease,0.5396,35302604
109,FLT,gene,0.9834,35302604
110,tumor,disease,0.577,35302604
111,tumor,disease,1.0,35302604
112,EFGR,gene,0.997,35302604
113,FLT,gene,0.9893,35302604
114,tumor,disease,0.939,35302604
115,humans,species,0.9746,35302604
116,cancer,disease,0.9946,35302604
117,Sigmoid Colon Cancer,disease,1.0,35299187
118,Bladder Fistula,disease,0.9985,35299187
119,patient,species,0.9673,35299187
120,woman,species,0.916,35299187
121,sigmoid colon tumor,disease,0.989,35299187
122,fistula,disease,0.5347,35299187
123,patient,species,0.977,35299187
124,peritonitis,disease,0.817,35299187
125,tumor,disease,0.918,35299187
126,CAPOX,drug,0.93,35299187
127,FOLFIRI,drug,0.8843,35299187
128,panitumumab,gene,0.696,35299187
129,tumor,disease,0.9917,35299187
130,patient,species,0.9697,35299187
131,patient,species,0.9736,35299187
132,sigmoid colon cancer,disease,1.0,35299187
133,bladder fistula,disease,0.99,35299187
134,Lower Rectal Cancer,disease,1.0,35299186
135,Patients,species,0.9927,35299186
136,lower advanced rectal cancer,disease,0.9863,35299186
137,patients,species,0.9893,35299186
138,woman,species,0.889,35299186
139,lower rectal cancer,disease,1.0,35299186
140,advanced rectal cancer,disease,0.9995,35299186
141,mesenteric lymph node metastasis,disease,0.8594,35299186
142,bilateral inguinal lymph node metastasis,disease,0.9062,35299186
143,patient,species,0.9863,35299186
144,FOLFOX,drug,0.694,35299186
145,panitumumab,gene,0.6626,35299186
146,rectal cancer,disease,1.0,35299186
147,RAS,gene,0.9976,35299186
148,BRAF,gene,0.9976,35299186
149,inguinal,DNA,0.617,35299186
150,inguinal lymph node metastasis,disease,0.793,35299186
151,N064A,mutation,,35285484
152,Panitumumab,gene,0.8115,35285484
153,Cancer,disease,0.9824,35285484
154,N064A,mutation,,35285484
155,EGFR,gene,0.9956,35285484
156,panitumumab,gene,0.664,35285484
157,gemcitabine,drug,0.9985,35285484
158,panitumumab,gene,0.7495,35285484
159,non-metastatic pancreatic cancer,disease,0.9985,35285484
160,fluoropyrimidine,drug,0.96,35285484
161,panitumumab,gene,0.706,35285484
162,gemcitabine,drug,0.9976,35285484
163,panitumumab,gene,0.687,35285484
164,panitumumab,gene,0.73,35285484
165,patients,species,0.9863,35285484
166,patients,species,0.9834,35285484
167,patients,species,0.9873,35285484
168,women,species,0.852,35285484
169,patients,species,0.987,35285484
170,patients,species,0.99,35285484
171,panitumumab,gene,0.9087,35285484
172,Anti-cancer,disease,0.965,35273301
173,tumor,disease,0.997,35273301
174,tumor,disease,1.0,35273301
175,cancer,disease,0.999,35273301
176,clonal populations,cell_line,0.7607,35273301
177,tumor,disease,1.0,35273301
178,mutant KRAS,gene,0.9946,35273301
179,circulating tumor DNA,DNA,0.866,35273301
180,ctDNA,DNA,0.903,35273301
181,patients,species,0.983,35273301
182,metastatic colorectal cancer,disease,1.0,35273301
183,panitumumab,gene,0.8145,35273301
184,ctDNA,DNA,0.795,35273301
185,tumor,disease,0.715,35273301
186,Liver Metastases,disease,0.9995,35249059
187,colorectal liver metastases,disease,1.0,35249059
188,5-FU,drug,0.9985,35249059
189,l-LV,drug,0.997,35249059
190,L-OHP,drug,0.9985,35249059
191,panitumumab,gene,0.8364,35249059
192,patients,species,0.9917,35249059
193,patients,species,0.977,35249059
194,patients,species,0.991,35249059
195,patients,species,0.9854,35249059
196,panitumumab,gene,0.8623,35249059
197,patients,species,0.9478,35249059
198,colorectal liver metastases,disease,0.999,35249059
199,interleukin-1,gene,0.9854,35236282
200,EGFR,gene,0.991,35236282
201,metastatic colorectal cancer,disease,1.0,35236282
202,mCRC,disease,1.0,35236282
203,patients,species,0.994,35236282
204,KRAS,gene,0.8843,35236282
205,BRAF,gene,0.985,35236282
206,anti-EGFR monoclonal antibodies,gene,0.983,35236282
207,cetuximab,gene,0.777,35236282
208,CTX,gene,0.9526,35236282
209,panitumumab,gene,0.8657,35236282
210,patients,species,0.9434,35236282
211,Tumor,disease,0.9985,35236282
212,CTX,gene,0.8423,35236282
213,IL-1,gene,0.978,35236282
214,IL-1,gene,0.9893,35236282
215,mCRC,disease,0.9995,35236282
216,CTX,gene,0.946,35236282
217,IL-1R1,gene,0.996,35236282
218,colorectal cancer (CRC) cell lines,cell_line,0.941,35236282
219,colorectal cancer,disease,1.0,35236282
220,CRC cells,cell_line,0.952,35236282
221,CRC,disease,0.9946,35236282
222,IL-1,gene,0.99,35236282
223,CTX,gene,0.9087,35236282
224,CTX-resistant CRC cells,cell_line,0.9395,35236282
225,CTX,drug,0.943,35236282
226,CRC cells,cell_type,0.795,35236282
227,CRC,disease,0.904,35236282
228,CXR,cell_line,0.9053,35236282
229,mRNA,RNA,0.875,35236282
230,IL-1R1,gene,0.9966,35236282
231,SNAIL,gene,0.994,35236282
232,CXR cells,cell_line,0.9487,35236282
233,IL-1,gene,0.987,35236282
234,CTX,disease,0.979,35236282
235,CRC cells,cell_type,0.5083,35236282
236,CRC,disease,0.875,35236282
237,IL-1,gene,0.9697,35236282
238,EGFR,gene,0.989,35236282
239,EGFR,gene,0.989,35236282
240,IL-1,gene,0.977,35236282
241,IL-1R,gene,0.995,35236282
242,EGFR,gene,0.9834,35236282
243,EGFR,gene,0.8843,35236282
244,monoclonal,gene,0.675,35236282
245,advanced esophagogastric cancer,disease,1.0,35226933
246,EGC,DNA,0.777,35226933
247,NEOPECX,DNA,0.4734,35226933
248,panitumumab,gene,0.839,35226933
249,patients,species,0.9893,35226933
250,patients,species,0.9893,35226933
251,Patients,species,0.9365,35226933
252,patients,species,0.9897,35226933
253,patients,species,0.9424,35226933
254,EGC,disease,0.995,35226933
255,patients,species,0.9663,35226933
256,EGC,disease,0.9785,35226933
257,Clostridium difficile Colitis,disease,1.0,35226656
258,Woman,species,0.7397,35226656
259,chronic colitis,disease,1.0,35226656
260,diarrhea,disease,0.9995,35226656
261,UGT1A1 gene,gene,0.9814,35226656
262,irinotecan,drug,0.9985,35226656
263,Clostridium difficile (C. difficile) colitis,disease,1.0,35226656
264,woman,species,0.8745,35226656
265,UGT1A1 gene,gene,0.992,35226656
266,colorectal carcinoma,disease,1.0,35226656
267,woman,species,0.912,35226656
268,low-differentiated colonic adenocarcinoma,disease,0.9917,35226656
269,irinotecan,drug,0.999,35226656
270,5 fluorouracil,drug,0.998,35226656
271,diarrhea,disease,0.9995,35226656
272,UGT1A1 gene,gene,0.991,35226656
273,irinotecan,drug,0.9985,35226656
274,C. difficile toxins A,gene,0.921,35226656
275,C. difficile,species,0.944,35226656
276,irinotecan,drug,0.9995,35226656
277,oxaliplatin,drug,0.9995,35226656
278,C,disease,0.5386,35226656
279,C. difficile,species,0.9194,35226656
280,metronidazole,drug,1.0,35226656
281,vancomycin,drug,0.9985,35226656
282,fidaxomicin,drug,0.999,35226656
283,patients,species,0.991,35226656
284,chronic diarrhea,disease,0.9995,35226656
285,patient,species,0.988,35226656
286,Colorectal Cancer,disease,1.0,35223449
287,Patients,species,0.987,35223449
288,patients,species,0.972,35223449
289,colorectal cancer,disease,1.0,35223449
290,CRC,disease,1.0,35223449
291,CRC,disease,0.896,35223449
292,capecitabine,drug,0.9995,35223449
293,5-fluorouracil,drug,0.9995,35223449
294,leucovorin,drug,0.9995,35223449
295,irinotecan,drug,0.999,35223449
296,bevacizumab,gene,0.8003,35223449
297,cetuximab,gene,0.822,35223449
298,oxaliplatin,drug,0.9995,35223449
299,panitumumab,gene,0.852,35223449
300,participants,species,0.973,35223449
301,FOLFIRI,drug,0.871,35223449
302,FOLFOX,drug,0.9204,35223449
303,FOLFOXIRI,drug,0.9263,35223449
304,bevacizumab,gene,0.778,35223449
305,FOLFIRI,drug,0.9355,35223449
306,FOLFOX,drug,0.538,35223449
307,FOLFIRI,drug,0.731,35223449
308,FOLFOX,drug,0.922,35223449
309,cetuximab,gene,0.8086,35223449
310,panitumumab,gene,0.9585,35223449
311,bevacizumab,gene,0.883,35223449
312,panitumumab,gene,0.958,35223449
313,bevacizumab,gene,0.951,35223449
314,patients,species,0.987,35223449
315,hypomagnesemia,disease,1.0,35209968
316,Panitumumab,gene,0.9126,35209968
317,advanced/recurrent colorectal cancer,disease,0.952,35209968
318,human IgG2 monoclonal,gene,0.971,35209968
319,human,species,0.9526,35209968
320,epidermal growth factor receptor,gene,0.997,35209968
321,EGFR,gene,0.994,35209968
322,hypomagnesemia,disease,1.0,35209968
323,EGFR,gene,0.6416,35209968
324,panitumumab,gene,0.85,35209968
325,Mg,drug,,35209968
326,tubules,cell_type,0.3965,35209968
327,magnesium,drug,0.998,35209968
328,patients,species,0.986,35209968
329,panitumumab,gene,0.635,35209968
330,hypomagnesemia,disease,1.0,35209968
331,hypomagnesemia,disease,1.0,35209968
332,patients,species,0.988,35209968
333,serum,gene,0.758,35209968
334,albumin,gene,0.515,35209968
335,panitumumab,gene,0.9287,35209968
336,hypomagnesemia,disease,0.9995,35209968
337,serum albumin,gene,0.7886,35209968
338,magnesium oxide,drug,0.9995,35209968
339,magnesium,drug,0.9995,35209968
340,patients,species,0.9805,35209968
341,panitumumab,gene,0.872,35209968
342,Metastatic Colorectal Cancer,disease,1.0,35184993
343,Patients,species,0.993,35184993
344,Epidermal Growth Factor Receptor,gene,0.981,35184993
345,EGFR,gene,0.996,35184993
346,patients,species,0.952,35184993
347,metastatic colorectal cancer,disease,1.0,35184993
348,mCRC,disease,1.0,35184993
349,patients,species,0.9707,35184993
350,mCRC,disease,0.9985,35184993
351,anti-EGFR,gene,0.8076,35184993
352,panitumumab,gene,0.689,35184993
353,cetuximab,gene,0.791,35184993
354,anti-EGFR,gene,0.8843,35184993
355,fluoropyrimidine,drug,0.995,35184993
356,patients,species,0.9854,35184993
357,anti-EGFR,gene,0.7554,35184993
358,bevacizumab,gene,0.7173,35184993
359,anti-EGFR,gene,0.8535,35184993
360,patients,species,0.9277,35184993
361,anti-EGFR,gene,0.793,35184993
362,anti-EGFR,gene,0.9585,35184993
363,anti-EGFR,gene,0.9844,35184993
364,anti-EGFR,gene,0.9175,35184993
365,anti-EGFR,gene,0.955,35184993
366,RAS wild-type,disease,0.759,35184993
367,RAS,gene,0.9688,35184993
368,mCRC,disease,0.909,35184993
369,BRAF,gene,0.988,35184993
370,mCRC,disease,0.999,35184993
371,patients,species,0.9883,35184993
372,patients,species,0.9883,35184650
373,Stage IV,disease,0.9844,35184650
374,colorectal cancers,disease,0.998,35184650
375,CRC,disease,1.0,35184650
376,microsatellite,DNA,0.6504,35184650
377,deficient mismatch repair (dMMR) tumors,disease,0.9224,35184650
378,Patients,species,0.987,35184650
379,patients,species,0.986,35184650
380,CRC,disease,0.884,35184650
381,Pembrolizumab,drug,0.5107,35184650
382,MSI-H,disease,0.9385,35184650
383,5-fluorouracil,drug,0.999,35184650
384,bevacizumab,gene,0.815,35184650
385,cetuximab,gene,0.7847,35184650
386,MSI,cell_line,0.638,35184650
387,MSI-H,disease,0.7886,35184650
388,EQ,DNA,,35184650
389,pembrolizumab,drug,0.77,35184650
390,Pembrolizumab,gene,0.756,35184650
391,panitumumab,gene,0.882,35184650
392,bevacizumab,gene,0.987,35184650
393,bevacizumab,gene,0.9775,35184650
394,MSI-H/dMMR CRC,disease,0.998,35184650
395,patients,species,0.985,35184650
396,MSI,cell_line,0.4746,35184650
397,MSI-H/dMMR colorectal cancer,disease,0.9985,35184650
398,patients,species,0.9873,35184650
399,pembrolizumab,drug,0.945,35184650
400,Cabozantinib,drug,0.999,35171350
401,Panitumumab,gene,0.667,35171350
402,RAS,gene,0.9883,35171350
403,EGFR,gene,0.9917,35171350
404,metastatic colorectal cancer,disease,1.0,35171350
405,mCRC,disease,1.0,35171350
406,MET,gene,0.9946,35171350
407,EGFR,gene,0.995,35171350
408,MET,gene,0.991,35171350
409,mCRC,disease,0.9067,35171350
410,patients,species,0.99,35171350
411,cabozantinib,drug,0.998,35171350
412,patients,species,0.9893,35171350
413,cabozantinib,drug,0.998,35171350
414,panitumumab,gene,0.926,35171350
415,MET,gene,0.9966,35171350
416,patients,species,0.985,35171350
417,cabozantinib,drug,0.998,35171350
418,patients,species,0.9883,35171350
419,cabozantinib,drug,0.9985,35171350
420,panitumumab,gene,0.886,35171350
421,patients,species,0.987,35171350
422,patient,species,0.993,35171350
423,plasma,cell_type,0.424,35171350
424,MET,gene,0.9946,35171350
425,HGF,gene,0.996,35171350
426,OPN,gene,0.9883,35171350
427,IL-6,gene,0.9883,35171350
428,VCAM-1,gene,0.99,35171350
429,VEGF-R1,gene,0.9976,35171350
430,TSP-2,gene,0.9893,35171350
431,TIMP-1,gene,0.9927,35171350
432,ICAM-1,gene,0.9897,35171350
433,patients,species,0.982,35171350
434,MET,gene,0.994,35171350
435,PDGF-AA,gene,0.998,35171350
436,PDGF-BB,gene,0.9976,35171350
437,TGF-1,gene,0.9917,35171350
438,VEGF-C,gene,0.9937,35171350
439,TGF-R3,gene,0.986,35171350
440,MET,gene,0.989,35171350
441,patients,species,0.983,35171350
442,CD73,gene,0.97,35171350
443,PlGF,gene,0.9917,35171350
444,PDGF-BB,gene,0.997,35171350
445,VEGF,gene,0.9917,35171350
446,MET,gene,0.9937,35171350
447,HGF,gene,0.999,35171350
448,MET,gene,0.991,35171350
449,TGF-,gene,0.943,35171350
450,EGFR,gene,0.9863,35147837
451,UMUC3 Orthotopic,cell_line,0.699,35147837
452,UMUC3,disease,0.6504,35147837
453,Orthotopic Bladder Tumors,disease,0.8833,35147837
454,cancer,disease,0.999,35147837
455,[(89)Zr]Zr,drug,0.993,35147837
456,DFO,drug,0.974,35147837
457,Panitumumab,gene,0.9297,35147837
458,epidermal growth factor receptor,gene,0.9966,35147837
459,EGFR,gene,0.9897,35147837
460,bladder cancer,disease,1.0,35147837
461,BCa,disease,1.0,35147837
462,EGFR receptors,gene,0.99,35147837
463,BCa cell lines,cell_line,0.939,35147837
464,BCa,disease,1.0,35147837
465,[(89)Zr]Zr,drug,0.991,35147837
466,DFO,drug,0.985,35147837
467,Panitumumab,gene,0.967,35147837
468,EGFR,gene,0.994,35147837
469,-expressing UMUC3 BCa cells,cell_type,0.5757,35147837
470,UMUC3 xenografts,cell_line,0.7837,35147837
471,UMUC3,disease,0.937,35147837
472,tumor,disease,0.8467,35147837
473,mice,species,0.9834,35147837
474,(89)Zr,drug,0.9995,35147837
475,non-specific IgG,gene,0.6895,35147837
476,[(89)Zr]Zr,drug,0.9976,35147837
477,DFO,drug,0.911,35147837
478,Panitumumab,gene,0.9473,35147837
479,EGFR-expressing UMUC3 cells,cell_line,0.884,35147837
480,EGFR,gene,0.9907,35147837
481,EGFRs,gene,0.993,35147837
482,subcutaneous,cell_line,0.8345,35147837
483,UMUC3 xenografts,cell_line,0.4954,35147837
484,murine,species,0.9863,35147837
485,tumor,disease,0.9956,35147837
486,EGFR,gene,0.997,35147837
487,BCa,disease,0.958,35147837
488,EGFR protein,gene,0.856,35147837
489,anti-epidermal growth factor receptor antibody,gene,0.9224,35127316
490,anti-epidermal growth factor receptor,gene,0.988,35127316
491,EGFR,gene,0.9976,35127316
492,SRCC,disease,1.0,35127316
493,patients,species,0.9907,35127316
494,appendiceal SRCC,disease,0.995,35127316
495,RAS,gene,0.998,35127316
496,panitumumab,gene,0.896,35127316
497,cetuximab,gene,0.8423,35127316
498,cetuximab,gene,0.848,35127316
499,anti-,gene,0.7485,35127316
500,vascular endothelial growth factor antibody,gene,0.911,35127316
501,anti-,gene,0.7686,35127316
502,EGFR,gene,0.81,35127316
503,appendiceal SRCC,disease,0.9976,35127316
504,facial acneiform eruption,disease,1.0,35113224
505,EGFR,gene,0.994,35113224
506,tetracycline,drug,0.9966,35113224
507,acneiform eruption,disease,1.0,35113224
508,AfE,disease,1.0,35113224
509,epidermal growth factor receptor,gene,0.998,35113224
510,EGFR,gene,0.997,35113224
511,corticosteroids,drug,0.97,35113224
512,facial AfE,disease,0.9995,35113224
513,FAfE,disease,1.0,35113224
514,PATIENTS,species,0.965,35113224
515,patients,species,0.9585,35113224
516,RAS,gene,0.9966,35113224
517,minocycline,drug,0.998,35113224
518,cetuximab,gene,0.884,35113224
519,panitumumab,gene,0.802,35113224
520,Patients,species,0.9736,35113224
521,FAfE,disease,1.0,35113224
522,FAfE,disease,1.0,35113224
523,FAfE,disease,0.85,35113224
524,patient,species,0.992,35113224
525,FAfE,disease,0.921,35113224
526,FAfE,disease,0.5903,35113224
527,FAfE,disease,1.0,35113224
528,FAfE,disease,1.0,35113224
529,EGFR,gene,0.982,35113224
530,Metastatic colorectal cancer,disease,0.994,35112975
531,colorectal cancer,disease,0.8364,35112975
532,mCRC,disease,0.9995,35112975
533,patients,species,0.9854,35112975
534,patients,species,0.9683,35112975
535,mCRC,disease,0.9956,35112975
536,mCRC,disease,0.9873,35112975
537,patients,species,0.989,35112975
538,RAS,gene,0.989,35112975
539,BRAF,gene,0.998,35112975
540,patients,species,0.9854,35112975
541,bevacizumab,gene,0.824,35112975
542,EGFR,gene,0.6465,35112975
543,patients,species,0.9556,35112975
544,metastases,disease,0.5796,35112975
545,RAS,gene,0.575,35112975
546,BRAF,DNA,0.5083,35112975
547,BRAF mutations,gene,0.832,35112975
548,patient,species,0.9907,35112975
549,tumor,disease,0.6387,35112975
550,metastatic,disease,0.8403,35112975
551,mCRC,disease,0.963,35112975
552,CHO,cell_line,0.5073,35109731
553,EGFR,gene,0.994,35109731
554,colorectal cancer,disease,1.0,35109731
555,cancer,disease,0.9995,35109731
556,patients,species,0.9927,35109731
557,CHO-S cell line,cell_line,0.8213,35109731
558,panitumumab,gene,0.929,35109731
559,P-mAb,gene,0.97,35109731
560,human,species,0.9956,35109731
561,IgG2,gene,0.73,35109731
562,anti-EGFR,gene,0.5317,35109731
563,Vectibix,drug,0.953,35109731
564,single-cell clone,cell_line,0.829,35109731
565,CHO-S cell pools,cell_line,0.847,35109731
566,P-mAb,gene,0.966,35109731
567,P-mAb,gene,0.9746,35109731
568,MTT,drug,0.9995,35109731
569,anti-EGFR,gene,0.9604,35109731
570,P-mAb,gene,0.9927,35109731
571,CHO-S cell line,cell_line,0.8867,35109731
572,P-mAb,gene,0.938,35109731
573,vectibix,drug,0.9985,35109731
574,patients,species,0.9717,35093899
575,locally advanced rectal cancer,disease,1.0,35093899
576,LARC,disease,1.0,35093899
577,PATIENTS,species,0.909,35093899
578,patients,species,0.9556,35093899
579,LARC,disease,1.0,35093899
580,TNT,drug,0.999,35093899
581,bevacizumab,gene,0.5317,35093899
582,Ras,gene,0.933,35093899
583,BRAF,gene,0.9976,35093899
584,panitumumab,gene,0.8154,35093899
585,cetuximab,gene,0.914,35093899
586,wild-type Ras,gene,0.986,35093899
587,-,DNA,0.7275,35093899
588,BRAF,gene,0.944,35093899
589,oxaliplatin,drug,1.0,35093899
590,5-fluorouracil,drug,0.9995,35093899
591,patients,species,0.996,35093899
592,patients,species,0.994,35093899
593,TNT,drug,0.7993,35093899
594,patients,species,0.9897,35093899
595,patients,species,0.9897,35093899
596,Erosive pustular dermatosis of the scalp,disease,0.9995,35072271
597,panitumumab,gene,0.6597,35072271
598,Liver Metastasis,disease,0.9136,35046336
599,Rectal Cancer,disease,1.0,35046336
600,rectal cancer,disease,1.0,35046336
601,liver metastases,disease,0.9473,35046336
602,woman,species,0.9087,35046336
603,rectal RS carcinoma,disease,1.0,35046336
604,liver,disease,0.619,35046336
605,panitumumab,gene,0.849,35046336
606,liver metastatic lesion,disease,0.9785,35046336
607,cholecystectomy,disease,0.973,35046336
608,patient,species,0.982,35046336
609,man,species,0.9053,35046323
610,sigmoid colon carcinoma,disease,1.0,35046323
611,patient,species,0.965,35046323
612,Leucovorin,drug,0.999,35046323
613,fluorouracil,drug,0.9995,35046323
614,oxaliplatin,drug,0.9995,35046323
615,panitumumab,gene,0.7007,35046323
616,patient,species,0.9805,35046323
617,mFOLFOX6,drug,0.6934,35046323
618,cancer,disease,1.0,35046323
619,locally advanced colon cancer,disease,0.9766,35046323
620,Colorectal Cancer,disease,0.8584,35046292
621,Regorafenib,drug,0.992,35046292
622,patient,species,0.984,35046292
623,colorectal cancer,disease,1.0,35046292
624,regorafenib,drug,0.982,35046292
625,man,species,0.9307,35046292
626,descending colon cancer,disease,1.0,35046292
627,paraaortic lymph node,disease,0.7026,35046292
628,SOX,drug,0.9805,35046292
629,bevacizumab,gene,0.8423,35046292
630,Panitumumab,gene,0.861,35046292
631,regorafenib,drug,0.9546,35046292
632,regorafenib,drug,0.994,35046292
633,CEA,gene,0.9893,35046292
634,regorafenib,drug,0.995,35046292
635,colorectal cancer,disease,1.0,35046292
636,SM Carcinoma of the Sigmoid Colon,disease,1.0,35046279
637,submucosal(SM)adenocarcinoma of the,disease,1.0,35046279
638,Isp sigmoid polyp,cell_line,0.507,35046279
639,sigmoid polyp,disease,0.823,35046279
640,adenocarcinoma,disease,1.0,35046279
641,panitumumab,gene,0.871,35046279
642,bevacizumab,gene,0.6006,35046279
643,patient,species,0.99,35046279
644,liver failure,disease,1.0,35046279
645,liver metastasis,disease,0.984,35046279
646,T1 sigmoid adenocarcinoma,disease,0.958,35046279
647,Hyperammonemic Encephalopathy,disease,1.0,35045497
648,Panitumumab,gene,0.8413,35045497
649,man,species,0.841,35045497
650,rectal cancer,disease,0.8687,35045497
651,RS rectal cancer,disease,0.9995,35045497
652,RAS,gene,0.9966,35045497
653,BRAF,gene,0.9946,35045497
654,panitumumab,gene,0.929,35045497
655,Pmab,gene,0.956,35045497
656,renal dysfunction,disease,1.0,35045497
657,patient,species,0.991,35045497
658,ammonia,drug,0.995,35045497
659,5-FU,drug,0.999,35045497
660,hyperammonemic encephalopathy,disease,0.994,35045497
661,5-FU,drug,0.9976,35045497
662,branched-chain amino acid,drug,0.991,35045497
663,ammonia,drug,0.995,35045497
664,CPT-11,drug,0.999,35045497
665,panitumumab,gene,0.8413,35042642
666,eyelash,disease,0.9946,35042642
667,Panitumumab,gene,0.86,35042642
668,epidermal growth factor receptor,gene,0.9976,35042642
669,metastatic colorectal cancer,disease,1.0,35042642
670,tumor cells,cell_line,0.8926,35042642
671,tumor,disease,1.0,35042642
672,epidermal keratinocytes,cell_type,0.8154,35042642
673,skin,disease,0.7163,35042642
674,patient,species,0.9214,35042642
675,eyelash trichomegaly,disease,0.997,35042642
676,curly hair,disease,1.0,35042642
677,paronychia,disease,1.0,35042642
678,panitumumab,gene,0.913,35042642
679,epidermal growth factor,gene,0.998,35042642
680,erlotinib,drug,0.9985,35042642
681,gefitinib,drug,0.9976,35042642
682,panitumumab,gene,0.6084,35042642
683,pili canaliculi,disease,0.9595,35042642
684,Panitumumab,gene,0.697,35037780
685,Acute Pancreatitis,disease,0.999,35037780
686,panitumumab,gene,0.8955,35037780
687,wild,cell_line,0.5425,35037780
688,metastatic colon cancer,disease,0.96,35037780
689,panitumumab,gene,0.8076,35037780
690,acute pancreatitis,disease,1.0,35037780
691,patient,species,0.9097,35037780
692,sigmoid colon cancer,disease,1.0,35037780
693,liver metastases,disease,0.992,35037780
694,panitumumab,gene,0.7466,35037780
695,patient,species,0.9937,35037780
696,abdominal pain,disease,0.971,35037780
697,acute pancreaatitis,disease,1.0,35037780
698,patient,species,0.987,35037780
699,acute pancreatitis,disease,1.0,35037780
700,patient,species,0.991,35037780
701,panitumumab,gene,0.8164,35037780
702,panitumumab,gene,0.871,35037780
703,acute pancreatitis,disease,1.0,35037780
704,Panitumumab,gene,0.9165,35037780
705,panitumumab,gene,0.942,35037780
706,pancreatitis,disease,1.0,35037780
707,Epidermal Growth Factor Receptor,gene,0.9985,35035479
708,tumor,disease,0.9985,35035479
709,colorectal cancer,disease,1.0,35035479
710,patients,species,0.9917,35035479
711,circulating tumor cells,cell_type,0.847,35035479
712,CTC,cell_type,0.831,35035479
713,liver metastasis,disease,0.9917,35035479
714,liver,disease,0.7266,35035479
715,rats,species,0.9873,35035479
716,epidermal growth factor receptor,gene,0.998,35035479
717,EGFR,gene,0.9927,35035479
718,colorectal cancer,disease,1.0,35035479
719,patients,species,0.987,35035479
720,patients,species,0.989,35035479
721,colorectal liver metastases,disease,1.0,35035479
722,EGFR,gene,0.995,35035479
723,CTCs,cell_type,0.4688,35035479
724,anti-EGFR mAbs,gene,0.9824,35035479
725,cetuximab,gene,0.9766,35035479
726,zalutumumab,gene,0.679,35035479
727,panitumumab,gene,0.9307,35035479
728,tumor cell lines,cell_line,0.958,35035479
729,tumor,disease,1.0,35035479
730,tumor cells,cell_type,0.5176,35035479
731,tumor,disease,0.998,35035479
732,macrophages,cell_type,0.8486,35035479
733,EGFR,gene,0.9897,35035479
734,cetuximab,gene,0.956,35035479
735,patients,species,0.961,35035479
736,tumor cells,cell_type,0.8613,35035479
737,tumor,disease,0.9863,35035479
738,epithelial cells,cell_type,0.792,35035479
739,anti-EGFR mAb,gene,0.9663,35035479
740,anti-EGFR mAbs,gene,0.912,35035479
741,tumor,disease,0.9893,35035479
742,CTCs,cell_type,0.9346,35035479
743,patient,species,0.9707,35035479
744,epidermal growth factor receptor,gene,0.986,35033994
745,patients,species,0.9873,35033994
746,RAS,gene,0.732,35033994
747,Colorectal cancer,disease,1.0,35033994
748,CRC,disease,1.0,35033994
749,epidermal growth factor receptor,gene,0.9873,35033994
750,EGFR,gene,0.9956,35033994
751,patients,species,0.9453,35033994
752,Patients,species,0.9585,35033994
753,RAS,gene,0.9517,35033994
754,metastatic CRC,disease,0.999,35033994
755,mCRC,disease,0.9995,35033994
756,DC,cell_type,,35033994
757,anti-EGFR,gene,0.85,35033994
758,DC,cell_type,,35033994
759,DC,cell_type,,35033994
760,anti-EGFR,gene,0.983,35033994
761,DC,cell_type,,35033994
762,anti-EGFR,gene,0.9883,35033994
763,DC,cell_type,,35033994
764,left-sided tumours,disease,1.0,35033994
765,patients,species,0.976,35033994
766,DC,cell_type,,35033994
767,anti-EGFR,gene,0.973,35033994
768,DC,cell_type,,35033994
769,anti-EGFR,gene,0.9224,35033994
770,DC,cell_type,,35033994
771,patients,species,0.984,35033994
772,left,cell_type,0.469,35033994
773,left-sided &#x27;only&#x27; tumours,disease,0.9956,35033994
774,patients,species,0.9834,35033994
775,DC,cell_type,,35033994
776,anti-EGFR,gene,0.99,35033994
777,DC,cell_type,,35033994
778,anti-EGFR,gene,0.968,35033994
779,DC,cell_type,,35033994
780,patients,species,0.9497,35033994
781,patients,species,0.9824,35033994
782,patients,species,0.9556,35033994
783,mCRC,disease,0.9995,35033994
784,RAS,DNA,0.7837,35033994
785,RAS WT,gene,0.9795,35033994
786,patients,species,0.9385,35033994
787,EGFR,gene,0.904,35033994
788,head and neck cancer,disease,1.0,35027369
789,tumour,disease,0.9995,35027369
790,patients,species,0.9727,35027369
791,oral squamous cell carcinoma,disease,1.0,35027369
792,panitumumab,gene,0.936,35027369
793,sentinel margin location,DNA,0.5454,35027369
794,head and neck cancer,disease,1.0,35027369
795,cancer,disease,1.0,35013765
796,APC,gene,0.995,35013765
797,target cells,cell_type,0.796,35013765
798,targeted cells,cell_type,0.8945,35013765
799,Panitumumab,gene,0.8604,35013765
800,cetuximab,gene,0.781,35013765
801,human epidermal growth factor receptor,gene,0.9976,35013765
802,human,species,0.948,35013765
803,hEGFR,gene,0.9907,35013765
804,athymic nude,cell_line,0.5337,35013765
805,nude,species,0.6704,35013765
806,mouse,species,0.541,35013765
807,panitumumab,gene,0.984,35013765
808,cetuximab,gene,0.982,35013765
809,panitumumab,gene,0.961,35013765
810,pan,gene,0.934,35013765
811,cetuximab,gene,0.9614,35013765
812,cet,gene,0.9824,35013765
813,nude,species,0.7964,35013765
814,mouse,species,0.8003,35013765
815,mice,species,0.9736,35013765
816,panitumumab,gene,0.9155,35013765
817,cetuximab,gene,0.864,35013765
818,APCs,cell_type,0.839,35013765
819,hEGFR-expressing cancer,disease,0.9985,35013765
820,hEGFR,gene,0.9966,35013765
821,cell line,cell_line,0.5947,35013765
822,mice,species,0.9297,35013765
823,mEERL-hEGFR cell line,cell_line,0.5674,35013765
824,hEGFR,gene,0.7163,35013765
825,cet,DNA,0.4688,35013765
826,mice,species,0.968,35013765
827,tumor,disease,1.0,35013765
828,CD8(+) T lymphocytes,cell_type,0.836,35013765
829,CD8(+),gene,0.891,35013765
830,CD8,cell_line,0.575,35013765
831,CD8(+) T lymphocytes,cell_type,0.845,35013765
832,tumor,disease,0.9736,35013765
833,cancer cell,cell_type,0.731,35013765
834,cancer,disease,0.997,35013765
835,mouse,species,0.9326,35013765
836,RAS,DNA,0.53,34997474
837,RAS mutant,gene,0.8193,34997474
838,patients,species,0.979,34997474
839,RAS,gene,0.9956,34997474
840,patients,species,0.983,34997474
841,mCRC,disease,0.995,34997474
842,RAS,gene,0.7095,34997474
843,RAS mutant,gene,0.9736,34997474
844,plasma,cell_type,0.4954,34997474
845,anti-VEGF,gene,0.8457,34997474
846,RAS mutant genes,gene,0.99,34997474
847,FOLFOX,drug,0.8853,34997474
848,CAPOX,drug,0.956,34997474
849,bevacizumab,gene,0.8823,34997474
850,panitumumab,gene,0.9424,34997474
851,FOLFIRI,drug,0.987,34997474
852,patients,species,0.985,34997474
853,RAS mutant,gene,0.9893,34997474
854,patients,species,0.99,34997474
855,RAS,DNA,0.4587,34997474
856,RAS mutant clones,cell_line,0.67,34997474
857,RAS mutant,gene,0.8887,34997474
858,patients,species,0.983,34997474
859,RAS,DNA,0.9146,34997474
860,RAS mutant clones,cell_line,0.6826,34997474
861,RAS mutant,gene,0.932,34997474
862,RAS,gene,0.839,34997474
863,Pancreatic Cancer,disease,1.0,34956889
864,Pancreatic ductal adenocarcinoma,disease,1.0,34956889
865,PDAC,disease,1.0,34956889
866,cancer,disease,1.0,34956889
867,patients,species,0.975,34956889
868,PDAC,disease,1.0,34956889
869,Epidermal growth factor receptor,gene,0.999,34956889
870,EGFR,gene,0.9966,34956889
871,patients,species,0.947,34956889
872,advanced pancreatic cancer,disease,1.0,34956889
873,KRAS,gene,0.991,34956889
874,wild,cell_line,0.559,34956889
875,patients,species,0.9814,34956889
876,KRAS,gene,0.9956,34956889
877,PDAC,disease,0.999,34956889
878,patients,species,0.985,34956889
879,anti-,gene,0.66,34956889
880,EGFR,gene,0.7427,34956889
881,PATIENTS,species,0.9717,34956889
882,PDAC,disease,1.0,34956889
883,patient,species,0.995,34956889
884,tumours,disease,0.998,34956889
885,KRAS,DNA,0.6978,34956889
886,KRAS mutations,gene,0.9414,34956889
887,patients,species,0.9863,34956889
888,KRAS,gene,0.9937,34956889
889,panitumumab,gene,0.8296,34956889
890,patient,species,0.992,34956889
891,KRAS,DNA,0.7715,34956889
892,KRAS mutations,gene,0.8076,34956889
893,patient,species,0.9893,34956889
894,KRAS,gene,0.9736,34956889
895,patients,species,0.97,34956889
896,panitumumab,gene,0.83,34956889
897,tumour,disease,0.946,34956889
898,hypomagnesaemia,disease,1.0,34956889
899,patients,species,0.9766,34956889
900,pancreatic cancer,disease,1.0,34956889
901,tumour,disease,1.0,34956889
902,panitumumab,gene,0.973,34956889
903,tumour,disease,1.0,34956889
904,BRAF,gene,0.996,34946284
905,MEK,gene,0.996,34946284
906,EGFR,gene,0.996,34946284
907,BRAF,gene,0.9985,34946284
908,Patients,species,0.897,34946284
909,BRAF,gene,0.997,34946284
910,metastatic colorectal cancer,disease,0.999,34946284
911,BRAF,gene,0.995,34946284
912,mitogen-activated protein kinase kinase,gene,0.9985,34946284
913,epidermal growth factor receptor,gene,0.999,34946284
914,patients,species,0.9053,34946284
915,BRAF,gene,0.996,34946284
916,metastatic colorectal cancer,disease,0.995,34946284
917,patients,species,0.9766,34946284
918,BRAF,gene,0.995,34946284
919,metastatic colorectal cancer,disease,0.9917,34946284
920,patients,species,0.9863,34946284
921,dabrafenib,drug,0.9985,34946284
922,trametinib,drug,0.9985,34946284
923,panitumumab,gene,0.7095,34946284
924,left-sided metastatic colorectal cancer,disease,0.8037,34946284
925,nausea,disease,1.0,34946284
926,hypertension,disease,1.0,34946284
927,gastrointestinal symptoms,disease,1.0,34946284
928,skin disorders,disease,1.0,34946284
929,BRAF,gene,0.997,34946284
930,mitogen-activated protein kinase kinase,gene,0.999,34946284
931,epidermal growth factor receptor,gene,0.998,34946284
932,BRAF,gene,0.9966,34946284
933,metastatic colorectal cancer,disease,0.9966,34946284
934,Eyelash trichomegaly,disease,1.0,34919300
935,Long eyelashes,disease,0.918,34919300
936,Eyelash trichomegaly,disease,1.0,34919300
937,eyelash trichomegaly,disease,1.0,34919300
938,eyelash trichomegaly,disease,1.0,34919300
939,human,species,0.9854,34919300
940,congenital and acquired diseases,disease,0.9766,34919300
941,eyelash trichomegaly,disease,0.9644,34919300
942,trichomegaly,disease,1.0,34919300
943,eyelash trichomegaly,disease,1.0,34919300
944,eyelash trichomegaly,disease,1.0,34919300
945,prostaglandin,drug,0.99,34919300
946,15-keto fluprostenol isopropyl ester,drug,0.9995,34919300
947,bimatoprost,drug,0.992,34919300
948,latanoprost,drug,0.977,34919300
949,travoprost,drug,0.991,34919300
950,epidermal growth factor receptor,gene,0.997,34919300
951,cetuximab,gene,0.9424,34919300
952,erlotinib,drug,0.8794,34919300
953,panitumumab,gene,0.845,34919300
954,interferon-alpha,gene,0.9966,34919300
955,calcineurin,gene,0.993,34919300
956,tacrolimus,drug,0.9995,34919300
957,cyclosporine,drug,0.998,34919300
958,allergic rhinitis,disease,1.0,34919300
959,atopic dermatitis,disease,1.0,34919300
960,HIV,disease,0.9995,34919300
961,ichthyosis vulgaris (IV,disease,0.8467,34919300
962,uveitis,disease,1.0,34919300
963,vernal keratoconjunctivitis,disease,1.0,34919300
964,eyelash,species,0.753,34919300
965,Congenital disorders,disease,1.0,34919300
966,lengthened eyelashes,disease,0.999,34919300
967,Cant syndrome,disease,1.0,34919300
968,CHOPS syndrome,disease,1.0,34919300
969,Coffin-Siris syndrome,disease,1.0,34919300
970,congenital heart disease,disease,1.0,34919300
971,Cornelia de Lange syndrome,disease,1.0,34919300
972,Costello syndrome,disease,1.0,34919300
973,familial trichomegaly,disease,1.0,34919300
974,Floating Harbor syndrome,disease,1.0,34919300
975,Hermansky-Pudlak syndrome,disease,1.0,34919300
976,Kabuki-Makeup syndrome,disease,1.0,34919300
977,KBG syndrome,disease,1.0,34919300
978,Oliver-McFarlane syndrome,disease,1.0,34919300
979,Rubinstein-Taybi syndrome,disease,1.0,34919300
980,Smith-Magenis syndrome,disease,1.0,34919300
981,eyelash trichomegaly,disease,1.0,34919300
982,bimatoprost,drug,0.8633,34919300
983,eyelash trichomegaly,disease,1.0,34919300
984,metastatic colorectal cancer,disease,0.9995,34916122
985,patients,species,0.9746,34916122
986,colorectal cancer,disease,0.957,34916122
987,mCRC,disease,0.9985,34916122
988,mCRC,disease,0.995,34916122
989,patients,species,0.992,34916122
990,panitumumab,gene,0.9165,34916122
991,aflibercept,gene,0.945,34916122
992,tumour,disease,0.999,34916122
993,tumour,disease,0.977,34916122
994,tumour,disease,0.993,34916122
995,patients,species,0.988,34916122
996,patients,species,0.984,34916122
997,patients,species,0.985,34916122
998,Patients,species,0.952,34910154
999,patients,species,0.9653,34910154
1000,metastatic colorectal cancer,disease,1.0,34910154
1001,mCRC,disease,1.0,34910154
1002,patients,species,0.9854,34910154
1003,patients,species,0.981,34910154
1004,patients,species,0.978,34910154
1005,PARTICIPANTS,species,0.5264,34910154
1006,patients,species,0.977,34910154
1007,mCRC,disease,0.9956,34910154
1008,Patient,species,0.975,34910154
1009,patients,species,0.984,34910154
1010,oxaliplatin,drug,1.0,34910154
1011,irinotecan,drug,0.9995,34910154
1012,5-fluorouracil,drug,0.9995,34910154
1013,capecitabine,drug,0.999,34910154
1014,bevacizumab,gene,0.8857,34910154
1015,cetuximab,gene,0.8555,34910154
1016,panitumumab,gene,0.8784,34910154
1017,ramucirumab,gene,0.5347,34910154
1018,aflibercept,gene,0.944,34910154
1019,patients,species,0.9707,34910154
1020,mCRC,disease,0.993,34910154
1021,patients,species,0.9717,34910154
1022,patients,species,0.991,34910154
1023,patients,species,0.9883,34910154
1024,patients,species,0.9873,34910154
1025,patients,species,0.99,34910154
1026,patients,species,0.993,34910154
1027,patients,species,0.979,34910154
1028,patients,species,0.972,34910154
1029,patients,species,0.9893,34910154
1030,patients,species,0.9893,34910154
1031,mCRC,disease,0.9976,34910154
1032,patients,species,0.9565,34910154
1033,patients,species,0.986,34910154
1034,Metastatic Rectal Carcinoma,disease,1.0,34899239
1035,RAS,gene,0.999,34899239
1036,BRAF,gene,0.9985,34899239
1037,patients,species,0.9507,34899239
1038,metastatic colorectal cancer,disease,1.0,34899239
1039,mCRC,disease,1.0,34899239
1040,rectal adenocarcinoma,disease,1.0,34899239
1041,liver metastases,disease,0.7886,34899239
1042,metastatic,disease,0.658,34899239
1043,oxaliplatin,drug,1.0,34899239
1044,panitumumab,gene,0.6055,34899239
1045,liver,disease,0.8677,34899239
1046,liver metastases,disease,0.772,34899239
1047,adenocarcinoma,disease,1.0,34899239
1048,primary tumor,disease,0.7925,34899239
1049,liver,disease,0.8325,34899239
1050,EGFR,gene,0.9927,34885014
1051,EGFR,gene,0.9307,34885014
1052,glomerular diseases,disease,1.0,34885014
1053,EGFR,gene,0.7236,34885014
1054,EGFR,gene,0.8276,34885014
1055,erlotinib,drug,0.9985,34885014
1056,gefitinib,drug,0.998,34885014
1057,afatinib,drug,0.996,34885014
1058,osimertinib,drug,0.995,34885014
1059,cetuximab,gene,0.7983,34885014
1060,panitumumab,gene,0.651,34885014
1061,ICRSs,cell_line,0.5347,34885014
1062,afatinib,drug,0.9927,34885014
1063,erlotinib,drug,0.999,34885014
1064,acute kidney injury,disease,1.0,34885014
1065,afatinib,drug,0.9976,34885014
1066,erlotinib,drug,0.9976,34885014
1067,renal failure,disease,1.0,34885014
1068,diarrhoea,disease,1.0,34885014
1069,erlotinib,drug,0.9976,34885014
1070,haemolytic and uremic syndrome,disease,1.0,34885014
1071,thrombotic microangiopathy,disease,1.0,34885014
1072,glomerular or tubule-interstitial diseases,disease,1.0,34885014
1073,EGFR,gene,0.982,34885014
1074,renal failure,disease,1.0,34885014
1075,Human cell lines,cell_line,0.939,34871357
1076,Human,species,0.9634,34871357
1077,Cas9,gene,0.825,34871357
1078,formalin,drug,0.9917,34871357
1079,paraffin,drug,0.814,34871357
1080,NGS sequence files,DNA,0.679,34871357
1081,Single and multinucleotide variants,RNA,0.5054,34871357
1082,multinucleotide variants,DNA,0.58,34871357
1083,KRAS,gene,0.9795,34871357
1084,NRAS,gene,0.9917,34871357
1085,variant allele,DNA,0.872,34871357
1086,EGFR,gene,0.996,34871357
1087,panitumumab,gene,0.6265,34871357
1088,metastatic colorectal cancer,disease,0.9995,34871357
1089,Genetically engineered cell lines,cell_line,0.9385,34871357
1090,mutagenized sequence files,DNA,0.8364,34871357
1091,patient,species,0.9883,34871357
1092,Patient,species,0.9785,34853537
1093,Patient,species,0.9604,34853537
1094,cancer,disease,1.0,34853537
1095,PATIENTS,species,0.961,34853537
1096,Patient,species,0.7915,34853537
1097,patients,species,0.966,34853537
1098,solid malignant tumors,disease,1.0,34853537
1099,patients,species,0.9893,34853537
1100,"brain, ovarian and endometrial cancers",disease,1.0,34853537
1101,Fluorouracil,drug,0.9995,34853537
1102,gemcitabine,drug,0.9995,34853537
1103,pemetrexed,drug,0.9995,34853537
1104,pembrolizumab,drug,0.8193,34853537
1105,nivolumab,drug,0.775,34853537
1106,lapatinib,drug,0.9995,34853537
1107,palbociclib,drug,0.9995,34853537
1108,erlotinib,drug,0.9985,34853537
1109,pertuzumab,gene,0.924,34853537
1110,panitumumab,gene,0.76,34853537
1111,Patient,species,0.9595,34853537
1112,cancer,disease,1.0,34853537
1113,EGFR,gene,0.64,34839118
1114,epidermal growth factor receptor,gene,0.9136,34839118
1115,EGFR,gene,0.9297,34839118
1116,monoclonal antibodies,gene,0.5205,34839118
1117,cetuximab,gene,0.7646,34839118
1118,panitumumab,gene,0.856,34839118
1119,anti-vascular endothelial growth factor mAb bevacizumab,gene,0.89,34839118
1120,metastatic colorectal cancer,disease,0.9985,34839118
1121,mCRC,disease,1.0,34839118
1122,5-fluorouracil,drug,0.9995,34839118
1123,oxaliplatin,drug,0.9995,34839118
1124,irinotecan,drug,0.999,34839118
1125,FOLFOXIRI,drug,0.9736,34839118
1126,bevacizumab,gene,0.717,34839118
1127,FOLFOXIRI,drug,0.9907,34839118
1128,EGFR,gene,0.964,34839118
1129,patients,species,0.946,34839118
1130,mCRC,disease,0.977,34839118
1131,FOLFOXIRI,drug,0.5327,34839118
1132,bevacizumab,gene,0.665,34839118
1133,EGFR,gene,0.9526,34839118
1134,FOLFOXIRI,drug,0.909,34839118
1135,EGFR,gene,0.8677,34839118
1136,patients,species,0.971,34839118
1137,RAS,gene,0.996,34839118
1138,mCRC,disease,0.858,34839118
1139,Rothia dentocariosa and Streptococcus viridans Corneal Ulcer,disease,0.9243,34824873
1140,Streptococcus viridans,species,0.6914,34824873
1141,Keratitis,disease,1.0,34824873
1142,patient,species,0.9907,34824873
1143,keratitis,disease,1.0,34824873
1144,Rothia dentocariosa,species,0.922,34824873
1145,keratitis,disease,1.0,34824873
1146,patients,species,0.9927,34824873
1147,patient,species,0.931,34824873
1148,folinic acid,drug,0.9995,34824873
1149,fluorouracil,drug,0.9995,34824873
1150,irinotecan,drug,0.999,34824873
1151,Rothia dentocariosa,species,0.9214,34824873
1152,Streptococcus viridans,species,0.936,34824873
1153,patient,species,0.9844,34824873
1154,keratitis,disease,1.0,34824873
1155,keratitis,disease,1.0,34824873
1156,Rothia dentocariosa,species,0.961,34824873
1157,patients,species,0.9854,34824873
1158,Metastatic Colorectal Cancer,disease,1.0,34816395
1159,Colorectal cancer,disease,1.0,34816395
1160,CRC,disease,1.0,34816395
1161,patients,species,0.977,34816395
1162,metastatic CRC,disease,1.0,34816395
1163,mCRC,disease,0.9995,34816395
1164,mCRC,disease,0.9995,34816395
1165,mCRC,disease,0.988,34816395
1166,cetuximab,gene,0.831,34816395
1167,panitumumab,gene,0.979,34816395
1168,bevacizumab,gene,0.7104,34816395
1169,cetuximab,gene,0.8516,34816395
1170,bevacizumab,gene,0.786,34816395
1171,aflibercept,gene,0.993,34816395
1172,cetuximab,gene,0.8433,34816395
1173,panitumumab,gene,0.87,34816395
1174,cetuximab,gene,0.662,34816395
1175,panitumumab,gene,0.828,34816395
1176,RAS,gene,0.9854,34816395
1177,epidermal growth factor receptor,gene,0.884,34816395
1178,EGFR,gene,0.9966,34816395
1179,Bevacizumab,gene,0.926,34816395
1180,bevacizumab,gene,0.8564,34816395
1181,KRAS,gene,0.966,34816395
1182,RAS mutations,gene,0.8945,34816395
1183,EGFR,gene,0.705,34816395
1184,RAS,gene,0.995,34816395
1185,mCRCs,disease,0.9985,34816395
1186,anti-EGFR,gene,0.9263,34816395
1187,panitumumab,gene,0.8755,34816395
1188,cetuximab,gene,0.584,34816395
1189,anti-VEGF,gene,0.991,34816395
1190,Cetuximab,gene,0.8438,34816395
1191,EGFR,gene,0.741,34816395
1192,RAS,gene,0.994,34816395
1193,mCRCs,disease,0.991,34816395
1194,Aflibercept,gene,0.9663,34816395
1195,ramucirumab,gene,0.4631,34816395
1196,circulating tumour DNA,DNA,0.753,34811502
1197,tumour,disease,0.559,34811502
1198,patients,species,0.9224,34811502
1199,metastatic colorectal cancer,disease,1.0,34811502
1200,mCRC,disease,1.0,34811502
1201,circulating tumour DNA,DNA,0.806,34811502
1202,ctDNA,DNA,0.8633,34811502
1203,variant,DNA,0.502,34811502
1204,CEA,gene,0.99,34811502
1205,patients,species,0.945,34811502
1206,RAS,gene,0.995,34811502
1207,mCRC,disease,0.7905,34811502
1208,panitumumab,gene,0.9497,34811502
1209,CtDNA,DNA,0.7485,34811502
1210,14-gene NGS panel,DNA,0.804,34811502
1211,patient,species,0.9844,34811502
1212,ctDNA,DNA,0.621,34811502
1213,patients,species,0.986,34811502
1214,patients,species,0.985,34811502
1215,liver metastases,disease,0.994,34811502
1216,Patients,species,0.9414,34811502
1217,CEA,gene,0.971,34811502
1218,CtDNA,DNA,0.7134,34811502
1219,patients,species,0.8945,34811502
1220,RAS,gene,0.9917,34811502
1221,mCRC,disease,0.878,34811502
1222,tumour,disease,0.994,34811502
1223,panitumumab,gene,0.9043,34785017
1224,patients,species,0.89,34779921
1225,patients,species,0.9653,34779921
1226,metastatic colorectal cancer,disease,1.0,34779921
1227,mCRC,disease,1.0,34779921
1228,epidermal growth factor receptor,gene,0.998,34779921
1229,EGFR,gene,0.998,34779921
1230,anti-EGFR,gene,0.935,34779921
1231,patients,species,0.9756,34779921
1232,RAS,gene,0.995,34779921
1233,BRAF,gene,0.998,34779921
1234,mCRC,disease,0.7695,34779921
1235,anti-EGFR monoclonal,gene,0.832,34779921
1236,panitumumab,gene,0.836,34779921
1237,cetuximab,gene,0.6914,34779921
1238,patients,species,0.972,34779921
1239,acneiform rash,disease,1.0,34779921
1240,patients,species,0.9834,34779921
1241,panitumumab,gene,0.689,34779921
1242,cetuximab,gene,0.5107,34779921
1243,paronychia,disease,1.0,34779921
1244,nail disorders,disease,1.0,34779921
1245,patients,species,0.9883,34779921
1246,anti-EGFR,gene,0.914,34779921
1247,EGFR,gene,0.7744,34779921
1248,mCRC,disease,0.9995,34779921
1249,patients,species,0.993,34779921
1250,patients,species,0.988,34779921
1251,Patients,species,0.9756,34778029
1252,RAS,gene,0.987,34778029
1253,BRAF,gene,0.996,34778029
1254,epidermal growth factor receptor,gene,0.996,34778029
1255,EGFR,gene,0.999,34778029
1256,patients,species,0.957,34778029
1257,RAS,gene,0.9907,34778029
1258,BRAF,gene,0.9985,34778029
1259,metastatic colorectal cancer,disease,0.9966,34778029
1260,mCRC,disease,1.0,34778029
1261,patients,species,0.9795,34778029
1262,RAS,gene,0.9854,34778029
1263,BRAF,gene,0.9985,34778029
1264,mCRC,disease,0.969,34778029
1265,EGFR,gene,0.9263,34778029
1266,patients,species,0.931,34778029
1267,RAS,gene,0.985,34778029
1268,BRAF,gene,0.998,34778029
1269,mCRC,disease,0.7485,34778029
1270,anti-EGFR,gene,0.9536,34778029
1271,patients,species,0.9897,34778029
1272,5-fluorouracil,drug,0.9995,34778029
1273,leucovorin,drug,0.9995,34778029
1274,5FU,drug,0.997,34778029
1275,anti-EGFR,gene,0.9937,34778029
1276,anti-EGFR,gene,0.993,34778029
1277,5FU,drug,0.9976,34778029
1278,patients,species,0.9697,34778029
1279,patient,species,0.9385,34778029
1280,5FU,drug,0.995,34778029
1281,anti-EGFR,gene,0.994,34778029
1282,anti-EGFR,gene,0.994,34778029
1283,5FU,drug,0.9976,34778029
1284,5FU,drug,0.9976,34778029
1285,anti-EGFR,gene,0.983,34778029
1286,anti-EGFR,gene,0.951,34778029
1287,5FU,drug,0.994,34778029
1288,anti-EGFR,gene,0.97,34778029
1289,anti-EGFR,gene,0.9463,34778029
1290,patients,species,0.965,34778029
1291,RAS,gene,0.9824,34778029
1292,BRAF,gene,0.9976,34778029
1293,mCRC,disease,0.9844,34778029
1294,5FU,drug,0.996,34778029
1295,anti-EGFR,gene,0.8936,34778029
1296,pembrolizumab,gene,0.682,34759103
1297,small bowel mucinous adenocarcinoma,disease,0.9946,34759103
1298,advanced small bowel mucinous adenocarcinoma,disease,0.997,34759103
1299,Peutz-Jeghers syndrome,disease,1.0,34759103
1300,capecitabine,drug,0.9976,34759103
1301,oxaliplatin,drug,0.9985,34759103
1302,CapeOX,drug,0.9956,34759103
1303,tumor,disease,0.9185,34759103
1304,CapeOX,drug,0.654,34759103
1305,bevacizumab,gene,0.8896,34759103
1306,fluorouracil,drug,0.9995,34759103
1307,leucovorin,drug,0.998,34759103
1308,irinotecan,drug,0.999,34759103
1309,panitumumab,gene,0.932,34759103
1310,FOLFIRI,drug,0.96,34759103
1311,panitumumab,gene,0.963,34759103
1312,tumor,disease,0.995,34759103
1313,Hematochezia,disease,1.0,34744108
1314,Panitumumab,gene,0.5254,34744108
1315,Colitis,disease,0.5264,34744108
1316,Vitamin,disease,0.7935,34744108
1317,Vitamin K,drug,0.998,34744108
1318,Panitumumab,gene,0.6807,34744108
1319,human,species,0.949,34744108
1320,anti-epidermal growth factor receptor,gene,0.9634,34744108
1321,EGFR,gene,0.955,34744108
1322,advanced or recurrent,disease,0.7656,34744108
1323,KRAS,disease,0.8936,34744108
1324,NRAS,gene,0.8115,34744108
1325,BRAF,gene,0.992,34744108
1326,colorectal cancer,disease,0.982,34744108
1327,man,species,0.8813,34744108
1328,short bowel syndrome,disease,1.0,34744108
1329,hematochezia,disease,0.995,34744108
1330,panitumumab,gene,0.998,34744108
1331,colitis,disease,0.978,34744108
1332,vitamin K,drug,0.9985,34744108
1333,vitamin K deficiency,disease,0.8696,34744108
1334,vitamin K,drug,0.9995,34744108
1335,vitamin K,drug,0.999,34744108
1336,colitis,disease,0.9995,34744108
1337,patients,species,0.988,34744108
1338,short bowel syndrome,disease,1.0,34744108
1339,Colorectal Liver Metastases,disease,0.988,34732462
1340,colorectal liver metastases,disease,1.0,34732462
1341,patient,species,0.933,34732462
1342,rectal cancer,disease,1.0,34732462
1343,colorectal liver metastases,disease,0.9995,34732462
1344,panitumumab,gene,0.9453,34732462
1345,colorectal liver metastases,disease,0.999,34732462
1346,tumor,disease,1.0,34732462
1347,patients,species,0.9824,34732462
1348,colorectal liver metastases,disease,1.0,34732462
1349,Panitumumab,gene,0.958,34718946
1350,Patients,species,0.947,34718946
1351,Regorafenib,drug,0.995,34718946
1352,trifluridine,drug,0.9966,34718946
1353,tipiracil,drug,0.998,34718946
1354,colorectal cancer,disease,1.0,34718946
1355,patients,species,0.979,34718946
1356,epidermal growth factor receptor antibody,gene,0.8784,34718946
1357,patients,species,0.9824,34718946
1358,cetuximab,gene,0.856,34718946
1359,panitumumab,gene,0.954,34718946
1360,cetuximab,gene,0.9316,34718946
1361,panitumumab,gene,0.932,34718946
1362,patients,species,0.928,34718946
1363,metastatic,disease,0.716,34718946
1364,KRAS exon 2,gene,0.8677,34718946
1365,panitumumab,gene,0.9517,34718946
1366,PATIENTS,species,0.9253,34718946
1367,KRAS exon 2,gene,0.9688,34718946
1368,panitumumab,gene,0.966,34718946
1369,Irinotecan,drug,0.998,34718946
1370,panitumumab,gene,0.92,34718946
1371,patients,species,0.9863,34718946
1372,acneiform rash,disease,1.0,34718946
1373,hypomagnesemia,disease,1.0,34718946
1374,dry skin,disease,0.9995,34718946
1375,Irinotecan,drug,0.9985,34718946
1376,panitumumab,gene,0.9307,34718946
1377,patients,species,0.8975,34718946
1378,metastatic wild-type,disease,0.8623,34718946
1379,anti-EGFR antibodies,gene,0.79,34716122
1380,FOLFOX,drug,0.7607,34716122
1381,anti-EGFR antibodies,gene,0.9478,34716122
1382,cetuximab,gene,0.8574,34716122
1383,panitumumab,gene,0.76,34716122
1384,patients,species,0.967,34716122
1385,metastatic colorectal cancer,disease,0.9995,34716122
1386,mCRC,disease,0.999,34716122
1387,PATIENTS,species,0.952,34716122
1388,RAS,gene,0.996,34716122
1389,BRAF,gene,0.996,34716122
1390,patients,species,0.971,34716122
1391,mCRC,disease,0.9966,34716122
1392,patients,species,0.9814,34716122
1393,patients,species,0.9824,34716122
1394,patients,species,0.981,34716122
1395,FOLFOX,drug,0.785,34716122
1396,panitumumab,gene,0.822,34716122
1397,neutropenia,disease,0.9995,34716122
1398,skin rash,disease,1.0,34716122
1399,skin rash,disease,1.0,34716122
1400,diarrhea,disease,1.0,34716122
1401,nausea,disease,0.987,34716122
1402,patients,species,0.976,34716122
1403,patients,species,0.978,34716122
1404,anti-EGFR antibodies,gene,0.6772,34716122
1405,EGFR,gene,0.9834,34663410
1406,metastatic colorectal cancer,disease,1.0,34663410
1407,Cetuximab,gene,0.7246,34663410
1408,panitumumab,gene,0.5728,34663410
1409,epidermal growth factor receptor,gene,0.997,34663410
1410,EGFR,gene,0.994,34663410
1411,metastatic colorectal cancer,disease,1.0,34663410
1412,mCRC,disease,1.0,34663410
1413,Cetuximab,gene,0.6636,34663410
1414,RAS,gene,0.9893,34663410
1415,mCRC,disease,0.9995,34663410
1416,patients,species,0.9917,34663410
1417,tumours,disease,1.0,34663410
1418,anti-EGFR mAbs,gene,0.926,34663410
1419,EGFR ligand,gene,0.974,34663410
1420,EGFR,gene,0.9854,34663410
1421,RAS/RAF/PI3K gene,DNA,0.5996,34663410
1422,RAS,gene,0.993,34663410
1423,RAF,gene,0.999,34663410
1424,PI3K,gene,0.998,34663410
1425,ERBB2,gene,0.9927,34663410
1426,MET,gene,0.999,34663410
1427,IGF-1R,gene,0.998,34663410
1428,microsatellite,DNA,0.599,34663410
1429,EGFR,gene,0.992,34663410
1430,cetuximab,gene,0.9487,34663410
1431,tumour,disease,1.0,34663410
1432,immune cells,cell_type,0.5566,34663410
1433,cancer-,cell_line,0.4163,34663410
1434,cancer-associated fibroblasts,cell_type,0.8906,34663410
1435,cancer,disease,0.967,34663410
1436,CAFs,cell_line,0.543,34663410
1437,immune cells,cell_type,0.8413,34663410
1438,CAFs,cell_type,0.8276,34663410
1439,VEGFR,gene,0.989,34663410
1440,anti-EGFR monoclonal antibodies,gene,0.995,34663410
1441,anti-EGFR mAbs,gene,0.995,34663410
1442,mCRC,disease,0.999,34663410
1443,F(c) receptors,gene,0.998,34644231
1444,F,gene,0.996,34644231
1445,immune cells,cell_type,0.923,34644231
1446,cytokine release syndrome,disease,0.9995,34644231
1447,F(c)R,gene,0.992,34644231
1448,human peripheral blood mononuclear cells,cell_type,0.8867,34644231
1449,human,species,0.888,34644231
1450,PBMC,cell_type,0.8237,34644231
1451,F(c)R,gene,0.995,34644231
1452,PBMC,cell_type,0.923,34644231
1453,panitumumab,gene,0.951,34644231
1454,trastuzumab,gene,0.945,34644231
1455,rituximab,gene,0.948,34644231
1456,alemtuzumab,gene,0.5527,34644231
1457,T,cell_type,0.503,34644231
1458,anti-CD3 mAb,gene,0.9966,34644231
1459,anti-CD28 super-agonist [SA] mAb,gene,0.9673,34644231
1460,Panitumumab,gene,0.9233,34644231
1461,trastuzumab,gene,0.9546,34644231
1462,rituximab,gene,0.9224,34644231
1463,alemtuzumab,gene,0.734,34644231
1464,alemtuzumab,gene,0.6406,34644231
1465,F(c)R,gene,0.994,34644231
1466,panitumumab,gene,0.782,34644231
1467,trastuzumab,gene,0.9233,34644231
1468,rituximab,gene,0.9067,34644231
1469,alemtuzumab,gene,0.538,34644231
1470,anti-F(c)RI,gene,0.997,34644231
1471,-F(c)RII,gene,0.9873,34644231
1472,-F(c)RIII F,gene,0.963,34644231
1473,trastuzumab,gene,0.96,34644231
1474,rituximab,gene,0.907,34644231
1475,alemtuzumab,gene,0.5254,34644231
1476,anti-F(c)RIII F(ab&,gene,0.9585,34644231
1477,anti-F(c)RI,gene,0.999,34644231
1478,anti-F(c)RII,gene,0.9985,34644231
1479,F(c)R,gene,0.9976,34644231
1480,F(c)RIII,gene,0.9976,34644231
1481,PBMC,cell_type,0.8525,34644231
1482,panitumumab,gene,0.7627,34644231
1483,anti-F(c)RIII F(ab&#x27;)(2),gene,0.978,34644231
1484,Anti-CD3 mAb,gene,0.9956,34644231
1485,anti-CD28 SA mAb,gene,0.966,34644231
1486,human PBMC,cell_type,0.6304,34644231
1487,human,species,0.9067,34644231
1488,F(c)R,gene,0.991,34644231
1489,metastatic colorectal cancer,disease,1.0,34619647
1490,mCRC,disease,1.0,34619647
1491,patients,species,0.9927,34619647
1492,metastatic colorectal cancer,disease,1.0,34619647
1493,mCRC,disease,0.991,34619647
1494,patients,species,0.9873,34619647
1495,mCRC,disease,0.984,34619647
1496,patients,species,0.9946,34619647
1497,mCRC,disease,0.997,34619647
1498,patients,species,0.994,34619647
1499,patients,species,0.991,34619647
1500,Aflibercept,gene,0.9956,34619647
1501,Aflibercept,gene,0.9927,34619647
1502,Ramucirumab,gene,0.742,34619647
1503,panitumumab,gene,0.955,34619647
1504,patients,species,0.954,34619647
1505,mCRC,disease,0.9883,34619647
1506,Growth Factor Receptor,gene,0.9976,34593037
1507,EGFR,gene,0.997,34593037
1508,colorectal cancer,disease,1.0,34593037
1509,patients,species,0.972,34593037
1510,colorectal cancer,disease,1.0,34593037
1511,panitumumab,gene,0.802,34593037
1512,KRAS,gene,0.9976,34593037
1513,metastatic colorectal cancer,disease,0.9995,34593037
1514,panitumumab,gene,0.936,34593037
1515,KRAS,gene,0.9976,34593037
1516,colorectal cancer,disease,1.0,34593037
1517,skin-toxicity,disease,0.982,34593037
1518,skin-toxicity,disease,0.8667,34593037
1519,panitumumab,gene,0.7925,34593037
1520,KRAS,gene,0.9966,34593037
1521,mCRC,disease,0.9956,34593037
1522,Patients,species,0.985,34554888
1523,patients,species,0.9424,34554888
1524,metastatic colorectal cancer,disease,0.997,34554888
1525,fluorouracil,drug,0.9995,34554888
1526,irinotecan,drug,0.999,34554888
1527,oxaliplatin,drug,0.9995,34554888
1528,bevacizumab,gene,0.786,34554888
1529,epidermal growth factor receptor,gene,0.9966,34554888
1530,cetuximab,gene,0.8525,34554888
1531,panitumumab,gene,0.869,34554888
1532,mCRC,disease,0.98,34554888
1533,patients,species,0.9917,34554888
1534,fluorouracil,drug,1.0,34554888
1535,leucovorin,drug,0.999,34554888
1536,oxaliplatin,drug,0.9995,34554888
1537,irinotecan,drug,0.999,34554888
1538,bevacizumab,gene,0.534,34554888
1539,bevacizumab,gene,0.6953,34554888
1540,bevacizumab,gene,0.7983,34554888
1541,bevacizumab,gene,0.785,34554888
1542,patients,species,0.9453,34554888
1543,mCRC,disease,0.993,34554888
1544,Panitumumab,gene,0.9243,34533973
1545,Fluorouracil,drug,0.9995,34533973
1546,Folinic Acid,drug,0.997,34533973
1547,Fluorouracil,drug,0.9995,34533973
1548,Folinic Acid,drug,0.9985,34533973
1549,panitumumab,gene,0.953,34533973
1550,Pmab,gene,0.9795,34533973
1551,fluorouracil,drug,0.9995,34533973
1552,folinic acid,drug,0.9966,34533973
1553,patients,species,0.9375,34533973
1554,RAS,gene,0.9976,34533973
1555,metastatic colorectal cancer,disease,0.9536,34533973
1556,oxaliplatin,drug,0.9995,34533973
1557,Pmab,gene,0.773,34533973
1558,patients,species,0.97,34533973
1559,FU,drug,,34533973
1560,FA,drug,1.0,34533973
1561,Pmab,gene,0.8823,34533973
1562,patients,species,0.977,34533973
1563,Pmab,gene,0.8027,34533973
1564,patients,species,0.95,34533973
1565,FU,drug,,34533973
1566,patients,species,0.9727,34533973
1567,patients,species,0.985,34533973
1568,Pmab,gene,0.775,34533973
1569,patients,species,0.978,34533973
1570,skin rash,disease,0.9995,34533973
1571,RAS,gene,0.9956,34533973
1572,metastatic colorectal cancer,disease,0.8726,34533973
1573,Pmab,gene,0.5483,34533973
1574,FU,drug,,34533973
1575,oxaliplatin,drug,0.9995,34533973
1576,Pmab,gene,0.8965,34533973
1577,FU,drug,,34533973
1578,Pmab,gene,0.863,34533973
1579,cetuximab,gene,0.897,34529522
1580,FOLFIRI,drug,0.9805,34529522
1581,cetuximab,gene,0.9214,34529522
1582,folinic acid,drug,0.9995,34529522
1583,fluorouracil,drug,0.9995,34529522
1584,irinotecan,drug,0.9985,34529522
1585,FOLFIRI,drug,0.986,34529522
1586,panitumumab,gene,0.894,34529522
1587,folinic acid,drug,0.9995,34529522
1588,fluorouracil,drug,0.9995,34529522
1589,oxaliplatin,drug,0.999,34529522
1590,FOLFOX,drug,0.9883,34529522
1591,patients,species,0.9707,34529522
1592,Kirsten,disease,1.0,34529522
1593,s,disease,1.0,34529522
1594,s rat,species,0.6973,34529522
1595,KRAS,gene,0.9927,34529522
1596,metastatic colorectal cancer,disease,1.0,34529522
1597,mCRC,disease,1.0,34529522
1598,patient,species,0.9805,34529522
1599,cetuximab,gene,0.892,34529522
1600,FOLFIRI,drug,0.984,34529522
1601,panitumumab,gene,0.8516,34529522
1602,FOLFOX,drug,0.989,34529522
1603,RAS,DNA,0.666,34529522
1604,cetuximab,gene,0.607,34529522
1605,panitumumab,gene,0.765,34529522
1606,men,species,0.9604,34529522
1607,women,species,0.984,34529522
1608,cetuximab,gene,0.904,34529522
1609,panitumumab,gene,0.844,34529522
1610,FOLFOX,drug,0.8813,34529522
1611,patient,species,0.992,34529522
1612,cetuximab,gene,0.9375,34529522
1613,FOLFIRI,drug,0.9795,34529522
1614,men,species,0.989,34529522
1615,women,species,0.9873,34529522
1616,cetuximab,gene,0.6196,34529522
1617,men,species,0.9463,34529522
1618,women,species,0.9697,34529522
1619,panitumumab,gene,0.8203,34529522
1620,cetuximab,gene,0.948,34529522
1621,FOLFIRI,drug,0.9263,34529522
1622,IR,disease,,34529522
1623,cetuximab,gene,0.94,34529522
1624,panitumumab,gene,0.8926,34529522
1625,ASPECCT,DNA,0.904,34529522
1626,cetuximab,gene,0.954,34529522
1627,FOLFIRI,drug,0.9287,34529522
1628,panitumumab,gene,0.8193,34529522
1629,FOLFOX,drug,0.968,34529522
1630,patients,species,0.948,34529522
1631,KRAS,gene,0.9937,34529522
1632,mCRC,disease,0.9946,34529522
1633,men,species,0.972,34529522
1634,women,species,0.9893,34529522
1635,Capecitabine,drug,0.9995,34507891
1636,panitumumab,gene,0.812,34507891
1637,fluorouracil,drug,0.9995,34505885
1638,folinic acid,drug,0.9995,34505885
1639,oxaliplatin,drug,0.9995,34505885
1640,irinotecan,drug,0.999,34505885
1641,patients,species,0.972,34505885
1642,metastatic colorectal cancer,disease,1.0,34505885
1643,mCRC,disease,1.0,34505885
1644,FOLFOXIRI-B,drug,0.9893,34505885
1645,FOLFOXIRI,drug,0.542,34505885
1646,patients,species,0.946,34505885
1647,mCRC,disease,0.9824,34505885
1648,PARTICIPANTS,species,0.6606,34505885
1649,patient,species,0.969,34505885
1650,patients,species,0.984,34505885
1651,mCRC,disease,0.9985,34505885
1652,patients,species,0.9883,34505885
1653,mCRC,disease,0.9927,34505885
1654,FOLFOXIRI-B,drug,0.999,34505885
1655,FOLFOXIRI-B,drug,0.9346,34505885
1656,FOLFOXIRI-B,drug,0.9863,34505885
1657,patients,species,0.992,34505885
1658,left,DNA,0.5454,34505885
1659,left-sided or rectal tumor,disease,0.999,34505885
1660,mCRC,disease,0.9795,34505885
1661,patients,species,0.9805,34505885
1662,mCRC,disease,0.9966,34505885
1663,patients,species,0.986,34505885
1664,oxaliplatin,drug,1.0,34505885
1665,bevacizumab,gene,0.595,34505885
1666,irinotecan,drug,0.9995,34505885
1667,bevacizumab,gene,0.5986,34505885
1668,panitumumab,gene,0.8486,34505885
1669,cetuximab,gene,0.7646,34505885
1670,irinotecan,drug,0.9985,34505885
1671,bevacizumab,gene,0.8486,34505885
1672,patients,species,0.988,34505885
1673,fluoropyrimidine,drug,0.986,34505885
1674,bevacizumab,gene,0.6875,34505885
1675,patient,species,0.981,34505885
1676,panitumumab,gene,0.9194,34505885
1677,patients,species,0.9844,34505885
1678,FOLFOXIRI,drug,0.918,34505885
1679,patients,species,0.981,34505885
1680,FOLFOXIRI-B,drug,0.9834,34505885
1681,FOLFOXIRI,drug,0.978,34505885
1682,patients,species,0.9844,34505885
1683,patients,species,0.981,34505885
1684,oncologists,cell_type,0.547,34505885
1685,FOLFOXIRI-B,drug,0.9985,34505885
1686,dysphonia,disease,0.9985,34503645
1687,Dysphonia,disease,1.0,34503645
1688,Dysphonia,disease,1.0,34503645
1689,patients,species,0.9717,34503645
1690,cancer,disease,1.0,34503645
1691,vascular endothelial growth factor receptor,gene,0.998,34503645
1692,dysphonia,disease,1.0,34503645
1693,patients,species,0.996,34503645
1694,dysphonia,disease,1.0,34503645
1695,panitumumab,gene,0.8384,34503645
1696,Peripheral edema,disease,0.9873,34503645
1697,dysphonia,disease,1.0,34503645
1698,aflibercept,gene,0.986,34503645
1699,bevacizumab,gene,0.7944,34503645
1700,panitumumab,gene,0.894,34503645
1701,peripheral edema,disease,0.843,34503645
1702,dysphonia,disease,1.0,34503645
1703,COVID-19 Lockdown,gene,0.99,34495337
1704,Tumor,disease,0.999,34495337
1705,Patients,species,0.976,34495337
1706,COVID-19,disease,0.9976,34495337
1707,patients,species,0.9863,34495337
1708,cancer,disease,1.0,34495337
1709,cancer,disease,1.0,34495337
1710,patient,species,0.9946,34495337
1711,COVID-19,disease,0.9985,34495337
1712,patients,species,0.9805,34495337
1713,metastatic colorectal cancer,disease,1.0,34495337
1714,mCRC,disease,1.0,34495337
1715,PARTICIPANTS,species,0.6606,34495337
1716,participants,species,0.9375,34495337
1717,FOLFIRINOX,drug,0.897,34495337
1718,Panitumumab,gene,0.8794,34495337
1719,FOLFOX,drug,0.6973,34495337
1720,Panitumumab,gene,0.7393,34495337
1721,Metastatic Colorectal Cancer,disease,1.0,34495337
1722,Patients,species,0.981,34495337
1723,RAS,gene,0.9956,34495337
1724,Circulating DNA,DNA,0.591,34495337
1725,patients,species,0.988,34495337
1726,Patients,species,0.9707,34495337
1727,RAS,gene,0.995,34495337
1728,BRAF,DNA,0.754,34495337
1729,BRAF,gene,0.996,34495337
1730,tumor,disease,0.996,34495337
1731,mCRC,disease,0.9834,34495337
1732,Circulating tumor DNA,DNA,0.581,34495337
1733,Circulating tumor DNA,RNA,0.5073,34495337
1734,Circulating,cell_type,0.4517,34495337
1735,ctDNA,DNA,0.8535,34495337
1736,RAS,gene,0.996,34495337
1737,BRAF,DNA,0.7686,34495337
1738,BRAF,gene,0.9966,34495337
1739,Tumor,disease,0.9946,34495337
1740,plasma,DNA,0.489,34495337
1741,plasma ctDNA,RNA,0.5425,34495337
1742,ctDNA,DNA,0.4348,34495337
1743,ctDNA,DNA,0.7544,34495337
1744,patients,species,0.981,34495337
1745,patients,species,0.9937,34495337
1746,PANIRINOX,drug,0.6074,34495337
1747,patients,species,0.9785,34495337
1748,COVID-19,disease,0.999,34495337
1749,patients,species,0.9727,34495337
1750,men,species,0.9834,34495337
1751,women,species,0.9897,34495337
1752,ctDNA,DNA,0.7896,34495337
1753,ctDNA,RNA,0.6196,34495337
1754,patients,species,0.9893,34495337
1755,Patients,species,0.937,34495337
1756,mCRC,disease,0.9995,34495337
1757,ctDNA,DNA,0.7124,34495337
1758,COVID-19,disease,0.9995,34495337
1759,tumor,disease,0.842,34495337
1760,patients,species,0.9883,34495337
1761,mCRC,disease,1.0,34495337
1762,COVID-19,disease,0.9985,34495337
1763,CRC,disease,0.997,34495337
1764,anti-HER3,gene,0.814,34482024
1765,HER1,gene,0.9517,34482024
1766,HER2,gene,0.9604,34482024
1767,cancer,disease,1.0,34482024
1768,breast and colon malignancies,disease,1.0,34482024
1769,cancer cells,cell_type,0.8174,34482024
1770,cancer,disease,0.9995,34482024
1771,HER1,gene,0.9907,34482024
1772,HER2,gene,0.991,34482024
1773,anti-HER3 rat monoclonal antibodies,gene,0.9756,34482024
1774,rat,species,0.9814,34482024
1775,Ab1Ab6,gene,0.973,34482024
1776,HER family proteins,gene,0.9854,34482024
1777,Ab3,gene,0.996,34482024
1778,Ab6,gene,0.9937,34482024
1779,Ab1,gene,0.9937,34482024
1780,Ab4,gene,0.994,34482024
1781,Ab6,gene,0.9326,34482024
1782,LS-174T colon cancer cells,cell_line,0.6455,34482024
1783,colon cancer,disease,0.972,34482024
1784,Pertuzumab,gene,0.8115,34482024
1785,anti-HER2 mAb,gene,0.992,34482024
1786,Ab6,gene,0.987,34482024
1787,Ab6,gene,0.9805,34482024
1788,NCI-H1838 lung or BT474 breast cancer cells,cell_line,0.8677,34482024
1789,breast cancer,disease,0.8726,34482024
1790,Panitumumab,gene,0.939,34482024
1791,anti-HER1 mAb,gene,0.996,34482024
1792,Perutuzumab,gene,0.8267,34482024
1793,Ab6,gene,0.9907,34482024
1794,Ab6,gene,0.9897,34482024
1795,NCI-H1838,cell_line,0.8857,34482024
1796,BT474,cell_line,0.947,34482024
1797,Erlotinib,drug,0.996,34482024
1798,HER1,gene,0.9966,34482024
1799,Lapatinib,drug,0.998,34482024
1800,HER1,gene,0.9946,34482024
1801,HER2,gene,0.9956,34482024
1802,HER1-knockout (KO) NCI-H1838,cell_line,0.8843,34482024
1803,HER1,gene,0.9917,34482024
1804,Ab4,gene,0.9873,34482024
1805,NCI-H1838,cell_line,0.876,34482024
1806,HER1-KO or HER3-KO SW1116 colon cancer cells,cell_line,0.8735,34482024
1807,HER1,gene,0.9873,34482024
1808,HER3,gene,0.9736,34482024
1809,colon cancer,disease,0.9946,34482024
1810,Pertuzumab,gene,0.9062,34482024
1811,Ab6,gene,0.9556,34482024
1812,Pertuzumab,gene,0.971,34482024
1813,HER1-KO,cell_line,0.898,34482024
1814,HER1,gene,0.9883,34482024
1815,SW1116,cell_line,0.7725,34482024
1816,Anti-EGFR,gene,0.9795,34441007
1817,rash,disease,0.9995,34441007
1818,anti-epidermal growth factor receptor,gene,0.9326,34441007
1819,EGFR,gene,0.9766,34441007
1820,rash,disease,0.999,34441007
1821,patients,species,0.9766,34441007
1822,cancer,disease,1.0,34441007
1823,patients,species,0.984,34441007
1824,colorectal or head and neck cancer,disease,1.0,34441007
1825,cetuximab,gene,0.8594,34441007
1826,panitumumab,gene,0.788,34441007
1827,patient,species,0.9824,34441007
1828,rash,disease,0.9995,34441007
1829,Rashes,disease,0.995,34441007
1830,rashes,disease,0.975,34441007
1831,patients,species,0.977,34441007
1832,rashes,disease,0.7026,34441007
1833,patient,species,0.9683,34441007
1834,skin rashes,disease,1.0,34441007
1835,anti-EGFR antibodies,gene,0.9805,34441007
1836,Trametinib,drug,0.9985,34417144
1837,Panitumumab,gene,0.5723,34417144
1838,RAS,gene,0.997,34417144
1839,RAF,gene,0.999,34417144
1840,MEK,gene,0.991,34417144
1841,EGFR,gene,0.991,34417144
1842,patients,species,0.933,34417144
1843,RAS,gene,0.994,34417144
1844,metastatic colorectal cancer,disease,1.0,34417144
1845,mCRC,disease,1.0,34417144
1846,trametinib,drug,0.9985,34417144
1847,MEK1/2,gene,0.997,34417144
1848,panitumumab,gene,0.6636,34417144
1849,EGFR monoclonal antibody,gene,0.9443,34417144
1850,Patients,species,0.9624,34417144
1851,"KRAS, NRAS, and BRAF",DNA,0.5083,34417144
1852,KRAS,gene,0.9873,34417144
1853,NRAS,gene,0.9873,34417144
1854,BRAF,gene,0.992,34417144
1855,mCRC,disease,0.9863,34417144
1856,5-FU,drug,0.9985,34417144
1857,irinotecan,drug,0.999,34417144
1858,oxaliplatin,drug,0.9995,34417144
1859,bevacizumab,gene,0.5503,34417144
1860,EGFR,gene,0.937,34417144
1861,trametinib,drug,0.9937,34417144
1862,panitumumab,gene,0.733,34417144
1863,plasma,cell_type,0.4458,34417144
1864,cfDNA,DNA,0.608,34417144
1865,patients,species,0.9785,34417144
1866,acneiform rash,disease,1.0,34417144
1867,diarrhea,disease,1.0,34417144
1868,maculopapular rash,disease,1.0,34417144
1869,mucositis,disease,1.0,34417144
1870,trametinib,drug,0.999,34417144
1871,panitumumab,gene,0.791,34417144
1872,patients,species,0.9814,34417144
1873,RAS,gene,0.9937,34417144
1874,BRAF mutations,gene,0.8022,34417144
1875,cfDNA,RNA,0.6846,34417144
1876,patients,species,0.9814,34417144
1877,trametinib,drug,0.9985,34417144
1878,panitumumab,gene,0.9136,34417144
1879,tumor,disease,0.7354,34417144
1880,RAS/RAF wt,DNA,0.8115,34417144
1881,RAS,gene,0.9976,34417144
1882,RAF,gene,0.992,34417144
1883,metastatic colorectal cancer,disease,1.0,34417144
1884,skin,disease,0.824,34417144
1885,panitumumab,gene,0.932,34417144
1886,metastatic colorectal cancer,disease,1.0,34416469
1887,mCRC,disease,1.0,34416469
1888,patients,species,0.98,34416469
1889,epidermal growth factor receptor,gene,0.8657,34416469
1890,EGFR,gene,0.997,34416469
1891,PATIENTS,species,0.9414,34416469
1892,panitumumab,gene,0.944,34416469
1893,panitumumab,gene,0.9224,34416469
1894,FOLFOX,drug,0.8936,34416469
1895,RAS,gene,0.9883,34416469
1896,mCRC,disease,0.9995,34416469
1897,patients,species,0.9854,34416469
1898,patients,species,0.989,34416469
1899,patients,species,0.963,34416469
1900,thrombocytopenia,disease,0.9966,34416469
1901,neutropenia,disease,0.9995,34416469
1902,conjunctivitis,disease,1.0,34416469
1903,patients,species,0.983,34416469
1904,skin rash,disease,1.0,34416469
1905,hypomagnesemia,disease,1.0,34416469
1906,patients,species,0.9766,34416469
1907,RAS wild,gene,0.809,34416469
1908,mCRC,disease,0.707,34416469
1909,patients,species,0.969,34416469
1910,panitumumab,gene,0.9243,34407800
1911,panitumumab,gene,0.7476,34407800
1912,patients,species,0.8896,34407800
1913,metastatic colorectal cancer,disease,0.9985,34407800
1914,bevacizumab,gene,0.596,34407800
1915,RAS,gene,0.9893,34407800
1916,EGFR,gene,0.7666,34407800
1917,RAS,gene,0.995,34407800
1918,metastatic colorectal cancer,disease,0.9976,34407800
1919,5-fluorouracil,drug,0.999,34407800
1920,patients,species,0.9634,34407800
1921,RAS,gene,0.997,34407800
1922,BRAF,gene,0.998,34407800
1923,metastatic colorectal cancer,disease,1.0,34407800
1924,panitumumab,gene,0.8555,34407800
1925,panitumumab,gene,0.726,34407800
1926,5-fluorouracil,drug,0.9995,34407800
1927,RAS,gene,0.9917,34407800
1928,BRAF,gene,0.9966,34407800
1929,Patient,species,0.9434,34407800
1930,patient,species,0.9854,34407800
1931,tumour,disease,0.9937,34407800
1932,panitumumab,gene,0.9673,34407800
1933,patients,species,0.968,34407800
1934,metastatic colorectal cancer,disease,1.0,34407800
1935,Tumor,disease,0.4805,34397558
1936,Patients,species,0.984,34397558
1937,primary tumor,disease,0.9604,34397558
1938,patients,species,0.9614,34397558
1939,colorectal cancer,disease,0.9995,34397558
1940,tumor,disease,0.9995,34397558
1941,patients,species,0.982,34397558
1942,patients,species,0.987,34397558
1943,cancer,disease,0.9033,34397558
1944,PATIENTS,species,0.79,34397558
1945,patients,species,0.97,34397558
1946,colorectal cancer,disease,0.9995,34397558
1947,Patients,species,0.9805,34397558
1948,primary tumors,disease,0.9844,34397558
1949,patients,species,0.996,34397558
1950,patients,species,0.9956,34397558
1951,tumor,disease,1.0,34397558
1952,tumor,disease,0.9995,34397558
1953,tumor,disease,0.99,34397558
1954,pacientes,species,0.956,34397558
1955,pacientes,species,0.911,34397558
1956,pacientes,species,0.8755,34397558
1957,cncer colorrectal,disease,0.9966,34397558
1958,reseccin,drug,0.717,34397558
1959,tumor,disease,1.0,34397558
1960,pacientes,species,0.8706,34397558
1961,tumores primarios,disease,0.994,34397558
1962,pacientes,species,0.93,34397558
1963,pacientes,species,0.9185,34397558
1964,tumor,disease,1.0,34397558
1965,tumor,disease,0.996,34397558
1966,tumor,disease,0.9976,34397558
1967,Panitumumab,gene,0.4426,34397194
1968,Anti-PD-1 Antibody,gene,0.979,34397194
1969,Cutaneous Squamous Cell Carcinoma,disease,1.0,34397194
1970,Anti-epidermal growth factor receptor,gene,0.925,34397194
1971,EGFR,gene,0.955,34397194
1972,PD-1,gene,0.9375,34397194
1973,metastatic cutaneous squamous cell carcinoma,disease,0.9526,34397194
1974,cSCC,disease,1.0,34397194
1975,anti-EGFR antibodies,gene,0.9614,34397194
1976,cetuximab,gene,0.5415,34397194
1977,panitumumab,gene,0.524,34397194
1978,anti-PD-1 antibody,gene,0.9683,34397194
1979,patients,species,0.9424,34397194
1980,cSCC,disease,0.9995,34397194
1981,patients,species,0.964,34397194
1982,cutaneous squamous cell carcinoma,disease,0.9995,34397194
1983,cSCC,disease,1.0,34397194
1984,anti-PD-1 antibody,gene,0.9062,34397194
1985,Fatigue,disease,0.9976,34397194
1986,rash,disease,0.9995,34397194
1987,hypomagnesemia,disease,1.0,34397194
1988,patients,species,0.9854,34397194
1989,anti-PD1,gene,0.994,34397194
1990,anti-EGFR antibodies,gene,0.7837,34397194
1991,cSCC of the face or scalp,disease,0.993,34397194
1992,[(177)Lu]Lu-DOTA,drug,0.934,34383182
1993,panitumumab F(ab,gene,0.8438,34383182
1994,mice,species,0.8013,34383182
1995,HNSCC,disease,1.0,34383182
1996,Epidermal growth factor receptors,gene,0.998,34383182
1997,EGFR,gene,0.9956,34383182
1998,head and neck squamous cell carcinoma,disease,1.0,34383182
1999,HNSCC,disease,1.0,34383182
2000,anti-EGFR monoclonal antibody panitumumab,gene,0.911,34383182
2001,(177)Lu,drug,0.9937,34383182
2002,HNSCC,disease,1.0,34383182
2003,[(64)Cu]Cu-DOTA-,drug,0.994,34383182
2004,panitumumab F(ab&,gene,0.911,34383182
2005,HNSCC,disease,0.9985,34383182
2006,tumour,disease,0.947,34383182
2007,[(177)Lu]Lu-DOTA,drug,0.9673,34383182
2008,Panitumumab F(ab&#x27;)(2,gene,0.9517,34383182
2009,DOTA,drug,0.9985,34383182
2010,(64)Cu,drug,0.998,34383182
2011,(177)Lu,drug,0.997,34383182
2012,EGFR,gene,0.994,34383182
2013,[(64)Cu]Cu-DOTA,drug,0.996,34383182
2014,[(177)Lu,drug,0.9697,34383182
2015,]Lu,drug,0.9976,34383182
2016,panitumumab F(ab,gene,0.756,34383182
2017,mice,species,0.9326,34383182
2018,HNSCC patient-derived xenografts,cell_line,0.485,34383182
2019,HNSCC,disease,1.0,34383182
2020,patient,species,0.969,34383182
2021,PDX,cell_line,0.6797,34383182
2022,Tumours,disease,0.977,34383182
2023,[(64)Cu]Cu-DOTA,drug,0.981,34383182
2024,panitumumab F(ab,gene,0.8374,34383182
2025,[(177)Lu]Lu,drug,0.99,34383182
2026,DOTA,drug,0.8535,34383182
2027,panitumumab F(ab&,gene,0.8345,34383182
2028,[(177)Lu]Lu-DOTA,drug,0.9907,34383182
2029,trastuzumab F(ab&,gene,0.8467,34383182
2030,[(64)Cu]Cu-DOTA,drug,0.9946,34383182
2031,panitumumab F(ab&,gene,0.87,34383182
2032,[(177)Lu]Lu-DOTA,drug,0.9756,34383182
2033,panitumumab F(ab&,gene,0.96,34383182
2034,[(177)Lu]Lu-DOTA,drug,0.91,34383182
2035,trastuzumab,gene,0.8896,34383182
2036,EGFR,gene,0.9917,34383182
2037,tumour,disease,0.999,34383182
2038,tumour,disease,1.0,34383182
2039,[(177)Lu]Lu,drug,0.995,34383182
2040,DOTA,drug,0.9604,34383182
2041,panitumumab,gene,0.9746,34383182
2042,[(64)Cu]Cu-DOTA,drug,0.999,34383182
2043,panitumumab F(ab,gene,0.7993,34383182
2044,[(177)Lu]Lu,drug,0.998,34383182
2045,panitumumab,gene,0.8027,34383182
2046,[(64)Cu]Cu-DOTA,drug,0.96,34383182
2047,tumour,disease,1.0,34383182
2048,Human,species,0.995,34383182
2049,[(177)Lu]Lu-DOTA,drug,0.916,34383182
2050,panitumumab F(ab&,gene,0.877,34383182
2051,HNSCC tumour,disease,1.0,34383182
2052,patient,species,0.9917,34383182
2053,[(64)Cu]Cu-DOTA,drug,0.966,34383182
2054,panitumumab F(ab&,gene,0.916,34383182
2055,HNSCC tumours,disease,1.0,34383182
2056,tumour,disease,0.991,34383182
2057,[(177)Lu]Lu,drug,0.9893,34383182
2058,DOTA,drug,0.7715,34383182
2059,panitumumab,gene,0.888,34383182
2060,[(177)Lu]Lu-DOTA,drug,0.971,34383182
2061,panitumumab F(ab&,gene,0.901,34383182
2062,HNSCC,disease,0.998,34383182
2063,EGFR,gene,0.9897,34383182
2064,Anti-EGFR,gene,0.992,34380594
2065,Bevacizumab,gene,0.641,34380594
2066,antiepidermal growth factor receptors monoclonal,gene,0.943,34380594
2067,EGFRi,gene,0.9927,34380594
2068,patients,species,0.952,34380594
2069,RAS,gene,0.9946,34380594
2070,BRAF,gene,0.9985,34380594
2071,metastatic colorectal cancer,disease,0.998,34380594
2072,mCRC,disease,1.0,34380594
2073,bevacizumab,gene,0.7104,34380594
2074,EGFRi,gene,0.9907,34380594
2075,bevacizumab,gene,0.7104,34380594
2076,bevacizumab,gene,0.948,34380594
2077,EGFRi,gene,0.9927,34380594
2078,patients,species,0.95,34380594
2079,RAS,gene,0.9917,34380594
2080,BRAF,gene,0.999,34380594
2081,mCRC,disease,0.9946,34380594
2082,bevacizumab,gene,0.954,34380594
2083,EGFRi,gene,0.9937,34380594
2084,patients,species,0.9756,34380594
2085,EGFRi,gene,0.9956,34380594
2086,bevacizumab,gene,0.8774,34380594
2087,EGFRi,gene,0.9897,34380594
2088,bevacizumab,gene,0.8447,34380594
2089,EGFRi,gene,0.995,34380594
2090,bevacizumab,gene,0.848,34380594
2091,bevacizumab,gene,0.9062,34380594
2092,neutropenia,disease,0.999,34380594
2093,EGFRi,gene,0.986,34380594
2094,patients,species,0.89,34380594
2095,RAS,gene,0.9614,34380594
2096,BRAF,gene,0.992,34380594
2097,mCRC,disease,0.9614,34380594
2098,bevacizumab,gene,0.76,34380594
2099,regorafenib,drug,0.9844,34364814
2100,cetuximab,gene,0.9404,34364814
2101,irinotecan,drug,0.994,34364814
2102,anti-EGFR,gene,0.9814,34364814
2103,RAS,gene,0.9507,34364814
2104,mCRC,disease,0.998,34364814
2105,patients,species,0.9805,34364814
2106,anti-EGFR antibodies,gene,0.7954,34364814
2107,patients,species,0.979,34364814
2108,left,DNA,0.493,34364814
2109,RAS,gene,0.9824,34364814
2110,/,DNA,0.4966,34364814
2111,BRAF,gene,0.992,34364814
2112,anti-EGFRs,gene,0.943,34364814
2113,metastatic colorectal cancer,disease,1.0,34364814
2114,mCRC,disease,0.9995,34364814
2115,patients,species,0.9863,34364814
2116,EGFR,gene,0.6074,34364814
2117,RAS,DNA,0.3462,34364814
2118,RAS mutations,gene,0.957,34364814
2119,circulating tumour DNA,DNA,0.406,34364814
2120,ct-DNA,DNA,0.686,34364814
2121,patients,species,0.993,34364814
2122,PATIENTS,species,0.9624,34364814
2123,RAS,gene,0.9976,34364814
2124,BRAF,gene,0.9966,34364814
2125,mCRC,disease,0.9717,34364814
2126,patients,species,0.9834,34364814
2127,anti-EGFR,gene,0.8193,34364814
2128,RAS/BRAF wt ct-DNA,DNA,0.8696,34364814
2129,RAS,gene,0.9976,34364814
2130,BRAF,gene,0.9937,34364814
2131,panitumumab,gene,0.6543,34364814
2132,regorafenib,drug,0.98,34364814
2133,EGFR,gene,0.685,34364814
2134,mCRC,disease,0.998,34364814
2135,patients,species,0.9863,34364814
2136,ct-DNA,DNA,0.874,34364814
2137,ct-,RNA,0.547,34364814
2138,Receptor Tyrosine Kinase,gene,0.9946,34350378
2139,Tyrosine,drug,0.913,34350378
2140,Solid Cancers,disease,1.0,34350378
2141,receptor tyrosine kinase,gene,0.997,34350378
2142,tyrosine,drug,0.972,34350378
2143,RTKis,gene,0.9844,34350378
2144,lapatinib,drug,0.9995,34350378
2145,erlotinib,drug,0.9985,34350378
2146,cetuximab,gene,0.782,34350378
2147,bevacizumab,gene,0.889,34350378
2148,panitumumab,gene,0.9224,34350378
2149,solid tumors,disease,1.0,34350378
2150,patients,species,0.982,34350378
2151,solid tumor cancers,disease,1.0,34350378
2152,RTKis,gene,0.787,34350378
2153,RTKi,gene,0.9663,34350378
2154,patients,species,0.9893,34350378
2155,cancers of the head and neck,disease,1.0,34350378
2156,patients,species,0.9717,34350378
2157,patients,species,0.9287,34350378
2158,lung,disease,0.9487,34350378
2159,patients,species,0.986,34350378
2160,patients,species,0.986,34350378
2161,patients,species,0.9917,34350378
2162,patients,species,0.991,34350378
2163,RTKis,gene,0.9053,34350378
2164,RTKis,gene,0.9575,34350378
2165,clarithromycin,drug,0.9927,34345969
2166,panitumumab,gene,0.964,34345969
2167,panitumumab,gene,0.9375,34345969
2168,patients,species,0.949,34345969
2169,colorectal cancer,disease,0.9995,34345969
2170,mCRC,disease,0.999,34345969
2171,skin toxicities,disease,0.994,34345969
2172,clarithromycin,drug,0.9966,34345969
2173,CAM,drug,0.999,34345969
2174,panitumumab,gene,0.8296,34345969
2175,mCRC,disease,0.998,34345969
2176,patients,species,0.9897,34345969
2177,panitumumab,gene,0.913,34345969
2178,patients,species,0.9526,34345969
2179,CAM,drug,0.9927,34345969
2180,panitumumab,gene,0.9277,34345969
2181,patients,species,0.981,34345969
2182,diarrhea,disease,0.9966,34345969
2183,skin toxicities,disease,0.876,34345969
2184,panitumumab,gene,0.8984,34345969
2185,UMIN000011485,DNA,0.4575,34345969
2186,(18)F-FDG,drug,0.9995,34330811
2187,Cardiac Arrhythmia,disease,1.0,34330811
2188,Patient,species,0.9785,34330811
2189,Panitumumab,gene,0.621,34330811
2190,humanized antiepidermal growth factor receptor monoclonal antibody,gene,0.878,34330811
2191,humanized,species,0.6104,34330811
2192,advanced colorectal cancer,disease,0.9937,34330811
2193,advanced colorectal cancer,disease,0.93,34330811
2194,(18)F-FDG,drug,0.9995,34330811
2195,cardiac arrhythmia,disease,1.0,34330811
2196,patient,species,0.9746,34330811
2197,panitumumab,gene,0.8066,34330811
2198,metastatic infiltrating rectal,disease,0.9995,34330811
2199,adenocarcinoma,disease,1.0,34330811
2200,Cardiotoxicity,disease,0.9995,34330811
2201,panitumumab,gene,0.7515,34330811
2202,Colorectal Cancer,disease,1.0,34326875
2203,Colorectal cancer,disease,1.0,34326875
2204,CRC,disease,1.0,34326875
2205,cancer,disease,1.0,34326875
2206,CRC,disease,0.998,34326875
2207,tumor,disease,1.0,34326875
2208,CRC,disease,0.9985,34326875
2209,CRC,disease,0.996,34326875
2210,VEGF,gene,0.6094,34326875
2211,EGFR,gene,0.526,34326875
2212,CRC,disease,1.0,34326875
2213,anti-EGFR monoclonal antibodies,gene,0.963,34326875
2214,cetuximab,gene,0.943,34326875
2215,panitumumab,gene,0.8594,34326875
2216,metastatic CRC,disease,0.524,34326875
2217,CRC,disease,0.999,34326875
2218,colorectal tumors,disease,1.0,34326875
2219,CRC,disease,0.9995,34326875
2220,vascular endothelial growth factor,gene,0.9985,34305277
2221,epidermal growth factor,gene,0.998,34305277
2222,tyrosine,drug,0.9814,34305277
2223,tyrosine kinase receptor,gene,0.9927,34305277
2224,rat sarcoma mutations,gene,0.9414,34305277
2225,rat,species,0.9526,34305277
2226,sarcoma,disease,0.639,34305277
2227,cancers,disease,0.9976,34305277
2228,trastuzumab,gene,0.967,34305277
2229,bevacizumab,gene,0.907,34305277
2230,cetuximab,gene,0.8843,34305277
2231,panitumumab,gene,0.892,34305277
2232,COVID-19,disease,0.997,34305277
2233,IL-6,gene,0.988,34305277
2234,c-reactive protein,gene,0.9956,34305277
2235,infectious diseases,disease,0.999,34305277
2236,chronic diseases,disease,0.9956,34305277
2237,asthma,disease,1.0,34305277
2238,connective tissue diseases,disease,1.0,34305277
2239,cardiovascular diseases,disease,1.0,34305277
2240,diabetes,disease,1.0,34305277
2241,obesity,disease,1.0,34305277
2242,cancer,disease,0.9956,34305277
2243,patients,species,0.9873,34305277
2244,live cells,cell_type,0.612,34302187
2245,Trastuzumab,gene,0.9873,34302187
2246,Rituximab,gene,0.9634,34302187
2247,Panitumumab,gene,0.9355,34302187
2248,Pertuzumab,gene,0.926,34302187
2249,Cetuximab,gene,0.9434,34302187
2250,cognate,DNA,0.5103,34302187
2251,live cells,cell_type,0.7817,34302187
2252,patient,species,0.883,34277827
2253,metastatic colorectal cancer,disease,1.0,34277827
2254,MCRC,disease,1.0,34277827
2255,FIr-B,drug,0.9985,34277827
2256,FOx,drug,0.95,34277827
2257,bevacizumab,gene,0.6636,34277827
2258,woman,species,0.8843,34277827
2259,rectal cancer,disease,1.0,34277827
2260,lymph nodes involvement,disease,0.8496,34277827
2261,liver metastases,disease,0.966,34277827
2262,FIr-B,drug,0.996,34277827
2263,FOx,drug,0.9395,34277827
2264,FIr-B,drug,0.9814,34277827
2265,FIr,drug,0.672,34277827
2266,Patient,species,0.9546,34277827
2267,limiting toxicity syndrome,disease,0.8857,34277827
2268,LTS,disease,0.93,34277827
2269,diarrhea,disease,0.9995,34277827
2270,asthenia,disease,0.9995,34277827
2271,nausea,disease,0.997,34277827
2272,irinotecan,drug,0.997,34277827
2273,5-fluorouracil,drug,0.999,34277827
2274,oxaliplatin,drug,0.9995,34277827
2275,infusional hypersensitivity reaction,disease,0.99,34277827
2276,aflibercept,gene,0.9385,34277827
2277,irinotecan,drug,0.999,34277827
2278,panitumumab,gene,0.902,34277827
2279,KRAS,gene,0.9497,34277827
2280,NRAS,gene,0.997,34277827
2281,BRAF,gene,0.998,34277827
2282,EGFR c,DNA,0.7104,34277827
2283,EGFR c.2156,gene,0.7656,34277827
2284,G719A,mutation,,34277827
2285,regorafenib,drug,0.9917,34277827
2286,trifluridine,drug,0.999,34277827
2287,tipiracil,drug,0.999,34277827
2288,leucopenia,disease,0.7627,34277827
2289,neutropenia,disease,0.941,34277827
2290,thrombocytopenia,disease,1.0,34277827
2291,asthenia,disease,1.0,34277827
2292,anemia,disease,0.994,34277827
2293,diarrhea,disease,1.0,34277827
2294,hypotension,disease,1.0,34277827
2295,patient,species,0.975,34277827
2296,patient,species,0.9917,34277827
2297,RAS,gene,0.999,34277827
2298,BRAF,gene,0.998,34277827
2299,patient,species,0.9395,34277827
2300,MCRC,disease,0.993,34277827
2301,BRAF,gene,0.9985,34267639
2302,Advanced Rectal Cancer,disease,1.0,34267639
2303,Epidermal,gene,0.55,34267639
2304,v-raf murine sarcoma viral oncogene homologue B (BRAF) fusions,DNA,0.8047,34267639
2305,v-raf murine sarcoma viral oncogene homologue B,gene,0.9976,34267639
2306,BRAF,gene,0.9985,34267639
2307,cancer,disease,1.0,34267639
2308,BRAF fusions,gene,0.9834,34267639
2309,patients,species,0.934,34267639
2310,metastatic colorectal cancer,disease,1.0,34267639
2311,mCRC,disease,1.0,34267639
2312,mCRC,disease,0.93,34267639
2313,BRAF fusions,gene,0.979,34267639
2314,colorectal cancer,disease,1.0,34267639
2315,EXOC4,gene,0.965,34267639
2316,-BRAF fusion,DNA,0.752,34267639
2317,BRAF,gene,0.9956,34267639
2318,patient,species,0.961,34267639
2319,type 2 diabetes,disease,1.0,34267639
2320,stage IV,disease,0.7744,34267639
2321,rectal adenocarcinoma,disease,0.977,34267639
2322,liver metastasis,disease,0.89,34267639
2323,rectal cancer,disease,1.0,34267639
2324,EXOC4,gene,0.9893,34267639
2325,-,DNA,0.7456,34267639
2326,BRAF fusion,DNA,0.8403,34267639
2327,BRAF,gene,0.9956,34267639
2328,panitumumab,gene,0.7734,34267639
2329,human,species,0.9014,34267639
2330,epidermal growth factor receptor,gene,0.997,34267639
2331,EXOC4,gene,0.991,34267639
2332,-,DNA,0.822,34267639
2333,BRAF fusions,DNA,0.602,34267639
2334,BRAF,gene,0.998,34267639
2335,colorectal cancer,disease,1.0,34267639
2336,BRAF,gene,0.997,34259881
2337,metastatic colorectal carcinoma,disease,1.0,34259881
2338,metastatic colorectal cancer,disease,1.0,34259881
2339,mCRC,disease,1.0,34259881
2340,irinotecan,drug,0.9995,34259881
2341,oxaliplatin,drug,0.9995,34259881
2342,epidermal,gene,0.8613,34259881
2343,EGFR,gene,0.9966,34259881
2344,cetuximab,gene,0.9004,34259881
2345,panitumumab,gene,0.8955,34259881
2346,bevacizumab,gene,0.686,34259881
2347,aflibercept,gene,0.9365,34259881
2348,mCRC,disease,0.995,34259881
2349,mCRC,disease,0.975,34259881
2350,patients,species,0.9946,34259881
2351,RAS,gene,0.991,34259881
2352,cetuximab,gene,0.7964,34259881
2353,panitumumab,gene,0.78,34259881
2354,BRAF,gene,0.993,34259881
2355,BRAF,gene,0.9927,34259881
2356,encorafenib,drug,0.9517,34259881
2357,cetuximab,gene,0.56,34259881
2358,BRAF-V600E,DNA,0.7603,34259881
2359,BRAF-V600E mutation,gene,0.913,34259881
2360,V600E,mutation,,34259881
2361,BRAF,gene,0.998,34259881
2362,mCRC,disease,0.996,34259881
2363,BRAF,gene,0.994,34259881
2364,mCRC,disease,0.998,34259881
2365,patients,species,0.9897,34259881
2366,BRAF,DNA,0.771,34259881
2367,BRAF mutations,gene,0.7783,34259881
2368,mCRC,disease,0.9985,34259881
2369,patients,species,0.994,34259881
2370,EGFR,gene,0.939,34253874
2371,colorectal cancer,disease,1.0,34253874
2372,Patient,species,0.7007,34253874
2373,EGFR,gene,0.94,34253874
2374,patients,species,0.8223,34253874
2375,RAS,gene,0.989,34253874
2376,BRAF,gene,0.9976,34253874
2377,metastatic colorectal cancer,disease,0.9995,34253874
2378,EGFR,gene,0.6665,34253874
2379,primary,disease,0.9834,34253874
2380,tumour,disease,0.8276,34253874
2381,CMS,DNA,0.4873,34253874
2382,oxaliplatin,drug,0.9995,34253874
2383,cetuximab,gene,0.647,34253874
2384,irinotecan,drug,0.996,34253874
2385,panitumumab,gene,0.9053,34253874
2386,Tumour,disease,0.981,34253874
2387,patients,species,0.9937,34253874
2388,irinotecan,drug,0.9985,34253874
2389,EGFR,gene,0.6997,34253874
2390,CMS4,disease,0.8105,34253874
2391,oxaliplatin,drug,0.9995,34253874
2392,left-sided CMS2/3 tumours,disease,0.9053,34253874
2393,EGFR,gene,0.785,34253874
2394,EGFR,gene,0.665,34253874
2395,patients,species,0.9663,34226158
2396,gastrointestinal cancers,disease,1.0,34226158
2397,malignancies,disease,1.0,34226158
2398,gastrointestinal cancers,disease,1.0,34226158
2399,patients,species,0.9805,34226158
2400,patients,species,0.9834,34226158
2401,patients,species,0.9863,34226158
2402,patients,species,0.9854,34226158
2403,patients,species,0.967,34226158
2404,gastrointestinal cancer,disease,1.0,34226158
2405,colorectal cancer,disease,1.0,34226158
2406,patients,species,0.962,34226158
2407,gastrointestinal carcinomas,disease,1.0,34226158
2408,colon and rectum,disease,0.9966,34226158
2409,esophagus,disease,0.689,34226158
2410,cetuximab,gene,0.9644,34226158
2411,panitumumab,gene,0.9463,34226158
2412,bevacizumab,gene,0.852,34226158
2413,ramucirumab,gene,0.564,34226158
2414,aflibercept,gene,0.987,34226158
2415,regorafenib,drug,0.9976,34226158
2416,encorafenib,drug,0.9966,34226158
2417,trastuzumab,gene,0.95,34226158
2418,sorafenib,drug,0.9995,34226158
2419,lenvatinib,drug,0.9985,34226158
2420,cabozantinib,drug,0.999,34226158
2421,erlotinib,drug,0.999,34226158
2422,olaparib,drug,0.9995,34226158
2423,EGFR,gene,0.991,34224369
2424,patients,species,0.9663,34224369
2425,metastatic colorectal cancer,disease,1.0,34224369
2426,EGFR,gene,0.701,34224369
2427,patients,species,0.9844,34224369
2428,panitumumab,gene,0.862,34224369
2429,circulating tumor DNA,DNA,0.812,34224369
2430,EGFR,gene,0.94,34224369
2431,Zr-89,drug,0.999,34214913
2432,Sm-153,drug,0.996,34214913
2433,Lu-177,drug,0.9946,34214913
2434,MIRDOSE3,DNA,0.508,34214913
2435,Eckerman stylized family phantoms,cell_line,0.511,34214913
2436,(89)Zr,drug,0.999,34214913
2437,(153)Sm,drug,0.998,34214913
2438,(177)Lu,drug,0.999,34214913
2439,(89)Zr,drug,0.999,34214913
2440,(153)Sm,drug,0.999,34214913
2441,(177)Lu,drug,0.999,34214913
2442,(89)Zr,drug,0.9995,34214913
2443,Zr,drug,,34214913
2444,cMAb U36,gene,0.9165,34214913
2445,Zr-89,drug,0.9756,34214913
2446,Panitumumab,gene,0.4265,34214913
2447,patients,species,0.996,34214913
2448,Zr-89,drug,0.9976,34214913
2449,red bone marrow,cell_type,0.525,34214913
2450,(177)Lu-EDTMP,drug,0.98,34214913
2451,patients,species,0.9756,34213592
2452,Panitumumab,gene,0.7324,34213592
2453,human,species,0.8047,34213592
2454,epidermal growth factor receptor,gene,0.996,34213592
2455,wild,DNA,0.667,34213592
2456,wild-type RAS,gene,0.993,34213592
2457,metastatic colorectal cancer,disease,1.0,34213592
2458,mCRC,disease,1.0,34213592
2459,organ impairment,disease,0.9775,34213592
2460,panitumumab,gene,0.8516,34213592
2461,panitumumab,gene,0.8687,34213592
2462,patients,species,0.93,34213592
2463,mCRC,disease,0.9976,34213592
2464,hepatic or renal impairment,disease,0.999,34213592
2465,panitumumab,gene,0.903,34213592
2466,patients,species,0.9473,34213592
2467,Patients,species,0.9893,34213592
2468,panitumumab,gene,0.8833,34213592
2469,patients,species,0.989,34213592
2470,hepatic and renal organ dysfunction,disease,1.0,34213592
2471,patients,species,0.9873,34213592
2472,hepatic impairment,disease,0.6763,34213592
2473,panitumumab,gene,0.722,34213592
2474,panitumumab,gene,0.8896,34213592
2475,patients,species,0.99,34213592
2476,renal impairment,disease,1.0,34213592
2477,panitumumab,gene,0.7134,34213592
2478,renal or hepatic impairment,disease,1.0,34213592
2479,panitumumab,gene,0.7812,34213592
2480,patients,species,0.9805,34213592
2481,mCRC,disease,0.9995,34213592
2482,hepatic or renal impairment,disease,0.9995,34213592
2483,patient,species,0.972,34213592
2484,panitumumab,gene,0.797,34213592
2485,patients,species,0.9453,34213592
2486,mCRC,disease,0.998,34213592
2487,hepatic or renal dysfunction,disease,0.999,34213592
2488,panitumumab,gene,0.8335,34213592
2489,patients,species,0.8613,34213592
2490,mCRC,disease,0.9976,34213592
2491,panitumumab,gene,0.891,34213592
2492,patients,species,0.926,34213592
2493,mCRC,disease,0.994,34213592
2494,hepatic or renal dysfunction,disease,0.999,34213592
2495,IgG1,gene,0.992,34205175
2496,FcRIIA,gene,0.9927,34205175
2497,Platelet,cell_type,0.4297,34205175
2498,FcRIIA,gene,0.999,34205175
2499,CD32A,gene,0.9956,34205175
2500,platelets,cell_type,0.8003,34205175
2501,myeloid,cell_line,0.6216,34205175
2502,endothelial cells,cell_type,0.6167,34205175
2503,IgG,gene,0.76,34205175
2504,H131R,mutation,,34205175
2505,histidine,drug,0.998,34205175
2506,arginine,drug,0.9946,34205175
2507,multimeric IgG2,gene,0.9766,34205175
2508,Platelet FcRIIA,gene,0.9556,34205175
2509,IgG,gene,0.987,34205175
2510,platelet FcRIIA,gene,0.666,34205175
2511,IgG,gene,0.7847,34205175
2512,platelets,cell_type,0.726,34205175
2513,FcRIIA,gene,0.991,34205175
2514,IgG antibody,gene,0.9253,34205175
2515,infliximab,gene,0.977,34205175
2516,IgG1,gene,0.995,34205175
2517,Crohn&#x27;s disease,disease,0.9995,34205175
2518,platelet,cell_type,0.6343,34205175
2519,FcRIIA,gene,0.9897,34205175
2520,infliximab,gene,0.983,34205175
2521,R allele,DNA,0.7896,34205175
2522,patients,species,0.975,34205175
2523,infliximab,gene,0.9385,34205175
2524,IgG1,gene,0.736,34205175
2525,platelet,cell_type,0.6045,34205175
2526,platelet FcRIIA H and R allotypes,gene,0.886,34205175
2527,panitumumab,gene,0.8896,34205175
2528,IgG2,gene,0.993,34205175
2529,infliximab,gene,0.909,34205175
2530,IgG1 antibody,gene,0.994,34205175
2531,platelet,cell_type,0.5376,34205175
2532,platelet FcRIIA,gene,0.824,34205175
2533,IgG2,gene,0.995,34205175
2534,EGFR,gene,0.952,34188197
2535,metastatic colorectal cancer,disease,0.9966,34188197
2536,metastatic rectal cancer,disease,1.0,34188197
2537,left-sided colon cancer,disease,0.985,34188197
2538,rectal cancers,disease,0.9976,34188197
2539,epidermal growth factor receptor,gene,0.973,34188197
2540,EGFR,gene,0.9946,34188197
2541,middle/low rectal and left-sided colon cancers,disease,1.0,34188197
2542,patients,species,0.9805,34188197
2543,metastatic colorectal cancer,disease,0.9995,34188197
2544,EGFR,gene,0.9717,34188197
2545,tumour,disease,0.999,34188197
2546,anti-,gene,0.8022,34188197
2547,EGFR,gene,0.641,34188197
2548,colorectal cancer,disease,1.0,34188197
2549,Cancer,disease,0.931,34188197
2550,patients,species,0.972,34188197
2551,middle/low rectal tumours,disease,1.0,34188197
2552,left-sided colon cancer,disease,1.0,34188197
2553,anti-EGFR,gene,0.6973,34188197
2554,rectal tumours,disease,1.0,34188197
2555,left- and right-sided colon cancer,disease,1.0,34188197
2556,EGFR,gene,0.981,34188197
2557,metastatic middle/low rectal cancer,disease,0.9956,34188197
2558,left-sided colon cancer,disease,1.0,34188197
2559,Pulmonary Toxicity,disease,0.981,34182912
2560,COVID-19 Pneumonia,disease,1.0,34182912
2561,COVID-19,disease,0.999,34182912
2562,pneumonic infiltration,disease,1.0,34182912
2563,ground-glass opacities,disease,1.0,34182912
2564,COVID-19 pneumonia,disease,1.0,34182912
2565,CPT,disease,0.9316,34182912
2566,CPT,disease,1.0,34182912
2567,COVID-19 pneumonia,disease,1.0,34182912
2568,patient,species,0.979,34182912
2569,5-fluorouracil,drug,0.9995,34182912
2570,folinicacid,drug,0.9995,34182912
2571,oxaliplatin,drug,0.9995,34182912
2572,panitumumab,gene,0.511,34182912
2573,FOLFOX,drug,0.886,34182912
2574,metastatic rectal cancer,disease,1.0,34182912
2575,patient,species,0.9707,34182912
2576,testicular seminoma,disease,1.0,34182912
2577,bleomycin,drug,0.9995,34182912
2578,etoposide,drug,0.99,34182912
2579,cisplatin,drug,0.9995,34182912
2580,patients,species,0.988,34182912
2581,dyspnea,disease,0.9995,34182912
2582,COVID-19 pneumonia,disease,1.0,34182912
2583,COVID-19,disease,0.877,34182912
2584,patients,species,0.9814,34182912
2585,oncologic,disease,0.963,34182912
2586,patients,species,0.9805,34182912
2587,COVID-19 pneumonia,disease,1.0,34182912
2588,Patients,species,0.9727,34176711
2589,Locally Advanced Rectal AIMS,disease,0.999,34176711
2590,leucovorin,drug,0.999,34176711
2591,oxaliplatin,drug,0.9995,34176711
2592,irinotecan,drug,0.999,34176711
2593,patients,species,0.9575,34176711
2594,locally advanced rectal cancer,disease,0.9897,34176711
2595,patients,species,0.982,34176711
2596,Ras,gene,0.998,34176711
2597,BRAF,gene,0.9985,34176711
2598,patients,species,0.983,34176711
2599,Ras,gene,0.9736,34176711
2600,BRAF,gene,0.9976,34176711
2601,panitumumab,gene,0.8564,34176711
2602,cetuximab,gene,0.87,34176711
2603,Ras,gene,0.882,34176711
2604,BRAF,gene,0.9946,34176711
2605,oxaliplatin,drug,1.0,34176711
2606,5-fluorouracil,drug,0.9995,34176711
2607,tumour,disease,0.979,34176711
2608,patients,species,0.9824,34176711
2609,patients,species,0.967,34176711
2610,bevacizumab,gene,0.7764,34176711
2611,Ras,gene,0.9736,34176711
2612,BRAF,gene,0.9897,34176711
2613,patients,species,0.9795,34176711
2614,Ras,gene,0.968,34176711
2615,BRAF,gene,0.9966,34176711
2616,patients,species,0.982,34176711
2617,panitumumab,gene,0.8813,34176711
2618,cetuximab,gene,0.8955,34176711
2619,patients,species,0.988,34176711
2620,patients,species,0.9863,34176711
2621,febrile neutropenia,disease,0.999,34176711
2622,FOLFOXIRI,drug,0.661,34176711
2623,locally advanced rectal cancer,disease,0.9995,34176711
2624,patients,species,0.9873,34176711
2625,metastatic colorectal cancer,disease,1.0,34172397
2626,mCRC,disease,1.0,34172397
2627,tumor,disease,0.7065,34172397
2628,patient,species,0.9717,34172397
2629,patients,species,0.9814,34172397
2630,RAS,gene,0.9927,34172397
2631,mCRC,disease,0.9873,34172397
2632,BRAF,gene,0.9966,34172397
2633,patients,species,0.9746,34172397
2634,Patients,species,0.983,34172397
2635,BRAF,DNA,0.6553,34172397
2636,BRAF mutations,gene,0.8086,34172397
2637,BRAF,DNA,0.8657,34172397
2638,BRAF mutant,gene,0.9844,34172397
2639,Patients,species,0.9487,34172397
2640,mCRC,disease,0.9995,34172397
2641,BRAF mutations,gene,0.8955,34172397
2642,ETS,DNA,0.859,34172397
2643,Panitumumab,gene,0.711,34169732
2644,cetuximab,gene,0.7437,34169732
2645,miRNA,RNA,0.6665,34169732
2646,colorectal cancer,disease,1.0,34169732
2647,anti-EGFR monoclonal antibodies,gene,0.9785,34169732
2648,metastatic colorectal cancer,disease,1.0,34169732
2649,CRC,disease,1.0,34169732
2650,MicroRNAs,RNA,0.6216,34169732
2651,cetuximab,gene,0.9204,34169732
2652,panitumumab,gene,0.8105,34169732
2653,miR,RNA,0.6523,34169732
2654,colorectal cancer cells,cell_line,0.7515,34169732
2655,colorectal cancer,disease,1.0,34169732
2656,EGFR,gene,0.9956,34169732
2657,miR,RNA,0.5845,34169732
2658,patients,species,0.9688,34169732
2659,advanced CRC,disease,1.0,34169732
2660,cetuximab,gene,0.898,34169732
2661,panitumumab,gene,0.881,34169732
2662,Cetuximab,gene,0.9434,34169732
2663,panitumumab,gene,0.8994,34169732
2664,miR,RNA,0.44,34169732
2665,miRnome panel,DNA,0.496,34169732
2666,EGFR,gene,0.991,34169732
2667,anti-EGFR monoclonal antibody,gene,0.9727,34169732
2668,miR,gene,0.554,34169732
2669,miR-139-5p,RNA,0.461,34169732
2670,miR-145-5p,RNA,0.6523,34169732
2671,miR-429,RNA,0.6567,34169732
2672,miR,gene,0.553,34169732
2673,miR-1247-5p,RNA,0.5425,34169732
2674,miR-139-5p,gene,0.8784,34169732
2675,miR-145-5p,gene,0.8857,34169732
2676,patients,species,0.959,34169732
2677,metastatic CRC,disease,0.9995,34169732
2678,Neuropathic Cancer Pain,disease,1.0,34161812
2679,Patients,species,0.9927,34161812
2680,EGFR,gene,0.9937,34161812
2681,tumour,disease,1.0,34158844
2682,malignancies,disease,0.9995,34158844
2683,patients,species,0.9775,34158844
2684,oral squamous cell carcinoma,disease,1.0,34158844
2685,OSCC,disease,1.0,34158844
2686,Patients,species,0.9854,34158844
2687,Panitumumab,gene,0.9727,34158844
2688,tumour,disease,0.96,34158844
2689,Panitumumab,gene,0.969,34158844
2690,benign LNs,cell_type,0.501,34158844
2691,patient,species,0.9824,34158844
2692,tumour,disease,1.0,34158844
2693,malignancies,disease,0.958,34158844
2694,tumour,disease,1.0,34158844
2695,EGFR,gene,0.9946,34158840
2696,high-grade glioma,disease,1.0,34158840
2697,high-grade gliomas,disease,1.0,34158840
2698,HGGs,disease,1.0,34158840
2699,epidermal growth factor receptor,gene,0.9985,34158840
2700,EGFR,gene,0.9966,34158840
2701,HGG,disease,1.0,34158840
2702,anti-EGFR antibody,gene,0.9595,34158840
2703,panitumuab-,gene,0.6694,34158840
2704,HGG,disease,1.0,34158840
2705,patients,species,0.965,34158840
2706,HGGs,disease,0.9995,34158840
2707,panitumumab,gene,0.9663,34158840
2708,tumor,disease,0.9087,34158840
2709,tumor,disease,0.991,34158840
2710,EGFR,gene,0.9805,34158840
2711,panitumumab,gene,0.953,34158840
2712,panitumumab,gene,0.983,34158840
2713,tumor,disease,1.0,34158840
2714,panitumumab,gene,0.9805,34158840
2715,EGFR,gene,0.992,34158840
2716,HGG,disease,1.0,34158840
2717,tumor tissue,cell_type,0.4585,34158840
2718,tumor,disease,0.999,34158840
2719,Panitumumab,gene,0.9785,34158840
2720,tumor,disease,0.741,34158840
2721,tumor,disease,0.9956,34158840
2722,NeoRAS,DNA,0.603,34153718
2723,NeoRAS wild,gene,0.801,34153718
2724,metastatic colorectal cancer,disease,1.0,34153718
2725,KRAS,gene,0.99,34153718
2726,NRAS gene,gene,0.835,34153718
2727,RAS,gene,0.9233,34153718
2728,metastatic colorectal cancer,disease,1.0,34153718
2729,mCRC,disease,0.993,34153718
2730,RAS,DNA,0.8945,34153718
2731,RAS mutation,gene,0.9707,34153718
2732,anti-EGFR antibodies,gene,0.969,34153718
2733,cetuximab,gene,0.82,34153718
2734,panitumumab,gene,0.753,34153718
2735,RAS wild-type (WT) mCRC,cell_line,0.505,34153718
2736,RAS,gene,0.9893,34153718
2737,mCRC,disease,0.999,34153718
2738,RAS,DNA,0.675,34153718
2739,RAS WT,gene,0.9946,34153718
2740,RAS MT mCRC,cell_line,0.616,34153718
2741,RAS MT,gene,0.9795,34153718
2742,mCRC,disease,0.994,34153718
2743,anti-,gene,0.818,34153718
2744,EGFR antibodies,gene,0.758,34153718
2745,NeoRAS,gene,0.9893,34153718
2746,RAS,DNA,0.573,34153718
2747,RAS MT,gene,0.995,34153718
2748,RAS WT,gene,0.9956,34153718
2749,RAS,gene,0.997,34153718
2750,mCRC,disease,0.999,34153718
2751,patients,species,0.994,34153718
2752,RAS MT,gene,0.9966,34153718
2753,RAS WT,gene,0.9966,34153718
2754,NeoRAS,cell_line,0.5728,34153718
2755,NeoRAS WT,gene,0.635,34153718
2756,patients,species,0.9834,34153718
2757,anti-,gene,0.806,34153718
2758,EGFR antibodies,gene,0.734,34153718
2759,NeoRAS,gene,0.979,34153718
2760,mCRC,disease,0.9985,34153718
2761,patients,species,0.9956,34153718
2762,RAS,gene,0.982,34153718
2763,mCRC,disease,0.996,34153718
2764,Anti-,gene,0.7734,34153718
2765,EGFR antibodies,gene,0.7676,34153718
2766,patients,species,0.9937,34153718
2767,patients,species,0.9927,34153718
2768,NeoRAS WT,gene,0.995,34153718
2769,RAS,gene,0.9956,34153718
2770,patients,species,0.9844,34153718
2771,RAS,gene,0.945,34153718
2772,mCRC,disease,0.9976,34153718
2773,anti-EGFR antibodies,gene,0.915,34153718
2774,Panitumumab,gene,0.6924,34152568
2775,Panitumumab,gene,0.6636,34152568
2776,human,species,0.9106,34152568
2777,epidermal growth factor receptor,gene,0.9956,34152568
2778,EGFR,gene,0.9927,34152568
2779,tumors,disease,1.0,34152568
2780,EGFR,gene,0.9834,34152568
2781,Panitumumab,gene,0.6675,34152568
2782,wild-type RAS,gene,0.913,34152568
2783,KRAS,gene,0.993,34152568
2784,NRAS,gene,0.9937,34152568
2785,metastatic colorectal cancer,disease,0.9746,34152568
2786,panitumumab,gene,0.84,34152568
2787,panitumumab,gene,0.6133,34152568
2788,Panitumumab,gene,0.861,34152568
2789,renal or hepatic impairment,disease,1.0,34152568
2790,panitumumab,gene,0.863,34152568
2791,irinotecan,drug,0.9985,34152568
2792,paclitaxel,drug,0.9995,34152568
2793,carboplatin,drug,0.9995,34152568
2794,tumor,cell_type,0.4553,34152568
2795,panitumumab,gene,0.6816,34152568
2796,anti-panitumumab antibodies,gene,0.977,34152568
2797,anti-panitumumab antibodies,gene,0.992,34152568
2798,panitumumab,gene,0.8657,34152568
2799,panitumumab,gene,0.816,34152568
2800,wild-type RAS,gene,0.9917,34152568
2801,patients,species,0.9785,34152568
2802,Metastatic Colorectal Cancer,disease,1.0,34139727
2803,FOLFIRI,drug,0.9272,34139727
2804,patients,species,0.9463,34139727
2805,metastatic colorectal cancer,disease,0.9985,34139727
2806,patients,species,0.956,34139727
2807,FOLFIRI,drug,0.9263,34139727
2808,metastatic colorectal cancer,disease,0.9985,34139727
2809,FOLFIRI,drug,0.8647,34139727
2810,irinotecan,drug,0.991,34139727
2811,irinotecan,drug,0.996,34139727
2812,FOLFIRI,drug,0.796,34139727
2813,patients,species,0.9653,34139727
2814,wild-type RAS,gene,0.9404,34139727
2815,primary tumors,disease,0.99,34139727
2816,epidermal growth factor receptor,gene,0.95,34139727
2817,panitumumab,gene,0.671,34139727
2818,cetuximab,gene,0.517,34139727
2819,FOLFIRI,drug,0.9316,34139727
2820,patients,species,0.9883,34139727
2821,nephrosis syndrome,disease,1.0,34139727
2822,metastatic colorectal cancer,disease,0.981,34120762
2823,Colorectal cancer,disease,0.9995,34120762
2824,tumor,disease,1.0,34120762
2825,metastatic colorectal cancer,disease,1.0,34120762
2826,Patients,species,0.99,34120762
2827,primary,disease,0.931,34120762
2828,tumor,disease,0.989,34120762
2829,tumor&#,DNA,0.806,34120762
2830,tumor,disease,0.661,34120762
2831,wild-type RAS,gene,0.904,34120762
2832,BRAF,gene,0.994,34120762
2833,cetuximab,gene,0.8916,34120762
2834,panitumumab,gene,0.8643,34120762
2835,tumors,disease,1.0,34120762
2836,bevacizumab,gene,0.6113,34120762
2837,right,DNA,0.7656,34120762
2838,right-sided tumors,disease,0.994,34120762
2839,metastatic colorectal cancer,disease,0.9995,34120762
2840,tumor,disease,1.0,34120762
2841,EGFR,gene,0.995,34098908
2842,patients,species,0.978,34098908
2843,RAS,gene,0.991,34098908
2844,BRAF V600E,gene,0.893,34098908
2845,V600E,mutation,,34098908
2846,metastatic colorectal cancer,disease,0.9883,34098908
2847,mCRC,disease,1.0,34098908
2848,RAS,gene,0.9976,34098908
2849,circulating tumor DNA,DNA,0.5576,34098908
2850,ctDNA,DNA,0.522,34098908
2851,patients,species,0.9897,34098908
2852,anti-EGFR mAb,gene,0.9717,34098908
2853,plasma,gene,0.5957,34098908
2854,RAS,gene,0.573,34098908
2855,patients,species,0.986,34098908
2856,mCRC,disease,0.9946,34098908
2857,RAS,gene,0.9863,34098908
2858,BRAF,gene,0.9956,34098908
2859,V600E,mutation,,34098908
2860,anti-,gene,0.5366,34098908
2861,EGFR,gene,0.688,34098908
2862,panitumumab,gene,0.9004,34098908
2863,irinotecan,drug,0.9995,34098908
2864,patients,species,0.984,34098908
2865,RAS mutations,gene,0.801,34098908
2866,ctDNA,DNA,0.8916,34098908
2867,plasma RAS,gene,0.8613,34098908
2868,RAS,gene,0.9863,34098908
2869,BRAF V600E,gene,0.8945,34098908
2870,V600E,mutation,,34098908
2871,mCRC,disease,0.945,34098908
2872,fluoropyrimidine,drug,0.999,34098908
2873,oxaliplatin,drug,0.9995,34098908
2874,irinotecan,drug,0.999,34098908
2875,EGFR,gene,0.6733,34098908
2876,RAS,gene,0.8384,34098908
2877,RAS0,gene,0.9854,34098908
2878,anti-EGFR mAb,gene,0.988,34098908
2879,patients,species,0.9863,34098908
2880,CRC,disease,0.9316,34098908
2881,ctDNA,DNA,0.868,34098908
2882,anti-EGFR mAb,gene,0.957,34098908
2883,patients,species,0.939,34098908
2884,plasma,gene,0.5566,34098908
2885,RAS,gene,0.6797,34098908
2886,patients,species,0.9795,34098908
2887,RAS,gene,0.728,34098908
2888,KRAS,DNA,0.616,34094546
2889,KRAS mutations,gene,0.785,34094546
2890,colorectal cancer,disease,1.0,34094546
2891,Colorectal cancer,disease,1.0,34094546
2892,Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) gene,DNA,0.8477,34094546
2893,Kirsten rat sarcoma 2 viral oncogene homolog,gene,0.998,34094546
2894,KRAS,gene,0.995,34094546
2895,EGFR,gene,0.9854,34094546
2896,G12D,mutation,,34094546
2897,KRAS,DNA,0.7954,34094546
2898,KRAS mutation,gene,0.909,34094546
2899,colorectal cancer,disease,1.0,34094546
2900,G12V,mutation,,34094546
2901,G13D,DNA,0.514,34094546
2902,G13D,mutation,,34094546
2903,patients,species,0.9673,34094546
2904,colorectal cancer,disease,1.0,34094546
2905,G12D and G12V KRAS mutations,DNA,0.5557,34094546
2906,G12D,gene,0.649,34094546
2907,G12D,mutation,,34094546
2908,G12V,mutation,,34094546
2909,EGFR,gene,0.933,34094546
2910,G13D,gene,0.758,34094546
2911,G13D,mutation,,34094546
2912,KRAS,DNA,0.6265,34094546
2913,KRAS mutations,gene,0.8374,34094546
2914,G12A,DNA,0.7437,34094546
2915,G12A,mutation,,34094546
2916,G12C,mutation,,34094546
2917,G12S,DNA,0.7207,34094546
2918,G12S,mutation,,34094546
2919,Q61H,DNA,0.4712,34094546
2920,Q61H,mutation,,34094546
2921,A146T,mutation,,34094546
2922,anti-EGFR antibodies,gene,0.8696,34094546
2923,mix culture,cell_line,0.6553,34094546
2924,KRAS mutations,gene,0.8228,34094546
2925,EGFR,gene,0.6836,34094546
2926,Cetuximab,gene,0.762,34094546
2927,panitumumab,gene,0.784,34094546
2928,MEK,gene,0.991,34094546
2929,BCL-XL,gene,0.992,34094546
2930,colorectal cancer cells,cell_line,0.7935,34094546
2931,colorectal cancer,disease,1.0,34094546
2932,KRAS,gene,0.9927,34094546
2933,MEK,gene,0.9795,34094546
2934,BCL-XL,gene,0.977,34094546
2935,KRAS minor,DNA,0.545,34094546
2936,KRAS,gene,0.991,34094546
2937,AMG510,drug,0.976,34094546
2938,KRAS,DNA,0.638,34094546
2939,KRAS G12C,gene,0.956,34094546
2940,G12C,DNA,0.79,34094546
2941,G12C,mutation,,34094546
2942,AMG510,drug,0.991,34094546
2943,colon cancer cells,cell_line,0.6714,34094546
2944,colon cancer,disease,1.0,34094546
2945,G12C KRAS,DNA,0.6055,34094546
2946,G12C KRAS mutation,gene,0.8516,34094546
2947,G12C,mutation,,34094546
2948,MEK,gene,0.9917,34094546
2949,BCL-XL,gene,0.993,34094546
2950,AMG510,drug,0.9854,34094546
2951,colon cancer cells,cell_line,0.7295,34094546
2952,colon cancer,disease,1.0,34094546
2953,AMG510,drug,0.997,34094546
2954,MEK,gene,0.9966,34094546
2955,BCL-XL,gene,0.9937,34094546
2956,patients,species,0.945,34094546
2957,colorectal cancer,disease,1.0,34094546
2958,G12C,DNA,0.8354,34094546
2959,G12C KRAS mutation,gene,0.8564,34094546
2960,G12C,mutation,,34094546
2961,KRAS,DNA,0.4688,34094546
2962,epidermal growth factor receptor,gene,0.999,34058788
2963,tumor,disease,0.997,34058788
2964,Integrin associated protein,gene,0.994,34058788
2965,CD47,gene,0.995,34058788
2966,tumor cells,cell_type,0.8335,34058788
2967,tumor,disease,1.0,34058788
2968,signal regulatory protein alpha,gene,0.989,34058788
2969,SIRP,gene,0.9834,34058788
2970,myeloid cells,cell_type,0.8774,34058788
2971,glutaminyl,drug,0.6045,34058788
2972,glutaminyl cyclase,gene,0.853,34058788
2973,QC,gene,0.9995,34058788
2974,Glutaminyl,drug,0.971,34058788
2975,Glutaminyl cyclase,gene,0.979,34058788
2976,N,drug,1.0,34058788
2977,pyro-glutamate,drug,0.998,34058788
2978,CD47,gene,0.9785,34058788
2979,SIRP binding site,gene,0.9663,34058788
2980,QC,gene,,34058788
2981,myeloid effector cell,cell_type,0.642,34058788
2982,tumor,disease,1.0,34058788
2983,epidermal growth factor receptor,gene,0.9976,34058788
2984,EGFR,gene,0.925,34058788
2985,Ab isotypes,gene,0.8247,34058788
2986,SEN177,drug,0.9927,34058788
2987,EGFR Ab,gene,0.995,34058788
2988,mononuclear cells,cell_type,0.905,34058788
2989,human,species,0.7744,34058788
2990,SIRP,gene,0.901,34058788
2991,SEN177,drug,0.9487,34058788
2992,cancer cells,cell_type,0.7954,34058788
2993,cancer,disease,0.9526,34058788
2994,glutamate,drug,0.9326,34058788
2995,CD47,gene,0.9785,34058788
2996,Glutaminyl,drug,0.9673,34058788
2997,Glutaminyl cyclase,gene,0.9854,34058788
2998,tumor cells,cell_line,0.598,34058788
2999,tumor,disease,0.9995,34058788
3000,macrophages,cell_type,0.719,34058788
3001,polymorphonuclear neutrophilic granulocytes,cell_type,0.531,34058788
3002,Polymorphonuclear neutrophilic granulocyte,cell_type,0.8125,34058788
3003,EGFR Abs,gene,0.9946,34058788
3004,human IgG2,gene,0.926,34058788
3005,human,species,0.933,34058788
3006,IgA2 isotypes,gene,0.886,34058788
3007,IgG1 Abs,gene,0.9883,34058788
3008,EGFR Abs,gene,0.9556,34058788
3009,myeloid effector cell,cell_type,0.82,34058788
3010,EGFR Abs,gene,0.9688,34058788
3011,QC,gene,,34058788
3012,panitumumab,gene,0.864,34000921
3013,interstitial lung disease,disease,1.0,34000921
3014,patient,species,0.9785,34000921
3015,cancer,disease,0.9995,34000921
3016,Panitumumab,gene,0.69,34000921
3017,epidermal growth factor receptor,gene,0.9976,34000921
3018,EGFR,gene,0.9946,34000921
3019,metastatic colorectal carcinoma,disease,0.9395,34000921
3020,panitumumab,gene,0.7046,34000921
3021,patients,species,0.972,34000921
3022,interstitial lung disease,disease,1.0,34000921
3023,ILD,disease,1.0,34000921
3024,panitumumab,gene,0.9224,34000921
3025,ILD,disease,0.966,34000921
3026,pneumomediastinum,disease,1.0,34000921
3027,subcutaneous emphysema,disease,1.0,34000921
3028,metastatic colorectal carcinoma,disease,0.9985,34000921
3029,FOLFIRI,drug,0.6235,34000921
3030,folinic acid,drug,0.9995,34000921
3031,5-fluorouracil,drug,0.9995,34000921
3032,irinotecan,drug,0.9976,34000921
3033,panitumumab,gene,0.8657,34000921
3034,dyspnea,disease,0.9976,34000921
3035,dyspnea,disease,0.9985,34000921
3036,patient,species,0.983,34000921
3037,ILD,disease,1.0,34000921
3038,pneumomediastinum,disease,1.0,34000921
3039,subcutaneous emphysema,disease,1.0,34000921
3040,panitumumab,gene,0.593,34000921
3041,ILD,disease,1.0,34000921
3042,Oxygen,drug,0.996,34000921
3043,methylprednisolone,drug,0.661,34000921
3044,patient,species,0.9883,34000921
3045,Panitumumab,gene,0.8325,34000921
3046,ILD,disease,0.9976,34000921
3047,Monoclonal Antibodies,gene,0.687,33999602
3048,Bevacizumab,gene,0.4775,33999602
3049,patient,species,0.9966,33999602
3050,mAb Bevacizumab,gene,0.8525,33999602
3051,patient,species,0.9966,33999602
3052,nylon,drug,0.775,33999602
3053,Bevacizumab,gene,0.9204,33999602
3054,Rituximab,gene,0.956,33999602
3055,Panitumumab,gene,0.903,33999602
3056,capture,DNA,0.607,33999602
3057,mAbs,gene,0.6074,33999602
3058,Bevacizumab,gene,0.801,33999602
3059,rare,cell_line,0.6187,33983701
3060,rare cells,cell_type,0.879,33983701
3061,patient,species,0.8887,33983701
3062,cell model,cell_line,0.8623,33983701
3063,tumor,disease,1.0,33983701
3064,3D cell spheroids,cell_line,0.7817,33983701
3065,tumors,disease,1.0,33983701
3066,cell lines,cell_line,0.8853,33983701
3067,Caco-2,cell_line,0.927,33983701
3068,MCF-7,cell_line,0.861,33983701
3069,HeLa,cell_line,0.8193,33983701
3070,patients,species,0.985,33983701
3071,colon cancer,disease,1.0,33983701
3072,5-fluorouracil,drug,0.9995,33983701
3073,cetuximab,gene,0.939,33983701
3074,panitumumab,gene,0.93,33983701
3075,patients,species,0.992,33983701
3076,patient,species,0.951,33983701
3077,tumor,disease,1.0,33983701
3078,Subarachnoid Hemorrhage,disease,1.0,33976060
3079,Bevacizumab,gene,0.8423,33976060
3080,woman,species,0.94,33976060
3081,cStage  sigmoid colon cancer,disease,0.891,33976060
3082,RAS gene,gene,0.9854,33976060
3083,EGFR,gene,0.9946,33976060
3084,panitumumab,gene,0.8833,33976060
3085,pani,gene,0.883,33976060
3086,liver,disease,0.961,33976060
3087,CEA,gene,0.987,33976060
3088,hilar lymph,DNA,0.881,33976060
3089,FOLFIRI,drug,0.989,33976060
3090,pani,drug,0.8447,33976060
3091,metastatic liver tumor,disease,0.9995,33976060
3092,TAS102,drug,0.9966,33976060
3093,bevacizumab,gene,0.6772,33976060
3094,headache,disease,0.5493,33976060
3095,vomiting,disease,0.9575,33976060
3096,subarachnoid hemorrhage,disease,0.999,33976060
3097,brain metastases,disease,1.0,33976060
3098,organic lesions,disease,1.0,33976060
3099,cerebral aneurysms,disease,1.0,33976060
3100,stenotic lesions,disease,1.0,33976060
3101,bevacizumab,gene,0.5913,33976060
3102,Liver Metastasis,disease,0.9956,33976045
3103,Colorectal Cancer,disease,0.9985,33976045
3104,Patient,species,0.98,33976045
3105,man,species,0.9155,33976045
3106,chronic renal failure,disease,0.999,33976045
3107,diabetic nephropathy,disease,1.0,33976045
3108,sigmoid colon cancer,disease,1.0,33976045
3109,tumor,disease,0.993,33976045
3110,adenocarcinoma,disease,1.0,33976045
3111,RAS,gene,0.994,33976045
3112,BRAF,gene,0.9966,33976045
3113,panitumumab,gene,0.8745,33976045
3114,oxaliplatin,drug,1.0,33976045
3115,fluorouracil,drug,0.9956,33976045
3116,fluorouracil,drug,0.9976,33976045
3117,Leucovorin,drug,0.9985,33976045
3118,panitumumab,gene,0.8457,33976045
3119,colorectal cancer,disease,1.0,33976045
3120,metastatic colorectal,disease,0.998,33973081
3121,patient,species,0.9546,33973081
3122,metastatic colorectal cancer,disease,1.0,33973081
3123,mCRC,disease,1.0,33973081
3124,patients,species,0.982,33973081
3125,skin rash,disease,0.9995,33973081
3126,Vectibix,drug,0.998,33973081
3127,patient,species,0.996,33973081
3128,mCRC,disease,0.9985,33973081
3129,patients,species,0.9824,33973081
3130,Vectibix,drug,0.9565,33973081
3131,Vectibix,drug,0.9307,33973081
3132,cetuximab,gene,0.862,33973081
3133,Vectibix,drug,0.737,33973081
3134,Vectibix,drug,0.996,33973081
3135,skin rash,disease,0.9985,33973081
3136,Vectibix,drug,0.533,33973081
3137,rash,disease,0.9956,33973081
3138,patients,species,0.991,33973081
3139,rash,disease,0.991,33973081
3140,patients,species,0.991,33973081
3141,rash,disease,0.994,33973081
3142,rash,disease,0.9995,33973081
3143,rash,disease,0.9995,33973081
3144,patients,species,0.9897,33973081
3145,rash,disease,0.9854,33973081
3146,rash,disease,0.9863,33973081
3147,patients,species,0.9854,33973081
3148,patient,species,0.9873,33973081
3149,rash,disease,1.0,33973081
3150,skin toxicity,disease,0.8994,33973081
3151,patient,species,0.993,33973081
3152,patients,species,0.983,33973081
3153,rash,disease,0.993,33973081
3154,BRAF,DNA,0.8745,33956173
3155,BRAF-V600E,gene,0.9346,33956173
3156,V600E,DNA,0.4207,33956173
3157,V600E,mutation,,33956173
3158,metastatic colorectal cancer,disease,1.0,33956173
3159,metastatic colorectal cancer,disease,1.0,33956173
3160,mCRC,disease,1.0,33956173
3161,irinotecan,drug,0.9995,33956173
3162,oxaliplatin,drug,0.9995,33956173
3163,epidermal,gene,0.8613,33956173
3164,EGFR,gene,0.9966,33956173
3165,cetuximab,gene,0.9004,33956173
3166,panitumumab,gene,0.8955,33956173
3167,bevacizumab,gene,0.686,33956173
3168,aflibercept,gene,0.9365,33956173
3169,mCRC,disease,0.995,33956173
3170,mCRC,disease,0.975,33956173
3171,patients,species,0.9946,33956173
3172,RAS,gene,0.991,33956173
3173,cetuximab,gene,0.7964,33956173
3174,panitumumab,gene,0.78,33956173
3175,BRAF,gene,0.993,33956173
3176,BRAF,gene,0.9927,33956173
3177,encorafenib,drug,0.9517,33956173
3178,cetuximab,gene,0.56,33956173
3179,BRAF-V600E,DNA,0.771,33956173
3180,BRAF-V600E mutation,gene,0.913,33956173
3181,V600E,mutation,,33956173
3182,BRAF,gene,0.998,33956173
3183,mCRC,disease,0.996,33956173
3184,BRAF,gene,0.994,33956173
3185,mCRC,disease,0.998,33956173
3186,patients,species,0.9897,33956173
3187,BRAF,DNA,0.802,33956173
3188,BRAF mutations,gene,0.7783,33956173
3189,mCRC,disease,0.9985,33956173
3190,patients,species,0.994,33956173
3191,colorectal cancer,disease,1.0,33950515
3192,patients,species,0.99,33950515
3193,colorectal adenocarcinoma,disease,1.0,33950515
3194,patients,species,0.9565,33950515
3195,colon,disease,0.999,33950515
3196,patients,species,0.966,33950515
3197,oxaliplatin,drug,0.997,33950515
3198,oxaliplatin,drug,0.9995,33950515
3199,irinotecan,drug,0.998,33950515
3200,cetuximab,gene,0.686,33950515
3201,panitumumab,gene,0.5635,33950515
3202,patients,species,0.9614,33950515
3203,rectal cancer,disease,1.0,33950515
3204,oxaliplatin,drug,0.997,33950515
3205,oxaliplatin,drug,0.9995,33950515
3206,irinotecan,drug,0.999,33950515
3207,patients,species,0.989,33950515
3208,Pmab,gene,0.971,33938493
3209,Pmab,gene,0.9834,33938493
3210,floxuridine,drug,0.9985,33938493
3211,FUDR,drug,0.999,33938493
3212,leucovorin,drug,0.999,33938493
3213,fluorouracil,drug,0.9995,33938493
3214,irinotecan,drug,0.999,33938493
3215,FOLFIRI,drug,0.999,33938493
3216,patients,species,0.981,33938493
3217,RAS,DNA,0.5684,33938493
3218,RAS wild,gene,0.793,33938493
3219,patients,species,0.9463,33938493
3220,KRAS,gene,0.996,33938493
3221,colorectal liver metastases,disease,1.0,33938493
3222,SYS,drug,0.7524,33938493
3223,FOLFIRI,drug,0.4146,33938493
3224,Patients,species,0.972,33938493
3225,patients,species,0.979,33938493
3226,patients,species,0.9795,33938493
3227,Patient,species,0.994,33938493
3228,rash,disease,0.8257,33938493
3229,bilirubin,drug,0.9946,33938493
3230,alkaline phosphatase,gene,0.992,33938493
3231,patients,species,0.989,33938493
3232,patients,species,0.973,33938493
3233,Pmab,gene,0.757,33938493
3234,Pmab,DNA,0.7397,33938493
3235,Pmab,gene,0.938,33938493
3236,Pmab,gene,0.869,33938493
3237,SYS FOLFIRI,drug,0.675,33938493
3238,human-EGFR,gene,0.7075,33933782
3239,human,species,0.976,33933782
3240,mouse,species,0.976,33933782
3241,tumor,disease,0.998,33933782
3242,cancer,disease,1.0,33933782
3243,IRDye700DX,drug,0.861,33933782
3244,target cells,cell_type,0.8223,33933782
3245,human epidermal growth factor receptor,gene,0.9985,33933782
3246,human,species,0.704,33933782
3247,hEGFR,gene,0.9937,33933782
3248,hEGFR expressing human tumor cells,cell_type,0.7734,33933782
3249,hEGFR,gene,0.983,33933782
3250,human,species,0.961,33933782
3251,mouse,species,0.7715,33933782
3252,tumor,disease,1.0,33933782
3253,CD25,gene,0.993,33933782
3254,T cells,cell_type,0.8467,33933782
3255,Tregs,cell_type,0.8047,33933782
3256,tumor,disease,1.0,33933782
3257,hEGFR,gene,0.9976,33933782
3258,CD25,gene,0.9814,33933782
3259,hEGFR expressing murine oropharyngeal cell line,cell_line,0.5664,33933782
3260,hEGFR expressing murine oropharyngeal cell,cell_type,0.694,33933782
3261,hEGFR,gene,0.9966,33933782
3262,murine,species,0.916,33933782
3263,mEERL-,cell_line,0.716,33933782
3264,hEGFR,gene,0.826,33933782
3265,panitumumab,gene,0.9717,33933782
3266,pan,gene,0.923,33933782
3267,cancer cell,cell_type,0.6367,33933782
3268,cancer,disease,0.9673,33933782
3269,anti-CD25,gene,0.86,33933782
3270,tumor,disease,0.9863,33933782
3271,tumor,disease,0.999,33933782
3272,mice,species,0.751,33933782
3273,anti-CD25-,gene,0.985,33933782
3274,F(ab,gene,0.592,33933782
3275,CD25,gene,0.916,33933782
3276,anti-CD25- F,gene,0.81,33933782
3277,tumor,disease,0.9985,33933782
3278,cancer cells,cell_type,0.8394,33933782
3279,cancer,disease,0.9995,33933782
3280,Tregs,cell_type,0.738,33933782
3281,tumor,disease,1.0,33933782
3282,hEGFR,gene,0.991,33933782
3283,CD25,gene,0.9937,33933782
3284,hEGFR,gene,0.9976,33933782
3285,cancers,disease,0.9204,33933782
3286,Treg cells,cell_type,0.9155,33933782
3287,Panitumumab,gene,0.806,33933278
3288,trichomegaly,disease,0.985,33933278
3289,panitumumab,gene,0.904,33928486
3290,trifluridine,drug,0.999,33928486
3291,tipiracil,drug,0.999,33928486
3292,panitumumab,gene,0.867,33928486
3293,trifluridine,drug,0.9985,33928486
3294,tipiracil,drug,0.997,33928486
3295,FTD,drug,0.99,33928486
3296,TPI,drug,0.9976,33928486
3297,patients,species,0.982,33928486
3298,wild-type RAS,gene,0.9834,33928486
3299,metastatic colorectal cancer,disease,1.0,33928486
3300,mCRC,disease,1.0,33928486
3301,epidermal growth factor receptor,gene,0.9824,33928486
3302,patients,species,0.9893,33928486
3303,TTF,DNA,0.657,33928486
3304,patients,species,0.9565,33928486
3305,patients,species,0.986,33928486
3306,panitumumab,gene,0.9,33928486
3307,FTD,drug,0.9526,33928486
3308,TPI,drug,0.9946,33928486
3309,Neutrophil,cell_type,0.799,33928486
3310,Panitumumab,gene,0.969,33928486
3311,TPI,drug,0.888,33928486
3312,tumour,disease,0.815,33928486
3313,mCRC,disease,0.9897,33928486
3314,patients,species,0.989,33928486
3315,Egfr,gene,0.5186,33920531
3316,Metastatic Colorectal Cancer,disease,1.0,33920531
3317,patients,species,0.9805,33920531
3318,metastatic colorectal cancer,disease,1.0,33920531
3319,mCRC,disease,1.0,33920531
3320,anti-epidermal growth factor receptor,gene,0.9707,33920531
3321,EGFR,gene,0.9976,33920531
3322,mCRC,disease,0.998,33920531
3323,patients,species,0.9956,33920531
3324,anti-,gene,0.8335,33920531
3325,EGFR,gene,0.758,33920531
3326,EGFR,gene,0.994,33920531
3327,EGFR,gene,0.9653,33920531
3328,RAS mutant cancer cell,cell_line,0.726,33920531
3329,RAS,gene,0.987,33920531
3330,cancer,disease,0.5093,33920531
3331,cancer cells,cell_type,0.8325,33920531
3332,cancer,disease,0.7627,33920531
3333,cetuximab,gene,0.8696,33920531
3334,panitumumab,gene,0.838,33920531
3335,EGFR,gene,0.7354,33920531
3336,patients,species,0.946,33920531
3337,RAS,gene,0.9106,33920531
3338,BRAF,gene,0.996,33920531
3339,patients,species,0.985,33920531
3340,EGFR,gene,0.995,33910927
3341,BRAF,gene,0.9966,33910927
3342,cancer,disease,1.0,33910927
3343,EGFR,gene,0.9937,33910927
3344,MAPK,gene,0.9717,33910927
3345,BRAF,gene,0.963,33910927
3346,MAPK,gene,0.862,33910927
3347,EGFR,gene,0.9893,33910927
3348,human skin keratinocytes,cell_type,0.8223,33910927
3349,human,species,0.961,33910927
3350,BRAF,gene,0.9985,33910927
3351,LUT014,drug,0.981,33910927
3352,EGFR,gene,0.993,33910927
3353,patients,species,0.967,33910927
3354,metastatic colorectal cancer,disease,1.0,33910927
3355,acneiform rash,disease,1.0,33910927
3356,cetuximab,gene,0.928,33910927
3357,panitumumab,gene,0.918,33910927
3358,LUT014,drug,0.995,33910927
3359,acneiform rash,disease,1.0,33910927
3360,patients,species,0.9937,33910927
3361,LUT014,drug,0.9927,33910927
3362,rash,disease,1.0,33910927
3363,EGFR,gene,0.991,33910927
3364,MAPK,gene,0.989,33910927
3365,BRAF,gene,0.9907,33910927
3366,EGFR,gene,0.99,33910927
3367,Amphiregulin,gene,0.996,33888518
3368,Epiregulin,gene,0.9766,33888518
3369,tumor mRNA,RNA,0.8457,33888518
3370,EGFR ligands,gene,0.816,33888518
3371,amphiregulin,gene,0.979,33888518
3372,AREG,gene,0.9976,33888518
3373,epiregulin,gene,0.997,33888518
3374,EREG,gene,0.9956,33888518
3375,EGFR,gene,0.945,33888518
3376,metastatic colorectal cancer,disease,1.0,33888518
3377,mCRC,disease,1.0,33888518
3378,ligand RNA,RNA,0.4927,33888518
3379,AREG,gene,0.984,33888518
3380,EREG,gene,0.9956,33888518
3381,EGFR,gene,0.684,33888518
3382,panitumumab,gene,0.593,33888518
3383,AREG,gene,0.991,33888518
3384,EREG,gene,0.9956,33888518
3385,patients,species,0.986,33888518
3386,irinotecan,drug,0.9976,33888518
3387,panitumumab,gene,0.829,33888518
3388,RAS,DNA,0.6973,33888518
3389,RAS wild,gene,0.86,33888518
3390,mCRC,disease,0.996,33888518
3391,BRAF,gene,0.9937,33888518
3392,tumor,disease,0.6323,33888518
3393,IrPan,drug,0.989,33888518
3394,Ir,drug,,33888518
3395,BRAF,gene,0.9956,33888518
3396,patients,species,0.991,33888518
3397,AREG,gene,0.9824,33888518
3398,EREG,gene,0.994,33888518
3399,patients,species,0.9873,33888518
3400,panitumumab,gene,0.739,33888518
3401,irinotecan,drug,0.998,33888518
3402,panitumumab,gene,0.9487,33876416
3403,paclitaxel,drug,0.998,33876416
3404,Panitumumab,gene,0.9346,33876416
3405,Paclitaxel,drug,0.9995,33876416
3406,Pb,drug,,33876416
3407,locally advanced squamous cell carcinoma of the head and neck,disease,0.998,33876416
3408,LA-SCCHN,disease,0.9995,33876416
3409,patients,species,0.9907,33876416
3410,cisplatin,drug,0.9985,33876416
3411,patients18,species,0.9473,33876416
3412,LA-,disease,0.9893,33876416
3413,SCCHN,disease,0.9976,33876416
3414,platinum,drug,0.999,33876416
3415,Patients,species,0.98,33876416
3416,Pb,drug,1.0,33876416
3417,Pb,drug,1.0,33876416
3418,patients,species,0.9756,33876416
3419,patients,species,0.97,33876416
3420,patients,species,0.983,33876416
3421,Pb,drug,,33876416
3422,Pb,drug,,33876416
3423,Px,gene,,33876416
3424,Pb,drug,1.0,33876416
3425,Pb,drug,,33876416
3426,platinum,drug,1.0,33876416
3427,LA-SCCHN,disease,0.9995,33876416
3428,EGFR,gene,0.994,33868486
3429,EGFR ligand,gene,0.9536,33868486
3430,patients,species,0.946,33868486
3431,patients,species,0.971,33868486
3432,colorectal cancer,disease,1.0,33868486
3433,CRC,disease,1.0,33868486
3434,hepatic metastases,disease,0.5513,33868486
3435,Patients,species,0.965,33868486
3436,metastatic CRC,disease,1.0,33868486
3437,mCRC,disease,1.0,33868486
3438,tumors,disease,0.9854,33868486
3439,wild-type KRAS,gene,0.996,33868486
3440,cetuximab,gene,0.8027,33868486
3441,panitumumab,gene,0.8496,33868486
3442,epidermal growth factor receptor,gene,0.9956,33868486
3443,EGFR,gene,0.997,33868486
3444,EGFRs,gene,0.9976,33868486
3445,tumors,disease,1.0,33868486
3446,cetuximab,gene,0.692,33868486
3447,patients,species,0.941,33868486
3448,mCRC,disease,0.9985,33868486
3449,EGFR,gene,0.9976,33868486
3450,ErbB1,gene,0.9985,33868486
3451,ErbB2,gene,0.99,33868486
3452,ErbB3,gene,0.987,33868486
3453,EGFR,gene,0.9966,33868486
3454,heregulin,gene,0.8677,33868486
3455,amphiregulin,gene,0.9697,33868486
3456,cetuximab,gene,0.7075,33868486
3457,solid tumors,disease,0.9414,33868486
3458,EGFRs,gene,0.9976,33868486
3459,cetuximab,gene,0.9517,33868486
3460,patients,species,0.9927,33868486
3461,cetuximab,gene,0.9297,33868486
3462,EGFRs,gene,0.996,33868486
3463,EGFR,gene,0.9976,33868486
3464,ErbB1,gene,0.998,33868486
3465,ErbB2,gene,0.996,33868486
3466,ErbB3,gene,0.996,33868486
3467,heregulin,gene,0.9863,33868486
3468,amphiregulin,gene,0.9917,33868486
3469,cetuximab,gene,0.9727,33868486
3470,EGFR,gene,0.995,33868486
3471,EGFR ligand,gene,0.883,33868486
3472,patients,species,0.967,33868486
3473,CRC,disease,0.9995,33868486
3474,liver metastases,disease,0.949,33868486
3475,cetuximab,gene,0.7383,33868486
3476,Aflibercept,gene,0.948,33854566
3477,bevacizumab,gene,0.843,33854566
3478,FOLFIRI,drug,0.981,33854566
3479,metastatic colorectal cancer,disease,1.0,33854566
3480,mCRC,disease,1.0,33854566
3481,patients,species,0.993,33854566
3482,mRAS,gene,0.9683,33854566
3483,mutated,RNA,0.607,33854566
3484,mutated RAS,gene,0.9604,33854566
3485,mCRC,disease,0.9995,33854566
3486,patients,species,0.993,33854566
3487,EGFR,gene,0.8716,33854566
3488,cetuximab,gene,0.769,33854566
3489,panitumumab,gene,0.759,33854566
3490,patients,species,0.985,33854566
3491,bevacizumab,gene,0.9644,33854566
3492,aflibercept,gene,0.985,33854566
3493,bevacizumab,gene,0.929,33854566
3494,bevacizumab,gene,0.8794,33854566
3495,aflibercept,gene,0.968,33854566
3496,fluorouracil,drug,0.9995,33854566
3497,irinotecan,drug,0.9995,33854566
3498,FOLFIRI,drug,0.9966,33854566
3499,bevacizumab,gene,0.9805,33854566
3500,FOLFIRI,drug,0.871,33854566
3501,aflibercept,gene,0.995,33854566
3502,fluoropyrimidines,drug,0.999,33854566
3503,oxaliplatin,drug,0.999,33854566
3504,mRAS,gene,0.994,33854566
3505,mCRC,disease,0.998,33854566
3506,patients,species,0.995,33854566
3507,patients,species,0.9907,33854566
3508,patients,species,0.995,33854566
3509,FOLFIRI,drug,0.989,33854566
3510,bevacizumab,gene,0.912,33854566
3511,FOLFIRI,drug,0.5913,33854566
3512,aflibercept,gene,0.991,33854566
3513,mRAS,gene,0.988,33854566
3514,mCRC,disease,0.9746,33854566
3515,patients,species,0.9956,33854566
3516,oncologists,cell_type,0.4006,33854566
3517,Panitumumab,gene,0.558,33852238
3518,Eyelash Elongation,disease,0.9414,33852238
3519,Patient,species,0.915,33852238
3520,Metastatic Gastrointestinal,disease,0.9995,33852238
3521,Syndecan-4,gene,0.9907,33810567
3522,Cancer,disease,0.9995,33810567
3523,Cancer,disease,0.9995,33810567
3524,cancer,disease,0.997,33810567
3525,Syndecan-4,gene,0.9937,33810567
3526,sulfate,drug,0.806,33810567
3527,syndecan-4,gene,0.996,33810567
3528,multiple cancer,disease,0.999,33810567
3529,syndecan-4,gene,0.9937,33810567
3530,estrogen receptor-negative breast cancer,disease,0.913,33810567
3531,estrogen,drug,1.0,33810567
3532,estrogen receptor,gene,0.9844,33810567
3533,glioma,disease,1.0,33810567
3534,liver cancer,disease,1.0,33810567
3535,melanoma,disease,1.0,33810567
3536,osteosarcoma,disease,1.0,33810567
3537,papillary thyroid carcinoma,disease,1.0,33810567
3538,"testicular, kidney and bladder cancer",disease,1.0,33810567
3539,neuroblastoma,disease,1.0,33810567
3540,colorectal cancer,disease,1.0,33810567
3541,syndecan-4,gene,0.9893,33810567
3542,syndecan-4,gene,0.9893,33810567
3543,zoledronate,drug,0.996,33810567
3544,breast cancer cells,cell_line,0.775,33810567
3545,breast cancer,disease,0.999,33810567
3546,syndecan-4,gene,0.988,33810567
3547,trastuzumab,gene,0.96,33810567
3548,syndecan-4,gene,0.982,33810567
3549,panitumumab,gene,0.8257,33810567
3550,syndecan-4,gene,0.9937,33810567
3551,syndecan-4,gene,0.9937,33810567
3552,cancer,disease,1.0,33810567
3553,Panitumumab,gene,0.8887,33796558
3554,Paronychia,disease,0.994,33796558
3555,Panitumumab,gene,0.7583,33796558
3556,humanized,species,0.706,33796558
3557,epidermal growth factor receptor,gene,0.9976,33796558
3558,EGFR,gene,0.9956,33796558
3559,Panitumumab,gene,0.76,33796558
3560,patients,species,0.9424,33796558
3561,metastatic colorectal cancer,disease,0.9995,33796558
3562,EGFR,gene,0.9946,33796558
3563,EGFRIs,gene,0.926,33796558
3564,nail toxicity,disease,0.9756,33796558
3565,panitumumab,gene,0.929,33796558
3566,EGFRIs,gene,0.9727,33796558
3567,EGFRIs,gene,0.9414,33796558
3568,panitumumab,gene,0.802,33796558
3569,nail toxicity,disease,0.9634,33796558
3570,panitumumab,gene,0.844,33796558
3571,panitumumab,gene,0.9478,33796558
3572,paronychia,disease,0.9995,33796558
3573,woman,species,0.87,33796558
3574,metastatic colon cancer,disease,1.0,33796558
3575,genetic variants,DNA,0.709,33795829
3576,patients,species,0.9873,33795829
3577,Squamous cell carcinoma,disease,1.0,33795829
3578,anal carcinoma,disease,1.0,33795829
3579,5-fluorouracil,drug,0.9995,33795829
3580,mitomycin C,drug,0.9976,33795829
3581,T1,disease,,33795829
3582,tumors,disease,1.0,33795829
3583,T3,disease,,33795829
3584,panitumumab,gene,0.769,33795829
3585,paraffin,cell_line,,33795829
3586,patients,species,0.971,33795829
3587,genetic variants,DNA,0.5024,33795829
3588,panitumumab,gene,0.869,33795829
3589,PIK3CA,gene,0.9893,33795829
3590,panitumumab,gene,0.834,33795829
3591,copy number variants,DNA,0.6074,33795829
3592,FGFR3,gene,0.9966,33795829
3593,GRB2,gene,0.9946,33795829
3594,JAK1,gene,0.996,33795829
3595,panitumumab,gene,0.814,33795829
3596,patients,species,0.993,33795829
3597,panitumumab,gene,0.906,33795829
3598,panitumumab,gene,0.872,33795829
3599,patient,species,0.982,33795829
3600,anti-EGFR,gene,0.9443,33795829
3601,Hypertriglyceridemia,disease,1.0,33776705
3602,Fluorouracil,drug,0.998,33776705
3603,hypertriglyceridemia,disease,1.0,33776705
3604,fluorouracil,drug,1.0,33776705
3605,hypertriglyceridemia,disease,1.0,33776705
3606,patient,species,0.964,33776705
3607,capecitabine,drug,0.999,33776705
3608,hypertriglyceridemia,disease,0.989,33776705
3609,woman,species,0.919,33776705
3610,hypertriglyceridemia,disease,1.0,33776705
3611,oxaliplatin,drug,1.0,33776705
3612,capecitabine,drug,0.9995,33776705
3613,fluorouracil,drug,0.9995,33776705
3614,oxaliplatin,drug,0.9995,33776705
3615,levofolinate calcium,drug,0.9897,33776705
3616,panitumumab,gene,0.811,33776705
3617,hypertriglyceridemia,disease,1.0,33776705
3618,Bezafibrate,drug,0.998,33776705
3619,bezafibrate,drug,0.999,33776705
3620,fluorouracil,drug,1.0,33776705
3621,irinotecan,drug,0.998,33776705
3622,levofolinate calcium,drug,0.993,33776705
3623,triglyceride,drug,0.999,33776705
3624,fenofibrate,drug,0.9834,33776705
3625,triglyceride,drug,0.995,33776705
3626,fluorouracil,drug,0.999,33776705
3627,fluorouracil,drug,1.0,33776705
3628,hypertriglyceridemia,disease,1.0,33776705
3629,tegafur,drug,0.9985,33776705
3630,capecitabine,drug,0.999,33776705
3631,hypertriglyceridemia,disease,1.0,33776705
3632,fluorouracil,drug,1.0,33776705
3633,fluorouracil,drug,0.9995,33776705
3634,patient,species,0.988,33776705
3635,triglyceride,drug,0.979,33776705
3636,Fluorouracil,drug,0.9995,33776705
3637,hypertriglyceridemia,disease,0.974,33776705
3638,tegafur,drug,0.9966,33776705
3639,capecitabine,drug,0.9985,33776705
3640,Panitumumab,gene,0.7695,33776687
3641,Patient,species,0.977,33776687
3642,Severe,disease,0.553,33776687
3643,thrombocytopenia,disease,0.9907,33776687
3644,panitumumab,gene,0.8794,33776687
3645,patient,species,0.9556,33776687
3646,metastatic colorectal cancer,disease,1.0,33776687
3647,thrombocytopenia,disease,1.0,33776687
3648,panitumumab,gene,0.9053,33776687
3649,drug-induced immune thrombocytopenia,disease,0.9097,33776687
3650,DITP,disease,1.0,33776687
3651,DITP,disease,1.0,33776687
3652,thrombocytopenia,disease,1.0,33776687
3653,thrombocytopenia,disease,1.0,33776687
3654,panitumumab,gene,0.5557,33776687
3655,DITP,disease,0.988,33776687
3656,platelet,cell_type,0.4749,33776687
3657,thrombocytopenia,disease,1.0,33776687
3658,patients,species,0.945,33775193
3659,metastatic colorectal cancer,disease,1.0,33775193
3660,mCRC,disease,1.0,33775193
3661,epidermal growth factor receptor,gene,0.9985,33775193
3662,EGFR,gene,0.9976,33775193
3663,patients,species,0.973,33775193
3664,RAS wild-type tumours,disease,0.9946,33775193
3665,RAS,gene,0.9946,33775193
3666,patients,species,0.9897,33775193
3667,EGFR ligands,gene,0.8677,33775193
3668,amphiregulin,gene,0.9443,33775193
3669,AREG,gene,0.998,33775193
3670,epiregulin,gene,0.995,33775193
3671,EREG,gene,0.9976,33775193
3672,KRAS wild-type tumours,disease,0.9624,33775193
3673,KRAS,gene,0.992,33775193
3674,AREG,gene,0.9893,33775193
3675,EREG,gene,0.9883,33775193
3676,primary tumour,disease,0.997,33775193
3677,OS,cell_type,0.4426,33775193
3678,AREG,gene,0.993,33775193
3679,EREG,gene,0.9937,33775193
3680,patients,species,0.9893,33775193
3681,EGFR,gene,0.992,33775193
3682,EREG,gene,0.99,33775193
3683,patients,species,0.9844,33775193
3684,left,DNA,0.492,33775193
3685,EREG,gene,0.995,33775193
3686,mCRC,disease,0.9995,33775193
3687,Methotrexate,drug,1.0,33753043
3688,Vinblastine,drug,1.0,33753043
3689,Doxorubicin,drug,0.9995,33753043
3690,Cisplatin,drug,0.9995,33753043
3691,epidermal growth factor receptor,gene,0.996,33753043
3692,panitumumab,gene,0.5996,33753043
3693,advanced urothelial cancer,disease,1.0,33753043
3694,Epidermal growth factor receptor,gene,0.9985,33753043
3695,EGFR,gene,0.996,33753043
3696,urothelial carcinoma,disease,1.0,33753043
3697,EGFR,gene,0.99,33753043
3698,PATIENTS,species,0.9443,33753043
3699,Patients,species,0.98,33753043
3700,advanced urothelial carcinoma,disease,1.0,33753043
3701,HRAS,gene,0.9946,33753043
3702,KRAS,gene,0.989,33753043
3703,primary,disease,0.979,33753043
3704,tumor,disease,0.9683,33753043
3705,methotrexate,drug,0.9995,33753043
3706,vinblastine,drug,1.0,33753043
3707,doxorubicin,drug,0.9995,33753043
3708,cisplatin,drug,0.9995,33753043
3709,MVAC,drug,0.932,33753043
3710,anti-EGFR monoclonal antibody,gene,0.969,33753043
3711,panitumumab,gene,0.5938,33753043
3712,Pmab,gene,0.958,33753043
3713,patients,species,0.9795,33753043
3714,patients,species,0.989,33753043
3715,Pmab,gene,0.9336,33753043
3716,basal/squamous,cell_type,0.5205,33753043
3717,basal/squamous-like (BASQ) tumors,disease,0.999,33753043
3718,BASQ,DNA,0.596,33753043
3719,tumors,disease,0.8535,33753043
3720,Pmab,gene,0.847,33753043
3721,patients,species,0.9805,33741057
3722,malignancies,disease,1.0,33741057
3723,colorectal cancer,disease,1.0,33741057
3724,patients,species,0.994,33741057
3725,patient,species,0.9795,33741057
3726,metastatic colon cancer,disease,0.9473,33741057
3727,patient,species,0.9263,33741057
3728,hypertension,disease,1.0,33741057
3729,type 2 diabetes mellitus,disease,1.0,33741057
3730,paroxysmal atrial fibrillation,disease,1.0,33741057
3731,renal failure,disease,1.0,33741057
3732,adenocarcinoma of the sigmoid colon,disease,1.0,33741057
3733,low-grade adenocarcinoma,disease,0.6377,33741057
3734,Fluorodeoxyglucose,drug,0.9995,33741057
3735,metastatic (stage IV),disease,0.8843,33741057
3736,sigmoid colon cancer,disease,0.983,33741057
3737,patient,species,0.9775,33741057
3738,cardiovascular comorbidities,disease,1.0,33741057
3739,cetuximab,gene,0.958,33741057
3740,folinic acid,drug,0.999,33741057
3741,fluorouracil,drug,0.9995,33741057
3742,irinotecan,drug,0.9985,33741057
3743,cetuximab,gene,0.9326,33741057
3744,panitumumab,gene,0.876,33741057
3745,patient,species,0.99,33741057
3746,panitumumab,gene,0.934,33741057
3747,folinic acid,drug,0.999,33741057
3748,fluorouracil,drug,0.9995,33741057
3749,irinotecan,drug,0.999,33741057
3750,patient,species,0.984,33741057
3751,liver metastasis,disease,0.998,33741057
3752,panitumumab,gene,0.98,33741057
3753,liver,disease,0.935,33741057
3754,paraaortic,DNA,0.569,33741057
3755,paraaortic lesion,disease,0.9873,33741057
3756,patient,species,0.9863,33741057
3757,panitumumab,gene,0.6387,33741057
3758,patient,species,0.983,33741057
3759,hemorrhagic stroke,disease,1.0,33741057
3760,cardiovascular comorbidities,disease,0.9995,33741057
3761,patients,species,0.9883,33741057
3762,patient,species,0.927,33741057
3763,metastatic colorectal cancer,disease,0.9995,33741057
3764,epidermal growth factor receptor,gene,0.998,33707521
3765,high-grade glioma,disease,1.0,33707521
3766,HGG,disease,1.0,33707521
3767,Epidermal growth factor receptor,gene,0.9985,33707521
3768,EGFR,gene,0.9956,33707521
3769,HGG,disease,1.0,33707521
3770,HGG,disease,1.0,33707521
3771,EGFR,gene,0.991,33707521
3772,Mice,species,0.8203,33707521
3773,HGG xenografts,cell_line,0.453,33707521
3774,HGG,disease,1.0,33707521
3775,EGFR,gene,0.9937,33707521
3776,panitumumab,gene,0.9736,33707521
3777,EGFR,gene,0.99,33707521
3778,HGG,disease,1.0,33707521
3779,patients,species,0.9907,33707521
3780,mouse xenografts,cell_line,0.5605,33707521
3781,mouse,species,0.9507,33707521
3782,panitumumab,gene,0.9697,33707521
3783,EGFR,gene,0.9927,33707521
3784,tumor cells,cell_type,0.516,33707521
3785,tumor,disease,0.994,33707521
3786,panitumumab,gene,0.983,33707521
3787,EGFR protein,gene,0.959,33707521
3788,mouse xenografts,cell_line,0.818,33707521
3789,mouse,species,0.903,33707521
3790,HGG,disease,1.0,33707521
3791,patients,species,0.9966,33707521
3792,IDH,gene,0.9966,33707521
3793,EGFR protein,gene,0.901,33707521
3794,human,species,0.996,33707521
3795,tumors,disease,1.0,33707521
3796,panitumumab,gene,0.974,33707521
3797,HGGs,disease,1.0,33707521
3798,EGFR,gene,0.988,33707521
3799,benzoyl peroxide,drug,0.9995,33682955
3800,acneiform eruptions,disease,1.0,33682955
3801,epidermal growth factor receptor,gene,0.9966,33682955
3802,colorectal,disease,0.9995,33682955
3803,"small cell lung, and head and neck cancers",disease,0.9795,33682955
3804,acneiform eruptions,disease,1.0,33682955
3805,bacterial infections,disease,0.9946,33682955
3806,benzoyl peroxide,drug,0.999,33682955
3807,epidermal growth factor receptor,gene,0.9976,33682955
3808,acneiform eruptions,disease,0.9937,33682955
3809,Patients,species,0.9736,33682955
3810,"colorectal, non-small lung cell, and head and neck cancers",disease,1.0,33682955
3811,epidermal growth factor receptor,gene,0.9985,33682955
3812,acneiform eruptions,disease,1.0,33682955
3813,benzoyl peroxide,drug,0.9995,33682955
3814,acneiform eruption,disease,1.0,33682955
3815,patients,species,0.991,33682955
3816,patients,species,0.99,33682955
3817,acneiform eruptions,disease,0.9956,33682955
3818,patient,species,0.958,33682955
3819,benzoyl peroxide,drug,0.999,33682955
3820,acneiform eruptions,disease,1.0,33682955
3821,epidermal growth factor receptor,gene,0.9976,33682955
3822,RAS,gene,0.995,33629919
3823,metastatic colorectal cancer,disease,1.0,33629919
3824,patients,species,0.9917,33629919
3825,RAS,gene,0.988,33629919
3826,metastatic colorectal cancer,disease,1.0,33629919
3827,mCRC,disease,1.0,33629919
3828,patients,species,0.9775,33629919
3829,mCRC,disease,0.9717,33629919
3830,patients,species,0.9766,33629919
3831,mCRC,disease,0.9976,33629919
3832,patients,species,0.9893,33629919
3833,RAS,gene,0.994,33629919
3834,RAS,gene,0.9966,33629919
3835,CRC,disease,1.0,33629919
3836,mCRC,disease,0.9355,33629919
3837,patients,species,0.987,33629919
3838,RAS,gene,0.673,33629919
3839,Patients,species,0.9683,33615402
3840,colorectal cancer,disease,0.9014,33615402
3841,mCRC,disease,0.9985,33615402
3842,patients,species,0.9614,33615402
3843,mCRC,disease,0.9834,33615402
3844,patients,species,0.9663,33615402
3845,mCRC,disease,0.9824,33615402
3846,Digestive Tumours,disease,1.0,33615402
3847,advanced CRC,disease,0.981,33615402
3848,bevacizumab,gene,0.8423,33615402
3849,cetuximab,gene,0.856,33615402
3850,panitumumab,gene,0.883,33615402
3851,patients,species,0.9863,33615402
3852,patients,species,0.989,33615402
3853,patients,species,0.9736,33615402
3854,patients,species,0.9805,33615402
3855,Patients,species,0.986,33615402
3856,patients,species,0.9917,33615402
3857,patients,species,0.962,33615402
3858,mCRC,disease,0.9795,33615402
3859,patients,species,0.978,33615402
3860,colorectal peritoneal Colorectal cancer,disease,0.963,33609014
3861,malignancy,disease,0.986,33609014
3862,Colorectal peritoneal carcinomatosis,disease,1.0,33609014
3863,CPC,disease,1.0,33609014
3864,patients,species,0.989,33609014
3865,5-fluorouracil,drug,0.999,33609014
3866,vascular endothelial,disease,0.8735,33609014
3867,vascular endothelial growth factor,gene,0.996,33609014
3868,epidermal growth factor,gene,0.996,33609014
3869,CPC,disease,0.9995,33609014
3870,bevacizumab,gene,0.891,33609014
3871,cetuximab,gene,0.8784,33609014
3872,panitumumab,gene,0.9053,33609014
3873,tumour,disease,0.9995,33609014
3874,CPC,disease,1.0,33609014
3875,Metastatic Colorectal Cancer,disease,0.9995,33591350
3876,Colorectal cancer,disease,1.0,33591350
3877,CRC,disease,1.0,33591350
3878,cancer,disease,1.0,33591350
3879, with,mutation,,33591350
3880,colorectal cancer,disease,1.0,33591350
3881,patients,species,0.9795,33591350
3882,Colorectal cancer,disease,1.0,33591350
3883,cancer,disease,1.0,33591350
3884,men,species,0.9443,33591350
3885,women,species,0.962,33591350
3886,people,species,0.982,33591350
3887,metastatic colorectal cancer,disease,1.0,33591350
3888,patients,species,0.98,33591350
3889,CRC,disease,0.8306,33591350
3890,tumor,disease,0.9995,33591350
3891,patients,species,0.982,33591350
3892,metastatic CRC,disease,0.9966,33591350
3893,KRAS,gene,0.965,33591350
3894,NRAS,gene,0.9946,33591350
3895,BRAF,gene,0.996,33591350
3896,cetuximab,gene,0.6084,33591350
3897,panitumumab,gene,0.762,33591350
3898,EGFR,gene,0.9346,33591350
3899,patients,species,0.9907,33591350
3900,KRAS or NRAS sequence variations,DNA,0.797,33591350
3901,KRAS,gene,0.987,33591350
3902,NRAS sequence,gene,0.892,33591350
3903,BRAF V600E sequence variations,DNA,0.6743,33591350
3904,BRAF V600E sequence,gene,0.787,33591350
3905,V600E,mutation,,33591350
3906,BRAF,gene,0.993,33591350
3907,EGFR,gene,0.9795,33591350
3908,repetitive DNA units,DNA,0.9175,33591350
3909,mismatch repair deficiency,disease,1.0,33591350
3910,patients,species,0.95,33591350
3911,metastatic CRC,disease,0.991,33591350
3912,tumor,disease,0.981,33591350
3913,patient,species,0.978,33591350
3914,patients,species,0.984,33591350
3915,patients,species,0.99,33591350
3916,patient,species,0.9883,33589516
3917,patient,species,0.9785,33589516
3918,colorectal cancer,disease,1.0,33589516
3919,patients,species,0.988,33589516
3920,KRAS,DNA,0.819,33589516
3921,KRAS mutation,gene,0.97,33589516
3922,patient,species,0.989,33589516
3923,metastatic lesions,disease,0.9395,33589516
3924,patients,species,0.994,33589516
3925,tumor,disease,0.9854,33589516
3926,bevacizumab,gene,0.9585,33589516
3927,panitumumab,gene,0.9414,33589516
3928,liver lesions,disease,0.9995,33589516
3929,liver metastases,disease,0.73,33589516
3930,patient,species,0.9854,33589516
3931,lesions in the lungs and lymph nodes,disease,0.906,33589516
3932,patient,species,0.981,33589516
3933,patient,species,0.969,33589516
3934,HER2,gene,0.994,33562755
3935,Cetuximab,gene,0.897,33562755
3936,Patients,species,0.992,33562755
3937,RAS,gene,0.991,33562755
3938,HER2,gene,0.998,33562755
3939,mAb,gene,0.827,33562755
3940,trastuzumab,gene,0.9805,33562755
3941,patients,species,0.9355,33562755
3942,breast and gastric cancers,disease,1.0,33562755
3943,metastatic colorectal cancer,disease,1.0,33562755
3944,mCRC,disease,1.0,33562755
3945,anti-epidermal growth factor receptor,gene,0.9424,33562755
3946,EGFR,gene,0.974,33562755
3947,cetuximab,gene,0.645,33562755
3948,panitumumab,gene,0.866,33562755
3949,human epidermal growth factor receptor,gene,0.999,33562755
3950,human,species,0.6797,33562755
3951,HER,gene,0.9927,33562755
3952,cetuximab,gene,0.716,33562755
3953,patients,species,0.9785,33562755
3954,wild type RAS,gene,0.819,33562755
3955,RAS,DNA,0.4148,33562755
3956,mCRC,disease,0.999,33562755
3957,EGFR,gene,0.994,33562755
3958,HER2,gene,0.9907,33562755
3959,primary tumours,disease,0.994,33562755
3960,EGFR,gene,0.9927,33562755
3961,HER2,gene,0.993,33562755
3962,HER3,gene,0.9897,33562755
3963,HER4,gene,0.991,33562755
3964,HER family,DNA,0.519,33562755
3965,HER family members,gene,0.9897,33562755
3966,EGFR,gene,0.992,33562755
3967,HER2,gene,0.996,33562755
3968,HER3,gene,0.991,33562755
3969,HER2,gene,0.9893,33562755
3970,EGFR,gene,0.986,33562755
3971,HER family members,gene,0.979,33562755
3972,metastatic tumours,disease,1.0,33562755
3973,EGFR,gene,0.989,33562755
3974,HER2,gene,0.99,33562755
3975,HER family members,gene,0.9624,33562755
3976,anti-EGFR mAbs,gene,0.9736,33562755
3977,HER,gene,0.8823,33562755
3978,primary tumours,disease,0.9995,33562755
3979,mCRC,disease,1.0,33562755
3980,panitumumab,gene,0.757,33561312
3981,Biliary tract cancers,disease,1.0,33561312
3982,BTC,disease,1.0,33561312
3983,panitumumab,gene,0.9233,33561312
3984,bevacizumab,gene,0.8906,33561312
3985,gastrointestinal (GI) cancers,disease,1.0,33561312
3986,panitumumab,gene,0.9595,33561312
3987,bevacizumab,gene,0.848,33561312
3988,patients,species,0.9634,33561312
3989,panitumumab,gene,0.933,33561312
3990,bevacizumab,gene,0.599,33561312
3991,Arm B,DNA,0.534,33561312
3992,patients,species,0.9673,33561312
3993,gemcitabine,drug,0.9995,33561312
3994,oxaliplatin,drug,0.9995,33561312
3995,capecitabine,drug,0.9985,33561312
3996,Arm A,DNA,0.562,33561312
3997,Arm B,DNA,0.516,33561312
3998,panitumumab,gene,0.944,33561312
3999,bevacizumab,gene,0.8286,33561312
4000,BTC,disease,0.9995,33561312
4001,panitumumab,gene,0.894,33561312
4002,patients,species,0.991,33556095
4003,advanced colorectal cancer,disease,1.0,33556095
4004,advanced colorectal cancer,disease,1.0,33556095
4005,CRC,disease,1.0,33556095
4006,leucovorin,drug,0.9995,33556095
4007,5-fluorouracil,drug,0.9995,33556095
4008,irinotecan,drug,0.999,33556095
4009,bevacizumab,gene,0.9395,33556095
4010,ramucirumab,gene,0.532,33556095
4011,aflibercept beta,gene,0.9917,33556095
4012,Patients,species,0.964,33556095
4013,advanced CRC,disease,0.9985,33556095
4014,FOLFIRI,drug,0.979,33556095
4015,FOLFOX,drug,0.8994,33556095
4016,leucovorin,drug,0.9995,33556095
4017,5-fluorouracil,drug,0.9995,33556095
4018,oxaliplatin,drug,0.9995,33556095
4019,CAPOX,drug,0.9966,33556095
4020,capecitabine,drug,0.9995,33556095
4021,oxaliplatin,drug,0.9995,33556095
4022,RAS,DNA,0.5376,33556095
4023,RAS-,gene,0.9634,33556095
4024,FOLFOX,drug,0.6616,33556095
4025,panitumumab,gene,0.5684,33556095
4026,RAS,gene,0.9976,33556095
4027,CRC,disease,0.6387,33556095
4028,FOLFIRI,drug,0.99,33556095
4029,patients,species,0.9946,33556095
4030,patients,species,0.983,33556095
4031,RAS-mutant CRC,disease,0.8735,33556095
4032,RAS,gene,0.994,33556095
4033,CRC,disease,0.918,33556095
4034,FOLFIRI,drug,0.8813,33556095
4035,patients,species,0.979,33556095
4036,RAS,gene,0.9966,33556095
4037,CRC,disease,0.7676,33556095
4038,fluoropyrimidines,drug,0.999,33556095
4039,proteinuria,disease,1.0,33556095
4040,advanced CRC,disease,0.943,33556095
4041,hypertension,disease,1.0,33556095
4042,proteinuria,disease,0.9995,33556095
4043,oxaliplatin,drug,0.9995,33555359
4044,colon cancer,disease,0.991,33555359
4045,patients,species,0.989,33555359
4046,oxaliplatin,drug,0.999,33555359
4047,Stage II/III colon cancer,disease,0.9927,33555359
4048,patients,species,0.985,33555359
4049,neuropathies,disease,1.0,33555359
4050,patients,species,0.964,33555359
4051,5-fluorouracil,drug,0.9995,33555359
4052,l-leucovorin,drug,0.9995,33555359
4053,capecitabine,drug,0.9985,33555359
4054,S,drug,0.4907,33555359
4055,patients,species,0.9824,33555359
4056,patients,species,0.9897,33555359
4057,5-fluorouracil,drug,0.9995,33555359
4058,l-leucovorin,drug,0.9995,33555359
4059,patients,species,0.992,33555359
4060,capecitabine,drug,0.999,33555359
4061,patients,species,0.9907,33555359
4062,S-1,drug,0.965,33555359
4063,patients,species,0.987,33555359
4064,FOLFOX,drug,0.9355,33555359
4065,cetuximab,gene,0.8486,33555359
4066,panitumumab,gene,0.82,33555359
4067,neutropenia,disease,1.0,33555359
4068,patients,species,0.987,33555359
4069,peripheral sensory neuropathy,disease,0.9995,33555359
4070,patients,species,0.989,33555359
4071,diarrhea,disease,1.0,33555359
4072,patients,species,0.989,33555359
4073,hypertension,disease,1.0,33555359
4074,patients,species,0.991,33555359
4075,anorexia,disease,1.0,33555359
4076,patients,species,0.992,33555359
4077,allergic reactions,disease,1.0,33555359
4078,patients,species,0.9937,33555359
4079,colon cancer,disease,1.0,33555359
4080,patients,species,0.987,33555359
4081,Circulating Tumor DNA,RNA,0.683,33547199
4082,Patients,species,0.978,33547199
4083,patients,species,0.9346,33547199
4084,metastatic colorectal cancer,disease,1.0,33547199
4085,mCRC,disease,1.0,33547199
4086,patients,species,0.9736,33547199
4087,RAS,gene,0.9966,33547199
4088,BRAF,gene,0.999,33547199
4089,HER2,gene,0.8926,33547199
4090,mCRC,disease,0.996,33547199
4091,panitumumab,gene,0.8296,33547199
4092,14 genes,DNA,0.612,33547199
4093,tumor,disease,1.0,33547199
4094,circulating tumor DNA,DNA,0.538,33547199
4095,ctDNA,DNA,0.794,33547199
4096,patients,species,0.9756,33547199
4097,RAS,gene,0.989,33547199
4098,PIK3CA,gene,0.9956,33547199
4099,ctDNA,DNA,0.8657,33547199
4100,RAS or PIK3CA mutations,DNA,0.652,33547199
4101,RAS,gene,0.995,33547199
4102,PIK3CA mutations,gene,0.947,33547199
4103,ctDNA,DNA,0.782,33547199
4104,RAS,gene,0.997,33547199
4105,ctDNA,DNA,0.7407,33547199
4106,tumor,disease,0.9824,33547199
4107,PIK3CA,gene,0.995,33547199
4108,Patients,species,0.99,33547199
4109,RAS,gene,0.998,33547199
4110,PIK3CA,gene,0.999,33547199
4111,variant allele,DNA,0.628,33547199
4112,ctDNA,DNA,0.6514,33547199
4113,ctDNA,DNA,0.4966,33547199
4114,tumor,disease,0.6777,33547199
4115,patients,species,0.936,33547199
4116,mCRC,disease,0.9937,33547199
4117,EGFR,gene,0.7007,33547199
4118,Bevacizumab,gene,0.882,33539032
4119,Panitumumab,gene,0.904,33539032
4120,RAS,gene,0.9893,33539032
4121,BRAF,gene,0.999,33539032
4122,FOLFOXIRI,drug,0.5635,33539032
4123,fluorouracil,drug,1.0,33539032
4124,leucovorin,drug,0.9995,33539032
4125,oxaliplatin,drug,0.9995,33539032
4126,irinotecan,drug,0.9985,33539032
4127,bevacizumab,gene,0.8765,33539032
4128,FOLFOX,drug,0.532,33539032
4129,fluorouracil,drug,1.0,33539032
4130,leucovorin,drug,0.999,33539032
4131,oxaliplatin,drug,0.9995,33539032
4132,panitumumab,gene,0.88,33539032
4133,Metastatic Colorectal INTRODUCTION,disease,0.9463,33506317
4134,cancer,disease,1.0,33506317
4135,bevacizumab,gene,0.973,33506317
4136,cetuximab,gene,0.963,33506317
4137,panitumumab,gene,0.9595,33506317
4138,metastatic colorectal cancer,disease,1.0,33506317
4139,mCRC,disease,1.0,33506317
4140,bevacizumab,gene,0.799,33506317
4141,cetuximab,gene,0.91,33506317
4142,panitumumab,gene,0.901,33506317
4143,mCRC,disease,0.9,33506317
4144,mCRC,disease,0.9697,33506317
4145,mCRC,disease,0.9956,33506317
4146,panitumumab,gene,0.8887,33506317
4147,bevacizumab,gene,0.666,33506317
4148,cetuximab,gene,0.7207,33506317
4149,anti-epidermal growth factor receptor,gene,0.916,33506317
4150,EGFR,gene,0.8164,33506317
4151,cetuximab,gene,0.845,33506317
4152,panitumumab,gene,0.7803,33506317
4153,patients,species,0.9756,33506317
4154,KRAS,gene,0.964,33506317
4155,panitumumab,gene,0.969,33506317
4156,bevacizumab,gene,0.8965,33506317
4157,bevacizumab,gene,0.8936,33506317
4158,cetuximab,gene,0.8794,33506317
4159,panitumumab,gene,0.9165,33506317
4160,Cetuximab,gene,0.9883,33499047
4161,Epidermal growth factor receptor,gene,0.999,33499047
4162,EGFR,gene,0.996,33499047
4163,colorectal cancer,disease,1.0,33499047
4164,CRC,disease,1.0,33499047
4165,EGFR,gene,0.764,33499047
4166,cetuximab,gene,0.914,33499047
4167,panitumumab,gene,0.8604,33499047
4168,metastatic CRC,disease,0.966,33499047
4169,anti-EGFR monoclonal antibodies,gene,0.9424,33499047
4170,AuNPs,cell_type,0.6553,33499047
4171,cetuximab,gene,0.9907,33499047
4172,AuNPs,drug,0.537,33499047
4173,cetuximab,gene,0.9575,33499047
4174,cancer cells,cell_type,0.8105,33499047
4175,cancer,disease,1.0,33499047
4176,cancer cell,cell_type,0.7656,33499047
4177,cancer,disease,0.998,33499047
4178,cetuximab,gene,0.9663,33499047
4179,AuNPs,cell_type,0.572,33499047
4180,CRC cell line,cell_line,0.722,33499047
4181,CRC,disease,1.0,33499047
4182,HT-29,cell_line,0.51,33499047
4183,cetuximab,gene,0.949,33499047
4184,cetuximab,gene,0.943,33499047
4185,AuNPs,cell_type,0.4934,33499047
4186,epithelial cell adhesion molecule,gene,0.997,33499047
4187,EpCAM,gene,0.9956,33499047
4188,melanoma cell adhesion molecule,gene,0.9927,33499047
4189,MCAM,gene,0.991,33499047
4190,human epidermal growth factor receptor-3,gene,0.998,33499047
4191,human,species,0.736,33499047
4192,HER-3),gene,0.971,33499047
4193,cetuximab,gene,0.924,33499047
4194,AuNPs,cell_type,0.513,33499047
4195,AuNPs,DNA,0.4546,33499047
4196,cancer,disease,1.0,33499047
4197,cetuximab,gene,0.928,33489709
4198,cetuximab,gene,0.9526,33489709
4199,Cmab,gene,0.9663,33489709
4200,panitumumab,gene,0.855,33489709
4201,Pmab,gene,0.783,33489709
4202,Cmab,gene,0.976,33489709
4203,Pmab,gene,0.9785,33489709
4204,patient,species,0.9697,33489709
4205,advanced rectal cancer,disease,1.0,33489709
4206,dyspnea,disease,0.9995,33489709
4207,shortness of breath,disease,0.9873,33489709
4208,wheezing,disease,0.9956,33489709
4209,Pmab,gene,0.5664,33489709
4210,Cmab,drug,0.977,33489709
4211,patient,species,0.961,33489709
4212,Cmab,gene,0.9595,33489709
4213,Pmab,gene,0.973,33489709
4214,patients,species,0.9795,33489709
4215,Pmab,gene,0.962,33489709
4216,Cabozantinib,drug,0.999,33469991
4217,Panitumumab,gene,0.611,33469991
4218,RAS,gene,0.9956,33469991
4219,cabozantinib,drug,0.998,33469991
4220,patient,species,0.9814,33469991
4221,cabozantinib,drug,0.999,33469991
4222,panitumumab,gene,0.805,33469991
4223,patients,species,0.9517,33469991
4224,metastatic colorectal cancer,disease,0.9995,33469991
4225,epidermal growth factor receptor,gene,0.999,33469991
4226,EGFR,gene,0.996,33469991
4227,panitumumab,gene,0.3987,33469991
4228,patients,species,0.9585,33469991
4229,RAS,gene,0.986,33469991
4230,metastatic colorectal cancer,disease,1.0,33469991
4231,mCRC,disease,1.0,33469991
4232,patients,species,0.9946,33469991
4233,MET,gene,0.9956,33469991
4234,panitumumab,gene,0.7554,33469991
4235,Cabozantinib,drug,0.9995,33469991
4236,vascular endothelial growth factor receptor 2,gene,0.9976,33469991
4237,VEGFR2,gene,0.9897,33469991
4238,c-MET,gene,0.9976,33469991
4239,EGFR,gene,0.995,33469991
4240,cabozantinib,drug,0.999,33469991
4241,panitumumab,gene,0.89,33469991
4242,RP2D,DNA,0.562,33469991
4243,patients,species,0.966,33469991
4244,KRAS,gene,0.9917,33469991
4245,mCRC,disease,0.996,33469991
4246,RAS,gene,0.994,33469991
4247,mCRC,disease,0.996,33469991
4248,fluoropyrimidine,drug,0.999,33469991
4249,oxaliplatin,drug,0.9995,33469991
4250,irinotecan,drug,0.999,33469991
4251,bevacizumab,gene,0.8228,33469991
4252,patients,species,0.981,33469991
4253,cabozantinib,drug,0.999,33469991
4254,panitumumab,gene,0.8125,33469991
4255,patients,species,0.9893,33469991
4256,patients,species,0.9883,33469991
4257,cabozantinib,drug,0.9985,33469991
4258,cabozantinib,drug,0.999,33469991
4259,panitumumab,gene,0.8755,33469991
4260,cabozantinib,drug,0.998,33469991
4261,Advanced Rectal Cancer,disease,0.9995,33468842
4262,man,species,0.898,33468842
4263,obstructed defecation,disease,0.941,33468842
4264,advanced lower rectal cancer,disease,1.0,33468842
4265,tumor,disease,0.999,33468842
4266,RAS,gene,0.9985,33468842
4267,BRAF V600E,gene,0.9673,33468842
4268,V600E,mutation,,33468842
4269,patient,species,0.9795,33468842
4270,panitumumab,gene,0.93,33468842
4271,Pmab,gene,0.9736,33468842
4272,primary,disease,0.6436,33468842
4273,lymph,disease,0.8677,33468842
4274,18F-fluorodeoxyglucose,drug,0.997,33468842
4275,18F-FDG,drug,0.9985,33468842
4276,18F-FDG,drug,0.999,33468842
4277,tumor,disease,0.9956,33468842
4278,left external,DNA,0.582,33468842
4279,cancer,disease,0.9424,33468842
4280,tumor,disease,0.8413,33468842
4281,malignant cells,cell_type,0.866,33468842
4282,patient,species,0.9854,33468842
4283,Pmab,drug,0.521,33468842
4284,advanced RAS wild-type rectal cancer,disease,0.9575,33468842
4285,RAS,gene,0.9297,33468842
4286,Colorectal Cancer,disease,1.0,33468805
4287,man,species,0.898,33468805
4288,melena,disease,0.9653,33468805
4289,locally advanced sigmoid colon cancer,disease,1.0,33468805
4290,panitumumab,gene,0.8237,33468805
4291,tumor,disease,0.996,33468805
4292,patient,species,0.959,33468805
4293,tumor,disease,0.967,33468805
4294,urinary incontinence,disease,1.0,33468805
4295,patients,species,0.9463,33468805
4296,locally advanced colorectal cancer,disease,0.9087,33468805
4297,doxycycline,drug,0.997,33392769
4298,anti-EGFR,gene,0.9688,33392769
4299,anti-EGFRs,gene,0.975,33392769
4300,patients,species,0.9775,33392769
4301,RAS,gene,0.9976,33392769
4302,BRAF,gene,0.999,33392769
4303,left-sided metastatic colorectal cancer,disease,0.958,33392769
4304,mCRC,disease,1.0,33392769
4305,tetracyclines,drug,0.9985,33392769
4306,EGFR,gene,0.993,33392769
4307,skin toxicity,disease,0.6357,33392769
4308,RAS,gene,0.9927,33392769
4309,mCRC,disease,0.962,33392769
4310,patients,species,0.979,33392769
4311,panitumumab,gene,0.8794,33392769
4312,doxycycline,drug,0.9893,33392769
4313,anti-EGFR,gene,0.8696,33392769
4314,skin toxicity,disease,0.599,33392769
4315,panitumumab,gene,0.937,33392769
4316,patients,species,0.992,33392769
4317,patients,species,0.9863,33392769
4318,panitumumab,gene,0.8813,33392769
4319,patients,species,0.993,33392769
4320,skin rash,disease,0.9995,33392769
4321,patients,species,0.979,33392769
4322,mCRC,disease,0.9897,33392769
4323,patients,species,0.9814,33392769
4324,patients,species,0.9272,33392769
4325,Cancer,disease,0.9995,33392444
4326,cancer,disease,1.0,33392444
4327,hypertension,disease,0.9487,33392444
4328,bevacizumab,gene,0.8604,33392444
4329,axitinib,drug,0.998,33392444
4330,cediranib,drug,0.998,33392444
4331,pazopanib,drug,0.999,33392444
4332,sorafenib,drug,0.9995,33392444
4333,sunitinib,drug,0.999,33392444
4334,vandetanib,drug,0.9985,33392444
4335,aflibercept,gene,0.9854,33392444
4336,hypertension,disease,0.963,33392444
4337,nintedanib,drug,0.999,33392444
4338,arterial thromboembolism,disease,1.0,33392444
4339,bevacizumab,gene,0.9014,33392444
4340,abiraterone,drug,0.5513,33392444
4341,arterial thromboembolism,disease,1.0,33392444
4342,trastuzumab,gene,0.8374,33392444
4343,arterial thromboembolism,disease,1.0,33392444
4344,sorafenib,drug,0.9995,33392444
4345,tamoxifen,drug,1.0,33392444
4346,venous thromboembolism,disease,1.0,33392444
4347,VTE,disease,1.0,33392444
4348,lenalidomide,drug,0.9995,33392444
4349,thalidomide,drug,0.9995,33392444
4350,VTE,disease,0.9014,33392444
4351,cetuximab,gene,0.9536,33392444
4352,panitumumab,gene,0.9565,33392444
4353,VTE,disease,0.7246,33392444
4354,bevacizumab,gene,0.891,33392444
4355,congestive heart failure,disease,0.9946,33392444
4356,bevacizumab,gene,0.761,33392444
4357,trastuzumab,gene,0.9727,33392444
4358,congestive heart failure,disease,1.0,33392444
4359,pazopanib,drug,0.9985,33392444
4360,sunitinib,drug,0.999,33392444
4361,vandetanib,drug,0.998,33392444
4362,patients,species,0.9785,33392444
4363,EGFR,gene,0.9907,33364187
4364,Esophagogastric Cancer,disease,1.0,33364187
4365,Esophagogastric cancer,disease,1.0,33364187
4366,EGC,disease,1.0,33364187
4367,cancer,disease,1.0,33364187
4368,HER2,gene,0.993,33364187
4369,ERBB2,gene,0.9536,33364187
4370,VEGFR2,gene,0.7656,33364187
4371,patients,species,0.935,33364187
4372,PD-L1,gene,0.998,33364187
4373,MSI,cell_line,0.5317,33364187
4374,H,disease,1.0,33364187
4375,patients,species,0.9814,33364187
4376,EGFR,gene,0.9844,33364187
4377,EGC,disease,0.9995,33364187
4378,cetuximab,gene,0.8193,33364187
4379,panitumumab,gene,0.7485,33364187
4380,gefitinib,drug,0.993,33364187
4381,EGFR,gene,0.996,33364187
4382,EGC,cell_line,0.772,33364187
4383,patients,species,0.9463,33364187
4384,EGFR-amplified tumors,disease,0.993,33364187
4385,EGFR,gene,0.9917,33364187
4386,cetuximab,gene,0.904,33349195
4387,panitumumab,gene,0.8677,33349195
4388,FOLFIRI,drug,0.9746,33349195
4389,Panitumumab,gene,0.9097,33349195
4390,cetuximab,gene,0.957,33349195
4391,metastatic colorectal cancer,disease,1.0,33349195
4392,mCRC,disease,1.0,33349195
4393,cetuximab,gene,0.896,33349195
4394,panitumumab,gene,0.7544,33349195
4395,patients,species,0.9854,33349195
4396,K-ras,gene,0.999,33349195
4397,mCRC,disease,0.9995,33349195
4398,cetuximab,gene,0.931,33349195
4399,panitumumab,gene,0.8423,33349195
4400,FOLFIRI,drug,0.6846,33349195
4401,cetuximab,gene,0.9453,33349195
4402,panitumumab,gene,0.9053,33349195
4403,cetuximab,gene,0.9634,33349195
4404,panitumumab,gene,0.92,33349195
4405,K-ras,gene,0.9985,33349195
4406,mCRC,disease,0.993,33349195
4407,patients,species,0.973,33349195
4408,cetuximab,gene,0.7944,33349195
4409,patients,species,0.938,33349195
4410,panitumumab,gene,0.883,33349195
4411,cholangiocarcinoma,disease,1.0,33345417
4412,cancers,disease,1.0,33345417
4413,IR700,drug,0.943,33345417
4414,cholangiocarcinoma,disease,1.0,33345417
4415,CCA,disease,1.0,33345417
4416,CCA,disease,0.991,33345417
4417,anti-epidermal growth factor receptor,gene,0.9897,33345417
4418,EGFR,gene,0.9927,33345417
4419,Panitumumab,gene,0.8755,33345417
4420,anti-human epidermal growth factor receptor type 2,gene,0.964,33345417
4421,human,species,0.939,33345417
4422,HER2,gene,0.9946,33345417
4423,Trastuzumab,gene,0.9893,33345417
4424,EGFR- or HER2-expressing cell lines,cell_line,0.943,33345417
4425,EGFR,gene,0.983,33345417
4426,HER2,gene,0.8247,33345417
4427,cultured cells,cell_line,0.828,33345417
4428,mouse,species,0.901,33345417
4429,tumor,disease,1.0,33345417
4430,CCA xenografts,disease,0.8486,33345417
4431,mice,species,0.968,33345417
4432,Panitumumab,gene,0.93,33345417
4433,IR700 conjugate,cell_line,0.5654,33345417
4434,Trastuzumab,gene,0.968,33345417
4435,CCA cells,cell_line,0.7964,33345417
4436,CCA,disease,0.9995,33345417
4437,Tumor,disease,0.985,33345417
4438,mice,species,0.9497,33345417
4439,EGFR- and HER2-expressing CCA cells,cell_line,0.5503,33345417
4440,EGFR,gene,0.995,33345417
4441,HER2,gene,0.985,33345417
4442,CCA,disease,0.987,33345417
4443,CCA,disease,0.9727,33345417
4444,Bevacizumab,gene,0.8843,33336844
4445,Panitumumab,gene,0.9263,33336844
4446,Patients,species,0.9854,33336844
4447,RAS,gene,0.9956,33336844
4448,/,DNA,0.607,33336844
4449,BRAF,gene,0.9966,33336844
4450,anti-,gene,0.624,33336844
4451,epidermal growth factor receptors,gene,0.906,33336844
4452,EGFRs,gene,0.994,33336844
4453,patients,species,0.962,33336844
4454,RAS,gene,0.996,33336844
4455,BRAF,gene,0.999,33336844
4456,metastatic colorectal cancer,disease,0.999,33336844
4457,mCRC,disease,1.0,33336844
4458,bevacizumab,gene,0.802,33336844
4459,bevacizumab,gene,0.5977,33336844
4460,tumor,disease,0.68,33336844
4461,RAS,gene,0.998,33336844
4462,BRAF,gene,0.9985,33336844
4463,bevacizumab,gene,0.8735,33336844
4464,anti-,gene,0.7246,33336844
4465,EGFRs,gene,0.745,33336844
4466,RAS,gene,0.9863,33336844
4467,BRAF,gene,0.9976,33336844
4468,mCRC,disease,0.9814,33336844
4469,patients,species,0.9526,33336844
4470,RAS,gene,0.982,33336844
4471,BRAF,gene,0.995,33336844
4472,mCRC,disease,0.879,33336844
4473,panitumumab,gene,0.934,33336844
4474,bevacizumab,gene,0.8774,33336844
4475,bevacizumab,gene,0.972,33336844
4476,panitumumab,gene,0.9727,33336844
4477,patients,species,0.9834,33336844
4478,panitumumab,gene,0.975,33336844
4479,bevacizumab,gene,0.9517,33336844
4480,bevacizumab,gene,0.9824,33336844
4481,panitumumab,gene,0.9863,33336844
4482,bevacizumab,gene,0.9287,33336844
4483,bevacizumab,gene,0.98,33336844
4484,neutropenia,disease,0.981,33336844
4485,bevacizumab,gene,0.9346,33336844
4486,panitumumab,gene,0.932,33336844
4487,RAS,gene,0.989,33336844
4488,BRAF,gene,0.9976,33336844
4489,mCRC,disease,0.993,33336844
4490,panitumumab,gene,0.969,33336844
4491,bevacizumab,gene,0.896,33336844
4492,BRAF,gene,0.9976,33336844
4493,metastatic colorectal cancer,disease,1.0,33336844
4494,mCRC,disease,1.0,33336844
4495,bevacizumab,gene,0.97,33336844
4496,panitumumab,gene,0.9673,33336844
4497,bevacizumab,gene,0.9478,33336844
4498,EGFRs,gene,0.9326,33336844
4499,patients,species,0.881,33336844
4500,RAS,gene,0.9883,33336844
4501,BRAF,gene,0.9976,33336844
4502,mCRC,disease,0.963,33336844
4503,bevacizumab,gene,0.7827,33336844
4504,patients,species,0.987,33336844
4505,Panitumumab,gene,0.7563,33328769
4506,patients,species,0.9536,33321462
4507,metastatic colorectal cancer,disease,1.0,33321462
4508,mCRC,disease,1.0,33321462
4509,tumor,disease,0.913,33321462
4510,RAS,gene,0.992,33321462
4511,mCRC,disease,0.889,33321462
4512,patients,species,0.9663,33321462
4513,panitumumab,gene,0.868,33321462
4514,FOLFOX,drug,0.7876,33321462
4515,panitumumab,gene,0.773,33321462
4516,panitumumab,gene,0.6836,33321462
4517,5-,drug,,33321462
4518,LV,drug,1.0,33321462
4519,PATIENTS,species,0.959,33321462
4520,patients,species,0.968,33321462
4521,PRESSING,DNA,0.622,33321462
4522,anti-EGFRs,gene,0.7866,33321462
4523,RAS,gene,0.9976,33321462
4524,BRAF,gene,0.969,33321462
4525,patients,species,0.955,33321462
4526,ETS,disease,1.0,33321462
4527,ETS,gene,0.614,33321462
4528,5-FU,drug,0.998,33321462
4529,panitumumab,gene,0.8364,33321462
4530,ETS,gene,0.735,33321462
4531,patients,species,0.9873,33321462
4532,panitumumab,gene,0.9487,33321462
4533,PRESSING panel,DNA,0.4958,33321462
4534,OS,disease,,33321462
4535,ETS,gene,0.99,33321462
4536,DoR,gene,0.959,33321462
4537,anti-EGFR,gene,0.9795,33321462
4538,ETS,gene,0.9736,33321462
4539,patient,species,0.82,33321462
4540,tumor,disease,0.9917,33321462
4541,EGFR,gene,0.9897,33288613
4542,Hypomagnesemia,disease,1.0,33288613
4543,hypomagnesemia,disease,1.0,33288613
4544,epidermal growth factor receptor antibody,gene,0.947,33288613
4545,metastatic colorectal cancer,disease,1.0,33288613
4546,mCRC,disease,1.0,33288613
4547,PATIENTS,species,0.918,33288613
4548,patients,species,0.98,33288613
4549,cetuximab,gene,0.9097,33288613
4550,panitumumab,gene,0.9014,33288613
4551,mCRC,disease,0.992,33288613
4552,cetuximab,gene,0.956,33288613
4553,panitumumab,gene,0.9043,33288613
4554,panitumumab,gene,0.919,33288613
4555,cetuximab,gene,0.796,33288613
4556,Hypomagnesemia,disease,1.0,33288613
4557,Panitumumab,gene,0.9023,33288613
4558,cetuximab,gene,0.886,33288613
4559,mCRC,disease,0.94,33288613
4560,hypomagnesemia,disease,1.0,33288613
4561,cetuximab,gene,0.9067,33288613
4562,panitumumab,gene,0.8438,33288613
4563,patients,species,0.9727,33288613
4564,reactive perforating collagenosis,disease,0.997,33264448
4565,panitumumab,gene,0.4932,33264448
4566,Panitumumab,gene,0.7217,33259157
4567,RAS,gene,0.991,33259157
4568,BRAF,gene,0.998,33259157
4569,Panitumumab,gene,0.8906,33259157
4570,metastatic colorectal cancer,disease,1.0,33259157
4571,mCRC,disease,1.0,33259157
4572,Panitumumab,gene,0.5205,33259157
4573,epidermal growth factor receptor,gene,0.999,33259157
4574,EGFR,gene,0.9937,33259157
4575,cancer cells,cell_type,0.8696,33259157
4576,cancer,disease,0.9995,33259157
4577,Panitumumab,gene,0.8574,33259157
4578,folinic acid,drug,0.9995,33259157
4579,fluorouracil,drug,0.9995,33259157
4580,oxaliplatin,drug,0.9995,33259157
4581,FOLFOX,drug,0.93,33259157
4582,fluoropyrimidine,drug,0.9956,33259157
4583,oxaliplatin,drug,0.9995,33259157
4584,irinotecan,drug,0.996,33259157
4585,tumor,disease,0.74,33259157
4586,mCRC,disease,0.9995,33259157
4587,EGFR,gene,0.894,33259157
4588,left-sided tumors,disease,0.9995,33259157
4589,EGFR,gene,0.8174,33259157
4590,right,DNA,0.669,33259157
4591,right-sided tumors,disease,0.9194,33259157
4592,EGFR,gene,0.9644,33259157
4593,tumor,disease,1.0,33259157
4594,tumor,disease,1.0,33259157
4595,panitumumab,gene,0.7437,33259157
4596,RAS mutations,gene,0.9478,33259157
4597,RAS,gene,0.9863,33259157
4598,oncogenes,DNA,0.6543,33259157
4599,KRAS and NRAS genes,DNA,0.543,33259157
4600,KRAS,gene,0.971,33259157
4601,NRAS genes,gene,0.988,33259157
4602,normal cells,cell_type,0.898,33259157
4603,cancerous cells,cell_type,0.814,33259157
4604,cancerous,disease,0.9995,33259157
4605,KRAS,DNA,0.593,33259157
4606,KRAS mutations,gene,0.9307,33259157
4607,metastatic colorectal tumors,disease,0.9897,33259157
4608,KRAS,gene,0.991,33259157
4609,EGFR,gene,0.9927,33259157
4610,EGFR,gene,0.9824,33259157
4611,panitumumab,gene,0.6997,33259157
4612,NRAS,gene,0.9917,33259157
4613,BRAF,gene,0.9766,33259157
4614,EGFR,gene,0.6904,33259157
4615,panitumumab,gene,0.782,33259157
4616,wild,gene,0.5327,33259157
4617,RAS,gene,0.645,33259157
4618,KRAS,gene,0.9927,33259157
4619,NRAS,gene,0.9946,33259157
4620,mCRC,disease,0.999,33259157
4621,RAS,DNA,0.499,33259157
4622,RAS mutations,gene,0.937,33259157
4623,panitumumab,gene,0.8916,33259157
4624,panitumumab,gene,0.844,33259157
4625,colorectal cancer,disease,1.0,33259157
4626,RAS,gene,0.992,33259157
4627,NRAS,gene,0.9917,33259157
4628,KRAS,gene,0.9883,33259157
4629,RAS,gene,0.998,33259157
4630,EGFR,gene,0.9316,33259157
4631,tumor,disease,1.0,33259157
4632,RAS,gene,0.995,33259157
4633,Cancer,disease,0.8726,33259157
4634,KRAS,gene,0.9917,33259157
4635,NRAS,gene,0.996,33259157
4636,tumor,disease,0.91,33259157
4637,mCRC,disease,0.992,33259157
4638,V600E,mutation,,33259157
4639,BRAF gene,gene,0.99,33259157
4640,panitumumab,gene,0.8193,33259157
4641,BRAF,gene,0.996,33259157
4642,Cetuximab,gene,0.8105,33237690
4643,RAS,gene,0.9937,33237690
4644,BRAF,gene,0.998,33237690
4645,Cetuximab,gene,0.8975,33237690
4646,Erbitux,gene,0.4912,33237690
4647,metastatic colorectal cancer,disease,1.0,33237690
4648,mCRC,disease,1.0,33237690
4649,cancer of the head and neck,disease,1.0,33237690
4650,Cetuximab,gene,0.6177,33237690
4651,epidermal growth factor receptor,gene,0.999,33237690
4652,EGFR,gene,0.994,33237690
4653,cancer cells,cell_type,0.876,33237690
4654,cancer,disease,0.9995,33237690
4655,FOLFIRI,drug,0.797,33237690
4656,FOLFOX,drug,0.8657,33237690
4657,Cetuximab,gene,0.872,33237690
4658,non-small cell lung cancer,disease,1.0,33237690
4659,squamous cell carcinoma of the skin,disease,1.0,33237690
4660,Menetriers disease,disease,1.0,33237690
4661,colorectal cancer,disease,1.0,33237690
4662,tumor,disease,0.9746,33237690
4663,mCRC,disease,0.9995,33237690
4664,EGFR,gene,0.6577,33237690
4665,left-sided tumors,disease,0.9995,33237690
4666,EGFR,gene,0.8174,33237690
4667,right,DNA,0.675,33237690
4668,right-sided tumors,disease,0.9194,33237690
4669,EGFR,gene,0.9644,33237690
4670,tumor,disease,1.0,33237690
4671,tumor,disease,1.0,33237690
4672,cetuximab,gene,0.7686,33237690
4673,RAS mutations,gene,0.973,33237690
4674,RAS family of,DNA,0.6377,33237690
4675,RAS family,gene,0.995,33237690
4676,oncogenes,DNA,0.543,33237690
4677,KRAS and NRAS genes,DNA,0.6626,33237690
4678,KRAS,gene,0.981,33237690
4679,NRAS genes,gene,0.9883,33237690
4680,normal cells,cell_type,0.893,33237690
4681,cancerous cells,cell_type,0.8105,33237690
4682,cancerous,disease,1.0,33237690
4683,KRAS,DNA,0.8896,33237690
4684,KRAS mutations,gene,0.9307,33237690
4685,metastatic colorectal tumors,disease,0.9897,33237690
4686,KRAS,gene,0.9917,33237690
4687,mitogen-activated protein kinase,gene,0.997,33237690
4688,MAPK,gene,0.9976,33237690
4689,EGFR,gene,0.9736,33237690
4690,cetuximab,gene,0.924,33237690
4691,NRAS,gene,0.9883,33237690
4692,BRAF,gene,0.992,33237690
4693,BRAF,DNA,0.6743,33237690
4694,BRAF mutation,gene,0.8223,33237690
4695,EGFR,gene,0.926,33237690
4696,BRAF,gene,0.9956,33237690
4697,EGFR,gene,0.9854,33237690
4698,wild-type RAS,gene,0.9946,33237690
4699,mutant BRAF,gene,0.995,33237690
4700,cetuximab,gene,0.761,33237690
4701,mCRC,disease,0.995,33237690
4702,cetuximab,gene,0.755,33237690
4703,K- and N-RAS,gene,0.9727,33237690
4704,EGFR-expressing tumors,disease,0.8994,33237690
4705,EGFR,gene,0.9927,33237690
4706,RAS mutation,gene,0.964,33237690
4707,KRAS,gene,0.97,33237690
4708,NRAS,gene,0.9854,33237690
4709,cetuximab,gene,0.881,33237690
4710,EGFR,gene,0.9937,33237690
4711,mCRC,disease,0.998,33237690
4712,EGFR,gene,0.9316,33237690
4713,tumor,disease,1.0,33237690
4714,RAS,gene,0.996,33237690
4715,Cancer,disease,0.8726,33237690
4716,KRAS,gene,0.9917,33237690
4717,NRAS,gene,0.996,33237690
4718,tumor,disease,0.91,33237690
4719,mCRC,disease,0.992,33237690
4720,V600E,mutation,,33237690
4721,BRAF gene,gene,0.9917,33237690
4722,cetuximab,gene,0.882,33237690
4723,panitumumab,gene,0.8477,33237690
4724,BRAF,gene,0.9976,33237690
4725,Neratinib,drug,0.9976,33203645
4726,Cetuximab,gene,0.9575,33203645
4727,KRAS,gene,0.9927,33203645
4728,NRAS,gene,0.9897,33203645
4729,BRAF,gene,0.995,33203645
4730,PIK3CA,gene,0.9946,33203645
4731,metastatic colorectal cancer,disease,0.9995,33203645
4732,mCRC,disease,1.0,33203645
4733,HER2,gene,0.9966,33203645
4734,ERBB2,gene,0.9907,33203645
4735,EGFR,gene,0.9697,33203645
4736,neratinib,drug,0.9893,33203645
4737,ERBB kinase,gene,0.9033,33203645
4738,cetuximab,gene,0.679,33203645
4739,patients,species,0.9805,33203645
4740,anti-,gene,0.618,33203645
4741,EGFR,gene,0.71,33203645
4742,PATIENTS,species,0.9385,33203645
4743,patients,species,0.9604,33203645
4744,quadruple,DNA,0.859,33203645
4745,mCRC,disease,0.9927,33203645
4746,cetuximab,gene,0.936,33203645
4747,neratinib,drug,0.995,33203645
4748,patients,species,0.9873,33203645
4749,patients,species,0.994,33203645
4750,patients,species,0.9834,33203645
4751,HER2,gene,0.9927,33203645
4752,tumors,disease,1.0,33203645
4753,anti-EGFR,gene,0.788,33203645
4754,HER2 CNV,DNA,0.7603,33203645
4755,HER2,gene,0.9653,33203645
4756,circulating cell-free DNA,RNA,0.5947,33203645
4757,SD,disease,,33203645
4758,patients,species,0.9893,33203645
4759,HER2,gene,0.988,33203645
4760,HER-family receptors,gene,0.9956,33203645
4761,neratinib,drug,0.9907,33203645
4762,neratinib,drug,0.9907,33203645
4763,HER2,gene,0.9917,33203645
4764,EGFR,gene,0.7246,33203645
4765,EGFR,gene,0.9883,33199443
4766,Epidermal growth factor receptor,gene,0.9976,33199443
4767,EGFR,gene,0.996,33199443
4768,advanced gastro-oesophageal adenocarcinoma,disease,1.0,33199443
4769,aGEA,disease,1.0,33199443
4770,patients,species,0.9873,33199443
4771,EGFR,gene,0.9937,33199443
4772,plasma cell-free DNA,DNA,0.828,33199443
4773,cfDNA,DNA,0.8125,33199443
4774,patients,species,0.949,33199443
4775,anti-EGFR monoclonal antibody panitumumab,gene,0.837,33199443
4776,EGFR,gene,0.993,33199443
4777,plasma cfDNAs,cell_type,0.6885,33199443
4778,patients,species,0.976,33199443
4779,receptor tyrosine kinases,gene,0.9946,33199443
4780,tyrosine,drug,0.9272,33199443
4781,EGFR,gene,0.9956,33199443
4782,patient,species,0.945,33199443
4783,patients,species,0.9736,33199443
4784,EGFR,gene,0.9927,33199443
4785,cfDNA,DNA,0.6777,33199443
4786,EGFR,gene,0.9917,33199443
4787,patients,species,0.9385,33199443
4788,EGFR,gene,0.9785,33199443
4789,EGFR,gene,0.6943,33199443
4790,epirubicin,drug,0.9893,33199443
4791,PDOs,cell_line,0.8223,33199443
4792,p21,gene,0.993,33199443
4793,cyclin B1,gene,0.994,33199443
4794,cyclin E1,gene,0.9956,33199443
4795,EGFR-amplified aGEA,cell_line,0.924,33199443
4796,EGFR,gene,0.9937,33199443
4797,EGFR,gene,0.9897,33199443
4798,patients,species,0.9897,33199443
4799,EGFR,gene,0.987,33199443
4800,anthracyclines,drug,0.9985,33199443
4801,EGFR,gene,0.9873,33188892
4802,cancer,disease,1.0,33188892
4803,epidermal growth factor receptor,gene,0.998,33188892
4804,EGFR,gene,0.9956,33188892
4805,tyrosine,drug,0.9946,33188892
4806,tyrosine kinase receptors family,gene,0.9966,33188892
4807,epithelial cell membrane,cell_type,0.717,33188892
4808,epidermal growth factor,gene,0.9966,33188892
4809,EGF,gene,0.9976,33188892
4810,normal cellular,cell_type,0.42,33188892
4811,EGFR,gene,0.992,33188892
4812,tumors,disease,1.0,33188892
4813,Ras,gene,0.994,33188892
4814,Raf,gene,0.9985,33188892
4815,MAPK,gene,0.997,33188892
4816,PIK-3,gene,0.995,33188892
4817,AKT,gene,0.994,33188892
4818,PLC,gene,0.988,33188892
4819,PKC,gene,0.994,33188892
4820,STAT,gene,0.987,33188892
4821,EGFR,gene,0.9907,33188892
4822,cancer,disease,1.0,33188892
4823,cetuximab,gene,0.9663,33188892
4824,CTX,gene,0.988,33188892
4825,panitumumab,gene,0.915,33188892
4826,nimotuzumab,gene,0.864,33188892
4827,necitumumab,gene,0.928,33188892
4828,EGFR,gene,0.9946,33188892
4829,tumor tissues,cell_type,0.6104,33188892
4830,tumor,disease,1.0,33188892
4831,ADCs,gene,0.7603,33188892
4832,ADCs,cell_type,0.544,33188892
4833,EGFR,gene,0.993,33188892
4834,ANCs,cell_type,0.4653,33188892
4835,tumor,disease,0.999,33188892
4836,ANCs,cell_type,0.521,33188892
4837,EGFR,gene,0.989,33188892
4838,cytosol,cell_type,0.669,33188892
4839,EGFR,gene,0.9946,33188892
4840,EGFR,gene,0.994,33188892
4841,cancer,disease,1.0,33188892
4842,ANCs,cell_type,0.4885,33188892
4843,EGFR,gene,0.9927,33188892
4844,ANCs,cell_type,0.6924,33188892
4845,sulfate,drug,0.544,33180600
4846,cancer,disease,0.9995,33180600
4847,sulfate,drug,0.8394,33180600
4848,cancer,disease,1.0,33180600
4849,anticancer,disease,0.8164,33180600
4850,core protein,gene,0.851,33180600
4851,HSPG,gene,0.9966,33180600
4852,HSPGs,gene,0.935,33180600
4853,HSPGs,gene,0.9927,33180600
4854,cancer,disease,1.0,33180600
4855,trastuzumab,gene,0.9746,33180600
4856,panitumumab,gene,0.9365,33180600
4857,bleomycin,drug,0.9976,33180600
4858,bisphosphonate,drug,0.999,33180600
4859,zoledronic acid,drug,0.8413,33180600
4860,ASCO,drug,0.999,33180600
4861,genistein,drug,0.994,33180600
4862,anticancer,disease,0.941,33180600
4863,panitumumab,gene,0.765,33169707
4864,patients,species,0.987,33169707
4865,cancer,disease,0.918,33169707
4866,Cancer,disease,0.5815,33169707
4867,cancer,disease,1.0,33169707
4868,patients,species,0.867,33169707
4869,colorectal cancer,disease,1.0,33169707
4870,patient,species,0.956,33169707
4871,Panitumumab,gene,0.946,33169707
4872,patients,species,0.992,33169707
4873,wild-type Kirsten rat sarcoma,disease,0.9775,33169707
4874,metastatic colorectal cancer,disease,1.0,33169707
4875,mCRC,disease,1.0,33169707
4876,oxaliplatine,drug,0.9995,33169707
4877,irinotecan,drug,0.999,33169707
4878,panitumumab,gene,0.9517,33169707
4879,mCRC,disease,0.9985,33169707
4880,panitumumab,gene,0.877,33169707
4881,antiepidermal growth factor receptor antibody,gene,0.9614,33169707
4882,mCRC,disease,0.9873,33169707
4883,panitumumab,gene,0.904,33169707
4884,patients,species,0.9697,33169707
4885,panitumumab,gene,0.808,33169707
4886,PANC-1 human pancreatic cancer xenografts,cell_line,0.888,33169241
4887,human,species,0.9688,33169241
4888,Epidermal growth factor receptors,gene,0.998,33169241
4889,EGFR,gene,0.992,33169241
4890,pancreatic cancers,disease,1.0,33169241
4891,PnCa,disease,1.0,33169241
4892,PANC-1 human PnCa xenografts,cell_line,0.8926,33169241
4893,human,species,0.989,33169241
4894,PnCa,disease,0.9624,33169241
4895,mice,species,0.9395,33169241
4896,anti-EGFR monoclonal antibody,gene,0.8735,33169241
4897,panitumumab,gene,0.7905,33169241
4898,(111)In,drug,0.9985,33169241
4899,(177)Lu,drug,0.999,33169241
4900,Panitumumab,gene,0.9277,33169241
4901,DOTA,drug,0.999,33169241
4902,(111)In,drug,0.9995,33169241
4903,(177)Lu,drug,0.999,33169241
4904,panitumumab,gene,0.963,33169241
4905,DOTA,drug,0.9995,33169241
4906,(111)In,drug,0.996,33169241
4907,panitumumab,gene,0.9155,33169241
4908,DOTA,drug,0.998,33169241
4909,[(177)Lu]Lu,drug,0.9917,33169241
4910,DOTA,drug,0.999,33169241
4911,111)In,drug,0.976,33169241
4912,panitumumab,gene,0.7676,33169241
4913,[,drug,0.9995,33169241
4914,(111)In]In,drug,0.9224,33169241
4915,Panitumumab,gene,0.938,33169241
4916,DOTA,drug,0.998,33169241
4917,[(177)Lu]Lu,drug,0.9976,33169241
4918,PANC-1 cells,cell_line,0.967,33169241
4919,PANC,disease,0.622,33169241
4920,panitumumab,gene,0.648,33169241
4921,DOTA,drug,0.999,33169241
4922,[(111)In]In,drug,0.999,33169241
4923,panitumumab,gene,0.867,33169241
4924,MCP,drug,0.937,33169241
4925,[(111)In]In,drug,0.999,33169241
4926,Panitumumab,gene,0.941,33169241
4927,DOTA,drug,0.9995,33169241
4928,[(177)Lu]Lu,drug,0.9985,33169241
4929,DNA double,DNA,0.568,33169241
4930,for -,gene,0.565,33169241
4931,H2AX,gene,0.7812,33169241
4932,panitumumab,gene,0.9805,33169241
4933,DOTA,drug,0.9995,33169241
4934,[(177)Lu]Lu,drug,0.9976,33169241
4935,panitumumab,gene,0.97,33169241
4936,DOTA,drug,0.9995,33169241
4937,[(111)In]In,drug,0.999,33169241
4938,panitumumab,gene,0.799,33169241
4939,[(111)In]In,drug,0.999,33169241
4940,mice,species,0.8325,33169241
4941,panitumumab,gene,0.9463,33169241
4942,DOTA,drug,0.999,33169241
4943,[(111)In]In,drug,0.999,33169241
4944,panitumumab,gene,0.916,33169241
4945,MCP,drug,0.9873,33169241
4946,[(111)In]In,drug,0.998,33169241
4947,mice,species,0.855,33169241
4948,panitumumab,gene,0.9443,33169241
4949,DOTA,drug,0.9946,33169241
4950,[(177)Lu]Lu,drug,0.985,33169241
4951,serum alanine aminotransferase,gene,0.954,33169241
4952,alanine,drug,0.9976,33169241
4953,ALT,gene,0.9883,33169241
4954,creatinine,drug,0.999,33169241
4955,Cr,drug,1.0,33169241
4956,PANC-1 tumours,disease,1.0,33169241
4957,panitumumab,gene,0.97,33169241
4958,DOTA,drug,0.999,33169241
4959,[(111)In]In,drug,0.999,33169241
4960,panitumumab,gene,0.615,33169241
4961,[(111)In]In,drug,0.997,33169241
4962,tumour,disease,0.9976,33169241
4963,panitumumab,gene,0.969,33169241
4964,DOTA,drug,0.9976,33169241
4965,[(177)Lu]Lu,drug,0.997,33169241
4966,tumour,disease,0.987,33169241
4967,mice,species,0.8525,33169241
4968,PANC,cell_type,0.7324,33169241
4969,PANC-1 tumours,disease,0.9756,33169241
4970,panitumumab,gene,0.963,33169241
4971,DOTA,drug,0.999,33169241
4972,[(111)In]In,drug,0.999,33169241
4973,panitumumab,gene,0.8926,33169241
4974,MCP,drug,0.816,33169241
4975,[(111)In]In,drug,0.9985,33169241
4976,Panitumumab,gene,0.85,33169241
4977,mice,species,0.989,33169241
4978,RIT,disease,0.678,33169241
4979,mice,species,0.9463,33169241
4980,PANC,cell_type,0.4622,33169241
4981,PANC-1 tumours,disease,0.9883,33169241
4982,panitumumab,gene,0.956,33169241
4983,DOTA,drug,0.9966,33169241
4984,[(177)Lu]Lu,drug,0.988,33169241
4985,panitumumab,gene,0.8115,33169241
4986,PANC-1 tumours,disease,0.9995,33169241
4987,panitumumab,gene,0.9673,33169241
4988,DOTA,drug,0.9995,33169241
4989,[(111)In]In,drug,0.9946,33169241
4990,[,drug,1.0,33169241
4991,(111)In]In,drug,0.938,33169241
4992,panitumumab,gene,0.9336,33169241
4993,DOTA,drug,0.9976,33169241
4994,(,drug,0.886,33169241
4995,177)Lu]Lu,drug,0.8687,33169241
4996,panitumumab,gene,0.9385,33169241
4997,(111)In,drug,0.999,33169241
4998,(177)Lu,drug,0.9995,33169241
4999,PANC,cell_type,0.48,33169241
5000,PANC-1 tumours,disease,0.999,33169241
5001,mice,species,0.82,33169241
5002,EGFR,gene,0.9946,33169241
5003,PnCa,disease,1.0,33169241
5004,human,species,0.9883,33168818
5005,solid tumors,disease,1.0,33168818
5006,panitumumab,gene,0.931,33168818
5007,patients,species,0.9917,33168818
5008,healthy tissue,cell_type,0.5933,33168818
5009,Panitumumab,gene,0.7563,33162757
5010,Patient,species,0.9062,33121919
5011,ATM Mutation,gene,0.954,33121919
5012,EGFR,gene,0.993,33102237
5013,Colorectal Cancer,disease,1.0,33102237
5014,metastatic colorectal cancer,disease,1.0,33102237
5015,mCRC,disease,1.0,33102237
5016,epithelial growth factor receptor,gene,0.998,33102237
5017,EGFR,gene,0.991,33102237
5018,cetuximab,gene,0.7007,33102237
5019,panitumumab,gene,0.768,33102237
5020,RAS genes,gene,0.9126,33102237
5021,tumor,disease,0.9995,33102237
5022,EGFR,gene,0.9077,33102237
5023,tumor,disease,0.9995,33102237
5024,EGFR,gene,0.9854,33102237
5025,circulating tumor cells,cell_type,0.929,33102237
5026,CTCs,cell_type,0.882,33102237
5027,cell-free tumor DNA,DNA,0.8984,33102237
5028,ctDNA,DNA,0.9023,33102237
5029,tumor-derived exosomes,cell_type,0.524,33102237
5030,tumor,disease,0.904,33102237
5031,mCRC,disease,0.9995,33102237
5032,ctDNA,RNA,0.532,33102237
5033,genes,DNA,0.3647,33102237
5034,tumor,disease,0.999,33102237
5035,EGFR,gene,0.9775,33102237
5036,mCRC,disease,0.9844,33102237
5037,EGFR,gene,0.9917,33102237
5038,mCRC,disease,0.9907,33102237
5039,Caspase,gene,0.991,33079558
5040,Temozolomide,drug,0.9995,33079558
5041,Panitumumab,gene,0.9575,33079558
5042,Poly(lactic-co-glycolic acid),drug,0.9995,33079558
5043,Epidermal Growth Factor Receptor,gene,0.998,33079558
5044,Glioblastoma Cells,cell_line,0.825,33079558
5045,Glioblastoma,disease,1.0,33079558
5046,antitumor,disease,0.673,33079558
5047,panitumumab,gene,0.9644,33079558
5048,PmAb,gene,0.991,33079558
5049,temozolomide,drug,0.9995,33079558
5050,TMZ,drug,0.9985,33079558
5051,poly(lactic-co-glycolic acid),drug,0.9995,33079558
5052,PLGA,drug,0.999,33079558
5053,PmAb,gene,0.848,33079558
5054,TMZ,drug,0.999,33079558
5055,PLGA,drug,0.9995,33079558
5056,PmAb,gene,0.9814,33079558
5057,TMZ,drug,0.996,33079558
5058,PLGA,drug,0.998,33079558
5059,ethyl(dimethylaminopropyl)carbodiimide,drug,0.999,33079558
5060,EDC,drug,0.999,33079558
5061,N-hydroxysuccinimide,drug,0.9995,33079558
5062,NHS,drug,0.998,33079558
5063,PLGA,drug,0.999,33079558
5064,U-87 MG cell line,cell_line,0.945,33079558
5065,U-87 MG cell,cell_type,0.591,33079558
5066,epidermal growth factor receptor,gene,0.9976,33079558
5067,EGFR,gene,0.97,33079558
5068,LN229 cell line,cell_line,0.9575,33079558
5069,LN229,cell_type,0.5747,33079558
5070,PmAb,gene,0.986,33079558
5071,TMZ,drug,0.999,33079558
5072,PLGA,drug,0.999,33079558
5073,anticancer,disease,0.837,33079558
5074,TMZ,drug,0.994,33079558
5075,TMZ,drug,0.9937,33079558
5076,PLGA,drug,0.9697,33079558
5077,PmAb,gene,0.965,33079558
5078,TMZ,drug,0.9966,33079558
5079,PLGA,drug,0.9985,33079558
5080,EGFR,gene,0.995,33079558
5081,glioblastoma multiforme,disease,1.0,33079558
5082,GBM,disease,1.0,33079558
5083,U-87 MG) cell line,cell_line,0.79,33079558
5084,low EGFR GBM model,cell_line,0.7183,33079558
5085,EGFR,gene,0.9116,33079558
5086,GBM,disease,0.999,33079558
5087,LN229,cell_line,0.9077,33079558
5088,PmAb,gene,0.918,33079558
5089,TMZ,drug,0.998,33079558
5090,PLGA,drug,0.999,33079558
5091,GBM,disease,1.0,33079558
5092,autophagic,DNA,0.566,33079558
5093,Beclin-1,gene,0.996,33079558
5094,LC3B,gene,0.9946,33079558
5095,caspase-9,gene,0.9937,33079558
5096,PARP,gene,0.9854,33079558
5097,caspase-9,gene,0.994,33079558
5098,PARP,gene,0.9883,33079558
5099,Beclin-1,gene,0.997,33079558
5100,LC3B,gene,0.994,33079558
5101,PmAb,gene,0.944,33079558
5102,TMZ,drug,0.9976,33079558
5103,PLGA,drug,0.9995,33079558
5104,GBM,disease,1.0,33079558
5105,caspase-9,gene,0.9917,33079558
5106,oxygen,drug,0.9995,33079558
5107,PmAb,gene,0.8735,33079558
5108,TMZ,drug,0.9966,33079558
5109,PLGA,drug,0.999,33079558
5110,PmAb,gene,0.9536,33079558
5111,TMZ,drug,0.9946,33079558
5112,PLGA,drug,0.999,33079558
5113,EGFR,gene,0.992,33079558
5114,cancer,disease,1.0,33079558
5115,Formalin,drug,0.978,33078373
5116,formalin,drug,0.9976,33078373
5117,panitumumab,gene,0.962,33078373
5118,patients,species,0.974,33078373
5119,head and neck squamous cell carcinoma,disease,1.0,33078373
5120,HNSCC,disease,1.0,33078373
5121,HNSCC,disease,1.0,33078373
5122,patients,species,0.991,33078373
5123,panitumumab,gene,0.939,33078373
5124,tumor,disease,0.956,33078373
5125,formalin,drug,0.9717,33078373
5126,formalin,drug,0.997,33078373
5127,formalin,drug,0.9897,33078373
5128,primary,disease,0.783,33078373
5129,tumor,disease,0.9023,33078373
5130,formalin,drug,0.9873,33078373
5131,patients,species,0.993,33078373
5132,Formalin,drug,0.9937,33078373
5133,tumor,disease,0.9976,33078373
5134,formalin,drug,0.9624,33078373
5135,formalin,drug,0.996,33078373
5136,formalin,drug,0.966,33078373
5137,tumor,disease,0.9976,33078373
5138,TBR,DNA,0.511,33078373
5139,formalin,drug,0.999,33078373
5140,EGFR,gene,0.9243,33068283
5141,Metastatic Colorectal Cancer,disease,1.0,33068283
5142,mCRC,disease,1.0,33068283
5143,Anti-epidermal growth factor receptor,gene,0.8584,33068283
5144,EGFR,gene,0.992,33068283
5145,cetuximab,gene,0.7686,33068283
5146,panitumumab,gene,0.8594,33068283
5147,RAS,gene,0.5024,33068283
5148,metastatic colorectal cancer,disease,0.999,33068283
5149,CRC,disease,1.0,33068283
5150,EGFR,gene,0.5527,33068283
5151,metastatic CRC,disease,0.9995,33068283
5152,anti-EGFR,gene,0.9546,33068283
5153,PATIENTS,species,0.841,33068283
5154,EGFR,gene,0.7544,33068283
5155,metastatic CRC,disease,0.996,33068283
5156,anti-EGFR,gene,0.983,33068283
5157,EGFR,gene,0.8887,33068283
5158,RAS,gene,0.4834,33068283
5159,metastatic CRC,disease,0.881,33068283
5160,Trichomegaly,disease,1.0,33053288
5161,Panitumumab,gene,0.7354,33053288
5162,Epidermal growth factor receptor,gene,0.9985,33028137
5163,EGFRs,gene,0.9766,33028137
5164,multiple solid organ malignity,disease,0.999,33028137
5165,papulopustular (PPL) lesions,disease,1.0,33028137
5166,patient,species,0.995,33028137
5167,EGFR,gene,0.9873,33028137
5168,patients,species,0.9897,33028137
5169,EGFR,gene,0.9927,33028137
5170,breast and colorectal carcinoma,disease,1.0,33028137
5171,patients,species,0.993,33028137
5172,EGFR,gene,0.993,33028137
5173,patients,species,0.9795,33028137
5174,skin rash,disease,1.0,33028137
5175,patients,species,0.9897,33028137
5176,patients,species,0.9927,33028137
5177,EGFR,gene,0.9736,33028137
5178,patients,species,0.9927,33028137
5179,patients,species,0.994,33028137
5180,carcinoma,disease,1.0,33028137
5181,patients,species,0.991,33028137
5182,colorectal carcinoma,disease,1.0,33028137
5183,patients,species,0.989,33028137
5184,renal cancer,disease,1.0,33028137
5185,patients,species,0.989,33028137
5186,breast cancer,disease,1.0,33028137
5187,patients,species,0.9927,33028137
5188,trastuzumab,gene,0.97,33028137
5189,patients,species,0.9956,33028137
5190,patients,species,0.9946,33028137
5191,patients,species,0.9917,33028137
5192,cetuximab,gene,0.6147,33028137
5193,patients,species,0.9907,33028137
5194,sunitinib,drug,0.9985,33028137
5195,patients,species,0.9966,33028137
5196,panitumumab,gene,0.8345,33028137
5197,patients,species,0.9956,33028137
5198,pertuzumab,gene,0.928,33028137
5199,patients,species,0.9907,33028137
5200,PPL,drug,0.8066,33028137
5201,patients,species,0.992,33028137
5202,patients,species,0.9897,33028137
5203,patients,species,0.99,33028137
5204,acneiform,disease,0.9907,33028137
5205,doxycycline,drug,0.999,33028137
5206,tetracycline,drug,0.9976,33028137
5207,clindamycin,drug,0.9985,33028137
5208,patient,species,0.992,33028137
5209,trastuzumab,gene,0.975,33028137
5210,patients,species,0.991,33028137
5211,lesions,disease,0.737,33028137
5212,patient,species,0.9834,33028137
5213,granulomatous follicular reaction,disease,1.0,33028137
5214,Xerosis,disease,1.0,33028137
5215,paronychia,disease,1.0,33028137
5216,pyogenic granuloma,disease,1.0,33028137
5217,trichomegaly,disease,1.0,33028137
5218,madarosis,disease,1.0,33028137
5219,patient,species,0.959,33028137
5220,patients,species,0.9917,33028137
5221,acneiform rash,disease,1.0,33028137
5222,patients,species,0.992,33028137
5223,patients,species,0.994,33028137
5224,acneiform skin rash,disease,1.0,33028137
5225,EGFR,gene,0.9863,33028137
5226,Clindamycin,drug,0.9985,33028137
5227,doxycycline,drug,0.9985,33028137
5228,epidermal growth factor receptor,gene,0.998,33026965
5229,plasma DNA,DNA,0.6753,33026965
5230,metastatic colorectal cancer,disease,1.0,33026965
5231,panitumumab,gene,0.793,33026965
5232,epidermal growth factor receptor,gene,0.997,33026965
5233,EGFR,gene,0.984,33026965
5234,panitumumab,gene,0.8105,33026965
5235,cetuximab,gene,0.6772,33026965
5236,mouse,species,0.777,33026965
5237,metastatic colorectal cancer,disease,1.0,33026965
5238,mCRC,disease,1.0,33026965
5239,ASPECCT,DNA,0.5093,33026965
5240,panitumumab,gene,0.918,33026965
5241,cetuximab,gene,0.8794,33026965
5242,wild-type KRAS exon 2,gene,0.5723,33026965
5243,mCRC,disease,0.9917,33026965
5244,EGFR,gene,0.933,33026965
5245,EGFR,gene,0.995,33026965
5246,p.S492R,DNA,0.413,33026965
5247,cetuximab,gene,0.831,33026965
5248,panitumumab,gene,0.886,33026965
5249,plasma,cell_type,0.5366,33026965
5250,EGFR p.S492R,DNA,0.5107,33026965
5251,EGFR p.S492R mutations,gene,0.7603,33026965
5252,EGFR p.S492R mutation,gene,0.8003,33026965
5253,panitumumab,gene,0.8584,33026965
5254,cetuximab,gene,0.843,33026965
5255,cetuximab,gene,0.942,33026965
5256,panitumumab,gene,0.8457,33026965
5257,S492R,DNA,0.4934,33026965
5258,cetuximab,gene,0.8535,33026965
5259,EGFR mutations,gene,0.963,33026965
5260,EGFR,gene,0.747,33026965
5261,panitumumab,gene,0.761,33026965
5262,EGFR p.S492R mutant,gene,0.8794,33026965
5263,epidermal growth factor receptor,gene,0.9966,33014289
5264,epidermal growth factor receptor,gene,0.998,33014289
5265,EGFR,gene,0.99,33014289
5266,solid tumors,disease,1.0,33014289
5267,EGFR,gene,0.9946,33014289
5268,cancer,disease,1.0,33014289
5269,hybridoma,cell_line,0.613,33014289
5270,anti-EGFR monoclonal antibodies,gene,0.975,33014289
5271,Cetuximab,gene,0.832,33014289
5272,Panitumumab,gene,0.8667,33014289
5273,tumor,disease,0.9917,33014289
5274,EGFR,gene,0.9927,33014289
5275,cancer,disease,1.0,33014289
5276,Head and Neck Cancer,disease,1.0,33008927
5277,anti-EGFR,gene,0.9956,33008927
5278,head and neck squamous cell carcinoma,disease,1.0,33008927
5279,HNSCC,disease,1.0,33008927
5280,anti-epidermal growth factor receptor,gene,0.995,33008927
5281,EGFR,gene,0.9434,33008927
5282,panitumumab,gene,0.827,33008927
5283,panitumumab,gene,0.938,33008927
5284,HNSCC,disease,0.999,33008927
5285,Metastatic,disease,0.5,33008927
5286,benign LNs,cell_type,0.492,33008927
5287,benign,cell_type,0.4878,33008927
5288,pan800,cell_line,0.447,33008927
5289,benign LNs,cell_type,0.6255,33008927
5290,HNSCC,disease,0.9995,33008927
5291,RAS,gene,0.8384,33002301
5292,metastatic colorectal cancer,disease,1.0,33002301
5293,RAS,gene,0.838,33002301
5294,metastatic colorectal cancer,disease,1.0,33002301
5295,mCRC,disease,1.0,33002301
5296,bevacizumab,gene,0.896,33002301
5297,cetuximab,gene,0.912,33002301
5298,panitumumab,gene,0.9243,33002301
5299,colorectal cancer,disease,1.0,33002301
5300,RAS,DNA,0.779,33002301
5301,RAS mutation,gene,0.9385,33002301
5302,mCRC,disease,0.9956,33002301
5303,wild,cell_line,0.492,33002301
5304,wild-type RAS tumours,disease,1.0,33002301
5305,mutant RAS tumours,disease,0.9995,33002301
5306,mutant RAS,gene,0.832,33002301
5307,liver,disease,0.957,33002301
5308,RAS,gene,0.74,33002301
5309,RAS,gene,0.68,33002301
5310,wild,cell_line,0.593,33002301
5311,wild-type RAS tumour,disease,1.0,33002301
5312,wild-type RAS,gene,0.646,33002301
5313,RAS,gene,0.7812,33002301
5314,mCRC,disease,0.9995,33002301
5315,wild,gene,0.4941,33002301
5316,mCRC,disease,0.553,33002301
5317,Statin,drug,0.9893,32998959
5318,EGFR- and PSMA-Expressing Tumors,disease,0.6235,32998959
5319,EGFR,gene,0.996,32998959
5320,PSMA,gene,0.9604,32998959
5321,Statins,drug,0.9565,32998959
5322,cholesterol,drug,0.999,32998959
5323,hypercholesterolemia,disease,1.0,32998959
5324,statins,drug,0.99,32998959
5325,tumor,disease,0.998,32998959
5326,monoclonal,gene,0.531,32998959
5327,lovastatin,drug,0.9995,32998959
5328,simvastatin,drug,0.999,32998959
5329,rosuvastatin,drug,0.999,32998959
5330,epidermal growth factor receptor,gene,0.9976,32998959
5331,EGFR,gene,0.9893,32998959
5332,prostate-specific membrane antigen,gene,0.995,32998959
5333,PSMA,gene,0.8965,32998959
5334,tumor cell,cell_type,0.7246,32998959
5335,tumor,disease,0.995,32998959
5336,89Zr,drug,0.9976,32998959
5337,ectopic xenografts,cell_line,0.531,32998959
5338,EGFR,gene,0.981,32998959
5339,PSMA,gene,0.926,32998959
5340,statin,gene,0.8394,32998959
5341,lovastatin,drug,0.9995,32998959
5342,simvastatin,drug,0.999,32998959
5343,rosuvastatin,drug,0.9995,32998959
5344,tumors,disease,1.0,32998959
5345,mAbs panitumumab,gene,0.8506,32998959
5346,cetuximab,gene,0.9697,32998959
5347,huJ591,gene,0.9688,32998959
5348,Statins,drug,0.993,32998959
5349,caveolin-1,gene,0.995,32998959
5350,cavin-1,gene,0.988,32998959
5351,endophilin,gene,0.973,32998959
5352,clathrin,gene,0.9917,32998959
5353,dynamin proteins,gene,0.848,32998959
5354,EGFR- and PSMA-overexpressing xenografts,cell_line,0.742,32998959
5355,EGFR,gene,0.997,32998959
5356,PSMA,gene,0.9844,32998959
5357,statins,drug,0.9976,32998959
5358,tumors,disease,1.0,32998959
5359,statins,drug,0.9814,32998959
5360,tumors,disease,1.0,32998959
5361,Metastatic Colorectal Cancer,disease,1.0,32988968
5362,Tumor,disease,0.5923,32988968
5363,cancer,disease,1.0,32988968
5364,tumor,disease,0.979,32988968
5365,aflibercept,gene,0.985,32988968
5366,panitumumab,gene,0.93,32988968
5367,advanced colorectal cancer,disease,1.0,32988968
5368,metastatic lesions,disease,0.882,32988968
5369,panitumumab,gene,0.8877,32988968
5370,aflibercept,gene,0.9746,32988968
5371,tumor,disease,0.947,32988968
5372,tumor,disease,0.8906,32988968
5373,tumor,disease,0.875,32988968
5374,colorectal cancer,disease,1.0,32988968
5375,advanced or metastatic colorectal cancer,disease,0.8604,32961943
5376,FOLFOX,drug,0.8047,32961943
5377,FOLFIRIbevacizumab,drug,0.8984,32961943
5378,Bmab,gene,0.966,32961943
5379,cetuximab,gene,0.9834,32961943
5380,Cmab,gene,0.977,32961943
5381,panitumumab,gene,0.9673,32961943
5382,Pmab,gene,0.987,32961943
5383,FOLFOX,drug,0.9194,32961943
5384,FOLFOX,drug,0.8457,32961943
5385,FOLFIRI,drug,0.8965,32961943
5386,Cmab,drug,0.7725,32961943
5387,FOLFIRI,drug,0.968,32961943
5388,FOLFOX,drug,0.67,32961943
5389,Cmab,drug,0.9775,32961943
5390,FOLFOXIRI,drug,0.9736,32961943
5391,FOLFOX,drug,0.9775,32961943
5392,Cmab,drug,0.99,32961943
5393,FOLFIRI,drug,0.818,32961943
5394,Bmab,drug,0.8535,32961943
5395,FOLFIRI,drug,0.994,32961943
5396,Pmab,drug,0.932,32961943
5397,FOLFIRI,drug,0.9956,32961943
5398,FOLFIRI,drug,0.9307,32961943
5399,Bmab,drug,0.753,32961943
5400,FOLFOX,drug,0.9688,32961943
5401,Cmab,gene,0.7515,32961943
5402,FOLFIRI,drug,0.9316,32961943
5403,KRAS,gene,0.982,32960408
5404,patients,species,0.9917,32960408
5405,metastatic colorectal cancer,disease,1.0,32960408
5406,mCRC,disease,1.0,32960408
5407,patients,species,0.96,32960408
5408,KRAS exon 2,gene,0.987,32960408
5409,mCRC,disease,0.9434,32960408
5410,FOLFIRI,drug,0.87,32960408
5411,panitumumab,gene,0.8213,32960408
5412,bevacizumab,gene,0.728,32960408
5413,Bev,gene,0.8403,32960408
5414,PATIENTS,species,0.974,32960408
5415,tumor,disease,0.542,32960408
5416,VEGF-D,gene,0.998,32960408
5417,VEGF-D,gene,0.7705,32960408
5418,patients,species,0.9844,32960408
5419,Patients,species,0.9336,32960408
5420,ETS,gene,0.9756,32960408
5421,patients,species,0.9946,32960408
5422,ETS,disease,0.996,32960408
5423,left-sided tumors,disease,0.9966,32960408
5424,VEGF-D,gene,0.998,32960408
5425,ETS,gene,0.9907,32960408
5426,DpR,DNA,0.6074,32960408
5427,mCRC,disease,0.997,32960408
5428,Colorectal Carcinoma,disease,1.0,32933095
5429,colorectal cancer,disease,1.0,32933095
5430,CRC,disease,1.0,32933095
5431,CRC,disease,0.998,32933095
5432,cancer,disease,1.0,32933095
5433,unresectable tumors,disease,0.88,32933095
5434,CRC cells,cell_line,0.7896,32933095
5435,CRC,disease,0.9995,32933095
5436,pyrimidine,drug,0.9995,32933095
5437,5-fluorouracil,drug,0.9995,32933095
5438,capecitabine,drug,0.999,32933095
5439,trifluridine,drug,0.999,32933095
5440,tipiracil,drug,0.9985,32933095
5441,oxaliplatin,drug,0.9995,32933095
5442,irinotecan,drug,0.998,32933095
5443,tyrosine,drug,0.995,32933095
5444,tyrosine kinase receptors,gene,0.996,32933095
5445,regorafenib,drug,0.997,32933095
5446,aflibercept,gene,0.9746,32933095
5447,bevacizumab,gene,0.883,32933095
5448,cetuximab,gene,0.8945,32933095
5449,panitumumab,gene,0.9014,32933095
5450,genes,DNA,0.4895,32933095
5451,CRC,disease,0.9995,32933095
5452,MOC-7,cell_line,0.5713,32933095
5453,cancer cell,cell_type,0.762,32933095
5454,cancer,disease,0.9995,32933095
5455,liposomes,cell_type,0.4268,32933095
5456,exosomes,cell_type,0.6357,32933095
5457,tumor,disease,0.9966,32933095
5458,oncogenes,DNA,0.8833,32933095
5459,Panitumumab,gene,0.943,32918848
5460,Panitumumab,gene,0.935,32918848
5461,frail,disease,0.545,32918848
5462,patients,species,0.9575,32918848
5463,RAS,gene,0.998,32918848
5464,colorectal cancer,disease,0.9995,32918848
5465,left,DNA,0.5146,32918848
5466,left-sided tumors,disease,0.967,32918848
5467,panitumumab,gene,0.9224,32918848
5468,patients,species,0.989,32918848
5469,oxaliplatin,drug,0.9995,32918848
5470,irinotecan,drug,0.998,32918848
5471,panitumumab,gene,0.9497,32918848
5472,patients,species,0.9805,32918848
5473,patients,species,0.9697,32918848
5474,RAS wild-type (,disease,0.9634,32918848
5475,RAS,gene,0.9937,32918848
5476,CRC,disease,1.0,32918848
5477,panitumumab,gene,0.838,32918848
5478,patients,species,0.984,32918848
5479,Panitumumab,gene,0.8613,32918848
5480,patients,species,0.9785,32918848
5481,patients,species,0.9893,32918848
5482,patients,species,0.9854,32918848
5483,patients,species,0.869,32918848
5484,patient,species,0.9785,32918848
5485,patients,species,0.987,32918848
5486,CRC,disease,0.966,32918848
5487,CRC,disease,0.9707,32918848
5488,patients,species,0.9927,32918848
5489,patients,species,0.988,32918848
5490,left- and right-sided tumors,disease,0.9956,32918848
5491,rash,disease,0.9995,32918848
5492,hypomagnesemia,disease,1.0,32918848
5493,fatigue,disease,0.9976,32918848
5494,paronychia,disease,1.0,32918848
5495,hyponatremia,disease,1.0,32918848
5496,neutropenia,disease,1.0,32918848
5497,Panitumumab,gene,0.935,32918848
5498,patients,species,0.9697,32918848
5499,RAS WT,gene,0.997,32918848
5500,CRC,disease,0.977,32918848
5501,Hyperammonemia,disease,1.0,32909537
5502,impaired consciousness,disease,0.9746,32909537
5503,5-fluorouracil,drug,0.9985,32909537
5504,woman,species,0.8906,32909537
5505,stage IVb sigmoid colon cancer,disease,0.9155,32909537
5506,levofolinatefluorouraciloxaliplatin,drug,0.997,32909537
5507,panitumumab,gene,0.848,32909537
5508,oxaliplatin,drug,0.9995,32909537
5509,5-fluorouracil,drug,0.999,32909537
5510,5-FU,drug,0.999,32909537
5511,patient,species,0.9873,32909537
5512,impaired consciousness,disease,0.803,32909537
5513,hemorrhage,disease,0.9507,32909537
5514,infarction,disease,0.996,32909537
5515,brain metastasis,disease,0.9995,32909537
5516,leukoencephalopathy,disease,1.0,32909537
5517,ammonia,drug,0.9985,32909537
5518,Impaired consciousness,disease,1.0,32909537
5519,hyperammonemia,disease,1.0,32909537
5520,branched chain amino acids,drug,0.921,32909537
5521,ammonia,drug,0.998,32909537
5522,5-FU,drug,0.9976,32909537
5523,hyperammonemia,disease,1.0,32909537
5524,L-OHP,drug,0.999,32909537
5525,5-FU,drug,0.9985,32909537
5526,5-FU,drug,0.998,32909537
5527,impaired consciousness,disease,0.995,32909537
5528,hyperammonemia,disease,1.0,32909537
5529,hyperammonemia,disease,1.0,32909537
5530,5-FU,drug,0.998,32909537
5531,trametinib,drug,0.998,32901840
5532,BclxL,gene,0.993,32901840
5533,KRASmutant,gene,0.992,32901840
5534,colorectal cancer,disease,0.9985,32901840
5535,CRC,disease,1.0,32901840
5536,cancer,disease,0.9976,32901840
5537,KRAS,DNA,0.7305,32901840
5538,KRAS mutations,gene,0.938,32901840
5539,EGFR,gene,0.998,32901840
5540,cetuximab,gene,0.7935,32901840
5541,panitumumab,gene,0.861,32901840
5542,patients,species,0.967,32901840
5543,CRC,disease,0.9995,32901840
5544,KRASmutant CRC,cell_line,0.6377,32901840
5545,KRASmutant,gene,0.983,32901840
5546,CRC,disease,0.604,32901840
5547,KRASmutant CRC,cell_line,0.714,32901840
5548,KRASmutant,gene,0.992,32901840
5549,CRC,disease,0.5547,32901840
5550,KRAS gene,DNA,0.911,32901840
5551,KRAS gene,gene,0.9946,32901840
5552,KRAS gene,gene,0.9907,32901840
5553,G12D,DNA,0.7197,32901840
5554,G12,mutation,,32901840
5555,G12,mutation,,32901840
5556,G13,mutation,,32901840
5557,CACO2 cells,cell_line,0.9536,32901840
5558,MEK,gene,0.993,32901840
5559,trametinib,drug,0.997,32901840
5560,Cetuximab,gene,0.588,32901840
5561,Panitumumab,gene,0.8013,32901840
5562,Regorafenib,drug,0.996,32901840
5563,Vemurafenib,drug,0.998,32901840
5564,BEZ235,drug,0.995,32901840
5565,Palbociclib,drug,0.998,32901840
5566,Trametinib,drug,0.993,32901840
5567,phosphorylated ERK,gene,0.684,32901840
5568,pERK,gene,0.9863,32901840
5569,KRASmutant CACO2 cells,cell_line,0.941,32901840
5570,KRASmutant CACO2 cells,cell_type,0.583,32901840
5571,KRASmutant,gene,0.99,32901840
5572,trametinib,drug,0.9985,32901840
5573,antiapoptotic protein,gene,0.7285,32901840
5574,BclxL,gene,0.7505,32901840
5575,KRASmutant CRC,cell_line,0.7896,32901840
5576,KRASmutant,gene,0.9873,32901840
5577,trametinib,drug,0.998,32901840
5578,BclxL,gene,0.9956,32901840
5579,ABT263,drug,0.9985,32901840
5580,trametinib,drug,0.997,32901840
5581,ABT263,drug,0.9995,32901840
5582,mutant KRAS transductants,cell_line,0.868,32901840
5583,mutant KRAS,gene,0.9824,32901840
5584,trametinib,drug,0.9985,32901840
5585,ABT263,drug,0.9995,32901840
5586,KRASmutant (G12V) xenograft,cell_line,0.8267,32901840
5587,KRASmutant,gene,0.985,32901840
5588,G12,mutation,,32901840
5589,trametinib,drug,0.999,32901840
5590,trametinib,drug,0.999,32901840
5591,ABT263,drug,1.0,32901840
5592,BclxL,gene,0.993,32901840
5593,pERK,gene,0.993,32901840
5594,KRASmutant cells,cell_line,0.9414,32901840
5595,KRASmutant,gene,0.98,32901840
5596,KRASmutant,DNA,0.628,32901840
5597,KRASmutant CRC,cell_line,0.5767,32901840
5598,KRASmutant,gene,0.992,32901840
5599,CRC,disease,0.6836,32901840
5600,Panitumumab,gene,0.5884,32888816
5601,metastatic squamous cell,disease,1.0,32888816
5602,panitumumab,gene,0.974,32880818
5603,Panitumumab,gene,0.9214,32880818
5604,"head and neck, lung, pancreas, and brain cancers",disease,1.0,32880818
5605,panitumumab,gene,0.957,32880818
5606,Panitumumab,gene,0.971,32880818
5607,Panitumumab,gene,0.9385,32880818
5608,panitumumab,gene,0.9087,32880818
5609,oxaliplatin,drug,0.9995,32871526
5610,patients,species,0.958,32871526
5611,colorectal liver metastases,disease,1.0,32871526
5612,CRLM,disease,1.0,32871526
5613,floruxidine,drug,0.999,32871526
5614,bevacizumab,gene,0.7705,32871526
5615,oxaliplatin,drug,0.9995,32871526
5616,patients,species,0.9756,32871526
5617,CRLM,disease,0.9995,32871526
5618,oxaliplatin,drug,0.9995,32871526
5619,cetuximab,gene,0.9897,32871526
5620,panitumumab,gene,0.984,32871526
5621,bevacizumab,gene,0.607,32871526
5622,patients,species,0.992,32871526
5623,oxaliplatin,drug,0.998,32871526
5624,oxaliplatin,drug,1.0,32871526
5625,FOLFIRI,drug,0.662,32871526
5626,anti-EGFR,gene,0.9204,32871526
5627,bevacizumab,gene,0.5054,32871526
5628,neutropenia,disease,1.0,32871526
5629,HAI,disease,0.7017,32871526
5630,abdominal pain,disease,0.983,32871526
5631,neurotoxicity,disease,1.0,32871526
5632,CRLM,disease,0.9995,32871526
5633,patients,species,0.981,32871526
5634,oxaliplatin,drug,0.9995,32871526
5635,miR,DNA,0.52,32859639
5636,miR-125b,gene,0.957,32859639
5637,miR-17,gene,0.954,32859639
5638,let-7c,gene,0.867,32859639
5639,MicroRNAs,RNA,0.63,32859639
5640,cancer,disease,1.0,32859639
5641,cancer,disease,1.0,32859639
5642,anti-EGFR monoclonal antibodies,gene,0.989,32859639
5643,miR,RNA,0.5864,32859639
5644,miR-,RNA,0.6465,32859639
5645,125b,DNA,0.66,32859639
5646,let-7c,gene,0.754,32859639
5647,miR,RNA,0.551,32859639
5648,miR-99a,gene,0.705,32859639
5649,miR-17,gene,0.8887,32859639
5650,miR-143,gene,0.8936,32859639
5651,miR-145,RNA,0.56,32859639
5652,miR-145,gene,0.802,32859639
5653,metastatic colorectal cancer,disease,1.0,32859639
5654,mCRC,disease,1.0,32859639
5655,patients,species,0.9834,32859639
5656,PATIENTS,species,0.9375,32859639
5657,patients,species,0.969,32859639
5658,mCRC,disease,0.9966,32859639
5659,wild-type RAS gene,gene,0.9683,32859639
5660,cetuximab,gene,0.79,32859639
5661,panitumumab,gene,0.6543,32859639
5662,miR,RNA,0.652,32859639
5663,miR-125b,gene,0.9106,32859639
5664,let-7c,gene,0.9062,32859639
5665,miR,RNA,0.4846,32859639
5666,miR-17,gene,0.886,32859639
5667,tumour,disease,1.0,32859639
5668,miR,DNA,0.6064,32859639
5669,miR-125b,gene,0.9575,32859639
5670,miR,DNA,0.52,32859639
5671,miR-125b,gene,0.9463,32859639
5672,let-7c,gene,0.9146,32859639
5673,miR,DNA,0.594,32859639
5674,miR-17,gene,0.944,32859639
5675,MiR,DNA,0.5864,32859639
5676,MiR-125b,gene,0.9185,32859639
5677,miR,DNA,0.6064,32859639
5678,miR-125b,gene,0.97,32859639
5679,let-7c,gene,0.905,32859639
5680,miR-17,RNA,0.462,32859639
5681,miR-17,gene,0.868,32859639
5682,mCRC,disease,0.999,32859639
5683,patients,species,0.9834,32859639
5684,anti-EGFR mAbs,gene,0.917,32859639
5685,Panitumumab,gene,0.958,32832029
5686,cancer,disease,0.9995,32832029
5687,monoclonal,gene,0.6367,32832029
5688,tumor,disease,1.0,32832029
5689,panitumumab,gene,0.8647,32832029
5690,IRDye700DX,drug,0.6274,32832029
5691,IR700,drug,0.6206,32832029
5692,mAb,gene,0.7573,32832029
5693,APC,gene,0.988,32832029
5694,APCs,cell_type,0.856,32832029
5695,mAb,gene,0.7583,32832029
5696,EGFR,gene,0.9277,32821190
5697,Metastatic Small Bowel Adenocarcinoma,disease,1.0,32821190
5698,small bowel adenocarcinoma,disease,1.0,32821190
5699,SBA,disease,1.0,32821190
5700,anti-,gene,0.896,32821190
5701,epidermal growth factor receptor,gene,0.896,32821190
5702,EGFR,gene,0.9937,32821190
5703,vascular endothelial growth factor,gene,0.8877,32821190
5704,VEGF,gene,0.9966,32821190
5705,PATIENTS,species,0.8994,32821190
5706,patients,species,0.9673,32821190
5707,metastatic SBA,disease,0.963,32821190
5708,anti-EGFR antibodies,gene,0.904,32821190
5709,cetuximab,gene,0.906,32821190
5710,panitumumab,gene,0.8276,32821190
5711,patients,species,0.976,32821190
5712,SBA,disease,0.8193,32821190
5713,patients,species,0.9805,32821190
5714,EGFR,gene,0.82,32821190
5715,skin reaction,disease,0.9717,32821190
5716,patients,species,0.996,32821190
5717,hypomagnesemia,disease,1.0,32821190
5718,patients,species,0.9946,32821190
5719,diarrhea,disease,1.0,32821190
5720,patients,species,0.9917,32821190
5721,diarrhea,disease,1.0,32821190
5722,patient,species,0.984,32821190
5723,Conjunctivitis,disease,0.999,32821190
5724,patients,species,0.9644,32821190
5725,patients,species,0.9673,32821190
5726,patients,species,0.966,32821190
5727,patients,species,0.971,32821190
5728,patients,species,0.9814,32821190
5729,EGFR,gene,0.6377,32821190
5730,Panitumumab,gene,0.797,32801947
5731,Cancer,disease,1.0,32801947
5732,Panitumumab,gene,0.775,32801947
5733,wild,DNA,0.5273,32801947
5734,wild-type RAS,gene,0.9683,32801947
5735,panitumumab,gene,0.89,32801947
5736,panitumumab,gene,0.8345,32801947
5737,panitumumab,gene,0.896,32801947
5738,panitumumab,gene,0.8457,32801947
5739,panitumumab,gene,0.9478,32801947
5740,panitumumab,gene,0.8867,32801947
5741,anti-,gene,0.75,32799569
5742,EGFR monoclonal,gene,0.6978,32799569
5743,anal squamous cell carcinoma,disease,0.91,32799569
5744,squamous cell carcinoma anal cancer,disease,0.9736,32799569
5745,SCCA,disease,1.0,32799569
5746,platinum,drug,0.999,32799569
5747,programmed death-1,gene,0.966,32799569
5748,anti-EGFR monoclonal antibody,gene,0.9463,32799569
5749,metastatic SCCA,disease,0.953,32799569
5750,anti-EGFR mAb,gene,0.892,32799569
5751,anti-EGFR mAbs,gene,0.8306,32799569
5752,anti-EGFR mAb,gene,0.976,32799569
5753,fluoropyrimidine,drug,0.9604,32799569
5754,pts,species,0.963,32799569
5755,pts,species,0.937,32799569
5756,PIK3CA,DNA,0.8105,32799569
5757,PIK3CA mutation,gene,0.875,32799569
5758,anti-,gene,0.77,32799569
5759,EGFR mAb,gene,0.811,32799569
5760,metastatic SCCA,disease,0.67,32799569
5761,PIK3CA,gene,0.985,32799569
5762,Metastatic SCCA,disease,0.976,32799569
5763,anti-EGFR mAbs,gene,0.902,32799569
5764,stage IIIA,disease,0.8228,32798022
5765,non-small cell lung cancer,disease,0.9575,32798022
5766,platinum,drug,0.9995,32798022
5767,N2+,cell_line,0.566,32798022
5768,non-small cell lung cancer,disease,1.0,32798022
5769,carboplatin,drug,0.999,32798022
5770,paclitaxel,drug,0.998,32798022
5771,panitumumab,gene,0.942,32798022
5772,EGFR Monoclonal Antibodies,gene,0.947,32793499
5773,Resistant Tumor Cells,cell_type,0.7773,32793499
5774,Tumor,disease,0.9683,32793499
5775,Epidermal growth factor receptor,gene,0.9985,32793499
5776,EGFR,gene,0.994,32793499
5777,tyrosine,drug,0.991,32793499
5778,tyrosine kinase receptor,gene,0.995,32793499
5779,normal cells,cell_type,0.8667,32793499
5780,epithelial malignancies,disease,1.0,32793499
5781,EGFR,gene,0.993,32793499
5782,EGFR monoclonal antibody,gene,0.863,32793499
5783,cetuximab,gene,0.8867,32793499
5784,panitumumab,gene,0.9116,32793499
5785,nimotuzumab,gene,0.889,32793499
5786,necitumumab,gene,0.933,32793499
5787,EGFR monoclonal antibodies,gene,0.9565,32793499
5788,anti,disease,0.715,32793499
5789,tumor,disease,0.9854,32793499
5790,EGFR monoclonal antibodies,gene,0.9434,32793499
5791,EGFR monoclonal antibodies,gene,0.916,32793499
5792,tumor cell,cell_type,0.7144,32793499
5793,tumor,disease,1.0,32793499
5794,exosomes,cell_type,0.5913,32793499
5795,non-coding RNA,RNA,0.6265,32793499
5796,tumor,disease,0.9995,32793499
5797,EGFR monoclonal antibodies,gene,0.9707,32793499
5798,EGFR monoclonal antibody,gene,0.914,32793499
5799,EGFR,gene,0.9946,32793499
5800,EGFR monoclonal antibodies,gene,0.9717,32793499
5801,resistant tumor cells,cell_line,0.669,32793499
5802,tumor,disease,0.976,32793499
5803,tumor,disease,0.929,32793499
5804,EGFR monoclonal,gene,0.834,32793499
5805,magnesium,drug,1.0,32789758
5806,Cetuximab,gene,0.7593,32789758
5807,panitumumab,gene,0.717,32789758
5808,epidermal growth factor receptor,gene,0.995,32789758
5809,EGFR,gene,0.9937,32789758
5810,cetuximab,gene,0.962,32789758
5811,panitumumab,gene,0.9224,32789758
5812,hypomagnesemia,disease,1.0,32789758
5813,magnesium,drug,0.9995,32789758
5814,hypomagnesemia,disease,0.9995,32789758
5815,colorectal cancer,disease,1.0,32789758
5816,patients,species,0.9893,32789758
5817,cetuximab,gene,0.9233,32789758
5818,panitumumab,gene,0.893,32789758
5819,patients,species,0.987,32789758
5820,cetuximab,gene,0.7905,32789758
5821,panitumumab,gene,0.842,32789758
5822,colorectal cancer,disease,1.0,32789758
5823,patient,species,0.9834,32789758
5824,hypomagnesemia,disease,1.0,32789758
5825,cetuximab,gene,0.926,32789758
5826,panitumumab,gene,0.895,32789758
5827,hypomagnesemia,disease,1.0,32789758
5828,hypomagnesemia,disease,1.0,32789758
5829,panitumumab,gene,0.922,32789758
5830,magnesium,drug,0.9966,32789758
5831,hypomagnesemia,disease,1.0,32789758
5832,cetuximab,gene,0.981,32789758
5833,panitumumab,gene,0.9185,32789758
5834,magnesium,drug,0.9995,32789758
5835,magnesium,drug,0.9995,32789758
5836,hypomagnesemia,disease,1.0,32789758
5837,magnesium,drug,0.9995,32789758
5838,patients,species,0.9272,32789758
5839,Regorafenib,drug,0.997,32770529
5840,metastatic colorectal cancer,disease,1.0,32770529
5841,mCRC,disease,1.0,32770529
5842,regorafenib,drug,0.9756,32770529
5843,patients,species,0.934,32770529
5844,mCRC,disease,0.937,32770529
5845,regorafenib,drug,0.992,32770529
5846,bevacizumab,gene,0.811,32770529
5847,regorafenib,drug,0.9907,32770529
5848,panitumumab,gene,0.851,32770529
5849,cetuximab,gene,0.8276,32770529
5850,conatumumab,gene,0.5825,32770529
5851,ganitumab,gene,0.687,32770529
5852,aflibercept,gene,0.966,32770529
5853,patients,species,0.9507,32770529
5854,mCRC,disease,0.9263,32770529
5855,patients,species,0.992,32770529
5856,bevacizumab,drug,0.5625,32770529
5857,regorafenib,drug,0.9966,32770529
5858,panitumumab,gene,0.519,32770529
5859,cetuximab,gene,0.827,32770529
5860,ramucirumab,drug,0.5737,32770529
5861,ganitumab,gene,0.8584,32770529
5862,aflibercept,gene,0.8965,32770529
5863,regorafenib,drug,0.9946,32770529
5864,aflibercept,gene,0.9595,32770529
5865,ganitumab,gene,0.9443,32770529
5866,panitumumab,gene,0.5386,32770529
5867,Regorafenib,drug,0.9976,32770529
5868,bevacizumab,gene,0.555,32770529
5869,tumor,disease,0.7295,32770529
5870,regorafenib,drug,0.996,32770529
5871,cetuximab,gene,0.827,32770529
5872,conatumumab,gene,0.827,32770529
5873,neutropenia,disease,1.0,32770529
5874,conatumumab,gene,0.7256,32770529
5875,fatigue,disease,0.9956,32770529
5876,cetuximab,gene,0.8467,32770529
5877,Regorafenib,drug,0.996,32770529
5878,patients,species,0.9556,32770529
5879,metastatic colorectal cancer,disease,1.0,32770529
5880,patients,species,0.989,32770529
5881,KRAS,gene,0.867,32770529
5882,BRAF,gene,0.985,32770529
5883,mCRC,disease,0.999,32770529
5884,colorectal cancer,disease,1.0,32729995
5885,irinotecan,drug,0.999,32729995
5886,oxaliplatin,drug,0.9995,32729995
5887,fluoropyrimidines,drug,0.9893,32729995
5888,cetuximab,gene,0.8994,32729995
5889,panitumumab,gene,0.893,32729995
5890,patients,species,0.991,32729995
5891,patients,species,0.99,32729995
5892,patients,species,0.9834,32729995
5893,colorectal cancer,disease,1.0,32729995
5894,patients,species,0.9946,32729995
5895,anti-EGFR,gene,0.901,32728385
5896,patients,species,0.983,32728385
5897,EGFR,gene,0.664,32728385
5898,anti-EGFR,gene,0.9863,32728385
5899,metastatic colorectal cancer,disease,1.0,32728385
5900,mCRC,disease,1.0,32728385
5901,patients,species,0.9863,32728385
5902,mCRC,disease,0.9985,32728385
5903,anti-EGFR,gene,0.906,32728385
5904,ReIn,drug,0.837,32728385
5905,patients,species,0.9834,32728385
5906,ReCH,drug,0.9995,32728385
5907,ReIn,drug,0.9995,32728385
5908,anti-EGFR,gene,0.966,32728385
5909,FOLFIRI,drug,0.6772,32728385
5910,Cetuximab,gene,0.912,32728385
5911,Panitumumab,gene,0.8457,32728385
5912,patients,species,0.98,32728385
5913,ReCH,drug,0.9995,32728385
5914,ReIn,drug,0.999,32728385
5915,ReCH,drug,0.9995,32728385
5916,ReIn,drug,0.999,32728385
5917,anti-EGFR,gene,0.9814,32728385
5918,ReCH,disease,0.7563,32728385
5919,panitumumab,gene,0.779,32728385
5920,anti-EGFR,gene,0.9844,32728385
5921,patient,species,0.99,32728385
5922,patients,species,0.9795,32725376
5923,cancer,disease,1.0,32725376
5924,metastatic colorectal cancer,disease,1.0,32725376
5925,patients,species,0.9937,32725376
5926,mCRC,disease,1.0,32725376
5927,cancer,disease,1.0,32725376
5928,patients,species,0.992,32725376
5929,mCRC,disease,0.9873,32725376
5930,patients,species,0.994,32725376
5931,patients,species,0.9795,32725376
5932,mCRC,disease,0.982,32725376
5933,FOLFIRI,drug,0.9614,32725376
5934,capecitabine,drug,0.999,32725376
5935,patients,species,0.92,32725376
5936,mCRC,disease,0.9976,32725376
5937,patients,species,0.9717,32725376
5938,mCRC,disease,0.979,32725376
5939,5-,drug,,32725346
5940,fluorouracil,drug,0.8643,32725346
5941,leucovorin,drug,0.997,32725346
5942,oxaliplatin,drug,0.999,32725346
5943,panitumumab,gene,0.565,32725346
5944,rectal cancer,disease,0.8174,32725346
5945,KRAS,gene,0.996,32725346
5946,KRAS,gene,0.9946,32725346
5947,rectal cancer,disease,0.946,32725346
5948,patients,species,0.989,32725346
5949,Patients,species,0.951,32725346
5950,panitumumab,gene,0.719,32725346
5951,patients,species,0.9897,32725346
5952,locally advanced tumor,disease,0.997,32725346
5953,patients,species,0.987,32725346
5954,patients,species,0.987,32725346
5955,patients,species,0.986,32725346
5956,patients,species,0.9805,32725346
5957,patients,species,0.9854,32725346
5958,patients,species,0.9785,32725346
5959,panitumumab,gene,0.766,32725346
5960,patients,species,0.985,32725346
5961,heptamethine cyanine,drug,0.999,32713525
5962,heptamethine cyanine,drug,0.998,32713525
5963,heptamethine cyanine,drug,0.9907,32713525
5964,panitumumab,gene,0.9375,32713525
5965,duocarmycin,drug,0.9985,32713525
5966,tumor,disease,1.0,32713525
5967,AMPK,gene,0.9917,32703218
5968,anti-,gene,0.7466,32703218
5969,EGFR antibody,gene,0.855,32703218
5970,KRAS,gene,0.9683,32703218
5971,Colorectal cancer,disease,1.0,32703218
5972,CRC,disease,1.0,32703218
5973,anti-,gene,0.7603,32703218
5974,epidermal growth factor receptor,gene,0.8438,32703218
5975,EGFR,gene,0.972,32703218
5976,KRAS oncogene,DNA,0.916,32703218
5977,KRAS oncogene,gene,0.987,32703218
5978,DLD1 cells,cell_line,0.957,32703218
5979,KRAS G13D mutant allele,gene,0.9707,32703218
5980,G13,mutation,,32703218
5981,Cetuximab,gene,0.9585,32703218
5982,Cet,gene,0.962,32703218
5983,panitumumab,gene,0.9204,32703218
5984,Pab,gene,0.933,32703218
5985,KRAS,DNA,0.805,32703218
5986,KRAS,gene,0.985,32703218
5987,anti-EGFR antibodies,gene,0.859,32703218
5988,AMPK,gene,0.9927,32703218
5989,KRAS,gene,0.9927,32703218
5990,anti-EGFR antibodies,gene,0.923,32703218
5991,CRC cells,cell_line,0.924,32703218
5992,CRC cells,cell_type,0.815,32703218
5993,CRC,disease,1.0,32703218
5994,Bcl-2 family proteins,gene,0.9946,32703218
5995,DLD1 cells,cell_line,0.9653,32703218
5996,AMPK,gene,0.9917,32703218
5997,xenograft tumor,disease,0.8228,32703218
5998,mouse,species,0.49,32703218
5999,DLD1 cells,cell_line,0.9526,32703218
6000,DLD1 cells,cell_type,0.6226,32703218
6001,AMPK,gene,0.9917,32703218
6002,KRAS,DNA,0.643,32703218
6003,KRAS,gene,0.985,32703218
6004,anti-EGFR antibody,gene,0.9385,32703218
6005,AMPK,gene,0.9907,32703218
6006,CRC cells,cell_line,0.9346,32703218
6007,CRC,disease,0.9995,32703218
6008,wild-type KRAS,gene,0.9585,32703218
6009,anti-,gene,0.891,32703218
6010,EGFR antibody,gene,0.862,32703218
6011,CRC cells,cell_line,0.911,32703218
6012,CRC cells,cell_type,0.8154,32703218
6013,CRC,disease,1.0,32703218
6014,KRAS,DNA,0.728,32703218
6015,KRAS,gene,0.926,32703218
6016,AMP,drug,0.9004,32703218
6017,AMP-activated protein kinase,gene,0.9976,32703218
6018,AMPK,gene,0.9937,32703218
6019,anti-EGFR,gene,0.862,32703218
6020,CRC cells,cell_line,0.8145,32703218
6021,CRC,disease,1.0,32703218
6022,KRAS,gene,0.916,32703218
6023,ATP,drug,0.9307,32703218
6024,AMPK,gene,0.992,32703218
6025,AMPK,gene,0.993,32703218
6026,CRC cells,cell_line,0.9536,32703218
6027,CRC cells,cell_type,0.789,32703218
6028,CRC,disease,0.9995,32703218
6029,WT KRAS,DNA,0.698,32703218
6030,WT KRAS,gene,0.977,32703218
6031,KRAS,DNA,0.5044,32703218
6032,cetuximab,gene,0.818,32703218
6033,AMPK,gene,0.992,32703218
6034,metformin,drug,0.984,32703218
6035,Met,drug,0.992,32703218
6036,5-aminoimidazole-4-carboxamide ribonucleotide,drug,0.9995,32703218
6037,AICAR,drug,0.9995,32703218
6038,KRAS,gene,0.9966,32703218
6039,anti-EGFR antibody,gene,0.8755,32703218
6040,AMPK,gene,0.9946,32703218
6041,myeloid cell leukemia 1,gene,0.996,32703218
6042,Mcl-1,gene,0.9956,32703218
6043,mammalian target of rapamycin,gene,0.8677,32703218
6044,rapamycin,drug,0.99,32703218
6045,mTOR,gene,0.9937,32703218
6046,AMPK,gene,0.9927,32703218
6047,CRC,disease,0.9995,32703218
6048,EGFR,gene,0.9644,32665850
6049,metastatic colorectal cancer,disease,1.0,32665850
6050,Cetuximab,gene,0.811,32665850
6051,panitumumab,gene,0.7847,32665850
6052,epidermal growth factor receptor,gene,0.998,32665850
6053,EGFR,gene,0.993,32665850
6054,metastatic colorectal cancer,disease,1.0,32665850
6055,mCRC,disease,1.0,32665850
6056,KRAS,gene,0.729,32665850
6057,NRAS,gene,0.716,32665850
6058,BRAF,gene,0.609,32665850
6059,HER2,gene,0.9937,32665850
6060,mCRC,disease,0.9995,32665850
6061,EGFR,gene,0.9927,32665850
6062,PIK3CA,gene,0.648,32665850
6063,PTEN,gene,0.6763,32665850
6064,TP53,gene,0.827,32665850
6065,MET,gene,0.6934,32665850
6066,HER3,gene,0.7646,32665850
6067,IRS2,gene,0.792,32665850
6068,FGFR1,gene,0.8115,32665850
6069,MAP2K1,gene,0.997,32665850
6070,insulin growth factor-1,gene,0.994,32665850
6071,Bcl-2-interacting mediator of cell death,gene,0.9956,32665850
6072,mismatch repair-deficient,disease,0.9004,32665850
6073,mCRC,disease,0.9995,32665850
6074,RAS,gene,0.9956,32665850
6075,RAF,gene,0.9985,32665850
6076,mitogen-activated protein kinase,gene,0.9976,32665850
6077,phosphatidylinositol,drug,0.9976,32665850
6078,phosphatidylinositol 3-kinase,gene,0.9946,32665850
6079,Akt,gene,0.993,32665850
6080,mammalian,gene,0.7437,32665850
6081,rapamycin,drug,0.999,32665850
6082,EGFR,gene,0.8755,32665850
6083,KRAS,DNA,0.8784,32664155
6084,KRAS mutation,gene,0.934,32664155
6085,colorectal cancer,disease,1.0,32664155
6086,plasma,cell_type,0.534,32664155
6087,KRAS,gene,0.8384,32664155
6088,cetuximab,gene,0.859,32664155
6089,panitumumab,gene,0.8013,32664155
6090,colorectal cancer,disease,1.0,32664155
6091,Metastatic colorectal cancer,disease,1.0,32664155
6092,tumor,disease,0.9985,32664155
6093,KRAS,DNA,0.8335,32664155
6094,KRAS mutation,gene,0.9736,32664155
6095,plasma,cell_type,0.506,32664155
6096,KRAS mutation,gene,0.731,32664155
6097,plasma,cell_type,0.533,32664155
6098,colorectal cancer,disease,1.0,32664155
6099,PARTICIPANTS,species,0.887,32664155
6100,KRAS mutation,gene,0.6377,32664155
6101,plasma samples,cell_type,0.664,32664155
6102,KRAS,DNA,0.8364,32664155
6103,KRAS mutation,gene,0.962,32664155
6104,Cancer,disease,0.8564,32655959
6105,Chemorefractory,disease,0.5664,32655959
6106,Metastatic Colorectal Cancer,disease,0.9565,32655959
6107,cecal cancer,disease,1.0,32655959
6108,cecal carcinoma,disease,1.0,32655959
6109,aspirin,drug,0.9966,32655959
6110,cerebral infarction,disease,1.0,32655959
6111,anti-vascular endothelial growth factor (receptor) antibody,gene,0.9175,32655959
6112,regorafenib,drug,0.9126,32655959
6113,cetuximab,gene,0.758,32655959
6114,trifluridine,drug,0.9966,32655959
6115,tipiracil,drug,0.997,32655959
6116,cancer,disease,1.0,32655959
6117,5-fluorouracil,drug,0.999,32655959
6118,anti-epidermal growth factor receptor,gene,0.9277,32655959
6119,EGFR,gene,0.99,32655959
6120,panitumumab,gene,0.5674,32655959
6121,metastatic colorectal cancer,disease,1.0,32655959
6122,Multi-RTK,gene,0.693,32646879
6123,Tumor Cell,cell_type,0.6294,32646879
6124,Tumor,disease,0.9585,32646879
6125,Receptor tyrosine kinase,gene,0.9976,32646879
6126,tyrosine,drug,0.9526,32646879
6127,RTK,gene,0.997,32646879
6128,tumor,disease,1.0,32646879
6129,PI3K,gene,0.9985,32646879
6130,AKT,gene,0.994,32646879
6131,KRAS,gene,0.94,32646879
6132,ERK,gene,0.992,32646879
6133,oncogenic RTKs,gene,0.655,32646879
6134,hepatocyte growth factor receptor,gene,0.902,32646879
6135,MET,gene,0.997,32646879
6136,epidermal growth factor receptor,gene,0.9946,32646879
6137,EGFR,gene,0.9946,32646879
6138,human epidermal growth factor receptor 2,gene,0.9966,32646879
6139,HER2,gene,0.9917,32646879
6140,tumor,disease,1.0,32646879
6141,RTK,gene,0.9907,32646879
6142,renal cell carcinoma,disease,1.0,32646879
6143,RCC,disease,1.0,32646879
6144,PDX,cell_line,0.556,32646879
6145,zirconium-89,drug,0.9893,32646879
6146,89Zr,drug,0.996,32646879
6147,RTKs,gene,0.848,32646879
6148,panitumumab,gene,0.8496,32646879
6149,trastuzumab,gene,0.9243,32646879
6150,MET,gene,0.996,32646879
6151,EGFR,gene,0.977,32646879
6152,HER2 protein,gene,0.975,32646879
6153,cetuximab,gene,0.777,32646879
6154,INC280,drug,0.9883,32646879
6155,trametinib,drug,0.9985,32646879
6156,Cetuximab,gene,0.8784,32646879
6157,tumor,disease,0.999,32646879
6158,RTK protein,gene,0.8726,32646879
6159,tumor,disease,0.925,32646879
6160,MET,gene,0.4968,32646879
6161,MEK,gene,0.992,32646879
6162,tumor,disease,0.9985,32646879
6163,RTK,gene,0.9644,32646879
6164,RTK,gene,0.9834,32646879
6165,RTK,gene,0.9927,32646879
6166,tumor,disease,1.0,32646879
6167,Cicatricial ectropion,disease,1.0,32642599
6168,madarosis,disease,0.9995,32642599
6169,panitumumab,gene,0.886,32642599
6170,cicatricial ectropion,disease,1.0,32642599
6171,madarosis,disease,1.0,32642599
6172,anti-epidermal growth factor receptor,gene,0.94,32642599
6173,panitumumab,gene,0.849,32642599
6174,man,species,0.8755,32642599
6175,metastatic colorectal cancer,disease,1.0,32642599
6176,cicatricial ectropion,disease,1.0,32642599
6177,madarosis,disease,1.0,32642599
6178,panitumumab,gene,0.6978,32642599
6179,anti-epidermal growth factor receptor,gene,0.9,32642599
6180,metastatic colorectal cancer,disease,0.991,32642599
6181,panitumumab,gene,0.85,32642599
6182,patients,species,0.9683,32642599
6183,anti-epidermal growth factor receptor,gene,0.9688,32642599
6184,anti-EGFR,gene,0.9917,32642599
6185,Panitumumab,gene,0.805,32631788
6186,Patients,species,0.9595,32631788
6187,panitumumab,gene,0.881,32631788
6188,patients,species,0.9644,32631788
6189,cetuximab,gene,0.9497,32631788
6190,metastatic colorectal cancer,disease,1.0,32631788
6191,mCRC,disease,1.0,32631788
6192,PATIENTS,species,0.9536,32631788
6193,patients,species,0.9834,32631788
6194,RAS,gene,0.6807,32631788
6195,renin,gene,0.9976,32631788
6196,mCRC,disease,0.994,32631788
6197,cetuximab,gene,0.7695,32631788
6198,Panitumumab,gene,0.8286,32631788
6199,patients,species,0.987,32631788
6200,KRAS,DNA,0.8096,32631788
6201,KRAS,gene,0.9966,32631788
6202,Kirsten rat sarcoma viral oncogene,gene,0.996,32631788
6203,RAS,DNA,0.5796,32631788
6204,patients,species,0.9707,32631788
6205,cetuximab,gene,0.772,32631788
6206,patients,species,0.982,32631788
6207,patients,species,0.9717,32631788
6208,patients,species,0.9854,32631788
6209,patients,species,0.994,32631788
6210,patients,species,0.991,32631788
6211,rash,disease,0.978,32631788
6212,panitumumab,gene,0.749,32631788
6213,patients,species,0.98,32631788
6214,cetuximab,gene,0.94,32631788
6215,RAS,gene,0.9937,32631788
6216,mCRC,disease,0.8623,32631788
6217,RAS,gene,0.625,32623288
6218,metastatic colorectal cancer,disease,0.84,32623288
6219,panitumumab,gene,0.91,32623288
6220,metastatic colorectal cancer,disease,1.0,32623288
6221,mCRC,disease,1.0,32623288
6222,panitumumab,gene,0.9453,32623288
6223,panitumumab,gene,0.955,32623288
6224,FOLFOX,drug,0.8804,32623288
6225,panitumumab,gene,0.922,32623288
6226,5-FU,drug,0.993,32623288
6227,RAS,gene,0.641,32623288
6228,mCRC,disease,0.931,32623288
6229,Cancer,disease,0.8164,32623288
6230,QLQ,DNA,0.655,32623288
6231,EORTC QLQ-CR29,DNA,0.4746,32623288
6232,fatigue,disease,0.9995,32623288
6233,nausea/vomiting,disease,0.766,32623288
6234,appetite loss,disease,0.9995,32623288
6235,diarrhoea,disease,1.0,32623288
6236,QLQ,DNA,0.536,32623288
6237,dry mouth,disease,1.0,32623288
6238,hair loss,disease,0.9937,32623288
6239,faecal incontinence,disease,1.0,32623288
6240,sore skin,disease,1.0,32623288
6241,RAS,gene,0.624,32623288
6242,mCRC,disease,0.9907,32623288
6243,oxaliplatin,drug,1.0,32623288
6244,EGFRs,gene,0.754,32623288
6245,oxaliplatin,drug,0.9995,32623288
6246,Metastatic Colorectal Cancer,disease,1.0,32612957
6247,mCRC,disease,1.0,32612957
6248,adenocarcinoma in the right and left colo-rectum,disease,1.0,32612957
6249,tumor,disease,0.967,32612957
6250,CRC,disease,0.997,32612957
6251,metastatic colorectal cancer,disease,1.0,32612957
6252,metastatic colorectal cancer,disease,0.977,32612957
6253,Patients,species,0.989,32609305
6254,patients,species,0.9883,32609305
6255,epidermal growth factor receptor,gene,0.998,32609305
6256,EGFRi,gene,0.9854,32609305
6257,Panitumumab,gene,0.8853,32609305
6258,doxycycline hyclate,drug,0.999,32609305
6259,EGFRi,gene,0.985,32609305
6260,PARTICIPANTS,species,0.621,32609305
6261,patients,species,0.985,32609305
6262,cetuximab,gene,0.66,32609305
6263,Panitumumab,gene,0.8794,32609305
6264,Skin Toxicities,disease,0.837,32609305
6265,rash,disease,1.0,32609305
6266,rash,disease,0.997,32609305
6267,cetuximab,gene,0.8447,32609305
6268,patients,species,0.9795,32609305
6269,men,species,0.939,32609305
6270,cetuximab,gene,0.8164,32609305
6271,patients,species,0.9897,32609305
6272,men,species,0.9707,32609305
6273,cetuximab,gene,0.751,32609305
6274,patients,species,0.9966,32609305
6275,patients,species,0.9966,32609305
6276,Dana,cell_line,0.4714,32609305
6277,cetuximab,gene,0.893,32609305
6278,patients,species,0.9927,32609305
6279,patients,species,0.9937,32609305
6280,tetracycline,drug,0.9985,32609305
6281,rash,disease,0.995,32609305
6282,Patients,species,0.9614,32609305
6283,rash,disease,0.9985,32609305
6284,rash,disease,0.999,32609305
6285,cetuximab,gene,0.9224,32609305
6286,patients,species,0.9897,32609305
6287,EGFRi,gene,0.95,32609305
6288,rash,disease,0.8457,32609305
6289,Panitumumab,gene,0.98,32606015
6290,5-Aminolevulinic Acid,drug,0.9995,32606015
6291,Glioblastoma Multiforme,disease,1.0,32606015
6292,glioblastoma,disease,1.0,32606015
6293,GBM,disease,1.0,32606015
6294,5-ALA,drug,0.999,32606015
6295,brain tumor,disease,1.0,32606015
6296,tumor,disease,0.9956,32606015
6297,5-ALA,drug,0.9985,32606015
6298,panitumumab,gene,0.9106,32606015
6299,patient-derived GBM xenograft model,cell_line,0.598,32606015
6300,GBM,disease,0.997,32606015
6301,nude mice,species,0.5513,32606015
6302,5-ALA,drug,0.999,32606015
6303,panitumumab,gene,0.9062,32606015
6304,5-ALA,drug,0.999,32606015
6305,panitumumab,gene,0.927,32606015
6306,tumor,disease,0.9946,32606015
6307,Panitumumab,gene,0.92,32606015
6308,5-ALA,drug,0.999,32606015
6309,5-ALA,drug,0.9995,32606015
6310,panitumumab,gene,0.9697,32606015
6311,Panitumumab,gene,0.961,32606015
6312,tumor,disease,0.9976,32606015
6313,5-ALA,drug,0.999,32606015
6314,panitumumab,gene,0.971,32606015
6315,5-ALA,drug,0.999,32606015
6316,panitumumab,gene,0.9805,32606015
6317,GBM,disease,1.0,32606015
6318,panitumumab,gene,0.9795,32606015
6319,GBM,disease,1.0,32606015
6320,5-ALA,drug,0.998,32606015
6321,Panitumumab,gene,0.9067,32605298
6322,Cetuximab,gene,0.92,32605298
6323,Colorectal Cancer,disease,1.0,32605298
6324,Bevacizumab,gene,0.882,32605298
6325,ASPECCT,DNA,0.525,32605298
6326,panitumumab,gene,0.9146,32605298
6327,cetuximab,gene,0.8496,32605298
6328,wild-,disease,0.8623,32605298
6329,metastatic colorectal cancer,disease,0.9463,32605298
6330,bevacizumab,gene,0.5864,32605298
6331,panitumumab,gene,0.913,32605298
6332,cetuximab,gene,0.8174,32605298
6333,irinotecan,drug,0.9985,32605298
6334,WJOG6510G,drug,0.9956,32605298
6335,panitumumab,gene,0.9033,32605298
6336,cetuximab,gene,0.9053,32605298
6337,panitumumab,gene,0.9385,32605298
6338,cetuximab,gene,0.8223,32605298
6339,Panitumumab,gene,0.5522,32605298
6340,cetuximab,gene,0.7905,32605298
6341,bevacizumab,gene,0.6865,32605298
6342,ASPECCT,DNA,0.545,32605298
6343,KRAS mutation,gene,0.77,32590745
6344,cell-free DNA,DNA,0.704,32590745
6345,cell-free,RNA,0.4858,32590745
6346,colorectal cancer,disease,1.0,32590745
6347,Cetuximab,gene,0.829,32590745
6348,panitumumab,gene,0.9097,32590745
6349,metastatic colorectal cancer,disease,0.9985,32590745
6350,KRAS,gene,0.861,32590745
6351,Tumor,disease,0.999,32590745
6352,cancer,disease,1.0,32590745
6353,tumor,disease,1.0,32590745
6354,tumor,disease,1.0,32590745
6355,KRAS,DNA,0.8457,32590745
6356,KRAS mutation,gene,0.98,32590745
6357,colorectal cancer,disease,1.0,32590745
6358,cell-free DNA,DNA,0.56,32590745
6359,cell,RNA,0.549,32590745
6360,tumor,disease,1.0,32590745
6361,KRAS mutation,gene,0.6763,32590745
6362,colorectal cancer,disease,1.0,32590745
6363,metastatic and non-metastatic colorectal cancer,disease,1.0,32590745
6364,panitumumab,gene,0.948,32580916
6365,capecitabine,drug,0.9985,32580916
6366,patients,species,0.987,32580916
6367,metastatic colorectal cancer,disease,1.0,32580916
6368,mCRC,disease,1.0,32580916
6369,patients,species,0.969,32580916
6370,panitumumab,gene,0.905,32580916
6371,capecitabine,drug,0.999,32580916
6372,patients,species,0.876,32580916
6373,RAS,gene,0.832,32580916
6374,mCRC,disease,0.9854,32580916
6375,PATIENTS,species,0.953,32580916
6376,Patients,species,0.982,32580916
6377,panitumumab,gene,0.893,32580916
6378,capecitabine,drug,0.997,32580916
6379,patients,species,0.961,32580916
6380,women,species,0.936,32580916
6381,patients,species,0.9653,32580916
6382,patients,species,0.9873,32580916
6383,panitumumab,gene,0.9673,32580916
6384,capecitabine,drug,0.9985,32580916
6385,skin,disease,0.6904,32580916
6386,panitumumab,gene,0.965,32580916
6387,capecitabine,drug,0.9985,32580916
6388,patients,species,0.942,32580916
6389,WT RAS,gene,0.966,32580916
6390,mCRC,disease,0.9995,32580916
6391,Head and Neck Squamous Cell Carcinoma,disease,0.999,32569853
6392,patients,species,0.98,32569853
6393,R,disease,1.0,32569853
6394,HNSCC,disease,0.604,32569853
6395,PD-1,gene,0.985,32569853
6396,PDL-1,gene,0.994,32569853
6397,R/M HNSCC,disease,0.976,32569853
6398,platinum,drug,0.9985,32569853
6399,PD-L11,gene,0.997,32569853
6400,tumours,disease,0.9966,32569853
6401,methotrexate,drug,0.999,32569853
6402,cetuximab,gene,0.8105,32569853
6403,panitumumab,gene,0.6294,32569853
6404,platinum,drug,0.9995,32569853
6405,PD-1,gene,0.994,32569853
6406,PD-L1,gene,0.9985,32569853
6407,R,disease,0.7715,32569853
6408,EGFR,gene,0.9917,32569853
6409,bevacizumab,gene,0.787,32569154
6410,cetuximab,gene,0.7993,32569154
6411,bevacizumab,gene,0.8047,32569154
6412,cetuximab,gene,0.9146,32569154
6413,panitumumab,gene,0.8345,32569154
6414,patients,species,0.98,32569154
6415,colorectal carcinoma,disease,1.0,32569154
6416,bevacizumab,gene,0.959,32569154
6417,cetuximab,gene,0.947,32569154
6418,panitumumab,gene,0.9546,32569154
6419,patients,species,0.9575,32569154
6420,colorectal cancer,disease,0.9614,32569154
6421,PATIENTS,species,0.9785,32569154
6422,bevacizumab,gene,0.85,32569154
6423,cetuximab,gene,0.937,32569154
6424,panitumumab,gene,0.886,32569154
6425,FAEs,disease,0.7905,32569154
6426,patients,species,0.975,32569154
6427,FAEs,disease,0.518,32569154
6428,bevacizumab,gene,0.945,32569154
6429,cetuximab,gene,0.937,32569154
6430,panitumumab,gene,0.952,32569154
6431,bevacizumab,gene,0.9185,32569154
6432,cetuximab,gene,0.8105,32569154
6433,panitumumab,gene,0.843,32569154
6434,FAEs,disease,0.564,32569154
6435,bevacizumab,gene,0.9453,32569154
6436,cetuximab,gene,0.925,32569154
6437,panitumumab,gene,0.914,32569154
6438,patients,species,0.9697,32569154
6439,colorectal carcinoma,disease,1.0,32569154
6440,Vitamin K1,drug,0.999,32541171
6441,Cetuximab,gene,0.931,32541171
6442,Panitumumab,gene,0.8213,32541171
6443,Acneiform Eruptions,disease,0.991,32541171
6444,anti-epidermal growth factor receptor,gene,0.9126,32541171
6445,EGFR,gene,0.9805,32541171
6446,vitamin K1,drug,0.9995,32541171
6447,VK1,drug,0.9966,32541171
6448,acneiform eruptions,disease,1.0,32541171
6449,anti-EGFR antibody,gene,0.9785,32541171
6450,VK1,drug,0.998,32541171
6451,acneiform,disease,0.9995,32541171
6452,acneiform eruptions,disease,0.9995,32541171
6453,acneiform eruptions,disease,0.9214,32541171
6454,acneiform eruptions,disease,1.0,32541171
6455,cetuximab,gene,0.8936,32541171
6456,panitumumab,gene,0.892,32541171
6457,VK1,gene,0.991,32541171
6458,skin lesions,disease,1.0,32541171
6459,ErbB1,gene,0.9956,32531343
6460,primary afferent nociceptors,cell_type,0.847,32531343
6461,hypersensitivity,disease,0.9995,32531343
6462,neuropathic pain,disease,0.994,32531343
6463,neuropathic pain,disease,1.0,32531343
6464,epidermal growth factor receptor,gene,0.997,32531343
6465,EGFRIs,gene,0.9663,32531343
6466,primary sensory neurons,cell_type,0.809,32531343
6467,EGFRIs,gene,0.9775,32531343
6468,anti-EGFR antibodies,gene,0.9844,32531343
6469,cetuximab,gene,0.5713,32531343
6470,panitumumab,gene,0.8164,32531343
6471,EGFRIs,gene,0.9595,32531343
6472,neuropathic pain,disease,0.9995,32531343
6473,EGFR,gene,0.9946,32531343
6474,ErbB1 protein,gene,0.981,32531343
6475,small nociceptive afferent neurons,cell_type,0.819,32531343
6476,ErbB family members,gene,0.9844,32531343
6477,ErbB1,gene,0.9893,32531343
6478,ErbB2,gene,0.9937,32531343
6479,ErbB3,gene,0.9927,32531343
6480,ErbB4,gene,0.9917,32531343
6481,ErbB1,gene,0.991,32531343
6482,nociceptors,cell_type,0.805,32531343
6483,ErbB1,gene,0.9917,32531343
6484,ErbB2,gene,0.9863,32531343
6485,ErbB1,gene,0.997,32531343
6486,ErbB2,gene,0.9937,32531343
6487,EGF,gene,0.993,32531343
6488,hypersensitivity,disease,0.8877,32531343
6489,nerve injury,disease,0.942,32531343
6490,ErbB1,gene,0.9917,32531343
6491,ErbB2,gene,0.9893,32531343
6492,ErbB1,gene,0.987,32531343
6493,neuropathic pain,disease,1.0,32531343
6494,Src tyrosine kinase,gene,0.9717,32531343
6495,tyrosine,drug,0.9946,32531343
6496,neuroinflammation,disease,0.9995,32531343
6497,ErbB1,gene,0.985,32531343
6498,neuropathic pain,disease,1.0,32531343
6499,ErbB1,gene,0.988,32531343
6500,PI 3-kinase,gene,0.995,32531343
6501,Akt,gene,0.9844,32531343
6502,Akt,gene,0.9883,32531343
6503,analgesia,disease,0.807,32531343
6504,Akt,gene,0.9966,32531343
6505,Akt,gene,0.995,32531343
6506,AS160,gene,0.995,32531343
6507,neuropathic pain,disease,1.0,32531343
6508,ErbB1,gene,0.9966,32531343
6509,ErbB2,gene,0.999,32531343
6510,Akt,gene,0.9824,32531343
6511,AS160,gene,0.5166,32531343
6512,LRP1,gene,0.971,32531343
6513,hyperexcitability,disease,1.0,32531343
6514,Nav1,gene,0.501,32531343
6515,Nav1,gene,0.916,32531343
6516,Cav1,gene,0.4802,32531343
6517,ErbB1,gene,0.9893,32531343
6518,Akt,gene,0.9688,32531343
6519,ErbB1,gene,0.9897,32531343
6520,neuropathic pain,disease,1.0,32531343
6521,neuronal,cell_type,0.509,32531343
6522,hyperexcitability,disease,1.0,32531343
6523,ErbB1,gene,0.9956,32531343
6524,ErbB2,gene,0.996,32531343
6525,neuropathic pain,disease,1.0,32531343
6526,panitumumab,gene,0.932,32526634
6527,irinotecan,drug,0.9985,32526634
6528,cetuximab,gene,0.931,32526634
6529,irinotecan,drug,0.9985,32526634
6530,KRAS,gene,0.643,32526634
6531,fluoropyrimidine,drug,0.9985,32526634
6532,irinotecan,drug,0.999,32526634
6533,oxaliplatin,drug,0.9995,32526634
6534,WJOG,cell_line,0.5137,32526634
6535,Cetuximab,gene,0.9194,32526634
6536,irinotecan,drug,0.998,32526634
6537,irinotecan,drug,0.9995,32526634
6538,metastatic colorectal cancer,disease,1.0,32526634
6539,mCRC,disease,1.0,32526634
6540,panitumumab,gene,0.9478,32526634
6541,irinotecan,drug,0.9976,32526634
6542,PATIENTS,species,0.9443,32526634
6543,wild-type KRAS exon 2,gene,0.7803,32526634
6544,mCRC,disease,0.9966,32526634
6545,fluorouracil,drug,0.9976,32526634
6546,oxaliplatin,drug,0.9995,32526634
6547,irinotecan,drug,0.9976,32526634
6548,panitumumab,gene,0.9673,32526634
6549,irinotecan,drug,0.9985,32526634
6550,panitumumab,gene,0.8677,32526634
6551,cetuximab,gene,0.952,32526634
6552,irinotecan,drug,0.9985,32526634
6553,panitumumab,gene,0.9346,32526634
6554,cetuximab,gene,0.8594,32526634
6555,bevacizumab,gene,0.857,32526634
6556,panitumumab,gene,0.902,32526634
6557,cetuximab,gene,0.8677,32526634
6558,hypomagnesaemia,disease,1.0,32526634
6559,panitumumab,gene,0.95,32526634
6560,cetuximab,gene,0.9175,32526634
6561,Panitumumab,gene,0.859,32526634
6562,cetuximab,gene,0.959,32526634
6563,irinotecan,drug,0.998,32526634
6564,irinotecan,drug,0.9995,32526634
6565,mCRC,disease,0.9907,32526634
6566,Metastatic Colorectal Cancer,disease,0.999,32507561
6567,Colorectal cancer,disease,1.0,32507561
6568,CRC,disease,1.0,32507561
6569,cancer,disease,1.0,32507561
6570,men,species,0.96,32507561
6571,women,species,0.9653,32507561
6572,cancer,disease,0.9976,32507561
6573,patients,species,0.9863,32507561
6574,metastatic CRC,disease,0.9995,32507561
6575,mCRC,disease,0.9995,32507561
6576,patients,species,0.979,32507561
6577,mCRC,disease,0.9897,32507561
6578,trifluridine,drug,0.999,32507561
6579,tipiracil,drug,0.9995,32507561
6580,regorafenib,drug,0.991,32507561
6581,cetuximab,gene,0.9297,32507561
6582,panitumumab,gene,0.634,32507561
6583,patients,species,0.9893,32507561
6584,RAS wild type,DNA,0.6353,32507561
6585,RAS wild,gene,0.8413,32507561
6586,oxaliplatin,drug,1.0,32507561
6587,irinotecan,drug,1.0,32507561
6588,fluoropyrimidine,drug,0.999,32507561
6589,anti-epidermal growth factor receptor,gene,0.9927,32507561
6590,RAS wild-type,gene,0.8877,32507561
6591,patients,species,0.9746,32507561
6592,trastuzumab,gene,0.978,32507561
6593,lapatinib,drug,0.9985,32507561
6594,mCRC,disease,0.9995,32507561
6595,human epidermal growth factor receptor 2,gene,0.9897,32507561
6596,human,species,0.9185,32507561
6597,microsatellite,DNA,0.4785,32507561
6598,patients,species,0.982,32507561
6599,EGFR,gene,0.9897,32499700
6600,KRAS,gene,0.6753,32499700
6601,Locally Advanced Rectal Cancer,disease,1.0,32499700
6602,locally advanced rectal cancer,disease,1.0,32499700
6603,LARC,disease,1.0,32499700
6604,metastatic diseases,disease,0.9927,32499700
6605,LARC,disease,0.999,32499700
6606,epidermal growth factor receptor,gene,0.998,32499700
6607,EGFR,gene,0.996,32499700
6608,kirsten rat sarcoma viral oncogene,gene,0.7407,32499700
6609,KRAS,gene,0.9453,32499700
6610,LARC,disease,0.4639,32499700
6611,EGFR,gene,0.9927,32499700
6612,LARC,disease,0.9995,32499700
6613,EGFR,gene,0.9897,32499700
6614,diarrhea,disease,0.998,32499700
6615,hand-foot syndrome,disease,1.0,32499700
6616,acneiform rash,disease,1.0,32499700
6617,EGFR,gene,0.994,32499700
6618,KRAS,gene,0.733,32499700
6619,LARC,disease,1.0,32499700
6620,epidermal growth factor receptor,gene,0.9966,32474402
6621,metastatic colorectal cancer,disease,1.0,32474402
6622,Colorectal cancer,disease,1.0,32474402
6623,CRC,disease,1.0,32474402
6624,tumors,disease,1.0,32474402
6625,Cetuximab,gene,0.8926,32474402
6626,panitumumab,gene,0.9155,32474402
6627,RAS,gene,0.9966,32474402
6628,metastatic colorectal cancer,disease,1.0,32474402
6629,mCRC,disease,1.0,32474402
6630,tumors,disease,0.432,32474402
6631,oncogenes,DNA,0.7017,32474402
6632,RAS,gene,0.8716,32474402
6633,BRAF,gene,0.852,32474402
6634,PI3KCA,gene,0.817,32474402
6635,PTEN,gene,0.7056,32474402
6636,epidermal growth factor receptor,gene,0.997,32474402
6637,EGFR,gene,0.9834,32474402
6638,HER2,gene,0.9927,32474402
6639,MET,gene,0.9946,32474402
6640,MAPK,gene,0.984,32474402
6641,ERK,gene,0.9937,32474402
6642,anti-EGFR,gene,0.7886,32474402
6643,CRCs,cell_line,0.6753,32474402
6644,metastatic colorectal PURPOSE,disease,0.876,32449003
6645,mCRC,disease,0.999,32449003
6646,tumor,disease,0.998,32449003
6647,BRAF,gene,0.9966,32449003
6648,patients,species,0.992,32449003
6649,tumor,disease,0.629,32449003
6650,patients,species,0.991,32449003
6651,BRAF wild,gene,0.808,32449003
6652,BRAF,gene,0.999,32449003
6653,BRAF,gene,0.997,32449003
6654,BRAF,gene,0.994,32449003
6655,patients,species,0.9844,32449003
6656,BRAF,DNA,0.7393,32449003
6657,BRAF,gene,0.9946,32449003
6658,patients,species,0.986,32449003
6659,patients,species,0.985,32449003
6660,tumor,disease,0.98,32449003
6661,BRAF,gene,0.9946,32449003
6662,patients,species,0.9893,32449003
6663,BRAF,gene,0.99,32449003
6664,patients,species,0.9824,32449003
6665,BRAF,gene,0.9966,32449003
6666,BRAF,cell_line,0.5034,32449003
6667,BRAF,gene,0.9834,32449003
6668,patients,species,0.9697,32449003
6669,tumor,disease,0.9976,32449003
6670,BRAF,DNA,0.6836,32449003
6671,BRAF-MT tumors,disease,0.945,32449003
6672,BRAF-,gene,0.994,32449003
6673,VEGF,gene,0.5195,32429380
6674,EGFR,gene,0.807,32429380
6675,RAS Wild-Type Metastatic Colorectal Cancer,disease,0.976,32429380
6676,RAS,gene,0.9624,32429380
6677,RAS,gene,0.593,32429380
6678,metastatic colorectal cancer,disease,0.994,32429380
6679,mCRC,disease,1.0,32429380
6680,Epidermal Growth Factor Receptor,gene,0.998,32429380
6681,Bevacizumab,gene,0.515,32429380
6682,Aflibercept,gene,0.977,32429380
6683,mCRC,disease,0.9966,32429380
6684,Bevacizumab,gene,0.954,32429380
6685,Aflibercept,gene,0.871,32429380
6686,Aflibercept,gene,0.984,32429380
6687,Bevacizumab,gene,0.8896,32429380
6688,Bevacizumab,gene,0.9565,32429380
6689,Aflibercept,gene,0.9844,32429380
6690,primary tumor,disease,0.9536,32429380
6691,Bevacizumab,gene,0.9346,32429380
6692,Aflibercept,gene,0.927,32429380
6693,VEGF,gene,0.986,32429380
6694,Bevacizumab,gene,0.9243,32429380
6695,Aflibercept,gene,0.9575,32429380
6696,Bevacizumab,gene,0.912,32429380
6697,Aflibercept,gene,0.954,32429380
6698,RAS,gene,0.4873,32429380
6699,mCRC,disease,0.8247,32429380
6700,anti-EGFR,gene,0.954,32429380
6701,cardiac toxicities,disease,0.961,32422068
6702,cancer,disease,1.0,32422068
6703,panitumumab,gene,0.8555,32422068
6704,cardiac toxicities,disease,0.966,32422068
6705,panitumumab,gene,0.7876,32422068
6706,advanced cancer,disease,1.0,32422068
6707,cardiac,disease,0.768,32422068
6708,Panitumumab,gene,0.9424,32422068
6709,cardiac arrhythmias,disease,1.0,32422068
6710,cardiac arrhythmia,disease,1.0,32422068
6711,hypertension,disease,1.0,32422068
6712,cardiac disease,disease,1.0,32422068
6713,panitumumab,gene,0.6284,32422068
6714,cardiac arrhythmias,disease,1.0,32422068
6715,panitumumab,gene,0.956,32422068
6716,cardiac arrhythmia,disease,1.0,32422068
6717,cardiac toxicity,disease,0.9614,32422068
6718,ischemic events,disease,0.9966,32422068
6719,pancreatic cancer,disease,1.0,32416765
6720,pancreatic cancer,disease,1.0,32416764
6721,panitumumab,gene,0.9688,32416764
6722,pancreatic ductal adenocarcinoma,disease,1.0,32416764
6723,tumour,disease,0.9355,32416764
6724,cancer,disease,0.9995,32416764
6725,pancreatic ductal adenocarcinomas,disease,1.0,32416764
6726,panitumumab,gene,0.954,32416764
6727,panitumumab,gene,0.9287,32416764
6728,panitumumab,gene,0.9326,32416764
6729,pancreatic ductal adenocarcinomas,disease,1.0,32416764
6730,tumour,disease,1.0,32416764
6731,pancreatic ductal adenocarcinoma,disease,1.0,32416764
6732,primary tumours,disease,0.986,32416764
6733,primary tumours,disease,0.9995,32416764
6734,peritoneal metastasis,disease,0.9717,32416764
6735,panitumumab,gene,0.976,32416764
6736,panitumumab,gene,0.965,32416764
6737,panitumumab,gene,0.9785,32416764
6738,pancreatic ductal adenocarcinomas,disease,1.0,32416764
6739,panitumumab,gene,0.9736,32416764
6740,pancreatic cancer,disease,1.0,32416764
6741,pancreatic ductal adenocarcinomas,disease,1.0,32416764
6742,Rectal Cancer,disease,1.0,32408333
6743,Virchow Lymph Node Metastasis,disease,1.0,32408333
6744,upper rectal cancer,disease,1.0,32408333
6745,para,disease,0.7256,32408333
6746,CapeOX,drug,0.944,32408333
6747,para-aortic lymph node metastasis,disease,0.9443,32408333
6748,Cape,drug,0.998,32408333
6749,Bev,drug,0.969,32408333
6750,metastasized lesions,disease,1.0,32408333
6751,FDG,drug,0.9976,32408333
6752,Virchow's lymph node,disease,0.97,32408333
6753,IRIS,drug,0.9937,32408333
6754,Bev,drug,0.8545,32408333
6755,S-1,drug,0.956,32408333
6756,Bev,drug,0.7295,32408333
6757,S-1,drug,0.9897,32408333
6758,Bev,drug,0.7437,32408333
6759,Virchow's lymph node,disease,1.0,32408333
6760,S,drug,0.6694,32408333
6761,FDG,drug,0.996,32408333
6762,mediastinal,DNA,0.4714,32408333
6763,Panitumumab,gene,0.935,32408333
6764,RAS,gene,0.589,32394048
6765,BRAF,gene,0.671,32394048
6766,EGFR,DNA,0.4175,32394048
6767,EGFR mutations,gene,0.8955,32394048
6768,cell-free DNA,DNA,0.6406,32394048
6769,cell,RNA,0.5522,32394048
6770,metastatic colorectal,disease,1.0,32394048
6771,EGFR,gene,0.927,32394048
6772,Oncogenic,cell_type,0.4854,32394048
6773,Oncogenic RAS mutations,gene,0.8237,32394048
6774,epidermal growth factor receptor,gene,0.9966,32394048
6775,EGFR,gene,0.9883,32394048
6776,RAS,DNA,0.61,32394048
6777,RAS mutations,gene,0.957,32394048
6778,colorectal tumors,disease,1.0,32394048
6779,primary tumors,disease,0.9834,32394048
6780,tumor,disease,1.0,32394048
6781,Cell-free DNA,DNA,0.4797,32394048
6782,Cell,cell_type,0.4478,32394048
6783,cfDNA,DNA,0.491,32394048
6784,cfDNA,DNA,0.4832,32394048
6785,EGFR,gene,0.992,32394048
6786,metastatic colorectal cancer,disease,1.0,32394048
6787,metastatic colorectal cancer,disease,1.0,32394048
6788,RAS,gene,0.6377,32394048
6789,BRAF,gene,0.567,32394048
6790,EGFR,gene,0.9907,32394048
6791,cfDNA,DNA,0.5474,32394048
6792,RAS,gene,0.6743,32394048
6793,BRAF,gene,0.823,32394048
6794,EGFR,gene,0.515,32394048
6795,S492R,DNA,0.456,32394048
6796,plasma,cell_type,0.3896,32394048
6797,RAS mutations,gene,0.6914,32394048
6798,cfDNA,DNA,0.6084,32394048
6799,cfDNA RAS,DNA,0.602,32394048
6800,cfDNA,cell_type,0.5654,32394048
6801,cfDNA,DNA,0.485,32394048
6802,RAS,gene,0.4568,32394048
6803,BRAF,gene,0.781,32394048
6804,EGFR,gene,0.853,32394048
6805,RAS,gene,0.614,32394048
6806,BRAF,gene,0.6797,32394048
6807,EGFR,DNA,0.4395,32394048
6808,EGFR mutations,gene,0.948,32394048
6809,EGFR,gene,0.989,32394048
6810,cfDNA,cell_type,0.56,32394048
6811,"advanced right-colon, left-colon and rectal cancers",disease,1.0,32387453
6812,panitumumab,gene,0.741,32387453
6813,Primary,DNA,0.5684,32387453
6814,PTL,DNA,0.516,32387453
6815,metastatic colorectal cancer,disease,1.0,32387453
6816,mCRC,disease,1.0,32387453
6817,PTL,gene,0.9805,32387453
6818,panitumumab,gene,0.803,32387453
6819,rectal tumours,disease,1.0,32387453
6820,PATIENTS,species,0.924,32387453
6821,mCRC,disease,0.978,32387453
6822,irinotecan,drug,0.999,32387453
6823,irinotecan,drug,0.9985,32387453
6824,panitumumab,gene,0.8975,32387453
6825,IrPan,drug,0.5596,32387453
6826,PTL,disease,1.0,32387453
6827,PTL,disease,0.9683,32387453
6828,PTL,disease,0.9697,32387453
6829,PTL,gene,0.854,32387453
6830,IrPan,drug,0.982,32387453
6831,RAS,gene,0.993,32387453
6832,RAS,gene,0.889,32387453
6833,irinotecan,drug,0.9976,32387453
6834,BRAF,gene,0.9766,32387453
6835,epiregulin,gene,0.9966,32387453
6836,amphiregulin,gene,0.997,32387453
6837,EREG,gene,0.997,32387453
6838,AREG,gene,0.998,32387453
6839,HER3 mRNA,gene,0.884,32387453
6840,RAS,gene,0.6724,32387453
6841,HER3,gene,0.9937,32387453
6842,panitumumab,gene,0.8823,32387453
6843,PTL,gene,0.7837,32387453
6844,EREG,gene,0.565,32387453
6845,AREG,gene,0.5605,32387453
6846,IrPan,drug,0.9043,32387453
6847,irinotecan,drug,0.997,32387453
6848,PTL,disease,0.635,32387453
6849,RAS,gene,0.5776,32387453
6850,BRAF,gene,0.7188,32387453
6851,rectal-PTL,disease,0.5474,32387453
6852,RAS,gene,0.994,32387453
6853,BRAF,gene,0.6406,32387453
6854,PTL,disease,0.821,32387453
6855,EREG,gene,0.997,32387453
6856,AREG,gene,0.994,32387453
6857,HER3,gene,0.9907,32387453
6858,EREG,gene,0.997,32387453
6859,AREG,gene,0.9976,32387453
6860,HER3,gene,0.9814,32387453
6861,irinotecan,drug,0.999,32387453
6862,rectal-PTL,disease,0.993,32387453
6863,EREG,gene,0.996,32387453
6864,AREG,gene,0.994,32387453
6865,HER3,gene,0.9966,32387453
6866,RAS,gene,0.469,32387453
6867,PTL,disease,0.722,32387453
6868,panitumumab,gene,0.508,32387453
6869,PTL,disease,0.8765,32387453
6870,PTL,disease,0.6987,32387453
6871,panitumumab,gene,0.753,32387453
6872,tumour,disease,0.9995,32387453
6873,AREG,gene,0.532,32387453
6874,EREG,gene,0.4814,32387453
6875,HER3 mRNA,gene,0.879,32387453
6876,PTL,disease,0.6743,32387453
6877,rectal-PTL,disease,0.9683,32387453
6878,panitumumab,gene,0.782,32387453
6879,Bladder-Infiltrating Sigmoid Colon Cancer,disease,1.0,32381885
6880,constipation,disease,0.9995,32381885
6881,melena,disease,0.993,32381885
6882,weight,disease,0.954,32381885
6883,sigmoid colon cancer,disease,1.0,32381885
6884,cancer,disease,0.997,32381885
6885,RAS,gene,0.4822,32381885
6886,adenocarcinoma,disease,1.0,32381885
6887,tub2,cell_line,0.5835,32381885
6888,sigmoid colon cancer,disease,1.0,32381885
6889,panitumumab,gene,0.7363,32381885
6890,cancer,disease,0.983,32381885
6891,colon cancer,disease,1.0,32381885
6892,Tumor,disease,0.962,32381884
6893,Colon Cancer,disease,1.0,32381884
6894,panitumumab,gene,0.885,32381884
6895,ascending colon cancer,disease,1.0,32381884
6896,adenocarcinoma,disease,1.0,32381884
6897,dyspnea,disease,0.9966,32381884
6898,pulmonary artery thromboembolism,disease,1.0,32381884
6899,superior vena cava thrombosis,disease,0.9907,32381884
6900,tumor embolism,disease,1.0,32381884
6901,colon cancer,disease,1.0,32381884
6902,respiratory failure,disease,0.9995,32381884
6903,tumor,disease,0.849,32381884
6904,left subclavian lymph node metastases,disease,0.9966,32381884
6905,tumor,disease,0.964,32381884
6906,tumor,disease,0.9707,32381884
6907,Rectal Cancer,disease,1.0,32381883
6908,rectal cancer,disease,1.0,32381883
6909,swollen,disease,0.844,32381883
6910,liver metastases,disease,0.9673,32381883
6911,panitumumab,gene,0.6934,32381883
6912,rectal cancer,disease,1.0,32381883
6913,para-aortic lymph nodes metastasis,disease,0.9985,32381883
6914,liver metastases,disease,0.9995,32381883
6915,Rectal cancer,disease,1.0,32381883
6916,liver metastases,disease,0.887,32381883
6917,rectal cancer,disease,1.0,32381883
6918,urinary bladder,disease,0.7363,32381883
6919,Right-Sided NeckPain,disease,0.9917,32381870
6920,thrombosis in the internal jugular vein,disease,0.991,32381870
6921,neck pain,disease,0.9985,32381870
6922,rectal cancer,disease,1.0,32381870
6923,right-sided neck pain,disease,0.9873,32381870
6924,levofolinic acid,drug,0.9995,32381870
6925,5-fluorouracil,drug,0.9995,32381870
6926,5-FU,drug,0.9995,32381870
6927,oxaliplatin,drug,0.9995,32381870
6928,L-OHP,drug,0.999,32381870
6929,panitumumab,gene,0.861,32381870
6930,CV catheter,DNA,0.4756,32381870
6931,thrombosis,disease,0.997,32381870
6932,thrombosis,disease,1.0,32381870
6933,neck pain,disease,0.7666,32381870
6934,phlebitis,disease,1.0,32381870
6935,L-OHP,drug,0.999,32381870
6936,5-FU,drug,0.9985,32381870
6937,neck pain,disease,0.7617,32381870
6938,thrombosis,disease,0.9995,32381870
6939,advanced refractory colorectal cancer,disease,0.9766,32379280
6940,CRC,disease,0.9976,32379280
6941,patients,species,0.993,32379280
6942,programmed death-ligand 1,gene,0.9976,32379280
6943,PD-L1,gene,0.9976,32379280
6944,cytotoxic T-lymphocyte-associated protein 4,gene,0.9956,32379280
6945,CTLA-4,gene,0.998,32379280
6946,patient,species,0.9814,32379280
6947,CRC,disease,0.9795,32379280
6948,PARTICIPANTS,species,0.5933,32379280
6949,cancer,disease,0.9995,32379280
6950,patients,species,0.979,32379280
6951,adenocarcinoma of the colon or rectum,disease,1.0,32379280
6952,fluoropyrimidines,drug,1.0,32379280
6953,oxaliplatin,drug,0.9995,32379280
6954,irinotecan,drug,0.9976,32379280
6955,panitumumab,gene,0.767,32379280
6956,RAS wild,cell_line,0.4836,32379280
6957,RAS wild-type tumors,disease,0.984,32379280
6958,RAS,gene,0.994,32379280
6959,regorafenib,drug,0.9307,32379280
6960,patients,species,0.9727,32379280
6961,tremelimumab,gene,0.7056,32379280
6962,Circulating cell-free DNA,RNA,0.6255,32379280
6963,microsatellite,DNA,0.4954,32379280
6964,tumor,disease,0.9785,32379280
6965,patients,species,0.9634,32379280
6966,men,species,0.9775,32379280
6967,women,species,0.9883,32379280
6968,tremelimumab,gene,0.5293,32379280
6969,patients,species,0.978,32379280
6970,Circulating cell-free DNA,RNA,0.571,32379280
6971,patients,species,0.987,32379280
6972,patients,species,0.9795,32379280
6973,tremelimumab,gene,0.5093,32379280
6974,Patients,species,0.9653,32379280
6975,MSS,disease,0.6406,32379280
6976,MSS,disease,0.9995,32379280
6977,patients,species,0.9907,32379280
6978,tremelimumab,gene,0.725,32379280
6979,patients,species,0.897,32379280
6980,CRC,disease,0.9487,32379280
6981,patients,species,0.985,32379280
6982,KRAS,gene,0.9897,32376853
6983,metastatic colon cancer,disease,1.0,32376853
6984,RAS,gene,0.977,32376853
6985,metastatic colorectal carcinomas,disease,1.0,32376853
6986,mCRCs,disease,1.0,32376853
6987,EGFR,gene,0.946,32376853
6988,mCRC,disease,0.9995,32376853
6989,RAS,DNA,0.7314,32376853
6990,RAS,gene,0.9956,32376853
6991,EGFR,gene,0.9873,32376853
6992,mCRCs,disease,0.9985,32376853
6993,RAS,gene,0.9946,32376853
6994,EGFR,gene,0.62,32376853
6995,RAS,DNA,0.8564,32376853
6996,RAS,gene,0.9966,32376853
6997,mCRC,disease,0.998,32376853
6998,patients,species,0.9927,32376853
6999,KRAS,gene,0.9746,32376853
7000,NRAS,DNA,0.783,32376853
7001,NRAS,gene,0.9824,32376853
7002,HRAS,gene,0.9795,32376853
7003,BRAF,DNA,0.843,32376853
7004,BRAF,gene,0.9893,32376853
7005,PIK3CA,gene,0.9946,32376853
7006,mCRC,disease,0.968,32376853
7007,patients,species,0.9756,32376853
7008,RAS,DNA,0.5146,32376853
7009,RAS,gene,0.993,32376853
7010,mCRCs,cell_type,0.4878,32376853
7011,mCRCs,disease,0.9937,32376853
7012,KRAS,gene,0.989,32376853
7013,NRAS,DNA,0.8716,32376853
7014,NRAS,gene,0.99,32376853
7015,HRAS,gene,0.9927,32376853
7016,Patients,species,0.9756,32376853
7017,KRAS,DNA,0.7285,32376853
7018,KRAS,gene,0.986,32376853
7019,mCRC,disease,0.9985,32376853
7020,inflammatory bowel disease,disease,1.0,32376853
7021,KRAS,gene,0.9453,32376853
7022,patient,species,0.943,32376853
7023,MMR proficiency,disease,1.0,32376853
7024,patients,species,0.951,32376853
7025,KRAS,DNA,0.6274,32376853
7026,KRAS,gene,0.9624,32376853
7027,mCRC,disease,0.9985,32376853
7028,RAS,gene,0.996,32376853
7029,BRAF,gene,0.9976,32376853
7030,PIK3CA,gene,0.997,32376853
7031,EGFR,gene,0.9927,32376853
7032,RAS,DNA,0.669,32376853
7033,RAS,gene,0.997,32376853
7034,patients,species,0.982,32376853
7035,patients,species,0.985,32376853
7036,KRAS,gene,0.9614,32376853
7037,mCRC,disease,0.998,32376853
7038,EGFR,gene,0.69,32376853
7039,patients,species,0.9673,32376853
7040,KRAS,DNA,0.837,32376853
7041,KRAS,gene,0.997,32376853
7042,mCRCs,cell_type,0.4082,32376853
7043,mCRCs,disease,1.0,32376853
7044,mCRC,disease,0.9995,32376853
7045,KRAS,gene,0.9927,32376853
7046,KRAS mutation,DNA,0.634,32376853
7047,KRAS mutation,gene,0.9736,32376853
7048,EGFR,gene,0.9824,32376853
7049,RAS,gene,0.9937,32376853
7050,Z-Leucinyl-Leucinyl-Norleucinal,drug,0.9995,32375292
7051,Colorectal Cancer Cell Lines,cell_line,0.901,32375292
7052,Colorectal Cancer,disease,1.0,32375292
7053,Colorectal cancer,disease,1.0,32375292
7054,CRC,disease,1.0,32375292
7055,cancer,disease,1.0,32375292
7056,cancer,disease,0.997,32375292
7057,cetuximab,gene,0.6763,32375292
7058,Cxm,gene,0.972,32375292
7059,panitumumab,gene,0.8286,32375292
7060,ERBB1,gene,0.992,32375292
7061,EGF receptor,gene,0.9946,32375292
7062,cancer,disease,1.0,32375292
7063,ERBB1,gene,0.9956,32375292
7064,tumors,disease,1.0,32375292
7065,ERBB1,gene,0.993,32375292
7066,immunoliposomes,cell_type,0.463,32375292
7067,cancer,disease,0.602,32375292
7068,leucine-,drug,0.9995,32375292
7069,leucin-,drug,0.903,32375292
7070,norleucinal,drug,0.6587,32375292
7071,LLNle,drug,0.9673,32375292
7072,gamma-secretase,gene,0.9863,32375292
7073,CRC cell lines,cell_line,0.953,32375292
7074,CRC,disease,0.5103,32375292
7075,ERBB1,gene,0.6514,32375292
7076,LLNle,drug,0.666,32375292
7077,Cxm,gene,0.8926,32375292
7078,LLNle,drug,0.578,32375292
7079,LLNle,gene,0.7456,32375292
7080,LLNle,gene,0.8174,32375292
7081,LLNle,drug,0.6562,32375292
7082,LLNle,gene,0.9478,32375292
7083,LLNle,gene,0.9917,32375292
7084,lysosomes,cell_type,0.55,32375292
7085,LLNle,gene,0.992,32375292
7086,LLNle,gene,0.9736,32375292
7087,CRC cell lines,cell_line,0.949,32375292
7088,CRC,disease,0.506,32375292
7089,LLNle,gene,0.9575,32375292
7090,cancer,disease,0.5264,32375292
7091,metastatic colorectal cancer,disease,1.0,32330071
7092,tumor,disease,0.999,32330071
7093,metastatic colorectal cancer,disease,0.9995,32330071
7094,metastatic colorectal cancer,disease,0.9995,32330071
7095,cetuximab,gene,0.7485,32330071
7096,RAS variant,gene,0.862,32330071
7097,cetuximab,gene,0.7085,32330071
7098,panitumumab,gene,0.9004,32294281
7099,cutaneous squamous cell carcinoma,disease,1.0,32294281
7100,cutaneous squamous cell carcinomas,disease,1.0,32294281
7101,panitumumab,gene,0.858,32294281
7102,cutaneous squamous cell carcinoma,disease,1.0,32294281
7103,panitumumab,gene,0.7876,32294281
7104,panitumumab,gene,0.868,32294281
7105,cutaneous squamous cell carcinoma,disease,1.0,32294281
7106,anti-PD-1 antibodies,gene,0.8604,32294281
7107,anaphylactic,disease,0.8726,32294281
7108,anti-EGFR antibodies,gene,0.857,32294281
7109,anti-PD-1 antibodies,gene,0.9385,32294281
7110,Rectal Cancer,disease,1.0,32231536
7111,Disseminated Carcinomatosis of the Bone Marrow,disease,0.9995,32231536
7112,Disseminated carcinomatosis of the bone marrow,disease,1.0,32231536
7113,DCBM,disease,1.0,32231536
7114,colorectal cancer,disease,1.0,32231536
7115,DCBM,disease,0.9995,32231536
7116,rectal cancer,disease,1.0,32231536
7117,epidermal growth factor receptor,gene,0.9805,32231536
7118,EGFR,gene,0.9946,32231536
7119,patient,species,0.924,32231536
7120,man,species,0.889,32231536
7121,rectal cancer,disease,1.0,32231536
7122,disseminated intravascular coagulation,disease,0.9995,32231536
7123,DIC,disease,0.9937,32231536
7124,FOLOX,drug,0.9883,32231536
7125,cetuximab,gene,0.7935,32231536
7126,FOLFOX,drug,0.982,32231536
7127,panitumumab,gene,0.7354,32231536
7128,FOLFOX,drug,0.7295,32231536
7129,EGFR,gene,0.564,32231536
7130,HER2,gene,0.9946,32229076
7131,Colorectal Cancer,disease,1.0,32229076
7132,metastatic colorectal cancer,disease,0.9995,32229076
7133,mCRC,disease,1.0,32229076
7134,Cetuximab,gene,0.5376,32229076
7135,panitumumab,gene,0.5684,32229076
7136,anti-epidermal growth factor receptor,gene,0.947,32229076
7137,EGFR,gene,0.9077,32229076
7138,patients,species,0.9546,32229076
7139,RAS,gene,0.9966,32229076
7140,mCRC,disease,0.982,32229076
7141,patients,species,0.9805,32229076
7142,RAS,gene,0.968,32229076
7143,mCRC,disease,0.915,32229076
7144,anti-EGFR mAbs,gene,0.8467,32229076
7145,human epidermal growth factor receptor,DNA,0.51,32229076
7146,human epidermal growth factor receptor 2,gene,0.999,32229076
7147,HER2,gene,0.999,32229076
7148,anti-EGFR mAbs,gene,0.899,32229076
7149,patients,species,0.8696,32229076
7150,RAS,gene,0.9644,32229076
7151,RAF,gene,0.9883,32229076
7152,mCRC,disease,0.9785,32229076
7153,HER2,gene,0.9893,32229076
7154,trastuzumab,gene,0.9854,32229076
7155,lapatinib,drug,0.9985,32229076
7156,pertuzumab,gene,0.9126,32229076
7157,tumoral,disease,0.979,32229076
7158,RAS,DNA,0.493,32229076
7159,RAS,gene,0.984,32229076
7160,mCRC,disease,0.985,32229076
7161,HER2,gene,0.992,32229076
7162,CRC,disease,0.9976,32229076
7163,HER2,DNA,0.725,32229076
7164,HER2,gene,0.9937,32229076
7165,HER2,gene,0.9883,32229076
7166,CRC,disease,0.9976,32229076
7167,end-stage cancer,disease,0.995,32208873
7168,cancer,disease,0.999,32208873
7169,DNA driver,DNA,0.574,32208873
7170,tumor,disease,1.0,32208873
7171,end-stage cancer,disease,0.876,32208873
7172,colorectal cancer,disease,1.0,32208873
7173,ALK,gene,0.9985,32208873
7174,ROS1,gene,0.999,32208873
7175,BRAF,gene,0.9985,32208873
7176,EGFR,gene,0.9927,32208873
7177,FGFR,gene,0.995,32208873
7178,mTOR,gene,0.995,32208873
7179,PARP,gene,0.9893,32208873
7180,PD-1,gene,0.993,32208873
7181,colorectal cancer,disease,1.0,32208873
7182,transient,disease,0.7754,32208873
7183,colitis,disease,0.737,32208873
7184,PD-1,gene,0.994,32208873
7185,tumor,disease,1.0,32208873
7186,cancer,disease,1.0,32208873
7187,Colorectal Cancer,disease,0.998,32192883
7188,colorectal cancer,disease,1.0,32192883
7189,regorafenib,drug,0.996,32192883
7190,TAS-102,drug,0.9976,32192883
7191,TAS-102,drug,0.998,32192883
7192,regorafenib,drug,0.994,32192883
7193,TAS-102,drug,0.9976,32192883
7194,regorafenib,drug,0.987,32192883
7195,regorafenib,drug,0.994,32192883
7196,TAS-102,drug,0.9873,32192883
7197,RAS,gene,0.8,32192883
7198,anti-,gene,0.722,32192883
7199,EGFR antibodies,gene,0.7593,32192883
7200,panitumumab,gene,0.73,32192883
7201,regorafenib,drug,0.993,32192883
7202,TAS-102,drug,0.9985,32192883
7203,TAS-102,drug,0.9985,32192883
7204,regorafenib,drug,0.992,32192883
7205,regorafenib,drug,0.994,32192883
7206,RAS,gene,0.64,32192883
7207,EGFR,gene,0.7407,32192883
7208,TAS-102,drug,0.9937,32192883
7209,regorafenib,drug,0.9795,32192883
7210,panitumumab,gene,0.9604,32176047
7211,colorectal cancer,disease,1.0,32176047
7212,panitumumab,gene,0.957,32176047
7213,colorectal cancer,disease,1.0,32176047
7214,panitumumab,gene,0.7607,32176047
7215,colorectal cancer,disease,1.0,32176047
7216,panitumumab,gene,0.93,32176047
7217,colorectal cancer,disease,1.0,32176047
7218,colorectal cancer,disease,1.0,32176047
7219,panitumumab,gene,0.897,32176047
7220,wild,DNA,0.595,32176047
7221,wild-type (WT) KRAS,gene,0.885,32176047
7222,mutant KRAS,gene,0.9907,32176047
7223,WT KRAS,gene,0.99,32176047
7224,WT KRAS,gene,0.9927,32176047
7225,panitumumab,gene,0.8726,32176047
7226,Panitumumab,gene,0.9575,32176047
7227,colorectal cancer,disease,1.0,32176047
7228,patients,species,0.986,32176047
7229,WT KRAS,gene,0.9614,32176047
7230,Fc,gene,0.9165,32169872
7231,hu14,gene,0.9805,32169872
7232,relapsed neuroblastoma,disease,0.971,32169872
7233,cancer,disease,1.0,32169872
7234,humanized,species,0.6245,32169872
7235,human antihuman antibody,gene,0.984,32169872
7236,HAHA,gene,0.6943,32169872
7237,neuroblastoma,disease,1.0,32169872
7238,humanized anti-GD2 mAb (immunoglobulin (Ig)G1 isotype),gene,0.9814,32169872
7239,humanized,species,0.861,32169872
7240,hu14,gene,0.961,32169872
7241,.,DNA,0.3867,32169872
7242,PATA,gene,0.821,32169872
7243,PATA,disease,0.634,32169872
7244,rituximab,gene,0.927,32169872
7245,Fc,gene,0.9526,32169872
7246,hu14,gene,0.9824,32169872
7247,rituximab,gene,0.9053,32169872
7248,Fab,gene,0.9326,32169872
7249,PATA+,cell_line,0.778,32169872
7250,dinutuximab,gene,0.963,32169872
7251,human IgG1 isotype,gene,0.9087,32169872
7252,mouse IgG2a isotype mAbs,gene,0.9146,32169872
7253,mouse,species,0.9883,32169872
7254,mouse IgG1 isotype,gene,0.9297,32169872
7255,mouse,species,0.994,32169872
7256,IgG2 isotype) mAb,gene,0.8525,32169872
7257,PATA,drug,0.4973,32169872
7258,PATA,cell_line,0.508,32169872
7259,Fc,gene,0.964,32169872
7260,PATA,DNA,0.5327,32169872
7261,relapsed neuroblastoma,disease,0.992,32169872
7262,antitumor,disease,0.9385,32169872
7263,Epidermal growth factor receptor,gene,0.998,32162758
7264,EGFR,gene,0.994,32162758
7265,epithelial-derived cancers,disease,1.0,32162758
7266,epidermal growth factor receptor,gene,0.998,32162758
7267,EGFR,gene,0.993,32162758
7268,tyrosine,drug,0.9937,32162758
7269,tyrosine kinase receptors,gene,0.9907,32162758
7270,EGFR,gene,0.9946,32162758
7271,germline,DNA,0.573,32162758
7272,EGFR,gene,0.996,32162758
7273,cancer,disease,1.0,32162758
7274,epithelial,cell_line,0.442,32162758
7275,epithelial-derived tumors,disease,0.565,32162758
7276,cancer,disease,1.0,32162758
7277,EGFR,gene,0.9937,32162758
7278,epithelial,cell_type,0.4924,32162758
7279,epithelial-derived cancer,disease,0.9985,32162758
7280,lung cancer,disease,1.0,32162758
7281,colorectal cancer,disease,1.0,32162758
7282,squamous cell carcinomas,disease,1.0,32162758
7283,EGFR,gene,0.9917,32162758
7284,tumors,disease,1.0,32162758
7285,anti-,gene,0.7495,32162758
7286,EGFR,gene,0.5938,32162758
7287,cetuximab,gene,0.9077,32162758
7288,panitumumab,gene,0.802,32162758
7289,EGFR-related epithelial cancers,disease,0.9995,32162758
7290,EGFR,gene,0.994,32162758
7291,Patient,species,0.982,32157050
7292,Advanced Rectal Cancer,disease,1.0,32157050
7293,woman,species,0.8833,32157050
7294,type 0-a cancer,disease,0.9937,32157050
7295,type 5 cancer,disease,1.0,32157050
7296,rectosigmoid colon cancer,disease,1.0,32157050
7297,upper rectal cancer,disease,1.0,32157050
7298,fluorodeoxyglucose,drug,0.989,32157050
7299,paraaortic,DNA,0.536,32157050
7300,paraaortic and lateral lymph node lesions,disease,0.9937,32157050
7301,renal dysfunction,disease,1.0,32157050
7302,paraaortic and,disease,0.781,32157050
7303,cancer,disease,1.0,32157050
7304,S-1,drug,0.683,32157050
7305,panitumumab,gene,0.892,32157050
7306,patient,species,0.9785,32157050
7307,Patient,species,0.936,32157041
7308,Mesenteric,disease,0.669,32157041
7309,man,species,0.887,32157041
7310,anal pain,disease,0.983,32157041
7311,patient,species,0.981,32157041
7312,early-stage,disease,0.8887,32157041
7313,rectal cancer,disease,0.774,32157041
7314,adenocarcinoma,disease,1.0,32157041
7315,solid,disease,0.882,32157041
7316,hematoma,disease,0.9414,32157041
7317,tumor,disease,0.987,32157041
7318,adenocarcinoma,disease,0.9956,32157041
7319,hematoma,disease,1.0,32157041
7320,mesenteric,disease,0.5464,32157041
7321,rectal cancer,disease,1.0,32157041
7322,patient,species,0.9927,32157041
7323,recurrent cancer,disease,0.9995,32157041
7324,5-FU,drug,0.999,32157041
7325,oxaliplatin,drug,0.9995,32157041
7326,panitumumab,gene,0.8413,32157041
7327,hematoma,disease,1.0,32157041
7328,recurrent cancer in the mesorectum,disease,0.996,32157041
7329,patient,species,0.9688,32157041
7330,patient,species,0.986,32157041
7331,Advanced Colorectal Cancer,disease,1.0,32156948
7332,advanced colorectal cancer,disease,1.0,32156948
7333,bevacizumab,gene,0.698,32156948
7334,descending colon cancer,disease,1.0,32156948
7335,liver metastases,disease,0.5996,32156948
7336,FOLFOXIRI,drug,0.9404,32156948
7337,bevacizumab,gene,0.503,32156948
7338,liver metastases,disease,0.8438,32156948
7339,rectal cancer,disease,1.0,32156948
7340,cancer embolism,disease,1.0,32156948
7341,bevacizumab,gene,0.753,32156948
7342,cancer,disease,1.0,32156948
7343,cancer,disease,0.9854,32156948
7344,malignant cells,cell_type,0.8823,32156948
7345,FOLFIRI,drug,0.7563,32156948
7346,panitumumab,gene,0.901,32156948
7347,patient,species,0.9336,32156948
7348,human IgG2 antibody,gene,0.979,32142185
7349,human,species,0.9697,32142185
7350,IgG2 subclass antibodies,gene,0.8633,32142185
7351,IgG2 subclasses,gene,0.7866,32142185
7352,IgG1,gene,0.9956,32142185
7353,monoclonal antibodies,gene,0.683,32142185
7354,IgG2,gene,0.9917,32142185
7355,IgG1,gene,0.9937,32142185
7356,"anti-2,4-dinitrophenol (DNP) IgG2",gene,0.989,32142185
7357,DNP,drug,0.7773,32142185
7358,anti-DNP IgG2 antibody,gene,0.9873,32142185
7359,DNP,drug,0.9453,32142185
7360,IgG2 antibody,gene,0.992,32142185
7361,IgG1 CH2 domain,gene,0.9463,32142185
7362,amino acids,drug,0.9946,32142185
7363,CH2 domain,gene,0.981,32142185
7364,F300,mutation,,32142185
7365,V309,mutation,,32142185
7366,T339,mutation,,32142185
7367,IgG2_YLA,gene,0.836,32142185
7368,CH2,drug,0.999,32142185
7369,IgG2,gene,0.9937,32142185
7370,IgG2,gene,0.994,32142185
7371,FcRIIIa,gene,0.9966,32142185
7372,C1q,gene,0.9897,32142185
7373,YLA,drug,0.985,32142185
7374,panitumumab,gene,0.9243,32142185
7375,IgG2 antibody,gene,0.994,32142185
7376,engineered human IgG2 antibody,gene,0.9565,32142185
7377,human,species,0.873,32142185
7378,IgG2 antibodies,gene,0.992,32142185
7379,Panitumumab,gene,0.828,32133314
7380,Eruptive Seborrhoeic Keratosis,disease,0.9985,32133314
7381,Patient,species,0.958,32133314
7382,epidermal growth factor receptor,gene,0.998,32133314
7383,EGFR,gene,0.9966,32133314
7384,"advanced lung, pancreatic, colorectal and head and neck cancers",disease,0.999,32133314
7385,seborrhoeic keratosis,disease,0.9653,32133314
7386,panitumumab,gene,0.618,32133314
7387,anti-EGFR monoclonal antibody,gene,0.985,32133314
7388,patient,species,0.9487,32133314
7389,stage 4 (IV),disease,0.94,32133314
7390,colorectal cancer,disease,0.991,32133314
7391,hepatic metastasis,disease,0.972,32133314
7392,panitumumab,gene,0.769,32133314
7393,RAS,gene,0.9946,32133314
7394,panitumumab,gene,0.5586,32133314
7395,eruptive seborrhoeic keratosis,disease,0.9263,32133314
7396,Panitumumab,gene,0.729,32133314
7397,human,species,0.739,32133314
7398,epidermal growth factor receptor,gene,0.9985,32133314
7399,EGFR,gene,0.996,32133314
7400,wild-type RAS,gene,0.8613,32133314
7401,colorectal cancer,disease,1.0,32133314
7402,patients,species,0.992,32133314
7403,EGFR,gene,0.987,32133314
7404,panitumumab,gene,0.8823,32133314
7405,eruptive seborrhoeic keratosis,disease,0.9966,32133314
7406,Therapeutic Monoclonal Antibody Hinge,gene,0.629,32117299
7407,immunoglobulin G,gene,0.9766,32117299
7408,IgG,gene,0.994,32117299
7409,C1q,gene,0.9785,32117299
7410,Fc,cell_line,0.464,32117299
7411,FcRIIIA,gene,0.9937,32117299
7412,-expressing natural killer (NK) cell,cell_type,0.8047,32117299
7413,tumor,disease,0.836,32117299
7414,matrix metalloproteinase 12,gene,0.9927,32117299
7415,MMP12,gene,0.9927,32117299
7416,immunoglobulin-degrading enzyme from Streptococcus pyogenes,gene,0.986,32117299
7417,Streptococcus pyogenes,species,0.841,32117299
7418,IdeS,gene,0.9907,32117299
7419,Fc,gene,0.95,32117299
7420,human IgG1,gene,0.749,32117299
7421,IgG2,gene,0.998,32117299
7422,IgG4,gene,0.998,32117299
7423,IgG1 TmAbs,gene,0.985,32117299
7424,trastuzumab,gene,0.9443,32117299
7425,rituximab,gene,0.9526,32117299
7426,cetuximab,gene,0.925,32117299
7427,infliximab,gene,0.9595,32117299
7428,ipilimumab,gene,0.91,32117299
7429,IgG2 TmAb,gene,0.972,32117299
7430,panitumumab,gene,0.943,32117299
7431,IgG4 TmAbs,gene,0.984,32117299
7432,nivolumab,gene,0.896,32117299
7433,pembrolizumab,gene,0.851,32117299
7434,MMP12,gene,0.9917,32117299
7435,IdeS,gene,0.993,32117299
7436,HCs,gene,0.4194,32117299
7437,Panitumumab,gene,0.821,32117299
7438,IgG1,gene,0.9976,32117299
7439,IgG4 TmAbs,gene,0.746,32117299
7440,IgG1 TmAbs,gene,0.8887,32117299
7441,IgG4,gene,0.997,32117299
7442,IgG1 TmAbs,gene,0.8403,32117299
7443,Nivolumab,gene,0.9243,32117299
7444,pembrolizumab,drug,0.9204,32117299
7445,MMP12,gene,0.983,32117299
7446,pembrolizumab,drug,0.951,32117299
7447,IdeS,gene,0.9824,32117299
7448,Ipilimumab,gene,0.5366,32117299
7449,IdeS,gene,0.9956,32117299
7450,MMP12,gene,0.991,32117299
7451,IgG1 TmAbs,gene,0.967,32117299
7452,G1m allotype,gene,0.776,32117299
7453,Fc,gene,0.9194,32117299
7454,IgG1 TmAbs,gene,0.958,32117299
7455,MMP12,gene,0.984,32117299
7456,IdeS,gene,0.9863,32117299
7457,ipilimumab Fc fragment,gene,0.977,32117299
7458,IdeS,gene,0.979,32117299
7459,trastuzumab,gene,0.9854,32117299
7460,cetuximab,gene,0.9883,32117299
7461,infliximab Fc fragment,gene,0.9883,32117299
7462,Fc,gene,0.9536,32117299
7463,TmAbs,gene,0.916,32117299
7464,IgG1,gene,0.9976,32117299
7465,IgG4,gene,0.9976,32117299
7466,TmAb,gene,0.712,32117299
7467,Fab region,gene,0.915,32117299
7468,IgG1 TmAbs,gene,0.9077,32117299
7469,FcRIIIA,gene,0.9966,32117299
7470,C1q,gene,0.978,32117299
7471,FcRIIIA,gene,0.995,32117299
7472,NK cells,cell_type,0.9053,32117299
7473,TmAbs,gene,0.9795,32117299
7474,Anti-,gene,0.714,32111744
7475,EGFR,gene,0.719,32111744
7476,Advanced Biliary Tract Cancer,disease,1.0,32111744
7477,biliary tract cancer,disease,1.0,32111744
7478,BTC,disease,1.0,32111744
7479,epidermal growth factor receptor,gene,0.997,32111744
7480,EGFR,gene,0.993,32111744
7481,gemcitabine,drug,0.9995,32111744
7482,EGFR,gene,0.984,32111744
7483,EGFR-mAbs,gene,0.949,32111744
7484,metastatic BTC,disease,0.9995,32111744
7485,gemcitabine,drug,0.9995,32111744
7486,EGFR,gene,0.994,32111744
7487,neutropenia,disease,0.878,32111744
7488,thrombocytopenia,disease,0.9927,32111744
7489,skin rash,disease,0.993,32111744
7490,EGFR,gene,0.992,32111744
7491,gemcitabine,drug,0.9995,32111744
7492,advanced BTC,disease,0.696,32111744
7493,Capecitabine,drug,0.9995,32110222
7494,Bevacizumab,gene,0.748,32110222
7495,Metastatic Appendiceal Adenocarcinoma,disease,1.0,32110222
7496,appendiceal adenocarcinoma,disease,1.0,32110222
7497,5-fluorouracil,drug,0.9995,32110222
7498,leucovorin,drug,0.999,32110222
7499,oxaliplatin,drug,0.9995,32110222
7500,FOLFOX,drug,0.9775,32110222
7501,5-fluorouracil,drug,0.9995,32110222
7502,leucovorin,drug,0.999,32110222
7503,irinotecan,drug,0.999,32110222
7504,FOLFIRI,drug,0.944,32110222
7505,panitumumab,gene,0.8857,32110222
7506,capecitabine,drug,0.9985,32110222
7507,bevacizumab,gene,0.75,32110222
7508,tumour,disease,0.8916,32110222
7509,bevacizumab,gene,0.7905,32110222
7510,bevacizumab,gene,0.7314,32110222
7511,neurological adverse,disease,0.782,32110222
7512,bevacizumab,gene,0.687,32110222
7513,5-Fluorouracil,drug,0.9985,32092755
7514,Patients,species,0.9883,32092755
7515,patients,species,0.89,32092755
7516,colorectal cancer,disease,1.0,32092755
7517,CRC,disease,0.9995,32092755
7518,liver metastases,disease,0.895,32092755
7519,5-fluorouracil,drug,0.999,32092755
7520,5FU,drug,0.999,32092755
7521,patients,species,0.9185,32092755
7522,liver metastases,disease,0.989,32092755
7523,CRC,disease,1.0,32092755
7524,patients,species,0.9814,32092755
7525,men,species,0.9775,32092755
7526,women,species,0.9785,32092755
7527,KRAS,DNA,0.787,32092755
7528,KRAS mutation,gene,0.9424,32092755
7529,patients,species,0.984,32092755
7530,fluoropyrimidine,drug,0.9995,32092755
7531,oxaliplatin,drug,1.0,32092755
7532,irinotecan,drug,0.9995,32092755
7533,bevacizumab,gene,0.9165,32092755
7534,cetuximab,gene,0.831,32092755
7535,panitumumab,gene,0.842,32092755
7536,patients,species,0.974,32092755
7537,5FU,drug,0.994,32092755
7538,liver metastases,disease,0.9966,32092755
7539,patients,species,0.976,32092755
7540,hyperbilirubinemia,disease,1.0,32092755
7541,liver abscess,disease,1.0,32092755
7542,myelosuppression,disease,1.0,32092755
7543,5FU,drug,0.9927,32092755
7544,liver metastases,disease,0.9976,32092755
7545,CRC,disease,1.0,32092755
7546,metastatic colorectal cancer,disease,1.0,32081104
7547,metastatic colorectal cancer,disease,1.0,32081104
7548,mCRC,disease,1.0,32081104
7549,Regorafenib,drug,0.999,32081104
7550,TAS-102,drug,0.9985,32081104
7551,fruquintinib,drug,0.9995,32081104
7552,panitumumab,gene,0.891,32081104
7553,cetuximab,gene,0.72,32081104
7554,cancer,disease,1.0,32081104
7555,KRAS gene,DNA,0.874,32081104
7556,KRAS gene mutation,gene,0.9204,32081104
7557,wild-type KRAS,DNA,0.7046,32081104
7558,panitumumab,gene,0.966,32081104
7559,Fruquintinib,drug,0.9985,32081104
7560,wild-type KRAS,gene,0.8384,32081104
7561,KRAS,gene,0.4626,32081104
7562,mCRC,disease,0.9985,32081104
7563,Colorectal Cancer,disease,0.9585,32074573
7564,advanced and recurrent colorectal cancer,disease,1.0,32074573
7565,ARCC,disease,1.0,32074573
7566,FOLFIRI,drug,0.6597,32074573
7567,bevacizumab,gene,0.9097,32074573
7568,Bmab,gene,0.8535,32074573
7569,Bmab,gene,0.823,32074573
7570,FOLFIRI,drug,0.925,32074573
7571,panitumumab,gene,0.966,32074573
7572,Pmab,gene,0.9697,32074573
7573,FOLFOXIRI,drug,0.9136,32074573
7574,ARCC,disease,1.0,32074573
7575,leukopenia,disease,0.9985,32074573
7576,febrile neutropenia,disease,0.999,32074573
7577,FN,disease,0.993,32074573
7578,tumor,disease,0.862,32074573
7579,ARCC,disease,1.0,32074573
7580,BRAF mutant colorectal,cell_line,0.547,32066410
7581,BRAF mutant colorectal cancer,disease,0.951,32066410
7582,BRAF,gene,0.9883,32066410
7583,ErbB2,gene,0.9814,32066410
7584,BRAF,gene,0.999,32066410
7585,ErbB,gene,0.988,32066410
7586,Colorectal cancer,disease,1.0,32066410
7587,CRC,disease,1.0,32066410
7588,altered genes,DNA,0.797,32066410
7589,BRAF,gene,0.855,32066410
7590,KRAS,gene,0.791,32066410
7591,PIK3CA,gene,0.685,32066410
7592,BRAF,gene,0.565,32066410
7593,CRC,disease,0.933,32066410
7594,RAF,gene,0.997,32066410
7595,RAFi,gene,0.9033,32066410
7596,ErbB,gene,0.983,32066410
7597,ErbBi,gene,0.654,32066410
7598,BRAFi,gene,0.941,32066410
7599,vemurafenib,drug,0.99,32066410
7600,panitumumab,gene,0.852,32066410
7601,afatinib,drug,0.8574,32066410
7602,CRC cells,cell_line,0.7583,32066410
7603,CRC,disease,0.9995,32066410
7604,BRAFi,gene,0.8354,32066410
7605,BRAFV600E mutated cells,cell_line,0.723,32066410
7606,BRAFV600E,gene,0.989,32066410
7607,ErbB2,gene,0.9805,32066410
7608,ErbB2,gene,0.9844,32066410
7609,BRAF,gene,0.9746,32066410
7610,CRC,disease,0.744,32066410
7611,BRAFi,gene,0.978,32066410
7612,pancreatic cancer,disease,0.982,32062317
7613,mice,species,0.854,32062317
7614,[64Cu]Cu,drug,0.997,32062317
7615,panitumumab F(ab')2,gene,0.843,32062317
7616,gemcitabine,drug,0.999,32062317
7617,PARP,gene,0.9863,32062317
7618,rucaparib,drug,0.98,32062317
7619,pancreatic cancer,disease,1.0,32062317
7620,PnCa,disease,1.0,32062317
7621,[64Cu]Cu-NOTA,drug,0.9873,32062317
7622,panitumumab F(ab')2,gene,0.8896,32062317
7623,64Cu,drug,0.988,32062317
7624,[64Cu]Cu,drug,0.9946,32062317
7625,NOTA,drug,0.987,32062317
7626,panitumumab F(ab')2,gene,0.8916,32062317
7627,gemcitabine,drug,0.998,32062317
7628,GEM,drug,0.9985,32062317
7629,poly(ADP)ribose,drug,0.999,32062317
7630,poly(ADP)ribose polymerase,gene,0.958,32062317
7631,PARPi,gene,0.9575,32062317
7632,rucaparib,drug,0.9927,32062317
7633,non-tumor-bearing NOD-scid,cell_line,0.725,32062317
7634,tumor,disease,0.9434,32062317
7635,mice,species,0.9287,32062317
7636,[64Cu]Cu,drug,0.9976,32062317
7637,panitumumab F(ab')2,gene,0.915,32062317
7638,[64Cu]Cu,drug,0.9976,32062317
7639,anti-mouse EGFR Ab30 F(ab')2,gene,0.784,32062317
7640,mouse,species,0.979,32062317
7641,ALT,gene,0.9194,32062317
7642,creatinine,drug,0.998,32062317
7643,mice,species,0.9414,32062317
7644,OCIP23 human PnCa patient-derived xenografts,cell_line,0.6875,32062317
7645,PnCa,disease,1.0,32062317
7646,PDX,cell_line,0.669,32062317
7647,[64Cu]Cu-NOTA,drug,0.9946,32062317
7648,panitumumab,gene,0.9673,32062317
7649,F(ab')2,gene,0.8096,32062317
7650,panitumumab F(ab')2,gene,0.861,32062317
7651,[64Cu]Cu,drug,0.998,32062317
7652,panitumumab F(ab')2,gene,0.875,32062317
7653,GEM,drug,0.9946,32062317
7654,PARPi,gene,0.9355,32062317
7655,rucaparib,drug,0.989,32062317
7656,mice,species,0.8535,32062317
7657,s,disease,0.838,32062317
7658,PANC-1 human PnCa xenografts,cell_line,0.8164,32062317
7659,PnCa,disease,0.999,32062317
7660,PANC-1 tumors,disease,0.618,32062317
7661,mice,species,0.957,32062317
7662,[64Cu]Cu-NOTA,drug,0.9917,32062317
7663,panitumumab F(ab')2,gene,0.878,32062317
7664,[64Cu]Cu,drug,0.9976,32062317
7665,NOTA,drug,0.983,32062317
7666,panitumumab F(ab'),gene,0.886,32062317
7667,tumor,disease,0.826,32062317
7668,mice,species,0.6816,32062317
7669,[64Cu]Cu-NOTA,drug,0.9395,32062317
7670,panitumumab F(ab')2,gene,0.874,32062317
7671,ALT,gene,0.923,32062317
7672,[64Cu]Cu-NOTA,drug,0.994,32062317
7673,anti-mouse EGFR Ab30 F(ab')2,gene,0.803,32062317
7674,mouse,species,0.9604,32062317
7675,ALT,gene,0.9404,32062317
7676,tumor,disease,0.9976,32062317
7677,NOD,gene,0.523,32062317
7678,mice,species,0.9214,32062317
7679,OCIP23 PDX,cell_line,0.791,32062317
7680,[64Cu]Cu,drug,0.9976,32062317
7681,NOTA,drug,0.5225,32062317
7682,panitumumab F(ab')2,gene,0.9023,32062317
7683,panitumumab F(ab')2,gene,0.8525,32062317
7684,mice,species,0.9873,32062317
7685,[64Cu]Cu-NOTA,drug,0.991,32062317
7686,panitumumab F(ab')2,gene,0.8853,32062317
7687,GEM,drug,0.994,32062317
7688,PARPi,gene,0.975,32062317
7689,PANC,cell_type,0.636,32062317
7690,PANC-1 tumors,disease,0.8384,32062317
7691,mice,species,0.974,32062317
7692,GEM,drug,0.9863,32062317
7693,PARPi,gene,0.974,32062317
7694,GEM,drug,0.999,32062317
7695,PARPi,gene,0.965,32062317
7696,RIT,drug,0.9985,32062317
7697,GEM,drug,0.998,32062317
7698,RIT,drug,0.999,32062317
7699,RIT,drug,0.8643,32062317
7700,GEM,drug,0.9897,32062317
7701,PARPi,gene,0.8486,32062317
7702,GEM,drug,0.991,32062317
7703,PARPi,gene,0.9487,32062317
7704,RIT,drug,0.999,32062317
7705,GEM,drug,0.9976,32062317
7706,PANC-1 tumors,disease,0.8003,32062317
7707,PANC,cell_line,0.5547,32062317
7708,PANC-1 tumors,disease,0.999,32062317
7709,[64Cu]Cu-NOTA,drug,0.9946,32062317
7710,panitumumab F(ab'),gene,0.8975,32062317
7711,[64Cu]Cu-NOTA,drug,0.9233,32062317
7712,panitumumab F(ab')2,gene,0.8633,32062317
7713,normal,cell_type,0.4663,32062317
7714,PnCa xenografts,cell_line,0.667,32062317
7715,PnCa,disease,0.4978,32062317
7716,mice,species,0.9214,32062317
7717,GEM,drug,0.985,32062317
7718,PARPi,gene,0.802,32062317
7719,rucaparib,drug,0.986,32062317
7720,tumors,disease,1.0,32062317
7721,64Cu,drug,0.981,32062317
7722,PnCa,disease,0.5195,32062317
7723,177Lu,drug,0.997,32062317
7724,64Cu,drug,0.994,32062317
7725,[64Cu]Cu,drug,0.9985,32062317
7726,NOTA,drug,0.7075,32062317
7727,anti-mouse EGFR Ab30 F(ab')2,gene,0.7505,32062317
7728,mouse,species,0.9717,32062317
7729,mouse EGFR,gene,0.99,32062317
7730,mouse,species,0.9863,32062317
7731,hematopoietic stem cells,cell_type,0.95,32062317
7732,PATIENT,species,0.9854,32062317
7733,64Cu,drug,0.994,32062317
7734,(,drug,0.9224,32062317
7735,Cu),drug,0.68,32062317
7736,NOTA,drug,0.8833,32062317
7737,panitumumab,gene,0.897,32062317
7738,64Cu,drug,0.9966,32062317
7739,177Lu,drug,0.9917,32062317
7740,Epidermal Growth Factor Receptor,gene,0.9985,32053874
7741,EGFR,gene,0.996,32053874
7742,Pediatric Colorectal Cancer,disease,0.9995,32053874
7743,Colorectal carcinoma,disease,1.0,32053874
7744,CRC,disease,1.0,32053874
7745,child,species,0.8447,32053874
7746,metastatic CRC,disease,0.989,32053874
7747,panitumumab,gene,0.9136,32053874
7748,CRC,disease,0.9995,32053874
7749,nodal,disease,0.5215,32053874
7750,peritoneal neoplastic effusion,disease,1.0,32053874
7751,RAS family genes,gene,0.9897,32053874
7752,anti-Epidermal Growth Factor Receptor,gene,0.983,32053874
7753,EGFR,gene,0.996,32053874
7754,panitumumab,gene,0.7686,32053874
7755,child,species,0.86,32053874
7756,Carbohydrate Antigen (CA) 19,gene,0.938,32053874
7757,neoplastic cells,cell_type,0.839,32053874
7758,neoplastic,disease,0.9995,32053874
7759,panitumomab,gene,0.609,32053874
7760,colorectal cancer,disease,1.0,32053874
7761,BRAF,gene,0.615,32047001
7762,BRAF,gene,0.997,32047001
7763,MEK,gene,0.9946,32047001
7764,EGFR,gene,0.99,32047001
7765,Dabrafenib,drug,0.9966,32047001
7766,Trametinib,drug,0.9897,32047001
7767,Panitumumab,gene,0.593,32047001
7768,Colorectal Cancer,disease,1.0,32047001
7769,cancer,disease,0.9995,32047001
7770,BRAF V600E-mutant (BM) colorectal cancer,disease,0.978,32047001
7771,BRAF V600E,gene,0.5347,32047001
7772,BM1,cell_line,0.618,32047001
7773,BM2,cell_line,0.6157,32047001
7774,BM,disease,0.4739,32047001
7775,BRAF,gene,0.996,32047001
7776,MEK,gene,0.992,32047001
7777,EGFR,gene,0.994,32047001
7778,colorectal cancer,disease,1.0,32047001
7779,PATIENTS,species,0.897,32047001
7780,BM colorectal cancer,disease,0.9097,32047001
7781,dabrafenib,drug,0.999,32047001
7782,trametinib,drug,0.999,32047001
7783,panitumumab,gene,0.9126,32047001
7784,BM subtype,cell_line,0.7236,32047001
7785,immune gene signature,DNA,0.859,32047001
7786,RNA,RNA,0.5034,32047001
7787,BM1,disease,0.984,32047001
7788,BM2,disease,0.9907,32047001
7789,BM,disease,0.996,32047001
7790,BM,disease,0.992,32047001
7791,BM,disease,0.99,32047001
7792,dabrafenib,drug,0.999,32047001
7793,trametinib,drug,0.9985,32047001
7794,panitumumab,gene,0.786,32047001
7795,Cancer Cells,cell_type,0.8774,32039027
7796,Cancer,disease,0.6445,32039027
7797,Oncogenic,disease,0.5034,32039027
7798,Rat Sarcoma,species,0.627,32039027
7799,Epidermal Epidermal growth factor receptor,gene,0.994,32039027
7800,EGFR,gene,0.9917,32039027
7801,patients,species,0.896,32039027
7802,metastatic colorectal cancer,disease,0.9995,32039027
7803,oncogenic Rat sarcoma,gene,0.9946,32039027
7804,Rat,species,0.4675,32039027
7805,RAS,gene,0.9946,32039027
7806,patients,species,0.983,32039027
7807,RAS,gene,0.9966,32039027
7808,EGFR,gene,0.9946,32039027
7809,tumor,disease,0.9995,32039027
7810,Ba/F3 cellular model system,cell_line,0.5117,32039027
7811,EGFR,gene,0.9985,32039027
7812,RAS,gene,0.9985,32039027
7813,RAS,gene,0.995,32039027
7814,MAPK,gene,0.9834,32039027
7815,wild-type RAS,DNA,0.612,32039027
7816,wild-type RAS isoforms,gene,0.9956,32039027
7817,EGFR antibodies,gene,0.957,32039027
7818,EGFR antibodies cetuximab,gene,0.791,32039027
7819,panitumumab,gene,0.7944,32039027
7820,cells,cell_type,0.3633,32039027
7821,oncogenic RAS,gene,0.9937,32039027
7822,KRAS G12V,gene,0.995,32039027
7823,G12V,mutation,,32039027
7824,EGFR,gene,0.9507,32039027
7825,mitogen-activated protein-Kinase,gene,0.99,32039027
7826,MAPK,gene,0.986,32039027
7827,EGFR,gene,0.9893,32039027
7828,RAS mutant cells,cell_line,0.9263,32039027
7829,RAS,gene,0.9854,32039027
7830,EGFR antibodies,gene,0.9336,32039027
7831,MAPK,gene,0.982,32039027
7832,oncogenic RAS,gene,0.9956,32039027
7833,RAS mutant tumors,disease,0.9985,32039027
7834,RAS,gene,0.977,32039027
7835,tumor subclones,cell_line,0.9497,32039027
7836,tumor,disease,1.0,32039027
7837,RAS mutant subclones,cell_line,0.9023,32039027
7838,RAS mutant,gene,0.9634,32039027
7839,EGFR,gene,0.9956,32039027
7840,177Lu,drug,0.9937,32022567
7841,Human Breast Cancer Cells,cell_line,0.578,32022567
7842,Breast Cancer,disease,0.999,32022567
7843,HER2,gene,0.9946,32022567
7844,EGFR,gene,0.9834,32022567
7845,HER2,gene,0.996,32022567
7846,breast cancer,disease,1.0,32022567
7847,BC,disease,1.0,32022567
7848,epidermal growth factor receptors,gene,0.998,32022567
7849,EGFR,gene,0.992,32022567
7850,BC,disease,1.0,32022567
7851,AuNPs,cell_type,0.4395,32022567
7852,trastuzumab,gene,0.9907,32022567
7853,TmAb,gene,0.976,32022567
7854,HER2,gene,0.9907,32022567
7855,panitumumab,gene,0.974,32022567
7856,PmAb,gene,0.986,32022567
7857,EGFR,gene,0.9927,32022567
7858,AuNPs,cell_type,0.5317,32022567
7859,poly(ethylene glycol),drug,0.9995,32022567
7860,PEG3k,drug,0.9985,32022567
7861,"1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaceti acid",drug,0.999,32022567
7862,DOTA,drug,0.999,32022567
7863,177Lu,drug,0.996,32022567
7864,177Lu,drug,0.998,32022567
7865,TmAb,gene,0.8716,32022567
7866,177Lu,drug,0.998,32022567
7867,PmAb,gene,0.8594,32022567
7868,177Lu,drug,0.9956,32022567
7869,177Lu,drug,0.996,32022567
7870,human BC cells,cell_line,0.67,32022567
7871,BC,disease,0.9907,32022567
7872,HER2,gene,0.9956,32022567
7873,EGFR,gene,0.986,32022567
7874,PEG5K,drug,0.9985,32022567
7875,TmAb,gene,0.991,32022567
7876,PmAb,gene,0.991,32022567
7877,PEG3k,drug,0.9985,32022567
7878,DOTA,drug,0.9995,32022567
7879,AuNP,cell_type,0.5723,32022567
7880,Au-thiol,drug,0.9473,32022567
7881,lipoic acid,drug,0.996,32022567
7882,AuNP,cell_type,0.4614,32022567
7883,177Lu,drug,0.998,32022567
7884,TmAb,gene,0.9927,32022567
7885,PmAb,gene,0.9863,32022567
7886,MDA-MB-231-H2N,cell_line,0.943,32022567
7887,MDA-MB-468,cell_line,0.953,32022567
7888,BT-474 human BC cells,cell_line,0.94,32022567
7889,BT,cell_type,0.508,32022567
7890,BC,disease,0.975,32022567
7891,"HER2mod/EGFRmod,",cell_line,0.5195,32022567
7892,HER2mod,gene,0.9927,32022567
7893,EGFRmod,gene,0.985,32022567
7894,EGFRhigh,gene,0.994,32022567
7895,HER2neg,cell_line,0.7017,32022567
7896,HER2high,gene,0.9966,32022567
7897,EGFRlow,gene,0.9956,32022567
7898,HER2,gene,0.995,32022567
7899,EGFR,gene,0.993,32022567
7900,BC cells,cell_line,0.812,32022567
7901,BC,disease,0.9985,32022567
7902,177Lu,drug,0.995,32022567
7903,TmAb,gene,0.8267,32022567
7904,177Lu,drug,0.9946,32022567
7905,PmAb,gene,0.7773,32022567
7906,177Lu,drug,0.9795,32022567
7907,177Lu,drug,0.998,32022567
7908,TmAb,gene,0.972,32022567
7909,PmAb,gene,0.9717,32022567
7910,AuNP,cell_type,0.4883,32022567
7911,BC cells,cell_type,0.868,32022567
7912,BC,disease,0.9683,32022567
7913,AuNP,DNA,0.629,32022567
7914,177Lu,drug,0.999,32022567
7915,177Lu,drug,0.998,32022567
7916,BC cells,cell_type,0.898,32022567
7917,AuNP,cell_type,0.4504,32022567
7918,TmAb,gene,0.9634,32022567
7919,177Lu,drug,0.997,32022567
7920,PmAb,gene,0.913,32022567
7921,177Lu,drug,0.996,32022567
7922,177Lu,drug,0.997,32022567
7923,AuNP,cell_type,0.5034,32022567
7924,177Lu,drug,0.9976,32022567
7925,BC cells,cell_type,0.7666,32022567
7926,BC,disease,0.9995,32022567
7927,HER2,gene,0.9946,32022567
7928,EGFR,gene,0.99,32022567
7929,SRT-TmAb,gene,0.996,32022567
7930,177Lu,drug,0.9976,32022567
7931,PmAb,gene,0.9478,32022567
7932,177Lu,drug,0.998,32022567
7933,BC cells,cell_type,0.805,32022567
7934,BC,disease,0.9985,32022567
7935,HER2,gene,0.996,32022567
7936,EGFR,gene,0.985,32022567
7937,177Lu,drug,0.9976,32022567
7938,BC cells,cell_type,0.8745,32022567
7939,DRT,gene,0.9473,32022567
7940,177Lu,drug,0.9976,32022567
7941,SRT-TmAb,gene,0.969,32022567
7942,177Lu,drug,0.997,32022567
7943,PmAb,gene,0.972,32022567
7944,177Lu,drug,0.9976,32022567
7945,BC cells,cell_type,0.8345,32022567
7946,BC,disease,0.811,32022567
7947,177Lu,drug,0.9966,32022567
7948,PmAb,gene,0.9565,32022567
7949,177Lu,drug,0.997,32022567
7950,MDA-MB-231-H2N cells,cell_line,0.594,32022567
7951,H2N,gene,0.4639,32022567
7952,HER2,gene,0.5103,32022567
7953,EGFR,gene,0.996,32022567
7954,177Lu,drug,0.9966,32022567
7955,BT-474 cells,cell_line,0.725,32022567
7956,HER2,gene,0.997,32022567
7957,EGFR,gene,0.995,32022567
7958,TmAb,gene,0.8677,32022567
7959,177Lu,drug,0.997,32022567
7960,PmAb,gene,0.84,32022567
7961,AuNP,cell_type,0.4365,32022567
7962,177Lu,drug,0.9956,32022567
7963,MDA-MB-468 cells,cell_line,0.519,32022567
7964,EGFR,gene,0.9946,32022567
7965,HER2,gene,0.9766,32022567
7966,177Lu,drug,0.996,32022567
7967,PmAb,gene,0.9062,32022567
7968,AuNP,cell_type,0.4956,32022567
7969,177Lu,drug,0.998,32022567
7970,TmAb,gene,0.7026,32022567
7971,AuNP,cell_type,0.4204,32022567
7972,177Lu,drug,0.9976,32022567
7973,AuNP,cell_type,0.4834,32022567
7974,177Lu,drug,0.998,32022567
7975,BC cells,cell_type,0.8716,32022567
7976,BC,disease,0.919,32022567
7977,177Lu,drug,0.998,32022567
7978,BC cells,cell_type,0.8486,32022567
7979,AuNP,DNA,0.4539,32022567
7980,177Lu,drug,0.998,32022567
7981,BC cells,cell_type,0.7246,32022567
7982,BC,disease,0.998,32022567
7983,HER2,gene,0.9946,32022567
7984,EGFR,gene,0.987,32022567
7985,AuNP,DNA,0.4602,32022567
7986,177Lu,drug,0.995,32022567
7987,BC tumors,disease,1.0,32022567
7988,HER2,gene,0.995,32022567
7989,EGFR,gene,0.987,32022567
7990,mice,species,0.958,32022567
7991,tumors,disease,1.0,32022567
7992,HER2,gene,0.9946,32022567
7993,TAS-102,drug,0.98,31999946
7994,bevacizumab,gene,0.6826,31999946
7995,metastatic colorectal cancer,disease,0.999,31999946
7996,TAS-102,drug,0.995,31999946
7997,trifluridine,drug,0.9995,31999946
7998,tipiracil,drug,0.998,31999946
7999,metastatic colorectal cancer,disease,0.997,31999946
8000,TAS-102,drug,0.9956,31999946
8001,bevacizumab,gene,0.8423,31999946
8002,metastatic colorectal cancer,disease,1.0,31999946
8003,TAS-102,drug,0.997,31999946
8004,bevacizumab,gene,0.882,31999946
8005,TAS-102,drug,0.9966,31999946
8006,metastatic colorectal cancer,disease,1.0,31999946
8007,metastatic colorectal,disease,1.0,31999946
8008,cancer,disease,1.0,31999946
8009,metastatic colorectal cancer,disease,1.0,31999946
8010,fluoropyrimidine,drug,0.9995,31999946
8011,irinotecan,drug,0.9995,31999946
8012,oxaliplatin,drug,0.9995,31999946
8013,cetuximab,gene,0.512,31999946
8014,panitumumab,gene,0.6763,31999946
8015,RAS,gene,0.495,31999946
8016,bevacizumab,gene,0.8438,31999946
8017,aflibercept,gene,0.969,31999946
8018,regorafenib,drug,0.9707,31999946
8019,TAS-102,drug,0.998,31999946
8020,bevacizumab,gene,0.712,31999946
8021,RAS,DNA,0.684,31999946
8022,RAS mutation,gene,0.9727,31999946
8023,TAS-102,drug,0.9897,31999946
8024,TAS-102,drug,0.983,31999946
8025,bevacizumab,gene,0.7017,31999946
8026,TAS-102,drug,0.987,31999946
8027,TAS-102,drug,0.9844,31999946
8028,bevacizumab,gene,0.853,31999946
8029,neutropenia,disease,1.0,31999946
8030,TAS-102,drug,0.993,31999946
8031,TAS-102,drug,0.9897,31999946
8032,bevacizumab,gene,0.8687,31999946
8033,TAS-102,drug,0.9536,31999946
8034,TAS-102,drug,0.9336,31999946
8035,bevacizumab,gene,0.9146,31999946
8036,metastatic colorectal cancer,disease,0.999,31999946
8037,TAS-102,drug,0.9966,31999946
8038,bevacizumab,gene,0.751,31999946
8039,TAS-102,drug,0.996,31999946
8040,TAS-102,drug,0.998,31999946
8041,bevacizumab,gene,0.871,31999946
8042,metastatic colorectal cancer,disease,1.0,31999946
8043,oral cancer,disease,1.0,31998640
8044,tumor,disease,0.998,31998640
8045,tumor,disease,0.9995,31998640
8046,patients,species,0.9746,31998640
8047,oral squamous cell carcinoma,disease,1.0,31998640
8048,Panitumumab IRDye800CW,gene,0.8794,31998640
8049,tumor,disease,0.999,31998640
8050,patients,species,0.9736,31998640
8051,patients,species,0.9917,31998640
8052,sentinel,DNA,0.5303,31998640
8053,sentinel,DNA,0.638,31998640
8054,Head and Neck Cancers,disease,1.0,31980465
8055,solid tumors,disease,0.9985,31980465
8056,head and neck cancers,disease,1.0,31980465
8057,tumor,disease,0.9995,31980465
8058,tumor,disease,0.818,31980465
8059,tumor,disease,0.989,31980465
8060,primary tumor,disease,0.9536,31980465
8061,solid tumors,disease,1.0,31980465
8062,Paclitaxel,drug,0.999,31965330
8063,Everolimus,drug,0.9976,31965330
8064,breast cancer,disease,1.0,31965330
8065,BC,disease,1.0,31965330
8066,cancer,disease,0.999,31965330
8067,tumors,disease,1.0,31965330
8068,cancer cells,cell_type,0.856,31965330
8069,cancer,disease,0.9966,31965330
8070,HER2,gene,0.996,31965330
8071,EGFR receptors,gene,0.888,31965330
8072,BC cells,cell_type,0.7515,31965330
8073,BC,disease,,31965330
8074,paclitaxel,drug,0.9995,31965330
8075,PTX,drug,0.9995,31965330
8076,mTOR,gene,0.994,31965330
8077,everolimus,drug,0.9995,31965330
8078,EVER,drug,0.999,31965330
8079,HER2,gene,0.992,31965330
8080,EGFR receptors,gene,0.9165,31965330
8081,BC cells,cell_type,0.8276,31965330
8082,BC,disease,,31965330
8083,antibody Fab fragments,gene,0.8823,31965330
8084,monolayer,cell_line,,31965330
8085,3D BC,cell_line,0.798,31965330
8086,HER2(high)/,cell_line,0.61,31965330
8087,HER2,gene,0.9976,31965330
8088,EGFR,gene,0.9966,31965330
8089,HER2(neg)/EGFR(low,cell_line,0.515,31965330
8090,HER2,gene,0.9956,31965330
8091,EGFR,gene,0.994,31965330
8092,BC cells,cell_type,0.8403,31965330
8093,HER2,gene,0.9956,31965330
8094,HER2(high)/EGFR(mod) monolayer BC cells,cell_line,0.68,31965330
8095,HER2,gene,0.978,31965330
8096,EGFR,gene,0.994,31965330
8097,BC cells,cell_type,0.63,31965330
8098,HER2(neg)/EGFR(low) cells,cell_line,0.649,31965330
8099,HER2(neg),cell_type,0.563,31965330
8100,HER2,gene,0.869,31965330
8101,EGFR(low) cells,cell_type,0.5903,31965330
8102,EGFR,gene,0.9824,31965330
8103,HER2(high)/EGFR(mod) spheroids,cell_line,0.758,31965330
8104,HER2,gene,0.9785,31965330
8105,EGFR,gene,0.9946,31965330
8106,EGFR,gene,0.9795,31965330
8107,2D,cell_line,0.9263,31965330
8108,BC,disease,,31965330
8109,HER2(high)/EGFR(mod) BC cells,cell_line,0.9224,31965330
8110,HER2(high),cell_type,0.4497,31965330
8111,HER2,gene,0.994,31965330
8112,EGFR,gene,0.988,31965330
8113,BC cells,cell_type,0.4592,31965330
8114,BC,disease,,31965330
8115,HER2(neg)/EGFR(low) cells,cell_line,0.9023,31965330
8116,HER2,gene,0.925,31965330
8117,EGFR,gene,0.9556,31965330
8118,HER2(high)/EGFR(mod) cells,cell_line,,31965330
8119,HER2,gene,0.9844,31965330
8120,EGFR,gene,0.95,31965330
8121,HER2,gene,0.9956,31965330
8122,EGFR,gene,0.983,31965330
8123,HER2(high)/EGFR(mod) BC cells,cell_line,0.9536,31965330
8124,HER2(high)/EGFR(mod),cell_type,0.5815,31965330
8125,HER2,gene,0.9927,31965330
8126,EGFR,gene,0.9624,31965330
8127,BC cells,cell_type,0.484,31965330
8128,BC,disease,,31965330
8129,EGFR,gene,0.9946,31965330
8130,HER2,gene,0.989,31965330
8131,BC cells,cell_line,0.966,31965330
8132,BC,disease,,31965330
8133,Cisplatin,drug,0.999,31959339
8134,5-fluorouracil,drug,0.9985,31959339
8135,epidermal growth factor receptor,gene,0.997,31959339
8136,panitumumab,gene,0.548,31959339
8137,oesophageal squamous cell cancer,disease,0.9985,31959339
8138,advanced oesophageal squamous cell cancer,disease,0.9976,31959339
8139,ESCC,disease,1.0,31959339
8140,cisplatin,drug,0.9995,31959339
8141,5-fluorouracil,drug,0.999,31959339
8142,epidermal growth factor receptor,gene,0.9976,31959339
8143,EGFR,gene,0.987,31959339
8144,panitumumab,gene,0.925,31959339
8145,advanced colorectal or squamous cell head and neck cancers,disease,1.0,31959339
8146,PATIENTS,species,0.9253,31959339
8147,ESCC,disease,0.9985,31959339
8148,cisplatin,drug,0.999,31959339
8149,5-fluorouracil,drug,0.997,31959339
8150,cisplatin,drug,0.999,31959339
8151,cisplatin,drug,0.999,31959339
8152,CFP,disease,0.992,31959339
8153,CF,disease,0.9995,31959339
8154,CFP,disease,0.9985,31959339
8155,kidney injury,disease,0.998,31959339
8156,dysphagia,disease,1.0,31959339
8157,CF,RNA,0.4546,31959339
8158,CFP,gene,0.573,31959339
8159,(s)EGFR,gene,0.739,31959339
8160,sEGFR,gene,0.9336,31959339
8161,EGFR,gene,0.858,31959339
8162,EGFR,gene,0.8457,31959330
8163,advanced oesophageal squamous cell carcinoma,disease,1.0,31959330
8164,MEK1,gene,0.636,31949931
8165,metastatic colorectal cancer,disease,0.993,31949931
8166,MEK,gene,0.978,31949931
8167,ERK,gene,0.9277,31949931
8168,MEK1,DNA,0.634,31949931
8169,MEK1 mutations,gene,0.8003,31949931
8170,MEK1,gene,0.992,31949931
8171,pMEK,gene,0.995,31949931
8172,pERK,gene,0.96,31949931
8173,RAF,gene,0.9976,31949931
8174,MEK,gene,0.9883,31949931
8175,MEK,gene,0.9937,31949931
8176,trametinib,drug,0.992,31949931
8177,MEK1,gene,0.501,31949931
8178,Langerhans cell histiocytosis,disease,0.998,31949931
8179,LCH,disease,1.0,31949931
8180,ERK,gene,0.995,31949931
8181,ulixertinib,drug,0.9917,31949931
8182,MEK1 mutated,disease,0.8325,31949931
8183,MEK1,gene,0.5093,31949931
8184,solid tumors,disease,0.9775,31949931
8185,metastatic colon cancer,disease,1.0,31949931
8186,MEK1E102_I103del,DNA,0.614,31949931
8187,MEK1E102,gene,0.998,31949931
8188,MEK,gene,0.9976,31949931
8189,trametinib,drug,0.9883,31949931
8190,ERK,gene,0.998,31949931
8191,ulixertinib,drug,0.988,31949931
8192,ulixertinib,drug,0.9863,31949931
8193,anti-EGFR antibody panitumumab,gene,0.9146,31949931
8194,MEK,gene,0.994,31949931
8195,ERK,gene,0.9883,31949931
8196,MAPK,gene,0.98,31949931
8197,MEK,gene,0.998,31949931
8198,ERK,gene,0.9946,31949931
8199,EGFR,gene,0.956,31949931
8200,colorectal cancer,disease,1.0,31949931
8201,MEK1,DNA,0.502,31949931
8202,MEK1 mutation,gene,0.776,31949931
8203,E102-,DNA,0.4988,31949931
8204,hearing loss,disease,0.9805,31912913
8205,Hearing loss,disease,0.866,31912913
8206,hearing loss,disease,0.9995,31912913
8207,patients,species,0.991,31912913
8208,hearing loss,disease,0.989,31912913
8209,hearing loss,disease,1.0,31912913
8210,hearing loss,disease,0.9985,31912913
8211,salicylate,drug,0.939,31912913
8212,hearing loss,disease,0.998,31912913
8213,azacitidine,drug,0.999,31912913
8214,nevirapine,drug,0.9995,31912913
8215,leflunomide,drug,0.999,31912913
8216,panitumumab,gene,0.882,31912913
8217,vandetanib,drug,0.9966,31912913
8218,hearing loss,disease,1.0,31912913
8219,epidermal growth factor receptor,gene,0.8857,31912793
8220,EGFR,gene,0.9946,31912793
8221,Epidermal growth factor receptor,gene,0.998,31912793
8222,EGFR,gene,0.998,31912793
8223,metastatic colorectal cancer,disease,1.0,31912793
8224,mCRC,disease,1.0,31912793
8225,Anti-,gene,0.743,31912793
8226,EGFR monoclonal antibodies,gene,0.655,31912793
8227,panitumumab,gene,0.6616,31912793
8228,patients,species,0.9683,31912793
8229,RAS,gene,0.992,31912793
8230,BRAF,gene,0.997,31912793
8231,mCRC,disease,0.9966,31912793
8232,EGFR,gene,0.927,31912793
8233,mCRC,disease,0.9946,31912793
8234,EGFR,gene,0.814,31912793
8235,EGFR,gene,0.9844,31912793
8236,mCRC,disease,0.996,31912793
8237,anti-EGFR,gene,0.894,31912793
8238,EGFR,gene,0.9873,31912793
8239,patients,species,0.9854,31912793
8240,EGFR,gene,0.7783,31912793
8241,Cetuximab,gene,0.7954,31912793
8242,KRAS,DNA,0.791,31912793
8243,KRAS,gene,0.989,31912793
8244,patients,species,0.9893,31912793
8245,patients,species,0.978,31912793
8246,EGFR,gene,0.9814,31912793
8247,EGFR,gene,0.724,31912793
8248,EGFR,gene,0.655,31912793
8249,RAS,gene,0.939,31912793
8250,BRAF,gene,0.9937,31912793
8251,mCRC,disease,0.998,31912793
8252,patients,species,0.9907,31912793
8253,Panitumumab,gene,0.807,31902066
8254,panitumumab,gene,0.8853,31902066
8255,fluorouracil,drug,0.9995,31902066
8256,leucovorin,drug,0.9985,31902066
8257,irinotecan,drug,0.9985,31902066
8258,FOLFIRI,drug,0.9526,31902066
8259,wild,DNA,0.5986,31902066
8260,wild-type RAS,gene,0.964,31902066
8261,metastatic colorectal cancer,disease,1.0,31902066
8262,mCRC,disease,1.0,31902066
8263,panitumumab,gene,0.941,31902066
8264,panitumumab,gene,0.8657,31902066
8265,cetuximab,gene,0.972,31902066
8266,panitumumab,gene,0.9106,31902066
8267,FOLFIRI,drug,0.9844,31902066
8268,FOLFIRI,drug,0.9536,31902066
8269,FOLFIRI,drug,0.97,31902066
8270,FOLFIRI,drug,0.967,31902066
8271,panitumumab,gene,0.911,31902066
8272,panitumumab,gene,0.9253,31902066
8273,panitumumab,gene,0.956,31902066
8274,FOLFIRI,drug,0.9023,31902066
8275,panitumumab,gene,0.8794,31902066
8276,panitumumab,gene,0.8906,31902066
8277,FOLFIRI,drug,0.9834,31902066
8278,panitumumab,gene,0.967,31902066
8279,FOLFIRI,drug,0.9844,31902066
8280,mCRC,disease,0.9937,31902066
8281,panitumumab,gene,0.8994,31902066
8282,FOLFIRI,drug,0.81,31902066
8283,anticancer,disease,0.971,31902066
8284,metastatic colorectal cancer,disease,1.0,31898053
8285,fluoropyrimidine,drug,0.991,31898053
8286,metastatic colorectal cancer,disease,1.0,31898053
8287,metastatic colorectal cancer,disease,1.0,31898053
8288,patients,species,0.992,31898053
8289,Sinonasal Cancer,disease,1.0,31854462
8290,sinonasal squamous cell carcinoma,disease,1.0,31854462
8291,human,species,0.991,31854462
8292,human,species,0.992,31854462
8293,squamous,cell_type,0.57,31854462
8294,squamous cell tumors,disease,1.0,31854462
8295,mice,species,0.9844,31854462
8296,Mice,species,0.9604,31854462
8297,panitumumab,gene,0.98,31854462
8298,tumor,disease,0.999,31854462
8299,human,species,0.986,31854462
8300,tumor,disease,0.981,31854462
8301,human,species,0.9785,31854462
8302,tumor,disease,1.0,31854462
8303,5-fluorouracil,drug,0.9995,31851776
8304,mitomycin-C,drug,0.9985,31851776
8305,panitumumab,gene,0.891,31851776
8306,squamous cell carcinomas of the anal canal,disease,0.9727,31851776
8307,panitumumab,gene,0.905,31851776
8308,5-fluorouracil,drug,0.9995,31851776
8309,5-FU,drug,0.999,31851776
8310,mitomycin-C,drug,0.9966,31851776
8311,MMC,drug,0.999,31851776
8312,squamous cell carcinoma of the anal canal,disease,1.0,31851776
8313,SCCAC,disease,1.0,31851776
8314,SCCAC,disease,0.9995,31851776
8315,panitumumab,gene,0.847,31851776
8316,5-FU,drug,0.9966,31851776
8317,MMC,drug,0.993,31851776
8318,primary,disease,0.6616,31851776
8319,mesorectal,DNA,0.4656,31851776
8320,primary tumor,disease,0.686,31851776
8321,radiation skin injury,disease,0.989,31851776
8322,neutropenia,disease,1.0,31851776
8323,toxic,disease,0.595,31851776
8324,human papilloma virus,disease,0.952,31851776
8325,human papilloma,species,0.75,31851776
8326,Panitumumab,gene,0.8955,31851776
8327,MMC,drug,0.9995,31851776
8328,5FU,drug,0.999,31851776
8329,SCCAC,disease,0.992,31851776
8330,MMC,drug,0.997,31851776
8331,5FU,drug,0.997,31851776
8332,SCCAC,disease,0.9995,31851776
8333,oral cavity cancer,disease,0.997,31837576
8334,recurrent and/or metastatic squamous cell carcinoma of the head and neck,disease,0.9976,31837576
8335,R/M-SCCHN,disease,0.9917,31837576
8336,cisplatin,drug,0.9995,31837576
8337,5-fluorouracil,drug,0.999,31837576
8338,taxane,drug,0.996,31837576
8339,cisplatin,drug,1.0,31837576
8340,tumoricidal,disease,0.8745,31837576
8341,carboplatin,drug,0.9995,31837576
8342,epidermal growth factor receptor,gene,0.998,31837576
8343,EGFR,gene,0.997,31837576
8344,cetuximab,gene,0.7017,31837576
8345,platinum,drug,1.0,31837576
8346,5-fluorouracil,drug,0.999,31837576
8347,anti-EGFR monoclonal antibodies,gene,0.9326,31837576
8348,cetuximab,gene,0.846,31837576
8349,panitumumab,gene,0.79,31837576
8350,tumour,disease,0.9756,31837576
8351,primary,disease,0.897,31837576
8352,cancer in the oral cavity,disease,0.936,31837576
8353,anti-programmed cell death protein-1,gene,0.9805,31837576
8354,anti-PD-1,gene,0.994,31837576
8355,KEYNOTE,drug,0.714,31837576
8356,oligometastatic disease,disease,0.972,31837576
8357,cancer,disease,1.0,31837576
8358,RAS Panel,DNA,0.583,31837434
8359,RAS,gene,0.663,31837434
8360,Metastatic Colorectal Cancer,disease,1.0,31837434
8361,formalin,drug,0.753,31837434
8362,paraffin,drug,0.607,31837434
8363,colorectal cancer,disease,1.0,31837434
8364,Extended,DNA,0.354,31837434
8365,RAS Panel,DNA,0.7188,31837434
8366,RAS,gene,0.8735,31837434
8367,panitumumab,gene,0.8345,31837434
8368,TruSeq amplicon,DNA,0.4878,31837434
8369,DNA,DNA,0.515,31837434
8370,KRAS and NRAS genes,DNA,0.7905,31837434
8371,KRAS,gene,0.9824,31837434
8372,NRAS genes,gene,0.9873,31837434
8373,amplicon,DNA,0.7144,31837434
8374,single,DNA,0.4685,31837434
8375,bevacizumab,gene,0.9683,31830075
8376,cetuximab,gene,0.9473,31830075
8377,panitumumab,gene,0.945,31830075
8378,aflibercept,gene,0.9536,31830075
8379,regorafenib,drug,0.981,31830075
8380,metastatic colorectal cancer,disease,0.999,31830075
8381,patient,species,0.9897,31830075
8382,cetuximab,gene,0.849,31830075
8383,bevacizumab,gene,0.7017,31830075
8384,panitumumab,gene,0.812,31830075
8385,aflibercept,gene,0.9814,31830075
8386,regorafenib,drug,0.9907,31830075
8387,epidermal growth factor,gene,0.9976,31803963
8388,papulopustular rash,disease,0.953,31803963
8389,Papulopustular rash,disease,1.0,31803963
8390,acneiform rash,disease,1.0,31803963
8391,epidermal growth factor receptor,gene,0.9985,31803963
8392,EGFRi,gene,0.9863,31803963
8393,rash,disease,0.999,31803963
8394,EGFRi,gene,0.9824,31803963
8395,Staphylococcus aureus,species,0.978,31803963
8396,papulopustular rash,disease,0.9927,31803963
8397,bacterial infection,disease,0.8877,31803963
8398,papulopustular,disease,0.936,31803963
8399,rash,disease,0.833,31803963
8400,EGFRi,gene,0.986,31803963
8401,papulopustular rash,disease,1.0,31803963
8402,EGFR,gene,0.9897,31803963
8403,papulopustular rash,disease,1.0,31803963
8404,methicillin,drug,1.0,31803963
8405,S. aureus,species,0.936,31803963
8406,methicillin,drug,1.0,31803963
8407,S. aureus,species,0.9316,31803963
8408,Staphylococcus species,species,0.7964,31803963
8409,Pseudomonas aeruginosa,species,0.9434,31803963
8410,S. aureus,species,0.9707,31803963
8411,minocycline,drug,0.998,31803963
8412,levofloxacin,drug,0.9795,31803963
8413,papulopustular rash,disease,1.0,31803963
8414,folliculitis,disease,1.0,31803963
8415,EGFRi,gene,0.986,31803963
8416,staphylococcal infection,disease,0.9995,31803963
8417,papulopustular rash,disease,1.0,31803963
8418,EGFR,gene,0.992,31803504
8419,KRAS,gene,0.988,31803504
8420,RAS,gene,0.999,31803504
8421,Metastatic colorectal cancer,disease,1.0,31803504
8422,mCRC,disease,1.0,31803504
8423,right-sided and left-sided tumours,disease,1.0,31803504
8424,Patients,species,0.9727,31803504
8425,KRAS,gene,0.9766,31803504
8426,RAS,gene,0.998,31803504
8427,mCRC,disease,0.9863,31803504
8428,epidermal growth factor receptor,gene,0.998,31803504
8429,EGFR,gene,0.965,31803504
8430,cetuximab,gene,0.9185,31803504
8431,panitumumab,gene,0.9517,31803504
8432,oxaliplatin,drug,0.9995,31803504
8433,irinotecan,drug,0.9976,31803504
8434,Digestive Tumours,disease,0.9995,31803504
8435,primary,disease,0.578,31803504
8436,tumour,disease,0.85,31803504
8437,Patients,species,0.988,31803504
8438,KRAS,gene,0.9937,31803504
8439,patients,species,0.9907,31803504
8440,KRAS,DNA,0.759,31803504
8441,KRAS,gene,0.9966,31803504
8442,sided tumours,disease,0.9473,31803504
8443,RAS-wt populations,cell_line,0.789,31803504
8444,RAS,cell_type,0.423,31803504
8445,RAS-wt,gene,0.8423,31803504
8446,left-sided tumours,disease,1.0,31803504
8447,patients,species,0.9556,31803504
8448,rectum tumours,disease,1.0,31803504
8449,patients,species,0.967,31803504
8450,KRAS,gene,0.984,31803504
8451,RAS,gene,0.998,31803504
8452,mCRC,disease,0.6284,31803504
8453,EGFR,gene,0.994,31803504
8454,right-sided primary tumours,disease,0.9995,31803504
8455,neutrophil,cell_type,0.797,31786848
8456,lymphocyte,cell_type,0.463,31786848
8457,platelet,cell_type,0.6855,31786848
8458,antiEGFR,gene,0.742,31786848
8459,bevacizumab,gene,0.581,31786848
8460,metastatic colorectal cancer,disease,1.0,31786848
8461,neutrophil,cell_type,0.793,31786848
8462,NLR,cell_type,0.4553,31786848
8463,platelet-lymphocyte,cell_type,0.5605,31786848
8464,PLR,cell_type,0.4446,31786848
8465,antiEGFR,gene,0.7715,31786848
8466,bevacizumab,gene,0.7373,31786848
8467,metastatic colorectal cancer,disease,1.0,31786848
8468,metastatic colorectal cancer,disease,1.0,31786848
8469,NLR,cell_type,0.4724,31786848
8470,bevacizumab,gene,0.5957,31786848
8471,cetuximab,gene,0.8696,31786848
8472,panitumumab,gene,0.8286,31786848
8473,bevacizumab,gene,0.8613,31786848
8474,NLR,cell_type,0.463,31786848
8475,NLR,cell_type,0.4678,31786848
8476,NLR,cell_type,0.4932,31786848
8477,NLR,cell_type,0.6,31786848
8478,bevacizumab,gene,0.7134,31786848
8479,antiEGFR,gene,0.961,31786848
8480,bevacizumab,gene,0.5977,31786848
8481,NLR,cell_type,0.5537,31786848
8482,antiEGFR,gene,0.8457,31786848
8483,PLR,gene,0.7896,31786848
8484,miRNA,RNA,0.709,31786833
8485,miRNA -31-3p,gene,0.8765,31786833
8486,miR-31-5p,gene,0.5264,31786833
8487,EGFR,gene,0.737,31786833
8488,wild-type K-RAS,gene,0.957,31786833
8489,miRNAs,RNA,0.701,31786833
8490,Colorectal cancer,disease,1.0,31786833
8491,CRC,disease,1.0,31786833
8492,cancers,disease,1.0,31786833
8493,metastatic colorectal cancer,disease,1.0,31786833
8494,mCRC,disease,1.0,31786833
8495,liver,disease,0.5244,31786833
8496,metastatic colorectal cancer,disease,1.0,31786833
8497,mCRC,disease,1.0,31786833
8498,Cetuximab,gene,0.835,31786833
8499,Bevacizumab,gene,0.669,31786833
8500,K-RAS,gene,0.6914,31786833
8501,microRNAs,RNA,0.7163,31786833
8502,miRNAs,RNA,0.484,31786833
8503,CRC,disease,0.9927,31786833
8504,miR-31-3p,gene,0.529,31786833
8505,miR-31-5p,gene,0.539,31786833
8506,EGFR,gene,0.7583,31786833
8507,miRNA,RNA,0.602,31786833
8508,miRNA-31-3p,gene,0.8413,31786833
8509,miR-31-5p,RNA,0.4868,31786833
8510,CRC,disease,0.999,31786833
8511,K-,disease,0.867,31786833
8512,K-RAS,gene,0.9736,31786833
8513,EGFR,gene,0.9824,31786833
8514,RAS,gene,0.621,31783291
8515,BRAF,gene,0.998,31783291
8516,metastatic colorectal cancer,disease,0.997,31783291
8517,metastatic colorectal cancer,disease,0.9985,31783291
8518,mCRC,disease,0.9995,31783291
8519,rat sarcoma,gene,0.8145,31783291
8520,rat,species,0.8223,31783291
8521,sarcoma,disease,0.7188,31783291
8522,RAS,gene,0.954,31783291
8523,mCRC,disease,0.998,31783291
8524,bevacizumab,gene,0.8335,31783291
8525,panitumumab,gene,0.911,31783291
8526,cetuximab,gene,0.635,31783291
8527,panitumumab,gene,0.924,31783291
8528,cetuximab,gene,0.861,31783291
8529,RAS,gene,0.629,31783291
8530,mCRC,disease,0.9985,31783291
8531,bevacizumab,gene,0.7544,31783291
8532,cetuximab,gene,0.797,31783291
8533,Cetuximab,gene,0.742,31783291
8534,panitumumab,gene,0.7866,31783291
8535,RAS,DNA,0.638,31783291
8536,RAS WT,gene,0.839,31783291
8537,mCRC,disease,0.998,31783291
8538,Bevacizumab,gene,0.8555,31783291
8539,mCRC,disease,0.9946,31783291
8540,GC1118,drug,0.9546,31771279
8541,Anti-EGFR Antibody,gene,0.9697,31771279
8542,KRAS,gene,0.9834,31771279
8543,Colorectal Cancer,disease,0.9883,31771279
8544,Epidermal growth factor receptor,gene,0.9985,31771279
8545,EGFR,gene,0.998,31771279
8546,cetuximab,gene,0.725,31771279
8547,panitumumab,gene,0.8555,31771279
8548,metastatic colorectal cancer,disease,1.0,31771279
8549,mCRC,disease,1.0,31771279
8550,mCRC,disease,0.9995,31771279
8551,wild-type KRAS GTPase,gene,0.9976,31771279
8552,GC1118,drug,0.6577,31771279
8553,humanized,species,0.826,31771279
8554,high-affinity EGFR,gene,0.899,31771279
8555,CRC patient-derived xenografts,cell_line,0.613,31771279
8556,CRC,disease,1.0,31771279
8557,PDXs,cell_line,0.689,31771279
8558,KRAS mutants,gene,0.587,31771279
8559,high-affinity EGFR,gene,0.9946,31771279
8560,wild-type KRAS,gene,0.703,31771279
8561,KRAS-mutant CRCPDXs,cell_line,0.711,31771279
8562,KRAS,gene,0.9927,31771279
8563,GC1118,drug,0.9507,31771279
8564,cetuximab,gene,0.578,31771279
8565,wild-,cell_line,0.7847,31771279
8566,wild-type KRAS,gene,0.969,31771279
8567,phosphatidylinositol,drug,0.9976,31771279
8568,phosphatidylinositol-3-kinase,gene,0.9937,31771279
8569,PI3K,gene,0.9956,31771279
8570,AKT,gene,0.996,31771279
8571,GC1118,drug,0.989,31771279
8572,anti-,disease,0.831,31771279
8573,cancer,disease,0.4893,31771279
8574,CRC PDX,cell_line,0.6904,31771279
8575,CRC,disease,0.999,31771279
8576,KRAS,gene,0.6377,31771279
8577,AKT,gene,0.995,31771279
8578,GC1118,drug,0.987,31771279
8579,PI3K,gene,0.999,31771279
8580,mammalian target of,gene,0.9575,31771279
8581,rapamycin,drug,0.993,31771279
8582,mTOR,gene,0.9985,31771279
8583,AKT,gene,0.999,31771279
8584,BEZ-235,drug,0.973,31771279
8585,GC1118,drug,0.989,31771279
8586,PI3K,gene,0.9946,31771279
8587,mTOR,gene,0.993,31771279
8588,AKT,gene,0.9985,31771279
8589,KRAS,gene,0.995,31771279
8590,mutant mCRC,cell_line,0.619,31771279
8591,mCRC,disease,0.6216,31771279
8592,EGFR,gene,0.993,31771279
8593,PI3K,gene,0.9956,31771279
8594,AKT,gene,0.9956,31771279
8595,RAS,gene,0.5234,31762802
8596,metastatic colon cancer,disease,0.9634,31762802
8597,anti-EGFR,gene,0.9556,31762802
8598,anti-,gene,0.6143,31762802
8599,VEGF,gene,0.5327,31762802
8600,metastatic colon cancer,disease,1.0,31762802
8601,mCC,disease,1.0,31762802
8602,tumor,disease,0.8506,31762802
8603,anti-EGFR,gene,0.9907,31762802
8604,Cetuximab,gene,0.834,31762802
8605,Panitumumab,gene,0.835,31762802
8606,Bevacizumab,gene,0.779,31762802
8607,RAS,gene,0.983,31762802
8608,mCC,disease,0.9863,31762802
8609,RAS,gene,0.5693,31762802
8610,mCC,disease,0.9995,31762802
8611,anti-,gene,0.5195,31762802
8612,EGFRs,gene,0.8496,31762802
8613,Bevacizumab,gene,0.5684,31762802
8614,tumor,disease,0.974,31762802
8615,colon cancer,disease,0.9995,31762802
8616,LCC,disease,0.992,31762802
8617,LCC,disease,1.0,31762802
8618,RCC,disease,0.9995,31762802
8619,Cetuximab,gene,0.8867,31762802
8620,Panitumumab,gene,0.871,31762802
8621,Bevacizumab,gene,0.69,31762802
8622,tumor,disease,0.562,31762802
8623,LCC,disease,1.0,31762802
8624,Cetuximab,gene,0.8936,31762802
8625,Panitumumab,gene,0.8384,31762802
8626,RCC,disease,0.9995,31762802
8627,RAS,DNA,0.583,31762802
8628,RAS wt,gene,0.77,31762802
8629,mCC,disease,0.9985,31762802
8630,LCC,disease,1.0,31762802
8631,RCC,disease,0.4502,31762802
8632,EGFR,gene,0.9214,31762802
8633,Bevacizumab,gene,0.558,31762802
8634,psoriasis,disease,1.0,31762004
8635,metastatic colon cancer,disease,0.999,31762004
8636,panitumumab,gene,0.919,31762004
8637,cutaneous squamous cell carcinoma,disease,1.0,31747091
8638,Cutaneous squamous cell carcinoma,disease,1.0,31747091
8639,cSCC,disease,1.0,31747091
8640,skin cancers,disease,1.0,31747091
8641,cSCCs,disease,1.0,31747091
8642,genes,DNA,0.4958,31747091
8643,TP53,gene,0.9966,31747091
8644,CDKN2A,DNA,0.8564,31747091
8645,CDKN2A,gene,0.991,31747091
8646,NOTCH1,gene,0.9976,31747091
8647,NOTCH2,DNA,0.8687,31747091
8648,NOTCH2,gene,0.998,31747091
8649,EGFR,gene,0.9937,31747091
8650,TERT,DNA,0.729,31747091
8651,TERT,gene,0.9917,31747091
8652,RAS,gene,0.995,31747091
8653,RAF,gene,0.9985,31747091
8654,MEK,gene,0.9985,31747091
8655,ERK,gene,0.995,31747091
8656,PI3K,gene,0.9966,31747091
8657,AKT,gene,0.9985,31747091
8658,mTOR,gene,0.998,31747091
8659,cSCC,disease,0.998,31747091
8660,TP53,gene,0.997,31747091
8661,CDKN2A,DNA,0.812,31747091
8662,CDKN2A,gene,0.9844,31747091
8663,cSCC,cell_line,0.4897,31747091
8664,cSCC,cell_type,0.594,31747091
8665,cSCC,disease,0.9956,31747091
8666,NOTCH,gene,0.993,31747091
8667,tumour,disease,1.0,31747091
8668,EGFR,gene,0.9854,31747091
8669,cetuximab,gene,0.9556,31747091
8670,panitumumab,gene,0.8257,31747091
8671,tyrosine,drug,0.934,31747091
8672,tyrosine kinase,gene,0.6807,31747091
8673,erlotinib,drug,0.998,31747091
8674,gefitinib,drug,0.9907,31747091
8675,dasatinib,drug,0.985,31747091
8676,cSCC,disease,0.899,31747091
8677,cemiplimab,gene,0.7686,31747091
8678,cSCC,disease,0.6377,31747091
8679,PD1,gene,0.9976,31747091
8680,PD-L1,gene,0.999,31747091
8681,cSCC,disease,0.9995,31747091
8682,PTEN,gene,0.978,31717544
8683,Colorectal Cancer,disease,1.0,31717544
8684,colorectal cancer,disease,1.0,31717544
8685,CRC,disease,1.0,31717544
8686,RAS,gene,0.9956,31717544
8687,BRAF,gene,0.9897,31717544
8688,cancer,disease,1.0,31717544
8689,PTEN,gene,0.996,31717544
8690,phosphatase and tensin homologue,gene,0.9985,31717544
8691,tumor,disease,1.0,31717544
8692,cetuximab,gene,0.83,31717544
8693,panitumumab,gene,0.727,31717544
8694,epidermal growth factor receptor,gene,0.9985,31717544
8695,EGFR,gene,0.9966,31717544
8696,PTEN,gene,0.991,31717544
8697,tumor,disease,1.0,31717544
8698,tumor,disease,1.0,31717544
8699,cancer,disease,1.0,31717544
8700,PI3K,gene,0.998,31717544
8701,Akt,gene,0.9927,31717544
8702,cancer,disease,1.0,31717544
8703,PTEN,gene,0.9863,31717544
8704,PTEN,gene,0.995,31717544
8705,CRC,disease,0.9966,31717544
8706,KRAS,gene,0.961,31711486
8707,NRAS,gene,0.982,31711486
8708,BRAF,DNA,0.7695,31711486
8709,BRAF mutations,gene,0.938,31711486
8710,metastatic colorectal cancers,disease,1.0,31711486
8711,Patients,species,0.9062,31711486
8712,metastatic colorectal cancer,disease,1.0,31711486
8713,EGFR,gene,0.9214,31711486
8714,cetuximab,gene,0.8975,31711486
8715,panitumumab,gene,0.902,31711486
8716,colorectal cancers,disease,1.0,31711486
8717,"KRAS, NRAS and BRAF genes",DNA,0.592,31711486
8718,KRAS,gene,0.969,31711486
8719,NRAS,gene,0.9717,31711486
8720,BRAF genes,gene,0.9854,31711486
8721,EGFR,gene,0.7524,31711486
8722,patients,species,0.987,31711486
8723,KRAS,gene,0.984,31711486
8724,NRAS,gene,0.982,31711486
8725,BRAF,gene,0.9946,31711486
8726,PCR products,DNA,0.5303,31711486
8727,formalin,drug,0.962,31711486
8728,KRAS,DNA,0.8184,31711486
8729,KRAS mutations,gene,0.959,31711486
8730,BNA,DNA,0.7915,31711486
8731,NRAS,gene,0.9937,31711486
8732,KRAS,gene,0.985,31711486
8733,NRAS mutations,gene,0.9663,31711486
8734,BNA,DNA,0.8174,31711486
8735,BRAF,DNA,0.7363,31711486
8736,BRAF mutations,gene,0.75,31711486
8737,tumor samples,cell_type,0.459,31711486
8738,tumor,disease,1.0,31711486
8739,BNA,DNA,0.87,31711486
8740,KRAS,gene,0.973,31711486
8741,NRAS,gene,0.98,31711486
8742,BRAF,gene,0.9907,31711486
8743,Panitumumab,gene,0.76,31708664
8744,pulmonary toxicity,disease,0.956,31708664
8745,EGFR,gene,0.9907,31708664
8746,cancer,disease,0.999,31708664
8747,epidermal growth factor receptor,gene,0.999,31708664
8748,egfr,gene,0.998,31708664
8749,cancers,disease,1.0,31708664
8750,anti-,gene,0.847,31708664
8751,egfr antibodies,gene,0.817,31708664
8752,cancers of the head and neck,disease,1.0,31708664
8753,metastatic colorectal cancers,disease,0.935,31708664
8754,egfr,gene,0.9077,31708664
8755,men,species,0.864,31708664
8756,panitumumab,gene,0.879,31708664
8757,pulmonary toxicity,disease,0.854,31708664
8758,woman,species,0.926,31708664
8759,head and neck cancer,disease,1.0,31695030
8760,solid tumors,disease,0.9995,31695030
8761,LNs,cell_type,0.503,31695030
8762,tumor,disease,0.924,31695030
8763,panitumumab,gene,0.9575,31695030
8764,head and neck cancer,disease,1.0,31695030
8765,benign,cell_type,0.4827,31695030
8766,head and neck cancer,disease,1.0,31695030
8767,ovarian metastasis,disease,0.774,31689847
8768,rectal cancer,disease,1.0,31689847
8769,Ovarian metastases,disease,0.999,31689847
8770,rectal cancer,disease,1.0,31689847
8771,PATIENTS,species,0.9434,31689847
8772,woman,species,0.935,31689847
8773,abdominal pain,disease,0.979,31689847
8774,carbohydrate,drug,0.9985,31689847
8775,carbohydrate antigen 19,gene,0.9834,31689847
8776,Ca19,gene,0.992,31689847
8777,carbohydrate,drug,0.9976,31689847
8778,carbohydrate antigen 125,gene,0.9863,31689847
8779,Ca125,gene,0.991,31689847
8780,metastatic tumor,disease,0.9995,31689847
8781,colon adenocarcinoma,disease,1.0,31689847
8782,primary ovarian cancer,disease,0.9956,31689847
8783,metastatic tumor,disease,0.998,31689847
8784,ovarian metastasis,disease,0.7563,31689847
8785,rectal cancer,disease,1.0,31689847
8786,FOLFOX,drug,0.914,31689847
8787,panitumumab,gene,0.7456,31689847
8788,ovarian tumors,disease,0.9937,31689847
8789,ovarian metastatic tumors,disease,1.0,31689847
8790,EGFR,gene,0.993,31678702
8791,metastatic colorectal cancer,disease,1.0,31678702
8792,metastatic colorectal cancer,disease,1.0,31678702
8793,mCRC,disease,1.0,31678702
8794,epidermal growth factor receptor,gene,0.998,31678702
8795,EGFR,gene,0.9946,31678702
8796,cetuximab,gene,0.882,31678702
8797,panitumumab,gene,0.835,31678702
8798,patient,species,0.9824,31678702
8799,RAS,DNA,0.7773,31678702
8800,RAS mutation,gene,0.7905,31678702
8801,mCRC,disease,0.997,31678702
8802,EGFR,gene,0.9966,31678702
8803,cancer cells,cell_type,0.7993,31678702
8804,cancer,disease,0.9995,31678702
8805,RAS,gene,0.9966,31678702
8806,RAF,gene,0.999,31678702
8807,MAPK,gene,0.9966,31678702
8808,patients,species,0.972,31678702
8809,EGFR,gene,0.9907,31678702
8810,EGFR,gene,0.9946,31678702
8811,mCRC,disease,0.9927,31678702
8812,free (cf)-DNA,DNA,0.681,31678702
8813,Tumor,disease,0.675,31676575
8814,Patients,species,0.98,31676575
8815,colorectal cancer,disease,1.0,31676575
8816,patients,species,0.9863,31676575
8817,tumor,disease,1.0,31676575
8818,metastatic colorectal cancer,disease,1.0,31676575
8819,mCRC,disease,1.0,31676575
8820,patients,species,0.966,31676575
8821,tumor,disease,1.0,31676575
8822,liver metastatic lesions,disease,0.808,31676575
8823,mCRC,disease,1.0,31676575
8824,patients,species,0.992,31676575
8825,patient,species,0.983,31676575
8826,patients,species,0.9956,31676575
8827,tumor,disease,1.0,31676575
8828,patient,species,0.9585,31676575
8829,resistant subclones,cell_line,0.9316,31676575
8830,patients,species,0.9507,31676575
8831,resistant subclones,cell_line,0.869,31676575
8832,patient,species,0.938,31676575
8833,patients,species,0.9897,31676575
8834,patient,species,0.9497,31676575
8835,mCRC,disease,0.9985,31676575
8836,patients,species,0.992,31676575
8837,mCRC,disease,0.999,31676575
8838,patients,species,0.9883,31676575
8839,patient,species,0.9893,31676575
8840,MicroRNA-425,RNA,0.5503,31673240
8841,MicroRNA-425-5p,gene,0.896,31673240
8842,BRAF,gene,0.9976,31673240
8843,RAS,gene,0.998,31673240
8844,MAPK,gene,0.996,31673240
8845,Colorectal Cancers,disease,1.0,31673240
8846,Colorectal cancer,disease,1.0,31673240
8847,CRC,disease,1.0,31673240
8848,cancer,disease,1.0,31673240
8849,EGFR,gene,0.7354,31673240
8850,patients,species,0.9883,31673240
8851,KRAS,DNA,0.785,31673240
8852,KRAS-mutations,gene,0.844,31673240
8853,tumor tissue,cell_type,0.492,31673240
8854,tumor,disease,1.0,31673240
8855,KRAS,gene,0.9956,31673240
8856,CRC,disease,0.9756,31673240
8857,patients,species,0.99,31673240
8858,cetuximab,gene,0.8984,31673240
8859,panitumumab,gene,0.8794,31673240
8860,MiRNAs,RNA,0.4954,31673240
8861,CRC,disease,0.999,31673240
8862,patients,species,0.993,31673240
8863,miRNA,RNA,0.6357,31673240
8864,anti-EGFR,gene,0.7295,31673240
8865,miRNA,RNA,0.5596,31673240
8866,KRAS,gene,0.992,31673240
8867,CRC,disease,0.8022,31673240
8868,KRAS,gene,0.991,31673240
8869,CRC,disease,0.9824,31673240
8870,NCT,cell_type,0.692,31673240
8871,miR,RNA,0.6387,31673240
8872,miR-425-5p,gene,0.912,31673240
8873,KRAS,gene,0.986,31673240
8874,CRC,disease,0.9536,31673240
8875,KRAS,gene,0.9565,31673240
8876,CRC,disease,0.883,31673240
8877,NCT,cell_type,0.693,31673240
8878,miR,RNA,0.5103,31673240
8879,miR-425,gene,0.9507,31673240
8880,target genes,DNA,0.845,31673240
8881,KRAS,cell_line,0.493,31673240
8882,KRAS-mutated CRC,disease,0.897,31673240
8883,KRAS,gene,0.9937,31673240
8884,KRAS-wildtype CRC,disease,0.9175,31673240
8885,KRAS,gene,0.9883,31673240
8886,miR-425,DNA,0.4976,31673240
8887,miR,RNA,0.6646,31673240
8888,miR-425-5p,gene,0.963,31673240
8889,targeted genes,DNA,0.616,31673240
8890,EGFR tyrosine kinase,gene,0.9,31673240
8891,miR-425-,gene,0.881,31673240
8892,5p,DNA,0.869,31673240
8893,KRAS,gene,0.994,31673240
8894,CRC,disease,0.9956,31673240
8895,miR-31-,RNA,0.5024,31673240
8896,miR-31-5p,gene,0.7183,31673240
8897,miR-625-5p,gene,0.705,31673240
8898,miR-579,RNA,0.5303,31673240
8899,miR-579,gene,0.54,31673240
8900,CRC,disease,0.9985,31673240
8901,NCT,cell_type,0.677,31673240
8902,miR-425-5p,gene,0.937,31673240
8903,oncogene,DNA,0.689,31673240
8904,KRAS,gene,0.969,31673240
8905,CRC,disease,0.9995,31673240
8906,Carbohydrate Antigen 19-9,gene,0.995,31655804
8907,Tumor,disease,0.9995,31655804
8908,Polaprezinc,drug,0.9946,31655804
8909,Deep Vein Thrombosis,disease,1.0,31655804
8910,Colon Cancer,disease,1.0,31655804
8911,Carbohydrate antigen 19-9,gene,0.998,31655804
8912,CA 19-9,gene,0.986,31655804
8913,adenocarcinoma,disease,1.0,31655804
8914,cancer,disease,1.0,31655804
8915,CA 19-9,gene,0.9663,31655804
8916,biliary tract obstruction,disease,1.0,31655804
8917,cholangitis,disease,1.0,31655804
8918,CA 19-9,gene,0.9644,31655804
8919,CPT-11,drug,0.9985,31655804
8920,irinotecan,drug,0.9995,31655804
8921,panitumumab,gene,0.7817,31655804
8922,stage IV cancer of the ascending colon,disease,0.99,31655804
8923,dysgeusia,disease,0.9995,31655804
8924,polaprezinc,drug,0.9956,31655804
8925,polaprezinc,drug,0.991,31655804
8926,CA 19-9,gene,0.9766,31655804
8927,deep vein thrombosis,disease,1.0,31655804
8928,DVT,disease,0.9883,31655804
8929,polaprezinc,drug,0.999,31655804
8930,CA 19-9,gene,0.9717,31655804
8931,polaprezinc,drug,0.999,31655804
8932,CA 19-9,gene,0.986,31655804
8933,DVT,disease,0.9507,31655804
8934,CA 19-9,gene,0.992,31655804
8935,panitumumab,gene,0.7305,31646791
8936,metastatic colorectal cancer,disease,1.0,31646791
8937,Panitumumab,gene,0.7173,31646791
8938,anti-,gene,0.862,31646791
8939,epithelial growth factor receptor,gene,0.911,31646791
8940,EGFR,gene,0.9785,31646791
8941,wild,DNA,0.5176,31646791
8942,wild-type KRAS,gene,0.9634,31646791
8943,metastatic colorectal cancer,disease,1.0,31646791
8944,mCRC,disease,1.0,31646791
8945,panitumumab,gene,0.918,31646791
8946,mCRC,disease,0.999,31646791
8947,panitumumab,gene,0.8496,31646791
8948,patients,species,0.9707,31646791
8949,mCRC,disease,0.9976,31646791
8950,mCRC,disease,0.9985,31646791
8951,patients,species,0.9897,31646791
8952,panitumumab,gene,0.9375,31646791
8953,panitumumab,gene,0.901,31646791
8954,patients,species,0.9634,31646791
8955,panitumumab,gene,0.9497,31646791
8956,irinotecan,drug,0.997,31646791
8957,panitumumab,gene,0.9546,31646791
8958,cetuximab,gene,0.887,31646791
8959,OS,disease,,31646791
8960,panitumumab,gene,0.934,31646791
8961,mCRC,disease,0.9893,31646791
8962,patients,species,0.99,31646791
8963,patients,species,0.9883,31646791
8964,panitumumab,gene,0.8125,31646791
8965,mCRC,disease,0.999,31646791
8966,Panitumumab,gene,0.7886,31643510
8967,Panitumumab,gene,0.6235,31643510
8968,human,species,0.7573,31643510
8969,epidermal growth factor (EGF) receptor,gene,0.991,31643510
8970,metastatic colorectal cancer,disease,0.9956,31643510
8971,Panitumumab,gene,0.6997,31643510
8972,liver injury,disease,0.999,31643510
8973,colorectal cancer,disease,1.0,31633039
8974,UGT1A1*28,gene,0.685,31633039
8975,irinotecan,drug,0.991,31633039
8976,epidermal growth factor receptor,gene,0.997,31633039
8977,EGFR,gene,0.995,31633039
8978,KRAS Proto-Oncogene,gene,0.754,31633039
8979,KRAS,gene,0.5312,31633039
8980,exon 2,DNA,0.4565,31633039
8981,cetuximab,gene,0.9453,31633039
8982,panitumumab,gene,0.921,31633039
8983,metastatic colorectal cancer,disease,0.9995,31633039
8984,CRC,disease,1.0,31633039
8985,KRAS exon 3/4,gene,0.83,31633039
8986,B-Raf Proto-Oncogene,gene,0.8853,31633039
8987,NRAF,gene,0.633,31633039
8988,PIK3CA,gene,0.66,31633039
8989,PETN,gene,0.771,31633039
8990,pharmacogenetic,DNA,0.4988,31633039
8991,anticancer,disease,0.991,31633039
8992,primary tumor cells,cell_type,0.868,31633039
8993,primary tumor,disease,0.87,31633039
8994,3'-Deoxy,drug,0.844,31633039
8995,3'-18F-fluorothymidine,drug,0.9985,31633039
8996,circulating tumor DNA,DNA,0.8345,31633039
8997,ctDNA,DNA,0.7954,31633039
8998,CRC,disease,0.9985,31633039
8999,EGFR,gene,0.9917,31624638
9000,Colorectal Cancer,disease,1.0,31624638
9001,Colorectal cancer,disease,1.0,31624638
9002,CRC,disease,1.0,31624638
9003,cancer,disease,1.0,31624638
9004,CRC,disease,1.0,31624638
9005,CRC,disease,0.9985,31624638
9006,epidermal growth factor receptor,gene,0.997,31624638
9007,EGFR,gene,0.9917,31624638
9008,CRC,disease,0.999,31624638
9009,EGFR pathway,gene,0.7476,31624638
9010,tumor,disease,1.0,31624638
9011,EGFR,gene,0.9937,31624638
9012,CRC,disease,0.9995,31624638
9013,cetuximab,gene,0.8794,31624638
9014,panitumumab,gene,0.7505,31624638
9015,metastatic colorectal cancer,disease,1.0,31624638
9016,KRAS wild-type gene,gene,0.927,31624638
9017,EGFR,gene,0.9897,31624638
9018,cetuximab,gene,0.9414,31624638
9019,panitumumab,gene,0.914,31624638
9020,skin toxicity,disease,0.7334,31624638
9021,bacterial infections,disease,1.0,31624638
9022,staphylococcal infection,disease,1.0,31624638
9023,skin peeling,disease,1.0,31624638
9024,cellulite,disease,1.0,31624638
9025,erysipelas,disease,1.0,31624638
9026,Staphylococcus sepsis,disease,1.0,31624638
9027,anti-EGFR,gene,0.6626,31624638
9028,metastatic CRC,disease,0.9995,31624638
9029,gene,DNA,0.5186,31624638
9030,skin,disease,0.602,31624638
9031,Cetuximab,gene,0.921,31616627
9032,Panitumumab,gene,0.796,31616627
9033,Colorectal Cancer,disease,1.0,31616627
9034,Solid Tumors,disease,1.0,31616627
9035,Cetuximab,gene,0.7993,31616627
9036,panitumumab,gene,0.732,31616627
9037,epidermal growth factor receptor,gene,0.9976,31616627
9038,EGFR,gene,0.99,31616627
9039,RAS,gene,0.5444,31616627
9040,immunoglobulin (Ig) G1 isotype mAb,gene,0.992,31616627
9041,cetuximab,gene,0.8135,31616627
9042,natural killer cells,cell_type,0.7314,31616627
9043,tumor,disease,0.9956,31616627
9044,dendritic cell,cell_type,0.815,31616627
9045,Panitumumab,gene,0.783,31616627
9046,IgG2 isotype mAb,gene,0.995,31616627
9047,EGFR,gene,0.995,31616627
9048,cetuximab,gene,0.888,31616627
9049,colorectal cancer,disease,0.9614,31616627
9050,FOLFOXIRI,drug,0.832,31609637
9051,Panitumumab,gene,0.7783,31609637
9052,RAS Wild-Type Metastatic Colorectal Cancer,disease,0.87,31609637
9053,RAS,gene,0.6333,31609637
9054,KRK0109,DNA,0.423,31609637
9055,panitumumab,gene,0.81,31609637
9056,fluorouracil,drug,0.9995,31609637
9057,folinic acid,drug,0.9985,31609637
9058,oxaliplatin,drug,0.9995,31609637
9059,irinotecan,drug,0.999,31609637
9060,FOLFOXIRI,drug,0.6074,31609637
9061,RAS,gene,0.9893,31609637
9062,metastatic colorectal cancer,disease,0.9146,31609637
9063,PATIENTS,species,0.963,31609637
9064,panitumumab,gene,0.8843,31609637
9065,panitumumab,gene,0.948,31609637
9066,panitumumab,gene,0.9,31609637
9067,panitumumab,gene,0.967,31609637
9068,panitumumab,gene,0.874,31609637
9069,RAS,DNA,0.7183,31609637
9070,RAS WT,gene,0.837,31609637
9071,metastatic colorectal cancer,disease,1.0,31609637
9072,panitumumab,gene,0.8887,31609637
9073,Localized biphasic malignant peritoneal mesothelioma,disease,0.9966,31602554
9074,rectal tumor,disease,1.0,31602554
9075,tumor,disease,0.512,31602554
9076,tumor,disease,0.571,31602554
9077,splenic and,disease,0.7983,31602554
9078,spindle,cell_type,0.4937,31602554
9079,spindle cell carcinoma,disease,1.0,31602554
9080,spindle cell carcinoma of the rectum,disease,1.0,31602554
9081,panitumumab,gene,0.814,31602554
9082,biphasic malignant peritoneal mesothelioma,disease,0.9956,31602554
9083,malignant peritoneal mesothelioma,disease,1.0,31602554
9084,colorectal tumor,disease,1.0,31602554
9085,malignant peritoneal mesothelioma,disease,1.0,31602554
9086,colorectal tumors,disease,1.0,31602554
9087,anti-EGFR monoclonal antibodies,gene,0.7773,31596544
9088,RAS,gene,0.6743,31596544
9089,metastatic colorectal cancer,disease,0.9326,31596544
9090,anti-epidermal growth factor receptor,gene,0.9937,31596544
9091,EGFR,gene,0.9883,31596544
9092,RAS,gene,0.6953,31596544
9093,metastasized colorectal cancer,disease,1.0,31596544
9094,RAS,DNA,0.524,31596544
9095,RAS WT,gene,0.825,31596544
9096,metastatic colorectal cancer,disease,1.0,31596544
9097,mCRC,disease,1.0,31596544
9098,anti-,gene,0.6245,31596544
9099,EGFR,gene,0.563,31596544
9100,RAS,DNA,0.7646,31596544
9101,RAS WT,gene,0.884,31596544
9102,mCRC,disease,0.9985,31596544
9103,oxaliplatin,drug,0.9995,31596544
9104,anti-EGFR,gene,0.9546,31596544
9105,anti-EGFR,gene,0.8853,31596544
9106,FOLFOLX,drug,0.9785,31596544
9107,irinotecan,drug,0.9995,31596544
9108,anti-EGFR MoAbs,gene,0.8623,31596544
9109,Anti-,gene,0.7656,31596544
9110,EGFR MoAbs,gene,0.5586,31596544
9111,irinotecan,drug,0.9966,31596544
9112,FOLFOX,drug,0.9917,31596544
9113,RAS,gene,0.981,31596544
9114,wild,cell_line,0.4722,31596544
9115,mCRC,disease,0.979,31596544
9116,anti-EGFR MoAbs,gene,0.804,31596544
9117,oxaliplatin,drug,0.9995,31596544
9118,Anti-,gene,0.8306,31596544
9119,EGFR,gene,0.5493,31596544
9120,RAS,DNA,0.6953,31596544
9121,RAS wild type,gene,0.954,31596544
9122,Colorectal Cancer,disease,1.0,31584925
9123,cancer,disease,1.0,31584925
9124,colorectal cancer,disease,1.0,31584925
9125,CRC,disease,1.0,31584925
9126,CRC,disease,1.0,31584925
9127,5-fluorouracil,drug,0.9995,31584925
9128,5-FU,drug,0.9995,31584925
9129,oxaliplatin,drug,1.0,31584925
9130,capecitabine,drug,0.9995,31584925
9131,irinotecan,drug,0.9995,31584925
9132,bevacizumab,gene,0.634,31584925
9133,cetuximab,gene,0.6616,31584925
9134,panitumumab,gene,0.6963,31584925
9135,irinotecan,drug,0.996,31584925
9136,irinotecan,drug,0.998,31584925
9137,capecitabine,drug,0.999,31584925
9138,5-FU,drug,0.997,31584925
9139,panitumumab,gene,0.795,31584925
9140,CRC,disease,0.9995,31584925
9141,IRDye800CW,drug,0.722,31571335
9142,patients,species,0.9585,31571335
9143,head and neck squamous cell carcinoma,disease,1.0,31571335
9144,panitumumab,gene,0.9053,31571335
9145,IRDye800CW,DNA,0.6353,31571335
9146,patients,species,0.9844,31571335
9147,tumor,disease,0.9995,31571335
9148,normal,cell_type,0.4575,31571335
9149,tumor,disease,0.999,31571335
9150,normal tissue,cell_type,0.5176,31571335
9151,tumor,disease,1.0,31571335
9152,Metastatic Colorectal Cancer,disease,1.0,31570462
9153,metastatic colorectal cancer,disease,1.0,31570462
9154,mCRC,disease,1.0,31570462
9155,wild-type RAS,gene,0.83,31570462
9156,PATIENTS,species,0.971,31570462
9157,cetuximab,gene,0.773,31570462
9158,panitumumab,gene,0.7925,31570462
9159,bevacizumab,gene,0.88,31570462
9160,right-sided tumours,disease,1.0,31570462
9161,R-CRC,disease,0.9927,31570462
9162,anti-EGFR mAbs,gene,0.9526,31570462
9163,bevacizumab,gene,0.632,31570462
9164,L-CRC,disease,0.9995,31570462
9165,anti-EGFR mAbs,gene,0.9717,31570462
9166,R-CRC,disease,0.997,31570462
9167,anti-EGFR mAbs,gene,0.9663,31570462
9168,bevacizumab,gene,0.9595,31570462
9169,anti-EGFR mAbs,gene,0.96,31570462
9170,L-CRC,disease,0.9995,31570462
9171,R-CRC,disease,0.996,31570462
9172,regorafenib,drug,0.9927,31559116
9173,colorectal cancer,disease,0.9995,31559116
9174,regorafenib,drug,0.995,31559116
9175,metastatic colorectal cancer,disease,1.0,31559116
9176,regorafenib,drug,0.994,31559116
9177,regorafenib,drug,0.993,31559116
9178,sigmoid colon cancer,disease,1.0,31559116
9179,regorafenib,drug,0.992,31559116
9180,regorafenib,drug,0.9976,31559116
9181,erythema multiforme,disease,1.0,31559116
9182,regorafenib,drug,0.997,31559116
9183,Regorafenib,drug,0.9985,31559116
9184,prednisolone,drug,0.9526,31559116
9185,skin rash,disease,1.0,31559116
9186,Prednisolone,drug,0.994,31559116
9187,rash,disease,0.825,31559116
9188,regorafenib,drug,0.9927,31559116
9189,prednisolone,drug,0.982,31559116
9190,rash,disease,0.9966,31559116
9191,prednisolone,drug,0.924,31559116
9192,regorafenib,drug,0.981,31559116
9193,metastatic,disease,0.707,31559116
9194,regorafenib,drug,0.9956,31559116
9195,folinic acid,drug,0.999,31559116
9196,fluorouracil,drug,0.9995,31559116
9197,irinotecan,drug,0.9976,31559116
9198,panitumumab,gene,0.9463,31559116
9199,regorafenib,drug,0.98,31559116
9200,regorafenib,drug,0.9917,31559116
9201,skin rash,disease,0.9995,31559116
9202,KRAS,gene,0.861,31553708
9203,NRAS,gene,0.8374,31553708
9204,BRAF,gene,0.84,31553708
9205,HER2,gene,0.888,31553708
9206,metastatic colorectal cancer,disease,0.9937,31553708
9207,Colorectal cancer,disease,1.0,31553708
9208,RAS gene family,gene,0.8765,31553708
9209,KRAS,gene,0.835,31553708
9210,NRAS,gene,0.8667,31553708
9211,epithelial growth factor receptor,gene,0.9824,31553708
9212,anti-EGFR,gene,0.8315,31553708
9213,NRAS,gene,0.7725,31553708
9214,NRAS,gene,0.8057,31553708
9215,wild type tumours,disease,0.507,31553708
9216,BRAF,DNA,0.8384,31553708
9217,BRAF V600E,gene,0.9634,31553708
9218,V600E,DNA,0.44,31553708
9219,tumors,disease,1.0,31553708
9220,BRAF,gene,0.61,31553708
9221,BRAF,gene,0.9897,31553708
9222,BRAF,gene,0.5254,31553708
9223,EGFR,gene,0.963,31553708
9224,metastatic colorectal cancer,disease,1.0,31553708
9225,HER2,gene,0.995,31553708
9226,HER2,gene,0.9883,31553708
9227,advanced colorectal cancer,disease,1.0,31553708
9228,genetic,DNA,0.505,31553708
9229,Colorectal Cancer,disease,1.0,31550189
9230,RAS,gene,0.6133,31539295
9231,BRAF,gene,0.406,31539295
9232,Panitumumab,gene,0.806,31539295
9233,tumor,disease,0.961,31539295
9234,EGFR,gene,0.9917,31539295
9235,RAS,gene,0.963,31539295
9236,BRAF,gene,0.9907,31539295
9237,metastatic colorectal cancer,disease,1.0,31539295
9238,anti-EGFR monoclonal antibodies,gene,0.951,31539295
9239,RAS,gene,0.4863,31539295
9240,BRAF,gene,0.5977,31539295
9241,metastatic colorectal cancer,disease,0.9985,31539295
9242,mCRC,disease,1.0,31539295
9243,panitumumab,gene,0.8853,31539295
9244,fluorouracil,drug,0.999,31539295
9245,leucovorin,drug,0.9976,31539295
9246,oxaliplatin,drug,0.9995,31539295
9247,panitumumab,gene,0.7275,31539295
9248,fluorouracil,drug,0.991,31539295
9249,leucovorin,drug,0.999,31539295
9250,PATIENTS,species,0.917,31539295
9251,RAS,gene,0.7104,31539295
9252,BRAF,gene,0.6343,31539295
9253,HER2,gene,0.6807,31539295
9254,MET,gene,0.4375,31539295
9255,ALK,gene,0.985,31539295
9256,ROS1,gene,0.6904,31539295
9257,NTRKs,gene,0.996,31539295
9258,RET,gene,0.997,31539295
9259,HER2,gene,0.9937,31539295
9260,PIK3CAex.20,DNA,0.627,31539295
9261,PIK3CAex,gene,0.999,31539295
9262,PTEN,gene,0.9976,31539295
9263,AKT1,gene,0.9985,31539295
9264,RAS,gene,0.979,31539295
9265,left- and right-sided tumors,disease,0.945,31539295
9266,PRESSING,gene,0.495,31539295
9267,tumors,disease,0.3801,31539295
9268,panitumumab,gene,0.9116,31539295
9269,panitumumab,gene,0.963,31539295
9270,right-sided tumors,disease,0.9004,31539295
9271,PRESSING-positive tumors,cell_line,0.648,31539295
9272,PRESSING,gene,0.544,31539295
9273,anti-EGFR,gene,0.774,31539295
9274,RAS,gene,0.984,31539295
9275,BRAF,gene,0.5063,31539295
9276,wt mCRC,disease,0.825,31539295
9277,anti-EGFR,gene,0.7725,31539295
9278,anti-EGFRs,gene,0.8,31539295
9279,panitumumab,gene,0.955,31531499
9280,colorectal,cell_type,0.4941,31531499
9281,colorectal cancer,disease,1.0,31531499
9282,cells,cell_type,0.4038,31531499
9283,panitumumab,gene,0.8506,31531499
9284,SW48,cell_line,0.938,31531499
9285,SW480 colorectal cancer cells,cell_line,0.7515,31531499
9286,SW480,cell_type,0.6416,31531499
9287,colorectal cancer cells,cell_type,0.6646,31531499
9288,colorectal cancer,disease,1.0,31531499
9289,K-RAS,gene,0.5854,31531499
9290,panitumumab,gene,0.762,31531499
9291,MAP kinase,gene,0.993,31531499
9292,colorectal cancer cells,cell_type,0.6846,31531499
9293,colorectal cancer,disease,1.0,31531499
9294,wild,DNA,0.527,31531499
9295,wild-type K-RAS,gene,0.9976,31531499
9296,K-RAS mutated cells,cell_line,0.902,31531499
9297,K,cell_type,0.6406,31531499
9298,K-RAS,gene,0.9893,31531499
9299,panitumumab,gene,0.9673,31531499
9300,RAS,gene,0.5347,31515083
9301,Panitumumab,gene,0.7915,31515083
9302,metastatic colorectal cancer,disease,1.0,31515083
9303,mCRC,disease,1.0,31515083
9304,panitumumab,gene,0.9766,31515083
9305,mCRC,disease,0.9985,31515083
9306,tumor,disease,0.804,31515083
9307,PATIENTS,species,0.928,31515083
9308,RAS,gene,0.6543,31515083
9309,mCRC,disease,0.956,31515083
9310,RAS,DNA,0.622,31515083
9311,RAS wild,gene,0.8867,31515083
9312,mCRC,disease,0.998,31515083
9313,PI3Kinase,gene,0.9956,31506897
9314,BKM120,drug,0.9927,31506897
9315,panitumumab,gene,0.6924,31506897
9316,Epidermal Growth Factor,gene,0.994,31506897
9317,EGFRi,gene,0.993,31506897
9318,patients,species,0.952,31506897
9319,KRAS,gene,0.9956,31506897
9320,Colorectal Cancer,disease,1.0,31506897
9321,CRC,disease,1.0,31506897
9322,PI3K,gene,0.998,31506897
9323,AKT,gene,0.998,31506897
9324,mTOR,gene,0.9976,31506897
9325,panitumumab,gene,0.8813,31506897
9326,EGFRi,gene,0.997,31506897
9327,BKM120,drug,0.9976,31506897
9328,PI3K,gene,0.989,31506897
9329,advanced CRC,disease,0.999,31506897
9330,Patients,species,0.9844,31506897
9331,KRAS,DNA,0.502,31506897
9332,KRAS,gene,0.9795,31506897
9333,CRC,disease,0.9155,31506897
9334,EGFRi,gene,0.9844,31506897
9335,panitumumab,gene,0.8955,31506897
9336,BKM120,drug,0.888,31506897
9337,patients,species,0.99,31506897
9338,mucositis,disease,1.0,31506897
9339,fatigue,disease,0.999,31506897
9340,patients,species,0.971,31506897
9341,Panitumumab,gene,0.8584,31506897
9342,BKM120,drug,0.9863,31506897
9343,patient,species,0.98,31506897
9344,PTEN,gene,0.994,31506897
9345,PIK3CA,gene,0.998,31506897
9346,Panitumumab,gene,0.9424,31506897
9347,BKM120,drug,0.9927,31506897
9348,fatigue,disease,0.9995,31506897
9349,rash,disease,1.0,31506897
9350,mucositis,disease,1.0,31506897
9351,Locally Advanced Sigmoid Colon Cancer,disease,0.999,31501377
9352,Panitumumab,gene,0.9453,31501377
9353,sigmoid colon cancer,disease,0.9404,31501377
9354,stenosis in the sigmoid colon,disease,1.0,31501377
9355,panitumumab,gene,0.945,31501377
9356,S-1,drug,0.9116,31501377
9357,Panitumumab,gene,0.777,31501377
9358,panitumumab,gene,0.969,31501377
9359,advanced colorectal cancer,disease,1.0,31501377
9360,Cetuximab,gene,0.88,31500586
9361,irinotecan,drug,0.9966,31500586
9362,fluorouracile,drug,0.996,31500586
9363,fluoropirimidines,drug,0.9995,31500586
9364,oxaliplatin,drug,0.9995,31500586
9365,irinotecan,drug,0.9985,31500586
9366,bevacizumab,gene,0.943,31500586
9367,panitumumab,gene,0.9624,31500586
9368,cetuximab,gene,0.834,31500586
9369,metastatic colorectal cancer,disease,1.0,31500586
9370,mCRC,disease,1.0,31500586
9371,patients,species,0.994,31500586
9372,Cetuximab,gene,0.8794,31500586
9373,Epidermal Growth Factor Receptor,gene,0.9985,31500586
9374,EGFR,gene,0.997,31500586
9375,Immunoglobulins,gene,0.9937,31500586
9376,Ig,gene,0.987,31500586
9377,antibody,DNA,0.541,31500586
9378,antibody-coated target cells,cell_line,0.7217,31500586
9379,immunologic effectors,cell_type,0.4587,31500586
9380,effector cells,cell_type,0.901,31500586
9381,Fc,gene,,31500586
9382,FcR,gene,0.9946,31500586
9383,FcR,gene,0.9937,31500586
9384,IgG1,gene,0.994,31500586
9385,high-affinity FcRIIIa V/V,gene,0.946,31500586
9386,cetuximab,gene,0.896,31500586
9387,CIFRA,DNA,0.4946,31500586
9388,cetuximab,gene,0.936,31500586
9389,irinotecan,drug,0.9976,31500586
9390,fluorouracile,drug,0.997,31500586
9391,FcRIIIa,gene,0.932,31500586
9392,patients,species,0.984,31500586
9393,KRAS,gene,0.9893,31500586
9394,NRAS,gene,0.992,31500586
9395,BRAF,gene,0.9966,31500586
9396,mCRC,disease,0.9995,31500586
9397,FcRIIIa,gene,0.994,31500586
9398,patients,species,0.9927,31500586
9399,cetuximab,gene,0.809,31500586
9400,patients,species,0.9946,31500586
9401,patients,species,0.992,31500586
9402,patients,species,0.9893,31500586
9403,cetuximab,gene,0.983,31500586
9404,tumor,disease,1.0,31500586
9405,CIFRA,DNA,0.4968,31500586
9406,cetuximab,gene,0.849,31500586
9407,mCRC,disease,0.997,31500586
9408,patients,species,0.991,31500586
9409,tumor,disease,0.9556,31500586
9410,cetuximab,gene,0.92,31500586
9411,CIFRA,DNA,0.573,31500586
9412,epidermal growth factor receptor-overexpressing cancer cells,cell_line,0.9097,31479522
9413,epidermal growth factor receptor,gene,0.9946,31479522
9414,Cetuximab,gene,0.8955,31479522
9415,panitumumab,gene,0.78,31479522
9416,human epidermal growth factor receptor,gene,0.9985,31479522
9417,human,species,0.884,31479522
9418,EGFR,gene,0.995,31479522
9419,chimeric cetuximab,gene,0.7217,31479522
9420,IgG1,gene,0.995,31479522
9421,EGFR positive target cells,cell_line,0.9,31479522
9422,EGFR positive target cells,cell_type,0.806,31479522
9423,EGFR,gene,0.988,31479522
9424,panitumumab,gene,0.9316,31479522
9425,human IgG2,gene,0.963,31479522
9426,human,species,0.8286,31479522
9427,panitumumab,gene,0.7812,31479522
9428,human IgG2 Fc,gene,0.9834,31479522
9429,human,species,0.9497,31479522
9430,FcRIII,gene,0.998,31479522
9431,CD16,gene,0.9966,31479522
9432,natural killer (NK) cells,cell_type,0.8906,31479522
9433,human IgG1,gene,0.991,31479522
9434,human,species,0.958,31479522
9435,IgG2,gene,0.996,31479522
9436,FcRII,gene,0.998,31479522
9437,CD32A,gene,0.998,31479522
9438,T cells,cell_type,0.928,31479522
9439,CD32A(131R) -chimeric receptor,gene,0.9497,31479522
9440,low-affinity CD16(158F) -CR T cells,cell_line,0.9487,31479522
9441,CD16(158F),gene,0.8213,31479522
9442,EGFR positive,cell_type,0.7314,31479522
9443,EGFR,gene,0.981,31479522
9444,epithelial cancer cells,cell_type,0.892,31479522
9445,epithelial cancer,disease,0.848,31479522
9446,ECCs,cell_type,0.8057,31479522
9447,cetuximab,gene,0.8706,31479522
9448,panitumumab,gene,0.824,31479522
9449,T-cell,cell_type,0.5146,31479522
9450,CD32A(,cell_line,0.5283,31479522
9451,CD32A(131R),gene,0.9326,31479522
9452,T,cell_type,0.341,31479522
9453,CD16(158F),gene,0.9546,31479522
9454,CR T cells,cell_type,0.786,31479522
9455,CD32A(131R) -CR T cells,cell_line,0.9526,31479522
9456,CD32A,cell_type,0.507,31479522
9457,CD32A(131R),gene,0.903,31479522
9458,-CR T cells,cell_type,0.5986,31479522
9459,panitumumab,gene,0.8823,31479522
9460,CD32A(131R) -CR T cells,cell_line,0.9473,31479522
9461,CD32A,cell_type,0.4978,31479522
9462,CD32A(131R,gene,0.69,31479522
9463,CR T cells,cell_type,0.5513,31479522
9464,mAb 8,gene,0.9883,31479522
9465,anti-CD32,gene,0.9966,31479522
9466,CD16(158F) -CR T cells,cell_line,0.95,31479522
9467,CD16,cell_type,0.502,31479522
9468,CD16(158F,gene,0.807,31479522
9469,mAb 3g8,gene,0.986,31479522
9470,anti-CD16,gene,0.9966,31479522
9471,colorectal carcinoma,disease,1.0,31479522
9472,CRC,disease,1.0,31479522
9473,HCT116(FcR+) cells,cell_line,0.966,31479522
9474,FcR,gene,0.8647,31479522
9475,CD32A(131R),gene,0.9575,31479522
9476,CR,gene,0.9917,31479522
9477,T cells,cell_type,0.8994,31479522
9478,cetuximab,gene,0.9053,31479522
9479,panitumumab,gene,0.871,31479522
9480,CD16(158F),gene,0.981,31479522
9481,CR,gene,0.9854,31479522
9482,T cells,cell_line,0.6216,31479522
9483,cetuximab,gene,0.9185,31479522
9484,TNBC,disease,0.851,31479522
9485,interferon gamma,gene,0.9907,31479522
9486,tumor necrosis factor alpha,gene,0.993,31479522
9487,cetuximab,gene,0.944,31479522
9488,panitumumab,gene,0.799,31479522
9489,Fc,gene,,31479522
9490,CR T,gene,0.938,31479522
9491,Kirsten rat sarcoma (KRAS)-mutated HCT116,cell_line,0.955,31479522
9492,Kirsten rat sarcoma,disease,0.9824,31479522
9493,Kirsten,gene,0.937,31479522
9494,KRAS,gene,0.798,31479522
9495,nonsmall-cell-lung-cancer,disease,1.0,31479522
9496,A549,cell_line,0.952,31479522
9497,"TNBC, MDA-MB-231 cells",cell_line,0.929,31479522
9498,TNBC,cell_type,0.753,31479522
9499,TNBC,disease,0.9595,31479522
9500,Fc-CR T cells,cell_line,0.9624,31479522
9501,Fc,gene,,31479522
9502,EGFR,gene,0.987,31479522
9503,ECCs,cell_type,0.857,31479522
9504,CD32A(131R) -CR T cells,cell_line,0.8945,31479522
9505,CD32A(131R),gene,0.879,31479522
9506,CR T cells,cell_type,0.5234,31479522
9507,cetuximab,gene,0.8076,31479522
9508,panitumumab,gene,0.691,31479522
9509,breast cancer cells,cell_type,0.7046,31479522
9510,breast cancer,disease,0.9985,31479522
9511,EGFR,gene,0.9834,31479522
9512,TAS-102,drug,0.995,31475067
9513,bevacizumab,gene,0.7324,31475067
9514,metastatic colorectal cancer,disease,1.0,31475067
9515,metastatic colorectal cancer,disease,0.9995,31475067
9516,TAS-102,drug,0.998,31475067
9517,nucleoside,drug,0.6543,31475067
9518,trifluridine,drug,0.9995,31475067
9519,tipiracil hydrochloride,drug,0.999,31475067
9520,bevacizumab,gene,0.705,31475067
9521,vascular endothelial growth factor-A,gene,0.998,31475067
9522,metastatic colorectal cancer,disease,1.0,31475067
9523,mCRC,disease,1.0,31475067
9524,TAS-102,drug,0.9873,31475067
9525,bevacizumab,gene,0.725,31475067
9526,mCRC,disease,0.9985,31475067
9527,wild-type or mutant RAS genes,gene,0.9087,31475067
9528,TAS-102,drug,0.9873,31475067
9529,bevacizumab,gene,0.77,31475067
9530,fluoropyrimidine,drug,0.999,31475067
9531,irinotecan,drug,0.997,31475067
9532,oxaliplatin,drug,0.9995,31475067
9533,bevacizumab,gene,0.684,31475067
9534,cetuximab,gene,0.9014,31475067
9535,panitumumab,gene,0.916,31475067
9536,RAS,gene,0.636,31475067
9537,tumor,disease,0.755,31475067
9538,left,DNA,0.4956,31475067
9539,TAS-102,drug,0.981,31475067
9540,bevacizumab,gene,0.752,31475067
9541,mGPS,DNA,0.694,31475067
9542,mGPS 1,gene,0.6353,31475067
9543,mGPS,DNA,0.7236,31475067
9544,mGPS 2,gene,0.853,31475067
9545,TAS-102,drug,0.996,31475067
9546,bevacizumab,gene,0.8555,31475067
9547,TAS-102,drug,0.9907,31475067
9548,bevacizumab,gene,0.842,31475067
9549,mCRC,disease,0.9834,31475067
9550,oxaliplatin,drug,0.9995,31445198
9551,panitumumab,gene,0.7183,31445198
9552,colorectal cancer,disease,1.0,31445198
9553,Fluorouracil,drug,0.9995,31445198
9554,5-FU,drug,0.9995,31445198
9555,leucovorin,drug,0.9995,31445198
9556,oxaliplatin,drug,0.9995,31445198
9557,FOLFOX,drug,0.981,31445198
9558,panitumumab,gene,0.842,31445198
9559,colorectal cancer,disease,0.9995,31445198
9560,mCRC,disease,0.9976,31445198
9561,oxaliplatin,drug,0.9995,31445198
9562,peripheral neuropathy,disease,1.0,31445198
9563,PN,disease,0.9995,31445198
9564,oxaliplatin,drug,0.998,31445198
9565,FOLFOX,drug,0.5664,31445198
9566,panitumumab,gene,0.9106,31445198
9567,PN,disease,0.9414,31445198
9568,PATIENTS,species,0.904,31445198
9569,RAS,gene,0.5923,31445198
9570,mCRC,disease,0.8545,31445198
9571,panitumumab,gene,0.871,31445198
9572,5-FU,drug,0.992,31445198
9573,panitumumab,gene,0.869,31445198
9574,PN,disease,0.842,31445198
9575,oxaliplatin,drug,0.9995,31445198
9576,panitumumab,gene,0.9023,31445198
9577,mCRC,disease,0.959,31445198
9578,oxaliplatin,drug,1.0,31445198
9579,PN,disease,0.596,31445198
9580,panitumumab,gene,0.8657,31445198
9581,Iodine,drug,0.923,31443247
9582,Hrthle Cell Cancer,disease,1.0,31443247
9583,Hrthle cell carcinoma,disease,1.0,31443247
9584,HCC,disease,1.0,31443247
9585,HCC,disease,0.9985,31443247
9586,HCC,disease,0.5156,31443247
9587,mitogen-activated protein kinase,gene,0.998,31443247
9588,MAPK,gene,0.988,31443247
9589,phosphatidylinositol,drug,0.983,31443247
9590,phosphatidylinositol 3-kiase,gene,0.9907,31443247
9591,PI3K,gene,0.9883,31443247
9592,AKT,gene,0.98,31443247
9593,cancer,disease,0.98,31443247
9594,HCC,disease,0.9966,31443247
9595,gene variants,DNA,0.888,31443247
9596,everolimus,drug,0.9995,31443247
9597,sorafenib,drug,0.9995,31443247
9598,nintedanib,drug,0.9995,31443247
9599,lenvatinib,drug,0.998,31443247
9600,panitumumab,gene,0.751,31443247
9601,metastatic tumor,disease,0.998,31443247
9602,panitumumab,gene,0.79,31443247
9603,thyroid cancer,disease,1.0,31443247
9604,control cell lines,cell_line,0.8984,31443247
9605,epidermal growth factor,gene,0.9976,31443247
9606,EGF,gene,0.9956,31443247
9607,panitumumab,gene,0.7686,31443247
9608,EGF receptor,gene,0.997,31443247
9609,EGFR,gene,0.9907,31443247
9610,near-homozygous genome,DNA,0.5796,31443247
9611,NHG,DNA,0.8027,31443247
9612,TSC1 variant,DNA,0.678,31443247
9613,TSC1,gene,0.9893,31443247
9614,primary,disease,0.9976,31443247
9615,tumor,disease,0.8843,31443247
9616,RAS variants,gene,0.7803,31443247
9617,panitumumab,gene,0.8975,31443247
9618,AKT,gene,0.988,31443247
9619,thyroid cancer cell lines,cell_line,0.9346,31443247
9620,thyroid cancer,disease,1.0,31443247
9621,NHG,gene,0.5225,31443247
9622,panitumumab,gene,0.788,31443247
9623,pEGFR,gene,0.9946,31443247
9624,cancer cell lines,cell_line,0.918,31443247
9625,cancer,disease,0.4866,31443247
9626,metastatic tumors,disease,0.9727,31443247
9627,cancers,disease,1.0,31443247
9628,RAS,DNA,0.636,31443247
9629,RAS variants,gene,0.5225,31443247
9630,panitumumab,gene,0.8984,31443247
9631,HCC,disease,0.9995,31443247
9632,Cetuximab,gene,0.9067,31426645
9633,Panitumumab,gene,0.797,31426645
9634,mCRC,disease,0.9976,31426645
9635,epidermal growth factor receptor,gene,0.9873,31426645
9636,EGFR,gene,0.997,31426645
9637,cetuximab,gene,0.76,31426645
9638,panitumumab,gene,0.7524,31426645
9639,metastatic colorectal cancer,disease,1.0,31426645
9640,mCRC,disease,1.0,31426645
9641,cetuximab,gene,0.961,31426645
9642,panitumumab,gene,0.8804,31426645
9643,cetuximab,gene,0.8867,31426645
9644,panitumumab,gene,0.9,31426645
9645,mCRC,disease,0.9966,31426645
9646,wild type KRAS,DNA,0.5596,31426645
9647,PATIENTS,species,0.965,31426645
9648,mCRC,disease,0.992,31426645
9649,wild type KRAS,gene,0.8765,31426645
9650,cancer,disease,0.999,31426645
9651,cetuximab,gene,0.909,31426645
9652,panitumumab,gene,0.862,31426645
9653,EGFR,gene,0.921,31426645
9654,cetuximab,gene,0.872,31426645
9655,panitumumab,gene,0.8994,31426645
9656,EGFR,gene,0.911,31426645
9657,cetuximab,gene,0.945,31426645
9658,panitumumab,gene,0.9575,31426645
9659,anti-EGFR,gene,0.9346,31426645
9660,cetuximab,gene,0.869,31426645
9661,panitumumab,gene,0.9424,31426645
9662,mCRC,disease,0.9966,31426645
9663,wild type KRAS,gene,0.6094,31426645
9664,cetuximab,gene,0.952,31426645
9665,panitumumab,gene,0.897,31426645
9666,High-grade dysplasia,disease,0.998,31421471
9667,epidermal growth factor receptor,gene,0.9355,31421471
9668,EGFR,gene,0.997,31421471
9669,high-grade dysplasia,disease,0.9287,31421471
9670,low-grade dysplasia,disease,0.988,31421471
9671,Patients,species,0.9766,31421471
9672,head and neck squamous cell carcinoma,disease,1.0,31421471
9673,HNSCC,disease,1.0,31421471
9674,EGFR,gene,0.996,31421471
9675,panitumumab,gene,0.974,31421471
9676,tumor,disease,1.0,31421471
9677,patients,species,0.982,31421471
9678,Hematoxylin,drug,0.9995,31421471
9679,eosin,drug,0.9976,31421471
9680,invasive squamous cell carcinoma,disease,1.0,31421471
9681,low-grade dysplasia,disease,0.8086,31421471
9682,EGFR,gene,0.991,31421471
9683,patient,species,0.9893,31421471
9684,patients,species,0.981,31421471
9685,low-grade dysplasia,disease,0.9653,31421471
9686,high-grade dysplasia,disease,0.695,31421471
9687,High-grade dysplasia,disease,0.9966,31421471
9688,normal,cell_type,0.4954,31421471
9689,low-grade dysplasia,disease,0.998,31421471
9690,EGFR,gene,0.991,31421471
9691,dysplasia,disease,0.7686,31421471
9692,EGFR,gene,0.708,31421471
9693,high-grade dysplastic lesions,disease,0.999,31421471
9694,skin toxicities,disease,0.7944,31413534
9695,panitumumab,gene,0.9307,31413534
9696,metastatic colorectal cancer,disease,1.0,31413534
9697,epidermal growth factor receptor,gene,0.977,31413534
9698,dermatological,disease,0.505,31413534
9699,panitumumab,gene,0.886,31413534
9700,panitumumab,gene,0.787,31413534
9701,wild,gene,0.674,31413534
9702,metastatic colorectal cancer,disease,0.9985,31413534
9703,dermatological,disease,0.908,31413534
9704,dermatological,disease,0.9814,31413534
9705,rash,disease,1.0,31413534
9706,acneiform rash,disease,1.0,31413534
9707,xerosis,disease,1.0,31413534
9708,skin cracks,disease,1.0,31413534
9709,dermatological,disease,0.9023,31413534
9710,skin toxicities,disease,0.9805,31413534
9711,TNS4,gene,0.9907,31409052
9712,Cetuximab,gene,0.7334,31409052
9713,KRAS Mutant Colorectal Cancer Cell Lines,cell_line,0.957,31409052
9714,KRAS,disease,0.6875,31409052
9715,KRAS Mutant,gene,0.8027,31409052
9716,epidermal growth factor receptor,gene,0.999,31409052
9717,EGFR,gene,0.9893,31409052
9718,anti-EGFR monoclonal antibodies,gene,0.9966,31409052
9719,cetuximab,gene,0.634,31409052
9720,panitumumab,gene,0.7437,31409052
9721,colorectal cancer,disease,1.0,31409052
9722,CRC,disease,1.0,31409052
9723,xenograft,cell_line,0.4648,31409052
9724,mouse,species,0.972,31409052
9725,tumors,disease,0.975,31409052
9726,KRASG12D mutation-bearing LS174T CRC cells,cell_line,0.6704,31409052
9727,KRASG12D mutation,gene,0.819,31409052
9728,CRC,disease,0.785,31409052
9729,cetuximab,gene,0.8057,31409052
9730,TNS4,gene,0.9854,31409052
9731,CRC,disease,0.9995,31409052
9732,KRAS mutation-harboring CRC cell lines,cell_line,0.745,31409052
9733,KRAS,gene,0.9727,31409052
9734,CRC,disease,0.792,31409052
9735,cetuximab,gene,0.8516,31409052
9736,TNS4,gene,0.9893,31409052
9737,LS174T,cell_line,0.9487,31409052
9738,DLD1,cell_line,0.543,31409052
9739,WiDr,cell_line,0.6284,31409052
9740,DiFi CRC cell,cell_type,0.468,31409052
9741,CRC,disease,0.6606,31409052
9742,TNS4,gene,0.987,31409052
9743,MAP kinase,gene,0.976,31409052
9744,selumetinib,drug,0.9956,31409052
9745,MEK1/2,gene,0.991,31409052
9746,CRC cells,cell_line,0.827,31409052
9747,CRC,disease,0.9995,31409052
9748,cetuximab,gene,0.886,31409052
9749,TNS4,gene,0.985,31409052
9750,CRC,disease,0.986,31409052
9751,TNS4,gene,0.9917,31409052
9752,cetuximab,gene,0.9316,31409052
9753,CRC,disease,0.9927,31409052
9754,KRAS,gene,0.7876,31409052
9755,CD16-158-valine chimeric receptor T,gene,0.9824,31396956
9756,valine,drug,0.973,31396956
9757,KRAS,gene,0.9937,31396956
9758,KRAS,gene,0.9683,31396956
9759,epidermal growth factor receptor,gene,0.998,31396956
9760,EGFR,gene,0.998,31396956
9761,cetuximab,gene,0.75,31396956
9762,panitumumab,gene,0.898,31396956
9763,EGFR+ cancers,cell_line,0.5103,31396956
9764,EGFR,disease,0.9644,31396956
9765,EGFR+,gene,0.9917,31396956
9766,cetuximab,gene,0.6714,31396956
9767,KRAS-mutated cancer cell,cell_line,0.7563,31396956
9768,KRAS-mutated cancer,disease,0.8926,31396956
9769,KRAS,gene,0.9775,31396956
9770,natural killer (NK) cell,cell_type,0.6436,31396956
9771,KRAS,gene,0.9893,31396956
9772,colorectal carcinoma (CRC) cells,cell_type,0.7334,31396956
9773,colorectal carcinoma,disease,0.9995,31396956
9774,cetuximab,gene,0.9565,31396956
9775,panitumumab,gene,0.8345,31396956
9776,Fc,cell_type,,31396956
9777,Fc chimeric receptor,gene,0.9854,31396956
9778,CR,gene,0.985,31396956
9779,KRAS-mutated HCT116 colorectal,cell_line,0.8403,31396956
9780,KRAS,gene,0.9546,31396956
9781,colorectal cancer,disease,1.0,31396956
9782,CRC,disease,1.0,31396956
9783,Fc-CR,gene,0.892,31396956
9784,CD16(158F) -CR,gene,0.928,31396956
9785,CD16(158V) -CR,gene,0.9644,31396956
9786,CD32(131H) -CR,gene,0.9355,31396956
9787,CD32(131R),gene,0.96,31396956
9788,T cells,cell_type,0.913,31396956
9789,transduced T cells,cell_line,0.8477,31396956
9790,CD32(131H) -CR,gene,0.932,31396956
9791,CD32(131R) -CR,gene,0.964,31396956
9792,CD16(158F) -CR,gene,0.9634,31396956
9793,CD16(158V) -CR,gene,0.962,31396956
9794,CD32(131R) -CR T cells,cell_line,0.982,31396956
9795,CD32(131R,gene,0.731,31396956
9796,CR T cells,cell_type,0.5654,31396956
9797,cetuximab,gene,0.957,31396956
9798,panitumumab,gene,0.8794,31396956
9799,CD16(158V) -CR T cells,cell_line,0.9507,31396956
9800,CD16,cell_type,0.5435,31396956
9801,CD16(158V),gene,0.947,31396956
9802,interferon gamma,gene,0.992,31396956
9803,IFN,gene,0.974,31396956
9804,tumor necrosis factor alpha,gene,0.993,31396956
9805,TNF,gene,0.9907,31396956
9806,cetuximab-opsonized HCT116 cells,cell_line,0.9575,31396956
9807,cetuximab,gene,0.972,31396956
9808,-,cell_type,0.532,31396956
9809,opsonized HCT116 cells,cell_type,0.5386,31396956
9810,CD16(158V) -CR T cells,cell_line,0.9043,31396956
9811,CD16(158V),gene,0.868,31396956
9812,-CR T cells,cell_type,0.4966,31396956
9813,cetuximab,gene,0.934,31396956
9814,HCT116 cells,cell_line,0.7837,31396956
9815,HCT116,disease,0.5024,31396956
9816,A549 KRAS-mutated cells,cell_line,0.958,31396956
9817,CD16(158V) -CR T cells,cell_line,0.975,31396956
9818,CD16(158V),gene,0.9277,31396956
9819,HCT116 cells,cell_line,0.8027,31396956
9820,HCT116,disease,0.7915,31396956
9821,mice,species,0.9204,31396956
9822,CD16(158V) -CR T cells,cell_line,0.959,31396956
9823,CD16,cell_type,0.57,31396956
9824,CD16(158V),gene,0.796,31396956
9825,-,cell_type,0.5596,31396956
9826,CR T cells,cell_type,0.665,31396956
9827,cetuximab,gene,0.535,31396956
9828,EGFR,gene,0.997,31396956
9829,KRAS,gene,0.9946,31396956
9830,CRC,disease,0.99,31396956
9831,panitumumab,gene,0.848,31388315
9832,RAS,gene,0.624,31388315
9833,metastatic colorectal cancer,disease,0.9644,31388315
9834,Panitumumab,gene,0.807,31388315
9835,epidermal growth factor receptor,gene,0.9966,31388315
9836,EGFR,gene,0.9917,31388315
9837,RAS wild,gene,0.7695,31388315
9838,metastatic colorectal cancer,disease,1.0,31388315
9839,mCRC,disease,1.0,31388315
9840,panitumumab,gene,0.7417,31388315
9841,EGFRs,gene,0.9946,31388315
9842,panitumumab,gene,0.8643,31388315
9843,5-FU,drug,0.997,31378656
9844,Metastatic Colorectal Cancer,disease,1.0,31378656
9845,metastatic colorectal cancer,disease,0.9873,31378656
9846,CRC,disease,1.0,31378656
9847,PATIENTS,species,0.9688,31378656
9848,nausea,disease,0.997,31378656
9849,peripheral neuropathy,disease,1.0,31378656
9850,oxaliplatin,drug,0.9995,31378656
9851,anemia,disease,0.9995,31378656
9852,anemia,disease,0.999,31378656
9853,neutropenia,disease,1.0,31378656
9854,neutropenia,disease,0.998,31378656
9855,hematological toxicities,disease,0.98,31378656
9856,anemia,disease,1.0,31378656
9857,neutropenia,disease,1.0,31378656
9858,nausea,disease,0.9985,31378656
9859,vomiting,disease,0.993,31378656
9860,peripheral neuropathy,disease,1.0,31378656
9861,metastatic CRC,disease,0.9985,31378656
9862,epidermal growth factor receptor,gene,0.997,31376243
9863,metastatic colorectal cancer,disease,1.0,31376243
9864,cancer,disease,1.0,31376243
9865,hypersensitivities,disease,0.999,31376243
9866,Metastatic colorectal cancer,disease,1.0,31376243
9867,mCRC,disease,1.0,31376243
9868,EGFR,gene,0.9077,31376243
9869,cetuximab,gene,0.7373,31376243
9870,panitumumab,gene,0.769,31376243
9871,mCRC,disease,0.999,31376243
9872,EGFR,gene,0.93,31376243
9873,hypersensitivity,disease,0.998,31376243
9874,allergy,disease,1.0,31376243
9875,anaphylaxis,disease,0.6274,31376243
9876,IRs,disease,0.8833,31376243
9877,RAS,gene,0.4893,31376243
9878,KRAS,gene,0.507,31376243
9879,cetuximab,gene,0.7837,31376243
9880,panitumumab,gene,0.6846,31376243
9881,mCRC,disease,0.9995,31376243
9882,anti-EGFR,gene,0.6484,31376243
9883,Sinusoidal Obstruction Syndrome,disease,1.0,31366558
9884,Colorectal Cancer Liver Metastasis,disease,0.999,31366558
9885,colorectal cancer,disease,1.0,31366558
9886,liver metastasis,disease,0.837,31366558
9887,PATIENTS,species,0.916,31366558
9888,colorectal cancer,disease,1.0,31366558
9889,bevacizumab,gene,0.7036,31366558
9890,cetuximab,gene,0.7954,31366558
9891,panitumumab,gene,0.838,31366558
9892,sinusoidal injuries,disease,0.999,31366558
9893,bevacizumab,gene,0.6924,31366558
9894,sinusoidal injury,disease,0.791,31366558
9895,bevacizumab,gene,0.7935,31366558
9896,sinusoidal injury,disease,0.9897,31366558
9897,tumors,disease,1.0,31366558
9898,Metastatic Colorectal Cancer,disease,1.0,31366129
9899,Colorectal cancer,disease,1.0,31366129
9900,CRC,disease,1.0,31366129
9901,cancer,disease,1.0,31366129
9902,metastatic CRC,disease,1.0,31366129
9903,mCRC,disease,0.9995,31366129
9904,mismatch repair (MMR),disease,0.9883,31366129
9905,mCRC,disease,0.997,31366129
9906,anti-vascular endothelial growth factor,gene,0.879,31366129
9907,anti-VGEF,gene,0.954,31366129
9908,bevacizumab,gene,0.6167,31366129
9909,mCRC,disease,0.9956,31366129
9910,epidermal growth factor receptor,gene,0.9927,31366129
9911,panitumumab,gene,0.5435,31366129
9912,KRAS,gene,0.5854,31366129
9913,RAS,gene,0.581,31366129
9914,mCRC,disease,0.9995,31366129
9915,EGFR,gene,0.7637,31366129
9916,receptor tyrosine kinase,gene,0.9956,31366129
9917,tyrosine,drug,0.878,31366129
9918,RTK,gene,0.984,31366129
9919,VEGF,gene,0.9956,31366129
9920,EGFR,gene,0.992,31366129
9921,RTKs,gene,0.943,31366129
9922,cancer,disease,0.9995,31366129
9923,human epidermal growth factor receptor 2,gene,0.999,31366129
9924,HER2,gene,0.995,31366129
9925,HER2,gene,0.4219,31366129
9926,mCRC,disease,0.99,31366129
9927,panitumumab,gene,0.9053,31363167
9928,irinotecan,drug,0.9946,31363167
9929,RAS,gene,0.9946,31363167
9930,metastatic colorectal cancer,disease,0.848,31363167
9931,epidermal growth factor receptor,gene,0.9985,31363167
9932,EGFR,gene,0.9946,31363167
9933,panitumumab,gene,0.8555,31363167
9934,irinotecan,drug,0.998,31363167
9935,irinotecan,drug,0.999,31363167
9936,patients,species,0.9756,31363167
9937,KRAS exon-2,gene,0.975,31363167
9938,patients,species,0.981,31363167
9939,irinotecan,drug,0.99,31363167
9940,panitumumab,gene,0.866,31363167
9941,irinotecan,drug,0.996,31363167
9942,KRAS exon-2,gene,0.9106,31363167
9943,NRAS,gene,0.9785,31363167
9944,BRAF,DNA,0.5703,31363167
9945,BRAF mutations,gene,0.8267,31363167
9946,epiregulin,gene,0.9946,31363167
9947,amphiregulin,gene,0.997,31363167
9948,PTEN,gene,0.9937,31363167
9949,EGFR,gene,0.996,31363167
9950,patients,species,0.979,31363167
9951,wild,DNA,0.7783,31363167
9952,wild-type RAS,gene,0.979,31363167
9953,patients,species,0.989,31363167
9954,BRAF,DNA,0.6577,31363167
9955,patients,species,0.9946,31363167
9956,diarrhoea,disease,1.0,31363167
9957,rash,disease,1.0,31363167
9958,hypomagnesaemia,disease,1.0,31363167
9959,asthenia,disease,1.0,31363167
9960,panitumumab,gene,0.915,31363167
9961,irinotecan,drug,0.9985,31363167
9962,irinotecan,drug,0.999,31363167
9963,metastatic colorectal cancer,disease,0.9966,31363167
9964,patient,species,0.965,31360471
9965,metastatic left-sided colon cancer,disease,1.0,31360471
9966,patients,species,0.9746,31360471
9967,metastatic colon cancer,disease,1.0,31360471
9968,EGFR,gene,0.9126,31319395
9969,epidermal growth factor receptor,gene,0.9897,31319395
9970,EGFR,gene,0.9956,31319395
9971,patients,species,0.9585,31319395
9972,metastatic colorectal cancer,disease,1.0,31319395
9973,mCRC,disease,1.0,31319395
9974,TAILOR,DNA,0.4905,31319395
9975,EGFR,gene,0.5815,31319395
9976,cetuximab,gene,0.961,31319395
9977,Cet,gene,0.9185,31319395
9978,panitumumab,gene,0.921,31319395
9979,Pani,gene,0.837,31319395
9980,RAS,gene,0.995,31319395
9981,right- and left-sided mCRC,disease,0.9756,31319395
9982,PATIENTS,species,0.959,31319395
9983,Cet,drug,0.9956,31319395
9984,Pani,drug,0.9966,31319395
9985,RAS,DNA,0.639,31319395
9986,RAS wt,gene,0.998,31319395
9987,mCRC,disease,0.835,31319395
9988,TAILOR,DNA,0.493,31319395
9989,Cet,drug,0.684,31319395
9990,Pani,drug,0.8057,31319395
9991,Cet,drug,0.982,31319395
9992,Pani,drug,0.9785,31319395
9993,patients,species,0.941,31319395
9994,RAS,gene,0.9937,31319395
9995,mCRC,disease,0.9404,31319395
9996,anti-,gene,0.663,31319395
9997,EGFR,gene,0.6523,31319395
9998,patients,species,0.9897,31319395
9999,Primary Tumour,disease,0.739,31300973
10000,Patients,species,0.9927,31300973
10001,panitumumab,gene,0.943,31300973
10002,FOLFIRI,drug,0.984,31300973
10003,folinic acid,drug,0.9985,31300973
10004,5-fluorouracil,drug,0.999,31300973
10005,irinotecan,drug,0.997,31300973
10006,metastatic colorectal cancer,disease,1.0,31300973
10007,primary tumour,disease,0.9785,31300973
10008,tumour,disease,0.996,31300973
10009,Patients,species,0.9614,31300973
10010,RAS,gene,0.9946,31300973
10011,metastatic colorectal cancer,disease,0.9663,31300973
10012,Tumours,disease,1.0,31300973
10013,primary,disease,0.8823,31300973
10014,tumour,disease,0.8037,31300973
10015,primary,DNA,0.7036,31300973
10016,tumour,disease,0.889,31300973
10017,tumour,disease,0.9463,31300973
10018,tumour,disease,0.9097,31300973
10019,patients,species,0.9814,31300973
10020,RAS,gene,0.9976,31300973
10021,metastatic colorectal cancer,disease,0.977,31300973
10022,patients,species,0.961,31300973
10023,left-sided tumours,disease,1.0,31300973
10024,patients,species,0.9834,31300973
10025,tumour,disease,0.9526,31300973
10026,tumour,disease,0.9985,31300973
10027,patients,species,0.9756,31300973
10028,tumour,disease,0.7393,31300973
10029,patients,species,0.9746,31300973
10030,left- and right-sided tumours,disease,0.999,31300973
10031,patients,species,0.941,31300973
10032,RAS,gene,0.996,31300973
10033,panitumumab,gene,0.758,31300973
10034,FOLFIRI,drug,0.934,31300973
10035,tumour,disease,0.9927,31300973
10036,patients,species,0.9863,31300973
10037,panitumumab,gene,0.796,31300973
10038,Colorectal Cancer,disease,1.0,31298142
10039,anti-EGFR,gene,0.8354,31298142
10040,cetuximab,gene,0.9434,31298142
10041,panitumumab,gene,0.9116,31298142
10042,bevacizumab,gene,0.841,31298142
10043,regorafeninb,gene,0.712,31298142
10044,ramucirumab,gene,0.5776,31298142
10045,aflibercept,gene,0.957,31298142
10046,metastatic colorectal cancer,disease,0.877,31298142
10047,CRC,disease,1.0,31298142
10048,advanced CRC,disease,0.991,31298142
10049,tumor,disease,0.9995,31298142
10050,germ,DNA,0.786,31298142
10051,inflammation,disease,0.9897,31298142
10052,tumor,disease,1.0,31298142
10053,KRAS 3'UTR region,gene,0.888,31298142
10054,EGF,gene,0.809,31298142
10055,/ EGFR genes,DNA,0.6343,31298142
10056,EGFR,gene,0.996,31298142
10057,cetuximab,gene,0.6895,31298142
10058,EGFR,gene,0.742,31298142
10059,germ-line variants,DNA,0.642,31298142
10060,COX-2,gene,0.995,31298142
10061,LIFR,gene,0.995,31298142
10062,IGF1,gene,0.9873,31298142
10063,FCGRs,gene,0.9834,31298142
10064,IL-1RA,gene,0.995,31298142
10065,RAS,gene,0.989,31298142
10066,Hippo pathway related genes,DNA,0.763,31298142
10067,Hippo,gene,0.949,31298142
10068,Rassf,gene,0.695,31298142
10069,YAP,gene,0.9976,31298142
10070,TAZ,gene,0.995,31298142
10071,VEGF,gene,0.963,31298142
10072,EGF,gene,0.998,31298142
10073,IGF-1,gene,0.9985,31298142
10074,HIF1,gene,0.9976,31298142
10075,eNOS,gene,0.994,31298142
10076,iNOS,gene,0.9946,31298142
10077,EGFL7,gene,0.5576,31298142
10078,CXCR-1/2,gene,0.9937,31298142
10079,CXCR4,gene,0.9844,31298142
10080,CXCL12,gene,0.967,31298142
10081,TLRs,gene,0.937,31298142
10082,GADD34,gene,0.9956,31298142
10083,PPP1R15A,gene,0.742,31298142
10084,ANXA11,gene,0.677,31298142
10085,MKNK1,gene,0.928,31298142
10086,bevacizumab,gene,0.8706,31298142
10087,inhered variants,DNA,0.5215,31298142
10088,CRC,disease,0.999,31298142
10089,Colorectal adenocarcinoma-derived EGFR,cell_line,0.619,31290142
10090,Colorectal,cell_type,0.441,31290142
10091,Colorectal adenocarcinoma,disease,1.0,31290142
10092,EGFR mutants,gene,0.955,31290142
10093,epidermal growth factor receptor,gene,0.997,31290142
10094,EGFR,gene,0.997,31290142
10095,colorectal cancer,disease,1.0,31290142
10096,CRC,disease,0.9995,31290142
10097,patients,species,0.99,31290142
10098,EGFR mutations,gene,0.9336,31290142
10099,colon cancer,disease,1.0,31290142
10100,G63R,mutation,,31290142
10101,E114K,mutation,,31290142
10102,R165Q,mutation,,31290142
10103,R222C,mutation,,31290142
10104,S492R,mutation,,31290142
10105,P596L,mutation,,31290142
10106,K708R,mutation,,31290142
10107,E709K,mutation,,31290142
10108,G719S,DNA,0.4995,31290142
10109,G719S,mutation,,31290142
10110,G724S,DNA,0.4856,31290142
10111,G724S,mutation,,31290142
10112,L858R,mutation,,31290142
10113,EGF,gene,0.993,31290142
10114,EGFR mutants,gene,0.991,31290142
10115,cetuximab,gene,0.7817,31290142
10116,panitumumab,gene,0.8154,31290142
10117,EGFR mutations,gene,0.979,31290142
10118,anti-EGFR antibodies,gene,0.8013,31290142
10119,metastatic CRC,disease,0.9995,31290142
10120,patients,species,0.992,31290142
10121,panitumumab,gene,0.887,31280434
10122,docetaxel,drug,0.997,31280434
10123,cisplatin,drug,0.998,31280434
10124,advanced gastric,disease,0.9985,31280434
10125,Panitumumab,gene,0.77,31280434
10126,RAS,gene,0.997,31280434
10127,metastatic colorectal cancer,disease,0.9976,31280434
10128,panitumumab,gene,0.9355,31280434
10129,docetaxel,drug,1.0,31280434
10130,DOC,drug,0.9995,31280434
10131,cisplatin,drug,1.0,31280434
10132,CIS,drug,0.999,31280434
10133,gastric or gastro-oesophageal junction (GEJ) adenocarcinoma,disease,1.0,31280434
10134,ADC,disease,1.0,31280434
10135,patients,species,0.989,31280434
10136,advanced gastric or GEJ-ADC,disease,0.9995,31280434
10137,patients,species,0.99,31280434
10138,Patients,species,0.9536,31280434
10139,panitumumab,gene,0.9214,31280434
10140,DOC,drug,0.9985,31280434
10141,CIS,drug,0.9976,31280434
10142,patient,species,0.98,31280434
10143,patients,species,0.9775,31280434
10144,panitumumab,gene,0.902,31280434
10145,patients,species,0.9756,31280434
10146,patients,species,0.956,31280434
10147,asthenia,disease,1.0,31280434
10148,mucosal inflammation,disease,1.0,31280434
10149,patients,species,0.9746,31280434
10150,panitumumab,gene,0.821,31280434
10151,DOC,drug,0.9995,31280434
10152,CIS,drug,0.9985,31280434
10153,patients,species,0.9707,31280434
10154,panitumumab,gene,0.94,31280434
10155,advanced gastric or GEJ-ADC,disease,1.0,31280434
10156,Metastatic Colorectal,disease,0.6353,31270570
10157,colorectal cancer,disease,1.0,31270570
10158,patients,species,0.981,31270570
10159,metastatic colorectal cancer,disease,1.0,31270570
10160,mCRC,disease,1.0,31270570
10161,mCRC,disease,0.8813,31270570
10162,vascular endothelial growth factor,gene,0.993,31270570
10163,VEGF,gene,0.9976,31270570
10164,Bevacizumab,gene,0.6772,31270570
10165,epidermal growth factor receptor,gene,0.9985,31270570
10166,EGRF,gene,0.9976,31270570
10167,Panitumumab,gene,0.75,31270570
10168,Cetuximab,gene,0.777,31270570
10169,tumor,disease,0.9995,31270570
10170,EGFR,gene,0.9966,31270570
10171,tumors,disease,1.0,31270570
10172,tumor,disease,0.624,31270570
10173,anti-VEGF-antibodies,gene,0.9766,31270570
10174,anti-EGFR antibodies,gene,0.8584,31270570
10175,tumors,disease,1.0,31270570
10176,rat sarcoma virus,disease,0.944,31270570
10177,RAS,gene,0.7466,31270570
10178,RAS,gene,0.997,31270570
10179,tumors,disease,0.9976,31270570
10180,RAS,gene,0.936,31270570
10181,VEGF,gene,0.9907,31270570
10182,tumor cells,cell_type,0.4648,31270570
10183,tumor,disease,0.999,31270570
10184,colorectal cancer,disease,1.0,31270570
10185,Panitumumab,gene,0.798,31268483
10186,Advanced Colorectal Cancer,disease,1.0,31268483
10187,Panitumumab,gene,0.8325,31268481
10188,Panitumumab,gene,0.8403,31268481
10189,epidermal growth factor receptors,gene,0.889,31268481
10190,patients,species,0.9707,31268481
10191,RAS,DNA,0.568,31268481
10192,RAS wild,gene,0.8354,31268481
10193,panitumumab,gene,0.953,31268481
10194,panitumumab,gene,0.8843,31268481
10195,fluorouracil,drug,0.9976,31268481
10196,leucovorin,drug,0.9976,31268481
10197,PARTICIPANTS,species,0.646,31268481
10198,Patients,species,0.97,31268481
10199,RAS,gene,0.9976,31268481
10200,metastatic,disease,0.6045,31268481
10201,colorectal adenocarcinoma,disease,0.9766,31268481
10202,panitumumab,gene,0.78,31268481
10203,FOLFOX,drug,0.816,31268481
10204,panitumumab,gene,0.945,31268481
10205,oxaliplatin,drug,0.9995,31268481
10206,leucovorin,drug,0.996,31268481
10207,calcium,drug,0.923,31268481
10208,fluorouracil,drug,0.9907,31268481
10209,Patients,species,0.931,31268481
10210,panitumumab,gene,0.898,31268481
10211,panitumumab,gene,0.8926,31268481
10212,fluorouracil,drug,0.9907,31268481
10213,leucovorin,drug,0.879,31268481
10214,panitumumab,gene,0.8726,31268481
10215,A,cell_line,0.4216,31268481
10216,patients,species,0.9883,31268481
10217,panitumumab,gene,0.709,31268481
10218,patients,species,0.9443,31268481
10219,RAS,gene,0.9956,31268481
10220,metastatic colorectal cancer,disease,0.9946,31268481
10221,panitumumab,gene,0.879,31268481
10222,panitumumab,gene,0.833,31268481
10223,fluorouracil,drug,0.9995,31268481
10224,leucovorin,drug,0.9995,31268481
10225,Skin Toxicities,disease,0.9956,31264159
10226,cancer,disease,1.0,31264159
10227,patients,species,0.99,31264159
10228,patient,species,0.9824,31264159
10229,cancer,disease,0.9995,31264159
10230,Panitumumab,gene,0.7603,31264159
10231,cetuximab,gene,0.549,31264159
10232,epidermal growth factor receptor,gene,0.9976,31264159
10233,EGFR,gene,0.9946,31264159
10234,metastatic colorectal cancer,disease,1.0,31264159
10235,mCRC,disease,1.0,31264159
10236,patients,species,0.9683,31264159
10237,mCRC,disease,0.9985,31264159
10238,EGFR,gene,0.8867,31264159
10239,papulopustular rash,disease,1.0,31264159
10240,xerosis,disease,1.0,31264159
10241,cracks and fissures on the palms and soles of the feet,disease,0.961,31264159
10242,paronychia,disease,1.0,31264159
10243,pruritus,disease,1.0,31264159
10244,abnormal hair and eyelash growth,disease,1.0,31264159
10245,EGFR,gene,0.994,31264159
10246,skin,disease,0.9287,31264159
10247,EGFR,gene,0.93,31264159
10248,EGFR,gene,0.966,31264159
10249,skin toxicities,disease,0.7163,31264159
10250,anti-cancer,disease,0.7803,31264159
10251,EGFR,gene,0.6196,31264159
10252,skin toxicities,disease,0.8735,31264159
10253,papulopustular rash,disease,1.0,31264159
10254,fusidic acid,drug,0.999,31264159
10255,betamethasone,drug,0.9907,31264159
10256,EGFR,gene,0.6484,31264159
10257,rash,disease,0.9985,31264159
10258,Cell-Line,cell_line,0.7534,31242384
10259,EGFR-Positive Tumor,disease,0.987,31242384
10260,EGFR,gene,0.9927,31242384
10261,Mice,species,0.777,31242384
10262,Panitumumab Fab,gene,0.9893,31242384
10263,Hexahistidine,drug,0.93,31242384
10264,99mTc(I) Tricarbonyl,drug,0.996,31242384
10265,hexahistidine,drug,0.747,31242384
10266,panitumumab Fab,gene,0.993,31242384
10267,PmFab,gene,0.9946,31242384
10268,[99mTc(H2O),drug,0.95,31242384
10269,3(CO)3]+,drug,0.995,31242384
10270,EGFR-overexpressing tumor xenografts,cell_line,0.614,31242384
10271,EGFR,gene,0.995,31242384
10272,tumor,disease,0.9673,31242384
10273,mice,species,0.92,31242384
10274,Fab,gene,0.988,31242384
10275,sulfo-SMCC,drug,0.998,31242384
10276,maleimide,drug,0.999,31242384
10277,thiol,drug,0.9507,31242384
10278,His6,drug,0.975,31242384
10279,Fab,gene,0.9927,31242384
10280,His6,drug,0.918,31242384
10281,His6,drug,0.9023,31242384
10282,123I,drug,0.9985,31242384
10283,PmFab,gene,0.975,31242384
10284,His6,gene,0.4666,31242384
10285,[99mTc(H2O)3(CO)3]+,drug,0.998,31242384
10286,[99mTcO4]-,drug,0.9976,31242384
10287,MDA-MB-468 human triple-negative breast cancer (TNBC) cells,cell_line,0.934,31242384
10288,MDA,cell_type,0.5107,31242384
10289,triple-negative breast cancer,disease,0.951,31242384
10290,99mTc,drug,0.9995,31242384
10291,PmFab,gene,0.747,31242384
10292,99mTc,drug,0.998,31242384
10293,Fab 3913,gene,0.797,31242384
10294,mice,species,0.7373,31242384
10295,EGFR-overexpressing MDA-,cell_line,0.822,31242384
10296,EGFR,gene,0.996,31242384
10297,MB-468,cell_line,0.891,31242384
10298,PANC-1 human,cell_line,0.8276,31242384
10299,CLX,cell_line,0.675,31242384
10300,99mTc,drug,0.999,31242384
10301,PmFab,gene,0.919,31242384
10302,His6,gene,0.791,31242384
10303,mice,species,0.886,31242384
10304,tumor,disease,0.8594,31242384
10305,PDX,cell_line,0.5566,31242384
10306,TNBC,disease,0.463,31242384
10307,PDCa,disease,0.9995,31242384
10308,head and neck squamous cell carcinoma,disease,1.0,31242384
10309,HNSCC,disease,1.0,31242384
10310,mice,species,0.861,31242384
10311,99mTc,drug,0.999,31242384
10312,PmFab,gene,0.6523,31242384
10313,PmFab,gene,0.986,31242384
10314,His6,drug,0.9814,31242384
10315,His6,drug,0.962,31242384
10316,99mTc,drug,0.9995,31242384
10317,PmFab,gene,0.943,31242384
10318,His6,gene,0.64,31242384
10319,EGFR,gene,0.995,31242384
10320,MDA-MB-468 cells,cell_line,0.623,31242384
10321,99mTc,drug,1.0,31242384
10322,PmFab,gene,0.8726,31242384
10323,99mTc,drug,0.9995,31242384
10324,Fab,gene,0.8647,31242384
10325,3913,drug,0.7964,31242384
10326,mice,species,0.9087,31242384
10327,MDA-MB-468 tumors,disease,0.668,31242384
10328,mice,species,0.9688,31242384
10329,PANC-1 tumors,disease,0.741,31242384
10330,mice,species,0.8984,31242384
10331,PDCa,disease,1.0,31242384
10332,PDCa tumors,disease,0.9995,31242384
10333,primary,disease,0.871,31242384
10334,tumors,disease,0.924,31242384
10335,mice,species,0.828,31242384
10336,TNBC,disease,0.674,31242384
10337,HNSCC PDX,cell_line,0.582,31242384
10338,HNSCC,disease,0.9995,31242384
10339,CLX,cell_line,0.7944,31242384
10340,PDX tumor xenografts,cell_line,0.674,31242384
10341,tumor,disease,0.954,31242384
10342,99mTc,drug,0.9995,31242384
10343,PmFab,gene,0.6133,31242384
10344,99mTc,drug,0.998,31242384
10345,medronate,drug,0.9766,31242384
10346,panitumumab,gene,0.9434,31238905
10347,patients,species,0.9785,31238905
10348,wild-type RAS,gene,0.9653,31238905
10349,patients,species,0.9834,31238905
10350,colorectal cancer,disease,1.0,31238905
10351,CRC,disease,1.0,31238905
10352,Panitumumab,gene,0.734,31238905
10353,epidermal growth factor receptor,gene,0.998,31238905
10354,EGFR,gene,0.995,31238905
10355,panitumumab,gene,0.8784,31238905
10356,patients,species,0.983,31238905
10357,panitumumab,gene,0.9204,31238905
10358,patients,species,0.9834,31238905
10359,CRC,disease,0.996,31238905
10360,Patients,species,0.948,31238905
10361,wild,DNA,0.59,31238905
10362,wild-type RAS,gene,0.96,31238905
10363,CRC,disease,0.9976,31238905
10364,patients,species,0.9893,31238905
10365,Gastrointestinal Cancer,disease,0.9956,31238905
10366,Panitumumab,gene,0.7646,31238905
10367,panitumumab,gene,0.884,31238905
10368,patients,species,0.9673,31238905
10369,CRC,disease,0.998,31238905
10370,panitumumab,gene,0.8804,31238905
10371,patients,species,0.9634,31238905
10372,wild-type RAS,gene,0.7427,31238905
10373,CRC,disease,0.9766,31238905
10374,participant,species,0.965,31238905
10375,EGFR,gene,0.9946,31228284
10376,anti-EGFR monoclonal antibodies,gene,0.9663,31228284
10377,epidermal growth factor receptor,gene,0.998,31228284
10378,EGFR,gene,0.9937,31228284
10379,anti-EGFR monoclonal antibodies,gene,0.9917,31228284
10380,EGFR,gene,0.995,31228284
10381,anti-EGFR,gene,0.931,31228284
10382,Cetuximab,gene,0.9136,31228284
10383,Panitumumab,gene,0.928,31228284
10384,Necitumumab,gene,0.917,31228284
10385,Matuzumab,gene,0.924,31228284
10386,EGFR,gene,0.9927,31228284
10387,anti-EGFR mAbs,gene,0.9727,31228284
10388,EGFRS492R,gene,0.501,31228284
10389,S492R,mutation,,31228284
10390,EGFRV441I,gene,0.9917,31228284
10391,V441I,mutation,,31228284
10392,Cetuximab,gene,0.9497,31228284
10393,EGFRR377S,gene,0.994,31228284
10394,R377S,mutation,,31228284
10395,EGFRS447Y,gene,0.5522,31228284
10396,S447Y,mutation,,31228284
10397,Panitumumab,gene,0.9395,31228284
10398,EGFRV441I,gene,0.9956,31228284
10399,V441I,mutation,,31228284
10400,Necitumumab,gene,0.9517,31228284
10401,EGFRWT,gene,0.6333,31228284
10402,V441I,DNA,0.4973,31228284
10403,Cetuximab,gene,0.9272,31228284
10404,Panitumumab,gene,0.842,31228284
10405,Necitumumab,gene,0.9004,31228284
10406,V211D,mutation,,31227518
10407,MEK1,gene,0.604,31227518
10408,MEK,gene,0.9917,31227518
10409,Colon Cancer,disease,1.0,31227518
10410,novel,mutation,,31227518
10411,MEK1,DNA,0.6055,31227518
10412,MEK1 V211D gatekeeper,gene,0.707,31227518
10413,V211D,DNA,,31227518
10414,V211D,mutation,,31227518
10415,BRAF,DNA,0.484,31227518
10416,BRAF K601E,gene,0.928,31227518
10417,K601E,mutation,,31227518
10418,colon cancer,disease,0.876,31227518
10419,MEK,gene,0.975,31227518
10420,binimetinib,drug,0.7544,31227518
10421,EGFR antibody,gene,0.7534,31227518
10422,panitumumab,gene,0.5864,31227518
10423,MEK1 V211D,gene,0.79,31227518
10424,V211D,DNA,,31227518
10425,V211D,mutation,,31227518
10426,BRAF K601E,gene,0.899,31227518
10427,K601E,mutation,,31227518
10428,RAF,gene,0.9966,31227518
10429,RAF,gene,0.995,31227518
10430,V211D,mutation,,31227518
10431,binimetinib,drug,0.9946,31227518
10432,MEK1,gene,0.9873,31227518
10433,MEK,gene,0.987,31227518
10434,MEK,gene,0.9956,31227518
10435,ATP,drug,0.9897,31227518
10436,MEK,gene,0.971,31227518
10437,MEK,gene,0.9907,31227518
10438,MEK1,DNA,0.633,31227518
10439,MEK1 V211D mutation,gene,0.8325,31227518
10440,V211D,DNA,,31227518
10441,V211D,mutation,,31227518
10442,BRAF,cell_line,0.486,31227518
10443,BRAF K601E,gene,0.81,31227518
10444,K601E,mutation,,31227518
10445,colon cancer,disease,0.7954,31227518
10446,MEK,gene,0.9624,31227518
10447,EGFR,gene,0.957,31227518
10448,MEK1,gene,0.9927,31227518
10449,binimetinib,drug,0.995,31227518
10450,ATP,drug,0.9937,31227518
10451,MEK,gene,0.9814,31227518
10452,transrenal DNA,DNA,0.843,31220949
10453,Anti-,gene,0.929,31220949
10454,EGFR mAb,gene,0.8037,31220949
10455,metastatic colorectal cancer,disease,1.0,31220949
10456,mCRC,disease,1.0,31220949
10457,transrenal DNA,DNA,0.8237,31220949
10458,transrenal DNA,DNA,0.8364,31220949
10459,transrenal,RNA,0.4958,31220949
10460,mCRC,disease,0.999,31220949
10461,patients,species,0.989,31220949
10462,DNA,RNA,0.4631,31220949
10463,KRAS and EGFR genes,DNA,0.738,31220949
10464,KRAS,gene,0.9775,31220949
10465,EGFR genes,gene,0.99,31220949
10466,patients,species,0.966,31220949
10467,EGFR,gene,0.992,31220949
10468,KRAS,DNA,0.625,31220949
10469,KRAS mutations,gene,0.953,31220949
10470,patients,species,0.983,31220949
10471,anti-EGFR mAb,gene,0.914,31220949
10472,patients,species,0.9854,31220949
10473,transrenal DNA,DNA,0.7104,31220949
10474,mutant DNA,DNA,0.8467,31220949
10475,Transrenal DNA,DNA,0.738,31220949
10476,mCRC,disease,0.999,31220949
10477,Patients,species,0.9727,31220949
10478,transrenal DNA,DNA,0.668,31220949
10479,Rectosigmoid Colon Cancer,disease,1.0,31189822
10480,patient,species,0.983,31189822
10481,man,species,0.8716,31189822
10482,rectosigmoid cancer,disease,1.0,31189822
10483,bevacizumab,gene,0.5854,31189822
10484,panitumumab,gene,0.804,31189822
10485,urinary bladder infiltration,disease,0.965,31189822
10486,tumor,disease,0.975,31189822
10487,patient,species,0.978,31189822
10488,advanced rectosigmoid cancer,disease,1.0,31189822
10489,urinary bladder,disease,0.883,31189822
10490,epidermal growth factor receptor,gene,0.998,31185328
10491,epidermoid anal cancer,disease,1.0,31185328
10492,5-fluorouracil,drug,0.9985,31185328
10493,5FU,drug,0.999,31185328
10494,mitomycin,drug,0.995,31185328
10495,C,drug,0.616,31185328
10496,MMC,drug,0.9995,31185328
10497,panitumumab,gene,0.978,31185328
10498,Pmab,gene,0.988,31185328
10499,Pmab,gene,0.9478,31185328
10500,patients,species,0.989,31185328
10501,locally advanced tumour,disease,1.0,31185328
10502,5FU,drug,0.8926,31185328
10503,MMC,drug,0.997,31185328
10504,Pmab,gene,0.622,31185328
10505,patients,species,0.9844,31185328
10506,patients,species,0.9785,31185328
10507,Pmab,drug,0.877,31185328
10508,5FU,drug,0.9917,31185328
10509,Pmab,drug,0.9526,31185328
10510,5FU,drug,0.993,31185328
10511,patients,species,0.979,31185328
10512,dermatitis,disease,1.0,31185328
10513,anaemia,disease,1.0,31185328
10514,patients,species,0.9863,31185328
10515,patient,species,0.9697,31185328
10516,tumour,disease,1.0,31185328
10517,5FU,drug,0.998,31185328
10518,MMC,drug,0.9927,31185328
10519,Pmab,drug,0.89,31185328
10520,MTD,DNA,0.473,31185328
10521,tumour,disease,1.0,31185328
10522,Rectal Cancer,disease,1.0,31164547
10523,rectal cancer,disease,1.0,31164547
10524,swollen para-aortic lymph nodes,disease,0.9907,31164547
10525,panitumumab,gene,0.749,31164547
10526,rectal cancer,disease,1.0,31164547
10527,S,drug,0.649,31164547
10528,advanced rectal cancer,disease,1.0,31164547
10529,Stevens-Johnson Syndrome,disease,1.0,31164523
10530,Metastatic Colon Cancer,disease,1.0,31164523
10531,semicircular ulcerative lesion,disease,0.985,31164523
10532,adenocarcinoma,disease,0.9414,31164523
10533,nodular,disease,0.785,31164523
10534,liver metastases,disease,0.9795,31164523
10535,panitumumab,gene,0.693,31164523
10536,hemorrhage of the ocular conjunctiva,disease,0.984,31164523
10537,eyelid edema,disease,1.0,31164523
10538,Edema of the lips,disease,1.0,31164523
10539,epidermolysis,disease,1.0,31164523
10540,erythema,disease,1.0,31164523
10541,vision impairment,disease,1.0,31164523
10542,SJS,disease,1.0,31164523
10543,Eyelid edema,disease,1.0,31164523
10544,vision impairment,disease,0.9995,31164523
10545,visual impairment,disease,1.0,31164523
10546,Panitumumab,gene,0.8228,31164512
10547,5-FU,drug,0.997,31164512
10548,l-LV,drug,0.9893,31164512
10549,Panitumumab,gene,0.8296,31164512
10550,Tumor,disease,0.9434,31164512
10551,Colon Carcinoma,disease,1.0,31164512
10552,Hepatic Metastases,disease,0.973,31164512
10553,ascending colon carcinoma,disease,1.0,31164512
10554,hepatic metastases,disease,0.901,31164512
10555,H3],drug,0.879,31164512
10556,panitumumab,gene,0.5205,31164512
10557,5-FU,drug,0.9985,31164512
10558,l-LV,drug,0.993,31164512
10559,wild- type KRAS,gene,0.7554,31164512
10560,CEA,gene,0.9043,31164512
10561,hepatic,disease,0.842,31164512
10562,CEA,gene,0.9897,31164512
10563,right colon cancer,disease,0.975,31164512
10564,anti-,gene,0.8037,31164512
10565,EGFR antibodies,gene,0.699,31164512
10566,RAS,gene,0.756,31164512
10567,GC1118,drug,0.9185,31164456
10568,Anti-Epidermal Growth Factor Receptor Antibody,gene,0.989,31164456
10569,Advanced Solid Tumors,disease,0.999,31164456
10570,GC1118,drug,0.989,31164456
10571,anti-epidermal growth factor receptor,gene,0.986,31164456
10572,EGFR,gene,0.9883,31164456
10573,binding epitopes,DNA,0.533,31164456
10574,cetuximab,gene,0.891,31164456
10575,panitumumab,gene,0.8467,31164456
10576,GC1118,drug,0.9155,31164456
10577,colorectal cancer,disease,1.0,31164456
10578,EGFR antibody,gene,0.8276,31164456
10579,Skin toxicities,disease,0.899,31164456
10580,diarrhea,disease,1.0,31164456
10581,anti-EGFR antibodies,gene,0.8447,31164456
10582,epidermal growth factor receptor,gene,0.998,31164456
10583,EGFR,gene,0.9917,31164456
10584,cetuximab,gene,0.8467,31164456
10585,panitumumab,gene,0.82,31164456
10586,solid tumors,disease,1.0,31164456
10587,GC1118,drug,0.931,31164456
10588,colorectal cancer,disease,1.0,31164456
10589,CRC,disease,1.0,31164456
10590,anti-EGFR,gene,0.844,31164456
10591,CRC,disease,0.9995,31164456
10592,tumors,disease,1.0,31164456
10593,EGFR,gene,0.924,31164456
10594,EGFR-overexpressing gastric,cell_line,0.768,31164456
10595,EGFR,gene,0.498,31164456
10596,skin toxicities,disease,0.968,31164456
10597,skin toxicities,disease,0.9966,31164456
10598,CONCLUSION GC1118,drug,0.701,31164456
10599,diarrhea,disease,1.0,31164456
10600,anti-EGFR antibodies,gene,0.9526,31164456
10601,Sentinel Margin,DNA,0.525,31142505
10602,head and neck cancer,disease,1.0,31142505
10603,anti-EGFR antibody,gene,0.9897,31142505
10604,tumor,disease,0.999,31142505
10605,head and neck cancer,disease,1.0,31142505
10606,tumor,disease,0.9595,31142505
10607,panitumumab,gene,0.954,31142505
10608,tumor,disease,0.9995,31142505
10609,tumor,disease,1.0,31142505
10610,tumor,disease,0.674,31142505
10611,tumor,disease,0.554,31142505
10612,tumor,disease,1.0,31142505
10613,FOLFOX,drug,0.981,31129386
10614,rilotumumab,gene,0.5537,31129386
10615,panitumumab,gene,0.64,31129386
10616,Epidermal growth factor receptor,gene,0.998,31129386
10617,EGFR,gene,0.996,31129386
10618,hepatocyte growth factor,gene,0.9966,31129386
10619,HGF,gene,0.9976,31129386
10620,tumour,disease,1.0,31129386
10621,advanced gastroesophageal adenocarcinomas,disease,0.978,31129386
10622,panitumumab,gene,0.6606,31129386
10623,EGFR,gene,0.9976,31129386
10624,HGF,gene,0.996,31129386
10625,fluoropyrimidine,drug,0.9966,31129386
10626,platinum,drug,0.998,31129386
10627,oxaliplatin,drug,0.9995,31129386
10628,leucovorin,drug,0.998,31129386
10629,fluorouracil,drug,0.9985,31129386
10630,patients,species,0.9277,31129386
10631,advanced gastroesophageal adenocarcinoma,disease,1.0,31129386
10632,PATIENTS,species,0.954,31129386
10633,patients,species,0.954,31129386
10634,advanced gastroesophageal adenocarcinoma,disease,0.995,31129386
10635,HER2,gene,0.9907,31129386
10636,Patients,species,0.8794,31129386
10637,oxaliplatin,drug,1.0,31129386
10638,leucovorin,drug,0.998,31129386
10639,5-fluorouracil,drug,0.9985,31129386
10640,panitumumab,gene,0.932,31129386
10641,patient,species,0.9897,31129386
10642,patients,species,0.9824,31129386
10643,panitumumab,gene,0.821,31129386
10644,panitumumab,gene,0.71,31129386
10645,panitumumab,gene,0.8438,31129386
10646,panitumumab,gene,0.8647,31129386
10647,advanced gastroesophageal adenocarcinoma,disease,1.0,31129386
10648,patients,species,0.991,31129386
10649,metastatic colorectal cancer,disease,1.0,31127994
10650,metastatic colorectal cancer,disease,1.0,31127994
10651,mCRC,disease,1.0,31127994
10652,mCRC,disease,0.9414,31127994
10653,anti-epidermal growth factor receptor,gene,0.968,31127994
10654,EGFR,gene,0.8374,31127994
10655,mCRC,disease,0.9805,31127994
10656,tumor,disease,0.998,31127994
10657,right or left colon cancer,disease,1.0,31127994
10658,tumor,disease,0.989,31127994
10659,mCRC,disease,0.998,31127994
10660,RAS,cell_line,0.553,31127994
10661,RAS-mutant,gene,0.7095,31127994
10662,mCRC,disease,0.997,31127994
10663,RAS-wild type tumor,disease,0.563,31127994
10664,RAS,gene,0.995,31127994
10665,left,DNA,0.486,31127994
10666,right,DNA,0.6196,31127994
10667,right-,disease,0.6953,31127994
10668,grade,cell_line,0.4927,31127994
10669,grade III tumor,disease,0.8975,31127994
10670,mCRC,disease,0.9985,31127994
10671,right,DNA,0.53,31127994
10672,right-sided colon tumors,disease,0.8276,31127994
10673,EGFR monoclonal antibody,gene,0.926,31115490
10674,panitumumab,gene,0.4307,31115490
10675,chronic proliferative cholangitis,disease,1.0,31115490
10676,EGFR,gene,0.9917,31115490
10677,hepatolithiasis,disease,1.0,31115490
10678,chronic proliferative cholangitis,disease,1.0,31115490
10679,CPC,disease,1.0,31115490
10680,inflammation of,disease,0.9614,31115490
10681,mucin,gene,0.976,31115490
10682,epidermal growth factor receptor,gene,0.9985,31115490
10683,EGFR,gene,0.995,31115490
10684,panitumumab,gene,0.807,31115490
10685,Pani,gene,0.649,31115490
10686,CPC,cell_type,0.6562,31115490
10687,CPC,disease,1.0,31115490
10688,rat,species,0.9736,31115490
10689,EGFR,gene,0.994,31115490
10690,EGFR,gene,0.9907,31115490
10691,mucin 5AC,gene,0.995,31115490
10692,MUC5AC,gene,0.9937,31115490
10693,Ki67,gene,0.9736,31115490
10694,type I collagen,gene,0.9956,31115490
10695,mammalian target of rapamycin,gene,0.965,31115490
10696,rapamycin,drug,0.9854,31115490
10697,mTOR,gene,0.9775,31115490
10698,glucuronidase,gene,0.992,31115490
10699,G,gene,0.987,31115490
10700,rats,species,0.9834,31115490
10701,hyperproliferation,disease,0.7773,31115490
10702,collagen,gene,0.981,31115490
10703,EGFR,gene,0.994,31115490
10704,mTOR,gene,0.9907,31115490
10705,EGFR,gene,0.9946,31115490
10706,MUC5AC,gene,0.9873,31115490
10707,Ki67,gene,0.899,31115490
10708,type I collagen,gene,0.9907,31115490
10709,G,gene,0.987,31115490
10710,rats,species,0.989,31115490
10711,Pani,drug,0.56,31115490
10712,rats,species,0.9844,31115490
10713,Pani,drug,0.6836,31115490
10714,EGFR monoclonal antibody Pani,gene,0.716,31115490
10715,CPC,cell_line,0.6113,31115490
10716,intrahepatic choledocholithiasis,disease,1.0,31115490
10717,Panitumumab,gene,0.812,31113346
10718,Forearm Panniculitis,disease,1.0,31113346
10719,Metastatic Colon Cancer,disease,1.0,31113346
10720,Panitumumab,gene,0.7764,31113346
10721,EGFR,gene,0.9966,31113346
10722,metastatic colorectal cancer,disease,1.0,31113346
10723,mCRC,disease,1.0,31113346
10724,skin toxicity,disease,0.6587,31113346
10725,forearm panniculitis,disease,1.0,31113346
10726,Panitumumab,gene,0.864,31113346
10727,FOLFOX-6,drug,0.893,31113346
10728,leucovorin,drug,0.999,31113346
10729,5- fluorouracil,drug,0.9995,31113346
10730,oxaliplatin,drug,0.9995,31113346
10731,mCRC,disease,0.9854,31113346
10732,panniculitis,disease,1.0,31113346
10733,panitumumab,gene,0.8257,31113346
10734,Panatimumab,gene,0.832,31113346
10735,panniculitis,disease,1.0,31113346
10736,Panitumumab,gene,0.905,31113346
10737,beta-lactams,drug,0.9907,31113346
10738,fluoroquinolones,drug,0.998,31113346
10739,oxazolidinone,drug,0.998,31113346
10740,mCRC,disease,0.9937,31113346
10741,ascending colon cancer,disease,0.9995,31103951
10742,panitumumab,gene,0.928,31103951
10743,metastatic colorectal cancer,disease,1.0,31103951
10744,mCRC,disease,1.0,31103951
10745,ascending colon cancer,disease,1.0,31103951
10746,peritoneal disseminations,disease,0.98,31103951
10747,panitumumab,gene,0.9272,31103951
10748,Pmab,gene,0.946,31103951
10749,mFOLFOX6,drug,0.569,31103951
10750,PDs,disease,0.773,31103951
10751,Pmab,gene,0.6655,31103951
10752,tumor,disease,0.963,31103951
10753,tumor,disease,0.748,31103951
10754,Pmab,gene,0.6084,31103951
10755,Pmab,gene,0.917,31103951
10756,Pmab,gene,0.727,31103951
10757,mCRC,disease,0.9937,31103951
10758,PDs,disease,0.8013,31103951
10759,lysine,drug,0.979,31065015
10760,2-cyanobenzothiazole,drug,0.999,31065015
10761,CBT,drug,0.9985,31065015
10762,N,drug,0.9995,31065015
10763,cysteine,drug,0.995,31065015
10764,lysine,drug,0.996,31065015
10765,N,drug,0.9976,31065015
10766,CBT,drug,0.976,31065015
10767,NanoLuc luciferase,gene,0.9927,31065015
10768,patient,species,0.9766,31060020
10769,high-grade colorectal cancer,disease,0.9995,31060020
10770,patients,species,0.976,31060020
10771,metastatic lesion,disease,0.74,31060020
10772,colon cancer,disease,1.0,31060020
10773,patient,species,0.984,31060020
10774,patient,species,0.9624,31060020
10775,metastatic lesions,disease,0.975,31060020
10776,colorectal cancer,disease,1.0,31060020
10777,patient,species,0.96,31060020
10778,occlusive cancer of the descending colon,disease,1.0,31060020
10779,Cancer,disease,0.886,31060020
10780,5-fluorouracil,drug,0.9995,31060020
10781,leucovorin,drug,0.999,31060020
10782,oxaliplatin,drug,0.9995,31060020
10783,panitumumab,gene,0.979,31060020
10784,Pmab,gene,0.9634,31060020
10785,patient,species,0.974,31060020
10786,patients,species,0.972,31060020
10787,colon cancer,disease,0.996,31060020
10788,patient,species,0.962,31060020
10789,colorectal cancer,disease,0.986,31060020
10790,advanced unresectable,disease,0.642,31060020
10791,colorectal cancer,disease,0.9214,31060020
10792,BSC,cell_type,0.4739,31060020
10793,Rash,disease,0.93,31054146
10794,mCRC,disease,0.999,31054146
10795,Panitumumab,gene,0.864,31054146
10796,metastatic colorectal cancer,disease,1.0,31054146
10797,mCRC,disease,1.0,31054146
10798,panitumumab,gene,0.861,31054146
10799,dermatologic toxicities,disease,0.933,31054146
10800,mCRC,disease,0.9985,31054146
10801,panitumumab,gene,0.8247,31054146
10802,oncologists,cell_type,0.4375,31054146
10803,panitumumab,gene,0.883,31054146
10804,panitumumab,gene,0.8374,31054146
10805,mCRC,disease,0.9976,31054146
10806,mCRC,disease,0.9985,31054146
10807,panitumumab,gene,0.919,31054146
10808,Panitumumab,gene,0.9526,31054001
10809,patients,species,0.961,31054001
10810,head,disease,0.64,31054001
10811,neck squamous cell carcinoma,disease,0.9995,31054001
10812,anti-epidermal growth factor receptor,gene,0.921,31054001
10813,EGFR,gene,0.9976,31054001
10814,panitumumab,gene,0.7837,31054001
10815,IRDye800CW,DNA,0.5034,31054001
10816,Patients,species,0.9937,31054001
10817,panitumumab,gene,0.92,31054001
10818,panitumumab,gene,0.94,31054001
10819,tumor,disease,0.9946,31054001
10820,tumor,disease,0.9707,31054001
10821,primary,disease,0.5493,31054001
10822,tumor,disease,0.995,31054001
10823,panitumumab,gene,0.981,31054001
10824,panitumumab,gene,0.976,31054001
10825,advanced cutaneous squamous cell carcinoma,disease,0.9995,31051028
10826,advanced cutaneous squamous cell carcinoma,disease,1.0,31051028
10827,cSCC,disease,1.0,31051028
10828,nonmelanoma skin cancers,disease,1.0,31051028
10829,cSCC,disease,0.629,31051028
10830,epidermal growth factor receptor,gene,0.997,31051028
10831,EGFR,gene,0.992,31051028
10832,cisplatin,drug,0.9995,31051028
10833,EGFR,gene,0.9937,31051028
10834,cSCC,disease,0.52,31051028
10835,cetuximab,gene,0.7725,31051028
10836,panitumumab,gene,0.817,31051028
10837,gefitinib,drug,0.9937,31051028
10838,programmed death-1,gene,0.9824,31051028
10839,PD-1,gene,0.995,31051028
10840,cSCC,disease,0.9956,31051028
10841,PD-1,gene,0.9966,31051028
10842,cSCC,disease,0.997,31051028
10843,cSCC,disease,0.556,31051028
10844,Epidermal growth factor receptor,gene,0.9985,31043822
10845,hypomagnesemia,disease,1.0,31043822
10846,hypomagnesemia,disease,1.0,31043822
10847,hMg,disease,0.841,31043822
10848,epidermal growth factor receptor,gene,0.998,31043822
10849,advanced colorectal cancer,disease,0.997,31043822
10850,egfri,DNA,0.4663,31043822
10851,Colorectal Cancer,disease,0.9956,31043822
10852,Gastrointestinal Cancer,disease,0.9927,31043822
10853,Panitumumab,gene,0.835,31043822
10854,cetuximab,gene,0.8804,31043822
10855,cetuximab,gene,0.8726,31043822
10856,panitumumab,gene,0.8027,31043822
10857,magnesium,drug,0.9995,31043822
10858,patient,species,0.988,31043822
10859,magnesium,drug,0.9995,31043822
10860,Magnesium sulfate,drug,0.9985,31043822
10861,magnesium oxide,drug,1.0,31043822
10862,magnesium,drug,0.9995,31043822
10863,patients,species,0.9785,31043822
10864,patients,species,0.9946,31043822
10865,anti-heparin-binding epidermal growth factor-like growth factor antibody,gene,0.9746,31020609
10866,U3-1565,drug,0.9937,31020609
10867,cetuximab,gene,0.8765,31020609
10868,cetuximab,gene,0.7246,31020609
10869,panitumumab,gene,0.7754,31020609
10870,metastatic colorectal cancer,disease,0.9995,31020609
10871,KRAS,gene,0.9927,31020609
10872,anti-endothelial growth factor receptor,gene,0.9805,31020609
10873,EGFR,gene,0.9272,31020609
10874,cetuximab,gene,0.939,31020609
10875,Cetu,gene,0.8774,31020609
10876,panitumumab,gene,0.9536,31020609
10877,Pani,gene,0.883,31020609
10878,EGFR,gene,0.9976,31020609
10879,heparin-binding EGF-like growth factor,gene,0.997,31020609
10880,HB-EGF,gene,0.998,31020609
10881,U3-1565,drug,0.998,31020609
10882,anti-HB-EGF antibody,gene,0.975,31020609
10883,KRAS,gene,0.6406,31020609
10884,metastatic colorectal cancer,disease,0.9116,31020609
10885,fluoropyrimidine,drug,0.9995,31020609
10886,oxaliplatin,drug,0.9995,31020609
10887,irinotecan,drug,0.9995,31020609
10888,Cetu,drug,0.5176,31020609
10889,Cetu,drug,0.965,31020609
10890,Cetu,drug,0.8394,31020609
10891,U3-1565,drug,0.999,31020609
10892,anemia,disease,1.0,31020609
10893,-GTP,gene,0.987,31020609
10894,acneiform,disease,1.0,31020609
10895,rash,disease,0.8315,31020609
10896,panitumumab,gene,0.935,31020480
10897,irinotecan,drug,0.9854,31020480
10898,panitumumab,gene,0.734,31020480
10899,Pmab,gene,0.9272,31020480
10900,irinotecan,drug,0.9985,31020480
10901,fluoropyrimidines,drug,0.9995,31020480
10902,panitumumab,gene,0.908,31020480
10903,patients,species,0.968,31020480
10904,KRAS,gene,0.9966,31020480
10905,mCRC,disease,0.973,31020480
10906,patients,species,0.9897,31020480
10907,patients,species,0.9805,31020480
10908,IRI,disease,0.8926,31020480
10909,Pmab,gene,0.962,31020480
10910,Pmab,gene,0.92,31020480
10911,Pmab,DNA,0.6074,31020480
10912,Pmab,gene,0.963,31020480
10913,Neutropenia,disease,1.0,31020480
10914,leukopenia,disease,1.0,31020480
10915,anorexia,disease,1.0,31020480
10916,carcinoembryonic antigen,gene,0.996,31020480
10917,lactate,drug,0.999,31020480
10918,lactate dehydrogenase,gene,0.99,31020480
10919,LDH,gene,0.9937,31020480
10920,patients,species,0.972,31020480
10921,LDH-1 and -2,gene,0.997,31020480
10922,LDH-4 and -5,gene,0.997,31020480
10923,tumor,disease,1.0,31020480
10924,irinotecan,drug,0.997,31020480
10925,panitumumab,gene,0.928,31020480
10926,patient,species,0.979,31020480
10927,LDH,gene,0.994,31020480
10928,tumor,disease,1.0,31020480
10929,carcinoembryonic antigen,gene,0.9956,31020480
10930,tumour,disease,0.9863,31010330
10931,papulopustular rash,disease,1.0,31010330
10932,Papulopustular rash,disease,1.0,31010330
10933,tumour,disease,0.9487,31010330
10934,epidermal growth factor receptor,gene,0.997,31010330
10935,EGFRIs,gene,0.9355,31010330
10936,papulopustular rash,disease,1.0,31010330
10937,tumour,disease,0.9985,31010330
10938,papulopustular rash,disease,1.0,31010330
10939,malignancy,disease,0.9995,31010330
10940,papulopustular rash,disease,1.0,31010330
10941,rash,disease,0.9355,31010330
10942,EGFRIs,gene,0.9336,31010330
10943,erlotinib,drug,0.999,31010330
10944,lapatinib,drug,0.9985,31010330
10945,cetuximab,gene,0.8716,31010330
10946,panitumumab,gene,0.8228,31010330
10947,papulopustular rash,disease,1.0,31010330
10948,Imatinib,drug,0.999,31010330
10949,bevacizumab,gene,0.7207,31010330
10950,oxaliplatin,drug,0.9995,31010330
10951,everolimus,drug,0.9966,31010330
10952,exemestane,drug,0.9917,31010330
10953,goserelin,drug,0.862,31010330
10954,rash,disease,0.986,31010330
10955,rash,disease,0.982,31010330
10956,Pruritus,disease,1.0,31010330
10957,xerosis,disease,1.0,31010330
10958,paronychia,disease,0.9995,31010330
10959,increased growth of the eyelashes,disease,0.8984,31010330
10960,mucositis,disease,1.0,31010330
10961,hand-foot syndrome,disease,1.0,31010330
10962,HSF,disease,1.0,31010330
10963,symmetrical drug-related intertriginous and flexural exanthema,disease,0.9976,31010330
10964,SDRIFE,disease,0.999,31010330
10965,skin,disease,0.549,31010330
10966,tumour,disease,0.999,31010330
10967,cancer,disease,1.0,31010330
10968,anti-EGFR antibodies,gene,0.913,31002307
10969,wtEGFR,gene,0.9805,31002307
10970,EGFRvIII,gene,0.9927,31002307
10971,epidermal growth factor receptor,gene,0.998,31002307
10972,EGFR,gene,0.9966,31002307
10973,EGFR,gene,0.7227,31002307
10974,variant,DNA,0.51,31002307
10975,variant (v)III,gene,0.5845,31002307
10976,gliomas,disease,1.0,31002307
10977,patient,species,0.9814,31002307
10978,EGFRvIII,gene,0.9956,31002307
10979,EGFR,gene,0.93,31002307
10980,EGFR antibodies,gene,0.887,31002307
10981,patient-derived gliomaspheres,cell_line,0.7363,31002307
10982,patient,species,0.93,31002307
10983,gliomaspheres,disease,0.9976,31002307
10984,EGFRvIII,gene,0.9966,31002307
10985,EGFR domain III-targeting antibodies,gene,0.7915,31002307
10986,cetuximab,gene,0.579,31002307
10987,necitumumab,gene,0.935,31002307
10988,nimotuzumab,gene,0.8213,31002307
10989,matuzumab,gene,0.918,31002307
10990,EGFRvIII,gene,0.9946,31002307
10991,Chimeric monoclonal antibody 806,gene,0.9937,31002307
10992,ch806,gene,0.976,31002307
10993,EGFRvIII,gene,0.9907,31002307
10994,wild-type (wt,gene,0.925,31002307
10995,Panitumumab,gene,0.861,31002307
10996,EGFRvIII,gene,0.9966,31002307
10997,wtEGFR,gene,0.9893,31002307
10998,p-S6,gene,0.9844,31002307
10999,panitumumab,gene,0.8877,31002307
11000,Panitumumab,gene,0.874,31002307
11001,EGFRvIII,gene,0.9946,31002307
11002,EGFRvIII,gene,0.997,31002307
11003,glioma,disease,1.0,31002307
11004,EGFR domain III-targeting antibodies,gene,0.826,31002307
11005,EGFRvIII,gene,0.996,31002307
11006,panitumumab,gene,0.7095,31002307
11007,EGFRvIII,gene,0.996,31002307
11008,glioma,disease,0.9546,31002307
11009,metastatic colorectal cancer,disease,0.999,30988631
11010,metastatic colorectal cancer,disease,1.0,30988631
11011,mCRC,disease,1.0,30988631
11012,regorafenib,drug,0.991,30988631
11013,TAS-102,drug,0.997,30988631
11014,mCRC,disease,0.991,30988631
11015,mCRC,disease,0.9995,30988631
11016,HER2,gene,0.649,30988631
11017,colon cancer,disease,1.0,30988631
11018,EGFR,gene,0.9946,30968289
11019,RAS,gene,0.999,30968289
11020,RAF,gene,0.995,30968289
11021,Metastatic Colorectal Cancer,disease,1.0,30968289
11022,epidermal growth factor receptor,gene,0.9985,30968289
11023,EGFR,gene,0.994,30968289
11024,RAS,gene,0.999,30968289
11025,RAF,gene,0.994,30968289
11026,tumor,disease,1.0,30968289
11027,anti-EGFR monoclonal antibodies,gene,0.801,30968289
11028,cetuximab,gene,0.8687,30968289
11029,panitumumab,gene,0.746,30968289
11030,metastatic colorectal cancer,disease,1.0,30968289
11031,mCRC,disease,1.0,30968289
11032,anti-,gene,0.5024,30968289
11033,EGFR antibodies,gene,0.7983,30968289
11034,anti-EGFR antibodies,gene,0.8945,30968289
11035,RAS,DNA,0.5503,30968289
11036,RAS mutations,gene,0.958,30968289
11037,anti-,gene,0.6616,30968289
11038,EGFR antibody,gene,0.819,30968289
11039,mutant-type BRAF,gene,0.856,30968289
11040,mCRC,disease,0.9736,30968289
11041,EGFR,gene,0.9956,30968289
11042,RAS,gene,0.9985,30968289
11043,RAF,gene,0.9976,30968289
11044,EGFR,gene,0.994,30968289
11045,RAS,gene,0.998,30968289
11046,RAF,gene,0.997,30968289
11047,Circulating Tumor DNA,RNA,0.6416,30967998
11048,EGFR,gene,0.647,30967998
11049,Advanced Colorectal Cancer,disease,1.0,30967998
11050,EGFR antibodies,gene,0.7456,30967998
11051,KRAS-,disease,0.608,30967998
11052,KRAS,gene,0.519,30967998
11053,Circulating tumor DNA,RNA,0.566,30967998
11054,ctDNA,DNA,0.625,30967998
11055,KRAS,DNA,0.542,30967998
11056,KRAS mutant clones,cell_line,0.8457,30967998
11057,KRAS mutant,gene,0.8203,30967998
11058,metastatic and recurrent rectal cancer,disease,0.8296,30967998
11059,tumor,disease,0.999,30967998
11060,KRAS,gene,0.8438,30967998
11061,cetuximab,gene,0.931,30967998
11062,panitumumab,gene,0.911,30967998
11063,ctDNA,cell_type,0.526,30967998
11064,KRAS,gene,0.869,30967998
11065,cetuximab,gene,0.964,30967998
11066,ctDNA,DNA,0.4524,30967998
11067,KRAS,DNA,0.819,30967998
11068,KRAS mutations,gene,0.955,30967998
11069,KRAS mutations,gene,0.736,30967998
11070,ctDNA,DNA,0.71,30967998
11071,KRAS mutation,gene,0.6895,30967998
11072,KRAS,gene,0.816,30967998
11073,anti-EGFR antibody,gene,0.966,30967998
11074,KRAS mutations,gene,0.686,30967998
11075,ctDNA,DNA,0.7217,30967998
11076,KRAS,gene,0.9,30967998
11077,ctDNA,DNA,0.503,30967998
11078,KRAS,gene,0.5776,30967998
11079,advanced colorectal cancers,disease,0.977,30967998
11080,resistant clones,cell_line,0.501,30967998
11081,resistant clones,cell_line,0.9336,30967998
11082,anti-EGFR antibodies,gene,0.988,30967998
11083,bevacizumab,gene,0.903,30941962
11084,cetuximab,gene,0.899,30941962
11085,panitimumab,gene,0.642,30941962
11086,RAS,gene,0.6333,30941962
11087,metastatic colorectal cancer,disease,0.999,30941962
11088,KRAS,gene,0.789,30941962
11089,metastatic colorectal cancer,disease,0.9995,30941962
11090,CRC,disease,1.0,30941962
11091,bevacizumab,gene,0.8164,30941962
11092,cetuximab,gene,0.825,30941962
11093,panitumumab,gene,0.869,30941962
11094,bevacizumab,gene,0.8354,30941962
11095,cetuximab,gene,0.8965,30941962
11096,panitumumab,gene,0.889,30941962
11097,KRAS,gene,0.683,30941962
11098,CRC adenocarcinoma,disease,0.9995,30941962
11099,tumor,disease,0.9937,30941962
11100,tumor,disease,0.998,30941962
11101,panitumumab,gene,0.941,30941962
11102,bevacizumab,gene,0.7515,30941962
11103,cetuximab,gene,0.911,30941962
11104,neuropathy,disease,1.0,30941962
11105,neutropenia,disease,1.0,30941962
11106,bevacizumab,gene,0.9634,30941962
11107,neutropenia,disease,1.0,30941962
11108,perforation,disease,0.9854,30941962
11109,FOLFIRI,drug,0.9595,30941962
11110,bevacizumab,gene,0.9546,30941962
11111,rash,disease,0.9995,30941962
11112,pustular infection,disease,1.0,30941962
11113,FOLFIRI,drug,0.996,30941962
11114,cetuximab,gene,0.9673,30941962
11115,diarrhea,disease,1.0,30941962
11116,FOLFIRI,drug,0.996,30941962
11117,panitumumab,gene,0.9756,30941962
11118,KRAS,DNA,0.774,30941962
11119,KRAS wild,gene,0.779,30941962
11120,metastatic colorectal cancer,disease,0.9927,30941962
11121,lymphangitic carcinomatosis,disease,1.0,30936723
11122,pulmonary lymphangitic carcinomatosis,disease,1.0,30936723
11123,patients,species,0.9775,30936723
11124,cancer,disease,1.0,30936723
11125,cancer,disease,1.0,30936723
11126,patients,species,0.958,30936723
11127,colorectal carcinoma,disease,1.0,30936723
11128,lymphangitic carcinomatosis,disease,1.0,30936723
11129,epidermal growth factor receptor,gene,0.9717,30936723
11130,anti-EGFR,gene,0.9565,30936723
11131,woman,species,0.9287,30936723
11132,cough,disease,0.9985,30936723
11133,dyspnea,disease,0.999,30936723
11134,advanced carcinoma of the sigmoid colon,disease,1.0,30936723
11135,lymphangitic carcinomatosis,disease,1.0,30936723
11136,FOLFIRI,drug,0.781,30936723
11137,cetuximab,gene,0.8438,30936723
11138,dyspnea,disease,0.9985,30936723
11139,lymphangitic carcinomatosis,disease,1.0,30936723
11140,man,species,0.8784,30936723
11141,fever,disease,0.999,30936723
11142,dyspnea,disease,0.9995,30936723
11143,advanced carcinoma of the transverse colon,disease,1.0,30936723
11144,lymphangitic carcinomatosis,disease,1.0,30936723
11145,FOLFIRI,drug,0.9873,30936723
11146,panitumumab,gene,0.7515,30936723
11147,dyspnea,disease,0.9985,30936723
11148,lymphangitic carcinomatosis,disease,1.0,30936723
11149,oncologic,disease,0.9966,30936723
11150,lymphangitic carcinomatosis,disease,1.0,30936723
11151,anti-EGFR antibodies,gene,0.7715,30936723
11152,anti-EGFR,gene,0.6206,30924091
11153,cetuximab,gene,0.983,30924091
11154,panitumumab,gene,0.956,30924091
11155,RAS,gene,0.996,30924091
11156,mCRC,disease,0.9995,30924091
11157,patients,species,0.9946,30924091
11158,patients,species,0.995,30924091
11159,patients,species,0.996,30924091
11160,cetuximab,gene,0.934,30924091
11161,patients,species,0.9956,30924091
11162,panitumumab,gene,0.8105,30924091
11163,patients,species,0.992,30924091
11164,patients,species,0.9893,30924091
11165,patients,species,0.9873,30924091
11166,-,DNA,0.4868,30924091
11167,cetuximab,gene,0.927,30924091
11168,panitumumab,gene,0.9106,30924091
11169,RAS,gene,0.9834,30924091
11170,mCRC,disease,0.997,30924091
11171,patients,species,0.9893,30924091
11172,anti-EGFR,gene,0.864,30924091
11173,patients,species,0.99,30924091
11174,muscle,disease,0.936,30924091
11175,EGFR,gene,0.617,30924091
11176,advanced esophageal squamous cell carcinoma,disease,1.0,30920626
11177,advanced esophageal squamous cell carcinoma,disease,1.0,30920626
11178,ESCC,disease,1.0,30920626
11179,Cisplatin,drug,0.9995,30920626
11180,5-fluorouracil,drug,0.999,30920626
11181,irinotecan,drug,0.9995,30920626
11182,oxaliplatin,drug,1.0,30920626
11183,paclitaxel,drug,0.9995,30920626
11184,gefitinib,drug,0.9956,30920626
11185,panitumumab,gene,0.824,30920626
11186,nimotuzumab,gene,0.755,30920626
11187,gefitinib,drug,0.9976,30920626
11188,panitumumab,gene,0.6455,30920626
11189,PD-1,gene,0.994,30920626
11190,patients,species,0.925,30920626
11191,ESCC,disease,0.9995,30920626
11192,ESCC,disease,0.991,30920626
11193,ESCC,disease,0.992,30920626
11194,Locally Advanced Rectal Cancer,disease,1.0,30914588
11195,Panitumumab,gene,0.812,30914588
11196,locally advanced rectal cancer,disease,0.9995,30914588
11197,lower abdominal pain,disease,0.8574,30914588
11198,rectal tumor,disease,0.9995,30914588
11199,panperitonitis,disease,1.0,30914588
11200,cancerous perforation,disease,0.9995,30914588
11201,rectal tumor,disease,1.0,30914588
11202,well-differentiated tubular adenocarcinoma,disease,0.9766,30914588
11203,wild-type RAS,gene,0.6685,30914588
11204,panitumumab,gene,0.687,30914588
11205,tumor cells,cell_type,0.723,30914588
11206,tumor,disease,0.9995,30914588
11207,histiocytes,cell_type,0.885,30914588
11208,panitumumab,gene,0.9365,30914588
11209,RAS,gene,0.564,30914588
11210,locally advanced colon cancer,disease,0.9897,30914588
11211,tumor,disease,0.732,30914588
11212,Hyperammonemic Encephalopathy,disease,0.996,30914529
11213,Metastatic Colon Cancer,disease,1.0,30914529
11214,colon cancer,disease,1.0,30914529
11215,liver metastases,disease,0.717,30914529
11216,panitumumab,gene,0.6343,30914529
11217,5-FU,drug,0.998,30914529
11218,hyperammonemia,disease,0.9624,30914529
11219,branchedchain amino acid,drug,0.9956,30914529
11220,fluoropyrimidine,drug,0.987,30914529
11221,hyperammonemic encephalopathy,disease,1.0,30914529
11222,FOLFOXIRI,drug,0.9062,30887844
11223,advanced colorectal cancer,disease,0.9995,30887844
11224,oxaliplatin,drug,1.0,30887844
11225,irinotecan,drug,0.9995,30887844
11226,fluorouracil,drug,0.9995,30887844
11227,5-FU,drug,0.9995,30887844
11228,leucovorin,drug,0.999,30887844
11229,FOLFOXIRI,drug,0.5366,30887844
11230,metastatic colorectal cancer,disease,1.0,30887844
11231,mCRC,disease,1.0,30887844
11232,FOLFOXIRI,drug,0.968,30887844
11233,FOLFOXIRI,drug,0.9453,30887844
11234,mCRC,disease,0.977,30887844
11235,metastatic,disease,0.852,30887844
11236,tumor,disease,0.738,30887844
11237,Panitumumab,gene,0.946,30887844
11238,FOLFOXIRI,drug,0.7354,30887844
11239,bevacizumab,gene,0.941,30887844
11240,bevacizumab,gene,0.6987,30887844
11241,anti-EGFR,gene,0.931,30887844
11242,metastatic colorectal cancer,disease,0.9473,30887616
11243,metastatic colorectal cancer,disease,1.0,30887616
11244,mCRC,disease,1.0,30887616
11245,5-fluorouracil,drug,0.9995,30887616
11246,capecitabine,drug,0.999,30887616
11247,irinotecan,drug,0.998,30887616
11248,oxaliplatin,drug,0.9995,30887616
11249,bevacizumab,gene,0.9297,30887616
11250,cetuximab,gene,0.9614,30887616
11251,panitumumab,gene,0.962,30887616
11252,mCRC,disease,0.967,30887616
11253,ACCORD,DNA,0.548,30887616
11254,mCRC,disease,0.9985,30887616
11255,mCRC,disease,0.9995,30887616
11256,KRAS,gene,0.8203,30887616
11257,KRAS,DNA,0.709,30887616
11258,KRAS wild,gene,0.7915,30887616
11259,KRAS,gene,0.7217,30887616
11260,KRAS,gene,0.539,30887616
11261,mCRC,disease,0.9805,30887616
11262,mCRC,disease,0.9966,30887616
11263,Dermatologic Toxicities,disease,0.8516,30880806
11264,Metastatic Colorectal Cancer,disease,1.0,30880806
11265,Panitumumab,gene,0.778,30880806
11266,metastatic colorectal cancer,disease,1.0,30880806
11267,mCRC,disease,1.0,30880806
11268,rash,disease,0.9873,30880806
11269,mCRC,disease,0.996,30880806
11270,panitumumab,gene,0.8384,30880806
11271,panitumumab,gene,0.8438,30880806
11272,rash,disease,1.0,30880806
11273,anti-EGFR,gene,0.8145,30863179
11274,VEGF mAb,gene,0.919,30863179
11275,metastatic colorectal cancer,disease,0.9985,30863179
11276,Anti-EGFR mAb,gene,0.9824,30863179
11277,cetuximab,gene,0.944,30863179
11278,panitumumab,gene,0.949,30863179
11279,anti-VEGF mAb,gene,0.9727,30863179
11280,bevacizumab,gene,0.7905,30863179
11281,RAS,DNA,0.5117,30863179
11282,RAS wild,gene,0.9136,30863179
11283,metastatic colorectal cancer,disease,1.0,30863179
11284,mCRC,disease,1.0,30863179
11285,anti-EGFR mAb,gene,0.9814,30863179
11286,VEGF mAb,gene,0.818,30863179
11287,bevacizumab,gene,0.687,30863179
11288,cetuximab,gene,0.899,30863179
11289,panitumumab,gene,0.904,30863179
11290,anti-EGFR mAb,gene,0.894,30863179
11291,anti-EGFR,gene,0.8936,30863179
11292,VEGF mAb,gene,0.838,30863179
11293,RAS,gene,0.4792,30863179
11294,KRAS,gene,0.906,30863179
11295,mCRC,disease,0.99,30863179
11296,mCRC,disease,0.998,30863179
11297,mCRC,disease,0.995,30863179
11298,Tivantinib,drug,0.998,30846365
11299,Cetuximab,gene,0.7227,30846365
11300,KRAS,gene,0.5176,30846365
11301,Metastatic Colorectal Cancer,disease,0.8647,30846365
11302,EGFR,gene,0.987,30846365
11303,MET,gene,0.9937,30846365
11304,EGFR,gene,0.9946,30846365
11305,MET,gene,0.991,30846365
11306,MET,gene,0.616,30846365
11307,epidermal growth factor receptor,gene,0.9966,30846365
11308,metastatic colorectal cancer,disease,1.0,30846365
11309,mCRC,disease,1.0,30846365
11310,tivantinib,drug,0.9976,30846365
11311,MET receptor tyrosine kinase,gene,0.994,30846365
11312,tyrosine,drug,0.9756,30846365
11313,epidermal growth factor receptor-resistant,disease,0.999,30846365
11314,epidermal growth factor receptor,gene,0.9736,30846365
11315,MET,gene,0.9834,30846365
11316,PATIENTS,species,0.934,30846365
11317,MET,gene,0.949,30846365
11318,KRAS,gene,0.776,30846365
11319,mCRC,disease,0.9717,30846365
11320,cetuximab,gene,0.886,30846365
11321,panitumumab,gene,0.8843,30846365
11322,tumor,disease,0.9985,30846365
11323,cetuximab,gene,0.8623,30846365
11324,panitumumab,gene,0.857,30846365
11325,tivantinib,drug,0.999,30846365
11326,cetuximab,gene,0.5,30846365
11327,MET,gene,0.828,30846365
11328,MET,gene,0.829,30846365
11329,neutropenia,disease,1.0,30846365
11330,fatigue,disease,0.9907,30846365
11331,tivantinib,drug,0.9985,30846365
11332,cetuximab,gene,0.8506,30846365
11333,KRAS,gene,0.8394,30840064
11334,NRAS,gene,0.799,30840064
11335,BRAF,gene,0.8247,30840064
11336,PIK3CA,gene,0.795,30840064
11337,metastatic colorectal cancer,disease,1.0,30840064
11338,panitumumab,gene,0.887,30840064
11339,FOLFIRI,drug,0.711,30840064
11340,ULTRA,DNA,0.4873,30840064
11341,KRAS,gene,0.781,30840064
11342,EGFR,gene,0.8975,30840064
11343,KRAS,gene,0.8003,30840064
11344,NRAS,gene,0.744,30840064
11345,BRAF,gene,0.716,30840064
11346,PIK3CA,gene,0.56,30840064
11347,panitumumab,gene,0.853,30840064
11348,FOLFIRI,drug,0.9688,30840064
11349,PATIENTS,species,0.977,30840064
11350,"KRAS, NRAS, BRAF and PIK3CA hotspots",DNA,0.729,30840064
11351,KRAS,gene,0.954,30840064
11352,NRAS,gene,0.964,30840064
11353,BRAF,gene,0.9834,30840064
11354,PIK3CA,gene,0.98,30840064
11355,tumour,disease,0.8247,30840064
11356,irinotecan,drug,0.9995,30840064
11357,metastatic colorectal cancer,disease,0.992,30840064
11358,panitumumab,gene,0.839,30840064
11359,FOLFIRI,drug,0.9062,30840064
11360,RAS,gene,0.962,30840064
11361,KRAS,gene,0.791,30840064
11362,NRAS,gene,0.6353,30840064
11363,RAS,gene,0.5303,30840064
11364,BRAF,gene,0.49,30840064
11365,PIK3CA,DNA,0.7935,30840064
11366,PIK3CA mutations,gene,0.912,30840064
11367,RAS,gene,0.5264,30840064
11368,KRAS,gene,0.8535,30840064
11369,NRAS,gene,0.6533,30840064
11370,RAS,gene,0.7437,30840064
11371,BRAF,gene,0.7046,30840064
11372,RAS,gene,0.998,30840064
11373,BRAF,gene,0.5454,30840064
11374,KRAS,gene,0.6626,30840064
11375,NRAS,gene,0.7036,30840064
11376,BRAF,gene,0.7617,30840064
11377,PIK3CA,DNA,0.4707,30840064
11378,PIK3CA mutations,gene,0.952,30840064
11379,RAS,gene,0.6313,30840064
11380,BRAF,gene,0.656,30840064
11381,Epidermal Growth Factor Receptor,gene,0.9985,30824613
11382,EGFR,gene,0.9946,30824613
11383,EGFR Antibodies,gene,0.947,30824613
11384,Epidermal growth factor receptor,gene,0.999,30824613
11385,EGFR,gene,0.9976,30824613
11386,cancer,disease,1.0,30824613
11387,cetuximab,gene,0.658,30824613
11388,panitumumab,gene,0.497,30824613
11389,EGFR nanobody,gene,0.9585,30824613
11390,7D12,gene,0.577,30824613
11391,IgG1 Fc portion,gene,0.872,30824613
11392,7D12,gene,0.991,30824613
11393,hcAb,gene,0.9497,30824613
11394,EGFR ectodomain,gene,0.9834,30824613
11395,EGFR,gene,0.987,30824613
11396,7D12-hcAb,gene,0.86,30824613
11397,cell lines,cell_line,0.937,30824613
11398,EGFR ectodomain variants,gene,0.929,30824613
11399,synthetic mutants,DNA,0.6055,30824613
11400,7D12-hcAb,gene,0.958,30824613
11401,7D12-hcAb,gene,0.9917,30824613
11402,7D12-hcAb epitope,gene,0.923,30824613
11403,EGF-binding site,gene,0.997,30824613
11404,7D12-hcAb,gene,0.961,30824613
11405,7D12,gene,0.977,30824613
11406,hcAb,gene,0.747,30824613
11407,cetuximab,gene,0.9937,30824613
11408,panitumumab epitope,gene,0.7324,30824613
11409,7D12-hcAb,gene,0.9404,30824613
11410,cetuximab,gene,0.9287,30824613
11411,cetuximab,gene,0.9556,30824613
11412,panitumumab,gene,0.981,30824613
11413,aberrantly N-glycosylated EGFR R521K,gene,0.902,30824613
11414,N,drug,0.7983,30824613
11415,R521K,mutation,,30824613
11416,Fc,gene,0.957,30824613
11417,7D12,gene,0.9697,30824613
11418,hcAb,gene,0.8955,30824613
11419,cells,cell_type,0.3584,30824613
11420,7D12-,gene,0.943,30824613
11421,hcAb,gene,0.651,30824613
11422,EGFR variants,gene,0.987,30824613
11423,EGFR antibody,gene,0.9644,30824613
11424,human papillomavirus,disease,0.9995,30819445
11425,HPV,disease,0.966,30819445
11426,patients,species,0.9766,30819445
11427,head and neck squamous cell carcinoma,disease,1.0,30819445
11428,HNSCC,disease,1.0,30819445
11429,epidermal growth factor receptor,gene,0.9976,30819445
11430,EGFR,gene,0.9956,30819445
11431,EGFR,gene,0.993,30819445
11432,HNSCCs,disease,0.998,30819445
11433,patient,species,0.978,30819445
11434,HPV,species,0.6826,30819445
11435,p16,gene,0.9976,30819445
11436,p16,gene,0.9946,30819445
11437,patients,species,0.982,30819445
11438,EGFR,gene,0.98,30819445
11439,patients,species,0.9517,30819445
11440,HPV,species,0.773,30819445
11441,Patient,species,0.944,30819445
11442,HPV,species,0.5015,30819445
11443,EGFR,gene,0.9883,30819445
11444,HNSCC,disease,0.999,30819445
11445,GC1118,drug,0.9243,30815759
11446,anti-EGFR antibody,gene,0.9126,30815759
11447,KRAS,gene,0.9917,30815759
11448,EGFR,gene,0.991,30815759
11449,gastric cancer,disease,1.0,30815759
11450,GC,disease,1.0,30815759
11451,patients,species,0.992,30815759
11452,anti-,gene,0.8706,30815759
11453,EGFR antibodies cetuximab,gene,0.7363,30815759
11454,panitumumab,gene,0.5483,30815759
11455,GC,disease,,30815759
11456,patients,species,0.9927,30815759
11457,anti-EGFR antibody,gene,0.989,30815759
11458,cetuximab,gene,0.945,30815759
11459,panitumumab,gene,0.8877,30815759
11460,GC,disease,,30815759
11461,GC cell lines,cell_line,0.853,30815759
11462,GC,disease,,30815759
11463,SNU-1,cell_line,0.9004,30815759
11464,SNU-5,cell_line,0.877,30815759
11465,SNU-16,cell_line,0.8784,30815759
11466,SNU-216,cell_line,0.9043,30815759
11467,SNU-484,cell_line,0.8843,30815759
11468,SNU-601,cell_line,0.859,30815759
11469,SNU-620,cell_line,0.8525,30815759
11470,SNU-638,cell_line,0.8105,30815759
11471,SNU-668,cell_line,0.7915,30815759
11472,SNU-719,cell_line,0.8276,30815759
11473,AGS,cell_line,0.859,30815759
11474,MKN-45,cell_line,0.882,30815759
11475,NCI-N87,cell_line,0.8833,30815759
11476,KATO-III,cell_line,0.9395,30815759
11477,cetuximab,gene,0.9497,30815759
11478,GC1118,drug,0.9263,30815759
11479,cisplatin,drug,0.9995,30815759
11480,5-fluorouracil,drug,0.9995,30815759
11481,5-FU,drug,0.9995,30815759
11482,EGF,gene,0.961,30815759
11483,HB-EGF,gene,0.9976,30815759
11484,GC1118,drug,0.801,30815759
11485,cell lines,cell_line,0.9443,30815759
11486,cetuximab,gene,0.732,30815759
11487,MTT,drug,0.999,30815759
11488,KRAS,DNA,0.688,30815759
11489,KRAS,gene,0.9946,30815759
11490,GC1118,drug,0.9937,30815759
11491,cisplatin,drug,0.9995,30815759
11492,5-FU,drug,0.999,30815759
11493,EGFR,gene,0.9873,30815759
11494,p-AKT,gene,0.9966,30815759
11495,p-ERK,gene,0.981,30815759
11496,GC1118,drug,0.7485,30815759
11497,cetuximab,gene,0.8735,30815759
11498,anti,disease,0.775,30815759
11499,tumor,disease,0.7495,30815759
11500,cetuximab,gene,0.733,30815759
11501,mouse,species,0.949,30815759
11502,GC1118,drug,0.9683,30815759
11503,tumor,disease,0.899,30815759
11504,cetuximab,gene,0.64,30815759
11505,GC cells,cell_line,0.8735,30815759
11506,GC,disease,,30815759
11507,KRAS,gene,0.99,30815759
11508,GC1118,drug,0.9824,30815759
11509,GC,disease,,30815759
11510,Panitumumab,gene,0.966,30798171
11511,cancer,disease,1.0,30798171
11512,colorectal cancer,disease,1.0,30798171
11513,CRC,disease,1.0,30798171
11514,malignancy,disease,0.997,30798171
11515,CRC,disease,0.9995,30798171
11516,panitumumab,gene,0.9526,30798171
11517,IgG,gene,0.99,30798171
11518,Mice,species,0.9023,30798171
11519,CRC cell lines,cell_line,0.917,30798171
11520,CRC,disease,1.0,30798171
11521,LS174T,cell_line,0.9575,30798171
11522,Colo205,cell_line,0.9214,30798171
11523,SW948,cell_line,0.9463,30798171
11524,tumor,disease,0.7275,30798171
11525,mice,species,0.9565,30798171
11526,tumors,disease,1.0,30798171
11527,Panitumumab,gene,0.9565,30798171
11528,cell lines,cell_line,0.9175,30798171
11529,LS174T,cell_line,0.938,30798171
11530,Colo205,cell_line,0.929,30798171
11531,SW948,cell_line,0.901,30798171
11532,Colo205,cell_line,0.9565,30798171
11533,SW948 cell lines,cell_line,0.938,30798171
11534,panitumumab,gene,0.9727,30798171
11535,epidermal growth factor receptor,gene,0.998,30798171
11536,EGFR,gene,0.9946,30798171
11537,EGFR,gene,0.991,30798171
11538,cell lines,cell_line,0.9087,30798171
11539,EGFR,gene,0.9897,30798171
11540,Panitumumab,gene,0.9785,30798171
11541,IgG,gene,0.993,30798171
11542,CRC,disease,0.9995,30798171
11543,CRC,disease,0.9995,30798171
11544,Epidermal Growth Factor Receptor,gene,0.999,30765854
11545,EGFR,gene,0.9956,30765854
11546,Human Epidermal Growth Factor Receptor 2,gene,0.999,30765854
11547,HER2,gene,0.9966,30765854
11548,Bladder Cancer,disease,1.0,30765854
11549,Bladder cancer,disease,1.0,30765854
11550,BC,disease,1.0,30765854
11551,tumors,disease,1.0,30765854
11552,tumors,disease,0.457,30765854
11553,EGFR,gene,0.9883,30765854
11554,tumor,disease,1.0,30765854
11555,EGFR,gene,0.9907,30765854
11556,BC,disease,0.6646,30765854
11557,EGFR,gene,0.991,30765854
11558,HER2,gene,0.9917,30765854
11559,panitumumab,gene,0.968,30765854
11560,pan,gene,0.944,30765854
11561,trastuzumab,gene,0.9854,30765854
11562,tra,gene,0.898,30765854
11563,BC,disease,1.0,30765854
11564,cell lines,cell_line,0.9424,30765854
11565,EGFR,gene,0.983,30765854
11566,HER2,gene,0.9907,30765854
11567,BC,disease,1.0,30765854
11568,EGFR,gene,0.991,30765854
11569,HER2,gene,0.988,30765854
11570,pan,DNA,0.516,30765854
11571,tra IR700,DNA,0.539,30765854
11572,Tumor xenografts,cell_line,0.652,30765854
11573,Tumor,disease,0.998,30765854
11574,tumor,disease,0.837,30765854
11575,BC,disease,0.9995,30765854
11576,bladder cancer,disease,1.0,30765854
11577,bladder tumors,disease,1.0,30765854
11578,Lower Rectal Cancer,disease,1.0,30765664
11579,melena,disease,0.9985,30765664
11580,advanced rectal cancer,disease,1.0,30765664
11581,capecitabine,drug,0.9995,30765664
11582,oxaliplatin,drug,0.9995,30765664
11583,CapeOX,drug,0.9966,30765664
11584,bevacizumab,gene,0.574,30765664
11585,CapeOX,drug,0.997,30765664
11586,panitumumab,gene,0.854,30765664
11587,RAS,DNA,0.6763,30765664
11588,RAS mutation,gene,0.7915,30765664
11589,tumor,disease,0.831,30765664
11590,cancer cells,cell_type,0.8467,30765664
11591,cancer,disease,0.993,30765664
11592,carcinoma,disease,1.0,30765664
11593,interstitial lung disease,disease,1.0,30739089
11594,Panitumumab,gene,0.6826,30739089
11595,recombinant human IgG(2) monoclonal antibody,gene,0.9966,30739089
11596,human,species,0.7305,30739089
11597,patients,species,0.9956,30739089
11598,metastatic colorectal cancer,disease,1.0,30739089
11599,mCRC,disease,1.0,30739089
11600,FOLFIRI,drug,0.8335,30739089
11601,fluoropyrimidine,drug,1.0,30739089
11602,oxaliplatin,drug,0.9995,30739089
11603,irinotecan,drug,0.999,30739089
11604,man,species,0.851,30739089
11605,KRAS,gene,0.994,30739089
11606,NRAS,gene,0.9985,30739089
11607,mCRC,disease,0.9844,30739089
11608,fluorouracil,drug,1.0,30739089
11609,leucovorin,drug,0.999,30739089
11610,oxaliplatin,drug,0.9995,30739089
11611,CRC,disease,0.9976,30739089
11612,panitumumab,gene,0.766,30739089
11613,FOLFIRI,drug,0.9565,30739089
11614,acute hypoxaemic respiratory failure,disease,0.9707,30739089
11615,interstitial lung disease,disease,1.0,30739089
11616,ILD,disease,1.0,30739089
11617,ILD,disease,1.0,30739089
11618,ILD,disease,1.0,30739089
11619,panitumumab,gene,0.6763,30739089
11620,Head and Neck Cancer,disease,1.0,30733319
11621,solid tumors,disease,1.0,30733319
11622,cancerous,disease,0.7,30733319
11623,head and neck cancer,disease,1.0,30733319
11624,Head and neck cancer,disease,1.0,30733319
11625,panitumumab,gene,0.972,30733319
11626,primary,disease,0.8813,30733319
11627,tumors,disease,0.786,30733319
11628,Panitumumab,gene,0.7837,30728710
11629,metastatic right and left colon cancer,disease,1.0,30722106
11630,colorectal cancer,disease,1.0,30722106
11631,CRC,disease,1.0,30722106
11632,metastatic CRC,disease,0.969,30722106
11633,right colon cancer,disease,1.0,30722106
11634,RCC,disease,1.0,30722106
11635,left colon cancer,disease,1.0,30722106
11636,LCC,disease,1.0,30722106
11637,metastatic RCC,disease,0.998,30722106
11638,LCC,disease,0.9995,30722106
11639,left,DNA,0.471,30722106
11640,left-sided tumors,disease,1.0,30722106
11641,right,DNA,0.4744,30722106
11642,right-sided tumors,disease,1.0,30722106
11643,panitumumab,gene,0.8267,30722106
11644,LCC,disease,1.0,30722106
11645,RCC,disease,1.0,30722106
11646,FOLFIRI,drug,0.7705,30722106
11647,cetuximab,gene,0.9146,30722106
11648,LCC,disease,1.0,30722106
11649,RCC,disease,1.0,30722106
11650,LCC,disease,1.0,30722106
11651,RCC,disease,0.4626,30722106
11652,EGFR,gene,0.9883,30701564
11653,head and neck cancers,disease,1.0,30701564
11654,Epidermal growth factor receptor,gene,0.998,30701564
11655,EGFR,gene,0.9956,30701564
11656,squamous cell carcinoma of the head and neck,disease,1.0,30701564
11657,SCCHN,disease,1.0,30701564
11658,EGFR,gene,0.9927,30701564
11659,transforming growth factor,gene,0.965,30701564
11660,EGFR,gene,0.991,30701564
11661,Cetuximab,gene,0.883,30701564
11662,SCCHN,disease,0.9995,30701564
11663,Cetuximab,gene,0.782,30701564
11664,EGFR,gene,0.9927,30701564
11665,Cetuximab,gene,0.7607,30701564
11666,EGFR,gene,0.9927,30701564
11667,EGFR,gene,0.9937,30701564
11668,SCCHN,disease,1.0,30701564
11669,Cancer,disease,0.9995,30698084
11670,cancer,disease,1.0,30698084
11671,PharmGKB,DNA,0.4702,30698084
11672,cancer,disease,0.9985,30698084
11673,cancer,disease,1.0,30698084
11674,fluoropyrimidine,drug,0.9995,30698084
11675,6-mercaptopurine,drug,0.9995,30698084
11676,irinotecan,drug,0.9995,30698084
11677,carboplatin,drug,0.9995,30698084
11678,cisplatin,drug,0.9995,30698084
11679,erlotinib,drug,0.999,30698084
11680,gefitinib,drug,0.998,30698084
11681,panitumumab,gene,0.9277,30698084
11682,trastuzumab,gene,0.974,30698084
11683,drug-gene pairs,DNA,0.7256,30698084
11684,cancer,disease,1.0,30698084
11685,Metastatic Colon Cancer,disease,1.0,30692476
11686,Patient,species,0.667,30692476
11687,man,species,0.8896,30692476
11688,diabetic nephropathy,disease,1.0,30692476
11689,sigmoid cancer,disease,1.0,30692476
11690,liver metastases,disease,0.9688,30692476
11691,FOLFIRI,drug,0.987,30692476
11692,panitumumab,gene,0.9604,30692476
11693,Pmab,gene,0.9697,30692476
11694,capecitabine,drug,0.9985,30692476
11695,bevacizumab,gene,0.798,30692476
11696,Bmab,gene,0.904,30692476
11697,heart disease,disease,1.0,30692476
11698,diabetic gangrene in both legs,disease,0.9956,30692476
11699,abscess of liver metastasis,disease,1.0,30692476
11700,Pmab,gene,0.725,30692476
11701,liver and para-aortic lymph node metastases,disease,0.9995,30692476
11702,liver metastasis,disease,0.9893,30692476
11703,patients,species,0.9814,30692476
11704,metastatic colon cancer,disease,1.0,30692476
11705,patient,species,0.981,30692476
11706,Sigmoid Colon Cancer,disease,1.0,30692417
11707,Liver Metastasis,disease,0.9053,30692417
11708,woman,species,0.8306,30692417
11709,CEA,gene,0.6436,30692417
11710,RAS,gene,0.997,30692417
11711,sigmoid colon cancer,disease,0.947,30692417
11712,synchronous,disease,0.8477,30692417
11713,liver metastasis,disease,0.9717,30692417
11714,LM,disease,1.0,30692417
11715,CapeOX,drug,0.9985,30692417
11716,LM lesion,disease,0.8965,30692417
11717,FOLFIRI,drug,0.9854,30692417
11718,panitumumab,gene,0.8716,30692417
11719,LM lesion,disease,0.961,30692417
11720,Solid Tumors,disease,0.893,30692417
11721,patient,species,0.9595,30692417
11722,cholecystectomy,disease,0.9414,30692417
11723,patient,species,0.98,30692417
11724,FOLFIRI,drug,0.886,30692417
11725,panitumumab,gene,0.8467,30692417
11726,PTPE,drug,0.908,30692417
11727,sigmoid colon cancer,disease,1.0,30692417
11728,LM,disease,,30692417
11729,Transverse Colon Cancer,disease,1.0,30692389
11730,woman,species,0.8467,30692389
11731,transverse colon cancer,disease,0.9097,30692389
11732,colonic obstruction,disease,1.0,30692389
11733,bowel obstruction,disease,1.0,30692389
11734,tumor,disease,0.6006,30692389
11735,obstructive,disease,0.8535,30692389
11736,transverse colon cancer,disease,0.9697,30692389
11737,tumor,disease,0.7817,30692389
11738,liver metastasis,disease,0.991,30692389
11739,lung metastases,disease,0.9346,30692389
11740,liver metastasis,disease,0.8384,30692389
11741,liver,disease,0.8877,30692389
11742,metastatic colorectal cancer,disease,1.0,30692389
11743,RAS,gene,0.997,30692389
11744,FOLFIRI,drug,0.9736,30692389
11745,panitumumab,gene,0.844,30692389
11746,colonic,DNA,0.476,30692389
11747,woman,species,0.8936,30692352
11748,sigmoid colon cancer,disease,1.0,30692352
11749,UFT,drug,0.9966,30692352
11750,UZEL,drug,0.9844,30692352
11751,lung lesions,disease,0.8564,30692352
11752,FOLFOX,drug,0.9463,30692352
11753,panitumumab,gene,0.844,30692352
11754,adenocarcinoma,disease,1.0,30692352
11755,primary sigmoid colon cancer,disease,0.9907,30692352
11756,lung lesions,disease,0.9976,30692352
11757,colon cancer,disease,0.8735,30692352
11758,patient,species,0.985,30692352
11759,man,species,0.8325,30692330
11760,synchronous liver metastases,disease,0.765,30692330
11761,sigmoid colon cancer,disease,1.0,30692330
11762,FOLFOX,drug,0.8853,30692330
11763,panitumumab,gene,0.902,30692330
11764,liver metastases,disease,0.821,30692330
11765,hepatic lesions,disease,0.8726,30692330
11766,cancer cells,cell_type,0.7373,30692330
11767,cancer,disease,0.9927,30692330
11768,patient,species,0.97,30692330
11769,FOLFOX,drug,0.8438,30692330
11770,panitumumab,gene,0.8774,30692330
11771,colorectal liver metastases,disease,1.0,30692330
11772,icterus,disease,0.9995,30692330
11773,Advanced Rectal Cancer,disease,1.0,30692328
11774,patient,species,0.945,30692328
11775,man,species,0.898,30692328
11776,diarrhea,disease,1.0,30692328
11777,malaise,disease,1.0,30692328
11778,Massive,disease,0.999,30692328
11779,ascites,disease,0.824,30692328
11780,systemic edema,disease,1.0,30692328
11781,anemia,disease,1.0,30692328
11782,hepatic dysfunction,disease,1.0,30692328
11783,stenosis,disease,0.9883,30692328
11784,liver metastases,disease,0.9014,30692328
11785,ascites,disease,0.9443,30692328
11786,adenocarcinoma,disease,0.9995,30692328
11787,panitumumab,gene,0.964,30692328
11788,Pmab,gene,0.9805,30692328
11789,FOLFIRI,drug,0.6504,30692328
11790,Pmab,gene,0.822,30692328
11791,primary tumor,disease,0.8706,30692328
11792,liver metastases,disease,0.9146,30692328
11793,ascites,disease,0.999,30692328
11794,patient,species,0.979,30692328
11795,patient,species,0.985,30692328
11796,melena,disease,0.9976,30692328
11797,rectal cancer,disease,1.0,30692328
11798,liver metastases,disease,0.9976,30692328
11799,cancerous ascites,disease,1.0,30692328
11800,Rectal Cancer,disease,1.0,30692290
11801,Sepsis,disease,0.9995,30692290
11802,rectal cancer,disease,1.0,30692290
11803,sepsis,disease,0.9985,30692290
11804,pelvic local recurrence,disease,0.703,30692290
11805,woman,species,0.916,30692290
11806,locally advanced rectal cancer,disease,0.9277,30692290
11807,sepsis,disease,0.9995,30692290
11808,panitumumab,gene,0.9316,30692290
11809,man,species,0.921,30692290
11810,rectal cancer,disease,0.9995,30692290
11811,esophageal variceal rupture,disease,1.0,30692290
11812,sepsis,disease,0.9995,30692290
11813,cetuximab,gene,0.9014,30692290
11814,metastatic colorectal cancer,disease,0.9863,30690295
11815,Metastatic colorectal cancer,disease,1.0,30690295
11816,mCRC,disease,1.0,30690295
11817,mCRC,disease,0.8745,30690295
11818,RAS,gene,0.996,30690295
11819,BRAF,DNA,0.858,30690295
11820,BRAF,gene,0.994,30690295
11821,bevacizumab,gene,0.7,30690295
11822,aflibercept,gene,0.94,30690295
11823,patients,species,0.9526,30690295
11824,epidermal growth factor receptor,gene,0.998,30690295
11825,EGFR,gene,0.9966,30690295
11826,RAS,gene,0.9897,30690295
11827,patients,species,0.976,30690295
11828,EGFR,gene,0.981,30690295
11829,cetuximab,gene,0.886,30690295
11830,panitumumab,gene,0.8135,30690295
11831,regorafenib,drug,0.9297,30690295
11832,trifluridine,drug,0.8716,30690295
11833,tipiracil,drug,0.9907,30690295
11834,patients,species,0.9746,30690295
11835,HER2,gene,0.9976,30690295
11836,neu,gene,0.9985,30690295
11837,CRC tumours,disease,1.0,30690295
11838,mCRC,disease,0.756,30690295
11839,tumour,disease,1.0,30690295
11840,Panitumumab,gene,0.8325,30689133
11841,panitumumab,gene,0.8813,30689133
11842,metastatic colorectal cancer,disease,0.983,30689133
11843,patients,species,0.975,30689133
11844,wild-type [Kirsten] rat sarcoma viral oncogene homolog,gene,0.998,30689133
11845,rat,species,0.3738,30689133
11846,[K]RAS,gene,0.998,30689133
11847,RAS,gene,0.9937,30689133
11848,metastatic colorectal cancer,disease,1.0,30689133
11849,mCRC,disease,1.0,30689133
11850,panitumumab,gene,0.9395,30689133
11851,fluorouracil,drug,0.9995,30689133
11852,leucovorin,drug,0.999,30689133
11853,oxaliplatin,drug,0.9995,30689133
11854,FOLFOX,drug,0.9683,30689133
11855,panitumumab,gene,0.935,30689133
11856,fluorouracil,drug,0.999,30689133
11857,leucovorin,drug,0.999,30689133
11858,irinotecan,drug,0.998,30689133
11859,FOLFIRI,drug,0.9956,30689133
11860,fluoropyrimidine,drug,0.998,30689133
11861,panitumumab,gene,0.8794,30689133
11862,patients,species,0.992,30689133
11863,panitumumab,gene,0.934,30689133
11864,FOLFOX,drug,0.8076,30689133
11865,patients,species,0.9897,30689133
11866,panitumumab,gene,0.9175,30689133
11867,FOLFIRI,drug,0.813,30689133
11868,panitumumab,gene,0.959,30689133
11869,FOLFOX,drug,0.8394,30689133
11870,patients,species,0.9873,30689133
11871,FOLFIRI,drug,0.8857,30689133
11872,patients,species,0.991,30689133
11873,panitumumab,gene,0.9097,30689133
11874,patients,species,0.957,30689133
11875,FOLFOX,drug,0.822,30689133
11876,FOLFIRI,drug,0.8975,30689133
11877,patients,species,0.9917,30689133
11878,cancer,disease,1.0,30689133
11879,tumor,disease,1.0,30689133
11880,skin disorders,disease,0.998,30689133
11881,FOLFOX,drug,0.936,30689133
11882,patients,species,0.9834,30689133
11883,FOLFIRI,DNA,0.4973,30689133
11884,FOLFIRI,drug,0.633,30689133
11885,patients,species,0.995,30689133
11886,panitumumab,gene,0.8096,30689133
11887,panitumumab,gene,0.8633,30689133
11888,metastatic colorectal,disease,1.0,30680449
11889,cancer,disease,1.0,30680449
11890,patients,species,0.991,30680449
11891,patient,species,0.9775,30680449
11892,patients,species,0.993,30680449
11893,patients,species,0.9805,30680449
11894,patients,species,0.9976,30680449
11895,patients,species,0.997,30680449
11896,bevacizumab,gene,0.8755,30680449
11897,panitumumab,gene,0.91,30680449
11898,panitumumab,gene,0.7505,30680449
11899,bevacizumab,gene,0.6772,30680449
11900,panitumumab,gene,0.8535,30680449
11901,Panitumumab,gene,0.879,30679315
11902,Erlotinib,drug,0.997,30679315
11903,Gemcitabine,drug,0.999,30679315
11904,Erlotinib,drug,0.998,30679315
11905,Gemcitabine,drug,0.999,30679315
11906,Metastatic,disease,0.569,30679315
11907,Pancreatic Adenocarcinoma,disease,0.874,30679315
11908,Cancer,disease,0.7705,30679315
11909,epidermal growth factor receptor,gene,0.997,30679315
11910,EGFR,gene,0.994,30679315
11911,erlotinib,drug,0.995,30679315
11912,panitumumab,gene,0.8877,30679315
11913,gemcitabine,drug,0.9995,30679315
11914,gemcitabine,drug,0.9995,30679315
11915,erlotinib,drug,0.997,30679315
11916,gemcitabine,drug,0.9985,30679315
11917,EGFR,gene,0.994,30679315
11918,EGFR,gene,0.9937,30679315
11919,Gemcitabine,drug,0.998,30679315
11920,advanced pancreatic adenocarcinoma,disease,0.9995,30679315
11921,erlotinib,drug,0.994,30679315
11922,epidermal growth factor receptor,gene,0.9985,30679315
11923,EGFR,gene,0.9956,30679315
11924,gemcitabine,drug,0.9995,30679315
11925,gemcitabine,drug,0.9995,30679315
11926,Cancer,disease,0.827,30679315
11927,gemcitabine,drug,0.9995,30679315
11928,erlotinib,drug,0.9854,30679315
11929,gemcitabine,drug,0.999,30679315
11930,EGFR,gene,0.985,30679315
11931,erlotinib,drug,0.991,30679315
11932,panitumumab,gene,0.8486,30679315
11933,metastatic adenocarcinoma of the pancreas,disease,1.0,30679315
11934,gemcitabine,drug,0.9985,30679315
11935,erlotinib,drug,0.989,30679315
11936,panitumumab,gene,0.764,30679315
11937,EGFR,gene,0.9927,30679315
11938,advanced adenocarcinoma of the pancreas,disease,1.0,30679315
11939,EGFR,gene,0.9927,30679315
11940,gemcitabine,drug,0.9976,30679315
11941,gemcitabine,drug,0.997,30679315
11942,metastatic pancreatic cancer,disease,0.999,30679315
11943,Metastatic Colorectal Cancer,disease,1.0,30679026
11944,metastatic colorectal cancer,disease,1.0,30679026
11945,5-fluorouracil,drug,0.9985,30679026
11946,PATIENTS,species,0.8853,30679026
11947,bevacizumab,gene,0.8726,30679026
11948,panitumumab,gene,0.8994,30679026
11949,FOLFOX,drug,0.627,30679026
11950,folinic acid,drug,0.9995,30679026
11951,fluorouracil,drug,0.9995,30679026
11952,oxaliplatin,drug,0.9995,30679026
11953,alopecia,disease,1.0,30679026
11954,diarrhea,disease,1.0,30679026
11955,nausea,disease,0.9976,30679026
11956,nausea,disease,0.938,30679026
11957,anemia,disease,1.0,30679026
11958,neutropenia,disease,1.0,30679026
11959,neutropenia,disease,0.9946,30679026
11960,metastatic colorectal cancer,disease,1.0,30679026
11961,FOLFIRI,drug,0.6304,30675264
11962,panitumumab,gene,0.804,30675264
11963,FOLFOX,drug,0.9194,30675264
11964,panitumumab,gene,0.6587,30675264
11965,RAS,gene,0.684,30675264
11966,colorectal cancer,disease,1.0,30675264
11967,circulating tumor DNA,DNA,0.6543,30675264
11968,panitumumab,gene,0.8955,30675264
11969,colorectal cancer,disease,1.0,30675264
11970,CRC,disease,1.0,30675264
11971,circulating tumor DNA,DNA,0.5664,30675264
11972,circulating,cell_type,0.5654,30675264
11973,panitumumab,gene,0.907,30675264
11974,FOLFIRI,drug,0.921,30675264
11975,panitumumab,gene,0.8696,30675264
11976,CRC,disease,0.9985,30675264
11977,panitumumab,gene,0.807,30675264
11978,circulating tumor DNA,DNA,0.5747,30675264
11979,circulating,cell_type,0.4583,30675264
11980,magnesium,drug,0.9995,30661095
11981,antacid,drug,0.9688,30661095
11982,Hypomagnesemia,disease,1.0,30661095
11983,panitumumab,gene,0.856,30661095
11984,magnesium,drug,1.0,30661095
11985,histamine,drug,0.988,30661095
11986,histamine H(2),gene,0.9526,30661095
11987,panitumumab,gene,0.9136,30661095
11988,hypomagnesemia,disease,1.0,30661095
11989,Patients,species,0.974,30661095
11990,colorectal cancer,disease,0.766,30661095
11991,panitumumab,gene,0.8403,30661095
11992,magnesium,drug,0.9995,30661095
11993,patients,species,0.9937,30661095
11994,panitumumab,gene,0.8174,30661095
11995,magnesium,drug,0.9995,30661095
11996,patients,species,0.987,30661095
11997,magnesium,drug,0.9995,30661095
11998,antacid,drug,0.9355,30661095
11999,panitumumab,gene,0.9316,30661095
12000,magnesium,drug,0.9995,30661095
12001,panitumumab,gene,0.8784,30661095
12002,magnesium,drug,1.0,30661095
12003,magnesium,drug,0.9995,30661095
12004,patients,species,0.982,30661095
12005,magnesium,drug,0.9995,30661095
12006,magnesium,drug,0.9995,30661095
12007,magnesium,drug,0.9995,30661095
12008,magnesium,drug,1.0,30661095
12009,magnesium,drug,0.9995,30661095
12010,magnesium,drug,1.0,30661095
12011,panitumumab,gene,0.8794,30661095
12012,hypomagnesemia,disease,1.0,30661095
12013,antacid,drug,0.7754,30661095
12014,magnesium,drug,0.9995,30661095
12015,hypomagnesemia,disease,1.0,30661095
12016,anti-EGFR antibody,gene,0.961,30661095
12017,hypomagnesemia,disease,1.0,30661095
12018,Leukocytoclastic vasculitis,disease,1.0,30646927
12019,purpura,disease,0.999,30646927
12020,renal failure,disease,1.0,30646927
12021,Panitumumab,gene,0.871,30646927
12022,human,species,0.9756,30646927
12023,metastatic colorectal carcinoma,disease,0.997,30646927
12024,patients,species,0.9653,30646927
12025,purpura,disease,1.0,30646927
12026,anti-epidermal growth factor receptor antibody,gene,0.9917,30646927
12027,Renal failure,disease,1.0,30646927
12028,anti-epidermal growth factor receptor antibody,gene,0.9614,30646927
12029,man,species,0.8203,30646927
12030,advanced colon cancer,disease,1.0,30646927
12031,panitumumab,gene,0.8833,30646927
12032,General malaise,disease,0.9917,30646927
12033,bilateral edema of his legs,disease,0.999,30646927
12034,bilateral purpura of his forearms,disease,0.999,30646927
12035,panitumumab,gene,0.789,30646927
12036,purpuric lesions,disease,1.0,30646927
12037,leukocytoclastic vasculitis,disease,1.0,30646927
12038,acute renal failure,disease,0.9995,30646927
12039,urea,drug,0.995,30646927
12040,nitrogen,drug,0.999,30646927
12041,creatinine,drug,0.9985,30646927
12042,leukocytoclastic vasculitis,disease,1.0,30646927
12043,purpura,disease,0.999,30646927
12044,acute renal failure,disease,1.0,30646927
12045,panitumumab,gene,0.899,30646927
12046,bevacizumab,gene,0.777,30643461
12047,EGFR,gene,0.9863,30643461
12048,metastatic colorectal,disease,0.9966,30643461
12049,vascular endothelial growth factor,gene,0.9985,30643461
12050,epidermal growth factor receptor,gene,0.998,30643461
12051,EGFRi,gene,0.9775,30643461
12052,metastatic colorectal cancer,disease,1.0,30643461
12053,mCRC,disease,1.0,30643461
12054,patients,species,0.984,30643461
12055,mCRC,disease,0.9927,30643461
12056,wild-type KRAS exon 2,gene,0.9766,30643461
12057,bevacizumab,gene,0.812,30643461
12058,EGFRi,gene,0.987,30643461
12059,cetuximab,gene,0.9233,30643461
12060,panitumumab,gene,0.869,30643461
12061,patients,species,0.987,30643461
12062,patients,species,0.991,30643461
12063,EGFRi,gene,0.9893,30643461
12064,bevacizumab,gene,0.6206,30643461
12065,patients,species,0.9927,30643461
12066,bevacizumab,gene,0.6772,30643461
12067,EGFRi,gene,0.9863,30643461
12068,patients,species,0.9775,30643461
12069,EGFRi,gene,0.988,30643461
12070,bevacizumab,gene,0.9004,30643461
12071,EGFRi,gene,0.982,30643461
12072,bevacizumab,gene,0.7715,30643461
12073,EGFRi,gene,0.8433,30643461
12074,EGFRi,gene,0.993,30643461
12075,bevacizumab,gene,0.833,30643461
12076,patients,species,0.9727,30643461
12077,wild,DNA,0.5835,30643461
12078,wild-type KRAS exon,gene,0.8345,30643461
12079,mCRC,disease,0.984,30643461
12080,bevacizumab,gene,0.511,30643461
12081,EGFRi,gene,0.9717,30643461
12082,bevacizumab,gene,0.979,30643461
12083,EGFRi sequence,DNA,0.574,30643461
12084,EGFRi,gene,0.974,30643461
12085,miRNAs,RNA,0.5596,30623370
12086,EGFR,gene,0.992,30623370
12087,Colorectal Cancer,disease,1.0,30623370
12088,cancer,disease,1.0,30623370
12089,anti-,gene,0.774,30623370
12090,epidermal growth factor receptor,gene,0.9062,30623370
12091,EGFR,gene,0.9985,30623370
12092,patients,species,0.953,30623370
12093,metastatic colorectal cancer,disease,1.0,30623370
12094,KRAS and NRAS genes,DNA,0.855,30623370
12095,KRAS,gene,0.987,30623370
12096,NRAS genes,gene,0.975,30623370
12097,primary,disease,0.995,30623370
12098,tumour,disease,0.6475,30623370
12099,RAS,gene,0.998,30623370
12100,cetuximab,gene,0.895,30623370
12101,panitumumab,gene,0.891,30623370
12102,miRNA,RNA,0.53,30623370
12103,EGFR,gene,0.993,30623370
12104,EGFR,gene,0.99,30623370
12105,patients,species,0.959,30623370
12106,metastatic colorectal cancer,disease,1.0,30623370
12107,miRNAs,RNA,0.607,30623370
12108,EGFR,gene,0.7324,30623370
12109,EGFR,gene,0.9634,30623369
12110,Metastatic Colorectal Cancer,disease,1.0,30623369
12111,cetuximab,gene,0.7236,30623369
12112,panitumumab,gene,0.833,30623369
12113,transmembrane,gene,0.5195,30623369
12114,EGFR,gene,0.995,30623369
12115,metastatic colorectal cancer,disease,1.0,30623369
12116,mCRC,disease,1.0,30623369
12117,patients,species,0.992,30623369
12118,tumour,disease,0.9966,30623369
12119,mCRC,disease,0.998,30623369
12120,patients,species,0.993,30623369
12121,RAS,gene,0.998,30623369
12122,RAS,gene,0.995,30623369
12123,RAS,gene,0.993,30623369
12124,patients,species,0.974,30623369
12125,WT,cell_line,,30623369
12126,patients,species,0.9927,30623369
12127,EGFR,gene,0.776,30623369
12128,tumour,disease,1.0,30623369
12129,EGFR,gene,0.995,30623369
12130,solid tumors,disease,1.0,30616798
12131,head and neck cancer,disease,1.0,30616798
12132,patients,species,0.981,30616798
12133,tumor,disease,0.9966,30616798
12134,human,species,0.9795,30616798
12135,patients,species,0.9927,30616798
12136,panitumumab,gene,0.776,30616798
12137,IRDye800,DNA,0.6055,30616798
12138,tumor,disease,1.0,30616798
12139,Patients,species,0.96,30616798
12140,head and neck squamous cell carcinoma,disease,1.0,30616798
12141,HNSCC,disease,1.0,30616798
12142,tumor,disease,0.9844,30616798
12143,cancer,disease,0.9995,30616798
12144,tumor,disease,0.997,30616798
12145,panitumumab,gene,0.985,30616798
12146,human,species,0.9917,30616798
12147,tumor,disease,0.9946,30616798
12148,HNSCC,disease,1.0,30616798
12149,tumor,disease,0.9043,30616798
12150,head and neck cancers,disease,1.0,30616798
12151,anti-,gene,0.7974,30616224
12152,EGFR monoclonal antibodies,gene,0.7275,30616224
12153,metastatic colorectal cancer,disease,1.0,30616224
12154,tumors,disease,1.0,30616224
12155,metastatic colorectal cancer,disease,1.0,30616224
12156,mCRC,disease,1.0,30616224
12157,RAS clones,cell_line,0.832,30616224
12158,RAS,gene,0.991,30616224
12159,EGFR,gene,0.9873,30616224
12160,EGFR,gene,0.992,30616224
12161,anti-EGFR monoclonal antibodies,gene,0.907,30616224
12162,anti-EGFR,gene,0.956,30616224
12163,anti-EGFR,gene,0.6587,30616224
12164,mCRC,disease,0.9883,30616224
12165,patients,species,0.9873,30616224
12166,ctDNA,DNA,0.632,30616224
12167,Panitumumab,gene,0.9575,30614531
12168,oxaliplatin,drug,0.9995,30614531
12169,Panitumumab,gene,0.8276,30614531
12170,RAS,gene,0.996,30614531
12171,metastatic colorectal cancer,disease,0.89,30614531
12172,panitumumab,gene,0.886,30614531
12173,oxaliplatin,drug,0.9995,30614531
12174,RAS,gene,0.997,30614531
12175,patients,species,0.98,30614531
12176,panitumumab,gene,0.9375,30614531
12177,bevacizumab,gene,0.777,30614531
12178,oxaliplatin,drug,0.999,30614531
12179,panitumumab,gene,0.912,30614531
12180,5-fluorouracil,drug,0.9995,30614531
12181,leucovorin,drug,0.9995,30614531
12182,5-FU,drug,0.9995,30614531
12183,5-FU,drug,0.9985,30614531
12184,panitumumab,gene,0.9272,30614531
12185,5-FU,drug,0.9956,30614531
12186,5-FU,drug,0.9956,30614531
12187,bevacizumab,gene,0.749,30614531
12188,panitumumab,gene,0.8926,30614531
12189,5-FU,drug,0.9976,30614531
12190,5-FU,drug,0.9966,30614531
12191,bevacizumab,gene,0.648,30614531
12192,oxaliplatin,drug,0.9995,30614531
12193,panitumumab,gene,0.9214,30614531
12194,5-FU,drug,0.997,30614531
12195,5-FU,drug,0.995,30614531
12196,bevacizumab,gene,0.7495,30614531
12197,rash,disease,1.0,30614531
12198,fatigue,disease,0.999,30614531
12199,diarrhoea,disease,1.0,30614531
12200,panitumumab,gene,0.9463,30614531
12201,5-FU,drug,0.9985,30614531
12202,oxaliplatin,drug,0.999,30614531
12203,patients,species,0.9756,30614531
12204,EGFR Protein,gene,0.7476,30612313
12205,KRAS,gene,0.9937,30612313
12206,Right- and left-sided colorectal cancers,disease,1.0,30612313
12207,RSCRC,disease,1.0,30612313
12208,LSCRC,disease,1.0,30612313
12209,EGFR,gene,0.8823,30612313
12210,EGFR,gene,0.99,30612313
12211,KRAS,DNA,0.5767,30612313
12212,KRAS,gene,0.992,30612313
12213,colorectal cancer,disease,0.9985,30612313
12214,anti-EGFR antibody,gene,0.809,30612313
12215,KRAS,gene,0.99,30612313
12216,colorectal cancer,disease,0.9326,30612313
12217,patients,species,0.9883,30612313
12218,EGFR protein,gene,0.959,30612313
12219,EGFR,DNA,0.8306,30612313
12220,EGFR,gene,0.997,30612313
12221,EGFR protein,gene,0.9785,30612313
12222,EGFR,gene,0.9883,30612313
12223,RSCRC,disease,0.9985,30612313
12224,LSCRC,disease,0.998,30612313
12225,tumors,disease,0.9526,30612313
12226,EGFR,gene,0.99,30612313
12227,RSCRC,disease,0.9985,30612313
12228,LSCRC,disease,0.998,30612313
12229,anti-,gene,0.6875,30612313
12230,EGFR antibody,gene,0.6704,30612313
12231,LSCRC,disease,0.993,30612313
12232,RSCRC,disease,0.9985,30612313
12233,LSCRC,disease,0.9907,30612313
12234,EGFR protein,gene,0.951,30612313
12235,KRAS wild type RSLCL,cell_line,0.9346,30612313
12236,KRAS,gene,0.991,30612313
12237,LSCRC,cell_line,0.811,30612313
12238,EGFR protein,gene,0.9775,30612313
12239,anti-EGFR antibody,gene,0.857,30612313
12240,colorectal cancer,disease,1.0,30612313
12241,doxycycline,drug,0.999,30607677
12242,epidermal growth factor,gene,0.9966,30607677
12243,Acneiform rash,disease,1.0,30607677
12244,epidermal growth factor receptor,gene,0.9976,30607677
12245,EGFRIs,gene,0.9937,30607677
12246,patient,species,0.991,30607677
12247,doxycycline,drug,0.9995,30607677
12248,EGFRI,gene,0.9966,30607677
12249,skin toxicity,disease,0.9077,30607677
12250,metastatic colorectal cancer,disease,0.999,30607677
12251,cetuximab,gene,0.9263,30607677
12252,panitumumab,gene,0.9277,30607677
12253,FDX104,drug,0.9756,30607677
12254,EGFRI,gene,0.99,30607677
12255,Rash,disease,0.9966,30607677
12256,EGFRI,gene,0.984,30607677
12257,FDX104,drug,0.6025,30607677
12258,rash,disease,0.9966,30607677
12259,FDX104,drug,0.878,30607677
12260,oral mucositis,disease,1.0,30607677
12261,nausea,disease,0.9985,30607677
12262,vomiting,disease,0.9897,30607677
12263,EGFRI,gene,0.9897,30607677
12264,skin reactions,disease,0.987,30607677
12265,cetuximab,gene,0.8877,30607677
12266,panitumumab,gene,0.901,30607677
12267,rash,disease,1.0,30607677
12268,rash,disease,0.9995,30607677
12269,GRB7,gene,0.996,30604896
12270,"basal-like, HER-2 positive human breast cancer cell lines",cell_line,0.9844,30604896
12271,HER-1,gene,0.9937,30604896
12272,GRB7 gene,gene,0.5737,30604896
12273,HER-2 amplicon,gene,0.8525,30604896
12274,GRB7,gene,0.9956,30604896
12275,HER-2,gene,0.9937,30604896
12276,breast cancer,disease,0.999,30604896
12277,GRB7,gene,0.994,30604896
12278,HER,cell_line,0.401,30604896
12279,HER-2,gene,0.992,30604896
12280,breast cancers,disease,0.9727,30604896
12281,HER-2,gene,0.9976,30604896
12282,HCC1954,cell_line,0.9204,30604896
12283,21MT1,cell_line,0.7217,30604896
12284,JIMT1,cell_line,0.93,30604896
12285,basal like HER-2 positive breast cancer cell lines,cell_line,0.9346,30604896
12286,HER-2 positive breast cancer,disease,0.948,30604896
12287,HER-2,gene,0.8877,30604896
12288,cell lines,cell_line,0.947,30604896
12289,trastuzumab,gene,0.9717,30604896
12290,lapatinib,drug,0.9985,30604896
12291,GRB7 protein,gene,0.9688,30604896
12292,HCC1954,cell_line,0.917,30604896
12293,21MT1,cell_line,0.8413,30604896
12294,JIMT1 cells,cell_line,0.5513,30604896
12295,tumor,disease,1.0,30604896
12296,ki-67,gene,0.96,30604896
12297,tumor,disease,0.9995,30604896
12298,21MT1 cells,cell_line,0.8403,30604896
12299,HCC1954 cells,cell_line,0.9375,30604896
12300,JIMT1 cells,cell_line,0.967,30604896
12301,HER-1,gene,0.9966,30604896
12302,tyrosine,drug,0.991,30604896
12303,GRB7,gene,0.9937,30604896
12304,JIMT1 cells,cell_line,0.623,30604896
12305,HER-1,gene,0.9917,30604896
12306,GRB7,gene,0.993,30604896
12307,cell lines,cell_line,0.912,30604896
12308,HER-1,gene,0.993,30604896
12309,HER-1,gene,0.995,30604896
12310,panitumumab,gene,0.755,30604896
12311,cell lines,cell_line,0.9023,30604896
12312,GRB7,gene,0.9937,30604896
12313,HER-1,gene,0.991,30604896
12314,HER-1,gene,0.9937,30604896
12315,HER-2 positive breast cancer,disease,0.945,30604896
12316,HER-2,gene,0.993,30604896
12317,PANC-1 Human Pancreatic Cancer Xenografts,cell_line,0.7812,30589553
12318,PANC-1,disease,0.9844,30589553
12319,Mice,species,0.776,30589553
12320,Panitumumab,gene,0.9097,30589553
12321,177Lu,drug,0.9937,30589553
12322,PANC-1 human,cell_line,0.9165,30589553
12323,PnCa,disease,0.9995,30589553
12324,mice,species,0.777,30589553
12325,anti-EGFR,gene,0.9946,30589553
12326,panitumumab,gene,0.619,30589553
12327,DOTA,drug,0.9985,30589553
12328,177Lu,drug,0.9966,30589553
12329,PANC-1 cells,cell_line,0.6147,30589553
12330,PANC-1,disease,0.857,30589553
12331,panitumumab,gene,0.9434,30589553
12332,177Lu,drug,0.997,30589553
12333,DNA double-strand breaks,DNA,0.714,30589553
12334,DSBs,DNA,0.5454,30589553
12335,-H2AX,gene,0.991,30589553
12336,panitumumab,gene,0.9785,30589553
12337,177Lu,drug,0.998,30589553
12338,tumor,disease,0.995,30589553
12339,mice,species,0.6924,30589553
12340,blood cell,cell_type,0.619,30589553
12341,serum alanine aminotransferase,gene,0.968,30589553
12342,alanine,drug,0.993,30589553
12343,ALT,gene,0.9614,30589553
12344,creatinine,drug,0.9995,30589553
12345,Cr,drug,0.9995,30589553
12346,panitumumab,gene,0.9473,30589553
12347,177Lu,drug,0.9966,30589553
12348,NRG,cell_line,0.4976,30589553
12349,mice,species,0.911,30589553
12350,PANC,cell_type,0.5205,30589553
12351,PANC-1 tumors,disease,0.714,30589553
12352,panitumumab,gene,0.9526,30589553
12353,177Lu,drug,0.9966,30589553
12354,mice,species,0.975,30589553
12355,177Lu,drug,0.9956,30589553
12356,panitumumab,gene,0.9473,30589553
12357,tumor,disease,0.5806,30589553
12358,Panitumumab,gene,0.9277,30589553
12359,MCP-177Lu,drug,0.723,30589553
12360,PANC-1 cells,cell_line,0.7026,30589553
12361,PANC,disease,0.919,30589553
12362,panitumumab,gene,0.95,30589553
12363,PANC-1 cells,cell_line,0.7515,30589553
12364,-H2AX,gene,0.9966,30589553
12365,panitumumab,gene,0.9546,30589553
12366,Panitumumab,gene,0.9526,30589553
12367,MCP,drug,0.7495,30589553
12368,177Lu,drug,0.9907,30589553
12369,PANC-1 cells,cell_line,0.7837,30589553
12370,PANC,disease,0.5054,30589553
12371,panitumumab,gene,0.9644,30589553
12372,177Lu,drug,0.997,30589553
12373,NRG,cell_line,0.509,30589553
12374,mice,species,0.8677,30589553
12375,ALT,gene,0.726,30589553
12376,Cr,drug,0.9976,30589553
12377,NRG,cell_line,0.476,30589553
12378,mice,species,0.964,30589553
12379,Panitumumab,gene,0.9614,30589553
12380,MCP,drug,0.8506,30589553
12381,177Lu,drug,0.908,30589553
12382,tumor,disease,0.9985,30589553
12383,NRG,cell_line,0.5005,30589553
12384,mice,species,0.8623,30589553
12385,mice,species,0.9634,30589553
12386,panitumumab,gene,0.962,30589553
12387,tumor,disease,0.968,30589553
12388,PANC,cell_type,0.5356,30589553
12389,PANC-1 tumors,disease,0.755,30589553
12390,EGFR,gene,0.9897,30589553
12391,panitumumab,gene,0.77,30589553
12392,177Lu,drug,0.9946,30589553
12393,panitumumab,gene,0.889,30589553
12394,KRAS mutant PANC-1 tumors,cell_line,0.6626,30589553
12395,KRAS mutant,disease,0.7964,30589553
12396,KRAS,gene,0.9883,30589553
12397,PANC-1 tumors,disease,0.9077,30589553
12398,mice,species,0.814,30589553
12399,PnCa,disease,1.0,30589553
12400,FOLFIRI,drug,0.917,30565584
12401,aflibercept,gene,0.981,30565584
12402,RAS,gene,0.5776,30565584
12403,BRAF,gene,0.997,30565584
12404,left-sided colon cancer,disease,0.9995,30565584
12405,oxaliplatin,drug,0.999,30565584
12406,liver metastases,disease,0.999,30565584
12407,liver,disease,0.6626,30565584
12408,oxaliplatin,drug,1.0,30565584
12409,RAS,gene,0.9863,30565584
12410,BRAF,gene,0.9883,30565584
12411,aflibercept,gene,0.993,30565584
12412,cetuximab,gene,0.9644,30565584
12413,panitumumab,gene,0.9287,30565584
12414,cetuximab,gene,0.886,30565584
12415,EGFR,gene,0.9346,30545999
12416,Right-Sided Metastatic Colorectal Cancer,disease,0.999,30545999
12417,EGFR,gene,0.9893,30545991
12418,Colorectal Cancer,disease,1.0,30545991
12419,metastatic colorectal cancer,disease,1.0,30545991
12420,mCRC,disease,1.0,30545991
12421,epidermal growth factor receptor,gene,0.9736,30545991
12422,EGFR,gene,0.9883,30545991
12423,tumor,disease,0.704,30545991
12424,EGFR,gene,0.836,30545991
12425,KRAS,gene,0.7227,30545991
12426,mCRC,disease,0.975,30545991
12427,EGFR,gene,0.925,30545991
12428,EGFR,gene,0.988,30545991
12429,left-sided primary tumors,disease,0.9316,30545991
12430,tumor,disease,0.9775,30545991
12431,anti-EGFR,gene,0.902,30545991
12432,anti-EGFR,gene,0.7456,30545991
12433,EGFR,gene,0.87,30545991
12434,mCRC,disease,0.9966,30545991
12435,EGFR,gene,0.994,30545991
12436,purpuric drug eruption,disease,0.992,30537161
12437,panitumumab,gene,0.8013,30537161
12438,Patients,species,0.9927,30519327
12439,metastatic colorectal cancer,disease,1.0,30519327
12440,mCRC,disease,1.0,30519327
12441,carcinoembryonic antigen,gene,0.9956,30519327
12442,CEA,gene,0.998,30519327
12443,carbohydrate,drug,0.987,30519327
12444,carbohydrate antigen 19-9,gene,0.979,30519327
12445,CA 19-9,gene,0.993,30519327
12446,thymidine,drug,0.997,30519327
12447,thymidine kinase,gene,0.9883,30519327
12448,TK,gene,0.999,30519327
12449,tissue polypeptide specific antigen,gene,0.9927,30519327
12450,TPS,gene,0.9917,30519327
12451,patients,species,0.9683,30519327
12452,mCRC,disease,0.9985,30519327
12453,epidermal growth factor receptor,gene,0.9976,30519327
12454,anti-EGFR mAbs,gene,0.964,30519327
12455,patients,species,0.9897,30519327
12456,anti-EGFR mAbs,gene,0.9526,30519327
12457,tumour,disease,0.973,30519327
12458,serum,gene,0.574,30519327
12459,CA 19-9,gene,0.7964,30519327
12460,CEA,gene,0.984,30519327
12461,TK,gene,,30519327
12462,TPS,gene,0.9487,30519327
12463,patients,species,0.9883,30519327
12464,CA 19-9,gene,0.9536,30519327
12465,tumour,disease,0.9956,30519327
12466,EGFR,gene,0.661,30519327
12467,Interstitial Lung Disease,disease,1.0,30504674
12468,drug-induced interstitial lung disease,disease,0.9873,30504674
12469,DILD,disease,1.0,30504674
12470,DILD,disease,1.0,30504674
12471,adalimumab,gene,0.8086,30504674
12472,bevacizumab,gene,0.7866,30504674
12473,cetuximab,gene,0.8125,30504674
12474,denosumab,gene,0.8115,30504674
12475,golimumab,gene,0.925,30504674
12476,infliximab,gene,0.8774,30504674
12477,nivolumab,gene,0.4834,30504674
12478,panitumumab,gene,0.8745,30504674
12479,pembrolizumab,gene,0.564,30504674
12480,tocilizumab,gene,0.875,30504674
12481,trastuzumab,gene,0.918,30504674
12482,DILD,disease,1.0,30504674
12483,DILD,disease,1.0,30504674
12484,pembrolizumab,gene,0.5063,30504674
12485,infliximab,gene,0.91,30504674
12486,DILD,disease,1.0,30504674
12487,cetuximab,gene,0.7876,30504674
12488,panitumumab,gene,0.9116,30504674
12489,bevacizumab,gene,0.822,30504674
12490,golimumab,gene,0.941,30504674
12491,trastuzumab,gene,0.923,30504674
12492,tocilizumab,gene,0.8164,30504674
12493,DILD,disease,1.0,30504674
12494,denosumab,gene,0.882,30504674
12495,adalimumab,gene,0.863,30504674
12496,Infliximab,gene,0.958,30504674
12497,trastuzumab,gene,0.965,30504674
12498,tocilizumab,gene,0.9556,30504674
12499,denosumab,gene,0.784,30504674
12500,Cetuximab,gene,0.936,30504674
12501,nivolumab,gene,0.6284,30504674
12502,panitumumab,gene,0.9214,30504674
12503,bevacizumab,gene,0.8374,30504674
12504,golimumab,gene,0.944,30504674
12505,adalimumab,gene,0.9136,30504674
12506,Pembrolizumab,drug,0.994,30504674
12507,DILD,disease,1.0,30504674
12508,DILD,disease,1.0,30504674
12509,Bevacizumab,gene,0.933,30499082
12510,Cetuximab,gene,0.9497,30499082
12511,Panitumumab,gene,0.962,30499082
12512,Metastatic Colorectal Cancer,disease,1.0,30499082
12513,5-fluorouracil,drug,0.9995,30499082
12514,oxaliplatin,drug,0.9995,30499082
12515,irinotecan,drug,0.998,30499082
12516,metastatic colorectal cancer,disease,0.997,30499082
12517,mCRC,disease,0.997,30499082
12518,mCRC,disease,0.9775,30499082
12519,bevacizumab,gene,0.9546,30499082
12520,cetuximab,gene,0.9663,30499082
12521,panitumumab,gene,0.975,30499082
12522,fluoropyrimidine,drug,0.9966,30499082
12523,fluoropyrimidine,drug,0.9937,30499082
12524,mCRC,disease,0.9937,30499082
12525,bevacizumab,gene,0.707,30499082
12526,bevacizumab,gene,0.758,30499082
12527,bevacizumab,gene,0.8755,30499082
12528,bevacizumab,gene,0.7744,30499082
12529,mCRC,disease,0.9907,30499082
12530,hypertension,disease,0.999,30499082
12531,gastrointestinal perforation,disease,1.0,30499082
12532,Circulating Cell-Free DNA,DNA,0.5806,30487126
12533,Metastatic Colorectal Cancer,disease,1.0,30487126
12534,Panitumumab,gene,0.701,30487126
12535,EGFR pathway genes,gene,0.814,30487126
12536,metastatic colorectal cancer,disease,0.998,30487126
12537,cell-free DNA,DNA,0.508,30487126
12538,tumors,disease,1.0,30487126
12539,panitumumab,gene,0.525,30487126
12540,ASPECCT,DNA,0.4753,30487126
12541,RAS,gene,0.454,30487126
12542,mutant,RNA,0.565,30487126
12543,cancer-related genes,DNA,0.6543,30487126
12544,cancer,disease,0.999,30487126
12545,EGFR pathway genes,gene,0.867,30487126
12546,panitumumab,gene,0.9087,30487126
12547,plasma,cell_type,0.4565,30487126
12548,RAS mutant,RNA,0.4578,30487126
12549,RAS mutant allele,gene,0.5854,30487126
12550,RAS,gene,0.6147,30487126
12551,RAS,DNA,0.4873,30487126
12552,RAS mutations,gene,0.912,30487126
12553,BRAF,gene,0.707,30487126
12554,63-gene panel,DNA,0.876,30487126
12555,EGFR pathway genes,gene,0.881,30487126
12556,EGFR pathway genes,gene,0.8784,30487126
12557,mutant allele,DNA,0.5884,30487126
12558,mutant,RNA,0.4443,30487126
12559,RAS,gene,0.6533,30487126
12560,panitumumab,gene,0.7188,30487126
12561,Colorectal Cancer,disease,0.9673,30484063
12562,tumors,disease,0.996,30484063
12563,patients,species,0.9844,30484063
12564,colorectal cancer,disease,0.9995,30484063
12565,patients,species,0.9717,30484063
12566,colorectal cancer,disease,0.9756,30484063
12567,bevacizumab,gene,0.7383,30484063
12568,cetuximab,gene,0.8115,30484063
12569,panitumumab,gene,0.795,30484063
12570,Cancer,disease,0.9946,30484063
12571,tumor,disease,0.8384,30484063
12572,CEA,gene,0.988,30484063
12573,patients,species,0.9844,30484063
12574,tumor,disease,0.9976,30484063
12575,5-Fluorouracil,drug,0.9995,30470591
12576,5-Fluorouracil,drug,0.999,30470591
12577,Metastatic Colorectal Cancer,disease,1.0,30470591
12578,5-Fluorouracil,drug,0.9995,30470591
12579,5-FU,drug,0.999,30470591
12580,colorectal cancer,disease,1.0,30470591
12581,5-FU,drug,0.9976,30470591
12582,metastatic colorectal,disease,1.0,30470591
12583,cancer,disease,0.728,30470591
12584,NCT00384176,DNA,0.396,30470591
12585,cardiac toxicities,disease,0.9736,30470591
12586,arrhythmias,disease,1.0,30470591
12587,ischemic events,disease,0.9824,30470591
12588,cardiac toxicity,disease,0.8306,30470591
12589,arrhythmia,disease,0.9907,30470591
12590,cardiac toxicities,disease,0.943,30470591
12591,bevacizumab,gene,0.861,30470591
12592,panitumumab,gene,0.862,30470591
12593,cardiac toxicity,disease,0.9863,30470591
12594,cardiac arrhythmias,disease,1.0,30470591
12595,panitumumab,gene,0.8296,30470591
12596,arrhythmias,disease,0.9497,30470591
12597,cardiac ischemia,disease,0.9995,30470591
12598,bevacizumab,gene,0.645,30470591
12599,Bevacizumab,gene,0.864,30470591
12600,panitumumab,gene,0.912,30470591
12601,cardiac toxicities,disease,0.958,30470591
12602,5-FU,drug,0.9966,30470591
12603,Bevacizumab,gene,0.947,30470591
12604,5-FU,drug,0.9966,30470591
12605,panitumumab,gene,0.966,30470591
12606,arrhythmias,disease,0.999,30470591
12607,cetuximab,gene,0.93,30459532
12608,panitumumab,gene,0.9385,30459532
12609,cancer,disease,1.0,30459532
12610,panitumumab,gene,0.913,30459532
12611,cetuximab,gene,0.8735,30459532
12612,metastatic CRC,disease,0.991,30459532
12613,mCRC,disease,0.9985,30459532
12614,wild-type KRAS,gene,0.7466,30459532
12615,ASPECCT,DNA,0.534,30459532
12616,Panitumumab,gene,0.935,30459532
12617,cetuximab,gene,0.8735,30459532
12618,panitumumab,gene,0.944,30459532
12619,cetuximab,gene,0.904,30459532
12620,cetuximab,gene,0.9365,30459532
12621,Panitumumab,gene,0.892,30459532
12622,mCRC,disease,0.993,30459532
12623,panitumumab,gene,0.674,30459532
12624,cetuximab,gene,0.8335,30459532
12625,RAS,gene,0.99,30459318
12626,EGFR,gene,0.989,30459318
12627,KRAS,gene,0.9873,30459318
12628,colorectal cancer,disease,1.0,30459318
12629,cetuximab,gene,0.7344,30459318
12630,epidermal growth factor receptor,gene,0.999,30459318
12631,EGFR,gene,0.9927,30459318
12632,cetuximab,gene,0.8306,30459318
12633,panitumumab,gene,0.8574,30459318
12634,metastatic colorectal cancer,disease,1.0,30459318
12635,CRC,disease,1.0,30459318
12636,KRAS mutations,gene,0.7285,30459318
12637,-catenin,gene,0.9966,30459318
12638,EGFR,gene,0.9917,30459318
12639,RAS,gene,0.991,30459318
12640,mutant KRAS,gene,0.9937,30459318
12641,CRC,disease,1.0,30459318
12642,adenomatous polyposis coli,disease,1.0,30459318
12643,APC,gene,0.6235,30459318
12644,CRCs,disease,1.0,30459318
12645,APC,gene,0.9614,30459318
12646,KYA1797K,drug,0.9985,30459318
12647,-catenin,gene,0.997,30459318
12648,Ras,gene,0.9907,30459318
12649,GSK3,gene,0.9897,30459318
12650,cetuximab,gene,0.913,30459318
12651,KRAS-mutated CRC cells,cell_line,0.604,30459318
12652,KRAS,gene,0.542,30459318
12653,KYA1797K,drug,0.998,30459318
12654,tumor,disease,0.998,30459318
12655,CRC cells,cell_line,0.819,30459318
12656,CRC,disease,1.0,30459318
12657,tumor,disease,0.9976,30459318
12658,CRC,disease,1.0,30459318
12659,APC,disease,0.954,30459318
12660,KRAS mutations,gene,0.448,30459318
12661,-catenin,gene,0.9976,30459318
12662,RAS,gene,0.9883,30459318
12663,EGFR,gene,0.977,30459318
12664,Wnt,gene,0.963,30459318
12665,-catenin,gene,0.9883,30459318
12666,CRC,disease,0.9995,30459318
12667,cancer,disease,0.999,30459318
12668,Wnt,gene,0.9463,30459318
12669,-catenin,gene,0.9966,30459318
12670,EGFR,gene,0.9976,30459318
12671,RAS,gene,0.9966,30459318
12672,EGFR,gene,0.9927,30459318
12673,KRAS,DNA,0.718,30459318
12674,KRAS mutations,gene,0.9604,30459318
12675,Cecal Cancer,disease,1.0,30449858
12676,Liver and Lung Metastases,disease,0.972,30449858
12677,Bevacizumab,gene,0.639,30449858
12678,cecum cancer,disease,1.0,30449858
12679,cecal cancer,disease,0.9995,30449858
12680,moderately,disease,0.6655,30449858
12681,mucinous adenocarcinoma,disease,1.0,30449858
12682,RAS,gene,0.671,30449858
12683,Liver metastasis,disease,0.9565,30449858
12684,liver metastasis,disease,0.9565,30449858
12685,bevacizumab,gene,0.5864,30449858
12686,Bmab,gene,0.747,30449858
12687,FOLFIRI,drug,0.9023,30449858
12688,panitumumab,gene,0.95,30449858
12689,Pmab,gene,0.935,30449858
12690,Lung metastases,disease,0.9,30449858
12691,TFTD,drug,0.9795,30449858
12692,Bmab,gene,0.5776,30449858
12693,TFTD,drug,0.9873,30449858
12694,Bmab,gene,0.5254,30449858
12695,TFID,drug,0.9966,30449858
12696,Bmab,gene,0.877,30449858
12697,Bmab,gene,0.779,30449858
12698,BRAF mutant colorectal carcinomas,cell_line,0.596,30427914
12699,BRAF mutant,disease,0.9473,30427914
12700,BRAF,gene,0.9946,30427914
12701,colorectal carcinomas,disease,0.78,30427914
12702,cancer,disease,1.0,30427914
12703,tumor,disease,1.0,30427914
12704,tumor,disease,1.0,30427914
12705,EGFR,gene,0.9893,30427914
12706,cetuximab,gene,0.9297,30427914
12707,panitumumab,gene,0.8726,30427914
12708,mCRC,disease,0.966,30427914
12709,cetuximab,gene,0.9575,30427914
12710,panitumumab,gene,0.7666,30427914
12711,patients,species,0.97,30427914
12712,solid tumors,disease,1.0,30427914
12713,colorectal cancer,disease,1.0,30427914
12714,anti-PD1,gene,0.996,30427914
12715,nivolumab,gene,0.754,30427914
12716,anti-CTLA-4,gene,0.9653,30427914
12717,mCRC,disease,0.997,30427914
12718,patients,species,0.981,30427914
12719,MSI,gene,0.6636,30427914
12720,mtBRAF,DNA,0.68,30427914
12721,mtBRAF,gene,0.9746,30427914
12722,anti-EGFR monoclonal antibodies,gene,0.984,30427914
12723,colorectal carcinoma cell lines,cell_line,0.887,30427914
12724,colorectal carcinoma,disease,1.0,30427914
12725,microsatellite,DNA,0.4954,30427914
12726,anti-EGFR antibodies,gene,0.9507,30427914
12727,MEK,gene,0.991,30427914
12728,anti-EGFR antibodies,gene,0.957,30427914
12729,colorectal cancer cell lines,cell_line,0.878,30427914
12730,colorectal,cell_type,0.517,30427914
12731,colorectal cancer,disease,1.0,30427914
12732,BRAF,DNA,0.7485,30427914
12733,BRAF mutant,gene,0.9404,30427914
12734,metastatic colorectal cancers,disease,1.0,30427914
12735,Colon Cancer,disease,1.0,30422707
12736,colon cancer,disease,1.0,30422707
12737,Fluoropyrimidine,drug,0.9995,30422707
12738,Oxaliplatin,drug,1.0,30422707
12739,Panitumumab,gene,0.9434,30422707
12740,colon cancer,disease,1.0,30422707
12741,patients,species,0.9897,30422707
12742,patients,species,0.9863,30422707
12743,tumors,disease,0.9478,30422707
12744,colon cancer,disease,1.0,30422707
12745,CTC,cell_type,0.4421,30422707
12746,tumor,disease,0.8887,30422707
12747,extramural vascular invasion,disease,0.878,30422707
12748,tumors,disease,0.9565,30422707
12749,tumors,disease,1.0,30422707
12750,tumors,disease,0.989,30422707
12751,"T3c, T3d,",disease,0.891,30422707
12752,tumors,disease,0.999,30422707
12753,CTC,cell_type,0.7856,30422707
12754,N2,drug,,30422707
12755,EMVI,drug,0.998,30422707
12756,CTC,cell_type,0.514,30422707
12757,tumors,disease,0.9546,30422707
12758,EMVI,disease,0.9727,30422707
12759,colon cancers,disease,1.0,30422707
12760,Polyaminocarboxylate,drug,0.9995,30403833
12761,Cancer,disease,0.5195,30403833
12762,polyaminocarboxylate,drug,0.9995,30403833
12763,cancer,disease,0.9844,30403833
12764,polyaminocarboxylate,drug,0.9995,30403833
12765,CAB-NE3TA,drug,0.999,30403833
12766,anticancer,disease,0.5376,30403833
12767,CAB-NE3TA,drug,0.8047,30403833
12768,cancer cell lines,cell_line,0.491,30403833
12769,cancer,disease,1.0,30403833
12770,epidermal growth factor receptor,gene,0.9976,30403833
12771,EGFR,gene,0.9966,30403833
12772,panitumumab,gene,0.9683,30403833
12773,PAN,gene,0.9307,30403833
12774,EGFR,gene,0.995,30403833
12775,PAN,drug,0.8315,30403833
12776,CAB,drug,0.9985,30403833
12777,NE3TA,drug,0.973,30403833
12778,CAB-,drug,0.9995,30403833
12779,NE3TA-PAN,drug,0.624,30403833
12780,CAB-NE3TA-PAN,drug,0.834,30403833
12781,EGFR-positive A431,cell_line,0.755,30403833
12782,EGFR,gene,0.991,30403833
12783,human skin cancer) cell xenograft mouse model,cell_line,0.747,30403833
12784,skin cancer,disease,0.983,30403833
12785,mouse,species,0.9854,30403833
12786,CAB,drug,0.8794,30403833
12787,NE3TA,drug,0.518,30403833
12788,PAN,drug,0.9375,30403833
12789,A431 tumors,disease,0.7363,30403833
12790,mice,species,0.929,30403833
12791,tumor,disease,0.9995,30403833
12792,tumor,disease,1.0,30403833
12793,tumors,disease,1.0,30403833
12794,mice,species,0.971,30403833
12795,cancer,disease,0.963,30403833
12796,Panitumumab,gene,0.8438,30386120
12797,docetaxel,drug,0.999,30386120
12798,cisplatin,drug,1.0,30386120
12799,5-fluorouracil,drug,0.9995,30386120
12800,gastric and gastroesophageal junction adenocarcinomas,disease,1.0,30386120
12801,docetaxel,drug,0.999,30386120
12802,cisplatin,drug,0.9995,30386120
12803,5-fluorouracil,drug,0.9995,30386120
12804,DCF,drug,0.915,30386120
12805,panitumumab,gene,0.773,30386120
12806,advanced gastroesophageal cancer,disease,0.9956,30386120
12807,cisplatin,drug,0.9995,30386120
12808,leucovorin,drug,0.9985,30386120
12809,5-fluorouracil,drug,0.9995,30386120
12810,5-fluorouracil,drug,0.999,30386120
12811,docetaxel,drug,0.996,30386120
12812,DCF,drug,0.994,30386120
12813,docetaxel,drug,0.998,30386120
12814,neutropenia,disease,0.9995,30386120
12815,febrile neutropenia,disease,1.0,30386120
12816,Allergic reactions,disease,0.9995,30386120
12817,mDCF,drug,0.9995,30386120
12818,Panitumumab,gene,0.7993,30382040
12819,Hypomagnesemia,disease,0.9844,30382040
12820,Hypomagnesemia,disease,1.0,30382040
12821,panitumumab,gene,0.886,30382040
12822,arrhythmia,disease,1.0,30382040
12823,panitumumab,gene,0.8594,30382040
12824,hypomagnesemia,disease,0.9995,30382040
12825,panitumumab,gene,0.75,30382040
12826,hypomagnesemia,disease,0.793,30382040
12827,magnesium,drug,0.999,30382040
12828,hypocalcemia,disease,1.0,30382040
12829,magnesium,drug,0.999,30382040
12830,hypomagnesemia,disease,0.9995,30382040
12831,panitumumab,gene,0.8286,30382040
12832,hypocalcemia,disease,1.0,30382040
12833,hypomagnesemia,disease,1.0,30382040
12834,hypomagnesemia,disease,0.9985,30382040
12835,hypomagnesemia,disease,0.965,30382040
12836,hypomagnesemia,disease,1.0,30382040
12837,hypomagnesemia,disease,0.998,30382040
12838,hypomagnesemia,disease,0.992,30382040
12839,hypomagnesemia,disease,1.0,30382040
12840,panitumumab,gene,0.9355,30382040
12841,magnesium,drug,0.9995,30382040
12842,calcium,drug,0.9966,30382040
12843,Colorectal Cancers,disease,1.0,35135170
12844,V600 BRAF,gene,0.6436,35135170
12845,BRAF,DNA,0.59,35135170
12846,BRAF mutations,gene,0.9546,35135170
12847,colorectal cancers,disease,1.0,35135170
12848,CRC,disease,1.0,35135170
12849,BRAF mutant CRCs,cell_line,0.798,35135170
12850,BRAF,gene,0.9966,35135170
12851,CRCs,disease,0.525,35135170
12852,V600,DNA,0.8013,35135170
12853,BRAF,DNA,0.4912,35135170
12854,BRAF mutations,gene,0.686,35135170
12855,BRAF,DNA,0.6704,35135170
12856,BRAF V600E,gene,0.904,35135170
12857,V600E,DNA,0.392,35135170
12858,V600E,mutation,,35135170
12859,CRC,disease,0.8945,35135170
12860,epidermal growth factor receptor,gene,0.9976,35135170
12861,EGFR,gene,0.996,35135170
12862,cetuximab,gene,0.801,35135170
12863,panitumumab,gene,0.703,35135170
12864,mitogen-activated protein kinase,gene,0.9966,35135170
12865,EGFR,gene,0.9893,35135170
12866,BRAF,DNA,0.8047,35135170
12867,BRAF mutations,gene,0.9355,35135170
12868,patients,species,0.991,35135170
12869,V600 BRAF,DNA,0.3972,35135170
12870,V600 BRAF mutations,gene,0.6904,35135170
12871,EGFR,gene,0.983,35135170
12872,patients,species,0.984,35135170
12873,tumors,disease,0.998,35135170
12874,V600,DNA,0.849,35135170
12875,V600 BRAF mutations,gene,0.6665,35135170
12876,mitogen-activated protein kinase,gene,0.9976,35135170
12877,RAS,gene,0.9634,35135170
12878,BRAF V600E mutations,gene,0.8794,35135170
12879,V600E,mutation,,35135170
12880,EGFR,gene,0.9805,35135170
12881,V600,DNA,0.568,35135170
12882,V600 BRAF mutant CRC,cell_line,0.509,35135170
12883,BRAF,gene,0.7793,35135170
12884,CRC,disease,1.0,35135170
12885,CRC,disease,0.9844,35135170
12886,V600E,DNA,0.6333,35135170
12887,V600E,mutation,,35135170
12888,BRAF,gene,0.997,35135170
12889,EGFR,gene,0.9946,35135170
12890,receptor tyrosine kinase,gene,0.9956,35135170
12891,tyrosine,drug,0.9746,35135170
12892,V600,DNA,0.577,35135170
12893,V600 BRAF,gene,0.893,35135170
12894,CRCs,disease,0.9995,35135170
12895,V600 BRAF,gene,0.903,35135170
12896,EGFR,gene,0.993,35135170
12897,panitumumab,gene,0.821,30366852
12898,patients,species,0.972,30366852
12899,metastatic colorectal cancer,disease,1.0,30366852
12900,colorectal cancer,disease,1.0,30366852
12901,CRC,disease,1.0,30366852
12902,patients,species,0.935,30366852
12903,patients,species,0.981,30366852
12904,panitumumab,gene,0.8706,30366852
12905,patients,species,0.936,30366852
12906,patients,species,0.9077,30366852
12907,metastatic CRC,disease,1.0,30366852
12908,mCRC,disease,1.0,30366852
12909,panitumumab,gene,0.9546,30366852
12910,patients,species,0.9443,30366852
12911,mCRC,disease,0.9824,30366852
12912,patients,species,0.9414,30366852
12913,KRAS exon 2 wild,DNA,0.792,30366852
12914,KRAS exon 2,gene,0.9785,30366852
12915,tumors,disease,0.908,30366852
12916,panitumumab,gene,0.6543,30366852
12917,patients,species,0.9795,30366852
12918,left,disease,0.8384,30366852
12919,metastatic sites,DNA,0.4797,30366852
12920,patients,species,0.9893,30366852
12921,right,DNA,0.529,30366852
12922,neutropenia,disease,1.0,30366852
12923,diarrhea,disease,1.0,30366852
12924,skin rash,disease,1.0,30366852
12925,panitumumab,gene,0.8516,30366852
12926,patients,species,0.943,30366852
12927,mCRC,disease,0.997,30366852
12928,Metastatic colorectal cancer,disease,0.999,30365654
12929,panitumumab,gene,0.875,30365654
12930,doctors,cell_type,0.5015,30365654
12931,EGFR antibody,gene,0.9053,30364934
12932,V600,cell_line,0.4236,30364934
12933,V600 BRAF,gene,0.4907,30364934
12934,metastatic colorectal cancer,disease,0.9995,30364934
12935,Panitumumab,gene,0.86,30359979
12936,Cetuximab,gene,0.8413,30359979
12937,Metastatic Colorectal Cancer,disease,1.0,30359979
12938,Bevacizumab,gene,0.7,30359979
12939,epithelial growth factor receptor,gene,0.9595,30359979
12940,EGFR,gene,0.973,30359979
12941,cetuximab,gene,0.732,30359979
12942,Cmab,gene,0.9204,30359979
12943,panitumumab,gene,0.8926,30359979
12944,Pmab,gene,0.934,30359979
12945,metastatic colorectal cancer,disease,1.0,30359979
12946,mCRC,disease,1.0,30359979
12947,bevacizumab,drug,0.526,30359979
12948,anti-EGFR antibody,gene,0.9414,30359979
12949,bevacizumab,drug,0.5327,30359979
12950,mCRC,disease,0.9897,30359979
12951,Cmab,drug,0.9795,30359979
12952,Pmab,drug,0.9404,30359979
12953,irinotecan,drug,0.9917,30359979
12954,mCRC,disease,0.997,30359979
12955,KRAS exon 2 wild-type tumor,DNA,0.6714,30359979
12956,KRAS exon 2,gene,0.951,30359979
12957,fluoropyrimidines,drug,0.9995,30359979
12958,oxali platin,drug,0.995,30359979
12959,irinotecan,drug,0.9985,30359979
12960,Pmab,cell_line,0.534,30359979
12961,Cmab,drug,0.3833,30359979
12962,Cmab,DNA,0.4463,30359979
12963,Pmab,drug,0.825,30359979
12964,Cmab,drug,0.7114,30359979
12965,Pmab,gene,0.823,30359979
12966,Pmab,gene,0.67,30359979
12967,bevacizumab,gene,0.719,30359979
12968,bevacizumab,gene,0.502,30359979
12969,EGFR,gene,0.8696,30359979
12970,EGFR,gene,0.7803,30359979
12971,Anti-EGFR Monoclonal Antibodies,gene,0.9556,30353488
12972,epidermal growth factor receptor,gene,0.997,30353488
12973,EGFR Abs,gene,0.946,30353488
12974,metastatic colorectal carcinoma,disease,1.0,30353488
12975,mCRC,disease,1.0,30353488
12976,RAS,gene,0.9937,30353488
12977,anti-EGFR mAbs,gene,0.9067,30353488
12978,mCRC,disease,0.99,30353488
12979,patients,species,0.973,30353488
12980,PATIENTS,species,0.9473,30353488
12981,patients,species,0.99,30353488
12982,RAS,gene,0.965,30353488
12983,mCRC,disease,0.973,30353488
12984,anti-,gene,0.882,30353488
12985,EGFR mAbs,gene,0.7515,30353488
12986,Patients,species,0.9854,30353488
12987,anti-EGFR mAbs,gene,0.924,30353488
12988,patients,species,0.9883,30353488
12989,anti-EGFR mAbs,gene,0.9497,30353488
12990,patients,species,0.9917,30353488
12991,anti-EGFR mAbs,gene,0.9585,30353488
12992,patients,species,0.9917,30353488
12993,anti-EGFR mAbs,gene,0.9883,30353488
12994,patients,species,0.991,30353488
12995,panitumumab,gene,0.839,30353488
12996,patients,species,0.991,30353488
12997,cetuximab,gene,0.654,30353488
12998,patients,species,0.976,30353488
12999,anti-EGFR mAbs,gene,0.851,30353488
13000,anti-EGFR mAbs,gene,0.8496,30353488
13001,Patients,species,0.948,30348618
13002,Colorectal Liver,disease,0.997,30348618
13003,albumin,gene,0.9956,30348618
13004,bilirubin,drug,0.9995,30348618
13005,patients,species,0.9717,30348618
13006,hepatocellular carcinoma,disease,1.0,30348618
13007,patients,species,0.9575,30348618
13008,colorectal liver metastases,disease,1.0,30348618
13009,Panitumumab,gene,0.8696,30348618
13010,Metastatic Colorectal Cancer,disease,1.0,30348618
13011,patient,species,0.9893,30348618
13012,patients,species,0.988,30348618
13013,colorectal liver metastases,disease,1.0,30348618
13014,ALBI,DNA,0.5024,30348618
13015,lactate,drug,0.999,30348618
13016,lactate dehydrogenase,gene,0.989,30348618
13017,LDH,gene,0.99,30348618
13018,LDH,gene,0.9907,30348618
13019,LDH,gene,0.991,30348618
13020,ALBI,DNA,0.552,30348618
13021,LDH,gene,0.995,30348618
13022,ALBI,DNA,0.4902,30348618
13023,patients,species,0.9263,30348618
13024,colorectal liver metastases,disease,1.0,30348618
13025,Panitumumab,gene,0.8203,30321552
13026,Invasive Bladder Cancer,disease,1.0,30321552
13027,panitumumab,gene,0.6836,30321552
13028,invasive bladder cancer,disease,1.0,30321552
13029,bladder cancer,disease,0.9927,30321552
13030,platinum,drug,0.9946,30321552
13031,panitumumab,gene,0.9087,30321552
13032,cisplatin,drug,0.9995,30321552
13033,EGFR,gene,0.9946,30321552
13034,epidermal growth factor receptor,gene,0.998,30321552
13035,RAS,gene,0.995,30321552
13036,panitumumab,gene,0.925,30321552
13037,panitumumab,gene,0.9126,30321552
13038,tumors,disease,0.4631,30321552
13039,EGFR,gene,0.9946,30321552
13040,RAS,gene,0.9946,30321552
13041,EGFR,gene,0.9907,30321552
13042,panitumumab,gene,0.573,30321552
13043,cisplatin,drug,0.9995,30321552
13044,HER2,gene,0.9883,30294606
13045,Human epidermal growth factor receptor 2,gene,0.988,30294606
13046,Human,species,0.884,30294606
13047,HER2,gene,0.9976,30294606
13048,epidermal growth factor receptor,gene,0.998,30294606
13049,EGFR,gene,0.998,30294606
13050,patients,species,0.955,30294606
13051,metastatic colorectal cancer,disease,1.0,30294606
13052,mCRC,disease,1.0,30294606
13053,HER2,gene,0.9253,30294606
13054,HER2,gene,0.9873,30294606
13055,mCRC,disease,0.916,30294606
13056,cancer,disease,0.988,30294606
13057,HER2,gene,0.9907,30294606
13058,trastuzumab,gene,0.955,30294606
13059,lapatinib,drug,0.996,30294606
13060,patients,species,0.9624,30294606
13061,HER2-positive,cell_line,0.608,30294606
13062,HER2,gene,0.8135,30294606
13063,mCRC,disease,0.995,30294606
13064,anti-EGFR antibodies cetuximab,gene,0.902,30294606
13065,panitumumab,gene,0.649,30294606
13066,HER2,gene,0.9927,30294606
13067,EGFR,gene,0.9307,30294606
13068,HER2,gene,0.9966,30294606
13069,Oral mucositis,disease,1.0,30290786
13070,EGFR,gene,0.945,30290786
13071,colorectal cancer,disease,1.0,30290786
13072,oral mucositis,disease,0.9995,30290786
13073,oral mucositis,disease,1.0,30290786
13074,anti-epidermal growth factor receptor,gene,0.979,30290786
13075,EGFR,gene,0.9805,30290786
13076,colorectal cancer,disease,1.0,30290786
13077,oral mucositis,disease,1.0,30290786
13078,panitumumab,gene,0.966,30290786
13079,Pmab,gene,0.983,30290786
13080,cetuximab,gene,0.9663,30290786
13081,Cmab,gene,0.9795,30290786
13082,5-fluorouracil,drug,0.9985,30290786
13083,5-FU,drug,0.9663,30290786
13084,colorectal cancer,disease,1.0,30290786
13085,anti-EGFR antibody,gene,0.8496,30290786
13086,FOLFOX,drug,0.902,30290786
13087,FOLFIRI,drug,0.7393,30290786
13088,5-FU,drug,0.999,30290786
13089,leucovorin,drug,0.999,30290786
13090,oral mucositis,disease,1.0,30290786
13091,oral mucositis,disease,1.0,30290786
13092,skin toxicity,disease,0.939,30290786
13093,hypomagnesaemia,disease,1.0,30290786
13094,neutropenia,disease,1.0,30290786
13095,patients,species,0.991,30290786
13096,Pmab,drug,0.956,30290786
13097,patients,species,0.995,30290786
13098,Cmab,drug,0.9536,30290786
13099,Patient,species,0.9863,30290786
13100,oral mucositis,disease,1.0,30290786
13101,Pmab,drug,0.9683,30290786
13102,Cmab,DNA,0.4954,30290786
13103,Cmab,drug,0.9395,30290786
13104,oral mucositis,disease,0.999,30290786
13105,patients,species,0.9614,30290786
13106,Pmab,gene,0.6064,30290786
13107,mucositis,disease,0.894,30290786
13108,Pmab,drug,0.636,30290786
13109,Cmab,drug,0.851,30290786
13110,Oral mucositis,disease,1.0,30290786
13111,glossitis,disease,1.0,30290786
13112,cheilitis,disease,1.0,30290786
13113,Pmab,DNA,0.7075,30290786
13114,Cmab,DNA,0.4482,30290786
13115,hypomagnesaemia,disease,1.0,30290786
13116,neutropenia,disease,0.998,30290786
13117,Pmab,gene,0.751,30290786
13118,Cmab,DNA,0.5493,30290786
13119,Cmab,gene,0.6646,30290786
13120,Pmab,drug,0.969,30290786
13121,oral mucositis,disease,0.9995,30290786
13122,Cmab,drug,0.951,30290786
13123,patients,species,0.97,30290786
13124,Pmab,gene,0.6396,30290786
13125,Human IgG2 Antibodies,gene,0.9375,30282813
13126,EGFR,gene,0.986,30282813
13127,epidermal growth factor receptor,gene,0.999,30282813
13128,EGFR,gene,0.9766,30282813
13129,cetuximab,gene,0.7812,30282813
13130,panitumumab,gene,0.876,30282813
13131,necitumumab,gene,0.9307,30282813
13132,cancers,disease,1.0,30282813
13133,panitumumab,gene,0.931,30282813
13134,human IgG2 isotype,gene,0.9463,30282813
13135,human IgG2 antibodies,gene,0.935,30282813
13136,EGFR,gene,0.9883,30282813
13137,EGFR antibody,gene,0.892,30282813
13138,human IgG1,gene,0.8657,30282813
13139,IgG2 isotype,gene,0.9595,30282813
13140,EGFR antibodies,gene,0.952,30282813
13141,human IgG2 isotype,gene,0.808,30282813
13142,M1 macrophages,cell_line,0.6885,30282813
13143,PMN,cell_type,0.7495,30282813
13144,tumor,disease,0.996,30282813
13145,Tumor,disease,0.708,30282813
13146,PMN,cell_type,0.8613,30282813
13147,IgG2,gene,0.9966,30282813
13148,IgG1 antibodies,gene,0.949,30282813
13149,tumor cells,cell_type,0.8647,30282813
13150,tumor,disease,0.9897,30282813
13151,EGFR,gene,0.9863,30282813
13152,CD47,gene,0.9424,30282813
13153,tumor cells,cell_type,0.7783,30282813
13154,tumor,disease,0.9995,30282813
13155,M2 macrophages,cell_line,0.5566,30282813
13156,PMN,cell_type,0.74,30282813
13157,macrophage,cell_type,0.6396,30282813
13158,CD47,gene,0.996,30282813
13159,solid,cell_type,0.453,30282813
13160,solid tumor,disease,1.0,30282813
13161,human IgG2 antibodies,gene,0.869,30282813
13162,EGFR,gene,0.981,30282813
13163,Fc,gene,0.9814,30282813
13164,myeloid effector cells,cell_type,0.8823,30282813
13165,metastatic colorectal cancer,disease,0.9995,30230679
13166,metastatic colorectal cancer,disease,0.9985,30230679
13167,5-fluorouracil,drug,0.9995,30230679
13168,oxaliplatin,drug,0.9995,30230679
13169,irinotecan,drug,0.9985,30230679
13170,FOLFOXIRI,drug,0.757,30230679
13171,epidermal growth factor receptor,gene,0.9985,30230679
13172,EGFRi,gene,0.978,30230679
13173,RAS wild,cell_line,0.5513,30230679
13174,RAS wild-type tumour,disease,0.9795,30230679
13175,RAS,gene,0.9824,30230679
13176,left-sided primary tumour,disease,1.0,30230679
13177,metastatic colorectal cancer,disease,0.998,30230679
13178,Colorectal Cancer,disease,0.819,30230679
13179,metastatic colorectal cancer,disease,1.0,30230679
13180,Colorectal Cancer,disease,0.8457,30230679
13181,bevacizumab,gene,0.8325,30230679
13182,EGFRi,gene,0.9775,30230679
13183,KRAS,gene,0.647,30230679
13184,left-sided tumour,disease,0.886,30230679
13185,EGFRi,gene,0.9854,30230679
13186,EGFRi,gene,0.9697,30230679
13187,bevacizumab,gene,0.668,30230679
13188,bevacizumab,gene,0.7803,30230679
13189,EGFRi,gene,0.976,30230679
13190,EGFRi,gene,0.9746,30230679
13191,Cetuximab,gene,0.991,30226780
13192,Docetaxel,drug,1.0,30226780
13193,Panitumumab,gene,0.981,30226780
13194,Docetaxel,drug,1.0,30226780
13195,anticancer,disease,0.502,30226780
13196,tumor,disease,1.0,30226780
13197,docetaxel,drug,0.999,30226780
13198,cetuximab,gene,0.983,30226780
13199,CET,gene,0.9766,30226780
13200,panitumumab,gene,0.9644,30226780
13201,PAN,gene,0.9697,30226780
13202,EGFR,gene,0.9946,30226780
13203,anticancer,disease,0.9395,30226780
13204,EGFR,gene,0.9927,30226780
13205,wildtype EGFR,gene,0.9824,30226780
13206,EGFR-expressing A431 and MDA-MB-231 cell lines,cell_line,0.826,30226780
13207,EGFR,gene,0.921,30226780
13208,U87MG cells,cell_line,0.9673,30226780
13209,U87MG cells,cell_type,0.687,30226780
13210,A431 tumor,disease,0.709,30226780
13211,mice,species,0.952,30226780
13212,cetuximab,gene,0.9844,30226780
13213,docetaxel,drug,1.0,30226780
13214,CET,drug,0.9897,30226780
13215,CET,drug,0.9897,30226780
13216,patients,species,0.9824,30226780
13217,wild,cell_line,0.4783,30226780
13218,wild-type and mutated EGFR-overexpressing cancers,disease,1.0,30226780
13219,wild,gene,0.5254,30226780
13220,EGFR,gene,0.996,30226780
13221,ADC,disease,0.994,30226780
13222,anti-EGFR antibody,gene,0.9146,30215532
13223,anti-EGFR antibody,gene,0.954,30215532
13224,colorectal cancer,disease,1.0,30215532
13225,colorectal cancer,disease,1.0,30215532
13226,colorectal cancer,disease,1.0,30215532
13227,PATIENTS,species,0.9326,30215532
13228,colorectal cancer,disease,1.0,30215532
13229,anti-EGFR antibody,gene,0.913,30215532
13230,skin,disease,0.9175,30215532
13231,Cell,RNA,0.6206,30211110
13232,Cabozantinib,drug,0.9995,30211110
13233,Panitumumab,gene,0.7695,30211110
13234,Metastatic Colorectal Cancer,disease,1.0,30211110
13235,MET,gene,0.605,30211110
13236,metastatic colorectal cancer (CRC) tumors,disease,0.966,30211110
13237,EGFR,gene,0.5596,30211110
13238,MET,gene,0.71,30211110
13239,MET,gene,0.9966,30211110
13240,Cabozantinib,drug,0.9995,30211110
13241,tyrosine,drug,0.9663,30211110
13242,tyrosine kinases,gene,0.995,30211110
13243,c-MET,gene,0.998,30211110
13244,Panitumumab,gene,0.623,30211110
13245,EGFR,gene,0.991,30211110
13246,"KRAS, NRAS",DNA,0.607,30211110
13247,KRAS,gene,0.9644,30211110
13248,NRAS,gene,0.99,30211110
13249,BRAF,gene,0.993,30211110
13250,metastatic CRC,disease,0.8296,30211110
13251,anti-,gene,0.8164,30211110
13252,EGFR antibody,gene,0.632,30211110
13253,cabozantinib,drug,0.999,30211110
13254,panitumumab,gene,0.9287,30211110
13255,tumor,disease,0.953,30211110
13256,tumor,disease,1.0,30211110
13257,MET,gene,0.743,30211110
13258,cell-free DNA,DNA,0.6455,30211110
13259,cell,RNA,0.5073,30211110
13260,cfDNA,DNA,0.6455,30211110
13261,MET,gene,0.723,30211110
13262,cabozantinib,drug,0.9985,30211110
13263,panitumumab,gene,0.855,30211110
13264,metastatic CRC,disease,0.9985,30211110
13265,MET,gene,0.5605,30211110
13266,cfDNA,DNA,0.5317,30211110
13267,MET,gene,0.5225,30211110
13268,metastatic CRC,disease,0.974,30211110
13269,RAS,gene,0.9956,30199395
13270,HER2,gene,0.9863,30199395
13271,Metastatic Colorectal Cancer,disease,1.0,30199395
13272,Cetuximab,gene,0.938,30199395
13273,panitumumab,gene,0.944,30199395
13274,metastatic colorectal cancer,disease,1.0,30199395
13275,mCRC,disease,1.0,30199395
13276,RAS,gene,0.6973,30199395
13277,RAS,gene,0.9844,30199395
13278,human epidermal growth factor receptor 2,gene,0.9985,30199395
13279,HER2,gene,0.9873,30199395
13280,KRAS exon 2,gene,0.693,30199395
13281,mCRC,disease,0.9985,30199395
13282,mCRC,disease,0.9966,30199395
13283,cetuximab,gene,0.859,30199395
13284,KRAS codon 146,gene,0.8853,30199395
13285,NRAS codon 12,gene,0.8823,30199395
13286,HER2,gene,0.9937,30199395
13287,carcinoma,disease,0.53,30199395
13288,RAS,gene,0.7163,30199395
13289,HER2,gene,0.9897,30199395
13290,neu,gene,0.995,30199395
13291,RAS gene,gene,0.903,30199395
13292,RAS,gene,0.995,30199395
13293,RAS-mutated disease,disease,0.792,30199395
13294,RAS,gene,0.4905,30199395
13295,cetuximab,gene,0.795,30199395
13296,RAS,gene,0.637,30199395
13297,RAS-expanded genes,DNA,0.8784,30199395
13298,RAS,gene,0.9966,30199395
13299,cetuximab,gene,0.5073,30199395
13300,KRAS WT exon 2,gene,0.6514,30199395
13301,HER2,gene,0.995,30199395
13302,cetuximab,gene,0.9536,30199395
13303,mCRC,disease,0.986,30199395
13304,metastatic colorectal cancer,disease,1.0,30196427
13305,metastatic colorectal cancer,disease,1.0,30196427
13306,CRC,disease,0.9995,30196427
13307,mCRC,disease,1.0,30196427
13308,mCRC,disease,0.977,30196427
13309,FOLFOX,drug,0.848,30196427
13310,irinotecan,drug,0.9946,30196427
13311,FOLFOX,drug,0.99,30196427
13312,FOLFOXIRI,drug,0.905,30196427
13313,cetuximab,gene,0.884,30196427
13314,KRAS,gene,0.5728,30196427
13315,panitumumab,gene,0.943,30196427
13316,KRAS,gene,0.723,30196427
13317,bevacizumab,gene,0.7734,30196427
13318,EGFR,gene,0.9946,30196427
13319,cetuximab,gene,0.8325,30196427
13320,panitumumab,gene,0.8633,30196427
13321,bevacizumab,gene,0.873,30196427
13322,mCRC,disease,0.9824,30196427
13323,bevacizumab,gene,0.841,30100734
13324,epidermal growth factor receptor,gene,0.998,30100734
13325,wild-type RAS,gene,0.9463,30100734
13326,epidermal growth factor receptor,gene,0.9688,30100734
13327,EGFR,gene,0.995,30100734
13328,vascular endothelial growth factor,gene,0.9624,30100734
13329,VEGF,gene,0.998,30100734
13330,wild,DNA,0.5586,30100734
13331,wild-type RAS,gene,0.8574,30100734
13332,metastatic colorectal cancer,disease,1.0,30100734
13333,mCRC,disease,1.0,30100734
13334,VEGF,gene,0.993,30100734
13335,bevacizumab,gene,0.588,30100734
13336,EGFR,gene,0.9785,30100734
13337,cetuximab,gene,0.76,30100734
13338,panitumumab,gene,0.7593,30100734
13339,RAS,gene,0.668,30100734
13340,KRAS,gene,0.793,30100734
13341,mCRC,disease,0.9985,30100734
13342,EGFR,gene,0.9844,30100734
13343,VEGF,gene,0.988,30100734
13344,wild-type KRAS,gene,0.8794,30100734
13345,wild-type RAS,gene,0.844,30100734
13346,wild-type RAS,gene,0.7554,30100734
13347,EGFR,gene,0.988,30100734
13348,VEGF,gene,0.9946,30100734
13349,EGFR,gene,0.9883,30100734
13350,VEGF,gene,0.994,30100734
13351,VEGF,gene,0.9966,30100734
13352,right-sided tumors,disease,0.983,30100734
13353,left-sided tumors,disease,0.786,30100734
13354,EGFR,gene,0.9795,30100734
13355,EGFR,gene,0.9175,30100734
13356,VEGF,gene,0.956,30100734
13357,mCRC,disease,0.9917,30100734
13358,wild-type RAS,gene,0.7573,30100734
13359,tumor,disease,0.998,30100734
13360,anti-EGFR antibody,gene,0.9756,30099818
13361,-,DNA,0.4426,30099818
13362,overlapping epitopes,DNA,0.428,30099818
13363,epidermal growth factor receptor,gene,0.9985,30099818
13364,cetuximab,gene,0.9556,30099818
13365,panitumumab,gene,0.94,30099818
13366,Patients,species,0.965,30099818
13367,late-stage solid tumors,disease,0.9985,30099818
13368,Sym004,drug,0.958,30099818
13369,Patients,species,0.971,30099818
13370,esophageal squamous cell carcinoma,disease,1.0,30099818
13371,Sym004,drug,0.989,30099818
13372,patients,species,0.972,30099818
13373,Sym004,drug,0.818,30099818
13374,patients,species,0.9805,30099818
13375,dermatitis acneiform,disease,1.0,30099818
13376,cardiac arrest,disease,1.0,30099818
13377,lung infection,disease,1.0,30099818
13378,interstitial lung disease,disease,1.0,30099818
13379,toxic skin eruption,disease,1.0,30099818
13380,creatinine,drug,0.9995,30099818
13381,patients,species,0.99,30099818
13382,cardiac arrest,disease,1.0,30099818
13383,creatinine,drug,0.993,30099818
13384,patients,species,0.9814,30099818
13385,patients,species,0.959,30099818
13386,esophageal squamous cell carcinoma,disease,1.0,30099818
13387,EGFR gene,gene,0.806,30096327
13388,anti-,gene,0.858,30096327
13389,EGFR antibody,gene,0.8,30096327
13390,colorectal cancer,disease,1.0,30096327
13391,Epidermal growth factor receptor (EGFR) gene,DNA,0.76,30096327
13392,Epidermal growth factor receptor,gene,0.999,30096327
13393,EGFR,gene,0.9976,30096327
13394,anti-EGFR antibody,gene,0.8755,30096327
13395,RAS,gene,0.9956,30096327
13396,metastatic colorectal cancer,disease,0.999,30096327
13397,EGFR,gene,0.995,30096327
13398,colorectal cancer tumors,disease,0.973,30096327
13399,anti-,gene,0.8086,30096327
13400,EGFR antibody,gene,0.7114,30096327
13401,EGFR,gene,0.6255,30096327
13402,GCN,DNA,0.5444,30096327
13403,EGFR,gene,0.994,30096327
13404,GCN,gene,0.7783,30096327
13405,EGFR,gene,0.8047,30096327
13406,EGFR,gene,0.9966,30096327
13407,GCN,DNA,0.5493,30096327
13408,EGFR,gene,0.9927,30096327
13409,silver,drug,0.9404,30096327
13410,local or metastatic tumors,disease,0.9106,30096327
13411,colorectal cancer,disease,1.0,30096327
13412,GCN,gene,0.988,30096327
13413,KRAS,gene,0.6934,30096327
13414,anti-EGFR,gene,0.887,30096327
13415,EGFR,gene,0.9937,30096327
13416,tumors,disease,0.992,30096327
13417,anti-EGFR,gene,0.868,30096327
13418,EGFR,gene,0.7505,30096327
13419,EGFR,gene,0.9907,30096327
13420,GCN,DNA,0.4478,30096327
13421,tumors,disease,0.9976,30096327
13422,anti-EGFR antibodies,gene,0.897,30096327
13423,EGFR,gene,0.9937,30096327
13424,GCN,DNA,0.4766,30096327
13425,EGFR,gene,0.874,30096327
13426,anti-,gene,0.5874,30096327
13427,EGFR antibody,gene,0.773,30096327
13428,EGFR,gene,0.989,30096327
13429,GCN,DNA,0.5996,30096327
13430,colorectal adenocarcinomas,disease,1.0,30096327
13431,GCN,gene,0.9585,30096327
13432,panitumumab,gene,0.916,30091652
13433,bevacizumab,gene,0.7188,30091652
13434,wild-type RAS,gene,0.916,30091652
13435,panitumumab,gene,0.9097,30091652
13436,oxaliplatin,drug,1.0,30091652
13437,5-fluorouracil,drug,0.9995,30091652
13438,leucovorin,drug,0.9985,30091652
13439,bevacizumab,gene,0.779,30091652
13440,wild,DNA,0.6655,30091652
13441,wild-type RAS,gene,0.9736,30091652
13442,metastatic colorectal cancer,disease,1.0,30091652
13443,mCRC,disease,1.0,30091652
13444,wild-type RAS,gene,0.865,30091652
13445,mCRC,disease,0.964,30091652
13446,panitumumab,gene,0.966,30091652
13447,bevacizumab,gene,0.862,30091652
13448,mCRC,disease,0.999,30091652
13449,panitumumab,gene,0.714,30091652
13450,bevacizumab,gene,0.904,30091652
13451,panitumumab,gene,0.933,30091652
13452,panitumumab,gene,0.792,30091652
13453,panitumumab,gene,0.8774,30091652
13454,wild,gene,0.7344,30091652
13455,mCRC,disease,0.613,30091652
13456,bevacizumab,gene,0.6367,30091652
13457,colorectal cancer,disease,1.0,30075835
13458,colorectal cancer,disease,1.0,30075835
13459,CRC,disease,1.0,30075835
13460,fluoropyrimidines,drug,0.9995,30075835
13461,irinotecan,drug,0.9985,30075835
13462,oxaliplatin,drug,0.9995,30075835
13463,CRC,disease,0.9995,30075835
13464,anti-EGFR,gene,0.7554,30075835
13465,cetuximab,gene,0.891,30075835
13466,panitumumab,gene,0.889,30075835
13467,bevacizumab,gene,0.574,30075835
13468,regorafenib,drug,0.97,30075835
13469,advanced CRC,disease,0.9937,30075835
13470,CRC,disease,0.998,30075835
13471,inhered,DNA,0.491,30075835
13472,ATP,drug,0.9976,30075835
13473,ATP-binding cassette,gene,0.9795,30075835
13474,ABC,gene,0.7905,30075835
13475,solute carrier,gene,0.8286,30075835
13476,SLC,gene,0.8906,30075835
13477,folate,drug,0.9995,30075835
13478,fluoropyrimidines,drug,0.999,30075835
13479,irinotecan,drug,0.997,30075835
13480,oxaliplatin,drug,0.9995,30075835
13481,peripheral neuropathy,disease,1.0,30075835
13482,host genetic markers,DNA,0.596,30075835
13483,irinotecan,drug,0.9966,30075835
13484,UGT1A1,DNA,0.512,30075835
13485,UGT1A1*28 genotype,gene,0.9214,30075835
13486,fluoropyrimidines,drug,0.999,30075835
13487,DPYD genetic variants,DNA,0.6265,30075835
13488,DPYD genetic,gene,0.745,30075835
13489,CRC,disease,0.999,30075835
13490,UMPBI,drug,0.997,30066466
13491,UMPBI,DNA,0.6777,30066466
13492,UMPBI,DNA,0.525,30066466
13493,panitumumab,gene,0.96,30066466
13494,gemcitabine,drug,0.9985,30066466
13495,interstitial lung disease,disease,1.0,30034518
13496,Panitumumab,gene,0.6953,30034518
13497,interstitial lung disease,disease,1.0,30034518
13498,ILD,disease,1.0,30034518
13499,Panitumumab,gene,0.663,30034518
13500,ILD,disease,1.0,30034518
13501,metastatic rectal cancer,disease,1.0,30034518
13502,K-RAS,gene,0.726,30034518
13503,ILD,disease,1.0,30034518
13504,Panitumumab,gene,0.9473,30034518
13505,locally advanced rectal cancer,disease,0.9487,30034518
13506,liver metastases,disease,0.8843,30034518
13507,folinic acid,drug,0.9995,30034518
13508,fluorouracil,drug,0.9985,30034518
13509,Oxaliplatin,drug,0.9995,30034518
13510,Panitumumab,gene,0.698,30034518
13511,liver,disease,0.6426,30034518
13512,Oxaliplatin,drug,0.9995,30034518
13513,Panitumumab,gene,0.839,30034518
13514,shortness of breath,disease,0.997,30034518
13515,interstitial pneumonitis,disease,1.0,30034518
13516,respiratory failure,disease,0.9995,30034518
13517,Rectal Cancer,disease,1.0,30022919
13518,rectal cancer,disease,1.0,30022919
13519,advanced rectal cancer tumor,disease,0.9995,30022919
13520,FOLFOX4,drug,0.985,30022919
13521,FOLFIRI,drug,0.9507,30022919
13522,panitumumab,gene,0.821,30022919
13523,rectal cancer,disease,1.0,30022919
13524,RAS Panel,gene,0.92,30019318
13525,RAS mutations,gene,0.982,30019318
13526,formalin,drug,0.982,30019318
13527,metastatic colorectal cancer (,disease,1.0,30019318
13528,mCRC),disease,0.8574,30019318
13529,tumor,disease,0.5107,30019318
13530,patients,species,0.97,30019318
13531,mCRC,disease,0.9985,30019318
13532,panitumumab,gene,0.8364,30019318
13533,panitumumab,gene,0.9336,30019318
13534,FOLFOX4,drug,0.965,30019318
13535,FOLFOX4,drug,0.7803,30019318
13536,KRAS,gene,0.9834,30019318
13537,"NRAS exons 2, 3, and 4",DNA,0.757,30019318
13538,NRAS,gene,0.991,30019318
13539,Extended,DNA,0.607,30019318
13540,RAS Panel,gene,0.8315,30019318
13541,patients,species,0.99,30019318
13542,RAS,DNA,0.878,30019318
13543,RAS mutations,gene,0.782,30019318
13544,RAS,gene,0.9927,30019318
13545,RAS,gene,0.9946,30019318
13546,Panitumumab,gene,0.8906,30019318
13547,FOLFOX4,drug,0.9307,30019318
13548,RAS,gene,0.9927,30019318
13549,patients,species,0.9863,30019318
13550,panitumumab,gene,0.9272,30019318
13551,FOLFOX4,drug,0.946,30019318
13552,FOLFOX4,drug,0.7285,30019318
13553,RAS,gene,0.994,30019318
13554,RAS,gene,0.9966,30019318
13555,genomic regions,DNA,0.827,30019318
13556,Extended,DNA,0.6973,30019318
13557,RAS Panel,gene,0.8193,30019318
13558,patients,species,0.9785,30019318
13559,panitumumab,gene,0.6333,30019318
13560,mCRC,disease,0.999,30019318
13561,RAS,gene,0.767,30019318
13562,patients,species,0.9707,30019318
13563,RAS Panel,DNA,0.6885,30019318
13564,RAS,gene,0.969,30019318
13565,KRAS exon 2,gene,0.988,30019318
13566,cetuximab,gene,0.84,30019286
13567,cetuximab,gene,0.7915,30019286
13568,patients,species,0.988,30019286
13569,KRAS,gene,0.988,30019286
13570,metastatic colorectal cancer,disease,1.0,30019286
13571,mCRC,disease,1.0,30019286
13572,Patients,species,0.9854,30019286
13573,KRAS,gene,0.9946,30019286
13574,mCRC,disease,0.998,30019286
13575,cetuximab,gene,0.753,30019286
13576,patient,species,0.984,30019286
13577,cetuximab,gene,0.926,30019286
13578,mCRC,disease,0.996,30019286
13579,cetuximab,gene,0.9336,30019286
13580,cetuximab,gene,0.8457,30019286
13581,cetuximab,gene,0.716,30019286
13582,patients,species,0.9307,30019286
13583,KRAS (exon 2),gene,0.8423,30019286
13584,mCRC,disease,0.999,30019286
13585,cetuximab,gene,0.886,30019286
13586,panitumumab,gene,0.894,30019286
13587,panitumumab,gene,0.8647,30018814
13588,bevacizumab,gene,0.7466,30018814
13589,patients,species,0.901,30018814
13590,metastatic colorectal cancer,disease,1.0,30018814
13591,RAS,gene,0.998,30018814
13592,BRAF,gene,0.9976,30018814
13593,cetuximab,gene,0.8223,30018814
13594,panitumumab,gene,0.763,30018814
13595,RAS,gene,0.9956,30018814
13596,BRAF,gene,0.997,30018814
13597,patients,species,0.9907,30018814
13598,panitumumab,gene,0.7817,30018814
13599,patients,species,0.9897,30018814
13600,RAS,gene,0.9946,30018814
13601,BRAF,gene,0.9946,30018814
13602,metastatic colorectal cancer,disease,0.9937,30018814
13603,RAS,gene,0.9976,30018814
13604,BRAF,gene,0.9917,30018814
13605,patients,species,0.9756,30018814
13606,panitumumab,gene,0.7207,30018814
13607,irinotecan,drug,0.999,30018814
13608,oxaliplatin,drug,0.999,30018814
13609,L-leucovorin,drug,0.999,30018814
13610,5-fluoruracil,drug,0.9985,30018814
13611,panitumumab,gene,0.849,30018814
13612,panitumumab,gene,0.835,30018814
13613,5-fluorouracil,drug,0.999,30018814
13614,L-leucovorin,drug,0.998,30018814
13615,EGFR,gene,0.639,30018814
13616,patients,species,0.9595,30018814
13617,panitumumab,gene,0.88,30013091
13618,metastatic colorectal cancer,disease,1.0,30013091
13619,mCRC,disease,1.0,30013091
13620,tumour,disease,0.9434,30013091
13621,tumour,disease,0.925,30013091
13622,Patients,species,0.973,30013091
13623,RAS,gene,0.991,30013091
13624,mCRC,disease,0.973,30013091
13625,ETS,disease,0.888,30013091
13626,patients,species,0.963,30013091
13627,patients,species,0.9785,30013091
13628,patients,species,0.9883,30013091
13629,panitumumab,gene,0.8823,30013091
13630,panitumumab,gene,0.8257,30013091
13631,patients,species,0.9663,30013091
13632,panitumumab,gene,0.8237,30013091
13633,Panitumumab,gene,0.868,30013091
13634,panitumumab,gene,0.942,30013091
13635,patients,species,0.911,30013091
13636,ETS,gene,0.96,30013091
13637,patients,species,0.9883,30013091
13638,panitumumab,gene,0.748,30013091
13639,Panitumumab,gene,0.7886,29999651
13640,panitumumab,gene,0.9224,29999651
13641,panitumumab,gene,0.9204,29999651
13642,infant,species,0.929,29999651
13643,infant,species,0.7734,29999651
13644,panitumumab,gene,0.8716,29999651
13645,infant,species,0.7007,29999651
13646,panitumumab,gene,0.914,29999651
13647,Panitumumab,gene,0.746,29999651
13648,human immunoglobulin G2 (,gene,0.8594,29999651
13649,human,species,0.951,29999651
13650,IgG2) kappa antibody,gene,0.662,29999651
13651,immunoglobulin G,gene,0.749,29999651
13652,IgG,gene,0.996,29999651
13653,IgG,gene,0.9956,29999651
13654,IgG2,gene,0.9956,29999651
13655,IgG,gene,0.9893,29999651
13656,Tumor,disease,0.8813,29967260
13657,solid tumors,disease,1.0,29967260
13658,cancers,disease,1.0,29967260
13659,tumor,disease,0.9263,29967260
13660,tumor,disease,0.9985,29967260
13661,squamous cell carcinoma,disease,1.0,29967260
13662,HNSCC,disease,0.9995,29967260
13663,panitumumab,gene,0.9673,29967260
13664,tumor,disease,0.999,29967260
13665,normal,cell_type,0.4846,29967260
13666,tumor,disease,0.9985,29967260
13667,tumor,disease,0.463,29967260
13668,head and neck cancers,disease,1.0,29967260
13669,cancers,disease,0.7954,29967260
13670,patients,species,0.9556,29936654
13671,K-RAS,gene,0.9985,29936654
13672,regorafenib,drug,0.9907,29936654
13673,patients,species,0.8623,29936654
13674,metastatic colorectal cancer,disease,0.9995,29936654
13675,mCRC,disease,1.0,29936654
13676,regorafenib,drug,0.9966,29936654
13677,regorafenib,drug,0.9766,29936654
13678,patients,species,0.985,29936654
13679,mCRC,disease,0.9897,29936654
13680,panitumumab,gene,0.893,29936654
13681,cetuximab,gene,0.8115,29936654
13682,patient,species,0.9644,29936654
13683,patients,species,0.984,29936654
13684,regorafenib,drug,0.9893,29936654
13685,panitumumab,gene,0.9087,29936654
13686,cetuximab,gene,0.786,29936654
13687,patients,species,0.9756,29936654
13688,bilirubin,drug,0.9995,29936654
13689,thromboembolic events,disease,1.0,29936654
13690,regorafenib,drug,0.9917,29936654
13691,patients,species,0.989,29936654
13692,panitumumab,gene,0.872,29936654
13693,cetuximab,gene,0.7026,29936654
13694,regorafenib,drug,0.997,29936654
13695,regorafenib,DNA,0.479,29936654
13696,regorafenib,drug,0.997,29936654
13697,patients,species,0.9473,29936654
13698,patients,species,0.972,29936654
13699,mCRC,disease,0.9946,29936654
13700,regorafenib,drug,0.995,29936654
13701,colorectal cancer,disease,1.0,29928383
13702,colon cancer,disease,1.0,29928383
13703,colon cancer,disease,1.0,29928383
13704,metastatic colon cancer,disease,1.0,29928383
13705,vascular endothelial growth factor,gene,0.9976,29928383
13706,VEGF,gene,0.995,29928383
13707,bevacizumab,gene,0.5215,29928383
13708,ziv-aflibercept,gene,0.964,29928383
13709,regorafenib,drug,0.9653,29928383
13710,epithelial growth factor receptor,gene,0.9966,29928383
13711,EGFR,gene,0.994,29928383
13712,cetuximab,gene,0.8325,29928383
13713,panitumumab,gene,0.876,29928383
13714,VEGF,gene,0.9736,29928383
13715,cardiovascular and kidney problems,disease,0.979,29928383
13716,EGFR receptor,gene,0.9824,29928383
13717,rashes,disease,0.9985,29928383
13718,diarrhea,disease,1.0,29928383
13719,hypertension,disease,1.0,29928383
13720,oxaliplatin,drug,0.9995,29927360
13721,EGFR,gene,0.5737,29927360
13722,oxaliplatin,drug,0.9995,29927360
13723,EGFR,gene,0.767,29927360
13724,cancer,disease,1.0,29927360
13725,oxaliplatin,drug,0.9995,29927360
13726,EGFR,gene,0.947,29927360
13727,KRAS,gene,0.5737,29927360
13728,advanced colorectal cancer,disease,0.9937,29927360
13729,F(ab,gene,0.7266,29916748
13730,panitumumab F(ab&#39;)(2) fragment,gene,0.9087,29916748
13731,epidermal growth factor receptor,gene,0.998,29916748
13732,TCMC,drug,0.981,29916748
13733,(203)Pb,drug,0.999,29916748
13734,(212)Pb,drug,0.9985,29916748
13735,(212)Pb,drug,0.999,29916748
13736,LS-174T,cell_line,0.5684,29916748
13737,LS-174T tumor,disease,0.9927,29916748
13738,(203)Pb,drug,0.999,29916748
13739,panitumumab F(ab&,gene,0.916,29916748
13740,panitumumab IgG,gene,0.9956,29916748
13741,(212)Pb,drug,0.999,29916748
13742,gemcitabine,drug,0.999,29916748
13743,paclitaxel,drug,0.999,29916748
13744,(212)Pb,drug,0.999,29916748
13745,panitumumab F(ab&,gene,0.833,29916748
13746,LS,cell_type,,29916748
13747,LS-174T tumor,disease,0.9844,29916748
13748,mice,species,0.911,29916748
13749,mice,species,0.9795,29916748
13750,(212)Pb,drug,0.9995,29916748
13751,panitumumab F(ab&#39;)(2),gene,0.85,29916748
13752,mice,species,0.986,29916748
13753,panitumumab F(ab&#39;)(2) fragment,gene,0.9233,29916748
13754,i.p. disease,disease,1.0,29916748
13755,Epithelial growth factor receptor,gene,0.997,29913887
13756,EGFR,gene,0.9956,29913887
13757,neuropathic pain,disease,1.0,29913887
13758,Neuropathic pain,disease,1.0,29913887
13759,"neuronal, glial and immune cells",cell_type,0.801,29913887
13760,mitogen-activated protein kinase,gene,0.996,29913887
13761,MAPK,gene,0.9854,29913887
13762,rectal cancer,disease,1.0,29913887
13763,patient,species,0.986,29913887
13764,epithelial growth factor receptor,gene,0.999,29913887
13765,EGFR,gene,0.999,29913887
13766,cetuximab,gene,0.4902,29913887
13767,neuropathic pain,disease,0.9956,29913887
13768,EGFR,gene,0.997,29913887
13769,patients,species,0.972,29913887
13770,neuropathic pain,disease,1.0,29913887
13771,patients,species,0.983,29913887
13772,neuropathic pain syndromes,disease,1.0,29913887
13773,inflammatory polyneuropathy,disease,1.0,29913887
13774,complex regional pain syndrome type 1,disease,1.0,29913887
13775,radiculopathy,disease,1.0,29913887
13776,bladder cancer,disease,1.0,29913887
13777,phantom limb pain,disease,1.0,29913887
13778,patients,species,0.9893,29913887
13779,EGFR,gene,0.998,29913887
13780,cetuximab,gene,0.898,29913887
13781,panitumumab,gene,0.8447,29913887
13782,gefitinib,drug,0.9995,29913887
13783,erlotinib,drug,0.997,29913887
13784,patients,species,0.973,29913887
13785,EGFR,gene,0.993,29913887
13786,patient,species,0.994,29913887
13787,EGFR,gene,0.99,29913887
13788,neuropathic pain,disease,1.0,29913887
13789,MAPK,gene,0.955,29913887
13790,EGFR,gene,0.987,29913887
13791,neuropathic pain,disease,1.0,29913887
13792,Metastatic Colorectal Cancer,disease,1.0,29910669
13793,metastatic colorectal cancer,disease,0.994,29910669
13794,Fluorouracil,drug,0.999,29910669
13795,metastatic colorectal cancer,disease,1.0,29910669
13796,fluorouracil,drug,0.9995,29910669
13797,irinotecan,drug,0.999,29910669
13798,FOLFIRI,drug,0.998,29910669
13799,oxaliplatin,drug,0.9995,29910669
13800,FOLFOX,drug,0.9995,29910669
13801,capecitabine,drug,0.999,29910669
13802,CAPOX,drug,0.999,29910669
13803,XELOX,drug,0.9917,29910669
13804,bevacizumab,gene,0.8145,29910669
13805,aflibercept,gene,0.9805,29910669
13806,anti-vascular endothelial growth factor monoclonal antibody,gene,0.997,29910669
13807,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9453,29910669
13808,patients,species,0.9663,29910669
13809,patients,species,0.947,29910669
13810,patient,species,0.994,29910669
13811,metastatic colorectal cancer,disease,1.0,29910669
13812,patients,species,0.995,29910669
13813,regorafenib,drug,0.986,29910669
13814,TAS,drug,0.944,29910669
13815,metastatic colorectal cancer,disease,1.0,29910669
13816,Gene signatures,DNA,0.6274,29909889
13817,miRNAs,RNA,0.666,29909889
13818,panitumumab,gene,0.728,29909889
13819,Platinum,drug,0.9995,29909889
13820,anti-EGFR monoclonal antibody,gene,0.9927,29909889
13821,mAb,gene,0.9126,29909889
13822,cetuximab,gene,0.8193,29909889
13823,head-neck squamous cell carcinoma,disease,0.9966,29909889
13824,HNSCC,disease,1.0,29909889
13825,Cluster3 gene,DNA,0.5913,29909889
13826,cetuximab,gene,0.8594,29909889
13827,RM-HNSCC,disease,0.9736,29909889
13828,patients,species,0.984,29909889
13829,FDG,drug,0.9985,29909889
13830,afatinib,drug,0.982,29909889
13831,anti-EGFR-mAb,gene,0.959,29909889
13832,panitumumab,gene,0.891,29909889
13833,RM-,disease,0.909,29909889
13834,HNSCC,disease,0.655,29909889
13835,patients,species,0.995,29909889
13836,PANI01 tumor samples,cell_line,0.621,29909889
13837,tumor samples,cell_type,0.514,29909889
13838,tumor,disease,0.9995,29909889
13839,EGFR,gene,0.842,29909889
13840,patients,species,0.99,29909889
13841,gene,DNA,0.561,29909889
13842,RAS onco-signature,DNA,0.5776,29909889
13843,RAS,gene,0.9937,29909889
13844,miRNAs,RNA,0.7056,29909889
13845,panitumumab,gene,0.879,29909889
13846,Cluster3,gene,0.8096,29909889
13847,RAS,gene,0.995,29909889
13848,miRNA,RNA,0.525,29909889
13849,patients,species,0.9863,29909889
13850,Patients,species,0.974,29909889
13851,patients,species,0.9834,29909889
13852,anti-EGFR,gene,0.7363,29909889
13853,miRNAs,RNA,0.7104,29909889
13854,locally advanced colon cancer,disease,1.0,29904815
13855,locally advanced colon cancer,disease,1.0,29904815
13856,patient,species,0.9575,29904815
13857,locally advanced ascending colon cancer,disease,0.9985,29904815
13858,woman,species,0.864,29904815
13859,malaise,disease,1.0,29904815
13860,hematochezia,disease,1.0,29904815
13861,tumor,disease,0.9897,29904815
13862,locally advanced ascending colon cancer,disease,0.9956,29904815
13863,panitumumab,gene,0.725,29904815
13864,patient,species,0.982,29904815
13865,cancer cells,cell_type,0.7593,29904815
13866,cancer,disease,0.9995,29904815
13867,patient,species,0.96,29904815
13868,locally advanced colon cancer,disease,0.8716,29904815
13869,Circulating Tumor DNA,DNA,0.724,29898991
13870,Circulating Tumor,cell_type,0.5137,29898991
13871,RAS,DNA,0.6895,29898991
13872,RAS Mutation,gene,0.821,29898991
13873,Panitumumab,gene,0.614,29898991
13874,RAS mutations,gene,0.986,29898991
13875,EGFR,gene,0.6064,29898991
13876,EGFR,gene,0.897,29898991
13877,circulating tumor (ct) DNA,DNA,0.865,29898991
13878,RAS,gene,0.997,29898991
13879,RAS ctDNA mutations,DNA,0.723,29898991
13880,RAS ctDNA,gene,0.811,29898991
13881,panitumumab,gene,0.775,29898991
13882,patients,species,0.982,29898991
13883,RAS mutations,gene,0.977,29898991
13884,R 64-gene panel,DNA,0.625,29898991
13885,panitumumab,gene,0.8735,29898991
13886,patients,species,0.973,29898991
13887,plasma,cell_type,0.5015,29898991
13888,(WT) RAS,gene,0.9624,29898991
13889,mutant RAS,DNA,0.719,29898991
13890,mutant RAS,gene,0.99,29898991
13891,patients,species,0.962,29898991
13892,ctDNA WT RAS,DNA,0.6997,29898991
13893,ctDNA,RNA,0.554,29898991
13894,WT RAS,gene,0.772,29898991
13895,RAS mutations,gene,0.9805,29898991
13896,RAS,DNA,0.6846,29898991
13897,RAS mutant,gene,0.9824,29898991
13898,ctDNA,DNA,0.7256,29898991
13899,patients,species,0.985,29898991
13900,ctDNA,DNA,0.9043,29898991
13901,ctDNA RAS,gene,0.631,29898991
13902,RAS,DNA,0.4473,29898991
13903,patients,species,0.9844,29898991
13904,ctDNA RAS,DNA,0.725,29898991
13905,ctDNA RAS mutations,gene,0.6807,29898991
13906,patients,species,0.9653,29898991
13907,RAS,gene,0.7617,29898991
13908,ctDNA,DNA,0.819,29898991
13909,RAS,gene,0.815,29898991
13910,patient,species,0.9634,29898991
13911,panitumumab,gene,0.7656,29898991
13912,patients,species,0.9766,29898991
13913,ctDNA RAS mutations,DNA,0.6226,29898991
13914,ctDNA,cell_type,0.6123,29898991
13915,ctDNA RAS mutations,gene,0.921,29898991
13916,advanced biliary tract cancer,disease,1.0,29893894
13917,Biliary tract cancer,disease,1.0,29893894
13918,carcinoma of the extrahepatic bile ducts,disease,1.0,29893894
13919,carcinoma of the gall bladder,disease,1.0,29893894
13920,ampullary carcinoma,disease,1.0,29893894
13921,intrahepatic cholangiocarcinoma,disease,1.0,29893894
13922,gemcitabine,drug,0.999,29893894
13923,cisplatin,drug,0.999,29893894
13924,advanced biliary tract cancer,disease,1.0,29893894
13925,gemcitabine,drug,0.9995,29893894
13926,cisplatin,drug,0.999,29893894
13927,gemcitabine,drug,0.9995,29893894
13928,S-1,drug,0.897,29893894
13929,gemcitabine,drug,0.9995,29893894
13930,gemcitabine,drug,0.9995,29893894
13931,cisplatin,drug,0.9995,29893894
13932,gemcitabine,drug,0.9995,29893894
13933,cisplatin,drug,0.9995,29893894
13934,gemcitabine,drug,0.9995,29893894
13935,cisplatin,drug,0.9995,29893894
13936,S-1,drug,0.9155,29893894
13937,Fluoropyrimidines,drug,0.999,29893894
13938,erlotinib,drug,0.999,29893894
13939,cetuximab,gene,0.893,29893894
13940,panitumumab,gene,0.947,29893894
13941,bevacizumab,gene,0.686,29893894
13942,sorafenib,drug,0.999,29893894
13943,cediranib,drug,0.9985,29893894
13944,trametinib,drug,0.999,29893894
13945,vandetanib,drug,0.999,29893894
13946,advanced biliary tract cancer,disease,1.0,29893894
13947,multiple genes,DNA,0.656,29893894
13948,human,species,0.9966,29893894
13949,cancers,disease,1.0,29893894
13950,FGFR2 fusion gene,gene,0.9917,29893894
13951,IDH1,DNA,0.8936,29893894
13952,IDH1/2,gene,0.996,29893894
13953,BRAF,gene,0.991,29893894
13954,BRCA1/2,gene,0.9873,29893894
13955,ATM,gene,0.9937,29893894
13956,PIK3CA,gene,0.994,29893894
13957,c-MET,gene,0.997,29893894
13958,HER2,gene,0.9976,29893894
13959,neu,gene,0.9946,29893894
13960,anti-PD-1,gene,0.993,29893894
13961,anti-PD-L1,gene,0.974,29893894
13962,anti-CTLA4 antibodies,gene,0.947,29893894
13963,patients,species,0.9473,29890514
13964,locally advanced rectal cancer,disease,1.0,29890514
13965,LARC,disease,1.0,29890514
13966,patients,species,0.9097,29890514
13967,LARC,disease,0.9995,29890514
13968,patients,species,0.95,29890514
13969,LARC,disease,0.9995,29890514
13970,patients,species,0.9893,29890514
13971,patients,species,0.9917,29890514
13972,NAC,drug,0.943,29890514
13973,NAC,drug,0.91,29890514
13974,FOLFOX,drug,0.745,29890514
13975,panitumumab,gene,0.931,29890514
13976,cetuximab,gene,0.8555,29890514
13977,bevacizumab,gene,0.6567,29890514
13978,NAC,drug,0.986,29890514
13979,NAC,drug,0.9844,29890514
13980,patients,species,0.9893,29890514
13981,patient,species,0.9893,29890514
13982,NAC,drug,0.969,29890514
13983,patients,species,0.941,29890514
13984,LARC,disease,0.9995,29890514
13985,Panitumumab,gene,0.881,29879283
13986,Patients,species,0.965,29879283
13987,patients,species,0.9775,29879283
13988,inflammatory breast cancer,disease,1.0,29879283
13989,IBC,disease,1.0,29879283
13990,Epidermal growth factor receptor,gene,0.9985,29879283
13991,EGFR,gene,0.997,29879283
13992,patients,species,0.948,29879283
13993,IBC,disease,0.9995,29879283
13994,anti-,gene,0.8745,29879283
13995,EGFR antibody panitumumab,gene,0.763,29879283
13996,patients,species,0.9287,29879283
13997,human epidermal growth factor receptor 2,gene,0.9966,29879283
13998,human,species,0.694,29879283
13999,HER2,gene,0.9917,29879283
14000,IBC,cell_type,0.5337,29879283
14001,PARTICIPANTS,species,0.518,29879283
14002,Women,species,0.869,29879283
14003,HER2-negative IBC,disease,0.8633,29879283
14004,HER2,gene,0.9863,29879283
14005,panitumumab,gene,0.846,29879283
14006,Tumor,disease,0.9873,29879283
14007,panitumumab,gene,0.81,29879283
14008,RNA,RNA,0.6313,29879283
14009,Patients,species,0.9614,29879283
14010,panitumumab,gene,0.912,29879283
14011,panitumumab,gene,0.8174,29879283
14012,nab-paclitaxel,drug,0.9814,29879283
14013,carboplatin,drug,0.999,29879283
14014,fluorouracil,drug,0.997,29879283
14015,epirubicin,drug,0.9976,29879283
14016,cyclophosphamide,drug,0.999,29879283
14017,patients,species,0.9814,29879283
14018,women,species,0.957,29879283
14019,patients,species,0.988,29879283
14020,patients,species,0.9775,29879283
14021,IBC,disease,0.999,29879283
14022,triple-negative,disease,0.8677,29879283
14023,IBC,disease,0.6523,29879283
14024,HER2,gene,0.9595,29879283
14025,IBC,disease,0.9976,29879283
14026,panitumumab,gene,0.905,29879283
14027,nab-paclitaxel,drug,0.788,29879283
14028,carboplatin,drug,0.999,29879283
14029,patients,species,0.981,29879283
14030,neutropenia,disease,1.0,29879283
14031,skin rash,disease,1.0,29879283
14032,pEGFR,gene,0.9614,29879283
14033,COX-2,gene,0.9917,29879283
14034,panitumumab,gene,0.899,29879283
14035,triple-negative IBC,disease,0.995,29879283
14036,panitumumab,gene,0.7466,29879283
14037,patients,species,0.9365,29879283
14038,epidermal growth factor receptor,gene,0.998,29856819
14039,murine,species,0.8735,29856819
14040,lung cancer,disease,0.989,29856819
14041,lung cancer,disease,1.0,29856819
14042,indocyanine green,drug,0.999,29856819
14043,epidermal growth,disease,0.8794,29856819
14044,epidermal growth factor receptor,gene,0.978,29856819
14045,EGFR,gene,0.998,29856819
14046,squamous cell carcinoma,disease,0.9995,29856819
14047,Tumors,disease,0.997,29856819
14048,H226,cell_line,0.9214,29856819
14049,EGFR-positive,cell_line,0.587,29856819
14050,EGFR,gene,0.996,29856819
14051,H520,cell_line,0.776,29856819
14052,EGFR-negative) cell lines,cell_line,0.622,29856819
14053,EGFR,gene,0.9854,29856819
14054,mice,species,0.8135,29856819
14055,tumors,disease,1.0,29856819
14056,atelectasis,disease,0.9995,29856819
14057,panitumumab,gene,0.9272,29856819
14058,Pan,gene,0.742,29856819
14059,ICG,drug,0.982,29856819
14060,mice,species,0.9775,29856819
14061,mouse,species,0.9653,29856819
14062,-,DNA,0.452,29856819
14063,ICG,drug,0.997,29856819
14064,sodium dodecyl sulfate,drug,0.9995,29856819
14065,H226,cell_line,0.7964,29856819
14066,H520,cell_line,0.8374,29856819
14067,EGFR,gene,0.4338,29856819
14068,mediastinal lymph node metastases,disease,0.986,29856819
14069,EGFR,gene,0.502,29856819
14070,ICG,drug,0.975,29856819
14071,EGFR,gene,0.993,29856819
14072,mediastinal lymph node,disease,0.787,29856819
14073,panitumumab,gene,0.9175,29855806
14074,capecitabine,drug,0.9995,29855806
14075,oxaliplatin,drug,0.9995,29855806
14076,panitumumab,gene,0.9097,29855806
14077,oxaliplatin,drug,0.9995,29855806
14078,capecitabine,drug,0.9995,29855806
14079,KRAS exon 2,gene,0.974,29855806
14080,metastatic colorectal cancer,disease,1.0,29855806
14081,mCRC,disease,1.0,29855806
14082,patients,species,0.988,29855806
14083,Patients,species,0.919,29855806
14084,exon 2 KRAS,DNA,0.69,29855806
14085,KRAS,gene,0.895,29855806
14086,mCRC,disease,0.988,29855806
14087,panitumumab,gene,0.7456,29855806
14088,oxaliplatin,drug,0.9995,29855806
14089,capecitabine,drug,0.998,29855806
14090,CRC,disease,1.0,29855806
14091,ERBB2,gene,0.996,29855806
14092,EGFR,gene,0.9897,29855806
14093,tumor-infiltrating lymphocyte,cell_type,0.83,29855806
14094,tumor,disease,0.584,29855806
14095,patients,species,0.969,29855806
14096,skin rash,disease,0.9995,29855806
14097,diarrhea,disease,1.0,29855806
14098,neuropathy,disease,1.0,29855806
14099,patients,species,0.979,29855806
14100,KRAS,gene,0.988,29855806
14101,NRAS,DNA,0.8115,29855806
14102,NRAS,gene,0.9966,29855806
14103,BRAF,gene,0.9985,29855806
14104,tumors,disease,1.0,29855806
14105,KRAS,DNA,0.8477,29855806
14106,KRAS,gene,0.9814,29855806
14107,NRAS,gene,0.994,29855806
14108,BRAF,DNA,0.719,29855806
14109,BRAF,gene,0.9976,29855806
14110,PI3K,gene,0.9907,29855806
14111,-,DNA,0.407,29855806
14112,Patients,species,0.9775,29855806
14113,TP53,DNA,0.8784,29855806
14114,TP53 mutations,gene,0.8594,29855806
14115,left colon primary tumors,disease,0.9395,29855806
14116,TP53,DNA,0.8765,29855806
14117,TP53 mutations,gene,0.912,29855806
14118,p-IGF-1R,gene,0.996,29842993
14119,MMP-7,gene,0.988,29842993
14120,Panitumumab,gene,0.655,29842993
14121,Cetuximab,gene,0.6562,29842993
14122,RAS Wild,gene,0.8257,29842993
14123,pIGF-1R,gene,0.998,29842993
14124,MMP-7,gene,0.9907,29842993
14125,KRAS,gene,0.99,29842993
14126,exon 2,DNA,0.493,29842993
14127,metastatic colorectal cancer,disease,1.0,29842993
14128,mCRC,disease,1.0,29842993
14129,irinotecan,drug,0.9985,29842993
14130,cetuximab,gene,0.968,29842993
14131,RAS,gene,0.646,29842993
14132,mCRC,disease,0.99,29842993
14133,panitumumab,gene,0.769,29842993
14134,FOLFOX6,drug,0.86,29842993
14135,cetuximab,gene,0.672,29842993
14136,FOLFOX6,drug,0.573,29842993
14137,FOLFIRI,drug,0.9023,29842993
14138,DP,disease,0.5366,29842993
14139,DP,cell_line,0.479,29842993
14140,DP,cell_line,0.4592,29842993
14141,DP,disease,0.9995,29842993
14142,MMP-7,gene,0.995,29842993
14143,pIGF-1R,gene,0.9956,29842993
14144,anti-EGFRs,gene,0.6753,29842993
14145,DP,cell_line,0.601,29842993
14146,DP phenotype,cell_type,0.5195,29842993
14147,Panitumumab,gene,0.5757,29842993
14148,RAS,gene,0.596,29842993
14149,mCRC,disease,0.961,29842993
14150,cetuximab,gene,0.6436,29842993
14151,Colorectal Cancer Xenograft Tumors,cell_line,0.7437,29802988
14152,Colorectal Cancer,disease,1.0,29802988
14153,RAS,gene,0.9946,29802988
14154,metastatic colorectal cancer,disease,1.0,29802988
14155,mCRC,disease,1.0,29802988
14156,anti-epidermal growth factor receptor,gene,0.986,29802988
14157,anti-EGFR,gene,0.996,29802988
14158,anti-,gene,0.947,29802988
14159,vascular endothelial growth factor,gene,0.9233,29802988
14160,anti-VEGF,gene,0.9893,29802988
14161,anti-EGFR antibody,gene,0.846,29802988
14162,anti-VEGF,gene,0.6035,29802988
14163,LIM1215 xenografts,cell_line,0.7524,29802988
14164,LIM1215,gene,0.608,29802988
14165,RAS,DNA,0.5815,29802988
14166,RAS WT,gene,0.9946,29802988
14167,mCRC,disease,0.9976,29802988
14168,panitumumab,gene,0.9204,29802988
14169,bevacizumab,gene,0.8525,29802988
14170,tumor,disease,1.0,29802988
14171,bevacizumab,gene,0.7534,29802988
14172,panitumumab,gene,0.904,29802988
14173,Ki-67,gene,0.933,29802988
14174,EGFR,gene,0.9937,29802988
14175,EPHA2,gene,0.9883,29802988
14176,EPHA2,DNA,0.606,29802988
14177,EPHA2,gene,0.9937,29802988
14178,RSK,gene,0.9946,29802988
14179,FASN,gene,0.999,29802988
14180,MVD,gene,0.997,29802988
14181,CA9,gene,0.977,29802988
14182,TGFBI,gene,0.996,29802988
14183,genes,DNA,0.521,29802988
14184,BP,drug,,29802988
14185,patients,species,0.916,29802988
14186,RAS,DNA,0.6553,29802988
14187,RAS WT,gene,0.9946,29802988
14188,mCRC,disease,0.9985,29802988
14189,Right Versus Left Colon Cancer,disease,1.0,29796712
14190,Colorectal cancer,disease,1.0,29796712
14191,tumours,disease,1.0,29796712
14192,right colorectal cancers,disease,0.9966,29796712
14193,BRAF,gene,0.8384,29796712
14194,EGFR,gene,0.9556,29796712
14195,cetuximab,gene,0.8896,29796712
14196,panitumumab,gene,0.805,29796712
14197,RAS wild-type disease,disease,0.9805,29796712
14198,RAS,gene,0.9893,29796712
14199,left colon cancer,disease,1.0,29796712
14200,right colon cancer,disease,0.997,29796712
14201,colorectal cancer disease,disease,0.9736,29796712
14202,EGFR,gene,0.897,29796712
14203,RAS,gene,0.993,29773991
14204,RAS,gene,0.988,29773991
14205,metastatic colorectal cancer,disease,1.0,29773991
14206,mCRC,disease,1.0,29773991
14207,patients,species,0.9756,29773991
14208,EGFR,gene,0.71,29773991
14209,Patients,species,0.906,29773991
14210,RAS,DNA,0.675,29773991
14211,RAS wt,gene,0.997,29773991
14212,mCRC,disease,0.9937,29773991
14213,patients,species,0.9863,29773991
14214,bevacizumab,gene,0.8667,29773991
14215,EGFR,gene,0.8027,29773991
14216,patients,species,0.979,29773991
14217,anti-EGFR,gene,0.976,29773991
14218,bevacizumab,gene,0.8086,29773991
14219,RAS,DNA,0.727,29773991
14220,RAS wt,gene,0.995,29773991
14221,patients,species,0.9844,29773991
14222,anti-EGFR,gene,0.945,29773991
14223,anti-EGFR,gene,0.968,29773991
14224,bevacizumab,gene,0.823,29773991
14225,anti-EGFR,gene,0.932,29773991
14226,left colon cancer,disease,0.9995,29773991
14227,bevacizumab,gene,0.889,29773991
14228,right colon cancer,disease,0.984,29773991
14229,RAS,gene,0.988,29773991
14230,mCRC,disease,0.9946,29773991
14231,patients,species,0.992,29773991
14232,EGFR,gene,0.968,29773991
14233,Irinotecan,drug,0.996,29769385
14234,Panitumumab,gene,0.9253,29769385
14235,Patients,species,0.966,29769385
14236,Panitumumab,gene,0.934,29769385
14237,irinotecan,drug,0.997,29769385
14238,esophageal adenocarcinoma,disease,1.0,29769385
14239,Esophageal adenocarcinoma,disease,1.0,29769385
14240,EAC,disease,1.0,29769385
14241,cancer,disease,1.0,29769385
14242,Panitumumab,gene,0.882,29769385
14243,Pa,gene,0.9985,29769385
14244,humanized,species,0.7563,29769385
14245,human EGFR,gene,0.9946,29769385
14246,human,species,0.984,29769385
14247,Cetuximab,gene,0.954,29769385
14248,Cx,gene,0.999,29769385
14249,irinotecan,drug,0.998,29769385
14250,colorectal cancer,disease,1.0,29769385
14251,Ir,drug,,29769385
14252,EAC,disease,0.991,29769385
14253,Patients,species,0.9634,29769385
14254,Ir,drug,,29769385
14255,EAC,disease,0.9985,29769385
14256,patients,species,0.979,29769385
14257,patients,species,0.9624,29769385
14258,men,species,0.953,29769385
14259,women,species,0.9097,29769385
14260,fatigue,disease,0.9995,29769385
14261,diarrhea,disease,1.0,29769385
14262,anemia,disease,1.0,29769385
14263,leukopenia,disease,1.0,29769385
14264,hypoalbuminemia,disease,1.0,29769385
14265,rash,disease,0.997,29769385
14266,fatigue,disease,0.9985,29769385
14267,weight loss,disease,0.9653,29769385
14268,Irinotecan,drug,0.997,29769385
14269,panitumumab,gene,0.852,29769385
14270,EAC,disease,0.9683,29769385
14271,PUMA,gene,0.992,29755130
14272,KRAS,gene,0.5903,29755130
14273,anti-,gene,0.9194,29755130
14274,EGFR antibodies,gene,0.706,29755130
14275,colorectal cancer,disease,1.0,29755130
14276,EGFR antibody,gene,0.79,29755130
14277,KRAS oncogene,gene,0.8013,29755130
14278,colorectal cancer,disease,0.9453,29755130
14279,CRC,disease,1.0,29755130
14280,KRAS,gene,0.771,29755130
14281,anti-EGFR antibodies,gene,0.9604,29755130
14282,cetuximab,gene,0.613,29755130
14283,panitumumab,gene,0.6826,29755130
14284,CRC cells,cell_line,0.8154,29755130
14285,CRC,disease,0.9995,29755130
14286,p73,gene,0.995,29755130
14287,pro-apoptotic Bcl-2 family protein,gene,0.959,29755130
14288,PUMA,gene,0.9053,29755130
14289,PUMA,gene,0.989,29755130
14290,p73,gene,0.996,29755130
14291,CRC cells,cell_line,0.777,29755130
14292,CRC,disease,1.0,29755130
14293,anti-EGFR antibodies,gene,0.855,29755130
14294,KRAS,gene,0.742,29755130
14295,aurora kinases,gene,0.9937,29755130
14296,mutant KRAS CRC cells,cell_line,0.9346,29755130
14297,mutant KRAS,gene,0.965,29755130
14298,CRC,disease,0.7065,29755130
14299,KRAS,gene,0.5327,29755130
14300,anti-EGFR antibodies,gene,0.933,29755130
14301,PUMA,gene,0.99,29755130
14302,PUMA,gene,0.9937,29755130
14303,CRC cells,cell_line,0.7964,29755130
14304,CRC,disease,0.9995,29755130
14305,anti-EGFR antibodies,gene,0.946,29755130
14306,PUMA,gene,0.978,29755130
14307,EGFR,gene,0.9927,29755130
14308,Panitumumab,gene,0.7944,29739790
14309,Irinotecan,drug,0.9907,29739790
14310,Everolimus,drug,0.9976,29739790
14311,KRAS,gene,0.7183,29739790
14312,mTOR,gene,0.993,29739790
14313,EGFR,gene,0.99,29739790
14314,EGFR,gene,0.9844,29739790
14315,metastatic colorectal cancer,disease,1.0,29739790
14316,mCRC,disease,1.0,29739790
14317,irinotecan,drug,0.999,29739790
14318,panitumumab,gene,0.874,29739790
14319,everolimus,drug,0.997,29739790
14320,KRAS exon,gene,0.6655,29739790
14321,mCRC,disease,0.9897,29739790
14322,fluoropyrimidine,drug,0.996,29739790
14323,irinotecan,drug,0.994,29739790
14324,panitumumab,gene,0.729,29739790
14325,everolimus,drug,0.9956,29739790
14326,irinotecan,drug,0.999,29739790
14327,panitumumab,gene,0.9414,29739790
14328,everolimus,drug,0.997,29739790
14329,diarrhea,disease,1.0,29739790
14330,mucositis,disease,1.0,29739790
14331,rash,disease,0.9995,29739790
14332,fatigue,disease,0.999,29739790
14333,dehydration,disease,1.0,29739790
14334,neutropenia,disease,1.0,29739790
14335,febrile neutropenia,disease,1.0,29739790
14336,hypomagnesemia,disease,1.0,29739790
14337,hypokalemia,disease,1.0,29739790
14338,hypomagnesemia,disease,1.0,29739790
14339,neutropenia,disease,1.0,29739790
14340,RAS,gene,0.7275,29739790
14341,RAF,gene,0.3877,29739790
14342,panitumumab,gene,0.9346,29739790
14343,irinotecan,drug,0.9976,29739790
14344,everolimus,drug,0.9985,29739790
14345,RAS,gene,0.702,29739790
14346,RAF,gene,0.9976,29739790
14347,Panitumumab,gene,0.696,29737864
14348,metastatic colorectal cancer,disease,1.0,29737864
14349,wild-type RAS,disease,0.622,29737864
14350,KRAS,gene,0.99,29737864
14351,NRAS,gene,0.993,29737864
14352,mCRC,disease,0.679,29737864
14353,panitumumab,gene,0.468,29737864
14354,EGFR,gene,0.9897,29737864
14355,metastatic colorectal cancer,disease,0.9995,29737864
14356,panitumumab,gene,0.5913,29737864
14357,RAS,DNA,0.5596,29737864
14358,RAS mutation,gene,0.867,29737864
14359,panitumumab,gene,0.8647,29737864
14360,RAS mutations,gene,0.564,29737864
14361,Panitumumab,gene,0.766,29737864
14362,panitumumab,gene,0.834,29737864
14363,liver metastases,disease,0.996,29737864
14364,Advanced,disease,0.5938,29728940
14365,Squamous Cell Anal Cancer,disease,0.99,29728940
14366,advanced anal cancer,disease,1.0,29728940
14367,platinum,drug,0.9966,29728940
14368,fluoropyrimidine,drug,0.9756,29728940
14369,docetaxel,drug,0.999,29728940
14370,paclitaxel,drug,0.999,29728940
14371,metastatic colorectal cancer,disease,1.0,31579770
14372,Metastatic colorectal cancer,disease,1.0,31579770
14373,mCRC,disease,1.0,31579770
14374,cancers,disease,1.0,31579770
14375,cancer,disease,0.9995,31579770
14376,anti-vascular endothelial growth factor,gene,0.9976,31579770
14377,VEGF,gene,0.9976,31579770
14378,anti-epidermal growth factor receptor,gene,0.9224,31579770
14379,EGFR,gene,0.993,31579770
14380,patients,species,0.9756,31579770
14381,mCRC,disease,0.9927,31579770
14382,anti-VEGF(R),gene,0.902,31579770
14383,EGFR,gene,0.9956,31579770
14384,patients,species,0.97,31579770
14385,mCRC,disease,0.9976,31579770
14386,VEGF-antibody,gene,0.789,31579770
14387,bevacizumab,gene,0.598,31579770
14388,5-fluoropyrimidine,drug,0.9995,31579770
14389,5-FU,drug,0.9995,31579770
14390,oxaliplatin,drug,0.9995,31579770
14391,irinotecan,drug,0.9966,31579770
14392,patients,species,0.9785,31579770
14393,liver-limited disease,disease,0.7554,31579770
14394,EGFR-antibodies cetuximab,gene,0.773,31579770
14395,panitumumab,gene,0.662,31579770
14396,patients,species,0.9805,31579770
14397,tumors,disease,0.9995,31579770
14398,RAS,gene,0.7803,31579770
14399,patients,species,0.975,31579770
14400,colorectal liver metastases,disease,1.0,31579770
14401,EGFR,gene,0.996,31579770
14402,CLGB,cell_line,0.497,31579770
14403,VEGF,gene,0.5884,31579770
14404,EGFR,gene,0.987,31579770
14405,patients,species,0.9795,31579770
14406,left-sided tumors,disease,0.998,31579770
14407,EGFR,gene,0.9927,31579770
14408,right,DNA,0.5034,31579770
14409,right-sided tumors,disease,0.954,31579770
14410,EGFR,gene,0.708,31579770
14411,patients,species,0.9536,31579770
14412,mCRC,disease,0.996,31579770
14413,patients,species,0.9795,31579770
14414,RAS,gene,0.9966,31579770
14415,left,disease,0.8706,31579770
14416,EGFR,gene,0.7617,31579770
14417,patients,species,0.989,31579770
14418,EGFR,gene,0.9927,29727211
14419,cutaneous toxicity,disease,0.919,29727211
14420,Cutaneous toxicities,disease,0.996,29727211
14421,EGFR,gene,0.994,29727211
14422,EGFRIs,gene,0.9688,29727211
14423,patient,species,0.973,29727211
14424,EGFRI,gene,0.996,29727211
14425,cutaneous toxicities,disease,0.992,29727211
14426,patients,species,0.935,29727211
14427,colorectal cancer,disease,1.0,29727211
14428,healthcare professionals,cell_type,0.4973,29727211
14429,patients,species,0.991,29727211
14430,EGFRIs,gene,0.971,29727211
14431,patients,species,0.978,29727211
14432,EGFRIs,gene,0.983,29727211
14433,metastatic colorectal cancer,disease,1.0,29727211
14434,EGFRI,gene,0.9966,29727211
14435,HNSCC,disease,1.0,29725456
14436,patients,species,0.981,29725456
14437,HNSCC,disease,0.8516,29725456
14438,patients,species,0.9814,29725456
14439,HNSCC,disease,0.9995,29725456
14440,Epidermal growth factor receptor,gene,0.9985,29725456
14441,EGFR,gene,0.9907,29725456
14442,cetuximab,gene,0.9424,29725456
14443,panitumumab,gene,0.9087,29725456
14444,zalutumumab,gene,0.6763,29725456
14445,nimotuzumab,gene,0.8296,29725456
14446,EGFR tyrosine kinase,gene,0.8384,29725456
14447,tyrosine,drug,0.876,29725456
14448,gefitinib,drug,0.9995,29725456
14449,erlotinib,drug,0.999,29725456
14450,lapatinib,drug,0.999,29725456
14451,afatinib,drug,0.9976,29725456
14452,dacomitinib,drug,0.999,29725456
14453,vascular endothelial growth factor,gene,0.9966,29725456
14454,VEGF,gene,0.998,29725456
14455,vascular endothelial growth factor receptor,gene,0.9976,29725456
14456,VEGFR,gene,0.993,29725456
14457,sorafenib,drug,0.9995,29725456
14458,sunitinib,drug,0.9966,29725456
14459,vandetanib,drug,0.9966,29725456
14460,phosphatidylinositol,drug,0.999,29725456
14461,phosphatidylinositol 3-kinase,gene,0.993,29725456
14462,serine,drug,0.999,29725456
14463,serine/threonine-specific protein kinase,gene,0.9917,29725456
14464,threonine,drug,0.99,29725456
14465,mammalian target,gene,0.981,29725456
14466,rapamycin,drug,0.9976,29725456
14467,panitumumab,gene,0.975,29721094
14468,cetuximab,gene,0.973,29721094
14469,anti-epidermal growth factor receptor antibodies,gene,0.9434,29721094
14470,cetuximab,gene,0.735,29721094
14471,panitumumab,gene,0.8257,29721094
14472,head and neck squamous cell carcinoma,disease,1.0,29721094
14473,cetuximab,gene,0.9243,29721094
14474,panitumumab,gene,0.965,29721094
14475,patients,species,0.9473,29721094
14476,cetuximab,gene,0.9233,29721094
14477,panitumumab,gene,0.875,29721094
14478,cetuximab,gene,0.9717,29721094
14479,panitumumab,gene,0.946,29721094
14480,IRDye800CW,gene,0.839,29721094
14481,cetuximab,gene,0.961,29721094
14482,panitumumab,gene,0.9795,29721094
14483,Panitumumab,gene,0.9663,29721094
14484,cetuximab,gene,0.9546,29721094
14485,RAS,gene,0.743,29703606
14486,BRAF,gene,0.618,29703606
14487,Panitumumab,gene,0.706,29703606
14488,Chemorefractory,disease,0.9243,29703606
14489,Wild Type KRAS Metastatic Colorectal Cancer,disease,0.8687,29703606
14490,Tumor,disease,0.663,29703606
14491,Tumor rat sarcoma gene,gene,0.713,29703606
14492,RAS,gene,0.5444,29703606
14493,epidermal growth factor receptor,gene,0.991,29703606
14494,EGFR,gene,0.993,29703606
14495,metastatic colorectal cancer,disease,1.0,29703606
14496,mCRC,disease,0.9985,29703606
14497,RAS,gene,0.6045,29703606
14498,v-Raf murine sarcoma viral oncogene homolog B,gene,0.8076,29703606
14499,BRAF,gene,0.728,29703606
14500,tumor,disease,0.9995,29703606
14501,wild,DNA,0.5293,29703606
14502,wild type,gene,0.7134,29703606
14503,RAS,gene,0.4937,29703606
14504,PATIENTS,species,0.965,29703606
14505,metastatic colon or rectum adenocarcinoma,disease,1.0,29703606
14506,sarcoma,disease,1.0,29703606
14507,irinotecan,drug,0.9985,29703606
14508,oxaliplatin,drug,0.9995,29703606
14509,EGFR,gene,0.768,29703606
14510,panitumumab,gene,0.801,29703606
14511,RAS,gene,0.559,29703606
14512,BRAF,gene,0.743,29703606
14513,tumor,disease,0.874,29703606
14514,RAS,gene,0.6934,29703606
14515,mCRC,disease,0.995,29703606
14516,panitumumab,gene,0.832,29703606
14517,BSC,drug,0.741,29703606
14518,wild,cell_line,0.522,29703606
14519,wild type RAS tumors,disease,0.857,29703606
14520,wild type RAS,gene,0.768,29703606
14521,panitumumab,gene,0.8413,29703606
14522,BSC,drug,0.9136,29703606
14523,wild,gene,0.631,29703606
14524,RAS,gene,0.531,29703606
14525,wild,cell_line,0.5195,29703606
14526,wild type BRAF tumors,disease,0.978,29703606
14527,BRAF,gene,0.383,29703606
14528,panitumumab,gene,0.906,29703606
14529,BSC,cell_type,0.423,29703606
14530,wild type RAS,gene,0.622,29703606
14531,tumor,disease,0.99,29703606
14532,panitumumab,gene,0.8804,29703606
14533,wild type RAS,gene,0.9487,29703606
14534,mCRC,disease,0.9985,29703606
14535,ETS,gene,0.582,29703606
14536,DpR,gene,0.4941,29703606
14537,EGFR,gene,0.996,29680500
14538,IL-6,gene,0.984,29680500
14539,cancer,disease,0.9995,29680500
14540,Epidermal growth factor receptor,gene,0.998,29680500
14541,EGFR,gene,0.9907,29680500
14542,cancer,disease,1.0,29680500
14543,cancers,disease,1.0,29680500
14544,EGFR,gene,0.9873,29680500
14545,EGFR,gene,0.9937,29680500
14546,Cetuximab,gene,0.8745,29680500
14547,Panitumumab,gene,0.843,29680500
14548,Gefitinib,drug,0.9985,29680500
14549,Erlotinib,drug,0.997,29680500
14550,tyrosine,drug,0.9736,29680500
14551,EGFR,gene,0.791,29680500
14552,tumor,disease,1.0,29680500
14553,tumor,disease,1.0,29680500
14554,Interleukin 6,gene,0.974,29680500
14555,IL-6,gene,0.993,29680500
14556,inflammation-driven cancers,disease,1.0,29680500
14557,EGFR,gene,0.985,29680500
14558,EGFR,gene,0.9976,29680500
14559,IL-6,gene,0.9927,29680500
14560,cancer,disease,1.0,29680500
14561,EGFR,gene,0.9966,29680500
14562,IL-6,gene,0.99,29680500
14563,EGFR,gene,0.9956,29666669
14564,pancreatic acinar cell carcinoma,disease,1.0,29666669
14565,Pancreatic acinar cell carcinoma,disease,1.0,29666669
14566,PACC,disease,0.515,29666669
14567,cancer,disease,1.0,29666669
14568,tumor,disease,1.0,29666669
14569,tumor,disease,0.4834,29666669
14570,rare cancers,disease,0.9883,29666669
14571,PACC,disease,0.9995,29666669
14572,EGFR gene,gene,0.901,29666669
14573,panitumumab,gene,0.844,29666669
14574,liver metastasis,disease,0.8545,29666669
14575,primary tumor,disease,0.7188,29666669
14576,HER2,gene,0.56,29666669
14577,MET,gene,0.678,29666669
14578,EGFR,gene,0.993,29666669
14579,exome,DNA,0.4998,29666669
14580,rare cancers,disease,0.9385,29666669
14581,PACC,disease,0.504,29666669
14582,EGFR,gene,0.99,29666669
14583,Hepatic Encephalopathy,disease,1.0,29650838
14584,Metastatic Colorectal Cancer,disease,1.0,29650838
14585,hepatic encephalopathy,disease,1.0,29650838
14586,advanced colorectal cancer,disease,1.0,29650838
14587,advanced sigmoid colon cancer,disease,1.0,29650838
14588,bevacizumab,gene,0.7954,29650838
14589,comatose,disease,0.9385,29650838
14590,advanced rectal cancer,disease,1.0,29650838
14591,panitumumab,gene,0.9,29650838
14592,comatose,disease,0.94,29650838
14593,ammonia,drug,0.994,29650838
14594,disturbance of consciousness,disease,1.0,29650838
14595,hepatic encephalopathy,disease,1.0,29650838
14596,Branched-chain amino acid,drug,0.972,29650838
14597,disturbance of consciousness,disease,0.9946,29650838
14598,hepatic encephalopathy,disease,1.0,29650838
14599,advanced colorectal cancer,disease,1.0,29650838
14600,RAS,gene,0.9937,29650279
14601,metastatic colorectal cancer,disease,0.997,29650279
14602,patients,species,0.995,29650279
14603,RAS,gene,0.995,29650279
14604,metastatic colorectal cancer,disease,1.0,29650279
14605,mCRC,disease,1.0,29650279
14606,patients,species,0.984,29650279
14607,patients,species,0.991,29650279
14608,RAS,DNA,0.6616,29650279
14609,RAS WT,gene,0.996,29650279
14610,mCRC,disease,0.9995,29650279
14611,patients,species,0.9946,29650279
14612,tumor,disease,0.53,29650279
14613,anti-EGFR,gene,0.988,29650279
14614,LSCC,disease,0.9966,29650279
14615,bevacizumab,gene,0.8706,29650279
14616,cetuximab,gene,0.9727,29650279
14617,panitumumab,gene,0.9844,29650279
14618,FOLFOX,drug,0.653,29650279
14619,panitumumab,gene,0.957,29650279
14620,patients,species,0.8936,29650279
14621,RAS,gene,0.9966,29650279
14622,mCRC,disease,0.966,29650279
14623,Colorectal Liver Metastases,disease,1.0,29629795
14624,colorectal liver metastases,disease,1.0,29629795
14625,CLMs,disease,1.0,29629795
14626,patient,species,0.994,29629795
14627,patients,species,0.9814,29629795
14628,men,species,0.9727,29629795
14629,women,species,0.973,29629795
14630,colorectal liver metastases,disease,0.9995,29629795
14631,patients,species,0.9917,29629795
14632,colorectal liver metastases,disease,0.9995,29629795
14633,patients,species,0.99,29629795
14634,CLMs,disease,0.9976,29629795
14635,tumor,disease,0.9907,29629795
14636,tumor,disease,0.516,29629795
14637,cetuximab,gene,0.861,29629795
14638,panitumumab,gene,0.894,29629795
14639,CLMs,disease,1.0,29629795
14640,metastatic colorectal cancer,disease,1.0,29627309
14641,mCRC,disease,0.999,29627309
14642,panitumumab,gene,0.896,29627309
14643,patients,species,0.927,29627309
14644,RAS,gene,0.9946,29627309
14645,mCRC,disease,0.9863,29627309
14646,patients,species,0.975,29627309
14647,RAS,gene,0.985,29627309
14648,mCRC,disease,0.9917,29627309
14649,PATIENTS,species,0.983,29627309
14650,RAS WT,gene,0.995,29627309
14651,panitumumab,gene,0.8438,29627309
14652,tumor,disease,0.9873,29627309
14653,RAS,cell_line,0.5264,29627309
14654,RAS MT,disease,1.0,29627309
14655,patients,species,0.9927,29627309
14656,panitumumab,gene,0.7344,29627309
14657,Primary tumors,disease,0.972,29627309
14658,patients,species,0.988,29627309
14659,tumor,disease,0.9736,29627309
14660,patients,species,0.9775,29627309
14661,left,DNA,0.4827,29627309
14662,left-sided tumors,disease,0.9995,29627309
14663,RAS,disease,0.751,29627309
14664,patients,species,0.995,29627309
14665,right-sided tumors,disease,0.934,29627309
14666,left-sided tumors,disease,0.9844,29627309
14667,patients,species,0.9824,29627309
14668,left,DNA,0.5024,29627309
14669,left-sided tumors,disease,0.9883,29627309
14670,panitumumab,gene,0.8877,29627309
14671,patient,species,0.9795,29627309
14672,mCRC,disease,0.9746,29627309
14673,RAS,cell_line,0.4985,29627309
14674,RAS MT,disease,1.0,29627309
14675,patients,species,0.9966,29627309
14676,RAS,DNA,0.7217,29627309
14677,RAS WT,gene,0.9976,29627309
14678,mCRC,disease,0.978,29627309
14679,RAS,DNA,0.559,29627309
14680,RAS WT,gene,0.9966,29627309
14681,patients,species,0.99,29627309
14682,left-sided tumors,disease,0.9785,29627309
14683,panitumumab,gene,0.77,29627309
14684,mCRC,disease,0.839,29627309
14685,RAS,cell_type,0.4404,29627309
14686,RAS MT tumors,disease,0.998,29627309
14687,RAS MT,gene,0.974,29627309
14688,Circulating Tumor DNA,DNA,0.575,29605591
14689,Circulating Tumor,cell_type,0.4934,29605591
14690,Metastatic Colorectal Cancer,disease,1.0,29605591
14691,metastatic colorectal cancer,disease,1.0,29605591
14692,mCRC,disease,1.0,29605591
14693,tumor,disease,0.999,29605591
14694,tumor disease,disease,0.8374,29605591
14695,PATIENTS,species,0.976,29605591
14696,mCRC,disease,0.997,29605591
14697,NPY,gene,0.9976,29605591
14698,circulating DNA,DNA,0.806,29605591
14699,tumor DNA,DNA,0.5854,29605591
14700,tumor,disease,0.8555,29605591
14701,circulating tumor DNA,DNA,0.7095,29605591
14702,tumor,disease,0.5713,29605591
14703,NPY,gene,0.9873,29605591
14704,mCRC,disease,0.999,29605591
14705,NPY,gene,0.5757,29605591
14706,tumor,disease,1.0,29605591
14707,phenyl,drug,1.0,29602545
14708,silica,drug,0.9995,29602545
14709,phenyl,drug,0.9995,29602545
14710,monoclonal,gene,0.647,29602545
14711,trifluoroacetic acid,drug,0.9995,29602545
14712,wide,cell_line,0.422,29602545
14713,phenyl,drug,0.997,29602545
14714,silica,drug,1.0,29602545
14715,silica,drug,0.9995,29602545
14716,C4,cell_line,,29602545
14717,divinyl benzene,drug,0.9995,29602545
14718,DVB,drug,0.998,29602545
14719,phenyl,drug,0.99,29602545
14720,ADC,gene,0.9785,29602545
14721,C4,drug,,29602545
14722,C18,drug,0.777,29602545
14723,trifluoroacetic acid,drug,0.999,29602545
14724,TAS-102,drug,0.997,29599371
14725,Metastatic Colorectal Cancer,disease,1.0,29599371
14726,TAS-102,drug,0.9976,29599371
14727,metastatic colorectal cancer,disease,0.9995,29599371
14728,mCRC,disease,0.9985,29599371
14729,PATIENTS,species,0.8916,29599371
14730,mCRC,disease,0.996,29599371
14731,TAS,drug,0.845,29599371
14732,mCRC,disease,0.997,29599371
14733,Kirsten rat sarcoma viral oncogene homolog (KRAS) wild-type,DNA,0.7827,29599371
14734,Kirsten rat sarcoma viral oncogene homolog,gene,0.9985,29599371
14735,KRAS,gene,0.996,29599371
14736,irinotecan,drug,0.998,29599371
14737,panitumumab,gene,0.7715,29599371
14738,TAS-102,drug,0.996,29599371
14739,TAS-102,drug,0.9517,29599371
14740,mCRC,disease,0.9795,29599371
14741,Advanced Colorectal Cancer,disease,0.983,29589315
14742,advanced CRC,disease,0.8623,29589315
14743,CRC,disease,0.998,29589315
14744,EGFR,gene,0.865,29589315
14745,RAS,gene,0.7383,29589315
14746,cetuximab,gene,0.6006,29589315
14747,panitumumab,gene,0.858,29589315
14748,HER2,gene,0.8267,29589315
14749,advanced CRC,disease,1.0,29589315
14750,BRAF V600E,DNA,0.609,29589315
14751,BRAF V600E mutation,gene,0.9673,29589315
14752,V600E,mutation,,29589315
14753,EGFR,gene,0.997,29589315
14754,BRAF,gene,0.997,29589315
14755,BRAF,gene,0.9976,29589315
14756,MEK,gene,0.9907,29589315
14757,MAP kinase,gene,0.9956,29589315
14758,BRAF,DNA,0.7847,29589315
14759,BRAF V600E,gene,0.907,29589315
14760,V600E,DNA,,29589315
14761,V600E,mutation,,29589315
14762,cancer,disease,0.9917,29589315
14763,tumors,disease,1.0,29589315
14764,UGT1A1*28,gene,0.7397,29589315
14765,irinotecan,drug,0.9976,29589315
14766,VEGF,gene,0.6367,29589315
14767,advanced CRC,disease,0.939,29589315
14768,tumor,disease,1.0,29589315
14769,cancer,disease,0.9995,29589315
14770,advanced CRC,disease,0.8237,29589315
14771,FOLFIRI,drug,0.815,29587749
14772,panitumumab,gene,0.8677,29587749
14773,wild,DNA,0.4993,29587749
14774,wild-type KRAS,gene,0.9307,29587749
14775,wild-type NRAS,gene,0.8843,29587749
14776,panitumumab,gene,0.858,29587749
14777,folinic acid,drug,0.998,29587749
14778,5-fluorouracil,drug,0.999,29587749
14779,irinotecan,drug,0.998,29587749
14780,FOLFIRI,drug,0.8354,29587749
14781,patients,species,0.9614,29587749
14782,wild-type KRAS,gene,0.765,29587749
14783,wild-type NRAS,gene,0.68,29587749
14784,NRAS,DNA,0.3818,29587749
14785,colorectal cancer,disease,0.9995,29587749
14786,mCRC,disease,0.999,29587749
14787,Patients,species,0.9834,29587749
14788,wild,gene,0.7803,29587749
14789,wild,gene,0.767,29587749
14790,mCRC,disease,0.998,29587749
14791,patients,species,0.988,29587749
14792,patients,species,0.966,29587749
14793,wild-type KRAS,gene,0.891,29587749
14794,wild,gene,0.6772,29587749
14795,mCRC,disease,0.9995,29587749
14796,patients,species,0.991,29587749
14797,patients,species,0.988,29587749
14798,panitumumab,gene,0.9097,29587749
14799,patients,species,0.922,29587749
14800,wild,gene,0.662,29587749
14801,wild,gene,0.598,29587749
14802,mCRC,disease,0.999,29587749
14803,patients,species,0.9814,29587749
14804,Anti-EGFR Monoclonal,gene,0.8574,29576427
14805,Metastatic Colorectal Cancer,disease,1.0,29576427
14806,epidermal growth factor receptor,gene,0.9985,29576427
14807,EGFR,gene,0.9917,29576427
14808,metastatic colorectal cancer,disease,1.0,29576427
14809,mCRC,disease,1.0,29576427
14810,RAS gene,gene,0.8955,29576427
14811,EGFR,gene,0.971,29576427
14812,dermatologic,disease,0.7285,29576427
14813,anti-EGFR monoclonal antibodies,gene,0.9287,29576427
14814,dermatologic,disease,0.5835,29576427
14815,mCRC,disease,0.736,29576427
14816,mCRC,disease,0.991,29576427
14817,EGFR,gene,0.883,29576427
14818,EGFR,gene,0.602,29576427
14819,dermatologic toxicities,disease,0.798,29576427
14820,papulopustular/acneiform rash,disease,1.0,29576427
14821,xerosis,disease,1.0,29576427
14822,pruritus,disease,1.0,29576427
14823,nail changes,disease,0.999,29576427
14824,hair abnormalities,disease,1.0,29576427
14825,ocular conditions,disease,1.0,29576427
14826,anti-EGFR monoclonal antibody,gene,0.827,29576427
14827,Colorectal Cancer,disease,1.0,29572704
14828,Cancer,disease,0.4048,29572704
14829,bevacizumab,gene,0.9116,29572704
14830,cetuximab,gene,0.933,29572704
14831,panitumumab,gene,0.951,29572704
14832,colorectal cancer,disease,1.0,29572704
14833,M1c,cell_line,0.469,29572704
14834,patients,species,0.9805,29572704
14835,Cancer,disease,0.9985,29572704
14836,M1c,cell_line,0.438,29572704
14837,patients,species,0.9883,29572704
14838,patients,species,0.9834,29572704
14839,patients,species,0.9805,29572704
14840,tumor,disease,0.993,29572704
14841,peritoneal metastasis,disease,0.8066,29572704
14842,patients,species,0.9165,29572704
14843,colorectal cancer,disease,0.9956,29572704
14844,patient,species,0.963,29572704
14845,IGF-1R Antibody Ganitumab,gene,0.82,29572245
14846,AMG 479,gene,0.859,29572245
14847,ganitumab,gene,0.973,29572245
14848,everolimus,drug,0.9976,29572245
14849,ganitumab,gene,0.959,29572245
14850,everolimus,drug,0.9985,29572245
14851,panitumumab,gene,0.9805,29572245
14852,ganitumab,gene,0.8857,29572245
14853,everolimus,drug,0.9795,29572245
14854,Panitumumab,gene,0.917,29572245
14855,ganitumab,gene,0.89,29572245
14856,everolimus,drug,0.9966,29572245
14857,insulin-like growth factor 1 receptor,gene,0.9985,29572245
14858,mammalian target of rapamycin,gene,0.958,29572245
14859,rapamycin,drug,0.996,29572245
14860,mTOR,gene,0.9946,29572245
14861,DLTs,disease,0.991,29572245
14862,DLTs,disease,0.9917,29572245
14863,thrombocytopenia,disease,1.0,29572245
14864,neutropenia,disease,1.0,29572245
14865,skin rash,disease,1.0,29572245
14866,mucositis,disease,1.0,29572245
14867,fatigue,disease,1.0,29572245
14868,hyperglycemia,disease,1.0,29572245
14869,patients,species,0.9814,29572245
14870,non-small cell lung cancer,disease,1.0,29572245
14871,NSCLC,disease,1.0,29572245
14872,patient,species,0.9727,29572245
14873,chondrosarcoma,disease,1.0,29572245
14874,dermal granulation tissue,cell_type,0.6523,29572245
14875,insulin-like growth factor receptor,gene,0.9995,29572245
14876,mTOR,gene,0.994,29572245
14877,ganitumab,gene,0.87,29572245
14878,everolimus,drug,0.988,29572245
14879,ganitumab,gene,0.919,29572245
14880,everolimus,drug,0.9966,29572245
14881,panitumumab,gene,0.826,29572245
14882,ganitumab,gene,0.961,29572245
14883,everolimus,drug,0.9956,29572245
14884,patients,species,0.953,29572245
14885,NSCLC,disease,1.0,29572245
14886,sarcoma,disease,1.0,29572245
14887,ganitumab,gene,0.9604,29572245
14888,everolimus,drug,0.997,29572245
14889,ganitumab,gene,0.8506,29572245
14890,everolimus,drug,0.997,29572245
14891,panitumumab,gene,0.9307,29572245
14892,ganitumab,gene,0.955,29572245
14893,everolimus,drug,0.997,29572245
14894,panitumumab,gene,0.902,29572245
14895,ganitumab,gene,0.9546,29572245
14896,everolimus,drug,0.997,29572245
14897,patients,species,0.9136,29572245
14898,non-small cell lung cancer,disease,1.0,29572245
14899,sarcoma,disease,1.0,29572245
14900,Colorectal Cancer,disease,1.0,29549923
14901,Patients,species,0.975,29549923
14902,colorectal cancer,disease,1.0,29549923
14903,CRC,disease,1.0,29549923
14904,epidermal growth factor antibodies,gene,0.993,29549923
14905,CRC,disease,1.0,29549923
14906,patients,species,0.992,29549923
14907,tumor,disease,0.9995,29549923
14908,Circulating tumor cells,cell_type,0.9067,29549923
14909,CTCs,cell_type,0.8364,29549923
14910,tumor DNA,DNA,0.8813,29549923
14911,ctDNA,DNA,0.906,29549923
14912,KRAS,gene,0.977,29549923
14913,NRAS,DNA,0.8403,29549923
14914,NRAS,gene,0.9863,29549923
14915,BRAF,gene,0.9966,29549923
14916,patients,species,0.99,29549923
14917,CRC,disease,0.999,29549923
14918,CTCs,cell_type,0.811,29549923
14919,ctDNA,DNA,0.8057,29549923
14920,tumor,disease,0.9346,29549923
14921,Patients,species,0.9785,29549923
14922,cetuximab,gene,0.792,29549923
14923,panitumumab,gene,0.745,29549923
14924,KRAS,gene,0.9844,29549923
14925,NRAS,DNA,0.8,29549923
14926,NRAS,gene,0.9927,29549923
14927,BRAF,gene,0.995,29549923
14928,CTCs,cell_line,0.771,29549923
14929,CTCs,cell_type,0.8525,29549923
14930,patients,species,0.988,29549923
14931,CRC,disease,0.9995,29549923
14932,patients,species,0.994,29549923
14933,CTCs,cell_type,0.776,29549923
14934,ctDNA,DNA,0.8643,29549923
14935,epidermal growth factor receptor,gene,0.98,29531837
14936,EGFRi,gene,0.996,29531837
14937,vascular endothelial growth factor,gene,0.9937,29531837
14938,VEGFi,gene,0.977,29531837
14939,patients,species,0.9697,29531837
14940,RAS wild-type,gene,0.885,29531837
14941,metastatic colorectal carcinoma,disease,1.0,29531837
14942,mCRC,disease,1.0,29531837
14943,patients,species,0.931,29531837
14944,panitumumab,gene,0.853,29531837
14945,EGFRi,gene,0.9966,29531837
14946,VEGFi,gene,0.9785,29531837
14947,bevacizumab,gene,0.6587,29531837
14948,VEGFi,gene,0.995,29531837
14949,EGFRi,gene,0.9873,29531837
14950,Patients,species,0.9834,29531837
14951,RAS WT,disease,0.588,29531837
14952,RAS,gene,0.9966,29531837
14953,RAS WT,disease,0.9795,29531837
14954,RAS,gene,0.9766,29531837
14955,BRAF WT tumours,disease,0.889,29531837
14956,BRAF,gene,0.9946,29531837
14957,patients,species,0.974,29531837
14958,panitumumab,gene,0.909,29531837
14959,bevacizumab,gene,0.677,29531837
14960,VEGFi,gene,0.98,29531837
14961,EGFRi,gene,0.9775,29531837
14962,RAS,DNA,0.7515,29531837
14963,RAS WT,gene,0.993,29531837
14964,patients,species,0.9907,29531837
14965,panitumumabVEGFi,gene,0.9634,29531837
14966,bevacizumabEGFRi,gene,0.8994,29531837
14967,patients,species,0.978,29531837
14968,panitumumabVEGFi,gene,0.98,29531837
14969,bevacizumabEGFRi,gene,0.9077,29531837
14970,patients,species,0.952,29531837
14971,RAS,gene,0.9956,29531837
14972,BRAF,DNA,0.6123,29531837
14973,BRAF,gene,0.9976,29531837
14974,mCRC,disease,0.9995,29531837
14975,left-sided tumours,disease,1.0,29531837
14976,panitumumab,gene,0.92,29531837
14977,VEGFi,gene,0.9927,29531837
14978,bevacizumab,gene,0.77,29531837
14979,EGFRi,gene,0.984,29531837
14980,patients,species,0.8726,29531837
14981,RAS,gene,0.995,29531837
14982,RAS,gene,0.9907,29531837
14983,BRAF,gene,0.996,29531837
14984,mCRC,disease,0.9937,29531837
14985,EGFRi,gene,0.988,29531837
14986,VEGFi,gene,0.9766,29531837
14987,mCRC,disease,0.9956,29531837
14988,Posterior Reversible Encephalopathy Syndrome,disease,1.0,29526944
14989,woman,species,0.8657,29526944
14990,advanced metastatic colon cancer,disease,0.9995,29526944
14991,oxaliplatin,drug,0.9995,29526944
14992,capecitabine,drug,0.999,29526944
14993,XELOX,drug,0.9985,29526944
14994,irinotecan hydrochloride,drug,0.9565,29526944
14995,leucovorin,drug,0.9995,29526944
14996,calcium,drug,0.953,29526944
14997,fluorouracil,drug,0.9995,29526944
14998,irinotecan,drug,0.995,29526944
14999,FOLFIRI,drug,0.9487,29526944
15000,panitumumab,gene,0.9824,29526944
15001,bevacizumab,gene,0.8887,29526944
15002,headache,disease,0.9995,29526944
15003,drowsiness,disease,1.0,29526944
15004,seizure,disease,0.9985,29526944
15005,fever,disease,0.9336,29526944
15006,hypertension,disease,1.0,29526944
15007,spasms of bilateral cerebral arteries,disease,0.9966,29526944
15008,Posterior reversible encephalopathy syndrome,disease,1.0,29526944
15009,PRES,disease,1.0,29526944
15010,patient,species,0.97,29526944
15011,cerebral infarction,disease,1.0,29526944
15012,cancer,disease,0.9473,29526944
15013,PRES,disease,1.0,29526944
15014,Panitumumab,gene,0.8545,29523646
15015,fluoropyrimidines,drug,0.997,29523646
15016,locally advanced rectal cancer,disease,1.0,29523646
15017,LARC,disease,1.0,29523646
15018,panitumumab,gene,0.6377,29523646
15019,LARC,disease,0.998,29523646
15020,Patients,species,0.9844,29523646
15021,adenocarcinoma of the mid-low rectum,disease,1.0,29523646
15022,KRAS,gene,0.9927,29523646
15023,circumferential,DNA,0.5156,29523646
15024,Panitumumab,gene,0.708,29523646
15025,FOLFOX,drug,0.84,29523646
15026,patients,species,0.9707,29523646
15027,panitumumab,gene,0.957,29523646
15028,patients,species,0.983,29523646
15029,patients,species,0.9834,29523646
15030,patients,species,0.9614,29523646
15031,patients,species,0.973,29523646
15032,patients,species,0.956,29523646
15033,patients,species,0.98,29523646
15034,skin rash,disease,0.9985,29523646
15035,patients,species,0.983,29523646
15036,panitumumab,gene,0.887,29523646
15037,LARC,disease,1.0,29523646
15038,pCR,DNA,0.586,29523646
15039,wild-type RAS,gene,0.9956,29523646
15040,anti-epidermal growth factor receptor,gene,0.9517,29523646
15041,EGFR,gene,0.936,29523646
15042,panitumumab,gene,0.798,29523646
15043,locally advanced rectal cancer,disease,0.999,29523646
15044,LARC,disease,1.0,29523646
15045,panitumumab,gene,0.9233,29523646
15046,patients,species,0.9795,29523646
15047,KRAS,DNA,0.8154,29523646
15048,KRAS,gene,0.997,29523646
15049,LARC,disease,0.9995,29523646
15050,NRAS,gene,0.9907,29523646
15051,BRAF,DNA,0.8384,29523646
15052,BRAF,gene,0.994,29523646
15053,EGFR ligands,gene,0.7993,29523646
15054,soluble vascular endothelial growth factor,gene,0.8726,29523646
15055,E-selectin,gene,0.994,29523646
15056,EGFR,gene,0.8115,29523646
15057,FOLFOX,drug,0.959,29517682
15058,anti-,gene,0.9214,29517682
15059,epidermal growth factor receptor,gene,0.901,29517682
15060,EGFR,gene,0.8765,29517682
15061,oxaliplatin,drug,0.9995,29517682
15062,EGFR,gene,0.979,29517682
15063,metastatic colorectal cancer,disease,1.0,29517682
15064,mCRC,disease,1.0,29517682
15065,panitumumab,gene,0.881,29517682
15066,cetuximab,gene,0.8105,29517682
15067,oxaliplatin,drug,1.0,29517682
15068,RAS,gene,0.9937,29517682
15069,mCRC,disease,0.991,29517682
15070,patients,species,0.9897,29517682
15071,tumor,disease,0.774,29517682
15072,anti-EGFR mAbs,gene,0.8906,29517682
15073,FOLFOX,drug,0.892,29517682
15074,RAS,DNA,0.544,29517682
15075,RAS,gene,0.9834,29517682
15076,mCRC,disease,0.989,29517682
15077,patients,species,0.99,29517682
15078,RAS,gene,0.9863,29517682
15079,BRAF,DNA,0.6694,29517682
15080,BRAF,gene,0.9985,29517682
15081,patients,species,0.9897,29517682
15082,anti-EGFR mAb,gene,0.9585,29517682
15083,FLOX,drug,0.9863,29517682
15084,XELOX,drug,0.9277,29517682
15085,anti-EGFR mAb,gene,0.935,29517682
15086,EGFR antibody,gene,0.804,29517682
15087,FOLFOX,drug,0.985,29517682
15088,RAS,gene,0.994,29517682
15089,mCRC,disease,0.9775,29517682
15090,patients,species,0.9785,29517682
15091,anti-EGFR mAb,gene,0.8223,29517682
15092,mCRC,disease,0.796,29517682
15093,patients,species,0.9893,29517682
15094,anti-EGFR mAb,gene,0.9404,29517682
15095,oxaliplatin,drug,0.999,29517682
15096,EGFR,gene,0.991,29517682
15097,FOLFOX,drug,0.9424,29517682
15098,RAS,gene,0.9956,29517682
15099,patients,species,0.957,29517682
15100,mCRC,disease,0.52,29517682
15101,RAS,gene,0.9946,29517682
15102,BRAF,gene,0.999,29517682
15103,patients,species,0.954,29517682
15104,patients,species,0.979,29517682
15105,right,DNA,0.5654,29517682
15106,right,disease,0.7646,29517682
15107,anti-EGFR mAb,gene,0.918,29517682
15108,tumor,disease,1.0,29517682
15109,panitumumab,gene,0.7876,29508026
15110,Fluorouracil,drug,0.9976,29508026
15111,patients,species,0.9834,29508026
15112,oxaliplatin,drug,0.9995,29508026
15113,irinotecan,drug,0.999,29508026
15114,fluorouracil,drug,0.9976,29508026
15115,panitumumab,gene,0.912,29508026
15116,patients,species,0.9556,29508026
15117,KRAS,gene,0.992,29508026
15118,mCRC,disease,0.997,29508026
15119,oxaliplatin,drug,0.9995,29508026
15120,irinotecan,drug,0.9985,29508026
15121,patients,species,0.949,29508026
15122,KRAS,gene,0.994,29508026
15123,mCRC,disease,0.9897,29508026
15124,Panitumumab,gene,0.8486,29508026
15125,fluorouracil,drug,0.9976,29508026
15126,patients,species,0.9834,29508026
15127,colon cancer,disease,1.0,29508026
15128,fluorouracil,drug,0.9976,29508026
15129,panitumumab,gene,0.7754,29508026
15130,patients,species,0.9854,29508026
15131,lactase dehydrogenase,gene,0.9985,29508026
15132,LDH,gene,0.9976,29508026
15133,LDH-4,gene,0.995,29508026
15134,LDH-5,gene,0.995,29508026
15135,Fluorouracil,drug,0.9995,29508026
15136,panitumumab,gene,0.8315,29508026
15137,patients,species,0.964,29508026
15138,KRAS,DNA,0.7476,29508026
15139,KRAS,gene,0.9956,29508026
15140,mCRC,disease,0.9927,29508026
15141,oxaliplatin,drug,0.9995,29508026
15142,irinotecan,drug,0.998,29508026
15143,Serum LDH,gene,0.685,29508026
15144,epidermal growth factor receptor,gene,0.9976,29505011
15145,small bowel adenocarcinoma,disease,1.0,29505011
15146,Small bowel adenocarcinoma,disease,1.0,29505011
15147,SBA,disease,1.0,29505011
15148,gastrointestinal cancer,disease,1.0,29505011
15149,advanced colorectal cancer,disease,0.9966,29505011
15150,bevacizumab,gene,0.914,29505011
15151,cetuximab,gene,0.9004,29505011
15152,PATIENT,species,0.943,29505011
15153,woman,species,0.859,29505011
15154,abdominal pain,disease,0.927,29505011
15155,nausea,disease,0.996,29505011
15156,vomiting,disease,0.9863,29505011
15157,jejunal stenosis,disease,1.0,29505011
15158,poorly,cell_line,0.603,29505011
15159,cancerous cells,cell_type,0.729,29505011
15160,cancerous,disease,0.93,29505011
15161,primary intestinal cancer,disease,1.0,29505011
15162,mucinous adenocarcinoma of the jejunum,disease,1.0,29505011
15163,patient,species,0.9824,29505011
15164,bevacizumab,gene,0.657,29505011
15165,epidermal growth factor receptor,gene,0.921,29505011
15166,EGFR,gene,0.989,29505011
15167,panitumumab,gene,0.834,29505011
15168,Folfox,drug,0.9907,29505011
15169,panitumumab,gene,0.838,29505011
15170,panitumumab,gene,0.757,29505011
15171,panitumumab,gene,0.8896,29505011
15172,patient,species,0.97,29505011
15173,SBA,disease,1.0,29505011
15174,panitumumab,gene,0.777,29505011
15175,epidermal growth factor receptor,gene,0.997,29501977
15176,patients,species,0.9272,29501977
15177,locally advanced oesophagogastric cancer,disease,0.8228,29501977
15178,EGC,disease,1.0,29501977
15179,patients,species,0.994,29501977
15180,PATIENTS,species,0.8926,29501977
15181,panitumumab,gene,0.882,29501977
15182,patients,species,0.898,29501977
15183,EGC,disease,0.9985,29501977
15184,epirubicin,drug,0.999,29501977
15185,cisplatin,drug,0.999,29501977
15186,capecitabine,drug,0.9985,29501977
15187,panitumumab,gene,0.8823,29501977
15188,EGFR,gene,0.995,29501977
15189,HER2,gene,0.9927,29501977
15190,MET,gene,0.995,29501977
15191,patients,species,0.991,29501977
15192,patients,species,0.9854,29501977
15193,panitumumab,gene,0.8896,29501977
15194,thromboembolic events,disease,1.0,29501977
15195,skin toxicity,disease,0.914,29501977
15196,Patients,species,0.9814,29501977
15197,EGFR,gene,0.869,29501977
15198,HER2,gene,0.9966,29501977
15199,MET,gene,0.9927,29501977
15200,EGFR,gene,0.962,29501977
15201,panitumumab,gene,0.896,29501977
15202,panitumumab,gene,0.938,29501977
15203,EGC,disease,0.9985,29501977
15204,sEGFR,gene,0.9844,29501977
15205,patients,species,0.9873,29501977
15206,EGFR,gene,0.992,29501977
15207,Cetuximab,gene,0.869,29498000
15208,Panitumumab,gene,0.7783,29498000
15209,RAS,gene,0.9785,29498000
15210,cetuximab,gene,0.8906,29498000
15211,panitumumab,gene,0.8486,29498000
15212,metastatic colorectal cancer,disease,1.0,29498000
15213,"exons 2, 3",DNA,0.854,29498000
15214,KRAS and NRAS oncogenes,DNA,0.734,29498000
15215,KRAS,gene,0.981,29498000
15216,NRAS oncogenes,gene,0.9873,29498000
15217,rat sarcoma,disease,0.9736,29498000
15218,rat sarcoma (,gene,0.9873,29498000
15219,rat,species,0.871,29498000
15220,RAS,gene,0.604,29498000
15221,patients,species,0.985,29498000
15222,RAS,DNA,0.71,29498000
15223,RAS wild-type,gene,0.8887,29498000
15224,metastatic,disease,1.0,29498000
15225,colorectal cancer,disease,0.947,29498000
15226,cetuximab,gene,0.8945,29498000
15227,panitumumab,gene,0.8057,29498000
15228,FOLFOX,drug,0.982,29498000
15229,folinic acid,drug,0.9995,29498000
15230,fluorouracil,drug,0.9995,29498000
15231,oxaliplatin,drug,1.0,29498000
15232,FOLFIRI,drug,0.929,29498000
15233,folinic acid,drug,0.9995,29498000
15234,fluorouracil,drug,0.9995,29498000
15235,irinotecan,drug,0.999,29498000
15236,FOLFOX,drug,0.975,29498000
15237,FOLFIRI,drug,0.9854,29498000
15238,patient,species,0.948,29498000
15239,cetuximab,gene,0.906,29498000
15240,FOLFOX,drug,0.873,29498000
15241,panitumumab,gene,0.912,29498000
15242,FOLFOX,drug,0.967,29498000
15243,cetuximab,gene,0.742,29498000
15244,FOLFIRI,drug,0.974,29498000
15245,Cetuximab,gene,0.7944,29498000
15246,panitumumab,gene,0.805,29498000
15247,patients,species,0.9688,29498000
15248,RAS,DNA,0.6074,29498000
15249,RAS wild,gene,0.7476,29498000
15250,Cancer,disease,0.998,29498000
15251,bevacizumab,gene,0.879,29484148
15252,panitumumab,gene,0.911,29484148
15253,cetuximab,gene,0.9043,29484148
15254,KRAS,gene,0.5664,29484148
15255,colorectal cancer,disease,0.9834,29484148
15256,Colorectal cancer,disease,1.0,29484148
15257,cancer,disease,1.0,29484148
15258,colorectal cancer,disease,1.0,29484148
15259,bevacizumab,gene,0.9355,29484148
15260,panitumumab,gene,0.964,29484148
15261,cetuximab,gene,0.8784,29484148
15262,KRAS gene,gene,0.9087,29484148
15263,colorectal cancer,disease,1.0,29484148
15264,KRAS,gene,0.5884,29484148
15265,colorectal cancer,disease,1.0,29484148
15266,bevacizumab,gene,0.965,29484148
15267,FOLFOX-4,drug,0.745,29484148
15268,KRAS,gene,0.5713,29484148
15269,panitumumab,gene,0.895,29484148
15270,wild,DNA,0.508,29484148
15271,wild type KRAS,gene,0.9546,29484148
15272,mutant KRAS,gene,0.5493,29484148
15273,Cetuximab,gene,0.9,29484148
15274,FOLFOX,drug,0.5806,29484148
15275,wild,DNA,0.5215,29484148
15276,wild type KRAS,gene,0.8813,29484148
15277,panitumumab,gene,0.9097,29484148
15278,wild,DNA,0.524,29484148
15279,wild type KRAS,gene,0.956,29484148
15280,colorectal cancer,disease,1.0,29484148
15281,panitumumab,gene,0.837,29484148
15282,FOLFOX,drug,0.7554,29484148
15283,colorectal cancer,disease,1.0,29484148
15284,FOLFOX,drug,0.866,29484148
15285,squamous cell carcinoma of the anal canal,disease,1.0,29482779
15286,EGFR,gene,0.8774,29482779
15287,squamous cell carcinoma of the anal canal,disease,1.0,29482779
15288,SCAC,disease,1.0,29482779
15289,epidermal growth factor receptor,gene,0.989,29482779
15290,EGFR,gene,0.9946,29482779
15291,tumor,disease,0.9985,29482779
15292,EGFR,gene,0.7803,29482779
15293,Colorectal cancer,disease,1.0,29478126
15294,colorectal cancer stem cells,cell_type,0.687,29478126
15295,colorectal cancer,disease,1.0,29478126
15296,CSCs,cell_line,0.7847,29478126
15297,patients,species,0.9556,29478126
15298,spheroids,cell_line,0.4844,29478126
15299,cetuximab,gene,0.828,29478126
15300,stem cell-enriched spheroids,cell_line,0.8696,29478126
15301,stem cell,cell_type,0.728,29478126
15302,microsatellite stable (MSS) CSCs,cell_line,0.874,29478126
15303,KRAS (G12D),DNA,0.5386,29478126
15304,KRAS (G12D) mutation,gene,0.9673,29478126
15305,G12,mutation,,29478126
15306,epidermal growth factor,gene,0.997,29478126
15307,EGF,gene,0.9946,29478126
15308,anti-EGF-receptor,gene,0.928,29478126
15309,EGFR,gene,0.9966,29478126
15310,EGFR,gene,0.8345,29478126
15311,microsatellite instable (MSI) CSC lines,cell_line,0.958,29478126
15312,CSC,cell_type,0.3953,29478126
15313,KRAS,gene,0.9937,29478126
15314,MSI CSC lines,cell_line,0.9546,29478126
15315,RAS,gene,0.9946,29478126
15316,calcium,drug,0.9927,29478126
15317,EGFR,gene,0.9233,29478126
15318,EGFR,gene,0.602,29478126
15319,EGFR,gene,0.991,29478126
15320,EGFR,gene,0.989,29478126
15321,EGFR,gene,0.707,29478126
15322,Cetuximab,gene,0.917,29470838
15323,KRAS,gene,0.9746,29470838
15324,NRAS,gene,0.9985,29470838
15325,BRAF,gene,0.9976,29470838
15326,Colorectal carcinomas,disease,1.0,29470838
15327,CRCs,disease,1.0,29470838
15328,EGFR,gene,0.9966,29470838
15329,EGFR,gene,0.996,29470838
15330,KRAS,gene,0.991,29470838
15331,NRAS,DNA,0.8135,29470838
15332,NRAS,gene,0.9966,29470838
15333,BRAF,gene,0.998,29470838
15334,CRC,disease,0.97,29470838
15335,patients,species,0.985,29470838
15336,cetuximab,gene,0.9624,29470838
15337,panitumumab,gene,0.9424,29470838
15338,patients,species,0.9663,29470838
15339,EGFR,gene,0.651,29470838
15340,patients,species,0.961,29470838
15341,KRAS,DNA,0.682,29470838
15342,KRAS,gene,0.987,29470838
15343,NRAS,gene,0.9985,29470838
15344,BRAF,DNA,0.612,29470838
15345,BRAF,gene,0.998,29470838
15346,CRC,disease,0.998,29470838
15347,patients,species,0.9883,29470838
15348,patients,species,0.9653,29470838
15349,Cetuximab,gene,0.9272,29470838
15350,RNA,RNA,0.748,29470838
15351,EGFR,gene,0.99,29470838
15352,insulin-like growth factor 2,gene,0.9985,29470838
15353,IGF2,gene,0.999,29470838
15354,tumor,disease,1.0,29470838
15355,PIK3CA,DNA,0.8374,29470838
15356,PIK3CA mutation,gene,0.9,29470838
15357,CRC,disease,1.0,29470838
15358,cetuximab,gene,0.77,29470838
15359,patients,species,0.984,29470838
15360,CRC,disease,0.999,29470838
15361,HER2 oncogene,gene,0.996,29470838
15362,patients,species,0.9785,29470838
15363,PD,disease,,29470838
15364,cetuximab,gene,0.7886,29470838
15365,KRAS,DNA,0.492,29470838
15366,KRAS,gene,0.956,29470838
15367,NRAS,gene,0.9985,29470838
15368,BRAF,gene,0.9985,29470838
15369,patients,species,0.9604,29470838
15370,fluoropyrimidines,drug,0.9844,29470838
15371,cetuximab,gene,0.8794,29470838
15372,Cetuximab,gene,0.7783,29470838
15373,KRAS,gene,0.982,29470838
15374,NRAS,DNA,0.5864,29470838
15375,NRAS,gene,0.998,29470838
15376,BRAF,gene,0.998,29470838
15377,CRC,disease,0.9956,29470838
15378,patients,species,0.9795,29470838
15379,patient,species,0.9727,29470838
15380,cetuximab,gene,0.9565,29470838
15381,cancer,disease,0.9526,29466887
15382,cancer,disease,0.9946,29466887
15383,patients,species,0.983,29466887
15384,cancer,disease,1.0,29466887
15385,cancer,disease,1.0,29466887
15386,cancer,disease,1.0,29466887
15387,"breast, colorectal, lung, head &amp; neck, and gastric cancer",disease,0.999,29466887
15388,trastuzumab,gene,0.982,29466887
15389,pertuzumab,gene,0.968,29466887
15390,bevacizumab,gene,0.828,29466887
15391,cetuximab,gene,0.865,29466887
15392,panitumumab,gene,0.933,29466887
15393,erlotinib,drug,0.9976,29466887
15394,gefitinib,drug,0.998,29466887
15395,crizotinib,drug,0.9985,29466887
15396,gastric cancer,disease,1.0,29466887
15397,patient,species,0.965,29466887
15398,cancer,disease,1.0,29466887
15399,patients,species,0.982,29466887
15400,5-FU,drug,0.9995,29464396
15401,oxaliplatin,drug,0.9995,29464396
15402,irinotecan,drug,0.9995,29464396
15403,levofolinate,drug,0.9976,29464396
15404,FOLFOXIRI,drug,0.958,29464396
15405,colorectal cancer,disease,1.0,29464396
15406,panitumumab,gene,0.9224,29464396
15407,FOLFOXIRI,drug,0.7227,29464396
15408,panitumumab,gene,0.859,29464396
15409,RAS,gene,0.9956,29464396
15410,metastatic colorectal cancer,disease,0.9785,29464396
15411,mCRC,disease,1.0,29464396
15412,Patients,species,0.9185,29464396
15413,panitumumab,gene,0.8457,29464396
15414,FOLFOXIRI,drug,0.991,29464396
15415,irinotecan,drug,0.9995,29464396
15416,CPT-11,drug,0.999,29464396
15417,oxaliplatin,drug,0.9995,29464396
15418,L-OHP,drug,0.998,29464396
15419,folinate,drug,0.9976,29464396
15420,fluorouracil,drug,0.999,29464396
15421,5-FU,drug,0.9995,29464396
15422,RAS,gene,0.996,29464396
15423,mCRC,disease,0.996,29464396
15424,patients,species,0.991,29464396
15425,CPT-11,drug,0.9985,29464396
15426,CPT-11,drug,0.9985,29464396
15427,patients,species,0.983,29464396
15428,patients,species,0.9824,29464396
15429,diarrhea,disease,1.0,29464396
15430,hypokalemia,disease,1.0,29464396
15431,stomatitis,disease,1.0,29464396
15432,patients,species,0.985,29464396
15433,panitumumab,gene,0.925,29464396
15434,patients,species,0.9473,29464396
15435,mCRC,disease,0.989,29464396
15436,postoperative liver failure,disease,0.994,29453737
15437,POLF,disease,0.9985,29453737
15438,patient,species,0.967,29453737
15439,colorectal liver metastases,disease,0.9946,29453737
15440,man,species,0.886,29453737
15441,sigmoid colon cancer,disease,1.0,29453737
15442,intraabdominal abscess,disease,1.0,29453737
15443,liver metastases,disease,0.9766,29453737
15444,liver tumors,disease,1.0,29453737
15445,tumor,disease,0.997,29453737
15446,tumor,disease,0.999,29453737
15447,tumor,disease,1.0,29453737
15448,liver,disease,0.8354,29453737
15449,panitumumab,gene,0.9663,29453737
15450,5-fluorouracil,drug,0.9995,29453737
15451,leucovorin,drug,0.9985,29453737
15452,oxaliplatin,drug,0.9995,29453737
15453,FOLFOX,drug,0.93,29453737
15454,tumor,disease,0.9956,29453737
15455,MHV,DNA,0.518,29453737
15456,TSH,gene,0.689,29453737
15457,POLF,disease,0.9946,29453737
15458,RHV,DNA,0.5757,29453737
15459,patient,species,0.9785,29453737
15460,RHV,DNA,0.5273,29453737
15461,patient,species,0.989,29453737
15462,panitumumab,gene,0.9316,29453737
15463,FOLFOX,drug,0.7725,29453737
15464,TSH,gene,0.9634,29453737
15465,POLF,disease,0.9995,29453737
15466,cancer,disease,0.999,29450993
15467,tumors,disease,1.0,29450993
15468,Panitumumab,gene,0.8193,29450993
15469,mice,species,0.957,29450993
15470,A431-luc xenografts,cell_line,0.8667,29450993
15471,epithelial growth factor receptor,gene,0.9985,29450993
15472,EGFR,gene,0.982,29450993
15473,tumors,disease,1.0,29450993
15474,tumor,disease,0.7896,29450993
15475,tumors,disease,1.0,29450993
15476,tumour,disease,0.9365,29450632
15477,RAS,gene,0.5195,29450632
15478,panitumumab,gene,0.9307,29450632
15479,EGFR,gene,0.9004,29438094
15480,Small Bowel Adenocarcinoma,disease,1.0,29438094
15481,BRAF,gene,0.993,29431699
15482,EGFR,gene,0.991,29431699
15483,MEK,gene,0.9893,29431699
15484,Patients,species,0.984,29431699
15485,BRAF(V600E)-Mutant,gene,0.9756,29431699
15486,V600,mutation,,29431699
15487,BRAF,gene,0.997,29431699
15488,BRAF,cell_line,0.6064,29431699
15489,BRAF(,disease,0.996,29431699
15490,BRAF(V600),gene,0.7812,29431699
15491,patients,species,0.9766,29431699
15492,BRAF(,disease,0.999,29431699
15493,BRAF,gene,0.98,29431699
15494,V600,mutation,,29431699
15495,BRAF,cell_line,0.5923,29431699
15496,BRAF(,disease,0.9995,29431699
15497,BRAF,gene,0.9697,29431699
15498,V600,mutation,,29431699
15499,MAPK,gene,0.9673,29431699
15500,EGFR,gene,0.9907,29431699
15501,BRAF,gene,0.998,29431699
15502,EGFR,gene,0.9834,29431699
15503,dabrafenib,drug,0.997,29431699
15504,panitumumab,gene,0.868,29431699
15505,MEK,gene,0.9946,29431699
15506,trametinib,drug,0.9976,29431699
15507,MAPK,gene,0.89,29431699
15508,patients,species,0.9683,29431699
15509,BRAF(,disease,0.9873,29431699
15510,BRAF,gene,0.9844,29431699
15511,V600E,DNA,0.567,29431699
15512,V600,mutation,,29431699
15513,colorectal cancer,disease,0.8857,29431699
15514,MAPK,gene,0.9785,29431699
15515,cell,RNA,0.621,29431699
15516,KRAS,gene,0.9814,29431699
15517,NRAS mutations,DNA,0.5347,29431699
15518,NRAS mutations,gene,0.977,29431699
15519,BRAF(V600E,cell_line,0.592,29431699
15520,BRAF(,disease,0.9956,29431699
15521,BRAF,gene,0.975,29431699
15522,V600,mutation,,29431699
15523,MAPK,gene,0.96,29431699
15524,BRAF,gene,0.998,29431699
15525,EGFR,gene,0.9966,29431699
15526,MEK,gene,0.995,29431699
15527,patients,species,0.9214,29431699
15528,BRAF(V600E) colorectal cancer,disease,0.972,29431699
15529,BRAF,gene,0.9263,29431699
15530,V600,mutation,,29431699
15531,MAPK,gene,0.9893,29431699
15532,BRAF(V600E),cell_line,0.5938,29431699
15533,BRAF(V600E) colorectal cancer,disease,0.965,29431699
15534,BRAF,gene,0.974,29431699
15535,V600,mutation,,29431699
15536,Infections,disease,0.9473,29426804
15537,Infections,disease,0.9224,29426804
15538,cancer,disease,1.0,29426804
15539,patients,species,0.9883,29426804
15540,Vascular endothelial growth factor,gene,0.995,29426804
15541,VEGF,gene,0.9985,29426804
15542,bevacizumab,gene,0.9395,29426804
15543,aflibercept,gene,0.9766,29426804
15544,neutropaenia,disease,0.9995,29426804
15545,VEGF tyrosine kinase,gene,0.9097,29426804
15546,tyrosine,drug,0.6523,29426804
15547,sorafenib,drug,0.999,29426804
15548,sunitinib,drug,0.998,29426804
15549,Anti-,gene,0.886,29426804
15550,epidermal growth factor receptor,gene,0.888,29426804
15551,EGFR,gene,0.968,29426804
15552,cetuximab,gene,0.9136,29426804
15553,panitumumab,gene,0.8525,29426804
15554,neutropaenia,disease,1.0,29426804
15555,skin and soft tissue infection,disease,1.0,29426804
15556,papulopustular,disease,1.0,29426804
15557,rash,disease,0.833,29426804
15558,doxycycline,drug,0.9995,29426804
15559,minocycline,drug,0.998,29426804
15560,Pneumocystis,disease,0.9995,29426804
15561,ErbB2,gene,0.7026,29426804
15562,HER2,gene,0.9946,29426804
15563,trastuzumab,gene,0.9673,29426804
15564,pertuzumab,gene,0.9316,29426804
15565,ErbB receptor tyrosine kinase,gene,0.8965,29426804
15566,tyrosine,drug,0.9077,29426804
15567,EGFR,gene,0.9976,29426804
15568,ErbB2,gene,0.9985,29426804
15569,lapatinib,drug,0.9937,29426804
15570,neratinib,drug,0.98,29426804
15571,neutropaenia,disease,0.982,29426804
15572,VEGF,gene,0.995,29426804
15573,panitumumab,gene,0.8555,29413685
15574,cisplatin,drug,0.9995,29413685
15575,gemcitabine,drug,0.9995,29413685
15576,KRAS,gene,0.6587,29413685
15577,biliary cancer,disease,1.0,29413685
15578,biliary cancer,disease,1.0,29413685
15579,monoclonal,gene,0.607,29413685
15580,EGFR antibody panitumumab,gene,0.649,29413685
15581,KRAS,gene,0.619,29413685
15582,PATIENTS,species,0.944,29413685
15583,advanced biliary,disease,1.0,29413685
15584,tract cancer,disease,0.9795,29413685
15585,cisplatin,drug,0.9995,29413685
15586,gemcitabine,drug,0.9985,29413685
15587,panitumumab,gene,0.8003,29413685
15588,EGFR antibodies,gene,0.7744,29413685
15589,cisplatin,drug,1.0,29413685
15590,gemcitabine,drug,0.9995,29413685
15591,panitumumab,gene,0.844,29413685
15592,cisplatin,drug,1.0,29413685
15593,gemcitabine,drug,0.9995,29413685
15594,p53,gene,0.9985,29413685
15595,IDH1,DNA,0.6753,29413685
15596,IDH1/2,gene,0.9814,29413685
15597,EGFR antibodies,gene,0.785,29413685
15598,Panitumumab,gene,0.707,29413685
15599,KRAS,gene,0.7803,29413685
15600,advanced biliary cancer,disease,1.0,29413685
15601,CCA,disease,0.9995,29413685
15602,Colorectal Cancer Liver Metastases,disease,0.9126,29394831
15603,ascending colon cancer,disease,1.0,29394831
15604,tegafur,drug,0.999,29394831
15605,gimeracil,drug,0.995,29394831
15606,oteracil,drug,0.9946,29394831
15607,SOX,drug,0.741,29394831
15608,panitumumab,gene,0.552,29394831
15609,metastatic tumor,disease,0.9985,29394831
15610,hepatic failure,disease,1.0,29394831
15611,multiple bilobar liver metastases,disease,0.817,29394831
15612,Ascending Colon Cancer,disease,1.0,29394769
15613,Abdominal Trauma,disease,0.9736,29394769
15614,abdominal trauma,disease,0.8447,29394769
15615,retroperitoneal abscess,disease,1.0,29394769
15616,advanced cancer,disease,0.965,29394769
15617,panitumumab,gene,0.9497,29394769
15618,Pmab,gene,0.9653,29394769
15619,tumor,disease,0.816,29394769
15620,5-FU,drug,0.9985,29394769
15621,tumor,disease,0.873,29394769
15622,capecitabine,drug,0.9985,29394769
15623,Mediastinal Lymph Node Metastasis,disease,0.9995,29394747
15624,Cecal Cancer,disease,1.0,29394747
15625,cecal colon cancer,disease,1.0,29394747
15626,liver,disease,0.518,29394747
15627,liver,disease,0.967,29394747
15628,hemoptysis,disease,0.9976,29394747
15629,cough,disease,0.9883,29394747
15630,lymph node,disease,0.8374,29394747
15631,lymph nodes,disease,0.7227,29394747
15632,right pulmonary artery,DNA,0.5596,29394747
15633,FOLFIRI,drug,0.7637,29394747
15634,panitumumab,gene,0.9424,29394747
15635,FOLFIRI,drug,0.873,29394701
15636,Metastatic Colorectal Cancer,disease,1.0,29394701
15637,FOLFIRI,drug,0.9795,29394701
15638,panitumumab,gene,0.863,29394701
15639,rectal cancer,disease,1.0,29394701
15640,liver metastases,disease,0.9463,29394701
15641,FOLFIRI,drug,0.965,29394701
15642,febrile neutropenia,disease,0.954,29394701
15643,panitumumab,gene,0.896,29394701
15644,intestinal obstruction,disease,0.999,29394701
15645,liver metastasis,disease,0.992,29394701
15646,FOLFIRI,drug,0.7715,29394701
15647,metastatic,disease,0.8364,29394701
15648,FOLFIRI,drug,0.8896,29394701
15649,metastatic colorectal cancer,disease,1.0,29394701
15650,Advanced Rectal Cancer,disease,1.0,29394695
15651,Multiple Liver Metastases,disease,0.74,29394695
15652,cancer of the lower rectum,disease,1.0,29394695
15653,liver metastases,disease,0.9907,29394695
15654,tubular adenocarcinoma,disease,0.996,29394695
15655,All-,DNA,0.599,29394695
15656,All-RAS,gene,0.8296,29394695
15657,RAS,DNA,0.4365,29394695
15658,advanced rectal cancer,disease,1.0,29394695
15659,5- fluorouracil,drug,0.9995,29394695
15660,Leucovorin,drug,0.9995,29394695
15661,oxaliplatin,drug,0.9995,29394695
15662,FOLFOX,drug,0.946,29394695
15663,panitumumab,gene,0.599,29394695
15664,rectal cancer,disease,0.999,29394695
15665,cancer cells,cell_type,0.845,29394695
15666,cancer,disease,0.9897,29394695
15667,lymphadenopathy,disease,0.996,29394695
15668,liver metastases,disease,0.8813,29394695
15669,liver metastases,disease,0.839,29394695
15670,rectal cancer,disease,1.0,29394695
15671,Stage IV Advanced Sigmoid Colon Cancer,disease,0.8584,29394654
15672,advanced sigmoid colon cancer,disease,1.0,29394654
15673,colon cancer,disease,1.0,29394654
15674,LYM,cell_line,0.518,29394654
15675,KRAS,gene,0.775,29394654
15676,EGFR,gene,0.9966,29394654
15677,FOLFOX,drug,0.936,29394654
15678,bevacizumab,gene,0.7095,29394654
15679,Bmab,gene,0.5747,29394654
15680,lung metastases,disease,0.9526,29394654
15681,FOLFIRI,drug,0.983,29394654
15682,panitumumab,gene,0.9243,29394654
15683,SOX,drug,0.966,29394654
15684,Bmab,gene,0.9136,29394654
15685,CapeOX,drug,0.972,29394654
15686,FOLFIRI,drug,0.9873,29394654
15687,Advanced Sigmoid Colon Cancer,disease,1.0,29394642
15688,advanced sigmoid colon cancer,disease,1.0,29394642
15689,diarrhea,disease,1.0,29394642
15690,giant tumor,disease,0.998,29394642
15691,lymph node enlargement,disease,0.899,29394642
15692,tumor,disease,0.9883,29394642
15693,RAS,gene,0.7314,29394642
15694,panitumumab,gene,0.579,29394642
15695,advanced colorectal cancer,disease,0.998,29394642
15696,Cecal Cancer,disease,1.0,29394611
15697,Para-Aortic Lymph Node Metastasis,disease,0.997,29394611
15698,Panitumumab,gene,0.8315,29394611
15699,cecal cancer,disease,1.0,29394611
15700,para-aortic lymph node metastasis,disease,0.9985,29394611
15701,left breast cancer,disease,1.0,29394611
15702,panitumumab,gene,0.714,29394611
15703,cecal cancer,disease,1.0,29394611
15704,aromatase,gene,0.9536,29394611
15705,breast cancer,disease,1.0,29394611
15706,panitumumab,gene,0.5566,29394611
15707,adenocarcinoma,disease,1.0,29394611
15708,cancers,disease,1.0,29394611
15709,Rectal Cancer,disease,0.999,29394605
15710,recto-sigmoid colon cancer,disease,1.0,29394605
15711,FOLFOX,drug,0.7036,29394605
15712,panitumumab,gene,0.9395,29394605
15713,Pmab,gene,0.957,29394605
15714,pulmonary metastasis,disease,0.999,29394605
15715,liver metastasis,disease,0.999,29394605
15716,hepatic dysfunction,disease,1.0,29394605
15717,advanced fatty liver,disease,1.0,29394605
15718,extrahepatic,DNA,0.472,29394605
15719,extrahepatic lesions,disease,0.9976,29394605
15720,liver,disease,0.982,29394605
15721,liver,disease,0.9473,29394605
15722,colon cancer,disease,1.0,29394605
15723,Transverse Colon Carcinoma,disease,1.0,29394570
15724,transverse colon cancer,disease,1.0,29394570
15725,tub2,cell_line,0.5234,29394570
15726,XELOX,drug,0.551,29394570
15727,FOLFIRI,drug,0.93,29394570
15728,panitumumab,gene,0.9614,29394570
15729,Pmab,gene,0.9556,29394570
15730,Stenosis due to duodenum,disease,1.0,29394570
15731,enlargement of duodenum,disease,1.0,29394570
15732,mFOLFOX6,drug,0.9507,29394570
15733,anti-PD-1,gene,0.994,29394570
15734,tumor,disease,1.0,29394570
15735,Cetuximab,gene,0.9443,29393280
15736,Panitumumab,gene,0.861,29393280
15737,Metastatic Colorectal Cancer,disease,1.0,29393280
15738,cetuximab,gene,0.909,29393280
15739,panitumumab,gene,0.8364,29393280
15740,cetuximab,gene,0.952,29393280
15741,panitumumab,gene,0.871,29393280
15742,cetuximab,gene,0.6777,29393280
15743,panitumumab,gene,0.908,29393280
15744,colorectal cancer,disease,1.0,29393280
15745,colorectal carcinoma,disease,1.0,29393280
15746,skin toxicities,disease,0.999,29393280
15747,Cetuximab,gene,0.722,29393280
15748,acne-like rash,disease,1.0,29393280
15749,paronychia,disease,1.0,29393280
15750,skin fissures,disease,1.0,29393280
15751,pruritus,disease,1.0,29393280
15752,cetuximab,gene,0.925,29393280
15753,panitumumab,gene,0.772,29393280
15754,Hypomagnesemia,disease,1.0,29391418
15755,anti-EGFR monoclonal antibodies,gene,0.8486,29391418
15756,Hypomagnesemia,disease,1.0,29391418
15757,cetuximab,gene,0.818,29391418
15758,panitumumab,gene,0.5874,29391418
15759,metastatic colorectal cancer,disease,1.0,29391418
15760,mCRC,disease,1.0,29391418
15761,hypomagnesemia,disease,1.0,29391418
15762,hypomagnesemia,disease,1.0,29391418
15763,magnesium,drug,0.9995,29391418
15764,wild-type KRAS,gene,0.992,29391418
15765,patients,species,0.985,29391418
15766,Patients,species,0.8677,29391418
15767,hypomagnesemia,disease,1.0,29391418
15768,hypomagnesemia,disease,1.0,29391418
15769,patients,species,0.9614,29391418
15770,wild,gene,0.6094,29391418
15771,mCRC,disease,0.968,29391418
15772,hypomagnesemia,disease,1.0,29391418
15773,cetuximab,gene,0.9688,29391418
15774,panitumumab,gene,0.8667,29391418
15775,docetaxel,drug,0.999,29390067
15776,cisplatin,drug,0.9995,29390067
15777,panitumumab,gene,0.7026,29390067
15778,Epidermal Growth Factor Receptor,gene,0.9985,29389408
15779,Trichomegaly,disease,1.0,29389408
15780,Poliosis,disease,1.0,29389408
15781,HER2,gene,0.9937,29387480
15782,HER2,gene,0.993,29387480
15783,HER2,gene,0.995,29387480
15784,HER2,DNA,0.784,29387480
15785,HER2 gene,gene,0.8193,29387480
15786,HER2 mutations,gene,0.7676,29387480
15787,cancer,disease,1.0,29387480
15788,cetuximab,gene,0.903,29387480
15789,panitumumab,gene,0.8994,29387480
15790,metastatic colorectal cancer,disease,1.0,29387480
15791,mCRC,disease,1.0,29387480
15792,HER2,gene,0.9946,29387480
15793,Colorectal Cancer,disease,1.0,29387480
15794,HER2,gene,0.9883,29387480
15795,patients,species,0.9736,29387480
15796,PATIENT,species,0.967,29387480
15797,HER2 gene,DNA,0.835,29387480
15798,HER2 gene,gene,0.9893,29387480
15799,HER2 protein,gene,0.757,29387480
15800,tumour,disease,1.0,29387480
15801,HER2,gene,0.991,29387480
15802,HER2,gene,0.994,29387480
15803,Colon and Lung Cancer,disease,0.991,29387480
15804,patient,species,0.9814,29387480
15805,HER2 gene,DNA,0.898,29387480
15806,HER2,gene,0.9966,29387480
15807,RAS,gene,0.9834,29387480
15808,BRAF,gene,0.9985,29387480
15809,mCRC,disease,0.993,29387480
15810,HER2,gene,0.8877,29387480
15811,trastuzumab,gene,0.979,29387480
15812,lapatinib,drug,0.998,29387480
15813,pertuzumab,gene,0.938,29387480
15814,trastuzumab,gene,0.9766,29387480
15815,trastuzumab emtansine,gene,0.826,29387480
15816,trastuzumab,gene,0.9526,29387480
15817,capecitabine,drug,0.998,29387480
15818,mCRC,disease,0.996,29387480
15819,HER gene,DNA,0.9,29387480
15820,HER gene,gene,0.9873,29387480
15821,HER2 gene,gene,0.928,29387480
15822,cancer,disease,1.0,29387480
15823,mCRC,disease,0.997,29387480
15824,HER2,gene,0.9956,29387480
15825,Hypertrichosis of the pinnae,disease,1.0,29377278
15826,panitumumab,gene,0.9487,29377278
15827,FOLFOX,drug,0.748,29370781
15828,panitumumab,gene,0.842,29370781
15829,5FU,drug,0.9297,29370781
15830,panitumumab,gene,0.8193,29370781
15831,RAS,gene,0.485,29370781
15832,BRAF,gene,0.9946,29370781
15833,metastatic colorectal,disease,0.994,29370781
15834,cancer,disease,1.0,29370781
15835,metastatic colorectal cancer,disease,1.0,29370781
15836,EGFR,gene,0.969,29370781
15837,FOLFOX,drug,0.879,29370781
15838,panitumumab,gene,0.7065,29370781
15839,RAS,gene,0.7134,29370781
15840,metastatic colorectal cancer,disease,0.9194,29370781
15841,cancer,disease,1.0,29370781
15842,panitumumab,gene,0.8438,29370781
15843,5-fluorouracil,drug,0.998,29370781
15844,RAS,gene,0.986,29370781
15845,BRAF,gene,0.565,29370781
15846,unresectable,disease,0.8345,29370781
15847,metastatic colorectal cancer,disease,0.841,29370781
15848,RAS,gene,0.606,29370781
15849,BRAF,gene,0.8364,29370781
15850,panitumumab,gene,0.7866,29370781
15851,FOLFOX,drug,0.551,29370781
15852,5FU,drug,0.995,29370781
15853,RAS,gene,0.522,29370781
15854,BRAF,gene,0.994,29370781
15855,metastatic colorectal cancer,disease,0.991,29370781
15856,Panitumumab,gene,0.9844,29368506
15857,Platinum,drug,0.9995,29368506
15858,Apoferritin,gene,0.9834,29368506
15859,Apoferritin,gene,0.997,29368506
15860,AF,gene,0.999,29368506
15861,iron,drug,0.9995,29368506
15862,AF,cell_type,,29368506
15863,amine,drug,0.9917,29368506
15864,oxaliplatin,drug,1.0,29368506
15865,panitumumab,gene,0.801,29368506
15866,polyethylene glycol,drug,0.9995,29368506
15867,oxaliplatin,drug,1.0,29368506
15868,panitumumab,gene,0.933,29368506
15869,AFPO,gene,0.831,29368506
15870,cell lines,cell_line,0.9307,29368506
15871,cell,cell_type,0.483,29368506
15872,epidermal growth factor receptor,gene,0.998,29368506
15873,EGFR,gene,0.995,29368506
15874,AFPO,gene,0.783,29368506
15875,oxaliplatin,drug,0.9995,29368506
15876,tumor,disease,1.0,29368506
15877,AFPO,drug,0.981,29368506
15878,tumor,disease,1.0,29368506
15879,EGFR,gene,0.9883,29368506
15880,panitumumab,gene,0.9775,29368506
15881,oxaliplatin,drug,0.9995,29368506
15882,patients,species,0.9917,29353396
15883,healthcare,cell_type,0.4688,29353396
15884,patients,species,0.988,29353396
15885,Patients,species,0.993,29353396
15886,ipilimumab,drug,0.7554,29353396
15887,panitumumab,gene,0.606,29353396
15888,nurses,cell_type,0.4805,29353396
15889,patients,species,0.9937,29353396
15890,vomiting,disease,0.9146,29353396
15891,alopecia,disease,1.0,29353396
15892,fatigue,disease,0.999,29353396
15893,mood,disease,0.6465,29353396
15894,anxiety,disease,1.0,29353396
15895,hearing impairment,disease,1.0,29353396
15896,allergic reactions,disease,0.987,29353396
15897,patients,species,0.975,29353396
15898,cancer,disease,1.0,29353396
15899,cancer,disease,1.0,29353396
15900,EGFR,gene,0.994,29352306
15901,biliary cancer,disease,1.0,29352306
15902,anti-EGFR,gene,0.869,29352306
15903,gemcitabine,drug,0.9995,29352306
15904,oxaliplatin,drug,0.999,29352306
15905,GEMOX,drug,0.998,29352306
15906,biliary tract carcinoma,disease,1.0,29352306
15907,BTC,disease,1.0,29352306
15908,patients,species,0.985,29352306
15909,anti-EGFR,gene,0.8984,29352306
15910,EGFR extracellular domain,gene,0.992,29352306
15911,ECD,gene,0.794,29352306
15912,tyrosine,drug,0.992,29352306
15913,tyrosine kinase domain,gene,0.993,29352306
15914,TKD,gene,0.865,29352306
15915,EGFR,gene,0.992,29352306
15916,"exons 12, 18-21",DNA,0.8804,29352306
15917,tumors,disease,1.0,29352306
15918,EGFR,gene,0.988,29352306
15919,tumors,disease,1.0,29352306
15920,patients,species,0.985,29352306
15921,exon 12,DNA,0.8438,29352306
15922,EGFR ECD,gene,0.969,29352306
15923,EGFR TKD,gene,0.9316,29352306
15924,EGFR ECD,gene,0.9863,29352306
15925,TKD,DNA,0.567,29352306
15926,panitumumab,gene,0.9385,29352306
15927,GEMOX,drug,0.988,29352306
15928,GEMOX,drug,0.9917,29352306
15929,ECD,gene,0.5483,29352306
15930,patients,species,0.9873,29352306
15931,EGFR TKD,gene,0.971,29352306
15932,patients,species,0.988,29352306
15933,EGFR,gene,0.9937,29352306
15934,extrahepatic cholangiocarcinoma,disease,1.0,29352306
15935,ECC,disease,1.0,29352306
15936,patients,species,0.979,29352306
15937,tumors,disease,1.0,29352306
15938,EGFR,gene,0.994,29352306
15939,ECC,disease,0.9077,29352306
15940,EGFR,gene,0.9746,29352306
15941,patients,species,0.9863,29352306
15942,gallbladder carcinoma,disease,1.0,29352306
15943,patients,species,0.993,29352306
15944,BTC,cell_type,0.499,29352306
15945,BTC,disease,1.0,29352306
15946,EGFR,gene,0.9565,29352306
15947,panitumumab,gene,0.7944,29345521
15948,Panitumumab,gene,0.829,29345521
15949,EGFR,gene,0.9917,29345521
15950,metastatic colorectal cancer,disease,0.9893,29345521
15951,panitumumab,gene,0.6187,29345521
15952,cetuximab,gene,0.958,29343971
15953,panitumumab,gene,0.948,29343971
15954,cetuximab,gene,0.9595,29343971
15955,panitumumab,gene,0.93,29343971
15956,cetuximab,gene,0.954,29343971
15957,panitumumab,gene,0.9497,29343971
15958,metastatic colorectal cancer,disease,0.9995,29343971
15959,mCRC,disease,0.9995,29343971
15960,patients,species,0.9854,29343971
15961,PATIENTS,species,0.94,29343971
15962,patients,species,0.963,29343971
15963,patients,species,0.9795,29343971
15964,panitumumab,gene,0.7954,29343971
15965,troponin I,gene,0.997,29343971
15966,TNI,gene,0.9785,29343971
15967,patients,species,0.9893,29343971
15968,cetuximab,gene,0.838,29343971
15969,panitumumab,gene,0.7617,29343971
15970,palpitations,disease,1.0,29343971
15971,dyspnea,disease,1.0,29343971
15972,chest pain,disease,0.997,29343971
15973,arrhythmias,disease,1.0,29343971
15974,Rash,disease,0.986,29343971
15975,Cetuximab,gene,0.945,29343971
15976,panitumumab,gene,0.938,29343971
15977,mCRC,disease,0.991,29343971
15978,patients,species,0.9893,29343971
15979,cardiac,disease,0.589,29343971
15980,docetaxel,drug,0.9995,29340092
15981,cisplatin,drug,0.9995,29340092
15982,folinic acid,drug,0.999,29340092
15983,patients,species,0.966,29340092
15984,advanced gastroesophageal cancer,disease,1.0,29340092
15985,AGC,disease,1.0,29340092
15986,EGFR,gene,0.986,29340092
15987,AGC,disease,1.0,29340092
15988,panitumumab,gene,0.825,29340092
15989,HER2,gene,0.9907,29340092
15990,patients,species,0.9746,29340092
15991,panitumumab,gene,0.8193,29340092
15992,docetaxel,drug,0.9946,29340092
15993,cisplatin,drug,0.9995,29340092
15994,l-folinic acid,drug,0.9985,29340092
15995,5-FU,drug,0.9966,29340092
15996,pegfilgrastim,gene,0.9497,29340092
15997,Patients,species,0.9463,29340092
15998,panitumumab,gene,0.6655,29340092
15999,patients,species,0.979,29340092
16000,adenocarcinoma,disease,1.0,29340092
16001,leucopenia,disease,1.0,29340092
16002,asthenia,disease,1.0,29340092
16003,skin rash,disease,0.9995,29340092
16004,neutropenia,disease,1.0,29340092
16005,anorexia,disease,1.0,29340092
16006,febrile neutropenia,disease,1.0,29340092
16007,diarrhea,disease,1.0,29340092
16008,EGFR,gene,0.9946,29340092
16009,DCF,drug,0.85,29340092
16010,panitumumab,gene,0.7544,29340092
16011,AGC,disease,1.0,29340092
16012,EGFR,gene,0.9956,29338219
16013,(18)F,drug,0.9995,29338219
16014,tetrazine,drug,0.999,29338219
16015,EGFR,gene,0.996,29338219
16016,cetuximab,gene,0.6875,29338219
16017,panitumumab,gene,0.917,29338219
16018,cicatricial ectropion,disease,1.0,29336655
16019,EGFR,gene,0.99,29336655
16020,cicatricial ectropion,disease,1.0,29336655
16021,epidermal growth factor receptor,gene,0.9976,29336655
16022,EGFR,gene,0.997,29336655
16023,cicatricial ectropion,disease,1.0,29336655
16024,EGFR,gene,0.9966,29336655
16025,doxycycline,drug,0.9937,29336655
16026,steroid,drug,0.6978,29336655
16027,panitumumab,gene,0.9214,29336655
16028,cituximab,gene,0.859,29336655
16029,cicatricial ectropion,disease,0.9697,29336655
16030,EGFR,gene,0.989,29336655
16031,Ramucirumab,gene,0.536,29327066
16032,Multiple Haemangiomas of the Skin,disease,0.97,29327066
16033,BRAF,gene,0.997,29326440
16034,receptor tyrosine kinases,gene,0.998,29326440
16035,tyrosine,drug,0.6924,29326440
16036,BRAF,DNA,0.526,29326440
16037,BRAF mutations,gene,0.9136,29326440
16038,colorectal cancer,disease,1.0,29326440
16039,CRC,disease,1.0,29326440
16040,BRAF(V600E) oncoprotein,gene,0.9746,29326440
16041,V600E,mutation,,29326440
16042,BRAF mutant,gene,0.989,29326440
16043,BRAF-mutant CRC,disease,0.9946,29326440
16044,BRAF,gene,0.989,29326440
16045,epidermal growth factor receptor,gene,0.9976,29326440
16046,EGFR,gene,0.9966,29326440
16047,BRAF,gene,0.996,29326440
16048,MEK,gene,0.9927,29326440
16049,anti-EGFR antibodies cetuximab,gene,0.7944,29326440
16050,panitumumab,gene,0.7837,29326440
16051,BRAF,gene,0.9966,29326440
16052,receptor tyrosine kinases,gene,0.9966,29326440
16053,tyrosine,drug,0.987,29326440
16054,RTKs,gene,0.99,29326440
16055,CRC cell lines,cell_line,0.6787,29326440
16056,CRC,disease,1.0,29326440
16057,EGFR,gene,0.9897,29326440
16058,human epidermal growth factor receptor (HER) 2,gene,0.9966,29326440
16059,human,species,0.595,29326440
16060,HER3,gene,0.9917,29326440
16061,BRAF,gene,0.996,29326440
16062,BRAFi,gene,0.881,29326440
16063,vemurafenib,drug,0.9956,29326440
16064,PLX4032,drug,0.9995,29326440
16065,dabrafenib,drug,0.9976,29326440
16066,encorafenib,drug,0.981,29326440
16067,EGFR,gene,0.9907,29326440
16068,HER2,gene,0.983,29326440
16069,lapatinib,drug,0.999,29326440
16070,canertinib,drug,0.995,29326440
16071,afatinib,drug,0.996,29326440
16072,CRC cells,cell_line,0.9536,29326440
16073,CRC,disease,1.0,29326440
16074,HER2,gene,0.9946,29326440
16075,HER3,gene,0.988,29326440
16076,BRAF,gene,0.972,29326440
16077,RTKs,gene,0.99,29326440
16078,GRB2-associated binders (Gab) 1,gene,0.913,29326440
16079,Gab2,gene,0.9946,29326440
16080,RTK,gene,0.9927,29326440
16081,BRAF(V600E),gene,0.975,29326440
16082,V600E,mutation,,29326440
16083,Gab2,gene,0.9897,29326440
16084,Gab2,gene,0.995,29326440
16085,Gab2,gene,0.9966,29326440
16086,Shp2,gene,0.9946,29326440
16087,BRAFi,gene,0.9834,29326440
16088,RTK,gene,0.9854,29326440
16089,BRAF-mutant CRC,disease,0.7617,29326440
16090,BRAF,gene,0.9956,29326440
16091,Panitumumab,gene,0.9043,29323221
16092,Bevacizumab,gene,0.7285,29323221
16093,Panitumumab,gene,0.8896,29323221
16094,bevacizumab,gene,0.7905,29323221
16095,patients,species,0.9624,29323221
16096,wild type,disease,0.818,29323221
16097,metastatic colorectal cancer,disease,0.998,29323221
16098,mCRC,disease,0.999,29323221
16099,panitumumab,gene,0.966,29323221
16100,bevacizumab,gene,0.819,29323221
16101,panitumumab,gene,0.9297,29323221
16102,bevacizumab,gene,0.56,29323221
16103,RAS,gene,0.9727,29323221
16104,mCRC,disease,0.997,29323221
16105,patients,species,0.9907,29323221
16106,wild type RAS,gene,0.977,29323221
16107,patients,species,0.9644,29323221
16108,wild type RAS,gene,0.8955,29323221
16109,mCRC,disease,0.9907,29323221
16110,Panitumumab,gene,0.796,29314858
16111,(111)In,drug,0.998,29314858
16112,polyglutamide,drug,0.999,29314858
16113,PGlu,drug,0.78,29314858
16114,DOTA,drug,0.999,29314858
16115,"tetraazacyclododecane-1,4,7,10-tetraacetic acid",drug,1.0,29314858
16116,(111)In,drug,0.9985,29314858
16117,(,drug,0.798,29314858
16118,177)Lu,drug,0.9316,29314858
16119,polyethylene glycol,drug,0.9995,29314858
16120,PEG,drug,1.0,29314858
16121,antiepidermal growth factor receptor,gene,0.993,29314858
16122,EGFR,gene,0.9946,29314858
16123,panitumumab,gene,0.941,29314858
16124,panitumumab,gene,0.9805,29314858
16125,MCP,gene,0.903,29314858
16126,(111)In,drug,0.9985,29314858
16127,(177)Lu,drug,0.997,29314858
16128,panitumumab,gene,0.9814,29314858
16129,EGFR,gene,0.994,29314858
16130,PnCa,disease,0.8887,29314858
16131,hydrazine nicotinamide,drug,0.9985,29314858
16132,HyNIC,drug,0.999,29314858
16133,aryl aromatic aldehyde,drug,0.9985,29314858
16134,panitumumab,gene,0.7656,29314858
16135,succinimidyl-4-formylbenzamide,drug,0.998,29314858
16136,S-4FB,drug,0.998,29314858
16137,bis-aryl hydrazone,drug,0.9995,29314858
16138,panitumumab,gene,0.977,29314858
16139,panitumumab,gene,0.9683,29314858
16140,(111)In,drug,0.9985,29314858
16141,(177)Lu,drug,0.9976,29314858
16142,Panitumumab,gene,0.972,29314858
16143,DOTA,drug,0.9995,29314858
16144,DOTA,drug,0.9966,29314858
16145,(111)In,drug,0.9985,29314858
16146,(177)Lu,drug,0.9966,29314858
16147,Panitumumab,gene,0.9585,29314858
16148,(177)Lu,drug,0.9995,29314858
16149,EGFR-overexpressing MDA-MB-468 human breast cancer cells,cell_line,0.479,29314858
16150,EGFR,gene,0.995,29314858
16151,-overexpressing MDA-MB-468 human breast cancer cells,cell_type,0.5635,29314858
16152,human,species,0.9883,29314858
16153,panitumumab,gene,0.9644,29314858
16154,MCP,gene,0.808,29314858
16155,(177)Lu,drug,0.9985,29314858
16156,EGFR,gene,0.991,29314858
16157,panitumumab,gene,0.9077,29314858
16158,DOTA,drug,0.9995,29314858
16159,(177)Lu,drug,0.9995,29314858
16160,(111)In,drug,0.999,29314858
16161,177)Lu,drug,0.9976,29314858
16162,panitumumab,gene,0.972,29314858
16163,MCP,gene,0.9517,29314858
16164,Panitumumab,gene,0.961,29314858
16165,MCP,drug,0.926,29314858
16166,(111)In,drug,0.9995,29314858
16167,panitumumab,gene,0.979,29314858
16168,DOTA,drug,0.9995,29314858
16169,(111)In,drug,0.9995,29314858
16170,NOD,disease,0.994,29314858
16171,mice,species,0.95,29314858
16172,panitumumab,gene,0.9546,29314858
16173,MCP,gene,0.7773,29314858
16174,(111)In,drug,0.999,29314858
16175,mice,species,0.826,29314858
16176,EGFR-positive PANC-1 human,cell_line,0.8896,29314858
16177,EGFR,gene,0.995,29314858
16178,PANC-1,disease,0.754,29314858
16179,human,species,0.977,29314858
16180,(PnCa) xenografts,cell_line,0.4866,29314858
16181,(PnCa,disease,0.9893,29314858
16182,panitumumab,gene,0.9663,29314858
16183,DOTA,drug,0.9976,29314858
16184,(111)In,drug,0.9995,29314858
16185,panitumumab,gene,0.951,29314858
16186,(111)In,drug,0.999,29314858
16187,panitumumab,gene,0.9565,29314858
16188,(111)In,drug,0.9995,29314858
16189,panitumumab,gene,0.9375,29314858
16190,DOTA,drug,0.9995,29314858
16191,(11)In,drug,0.999,29314858
16192,panitumumab,gene,0.9766,29314858
16193,(111)In,drug,0.999,29314858
16194,panitumumab,gene,0.968,29314858
16195,DOTA,drug,1.0,29314858
16196,(111)In,drug,0.999,29314858
16197,panitumumab,gene,0.9795,29314858
16198,EGFR,gene,0.994,29314858
16199,IgG,gene,0.9976,29314858
16200,MCP,gene,0.795,29314858
16201,panitumumab,gene,0.97,29314858
16202,MCP,gene,0.8643,29314858
16203,IgG,gene,0.994,29314858
16204,tumor,disease,0.9966,29314858
16205,panitumumab,gene,0.984,29314858
16206,DOTA,drug,1.0,29314858
16207,(111)In,drug,0.999,29314858
16208,IgG,gene,0.995,29314858
16209,DOTA,drug,0.999,29314858
16210,(111)In,drug,0.9985,29314858
16211,PANC-1,cell_line,0.702,29314858
16212,PANC-1 tumors,disease,0.9805,29314858
16213,panitumumab,gene,0.958,29314858
16214,(111)In,drug,0.9995,29314858
16215,panitumumab,gene,0.964,29314858
16216,DOTA-(111)In,drug,0.989,29314858
16217,Tumors,disease,0.995,29314858
16218,panitumumab,gene,0.9185,29314858
16219,EGFR,gene,0.985,29314858
16220,IgG,gene,0.9956,29314858
16221,panitumumab,gene,0.963,29314858
16222,(111)In,drug,0.9985,29314858
16223,(177)Lu,drug,0.9985,29314858
16224,DOTA,drug,0.9995,29314858
16225,panitumumab,gene,0.9478,29314858
16226,EGFR,gene,0.9937,29314858
16227,tumor,disease,0.9863,29314858
16228,mice,species,0.9634,29314858
16229,PANC-1 human PnCa xenografts,cell_line,0.82,29314858
16230,human,species,0.997,29314858
16231,PnCa,disease,0.999,29314858
16232,Patient,species,0.987,29314360
16233,patients,species,0.95,29314360
16234,epidermal growth factor,gene,0.9966,29314360
16235,EGFRi,gene,0.97,29314360
16236,patient,species,0.955,29314360
16237,EGFRi,gene,0.971,29314360
16238,DMs,disease,0.9956,29314360
16239,patient,species,0.9927,29314360
16240,healthcare,cell_type,0.472,29314360
16241,patients,species,0.9673,29314360
16242,cetuximab,gene,0.768,29314360
16243,panitumumab,gene,0.771,29314360
16244,squamous cell carcinoma of head and neck,disease,1.0,29314360
16245,SCCHN,disease,1.0,29314360
16246,metastatic colorectal carcinoma,disease,0.998,29314360
16247,patients,species,0.954,29314360
16248,anorexia,disease,1.0,29314360
16249,dysphagia,disease,1.0,29314360
16250,oral pain,disease,0.997,29314360
16251,patients,species,0.9224,29314360
16252,EGFRi,gene,0.9385,29314360
16253,SCCHN,disease,1.0,29314360
16254,patients,species,0.987,29314360
16255,patient,species,0.9814,29314360
16256,mFOLFOX6,drug,0.9897,29311468
16257,KRAS,gene,0.9946,29311468
16258,colorectal cancer,disease,0.7354,29311468
16259,bevacizumab,gene,0.9487,29311468
16260,Bmab,gene,0.9575,29311468
16261,cetuximab,gene,0.9487,29311468
16262,Cmab,gene,0.947,29311468
16263,panitumumab,gene,0.9624,29311468
16264,Pmab,gene,0.939,29311468
16265,patients,species,0.974,29311468
16266,colorectal cancer,disease,0.9907,29311468
16267,Bmab,gene,0.789,29311468
16268,Cmab,gene,0.826,29311468
16269,mFOLFOX6,gene,0.986,29311468
16270,Cmab,gene,0.755,29311468
16271,mFOLFOX6,gene,0.992,29311468
16272,Pmab,gene,0.7925,29311468
16273,TP53,DNA,0.834,29298682
16274,TP53 mutations,gene,0.95,29298682
16275,anti-EGFR,gene,0.9727,29298682
16276,anti-VEGF,gene,0.946,29298682
16277,mCRC,disease,0.7944,29298682
16278,metastatic colorectal cancer,disease,1.0,29298682
16279,mCRC,disease,1.0,29298682
16280,tumour,disease,0.6724,29298682
16281,mCRC,disease,0.9966,29298682
16282,patients,species,0.992,29298682
16283,KRAS,gene,0.9624,29298682
16284,mCRC,disease,0.995,29298682
16285,patients,species,0.977,29298682
16286,right-sided tumours,disease,0.9995,29298682
16287,EGFR,gene,0.998,29298682
16288,vascular endothelial growth factor,gene,0.8545,29298682
16289,VEGF,gene,0.996,29298682
16290,patients,species,0.979,29298682
16291,left-sided tumours,disease,1.0,29298682
16292,anti-EGFR,gene,0.979,29298682
16293,VEGF,gene,0.9946,29298682
16294,tumour,disease,0.8853,29298682
16295,TP53,gene,0.9937,29298682
16296,mCRC,disease,0.989,29298682
16297,EGFR,gene,0.6616,29298682
16298,VEGF,gene,0.8076,29298682
16299,patients,species,0.985,29298682
16300,TP53 wild-,cell_type,0.4243,29298682
16301,TP53 wild-type tumours,disease,0.9365,29298682
16302,TP53 wild,gene,0.8477,29298682
16303,TP53,gene,0.995,29298682
16304,anti-EGFR,gene,0.958,29298682
16305,patients,species,0.9824,29298682
16306,TP53,gene,0.996,29298682
16307,mCRC,disease,0.9995,29298682
16308,TP53,DNA,0.7974,29298682
16309,TP53 mutant,gene,0.9604,29298682
16310,TP53,DNA,0.803,29298682
16311,TP53 wild,gene,0.901,29298682
16312,TP53 mutant,gene,0.9834,29298682
16313,TP53,gene,0.9937,29298682
16314,patients,species,0.951,29298682
16315,anti-EGFR,gene,0.7524,29298682
16316,VEGF,gene,0.633,29298682
16317,TP53,DNA,0.673,29298682
16318,TP53 mutation,gene,0.834,29298682
16319,anti-epidermal growth factor receptor,gene,0.9814,29289981
16320,Anti-,disease,0.5605,29289981
16321,Anti-epidermal growth factor receptor,gene,0.9473,29289981
16322,EGFR,gene,0.998,29289981
16323,skin rash,disease,0.976,29289981
16324,cancers,disease,1.0,29289981
16325,rash,disease,0.963,29289981
16326,biliary cancer,disease,1.0,29289981
16327,malignancy,disease,0.9995,29289981
16328,skin rash,disease,0.996,29289981
16329,EGFR,gene,0.5156,29289981
16330,biliary cancer,disease,1.0,29289981
16331,patients,species,0.9756,29289981
16332,advanced biliary cancer,disease,1.0,29289981
16333,rash,disease,0.9985,29289981
16334,EGFR,gene,0.9375,29289981
16335,skin rash,disease,1.0,29289981
16336,rash,disease,0.9106,29289981
16337,patients,species,0.994,29289981
16338,anti-EGFR,gene,0.832,29289981
16339,EGFR,gene,0.984,29289981
16340,skin rash,disease,1.0,29289981
16341,advanced biliary cancer,disease,1.0,29289981
16342,patients,species,0.99,29289981
16343,rash,disease,0.939,29289981
16344,EGFR,gene,0.653,29289981
16345,biliary cancer,disease,1.0,29289981
16346,tumor,disease,0.998,29289705
16347,tumor,disease,0.5728,29289705
16348,epidermal growth factor receptor,gene,0.9956,29289705
16349,EGFR,gene,0.997,29289705
16350,tumoricidal,disease,0.8887,29289705
16351,"[1,4-(13)C(2)] fumarate",drug,0.9995,29289705
16352,fumarate,drug,0.9634,29289705
16353,malate,drug,0.641,29289705
16354,EGFR-expressing A431 tumor xenografts,cell_line,0.881,29289705
16355,EGFR,gene,0.992,29289705
16356,tumor,disease,0.9844,29289705
16357,deoxyhemoglobin,gene,0.9863,29289705
16358,EGFR-expressing A431 tumor xenografts,cell_line,0.886,29289705
16359,EGFR,gene,0.993,29289705
16360,tumor,disease,0.8296,29289705
16361,tumors,disease,1.0,29289705
16362,doxycycline,drug,0.996,29285233
16363,erythromycin,drug,0.9985,29285233
16364,panitumumab,gene,0.879,29285233
16365,metastatic,disease,0.735,29285233
16366,colorectal cancer,disease,0.9487,29285233
16367,akne-like skin rash,disease,1.0,29285233
16368,epidermal growth factor receptor,gene,0.9756,29285233
16369,EGFR,gene,0.993,29285233
16370,tetracyclines,drug,0.9966,29285233
16371,tetracyclines,drug,0.999,29285233
16372,(K)Ras,gene,0.991,29285233
16373,panitumumab,gene,0.8013,29285233
16374,doxycycline,drug,0.9956,29285233
16375,erythromycin,drug,0.998,29285233
16376,doxycycline,drug,0.9917,29285233
16377,panitumumab,gene,0.9,29285233
16378,erythromycin,drug,0.9995,29285233
16379,erythromycin,drug,0.9985,29285233
16380,erythromycin,drug,0.999,29285233
16381,doxycycline,drug,0.996,29285233
16382,EGFR,gene,0.991,29285233
16383,skin toxicity,disease,0.9194,29285233
16384,Panitumumab,gene,0.7305,29259073
16385,RAS,gene,0.6978,29259073
16386,Panitumumab,gene,0.812,29259073
16387,RAS,gene,0.4836,29259073
16388,SBA,disease,1.0,29259073
16389,ampullary adenocarcinoma,disease,1.0,29259073
16390,AAC,disease,1.0,29259073
16391,SBA,disease,0.5576,29259073
16392,SBA,disease,0.4797,29259073
16393,intestinal malignancy,disease,1.0,29259073
16394,colorectal cancer,disease,1.0,29259073
16395,SBA,disease,1.0,29259073
16396,AAC,disease,1.0,29259073
16397,epidermal growth factor receptor,gene,0.9985,29259073
16398,EGFR,gene,0.994,29259073
16399,colorectal cancer,disease,1.0,29259073
16400,CRC,disease,1.0,29259073
16401,panitumumab,gene,0.849,29259073
16402,RAS,gene,0.4854,29259073
16403,small bowel adenocarcinoma,disease,0.9697,29259073
16404,SBA,disease,1.0,29259073
16405,ampullary adenocarcinoma,disease,1.0,29259073
16406,AAC,disease,1.0,29259073
16407,Panitumumab,gene,0.84,29259073
16408,AAC,disease,1.0,29259073
16409,SBA,disease,1.0,29259073
16410,Acneiform rash,disease,1.0,29259073
16411,RAS,DNA,0.587,29259073
16412,RAS mutations,gene,0.7827,29259073
16413,exons 2/3/4,DNA,0.8325,29259073
16414,BRAF,DNA,0.5034,29259073
16415,BRAF G469A,gene,0.8516,29259073
16416,G469A,DNA,,29259073
16417,G469A,mutation,,29259073
16418,PIK3CA H1074R,gene,0.789,29259073
16419,H1074R,DNA,,29259073
16420,H1074R,mutation,,29259073
16421,Panitumumab,gene,0.6123,29259073
16422,RAS,gene,0.985,29259073
16423,SBA,disease,0.706,29259073
16424,AAC,disease,1.0,29259073
16425,Cancer,disease,0.999,29237807
16426,Duocarmycin,drug,0.998,29237807
16427,tumor,disease,1.0,29237807
16428,heptamethine cyanine,drug,0.9956,29237807
16429,panitumumab,gene,0.9795,29237807
16430,pan,gene,0.886,29237807
16431,CyEt,drug,0.72,29237807
16432,panitumumab,gene,0.931,29237807
16433,duocarmycin,drug,0.9985,29237807
16434,EGFR-expressing MDAMB468 cell line,cell_line,0.866,29237807
16435,EGFR,gene,0.9863,29237807
16436,tumor,disease,0.8584,29237807
16437,tumor,disease,1.0,29237807
16438,mice,species,0.924,29237807
16439,Tumor,disease,0.9663,29237807
16440,Natural killer cells,cell_type,0.9106,29204427
16441,metastatic colorectal cancer,disease,1.0,29204427
16442,patient,species,0.9795,29204427
16443,man,species,0.845,29204427
16444,fluorouracile,drug,0.991,29204427
16445,folinic acid,drug,0.999,29204427
16446,oxaliplatin,drug,0.999,29204427
16447,stage IIIb adenocarcinoma,disease,0.872,29204427
16448,abdominal lymphnodes,disease,0.6997,29204427
16449,carcinoembryonic antigen,gene,0.996,29204427
16450,CEA,gene,0.992,29204427
16451,capecitabine,drug,0.9995,29204427
16452,oxaliplatin,drug,0.9995,29204427
16453,bevacizumab,gene,0.703,29204427
16454,CEA,gene,0.985,29204427
16455,patient,species,0.983,29204427
16456,bevacizumab,gene,0.5654,29204427
16457,patient,species,0.934,29204427
16458,CEA,gene,0.991,29204427
16459,RAS,gene,0.996,29204427
16460,patient,species,0.984,29204427
16461,fluorouracile,drug,0.999,29204427
16462,folinic acid,drug,0.9985,29204427
16463,irinotecan,drug,0.997,29204427
16464,folfiri,drug,0.9956,29204427
16465,panitumumab,gene,0.5273,29204427
16466,CEA,gene,0.984,29204427
16467,folfiri,drug,0.9927,29204427
16468,panitumumab,gene,0.7593,29204427
16469,patient,species,0.9937,29204427
16470,CEA,gene,0.951,29204427
16471,patient,species,0.954,29204427
16472,circulating natural killer (NK) cells,cell_type,0.8657,29204427
16473,tumor cells,cell_type,0.8447,29204427
16474,tumor,disease,1.0,29204427
16475,NK,cell_line,,29204427
16476,patients,species,0.9697,29204427
16477,advanced colorectal cancer,disease,0.9995,29204427
16478,Actinic Keratosis,disease,1.0,29187286
16479,Panitumumab,gene,0.8184,29187286
16480,Panitumumab,gene,0.8706,29183279
16481,metastatic colorectal cancer,disease,1.0,29183279
16482,RAS,gene,0.8374,29183279
16483,metastatic colorectal cancer,disease,1.0,29183279
16484,mCRC,disease,1.0,29183279
16485,panitumumab,gene,0.7495,29183279
16486,RAS wild,DNA,0.5854,29183279
16487,RAS wild-type mutation,gene,0.853,29183279
16488,panitumumab,gene,0.8696,29183279
16489,RAS,DNA,0.588,29183279
16490,KRAS,gene,0.8657,29183279
16491,exon 2,DNA,0.837,29183279
16492,RAS,gene,0.6777,29183279
16493,"exons 2, 3, 4",DNA,0.8315,29183279
16494,KRAS,gene,0.8545,29183279
16495,NRAS,gene,0.778,29183279
16496,KRAS,gene,0.895,29183279
16497,RAS,gene,0.764,29183279
16498,panitumumab,gene,0.898,29183279
16499,mCRC,disease,0.9995,29183279
16500,panitumumab,gene,0.724,29183279
16501,RAS,gene,0.6694,29183279
16502,mCRC,disease,0.9917,29183279
16503,KRAS,gene,0.873,29183279
16504,KRAS,gene,0.829,29183279
16505,RAS,gene,0.5557,29183279
16506,panitumumab,gene,0.6465,29183279
16507,KRAS,gene,0.879,29183279
16508,RAS,gene,0.828,29183279
16509,KRAS,gene,0.888,29183279
16510,panitumumab,gene,0.8477,29183279
16511,KRAS,gene,0.7954,29183279
16512,RAS,gene,0.994,29183279
16513,mCRC,disease,0.9907,29183279
16514,RAS,gene,0.847,29183279
16515,fatigue,disease,0.997,29181651
16516,cancer,disease,1.0,29181651
16517,anti-EGFR monoclonal antibodies,gene,0.9204,29181651
16518,fatigue,disease,0.9995,29181651
16519,anti-epidermal growth factor receptor monoclonal antibodies,gene,0.985,29181651
16520,anti-EGFR MAbs,gene,0.9775,29181651
16521,fatigue,disease,0.998,29181651
16522,anti-EGFR MAbs,gene,0.85,29181651
16523,fatigue,disease,0.9985,29181651
16524,anti-EGFR MAbs,gene,0.7437,29181651
16525,fatigue,disease,0.982,29181651
16526,anti-,gene,0.5186,29181651
16527,EGFR,gene,0.53,29181651
16528,fatigue,disease,0.983,29181651
16529,fatigue,disease,0.9893,29181651
16530,anti-EGFR MAbs,gene,0.9478,29181651
16531,tumor,disease,1.0,29181651
16532,fatigue,disease,0.971,29181651
16533,anti-EGFR MAbs,gene,0.7725,29181651
16534,fatigue,disease,0.9985,29181651
16535,cancer,disease,1.0,29181651
16536,panitumumab,gene,0.8384,29170802
16537,patient,species,0.9297,29170802
16538,chronic kidney disease,disease,1.0,29170802
16539,panitumumab,gene,0.8936,29170802
16540,cancer,disease,1.0,29170802
16541,patients,species,0.983,29170802
16542,renal insufficiency,disease,1.0,29170802
16543,metastatic colorectal cancer,disease,1.0,29170802
16544,patient,species,0.981,29170802
16545,chronic kidney injury,disease,1.0,29170802
16546,patients,species,0.9824,29170802
16547,patient,species,0.969,29170802
16548,kidney failure,disease,1.0,29170802
16549,patients,species,0.986,29170802
16550,patient,species,0.9897,29170802
16551,panitumumab,gene,0.8555,29170802
16552,cancer,disease,1.0,29170802
16553,patients,species,0.9863,29170802
16554,renal impairment,disease,1.0,29170802
16555,irinotecan,drug,0.9966,29169974
16556,KRAS,gene,0.9946,29169974
16557,metastatic colorectal cancer,disease,0.9937,29169974
16558,mCRC,disease,1.0,29169974
16559,panitumumab,gene,0.957,29169974
16560,PATIENTS,species,0.934,29169974
16561,patients,species,0.9688,29169974
16562,KRAS,DNA,0.761,29169974
16563,KRAS,gene,0.994,29169974
16564,mCRC,disease,0.997,29169974
16565,irinotecan,drug,0.9995,29169974
16566,fluoropyrimidine,drug,0.999,29169974
16567,oxaliplatin,drug,1.0,29169974
16568,patients,species,0.9775,29169974
16569,panitumumab,gene,0.7964,29169974
16570,irinotecan,drug,0.983,29169974
16571,panitumumab,gene,0.9473,29169974
16572,Solid Tumors,disease,0.7754,29169974
16573,patients,species,0.982,29169974
16574,anorexia,disease,1.0,29169974
16575,leukopenia,disease,1.0,29169974
16576,neutropenia,disease,1.0,29169974
16577,patients,species,0.992,29169974
16578,panitumumab,gene,0.9663,29169974
16579,patients,species,0.93,29169974
16580,KRAS,gene,0.9976,29169974
16581,oxaliplatin,drug,0.999,29169974
16582,irinotecan,drug,0.9995,29169974
16583,mCRC,disease,0.9805,29169974
16584,Necitumumab,gene,0.8804,29158469
16585,EGFR Variants,gene,0.9546,29158469
16586,cetuximab,gene,0.6836,29158469
16587,EGFR,gene,0.9917,29158469
16588,colorectal cancers,disease,1.0,29158469
16589,cetuximab,gene,0.8223,29158469
16590,cetuximab epitope,gene,0.937,29158469
16591,EGFR,gene,0.996,29158469
16592,necitumumab,gene,0.918,29158469
16593,EGFR antibody,gene,0.93,29158469
16594,EGFR,gene,0.9956,29158469
16595,cetuximab,gene,0.8867,29158469
16596,S468,mutation,,29158469
16597,S492,mutation,,29158469
16598,amino acid,drug,0.9995,29158469
16599,necitumumab Fab,gene,0.9937,29158469
16600,S468R,DNA,0.595,29158469
16601,S468R variant,gene,0.7554,29158469
16602,S468,mutation,,29158469
16603,EGFR domain III,gene,0.962,29158469
16604,arginine,drug,0.9946,29158469
16605,necitumumab paratope,gene,0.8623,29158469
16606,necitumumab,gene,0.9834,29158469
16607,cetuximab,gene,0.982,29158469
16608,panitumumab,gene,0.935,29158469
16609,EGFR variants,gene,0.977,29158469
16610,EGFR epitope,gene,0.769,29158469
16611,necitumumab,gene,0.889,29158469
16612,EGFR,gene,0.9927,29158469
16613,necitumumab,gene,0.914,29158469
16614,patients,species,0.993,29158469
16615,cetuximab,gene,0.732,29158469
16616,panitumumab,gene,0.7695,29158469
16617,EGFR epitope,gene,0.96,29158469
16618,Luciferase,gene,0.995,29135265
16619,Luciferin,gene,0.8696,29135265
16620,cancer,disease,1.0,29135265
16621,luciferase,gene,0.9966,29135265
16622,luciferin,gene,0.682,29135265
16623,A431-luc-GFP cells,cell_line,0.898,29135265
16624,GFP,gene,0.957,29135265
16625,tumors,disease,1.0,29135265
16626,mouse,species,0.9478,29135265
16627,EGFR,gene,0.9956,29135265
16628,panitumumab,gene,0.879,29135265
16629,tumor,disease,0.8687,29135265
16630,mice,species,0.9946,29135265
16631,luciferase,gene,0.996,29135265
16632,luciferin,gene,0.845,29135265
16633,green fluorescent protein,gene,0.9897,29135265
16634,GFP,gene,0.9775,29135265
16635,mice,species,0.9683,29135265
16636,luciferase,gene,0.9946,29135265
16637,luciferin,drug,0.514,29135265
16638,GFP,gene,0.9873,29135265
16639,GFP,gene,0.5093,29135265
16640,luciferase,gene,0.993,29135265
16641,luciferase,gene,0.996,29135265
16642,luciferin,drug,0.7065,29135265
16643,GFP,gene,0.9604,29135265
16644,tumor,disease,0.9995,29135265
16645,luciferase,gene,0.9956,29135265
16646,luciferin,drug,0.973,29135265
16647,luciferase,gene,0.9956,29135265
16648,luciferin,drug,0.9883,29135265
16649,GFP,gene,0.9844,29135265
16650,IGF-1R,gene,0.923,29123263
16651,metastatic colorectal cancer,disease,0.9995,29123263
16652,metastatic colorectal cancer,disease,1.0,29123263
16653,mCRC,disease,1.0,29123263
16654,insulin-like growth factor-1 receptor,gene,0.999,29123263
16655,IGF-1R,gene,0.9966,29123263
16656,mCRC,disease,0.998,29123263
16657,RAS,gene,0.7583,29123263
16658,BRAF,gene,0.7627,29123263
16659,p-IGF-1R,gene,0.996,29123263
16660,metastatic CRC,disease,0.995,29123263
16661,IGF-1R,gene,0.9927,29123263
16662,CRC,disease,0.999,29123263
16663,Nuclear IGF-1R,gene,0.8374,29123263
16664,metastatic tumours,disease,0.9995,29123263
16665,primary tumours,disease,0.9893,29123263
16666,mCRC,disease,0.999,29123263
16667,chemo-resistant cell lines,cell_line,0.9604,29123263
16668,IGF-1R,gene,0.9985,29123263
16669,PIAS3,gene,0.994,29123263
16670,IGF-1R,gene,0.9976,29123263
16671,PIAS3,gene,0.992,29123263
16672,ganitumab,gene,0.679,29123263
16673,IGF-1R,gene,0.9985,29123263
16674,dasatinib,drug,0.9927,29123263
16675,SRC,gene,0.994,29123263
16676,IGF-1R,gene,0.9985,29123263
16677,IGF-1R,gene,0.998,29123263
16678,hepatocellular carcinoma,disease,1.0,29113030
16679,hepatocellular carcinoma,disease,1.0,29113030
16680,HCC,disease,1.0,29113030
16681,Yttrium 90,drug,0.9863,29113030
16682,90Y,drug,0.984,29113030
16683,HCC,disease,0.996,29113030
16684,HCC,disease,0.9966,29113030
16685,HCC,disease,0.9956,29113030
16686,Human Fc receptor-like 5,gene,0.998,29101848
16687,Human,species,0.7114,29101848
16688,IgG2 disulfide isoforms,gene,0.705,29101848
16689,disulfide,drug,0.9956,29101848
16690,Human Fc receptor-like 5,gene,0.9985,29101848
16691,Human,species,0.9043,29101848
16692,FCRL5,gene,0.9956,29101848
16693,IgG receptor,gene,0.994,29101848
16694,IgG2,gene,0.996,29101848
16695,FCRL5,gene,0.9814,29101848
16696,IgG2 molecule,gene,0.9233,29101848
16697,IgG2,gene,0.997,29101848
16698,FCRL5,gene,0.979,29101848
16699,disulfide,drug,0.9995,29101848
16700,panitumumab,gene,0.9717,29101848
16701,denosumab,gene,0.934,29101848
16702,disulfide,drug,0.99,29101848
16703,FCRL5,gene,0.967,29101848
16704,B isoform,RNA,0.5273,29101848
16705,FCRL5,gene,0.991,29101848
16706,panitumumab,gene,0.833,29101848
16707,panitumumab,gene,0.9707,29101848
16708,FCRL5,gene,0.987,29101848
16709,panitumumab,gene,0.9746,29101848
16710,FCRL5,gene,0.99,29101848
16711,IgG2 disulfide,gene,0.8003,29101848
16712,disulfide,drug,0.998,29101848
16713,FCRL5,gene,0.986,29101848
16714,FCRL5,gene,0.986,29101848
16715,IgG2 molecule,gene,0.8857,29101848
16716,disulfide,drug,0.9985,29101848
16717,IgG2,gene,0.997,29101848
16718,disulfide,drug,0.9976,29101848
16719,FCRL5,gene,0.9224,29101848
16720,Patients,species,0.9707,29096990
16721,RAS,gene,0.995,29096990
16722,patients,species,0.979,29096990
16723,metastatic colorectal cancer,disease,1.0,29096990
16724,mCRC,disease,1.0,29096990
16725,patients,species,0.9883,29096990
16726,fibrosarcoma murine sarcoma viral oncogene,DNA,0.5703,29096990
16727,fibrosarcoma,disease,0.929,29096990
16728,fibrosarcoma murine sarcoma viral oncogene homolog B,gene,0.8667,29096990
16729,murine,species,0.5845,29096990
16730,homolog B,DNA,0.817,29096990
16731,BRAF,gene,0.9995,29096990
16732,PATIENTS,species,0.967,29096990
16733,Panitumumab,gene,0.9155,29096990
16734,Metastatic Colorectal Cancer,disease,1.0,29096990
16735,panitumumab,gene,0.8843,29096990
16736,rat sarcoma viral oncogene homolog (RAS,DNA,0.521,29096990
16737,rat sarcoma viral oncogene homolog,gene,0.999,29096990
16738,rat,species,0.917,29096990
16739,RAS,gene,0.997,29096990
16740,RAS,gene,0.992,29096990
16741,BRAF,gene,0.9966,29096990
16742,mCRC,disease,0.9966,29096990
16743,BRAF mutant (,cell_line,0.6426,29096990
16744,BRAF mutant,disease,0.921,29096990
16745,BRAF,gene,0.9746,29096990
16746,mCRC,disease,0.996,29096990
16747,patients,species,0.9727,29096990
16748,BRAF,gene,0.9927,29096990
16749,mCRC,disease,0.997,29096990
16750,RAS,gene,0.9976,29096990
16751,BRAF,gene,0.9985,29096990
16752,patients,species,0.9604,29096990
16753,RAS,gene,0.995,29096990
16754,BRAF,gene,0.994,29096990
16755,mCRC,disease,0.9956,29096990
16756,panitumumab,gene,0.8667,29096990
16757,patients,species,0.9478,29096990
16758,BRAF,gene,0.9854,29096990
16759,mCRC,disease,0.9985,29096990
16760,patients,species,0.964,29096990
16761,RAS,gene,0.9946,29096990
16762,BRAF,gene,0.9976,29096990
16763,mCRC,disease,0.993,29096990
16764,RAS,DNA,0.766,29096990
16765,RAS WT,gene,0.9956,29096990
16766,mCRC,disease,0.999,29096990
16767,BRAF,gene,0.9624,29096990
16768,mCRC,disease,0.9756,29096990
16769,Panitumumab,gene,0.8467,29096990
16770,RAS,gene,0.9976,29096990
16771,RAS,gene,0.9937,29096990
16772,BRAF,gene,0.997,29096990
16773,mCRC,disease,0.9956,29096990
16774,tumour,disease,1.0,29080924
16775,tumour,disease,0.9995,29080924
16776,patients,species,0.964,29080924
16777,RAS,gene,0.9893,29080924
16778,metastatic colorectal cancer,disease,1.0,29080924
16779,mCRC,disease,1.0,29080924
16780,panitumumab,gene,0.916,29080924
16781,patients,species,0.9775,29080924
16782,ETS,gene,0.99,29080924
16783,DpR,gene,0.9463,29080924
16784,ETS,gene,0.9937,29080924
16785,DpR,gene,0.9873,29080924
16786,patients,species,0.9785,29080924
16787,RAS,gene,0.997,29080924
16788,mCRC,disease,0.999,29080924
16789,Patients,species,0.922,29080924
16790,panitumumab,gene,0.733,29080924
16791,panitumumab,gene,0.838,29080924
16792,panitumumab,gene,0.7495,29080924
16793,WT BRAF,gene,0.9243,29080924
16794,patients,species,0.889,29080924
16795,DpR,DNA,0.813,29080924
16796,DpR,DNA,0.864,29080924
16797,panitumumab,gene,0.8667,29080924
16798,patients,species,0.8906,29080924
16799,RAS,DNA,0.6377,29080924
16800,RAS WT,gene,0.995,29080924
16801,mCRC,disease,0.9966,29080924
16802,Tumor HER3 Messenger RNA,gene,0.804,29075780
16803,Panitumumab,gene,0.8125,29075780
16804,Epidermal growth factor receptor,gene,0.9985,29075780
16805,EGFR,gene,0.997,29075780
16806,HER1,gene,0.992,29075780
16807,HER receptors,gene,0.995,29075780
16808,EGFR ligand,gene,0.876,29075780
16809,panitumumab,gene,0.756,29075780
16810,advanced colorectal cancer,disease,0.9995,29075780
16811,HER3,gene,0.9785,29075780
16812,RAS wild-type,gene,0.9375,29075780
16813,EGFR,gene,0.789,29075780
16814,HER3 messenger RNA,gene,0.9937,29075780
16815,EGFR,gene,0.9443,29075780
16816,panitumumab,gene,0.8413,29075780
16817,PARTICIPANTS,species,0.5737,29075780
16818,panitumumab,gene,0.826,29075780
16819,irinotecan,drug,0.999,29075780
16820,patients,species,0.967,29075780
16821,KRAS,DNA,0.8003,29075780
16822,KRAS wt,gene,0.9956,29075780
16823,advanced colorectal cancer,disease,0.9995,29075780
16824,fluoropyrimidine,drug,0.9976,29075780
16825,HER3,gene,0.9766,29075780
16826,patients,species,0.9766,29075780
16827,RAS,gene,0.996,29075780
16828,MEK,gene,0.9966,29075780
16829,AKT,gene,0.996,29075780
16830,EGFR,gene,0.9956,29075780
16831,epiregulin,gene,0.8433,29075780
16832,amphiregulin,gene,0.9805,29075780
16833,EREG,gene,0.9976,29075780
16834,AREG,gene,0.998,29075780
16835,patients,species,0.967,29075780
16836,men,species,0.938,29075780
16837,HER3,gene,0.9844,29075780
16838,HER3,gene,0.989,29075780
16839,irinotecan,drug,0.999,29075780
16840,panitumumab,gene,0.8765,29075780
16841,IrPan,drug,0.845,29075780
16842,irinotecan,drug,0.9976,29075780
16843,patients,species,0.976,29075780
16844,RAS wt,gene,0.9956,29075780
16845,HER3,gene,0.991,29075780
16846,panitumumab,gene,0.8257,29075780
16847,patients,species,0.9844,29075780
16848,HER3,gene,0.9917,29075780
16849,IrPan,drug,0.957,29075780
16850,irinotecan,drug,0.999,29075780
16851,Patients,species,0.954,29075780
16852,HER3,gene,0.9873,29075780
16853,IrPan,drug,0.9814,29075780
16854,irinotecan,drug,0.9995,29075780
16855,HER3,gene,0.9956,29075780
16856,patients,species,0.9756,29075780
16857,HER3,gene,0.9985,29075780
16858,AREG,gene,0.993,29075780
16859,EREG,gene,0.9985,29075780
16860,tumors,disease,0.999,29075780
16861,panitumumab,gene,0.5337,29075780
16862,patients,species,0.9854,29075780
16863,HER3,gene,0.9946,29075780
16864,AREG,gene,0.99,29075780
16865,EREG,gene,0.998,29075780
16866,tumors,disease,0.926,29075780
16867,HER3,gene,0.9937,29075780
16868,patients,species,0.988,29075780
16869,RAS wt,gene,0.9946,29075780
16870,panitumumab,gene,0.7256,29075780
16871,EGFR,gene,0.959,29075780
16872,DNA,DNA,0.4236,29075194
16873,Colorectal Cancer,disease,1.0,29075194
16874,Colorectal cancer,disease,1.0,29075194
16875,CRC,disease,1.0,29075194
16876,cancer,disease,1.0,29075194
16877,patients,species,0.974,29075194
16878,CRC,disease,0.5225,29075194
16879,5-fluorouracil,drug,0.9995,29075194
16880,capecitabine,drug,0.9995,29075194
16881,irinotecan,drug,0.9995,29075194
16882,oxaliplatin,drug,0.9995,29075194
16883,bevacizumab,gene,0.8643,29075194
16884,cetuximab,gene,0.9243,29075194
16885,panitumumab,gene,0.9565,29075194
16886,vemurafenib,drug,0.998,29075194
16887,dabrafenib,drug,0.999,29075194
16888,patients,species,0.967,29075194
16889,advanced CRC,disease,0.988,29075194
16890,patients,species,0.9917,29075194
16891,patient,species,0.9927,29075194
16892,patient,species,0.985,29075194
16893,germline pharmacogenomics DNA variants,DNA,0.8345,29075194
16894,germline variants,DNA,0.644,29075194
16895,codon location,DNA,0.641,29075194
16896,participants,species,0.949,29073892
16897,metastatic colorectal cancer,disease,1.0,29073892
16898,mCRC,disease,1.0,29073892
16899,patients,species,0.981,29073892
16900,cetuximab,gene,0.965,29073892
16901,panitumumab,gene,0.9575,29073892
16902,aflibercept,gene,0.9404,29073892
16903,Cetuximab,gene,0.912,29073892
16904,panitumumab,gene,0.9067,29073892
16905,aflibercept,gene,0.983,29073892
16906,FOLFIRI,drug,0.668,29073892
16907,participants,species,0.9404,29073892
16908,mCRC,disease,0.9995,29073892
16909,participants,species,0.974,29073892
16910,participants,species,0.95,29073892
16911,Anti-EGFR Antibody,gene,0.9517,29066705
16912,ascending colon cancer,disease,0.977,29066705
16913,EGFR,gene,0.8213,29066705
16914,recurrent,disease,0.9507,29066705
16915,cancer,disease,0.978,29066705
16916,man,species,0.9346,29066705
16917,ascending colon cancer,disease,1.0,29066705
16918,cancer,disease,0.9995,29066705
16919,wild-type KRAS gene,gene,0.993,29066705
16920,cetuximab,gene,0.5063,29066705
16921,colon cancer,disease,0.999,29066705
16922,FOLFOX6,drug,0.9956,29066705
16923,colon cancer,disease,0.995,29066705
16924,panitumumab,gene,0.6523,29066705
16925,tumor,disease,0.781,29066705
16926,anti-EGFR antibody,gene,0.805,29066705
16927,colon cancer,disease,0.9785,29066705
16928,Rectal Cancer,disease,1.0,29062621
16929,colorectal cancer,disease,1.0,29062621
16930,woman,species,0.87,29062621
16931,headaches,disease,0.9976,29062621
16932,constipation,disease,1.0,29062621
16933,cancer,disease,1.0,29062621
16934,primary rectal carcinoma,disease,0.9927,29062621
16935,leucovorin,drug,1.0,29062621
16936,fluorouracil,drug,0.9995,29062621
16937,oxaliplatin,drug,0.9995,29062621
16938,panitumumab,gene,0.5693,29062621
16939,cancer,disease,1.0,29062621
16940,Anti-Epidermal Growth Factor Receptor Antibody,gene,0.994,29061833
16941,anti-epidermal growth factor receptor,gene,0.9927,29061833
16942,EGFR,gene,0.997,29061833
16943,metastatic colorectal cancer,disease,1.0,29061833
16944,mCRC,disease,0.9985,29061833
16945,PATIENTS,species,0.959,29061833
16946,anti-EGFR antibody,gene,0.935,29061833
16947,mCRC,disease,0.9995,29061833
16948,patients,species,0.9893,29061833
16949,anti-EGFR antibody,gene,0.8926,29061833
16950,patients,species,0.9624,29061833
16951,anti-EGFR antibody,gene,0.902,29061833
16952,patients,species,0.992,29061833
16953,Anti-,gene,0.639,29061833
16954,EGFR antibody,gene,0.7666,29061833
16955,cetuximab,gene,0.5264,29061833
16956,panitumumab,gene,0.9106,29061833
16957,capecitabine,drug,0.999,29061833
16958,S-1,drug,0.938,29061833
16959,patients,species,0.9844,29061833
16960,panitumumab,gene,0.6284,29061833
16961,FOLFOX,drug,0.988,29061833
16962,patients,species,0.9844,29061833
16963,cetuximab,gene,0.5547,29061833
16964,irinotecan,drug,0.9985,29061833
16965,patients,species,0.991,29061833
16966,panitumumab,gene,0.9116,29061833
16967,patient,species,0.9893,29061833
16968,patients,species,0.9927,29061833
16969,patients,species,0.9893,29061833
16970,Patients,species,0.984,29061833
16971,EGFR,gene,0.65,29061833
16972,anti-EGFR antibody,gene,0.9673,29061833
16973,Anti-EGFR antibody,gene,0.802,29061833
16974,mCRC,disease,0.996,29061833
16975,patients,species,0.9907,29061833
16976,EGFR,gene,0.7144,29024937
16977,RAS,gene,0.9814,29024937
16978,Metastatic colorectal cancer,disease,1.0,29024937
16979,mCRC,disease,1.0,29024937
16980,mutant KRAS,gene,0.7876,29024937
16981,KRAS,DNA,0.4631,29024937
16982,NRAS,gene,0.7046,29024937
16983,anti-,gene,0.562,29024937
16984,epidermal growth factor receptor,gene,0.925,29024937
16985,anti-EGFR,gene,0.848,29024937
16986,RAS,gene,0.4954,29024937
16987,EGFR,gene,0.993,29024937
16988,RAS,gene,0.979,29024937
16989,EGFR,gene,0.9004,29024937
16990,anti-EGFR,gene,0.9536,29024937
16991,RAS WT,gene,0.847,29024937
16992,mCRC,disease,0.998,29024937
16993,EGFR,gene,0.9414,29024937
16994,EGFR,gene,0.998,29024937
16995,HER3,gene,0.9907,29024937
16996,EGFR,gene,0.997,29024937
16997,PI3K,gene,0.997,29024937
16998,MAPK,gene,0.988,29024937
16999,EGFR,gene,0.7056,29024937
17000,mCRC,disease,0.774,29024937
17001,ErbB2/3,gene,0.8623,29024937
17002,Wnt,gene,0.76,29024937
17003,EGFR,gene,0.8267,29024937
17004,right-sided mCRC,disease,0.736,29024937
17005,EGFR,gene,0.9976,29024937
17006,PI3K,gene,0.993,29024937
17007,EGFR,gene,0.916,29024937
17008,mCRC,disease,0.9976,29024937
17009,RAS,DNA,0.511,29024937
17010,RAS WT,gene,0.8394,29024937
17011,mCRC,disease,0.994,29024937
17012,EGFR,gene,0.7837,29024937
17013,Metastatic Colorectal Cancer,disease,1.0,29022151
17014,Metastatic colorectal cancer,disease,1.0,29022151
17015,mCRC,disease,1.0,29022151
17016,mCRC,disease,0.9995,29022151
17017,PATIENTS,species,0.973,29022151
17018,aflibercept,gene,0.989,29022151
17019,bevacizumab,gene,0.8745,29022151
17020,cetuximab,gene,0.8853,29022151
17021,panitumumab,gene,0.914,29022151
17022,regorafenib,drug,0.9897,29022151
17023,CRC,disease,0.9995,29022151
17024,anticancer,disease,0.8896,29022151
17025,ICSRs,disease,0.999,29022151
17026,ICSRs,disease,0.8364,29022151
17027,Neutropenia,disease,1.0,29022151
17028,diarrhea,disease,1.0,29022151
17029,panitumumab,gene,0.8125,29022151
17030,Cardiac disorders,disease,1.0,29022151
17031,heart failure,disease,1.0,29022151
17032,bevacizumab,gene,0.866,29022151
17033,cetuximab,gene,0.7373,29022151
17034,regorafenib,drug,0.99,29022151
17035,mediastinal disorders,disease,1.0,29022151
17036,encephalopathies,disease,1.0,29022151
17037,bevacizumab,gene,0.8613,29022151
17038,mCRC,disease,0.994,29022151
17039,Metastatic Colorectal Cancer,disease,0.9995,29021377
17040,metastatic colorectal cancer,disease,1.0,29021377
17041,mCRC,disease,1.0,29021377
17042,mCRC,disease,0.9976,29021377
17043,irinotecan,drug,0.9995,29021377
17044,oxaliplatin,drug,0.9995,29021377
17045,5-fluorouracil,drug,0.9995,29021377
17046,capecitabine,drug,0.9995,29021377
17047,TAS-102,drug,0.9985,29021377
17048,mCRC,disease,0.9277,29021377
17049,rat sarcoma viral oncogene homolog,gene,0.644,29021377
17050,rat,species,0.8984,29021377
17051,RAS,gene,0.9927,29021377
17052,mCRC,disease,0.9917,29021377
17053,anti-epidermal growth factor receptor antibodies cetuximab,gene,0.8965,29021377
17054,panitumumab,gene,0.8057,29021377
17055,bevacizumab,gene,0.6724,29021377
17056,ziv-aflibercept,gene,0.985,29021377
17057,RAS,gene,0.4995,29021377
17058,mCRC,disease,0.988,29021377
17059,Regorafenib,drug,0.9976,29021377
17060,RAS,gene,0.797,29021377
17061,mCRC,disease,0.999,29021377
17062,mCRC,disease,0.995,29021377
17063,metastatic colorectal cancer,disease,1.0,29021377
17064,mCRC,disease,1.0,29021377
17065,mCRC,disease,0.9946,29021377
17066,drug resistant colorectal cancer cell populations,cell_line,0.8315,28981524
17067,drug resistant,cell_type,0.575,28981524
17068,colorectal cancer,disease,1.0,28981524
17069,tumor,disease,1.0,28981524
17070,anti,disease,0.908,28981524
17071,cancer,disease,0.61,28981524
17072,cells,cell_type,0.3933,28981524
17073,patients,species,0.955,28981524
17074,metastatic colorectal cancer,disease,1.0,28981524
17075,mCRC,disease,1.0,28981524
17076,CRCs,cell_line,0.8403,28981524
17077,CRCs,cell_line,0.817,28981524
17078,tumors,disease,1.0,28981524
17079,patients,species,0.9443,28981524
17080,CRC,disease,1.0,28981524
17081,MT-KRAS DNA,gene,0.9385,28981524
17082,tumors,disease,1.0,28981524
17083,cells,cell_type,0.7266,28981524
17084,MT,DNA,0.9062,28981524
17085,MT-KRAS,gene,0.9966,28981524
17086,anti-EGFR,gene,0.893,28981524
17087,epidermal growth factor receptor,gene,0.995,28981524
17088,tumor,disease,0.9995,28981524
17089,panitumumab,gene,0.8315,28981524
17090,MT,DNA,,28981524
17091,MT-KRAS,gene,0.9956,28981524
17092,MT-KRAS cells,cell_line,0.9526,28981524
17093,MT-KRAS,gene,0.881,28981524
17094,anti-EGFR antibodies,gene,0.9595,28981524
17095,WT-KRAS cells,cell_line,0.9653,28981524
17096,WT-,cell_type,0.7676,28981524
17097,WT-KRAS,gene,0.9355,28981524
17098,tumor,disease,0.9736,28981524
17099,tumor,disease,1.0,28981524
17100,cancer-associated cachexia,disease,0.9404,28981524
17101,anti-EGFR antibodies,gene,0.962,28978055
17102,human,species,0.99,28978055
17103,Cetuximab,gene,0.891,28978055
17104,panitumumab,gene,0.8877,28978055
17105,RAS,gene,0.9854,28978055
17106,Wild,cell_line,0.593,28978055
17107,metastatic colorectal cancers,disease,1.0,28978055
17108,mCRCs,disease,1.0,28978055
17109,patients,species,0.985,28978055
17110,epidermal growth factor receptor,gene,0.998,28978055
17111,EGFR,gene,0.998,28978055
17112,human,species,0.937,28978055
17113,mouse,species,0.9062,28978055
17114,EGFR,gene,0.9917,28978055
17115,CRC models,cell_line,0.869,28978055
17116,CRC,disease,0.9985,28978055
17117,cetuximab,gene,0.7993,28978055
17118,SYM004,drug,0.556,28978055
17119,CRC cell lines,cell_line,0.9424,28978055
17120,CRC,disease,0.9995,28978055
17121,cetuximab,gene,0.805,28978055
17122,MET,gene,0.996,28978055
17123,SYM004,drug,0.99,28978055
17124,MET,gene,0.996,28978055
17125,AKT,gene,0.997,28978055
17126,MAPK,gene,0.9263,28978055
17127,resistant models,cell_line,0.5713,28978055
17128,SYM004,drug,0.974,28978055
17129,EGFR,gene,0.9946,28978055
17130,MET,gene,0.988,28978055
17131,TGF,gene,0.9927,28978055
17132,SYM004,drug,0.5103,28978055
17133,cetuximab,gene,0.6924,28978055
17134,CRC,disease,1.0,28978055
17135,cetuximab,gene,0.9697,28978055
17136,tumors,disease,0.893,28978055
17137,mice,species,0.976,28978055
17138,mice,species,0.9653,28978055
17139,EGFR,gene,0.667,28978055
17140,mCRC,disease,0.992,28978055
17141,MET,gene,0.9956,28978055
17142,BRAF,gene,0.9976,28972961
17143,V600E,DNA,0.767,28972961
17144,V600E,mutation,,28972961
17145,Patients,species,0.932,28972961
17146,BRAF(V600E,gene,0.783,28972961
17147,V600E,mutation,,28972961
17148,metastatic colorectal cancer,disease,1.0,28972961
17149,mCRC,disease,1.0,28972961
17150,anti-,gene,0.9214,28972961
17151,EGFR antibodies,gene,0.8145,28972961
17152,BRAF,gene,0.998,28972961
17153,BRAF,DNA,0.69,28972961
17154,BRAF(V600E),gene,0.86,28972961
17155,V600E,mutation,,28972961
17156,BRAF,gene,0.9976,28972961
17157,V600E,mutation,,28972961
17158,anti-EGFR antibody,gene,0.834,28972961
17159,patients,species,0.9775,28972961
17160,anti-EGFR antibody,gene,0.924,28972961
17161,KRAS,gene,0.9897,28972961
17162,NRAS,gene,0.997,28972961
17163,BRAF,gene,0.998,28972961
17164,patients,species,0.9907,28972961
17165,patients,species,0.996,28972961
17166,RAS,gene,0.992,28972961
17167,patients,species,0.9917,28972961
17168,BRAF,DNA,0.5176,28972961
17169,BRAF(V600E),gene,0.8335,28972961
17170,V600E,mutation,,28972961
17171,patients,species,0.9893,28972961
17172,BRAF,gene,0.9956,28972961
17173,V600E,DNA,0.6436,28972961
17174,V600E,mutation,,28972961
17175,RAS,gene,0.9966,28972961
17176,BRAF,gene,0.998,28972961
17177,V600E,mutation,,28972961
17178,BRAF(non-V600E),gene,0.7485,28972961
17179,V600E,mutation,,28972961
17180,RAS,gene,0.998,28972961
17181,BRAF,gene,0.999,28972961
17182,BRAF,gene,0.998,28972961
17183,V600E,mutation,,28972961
17184,RAS,gene,0.9907,28972961
17185,BRAF,DNA,0.7446,28972961
17186,BRAF(V600E,gene,0.72,28972961
17187,V600E,mutation,,28972961
17188,RAS,gene,0.9614,28972961
17189,/,DNA,0.6436,28972961
17190,BRAF,gene,0.997,28972961
17191,BRAF,DNA,0.6606,28972961
17192,BRAF(non-V600E),gene,0.874,28972961
17193,V600E,DNA,0.7603,28972961
17194,V600E,mutation,,28972961
17195,BRAF,DNA,0.7866,28972961
17196,BRAF(non-V600E),gene,0.9673,28972961
17197,V600E,mutation,,28972961
17198,anti-EGFR monoclonal antibody,gene,0.925,28972961
17199,EGFR,gene,0.61,28950807
17200,patient,species,0.9834,28950807
17201,anti-,gene,0.575,28950807
17202,EGFR,gene,0.652,28950807
17203,hypomagnesemia,disease,1.0,28950807
17204,woman,species,0.8457,28950807
17205,mCRC,disease,0.978,28950807
17206,cetuximab,gene,0.9004,28950807
17207,patient,species,0.986,28950807
17208,hypomagnesemia,disease,1.0,28950807
17209,amiloride,drug,0.999,28950807
17210,magnesium,drug,0.999,28950807
17211,patient,species,0.9863,28950807
17212,panitumumab,gene,0.6865,28950807
17213,panitumumab,gene,0.8306,28950807
17214,EGFR,gene,0.665,28950807
17215,patient,species,0.9824,28950807
17216,Hypomagnesemia,disease,1.0,28950807
17217,EGFR,gene,0.6025,28950807
17218,anti-,gene,0.7397,28950807
17219,EGFR,gene,0.685,28950807
17220,hypomagnesemia,disease,1.0,28950807
17221,tumor,disease,1.0,28945848
17222,rat sarcoma (RAS) genes,DNA,0.9146,28945848
17223,rat sarcoma,disease,0.685,28945848
17224,rat,species,0.58,28945848
17225,RAS,gene,0.9697,28945848
17226,epidermal growth factor receptor,gene,0.997,28945848
17227,patients,species,0.9766,28945848
17228,Tumor,disease,0.9077,28945848
17229,cell-free DNA,DNA,0.614,28945848
17230,panitumumab,gene,0.96,28945848
17231,irinotecan,drug,0.995,28945848
17232,patients,species,0.96,28945848
17233,metastatic colorectal cancer,disease,0.9995,28945848
17234,mCRC,disease,0.9946,28945848
17235,tumor,disease,0.999,28945848
17236,RAS mutations,gene,0.8745,28945848
17237,cell,RNA,0.641,28945848
17238,mutant RAS,DNA,0.591,28945848
17239,mutant RAS,gene,0.9937,28945848
17240,plasma,cell_type,0.5137,28945848
17241,patients,species,0.989,28945848
17242,RAS mutations,gene,0.9663,28945848
17243,patients,species,0.9844,28945848
17244,plasma samples,cell_type,0.5933,28945848
17245,RAS mutations,DNA,0.745,28945848
17246,RAS mutations,gene,0.9854,28945848
17247,mutant RAS,DNA,0.685,28945848
17248,mutant RAS allele,gene,0.919,28945848
17249,mCRC,disease,0.998,28945848
17250,tumor,disease,0.999,28945848
17251,mCRC,disease,0.9976,28945848
17252,Dermopathy,disease,1.0,28932126
17253,cetuximab,gene,0.904,28932126
17254,panitumumab,gene,0.8276,28932126
17255,skin exsiccation,disease,0.9263,28932126
17256,epidermal growth factor receptor,gene,0.9985,28932126
17257,EGFR,gene,0.994,28932126
17258,skin exsiccation,disease,0.9907,28932126
17259,EGFR,gene,0.988,28932126
17260,cancer,disease,1.0,28932126
17261,PATIENTS,species,0.888,28932126
17262,colorectal or head and neck cancer,disease,1.0,28932126
17263,cetuximab,gene,0.9233,28932126
17264,panitumumab,gene,0.9043,28932126
17265,EGFR,gene,0.99,28932126
17266,EGFR,gene,0.994,28932126
17267,EGFR,gene,0.9854,28932126
17268,horny,cell_type,0.4614,28932126
17269,acneiform rash,disease,1.0,28932126
17270,EGFR,gene,0.9883,28932126
17271,EGFR,gene,0.992,28932126
17272,dry skin,disease,0.9414,28932126
17273,EGFR,gene,0.995,28932126
17274,human,species,0.9863,28913158
17275,(89)Zr,drug,0.9995,28913158
17276,panitumumab,gene,0.841,28913158
17277,(89)Zr,drug,0.999,28913158
17278,panitumumab,gene,0.7583,28913158
17279,humanized IgG2 antibody,gene,0.8184,28913158
17280,humanized,species,0.7314,28913158
17281,panitumumab,gene,0.7705,28913158
17282,EGFR,gene,0.9893,28913158
17283,panitumumab,gene,0.9233,28913158
17284,EGFR,gene,0.988,28913158
17285,tumors,disease,1.0,28913158
17286,metastatic lesions,disease,0.9956,28913158
17287,patients,species,0.976,28913158
17288,patients,species,0.9736,28913158
17289,metastatic colon cancer,disease,1.0,28913158
17290,(89)Zr,drug,0.9995,28913158
17291,panitumumab,gene,0.798,28913158
17292,mice,species,0.962,28913158
17293,(89)Zr,drug,0.9995,28913158
17294,panitumumab,gene,0.862,28913158
17295,Panitumumab,gene,0.856,28870789
17296,RAS Wild-type Rectal Cancer,disease,0.989,28870789
17297,RAS,gene,0.4905,28870789
17298,anti-,gene,0.957,28870789
17299,epidermal growth factor receptor monoclonal,gene,0.8345,28870789
17300,panitumumab,gene,0.687,28870789
17301,cetuximab,gene,0.5396,28870789
17302,rectal cancer,disease,1.0,28870789
17303,epidermal growth factor receptor,gene,0.998,28870789
17304,panitumumab,gene,0.889,28870789
17305,RAS,gene,0.588,28870789
17306,locally advanced rectal cancer,disease,0.9326,28870789
17307,RAS,gene,0.562,28870789
17308,rectal cancer,disease,1.0,28870789
17309,tumor,disease,0.969,28870789
17310,tumor,disease,0.9917,28870789
17311,diarrhea,disease,0.999,28870789
17312,Panitumumab,gene,0.8516,28870789
17313,locally advanced rectal cancer,disease,0.9995,28870789
17314,Epidermal Growth Factor Receptor,gene,0.998,28853050
17315,Panitumumab,gene,0.437,28853050
17316,Colorectal Cancer,disease,1.0,28853050
17317,metastatic colorectal cancer,disease,1.0,28853050
17318,mCRC,disease,1.0,28853050
17319,Panitumumab,gene,0.728,28853050
17320,epidermal growth factor receptor,gene,0.996,28853050
17321,EGFR,gene,0.9883,28853050
17322,mCRC,disease,0.9976,28853050
17323,Panitumumab,gene,0.7026,28853050
17324,wild-type (WT),gene,0.8096,28853050
17325,RAS,gene,0.6016,28853050
17326,mCRC,disease,0.975,28853050
17327,RAS,DNA,0.699,28853050
17328,RAS mutations,gene,0.945,28853050
17329,anti-,gene,0.947,28853050
17330,EGFR antibodies,gene,0.751,28853050
17331,Panitumumab,gene,0.8257,28853050
17332,panitumumab,gene,0.711,28853050
17333,mCRC,disease,0.741,28853050
17334,metastatic colorectal cancer,disease,0.999,28844343
17335,metastatic colorectal cancer,disease,1.0,28844343
17336,mCRC,disease,1.0,28844343
17337,Colorectal cancer,disease,1.0,28844343
17338,CRC,disease,1.0,28844343
17339,mCRC,disease,0.9985,28844343
17340,bevacizumab,gene,0.927,28844343
17341,cetuximab,gene,0.8413,28844343
17342,panitumumab,gene,0.7524,28844343
17343,regorafenib,drug,0.988,28844343
17344,aflibercept,gene,0.9272,28844343
17345,mCRC,disease,0.995,28844343
17346,hypertension,disease,1.0,28844343
17347,heart failure,disease,1.0,28844343
17348,creatinine,drug,0.9985,28844343
17349,mCRC,disease,0.9883,28844343
17350,mCRC,disease,0.9966,28844343
17351,KRAS,gene,0.8105,28811946
17352,BRAF,DNA,0.4539,28811946
17353,BRAF Mutations,gene,0.955,28811946
17354,Metastatic Colon Adenocarcinoma,disease,1.0,28811946
17355,abdominal pain,disease,0.997,28811946
17356,nausea,disease,0.998,28811946
17357,fatigue,disease,0.997,28811946
17358,constipation,disease,1.0,28811946
17359,iron deficiency anemia,disease,0.995,28811946
17360,iron,drug,0.9995,28811946
17361,transaminitis,disease,1.0,28811946
17362,hepatomegaly,disease,1.0,28811946
17363,hepatic metastases,disease,0.9614,28811946
17364,pelvic lymphadenopathy,disease,0.997,28811946
17365,adenocarcinoma,disease,1.0,28811946
17366,pan-cytokeratin,gene,0.9766,28811946
17367,CMA5,gene,0.971,28811946
17368,villin,gene,0.993,28811946
17369,CDX2,gene,0.4949,28811946
17370,CA 19-9,gene,0.9746,28811946
17371,CA-125,gene,0.983,28811946
17372,CEA,gene,0.9927,28811946
17373,colorectal cancer,disease,1.0,28811946
17374,KRAS,gene,0.747,28811946
17375,BRAF,DNA,0.6304,28811946
17376,BRAF mutations,gene,0.946,28811946
17377,KRAS,gene,0.695,28811946
17378,BRAF,DNA,0.633,28811946
17379,BRAF mutations,gene,0.847,28811946
17380,Panitumumab,gene,0.8306,28811946
17381,Cetuximab,gene,0.9043,28811946
17382,wild type KRAS,gene,0.6616,28811946
17383,CRC,disease,0.815,28811946
17384,Vemurafenib,drug,0.999,28811946
17385,mutant BRAF,gene,0.996,28811946
17386,BRAF mutated,disease,0.9907,28811946
17387,BRAF,gene,0.5024,28811946
17388,colon cancer,disease,0.8945,28811946
17389,Vemurafenib,drug,0.9985,28811946
17390,colorectal cancers,disease,1.0,28811946
17391,Carboplatin,drug,0.9995,28762849
17392,Pemetrexed,drug,0.9995,28762849
17393,Panitumumab,gene,0.6294,28762849
17394,Patients,species,0.9883,28762849
17395,panitumumab,gene,0.793,28762849
17396,patients,species,0.948,28762849
17397,advanced,disease,0.599,28762849
17398,KRAS,gene,0.9424,28762849
17399,non-squamous NSCLC,disease,0.991,28762849
17400,Patients,species,0.926,28762849
17401,panitumumab,gene,0.8154,28762849
17402,pemetrexed,drug,0.9995,28762849
17403,carboplatin,drug,0.998,28762849
17404,panitumumab,gene,0.91,28762849
17405,pemetrexed,drug,0.999,28762849
17406,patients,species,0.9863,28762849
17407,Panitumumab,gene,0.8853,28762849
17408,skin rash,disease,0.9995,28762849
17409,panitumumab,gene,0.939,28762849
17410,Anti-,gene,0.911,28752777
17411,EGFR monoclonal,gene,0.7285,28752777
17412,patients,species,0.981,28752777
17413,metastatic colorectal cancer,disease,1.0,28752777
17414,mCRC,disease,0.999,28752777
17415,Panitumumab,gene,0.7485,28752777
17416,human,species,0.929,28752777
17417,epidermal growth factor receptor,gene,0.996,28752777
17418,EGFR,gene,0.9946,28752777
17419,patients,species,0.9824,28752777
17420,RAS gene,gene,0.99,28752777
17421,EGFR,gene,0.8696,28752777
17422,panitumumab,gene,0.833,28752777
17423,RAS wild,cell_line,0.549,28752777
17424,RAS wild-type (WT) tumors,disease,0.9663,28752777
17425,RAS,gene,0.979,28752777
17426,panitumumab,gene,0.7065,28752777
17427,anti-EGFR,gene,0.8384,28752777
17428,tumor,disease,0.945,28752777
17429,BRAF,DNA,0.766,28752777
17430,BRAF,gene,0.9907,28752777
17431,panitumumab,gene,0.9395,28752777
17432,Panitumumab,gene,0.874,28752777
17433,RAS,gene,0.995,28752777
17434,mCRC,disease,0.994,28752777
17435,panitumumab,gene,0.761,28752777
17436,patients,species,0.9575,28752777
17437,mCRC,disease,0.994,28752777
17438,panitumumab,gene,0.871,28752777
17439,Panitumumab,gene,0.722,28750125
17440,Panitumumab,gene,0.722,28750114
17441,gastrointestinal cancers,disease,1.0,28736637
17442,cancer,disease,1.0,28736637
17443,gastrointestinal cancers,disease,1.0,28736637
17444,vascular endothelial growth factor,gene,0.999,28736637
17445,VEGF,gene,0.9956,28736637
17446,epidermal growth factor receptor,gene,0.997,28736637
17447,EGFR,gene,0.992,28736637
17448,colon cancer,disease,1.0,28736637
17449,bevacizumab,gene,0.68,28736637
17450,cetuximab,gene,0.844,28736637
17451,panitumumab,gene,0.876,28736637
17452,colorectal cancers,disease,1.0,28736637
17453,Human epidermal growth factor receptor 2,gene,0.998,28736637
17454,HER2,gene,0.9893,28736637
17455,gastroesophageal cancers,disease,1.0,28736637
17456,HER2,gene,0.6953,28736637
17457,trastuzumab,gene,0.9487,28736637
17458,Metastatic Colorectal Cancer,disease,1.0,28712098
17459,PART 1,gene,0.9487,28712098
17460,Epidermal Growth Factor Receptor,gene,0.9985,28712098
17461,Vascular Endothelial Growth Factor,gene,0.9976,28712098
17462,metastatic colorectal cancer,disease,1.0,28712098
17463,metastatic colorectal cancer,disease,0.8223,28712098
17464,fluoropyrimidine,drug,0.998,28712098
17465,oxaliplatin,drug,0.9995,28712098
17466,irinotecan,drug,0.9985,28712098
17467,epidermal growth factor receptor,gene,0.9976,28712098
17468,EGFR,gene,0.994,28712098
17469,cetuximab,gene,0.84,28712098
17470,panitumumab,gene,0.9116,28712098
17471,vascular endothelial growth factor,gene,0.998,28712098
17472,VEGF,gene,0.997,28712098
17473,bevacizumab,gene,0.7256,28712098
17474,ziv-aflibercept,gene,0.9634,28712098
17475,regorafenib,drug,0.9683,28712098
17476,Bevacizumab,gene,0.884,28712098
17477,VEGF,gene,0.9966,28712098
17478,EGFR,gene,0.987,28712098
17479,RAS,gene,0.992,28712098
17480,BRAF wild-type tumors,disease,0.829,28712098
17481,BRAF,gene,0.988,28712098
17482,Tumor,disease,0.8535,28712098
17483,tumor,disease,0.977,28712098
17484,left-sided primary tumors,disease,0.943,28712098
17485,EGFR,gene,0.994,28712098
17486,right-sided primary tumors,disease,0.946,28712098
17487,EGFR,gene,0.9946,28712098
17488,VEGF,gene,0.994,28712098
17489,esophageal-gastric junction adenocarcinoma,disease,1.0,28708307
17490,bevacizumab,gene,0.61,28708307
17491,rilotumumab,gene,0.4932,28708307
17492,panitumumab,gene,0.8765,28708307
17493,cetuximab,gene,0.838,28708307
17494,trebananib,drug,0.997,28708307
17495,trastuzumab,gene,0.9336,28708307
17496,matuzumab,gene,0.8765,28708307
17497,esophageal-gastric junction adenocarcinoma,disease,1.0,28708307
17498,EGJA,disease,1.0,28708307
17499,EGJA,disease,0.999,28708307
17500,EGJA,disease,1.0,28708307
17501,Cetuximab,gene,0.894,28708307
17502,trastuzumab,gene,0.9673,28708307
17503,EGJA,disease,1.0,28708307
17504,EGJA,disease,0.9995,28708307
17505,EGJA,disease,0.9995,28708307
17506,Colorectal Cancer,disease,1.0,28708103
17507,metastatic colorectal cancer,disease,0.988,28708103
17508,CRC,disease,1.0,28708103
17509,epidermal growth factor receptor,gene,0.9624,28708103
17510,anti-EGFR,gene,0.7627,28708103
17511,cetuximab,gene,0.898,28708103
17512,panitumumab,gene,0.907,28708103
17513,bevacizumab,gene,0.7427,28708103
17514,regorafeninb,gene,0.711,28708103
17515,aflibercept,gene,0.9683,28708103
17516,CRC,disease,0.9995,28708103
17517,MAPK,gene,0.9976,28708103
17518,mitogen-activated protein kinase,gene,0.9985,28708103
17519,PI3K,gene,0.998,28708103
17520,AKT,gene,0.994,28708103
17521,phosphatidylinositol,drug,0.9995,28708103
17522,3-kinase,gene,0.987,28708103
17523,AKT serine/threonine kinase,gene,0.9453,28708103
17524,serine,drug,0.775,28708103
17525,threonine,drug,0.867,28708103
17526,mTOR,gene,0.9946,28708103
17527,mammalian target of rapamycin,gene,0.9473,28708103
17528,rapamycin,drug,0.9893,28708103
17529,HER-2 and 3,gene,0.9985,28708103
17530,human epidermal growth factor receptor-2 and -3,gene,0.9927,28708103
17531,BRAF,gene,0.897,28708103
17532,tumor,disease,1.0,28708103
17533,tumor,disease,0.9907,28708103
17534,RAS,gene,0.995,28708103
17535,RAF,gene,0.997,28708103
17536,EGFR,gene,0.9443,28708103
17537,EGFR pathway genes,gene,0.844,28708103
17538,tumor,disease,1.0,28708103
17539,circulating tumor DNA,DNA,0.818,28708103
17540,tumor,disease,0.9995,28708103
17541,cetuximab,gene,0.858,28682222
17542,Colorectal cancer,disease,1.0,28682222
17543,cancer,disease,1.0,28682222
17544,breast,disease,0.986,28682222
17545,lung and prostate cancer,disease,1.0,28682222
17546,People,species,0.877,28682222
17547,EGFR,gene,0.9966,28682222
17548,cetuximab,gene,0.811,28682222
17549,panitumumab,gene,0.866,28682222
17550,panitumumab,gene,0.8403,28682222
17551,cetuximab,gene,0.8374,28682222
17552,rat sarcoma,cell_line,0.594,28682222
17553,rat,species,0.9883,28682222
17554,sarcoma,disease,0.7036,28682222
17555,RAS,gene,0.9863,28682222
17556,patients,species,0.9785,28682222
17557,metastatic colorectal cancer,disease,0.9985,28682222
17558,cetuximab,gene,0.8604,28682222
17559,panitumumab,gene,0.851,28682222
17560,participants,species,0.9414,28682222
17561,colorectal cancer,disease,1.0,28682222
17562,RAS WT,gene,0.9976,28682222
17563,panitumumab,gene,0.942,28682222
17564,irinotecan,drug,0.9946,28682222
17565,folinic acid,drug,0.9995,28682222
17566,5-fluorouracil,drug,0.9995,28682222
17567,irinotecan,drug,0.998,28682222
17568,patients,species,0.9697,28682222
17569,RAS WT,DNA,0.835,28682222
17570,RAS WT,gene,0.997,28682222
17571,EGFR,gene,0.9634,28682222
17572,patients,species,0.982,28682222
17573,RAS,DNA,0.7983,28682222
17574,RAS WT,gene,0.997,28682222
17575,RAS,DNA,0.524,28682222
17576,RAS WT,gene,0.9946,28682222
17577,patients,species,0.985,28682222
17578,cetuximab,gene,0.888,28682222
17579,oxaliplatin,drug,0.9995,28682222
17580,folinic acid,drug,0.9966,28682222
17581,5-fluorouracil,drug,0.999,28682222
17582,oxaliplatin,drug,0.999,28682222
17583,FOLFOX,drug,0.8984,28682222
17584,FOLFOX,drug,0.788,28682222
17585,panitumumab,gene,0.825,28682222
17586,FOLFOX,drug,0.709,28682222
17587,FOLFOX,drug,0.5405,28682222
17588,cetuximab,gene,0.7544,28682222
17589,FOLFIRI,drug,0.763,28682222
17590,FOLFIRI,drug,0.69,28682222
17591,patients,species,0.991,28682222
17592,RAS,DNA,0.5303,28682222
17593,RAS WT,gene,0.9946,28682222
17594,panitumumab,gene,0.9126,28682222
17595,FOLFIRI,drug,0.948,28682222
17596,FOLFOX,drug,0.9443,28682222
17597,FOLFIRI,drug,0.8438,28682222
17598,cetuximab,gene,0.898,28682222
17599,panitumumab,gene,0.8584,28682222
17600,RAS,gene,0.9937,28682222
17601,patients,species,0.976,28682222
17602,patients,species,0.9824,28682222
17603,RAS,DNA,0.639,28682222
17604,RAS,gene,0.975,28682222
17605,RAS mutations,gene,0.7007,28665451
17606,colon tumor,disease,0.9976,28665451
17607,metastases,cell_type,0.4436,28665451
17608,K- and N-RAS,DNA,0.757,28665451
17609,K- and N-RAS mutations,gene,0.937,28665451
17610,metastatic colorectal cancer,disease,0.9976,28665451
17611,RAS,gene,0.993,28665451
17612,anti-EGFR monoclonal antibodies,gene,0.9336,28665451
17613,cetuximab,gene,0.7236,28665451
17614,panitumumab,gene,0.777,28665451
17615,metastatic sigmoid cancer,disease,1.0,28665451
17616,adenocarcinoma,disease,0.991,28665451
17617,KRAS,gene,0.8223,28665451
17618,exon 2,DNA,0.4907,28665451
17619,KRAS gene,gene,0.8936,28665451
17620,FOLFOX6,drug,0.589,28665451
17621,bevacizumab,gene,0.6685,28665451
17622,liver metastases,disease,0.7476,28665451
17623,colic adenocarcinoma,disease,1.0,28665451
17624,coagulative necrosis,disease,0.8604,28665451
17625,KRAS gene,gene,0.8867,28665451
17626,GGT,RNA,0.4673,28665451
17627,exon 2,DNA,0.628,28665451
17628,KRAS mutation,gene,0.5205,28665451
17629,primary tumor,disease,0.9814,28665451
17630,KRAS,DNA,0.8315,28665451
17631,KRAS-WT,gene,0.941,28665451
17632,liver,disease,0.9785,28665451
17633,tumor cells,cell_type,0.8564,28665451
17634,tumor,disease,0.7563,28665451
17635,tumor,disease,0.9565,28665451
17636,exon 2 KRAS gene,DNA,0.6284,28665451
17637,exon 2,RNA,0.466,28665451
17638,colorectal cancer,disease,1.0,28665451
17639,anti-EGFR monoclonal antibody,gene,0.9556,28665451
17640,panitumumab,gene,0.8667,28633089
17641,FOLFOX4,drug,0.7495,28633089
17642,FOLFIRI,drug,0.5137,28633089
17643,colorectal cancer,disease,1.0,28633089
17644,wild,disease,0.5864,28633089
17645,viral oncogene homologue,DNA,0.7603,28633089
17646,KRAS,gene,0.995,28633089
17647,metastatic colorectal cancer,disease,1.0,28633089
17648,mCRC,disease,1.0,28633089
17649,panitumumab,gene,0.918,28633089
17650,Pmab,gene,0.9526,28633089
17651,FOLFOX,drug,0.984,28633089
17652,folinic acid,drug,0.9995,28633089
17653,5-fluorouracil,drug,0.999,28633089
17654,oxaliplatin,drug,0.9995,28633089
17655,FOLFIRI,drug,0.923,28633089
17656,folinic acid,drug,0.9995,28633089
17657,5-fluorouracil,drug,0.9995,28633089
17658,irinotecan,drug,0.999,28633089
17659,patients,species,0.9536,28633089
17660,(WT)-KRAS,gene,0.898,28633089
17661,mCRC,disease,0.6387,28633089
17662,liver-limited disease,disease,0.9995,28633089
17663,LLD,disease,1.0,28633089
17664,FOLFOX4,drug,0.9395,28633089
17665,FOLFIRI,drug,0.964,28633089
17666,liver metastases,disease,0.9014,28633089
17667,RAS,DNA,0.65,28633089
17668,RAS,gene,0.994,28633089
17669,tumour,disease,0.979,28633089
17670,WT-RAS,gene,0.942,28633089
17671,patients,species,0.9927,28633089
17672,patients,species,0.979,28633089
17673,WT,DNA,,28633089
17674,WT-RAS,gene,0.8223,28633089
17675,RAS,DNA,0.512,28633089
17676,FOLFOX4,drug,0.905,28633089
17677,FOLFIRI,drug,0.947,28633089
17678,WT,DNA,0.9727,28633089
17679,WT-RAS,gene,0.9614,28633089
17680,RAS,DNA,0.486,28633089
17681,WT,DNA,0.9565,28633089
17682,WT-RAS,gene,0.9873,28633089
17683,WT,DNA,0.9575,28633089
17684,WT-RAS,gene,0.9893,28633089
17685,FOLFIRI,drug,0.7905,28633089
17686,FOLFOX4,drug,0.8813,28633089
17687,WT-RAS,gene,0.995,28633089
17688,WT,DNA,,28633089
17689,WT-RAS,gene,0.9814,28633089
17690,WT,cell_line,,28633089
17691,WT-RAS,gene,0.9854,28633089
17692,patients,species,0.99,28633089
17693,patients,species,0.977,28633089
17694,patients,species,0.958,28633089
17695,neutropenia,disease,0.999,28633089
17696,neuropathy,disease,1.0,28633089
17697,patients,species,0.9385,28633089
17698,WT-KRAS,gene,0.7734,28633089
17699,mCRC,disease,0.813,28633089
17700,LLD,disease,1.0,28633089
17701,Panitumumab,gene,0.621,28629896
17702,Non-Small Cell Lung,disease,0.9966,28629896
17703,Cancer,disease,0.9917,28629896
17704,NSCLC,disease,0.9985,28629896
17705,EGFR,gene,0.9897,28629896
17706,panitumumab,gene,0.8223,28629896
17707,NSCLC,disease,0.645,28629896
17708,carboplatin,drug,0.999,28629896
17709,paclitaxel,drug,0.999,28629896
17710,panitumumab,gene,0.7593,28629896
17711,carboplatin,drug,0.9985,28629896
17712,paclitaxel,drug,0.9883,28629896
17713,panitumumab,gene,0.8193,28629896
17714,panitumumab,gene,0.9326,28629896
17715,panitumumab,gene,0.889,28629896
17716,panitumumab,gene,0.923,28629896
17717,panitumumab,gene,0.9146,28629896
17718,panitumumab,gene,0.879,28629896
17719,Colorectal Cancer,disease,1.0,28622036
17720,colorectal cancer,disease,1.0,28622036
17721,tumor,disease,1.0,28622036
17722,tumors,disease,1.0,28622036
17723,colorectal cancer,disease,1.0,28622036
17724,metastatic colorectal cancer,disease,1.0,28622036
17725,mCRC,disease,1.0,28622036
17726,bevacizumab,gene,0.863,28622036
17727,aflibercept,gene,0.972,28622036
17728,regorafenib,drug,0.9517,28622036
17729,cetuximab,gene,0.877,28622036
17730,panitumumab,gene,0.9126,28622036
17731,mCRC,disease,0.9956,28622036
17732,programmed death (PD)-1,gene,0.9214,28622036
17733,L1,gene,0.8755,28622036
17734,MEK,gene,0.9946,28622036
17735,MET,gene,0.4495,28622036
17736,RAS,gene,0.9956,28622036
17737,RAF,gene,0.998,28622036
17738,PD-1,gene,0.9893,28622036
17739,mCRC,disease,0.9927,28622036
17740,Epidermal Growth Factor Receptor,gene,0.9976,28619755
17741,EGFR,gene,0.9956,28619755
17742,bladder cancer,disease,1.0,28619755
17743,tumor,disease,1.0,28619755
17744,EGFR-expressing bladder cancer,disease,0.7607,28619755
17745,EGFR,gene,0.996,28619755
17746,Anti-EGFR antibody,gene,0.9634,28619755
17747,panitumumab,gene,0.5225,28619755
17748,panitumumab,gene,0.9834,28619755
17749,Bladder cancer,disease,1.0,28619755
17750,bladder cancer cell lines,cell_line,0.4724,28619755
17751,bladder cancer,disease,1.0,28619755
17752,EGFR,gene,0.988,28619755
17753,oxygen,drug,1.0,28619755
17754,xenografts,cell_line,0.8228,28619755
17755,EGFR,gene,0.9844,28619755
17756,bladder cancers,disease,1.0,28619755
17757,EGFR,gene,0.988,28619755
17758,squamous cell carcinomas,disease,1.0,28619755
17759,SCC,disease,1.0,28619755
17760,EGFR,gene,0.9834,28619755
17761,Panitumumab,gene,0.962,28619755
17762,UMUC-5 cells,cell_line,0.643,28619755
17763,bladder SCC line,cell_line,0.9565,28619755
17764,bladder SCC,disease,0.9966,28619755
17765,Panitumumab,gene,0.9688,28619755
17766,panitumumab,gene,0.9824,28619755
17767,oxygen,drug,0.9995,28619755
17768,panitumumab,gene,0.969,28619755
17769,panitumumab,gene,0.9536,28619755
17770,UMUC,cell_type,0.6943,28619755
17771,UMUC-5 xenograft tumors,disease,0.906,28619755
17772,bladder cancer,disease,1.0,28619755
17773,Panitumumab,gene,0.975,28619755
17774,EGFR-expressing bladder cancer cells,cell_line,0.6445,28619755
17775,EGFR,gene,0.9873,28619755
17776,bladder cancer,disease,0.95,28619755
17777,cancer,disease,1.0,28619755
17778,patients,species,0.993,28619755
17779,metastatic colorectal cancer,disease,0.9976,28602170
17780,patients,species,0.933,28602170
17781,colorectal cancer,disease,1.0,28602170
17782,patients,species,0.985,28602170
17783,colorectal cancer,disease,1.0,28602170
17784,patients,species,0.9824,28602170
17785,hepatic dysfunction,disease,1.0,28602170
17786,patients,species,0.981,28602170
17787,hepatic insufficiency,disease,1.0,28602170
17788,5-fluorouracil,drug,0.9995,28602170
17789,oxaliplatin,drug,0.9995,28602170
17790,bevacizumab,gene,0.814,28602170
17791,cetuximab,gene,0.9326,28602170
17792,panitumumab,gene,0.9263,28602170
17793,irinotecan,drug,0.9976,28602170
17794,regorafenib,drug,0.9946,28602170
17795,patients,species,0.9756,28602170
17796,colorectal cancer,disease,1.0,28602170
17797,liver dysfunction,disease,0.9995,28602170
17798,patients,species,0.971,28602170
17799,colorectal cancer,disease,1.0,28602170
17800,hepatic impairment,disease,1.0,28602170
17801,cancer,disease,0.9995,28601576
17802,phthalocyanine,drug,0.9873,28601576
17803,IRDye,DNA,0.433,28601576
17804,IR700,drug,0.5273,28601576
17805,cancer cell,cell_type,0.5454,28601576
17806,cancer,disease,1.0,28601576
17807,tumor,disease,0.997,28601576
17808,tumor,disease,0.9966,28601576
17809,tumor,disease,0.9243,28601576
17810,tumor,disease,1.0,28601576
17811,deep,disease,0.6743,28601576
17812,tumors,disease,0.793,28601576
17813,mAb,gene,0.746,28601576
17814,green,RNA,0.5566,28601576
17815,green fluorescent protein,gene,0.9873,28601576
17816,GFP,gene,0.993,28601576
17817,tumor,disease,0.9185,28601576
17818,tumor,disease,0.9937,28601576
17819,tumor,disease,0.9995,28601576
17820,GFP,gene,0.985,28601576
17821,tumor,disease,1.0,28601576
17822,tumor,disease,0.999,28601576
17823,KRAS,gene,0.651,28593995
17824,KRAS,gene,0.6675,28593995
17825,EGFR,gene,0.984,28593995
17826,colorectal cancer,disease,1.0,28593995
17827,CRC,disease,1.0,28593995
17828,mutant HRAS,gene,0.996,28593995
17829,CRC,disease,0.9995,28593995
17830,mutant KRAS,gene,0.5366,28593995
17831,codon,DNA,0.543,28593995
17832,HRAS,gene,0.9097,28593995
17833,KRAS,gene,0.7656,28593995
17834,rare,DNA,0.526,28593995
17835,codons,DNA,0.5273,28593995
17836,cetuximab,gene,0.7563,28593995
17837,KRAS,gene,0.821,28593995
17838,KRASQ61,gene,0.827,28593995
17839,cancer cells,cell_type,0.8394,28593995
17840,cancer,disease,0.9995,28593995
17841,KRASG12,gene,0.837,28593995
17842,KRAS,gene,0.7563,28593995
17843,Panitumumab,gene,0.898,28592616
17844,Platinum,drug,0.999,28592616
17845,Advanced Head and LESSONS,disease,0.9995,28592616
17846,Panitumumab,gene,0.7847,28592616
17847,tumor,disease,0.7114,28592616
17848,head and neck squamous cell cancer,disease,1.0,28592616
17849,Epidermal growth factor receptor,gene,0.998,28592616
17850,EGFR,gene,0.9976,28592616
17851,tumor cells,cell_type,0.857,28592616
17852,tumor,disease,0.9736,28592616
17853,patients,species,0.986,28592616
17854,patients,species,0.989,28592616
17855,anti-EGFR-antibodies,gene,0.7812,28592616
17856,panitumumab,gene,0.717,28592616
17857,anti-epidermal growth factor receptor,gene,0.975,28592616
17858,EGFR,gene,0.814,28592616
17859,platinum,drug,1.0,28592616
17860,head and neck squamous cell cancer,disease,1.0,28592616
17861,HNSCC,disease,1.0,28592616
17862,Patients,species,0.9546,28592616
17863,platinum,drug,0.999,28592616
17864,Panitumumab,gene,0.8774,28592616
17865,patients,species,0.988,28592616
17866,patients,species,0.982,28592616
17867,patients,species,0.9746,28592616
17868,cutaneous rash,disease,1.0,28592616
17869,hypomagnesemia,disease,1.0,28592616
17870,patients,species,0.9775,28592616
17871,EGFR,gene,0.992,28592616
17872,patients,species,0.9897,28592616
17873,panitumumab,gene,0.71,28592616
17874,KRAS,DNA,0.7246,28592616
17875,KRAS mutations,gene,0.884,28592616
17876,G48,mutation,,28592616
17877,T50,mutation,,28592616
17878,PIK3CA,DNA,0.5996,28592616
17879,PIK3CA mutations,gene,0.8413,28592616
17880,E545K,DNA,0.4958,28592616
17881,E545,mutation,,28592616
17882,patients,species,0.9766,28592616
17883,EGFR CNG,gene,0.702,28592616
17884,CNG,DNA,0.3801,28592616
17885,patients,species,0.987,28592616
17886,EGFR,gene,0.99,28592616
17887,patients,species,0.983,28592616
17888,patients,species,0.9717,28592616
17889,EGFR CNG,DNA,0.5347,28592616
17890,EGFR,gene,0.993,28592616
17891,patients,species,0.99,28592616
17892,CNG,disease,0.8745,28592616
17893,Panitumumab,gene,0.9355,28592616
17894,HNSCC,disease,0.999,28592616
17895,patients,species,0.99,28592616
17896,patient,species,0.983,28592616
17897,gene signatures,DNA,0.6787,28592616
17898,HER1,gene,0.4512,28577439
17899,Human Anti-EGFR Monoclonal Antibody,gene,0.9,28577439
17900,Panitumumab,gene,0.787,28577439
17901,Panitumumab,gene,0.941,28577439
17902,epidermal growth factor receptor,gene,0.9985,28577439
17903,Erb1,gene,0.996,28577439
17904,HER1,gene,0.9956,28577439
17905,212Pb,drug,0.9893,28577439
17906,212Pb,drug,0.9976,28577439
17907,panitumumab,gene,0.954,28577439
17908,mice,species,0.9263,28577439
17909,LS-174T,cell_line,0.8823,28577439
17910,LS,cell_type,0.543,28577439
17911,LS-174T intraperitoneal (i,disease,0.9614,28577439
17912,212Pb,drug,0.9985,28577439
17913,trastuzumab,gene,0.95,28577439
17914,HER2,gene,0.9946,28577439
17915,212Pb,drug,0.9976,28577439
17916,panitumumab,gene,0.938,28577439
17917,tumor,disease,1.0,28577439
17918,mice,species,0.9014,28577439
17919,paclitaxel,drug,0.9995,28577439
17920,gemcitabine,drug,0.9995,28577439
17921,212Pb,drug,0.9966,28577439
17922,pantiumumab,gene,0.592,28577439
17923,topotecan,drug,0.9253,28577439
17924,212Pb,drug,0.996,28577439
17925,panitumumab,gene,0.893,28577439
17926,212Pb,drug,0.9946,28577439
17927,panitumumab,gene,0.8896,28577439
17928,HER1,gene,0.992,28577439
17929,i.p. disease,disease,0.9985,28577439
17930,212Pb,drug,0.9897,28577439
17931,pantiumumab,gene,0.8687,28577439
17932,BRAF,gene,0.7485,28576857
17933,Anti-EGFR Monoclonal Antibodies,gene,0.9087,28576857
17934,epidermal growth factor receptor,gene,0.997,28576857
17935,EGFR,gene,0.987,28576857
17936,metastatic colorectal cancer,disease,1.0,28576857
17937,anti-EGFR monoclonal antibodies,gene,0.992,28576857
17938,cetuximab,gene,0.786,28576857
17939,panitumumab,gene,0.6934,28576857
17940,Rat-Sarcoma,disease,0.9844,28576857
17941,Rat,species,0.4902,28576857
17942,RAS,gene,0.541,28576857
17943,Kirsten rat sarcoma viral oncogene homolog (KRAS) exon 2,DNA,0.862,28576857
17944,Kirsten rat sarcoma viral oncogene homolog,gene,0.9985,28576857
17945,KRAS,gene,0.969,28576857
17946,tumors,disease,1.0,28576857
17947,KRAS exons,gene,0.8394,28576857
17948,"neuroblastoma rat-sarcoma viral oncogene homolog (NRAS) exons 2, 3, and 4",DNA,0.911,28576857
17949,neuroblastoma rat-sarcoma viral oncogene homolog,gene,0.9976,28576857
17950,NRAS,gene,0.909,28576857
17951,EGFR,gene,0.992,28576857
17952,RAS mutated (mt) tumors,disease,0.57,28576857
17953,RAS,gene,0.992,28576857
17954,BRAFmt tumors,disease,0.4927,28576857
17955,BRAFmt,gene,0.547,28576857
17956,EGFR,gene,0.996,28576857
17957,BRAF,gene,0.636,28576857
17958,BRAF,gene,0.78,28576857
17959,BRAF,DNA,0.743,28576857
17960,BRAF mutations,gene,0.7876,28576857
17961,anti-EGFR mAbs,gene,0.8843,28576857
17962,BRAF mutations,gene,0.7056,28576857
17963,EGFR mAbs,gene,0.95,28576857
17964,BRAF,gene,0.72,28576857
17965,RAS,gene,0.96,28576857
17966,BRAF,gene,0.8506,28576857
17967,metastatic colorectal cancer,disease,0.9995,28576857
17968,mCRC,disease,1.0,28576857
17969,epidermal growth factor receptor,gene,0.9023,28576857
17970,EGFR,gene,0.9976,28576857
17971,cetuximab,gene,0.4915,28576857
17972,panitumumab,gene,0.7124,28576857
17973,RAS,DNA,0.577,28576857
17974,RAS mutations,gene,0.7847,28576857
17975,BRAF,DNA,0.7183,28576857
17976,BRAF mutations,gene,0.816,28576857
17977,mCRC,disease,0.9985,28576857
17978,anti-,gene,0.895,28576857
17979,EGFR-antibody,gene,0.7437,28576857
17980,BRAF,gene,0.8247,28576857
17981,BRAF,gene,0.86,28576857
17982,EGFR,gene,0.9937,28531891
17983,VEGF,gene,0.994,28531891
17984,Patients,species,0.9814,28531891
17985,irinotecan,drug,0.992,28531891
17986,bevacizumab,gene,0.8677,28531891
17987,cetuximab,gene,0.943,28531891
17988,panitumumab,gene,0.976,28531891
17989,patients,species,0.951,28531891
17990,metastatic colorectal cancer,disease,0.999,28531891
17991,patients,species,0.988,28531891
17992,KRAS,gene,0.9966,28531891
17993,metastatic colorectal cancer,disease,0.8794,28531891
17994,fluoropyrimidine,drug,0.999,28531891
17995,oxaliplatin,drug,0.9995,28531891
17996,irinotecan,drug,0.999,28531891
17997,cetuximab,gene,0.6035,28531891
17998,panitumumab,gene,0.9014,28531891
17999,patients,species,0.9917,28531891
18000,bevacizumab,gene,0.791,28531891
18001,patients,species,0.984,28531891
18002,patients,species,0.984,28531891
18003,patients,species,0.9834,28531891
18004,irinotecan,drug,0.999,28531891
18005,bevacizumab,gene,0.898,28531891
18006,cetuximab,gene,0.9673,28531891
18007,panitumumab,gene,0.9814,28531891
18008,patients,species,0.979,28531891
18009,metastatic colorectal cancer,disease,0.9995,28531891
18010,RAS,gene,0.9917,28507280
18011,anti-EGFR Monoclonal antibodies,gene,0.959,28507280
18012,epidermal growth factor receptor,gene,0.998,28507280
18013,EGFR,gene,0.9956,28507280
18014,cetuximab,gene,0.8184,28507280
18015,panitumumab,gene,0.814,28507280
18016,metastatic colorectal cancer,disease,1.0,28507280
18017,mCRC,disease,1.0,28507280
18018,patients,species,0.9897,28507280
18019,RAS,gene,0.9897,28507280
18020,anti-,gene,0.876,28507280
18021,EGFR antibodies,gene,0.796,28507280
18022,patients,species,0.9443,28507280
18023,mCRC,disease,0.997,28507280
18024,Oncogenic RAS,gene,0.993,28507280
18025,MAPK,gene,0.9727,28507280
18026,PI3K,gene,0.996,28507280
18027,AKT,gene,0.994,28507280
18028,RAS-mutant CRC,disease,0.7217,28507280
18029,RAS,gene,0.99,28507280
18030,RAS,gene,0.982,28507280
18031,cancer,disease,1.0,28507280
18032,EGFR,gene,0.867,28507280
18033,MAPK,gene,0.9854,28507280
18034,AKT,gene,0.9966,28507280
18035,RAF-1,gene,0.997,28507280
18036,AKT,gene,0.9966,28507280
18037,cancer cells,cell_line,0.715,28507280
18038,cancer cells,cell_type,0.8647,28507280
18039,cancer,disease,0.9976,28507280
18040,cancer models,cell_line,0.8574,28507280
18041,cancer,disease,0.9995,28507280
18042,anti-,gene,0.9478,28507280
18043,EGFR antibody,gene,0.866,28507280
18044,RAF-1,gene,0.9917,28507280
18045,AKT,gene,0.9956,28507280
18046,anti-apoptotic BCL-2 proteins,gene,0.954,28507280
18047,MAPK,gene,0.9727,28507280
18048,PI3K,gene,0.99,28507280
18049,AKT,gene,0.997,28507280
18050,mCRC,disease,0.994,28507280
18051,patients,species,0.978,28507280
18052,cetuximab,gene,0.8853,28507280
18053,PI3K,gene,0.994,28507280
18054,MEK,gene,0.987,28507280
18055,CRC models,cell_line,0.6963,28507280
18056,CRC,disease,0.9995,28507280
18057,EGFR,gene,0.954,28507280
18058,MAPK,gene,0.989,28507280
18059,PI3K,gene,0.9946,28507280
18060,AKT,gene,0.9946,28507280
18061,anti-EGFR antibody,gene,0.951,28507280
18062,patients,species,0.9795,28507280
18063,RAS,disease,0.7163,28507280
18064,RAS,cell_line,0.5874,28507280
18065,RAS wild type tumors,disease,0.9106,28507280
18066,RAS,gene,0.9844,28507280
18067,Panitumumab,gene,0.8545,28486761
18068,TAS-102,drug,0.9937,28486761
18069,EGFR,gene,0.996,28486761
18070,tumor,disease,0.9995,28486761
18071,trifluridine,drug,0.965,28486761
18072,Panitumumab,gene,0.7134,28486761
18073,human epidermal growth factor receptor,gene,0.9976,28486761
18074,EGFR,gene,0.991,28486761
18075,TAS-102,drug,0.9956,28486761
18076,trifluridine,drug,0.998,28486761
18077,FTD,drug,0.992,28486761
18078,panitumumab,gene,0.951,28486761
18079,TAS-102,drug,0.9746,28486761
18080,metastatic colorectal cancer,disease,0.9976,28486761
18081,panitumumab,gene,0.941,28486761
18082,TAS-102,drug,0.996,28486761
18083,Panitumumab,gene,0.948,28486761
18084,FTD,drug,0.6357,28486761
18085,SW48 colon cancer cells,cell_line,0.8667,28486761
18086,SW48,cell_type,0.5586,28486761
18087,colon cancer cells,cell_type,0.5996,28486761
18088,colon cancer,disease,0.999,28486761
18089,panitumumab,gene,0.9805,28486761
18090,TAS-102,drug,0.98,28486761
18091,LIM1215,cell_line,0.8584,28486761
18092,COL-01-JCK,cell_line,0.8604,28486761
18093,colon cancer,disease,1.0,28486761
18094,LIM1215 cells,cell_line,0.732,28486761
18095,FTD,gene,0.957,28486761
18096,extracellular signal-regulated kinase,gene,0.9233,28486761
18097,ERK,gene,0.997,28486761
18098,protein kinase B,gene,0.9917,28486761
18099,AKT,gene,0.997,28486761
18100,signal transducer and activator of transcription 3,gene,0.9424,28486761
18101,STAT3,gene,0.9907,28486761
18102,serine,drug,0.995,28486761
18103,threonine,drug,0.9956,28486761
18104,EGFR,gene,0.9863,28486761
18105,EGFR,gene,0.989,28486761
18106,tyrosine,drug,0.9956,28486761
18107,Panitumumab,gene,0.6504,28486761
18108,tyrosine,drug,0.791,28486761
18109,tyrosine kinase,gene,0.7773,28486761
18110,erlotinib,drug,0.956,28486761
18111,EGFR,gene,0.995,28486761
18112,tyrosine,drug,0.99,28486761
18113,ERK,gene,0.985,28486761
18114,AKT,gene,0.998,28486761
18115,STAT3,gene,0.9976,28486761
18116,EGFR,gene,0.975,28486761
18117,serine,drug,0.996,28486761
18118,threonine,drug,0.9917,28486761
18119,FTD,drug,0.934,28486761
18120,EGFR tyrosine kinase,gene,0.9766,28486761
18121,tyrosine,drug,0.9844,28486761
18122,ERK,gene,0.985,28486761
18123,AKT,gene,0.9976,28486761
18124,STAT3,gene,0.996,28486761
18125,panitumumab,gene,0.677,28486761
18126,FTD,disease,0.9927,28486761
18127,EGFR,gene,0.9966,28486761
18128,TAS-102,drug,0.995,28486761
18129,anti-EGFR antibodies,gene,0.9126,28486761
18130,TAS-102,drug,0.996,28486761
18131,metastatic colorectal cancer,disease,0.996,28486761
18132,gastrointestinal cancers,disease,1.0,28477738
18133,epidermal growth factor,gene,0.993,28477738
18134,epidermal growth factor receptor,gene,0.999,28477738
18135,EGFR,gene,0.9927,28477738
18136,gastrointestinal cancers,disease,1.0,28477738
18137,tyrosine,drug,0.998,28477738
18138,Skin conditions,disease,0.9854,28477738
18139,EGFR,gene,0.9917,28477738
18140,papulopustular rash,disease,1.0,28477738
18141,mucosal toxicity,disease,0.9927,28477738
18142,electrolyte imbalances,disease,0.979,28477738
18143,hypomagnesaemia,disease,1.0,28477738
18144,diarrhoea,disease,1.0,28477738
18145,cancer,disease,0.9365,28477738
18146,EGFR,gene,0.996,28477738
18147,gastrointestinal cancers,disease,1.0,28477738
18148,EGFR,gene,0.988,28456787
18149,skin rash,disease,0.9966,28456787
18150,Epidermal growth factor receptor,gene,0.9985,28456787
18151,cancer,disease,1.0,28456787
18152,erlotinib,drug,0.9956,28456787
18153,gefitinib,drug,0.995,28456787
18154,cetuximab,gene,0.827,28456787
18155,panitumumab,gene,0.8184,28456787
18156,papulopustular acneiform rash,disease,0.995,28456787
18157,cancer,disease,0.9995,28456787
18158,epidermal growth factor receptor,gene,0.999,28456787
18159,plasma,cell_type,0.5737,28456787
18160,rash,disease,1.0,28456787
18161,rash,disease,0.999,28456787
18162,amphiregulin,gene,0.9893,28456787
18163,hepatocyte growth factor,gene,0.9976,28456787
18164,HGF,gene,0.994,28456787
18165,calcidiol,drug,0.999,28456787
18166,HGF,gene,0.991,28456787
18167,HGF,gene,0.9595,28456787
18168,HGF,gene,0.997,28456787
18169,rash,disease,0.9995,28456787
18170,HGF,gene,0.993,28456787
18171,rash,disease,0.9995,28456787
18172,HGF,gene,0.9946,28456787
18173,MET,gene,0.994,28456787
18174,epidermal growth factor receptor,gene,0.997,28456787
18175,HGF,gene,0.9985,28456787
18176,MET,gene,0.994,28456787
18177,epidermal growth factor receptor,gene,0.9976,28456787
18178,skin,cell_type,0.6655,28456787
18179,tumor cells,cell_type,0.769,28456787
18180,tumor,disease,0.9697,28456787
18181,skin rash,disease,1.0,28456787
18182,tumor,disease,0.9937,28456787
18183,HGF,gene,0.9946,28456787
18184,cancer,disease,1.0,28456784
18185,APC,cell_type,0.686,28456784
18186,cancer cells,cell_type,0.868,28456784
18187,cancer,disease,0.997,28456784
18188,cancer cells,cell_type,0.768,28456784
18189,cancer,disease,0.999,28456784
18190,tumor,disease,0.9946,28456784
18191,APC,gene,0.4812,28456784
18192,tumor,disease,0.975,28456784
18193,cancer cells,cell_type,0.837,28456784
18194,cancer,disease,0.9985,28456784
18195,APC,cell_type,0.485,28456784
18196,tumor,disease,0.9995,28456784
18197,APC,gene,0.4734,28456784
18198,metastatic colorectal cancer,disease,1.0,28449055
18199,mCRC,disease,0.999,28449055
18200,cetuximab,gene,0.8315,28449055
18201,panitumumab,gene,0.9424,28449055
18202,mCRC,disease,0.997,28449055
18203,patients,species,0.9785,28449055
18204,RAS,DNA,0.5205,28449055
18205,RAS wild,gene,0.7725,28449055
18206,primary tumors,disease,0.9272,28449055
18207,panitumumab,gene,0.9214,28449055
18208,tumor,disease,0.88,28449055
18209,RAS,gene,0.9946,28449055
18210,patients,species,0.9883,28449055
18211,panitumumab,gene,0.927,28449055
18212,FOLFOX,drug,0.825,28449055
18213,FOLFOX,drug,0.7705,28449055
18214,panitumumab,gene,0.899,28449055
18215,FOLFOX,drug,0.737,28449055
18216,bevacizumab,gene,0.83,28449055
18217,FOLFOX,drug,0.941,28449055
18218,Primary tumors,disease,0.8447,28449055
18219,tumors,disease,1.0,28449055
18220,RAS,DNA,0.842,28449055
18221,RAS,gene,0.9976,28449055
18222,patients,species,0.9507,28449055
18223,right-sided tumors,disease,0.99,28449055
18224,Patients,species,0.9814,28449055
18225,right-sided tumors,disease,0.9956,28449055
18226,patients,species,0.9907,28449055
18227,RAS,gene,0.998,28449055
18228,RAS,gene,0.994,28449055
18229,BRAF,DNA,0.7383,28449055
18230,BRAF WT,gene,0.998,28449055
18231,patients,species,0.9814,28449055
18232,left-sided tumors,disease,0.9995,28449055
18233,panitumumab,gene,0.9004,28449055
18234,RAS,gene,0.995,28449055
18235,patients,species,0.9893,28449055
18236,right-sided primary tumors,disease,0.9824,28449055
18237,left-sided tumors,disease,0.999,28449055
18238,RAS,DNA,0.631,28449055
18239,RAS,gene,0.995,28449055
18240,patients,species,0.9897,28449055
18241,left-sided tumors,disease,0.998,28449055
18242,panitumumab,gene,0.8896,28449055
18243,bevacizumab,gene,0.4963,28449055
18244,RAS,gene,0.995,28449055
18245,patients,species,0.9937,28449055
18246,mCRC,disease,0.991,28449055
18247,Posterior reversible encephalopathy syndrome,disease,1.0,28439399
18248,colitis,disease,1.0,28439399
18249,patient,species,0.9497,28439399
18250,metastatic colorectal cancer,disease,1.0,28435294
18251,panitumumab,gene,0.8535,28435294
18252,Epidermal growth factor receptor,gene,0.998,28435294
18253,EGFR,gene,0.9907,28435294
18254,malignancies,disease,1.0,28435294
18255,colorectal cancer,disease,1.0,28435294
18256,CRC,disease,1.0,28435294
18257,EGFR,gene,0.9824,28435294
18258,Panitumumab,gene,0.757,28435294
18259,cetuximab,gene,0.7153,28435294
18260,EGFR,gene,0.9937,28435294
18261,metastatic CRC,disease,0.9995,28435294
18262,mCRC,disease,0.9995,28435294
18263,mCRC,disease,0.995,28435294
18264,tumor,disease,1.0,28435294
18265,CRC,disease,1.0,28435294
18266,malignancy,disease,1.0,28435294
18267,EGFR mAb,gene,0.9146,28435294
18268,Oncologists,cell_type,0.4438,28435294
18269,EGFR mAb,gene,0.922,28435294
18270,panitumumab,gene,0.817,28435294
18271,panitumumab,gene,0.798,28435294
18272,mCRC,disease,0.991,28435294
18273,Refractory,disease,0.591,28432610
18274,Metastatic Colorectal Cancer,disease,0.8813,28432610
18275,VEGF,gene,0.9946,28432610
18276,EGFR,gene,0.987,28432610
18277,metastatic colorectal cancer,disease,0.9907,28432610
18278,mCRC,disease,0.9966,28432610
18279,mCRC,disease,0.999,28432610
18280,VEGF-I,gene,0.9917,28432610
18281,EGFR-I,gene,0.9536,28432610
18282,mCRC,disease,0.9995,28432610
18283,mCRC,disease,0.992,28432610
18284,KRAS,gene,0.785,28432610
18285,EGFR,gene,0.9873,28432610
18286,KRAS,gene,0.7407,28432610
18287,mCRC,disease,0.9956,28432610
18288,EGFR,gene,0.991,28432610
18289,mCRC,disease,0.956,28432610
18290,EGFR,gene,0.9834,28432610
18291,EGFR,gene,0.9883,28432610
18292,KRAS,gene,0.4531,28432610
18293,mCRC,disease,0.988,28432610
18294,panitumumab,gene,0.9414,28424871
18295,bevacizumab,gene,0.685,28424871
18296,metastatic colorectal,disease,0.9995,28424871
18297,carcinoma,disease,0.8926,28424871
18298,KRAS exon 2,DNA,0.8228,28424871
18299,KRAS exon 2 wild,gene,0.848,28424871
18300,metastatic colorectal cancer,disease,1.0,28424871
18301,mCRC,disease,0.9995,28424871
18302,panitumumab,gene,0.854,28424871
18303,tumour RAS,gene,0.6943,28424871
18304,RAS,DNA,0.3596,28424871
18305,tumour,disease,0.9175,28424871
18306,RAS WT,gene,0.7183,28424871
18307,RAS WT,gene,0.7817,28424871
18308,BRAF,DNA,0.628,28424871
18309,BRAF WT,gene,0.744,28424871
18310,mCRC,disease,0.999,28424871
18311,panitumumab,gene,0.9307,28424871
18312,bevacizumab,gene,0.655,28424871
18313,RAS WT,gene,0.663,28424871
18314,RAS WT,gene,0.6255,28424871
18315,BRAF,gene,0.664,28424871
18316,panitumumab,gene,0.9473,28424871
18317,bevacizumab,gene,0.743,28424871
18318,RAS WT,gene,0.6675,28424871
18319,RAS WT,gene,0.7134,28424871
18320,BRAF WT,gene,0.5854,28424871
18321,panitumumab,gene,0.949,28424871
18322,panitumumab,gene,0.6274,28424871
18323,OS,cell_line,0.4514,28424871
18324,panitumumab,gene,0.9517,28424871
18325,bevacizumab,gene,0.8735,28424871
18326,RAS,DNA,0.7207,28424871
18327,RAS WT,gene,0.764,28424871
18328,mCRC,disease,0.975,28424871
18329,Panitumumab,gene,0.9673,28418176
18330,Pt,drug,0.997,28418176
18331,Colorectal Cancer,disease,1.0,28418176
18332,tumor cell,cell_type,0.5117,28418176
18333,tumor,disease,1.0,28418176
18334,Panitumumab,gene,0.9224,28418176
18335,platinum,drug,0.9995,28418176
18336,Pt,drug,0.9946,28418176
18337,Oxaliplatin,drug,0.997,28418176
18338,KRAS,disease,0.977,28418176
18339,BRAF,gene,0.9736,28418176
18340,colorectal cancer,disease,0.886,28418176
18341,(CRC) cells,cell_line,0.7783,28418176
18342,(CRC,disease,0.869,28418176
18343,epidermal growth factor receptors,gene,0.9985,28418176
18344,Pt,drug,0.8994,28418176
18345,tumor,disease,0.999,28418176
18346,TCT,disease,0.8535,28418176
18347,"dichloro(1,2-diaminocyclohexane)Pt(II)",drug,0.966,28418176
18348,Panitumumab,gene,0.864,28418176
18349,NANOPt,drug,0.974,28418176
18350,Pan,gene,0.5366,28418176
18351,Pt,drug,0.996,28418176
18352,Panitumumab,gene,0.8545,28418176
18353,tumors,disease,1.0,28418176
18354,Pt,drug,0.9746,28418176
18355,blood,cell_type,0.507,28418176
18356,NANOPt,drug,0.986,28418176
18357,Pan,drug,0.7935,28418176
18358,CRC,disease,1.0,28418176
18359,Pan,drug,0.837,28418176
18360,CRC,disease,0.9995,28418176
18361,colorectal liver metastases,disease,0.994,28407529
18362,colorectal liver metastases,disease,0.999,28407529
18363,CLM,disease,0.998,28407529
18364,PATIENTS,species,0.9824,28407529
18365,PCT,cell_line,0.4878,28407529
18366,CLM,disease,1.0,28407529
18367,CLM,disease,1.0,28407529
18368,extrahepatic disease,disease,0.999,28407529
18369,tumour,disease,0.9736,28407529
18370,CLM,disease,0.9316,28407529
18371,patients,species,0.959,28407110
18372,RAS,gene,0.996,28407110
18373,metastatic colorectal cancer,disease,1.0,28407110
18374,mCRC,disease,1.0,28407110
18375,tumours,disease,1.0,28407110
18376,patients,species,0.969,28407110
18377,KRAS,gene,0.9927,28407110
18378,RAS,gene,0.99,28407110
18379,mCRC,disease,0.9976,28407110
18380,patients,species,0.956,28407110
18381,RAS,DNA,0.633,28407110
18382,RAS wt,gene,0.9956,28407110
18383,mCRC,disease,0.999,28407110
18384,EGFR antibody,gene,0.8555,28407110
18385,bevacizumab,gene,0.7144,28407110
18386,patients,species,0.8877,28407110
18387,left-sided,disease,0.791,28407110
18388,ORs,DNA,0.8223,28407110
18389,tumour,disease,1.0,28407110
18390,tumour,disease,0.9976,28407110
18391,RAS,DNA,0.7363,28407110
18392,RAS mutation,gene,0.968,28407110
18393,patients,species,0.9927,28407110
18394,patients,species,0.9897,28407110
18395,right-sided tumours,disease,1.0,28407110
18396,left-sided tumours,disease,1.0,28407110
18397,EGFR,gene,0.993,28407110
18398,patients,species,0.939,28407110
18399,left-sided tumours,disease,0.9985,28407110
18400,right,DNA,0.4692,28407110
18401,right-sided tumours,disease,0.9985,28407110
18402,EGFR,gene,0.992,28407110
18403,patients,species,0.9834,28407110
18404,left-sided tumours,disease,1.0,28407110
18405,right-sided tumours,disease,1.0,28407110
18406,EGFR antibody,gene,0.8916,28407110
18407,patients,species,0.9834,28407110
18408,right-sided tumours,disease,1.0,28407110
18409,left-sided tumours,disease,1.0,28407110
18410,patients,species,0.9775,28407110
18411,RAS,gene,0.987,28407110
18412,mCRC,disease,0.9976,28407110
18413,tumour,disease,0.971,28407110
18414,EGFR antibody,gene,0.7935,28407110
18415,bevacizumab,gene,0.648,28407110
18416,patients,species,0.976,28407110
18417,left-sided tumours,disease,1.0,28407110
18418,patients,species,0.989,28407110
18419,Metastatic Colorectal Cancer,disease,1.0,28404754
18420,KRAS,gene,0.8022,28404754
18421,EGFR,gene,0.991,28404754
18422,Panitumumab,gene,0.602,28404754
18423,KRAS,gene,0.685,28404754
18424,metastatic colorectal cancers,disease,0.8477,28404754
18425,EGFR,gene,0.994,28404754
18426,EGFR,gene,0.9946,28404754
18427,panitumumab,gene,0.7456,28404754
18428,KRAS oncogene,gene,0.8926,28404754
18429,RAS family genes,gene,0.91,28404754
18430,EGFR,gene,0.991,28404754
18431,KRAS-mutated tumors,disease,0.945,28404754
18432,KRAS,gene,0.4585,28404754
18433,RAS mutations,gene,0.745,28404754
18434,EGFR,gene,0.9805,28404754
18435,"codons 12, 13, and 61",DNA,0.849,28404754
18436,metastatic colon cancer,disease,1.0,28404754
18437,p.A59T variant,DNA,0.5527,28404754
18438,A59T,mutation,,28404754
18439,KRAS,gene,0.797,28404754
18440,carcinoembryonic antigen,gene,0.9946,28404754
18441,panitumumab,gene,0.861,28404754
18442,FOLFIRI,drug,0.8633,28404754
18443,A59T,mutation,,28404754
18444,KRAS mutant tumors,disease,0.6567,28404754
18445,KRAS,gene,0.9795,28404754
18446,EGFR,gene,0.9854,28404754
18447,cetuximab,gene,0.93,28403233
18448,panitumumab,gene,0.862,28403233
18449,metastatic colorectal cancer,disease,1.0,28403233
18450,Cetuximab,gene,0.836,28403233
18451,panitumumab,gene,0.7783,28403233
18452,epidermal growth factor receptor,gene,0.996,28403233
18453,RAS,DNA,0.618,28403233
18454,RAS wild,gene,0.76,28403233
18455,metastatic colorectal cancer,disease,0.9995,28403233
18456,RAS -wt,cell_line,0.5127,28403233
18457,RAS,gene,0.5254,28403233
18458,mCRC,disease,0.999,28403233
18459,cetuximab,gene,0.9346,28403233
18460,panitumumab,gene,0.905,28403233
18461,mCRC,disease,0.996,28403233
18462,cetuximab,gene,0.9414,28403233
18463,panitumumab,gene,0.898,28403233
18464,RAS,DNA,0.5376,28403233
18465,RAS-,gene,0.989,28403233
18466,mCRC,disease,0.999,28403233
18467,Tyrosine,drug,0.982,28399109
18468,Tyrosine kinase,gene,0.982,28399109
18469,heart failure,disease,1.0,28399109
18470,cancer,disease,0.9995,28399109
18471,cardiac disease,disease,1.0,28399109
18472,cancer,disease,1.0,28399109
18473,tyrosine,drug,0.966,28399109
18474,tyrosine kinase,gene,0.996,28399109
18475,heart failure,disease,1.0,28399109
18476,HF,disease,1.0,28399109
18477,patients,species,0.993,28399109
18478,tyrosine,drug,0.994,28399109
18479,tyrosine kinase,gene,0.9946,28399109
18480,malignant disease,disease,1.0,28399109
18481,HF,disease,,28399109
18482,HF,disease,,28399109
18483,HF,disease,,28399109
18484,person,species,0.844,28399109
18485,Trastuzumab,gene,0.8647,28399109
18486,cetuximab,gene,0.723,28399109
18487,panitumumab,gene,0.7646,28399109
18488,sunitinib,drug,0.997,28399109
18489,HF,disease,,28399109
18490,diabetes mellitus,disease,1.0,28399109
18491,hypertension,disease,1.0,28399109
18492,chronic renal failure,disease,1.0,28399109
18493,ischaemic heart disease,disease,1.0,28399109
18494,valvular heart disease,disease,1.0,28399109
18495,arrhythmia,disease,1.0,28399109
18496,Trastuzumab,gene,0.937,28399109
18497,cetuximab,gene,0.8364,28399109
18498,panitumumab,gene,0.7764,28399109
18499,sunitinib,drug,0.996,28399109
18500,HF,disease,,28399109
18501,Anti-Epidermal Growth Factor Receptor,gene,0.925,28382467
18502,Metastatic Colorectal Cancer,disease,1.0,28382467
18503,Colorectal cancer,disease,1.0,28382467
18504,CRC,disease,1.0,28382467
18505,cancers,disease,1.0,28382467
18506,cancer,disease,1.0,28382467
18507,vascular endothelial growth factor,gene,0.9976,28382467
18508,VEGF,gene,0.995,28382467
18509,epidermal growth factor receptor,gene,0.997,28382467
18510,EGFR,gene,0.996,28382467
18511,CRC,disease,0.9976,28382467
18512,cancer,disease,1.0,28382467
18513,RAS-mutated cancers,disease,1.0,28382467
18514,RAS,gene,0.587,28382467
18515,EGFR,gene,0.9956,28382467
18516,RAS,gene,0.5093,28382467
18517,BRAF,gene,0.6226,28382467
18518,EGFR,gene,0.9893,28382467
18519,EGFR,gene,0.995,28382467
18520,metastatic CRC,disease,0.999,28382467
18521,Metastatic Colorectal Cancer,disease,1.0,28379722
18522,cancer,disease,0.9854,28379722
18523,metastatic colorectal cancer,disease,1.0,28379722
18524,mCRC,disease,1.0,28379722
18525,Cetuximab,gene,0.714,28379722
18526,panitumumab,gene,0.62,28379722
18527,mCRC,disease,0.9653,28379722
18528,panitumumab,gene,0.8594,28379722
18529,panitumumab,gene,0.9263,28379722
18530,cetuximab,gene,0.9385,28379722
18531,mCRC,disease,0.999,28379722
18532,cetuximab,gene,0.8823,28379722
18533,panitumumab,gene,0.8887,28379722
18534,cetuximab,gene,0.9155,28379722
18535,panitumumab,gene,0.9165,28379722
18536,Anti-EGFR,gene,0.8545,28375604
18537,epidermal growth factor receptor,gene,0.999,28375604
18538,EGFR,gene,0.9966,28375604
18539,hypervariable,DNA,0.499,28375604
18540,synthetic antigen-binding fragment (Fab) library,DNA,0.6704,28375604
18541,antigen-binding fragment,gene,0.908,28375604
18542,Fab,gene,0.96,28375604
18543,Fab,gene,0.9497,28375604
18544,Fab,gene,0.9814,28375604
18545,Fabs,gene,0.9727,28375604
18546,EGFR,gene,0.987,28375604
18547,Fabs,gene,0.87,28375604
18548,cell-surface EGFR,gene,0.905,28375604
18549,cetuximab,gene,0.7266,28375604
18550,panitumumab,gene,0.8657,28375604
18551,domains I,DNA,0.4604,28375604
18552,HER2,gene,0.9907,28363756
18553,Colorectal Cancer,disease,1.0,28363756
18554,Epidermal Growth Factor Receptor,gene,0.986,28363756
18555,HER2 gene,gene,0.9033,28363756
18556,malignancies,disease,0.9995,28363756
18557,breast and gastric cancer,disease,1.0,28363756
18558,HER2,gene,0.992,28363756
18559,HER2,gene,0.992,28363756
18560,anti-epidermal growth factor receptor,gene,0.9834,28363756
18561,EGFR,gene,0.9976,28363756
18562,HER2,gene,0.992,28363756
18563,anti-EGFR antibody,gene,0.9106,28363756
18564,colorectal cancer,disease,1.0,28363756
18565,Cell line,cell_line,0.7183,28363756
18566,HER2,gene,0.8735,28363756
18567,anti-EGFR antibody cetuximab,gene,0.854,28363756
18568,colorectal cancer,disease,1.0,28363756
18569,HER2,gene,0.994,28363756
18570,colorectal cancer,disease,1.0,28363756
18571,HER2,gene,0.9937,28363756
18572,colorectal cancer,disease,1.0,28363756
18573,anti-,gene,0.885,28363756
18574,EGFR antibody,gene,0.807,28363756
18575,HER2,gene,0.925,28363756
18576,colorectal cancer,disease,0.961,28363756
18577,cetuximab,gene,0.6074,28363756
18578,HER2,gene,0.994,28363756
18579,HER2,gene,0.9873,28363756
18580,HER2-positive,disease,0.992,28363756
18581,HER2,gene,0.97,28363756
18582,colorectal cancer,disease,0.8047,28363756
18583,EGFR,gene,0.994,28323034
18584,epidermal growth factor receptor,gene,0.998,28323034
18585,EGFR,gene,0.9946,28323034
18586,CRC,disease,1.0,28323034
18587,cetuximab,gene,0.8154,28323034
18588,panitumumab,gene,0.7725,28323034
18589,EGFR,gene,0.9854,28323034
18590,metastatic colorectal cancer,disease,1.0,28323034
18591,mCRC,disease,1.0,28323034
18592,anti-EGFR,gene,0.8394,28323034
18593,patients,species,0.946,28323034
18594,mCRC,disease,0.9966,28323034
18595,anti-EGFR MoAbs,gene,0.9253,28323034
18596,Ras,gene,0.99,28323034
18597,Raf,gene,0.998,28323034
18598,Mek,gene,0.9976,28323034
18599,Erk,gene,0.997,28323034
18600,PI3K,gene,0.9814,28323034
18601,Akt,gene,0.995,28323034
18602,mTOR,gene,0.9946,28323034
18603,anti-EGFR MoAbs,gene,0.837,28323034
18604,EGFR,gene,0.989,28323034
18605,anti-EGFR MoAbs,gene,0.8467,28323034
18606,anti-EGFR MoAbs,gene,0.8677,28323034
18607,cancer cells,cell_type,0.863,28323034
18608,cancer,disease,0.9995,28323034
18609,EGFR MoAbs,gene,0.9697,28323034
18610,autophagic,disease,0.8564,28323034
18611,anti-EGFR MoAbs,gene,0.9116,28323034
18612,mCRC,disease,0.992,28323034
18613,patients,species,0.981,28323034
18614,Epidermal growth factor receptor,gene,0.9976,28294296
18615,EGFR,gene,0.999,28294296
18616,EGFR,gene,0.9805,28294296
18617,Brigatinib,drug,0.998,28287083
18618,anti-EGFR antibody,gene,0.821,28287083
18619,osimertinib,drug,0.9956,28287083
18620,EGFR-mutated non-small-cell lung cancer,disease,0.9985,28287083
18621,EGFR,gene,0.5083,28287083
18622,Osimertinib,drug,0.995,28287083
18623,epidermal growth factor receptor,gene,0.9976,28287083
18624,EGFR,gene,0.969,28287083
18625,T790M,mutation,,28287083
18626,EGFR-,gene,0.99,28287083
18627,tyrosine,drug,0.823,28287083
18628,tyrosine kinase,gene,0.7466,28287083
18629,EGFR-,gene,0.9883,28287083
18630,C797S,mutation,,28287083
18631,cysteine,drug,0.9956,28287083
18632,EGFR,gene,0.9897,28287083
18633,osimertinib,drug,0.9937,28287083
18634,osimertinib,drug,0.9946,28287083
18635,C797S,DNA,,28287083
18636,C797S,mutation,,28287083
18637,T790M,DNA,,28287083
18638,T790M,mutation,,28287083
18639,EGFR,gene,0.9946,28287083
18640,brigatinib,drug,0.992,28287083
18641,triple-mutation-harbouring cells,cell_line,0.7153,28287083
18642,brigatinib,drug,0.9966,28287083
18643,ATP,drug,0.998,28287083
18644,triple-mutant EGFR,gene,0.991,28287083
18645,brigatinib,drug,0.9917,28287083
18646,triple-mutant EGFR,gene,0.991,28287083
18647,brigatinib,drug,0.996,28287083
18648,anti-EGFR antibody,gene,0.979,28287083
18649,EGFR,gene,0.9917,28287083
18650,brigatinib,drug,0.9956,28287083
18651,anti-EGFR antibody,gene,0.904,28287083
18652,triple-mutant EGFR,gene,0.989,28287083
18653,Panitumumab,gene,0.7573,28284575
18654,5-FU,drug,0.997,28284575
18655,Panitumumab,gene,0.738,28284575
18656,Panitumumab,gene,0.7124,28284575
18657,RAS Wild-type Colorectal Carcinoma,disease,0.9673,28284575
18658,RAS,gene,0.527,28284575
18659,oxaliplatin,drug,1.0,28284575
18660,OXA,drug,0.997,28284575
18661,5-fluorouracil,drug,0.9995,28284575
18662,5-FU,drug,0.9995,28284575
18663,leucovorin,drug,0.9985,28284575
18664,metastatic colorectal cancer,disease,0.9995,28284575
18665,peripheral nerve disorders,disease,0.996,28284575
18666,OXA,drug,0.999,28284575
18667,OXA,drug,0.997,28284575
18668,FOLFOX,drug,0.989,28284575
18669,OXA,drug,0.998,28284575
18670,peripheral nerve disorders,disease,0.999,28284575
18671,OXA,drug,0.9985,28284575
18672,PATIENTS,species,0.9297,28284575
18673,panitumumab,gene,0.7925,28284575
18674,5-FU,drug,0.997,28284575
18675,panitumumab,gene,0.9033,28284575
18676,advanced or recurrent,disease,0.8804,28284575
18677,colorectal carcinoma,disease,0.8276,28284575
18678,RAS,gene,0.551,28284575
18679,panitumumab,gene,0.8774,28284575
18680,panitumumab,gene,0.8945,28284575
18681,OXA,drug,0.642,28284575
18682,5-FU,drug,0.9985,28284575
18683,panitumumab,gene,0.7925,28284575
18684,peripheral nerve and skin disorders,disease,0.999,28284575
18685,OXA,drug,0.997,28284575
18686,panitumumab,gene,0.829,28284575
18687,panitumumab,gene,0.6514,28284575
18688,EGFR,gene,0.991,33465927
18689,PEG,drug,0.999,33465927
18690,polyethylene glycol,drug,0.9995,33465927
18691,PEG,drug,1.0,33465927
18692,panitumumab F(ab&#x27;)(2) fragments,gene,0.9907,33465927
18693,pmabF(ab&,gene,0.993,33465927
18694,methoxy-PEG,drug,0.993,33465927
18695,ethylene glycol,drug,0.9995,33465927
18696,PEG,drug,0.999,33465927
18697,PEG,drug,0.9976,33465927
18698,DOTA,drug,0.9995,33465927
18699,"1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacet acid",drug,1.0,33465927
18700,(64)Cu,drug,0.9995,33465927
18701,pmabF(ab&#x27;)(,gene,0.8203,33465927
18702,bis-aromatic hydrazone,drug,0.998,33465927
18703,aromatic aldehyde,drug,0.998,33465927
18704,NH(2),drug,0.998,33465927
18705,lysines,drug,0.896,33465927
18706,F,gene,0.6323,33465927
18707,hydrazinonicotinamide,drug,0.9985,33465927
18708,HyNic,drug,0.9995,33465927
18709,polyglutamide,drug,0.999,33465927
18710,PGlu,drug,0.997,33465927
18711,DOTA,drug,0.9995,33465927
18712,PEG,drug,1.0,33465927
18713,pmabF(ab&,gene,0.932,33465927
18714,MCP,drug,0.9233,33465927
18715,PEG,drug,0.9995,33465927
18716,PEG,drug,0.9995,33465927
18717,tumor,disease,0.9995,33465927
18718,mice,species,0.95,33465927
18719,pancreatic patient-derived xenografts tumors,cell_line,0.7705,33465927
18720,patient,species,0.896,33465927
18721,tumors,disease,0.7476,33465927
18722,PEG,drug,0.998,33465927
18723,erlotinib,drug,0.9976,28282789
18724,bevacizumab,gene,0.874,28282789
18725,panitumumab,gene,0.9404,28282789
18726,erlotinib,drug,0.998,28282789
18727,non-small-cell lung cancer,disease,0.9893,28282789
18728,erlotinib,drug,0.996,28282789
18729,bevacizumab,gene,0.917,28282789
18730,panitumumab,gene,0.925,28282789
18731,small-cell lung cancer,disease,1.0,28282789
18732,NSCLC,disease,1.0,28282789
18733,NSCLC,disease,1.0,28282789
18734,platinum,drug,0.9995,28282789
18735,erlotinib,drug,0.9966,28282789
18736,bevacizumab,gene,0.739,28282789
18737,panitumumab,gene,0.904,28282789
18738,erlotinib,drug,0.9956,28282789
18739,diarrhea,disease,1.0,28282789
18740,fatigue,disease,0.9995,28282789
18741,rash,disease,0.9995,28282789
18742,Erlotinib,drug,0.998,28282789
18743,bevacizumab,gene,0.8765,28282789
18744,panitumumab,gene,0.914,28282789
18745,NSCLC,disease,0.9995,28282789
18746,monoclonal antibodies,gene,0.7104,28281873
18747,engineered half-body IgG4s,gene,0.9624,28281873
18748,uncommon glycoforms,RNA,0.5127,28281873
18749,interactome,DNA,0.7227,28280605
18750,metastatic colorectal cancer,disease,1.0,28280605
18751,metastatic colorectal cancer,disease,1.0,28280605
18752,mCRC,disease,1.0,28280605
18753,KRAS,gene,0.811,28280605
18754,NRAS,gene,0.745,28280605
18755,BRAF,gene,0.72,28280605
18756,pts,species,0.8906,28280605
18757,mCRC,disease,1.0,28280605
18758,pts,species,0.9155,28280605
18759,mCRC,disease,0.9995,28280605
18760,pts,species,0.96,28280605
18761,fluoropyrimidines,drug,0.9995,28280605
18762,oxaliplatin,drug,0.9995,28280605
18763,irinotecan,drug,0.9985,28280605
18764,bevacizumab,gene,0.735,28280605
18765,cetuximab,gene,0.844,28280605
18766,panitumumab,gene,0.8906,28280605
18767,adenocarcinoma,disease,1.0,28280605
18768,TP53,gene,0.81,28280605
18769,APC,gene,0.8784,28280605
18770,KRAS,gene,0.745,28280605
18771,PIK3CA,gene,0.737,28280605
18772,BRAF,gene,0.806,28280605
18773,SMAD4,gene,0.6006,28280605
18774,SPTA1,gene,0.971,28280605
18775,FAT1,gene,0.5576,28280605
18776,PDGFRA,gene,0.917,28280605
18777,ATM,gene,0.706,28280605
18778,ROS1,gene,0.876,28280605
18779,ALK,gene,0.997,28280605
18780,CDKN2A,gene,0.836,28280605
18781,FBXW7,gene,0.7793,28280605
18782,TGFBR2,gene,0.7207,28280605
18783,NOTCH1,gene,0.4924,28280605
18784,HER3,gene,0.796,28280605
18785,HER2,gene,0.9966,28280605
18786,fibroblast growth factor receptor,gene,0.9976,28280605
18787,FGFR,gene,0.991,28280605
18788,p38,gene,0.9717,28280605
18789,BRAF,gene,0.9956,28280605
18790,MEK,gene,0.994,28280605
18791,RIT,gene,0.994,28280605
18792,RIN,gene,0.9976,28280605
18793,ARMS,gene,0.979,28280605
18794,MAPK,gene,0.9883,28280605
18795,VEGFR2,gene,0.977,28280605
18796,pts,species,0.98,28280605
18797,mCRC,disease,0.9995,28280605
18798,pts,species,0.938,28280605
18799,epidermal growth factor receptor,gene,0.9966,28271910
18800,Epidermal growth factor receptor,gene,0.9985,28271910
18801,EGFR,gene,0.9946,28271910
18802,breast cancer,disease,0.9995,28271910
18803,EGFR,gene,0.991,28271910
18804,EGFR,gene,0.9917,28271910
18805,breast cancer,disease,1.0,28271910
18806,EGFR,gene,0.994,28271910
18807,EGFR,gene,0.9927,28271910
18808,breast cancer,disease,1.0,28271910
18809,EGFR,gene,0.9917,28271910
18810,breast cancer,disease,0.9985,28271910
18811,patients,species,0.964,28271910
18812,triple-negative breast cancer,disease,1.0,28271910
18813,breast cancer,disease,1.0,28271910
18814,inflammatory breast cancer,disease,1.0,28271910
18815,EGFR,gene,0.9937,28271910
18816,EGFR,gene,0.9946,28271910
18817,breast cancer,disease,1.0,28271910
18818,EGFR,gene,0.991,28271910
18819,breast cancer,disease,0.9995,28271910
18820,breast cancer,disease,0.999,28271910
18821,EGFR,gene,0.9946,28271910
18822,Colorectal Cancer,disease,1.0,28249840
18823,colorectal cancer,disease,1.0,28249840
18824,colorectal cancer,disease,1.0,28249840
18825,PARADIGM,DNA,0.4763,28237539
18826,anti-VEGF,gene,0.9814,28237539
18827,anti-EGFR antibody,gene,0.8813,28237539
18828,patients,species,0.9526,28237539
18829,RAS,gene,0.9873,28237539
18830,KRAS,gene,0.999,28237539
18831,NRAS,gene,0.999,28237539
18832,metastatic colorectal cancer,disease,0.999,28237539
18833,mCRC,disease,1.0,28237539
18834,panitumumab,gene,0.9316,28237539
18835,bevacizumab,gene,0.7534,28237539
18836,oxaliplatin,drug,1.0,28237539
18837,5-fluorouracil,drug,0.9995,28237539
18838,leucovorin,drug,0.9995,28237539
18839,patients,species,0.958,28237539
18840,RAS,gene,0.998,28237539
18841,mCRC,disease,0.999,28237539
18842,PATIENTS,species,0.9697,28237539
18843,patients,species,0.9727,28237539
18844,RAS,gene,0.9985,28237539
18845,mCRC,disease,0.993,28237539
18846,patients,species,0.978,28237539
18847,panitumumab,gene,0.904,28237539
18848,bevacizumab,gene,0.622,28237539
18849,liver metastases,disease,0.999,28237539
18850,oxaliplatin,drug,1.0,28237539
18851,l-leucovorin,drug,0.9995,28237539
18852,5-fluorouracil,drug,0.9995,28237539
18853,5-FU,drug,0.995,28237539
18854,panitumumab,gene,0.922,28237539
18855,bevacizumab,gene,0.5405,28237539
18856,tumor,disease,1.0,28237539
18857,circulating tumor DNA,DNA,0.497,28237539
18858,patient,species,0.9893,28237539
18859,Patients,species,0.979,28229371
18860,Metastatic Colorectal PURPOSE,disease,0.99,28229371
18861,patients,species,0.9795,28229371
18862,metastatic colorectal cancer,disease,1.0,28229371
18863,bevacizumab,gene,0.9204,28229371
18864,epidermal growth factor receptor,gene,0.9937,28229371
18865,cetuximab,gene,0.9272,28229371
18866,panitumumab,gene,0.8867,28229371
18867,patients,species,0.9893,28229371
18868,patients,species,0.973,28229371
18869,tumors,disease,0.9985,28229371
18870,KRAS wild type,DNA,0.641,28229371
18871,KRAS,gene,0.9937,28229371
18872,irinotecan,drug,0.999,28229371
18873,cetuximab,gene,0.7466,28229371
18874,KRAS,gene,0.9956,28229371
18875,oxaliplatin,drug,0.9995,28229371
18876,liver metastasis,disease,0.997,28229371
18877,patients,species,0.99,28229371
18878,Patients,species,0.988,28229371
18879,KRAS,gene,0.9937,28229371
18880,cetuximab,gene,0.5054,28229371
18881,Patients,species,0.9824,28229371
18882,Pulmonary embolism,disease,1.0,28229371
18883,Cardiac metastasis,disease,0.999,28228152
18884,colon cancer,disease,1.0,28228152
18885,5-fluorouracil,drug,0.9976,28228152
18886,Cardiac metastasis,disease,0.999,28228152
18887,colorectal cancer,disease,1.0,28228152
18888,metastatic cardiac tumors,disease,0.999,28228152
18889,woman,species,0.8735,28228152
18890,cardiac tumor,disease,0.9917,28228152
18891,pulmonary nodules,disease,0.9473,28228152
18892,tumor,disease,0.9883,28228152
18893,CEA,gene,0.988,28228152
18894,CA19-9,gene,0.9336,28228152
18895,tumor,disease,0.9717,28228152
18896,well-differentiated adenocarcinoma of the transverse colon,disease,0.993,28228152
18897,wild-type KRAS,gene,0.9917,28228152
18898,5-fluorouracil,drug,0.9976,28228152
18899,leucovorin,drug,0.9985,28228152
18900,oxaliplatin,drug,0.9995,28228152
18901,panitumumab,gene,0.7686,28228152
18902,cardiac tumor,disease,0.998,28228152
18903,pulmonary nodules,disease,0.9775,28228152
18904,CEA,gene,0.9893,28228152
18905,CA19-9,gene,0.912,28228152
18906,patient,species,0.9727,28228152
18907,cardiac metastasis,disease,0.8945,28228152
18908,colon cancer,disease,1.0,28228152
18909,Cetuximab,gene,0.897,28220486
18910,irinotecan,drug,0.9927,28220486
18911,panitumumab,gene,0.7676,28220486
18912,patients,species,0.983,28220486
18913,irinotecan,drug,0.995,28220486
18914,epidermal growth factor receptor,gene,0.999,28220486
18915,EGFR,gene,0.993,28220486
18916,metastatic colorectal cancer,disease,1.0,28220486
18917,mCRC,disease,1.0,28220486
18918,cetuximab,gene,0.9746,28220486
18919,irinotecan,drug,0.994,28220486
18920,Cmab,gene,0.952,28220486
18921,panitumumab,gene,0.944,28220486
18922,Pmab,gene,0.974,28220486
18923,patients,species,0.9663,28220486
18924,RAS,gene,0.9404,28220486
18925,mCRC,disease,0.9805,28220486
18926,patients,species,0.991,28220486
18927,EGFR antibody,gene,0.8296,28220486
18928,mCRC,disease,0.9985,28220486
18929,Cancer,disease,0.876,28220486
18930,Cmab,drug,0.5894,28220486
18931,+I,gene,,28220486
18932,Pmab,gene,0.9473,28220486
18933,patients,species,0.9634,28220486
18934,Patients,species,0.9653,28220486
18935,irinotecan,drug,0.996,28220486
18936,Cmab,drug,0.9595,28220486
18937,Pmab,drug,0.9136,28220486
18938,patients,species,0.995,28220486
18939,ATM mutations,gene,0.756,28199979
18940,E-cadherin,gene,0.9937,28199979
18941,EGFR,gene,0.9937,28199979
18942,colorectal cancer,disease,1.0,28199979
18943,EGFR,gene,0.991,28199979
18944,RAS,gene,0.5986,28199979
18945,metastatic colorectal cancers,disease,0.994,28199979
18946,CRC,disease,1.0,28199979
18947,RAS,gene,0.966,28199979
18948,CRC,disease,0.9116,28199979
18949,EGFR,gene,0.994,28199979
18950,CRC cell lines,cell_line,0.896,28199979
18951,CRC,disease,1.0,28199979
18952,Caco-2,cell_line,0.887,28199979
18953,DLD1,cell_line,0.7812,28199979
18954,HCT116,cell_line,0.913,28199979
18955,HT29,cell_line,0.918,28199979
18956,LS174T,cell_line,0.9053,28199979
18957,RKO,cell_line,0.9033,28199979
18958,SW480,cell_line,0.903,28199979
18959,Cetuximab,gene,0.877,28199979
18960,EGFR promoter,gene,0.696,28199979
18961,EGFR,gene,0.994,28199979
18962,E-cadherin,gene,0.996,28199979
18963,tumors,disease,0.837,28199979
18964,liver and/or lung metastases,disease,0.981,28199979
18965,CRC,disease,1.0,28199979
18966,Cetuximab,gene,0.669,28199979
18967,Panitumumab,gene,0.68,28199979
18968,EGFR promoter,gene,0.8804,28199979
18969,EGFR,gene,0.984,28199979
18970,EGFR,gene,0.994,28199979
18971,RAS exon,cell_line,0.589,28199979
18972,RAS exon 2 p.G13,gene,0.5127,28199979
18973,CRC,disease,0.8096,28199979
18974,CRC,disease,0.9995,28199979
18975,PIK3CA exon 9,gene,0.6514,28199979
18976,EGFR,gene,0.9927,28199979
18977,ATM mutations,gene,0.6245,28199979
18978,E-cadherin,gene,0.9937,28199979
18979,E-cadherin,gene,0.992,28199979
18980,Cetuximab,gene,0.803,28199979
18981,E-cadherin positive cells,cell_type,0.683,28199979
18982,E-cadherin,gene,0.896,28199979
18983,ATM,gene,0.9966,28199979
18984,E-cadherin,gene,0.9873,28199979
18985,EGFR,gene,0.9946,28199979
18986,Pancreatic cancer,disease,0.908,28198009
18987,PC,disease,1.0,28198009
18988,patient,species,0.9844,28198009
18989,patient,species,0.976,28198009
18990,KRAS,gene,0.988,28198009
18991,PC,disease,,28198009
18992,patients,species,0.984,28198009
18993,epidermal growth factor receptor,gene,0.9976,28198009
18994,EGFR,gene,0.9976,28198009
18995,panitumumab,gene,0.6387,28198009
18996,KRAS,DNA,0.6187,28198009
18997,KRAS,gene,0.9966,28198009
18998,PC,disease,,28198009
18999,patients,species,0.991,28198009
19000,panitumumab,gene,0.9062,28198009
19001,tumor,disease,1.0,28198009
19002,patient,species,0.9507,28198009
19003,derived xenografts,cell_line,0.7383,28198009
19004,PDXs,cell_line,0.9204,28198009
19005,KRAS,gene,0.9927,28198009
19006,PC tumors,disease,0.926,28198009
19007,panitumumab,gene,0.832,28198009
19008,tumors,disease,1.0,28198009
19009,patients,species,0.977,28198009
19010,EUS-FNA-derived,RNA,0.5547,28198009
19011,tumor RNA,RNA,0.665,28198009
19012,PC,disease,,28198009
19013,transcriptome,DNA,0.6484,28198009
19014,KRAS,gene,0.9946,28198009
19015,tumor genomic DNA,DNA,0.824,28198009
19016,tumor,RNA,0.519,28198009
19017,PC,disease,,28198009
19018,patients,species,0.9956,28198009
19019,KRAS,gene,0.964,28198009
19020,KRAS wild,gene,0.7886,28198009
19021,tumor,disease,0.9785,28198009
19022,mice,species,0.7417,28198009
19023,KRAS,gene,0.9946,28198009
19024,PDXs,cell_line,0.7217,28198009
19025,panitumumab,gene,0.7744,28198009
19026,Cancer,disease,0.9517,28198009
19027,KRAS,gene,0.9946,28198009
19028,PC tumors,cell_type,0.454,28198009
19029,PC tumors,disease,0.9995,28198009
19030,differentially expressed genes,DNA,0.7856,28198009
19031,KRAS,DNA,0.827,28198009
19032,KRAS mutation,gene,0.9014,28198009
19033,PDXs,cell_line,0.813,28198009
19034,PC,disease,,28198009
19035,patients,species,0.991,28198009
19036,EGFR,gene,0.7144,28198009
19037,patients,species,0.935,28198009
19038,KRAS,gene,0.9907,28198009
19039,Metastatic Colorectal Cancer,disease,0.9995,28197947
19040,Metastatic colorectal cancer,disease,1.0,28197947
19041,mCRC,disease,1.0,28197947
19042,cancer,disease,1.0,28197947
19043,colorectal tumours,disease,1.0,28197947
19044,mCRC,disease,0.99,28197947
19045,AvidinOX,gene,0.973,28186982
19046,biotinylated trastuzumab,gene,0.7734,28186982
19047,pertuzumab,gene,0.9214,28186982
19048,ErbB2,gene,0.985,28186982
19049,tumor cell,cell_type,0.6846,28186982
19050,tumor,disease,1.0,28186982
19051,Avidin,gene,0.9956,28186982
19052,AvidinOX,gene,0.994,28186982
19053,AvidinOX,gene,0.9497,28186982
19054,biotin,drug,0.9834,28186982
19055,tumor lesions,disease,0.969,28186982
19056,anti-ErbB2 monoclonal antibodies,gene,0.9624,28186982
19057,Trastuzumab,gene,0.505,28186982
19058,Pertuzumab,gene,0.8896,28186982
19059,AvidinOX,gene,0.9897,28186982
19060,tumor cells,cell_type,0.8647,28186982
19061,tumor,disease,0.986,28186982
19062,biotinylated Trastuzumab,gene,0.8438,28186982
19063,bTrast,gene,0.7954,28186982
19064,Pertuzumab,gene,0.9385,28186982
19065,ErbB2,gene,0.9897,28186982
19066,ErbB2,gene,0.9917,28186982
19067,ErbB2,gene,0.9795,28186982
19068,AvidinOX,gene,0.9976,28186982
19069,Trastuzumab,gene,0.9683,28186982
19070,Pertuzumab,gene,0.942,28186982
19071,Epidermal Growth Factor Receptor,gene,0.998,28186982
19072,EGFR,gene,0.991,28186982
19073,AvidinOX,gene,0.9624,28186982
19074,Panitumumab,gene,0.936,28186982
19075,tumor,disease,1.0,28186982
19076,AvidinOX,gene,0.9224,28186982
19077,EGFR family,gene,0.992,28186982
19078,Chromosome 20q,DNA,0.837,28184012
19079,colorectal carcinoma,disease,1.0,28184012
19080,harboring chromosome,DNA,0.4355,28184012
19081,20q,DNA,0.788,28184012
19082,Tumor and normal DNA,DNA,0.765,28184012
19083,patients,species,0.9663,28184012
19084,advanced colorectal carcinoma,disease,1.0,28184012
19085,Oncoscan,DNA,0.694,28184012
19086,transcript,RNA,0.62,28184012
19087,Cancer,disease,0.8457,28184012
19088,colorectal carcinoma,disease,1.0,28184012
19089,colorectal carcinoma,disease,1.0,28184012
19090,patients,species,0.984,28184012
19091,20q,DNA,0.831,28184012
19092,20q,DNA,0.8584,28184012
19093,MSK,cell_line,0.4922,28184012
19094,BCL2L1,gene,0.9985,28184012
19095,20q oncogene,DNA,0.897,28184012
19096,SRC,gene,0.9966,28184012
19097,20q oncogene,DNA,0.9497,28184012
19098,mRNA,RNA,0.8677,28184012
19099,RAS,gene,0.987,28184012
19100,RAF,gene,0.998,28184012
19101,20q,DNA,0.5063,28184012
19102,colorectal carcinoma,disease,0.9995,28184012
19103,20q,DNA,0.8677,28184012
19104,wild,DNA,0.5444,28184012
19105,wild-type KRAS,gene,0.9966,28184012
19106,BRAF,gene,0.995,28184012
19107,tumors,disease,0.833,28184012
19108,mutant TP53,DNA,0.498,28184012
19109,mutant TP53,gene,0.9956,28184012
19110,chromosome 20q,DNA,0.8843,28184012
19111,diploid 20q,DNA,0.6265,28184012
19112,20q,DNA,0.8794,28184012
19113,colorectal cancer,disease,1.0,28184012
19114,patients,species,0.9854,28184012
19115,20q oncogenes,DNA,0.918,28184012
19116,SRC,gene,0.991,28184012
19117,patients,species,0.9814,28184012
19118,EGFR,gene,0.979,28152526
19119,Advanced Squamous Cell Anal Carcinomas,disease,0.973,28152526
19120,squamous,cell_type,0.515,28152526
19121,squamous cell anal carcinomas,disease,1.0,28152526
19122,epidermal growth factor receptor,gene,0.9976,28152526
19123,EGFR,gene,0.9937,28152526
19124,advanced squamous cell anal carcinomas,disease,0.991,28152526
19125,Cancer Tumor,disease,0.774,28152526
19126,advanced squamous cell anal carcinomas,disease,1.0,28152526
19127,EGFR,gene,0.992,28152526
19128,cetuximab,gene,0.9155,28152526
19129,panitumumab,gene,0.8916,28152526
19130,cetuximab,gene,0.8325,28152526
19131,panitumumab,gene,0.9365,28152526
19132,irinotecan,drug,0.998,28152526
19133,FOLFIRI,drug,0.9766,28152526
19134,EGFR,gene,0.9854,28152526
19135,squamous cell anal carcinomas,disease,1.0,28152526
19136,Mouse,species,0.928,28151706
19137,Epidermal Growth Factor Receptor (,disease,0.9995,28151706
19138,Epidermal Growth Factor Receptor,gene,0.975,28151706
19139,EGFR)-expressing Lung Cancer,disease,0.9565,28151706
19140,EGFR,gene,0.9927,28151706
19141,cancer,disease,1.0,28151706
19142,tumors,disease,1.0,28151706
19143,xenograft models,cell_line,0.572,28151706
19144,cancer,disease,0.9995,28151706
19145,spontaneous lung cancer,disease,0.98,28151706
19146,human EGFR,gene,0.9946,28151706
19147,hEGFR-TL,gene,0.6846,28151706
19148,Mice,species,0.9214,28151706
19149,panitumumab,gene,0.788,28151706
19150,EGFR,gene,0.9956,28151706
19151,APC,drug,0.998,28151706
19152,lung tumors,disease,1.0,28151706
19153,tumor,disease,0.7637,28151706
19154,spontaneous lung cancer,disease,0.903,28151706
19155,hEGFR-TL,gene,0.525,28151706
19156,mouse,species,0.896,28151706
19157,EZH2,gene,0.994,28147317
19158,colorectal cancer,disease,1.0,28147317
19159,EGFR,gene,0.983,28147317
19160,polycomb group protein,gene,0.948,28147317
19161,enhancer of zeste homolog 2,gene,0.969,28147317
19162,EZH2,gene,0.995,28147317
19163,microRNA-,RNA,0.722,28147317
19164,microRNA-31,gene,0.927,28147317
19165,miR-31,gene,0.856,28147317
19166,malignancies,disease,0.9844,28147317
19167,colorectal cancer,disease,1.0,28147317
19168,miR,RNA,0.491,28147317
19169,miR-31,gene,0.907,28147317
19170,epidermal growth factor receptor,gene,0.998,28147317
19171,EGFR,gene,0.99,28147317
19172,colorectal cancer,disease,1.0,28147317
19173,EZH2,gene,0.992,28147317
19174,colorectal cancer,disease,1.0,28147317
19175,EGFR,gene,0.9624,28147317
19176,EZH2,gene,0.9927,28147317
19177,miR-,RNA,0.5854,28147317
19178,miR-31,gene,0.7773,28147317
19179,KRAS,gene,0.703,28147317
19180,codon 61/146,DNA,0.7915,28147317
19181,NRAS,gene,0.7114,28147317
19182,codon 12/13/61,DNA,0.81,28147317
19183,BRAF,DNA,0.8174,28147317
19184,BRAF (,gene,0.99,28147317
19185,codon 600,DNA,0.57,28147317
19186,colorectal cancer,disease,1.0,28147317
19187,KRAS (codon 12/13),DNA,0.7173,28147317
19188,KRAS (codon 12/13) wild,gene,0.8896,28147317
19189,EZH2,gene,0.9937,28147317
19190,colorectal cancer,disease,1.0,28147317
19191,miR-31,gene,0.5093,28147317
19192,KRAS,gene,0.8115,28147317
19193,codon 61/146,DNA,0.686,28147317
19194,NRAS,gene,0.7173,28147317
19195,BRAF,gene,0.9956,28147317
19196,EZH2,gene,0.9956,28147317
19197,EZH2,gene,0.994,28147317
19198,miR,RNA,0.565,28147317
19199,EZH2,gene,0.996,28147317
19200,colorectal cancer,disease,1.0,28147317
19201,EGFR,gene,0.969,28147317
19202,EZH2,gene,0.9966,28147317
19203,cancer,disease,1.0,28147317
19204,EZH2,gene,0.992,28147317
19205,EGFR,gene,0.9194,28147317
19206,Bevacizumab,gene,0.5503,28142137
19207,Patients,species,0.9673,28142137
19208,Anti-epidermal growth factor receptor,gene,0.8916,28142137
19209,EGFR,gene,0.9614,28142137
19210,patients,species,0.9546,28142137
19211,metastatic colorectal cancer,disease,0.998,28142137
19212,bevacizumab,gene,0.597,28142137
19213,anti-EGFR antibody,gene,0.7935,28142137
19214,patients,species,0.9883,28142137
19215,bevacizumab,gene,0.807,28142137
19216,anti-EGFR antibody,gene,0.9346,28142137
19217,patients,species,0.987,28142137
19218,bevacizumab,gene,0.799,28142137
19219,EGFR,gene,0.689,28142137
19220,bevacizumab,gene,0.9526,28142137
19221,anti-EGFR antibody,gene,0.964,28142137
19222,Herpes zoster,disease,0.999,28140550
19223,Panitumumab,gene,0.772,28140550
19224,colorectal tumors,disease,1.0,28138221
19225,Colorectal cancer,disease,1.0,28138221
19226,geriatric,disease,0.9004,28138221
19227,patients,species,0.9854,28138221
19228,colorectal tumors,disease,1.0,28138221
19229,bevacizumab,gene,0.822,28138221
19230,cetuximab,gene,0.9307,28138221
19231,panitumumab,gene,0.903,28138221
19232,Bevacizumab,gene,0.592,28138221
19233,VEGF,gene,0.9927,28138221
19234,Cetuximab,gene,0.8096,28138221
19235,panitumumab,gene,0.6484,28138221
19236,EGFR,gene,0.992,28138221
19237,VEGFR-2,gene,0.9805,28138221
19238,VEGF-A,gene,0.9976,28138221
19239,VEGF-C,gene,0.998,28138221
19240,VEGF-D,gene,0.9985,28138221
19241,patient,species,0.9844,28138221
19242,colorectal tumors,disease,1.0,28138221
19243,anti-DR5,gene,0.9937,28138221
19244,anti-IGF-1R,gene,0.9976,28138221
19245,anti-EGFR,gene,0.998,28138221
19246,anti-NRP1,gene,0.9966,28138221
19247,anti-A33 antibodies,gene,0.994,28138221
19248,patients,species,0.9917,28138221
19249,locally advanced sigmoid colon cancer,disease,0.9717,28135678
19250,FOLFOX,drug,0.592,28135678
19251,panitumumab,gene,0.82,28135678
19252,metastatic colorectal cancer,disease,0.9985,28135678
19253,man,species,0.838,28135678
19254,abdominal pain,disease,0.999,28135678
19255,pneumaturia,disease,0.999,28135678
19256,RAS,gene,0.9976,28135678
19257,colovesical fistulas,disease,1.0,28135678
19258,cancer,disease,0.852,28135678
19259,oxaliplatin,drug,1.0,28135678
19260,leucovorin,drug,0.999,28135678
19261,5-fluorouracil,drug,0.9995,28135678
19262,panitumumab,gene,0.9595,28135678
19263,tumor,disease,0.941,28135678
19264,degenerated tumor,disease,0.7134,28135678
19265,patient,species,0.9854,28135678
19266,patient,species,0.975,28135678
19267,colorectal cancer,disease,0.989,28135678
19268,panitumumab,gene,0.708,28135678
19269,Patient,species,0.9683,28133349
19270,Sigmoid Colon Cancer,disease,1.0,28133349
19271,woman,species,0.8784,28133349
19272,pelvic tumor,disease,0.9966,28133349
19273,sigmoid colon cancer,disease,1.0,28133349
19274,patient,species,0.9873,28133349
19275,XELOX,drug,0.983,28133349
19276,IRIS,drug,0.9873,28133349
19277,Brain metastasis,disease,0.99,28133349
19278,Liver metastasis,disease,0.9775,28133349
19279,peritoneal dissemination,disease,0.8623,28133349
19280,patient,species,0.975,28133349
19281,brain metastasis,disease,0.902,28133349
19282,TAS-102,drug,0.9897,28133349
19283,CPT-11,drug,0.999,28133349
19284,panitumumab,gene,0.8784,28133349
19285,patient,species,0.9595,28133349
19286,Metastatic Colorectal Cancer,disease,1.0,28133304
19287,HER2,gene,0.98,28133304
19288,panitumumab,gene,0.7134,28133304
19289,rectal cancer,disease,0.9966,28133304
19290,HER2 gene,gene,0.983,28133304
19291,man,species,0.8975,28133304
19292,obstructive rectal cancer,disease,1.0,28133304
19293,KRAS,DNA,0.834,28133304
19294,KRAS,gene,0.9795,28133304
19295,CapeOx,drug,0.998,28133304
19296,bevacizumab,gene,0.7603,28133304
19297,lung and adrenal metastases,disease,0.848,28133304
19298,IRIS,drug,0.991,28133304
19299,panitumumab,gene,0.9795,28133304
19300,regorafenib,drug,0.9956,28133304
19301,TAS-102,drug,0.995,28133304
19302,cerebellar metastases,disease,0.953,28133304
19303,patient,species,0.953,28133304
19304,cerebellar metastases,disease,0.9478,28133304
19305,cancer,disease,0.997,28133304
19306,413 cancer-related genes,DNA,0.659,28133304
19307,cancer,disease,0.9966,28133304
19308,EGFR,gene,0.9946,28133304
19309,BRAF,gene,0.993,28133304
19310,KRAS,DNA,0.78,28133304
19311,KRAS,gene,0.974,28133304
19312,NRAS,gene,0.986,28133304
19313,HRAS,DNA,0.854,28133304
19314,HRAS,gene,0.986,28133304
19315,ERBB2,gene,0.988,28133304
19316,HER2 protein,gene,0.9814,28133304
19317,bone metastatictumor,disease,0.8647,28133304
19318,HER2,gene,0.9966,28133304
19319,EGFR,gene,0.985,28133304
19320,RAS,gene,0.994,28133304
19321,RAF,gene,0.9985,28133304
19322,MAPK,gene,0.993,28133304
19323,EGFR,gene,0.6904,28133304
19324,ERBB2,DNA,0.667,28133304
19325,ERBB2,gene,0.9927,28133304
19326,metastatic tumor,disease,0.993,28133304
19327,Oncogene,DNA,0.8955,28133295
19328,Tumor Suppressor Genes,DNA,0.7896,28133295
19329,man,species,0.9204,28133295
19330,rectal cancer,disease,1.0,28133295
19331,liver metastasis,disease,0.8706,28133295
19332,lung metastases,disease,0.8047,28133295
19333,XELOX,drug,0.668,28133295
19334,bevacizumab,gene,0.7935,28133295
19335,cancer,disease,0.9424,28133295
19336,tumor,disease,0.9995,28133295
19337,KRAS,DNA,0.7285,28133295
19338,KRAS wild,gene,0.751,28133295
19339,XELOX,drug,0.615,28133295
19340,brain metastases,disease,0.955,28133295
19341,IRIS,drug,0.627,28133295
19342,panitumumab,gene,0.886,28133295
19343,"liver, lung, and brain metastases",disease,0.825,28133295
19344,cancer-related genes,DNA,0.49,28133295
19345,cancer,disease,1.0,28133295
19346,BRAF gene,gene,0.994,28133295
19347,I326,mutation,,28133295
19348,BRAF,gene,0.9966,28133295
19349,KRAS,DNA,0.8296,28133295
19350,KRAS,gene,0.966,28133295
19351,RAS,gene,0.9707,28133295
19352,RAF,gene,0.9985,28133295
19353,MAPK,gene,0.9893,28133295
19354,BRAF gene,gene,0.996,28133295
19355,panitumumab,gene,0.7905,28133295
19356,oncogene,DNA,0.8687,28133295
19357,suppressor oncogenes,DNA,0.77,28133295
19358,patient,species,0.9893,28133295
19359,colorectal cancer,disease,1.0,28133295
19360,Retroperitoneal Metastasis,disease,1.0,28133258
19361,Ascending Colon Cancer,disease,0.9985,28133258
19362,patient,species,0.988,28133258
19363,ascending colon cancer,disease,1.0,28133258
19364,tumor,disease,0.9014,28133258
19365,tumor,disease,0.5664,28133258
19366,panitumumab,gene,0.6724,28133258
19367,tumor,disease,0.9346,28133258
19368,colon cancer,disease,1.0,28133258
19369,recurrent tumors,disease,0.93,28133258
19370,tumors,disease,1.0,28133258
19371,colon cancer,disease,1.0,28133258
19372,recurrent tumor,disease,0.99,28133258
19373,retroperitoneal,disease,0.8574,28133258
19374,Hyperbilirubinemia,disease,0.996,28133116
19375,hyperbilirubinemia,disease,0.997,28133116
19376,liver metastases,disease,0.999,28133116
19377,colorectal cancer,disease,1.0,28133116
19378,patients,species,0.9893,28133116
19379,man,species,0.845,28133116
19380,transverse colon cancer,disease,1.0,28133116
19381,primary,DNA,0.4597,28133116
19382,bevacizumab,gene,0.762,28133116
19383,panitumumab,gene,0.8687,28133116
19384,liver,disease,0.948,28133116
19385,Conjugated hyperbilirubinemia,disease,1.0,28133116
19386,biliary stenosis,disease,1.0,28133116
19387,prednisolone,drug,0.5728,28133116
19388,hyperbilirubinemia,disease,0.9995,28133116
19389,patient,species,0.9717,28133116
19390,man,species,0.841,28133116
19391,liver,disease,0.6777,28133116
19392,CapeOX,drug,0.992,28133116
19393,Conjugated hyperbilirubinemia,disease,0.9976,28133116
19394,prednisolone,drug,0.978,28133116
19395,hyperbilirubinemia,disease,0.9985,28133116
19396,fatty changes in the liver,disease,0.933,28133116
19397,hyperbilirubinemia,disease,0.989,28133116
19398,hyperbilirubinemia,disease,1.0,28133116
19399,Sigmoid Colon Cancer,disease,1.0,28133115
19400,man,species,0.881,28133115
19401,sigmoid colon cancer,disease,1.0,28133115
19402,liver metastases,disease,0.997,28133115
19403,panitumumab,gene,0.538,28133115
19404,cholecystectomy,disease,0.886,28133115
19405,liver metastases,disease,0.8306,28133115
19406,liver metastases,disease,0.882,28133115
19407,Patients,species,0.9917,28133082
19408,recurrent rectal cancer,disease,0.928,28133082
19409,patients,species,0.977,28133082
19410,lymph node,disease,0.646,28133082
19411,rectal cancer,disease,1.0,28133082
19412,Patient,species,0.9746,28133082
19413,woman,species,0.929,28133082
19414,Patient,species,0.9785,28133082
19415,man,species,0.916,28133082
19416,rectal cancer,disease,1.0,28133082
19417,FOLFIRI,drug,0.9097,28133082
19418,panitumumab,gene,0.9346,28133082
19419,Patient,species,0.9854,28133082
19420,man,species,0.9253,28133082
19421,Patient,species,0.983,28133082
19422,man,species,0.9185,28133082
19423,right internal artery,DNA,0.4753,28133082
19424,patients,species,0.99,28133082
19425,patients,species,0.974,28133082
19426,patients,species,0.985,28133082
19427,chronic hypomagnesemia,disease,1.0,28114816
19428,cancer,disease,1.0,28114816
19429,Hypomagnesemia,disease,1.0,28114816
19430,patients,species,0.965,28114816
19431,chronic hypomagnesemia,disease,0.963,28114816
19432,magnesium wasting,disease,0.981,28114816
19433,magnesium,drug,0.999,28114816
19434,woman,species,0.8027,28114816
19435,head and neck cancer,disease,1.0,28114816
19436,syncopal,disease,0.978,28114816
19437,carboplatin,drug,0.999,28114816
19438,magnesium,drug,0.9995,28114816
19439,renal wasting of magnesium,disease,0.999,28114816
19440,magnesium,drug,0.9614,28114816
19441,hypomagnesemia,disease,1.0,28114816
19442,carboplatin,drug,0.9995,28114816
19443,renal tubular damage,disease,0.769,28114816
19444,magnesium,drug,0.9995,28114816
19445,chronic hypomagnesemia,disease,1.0,28114816
19446,epidermal growth factor receptor,gene,0.9106,28114816
19447,cetuximab,gene,0.7725,28114816
19448,panitumumab,gene,0.785,28114816
19449,cyclosporine,drug,0.9976,28114816
19450,platinum,drug,0.997,28114816
19451,cisplatin,drug,0.9995,28114816
19452,carboplatin,drug,0.999,28114816
19453,chronic hypomagnesemia,disease,0.9985,28114816
19454,carboplatin,drug,0.9995,28114816
19455,cancer,disease,1.0,28114816
19456,cancer,disease,0.9995,28114816
19457,patients,species,0.9937,28114816
19458,hypomagnesemia,disease,1.0,28114816
19459,hypomagnesemia,disease,1.0,28114816
19460,renal,disease,0.5835,28114816
19461,platinum,drug,0.9995,28114816
19462,panitumumab,gene,0.8867,28107090
19463,panitumumab,gene,0.8896,28107090
19464,oxaliplatin,drug,1.0,28107090
19465,5-fluorouracil,drug,0.9995,28107090
19466,leucovorin,drug,0.998,28107090
19467,bevacizumab,gene,0.678,28107090
19468,patients,species,0.961,28107090
19469,wild-type RAS,gene,0.898,28107090
19470,mCRC,disease,0.9995,28107090
19471,patient,species,0.9844,28107090
19472,patient,species,0.986,28107090
19473,panitumumab,gene,0.854,28107090
19474,panitumumab,gene,0.9,28107090
19475,bevacizumab,gene,0.6685,28107090
19476,wild-type RAS,gene,0.9795,28107090
19477,mCRC,disease,0.9995,28107090
19478,patients,species,0.9946,28107090
19479,mCRC,disease,0.811,28107090
19480,panitumumab,gene,0.884,28107090
19481,bevacizumab,gene,0.8315,28107090
19482,colorectal cancer,disease,1.0,28105616
19483,aspirin,drug,0.994,28105616
19484,patients,species,0.9185,28105616
19485,colorectal cancer,disease,1.0,28105616
19486,metastatic colorectal cancer,disease,1.0,28105616
19487,mCRC,disease,1.0,28105616
19488,bevacizumab,gene,0.903,28105616
19489,cetuximab,gene,0.8564,28105616
19490,patients,species,0.9834,28105616
19491,panitumumab,gene,0.911,28105616
19492,cetuximab,gene,0.882,28105616
19493,left,DNA,0.5195,28105616
19494,left-sided tumors,disease,0.9756,28105616
19495,EGFR,gene,0.992,28105616
19496,metastatic colorectal cancer,disease,0.9995,28105616
19497,Cetuximab,gene,0.884,28105616
19498,panitumumab,gene,0.85,28105616
19499,patients,species,0.97,28105616
19500,metastatic colorectal cancer,disease,1.0,28105616
19501,tumor,disease,0.9834,28105616
19502,EGFR,gene,0.993,28105616
19503,bevacizumab,gene,0.784,28105616
19504,patients,species,0.979,28105616
19505,left,disease,0.6064,28105616
19506,PD-1,gene,0.9956,28105616
19507,patients,species,0.923,28105616
19508,deficient mismatch repair (dMMR) colorectal cancer,disease,1.0,28105616
19509,dMMR tumors,disease,1.0,28105616
19510,dMMR tumors,disease,1.0,28105616
19511,PD-1,gene,0.995,28105616
19512,Epidermal Growth Factor Receptor,gene,0.9985,28104566
19513,triple negative breast cancer,disease,1.0,28104566
19514,Triple negative breast cancer,disease,1.0,28104566
19515,TNBC,disease,1.0,28104566
19516,breast cancer,disease,1.0,28104566
19517,HER2,gene,0.9277,28104566
19518,breast cancers,disease,0.9917,28104566
19519,TNBC,disease,0.9995,28104566
19520,patients,species,0.9683,28104566
19521,TNBC,disease,0.9937,28104566
19522,EGFR,gene,0.9966,28104566
19523,EGFR,gene,0.9966,28104566
19524,tyrosine,drug,0.9854,28104566
19525,tyrosine kinase,gene,0.9443,28104566
19526,EGFR,gene,0.994,28104566
19527,TNBC,disease,0.9897,28104566
19528,TNBC,disease,0.9946,28104566
19529,polyethylene glycol,drug,0.9995,28089687
19530,-CyD,gene,0.5854,28089687
19531,polyethylene glycol,drug,0.999,28089687
19532,omalizumab,gene,0.902,28089687
19533,palivizumab,gene,0.919,28089687
19534,panitumumab,gene,0.8877,28089687
19535,ranibizumab,gene,0.5996,28089687
19536,omalizumab,gene,0.967,28089687
19537,immunoglobulin E receptor,gene,0.9966,28089687
19538,omalizumab,gene,0.982,28089687
19539,rats,species,0.991,28089687
19540,omalizumab,gene,0.98,28089687
19541,CyD PPRX,drug,0.718,28089687
19542,CyD PPRX,drug,0.6367,28089687
19543,metastatic disease,disease,0.92,28056412
19544,cetuximab,gene,0.805,28056412
19545,crizotinib,drug,0.998,28056412
19546,erlotinib,drug,0.9937,28056412
19547,gefitinib,drug,0.9995,28056412
19548,ipilimumab,drug,0.8325,28056412
19549,lapatinib,drug,0.9995,28056412
19550,sorafenib,drug,0.9995,28056412
19551,sunitinib,drug,0.9995,28056412
19552,trastuzumab,gene,0.9805,28056412
19553,vemurafenib,drug,0.998,28056412
19554,PLX4032,drug,0.999,28056412
19555,panitumumab,gene,0.861,28056412
19556,nivolumab,drug,0.9395,28056412
19557,pembrolizumab,drug,0.9453,28056412
19558,alectinib,drug,0.844,28056412
19559,ceritinib,drug,0.998,28056412
19560,dabrafenib,drug,0.9985,28056412
19561,trametinib,drug,0.999,28056412
19562,BRAF,gene,0.9956,28056412
19563,TKI,gene,0.9976,28056412
19564,MEK,gene,0.997,28056412
19565,PD1,gene,0.996,28056412
19566,EGFR,gene,0.995,28056412
19567,CTLA-4,gene,0.997,28056412
19568,ALK,gene,0.9946,28056412
19569,BRAF,gene,0.9907,28056412
19570,EGFR,gene,0.9966,28056412
19571,tyrosine,drug,0.927,28056412
19572,tyrosine kinase,gene,0.8354,28056412
19573,panitumumab,gene,0.9326,28040660
19574,PMab,gene,0.9297,28040660
19575,Patients,species,0.922,28040660
19576,squamous cell head-neck carcinoma,disease,1.0,28040660
19577,cisplatin,drug,0.999,28040660
19578,patients,species,0.9575,28040660
19579,p16,gene,0.997,28040660
19580,p16,gene,0.997,28040660
19581,HN,disease,,28040660
19582,cisplatin,drug,0.9985,28040660
19583,anti-EGFR antibody,gene,0.9595,28038457
19584,Epidermal growth factor receptor,gene,0.996,28038457
19585,EGFR,gene,0.9927,28038457
19586,Sym004,drug,0.502,28038457
19587,anti-EGFR antibody,gene,0.9414,28038457
19588,chimeric IgG1 antibodies,gene,0.7803,28038457
19589,EGFR,gene,0.9854,28038457
19590,EGFR,gene,0.987,28038457
19591,esophageal squamous cell carcinomas,disease,1.0,28038457
19592,ESCCs,disease,1.0,28038457
19593,Sym004,drug,0.943,28038457
19594,human ESCC cell lines,cell_line,0.9717,28038457
19595,human,species,0.8584,28038457
19596,ESCC,disease,0.741,28038457
19597,ESCC cell lines,cell_line,0.899,28038457
19598,ESCC,disease,1.0,28038457
19599,anti-EGFR antibodies,gene,0.8843,28038457
19600,cetuximab,gene,0.86,28038457
19601,panitumumab,gene,0.853,28038457
19602,anti-EGFR antibodies,gene,0.9497,28038457
19603,ESCC cells,cell_line,0.866,28038457
19604,ESCC cells,cell_type,0.7534,28038457
19605,ESCC,disease,0.9995,28038457
19606,EGFR,gene,0.993,28038457
19607,anti-EGFR antibodies,gene,0.9746,28038457
19608,anti-EGFR antibody,gene,0.847,28038457
19609,EGFR,gene,0.9863,28038457
19610,anti-EGFR antibodies,gene,0.9673,28038457
19611,cell lines,cell_line,0.961,28038457
19612,EGFR gene,gene,0.991,28038457
19613,cetuximab,gene,0.973,28038457
19614,panitumumab,gene,0.9575,28038457
19615,Sym004,drug,0.9805,28038457
19616,ESCC cell lines,cell_line,0.8843,28038457
19617,ESCC,disease,0.9985,28038457
19618,patients,species,0.938,28038457
19619,ESCC,disease,1.0,28038457
19620,EGFR,gene,0.9917,28038457
19621,Sym004,drug,0.8525,28038457
19622,Bisegmental herpes zoster,disease,1.0,28036152
19623,wild-type EGFR,gene,0.998,28032593
19624,Anti-EGFR mAbs cetuximab,gene,0.8906,28032593
19625,panitumumab,gene,0.728,28032593
19626,patients,species,0.9434,28032593
19627,KRAS,gene,0.9966,28032593
19628,metastatic colorectal cancer,disease,1.0,28032593
19629,mCRC,disease,1.0,28032593
19630,patients,species,0.9897,28032593
19631,EGFR protein,gene,0.932,28032593
19632,anti-EGFR,gene,0.917,28032593
19633,wild-type EGFR,gene,0.9976,28032593
19634,wtEGFR,gene,0.994,28032593
19635,mutated EGFRvIII,gene,0.932,28032593
19636,EGFR ligand proteins,gene,0.796,28032593
19637,mCRC,disease,0.9995,28032593
19638,patients,species,0.9854,28032593
19639,cetuximab,gene,0.938,28032593
19640,wtEGFR,gene,0.9927,28032593
19641,EGFRvIII,gene,0.9966,28032593
19642,EGFR ligand,gene,0.983,28032593
19643,tumour,disease,1.0,28032593
19644,positive,cell_type,0.58,28032593
19645,tumour cells,cell_type,0.734,28032593
19646,tumour,disease,0.9795,28032593
19647,wtEGFR,gene,0.982,28032593
19648,EGFRvIII,gene,0.995,28032593
19649,betacellulin,gene,0.985,28032593
19650,BTC,gene,0.995,28032593
19651,epigen,DNA,0.577,28032593
19652,epigen,gene,0.9517,28032593
19653,TGF,gene,0.9966,28032593
19654,amphiregulin,gene,0.997,28032593
19655,EGF,gene,0.996,28032593
19656,wtEGFR,gene,0.9966,28032593
19657,wtEGFR,gene,0.992,28032593
19658,cetuximab,gene,0.7153,28032593
19659,wtEGFR,DNA,0.5503,28032593
19660,wtEGFR,gene,0.992,28032593
19661,cetuximab,gene,0.7227,28032593
19662,BTC,gene,0.9487,28032593
19663,epigen,gene,0.944,28032593
19664,wtEGFR,gene,0.9897,28032593
19665,wtEGFR,gene,0.992,28032593
19666,anti-EGFR antibodies,gene,0.9507,28032593
19667,anti-EGFR mAbs,gene,0.876,28032593
19668,mCRC,disease,0.9995,28032593
19669,patients,species,0.992,28032593
19670,Colorectal Cancers,disease,1.0,27999270
19671,tumours,disease,1.0,27999270
19672,colorectal cancer,disease,1.0,27999270
19673,CRC,disease,1.0,27999270
19674,patients,species,0.9844,27999270
19675,RAS,gene,0.994,27999270
19676,KRAS,DNA,0.8994,27999270
19677,KRAS,gene,0.992,27999270
19678,NRAS,gene,0.987,27999270
19679,anti-,gene,0.664,27999270
19680,epidermal growth factor receptor,gene,0.921,27999270
19681,anti-,gene,0.8604,27999270
19682,EGFR,gene,0.7407,27999270
19683,short DNA sequences,DNA,0.6577,27999270
19684,colorectal cancer,disease,1.0,27999270
19685,colorectal cancer,disease,1.0,27993089
19686,metastatic colorectal cancer,disease,1.0,27993089
19687,patients,species,0.988,27993089
19688,oxaliplatin,drug,0.9995,27993089
19689,irinotecan,drug,0.998,27993089
19690,5-fluorouracil,drug,0.9995,27993089
19691,levofolinate,drug,0.9995,27993089
19692,VEGFA,gene,0.993,27993089
19693,bevacizumab,gene,0.92,27993089
19694,EGF receptor,gene,0.9966,27993089
19695,cetuximab,gene,0.956,27993089
19696,panitumumab,gene,0.916,27993089
19697,metastatic colorectal cancer,disease,1.0,27993089
19698,patients,species,0.995,27993089
19699,tumor,disease,0.9575,27993089
19700,cancer,disease,0.9995,27993089
19701,Colorectal Cancer,disease,1.0,27943689
19702,advanced colorectal cancer,disease,0.998,27943689
19703,metastatic colorectal cancer,disease,0.989,27943689
19704,metastatic colorectal cancer,disease,0.998,27943689
19705,irinotecan,drug,0.999,27943689
19706,oxaliplatin,drug,0.9995,27943689
19707,bevacizumab,gene,0.9565,27943689
19708,cetuximab,gene,0.9463,27943689
19709,panitumumab,gene,0.9307,27943689
19710,metastatic colorectal cancer,disease,0.9893,27943689
19711,mutant RAS,disease,0.947,27943689
19712,mutant BRAF V600E tumors,disease,0.7,27943689
19713,mutant BRAF V600E,gene,0.87,27943689
19714,V600E,mutation,,27943689
19715,bevacizumab,gene,0.8926,27943689
19716,anti-epidermal growth factor antibody,gene,0.9707,27943689
19717,anti-,gene,0.952,27943689
19718,vascular endothelial growth factor antibody,gene,0.918,27943689
19719,RAS wild-type tumors,disease,0.565,27943689
19720,RAS,gene,0.993,27943689
19721,metastatic colorectal cancer,disease,0.989,27943689
19722,Cisplatin,drug,0.997,27930762
19723,Cancer,disease,0.5586,27930762
19724,anti-epidermal growth factor receptor,gene,0.955,27930762
19725,EGFR,gene,0.983,27930762
19726,locoregionally advanced squamous cell carcinoma,disease,0.995,27930762
19727,LA-SCCHN,disease,0.998,27930762
19728,patients,species,0.921,27930762
19729,LA-SCCHN,disease,0.998,27930762
19730,cisplatin,drug,0.987,27930762
19731,anti-EGFR antibody panitumumab,gene,0.849,27930762
19732,PARTICIPANTS,species,0.697,27930762
19733,patients,species,0.986,27930762
19734,Patients,species,0.9526,27930762
19735,LA-SCCHN,disease,1.0,27930762
19736,cisplatin,drug,0.9956,27930762
19737,panitumumab,gene,0.8716,27930762
19738,patients,species,0.9746,27930762
19739,panitumumab,gene,0.836,27930762
19740,cisplatin,drug,0.993,27930762
19741,LA-SCCHN,disease,0.9966,27930762
19742,HN.6,cell_line,0.8345,27930762
19743,RAS,gene,0.9966,27929064
19744,EGFR,DNA,0.4956,27929064
19745,EGFR mutations,gene,0.9233,27929064
19746,EGFR,gene,0.976,27929064
19747,epidermal growth factor receptor,gene,0.9966,27929064
19748,EGFR,gene,0.994,27929064
19749,panitumumab,gene,0.8955,27929064
19750,colorectal cancers,disease,1.0,27929064
19751,CRCs,disease,1.0,27929064
19752,patients,species,0.982,27929064
19753,RAS,DNA,0.656,27929064
19754,RAS mutations,gene,0.8174,27929064
19755,EGFR extracellular domain,gene,0.9907,27929064
19756,ECD,gene,0.737,27929064
19757,patients,species,0.993,27929064
19758,EGFR,gene,0.987,27929064
19759,EGFR ECD,gene,0.9956,27929064
19760,RAS,DNA,0.579,27929064
19761,RAS,gene,0.9927,27929064
19762,patients,species,0.976,27929064
19763,tumour,disease,0.832,27929064
19764,cell-free tumour DNA,DNA,0.6187,27929064
19765,cell,RNA,0.505,27929064
19766,tumour,disease,0.7114,27929064
19767,patients,species,0.9917,27929064
19768,anti-EGFR antibodies,gene,0.9185,27929064
19769,RAS,DNA,0.6353,27929064
19770,RAS mutations,gene,0.976,27929064
19771,EGFR ECD variants,gene,0.8853,27929064
19772,RAS,gene,0.957,27929064
19773,EGFR ECD,DNA,0.751,27929064
19774,EGFR ECD mutations,gene,0.825,27929064
19775,CRC,disease,1.0,27929064
19776,EGFR,gene,0.986,27929064
19777,drug-resistant cells,cell_line,0.8354,27929064
19778,drug,cell_type,0.774,27929064
19779,-,cell_type,0.553,27929064
19780,resistant cells,cell_type,0.62,27929064
19781,CRC,disease,0.999,27929064
19782,patients,species,0.9893,27929064
19783,anti-,gene,0.745,27929064
19784,EGFR antibodies,gene,0.761,27929064
19785,metastatic colorectal cancer,disease,0.998,27907852
19786,PTL,drug,0.931,27907852
19787,metastatic colorectal cancer,disease,1.0,27907852
19788,mCRC,disease,1.0,27907852
19789,Right- and left-sided colorectal cancers,disease,1.0,27907852
19790,RC,disease,0.9927,27907852
19791,LC,disease,0.906,27907852
19792,RC,disease,0.985,27907852
19793,LC,disease,0.9976,27907852
19794,anti-EGFR antibody,gene,0.746,27907852
19795,RAS wild-type tumour,disease,0.6157,27907852
19796,RAS,gene,0.991,27907852
19797,LC,disease,0.969,27907852
19798,RAS wild-type LC,disease,0.997,27907852
19799,RAS,gene,0.9937,27907852
19800,EGFR,gene,0.715,27907852
19801,VEGF,gene,0.916,27907852
19802,RC,disease,0.999,27907852
19803,bevacizumab,gene,0.9185,27907852
19804,PTL,drug,0.857,27907852
19805,mCRC,disease,0.9893,27907852
19806,RAS,gene,0.4998,27907852
19807,mCRC,disease,0.9775,27907852
19808,anti-,gene,0.6714,27907852
19809,EGFR antibody,gene,0.624,27907852
19810,mCRC,disease,0.864,27907852
19811,bevacizumab,gene,0.669,27907852
19812,Skin toxicities,disease,0.984,27901405
19813,patients,species,0.974,27901405
19814,cancer,disease,1.0,27901405
19815,EGFR,gene,0.9937,27901405
19816,epidermal growth factor receptor,gene,0.9995,27901405
19817,patients,species,0.9844,27901405
19818,solid and metastatic tumours,disease,1.0,27901405
19819,Skin toxicities,disease,0.9976,27901405
19820,skin,disease,0.63,27901405
19821,patients,species,0.9434,27901405
19822,cancer,disease,1.0,27901405
19823,EGFR,gene,0.9824,27901405
19824,patients,species,0.9785,27901405
19825,skin toxicities,disease,0.767,27901405
19826,itching skin,disease,0.932,27901405
19827,rash,disease,1.0,27901405
19828,Patients,species,0.984,27901405
19829,skin,disease,0.721,27901405
19830,patients,species,0.9766,27901405
19831,EGFR,gene,0.9893,27901405
19832,EGFR gene,gene,0.9927,27879995
19833,EGFR,gene,0.8853,27879995
19834,RAS,gene,0.994,27879995
19835,Anti-EGFR antibodies,gene,0.8145,27879995
19836,RAS,gene,0.994,27879995
19837,colorectal cancer,disease,1.0,27879995
19838,EGFR gene,DNA,0.651,27879995
19839,EGFR gene,gene,0.8975,27879995
19840,EGFR,gene,0.9336,27879995
19841,KRAS exon 2,gene,0.9834,27879995
19842,metastatic colorectal cancer,disease,0.9985,27879995
19843,EGFR,gene,0.9956,27879995
19844,GCN,gene,0.9487,27879995
19845,RAS,gene,0.996,27879995
19846,BRAF,DNA,0.575,27879995
19847,BRAF,gene,0.999,27879995
19848,PIK3CA,gene,0.999,27879995
19849,metastatic colorectal cancer,disease,1.0,27879995
19850,patients,species,0.979,27879995
19851,KRAS exon 2,gene,0.9478,27879995
19852,metastatic colorectal cancer,disease,1.0,27879995
19853,EGFRcytotoxic,gene,0.9307,27879995
19854,KRAS,DNA,0.8413,27879995
19855,KRAS,gene,0.9814,27879995
19856,NRAS,gene,0.993,27879995
19857,BRAF,DNA,0.6763,27879995
19858,BRAF,gene,0.9985,27879995
19859,PIK3CA gene,gene,0.9683,27879995
19860,EGFR,gene,0.995,27879995
19861,GCN,DNA,0.5146,27879995
19862,EGFR,gene,0.99,27879995
19863,silver,drug,0.858,27879995
19864,EGFR,gene,0.9937,27879995
19865,EGFR,gene,0.604,27879995
19866,RAS,gene,0.9507,27879995
19867,BRAF,gene,0.998,27879995
19868,PIK3CA,gene,0.998,27879995
19869,patients,species,0.9673,27879995
19870,RAS,gene,0.9897,27879995
19871,BRAF,DNA,0.654,27879995
19872,BRAF,gene,0.998,27879995
19873,PIK3CA,gene,0.9985,27879995
19874,EGFR,gene,0.996,27879995
19875,patients,species,0.984,27879995
19876,patients,species,0.987,27879995
19877,mutant RAS,gene,0.5664,27879995
19878,BRAF,DNA,0.693,27879995
19879,BRAF,gene,0.9907,27879995
19880,PIK3CA,gene,0.995,27879995
19881,EGFR,gene,0.9956,27879995
19882,EGFR,gene,0.934,27879995
19883,patients,species,0.959,27879995
19884,RAS,DNA,0.5215,27879995
19885,RAS,gene,0.9907,27879995
19886,BRAF,gene,0.9976,27879995
19887,PIK3CA,gene,0.998,27879995
19888,metastatic CRC,disease,0.999,27879995
19889,Tumours,disease,1.0,27879995
19890,EGFR,gene,0.994,27879995
19891,EGFR,gene,0.883,27879995
19892,tumours,disease,1.0,27879995
19893,RAS,gene,0.9785,27879995
19894,RAF,DNA,0.6416,27879995
19895,RAF,gene,0.9937,27879995
19896,PIK3CA pathway genes,gene,0.9,27879995
19897,colorectal liver metastases,disease,1.0,27878479
19898,CLM,disease,0.9995,27878479
19899,morbid obesity,disease,0.9995,27878479
19900,PATIENT,species,0.984,27878479
19901,primary cancer,disease,0.9897,27878479
19902,liver metastasis,disease,0.5586,27878479
19903,metachronous CLM,disease,0.94,27878479
19904,SVII,DNA,0.4736,27878479
19905,choledochojejunostomy,disease,1.0,27878479
19906,FOLFIRI,drug,0.77,27878479
19907,panitumumab,gene,0.8857,27878479
19908,abdominal cancer,disease,1.0,27878479
19909,SVIII,disease,0.66,27878479
19910,anti-EGFR MoAb,gene,0.7686,27878357
19911,metastatic colorectal cancer,disease,1.0,27878357
19912,Skin toxicity,disease,0.9854,27878357
19913,ST,disease,0.9517,27878357
19914,tumor,disease,0.9995,27878357
19915,ETS,disease,0.681,27878357
19916,anti-epidermal growth factor receptor,gene,0.9937,27878357
19917,EGFR,gene,0.978,27878357
19918,ETS,gene,0.5034,27878357
19919,metastatic colorectal cancer,disease,0.9985,27878357
19920,mCRC,disease,0.999,27878357
19921,anti-EGFR MoAb,gene,0.9087,27878357
19922,mCRC,disease,0.993,27878357
19923,anti-EGFR MoAb,gene,0.7544,27878357
19924,anti-EGFR,gene,0.8276,27878357
19925,ST,disease,0.9214,27878357
19926,ETS,disease,0.9907,27878357
19927,anti-EGFR MoAb,gene,0.8164,27878357
19928,KRAS,gene,0.888,27878357
19929,mCRC,disease,0.999,27878357
19930,wild,DNA,0.547,27878357
19931,anti-EGFR,gene,0.7383,27878357
19932,BSC,DNA,0.4788,27878357
19933,ETS,gene,0.91,27878357
19934,anti-,gene,0.55,27878357
19935,EGFR,gene,0.573,27878357
19936,wild,cell_line,0.563,27878357
19937,wild-type KRAS tumors,disease,0.811,27878357
19938,tumor,disease,0.911,27878357
19939,anti-EGFR,gene,0.7754,27878357
19940,mCRC,disease,0.998,27878357
19941,KRAS,DNA,0.5747,27878357
19942,Panitumumab,gene,0.8765,27872609
19943,cancer,disease,0.9995,27872609
19944,patient,species,0.969,27872609
19945,encephalopathy,disease,1.0,27872609
19946,coma,disease,0.999,27872609
19947,panitumumab,gene,0.9194,27872609
19948,metastatic colorectal cancer,disease,1.0,27872609
19949,patient,species,0.982,27872609
19950,Toxic encephalopathy,disease,1.0,27872609
19951,panitumumab,gene,0.7764,27872609
19952,patients,species,0.98,27872609
19953,CNS,disease,0.9814,27872609
19954,panitumumab,gene,0.9243,27865372
19955,paclitaxel,drug,0.999,27865372
19956,panitumumab,gene,0.9336,27865372
19957,paclitaxel,drug,0.9985,27865372
19958,patients,species,0.9536,27865372
19959,SCCHN,disease,0.9995,27865372
19960,patients,species,0.9595,27865372
19961,metastatic and/or recurrent,disease,0.94,27865372
19962,SCCHN,disease,0.524,27865372
19963,patients,species,0.9766,27865372
19964,paclitaxel,drug,0.9985,27865372
19965,panitumumab,gene,0.79,27865372
19966,patients,species,0.986,27865372
19967,patients,species,0.981,27865372
19968,patients,species,0.9946,27865372
19969,patients,species,0.9805,27865372
19970,patients,species,0.9844,27865372
19971,skin rash,disease,1.0,27865372
19972,asthenia,disease,1.0,27865372
19973,neurotoxicity,disease,1.0,27865372
19974,hypomagnesemia,disease,1.0,27865372
19975,neutropenia,disease,1.0,27865372
19976,panitumumab,gene,0.934,27865372
19977,paclitaxel,drug,0.9956,27865372
19978,patients,species,0.98,27865372
19979,febrile neutropenia,disease,1.0,27865372
19980,Patient,species,0.9897,27865372
19981,Panitumumab,gene,0.9277,27865372
19982,paclitaxel,drug,0.998,27865372
19983,metastatic colorectal cancer,disease,1.0,27865140
19984,metastatic colorectal cancer,disease,1.0,27865140
19985,mCRC,disease,1.0,27865140
19986,fluorouracil,drug,0.9995,27865140
19987,oxaliplatin,drug,0.9995,27865140
19988,irinotecan,drug,0.9966,27865140
19989,Patient,species,0.9614,27865140
19990,VEGF,gene,0.9956,27865140
19991,bevacizumab,gene,0.9307,27865140
19992,VEGFR2,gene,0.9946,27865140
19993,EGFR,gene,0.963,27865140
19994,cetuximab,gene,0.851,27865140
19995,panitumumab,gene,0.7617,27865140
19996,patients,species,0.9927,27865140
19997,EGFR,gene,0.993,27865140
19998,RAS,gene,0.9946,27865140
19999,BRAF,DNA,0.8687,27865140
20000,BRAF,gene,0.9956,27865140
20001,ERB,DNA,0.4963,27865140
20002,ERB-B2,gene,0.9937,27865140
20003,MET,gene,0.9937,27865140
20004,EGFR,gene,0.99,27865140
20005,patients,species,0.976,27865140
20006,regorafenib,drug,0.981,27865140
20007,EGFR,gene,0.8486,27865140
20008,Anti-,gene,0.7153,27864890
20009,EGFR monoclonal,gene,0.7407,27864890
20010,epidermal growth factor receptor,gene,0.9985,27864890
20011,EGFR,gene,0.997,27864890
20012,triple-negative breast cancer,disease,1.0,27864890
20013,TNBC,disease,1.0,27864890
20014,EGFR,gene,0.994,27864890
20015,TNBC,disease,0.971,27864890
20016,anti-EGFR monoclonal antibodies,gene,0.982,27864890
20017,cetuximab,gene,0.8467,27864890
20018,panitumumab,gene,0.852,27864890
20019,docetaxel,drug,0.9995,27864890
20020,cisplatin,drug,0.9995,27864890
20021,epirubicin,drug,0.999,27864890
20022,EGFR-expressing TNBC cell lines,cell_line,0.9624,27864890
20023,EGFR,gene,0.938,27864890
20024,TNBC,disease,0.925,27864890
20025,oncogene,DNA,0.8525,27864890
20026,KRAS,gene,0.9854,27864890
20027,tumor suppressor genes,DNA,0.8423,27864890
20028,tumor,disease,0.9946,27864890
20029,PTEN,gene,0.9937,27864890
20030,BRCA1,gene,0.9844,27864890
20031,KRAS mutant cell line,cell_line,0.904,27864890
20032,KRAS,gene,0.98,27864890
20033,MDA-MB-231,cell_line,0.93,27864890
20034,PTEN-null cell lines,cell_line,0.945,27864890
20035,PTEN,gene,0.9736,27864890
20036,HCC-1937,cell_line,0.899,27864890
20037,MDA-MB-468,cell_line,0.9355,27864890
20038,cisplatin,drug,0.9995,27864890
20039,epirubicin,drug,0.999,27864890
20040,BRCA1-mutant cell line SUM-1315,cell_line,0.853,27864890
20041,BRCA1-mutant,gene,0.786,27864890
20042,wild-type KRAS,DNA,0.723,27864890
20043,wild-type KRAS,gene,0.997,27864890
20044,PTEN,gene,0.9443,27864890
20045,wild-type BRCA1,gene,0.9985,27864890
20046,SUM-1315 cells,cell_line,0.904,27864890
20047,SUM,cell_type,0.4995,27864890
20048,EGFR,gene,0.99,27864890
20049,ERK1/2 proteins,gene,0.906,27864890
20050,patients,species,0.9546,27864890
20051,BRCA1-associated TNBC,disease,0.9995,27864890
20052,BRCA1,gene,0.763,27864890
20053,PTEN and KRAS genes,DNA,0.8027,27864890
20054,PTEN,gene,0.9956,27864890
20055,KRAS genes,gene,0.978,27864890
20056,anti-,gene,0.8843,27864890
20057,EGFR mAbs,gene,0.8076,27864890
20058,bevacizumab,gene,0.8843,27861344
20059,FOLFIRI,drug,0.984,27861344
20060,irinotecan,drug,0.997,27861344
20061,bevacizumab,gene,0.814,27861344
20062,metastatic colorectal cancer,disease,0.9746,27861344
20063,bevacizumab,gene,0.8896,27861344
20064,irinotecan,drug,0.997,27861344
20065,5-fluorouracil,drug,0.9985,27861344
20066,leucovorin,drug,0.999,27861344
20067,FOLFIRI,drug,0.997,27861344
20068,irinotecan,drug,0.999,27861344
20069,fluorouracil,drug,0.9995,27861344
20070,leucovorin,drug,0.999,27861344
20071,IFL,drug,0.7715,27861344
20072,patients,species,0.9795,27861344
20073,metastatic colorectal cancer,disease,1.0,27861344
20074,mCRC,disease,1.0,27861344
20075,participants,species,0.9434,27861344
20076,panitumumab,gene,0.99,27861344
20077,cetuximab,gene,0.973,27861344
20078,bevacizumab,gene,0.873,27861344
20079,FOLFIRI,drug,0.97,27861344
20080,IFL,drug,0.581,27861344
20081,bevacizumb,drug,0.999,27861344
20082,IFL,gene,0.695,27861344
20083,bevacizumb,drug,0.999,27861344
20084,PFS,cell_line,0.4927,27861344
20085,bevacizumab,gene,0.881,27861344
20086,FOLFIRI,drug,0.987,27861344
20087,mCRC,disease,0.9507,27861344
20088,RAS,gene,0.996,27843597
20089,Metastatic colorectal cancer,disease,0.9995,27843597
20090,patients,species,0.98,27843597
20091,RAS,DNA,0.586,27843597
20092,RAS,gene,0.9956,27843597
20093,metastatic colorectal cancer,disease,0.9907,27843597
20094,panitumumab,gene,0.9395,27843597
20095,FOLFOX4,drug,0.911,27843597
20096,metastatic colorectal cancer,disease,1.0,27843597
20097,patients,species,0.9863,27843597
20098,wild,cell_type,0.4634,27843597
20099,wild-type RAS tumours,disease,0.9985,27843597
20100,wild-type RAS,gene,0.891,27843597
20101,patients,species,0.9614,27843597
20102,skin toxicity,disease,0.6196,27843597
20103,patients,species,0.967,27843597
20104,panitumumab,gene,0.9365,27843597
20105,FOLFOX4,drug,0.983,27843597
20106,FOLFOX4,drug,0.9785,27843597
20107,patients,species,0.991,27843597
20108,patients,species,0.9707,27843597
20109,panitumumab,gene,0.92,27843597
20110,FOLFOX4,drug,0.981,27843597
20111,FOLFOX4,drug,0.8853,27843597
20112,tumour,disease,0.996,27843597
20113,patients,species,0.964,27843597
20114,tumour,disease,1.0,27843597
20115,tumour,disease,1.0,27843597
20116,tumour,disease,0.9995,27843597
20117,panitumumab,gene,0.8813,27843597
20118,FOLFOX4,drug,0.943,27843597
20119,metastatic colorectal cancer,disease,1.0,27843597
20120,FOLFOX4,drug,0.9956,27843597
20121,Bevacizumab,gene,0.703,27835821
20122,epidermal growth factor receptor,gene,0.9883,27835821
20123,advanced/metastatic colorectal cancer,disease,0.998,27806321
20124,advanced/metastatic colorectal cancer,disease,1.0,27806321
20125,CRC,disease,0.9966,27806321
20126,bevacizumab,gene,0.895,27806321
20127,panitumumab,gene,0.9697,27806321
20128,Bevacizumab,gene,0.9097,27806321
20129,cetuximab,gene,0.9053,27806321
20130,panitumumab,gene,0.933,27806321
20131,trebananib,drug,0.9976,27806321
20132,bevacizumab,gene,0.9243,27806321
20133,bevacizumab,gene,0.7285,27806321
20134,cetuximab,gene,0.911,27806321
20135,panitumumab,gene,0.9385,27806321
20136,conatumumab,gene,0.7017,27806321
20137,ganitumab,gene,0.724,27806321
20138,brivanib,drug,0.9907,27806321
20139,cetuximab,gene,0.94,27806321
20140,advanced/metastatic CRC,disease,0.9946,27806321
20141,bevacizumab,gene,0.8687,27806321
20142,panitumumab,gene,0.9316,27806321
20143,conatumumab,gene,0.556,27806321
20144,brivanib,drug,0.998,27806321
20145,cetuximab,gene,0.925,27806321
20146,advanced/metastatic CRC,disease,0.996,27806321
20147,Anti-EGFR,gene,0.9604,27217441
20148,EGF receptor,gene,0.997,27217441
20149,EGFR,gene,0.9966,27217441
20150,cancers,disease,1.0,27217441
20151,anti-EGFR antibodies,gene,0.986,27217441
20152,Cetuximab,gene,0.8896,27217441
20153,IgG1 isotype,gene,0.9897,27217441
20154,EGFR,gene,0.9917,27217441
20155,panitumumab,gene,0.824,27217441
20156,IgG2 isotype,gene,0.986,27217441
20157,EGFR,gene,0.9946,27217441
20158,cetuximab,gene,0.8936,27217441
20159,patient,species,0.9883,27217441
20160,cetuximab,gene,0.9424,27217441
20161,panitumumab,gene,0.934,27217441
20162,natural killer (NK) cells,cell_type,0.9194,27217441
20163,cetuximab,gene,0.7817,27217441
20164,panitumumab,gene,0.773,27217441
20165,Cetuximab,gene,0.9854,27217441
20166,-,cell_type,0.5225,27217441
20167,activated neutrophils,cell_type,0.575,27217441
20168,head,cell_type,0.5693,27217441
20169,head and neck squamous cell carcinomas (HNSCC),disease,0.9844,27217441
20170,tumor,disease,0.664,27217441
20171,FcRIIa,gene,0.997,27217441
20172,FcRIIIa,gene,0.998,27217441
20173,Panitumumab,gene,0.8105,27217441
20174,monocytes,cell_type,0.4846,27217441
20175,CD32,gene,0.9946,27217441
20176,FcRIIa,gene,0.9897,27217441
20177,monocytes,cell_type,0.7417,27217441
20178,Cetuximab,gene,0.954,27217441
20179,dendritic cell,cell_type,0.734,27217441
20180,DC,cell_type,0.8994,27217441
20181,panitumumab,gene,0.752,27217441
20182,tumor,disease,0.9243,27217441
20183,cetuximab,gene,0.9663,27217441
20184,panitumumab,gene,0.8364,27217441
20185,EGFR-specific cytotoxic CD8(+) T cells,cell_line,0.5415,27217441
20186,EGFR,gene,0.982,27217441
20187,CD8(+,gene,0.59,27217441
20188,patients,species,0.9873,27217441
20189,cetuximab,gene,0.595,27217441
20190,panitumumab,gene,0.6265,27217441
20191,panitumumab,gene,0.7656,27217441
20192,EGFR,gene,0.99,27217441
20193,cetuximab,gene,0.8477,27217441
20194,HNSCC,disease,0.9995,27217441
20195,colorectal cancer,disease,1.0,30550697
20196,patients,species,0.973,30550697
20197,metastatic colorectal cancer,disease,0.999,30550697
20198,mCRC,disease,1.0,30550697
20199,patient,species,0.9893,30550697
20200,RAS,gene,0.998,30550697
20201,BRAF,DNA,0.6123,30550697
20202,BRAF,gene,0.9976,30550697
20203,liver limited disease,disease,1.0,30550697
20204,LLD,disease,1.0,30550697
20205,bevacizumab,gene,0.893,30550697
20206,cetuximab,gene,0.951,30550697
20207,panitumumab,gene,0.9634,30550697
20208,FOLFOX6,drug,0.5596,30550697
20209,panitumumab,gene,0.935,30550697
20210,bevaci- zumab,gene,0.7026,30550697
20211,patients,species,0.95,30550697
20212,LLD,disease,0.999,30550697
20213,Cutaneous toxicity,disease,0.913,27791234
20214,epidermal growth factor receptor,gene,0.9917,27791234
20215,Cetuximab,gene,0.6807,27791234
20216,panitumumab,gene,0.693,27791234
20217,epidermal growth factor receptor,gene,0.997,27791234
20218,EGFR,gene,0.993,27791234
20219,metastatic colorectal cancer,disease,0.9995,27791234
20220,EGFR,gene,0.9946,27791234
20221,EGFR,gene,0.962,27791234
20222,skin,disease,0.8135,27791234
20223,EGFR-,gene,0.9893,27791234
20224,EGFR,gene,0.992,27791234
20225,adenocarcinoma of the colon,disease,1.0,27791234
20226,EGFR,gene,0.9907,27791234
20227,skin toxicity,disease,0.928,27791234
20228,skin toxicity,disease,0.778,27791234
20229,cetuximab,gene,0.7827,27791234
20230,rash,disease,0.879,27791234
20231,cetuximab,gene,0.893,27791234
20232,EGFR,gene,0.9927,27791234
20233,EGFR,gene,0.9927,27791234
20234,advanced gastric cancer,disease,1.0,27781258
20235,gastric cancer,disease,1.0,27781258
20236,gastric cancer,disease,1.0,27781258
20237,human epidermal growth factor receptor,gene,0.9985,27781258
20238,HER,gene,0.988,27781258
20239,vascular endothelial,cell_type,0.5205,27781258
20240,VEGF,gene,0.99,27781258
20241,phosphatidylinositol,drug,0.983,27781258
20242,phosphatidylinositol 3-kinase-protein kinase,gene,0.9937,27781258
20243,mammalian target of,gene,0.9595,27781258
20244,rapamycin,drug,0.997,27781258
20245,PI3K,gene,0.994,27781258
20246,mTOR,gene,0.991,27781258
20247,NF-B,gene,0.9907,27781258
20248,HER,DNA,0.4863,27781258
20249,HER family,gene,0.9863,27781258
20250,Cetuximab,gene,0.922,27781258
20251,Nimotuzumab,gene,0.8774,27781258
20252,Matuzumab,gene,0.8584,27781258
20253,Panitumumab,gene,0.9087,27781258
20254,Erlotinib,drug,0.992,27781258
20255,HER-1,gene,0.994,27781258
20256,Trastuzumab,gene,0.9717,27781258
20257,Pertuzumab,gene,0.897,27781258
20258,trastuzumab emtansine,gene,0.9155,27781258
20259,HER-2,gene,0.9927,27781258
20260,Lapatinib,drug,0.997,27781258
20261,Afatinib,drug,0.991,27781258
20262,HER,gene,0.9893,27781258
20263,VEGF,gene,0.994,27781258
20264,anti-VEGF monoclonal antibody,gene,0.9824,27781258
20265,Bevacizumab,gene,0.77,27781258
20266,VEGFR,gene,0.8696,27781258
20267,Apatinib,drug,0.9707,27781258
20268,Sorafenib,drug,0.992,27781258
20269,Sunitinib,drug,0.999,27781258
20270,cediranib,drug,0.9976,27781258
20271,Aflibercept,gene,0.989,27781258
20272,LY294002,drug,0.998,27781258
20273,BEZ235,drug,0.9927,27781258
20274,Everolimus,drug,0.9976,27781258
20275,PI3K,gene,0.998,27781258
20276,mTOR,gene,0.9844,27781258
20277,Bortezomib,drug,0.9995,27781258
20278,NF-B,gene,0.993,27781258
20279,Trastuzumab,gene,0.9883,27781258
20280,Ramucirumab,gene,0.5884,27781258
20281,Apatinib,drug,0.993,27781258
20282,gastric cancer,disease,1.0,27781258
20283,EGFR,gene,0.9575,27422777
20284,metastatic colorectal cancer,disease,0.998,27422777
20285,epidermal growth factor receptor,gene,0.9937,27422777
20286,EGFR,gene,0.9937,27422777
20287,metastatic colorectal cancer,disease,1.0,27422777
20288,anti-EGFR,gene,0.8447,27422777
20289,anti-EGFR,gene,0.868,27422777
20290,epiregulin,gene,0.9946,27422777
20291,EREG,gene,0.994,27422777
20292,amphiregulin,gene,0.509,27422777
20293,AREG,gene,0.9956,27422777
20294,tumor,disease,1.0,27422777
20295,EGFR,gene,0.7183,27422777
20296,anti-EGFR mAbs,gene,0.8726,27422777
20297,EGFR mutations,gene,0.855,27422777
20298,rat sarcoma viral oncogene,gene,0.8184,27422777
20299,rat,species,0.775,27422777
20300,Ras,gene,0.9897,27422777
20301,B-Raf,gene,0.9966,27422777
20302,oncogene,DNA,0.902,27422777
20303,BRAF,gene,0.82,27422777
20304,phosphatidylinositol,drug,0.999,27422777
20305,phosphatidylinositol 3-kinase,gene,0.9927,27422777
20306,PI3K,gene,0.9897,27422777
20307,phosphatase and tensin homolog,gene,0.997,27422777
20308,PTEN,gene,0.9946,27422777
20309,hepatocyte growth factor,gene,0.999,27422777
20310,HGF,gene,0.9985,27422777
20311,c-Met,gene,0.9966,27422777
20312,EGFR,gene,0.936,27422777
20313,microRNAs,RNA,0.785,27422777
20314,EGFR,gene,0.7915,27422777
20315,cetuximab,gene,0.833,27422777
20316,panitumumab,gene,0.778,27422777
20317,EGFR,gene,0.9956,27422777
20318,epidermal growth factor receptor,gene,0.9985,27777877
20319,epidermal growth factor receptor,gene,0.999,27777877
20320,colorectal cancer,disease,1.0,27777877
20321,Epidermal growth factor receptor,gene,0.9985,27777877
20322,EGFR,gene,0.9927,27777877
20323,epithelial cancers,disease,1.0,27777877
20324,colorectal cancer,disease,1.0,27777877
20325,CRC,disease,1.0,27777877
20326,cetuximab,gene,0.8267,27777877
20327,panitumumab,gene,0.6763,27777877
20328,anti-EGFR monoclonal antibodies,gene,0.948,27777877
20329,metastatic CRC,disease,0.987,27777877
20330,EGFR,gene,0.995,27777877
20331,Kirsten RAS,gene,0.986,27777877
20332,KRAS,gene,0.961,27777877
20333,anti-EGFR antibodies,gene,0.9,27777877
20334,KRAS,gene,0.9956,27777877
20335,EGFR,gene,0.987,27777877
20336,EGFR,gene,0.9956,27777877
20337,KRAS,gene,0.764,27777877
20338,BRAF,gene,0.7905,27777877
20339,PIK3CA,gene,0.561,27777877
20340,PTEN,gene,0.9917,27777877
20341,EGFR,gene,0.99,27777877
20342,EGFR,gene,0.994,27777877
20343,oncogenic,DNA,0.5215,27777877
20344,subclones,cell_line,0.5933,27777877
20345,KRAS,gene,0.7573,27777877
20346,anti-EGFR,gene,0.8765,27777877
20347,metastatic CRC,disease,0.967,27777877
20348,EGFR,gene,0.992,27777877
20349,Colorectal Cancer,disease,1.0,27770002
20350,BRAF,gene,0.5596,27770002
20351,metastatic colorectal cancer,disease,0.886,27770002
20352,EGFR,gene,0.9946,27770002
20353,MAPK,gene,0.891,27770002
20354,Panitumumab,gene,0.7646,27770002
20355,trametinib,drug,0.9985,27770002
20356,dabrafenib,drug,0.999,27770002
20357,BRAF V600E,DNA,0.6807,27770002
20358,BRAF V600E mutant,gene,0.965,27770002
20359,V600E,mutation,,27770002
20360,RAS mutations,gene,0.638,27770002
20361,Panitumumab,gene,0.5806,27765383
20362,RAS,gene,0.4878,27764839
20363,BRAF,gene,0.6875,27764839
20364,panitumumab,gene,0.8545,27764839
20365,FOLFIRI,drug,0.8433,27764839
20366,metastatic colorectal cancer,disease,0.9995,27764839
20367,panitumumab,gene,0.892,27764839
20368,FOLFIRI,drug,0.9434,27764839
20369,metastatic colorectal carcinoma,disease,1.0,27764839
20370,mCRC,disease,1.0,27764839
20371,FOLFIRI,drug,0.9756,27764839
20372,RAS,gene,0.3877,27764839
20373,KRAS,gene,0.756,27764839
20374,NRAS,gene,0.636,27764839
20375,BRAF,gene,0.7144,27764839
20376,amphiregulin,gene,0.9976,27764839
20377,AREG,gene,0.997,27764839
20378,RAS wild type,gene,0.944,27764839
20379,RAS mutant,gene,0.9824,27764839
20380,mCRC,disease,0.982,27764839
20381,RAS WT,gene,0.4795,27764839
20382,BRAF,DNA,0.556,27764839
20383,BRAF WT,gene,0.9053,27764839
20384,RAS,gene,0.9336,27764839
20385,BRAF,gene,0.5107,27764839
20386,RAS,DNA,0.6553,27764839
20387,RAS WT,gene,0.93,27764839
20388,RAS MT,gene,0.4731,27764839
20389,RAS WT,gene,0.558,27764839
20390,MT,gene,0.5366,27764839
20391,RAS,gene,0.5254,27764839
20392,BRAF,gene,0.5474,27764839
20393,RAS,gene,0.9746,27764839
20394,BRAF,gene,0.627,27764839
20395,RAS,gene,0.5747,27764839
20396,BRAF,gene,0.686,27764839
20397,RAS WT tumours,cell_line,0.5356,27764839
20398,RAS,gene,0.5767,27764839
20399,AREG,gene,0.531,27764839
20400,AREG,gene,0.61,27764839
20401,panitumumab,gene,0.8325,27764839
20402,FOLFIRI,drug,0.797,27764839
20403,RAS,gene,0.9976,27764839
20404,RAS,gene,0.9966,27764839
20405,BRAF,gene,0.4177,27764839
20406,mCRC tumours,disease,0.4646,27764839
20407,epidermal growth factor receptor tyrosine kinase,gene,0.953,27398628
20408,tyrosine,drug,0.914,27398628
20409,dapsone,drug,0.996,27398628
20410,rash,disease,1.0,27398628
20411,tumor,disease,0.966,27398628
20412,epidermal growth factor receptor,gene,0.999,27398628
20413,EGFR,gene,0.9917,27398628
20414,epithelial tumors,disease,0.6006,27398628
20415,EGFR tyrosine kinase,gene,0.944,27398628
20416,tyrosine,drug,0.8755,27398628
20417,EGFR,gene,0.993,27398628
20418,EGFR,gene,0.9907,27398628
20419,erlotinib,drug,0.996,27398628
20420,gefitinib,drug,0.9946,27398628
20421,tyrosine,drug,0.919,27398628
20422,tyrosine kinase,gene,0.957,27398628
20423,cetuximab,gene,0.867,27398628
20424,panitumumab,gene,0.877,27398628
20425,EGFR,gene,0.9946,27398628
20426,cancer,disease,0.483,27398628
20427,interleukin-8,gene,0.9834,27398628
20428,tumor,disease,0.878,27398628
20429,sulfone,drug,0.997,27398628
20430,dapsone,drug,0.995,27398628
20431,interleukin-8,gene,0.9883,27398628
20432,Erlotinib,drug,0.998,27398628
20433,keratinocyte,cell_type,0.7563,27398628
20434,interleukin-8,gene,0.971,27398628
20435,neutrophilic dermatoses,disease,1.0,27398628
20436,dapsone,drug,0.999,27398628
20437,erlotinib,drug,0.9976,27398628
20438,rash,disease,0.9814,27398628
20439,erlotinib,drug,0.9956,27398628
20440,interleukin-8,gene,0.9863,27398628
20441,RAS,gene,0.7397,27747083
20442,BRAF,gene,0.876,27747083
20443,metastatic colorectal cancer,disease,0.9995,27747083
20444,metastatic colorectal cancer,disease,1.0,27747083
20445,mCRC,disease,1.0,27747083
20446,cetuximab,gene,0.8477,27747083
20447,panitumumab,gene,0.8237,27747083
20448,epidermal growth factor receptor,gene,0.9966,27747083
20449,EGFR,gene,0.979,27747083
20450,EGFR,gene,0.9634,27747083
20451,mCRC,disease,0.9917,27747083
20452,RAS-,cell_line,0.513,27747083
20453,RAS-mutant tumors,disease,0.9917,27747083
20454,RAS,gene,0.99,27747083
20455,BRAF,gene,0.609,27747083
20456,EGFR,gene,0.776,27747083
20457,mCRC,disease,0.995,27747083
20458,EGFR,gene,0.9854,27747083
20459,wild-type RAS,gene,0.915,27747083
20460,BRAF,gene,0.906,27747083
20461,metastatic colorectal tumors,disease,0.9395,27747083
20462,mitogen-activated protein kinase,gene,0.994,27747083
20463,MAPK,gene,0.987,27747083
20464,BRAF,gene,0.998,27747083
20465,EGFR,gene,0.9927,27747083
20466,MAPK kinase,gene,0.989,27747083
20467,MEK,gene,0.995,27747083
20468,BRAF,gene,0.6177,27747083
20469,mCRC,disease,0.705,27747083
20470,mCRC,disease,0.9897,27747083
20471,EGFR,gene,0.6,27747083
20472,RAS,gene,0.551,27747083
20473,BRAF,gene,0.7017,27747083
20474,EGFR,gene,0.7666,27747083
20475,mCRC,disease,0.9985,27747083
20476,MAPK,gene,0.982,27747083
20477,panitumumab,gene,0.8545,27736842
20478,panitumumab,gene,0.9155,27736842
20479,patients,species,0.9536,27736842
20480,wild,DNA,0.5684,27736842
20481,wild-type KRAS exon 2,gene,0.968,27736842
20482,metastatic colorectal cancer,disease,1.0,27736842
20483,mCRC,disease,1.0,27736842
20484,RAS,gene,0.5015,27736842
20485,Patients,species,0.9297,27736842
20486,wild-type KRAS exon 2,DNA,0.6465,27736842
20487,wild,gene,0.7104,27736842
20488,mCRC,disease,0.7305,27736842
20489,panitumumab,gene,0.7983,27736842
20490,RAS,DNA,0.6113,27736842
20491,RAS mutation,gene,0.89,27736842
20492,wild,gene,0.5728,27736842
20493,mCRC,disease,0.9556,27736842
20494,wild-type RAS,gene,0.7324,27736842
20495,mCRC,disease,0.935,27736842
20496,"KRAS and NRAS exons 2, 3,",DNA,0.84,27736842
20497,KRAS,gene,0.992,27736842
20498,NRAS,gene,0.9473,27736842
20499,patients,species,0.9375,27736842
20500,wild,DNA,0.5483,27736842
20501,wild-type KRAS exon 2,gene,0.824,27736842
20502,mCRC,disease,0.998,27736842
20503,panitumumab,gene,0.9385,27736842
20504,RAS,disease,0.761,27736842
20505,wild,DNA,0.563,27736842
20506,wild-type RAS,gene,0.9224,27736842
20507,mCRC,disease,0.9863,27736842
20508,panitumumab,gene,0.902,27736842
20509,Patients,species,0.9727,27736842
20510,RAS mutations,gene,0.864,27736842
20511,panitumumab,gene,0.651,27736842
20512,Panitumumab,gene,0.7715,27736842
20513,wild,gene,0.7354,27736842
20514,mCRC,disease,0.9907,27736842
20515,wild,cell_line,0.5137,27736842
20516,wild-type RAS,gene,0.8745,27736842
20517,mCRC,disease,0.997,27736842
20518,cisplatin,drug,0.988,27733374
20519,head and neck squamous cell carcinoma,disease,1.0,27733374
20520,HNSCC,disease,0.997,27733374
20521,epidermal growth-factor receptor,gene,0.9976,27733374
20522,EGFR,gene,0.9893,27733374
20523,IgG2 monoclonal antibody panitumumab,gene,0.9263,27733374
20524,cisplatin,drug,0.9985,27733374
20525,HNSCC,disease,1.0,27733374
20526,PATIENTS,species,0.949,27733374
20527,patients,species,0.9688,27733374
20528,"squamous cell carcinoma of the oral cavity, larynx, hypopharynx",disease,1.0,27733374
20529,human-papillomavirus,disease,0.9995,27733374
20530,tumor,disease,0.9434,27733374
20531,cisplatin,drug,0.9546,27733374
20532,panitumumab,gene,0.8364,27733374
20533,patients,species,0.983,27733374
20534,patients,species,0.9683,27733374
20535,patients,species,0.971,27733374
20536,patients,species,0.9814,27733374
20537,HNSCC,disease,1.0,27733374
20538,patients,species,0.991,27733374
20539,panitumumab,gene,0.9106,27733374
20540,cisplatin,drug,0.9907,27733374
20541,HNSCC,disease,0.9995,27733374
20542,patients,species,0.99,27733374
20543,bevacizumab,gene,0.937,27716478
20544,skin toxicity,disease,0.7354,27716478
20545,hypomagnesaemia,disease,1.0,27716478
20546,ASPECCT,DNA,0.4883,27716478
20547,panitumumab,gene,0.973,27716478
20548,cetuximab,gene,0.9536,27716478
20549,wild,DNA,0.6816,27716478
20550,wild-type KRAS exon 2,gene,0.938,27716478
20551,KRAS exon 2,DNA,0.5386,27716478
20552,metastatic colorectal cancer,disease,1.0,27716478
20553,panitumumab,gene,0.837,27716478
20554,cetuximab,gene,0.804,27716478
20555,wild,disease,0.6743,27716478
20556,KRAS exon 2,DNA,0.611,27716478
20557,metastatic colorectal cancer,disease,1.0,27716478
20558,mCRC,disease,1.0,27716478
20559,ASPECCT,DNA,0.547,27716478
20560,PATIENTS,species,0.966,27716478
20561,wild-type KRAS exon 2,DNA,0.673,27716478
20562,wild,gene,0.8413,27716478
20563,mCRC,disease,0.9976,27716478
20564,irinotecan,drug,0.9995,27716478
20565,oxaliplatin,drug,0.9995,27716478
20566,panitumumab,gene,0.825,27716478
20567,cetuximab,gene,0.683,27716478
20568,bevacizumab,gene,0.9272,27716478
20569,skin toxicity,disease,0.9736,27716478
20570,hypomagnesaemia,disease,1.0,27716478
20571,panitumumab,gene,0.709,27716478
20572,cetuximab,gene,0.8384,27716478
20573,panitumumab,gene,0.8965,27716478
20574,cetuximab,gene,0.6714,27716478
20575,panitumumab,gene,0.8154,27716478
20576,cetuximab,gene,0.6626,27716478
20577,hypomagnesaemia,disease,1.0,27716478
20578,bevacizumab,gene,0.522,27716478
20579,panitumumab,gene,0.8945,27716478
20580,cetuximab,gene,0.817,27716478
20581,ASPECCT,DNA,0.5234,27716478
20582,panitumumab,gene,0.8726,27716478
20583,cetuximab,gene,0.884,27716478
20584,mCRC,disease,0.999,27716478
20585,FOLFIRI,drug,0.673,27712015
20586,panitumumab,gene,0.939,27712015
20587,bevacizumab,gene,0.52,27712015
20588,wild-type KRAS colorectal cancer,disease,0.866,27712015
20589,wild-type KRAS,gene,0.7583,27712015
20590,panitumumab,gene,0.8867,27712015
20591,fluorouracil,drug,0.9995,27712015
20592,leucovorin,drug,0.997,27712015
20593,irinotecan,drug,0.9985,27712015
20594,FOLFIRI,drug,0.97,27712015
20595,bevacizumab,gene,0.716,27712015
20596,FOLFIRI,drug,0.9175,27712015
20597,(WT) KRAS exon 2,gene,0.806,27712015
20598,metastatic colorectal cancer,disease,1.0,27712015
20599,mCRC,disease,1.0,27712015
20600,oncogenes,DNA,0.8604,27712015
20601,circulating tumor DNA,DNA,0.8164,27712015
20602,ctDNA,DNA,0.8345,27712015
20603,WT KRAS exon 2,gene,0.6616,27712015
20604,mCRC,disease,0.934,27712015
20605,oxaliplatin,drug,0.9995,27712015
20606,bevacizumab,gene,0.545,27712015
20607,panitumumab,gene,0.907,27712015
20608,FOLFIRI,drug,0.983,27712015
20609,FOLFIRI,drug,0.983,27712015
20610,panitumumab,gene,0.9546,27712015
20611,FOLFIRI,drug,0.92,27712015
20612,bevacizumab,gene,0.7896,27712015
20613,FOLFIRI,drug,0.9565,27712015
20614,KRAS,gene,0.822,27712015
20615,NRAS,gene,0.85,27712015
20616,BRAF,gene,0.7744,27712015
20617,ctDNA,DNA,0.5005,27712015
20618,Panitumumab,gene,0.917,27712015
20619,FOLFIRI,drug,0.9214,27712015
20620,bevacizumab,gene,0.824,27712015
20621,FOLFIRI,drug,0.9517,27712015
20622,bevacizumab,gene,0.609,27712015
20623,FOLFIRI,drug,0.9272,27712015
20624,panitumumab,gene,0.707,27712015
20625,FOLFIRI,drug,0.9717,27712015
20626,serum vascular endothelial growth factor-A,gene,0.98,27712015
20627,VEGF-A,gene,0.998,27712015
20628,FOLFIRI,drug,0.8594,27712015
20629,panitumumab,gene,0.944,27712015
20630,FOLFIRI,drug,0.842,27712015
20631,bevacizumab,gene,0.79,27712015
20632,WT KRAS exon 2,gene,0.709,27712015
20633,mCRC,disease,0.987,27712015
20634,RAS,gene,0.975,27712015
20635,BRAF,gene,0.543,27712015
20636,ctDNA,DNA,0.7354,27712015
20637,panitumumab,gene,0.7593,27712015
20638,Human Papillomavirus,disease,0.809,27699535
20639,HPV,species,0.6465,27699535
20640,Squamous Cell Carcinoma of the Head and Neck,disease,1.0,27699535
20641,squamous cell carcinoma of the head and neck,disease,1.0,27699535
20642,SCCHN,disease,1.0,27699535
20643,HPV,species,0.8525,27699535
20644,p16,gene,0.9966,27699535
20645,SCCHN,disease,1.0,27699535
20646,metastatic,disease,0.549,27699535
20647,HPV,species,0.5146,27699535
20648,p16,gene,0.994,27699535
20649,oropharynx cancer,disease,1.0,27699535
20650,HPV,species,0.7075,27699535
20651,p16,gene,0.997,27699535
20652,magnesium,drug,0.9995,27688901
20653,calcium,drug,0.999,27688901
20654,patients,species,0.9883,27688901
20655,Hypomagnesemia,disease,1.0,27688901
20656,human anti-epidermal growth factor receptor,gene,0.945,27688901
20657,human,species,0.9883,27688901
20658,EGFR,gene,0.9946,27688901
20659,cetuximab,gene,0.914,27688901
20660,panitumumab,gene,0.912,27688901
20661,anti-EGFR antibody,gene,0.9487,27688901
20662,hypomagnesemia,disease,1.0,27688901
20663,EGFR,gene,0.9966,27688901
20664,Mg(2+),drug,0.9995,27688901
20665,Mg(2+),drug,1.0,27688901
20666,Ca(2+),drug,0.999,27688901
20667,parathyroid hormone,gene,0.9946,27688901
20668,PTH,gene,0.991,27688901
20669,Ca(2+),drug,1.0,27688901
20670,Mg(2+),drug,0.9995,27688901
20671,blood,cell_type,0.581,27688901
20672,blood,cell_type,0.4717,27688901
20673,Mg(2+),drug,0.9976,27688901
20674,Ca(2+),drug,0.999,27688901
20675,albumin,gene,0.9966,27688901
20676,cancer,disease,1.0,27688901
20677,patients,species,0.993,27688901
20678,cetuximab,gene,0.868,27688901
20679,panitumumab,gene,0.6816,27688901
20680,Hypomagnesemia,disease,1.0,27688901
20681,patients,species,0.992,27688901
20682,patients,species,0.983,27688901
20683,hypomagnesemia,disease,1.0,27688901
20684,blood,cell_type,0.4604,27688901
20685,Mg(2+),drug,0.9995,27688901
20686,Ca(2+),drug,0.9995,27688901
20687,Ca(2+),drug,0.9995,27688901
20688,Mg(2+),drug,1.0,27688901
20689,hypomagnesemia,disease,1.0,27688901
20690,Ca(2+),drug,0.9995,27688901
20691,patients,species,0.9844,27688901
20692,anti-EGFR antibodies,gene,0.978,27688901
20693,Mg(2+),drug,0.9995,27688901
20694,hypomagnesemia,disease,1.0,27688901
20695,anti-EGFR,gene,0.836,27659529
20696,phage,DNA,0.4558,27659529
20697,panitumumab,gene,0.8823,27659529
20698,epidermal growth factor receptor,gene,0.998,27659529
20699,EGFR,gene,0.9937,27659529
20700,epithelial tumors,disease,0.5425,27659529
20701,Anti,gene,0.502,27659529
20702,EGFR,gene,0.944,27659529
20703,humanized,species,0.5107,27659529
20704,cetuximab,gene,0.644,27659529
20705,panitumumab,gene,0.706,27659529
20706,wild,cell_line,0.5483,27659529
20707,wild-type RAS tumors,disease,0.857,27659529
20708,wild-type RAS,gene,0.927,27659529
20709,EGFR,gene,0.995,27659529
20710,EGFR,gene,0.994,27659529
20711,panitumumab,gene,0.873,27659529
20712,EGFR mimotopes,gene,0.7935,27659529
20713,P19,gene,0.5635,27659529
20714,P26,gene,0.714,27659529
20715,panitumumab,gene,0.86,27659529
20716,P19,gene,0.996,27659529
20717,P26,gene,0.998,27659529
20718,heat-shock cognate protein 70,gene,0.996,27659529
20719,Hsc70,gene,0.989,27659529
20720,Hsc70,gene,0.998,27659529
20721,P19,gene,0.9966,27659529
20722,Hsc70,gene,0.998,27659529
20723,P26,gene,0.998,27659529
20724,Hsc70,gene,0.993,27659529
20725,P19,gene,0.9956,27659529
20726,Hsc70,gene,0.9946,27659529
20727,P26,gene,0.995,27659529
20728,EGFR,gene,0.992,27659529
20729,mimotopes,DNA,0.4817,27659529
20730,EGFR-overexpressing A431 cells,cell_line,0.9023,27659529
20731,EGFR,gene,0.4744,27659529
20732,-overexpressing A431 cells,cell_type,0.571,27659529
20733,Hsc70,gene,0.9966,27659529
20734,P19,gene,0.998,27659529
20735,Hsc70,gene,0.996,27659529
20736,P26,gene,0.998,27659529
20737,tumor,disease,0.9995,27659529
20738,BALB/c,cell_line,0.535,27659529
20739,lung cancer,disease,0.9995,27659529
20740,EGFR,gene,0.9897,27659529
20741,EGFR,gene,0.9927,27659529
20742,panitumumab,gene,0.9077,27659529
20743,anti-,gene,0.9814,27659529
20744,EGFR,gene,0.501,27659529
20745,cancers,disease,1.0,27659529
20746,Panitumumab,gene,0.976,27658254
20747,EGFR,gene,0.9565,27658254
20748,Cetuximab,gene,0.931,27658254
20749,Panitumumab,gene,0.8047,27658254
20750,cetuximab,gene,0.7896,27658254
20751,epidermal growth factor receptor,gene,0.998,27658254
20752,metastatic colorectal cancer,disease,0.999,27658254
20753,metastatic colorectal cancer,disease,0.998,27658254
20754,wild,DNA,0.569,27658254
20755,wild-type RAS,gene,0.975,27658254
20756,EGFR,gene,0.985,27658254
20757,S468R,mutation,,27658254
20758,cetuximab,gene,0.869,27658254
20759,panitumumab,gene,0.8345,27658254
20760,cetuximab,gene,0.934,27658254
20761,EGFR domain III,gene,0.539,27658254
20762,panitumumab,gene,0.6963,27658254
20763,Anti-,gene,0.856,27655662
20764,EGFR monoclonal,gene,0.731,27655662
20765,EGFR tyrosine kinase,gene,0.8477,27655662
20766,tyrosine,drug,0.948,27655662
20767,triple-negative breast cancer,disease,1.0,27655662
20768,Triple-negative breast cancer,disease,1.0,27655662
20769,TNBC,disease,1.0,27655662
20770,epidermal growth factor receptor,gene,0.9985,27655662
20771,EGFR,gene,0.995,27655662
20772,EGFR,gene,0.9917,27655662
20773,cetuximab,gene,0.927,27655662
20774,panitumumab,gene,0.906,27655662
20775,tyrosine,drug,0.9805,27655662
20776,tyrosine kinase,gene,0.9893,27655662
20777,EGFR,gene,0.9897,27655662
20778,gefitinib,drug,0.9976,27655662
20779,erlotinib,drug,0.9937,27655662
20780,EGFR-expressing TNBC cell lines,cell_line,0.938,27655662
20781,EGFR,gene,0.9395,27655662
20782,TNBC,disease,0.84,27655662
20783,EGFR,gene,0.9937,27655662
20784,Cell lines,cell_line,0.856,27655662
20785,EGFR,gene,0.9727,27655662
20786,MDA-MB-468,cell_line,0.9214,27655662
20787,EGFR,gene,0.6855,27655662
20788,SUM-1315,cell_line,0.935,27655662
20789,KRAS,gene,0.9346,27655662
20790,PTEN wild-type) cells,cell_line,0.6846,27655662
20791,PTEN wild,gene,0.7646,27655662
20792,MDA-MB-231,cell_line,0.952,27655662
20793,KRAS,gene,0.634,27655662
20794,HCC-1937,cell_line,0.9463,27655662
20795,PTEN deletion,DNA,0.574,27655662
20796,PTEN,gene,0.995,27655662
20797,RAS,gene,0.9976,27655662
20798,MAPK,gene,0.9927,27655662
20799,mAb-sensitive cells,cell_line,0.645,27655662
20800,EGFR,gene,0.989,27655662
20801,TNBC,disease,0.674,27655662
20802,EGFR,gene,0.993,27655662
20803,KRAS,gene,0.822,27655662
20804,PTEN,gene,0.9956,27655662
20805,Panitumumab,gene,0.861,27630355
20806,Cetuximab,gene,0.8286,27630355
20807,metastatic colorectal cancer,disease,1.0,27630355
20808,mCRC,disease,1.0,27630355
20809,panitumumab,gene,0.9053,27630355
20810,cetuximab,gene,0.844,27630355
20811,mCRC,disease,0.988,27630355
20812,patients,species,0.993,27630355
20813,panitumumab,gene,0.8657,27630355
20814,PATIENTS,species,0.937,27630355
20815,wild,DNA,0.521,27630355
20816,wild-type KRAS,gene,0.838,27630355
20817,mCRC,disease,0.9995,27630355
20818,patients,species,0.993,27630355
20819,panitumumab,gene,0.9185,27630355
20820,cetuximab,gene,0.891,27630355
20821,mCRC,disease,0.5947,27630355
20822,cetuximab,gene,0.8286,27630355
20823,irinotecan,drug,0.9976,27630355
20824,irinotecan,drug,0.9976,27630355
20825,panitumumab,gene,0.906,27630355
20826,patients,species,0.9863,27630355
20827,patients,species,0.985,27630355
20828,patients,species,0.9814,27630355
20829,miR-31-,RNA,0.539,27630355
20830,miR-31-5p,gene,0.859,27630355
20831,tumor,disease,1.0,27630355
20832,patients,species,0.988,27630355
20833,cetuximab,gene,0.823,27630355
20834,miR-31-5p,gene,0.8906,27630355
20835,panitumumab,gene,0.877,27630355
20836,mCRC,disease,0.996,27630355
20837,patients,species,0.9897,27630355
20838,cetuximab,gene,0.89,27630355
20839,mCRC,disease,0.9927,27630355
20840,patients,species,0.989,27630355
20841,panitumumab,gene,0.8687,27630355
20842,cetuximab,gene,0.834,27630355
20843,Cetuximab,gene,0.8394,27630277
20844,epidermal growth factor receptor,gene,0.9976,27630277
20845,EGFR,gene,0.994,27630277
20846,cetuximab,gene,0.8584,27630277
20847,panitumumab,gene,0.8506,27630277
20848,patients,species,0.966,27630277
20849,colorectal cancer,disease,1.0,27630277
20850,EGFR,gene,0.9883,27630277
20851,anti-EGFR monoclonal antibodies,gene,0.9097,27630277
20852,patients,species,0.913,27630277
20853,colorectal cancer,disease,1.0,27630277
20854,Metastatic Colorectal Cancer,disease,0.9995,27628558
20855,metastatic colorectal cancer,disease,1.0,27628558
20856,cancer,disease,1.0,27628558
20857,5-FU,drug,0.9995,27628558
20858,oxaliplatin,drug,1.0,27628558
20859,irinotecan,drug,0.999,27628558
20860,CPT-11,drug,0.999,27628558
20861,bevacizumab,gene,0.7993,27628558
20862,Bmab,gene,0.9204,27628558
20863,panitumumab,gene,0.9673,27628558
20864,Pmab,gene,0.9297,27628558
20865,patients,species,0.983,27624917
20866,colorectal liver metastases,disease,1.0,27624917
20867,CRLM,disease,1.0,27624917
20868,patients,species,0.983,27624917
20869,liver-only CRLM,disease,0.9927,27624917
20870,extrahepatic metastases,disease,0.636,27624917
20871,patient,species,0.9736,27624917
20872,patients,species,0.981,27624917
20873,patients,species,0.984,27624917
20874,EGFR,gene,0.6753,27624917
20875,patients,species,0.9497,27624917
20876,bevacizumab,gene,0.7104,27624917
20877,patients,species,0.9927,27624917
20878,bevacizumab,gene,0.7295,27624917
20879,VEGF,gene,0.6636,27624917
20880,patient,species,0.978,27624917
20881,patients,species,0.984,27624917
20882,EGFR,gene,0.8584,27624917
20883,VEGF,gene,0.8965,27624917
20884,epidermal growth factor receptor,gene,0.994,27605871
20885,patients,species,0.983,27605871
20886,metastatic colorectal cancer,disease,1.0,27605871
20887,mCRC,disease,1.0,27605871
20888,cetuximab,gene,0.68,27605871
20889,panitumumab,gene,0.6997,27605871
20890,epidermal growth factor receptor,gene,0.9966,27605871
20891,EGFR,gene,0.995,27605871
20892,mCRC,disease,0.98,27605871
20893,anti-EGFR,gene,0.8125,27605871
20894,patients,species,0.9873,27605871
20895,KRAS,gene,0.9844,27605871
20896,NRAS,DNA,0.637,27605871
20897,NRAS mutations,gene,0.7695,27605871
20898,patients,species,0.9893,27605871
20899,EGFR,gene,0.968,27605871
20900,MEK,gene,0.9976,27605871
20901,ERK,gene,0.997,27605871
20902,PIK3CA,gene,0.9966,27605871
20903,AKT,gene,0.9976,27605871
20904,anti-EGFR moAbs,gene,0.8706,27605871
20905,epidermal growth factor receptor,gene,0.998,27592068
20906,RAS,gene,0.9917,27592068
20907,metastatic colorectal cancer,disease,0.9985,27592068
20908,epidermal growth factor receptor,gene,0.999,27592068
20909,EGFRI,gene,0.9863,27592068
20910,vascular endothelial growth factor,gene,0.998,27592068
20911,bevacizumab,gene,0.6196,27592068
20912,RAS,gene,0.5225,27592068
20913,metastatic colorectal cancer,disease,1.0,27592068
20914,mCRC,disease,1.0,27592068
20915,mCRC,disease,0.997,27592068
20916,EGFRI,gene,0.995,27592068
20917,bevacizumab,gene,0.784,27592068
20918,EGFRIs,gene,0.96,27592068
20919,RAS WT,gene,0.611,27592068
20920,mCRC,disease,0.993,27592068
20921,tumour,disease,0.648,27592068
20922,RAS,gene,0.978,27592068
20923,mCRC,disease,0.5015,27592068
20924,ETS,gene,0.54,27592068
20925,EGFRIs,gene,0.9736,27592068
20926,bevacizumab,gene,0.8706,27592068
20927,KRAS exon 2,gene,0.7905,27592068
20928,RAS,gene,0.9653,27592068
20929,mCRC,disease,0.999,27592068
20930,skin toxicities,disease,0.9985,27592068
20931,hypomagnesaemia,disease,1.0,27592068
20932,EGFRIs,gene,0.962,27592068
20933,nausea,disease,0.9883,27592068
20934,hypertension,disease,0.9263,27592068
20935,bevacizumab,gene,0.5337,27592068
20936,EGFRI,gene,0.993,27592068
20937,RAS,gene,0.681,27592068
20938,mCRC,disease,0.9985,27592068
20939,colorectal cancer,disease,1.0,27590223
20940,Colorectal cancer,disease,1.0,27590223
20941,CRC,disease,1.0,27590223
20942,cancers,disease,1.0,27590223
20943,CRC,disease,1.0,27590223
20944,KRAS,gene,0.846,27590223
20945,CRC,disease,0.9995,27590223
20946,KRAS,gene,0.626,27590223
20947,epidermal growth factor receptor,gene,0.997,27590223
20948,EGFR,gene,0.975,27590223
20949,KRAS,gene,0.7227,27590223
20950,CRC,disease,1.0,27590223
20951,CRC,disease,0.998,27590223
20952,KRAS,gene,0.838,27590223
20953,panitumumab,gene,0.857,27590223
20954,KRAS,gene,0.776,27590223
20955,"Phosphatidylinositol-4,5",drug,0.964,27590223
20956,"Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",gene,0.996,27590223
20957,PIK3CA,gene,0.9946,27590223
20958,metastatic colorectal cancer,disease,1.0,27590223
20959,PIK3CA,gene,0.9966,27590223
20960,exon 20,DNA,0.4875,27590223
20961,cetuximab,gene,0.7993,27590223
20962,KRAS,gene,0.593,27590223
20963,phosphatase and tensin homologue,gene,0.998,27590223
20964,chromosome ten,DNA,0.82,27590223
20965,disheveled binding,gene,0.937,27590223
20966,beta catenin 2,gene,0.9927,27590223
20967,CRC,disease,1.0,27590223
20968,metastatic colorectal cancer,disease,1.0,27570430
20969,EGFR,gene,0.9067,27570430
20970,metastatic colorectal cancers,disease,1.0,27570430
20971,mCRCs,disease,1.0,27570430
20972,epidermal growth factor receptor,gene,0.998,27570430
20973,EGFR,gene,0.998,27570430
20974,mCRC,disease,0.99,27570430
20975,patients,species,0.9917,27570430
20976,EGFR,gene,0.85,27570430
20977,colorectal cancer,disease,1.0,27570430
20978,EGFR,gene,0.781,27570430
20979,KRAS,gene,0.973,27570430
20980,NRAS,DNA,0.809,27570430
20981,NRAS,gene,0.9946,27570430
20982,PIK3CA,gene,0.997,27570430
20983,TP53,gene,0.997,27570430
20984,PTEN,gene,0.993,27570430
20985,EGFR,gene,0.9966,27570430
20986,MET,DNA,0.778,27570430
20987,MET,gene,0.9946,27570430
20988,HER2,gene,0.9946,27570430
20989,epiregulin,DNA,0.719,27570430
20990,epiregulin,gene,0.9917,27570430
20991,amphiregulin,gene,0.9946,27570430
20992,BRAF,gene,0.9956,27570430
20993,miRNA,RNA,0.706,27570430
20994,EGFR,gene,0.995,27570430
20995,cetuximab,gene,0.809,27570430
20996,panitumumab,gene,0.7544,27570430
20997,mCRCs,disease,0.992,27570430
20998,cetuximab,gene,0.9023,27570430
20999,patient,species,0.9785,27570430
21000,RAS,DNA,0.842,27570430
21001,RAS mutations,gene,0.814,27570430
21002,cetuximab,gene,0.834,27570430
21003,panitumumab,gene,0.7812,27570430
21004,patients,species,0.9644,27570430
21005,RAS,cell_line,0.484,27570430
21006,RAS-wild type,gene,0.7666,27570430
21007,colorectal cancers,disease,0.9287,27570430
21008,tumour mRNA,RNA,0.8354,27570430
21009,tumour,disease,0.606,27570430
21010,EGFR,gene,0.9897,27570430
21011,NRAS,DNA,0.84,27570430
21012,NRAS,gene,0.992,27570430
21013,PIK3CA,gene,0.997,27570430
21014,microRNAs,RNA,0.8647,27570430
21015,ADCC,gene,0.6074,27570430
21016,BRAF,DNA,0.793,27570430
21017,BRAF,gene,0.993,27570430
21018,mCRC,disease,0.9956,27570430
21019,patients,species,0.972,27570430
21020,EGFR,gene,0.8735,27570430
21021,adenocarcinoma of the,disease,0.9263,27568322
21022,metastatic adenocarcinoma of the gastroesophageal junction,disease,1.0,27568322
21023,epidermal growth factor receptor family,gene,0.998,27568322
21024,trastuzumab,gene,0.972,27568322
21025,cetuximab,gene,0.856,27568322
21026,panitumumab,gene,0.9272,27568322
21027,tyrosin kinase,gene,0.9873,27568322
21028,lapatinib,drug,0.999,27568322
21029,erlotinib,drug,0.998,27568322
21030,gefitinib,drug,0.9985,27568322
21031,trastuzumab,gene,0.9814,27568322
21032,cisplatin,drug,0.9985,27568322
21033,fluoropyrimidines,drug,0.9985,27568322
21034,bevacizumab,gene,0.876,27568322
21035,vascular endothelial growth factor-receptor 2,gene,0.999,27568322
21036,bevacizumab,gene,0.866,27568322
21037,sunitinib,drug,1.0,27568322
21038,sorafenib,drug,0.9995,27568322
21039,regorafenib,drug,0.9985,27568322
21040,apatinib,drug,0.9985,27568322
21041,hepatocyte growth factor receptor,gene,0.999,27568322
21042,MET,gene,0.996,27568322
21043,patients,species,0.979,27568322
21044,rilotumumab,gene,0.765,27568322
21045,Mammalian target of rapamycin,gene,0.969,27568322
21046,rapamycin,drug,0.998,27568322
21047,MTOR,gene,0.993,27568322
21048,everolimus,drug,0.998,27568322
21049,patients,species,0.976,27568322
21050,patients,species,0.981,27568322
21051,metastatic colorectal cancer,disease,0.8193,27555788
21052,cetuximab,gene,0.852,27555788
21053,panitumumab,gene,0.757,27555788
21054,metastatic colorectal cancer,disease,1.0,27555788
21055,RAS proto-oncogenes,gene,0.9897,27555788
21056,wild,cell_line,0.5283,27555788
21057,wild-type RAS,gene,0.932,27555788
21058,patients,species,0.9927,27555788
21059,anti-epidermal growth factor receptor,gene,0.97,27555788
21060,anti-EGFR,gene,0.989,27555788
21061,EGFR,gene,0.6934,27555788
21062,metastatic lesions,disease,0.8545,27555788
21063,PATIENTS,species,0.965,27555788
21064,metastatic colorectal cancer,disease,1.0,27555788
21065,patients,species,0.987,27555788
21066,cetuximab,gene,0.96,27555788
21067,EGFR,gene,0.995,27555788
21068,colorectal carcinogenesis,disease,0.9434,27555788
21069,primary,cell_type,0.4763,27555788
21070,primary tumors,disease,0.9844,27555788
21071,TP53,DNA,0.8774,27555788
21072,TP53,gene,0.997,27555788
21073,APC,gene,0.9814,27555788
21074,CTNNB1,DNA,0.68,27555788
21075,CTNNB1,gene,0.996,27555788
21076,"KRAS, PIK3CA, PTEN, and FBXW7 genes",DNA,0.726,27555788
21077,KRAS,gene,0.9614,27555788
21078,PIK3CA,gene,0.993,27555788
21079,PTEN,gene,0.9824,27555788
21080,FBXW7 genes,gene,0.9785,27555788
21081,Metastatic samples,cell_type,0.495,27555788
21082,primary tumors,disease,0.998,27555788
21083,FBXW7,gene,0.992,27555788
21084,EGFR,gene,0.7217,27555788
21085,KRAS mutations,gene,0.724,27555788
21086,patients,species,0.9873,27555788
21087,wild-type RAS,DNA,0.783,27555788
21088,wild-type RAS,gene,0.9956,27555788
21089,RAS,gene,0.9844,27555788
21090,KRAS,gene,0.8936,27555788
21091,cetuximab,gene,0.7266,27555788
21092,anti-EGFR,gene,0.9604,27555788
21093,Rectal Neuroendocrine Carcinoma,disease,1.0,27539046
21094,anal bleeding,disease,0.6787,27539046
21095,rectal cancer,disease,1.0,27539046
21096,Ra,cell_line,0.4868,27539046
21097,KRAS,DNA,0.8257,27539046
21098,KRAS wild type,gene,0.8545,27539046
21099,UFT,drug,0.9985,27539046
21100,UZEL,drug,0.986,27539046
21101,UFT,drug,0.9985,27539046
21102,UZEL,drug,0.9946,27539046
21103,PSK,drug,0.523,27539046
21104,carcinoma,disease,0.8926,27539046
21105,CBDCA,drug,0.9995,27539046
21106,CPT-11,drug,0.9976,27539046
21107,bone marrow suppression,disease,0.998,27539046
21108,FOLFOX4,drug,0.822,27539046
21109,panitumumab,gene,0.9624,27539046
21110,Pmab,gene,0.9346,27539046
21111,Pmab,gene,0.8174,27539046
21112,peripheral neuropathy,disease,0.999,27539046
21113,FOLFIRI,drug,0.969,27539046
21114,bevacizumab,gene,0.782,27539046
21115,Bmab,gene,0.728,27539046
21116,FOLFIRI,drug,0.983,27539046
21117,Bmab,gene,0.762,27539046
21118,cyanine,drug,0.978,27452807
21119,C4,drug,,27452807
21120,O,drug,0.6323,27452807
21121,C4,drug,,27452807
21122,cyanine,drug,0.961,27452807
21123,indolenine,drug,0.9985,27452807
21124,FNIR-Z-759,drug,0.996,27452807
21125,sulfonates,drug,0.999,27452807
21126,quaternary ammonium,drug,0.9985,27452807
21127,FNIR-G-765,drug,0.9995,27452807
21128,sulfonates,drug,0.9995,27452807
21129,guanidines,drug,0.9985,27452807
21130,FNIR,drug,0.9995,27452807
21131,Z-759,drug,0.969,27452807
21132,FNIR,drug,0.9985,27452807
21133,panitumumab,gene,0.94,27452807
21134,pan,gene,0.948,27452807
21135,FNIR,DNA,0.5005,27452807
21136,target cells,cell_type,0.8447,27452807
21137,FNIR-Z,DNA,0.511,27452807
21138,FNIR-Z-759,drug,0.8496,27452807
21139,mouse,species,0.9907,27452807
21140,tumor,disease,0.5186,27452807
21141,FNIR,drug,0.9985,27452807
21142,FNIR,DNA,0.5723,27452807
21143,FNIR-G-765,drug,0.99,27452807
21144,FNIR-Z-759,drug,0.9526,27452807
21145,FNIR-G-765,drug,0.9966,27452807
21146,cyanine,drug,0.9805,27452807
21147,cyanine,drug,0.869,27452807
21148,mAb,gene,0.6753,27452807
21149,thromboembolism,disease,1.0,27450994
21150,cancer,disease,1.0,27450994
21151,anti-EGFR monoclonal antibodies,gene,0.9355,27450994
21152,cetuximab,gene,0.86,27450994
21153,panitumumab,gene,0.879,27450994
21154,Cancer,disease,1.0,27450994
21155,thromboembolism,disease,0.5425,27450994
21156,fibrinopeptide A,gene,0.9897,27450994
21157,hypercoagulable states,disease,0.9805,27450994
21158,fluorouracil,drug,0.9985,27450994
21159,Anti-,gene,0.9717,27450994
21160,EGFR monoclonal,gene,0.6436,27450994
21161,panitumumab,gene,0.6387,27450994
21162,metastatic colorectal cancer,disease,1.0,27450994
21163,endothelial structures,cell_type,0.5034,27450994
21164,flouorouracil,drug,0.7007,27450994
21165,thromboembolism,disease,1.0,27450994
21166,cancer,disease,1.0,27450994
21167,anti-EGFR monoclonal antibodies cetuximab,gene,0.878,27450994
21168,panitumumab,gene,0.764,27450994
21169,thromboembolic events,disease,0.9995,27450994
21170,cancer,disease,0.914,27450994
21171,anti-EGFR monoclonal antibodies,gene,0.956,27450994
21172,venous thromboembolic events,disease,0.996,27450994
21173,venous thromboembolism,disease,1.0,27450994
21174,pulmonary embolism,disease,1.0,27450994
21175,Cancer,disease,1.0,27450994
21176,anti-EGFR monoclonal antibodies,gene,0.9043,27450994
21177,venous or pulmonary embolism,disease,0.9976,27450994
21178,anti-EGFR monoclonal antibodies,gene,0.95,27450994
21179,cetuximab,gene,0.8604,27450994
21180,panitumumab,gene,0.8384,27450994
21181,Ulcerative colitis,disease,1.0,27450459
21182,nephrotic syndrome,disease,1.0,27450459
21183,mesalazine,drug,0.9976,27450459
21184,rectal carcinoma,disease,1.0,27450459
21185,nephrotic syndrome,disease,1.0,27450459
21186,ulcerative colitis,disease,1.0,27450459
21187,UC,disease,1.0,27450459
21188,mesalazine,drug,0.9956,27450459
21189,Dysplasia,disease,0.999,27450459
21190,UC,disease,1.0,27450459
21191,colorectal carcinoma,disease,1.0,27450459
21192,diarrhea,disease,0.9995,27450459
21193,total-type UC,disease,0.9487,27450459
21194,mesalazine,drug,0.998,27450459
21195,low-grade dysplasia,disease,0.995,27450459
21196,LGD,disease,0.9995,27450459
21197,dyspnea,disease,0.9995,27450459
21198,edema,disease,0.999,27450459
21199,nephrotic syndrome,disease,1.0,27450459
21200,cyclosporine,drug,0.999,27450459
21201,mizoribine,drug,0.9985,27450459
21202,LGD,disease,1.0,27450459
21203,abdominal distension,disease,0.987,27450459
21204,Stenosis of the upper rectum,disease,0.9976,27450459
21205,advanced rectal carcinoma,disease,1.0,27450459
21206,rectal tumor,disease,0.9995,27450459
21207,panitumumab,gene,0.6914,27450459
21208,rectal carcinoma,disease,1.0,27450459
21209,UC,disease,1.0,27450459
21210,nephrotic syndrome,disease,1.0,27450459
21211,mesalazine,drug,0.9956,27450459
21212,LGD,disease,1.0,27450459
21213,advanced rectal carcinoma,disease,1.0,27450459
21214,nephrotic syndrome,disease,1.0,27450459
21215,rectal carcinoma,disease,1.0,27450459
21216,Skin Reactions,disease,0.993,27449521
21217,Epidermal Growth Factor Receptor,gene,0.998,27449521
21218,Solid Tumors,disease,1.0,27449521
21219,epidermal growth factor receptor,gene,0.998,27449521
21220,EGFR,gene,0.909,27449521
21221,tumor,disease,1.0,27449521
21222,EGFR,gene,0.98,27449521
21223,anti-EGFR monoclonal antibodies,gene,0.966,27449521
21224,cetuximab,gene,0.73,27449521
21225,panitumumab,gene,0.7026,27449521
21226,tyrosine,drug,0.9927,27449521
21227,tyrosine kinase,gene,0.9663,27449521
21228,afatinib,drug,0.9966,27449521
21229,gefitinib,drug,0.9985,27449521
21230,erlotinib,drug,0.9966,27449521
21231,EGFR,gene,0.9946,27449521
21232,papulopustular (acneiform) eruptions,disease,1.0,27449521
21233,skin,disease,0.5396,27449521
21234,skin reactions,disease,0.8867,27449521
21235,EGFR,gene,0.9883,27449521
21236,skin reactions,disease,0.961,27449521
21237,EGFR,gene,0.99,27449521
21238,EGFR,gene,0.9937,27449521
21239,Epidermal growth factor receptor,gene,0.9985,27449521
21240,EGFR,gene,0.997,27449521
21241,tumor,disease,1.0,27449521
21242,EGFR,gene,0.995,27449521
21243,skin reactions,disease,0.9985,27449521
21244,EGFR,gene,0.988,27449521
21245,EGFR,gene,0.992,27449521
21246,panitumumab,gene,0.9297,27438067
21247,KRAS,gene,0.7134,27438067
21248,colorectal cancer,disease,0.939,27438067
21249,fluoropyrimidine,drug,0.9985,27438067
21250,oxaliplatin,drug,0.9995,27438067
21251,irinotecan,drug,0.9976,27438067
21252,panitumumab,gene,0.949,27438067
21253,bevacizumab,gene,0.6934,27438067
21254,bevacizumab,gene,0.584,27438067
21255,metastatic colorectal cancer,disease,1.0,27438067
21256,mCRC,disease,1.0,27438067
21257,irinotecan,drug,0.9966,27438067
21258,panitumumab,gene,0.924,27438067
21259,Bevacizumab,gene,0.9316,27438067
21260,panitumumab,gene,0.954,27438067
21261,acneiform rash,disease,1.0,27438067
21262,irinotecan,drug,0.994,27438067
21263,leukopenia,disease,1.0,27438067
21264,neutropenia,disease,0.9995,27438067
21265,mucositis,disease,0.9995,27438067
21266,diarrhea,disease,1.0,27438067
21267,rash acneiform,disease,1.0,27438067
21268,thromboembolic event,disease,1.0,27438067
21269,mCRC,disease,0.9927,27438067
21270,panitumumab,gene,0.954,27438067
21271,bevacizumab,gene,0.8,27438067
21272,KRAS,gene,0.781,27438067
21273,bevacizumab,gene,0.827,27438067
21274,cytokine release syndrome,disease,1.0,27432238
21275,CRS,disease,1.0,27432238
21276,anti-CD28 monoclonal antibody,gene,0.995,27432238
21277,TGN1412,drug,0.998,27432238
21278,human blood cells,cell_type,0.8867,27432238
21279,CRS,disease,1.0,27432238
21280,human peripheral blood mononuclear cells,cell_type,0.871,27432238
21281,PBMC,cell_type,0.878,27432238
21282,whole blood,cell_type,0.4375,27432238
21283,CRS,disease,1.0,27432238
21284,TGN1412,drug,0.9995,27432238
21285,TGN1412,drug,0.9995,27432238
21286,anti-CD28 superagonistic mAb,gene,0.906,27432238
21287,CD28SA,gene,0.994,27432238
21288,FcR,gene,0.997,27432238
21289,alemutuzumab,gene,0.9175,27432238
21290,panitumumab,gene,0.894,27432238
21291,CD28SA,gene,0.99,27432238
21292,alemtuzumab,gene,0.673,27432238
21293,IL-8,gene,0.9536,27432238
21294,FcR,gene,0.9956,27432238
21295,alemtuzumab,gene,0.8447,27432238
21296,T-cell,cell_type,0.628,27432238
21297,CD28SA,gene,0.98,27432238
21298,CD28SA,gene,0.983,27432238
21299,WBCA,cell_line,0.54,27432238
21300,FcR,gene,0.9966,27432238
21301,CD28SA,gene,0.972,27432238
21302,T cell,cell_type,0.552,27432238
21303,EGFR,gene,0.9946,27429047
21304,MEK1/2,gene,0.945,27429047
21305,biliary tract carcinoma,disease,1.0,27429047
21306,Biliary tract carcinomas,disease,1.0,27429047
21307,BTC,disease,1.0,27429047
21308,malignant tumors,disease,1.0,27429047
21309,EGFR,gene,0.959,27429047
21310,EGFR,gene,0.9937,27429047
21311,MEK1/2,gene,0.9673,27429047
21312,BTC,disease,0.9995,27429047
21313,Panitumumab,gene,0.9478,27429047
21314,Trametinib,drug,0.9956,27429047
21315,EGI-1,cell_line,0.9023,27429047
21316,MT-CHC01,cell_line,0.883,27429047
21317,WITT cells,cell_line,0.4973,27429047
21318,BTC models,cell_line,0.766,27429047
21319,BTC,disease,0.5215,27429047
21320,K-RAS,gene,0.7373,27429047
21321,Trametinib,drug,0.996,27429047
21322,MAPK,gene,0.903,27429047
21323,wild type (WT) WITT cells,cell_line,0.8984,27429047
21324,K-RAS mutated cells,cell_line,0.8857,27429047
21325,K-,cell_type,0.683,27429047
21326,K-RAS,gene,0.991,27429047
21327,EGI,cell_line,0.7456,27429047
21328,EGI-1,gene,0.9346,27429047
21329,EGFR,gene,0.991,27429047
21330,EGI-1 cells,cell_line,0.6523,27429047
21331,MAPK,gene,0.9346,27429047
21332,WITT cells,cell_line,0.627,27429047
21333,Trametinib,drug,0.993,27429047
21334,K-RAS mutated cell lines,cell_line,0.8223,27429047
21335,K-RAS,gene,0.5884,27429047
21336,Panitumumab,gene,0.654,27429047
21337,K-RAS,gene,0.5625,27429047
21338,Panitumumab,gene,0.8887,27429047
21339,Trametinib,drug,0.9985,27429047
21340,mutated cells,cell_line,0.8926,27429047
21341,Trametinib,drug,0.995,27429047
21342,tumor,disease,0.9937,27429047
21343,K-RAS,gene,0.9985,27429047
21344,K-RAS WT,gene,0.957,27429047
21345,Panitumumab,gene,0.9507,27429047
21346,Trametinib,drug,0.9893,27429047
21347,MT-CHC01,cell_line,0.771,27429047
21348,anti-EGFR,gene,0.9893,27429047
21349,WITT cells,cell_line,0.7163,27429047
21350,K-RAS,gene,0.6343,27429047
21351,Trametinib,drug,0.9985,27429047
21352,Panitumumab,gene,0.7246,27429047
21353,Ki67,gene,0.7285,27429047
21354,CD31,gene,0.9683,27429047
21355,Trametinib,drug,0.9907,27429047
21356,K-RAS,gene,0.9966,27429047
21357,BTC,disease,1.0,27429047
21358,-,DNA,0.4634,27429047
21359,WT,disease,0.91,27429047
21360,BTC,disease,0.869,27429047
21361,single chain fragment variable,gene,0.8945,27391930
21362,scFv,gene,0.9062,27391930
21363,cancer,disease,1.0,27391930
21364,monoclonal,gene,0.779,27391930
21365,tumor,disease,0.9985,27391930
21366,scFvs,gene,0.9917,27391930
21367,scFvs,gene,0.9897,27391930
21368,cetuximab,gene,0.5947,27391930
21369,scFv2112,gene,0.975,27391930
21370,panitumumab,gene,0.982,27391930
21371,scFv1711,gene,0.961,27391930
21372,epidermal,cell_type,0.6665,27391930
21373,EGFR,gene,0.994,27391930
21374,scFvs,gene,0.9863,27391930
21375,SNAP-tag,gene,0.7666,27391930
21376,human DNA repair enzyme O(6)-alkylguanine DNA alkyltransferase,gene,0.956,27391930
21377,O(6),drug,0.908,27391930
21378,benzylguanine,drug,0.9985,27391930
21379,SNAP,gene,0.8354,27391930
21380,scFv,gene,0.9736,27391930
21381,scFv,gene,0.9893,27391930
21382,SNAP,gene,0.9927,27391930
21383,scFvs,gene,0.9927,27391930
21384,SNAP,DNA,0.4775,27391930
21385,SNAP-tag,gene,0.7954,27391930
21386,anti-epidermal growth factor receptor antibody,gene,0.993,29441917
21387,Electrolyte disturbances,disease,0.9766,29441917
21388,cetuximab,gene,0.9814,29441917
21389,cmab,gene,0.9756,29441917
21390,panitumumab,gene,0.9736,29441917
21391,pmab,gene,0.977,29441917
21392,pmab,DNA,0.5493,29441917
21393,pmab,DNA,0.5063,29441917
21394,magnesium,drug,1.0,29441917
21395,potassium,drug,0.9995,29441917
21396,calcium,drug,0.9995,29441917
21397,Hypokalemia,disease,1.0,29441917
21398,Hypomagnesemia,disease,1.0,29441917
21399,hypokalemia,disease,1.0,29441917
21400,magnesium,drug,0.9995,29441917
21401,cmab,gene,0.592,29441917
21402,magnesium,drug,0.9995,29441917
21403,calcium,drug,0.9985,29441917
21404,cmab,gene,0.725,29441917
21405,pmab,gene,0.8022,29441917
21406,Panitumumab,gene,0.8555,27354619
21407,Irinotecan,drug,0.9736,27354619
21408,Cetuximab,gene,0.8984,27354619
21409,Irinotecan,drug,0.9844,27354619
21410,KRAS,gene,0.996,27354619
21411,Panitumumab,gene,0.856,27354619
21412,cetuximab,gene,0.884,27354619
21413,KRAS,DNA,0.571,27354619
21414,KRAS,gene,0.9966,27354619
21415,colorectal cancer,disease,0.9995,27354619
21416,mCRC,disease,0.999,27354619
21417,irinotecan,drug,0.991,27354619
21418,patients,species,0.937,27354619
21419,KRAS,gene,0.996,27354619
21420,mCRC,disease,0.513,27354619
21421,fluoropyrimidine,drug,0.996,27354619
21422,oxaliplatin,drug,1.0,27354619
21423,irinotecan,drug,0.999,27354619
21424,PATIENTS,species,0.9766,27354619
21425,patients,species,0.985,27354619
21426,panitumumab,gene,0.862,27354619
21427,cetuximab,gene,0.7847,27354619
21428,irinotecan,drug,0.99,27354619
21429,KRAS,DNA,0.6943,27354619
21430,KRAS,gene,0.995,27354619
21431,mCRC,disease,0.951,27354619
21432,fluoropyrimidine,drug,0.988,27354619
21433,oxaliplatin,drug,1.0,27354619
21434,irinotecan,drug,0.9995,27354619
21435,panitumumab,gene,0.9307,27354619
21436,irinotecan,drug,0.998,27354619
21437,cetuximab,gene,0.9263,27354619
21438,irinotecan,drug,0.9985,27354619
21439,panitumumab,gene,0.938,27354619
21440,irinotecan,drug,0.9976,27354619
21441,cetuximab,gene,0.8716,27354619
21442,irinotecan,drug,0.9966,27354619
21443,patients,species,0.9775,27354619
21444,panitumumab,gene,0.973,27354619
21445,irinotecan,drug,0.9976,27354619
21446,cetuximab,gene,0.9653,27354619
21447,irinotecan,drug,0.998,27354619
21448,panitumumab,gene,0.9395,27354619
21449,cetuximab,gene,0.8,27354619
21450,panitumumab,gene,0.884,27354619
21451,cetuximab,gene,0.806,27354619
21452,Panitumumab,gene,0.921,27354619
21453,irinotecan,drug,0.998,27354619
21454,cetuximab,gene,0.959,27354619
21455,irinotecan,drug,0.998,27354619
21456,Panitumumab,gene,0.837,27342247
21457,irinotecan,drug,0.999,27342247
21458,S-1,drug,0.9834,27342247
21459,IRIS,drug,0.823,27342247
21460,Irinotecan,drug,0.9976,27342247
21461,S-1,drug,0.994,27342247
21462,IRIS,drug,0.959,27342247
21463,fluoropyrimidine,drug,0.9883,27342247
21464,metastatic colorectal cancer,disease,1.0,27342247
21465,mCRC,disease,1.0,27342247
21466,patients,species,0.9893,27342247
21467,IRIS,drug,0.989,27342247
21468,EGFR,gene,0.6587,27342247
21469,panitumumab,gene,0.8735,27342247
21470,wild-type KRAS,gene,0.76,27342247
21471,mCRC,disease,0.988,27342247
21472,patients,species,0.972,27342247
21473,wild,gene,0.562,27342247
21474,mCRC,disease,0.996,27342247
21475,mCRC,disease,0.998,27342247
21476,Patients,species,0.967,27342247
21477,panitumumab,gene,0.8936,27342247
21478,irinotecan,drug,0.991,27342247
21479,patients,species,0.9863,27342247
21480,patients,species,0.9854,27342247
21481,diarrhea,disease,1.0,27342247
21482,acne-like rash,disease,1.0,27342247
21483,neutropenia,disease,1.0,27342247
21484,patients,species,0.982,27342247
21485,IRIS,drug,0.5605,27342247
21486,panitumumab,gene,0.905,27342247
21487,patients,species,0.948,27342247
21488,wild-type KRAS,gene,0.894,27342247
21489,mCRC,disease,0.7476,27342247
21490,wild-type KRAS,gene,0.8613,27342247
21491,mCRC,disease,0.996,27342247
21492,Panitumumab,gene,0.811,27340049
21493,Gemcitabine,drug,0.9995,27340049
21494,Carboplatin,drug,0.9995,27340049
21495,Women,species,0.933,27340049
21496,Triple-negative breast cancer,disease,1.0,27340049
21497,TNBC,disease,1.0,27340049
21498,epidermal growth factor receptor,gene,0.9985,27340049
21499,EGFR,gene,0.995,27340049
21500,tumors,disease,1.0,27340049
21501,panitumumab,gene,0.8853,27340049
21502,gemcitabine,drug,0.9995,27340049
21503,carboplatin,drug,0.999,27340049
21504,TNBC,disease,0.767,27340049
21505,PATIENTS,species,0.9536,27340049
21506,women,species,0.894,27340049
21507,Patients,species,0.966,27340049
21508,gemcitabine,drug,0.9985,27340049
21509,carboplatin,drug,0.9976,27340049
21510,panitumumab,gene,0.7725,27340049
21511,"phosphatidylinositol-4,5-bisphosphate",drug,0.998,27340049
21512,"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",gene,0.99,27340049
21513,p53,gene,0.995,27340049
21514,tensin homolog,gene,0.994,27340049
21515,EGFR,gene,0.9854,27340049
21516,women,species,0.9727,27340049
21517,rash,disease,0.998,27340049
21518,patients,species,0.991,27340049
21519,fatigue,disease,0.9985,27340049
21520,patients,species,0.991,27340049
21521,neutropenia,disease,1.0,27340049
21522,patients,species,0.9907,27340049
21523,febrile neutropenia,disease,1.0,27340049
21524,thrombocytopenia,disease,1.0,27340049
21525,patients,species,0.9834,27340049
21526,panitumumab,gene,0.9453,27340049
21527,panitumumab,gene,0.9277,27340049
21528,gemcitabine,drug,0.9995,27340049
21529,carboplatin,drug,0.9995,27340049
21530,patients,species,0.9854,27340049
21531,TNBC,cell_type,0.5635,27340049
21532,TNBC,disease,0.951,27340049
21533,panitumumab,gene,0.904,27335026
21534,cisplatin,drug,0.999,27335026
21535,gemcitabine,drug,0.999,27335026
21536,biliary tract cancer,disease,1.0,27335026
21537,KRAS,gene,0.6963,27335026
21538,advanced biliary tract cancer,disease,1.0,27335026
21539,panitumumab,gene,0.8223,27335026
21540,KRAS,gene,0.5967,27335026
21541,cisplatin,drug,0.9995,27335026
21542,gemcitabine,drug,0.9985,27335026
21543,panitumumab,gene,0.797,27335026
21544,CA19,gene,0.9604,27335026
21545,rash,disease,1.0,27335026
21546,fatigue,disease,0.999,27335026
21547,hypomagnesemia,disease,1.0,27335026
21548,advanced biliary tract,disease,0.936,27335026
21549,cancer,disease,0.978,27335026
21550,panitumumab,gene,0.9155,27335026
21551,gemcitabine,drug,0.999,27335026
21552,cisplatin,drug,0.9995,27335026
21553,KRAS wild-type cancers,disease,0.9995,27335026
21554,KRAS,gene,0.992,27335026
21555,EGFR,gene,0.833,27335026
21556,MET,gene,0.4937,27325282
21557,EGFR,gene,0.996,27325282
21558,BRAF,gene,0.9946,27325282
21559,EGFR,gene,0.994,27325282
21560,MET,gene,0.9946,27325282
21561,BRAF-Mutated Colorectal Cancer,disease,0.9736,27325282
21562,BRAF,gene,0.8354,27325282
21563,metastatic,disease,0.7666,27325282
21564,BRAF-mutated colorectal cancer,disease,0.989,27325282
21565,BRAF,gene,0.7925,27325282
21566,EGFR,gene,0.9956,27325282
21567,BRAF,gene,0.995,27325282
21568,panitumumab,gene,0.8613,27325282
21569,vemurafenib,drug,0.9893,27325282
21570,Pre,cell_line,0.516,27325282
21571,Pre-existing cells,cell_type,0.7075,27325282
21572,MET gene,gene,0.7764,27325282
21573,tumor,disease,0.9995,27325282
21574,MET,gene,0.788,27325282
21575,BRAF-mutated colorectal cancer cells,cell_line,0.8955,27325282
21576,BRAF-mutated,cell_type,0.522,27325282
21577,BRAF,gene,0.9966,27325282
21578,colorectal cancer cells,cell_type,0.622,27325282
21579,colorectal cancer,disease,0.9976,27325282
21580,MET,gene,0.518,27325282
21581,panitumumab,gene,0.842,27325282
21582,vemurafenib,drug,0.989,27325282
21583,BRAF,gene,0.9946,27325282
21584,MET,gene,0.995,27325282
21585,ALK,gene,0.997,27325282
21586,MET,gene,0.998,27325282
21587,crizotinib,drug,0.9985,27325282
21588,vemurafenib,drug,0.9956,27325282
21589,MET,gene,0.922,27325282
21590,BRAF,gene,0.6147,27325282
21591,MET,gene,0.6,27325282
21592,EGFR,gene,0.991,27325282
21593,BRAF,gene,0.998,27325282
21594,BRAF-mutated,disease,0.997,27325282
21595,BRAF,gene,0.5356,27325282
21596,colorectal cancer,disease,0.8247,27325282
21597,EGFR,gene,0.9956,27325282
21598,MET,gene,0.997,27325282
21599,BRAF,gene,0.994,27325282
21600,MET,gene,0.9956,27325282
21601,NK Cells,cell_type,0.9146,27314237
21602,Cetuximab,gene,0.9414,27314237
21603,Tumor,disease,0.9805,27314237
21604,RAS Mutant,gene,0.9937,27314237
21605,Natural Killer (NK) cells,cell_type,0.92,27314237
21606,tumor,disease,1.0,27314237
21607,hematological malignancies,disease,1.0,27314237
21608,NK cell,cell_type,0.883,27314237
21609,solid tumors,disease,1.0,27314237
21610,Epidermal Growth Factor Receptor,gene,0.999,27314237
21611,EGFR,gene,0.9927,27314237
21612,cetuximab,gene,0.656,27314237
21613,panitumumab,gene,0.693,27314237
21614,metastatic colorectal cancer,disease,0.995,27314237
21615,mCRC,disease,0.995,27314237
21616,RAS gene,gene,0.992,27314237
21617,tumors,disease,1.0,27314237
21618,anti-EGFR mAb,gene,0.8823,27314237
21619,NK cells,cell_type,0.9243,27314237
21620,tumor cells,cell_type,0.757,27314237
21621,tumor,disease,1.0,27314237
21622,IgG1 mAbs,gene,0.992,27314237
21623,Fc receptors,gene,0.993,27314237
21624,CD16,gene,0.992,27314237
21625,FcRIIIa,gene,0.7773,27314237
21626,activated Peripheral Blood NK cells,cell_type,0.7974,27314237
21627,PBNK,cell_type,0.7456,27314237
21628,anti-EGFR mAbs,gene,0.9834,27314237
21629,EGFR+/- cancer cell lines,cell_line,0.7485,27314237
21630,EGFR+,gene,0.9897,27314237
21631,cancer,disease,0.942,27314237
21632,RAS,DNA,0.7393,27314237
21633,RAS mutations,gene,0.878,27314237
21634,colon cancer,disease,1.0,27314237
21635,cell lines,cell_line,0.8105,27314237
21636,COLO320,cell_line,0.873,27314237
21637,Caco-2,cell_line,0.885,27314237
21638,SW620,cell_line,0.8794,27314237
21639,SW480,cell_line,0.889,27314237
21640,HT-29,cell_line,0.902,27314237
21641,PBNK cells,cell_type,0.863,27314237
21642,tumor cells,cell_line,0.654,27314237
21643,tumor cells,cell_type,0.866,27314237
21644,tumor,disease,0.9985,27314237
21645,EGFR,gene,0.997,27314237
21646,RAS,gene,0.9956,27314237
21647,BRAF,DNA,0.7637,27314237
21648,BRAF,gene,0.997,27314237
21649,Cetuximab,gene,0.826,27314237
21650,NK cells,cell_type,0.9243,27314237
21651,EGFR+ tumor cells,cell_line,0.866,27314237
21652,EGFR,gene,0.982,27314237
21653,tumor cells,cell_type,0.5547,27314237
21654,tumor,disease,0.98,27314237
21655,RASwt,gene,0.986,27314237
21656,RASmut,cell_line,0.464,27314237
21657,RASmut,gene,0.9824,27314237
21658,BRAFmut,gene,0.987,27314237
21659,CD16,gene,0.9956,27314237
21660,EGFR,cell_line,0.824,27314237
21661,EGFR,gene,0.992,27314237
21662,NK cell,cell_type,0.7686,27314237
21663,cetuximab,gene,0.7104,27314237
21664,RAS,gene,0.989,27314237
21665,BRAF,gene,0.991,27314237
21666,mCRC,disease,0.9985,27314237
21667,patients,species,0.9897,27314237
21668,panitumumab,gene,0.953,27313739
21669,irinotecan,drug,0.9946,27313739
21670,colorectal cancer,disease,0.862,27313739
21671,panitumumab,gene,0.961,27313739
21672,irinotecan,drug,0.9873,27313739
21673,metastatic colorectal cancer,disease,1.0,27313739
21674,mCRC,disease,1.0,27313739
21675,mCRC,disease,0.9614,27313739
21676,mCRC,disease,0.999,27313739
21677,wild-type KRAS,gene,0.6484,27313739
21678,fluoropyrimidine,drug,0.9985,27313739
21679,oxaliplatin,drug,0.9995,27313739
21680,irinotecan,drug,0.998,27313739
21681,Panitumumab,gene,0.91,27313739
21682,irinotecan,drug,0.992,27313739
21683,skin,disease,0.7505,27313739
21684,minocycline,drug,0.9956,27313739
21685,irinotecan,drug,0.9946,27313739
21686,irinotecan,drug,0.9937,27313739
21687,irinotecan,drug,0.9956,27313739
21688,acne-like rash,disease,1.0,27313739
21689,panitumumab,gene,0.942,27313739
21690,irinotecan,drug,0.99,27313739
21691,mCRC,disease,0.9995,27313739
21692,KRAS,gene,0.681,27313739
21693,irinotecan,drug,0.996,27313739
21694,panitumumab,gene,0.87,27313739
21695,circulating tumor cells,cell_type,0.9346,27311775
21696,colorectal cancer,disease,1.0,27311775
21697,KRAS,DNA,0.8525,27311775
21698,KRAS mutations,gene,0.805,27311775
21699,colorectal cancer,disease,1.0,27311775
21700,CRC,disease,1.0,27311775
21701,KRAS,gene,0.738,27311775
21702,EGFR-,gene,0.9956,27311775
21703,panitumumab,gene,0.761,27311775
21704,tumor tissues,cell_type,0.6265,27311775
21705,tumor,disease,1.0,27311775
21706,KRAS,gene,0.8037,27311775
21707,Circulating tumor cells,cell_type,0.9185,27311775
21708,CTCs,cell_type,0.8525,27311775
21709,tumor,disease,0.9995,27311775
21710,CTCs,cell_type,0.8413,27311775
21711,KRAS,gene,0.859,27311775
21712,KRAS mutant cell,cell_line,0.7,27311775
21713,KRAS,gene,0.98,27311775
21714,CTCs,cell_type,0.81,27311775
21715,CRC,disease,1.0,27311775
21716,KRAS,gene,0.71,27311775
21717,KRAS codon 12/13,DNA,0.773,27311775
21718,KRAS codon 12/13 mutant,gene,0.9473,27311775
21719,KRAS,DNA,0.814,27311775
21720,KRAS mutant,gene,0.963,27311775
21721,KRAS,gene,0.8125,27311775
21722,formalin,drug,0.9897,27311775
21723,CTCs,cell_type,0.8267,27311775
21724,tumor,disease,0.9893,27311775
21725,KRAS,DNA,0.8755,27311775
21726,KRAS mutations,gene,0.9746,27311775
21727,CTCs,cell_type,0.7847,27311775
21728,CRC,disease,1.0,27311775
21729,tumor,disease,1.0,27311775
21730,tumor,disease,1.0,27311775
21731,nivolumab,gene,0.5938,27310175
21732,anti-programmed death (PD)1 IgG4 antibody,gene,0.9736,27310175
21733,cancer,disease,1.0,27310175
21734,nivolumab,gene,0.6772,27310175
21735,nivolumab,gene,0.65,27310175
21736,Fc,gene,,27310175
21737,IgGs,gene,0.9897,27310175
21738,tocilizumab,gene,0.961,27310175
21739,IgG1,gene,0.997,27310175
21740,panitumumab,gene,0.927,27310175
21741,IgG2,gene,0.997,27310175
21742,aglyco-IgG1,gene,0.9956,27310175
21743,IgG Fc subclasses,gene,0.8813,27310175
21744,IgG1,gene,0.9956,27310175
21745,aglyco-IgG1,gene,0.9937,27310175
21746,IgG2,gene,0.9976,27310175
21747,IgG4,gene,0.9956,27310175
21748,nivolumab,gene,0.6934,27310175
21749,mannitol,drug,0.977,27310175
21750,human IgG4,gene,0.8975,27310175
21751,human,species,0.995,27310175
21752,Colon Cancer,disease,1.0,27273467
21753,Epidermal growth factor receptor,gene,0.998,27272412
21754,metastatic anal cancer,disease,1.0,27272412
21755,Metastatic squamous cell carcinoma,disease,0.932,27272412
21756,SCCA,disease,1.0,27272412
21757,anal cancer,disease,0.9995,27272412
21758,cisplatin,drug,0.9995,27272412
21759,5-fluorouracil,drug,0.999,27272412
21760,cisplatin,drug,0.9995,27272412
21761,Epidermal growth factor receptor,gene,0.9985,27272412
21762,EGFR,gene,0.995,27272412
21763,SCCA,disease,1.0,27272412
21764,anal cancer,disease,0.983,27272412
21765,EGFR,gene,0.9907,27272412
21766,metastatic SCCA anal cancer,disease,0.991,27272412
21767,patients,species,0.99,27272412
21768,EGFR monoclonal,gene,0.893,27272412
21769,metastatic disease,disease,0.7944,27272412
21770,patients,species,0.985,27272412
21771,patients,species,0.96,27272412
21772,EGFR monoclonal,gene,0.885,27272412
21773,cetuximab,gene,0.9414,27272412
21774,panitumumab,gene,0.9087,27272412
21775,fluoropyrimidine,drug,0.9976,27272412
21776,platinum,drug,0.999,27272412
21777,carboplatin,drug,0.9995,27272412
21778,paclitaxel,drug,0.999,27272412
21779,cisplatin,drug,0.9995,27272412
21780,vinorelbine,drug,0.999,27272412
21781,patients,species,0.9673,27272412
21782,metastatic anal cancer,disease,1.0,27272412
21783,EGFR,gene,0.729,27272412
21784,metastatic SCCA anal cancer,disease,0.9976,27272412
21785,patient,species,0.9927,27272412
21786,cetuximab,gene,0.9077,27272412
21787,panitumumab,gene,0.884,27272412
21788,EGFR,gene,0.9907,27272412
21789,SCCA anal cancer,disease,0.988,27272412
21790,Metastatic Colorectal Cancer,disease,1.0,27220786
21791,metastatic colorectal cancer,disease,0.9995,27220786
21792,bevacizumab,gene,0.8613,27220786
21793,EGFR,gene,0.975,27220786
21794,bevacizumab,gene,0.9062,27220786
21795,erlotinib,drug,0.9834,27220786
21796,Dabrafenib,drug,0.999,27220786
21797,panitumumab,gene,0.8755,27220786
21798,trametinib,drug,0.9985,27220786
21799,encorafenib,drug,0.998,27220786
21800,cetuximab,gene,0.926,27220786
21801,alpelisib,drug,0.997,27220786
21802,BRAF,DNA,0.535,27220786
21803,BRAF mutant-type tumors,disease,0.66,27220786
21804,BRAF mutant,gene,0.7676,27220786
21805,panitumumab,gene,0.6025,27220786
21806,trametinib,drug,0.9937,27220786
21807,EGFR,gene,0.961,27220786
21808,KRAS,gene,0.694,27220786
21809,NRAS,gene,0.7334,27220786
21810,tumors,disease,0.4036,27220786
21811,trastuzumab,gene,0.9814,27220786
21812,lapatinib,drug,0.9966,27220786
21813,HER2,gene,0.997,27220786
21814,irinotecan,drug,0.9985,27220786
21815,cetuximab,gene,0.5215,27220786
21816,tivantinib,drug,0.9966,27220786
21817,irinotecan,drug,0.999,27220786
21818,cetuximab,gene,0.7324,27220786
21819,MET,gene,0.5903,27220786
21820,metastatic colorectal cancer,disease,0.999,27220786
21821,Advanced Rectal Cancer,disease,1.0,27210100
21822,advanced colon cancer,disease,1.0,27210100
21823,panitumumab,gene,0.859,27210100
21824,patient,species,0.9766,27210100
21825,man,species,0.9126,27210100
21826,type 2 colon cancer of the rectum,disease,0.9995,27210100
21827,rectal cancer,disease,1.0,27210100
21828,rectal cancer,disease,1.0,27210100
21829,panitumumab,gene,0.584,27210100
21830,rectal cancer,disease,1.0,27210100
21831,tubular adenocarcinoma,disease,1.0,27210100
21832,tub2-,cell_line,0.787,27210100
21833,mFOLFOX6,drug,0.81,27210100
21834,patient,species,0.9844,27210100
21835,panitumumab,gene,0.708,27210100
21836,advanced colon cancer,disease,1.0,27210100
21837,head and neck cancer,disease,1.0,27167827
21838,cancer,disease,0.9976,27167827
21839,panitumumab,gene,0.979,27167827
21840,Pan,gene,0.7495,27167827
21841,tumor,disease,0.9995,27167827
21842,human-,cell_type,0.4536,27167827
21843,cancer,disease,0.999,27167827
21844,mouse,species,0.958,27167827
21845,tumor,disease,0.926,27167827
21846,post,DNA,0.6313,27167827
21847,Mice,species,0.851,27167827
21848,tumor,disease,0.904,27167827
21849,tumor,disease,0.999,27167827
21850,epidermal growth factor receptor,gene,0.998,27167827
21851,EGFR,gene,0.9907,27167827
21852,SCCHN,disease,0.9995,27167827
21853,ATP,drug,0.7627,27167827
21854,EGFR,gene,0.992,27167827
21855,tumor,disease,0.7446,27167827
21856,Colorectal Cancer,disease,1.0,27165728
21857,HER2,gene,0.984,27165728
21858,HER2,gene,0.9336,27165728
21859,trastuzumab,gene,0.974,27165728
21860,lapatinib,drug,0.9976,27165728
21861,KRAS,gene,0.4924,27165728
21862,HER2,gene,0.9927,27165728
21863,metastatic colorectal cancer,disease,0.9995,27165728
21864,EGFR,gene,0.99,27165728
21865,cetuximab,gene,0.708,27165728
21866,panitumumab,gene,0.8467,27165728
21867,HER2,gene,0.9966,27165728
21868,panitumumab,gene,0.8843,27144068
21869,wild,DNA,0.627,27144068
21870,wild-type KRAS exon 2,gene,0.9272,27144068
21871,metastatic colorectal cancer,disease,0.995,27144068
21872,Panitumumab,gene,0.9536,27144068
21873,colorectal cancer,disease,1.0,27144068
21874,CRC,disease,1.0,27144068
21875,metastatic colorectal cancer,disease,1.0,27144068
21876,mCRC,disease,1.0,27144068
21877,panitumumab,gene,0.8164,27144068
21878,KRAS exon 2,gene,0.554,27144068
21879,mCRC,disease,0.872,27144068
21880,panitumumab,gene,0.763,27144068
21881,skin rash,disease,1.0,27144068
21882,Panitumumab,gene,0.609,27144068
21883,CRC,disease,0.621,27144068
21884,EGFR-specific,gene,0.751,27135741
21885,cetuximab,gene,0.5024,27135741
21886,Cetuximab,gene,0.8477,27135741
21887,metastatic colorectal cancer,disease,1.0,27135741
21888,mCRC,disease,1.0,27135741
21889,Cetuximab,gene,0.7954,27135741
21890,epidermal growth factor receptor,gene,0.9985,27135741
21891,EGFR,gene,0.992,27135741
21892,RAS,gene,0.997,27135741
21893,ERK,gene,0.994,27135741
21894,RAS,gene,0.4844,27135741
21895,cetuximab,gene,0.6973,27135741
21896,cetuximab,gene,0.949,27135741
21897,immunogenic cell,cell_type,0.548,27135741
21898,antitumor,disease,0.803,27135741
21899,cetuximab,gene,0.9336,27135741
21900,CRC cells,cell_line,0.802,27135741
21901,CRC,disease,1.0,27135741
21902,dendritic cells,cell_type,0.936,27135741
21903,ICD,gene,0.9546,27135741
21904,EGFR,gene,0.9946,27135741
21905,X-box binding protein 1,gene,0.9985,27135741
21906,XBP1,gene,0.989,27135741
21907,cetuximab,gene,0.9414,27135741
21908,mouse,species,0.96,27135741
21909,human EGFR-expressing CRC,cell_line,0.5977,27135741
21910,human EGFR,cell_type,0.4817,27135741
21911,EGFR-,disease,0.9556,27135741
21912,EGFR,gene,0.9014,27135741
21913,cetuximab,gene,0.747,27135741
21914,Metastatic Colon Cancer,disease,1.0,27125751
21915,metastatic colon cancer,disease,1.0,27125751
21916,metastatic colon cancer,disease,0.9995,27125751
21917,Bevacizumab,gene,0.9053,27125751
21918,Cetuximab,gene,0.905,27125751
21919,Panitumumab,gene,0.862,27125751
21920,Bevacizumab,gene,0.887,27125751
21921,Cetuximab,gene,0.953,27125751
21922,Panitumumab,gene,0.8135,27125751
21923,cancer,disease,1.0,27125751
21924,metastatic disease,disease,0.6895,27125751
21925,metastatic colon cancer,disease,1.0,27125751
21926,trastuzumab,gene,0.98,27108243
21927,lapatinib,drug,0.9976,27108243
21928,KRAS,gene,0.9795,27108243
21929,HER2,gene,0.99,27108243
21930,trastuzumab,gene,0.969,27108243
21931,lapatinib,drug,0.998,27108243
21932,tumour,disease,0.999,27108243
21933,patient,species,0.9307,27108243
21934,HER2-amplified metastatic colorectal cancer,disease,0.868,27108243
21935,HER2,gene,0.996,27108243
21936,trastuzumab,gene,0.9766,27108243
21937,lapatinib,drug,0.9976,27108243
21938,patients,species,0.8677,27108243
21939,HER2-positive colorectal cancer,disease,0.9917,27108243
21940,HER2,gene,0.9873,27108243
21941,cancer,disease,0.998,27108243
21942,patients,species,0.9717,27108243
21943,KRAS exon 2 (codons 12 and 13),DNA,0.734,27108243
21944,KRAS exon 2,gene,0.976,27108243
21945,HER2-positive metastatic colorectal cancer,disease,0.956,27108243
21946,HER2,gene,0.9736,27108243
21947,cetuximab,gene,0.963,27108243
21948,panitumumab,gene,0.947,27108243
21949,measurable lesion,DNA,0.5435,27108243
21950,HER2,gene,0.995,27108243
21951,tumour samples,cell_type,0.4795,27108243
21952,tumour,disease,1.0,27108243
21953,colorectal cancer,disease,1.0,27108243
21954,patients,species,0.9785,27108243
21955,trastuzumab,gene,0.962,27108243
21956,lapatinib,drug,0.9966,27108243
21957,patients,species,0.9917,27108243
21958,patients,species,0.99,27108243
21959,KRAS exon 2 (,DNA,0.715,27108243
21960,KRAS exon 2,gene,0.9575,27108243
21961,codons 12 and 13,DNA,0.4707,27108243
21962,patients,species,0.973,27108243
21963,HER2-positive tumours,disease,0.984,27108243
21964,HER2,gene,0.9927,27108243
21965,patients,species,0.993,27108243
21966,patients,species,0.987,27108243
21967,patient,species,0.978,27108243
21968,patients,species,0.9185,27108243
21969,patients,species,0.977,27108243
21970,fatigue,disease,0.9927,27108243
21971,patients,species,0.9907,27108243
21972,skin rash,disease,0.998,27108243
21973,patient,species,0.9814,27108243
21974,bilirubin,drug,0.998,27108243
21975,patient,species,0.969,27108243
21976,trastuzumab,gene,0.9805,27108243
21977,lapatinib,drug,0.9976,27108243
21978,patients,species,0.9624,27108243
21979,HER2-positive metastatic colorectal cancer,disease,0.985,27108243
21980,HER2,gene,0.993,27108243
21981,Hypomagnesemia,disease,1.0,27106835
21982,anti-EGFR monoclonal antibody,gene,0.9556,27106835
21983,Anti-EGFR monoclonal antibody,gene,0.8877,27106835
21984,KRAS,gene,0.9946,27106835
21985,metastatic colorectal cancer,disease,0.9976,27106835
21986,mCRC,disease,0.999,27106835
21987,hypomagnesemia,disease,1.0,27106835
21988,skin disorders,disease,1.0,27106835
21989,mCRC,disease,0.998,27106835
21990,patients,species,0.9917,27106835
21991,anti-EGFR monoclonal,gene,0.921,27106835
21992,mCRC,disease,0.9976,27106835
21993,patients,species,0.993,27106835
21994,cetuximab,gene,0.854,27106835
21995,panitumumab,gene,0.875,27106835
21996,patients,species,0.978,27106835
21997,minocycline,drug,0.998,27106835
21998,skin rash,disease,0.9995,27106835
21999,Hypomagnesemia,disease,1.0,27106835
22000,acneiform rash,disease,1.0,27106835
22001,patients,species,0.9927,27106835
22002,hypomagnesemia,disease,1.0,27106835
22003,acneiform rash,disease,1.0,27106835
22004,patients,species,0.979,27106835
22005,hypomagnesemia,disease,1.0,27106835
22006,patients,species,0.986,27106835
22007,hypomagnesemia,disease,1.0,27106835
22008,patients,species,0.989,27106835
22009,acneiform rash,disease,1.0,27106835
22010,Hypomagnesemia,disease,1.0,27106835
22011,anti-EGFR monoclonal antibody,gene,0.93,27106835
22012,mCRC,disease,0.999,27106835
22013,patients,species,0.9917,27106835
22014,Anti,gene,0.5703,27091467
22015,EGFR,gene,0.6367,27091467
22016,anti-VEGF,gene,0.729,27091467
22017,RAS,disease,0.812,27091467
22018,metastatic colorectal cancer,disease,1.0,27091467
22019,mCRC,disease,1.0,27091467
22020,mCRC,disease,0.997,27091467
22021,patients,species,0.993,27091467
22022,patients,species,0.989,27091467
22023,RAS,DNA,0.6255,27091467
22024,RAS mutational,gene,0.755,27091467
22025,EGFR,gene,0.914,27091467
22026,VEGF,gene,0.839,27091467
22027,EGFR,gene,0.986,27091467
22028,EGFR,gene,0.9893,27091467
22029,RAS,gene,0.996,27091467
22030,EGFR,gene,0.904,27091467
22031,mCRC,disease,0.9824,27091467
22032,patients,species,0.987,27091467
22033,Panitumumab,gene,0.837,27085587
22034,Cetuximab,gene,0.8574,27085587
22035,Patients,species,0.983,27085587
22036,cetuximab,gene,0.8784,27085587
22037,panitumumab,gene,0.8325,27085587
22038,patients,species,0.9644,27085587
22039,wild,gene,0.7285,27085587
22040,exon 2,DNA,0.7505,27085587
22041,metastatic colorectal cancer,disease,1.0,27085587
22042,mCRC,disease,1.0,27085587
22043,Panitumumab,gene,0.8506,27085587
22044,Cetuximab,gene,0.8496,27085587
22045,Patients,species,0.951,27085587
22046,KRAS,gene,0.9946,27085587
22047,panitumumab,gene,0.9136,27085587
22048,cetuximab,gene,0.888,27085587
22049,panitumumab,gene,0.879,27085587
22050,cetuximab,gene,0.8447,27085587
22051,wild,gene,0.6655,27085587
22052,mCRC,disease,0.961,27085587
22053,ASPECCT,DNA,0.7705,27085587
22054,ASPECCT,DNA,0.5903,27085587
22055,epidermal growth factor receptor,gene,0.9062,27085587
22056,ASPECCT,DNA,0.58,27085587
22057,panitumumab,gene,0.922,27085587
22058,cetuximab,gene,0.9004,27085587
22059,ASPECCT,DNA,0.496,27085587
22060,patients,species,0.99,27085587
22061,panitumumab,gene,0.909,27085587
22062,cetuximab,gene,0.722,27085587
22063,panitumumab,gene,0.9507,27085587
22064,patient,species,0.9883,27085587
22065,panitumumab,gene,0.658,27085587
22066,cetuximab,gene,0.938,27085587
22067,panitumumab,gene,0.8706,27085587
22068,cetuximab,gene,0.7285,27085587
22069,wild,gene,0.784,27085587
22070,mCRC,disease,0.9814,27085587
22071,panitumumab,gene,0.788,27085587
22072,panitumumab,gene,0.5713,27083443
22073,Epidermal growth factor receptor,gene,0.998,27083443
22074,panitumumab,gene,0.6934,27083443
22075,panitumumab,gene,0.942,27083443
22076,patients,species,0.9053,27083443
22077,metastatic colorectal cancer,disease,1.0,27083443
22078,mCRC,disease,0.999,27083443
22079,FOLFOX4,drug,0.94,27083443
22080,FOLFIRI,drug,0.8896,27083443
22081,KRAS,gene,0.992,27083443
22082,NRAS,gene,0.9985,27083443
22083,RAS,gene,0.997,27083443
22084,mCRC,disease,0.982,27083443
22085,panitumumab,gene,0.8794,27083443
22086,patients,species,0.9883,27083443
22087,panitumumab,gene,0.9565,27083443
22088,patients,species,0.987,27083443
22089,panitumumab,gene,0.9214,27083443
22090,RAS,gene,0.992,27083443
22091,mCRC,disease,0.944,27083443
22092,Skin toxicity,disease,0.927,27083443
22093,skin,disease,0.769,27083443
22094,irinotecan,drug,0.9927,27072236
22095,patients,species,0.9707,27072236
22096,gene polymorphisms,DNA,0.6797,27072236
22097,irinotecan,drug,0.997,27072236
22098,bevasizumab,gene,0.7715,27072236
22099,panitumumab,gene,0.87,27072236
22100,capecitabine,drug,0.999,27072236
22101,5-FU,drug,0.9985,27072236
22102,colorectal cancer,disease,0.981,27072236
22103,CRC,disease,1.0,27072236
22104,metastatic CRC,disease,0.9233,27072236
22105,Patients,species,0.983,27072236
22106,KRAS,gene,0.9243,27072236
22107,UGT1A1,gene,0.9624,27072236
22108,UGT1A1,DNA,0.792,27072236
22109,UGT1A1*28,gene,0.962,27072236
22110,DPD (IVS14+1 G. &,DNA,0.6235,27072236
22111,DPD (IVS14+1,gene,0.8535,27072236
22112,patients,species,0.9844,27072236
22113,SD disease,disease,0.9995,27072236
22114,PD,disease,,27072236
22115,KRAS mutated alleles,gene,0.8984,27072236
22116,PD,disease,,27072236
22117,DPD,gene,0.944,27072236
22118,UGT1A1,DNA,0.782,27072236
22119,UGT1A1 genotypes,gene,0.8867,27072236
22120,UGT1A1,DNA,0.6304,27072236
22121,UGT1A1 genotypes,gene,0.9487,27072236
22122,irinotecan,drug,0.9946,27072236
22123,5,drug,0.999,27072236
22124,irinotecan,drug,0.999,27072236
22125,DPD,gene,0.9946,27072236
22126,UGT1A1,gene,0.961,27072236
22127,Hypomagnesemia,disease,1.0,27067688
22128,Acneiform Rash,disease,1.0,27067688
22129,anti-EGFR monoclonal antibodies,gene,0.984,27067688
22130,cetuximab,gene,0.8545,27067688
22131,panitumumab,gene,0.873,27067688
22132,KRAS,gene,0.996,27067688
22133,advanced colorectal cancer,disease,0.999,27067688
22134,hypomagnesemia,disease,1.0,27067688
22135,acneiform rash,disease,1.0,27067688
22136,hypomagnesemia,disease,1.0,27067688
22137,acneiform rash,disease,1.0,27067688
22138,patients,species,0.93,27067688
22139,metastatic colorectal cancer,disease,1.0,27067688
22140,mCRC,disease,1.0,27067688
22141,mCRC,disease,0.9956,27067688
22142,patients,species,0.9917,27067688
22143,anti -EGFR monoclonal antibody,gene,0.864,27067688
22144,hypomagnesemia,disease,1.0,27067688
22145,acneiform rash,disease,1.0,27067688
22146,hypomagnesemia,disease,1.0,27067688
22147,acneiform rash,disease,1.0,27067688
22148,patients,species,0.9897,27067688
22149,tumor,disease,0.9985,27067688
22150,patients,species,0.9937,27067688
22151,tumor,disease,0.9956,27067688
22152,patients,species,0.9873,27067688
22153,hypomagnesemia,disease,1.0,27067688
22154,acneiform rash,disease,1.0,27067688
22155,anti-EGFR monoclonal antibody,gene,0.915,27067688
22156,metastatic Colorectal cancer,disease,0.9976,27057810
22157,cancer,disease,1.0,27057810
22158,patients,species,0.9873,27057810
22159,patients,species,0.994,27057810
22160,tumors,disease,0.9995,27057810
22161,metastatic colorectal cancer,disease,0.9995,27057810
22162,mCRC,disease,1.0,27057810
22163,5-fluorouracil,drug,0.999,27057810
22164,5-FU,drug,0.999,27057810
22165,patients,species,0.95,27057810
22166,mCRC,disease,0.9907,27057810
22167,irinotecan,drug,0.9995,27057810
22168,oxaliplatin,drug,0.9995,27057810
22169,capecitabine,drug,0.9995,27057810
22170,humanized,species,0.58,27057810
22171,vascular endothelial growth factor,gene,0.997,27057810
22172,bevacizumab,gene,0.797,27057810
22173,aflibercept,gene,0.926,27057810
22174,epidermal growth factor receptor,gene,0.996,27057810
22175,cetuximab,gene,0.9336,27057810
22176,panitumumab,gene,0.8813,27057810
22177,regorafenib,drug,0.936,27057810
22178,trifluridine,drug,0.996,27057810
22179,tipiracil,drug,0.9966,27057810
22180,mCRC,disease,0.9463,27057810
22181,oxaliplatin,drug,0.9995,27057810
22182,irinotecan,drug,0.9985,27057810
22183,5-FU,drug,0.996,27057810
22184,patient,species,0.9795,27057810
22185,mCRC,disease,0.998,27057810
22186,mCRC,disease,0.967,27057810
22187,patients,species,0.979,27057810
22188,mCRC,disease,0.979,27057810
22189,Metastatic Colorectal Cancer,disease,0.9995,27057668
22190,Colorectal cancer,disease,1.0,27057668
22191,CRC,disease,1.0,27057668
22192,patients,species,0.986,27057668
22193,CRC,disease,0.9985,27057668
22194,patients,species,0.965,27057668
22195,metastatic CRC,disease,0.9995,27057668
22196,mCRC,disease,1.0,27057668
22197,mCRC,disease,0.916,27057668
22198,irinotecan,drug,0.9927,27057668
22199,oxaliplatin,drug,1.0,27057668
22200,capecitabine,drug,0.9995,27057668
22201,fluoropyrimidine,drug,0.9995,27057668
22202,5-fluorouracil,drug,0.9995,27057668
22203,capecitabine,drug,0.999,27057668
22204,oxaliplatin,drug,0.9995,27057668
22205,irinotecan,drug,0.999,27057668
22206,mCRC,disease,0.722,27057668
22207,mCRC,disease,0.7227,27057668
22208,vascular endothelial growth factor receptor,gene,0.998,27057668
22209,bevacizumab,gene,0.8105,27057668
22210,ziv-aflibercept,gene,0.968,27057668
22211,epidermal growth factor receptor,gene,0.997,27057668
22212,cetuximab,gene,0.9297,27057668
22213,panitumumab,gene,0.8657,27057668
22214,mCRC,disease,0.6353,27057668
22215,Solid Tumors,disease,0.999,26995877
22216,solid tumors,disease,1.0,26995877
22217,EGFR,gene,0.9946,26995877
22218,gefitinib,drug,0.9917,26995877
22219,ALK fusion,gene,0.8135,26995877
22220,crizotinib,drug,0.999,26995877
22221,non-small-cell lung cancer,disease,1.0,26995877
22222,KRAS,gene,0.961,26995877
22223,cetuximab,gene,0.905,26995877
22224,panitumumab,gene,0.877,26995877
22225,colorectal cancer,disease,1.0,26995877
22226,HER2,gene,0.9956,26995877
22227,trastuzumab,gene,0.9106,26995877
22228,breast cancer,disease,1.0,26995877
22229,DNA sequence,DNA,0.6196,26995877
22230,germline,DNA,0.85,26995877
22231,KRAS Mutation,gene,0.931,26984642
22232,KRAS,gene,0.9478,26984642
22233,epidermal growth factor receptor,gene,0.981,26984642
22234,EGFR,gene,0.9956,26984642
22235,patients,species,0.953,26984642
22236,metastatic colorectal cancer,disease,1.0,26984642
22237,mCRC,disease,1.0,26984642
22238,mCRC,disease,1.0,26984642
22239,patients,species,0.9863,26984642
22240,KRAS,DNA,0.6587,26984642
22241,KRAS mutation,gene,0.8945,26984642
22242,KRAS,gene,0.833,26984642
22243,codons 12,DNA,0.8477,26984642
22244,KRAS,DNA,0.834,26984642
22245,KRAS mutation,gene,0.951,26984642
22246,cetuximab,gene,0.6353,26984642
22247,panitumumab,gene,0.5864,26984642
22248,KRAS,gene,0.936,26984642
22249,KRAS,DNA,0.6377,26984642
22250,KRAS mutations,gene,0.9404,26984642
22251,mCRC,disease,0.9956,26984642
22252,patients,species,0.9907,26984642
22253,EGFR,gene,0.5386,26984642
22254,colorectal cancer,disease,1.0,26982510
22255,bevacizumab,gene,0.8623,26982510
22256,cetuximab,gene,0.9185,26982510
22257,panitumumab,gene,0.9414,26982510
22258,metastatic colorectal cancer,disease,1.0,26982510
22259,mCRC,disease,1.0,26982510
22260,bevacizumab,gene,0.8745,26982510
22261,cetuximab,gene,0.9375,26982510
22262,panitumumab,gene,0.9395,26982510
22263,mCRC,disease,0.9907,26982510
22264,VEGF-A,gene,0.998,26982510
22265,bevacizumab,gene,0.4634,26982510
22266,hypertension,disease,1.0,26982510
22267,proteinuria,disease,1.0,26982510
22268,thromboembolism,disease,1.0,26982510
22269,bleeding,disease,0.906,26982510
22270,gastrointestinal perforation,disease,1.0,26982510
22271,prolonged wound,disease,0.9976,26982510
22272,hypertension,disease,1.0,26982510
22273,proteinuria,disease,1.0,26982510
22274,VEGFR2 antibody,gene,0.786,26982510
22275,EGFR,gene,0.9937,26982510
22276,skin rash,disease,1.0,26982510
22277,hypersensitivity reactions,disease,1.0,26982510
22278,hypomagnesemia,disease,1.0,26982510
22279,murine,species,0.96,26982510
22280,cetuximab,gene,0.9043,26982510
22281,panitumumab,gene,0.857,26982510
22282,human,species,0.9976,26982510
22283,panitumumab,gene,0.8013,26980732
22284,ERBB2,gene,0.9985,26980732
22285,HER2,gene,0.9966,26980732
22286,KRAS,gene,0.966,26980732
22287,metastatic colorectal cancer,disease,1.0,26980732
22288,mCRC,disease,1.0,26980732
22289,panitumumab,gene,0.899,26980732
22290,metastatic colorectal cancer,disease,1.0,26980732
22291,mCRC,disease,1.0,26980732
22292,codon 12/13 KRAS,DNA,0.846,26980732
22293,KRAS,gene,0.7,26980732
22294,mCRC,disease,0.999,26980732
22295,panitumumab,gene,0.815,26980732
22296,panitumumab,gene,0.9473,26980732
22297,5-gene expression signature,DNA,0.5146,26980732
22298,ERBB2,gene,0.748,26980732
22299,MLPH,gene,0.7715,26980732
22300,IRX3,gene,0.705,26980732
22301,MYRF,gene,0.728,26980732
22302,KLK6,gene,0.806,26980732
22303,panitumumab,gene,0.8643,26980732
22304,HER2,gene,0.996,26980732
22305,ERBB2,gene,0.996,26980732
22306,tumors,disease,0.9976,26980732
22307,ERBB2 gene,gene,0.724,26980732
22308,ERBB2,gene,0.6826,26980732
22309,codon 12/13,DNA,0.5884,26980732
22310,KRAS,gene,0.5874,26980732
22311,panitumumab,gene,0.716,26980732
22312,ERBB2,gene,0.9946,26980732
22313,HER2,gene,0.996,26980732
22314,5-gene signature,DNA,0.756,26980732
22315,panitumumab,gene,0.843,26980732
22316,ERBB2,gene,0.9844,26980732
22317,HER2,gene,0.9805,26980732
22318,KRAS wt tumors,cell_line,0.696,26980732
22319,KRAS,gene,0.4805,26980732
22320,tumors,disease,0.965,26980732
22321,EGFRi,gene,0.9897,26980732
22322,HER2,gene,0.996,26980732
22323,gastric cancer,disease,1.0,26971395
22324,Gastric cancer,disease,1.0,26971395
22325,GC,disease,1.0,26971395
22326,trastuzumab,gene,0.92,26971395
22327,panitumumab,gene,0.945,26971395
22328,cetuximab,gene,0.941,26971395
22329,bevacizumab,gene,0.9263,26971395
22330,rilotumumab,gene,0.5938,26971395
22331,gastric cancer,disease,1.0,26971395
22332,gastric cancer,disease,1.0,26971395
22333,Trastuzumab,gene,0.9287,26971395
22334,HER2,gene,0.9917,26971395
22335,advanced GC,disease,0.9824,26971395
22336,Locally Advanced Squamous Cell Carcinoma of the Head and Neck,disease,0.9995,26967327
22337,squamous cell carcinoma of the head and neck,disease,1.0,26967327
22338,SCCHN,disease,1.0,26967327
22339,SCCHN cells,cell_line,0.674,26967327
22340,SCCHN,disease,0.9995,26967327
22341,tumor,disease,1.0,26967327
22342,ErbB receptor,gene,0.995,26967327
22343,SCCHN,disease,1.0,26967327
22344,Cetuximab,gene,0.662,26967327
22345,epidermal growth factor receptor,gene,0.9976,26967327
22346,EGFR,gene,0.9883,26967327
22347,LA SCCHN,disease,0.9805,26967327
22348,EGFR,gene,0.9937,26967327
22349,ErbB family members,gene,0.9653,26967327
22350,panitumumab,gene,0.851,26967327
22351,nimotuzumab,gene,0.8535,26967327
22352,tyrosine,drug,0.9893,26967327
22353,tyrosine kinase,gene,0.978,26967327
22354,erlotinib,drug,0.998,26967327
22355,afatinib,drug,0.9976,26967327
22356,lapatinib,drug,0.999,26967327
22357,LA SCCHN,disease,0.9956,26967327
22358,LA SCCHN,disease,0.988,26967327
22359,EGFR,gene,0.996,26967327
22360,rapamycin,drug,0.9976,26967327
22361,Src family,gene,0.9834,26967327
22362,Aurora kinase family,gene,0.962,26967327
22363,LA SCCHN,disease,0.988,26967327
22364,RAS,DNA,0.7036,26952655
22365,RAS Mutations,gene,0.7793,26952655
22366,Metastatic Colorectal Cancer,disease,1.0,26952655
22367,anti-,gene,0.774,26952655
22368,epidermal growth factor receptor,gene,0.903,26952655
22369,EGFR,gene,0.998,26952655
22370,metastatic colorectal cancer,disease,1.0,26952655
22371,"codons 12, 13, 59, 61, 117, and 146",DNA,0.7754,26952655
22372,KRAS and NRAS genes,DNA,0.8,26952655
22373,KRAS,gene,0.984,26952655
22374,NRAS genes,gene,0.9663,26952655
22375,primary,disease,0.5996,26952655
22376,tumor,disease,0.999,26952655
22377,cetuximab,gene,0.9336,26952655
22378,panitumumab,gene,0.914,26952655
22379,Cancer,disease,0.9814,26952655
22380,KRAS mutations,gene,0.654,26952655
22381,KRAS mutations,gene,0.6753,26952655
22382,allele,DNA,0.4988,26952655
22383,tumor,disease,0.9976,26952655
22384,RAS,DNA,0.757,26952655
22385,RAS mutations,gene,0.953,26952655
22386,tumors,disease,1.0,26952655
22387,EGFR,gene,0.8813,26952655
22388,RAS,gene,0.626,26952655
22389,colorectal cancer,disease,1.0,26947960
22390,colorectal cancer liver metastasis,disease,0.9487,26947960
22391,metastatic colorectal cancer,disease,1.0,26947960
22392,tumour,disease,1.0,26947960
22393,tumour,disease,0.9756,26947960
22394,metastatic,disease,0.6626,26947960
22395,tumour,disease,0.999,26947960
22396,tumour,disease,0.9697,26947960
22397,tumour,disease,0.9775,26947960
22398,colorectal cancer liver metastasis,disease,0.9453,26947960
22399,Colon Cancer,disease,0.9995,26928314
22400,cetuximab,gene,0.88,26928314
22401,panitumumab,gene,0.8335,26928314
22402,EGFR,gene,0.9883,26928314
22403,colorectal cancer cell line,cell_line,0.735,26928314
22404,colorectal cancer,disease,1.0,26928314
22405,cetuximab,gene,0.943,26928314
22406,tumor,disease,0.9985,26928314
22407,tumors,disease,1.0,26928314
22408,EGFR,gene,0.8657,26927802
22409,Metastatic Colorectal Cancer,disease,1.0,26927802
22410,RAS Gene,gene,0.8643,26927802
22411,Colorectal cancer,disease,1.0,26927802
22412,CRC,disease,1.0,26927802
22413,cancer,disease,1.0,26927802
22414,cancer,disease,0.9995,26927802
22415,metastatic CRC,disease,0.9946,26927802
22416,CRC,disease,0.999,26927802
22417,Cetuximab,gene,0.7583,26927802
22418,panitumumab,gene,0.7656,26927802
22419,epidermal growth factor receptor,gene,0.9966,26927802
22420,Kristen rat Sarcoma viral oncogene,gene,0.9043,26927802
22421,KRAS,gene,0.821,26927802
22422,neuroblastoma,disease,0.8555,26927802
22423,neuroblastoma rat sarcoma viral oncogene,gene,0.904,26927802
22424,NRAS,gene,0.8457,26927802
22425,RAS gene,gene,0.914,26927802
22426,Gastrointestinal cancer,disease,1.0,26925961
22427,EGFR,gene,0.969,26925961
22428,KRAS,gene,0.763,26925640
22429,BRAF,gene,0.5537,26925640
22430,PIK3CA Mutations,gene,0.8228,26925640
22431,Colorectal Peritoneal Carcinomatosis,disease,1.0,26925640
22432,peritoneal carcinomatosis,disease,1.0,26925640
22433,PC,disease,1.0,26925640
22434,colorectal cancer,disease,1.0,26925640
22435,CRC,disease,1.0,26925640
22436,bevacizumab,gene,0.901,26925640
22437,cetuximab,gene,0.8896,26925640
22438,panitumumab,gene,0.9375,26925640
22439,metastatic CRC,disease,0.9995,26925640
22440,bevacizumab,gene,0.7495,26925640
22441,KRAS,gene,0.801,26925640
22442,BRAF,gene,0.6045,26925640
22443,PIK3CA gene mutations,gene,0.8447,26925640
22444,PC,disease,0.997,26925640
22445,PC,disease,0.971,26925640
22446,BRAF,DNA,0.875,26925640
22447,BRAF mutation,gene,0.759,26925640
22448,PC,disease,0.945,26925640
22449,bevacizumab,gene,0.7114,26925640
22450,bevacizumab,gene,0.6763,26925640
22451,BRAF V600E,DNA,0.643,26925640
22452,BRAF V600E mutation,gene,0.9097,26925640
22453,V600E,mutation,,26925640
22454,PC,disease,0.998,26925640
22455,PC,disease,0.902,26925640
22456,BRAF,DNA,0.7344,26925640
22457,BRAF mutations,gene,0.7817,26925640
22458,PC,disease,0.996,26925640
22459,bevacizumab,gene,0.5146,26925640
22460,PC,disease,0.9824,26925640
22461,CRC,disease,0.9946,26925640
22462,PC,disease,0.6084,26925640
22463,BRAF,gene,0.759,26925640
22464,PC,disease,1.0,26925640
22465,Panitumumab,gene,0.8276,26911408
22466,Metastatic KRAS Wild-Type Colorectal Cancer,disease,0.985,26911408
22467,KRAS,gene,0.456,26911408
22468,Liver Metastases,disease,0.937,26911408
22469,metastatic colorectal cancer,disease,0.987,26911408
22470,mCRC,disease,1.0,26911408
22471,folinic acid,drug,0.9995,26911408
22472,5-fluorouracil,drug,0.9995,26911408
22473,5-FU,drug,0.9995,26911408
22474,oxaliplatin,drug,1.0,26911408
22475,irinotecan,drug,0.9995,26911408
22476,FOLFOXIRI,drug,0.992,26911408
22477,panitumumab,gene,0.7856,26911408
22478,KRAS,gene,0.6323,26911408
22479,mCRC,disease,0.975,26911408
22480,5-FU,drug,0.987,26911408
22481,leucovorin,drug,0.998,26911408
22482,irinotecan,drug,0.9976,26911408
22483,oxaliplatin,drug,0.9995,26911408
22484,panitumumab,gene,0.869,26911408
22485,diarrhea,disease,1.0,26911408
22486,rash,disease,0.9985,26911408
22487,KRAS,gene,0.823,26911408
22488,NRAS,gene,0.536,26911408
22489,oxaliplatin,drug,0.9995,26911408
22490,KRAS,gene,0.8403,26911408
22491,NRAS,gene,0.61,26911408
22492,exon 2,DNA,0.8467,26911408
22493,KRAS,gene,0.7046,26911408
22494,NRAS,gene,0.61,26911408
22495,liver-only,disease,0.853,26911408
22496,mCRC,disease,0.9253,26911408
22497,KRAS,gene,0.696,26911408
22498,NRAS,gene,0.4377,26911408
22499,EGFR antibodies,gene,0.8076,26897044
22500,patients,species,0.9907,26897044
22501,patients,species,0.984,26897044
22502,metastatic colorectal cancer,disease,1.0,26897044
22503,bevacizumab,gene,0.9414,26897044
22504,cetuximab,gene,0.898,26897044
22505,panitumumab,gene,0.912,26897044
22506,patients,species,0.988,26897044
22507,bevacizumab,gene,0.7104,26897044
22508,EGFR,gene,0.9883,26897044
22509,EGFR,gene,0.8657,26897044
22510,Anti-EGFR Antibody,gene,0.9805,26888827
22511,Cetuximab,gene,0.914,26888827
22512,anti-EGFR antibodies,gene,0.9907,26888827
22513,cetuximab,gene,0.6177,26888827
22514,panitumumab,gene,0.822,26888827
22515,patients,species,0.9316,26888827
22516,metastatic colorectal cancer,disease,1.0,26888827
22517,MCRC,disease,1.0,26888827
22518,patients,species,0.9688,26888827
22519,EGFR,gene,0.989,26888827
22520,anti-EGFR mAbs,gene,0.9814,26888827
22521,MCRC,disease,0.993,26888827
22522,Sym004,drug,0.7217,26888827
22523,cetuximab,gene,0.7476,26888827
22524,EGFR ECD,gene,0.9927,26888827
22525,EGFR mutants,gene,0.9937,26888827
22526,cetuximab,gene,0.76,26888827
22527,panitumumab,gene,0.845,26888827
22528,Sym004,drug,0.8037,26888827
22529,cetuximab-resistant cell lines,cell_line,0.875,26888827
22530,cetuximab,gene,0.9717,26888827
22531,tumor,disease,1.0,26888827
22532,Sym004,drug,0.5615,26888827
22533,patients,species,0.9844,26888827
22534,cetuximab,gene,0.6196,26888827
22535,EGFR mutation,gene,0.978,26888827
22536,cetuximab,gene,0.972,26888827
22537,cetuximab,gene,0.948,26888827
22538,panitumumab,gene,0.8667,26888827
22539,Sym004,drug,0.693,26888827
22540,EGFR mutants,gene,0.991,26888827
22541,cetuximab,gene,0.913,26888827
22542,EGFR,gene,0.9893,26888827
22543,Sym004,drug,0.8584,26888827
22544,EGFR,gene,0.985,26888827
22545,tumor,disease,0.931,26888827
22546,patient,species,0.984,26888827
22547,tumor,disease,1.0,26888827
22548,EGFR,DNA,0.4976,26888827
22549,EGFR mutation,gene,0.9785,26888827
22550,G465R,gene,0.7324,26888827
22551,G465R,mutation,,26888827
22552,cetuximab,gene,0.7705,26888827
22553,Sym004,drug,0.8965,26888827
22554,MCRC,disease,0.9995,26888827
22555,cetuximab,gene,0.944,26888827
22556,panitumumab,gene,0.9604,26888827
22557,EGFR,gene,0.9937,26888827
22558,EGFR,DNA,0.49,26888827
22559,EGFR mutations,gene,0.911,26888827
22560,Sym004,drug,0.92,26888827
22561,cancer,disease,1.0,26885688
22562,tumors,disease,1.0,26885688
22563,panitumumab,gene,0.837,26885688
22564,pan-,gene,0.858,26885688
22565,EGFR-expressing A431,cell_line,0.732,26885688
22566,EGFR,gene,0.9966,26885688
22567,MDA-MB-468-luc cells,cell_line,0.8677,26885688
22568,luc cells,cell_type,0.639,26885688
22569,luc,gene,0.7637,26885688
22570,cell lines,cell_line,0.904,26885688
22571,cancer,disease,1.0,26885619
22572,tumors,disease,1.0,26885619
22573,tumor,disease,0.997,26885619
22574,A431 cells,cell_line,0.923,26885619
22575,mice,species,0.9756,26885619
22576,mice,species,0.9746,26885619
22577,panitumumab,gene,0.8887,26885619
22578,epidermal growth factor receptor,gene,0.9976,26885619
22579,tumor,disease,0.98,26885619
22580,gadofosveset,drug,0.9604,26885619
22581,mice,species,0.984,26885619
22582,gadopentetate dimeglumine,drug,0.9985,26885619
22583,mice,species,0.987,26885619
22584,tumors,disease,0.9985,26885619
22585,gadofosveset,drug,0.867,26885619
22586,gadofosveset,drug,0.599,26885619
22587,tumors,disease,1.0,26885619
22588,Advanced Gastric Cancer,disease,1.0,26880889
22589,gastric cancer,disease,1.0,26880889
22590,cancer,disease,1.0,26880889
22591,Patients,species,0.9917,26880889
22592,cancer,disease,1.0,26880889
22593,advanced cancer,disease,0.9985,26880889
22594,gastric cancer,disease,1.0,26880889
22595,Trastuzumab,gene,0.8975,26880889
22596,human epidermal growth factor receptor 2,gene,0.9985,26880889
22597,HER2,gene,0.994,26880889
22598,advanced gastric cancer,disease,1.0,26880889
22599,patients,species,0.9805,26880889
22600,HER2,gene,0.992,26880889
22601,advanced gastric cancer,disease,1.0,26880889
22602,VEGFR-2,gene,0.995,26880889
22603,paclitaxel,drug,0.991,26880889
22604,VEGFR-2 tyrosine kinase,gene,0.943,26880889
22605,tyrosine,drug,0.81,26880889
22606,apatinib,drug,0.991,26880889
22607,advanced gastric cancer,disease,1.0,26880889
22608,patients,species,0.9814,26880889
22609,EGFR,gene,0.9956,26880889
22610,cetuximab,gene,0.955,26880889
22611,panitumumab,gene,0.9146,26880889
22612,VEGF,gene,0.9946,26880889
22613,bevacizumab,gene,0.8433,26880889
22614,mTOR,gene,0.9956,26880889
22615,everolimus,drug,0.998,26880889
22616,HGF,gene,0.989,26880889
22617,MET,gene,0.993,26880889
22618,advanced gastric cancer,disease,1.0,26880889
22619,epidermal growth factor receptor,gene,0.9985,26869800
22620,metastatic colorectal cancer,disease,1.0,26869800
22621,wild,DNA,0.621,26869800
22622,wild-type KRAS,gene,0.938,26869800
22623,EGFR,gene,0.993,26869800
22624,tumors,disease,1.0,26869800
22625,metastatic colorectal cancer,disease,1.0,26869800
22626,mCRC,disease,1.0,26869800
22627,EGFR,gene,0.9946,26869800
22628,panitumumab,gene,0.564,26869800
22629,cetuximab,gene,0.785,26869800
22630,mCRC,disease,0.953,26869800
22631,anti-EGFR monoclonal antibodies,gene,0.7954,26869800
22632,mCRC,disease,0.9976,26869800
22633,wild,gene,0.635,26869800
22634,anti-EGFR monoclonal antibodies,gene,0.9805,26869800
22635,colorectal cancer,disease,1.0,26869800
22636,wild,gene,0.653,26869800
22637,KRAS,DNA,0.3816,26869800
22638,BRAF,gene,0.99,26869800
22639,PIK3CA,gene,0.644,26869800
22640,NRAS,gene,0.8315,26869800
22641,PTEN,gene,0.9688,26869800
22642,EGFR,gene,0.928,26869800
22643,mCRC,disease,0.9995,26869800
22644,anti-EGFR monoclonal antibody,gene,0.911,26869800
22645,anti-EGFR,gene,0.667,26869800
22646,mCRC,disease,1.0,26869800
22647,EGFR,gene,0.882,26869800
22648,wild-type KRAS,gene,0.596,26869800
22649,colorectal cancer,disease,1.0,26869800
22650,AREG,gene,0.7573,26869404
22651,EREG,gene,0.5864,26869404
22652,RAS Wild-Type Colorectal Cancer,disease,0.9907,26869404
22653,RAS,gene,0.9824,26869404
22654,Panitumumab,gene,0.6025,26869404
22655,Epiregulin,gene,0.9976,26867820
22656,Amphiregulin,gene,0.9966,26867820
22657,RAS wild-type,gene,0.9473,26867820
22658,epidermal growth factor receptor,gene,0.9937,26867820
22659,EGFR,gene,0.9976,26867820
22660,advanced colorectal cancer,disease,1.0,26867820
22661,aCRC,disease,1.0,26867820
22662,RNA,RNA,0.61,26867820
22663,EGFR ligands,gene,0.8535,26867820
22664,epiregulin,gene,0.9214,26867820
22665,EREG,gene,0.9966,26867820
22666,amphiregulin,gene,0.9937,26867820
22667,AREG,gene,0.997,26867820
22668,EGFR,gene,0.992,26867820
22669,panitumumab,gene,0.922,26867820
22670,irinotecan,drug,0.9937,26867820
22671,ciclosporin,drug,0.999,26867820
22672,colorectal cancer,disease,1.0,26867820
22673,AREG,gene,0.9946,26867820
22674,EREG,gene,0.9946,26867820
22675,panitumumab,gene,0.849,26867820
22676,RAS,gene,0.9937,26867820
22677,patients,species,0.977,26867820
22678,PARTICIPANTS,species,0.5947,26867820
22679,panitumumab,gene,0.722,26867820
22680,irinotecan,drug,0.995,26867820
22681,patients,species,0.964,26867820
22682,KRAS,gene,0.981,26867820
22683,wt aCRC,disease,0.7266,26867820
22684,fluoropyrimidine,drug,0.998,26867820
22685,tumors,disease,1.0,26867820
22686,EREG,gene,0.9946,26867820
22687,AREG,gene,0.9907,26867820
22688,messenger RNA,RNA,0.782,26867820
22689,EREG,gene,0.981,26867820
22690,AREG,gene,0.992,26867820
22691,AREG,gene,0.9927,26867820
22692,EREG,gene,0.9976,26867820
22693,RAS,gene,0.9834,26867820
22694,BRAF,DNA,0.6475,26867820
22695,BRAF mutations,gene,0.8174,26867820
22696,tumor,disease,1.0,26867820
22697,patients,species,0.99,26867820
22698,irinotecan,drug,0.9985,26867820
22699,irinotecan,drug,0.9985,26867820
22700,panitumumab,gene,0.9463,26867820
22701,tumor,disease,0.9727,26867820
22702,RAS,gene,0.984,26867820
22703,aCRC,disease,0.999,26867820
22704,RAS,gene,0.9785,26867820
22705,patients,species,0.988,26867820
22706,irinotecan,drug,0.999,26867820
22707,panitumumab,gene,0.917,26867820
22708,irinotecan,drug,0.999,26867820
22709,RAS,gene,0.9897,26867820
22710,patients,species,0.984,26867820
22711,irinotecan,drug,0.9985,26867820
22712,panitumumab,gene,0.84,26867820
22713,irinotecan,drug,0.997,26867820
22714,panitumumab,gene,0.82,26867820
22715,RAS,gene,0.9907,26867820
22716,patients,species,0.988,26867820
22717,patients,species,0.9624,26867820
22718,EGFR,gene,0.8984,26867820
22719,patients,species,0.959,26867820
22720,RAS,gene,0.9927,26867820
22721,aCRC,disease,0.9995,26867820
22722,EREG,gene,0.995,26867820
22723,AREG,gene,0.998,26867820
22724,anti-,gene,0.591,26867820
22725,EGFR,gene,0.795,26867820
22726,Panitumumab,gene,0.885,26867157
22727,docetaxel,drug,0.999,26867157
22728,cisplatin,drug,0.9995,26867157
22729,fluoropyrimidine,drug,0.999,26867157
22730,oesophagogastric cancer,disease,1.0,26867157
22731,panitumumab,gene,0.8955,26867157
22732,docetaxel,drug,0.9995,26867157
22733,advanced oesophagogastric cancer,disease,1.0,26867157
22734,"recurrent cancer of the oesophagus, oesophagogastric junction or stomach",disease,0.9688,26867157
22735,docetaxel,drug,0.9976,26867157
22736,fluoropyrimidine,drug,0.9897,26867157
22737,panitumumab,gene,0.808,26867157
22738,panitumumab,gene,0.8965,26867157
22739,infection,disease,0.8164,26867157
22740,anorexia,disease,1.0,26867157
22741,vomiting,disease,0.9956,26867157
22742,diarrhoea,disease,1.0,26867157
22743,fatigue,disease,0.9995,26867157
22744,panitumumab,gene,0.928,26867157
22745,docetaxel,drug,0.999,26867157
22746,oesophagogastric cancer,disease,0.9985,26867157
22747,mouse,species,0.9404,26864104
22748,monoclonal,gene,0.6577,26864104
22749,epidermal growth factor receptor,gene,0.998,26864104
22750,panitumumab,gene,0.72,26864104
22751,advanced colorectal cancer,disease,0.995,26864104
22752,Colorectal Cancer,disease,1.0,26849815
22753,metastatic colorectal cancer,disease,1.0,26849815
22754,mCRC,disease,1.0,26849815
22755,Lynch syndrome,disease,1.0,26849815
22756,KRAS exon 2,gene,0.8496,26849815
22757,panitumumab,gene,0.825,26849815
22758,cetuximab,gene,0.682,26849815
22759,KRAS exons 3 and 4,DNA,0.858,26849815
22760,KRAS,gene,0.995,26849815
22761,"NRAS exons 2, 3, and 4",DNA,0.896,26849815
22762,NRAS exons 2,gene,0.807,26849815
22763,KRAS,gene,0.8525,26849815
22764,NRAS,DNA,0.759,26849815
22765,NRAS mutations,gene,0.942,26849815
22766,RAS,gene,0.9854,26849815
22767,mCRC,disease,0.9985,26849815
22768,panitumumab,gene,0.643,26849815
22769,cetuximab,gene,0.573,26849815
22770,RAS,gene,0.609,26849815
22771,RAS,gene,0.5366,26849815
22772,mCRC,disease,0.9946,26849815
22773,mCRC,disease,0.954,26849815
22774,177Lu,drug,0.998,26848176
22775,Locally Advanced Breast Cancer,disease,0.9995,26848176
22776,locally advanced breast cancer,disease,0.9995,26848176
22777,LABC,disease,1.0,26848176
22778,AuNP,DNA,0.535,26848176
22779,polyethyleneglycol,drug,0.9995,26848176
22780,PEG,drug,0.9995,26848176
22781,DOTA,drug,0.9985,26848176
22782,(177)Lu,drug,0.999,26848176
22783,panitumumab,gene,0.8877,26848176
22784,epidermal growth factor receptors,gene,0.998,26848176
22785,EGFR,gene,0.9917,26848176
22786,(177)Lu,drug,0.9976,26848176
22787,AuNP,cell_type,0.4153,26848176
22788,LABC,disease,0.999,26848176
22789,(177)Lu,drug,0.9995,26848176
22790,panitumumab,gene,0.9575,26848176
22791,(177)Lu,drug,0.999,26848176
22792,(177)Lu,drug,0.9995,26848176
22793,mice,species,0.86,26848176
22794,EGFR-positive MDA-MB-468 human breast cancer,disease,0.985,26848176
22795,EGFR,gene,0.4236,26848176
22796,tumors,disease,0.575,26848176
22797,tumor,disease,0.843,26848176
22798,(177)Lu,drug,0.9985,26848176
22799,(177),drug,0.981,26848176
22800,Lu,drug,0.876,26848176
22801,AuNP,cell_type,0.4685,26848176
22802,blood cell,cell_type,0.8506,26848176
22803,serum alanine aminotransferase,gene,0.8228,26848176
22804,alanine,drug,0.9976,26848176
22805,creatinine,drug,0.9927,26848176
22806,tumor,disease,0.9946,26848176
22807,(177)Lu,drug,0.9976,26848176
22808,(177)Lu,drug,0.9917,26848176
22809,tumor,disease,1.0,26848176
22810,tumors,disease,1.0,26848176
22811,mice,species,0.9653,26848176
22812,PEG,drug,0.9927,26848176
22813,AuNP,cell_type,0.556,26848176
22814,mice,species,0.923,26848176
22815,(177)Lu,drug,0.9985,26848176
22816,(177)Lu,drug,0.999,26848176
22817,tumor,disease,0.9917,26848176
22818,(177)Lu,drug,0.999,26848176
22819,(177)Lu,drug,0.9985,26848176
22820,tumor,disease,1.0,26848176
22821,cancer tumors,disease,1.0,26848176
22822,mice,species,0.925,26848176
22823,LABC,disease,0.9976,26848176
22824,EGFR,gene,0.9917,26848176
22825,LABC,cell_type,0.8774,26848176
22826,cetuximab,gene,0.823,26843189
22827,panitumumab,gene,0.604,26843189
22828,colorectal cancers,disease,1.0,26843189
22829,EGFR extracellular domain mutations,gene,0.897,26843189
22830,anti-,gene,0.778,26843189
22831,epidermal growth factor receptor,gene,0.9707,26843189
22832,EGFR,gene,0.987,26843189
22833,cetuximab,gene,0.406,26843189
22834,panitumumab,gene,0.7305,26843189
22835,RAS,gene,0.994,26843189
22836,colorectal cancers,disease,0.767,26843189
22837,CRCs,disease,1.0,26843189
22838,EGFR,gene,0.989,26843189
22839,CRCs,disease,0.704,26843189
22840,EGFR extracellular domain,gene,0.9404,26843189
22841,EGFR,RNA,0.5234,26843189
22842,EGFR ECD,gene,0.937,26843189
22843,oligoclonal antibody MM-151,gene,0.872,26843189
22844,EGFR ECD,gene,0.991,26843189
22845,EGFR,gene,0.9907,26843189
22846,patient-derived cells,cell_type,0.857,26843189
22847,mutant EGFR,gene,0.989,26843189
22848,EGFR ECD,gene,0.9956,26843189
22849,circulating cell-free tumor DNA,DNA,0.7773,26843189
22850,ctDNA,DNA,0.824,26843189
22851,CRC,disease,0.999,26843189
22852,EGFR,gene,0.9897,26843189
22853,cetuximab,gene,0.836,26843189
22854,panitumumab,gene,0.7856,26843189
22855,EGFR ECD,gene,0.9937,26843189
22856,EGFR,gene,0.9834,26824184
22857,metastatic colorectal cancer,disease,0.999,26824184
22858,EGFR,gene,0.9346,26824184
22859,metastatic colorectal cancer,disease,0.998,26824184
22860,EGFR,gene,0.744,26824184
22861,patients,species,0.9717,26824184
22862,advanced colorectal cancer,disease,1.0,26824184
22863,KRAS,gene,0.984,26824184
22864,NRAS,gene,0.9937,26824184
22865,tumor,disease,0.8286,26824184
22866,patients,species,0.9927,26824184
22867,cetuximab,gene,0.916,26824184
22868,panitumumab,gene,0.856,26824184
22869,bevacizumab,gene,0.6978,26824184
22870,EGFR,gene,0.8286,26824184
22871,wild type KRAS and NRAS colon cancer cells,cell_line,0.9604,26824184
22872,wild,cell_type,0.4604,26824184
22873,wild type KRAS,gene,0.759,26824184
22874,NRAS,gene,0.7764,26824184
22875,colon cancer,disease,0.8447,26824184
22876,VEGF-A,gene,0.997,26824184
22877,cetuximab,gene,0.782,26824184
22878,EGFR,gene,0.6035,26824184
22879,bevacizumab,drug,0.7656,26824184
22880,VEGF-A,gene,0.9966,26824184
22881,cetuximab,gene,0.5664,26824184
22882,KRAS and NRAS wild type colon cancer cell lines,cell_line,0.9526,26824184
22883,KRAS,gene,0.969,26824184
22884,NRAS,gene,0.8613,26824184
22885,VEGFR2,gene,0.9976,26824184
22886,Stat-3,gene,0.996,26824184
22887,VEGF,gene,0.6504,26824184
22888,EGFR,gene,0.831,26824184
22889,patient,species,0.9287,26824184
22890,metastatic colorectal cancer,disease,1.0,26824184
22891,Regorafenib,drug,0.997,26820693
22892,small colon Colon cancer,disease,0.993,26820693
22893,cancer,disease,1.0,26820693
22894,colon cancer,disease,1.0,26820693
22895,multicellular spheroids,cell_line,0.925,26820693
22896,human colon cancer HCT116 cell line,cell_line,0.9497,26820693
22897,human,species,0.996,26820693
22898,colon cancer,disease,0.9097,26820693
22899,red fluorescent protein,gene,0.9736,26820693
22900,HCT116,cell_line,0.893,26820693
22901,RFP,gene,0.938,26820693
22902,colon cancer,disease,1.0,26820693
22903,regorafenib,drug,0.992,26820693
22904,mouse,species,0.943,26820693
22905,small tumors,disease,0.7905,26820693
22906,HCT116-RFP cells,cell_line,0.8696,26820693
22907,HCT116,cell_type,0.607,26820693
22908,RFP,gene,0.955,26820693
22909,bevacizumab,gene,0.9106,26820693
22910,capecitabine,drug,0.9985,26820693
22911,cetuximab,gene,0.812,26820693
22912,5-fluorouracil,drug,0.9995,26820693
22913,5-FU,drug,0.9995,26820693
22914,irinotecan,drug,0.999,26820693
22915,oxaliplatin,drug,0.9995,26820693
22916,panitumumab,gene,0.772,26820693
22917,regorafenib,drug,0.9927,26820693
22918,mice,species,0.951,26820693
22919,HCT116-,cell_line,0.9175,26820693
22920,RFP,gene,0.9624,26820693
22921,small tumors,disease,0.8887,26820693
22922,3&#x27;-[18F]-fluoro-3&#x27;-deoxythymidine,drug,0.962,26820693
22923,Regorafenib,drug,0.998,26820693
22924,tumor,disease,1.0,26820693
22925,5-,drug,,26820693
22926,5-FU,drug,0.9976,26820693
22927,colon cancer,disease,1.0,26820693
22928,regorafenib,drug,0.9956,26820693
22929,disseminated small colon cancer,disease,0.8877,26820693
22930,Thrombotic Thrombocytopenic Purpura,disease,1.0,26809542
22931,Panitumumab,gene,0.853,26809542
22932,Recurrent Rectal Cancer,disease,0.937,26809542
22933,panitumumab,gene,0.8306,26809542
22934,recurrent rectal cancer,disease,0.961,26809542
22935,thrombocytopenia,disease,1.0,26809542
22936,platelet,cell_type,0.5347,26809542
22937,jaundice,disease,1.0,26809542
22938,hematuria,disease,0.9995,26809542
22939,lactate,drug,0.871,26809542
22940,lactate dehydrogenase,gene,0.995,26809542
22941,schistocytes,cell_type,0.8457,26809542
22942,Anti-ADAMTS13 antibodies,gene,0.982,26809542
22943,ADAMTS13,gene,0.9746,26809542
22944,thrombotic thrombocytopenic purpura,disease,1.0,26809542
22945,Thrombocytopenia,disease,1.0,26809542
22946,myelosuppression,disease,1.0,26809542
22947,jaundice,disease,1.0,26809542
22948,indirect bilirubinemia,disease,0.998,26809542
22949,hematuria,disease,0.9995,26809542
22950,Signet-Ring Cell Carcinoma of the Sigmoid Colon,disease,1.0,26809308
22951,Disseminated Carcinomatosis,disease,0.9985,26809308
22952,CPT-11,drug,0.998,26809308
22953,Panitumumab,gene,0.8887,26809308
22954,S-1,drug,0.699,26809308
22955,oxaliplatin,drug,0.9995,26809308
22956,bevacizumab,gene,0.574,26809308
22957,signet-ring,cell_type,0.519,26809308
22958,signet-ring cell carcinoma of,disease,0.9224,26809308
22959,back pain,disease,0.9985,26809308
22960,lumbago,disease,0.9995,26809308
22961,disseminated carcinomatosis of the bone marrow,disease,1.0,26809308
22962,disseminated intravascular coagulation,disease,1.0,26809308
22963,DIC,disease,1.0,26809308
22964,CPT-11,drug,0.9985,26809308
22965,panitumumab,gene,0.876,26809308
22966,DIC,disease,1.0,26809308
22967,back pain,disease,1.0,26809308
22968,lumbago,disease,1.0,26809308
22969,Synchronous Liver Metastasis,disease,0.993,26805306
22970,Colon Cancer,disease,0.989,26805306
22971,subileus,disease,0.9995,26805306
22972,advanced sigmoid colon cancer,disease,1.0,26805306
22973,liver metasta- sis,disease,0.938,26805306
22974,sigmoid colon cancer,disease,1.0,26805306
22975,Colorectal Carcinoma,disease,0.9995,26805306
22976,FOLFIRI,drug,0.893,26805306
22977,panitumumab,gene,0.8857,26805306
22978,liver metastasis,disease,0.923,26805306
22979,S-1,drug,0.5537,26805306
22980,Sigmoid Colon Cancer,disease,1.0,26805299
22981,Liver Metastases,disease,0.996,26805299
22982,Panitumumab,gene,0.7075,26805299
22983,sigmoid colon cancer,disease,1.0,26805299
22984,panitumumab,gene,0.6567,26805299
22985,liver,disease,0.925,26805299
22986,primary,disease,0.846,26805299
22987,liver,disease,0.4912,26805299
22988,Unresectable Rectal Cancer,disease,0.996,26805129
22989,Hemorrhage,disease,0.995,26805129
22990,Primary Tumor,disease,0.7407,26805129
22991,abdominal pain,disease,0.9927,26805129
22992,hematuria,disease,0.9976,26805129
22993,rectal cancer,disease,1.0,26805129
22994,liver metastases,disease,0.997,26805129
22995,panitumumab,gene,0.703,26805129
22996,liver,disease,0.6294,26805129
22997,abdominal pain,disease,0.8994,26805129
22998,primary,disease,0.5034,26805129
22999,hemorrhage,disease,0.9917,26805129
23000,tumor,disease,0.873,26805129
23001,Colon Cancer,disease,0.9927,26805084
23002,colorectal cancer,disease,1.0,26805084
23003,tumors,disease,1.0,26805084
23004,panitumumab,gene,0.9644,26805084
23005,bevacizumab,gene,0.8193,26805084
23006,liver metastases,disease,0.991,26805084
23007,primary tumor,disease,0.906,26805084
23008,stoma,disease,0.7515,26805084
23009,liver,disease,0.712,26805084
23010,stomas,disease,0.8945,26805084
23011,Metastatic Colorectal Cancer,disease,0.9727,26791840
23012,stage IV,disease,0.9663,26791840
23013,colorectal cancer,disease,0.927,26791840
23014,advanced colorectal cancer,disease,1.0,26791840
23015,folinic acid,drug,0.999,26791840
23016,fluorouracil,drug,0.9995,26791840
23017,5-FU,drug,0.999,26791840
23018,oxaliplatin,drug,0.9995,26791840
23019,FOLFOX,drug,0.994,26791840
23020,folinic acid,drug,0.9995,26791840
23021,5-FU,drug,0.9995,26791840
23022,irinotecan,drug,0.9985,26791840
23023,FOLFIRI,drug,0.9653,26791840
23024,folinic acid,drug,0.9995,26791840
23025,5-FU,drug,0.9995,26791840
23026,oxaliplatin,drug,0.9995,26791840
23027,irinotecan,drug,0.999,26791840
23028,FOLFOXIRI,drug,0.9526,26791840
23029,bevacizumab,gene,0.866,26791840
23030,panitumumab,gene,0.9214,26791840
23031,cetuximab,gene,0.853,26791840
23032,metastatic colorectal cancer,disease,0.9653,26791840
23033,colorectal carcinoma cells,cell_line,0.769,26790446
23034,colorectal,cell_type,0.4978,26790446
23035,colorectal carcinoma,disease,1.0,26790446
23036,Colorectal cancer,disease,1.0,26790446
23037,cancer,disease,1.0,26790446
23038,primary cell lines,cell_line,0.9663,26790446
23039,colorectal cancer,disease,1.0,26790446
23040,primary colon cancer cells,cell_line,0.8423,26790446
23041,colon cancer,disease,0.839,26790446
23042,correspond immortalized cells,cell_line,0.935,26790446
23043,SW480,cell_line,0.961,26790446
23044,SW620,cell_line,0.947,26790446
23045,irinotecan,drug,0.9995,26790446
23046,oxaliplatin,drug,0.9995,26790446
23047,bevacizumab,gene,0.9624,26790446
23048,cetuximab,gene,0.939,26790446
23049,panitumumab,gene,0.971,26790446
23050,cell lines,cell_line,0.956,26790446
23051,ICAM-1,gene,0.962,26790446
23052,EpCAM,gene,0.9927,26790446
23053,N-cadherin,gene,0.991,26790446
23054,MMP-2 and -9,gene,0.9956,26790446
23055,cell lines,cell_line,0.957,26790446
23056,primary tumor cancer cells,cell_type,0.5693,26790446
23057,tumor,disease,0.9834,26790446
23058,miR,DNA,0.6543,26790446
23059,miR-21,gene,0.9775,26790446
23060,miR,DNA,0.495,26790446
23061,miR-29a,gene,0.946,26790446
23062,miR,DNA,0.589,26790446
23063,miR-200a,gene,0.9785,26790446
23064,oxaliplatin,drug,1.0,26790446
23065,irinotecan,drug,0.9985,26790446
23066,lymph node metastases,disease,0.967,26790446
23067,isolated cell lines,cell_line,0.7974,26790446
23068,isolated cell,cell_type,0.687,26790446
23069,immortalized cell lines,cell_line,0.9473,26790446
23070,miRNAs,RNA,0.5537,26790446
23071,tumor,disease,1.0,26790446
23072,malignant colorectal cancer,disease,1.0,26790446
23073,VEGF,gene,0.993,26789111
23074,tumor,disease,0.9893,26789111
23075,Vascular endothelial growth factor,gene,0.9985,26789111
23076,VEGF,gene,0.996,26789111
23077,anticancer,disease,0.5854,26789111
23078,"carcinoma of the cervix, stomach",disease,1.0,26789111
23079,VEGF,gene,0.996,26789111
23080,tumor,disease,0.9224,26789111
23081,bevacizumab,gene,0.923,26789111
23082,tumor,disease,0.7983,26789111
23083,tumor,disease,0.9907,26789111
23084,bevacizumab,gene,0.9233,26789111
23085,cetuximab,gene,0.982,26789111
23086,panitumumab,gene,0.968,26789111
23087,colorectal cancer,disease,1.0,26789111
23088,trastuzumab,gene,0.9795,26789111
23089,breast cancer,disease,1.0,26789111
23090,bevacizumab,gene,0.882,26789111
23091,cancer,disease,1.0,26789111
23092,tumor,disease,0.9443,26789111
23093,VEGF,gene,0.9966,26789111
23094,tumor,disease,0.9243,26789111
23095,hypomagnesemia,disease,1.0,26788202
23096,metastatic colorectal cancer,disease,1.0,26788202
23097,cetuximab,gene,0.8467,26788202
23098,metastatic colorectal cancer,disease,0.9985,26788202
23099,mCRC,disease,1.0,26788202
23100,cetuximab,gene,0.747,26788202
23101,panitumumab,gene,0.817,26788202
23102,epidermal growth factor receptor,gene,0.9966,26788202
23103,hypomagnesemia,disease,1.0,26788202
23104,mCRC,disease,0.9995,26788202
23105,cetuximab,gene,0.876,26788202
23106,hypomagnesemia,disease,1.0,26788202
23107,hypomagnesemia,disease,1.0,26788202
23108,magnesium,drug,1.0,26788202
23109,Mg,drug,0.9995,26788202
23110,primary tumor,disease,0.605,26788202
23111,hypomagnesemia,disease,1.0,26788202
23112,Hypomagnesemia,disease,1.0,26788202
23113,mCRC,disease,0.999,26788202
23114,cetuximab,gene,0.8755,26788202
23115,Mg,drug,0.9985,26788202
23116,Panitumumab,gene,0.659,26781010
23117,Cecal Cancer,disease,1.0,26781010
23118,5-fluorouracil,drug,0.9995,26781010
23119,leucovorin,drug,0.999,26781010
23120,oxaliplatin,drug,0.9995,26781010
23121,panitumumab,gene,0.663,26781010
23122,epidermal growth factor receptor,gene,0.9976,26781010
23123,EGFR,gene,0.99,26781010
23124,metastatic colorectal cancer,disease,1.0,26781010
23125,mCRC,disease,1.0,26781010
23126,KRAS,gene,0.7817,26781010
23127,chimeric,gene,0.7,26781010
23128,anti-EGFR antibody,gene,0.906,26781010
23129,renal impairment,disease,1.0,26781010
23130,panitumumab,gene,0.9614,26781010
23131,hemodialysis,disease,0.9985,26781010
23132,mCRC,disease,0.999,26781010
23133,panitumumab,gene,0.86,26781010
23134,colorectal cancer,disease,1.0,26751115
23135,VLM,disease,0.978,26751115
23136,tumor cells,cell_type,0.8555,26751115
23137,tumor,disease,0.973,26751115
23138,VLM,disease,0.9673,26751115
23139,VLM,disease,0.995,26751115
23140,patient,species,0.9087,26751115
23141,sigmoid colon cancer,disease,1.0,26751115
23142,Panitumumab,gene,0.8984,26751115
23143,tumor cells,cell_type,0.822,26751115
23144,tumor,disease,0.909,26751115
23145,liver metastasis,disease,0.9927,26751115
23146,human,species,0.9966,26744502
23147,mouse,species,0.952,26744502
23148,human,species,0.998,26744502
23149,mouse,species,0.948,26744502
23150,carbohydrate,drug,0.9634,26744502
23151,carbohydrate antigen 19-9,gene,0.9863,26744502
23152,recurrent cancer,disease,0.9727,26744502
23153,carbohydrate,drug,0.9927,26744502
23154,carbohydrate antigen 19-9,gene,0.9688,26744502
23155,carbohydrate,drug,0.961,26744502
23156,carbohydrate antigen 19-9,gene,0.838,26744502
23157,IgM,gene,0.991,26744502
23158,patient,species,0.9795,26744502
23159,carbohydrate,drug,0.9976,26744502
23160,carbohydrate antigen 19-9,gene,0.9126,26744502
23161,mouse immunoglobulins,gene,0.969,26744502
23162,mouse,species,0.995,26744502
23163,patient,species,0.9946,26744502
23164,patient,species,0.996,26744502
23165,IgM,gene,0.858,26744502
23166,carbohydrate,drug,0.988,26744502
23167,carbohydrate antigen 19-9,gene,0.9854,26744502
23168,carbohydrate,drug,0.9595,26744502
23169,carbohydrate antigen 19-9,gene,0.9204,26744502
23170,IgM,gene,0.993,26744502
23171,mouse immunoglobulins,gene,0.97,26744502
23172,mouse,species,0.9956,26744502
23173,anti-human IgM,gene,0.9976,26744502
23174,human,species,0.9014,26744502
23175,mouse immunoglobulins,gene,0.99,26744502
23176,mouse,species,0.9946,26744502
23177,IgM,gene,0.9937,26744502
23178,patient,species,0.9956,26744502
23179,carbohydrate,drug,0.9976,26744502
23180,carbohydrate antigen 19-9,gene,0.933,26744502
23181,human,species,0.9956,26744502
23182,mouse,species,0.961,26744502
23183,carbohydrate,drug,0.9966,26744502
23184,carbohydrate antigen 19-9,gene,0.926,26744502
23185,patient,species,0.9795,26744502
23186,rectal cancer,disease,1.0,26744502
23187,patients,species,0.9937,26744502
23188,mouse,species,0.943,26744502
23189,Demodex inflammatory eruption,disease,1.0,26719099
23190,epidermal growth factor receptor,gene,0.9976,26719099
23191,Epidermal growth factor receptor,gene,0.998,26709782
23192,colorectal cancer,disease,1.0,26709782
23193,epidermal growth factor receptor,gene,0.999,26709782
23194,EGFR,gene,0.9956,26709782
23195,colorectal cancer,disease,1.0,26709782
23196,CRC,disease,1.0,26709782
23197,EGFR,gene,0.9897,26709782
23198,CRC,disease,0.999,26709782
23199,EGFR,gene,0.9917,26709782
23200,EGFR antibodies,gene,0.908,26709782
23201,cetuximab,gene,0.8687,26709782
23202,panitumumab,gene,0.8384,26709782
23203,CRC,disease,0.9995,26709782
23204,CRC,disease,0.9995,26709782
23205,EGFR,gene,0.996,26709782
23206,CRC,disease,0.998,26709782
23207,EGFR antibodies,gene,0.9023,26709782
23208,cetuximab,gene,0.8975,26709782
23209,panitumumab,gene,0.902,26709782
23210,BRAF-Mutated Cholangiocarcinoma,disease,1.0,26687137
23211,BRAF,gene,0.9727,26687137
23212,Vemurafenib,drug,0.9985,26687137
23213,panitumumab,gene,0.95,26681429
23214,Panitumumab,gene,0.89,26681429
23215,Head and Neck Cancer,disease,1.0,26681429
23216,panitumumab,gene,0.9214,26681429
23217,patients,species,0.9023,26681429
23218,squamous cell carcinoma of the head and neck,disease,0.9995,26681429
23219,SCCHN,disease,1.0,26681429
23220,patients,species,0.9844,26681429
23221,SCCHN,disease,0.9873,26681429
23222,Patients,species,0.9727,26681429
23223,panitumumab,gene,0.6895,26681429
23224,patients,species,0.9834,26681429
23225,patients,species,0.984,26681429
23226,rash,disease,1.0,26681429
23227,dermatitis acneiform,disease,1.0,26681429
23228,fatigue,disease,0.997,26681429
23229,dry skin,disease,0.9995,26681429
23230,hypomagnesemia,disease,1.0,26681429
23231,angioedema,disease,1.0,26681429
23232,Panitumumab,gene,0.9043,26681429
23233,patients,species,0.9556,26681429
23234,SCCHN,disease,0.9927,26681429
23235,EGFR,gene,0.7607,26666825
23236,EGFR,gene,0.694,26666825
23237,epidermal growth factor receptor,gene,0.9976,26666825
23238,EGFR,gene,0.9966,26666825
23239,patients,species,0.962,26666825
23240,metastatic colorectal cancer,disease,1.0,26666825
23241,mCRC,disease,1.0,26666825
23242,anti-EGFR mAbs,gene,0.97,26666825
23243,KRAS,gene,0.9785,26666825
23244,NRAS,DNA,0.814,26666825
23245,NRAS,gene,0.9927,26666825
23246,anti-EGFR,gene,0.98,26666825
23247,KRAS,gene,0.995,26666825
23248,patients,species,0.9424,26666825
23249,EGFR gene polymorphism,DNA,0.7896,26666825
23250,EGFR gene polymorphism rs1050171,gene,0.7334,26666825
23251,rs1050171,DNA,0.611,26666825
23252,rs105017,mutation,,26666825
23253,RAS,gene,0.984,26666825
23254,patients,species,0.9497,26666825
23255,EGFR,gene,0.68,26666825
23256,patients,species,0.9805,26666825
23257,CRC,disease,0.999,26666825
23258,EGFR,gene,0.8105,26666825
23259,synonymous polymorphism,DNA,0.4707,26666825
23260,EGFR gene,gene,0.991,26666825
23261,cetuximab,gene,0.9414,26649807
23262,docetaxel,drug,0.9956,26649807
23263,triple negative breast cancer,disease,1.0,26649807
23264,TNBC,disease,1.0,26649807
23265,Epithelial Growth Factor Receptor,gene,0.9966,26649807
23266,EGFR,gene,0.9937,26649807
23267,TNBC,disease,0.9937,26649807
23268,cetuximab,gene,0.65,26649807
23269,anti-EGFR antibody,gene,0.984,26649807
23270,docetaxel,drug,0.995,26649807
23271,patients,species,0.9478,26649807
23272,TNBC,disease,0.9688,26649807
23273,cetuximab,gene,0.773,26649807
23274,docetaxel,drug,0.9985,26649807
23275,patients,species,0.9893,26649807
23276,tumor,disease,1.0,26649807
23277,patients,species,0.9624,26649807
23278,patients,species,0.9688,26649807
23279,CD8,cell_line,0.719,26649807
23280,CD8+,gene,0.9897,26649807
23281,FOXP3+ tumor-infiltrating lymphocytes,cell_type,0.606,26649807
23282,FOXP3,gene,0.968,26649807
23283,Cetuximab,gene,0.9253,26649807
23284,docetaxel,drug,0.9976,26649807
23285,TNBC,disease,0.991,26649807
23286,panitumumab,gene,0.8203,26649807
23287,anti-EGFR antibody,gene,0.988,26649807
23288,tumor,disease,0.999,26649807
23289,TNBC,disease,0.9043,26649807
23290,EGFR,gene,0.99,26644315
23291,colorectal cancer,disease,1.0,26644315
23292,patient,species,0.97,26644315
23293,liver metastasis,disease,0.9824,26644315
23294,cetuximab,gene,0.8086,26644315
23295,MEK1,DNA,0.584,26644315
23296,MEK1(K57T),gene,0.779,26644315
23297,K57T,DNA,0.555,26644315
23298,K57T,mutation,,26644315
23299,panitumumab,gene,0.839,26644315
23300,MEK,gene,0.9956,26644315
23301,trametinib,drug,0.9683,26644315
23302,circulating tumor DNA,DNA,0.811,26644315
23303,ctDNA,DNA,0.903,26644315
23304,mutant MEK1,gene,0.8477,26644315
23305,KRAS,DNA,0.638,26644315
23306,KRAS(Q61H),gene,0.9033,26644315
23307,Q61H,mutation,,26644315
23308,KRAS,DNA,0.735,26644315
23309,KRAS mutation,gene,0.941,26644315
23310,tumor biopsies,cell_type,0.4998,26644315
23311,tumor,disease,0.9995,26644315
23312,ctDNA,DNA,0.713,26644315
23313,tumor lesions,disease,0.9907,26644315
23314,patient,species,0.9834,26644315
23315,ctDNA,DNA,0.678,26644315
23316,panitumumab,gene,0.881,26613286
23317,patients,species,0.972,26613286
23318,Panitumumab,gene,0.821,26613286
23319,5-fluorouracil,drug,0.9985,26613286
23320,leucovorin,drug,0.995,26613286
23321,oxaliplatin,drug,0.9985,26613286
23322,FOLFOX4,drug,0.751,26613286
23323,FOLFOX4,drug,0.858,26613286
23324,patients,species,0.9336,26613286
23325,wild-type RAS,gene,0.988,26613286
23326,metastatic colorectal cancer,disease,1.0,26613286
23327,mCRC,disease,1.0,26613286
23328,patient,species,0.9946,26613286
23329,EuroQol 5-dimension,DNA,0.5044,26613286
23330,panitumumab,gene,0.895,26613286
23331,FOLFOX4,drug,0.7905,26613286
23332,FOLFOX4,drug,0.93,26613286
23333,patients,species,0.917,26613286
23334,wild-type RAS,gene,0.89,26613286
23335,mCRC,disease,0.8735,26613286
23336,panitumumab,gene,0.8794,26613286
23337,FOLFOX4,drug,0.697,26613286
23338,FOLFOX4,drug,0.8486,26613286
23339,Squamous Cell Carcinoma,disease,1.0,26606112
23340,Panitumumab,gene,0.7793,26606112
23341,Cetuximab,gene,0.8887,26606112
23342,EGFR,gene,0.993,26605007
23343,Cetuximab,gene,0.785,26605007
23344,Panitumumab,gene,0.7095,26605007
23345,Metastatic Colorectal Cancer,disease,1.0,26605007
23346,Metastatic colorectal cancer,disease,0.9995,26605007
23347,cancer,disease,0.9995,26605007
23348,epidermal growth factor receptor,gene,0.9976,26605007
23349,metastatic colorectal cancer,disease,0.9995,26605007
23350,anti epidermal growth factor receptor monoclonal antibodies,gene,0.928,26605007
23351,cetuximab,gene,0.8105,26605007
23352,panitumumab,gene,0.7754,26605007
23353,metastatic colorectal cancer,disease,0.9995,26605007
23354,cetuximab,gene,0.958,26605007
23355,panitumumab,gene,0.938,26605007
23356,metastatic colorectal cancer,disease,1.0,26605007
23357,bevacizumab,gene,0.777,26605007
23358,anti epidermal growth factor receptor monoclonal antibodies,gene,0.8755,26605007
23359,Cetuximab,gene,0.9053,26605007
23360,panitumumab,gene,0.8926,26605007
23361,mCRC,disease,0.963,26605007
23362,cetuximab,gene,0.955,26605007
23363,metastatic colorectal cancer,disease,1.0,26605007
23364,panitumumab,gene,0.7373,26605007
23365,epidermal growth factor receptor monoclonal antibodies,gene,0.9795,26605007
23366,anti epidermal growth factor receptor,gene,0.9805,26605007
23367,GC1118,drug,0.9194,26586721
23368,Anti-EGFR Antibody,gene,0.986,26586721
23369,Binding Epitope,DNA,0.5073,26586721
23370,EGFR,gene,0.996,26586721
23371,patients,species,0.9336,26586721
23372,metastatic colorectal cancer,disease,0.9966,26586721
23373,mCRC,disease,0.9985,26586721
23374,mCRC,disease,0.9995,26586721
23375,patients,species,0.9946,26586721
23376,EGFR,gene,0.993,26586721
23377,patient,species,0.9155,26586721
23378,GC1118,drug,0.904,26586721
23379,binding epitope,DNA,0.5806,26586721
23380,anti-EGFR,gene,0.983,26586721
23381,EGFR,gene,0.998,26586721
23382,GC1118,gene,0.916,26586721
23383,GC1118,drug,0.849,26586721
23384,N,drug,0.8335,26586721
23385,EGFR,gene,0.531,26586721
23386,EGF,gene,0.895,26586721
23387,EGFR,gene,0.995,26586721
23388,EGFR,gene,0.9956,26586721
23389,EGFR,gene,0.993,26586721
23390,EGFR,gene,0.9937,26586721
23391,cetuximab,gene,0.9937,26586721
23392,panitumumab,gene,0.788,26586721
23393,EGFR,gene,0.705,26586721
23394,tumor xenografts,cell_line,0.696,26586721
23395,tumor,disease,1.0,26586721
23396,cetuximab,gene,0.994,26586721
23397,EGFR,gene,0.8247,26586721
23398,tumor,disease,0.999,26586721
23399,cancer,disease,1.0,26586721
23400,GC1118,drug,0.9966,26586721
23401,patient,species,0.9775,26586721
23402,panitumumab,gene,0.811,26572750
23403,colorectal cancer,disease,1.0,26572750
23404,metastatic colorectal cancer,disease,0.997,26572750
23405,mCRC,disease,1.0,26572750
23406,Cetuximab,gene,0.814,26572750
23407,panitumumab,gene,0.8706,26572750
23408,epidermal growth factor receptor,gene,0.997,26572750
23409,EGFR,gene,0.9927,26572750
23410,Panitumumab,gene,0.85,26572750
23411,Panitumumab,gene,0.8467,26572750
23412,cetuximab,gene,0.7974,26572750
23413,mCRC,disease,0.993,26572750
23414,RAS (Rat Sarcoma) gene,DNA,0.8687,26572750
23415,RAS,gene,0.9927,26572750
23416,Rat Sarcoma,gene,0.9453,26572750
23417,Rat,species,0.8447,26572750
23418,EGFR,gene,0.995,26572750
23419,panitumumab,gene,0.9155,26572750
23420,panitumumab,gene,0.8877,26572750
23421,mCRC,disease,0.994,26572750
23422,Panitumumab,gene,0.8384,26572750
23423,Her-2 and,DNA,0.7305,26572750
23424,Her-2,gene,0.996,26572750
23425,BRAF gene,gene,0.684,26572750
23426,gastric cancer,disease,0.9995,26566626
23427,Gastric cancer,disease,1.0,26566626
23428,GC,disease,1.0,26566626
23429,cancer,disease,1.0,26566626
23430,GC,gene,0.9424,26566626
23431,solid tumors,disease,1.0,26566626
23432,"breast, colorectal, and lung cancers",disease,1.0,26566626
23433,GC,disease,0.4983,26566626
23434,trastuzumab,gene,0.9517,26566626
23435,GC,disease,0.532,26566626
23436,GC,disease,0.9995,26566626
23437,cancers,disease,1.0,26566626
23438,advanced/metastatic GC,disease,0.975,26566626
23439,panitumumab,gene,0.9463,26566372
23440,colorectal cancer,disease,1.0,26566372
23441,Epidermal growth factor receptor,gene,0.9976,26566372
23442,Skin toxicities,disease,0.992,26566372
23443,STs,disease,0.9873,26566372
23444,panitumumab,gene,0.86,26566372
23445,KRAS exon 2,gene,0.83,26566372
23446,metastatic colorectal cancer,disease,0.991,26566372
23447,5-fluorouracil,drug,0.9995,26566372
23448,oxaliplatin,drug,0.9995,26566372
23449,irinotecan,drug,0.9995,26566372
23450,panitumumab,gene,0.908,26566372
23451,ST,disease,0.9956,26566372
23452,KRAS,gene,0.85,26566372
23453,panitumumab,gene,0.8335,26566372
23454,ST,disease,0.986,26566372
23455,tumor,disease,0.784,26566372
23456,KRAS,gene,0.89,26566372
23457,KRAS,gene,0.8945,26566372
23458,Panitumumab,gene,0.835,26566372
23459,KRAS exon 2,gene,0.7817,26566372
23460,metastatic colorectal cancer,disease,0.9985,26566372
23461,ST,disease,0.9556,26566372
23462,Panitumumab,gene,0.693,26562760
23463,hematospermia,disease,1.0,26562760
23464,Regorafenib,drug,0.9976,26561209
23465,fluoropyrimidine,drug,0.995,26561209
23466,metastatic colorectal cancer,disease,1.0,26561209
23467,5-FU,drug,0.9976,26561209
23468,regorafenib,drug,0.998,26561209
23469,metastatic colorectal cancer,disease,1.0,26561209
23470,FOLFOX,drug,0.92,26561209
23471,FOLFIRI,drug,0.9087,26561209
23472,fluoropyrimidine,drug,0.995,26561209
23473,capecitabine,drug,0.9995,26561209
23474,dabrafenib,drug,0.999,26561209
23475,trametinib,drug,0.999,26561209
23476,regorafenib,drug,0.997,26561209
23477,regorafenib,drug,0.9966,26561209
23478,panitumumab,gene,0.847,26561209
23479,regorafenib,drug,0.996,26561209
23480,5-fluorouracil,drug,0.9995,26561209
23481,5-FU,drug,0.9995,26561209
23482,capecitabine,drug,0.998,26561209
23483,colorectal cancer,disease,1.0,26561209
23484,regorafenib,drug,0.9985,26561209
23485,capecitabine,drug,0.9995,26561209
23486,5-FU,drug,0.998,26561209
23487,metastatic colorectal cancer,disease,0.9995,26561209
23488,human colorectal cancer cell lines,cell_line,0.9463,26561209
23489,colorectal cancer,disease,0.992,26561209
23490,regorafenib,drug,0.995,26561209
23491,5-FU,drug,0.996,26561209
23492,colorectal cancer,disease,1.0,26561209
23493,KRAS,DNA,0.65,26561209
23494,KRAS mutation,gene,0.8555,26561209
23495,BRAF,DNA,0.741,26561209
23496,BRAF mutation,gene,0.878,26561209
23497,p53 mutation,gene,0.8677,26561209
23498,mismatch repair deficient cells,cell_line,0.4697,26561209
23499,mismatch repair,disease,0.988,26561209
23500,Regorafenib,drug,0.9976,26561209
23501,Mcl-1,gene,0.993,26561209
23502,Bcl-XL,gene,0.996,26561209
23503,cancer cells,cell_type,0.8354,26561209
23504,cancer,disease,0.9995,26561209
23505,5-FU,drug,0.9985,26561209
23506,regorafenib,drug,0.995,26561209
23507,5-FU,drug,0.9985,26561209
23508,capecitabine,drug,0.9985,26561209
23509,metastatic colorectal cancer,disease,0.9824,26561209
23510,regorafenib,drug,0.9976,26561209
23511,metastatic colorectal cancer,disease,1.0,26557880
23512,metastatic colorectal cancer,disease,1.0,26557880
23513,MCRC,disease,1.0,26557880
23514,tumour,disease,1.0,26557880
23515,cancerous cells,cell_type,0.8765,26557880
23516,cancerous,disease,0.9985,26557880
23517,MCRC,disease,0.9995,26557880
23518,MCRC,disease,0.9995,26557880
23519,cetuximab,gene,0.954,26557880
23520,bevacizumab,gene,0.8765,26557880
23521,panitumumab,gene,0.909,26557880
23522,MCRC,disease,0.9873,26557880
23523,metastatic colorectal cancer,disease,1.0,26557880
23524,Metastatic Colorectal Cancer,disease,1.0,26553578
23525,metastatic colorectal cancer,disease,1.0,26553578
23526,mCRC,disease,1.0,26553578
23527,mCRC,disease,0.9805,26553578
23528,tumor,disease,0.996,26553578
23529,mCRC,disease,0.9927,26553578
23530,CRC,disease,0.999,26553578
23531,FOLFOX,drug,0.8853,26553578
23532,5-fluorouracil,drug,0.9995,26553578
23533,leucovorin,drug,0.9985,26553578
23534,oxaliplatin,drug,0.9995,26553578
23535,CAPOX,drug,0.9937,26553578
23536,capecitabine,drug,0.999,26553578
23537,oxaliplatin,drug,0.9995,26553578
23538,FOLFIRI,drug,0.7026,26553578
23539,irinotecan,drug,0.999,26553578
23540,5-fluorouracil,drug,0.9995,26553578
23541,leucovorin,drug,0.9985,26553578
23542,bevacizumab,gene,0.721,26553578
23543,panitumumab,gene,0.93,26553578
23544,FOLFOX,drug,0.8657,26553578
23545,FOLFIRI,drug,0.8667,26553578
23546,mCRC,disease,0.99,26553578
23547,Bevacizumab,gene,0.8853,26553578
23548,metastatic colorectal cancer,disease,0.9907,26549053
23549,Colorectal cancer,disease,1.0,26549053
23550,CRC,disease,1.0,26549053
23551,cancer,disease,1.0,26549053
23552,vascular endothelial growth factor,gene,0.9976,26549053
23553,epidermal growth factor receptor,gene,0.9927,26549053
23554,EGFR,gene,0.995,26549053
23555,CRC,disease,0.998,26549053
23556,fluoropyrimidines,drug,0.9995,26549053
23557,irinotecan,drug,0.997,26549053
23558,oxaliplatin,drug,0.9995,26549053
23559,CRC,disease,0.9985,26549053
23560,bevacizumab,gene,0.828,26549053
23561,aflibercept,gene,0.9844,26549053
23562,metastatic CRC,disease,0.9185,26549053
23563,EGFR,gene,0.98,26549053
23564,cetuximab,gene,0.6777,26549053
23565,panitumumab,gene,0.6436,26549053
23566,wild,cell_line,0.596,26549053
23567,wild-type RAS tumors,disease,0.7856,26549053
23568,wild-type RAS,gene,0.9424,26549053
23569,regorafenib,drug,0.985,26549053
23570,TAS-102,drug,0.997,26549053
23571,colorectal cancer,disease,1.0,26549053
23572,CRC,disease,0.9995,26549053
23573,tumor,disease,1.0,26547132
23574,tumor cells,cell_type,0.8857,26547132
23575,tumor,disease,0.9985,26547132
23576,trastuzumab,gene,0.972,26547132
23577,pertuzumab,gene,0.925,26547132
23578,HER2-positive breast cancer,disease,0.999,26547132
23579,HER2,gene,0.9893,26547132
23580,nivolumab,gene,0.9097,26547132
23581,ipilimumab,gene,0.626,26547132
23582,advanced melanoma,disease,0.9995,26547132
23583,bevacizumab,gene,0.931,26547132
23584,cetuximab,gene,0.9634,26547132
23585,panitumumab,gene,0.9365,26547132
23586,advanced colorectal cancer,disease,1.0,26547132
23587,tumor,disease,1.0,26547132
23588,Metastatic Colorectal Cancer,disease,0.9995,26541320
23589,metastatic colorectal cancer,disease,1.0,26541320
23590,mCRC,disease,1.0,26541320
23591,5-fluorouracil,drug,0.9995,26541320
23592,irinotecan,drug,0.9995,26541320
23593,oxaliplatin,drug,0.9995,26541320
23594,EGFR,gene,0.9956,26541320
23595,VEGF,gene,0.9897,26541320
23596,bevacizumab,gene,0.744,26541320
23597,cetuximab,gene,0.8477,26541320
23598,panitumumab,gene,0.8687,26541320
23599,mCRC,disease,0.992,26541320
23600,mCRC,disease,0.9976,26541320
23601,Panitumumab,gene,0.9233,26540314
23602,gemcitabine,drug,0.9995,26540314
23603,oxaliplatin,drug,0.9995,26540314
23604,Biliary tract cancer,disease,1.0,26540314
23605,BTC,disease,1.0,26540314
23606,epidermal growth factor receptor,gene,0.9976,26540314
23607,EGFR,gene,0.993,26540314
23608,patients,species,0.9707,26540314
23609,advanced BTC,disease,0.8843,26540314
23610,KRAS,gene,0.983,26540314
23611,Patients,species,0.9287,26540314
23612,gemcitabine,drug,0.9995,26540314
23613,oxaliplatin,drug,0.9995,26540314
23614,panitumumab,gene,0.9106,26540314
23615,patients,species,0.983,26540314
23616,B,cell_type,0.3665,26540314
23617,tumor,disease,0.899,26540314
23618,patients,species,0.935,26540314
23619,intrahepatic cholangiocarcinoma,disease,1.0,26540314
23620,panitumumab,gene,0.8965,26540314
23621,skin,disease,0.6836,26540314
23622,patients,species,0.983,26540314
23623,diarrhea,disease,1.0,26540314
23624,mucositis,disease,1.0,26540314
23625,constipation,disease,1.0,26540314
23626,EGFR,gene,0.894,26540314
23627,WT KRAS,gene,0.9146,26540314
23628,BTC,disease,1.0,26540314
23629,colorectal cancer,disease,1.0,26508880
23630,regorafenib,drug,0.993,26508880
23631,Metastatic colorectal cancer,disease,1.0,26508880
23632,mCRC,disease,1.0,26508880
23633,anti-EGFR antibodies,gene,0.963,26508880
23634,cetuximab,gene,0.8643,26508880
23635,panitumumab,gene,0.8755,26508880
23636,VEGF,gene,0.9883,26508880
23637,bevacizumab,gene,0.771,26508880
23638,aflibercept,gene,0.923,26508880
23639,patients,species,0.992,26508880
23640,RAS mutation,gene,0.949,26508880
23641,EGFR antibodies,gene,0.899,26508880
23642,Regorafenib,drug,0.9966,26508880
23643,mCRC,disease,0.957,26508880
23644,regorafenib,drug,0.995,26508880
23645,mCRC,disease,0.9995,26508880
23646,RAS,gene,0.995,26508880
23647,BRAF,gene,0.9844,26508880
23648,regorafenib,drug,0.992,26508880
23649,anti-EGFR antibody,gene,0.862,26508446
23650,multigene,DNA,0.572,26508446
23651,anti-epidermal growth factor receptor,gene,0.9883,26508446
23652,EGFR,gene,0.9717,26508446
23653,monoclonal antibodies,gene,0.5625,26508446
23654,cetuximab,gene,0.8296,26508446
23655,panitumumab,gene,0.8354,26508446
23656,colorectal cancer,disease,1.0,26508446
23657,CRC,disease,1.0,26508446
23658,patients,species,0.988,26508446
23659,wild-type RAS proto-oncogenes,gene,0.994,26508446
23660,patients,species,0.994,26508446
23661,RAS genes,gene,0.9937,26508446
23662,BRAF,gene,0.9966,26508446
23663,PI3KCA,gene,0.9976,26508446
23664,PTEN,gene,0.995,26508446
23665,anti-EGFR,gene,0.8438,26508446
23666,anti-EGFR moAbs,gene,0.9287,26508446
23667,genes,DNA,0.935,26508446
23668,CRCs,disease,0.9946,26508446
23669,cetuximab,gene,0.853,26508446
23670,panitumumab,gene,0.804,26508446
23671,EGFR-pathway genes,DNA,0.909,26508446
23672,EGFR,gene,0.9956,26508446
23673,KRAS,gene,0.9775,26508446
23674,NRAS,gene,0.967,26508446
23675,BRAF,gene,0.9873,26508446
23676,PI3KCA,gene,0.9966,26508446
23677,KRAS,gene,0.9727,26508446
23678,NRAS,gene,0.972,26508446
23679,BRAF,gene,0.9937,26508446
23680,PI3KCA,gene,0.9985,26508446
23681,FBXW7,gene,0.9893,26508446
23682,SMAD4,gene,0.9946,26508446
23683,anti-EGFR moAb,gene,0.9023,26508446
23684,KRAS,gene,0.924,26508446
23685,KRAS,gene,0.9556,26508446
23686,five gene panel,DNA,0.708,26508446
23687,anti-EGFR moAbs,gene,0.7876,26508446
23688,cancer genes,DNA,0.665,26508446
23689,cancer,disease,0.9985,26508446
23690,Minocycline,drug,0.999,26504047
23691,Panitumumab,gene,0.944,26504047
23692,Acneiform Rash,disease,0.999,26504047
23693,Metastatic Colorectal Cancer,disease,1.0,26504047
23694,anti-EGFR monoclonal antibody panitumumab,gene,0.804,26504047
23695,colorectal cancer,disease,1.0,26504047
23696,skin disorders,disease,1.0,26504047
23697,minocycline,drug,0.9985,26504047
23698,skin disorders,disease,1.0,26504047
23699,tumor,disease,1.0,26504047
23700,metastatic colorectal cancer,disease,1.0,26504047
23701,panitumumab,gene,0.834,26504047
23702,PATIENTS,species,0.895,26504047
23703,Acneiform rash,disease,1.0,26504047
23704,acneiform rash,disease,1.0,26504047
23705,minocycline,drug,0.9976,26504047
23706,panitumumab,gene,0.9507,26504047
23707,acneiform rash,disease,1.0,26504047
23708,tumor,disease,1.0,26504047
23709,MicroRNA,RNA,0.69,26497852
23710,miR,DNA,0.617,26497852
23711,miR-31,RNA,0.5854,26497852
23712,miR-31-5p/3p,gene,0.8994,26497852
23713,wild-type RAS,gene,0.9893,26497852
23714,metastatic colorectal cancer,disease,1.0,26497852
23715,cetuximab,gene,0.799,26497852
23716,microRNAs,RNA,0.5874,26497852
23717,miRNAs,RNA,0.5386,26497852
23718,EGFR,gene,0.9453,26497852
23719,cetuximab,gene,0.802,26497852
23720,panitumumab,gene,0.871,26497852
23721,RAS,gene,0.9946,26497852
23722,wt-RAS,gene,0.7114,26497852
23723,metastatic colorectal cancer,disease,1.0,26497852
23724,mCRC,disease,1.0,26497852
23725,mCRC,disease,0.981,26497852
23726,MiRNAs,RNA,0.661,26497852
23727,wt-KRAS,gene,0.9243,26497852
23728,mCRC,disease,0.9893,26497852
23729,cetuximab,gene,0.6943,26497852
23730,miRNAs,RNA,0.716,26497852
23731,wt,cell_line,0.509,26497852
23732,wt-,disease,0.997,26497852
23733,wt-RAS,gene,0.934,26497852
23734,cetuximab,gene,0.851,26497852
23735,wt-RAS mCRC,disease,0.9155,26497852
23736,wt-RAS,gene,0.746,26497852
23737,panitumumab,gene,0.6987,26497852
23738,miRNAs,RNA,0.6406,26497852
23739,cetuximab,gene,0.863,26497852
23740,miRNAs,RNA,0.6143,26497852
23741,miR-31-3p,gene,0.534,26497852
23742,miR,RNA,0.5576,26497852
23743,miR-31-,gene,0.8857,26497852
23744,5p,DNA,0.825,26497852
23745,wt,cell_line,0.5293,26497852
23746,wt-RAS,gene,0.973,26497852
23747,mCRC,disease,0.986,26497852
23748,cetuximab,gene,0.791,26497852
23749,panitumumab,gene,0.7856,26497852
23750,cetuximab,gene,0.6143,26497852
23751,miR-31-3p,gene,0.5645,26497852
23752,miR-31-,RNA,0.5156,26497852
23753,miR-31-5p,gene,0.6553,26497852
23754,miR-31,RNA,0.5815,26497852
23755,miR-31-5p/3p,gene,0.944,26497852
23756,RAS mutated and wild-type tumor samples,cell_line,0.742,26497852
23757,RAS,gene,0.9893,26497852
23758,tumor samples,cell_type,0.4717,26497852
23759,tumor,disease,0.9956,26497852
23760,MiR-31-5p/3p,gene,0.8726,26497852
23761,cetuximab,gene,0.8037,26497852
23762,wt-RAS,gene,0.9795,26497852
23763,mCRC,disease,0.99,26497852
23764,Panitumumab,gene,0.865,26491871
23765,Metastatic Colorectal Cancer,disease,1.0,26491871
23766,KRAS,gene,0.9834,26491871
23767,panitumumab,gene,0.788,26491871
23768,patients,species,0.9863,26491871
23769,KRAS exon 2,gene,0.745,26491871
23770,panitumumab,gene,0.927,26491871
23771,panitumumab,gene,0.85,26491871
23772,patients,species,0.9624,26491871
23773,metastatic colorectal cancer,disease,1.0,26491871
23774,mCRC,disease,1.0,26491871
23775,KRAS,gene,0.95,26491871
23776,panitumumab,gene,0.817,26491871
23777,panitumumab,gene,0.944,26491871
23778,patients,species,0.9937,26491871
23779,KRAS,gene,0.541,26491871
23780,panitumumab,gene,0.7695,26491871
23781,panitumumab,gene,0.837,26491871
23782,mCRC,disease,0.9995,26491871
23783,patients,species,0.9883,26491871
23784,wild,DNA,0.8555,26491871
23785,wild-type KRAS,gene,0.9136,26491871
23786,KRAS,gene,0.935,26491871
23787,patients,species,0.993,26491871
23788,panitumumab,gene,0.8657,26491871
23789,patients,species,0.9883,26491871
23790,KRAS,DNA,0.6616,26491871
23791,KRAS mutation,gene,0.6045,26491871
23792,panitumumab,gene,0.893,26491871
23793,patients,species,0.985,26491871
23794,panitumumab,gene,0.813,26491871
23795,oxaliplatin,drug,0.9995,26491871
23796,wild,DNA,0.8794,26491871
23797,wild-type KRAS,gene,0.993,26491871
23798,panitumumab,gene,0.89,26491871
23799,KRAS,DNA,0.6685,26491871
23800,panitumumab,gene,0.898,26491871
23801,patients,species,0.9956,26491871
23802,tumors,disease,0.74,26491871
23803,wild,DNA,0.6304,26491871
23804,wild-type KRAS,gene,0.923,26491871
23805,panitumumab,gene,0.8096,26491871
23806,oxaliplatin,drug,0.9995,26491871
23807,Rectal Cancer,disease,1.0,26489570
23808,rectal cancer,disease,1.0,26489570
23809,woman,species,0.8823,26489570
23810,abdominal pain,disease,0.9985,26489570
23811,loss of,disease,0.7603,26489570
23812,rectal cancer,disease,1.0,26489570
23813,patient,species,0.9795,26489570
23814,bevacizumab,gene,0.859,26489570
23815,panitumumab,gene,0.8887,26489570
23816,patient,species,0.9824,26489570
23817,Cetuximab,gene,0.9316,26487956
23818,cisplatin,drug,0.998,26487956
23819,5-Fluorouracil,drug,0.9976,26487956
23820,Metastatic squamous cell carcinoma,disease,1.0,26487956
23821,SCC,disease,0.999,26487956
23822,Epidermal growth factor receptor,gene,0.998,26487956
23823,EGFR,gene,0.996,26487956
23824,SCC of the anal canal,disease,0.988,26487956
23825,Kristen,disease,0.7417,26487956
23826,Kristen rat sarcoma vial oncogene,gene,0.9966,26487956
23827,rat,species,0.3625,26487956
23828,KRAS,gene,0.996,26487956
23829,EGFR monoclonal antibodies,gene,0.796,26487956
23830,cetuximab,gene,0.888,26487956
23831,panitumumab,gene,0.8306,26487956
23832,patient,species,0.953,26487956
23833,metastatic SCC of the anal canal,disease,0.9985,26487956
23834,patient,species,0.9863,26487956
23835,cetuximab,gene,0.8394,26487956
23836,cisplatin,drug,0.9976,26487956
23837,5-Fluorouracil,drug,0.9976,26487956
23838,5-FU,drug,0.998,26487956
23839,Epidermal growth factor receptor,gene,0.9985,26475804
23840,EGFR,gene,0.9927,26475804
23841,neuropathic pain,disease,1.0,26475804
23842,mitogen-activated protein kinases,gene,0.994,26475804
23843,MAPK,gene,0.9604,26475804
23844,neurones,cell_type,0.6685,26475804
23845,glial cells,cell_type,0.8564,26475804
23846,epidermal growth factor receptor,gene,0.9976,26475804
23847,EGFR,gene,0.993,26475804
23848,EGFR,gene,0.955,26475804
23849,EGFR-I,gene,0.9526,26475804
23850,neuropathic pain,disease,1.0,26475804
23851,EGFR,gene,0.991,26475804
23852,neuropathic pain,disease,1.0,26475804
23853,neuropathic pain,disease,1.0,26475804
23854,EGFR,gene,0.9937,26475804
23855,cancer,disease,1.0,26475804
23856,neuropathic pain,disease,1.0,26475804
23857,EGFR,gene,0.9873,26475804
23858,Neuropathic pain,disease,1.0,26475804
23859,EGFR,gene,0.995,26475804
23860,skin reactions,disease,0.998,26475804
23861,EGFR,gene,0.6265,26475804
23862,neuropathic pain,disease,1.0,26475804
23863,EGFR,gene,0.9067,26474549
23864,metastatic colorectal cancer,disease,1.0,26474549
23865,EGFR,gene,0.637,26474549
23866,KRAS exon 2,gene,0.877,26474549
23867,metastatic colorectal,disease,1.0,26474549
23868,patients,species,0.987,26474549
23869,EGFR,gene,0.941,26474549
23870,cetuximab,gene,0.9355,26474549
23871,panitumumab,gene,0.919,26474549
23872,EGFR,gene,0.7056,26474549
23873,EGFR,gene,0.6484,26474549
23874,cetuximab,gene,0.5645,26474549
23875,cetuximab,gene,0.543,26474549
23876,erlotinib,drug,0.994,26474549
23877,Patients,species,0.9854,26474549
23878,cetuximab,gene,0.9546,26474549
23879,panitumumab,gene,0.9346,26474549
23880,anti-EGFR,gene,0.88,26474549
23881,patients,species,0.986,26474549
23882,Ascending Colon Cancer,disease,1.0,26469173
23883,Ascites,disease,0.98,26469173
23884,Bevacizumab,gene,0.891,26469173
23885,abdominal fullness,disease,0.9814,26469173
23886,ascites,disease,0.9995,26469173
23887,massive,disease,0.9536,26469173
23888,tumors,disease,0.95,26469173
23889,ascending colon cancer,disease,1.0,26469173
23890,ovarian metastasis,disease,0.938,26469173
23891,panitumumab,gene,0.943,26469173
23892,ascites,disease,0.992,26469173
23893,bevacizumab,gene,0.627,26469173
23894,FOLFIRI,drug,0.9824,26469173
23895,ascites,disease,0.9976,26469173
23896,metastatic lesions,disease,0.7397,26469173
23897,ascites,disease,0.983,26469173
23898,vascular endothelial growth factor,gene,0.9985,26469173
23899,VEGF,gene,0.997,26469173
23900,Colorectal Cancer,disease,1.0,26452385
23901,Colorectal cancer,disease,1.0,26452385
23902,CRC,disease,1.0,26452385
23903,cancer,disease,1.0,26452385
23904,metastatic CRC,disease,0.9995,26452385
23905,mCRC,disease,0.9995,26452385
23906,tumor,disease,1.0,26452385
23907,white blood counts,cell_type,0.7983,26452385
23908,lactate,drug,0.999,26452385
23909,lactate dehydrogenase,gene,0.9897,26452385
23910,alkaline phosphatase,gene,0.995,26452385
23911,mCRC,disease,0.9814,26452385
23912,FOLFOX,drug,0.936,26452385
23913,FOLFIRI,drug,0.913,26452385
23914,CAPOX,drug,0.9785,26452385
23915,panitumumab,gene,0.8867,26452385
23916,cetuximab,gene,0.859,26452385
23917,KRAS,gene,0.709,26452385
23918,NRAS WT,DNA,0.481,26452385
23919,NRAS,gene,0.996,26452385
23920,tyrosin-kinase receptors,gene,0.9937,26452385
23921,MET,gene,0.996,26452385
23922,HER2,gene,0.9966,26452385
23923,IGF-1R,gene,0.9976,26452385
23924,BRAF,gene,0.9976,26452385
23925,MEK,gene,0.997,26452385
23926,PI3K,gene,0.995,26452385
23927,AKT,gene,0.9966,26452385
23928,mTORC,gene,0.9897,26452385
23929,NOTCH,gene,0.9976,26452385
23930,JAK1,gene,0.99,26452385
23931,JAK2,gene,0.9766,26452385
23932,anti-PD-L1,gene,0.8853,26452385
23933,anti- PD1,gene,0.9795,26452385
23934,tumor cells,cell_type,0.878,26452385
23935,mCRC,disease,0.9995,26452385
23936,Panitumumab,gene,0.8584,26446234
23937,RAS,gene,0.985,26446234
23938,BRAF,gene,0.9727,26446234
23939,panitumumab,gene,0.8237,26446234
23940,metastatic colorectal cancer,disease,0.9995,26446234
23941,CRC,disease,1.0,26446234
23942,panitumumab,gene,0.9,26446234
23943,RAS,gene,0.976,26446234
23944,BRAF,gene,0.9844,26446234
23945,RAS,gene,0.991,26446234
23946,BRAF,gene,0.438,26446234
23947,panitumumab,gene,0.901,26446234
23948,fluoropyrimidine,drug,0.997,26446234
23949,irinotecan,drug,0.998,26446234
23950,skin rash,disease,0.994,26446234
23951,Panitumumab,gene,0.735,26446234
23952,RAS,gene,0.9897,26446234
23953,BRAF,gene,0.558,26446234
23954,metastatic CRC,disease,0.824,26446234
23955,metastatic colorectal cancer,disease,1.0,26446234
23956,frail,disease,0.909,26446234
23957,RAS,gene,0.9775,26446234
23958,BRAF,gene,0.6484,26446234
23959,anti-,gene,0.713,26446234
23960,epidermal growth factor receptor,gene,0.919,26446234
23961,panitumumab,gene,0.947,26446234
23962,RAS,gene,0.9897,26446234
23963,BRAF,gene,0.987,26446234
23964,cyanine,drug,0.965,26444497
23965,C4,drug,,26444497
23966,C4,DNA,,26444497
23967,C4&#x27;-O-aryl,drug,0.888,26444497
23968,cyanine,drug,0.9673,26444497
23969,indolenine,drug,0.9985,26444497
23970,FNIR-774,drug,0.9985,26444497
23971,sulfonate,drug,0.9976,26444497
23972,FNIR-Z-759,drug,0.9976,26444497
23973,sulfonates,drug,0.997,26444497
23974,quaternary ammonium,drug,0.9985,26444497
23975,FNIR-774,drug,0.992,26444497
23976,FNIR,DNA,0.4514,26444497
23977,FNIR-Z,drug,0.973,26444497
23978,panitumumab,gene,0.9443,26444497
23979,pan,gene,0.946,26444497
23980,target cells,cell_type,0.801,26444497
23981,FNIR-Z,DNA,0.533,26444497
23982,FNIR,drug,0.976,26444497
23983,mice,species,0.9653,26444497
23984,FNIR,DNA,0.6177,26444497
23985,FNIR-Z-759,drug,0.9404,26444497
23986,FNIR,DNA,0.4326,26444497
23987,FNIR-774,drug,0.9976,26444497
23988,cyanine,drug,0.933,26444497
23989,panitumumab,gene,0.829,26442575
23990,cetuximab,gene,0.7554,26442575
23991,epidermal growth factor receptor,gene,0.998,26442575
23992,EGFR,gene,0.9976,26442575
23993,panitumumab,gene,0.802,26442575
23994,cetuximab,gene,0.868,26442575
23995,metastatic colorectal cancer,disease,1.0,26442575
23996,mCRC,disease,1.0,26442575
23997,patients,species,0.909,26442575
23998,KRAS,DNA,0.529,26442575
23999,panitumumab,gene,0.923,26442575
24000,cetuximab,gene,0.9062,26442575
24001,irinotecan,drug,0.99,26442575
24002,patient,species,0.9634,26442575
24003,patient,species,0.985,26442575
24004,panitumumab,gene,0.8926,26442575
24005,cetuximab,gene,0.8657,26442575
24006,EGFR,gene,0.9927,26442575
24007,healthcare professionals,cell_type,0.564,26442575
24008,patient,species,0.9917,26442575
24009,panitumumab,gene,0.7715,26442575
24010,patient,species,0.9854,26442575
24011,cetuximab,gene,0.8228,26442575
24012,panitumumab,gene,0.8896,26442575
24013,patient,species,0.984,26442575
24014,patient,species,0.9927,26442575
24015,panitumumab,gene,0.8936,26442575
24016,panitumumab,gene,0.8984,26442575
24017,patient,species,0.986,26442575
24018,mCRC,disease,0.998,26442575
24019,patients,species,0.9844,26442575
24020,panitumumab,gene,0.898,26442575
24021,cetuximab,gene,0.888,26442575
24022,panitumumab,gene,0.8804,26442575
24023,cancer,disease,1.0,26442575
24024,EGFR,gene,0.9917,26416732
24025,colorectal cancer,disease,1.0,26416732
24026,Colorectal cancer,disease,1.0,26416732
24027,cancer,disease,1.0,26416732
24028,patients,species,0.981,26416732
24029,colorectal cancer,disease,1.0,26416732
24030,panitumumab,gene,0.811,26416732
24031,epidermal growth factor receptor,gene,0.9966,26416732
24032,EGFR,gene,0.995,26416732
24033,KRAS,gene,0.957,26416732
24034,anti-,gene,0.6914,26416732
24035,EGFR antibody,gene,0.8135,26416732
24036,EGFR,gene,0.9907,26416732
24037,colorectal cancer,disease,1.0,26416732
24038,colorectal cancer,disease,1.0,26416732
24039,anti-EGFR antibody,gene,0.855,26416732
24040,patient-derived tumour grafts,cell_line,0.8926,26416732
24041,patient,species,0.8403,26416732
24042,tumour,disease,0.989,26416732
24043,patient,species,0.994,26416732
24044,tumours,disease,1.0,26416732
24045,KRAS,gene,0.9917,26416732
24046,tumours,disease,1.0,26416732
24047,anti-EGFR antibody,gene,0.9634,26416732
24048,tumour graft models,cell_line,0.774,26416732
24049,tumour,disease,1.0,26416732
24050,ERBB2,gene,0.9966,26416732
24051,EGFR,gene,0.995,26416732
24052,FGFR1,gene,0.9966,26416732
24053,PDGFRA,gene,0.9937,26416732
24054,MAP2K1,gene,0.995,26416732
24055,EGFR,gene,0.9824,26416732
24056,patients,species,0.9927,26416732
24057,EGFR,gene,0.9897,26416732
24058,tyrosine,drug,0.7915,26416732
24059,tyrosine kinase receptor adaptor gene,gene,0.9897,26416732
24060,IRS2,gene,0.6997,26416732
24061,tumours,disease,1.0,26416732
24062,EGFR,gene,0.76,26416732
24063,EGFR,gene,0.9937,26416732
24064,tumour graft models,cell_line,0.593,26416732
24065,tumour,disease,1.0,26416732
24066,actionable genes,DNA,0.856,26416732
24067,human,species,0.9897,26416732
24068,cancer,disease,1.0,26416732
24069,EGFR,gene,0.762,26416732
24070,colorectal cancer,disease,1.0,26416732
24071,Cyanine,drug,0.98,26403799
24072,biomacromolecule,DNA,0.4963,26403799
24073,ADC,gene,0.9663,26403799
24074,cyanine,drug,0.973,26403799
24075,(67)Cu,drug,0.9995,26403524
24076,copper,drug,0.999,26403524
24077,(67)Cu,drug,0.999,26403524
24078,(67)Cu,drug,0.999,26403524
24079,divalent,DNA,0.5254,26403524
24080,(67)Cu,drug,0.9995,26403524
24081,(67)Cu,drug,0.9995,26403524
24082,anti-EGFR antibody,gene,0.993,26403524
24083,Panitumumab,gene,0.831,26403524
24084,mice,species,0.8984,26403524
24085,colon cancer,disease,1.0,26403524
24086,EGFR-Positive Breast Cancer,disease,0.8965,26402157
24087,EGFR,gene,0.9946,26402157
24088,Panitumumab,gene,0.9585,26402157
24089,breast cancer,disease,1.0,26402157
24090,BC,disease,1.0,26402157
24091,epidermal growth factor receptors,gene,0.998,26402157
24092,EGFR,gene,0.9966,26402157
24093,triple,cell_type,0.5347,26402157
24094,triple-negative tumors,disease,1.0,26402157
24095,TNBC,disease,1.0,26402157
24096,AuNP,cell_type,0.6904,26402157
24097,polyethylene glycol,drug,0.9995,26402157
24098,PEG,drug,1.0,26402157
24099,DOTA,drug,0.9995,26402157
24100,(177)Lu,drug,0.999,26402157
24101,PEG,drug,0.999,26402157
24102,panitumumab,gene,0.892,26402157
24103,BC cells,cell_type,0.669,26402157
24104,BC,disease,,26402157
24105,EGFR,gene,0.989,26402157
24106,AuNP,cell_type,0.872,26402157
24107,PEG,drug,0.9995,26402157
24108,EGFR,gene,0.995,26402157
24109,(177)Lu,drug,0.998,26402157
24110,BC cells,cell_line,0.712,26402157
24111,BC,disease,,26402157
24112,177,drug,0.7334,26402157
24113,Lu,drug,0.992,26402157
24114,AuNP,cell_type,0.5903,26402157
24115,(177)Lu,drug,0.999,26402157
24116,(177)Lu,drug,0.999,26402157
24117,BC cells,cell_type,0.7046,26402157
24118,BC,disease,,26402157
24119,EGFR,gene,0.9897,26402157
24120,MDA-MB-468,cell_line,0.8276,26402157
24121,MDA-MB-231,cell_line,0.79,26402157
24122,MCF-7 cells,cell_line,0.723,26402157
24123,MDA-MB-468 cells,cell_line,0.8438,26402157
24124,(177)Lu,drug,0.9985,26402157
24125,BC cells,cell_type,0.525,26402157
24126,EGFR,gene,0.9927,26402157
24127,(177)Lu,drug,0.9995,26402157
24128,AuNP,cell_type,0.89,26402157
24129,(177)Lu,drug,0.998,26402157
24130,MDA-MB-468 cells,cell_line,0.953,26402157
24131,)I,drug,,26402157
24132,(177)Lu,drug,0.999,26402157
24133,BC cells,cell_type,0.7627,26402157
24134,BC,disease,,26402157
24135,EGFR,gene,0.99,26402157
24136,MDA-MB-468 cells,cell_line,0.9336,26402157
24137,EGFR,gene,0.9907,26402157
24138,(177)Lu,drug,0.9995,26402157
24139,(177)Lu,drug,0.999,26402157
24140,MDA-MB-231 cells,cell_line,0.9546,26402157
24141,MCF-7 cells,cell_line,0.984,26402157
24142,EGFR,gene,0.9917,26402157
24143,(177)Lu,drug,0.9985,26402157
24144,(177)Lu,drug,0.999,26402157
24145,BC cells,cell_type,0.549,26402157
24146,(177)Lu,drug,0.999,26402157
24147,MDA-MB-468 cells,cell_line,0.659,26402157
24148,EGFR,gene,0.988,26402157
24149,(177)Lu,drug,0.999,26402157
24150,AuNP,cell_type,0.8574,26402157
24151,(177)Lu,drug,0.9937,26402157
24152,BC cells,cell_type,0.523,26402157
24153,BC,disease,,26402157
24154,tumors,disease,1.0,26402157
24155,EGFR,gene,0.987,26402157
24156,(177)Lu,drug,0.999,26402157
24157,MDA-MB-468 cell,cell_line,0.9385,26402157
24158,(177)Lu,drug,0.9985,26402157
24159,AuNP,cell_type,0.62,26402157
24160,(177)Lu,drug,0.998,26402157
24161,TNBC,disease,0.9854,26402157
24162,EGFR,gene,0.9907,26402157
24163,EGFR,gene,0.995,26392303
24164,colorectal,disease,0.572,26392303
24165,anti-cancer,disease,0.9277,26392303
24166,tumours,disease,1.0,26392303
24167,colorectal cancer,disease,1.0,26392303
24168,CRC,disease,1.0,26392303
24169,EGFR,gene,0.9956,26392303
24170,CRC cells,cell_line,0.885,26392303
24171,CRC,disease,1.0,26392303
24172,EGFR,gene,0.993,26392303
24173,RAS,gene,0.9937,26392303
24174,MEK,gene,0.992,26392303
24175,CRC cells,cell_line,0.931,26392303
24176,CRC,disease,0.9995,26392303
24177,anti-EGFR,gene,0.9004,26392303
24178,MEK,gene,0.8276,26392303
24179,EGFR,gene,0.99,26392303
24180,patient,species,0.9775,26392303
24181,EGFR,gene,0.9976,26392303
24182,MEK,gene,0.994,26392303
24183,EGFR,gene,0.996,26392303
24184,MEK,gene,0.994,26392303
24185,Bcl-2,gene,0.989,26392303
24186,Mcl-1,gene,0.9697,26392303
24187,Metastatic Colorectal Cancer,disease,0.9995,26374340
24188,CALGB,cell_line,0.551,26374340
24189,colorectal cancer,disease,1.0,26374340
24190,CRC,disease,1.0,26374340
24191,bevacizumab,gene,0.6704,26374340
24192,cetuximab,gene,0.671,26374340
24193,panitumumab,gene,0.6885,26374340
24194,FOLFOX,drug,0.889,26374340
24195,FOLFIRI,drug,0.688,26374340
24196,RAS,gene,0.995,26374340
24197,metastatic CRC,disease,0.9985,26374340
24198,AIO KRK-0306,drug,0.9985,26374340
24199,bevacizumab,gene,0.873,26374340
24200,cetuximab,gene,0.8784,26374340
24201,panitumumab,gene,0.8223,26374340
24202,FOLFOX,drug,0.9795,26374340
24203,FOLFIRI,drug,0.9375,26374340
24204,advanced CRC,disease,0.9907,26374340
24205,exons,DNA,0.765,26374340
24206,RAS,gene,0.5117,26374340
24207,anti-EGFR,gene,0.9756,26374340
24208,RAS,DNA,0.822,26374340
24209,RAS WT,gene,0.594,26374340
24210,metastatic CRC,disease,0.9795,26374340
24211,anti-EGFR mAb ICR62,gene,0.865,26372697
24212,cancer cells,cell_type,0.885,26372697
24213,cancer,disease,0.9995,26372697
24214,EGFR,gene,0.994,26372697
24215,HER-2,gene,0.998,26372697
24216,HER-3,gene,0.9976,26372697
24217,pan HER,DNA,0.536,26372697
24218,pan,gene,0.5176,26372697
24219,HER,gene,0.6255,26372697
24220,human epidermal growth factor receptor,gene,0.9966,26372697
24221,EGFR,gene,0.99,26372697
24222,cancer,disease,1.0,26372697
24223,EGFR antibodies cetuximab,gene,0.7637,26372697
24224,panitumumab,gene,0.748,26372697
24225,colorectal cancer,disease,1.0,26372697
24226,DiFi colorectal cancer cells,cell_line,0.757,26372697
24227,DiFi colorectal cancer,disease,0.923,26372697
24228,anti-EGFR mAb ICR62,gene,0.942,26372697
24229,tyrosine kinase,gene,0.971,26372697
24230,gefitinib,drug,0.999,26372697
24231,DiFi,cell_line,0.7905,26372697
24232,DiFiG cells,cell_line,0.899,26372697
24233,anti-EGFR mAb ICR62,gene,0.887,26372697
24234,DiFi62 cells,cell_line,0.7544,26372697
24235,EGFR,gene,0.9873,26372697
24236,HER-2,gene,0.9937,26372697
24237,HER-3,gene,0.994,26372697
24238,DiFi62 cells,cell_line,0.706,26372697
24239,anti-EGFR mAbs cetuximab,gene,0.9087,26372697
24240,ICR61,gene,0.7007,26372697
24241,EGFR,gene,0.9575,26372697
24242,parental cells,cell_line,0.841,26372697
24243,HER,gene,0.985,26372697
24244,afatinib,drug,0.979,26372697
24245,EGFR,gene,0.993,26372697
24246,colorectal cancer cells,cell_type,0.6807,26372697
24247,colorectal cancer,disease,1.0,26372697
24248,HER family,gene,0.9927,26372697
24249,colorectal cancer,disease,1.0,26372697
24250,EGFR,gene,0.995,26372697
24251,FCGR2A,gene,0.8257,26363448
24252,FCGR3A,gene,0.8135,26363448
24253,anti-EGFR monoclonal antibody,gene,0.875,26363448
24254,metastatic colorectal cancer,disease,0.9995,26363448
24255,Anti-EGFR monoclonal antibodies,gene,0.8857,26363448
24256,cetuximab,gene,0.6646,26363448
24257,panitumumab,gene,0.712,26363448
24258,metastatic colorectal cancer,disease,1.0,26363448
24259,mCRC,disease,1.0,26363448
24260,wild-KRAS genotype,gene,0.8237,26363448
24261,KRAS,DNA,0.4915,26363448
24262,mCRC,disease,0.991,26363448
24263,cetuximab,gene,0.838,26363448
24264,FCGR2A,gene,0.574,26363448
24265,H131R,DNA,,26363448
24266,H131R,mutation,,26363448
24267,FCGR3A,gene,0.684,26363448
24268,V158F,DNA,,26363448
24269,V158F,mutation,,26363448
24270,mCRC,disease,0.999,26363448
24271,anti-EGFR mAb,gene,0.924,26363448
24272,H131R,mutation,,26363448
24273,FCGR2A,gene,0.985,26363448
24274,V158F,mutation,,26363448
24275,FCGR3A,gene,0.985,26363448
24276,KRAS,gene,0.7407,26363448
24277,mCRC,disease,0.9927,26363448
24278,allele,DNA,0.4841,26363448
24279,FCGR3A V158F,gene,0.7407,26363448
24280,V158F,DNA,,26363448
24281,V158F,mutation,,26363448
24282,KRAS,gene,0.6772,26363448
24283,KRAS,gene,0.738,26363448
24284,mCRC,disease,0.979,26363448
24285,V158Fcan,RNA,0.5493,26363448
24286,anti-EGFR mAb,gene,0.9595,26363448
24287,mCRC,disease,0.9995,26363448
24288,anti-EGFR mAb,gene,0.876,26363448
24289,Panitumumab,gene,0.872,26362073
24290,Advanced Penile Squamous Cell Carcinoma,disease,0.996,26362073
24291,metastatic penile squamous cell carcinoma,disease,0.997,26362073
24292,SCC,disease,1.0,26362073
24293,panitumumab,gene,0.862,26362073
24294,PATIENTS,species,0.9136,26362073
24295,penile SCC,disease,0.9985,26362073
24296,panitumumab,gene,0.7554,26362073
24297,Solid Tumors,disease,0.767,26362073
24298,panitumumab,gene,0.9487,26362073
24299,cutaneous toxicity,disease,0.94,26362073
24300,diarrhea,disease,1.0,26362073
24301,mucositis,disease,0.9775,26362073
24302,skin,disease,0.7,26362073
24303,skin nodules,disease,0.996,26362073
24304,skin and,disease,0.7236,26362073
24305,skin metastases,disease,0.7983,26362073
24306,Panitumumab,gene,0.8687,26362073
24307,pretreated penile SCC,cell_line,0.597,26362073
24308,penile,cell_type,0.4937,26362073
24309,penile SCC,disease,0.999,26362073
24310,KRAS,gene,0.9897,26341920
24311,NRAS Mutations,DNA,0.49,26341920
24312,NRAS,gene,0.997,26341920
24313,Panitumumab,gene,0.784,26341920
24314,RAS,gene,0.975,26341920
24315,panitumumab,gene,0.9165,26341920
24316,fluorouracil,drug,0.9995,26341920
24317,leucovorin,drug,0.998,26341920
24318,irinotecan,drug,0.9985,26341920
24319,FOLFIRI,drug,0.9883,26341920
24320,FOLFIRI,drug,0.9624,26341920
24321,patients,species,0.925,26341920
24322,metastatic colorectal cancer,disease,1.0,26341920
24323,mCRC,disease,1.0,26341920
24324,RAS mutations,gene,0.743,26341920
24325,KRAS exon 2,DNA,0.9297,26341920
24326,"KRAS exons 3, 4",DNA,0.924,26341920
24327,KRAS exons 3,gene,0.8096,26341920
24328,"NRAS exons 2, 3, 4",DNA,0.9146,26341920
24329,BRAF exon 15,gene,0.942,26341920
24330,wild-type KRAS exon 2,DNA,0.6987,26341920
24331,wild-type KRAS exon 2,gene,0.9907,26341920
24332,tumor,disease,0.9805,26341920
24333,RAS,gene,0.9893,26341920
24334,wild-type KRAS exon 2 tumors,cell_line,0.6104,26341920
24335,wild,disease,0.971,26341920
24336,wild-type KRAS exon 2,gene,0.9546,26341920
24337,RAS mutations,gene,0.8525,26341920
24338,panitumumab,gene,0.911,26341920
24339,FOLFIRI,drug,0.99,26341920
24340,FOLFIRI,drug,0.989,26341920
24341,panitumumab,gene,0.7095,26341920
24342,wild-type RAS,gene,0.9336,26341920
24343,wild-type KRAS exon 2,gene,0.7305,26341920
24344,Patients,species,0.982,26341920
24345,RAS mutations,gene,0.9126,26341920
24346,panitumumab,gene,0.792,26341920
24347,RAS,DNA,0.6665,26341920
24348,RAS,gene,0.994,26341920
24349,patients,species,0.962,26341920
24350,panitumumab,gene,0.9404,26341920
24351,FOLFIRI,drug,0.9487,26341920
24352,FOLFIRI,drug,0.7866,26341920
24353,Patients,species,0.9653,26341920
24354,RAS mutations,gene,0.9224,26341920
24355,panitumumab,gene,0.8833,26341920
24356,FOLFIRI,drug,0.9893,26341920
24357,panitumumab,gene,0.9326,26341920
24358,FOLFIRI,drug,0.9907,26341920
24359,RAS,gene,0.9863,26341920
24360,wild-type KRAS exon 2,gene,0.9717,26341920
24361,RAS,DNA,0.874,26341920
24362,RAS,gene,0.995,26341920
24363,patients,species,0.9424,26341920
24364,mCRC,disease,0.9863,26341920
24365,colorectal cancer,disease,1.0,26327923
24366,patients,species,0.9634,26327923
24367,metastatic colorectal cancer,disease,1.0,26327923
24368,mCRC,disease,1.0,26327923
24369,fluorouracuil,drug,0.9995,26327923
24370,leucovorin,drug,0.9985,26327923
24371,oxaliplatin,drug,0.9995,26327923
24372,ininotecan,drug,0.959,26327923
24373,mCRC,disease,0.94,26327923
24374,epidermal growth factor receptor,gene,0.998,26327923
24375,EGFR,gene,0.991,26327923
24376,cetuximab,gene,0.9067,26327923
24377,panitumumab,gene,0.9453,26327923
24378,vascular endothelial growth factor monoclonal antibody,gene,0.9595,26327923
24379,patient,species,0.9863,26327923
24380,colon cancers,disease,1.0,26327923
24381,KRAS,gene,0.992,26327923
24382,exon 2,DNA,0.7734,26327923
24383,EGFR,gene,0.992,26327923
24384,KRAS,DNA,0.8594,26327923
24385,KRAS mutations,gene,0.792,26327923
24386,exons 3 and 4,DNA,0.738,26327923
24387,NRAS,DNA,0.7974,26327923
24388,NRAS mutations,gene,0.8115,26327923
24389,"exons 2, 3 and 4",DNA,0.713,26327923
24390,BRAF,gene,0.9946,26327923
24391,PIK3CA,gene,0.996,26327923
24392,mCRC,disease,0.985,26327923
24393,colorectal carcinomas,disease,1.0,26320600
24394,CqG-island methylator phenotype,cell_line,0.711,26320600
24395,CqG-island methylator,gene,0.766,26320600
24396,MLH1,gene,0.992,26320600
24397,MSH2,gene,0.9897,26320600
24398,MSH6,gene,0.985,26320600
24399,PMS2,gene,0.982,26320600
24400,colorectal carcinoma,disease,1.0,26320600
24401,colorectal carcinomas,disease,1.0,26320600
24402,liver metastases,disease,0.782,26320600
24403,tumours,disease,1.0,26320600
24404,tumour,disease,1.0,26320600
24405,Mismatch repair,gene,0.969,26320600
24406,metastases,cell_type,0.4329,26320600
24407,colorectal carcinomas,disease,1.0,26320600
24408,patient,species,0.981,26320600
24409,EGFR,gene,0.9194,26318427
24410,epidermal growth factor receptor,gene,0.8926,26318427
24411,panitumumab,gene,0.774,26318427
24412,metastatic colorectal cancer,disease,0.997,26318427
24413,patients,species,0.9907,26318427
24414,EGFR,gene,0.9946,26318427
24415,KRAS,gene,0.966,26318427
24416,NRAS,gene,0.9854,26318427
24417,BRAF,gene,0.9946,26318427
24418,PIK3CA,DNA,0.54,26318427
24419,PIK3CA mutations,gene,0.804,26318427
24420,PTEN,gene,0.8623,26318427
24421,AREG,gene,0.9907,26318427
24422,EREG,gene,0.988,26318427
24423,HER,DNA,0.5483,26318427
24424,HER-2,gene,0.9966,26318427
24425,EGFR,gene,0.8213,26318427
24426,KRAS,gene,0.952,26318427
24427,NRAS,DNA,0.562,26318427
24428,NRAS mutations,gene,0.9116,26318427
24429,circulating tumor DNA,DNA,0.591,26318427
24430,anti-EGFR monoclonal antibodies,gene,0.9663,26318427
24431,panitumumab,gene,0.9155,26300630
24432,patients,species,0.9854,26300630
24433,metastatic BACKGROUND,disease,0.7695,26300630
24434,panitumumab,gene,0.8955,26300630
24435,metastatic colorectal cancer,disease,0.992,26300630
24436,mCRC,disease,0.9985,26300630
24437,patients,species,0.955,26300630
24438,mCRC,disease,0.983,26300630
24439,panitumumab,gene,0.916,26300630
24440,patients,species,0.9746,26300630
24441,mCRC,disease,0.996,26300630
24442,patients,species,0.989,26300630
24443,panitumumab,gene,0.9097,26300630
24444,KRAS gene,gene,0.9917,26300630
24445,patients,species,0.98,26300630
24446,wild,disease,0.77,26300630
24447,wild-type KRAS,gene,0.93,26300630
24448,Irinotecan,drug,0.999,26300630
24449,panitumumab,gene,0.8525,26300630
24450,patients,species,0.9287,26300630
24451,mCRC,disease,0.9824,26300630
24452,panitumumab,gene,0.925,26300630
24453,panitumumab,gene,0.9204,26300630
24454,Panitumumab,gene,0.9463,26299740
24455,Bevacizumab,gene,0.907,26299740
24456,panitumumab,gene,0.92,26299740
24457,bevacizumab,gene,0.762,26299740
24458,patients,species,0.9414,26299740
24459,wildtype RAS,gene,0.8174,26299740
24460,metastatic colorectal cancer,disease,1.0,26299740
24461,mCRC,disease,1.0,26299740
24462,Panitumumab,gene,0.897,26299740
24463,patients,species,0.9795,26299740
24464,wildtype RAS,gene,0.7993,26299740
24465,mCRC,disease,0.9995,26299740
24466,Panitumumab,gene,0.914,26299740
24467,patients,species,0.966,26299740
24468,wildtype RAS,gene,0.7803,26299740
24469,mCRC,disease,0.961,26299740
24470,bevacizumab,gene,0.771,26299740
24471,amino-acid,drug,0.999,26266658
24472,oral mucositis,disease,0.999,26266658
24473,colorectal cancer,disease,1.0,26266658
24474,amino-acid,drug,0.9995,26266658
24475,oral mucositis,disease,1.0,26266658
24476,colorectal cancer,disease,1.0,26266658
24477,colorectal cancer,disease,1.0,26266658
24478,oral mucositis,disease,1.0,26266658
24479,fluorouracil,drug,0.999,26266658
24480,Elental,drug,0.93,26266658
24481,oral mucositis,disease,0.9976,26266658
24482,bevacizumab,gene,0.7705,26266658
24483,FOLFIRI,drug,0.8135,26266658
24484,bevacizumab,gene,0.738,26266658
24485,FOLFIRI,drug,0.8003,26266658
24486,panitumumab,gene,0.933,26266658
24487,FOLFIRI,drug,0.7505,26266658
24488,XELOX,drug,0.649,26266658
24489,bevacizumab,gene,0.7437,26266658
24490,S-1,drug,0.9897,26266658
24491,cetuximab,gene,0.9053,26266658
24492,5-fluorouracil,drug,0.9995,26266658
24493,5-FU,drug,0.999,26266658
24494,fluoropyrimidine,drug,0.8164,26266658
24495,oral mucositis,disease,1.0,26266658
24496,oral mucositis,disease,1.0,26266658
24497,oral mucositis,disease,1.0,26266658
24498,Elental,drug,0.9526,26266658
24499,5-FU,drug,0.9985,26266658
24500,fluoropyrimidine,drug,0.9536,26266658
24501,oral mucositis,disease,1.0,26266658
24502,amino-acid,drug,0.9995,26266658
24503,5-FU,drug,0.997,26266658
24504,oral mucositis,disease,1.0,26266658
24505,colorectal cancer,disease,1.0,26266658
24506,C4'-O-Alkyl,drug,0.861,26261913
24507,C4,drug,0.84,26261913
24508,O,drug,0.865,26261913
24509,tetrasulfonate,drug,0.999,26261913
24510,FNIR-774,drug,0.9966,26261913
24511,FNIR,DNA,0.4922,26261913
24512,FNIR-774,drug,0.7925,26261913
24513,panitumumab,gene,0.966,26261913
24514,pan,gene,0.9067,26261913
24515,cetuximab,gene,0.957,26261913
24516,cet,gene,0.966,26261913
24517,target cells,cell_type,0.801,26261913
24518,mice,species,0.9614,26261913
24519,FNIR,DNA,0.3674,26261913
24520,FNIR-774,drug,0.8228,26261913
24521,cet,DNA,0.4797,26261913
24522,cet-IR800,DNA,0.4746,26261913
24523,mAb,gene,0.965,26261913
24524,FNIR,gene,0.663,26261913
24525,tumors,disease,1.0,26261913
24526,mAb,gene,0.9565,26261913
24527,FNIR-774,drug,0.6187,26261913
24528,FNIR,cell_line,0.44,26261913
24529,FNIR-774,drug,0.998,26261913
24530,FOLFIRI,drug,0.622,26261259
24531,Cetuximab,gene,0.69,26261259
24532,KRAS,gene,0.5737,26261259
24533,Wild,cell_line,0.5767,26261259
24534,Metastatic Colorectal Cancer,disease,1.0,26261259
24535,FOLFIRI,drug,0.7554,26261259
24536,cetuximab,gene,0.8574,26261259
24537,bevacizumab,gene,0.679,26261259
24538,KRAS,gene,0.826,26261259
24539,metastatic colorectal cancer,disease,0.9966,26261259
24540,PATIENTS,species,0.9727,26261259
24541,bevacizumab,gene,0.788,26261259
24542,cetuximab,gene,0.971,26261259
24543,panitumumab,gene,0.9233,26261259
24544,Oxaliplatin,drug,0.9995,26261259
24545,RAS,gene,0.547,26261259
24546,epidermal growth factor receptor,gene,0.9805,26261259
24547,Cetuximab,gene,0.8984,26253687
24548,Panitumumab,gene,0.6895,26253687
24549,cancer,disease,1.0,26253687
24550,tumor cells,cell_type,0.8174,26253687
24551,tumor,disease,0.9995,26253687
24552,Cetuximab,gene,0.851,26253687
24553,anti-EGFR,gene,0.998,26253687
24554,Panitumumab,gene,0.9717,26253687
24555,anti-EGFR,gene,0.9976,26253687
24556,Trastuzumab,gene,0.961,26253687
24557,anti-HER2,gene,0.9927,26253687
24558,Herceptin,gene,0.4832,26253687
24559,dianthin,drug,0.9775,26253687
24560,recombinant dianthin,gene,0.8584,26253687
24561,Dianthin,drug,0.997,26253687
24562,MCF-7 cells,cell_line,0.9487,26253687
24563,glycosylated triterpenoid,drug,0.9766,26253687
24564,SO1861,drug,0.9995,26253687
24565,SO1861,drug,0.993,26253687
24566,dianthin,drug,0.962,26253687
24567,SO1861,drug,0.999,26253687
24568,dianthin,drug,0.9995,26253687
24569,Cetuximab,gene,0.9937,26253687
24570,dianthin,drug,0.9976,26253687
24571,Panitumumab,gene,0.981,26253687
24572,dianthin,drug,0.9985,26253687
24573,Trastuzumab,gene,0.989,26253687
24574,target cells,cell_type,0.865,26253687
24575,dianthin,drug,0.9946,26253687
24576,SO1861,drug,0.998,26253687
24577,Panitumumab,gene,0.865,26250414
24578,metastatic colorectal cancer,disease,0.995,26250414
24579,metastatic colorectal cancer,disease,1.0,26250414
24580,mCRC,disease,1.0,26250414
24581,patients,species,0.9863,26250414
24582,tumor cells,cell_type,0.8794,26250414
24583,tumor,disease,0.9907,26250414
24584,mCRC,disease,0.985,26250414
24585,Panitumumab,gene,0.707,26250414
24586,human,species,0.9385,26250414
24587,EGF receptor,gene,0.9976,26250414
24588,tumor cells,cell_line,0.6475,26250414
24589,tumor cells,cell_type,0.8374,26250414
24590,tumor,disease,1.0,26250414
24591,tumor,disease,1.0,26250414
24592,patients,species,0.9683,26250414
24593,RAS,gene,0.998,26250414
24594,mCRC,disease,0.9917,26250414
24595,panitumumab,gene,0.736,26250414
24596,patients,species,0.9546,26250414
24597,mCRC,disease,0.964,26250414
24598,HER2,gene,0.9917,26243863
24599,colorectal cancer,disease,1.0,26243863
24600,Cancer,disease,0.88,26243863
24601,HER2,DNA,0.714,26243863
24602,HER2,gene,0.9937,26243863
24603,patients,species,0.95,26243863
24604,colorectal cancer,disease,1.0,26243863
24605,HER2,DNA,0.4966,26243863
24606,HER2 mutations,gene,0.975,26243863
24607,S310F,DNA,0.4873,26243863
24608,S310,mutation,,26243863
24609,L755S,DNA,0.487,26243863
24610,L755,mutation,,26243863
24611,V777L,DNA,0.552,26243863
24612,V777,mutation,,26243863
24613,V842I,DNA,0.521,26243863
24614,V842,mutation,,26243863
24615,L866,mutation,,26243863
24616,colon epithelial cells,cell_type,0.8916,26243863
24617,HER2 activating mutations,DNA,0.511,26243863
24618,HER2,gene,0.9956,26243863
24619,colorectal cancer cell lines,cell_line,0.844,26243863
24620,colorectal cancer,disease,1.0,26243863
24621,cetuximab,gene,0.696,26243863
24622,panitumumab,gene,0.651,26243863
24623,MAPK,gene,0.9453,26243863
24624,HER2 mutants,gene,0.993,26243863
24625,tyrosine,drug,0.893,26243863
24626,tyrosine kinase,gene,0.9966,26243863
24627,neratinib,drug,0.9707,26243863
24628,afatinib,drug,0.962,26243863
24629,HER2 gene,gene,0.9966,26243863
24630,cetuximab,gene,0.914,26243863
24631,"KRAS,",DNA,0.571,26243863
24632,KRAS,gene,0.988,26243863
24633,"NRAS, BRAF, and PIK3CA) wild",DNA,0.5737,26243863
24634,NRAS,gene,0.973,26243863
24635,BRAF,gene,0.987,26243863
24636,PIK3CA,gene,0.9873,26243863
24637,colorectal cancer,disease,1.0,26243863
24638,patient,species,0.981,26243863
24639,derived xenografts,cell_line,0.6895,26243863
24640,PDX,cell_line,0.923,26243863
24641,PDXs,cell_line,0.822,26243863
24642,HER2,DNA,0.7793,26243863
24643,HER2 mutations,gene,0.854,26243863
24644,HER2,gene,0.991,26243863
24645,PDXs,cell_line,0.7944,26243863
24646,HER2,gene,0.998,26243863
24647,trastuzumab,gene,0.975,26243863
24648,neratinib,drug,0.9937,26243863
24649,lapatinib,drug,0.9976,26243863
24650,tumor,disease,0.998,26243863
24651,HER2,gene,0.994,26243863
24652,trastuzumab,gene,0.9756,26243863
24653,tyrosine,drug,0.9995,26243863
24654,HER2-mutated PDXs,cell_line,0.7524,26243863
24655,HER2,gene,0.996,26243863
24656,HER2,gene,0.9966,26243863
24657,EGFR antibody,gene,0.9507,26243863
24658,colorectal cell lines,cell_line,0.9565,26243863
24659,colorectal,disease,0.9873,26243863
24660,PDXs,cell_line,0.565,26243863
24661,HER2,gene,0.9976,26243863
24662,HER2,gene,0.9966,26243863
24663,HER2,DNA,0.551,26243863
24664,HER2,gene,0.9946,26243863
24665,metastatic colorectal cancer,disease,0.976,26243863
24666,RRx-001,drug,0.764,28162292
24667,Nitric-Oxide,drug,0.999,28162292
24668,RRx-001,drug,0.901,28162292
24669,NO,drug,,28162292
24670,anticancer,disease,0.857,28162292
24671,human,species,0.974,28162292
24672,patients,species,0.9854,28162292
24673,RRx,DNA,0.463,28162292
24674,RRx-001,gene,0.7437,28162292
24675,RRx-,drug,0.9214,28162292
24676,regorafenib,drug,0.983,28162292
24677,irinotecan refractory tumors,disease,0.667,28162292
24678,irinotecan,drug,0.998,28162292
24679,Patients,species,0.952,28162292
24680,irinotecan-refractory,disease,0.6963,28162292
24681,irinotecan,drug,0.9995,28162292
24682,metastatic colorectal cancer,disease,0.874,28162292
24683,oxaliplatin,drug,1.0,28162292
24684,irinotecan,drug,0.998,28162292
24685,bevacizumab,gene,0.9146,28162292
24686,cetuximab,gene,0.928,28162292
24687,panitumumab,gene,0.956,28162292
24688,regorafenib,drug,0.902,28162292
24689,irinotecan,drug,0.9976,28162292
24690,patients,species,0.965,28162292
24691,patients,species,0.986,28162292
24692,RRx,DNA,0.4873,28162292
24693,patients,species,0.98,28162292
24694,CEA,gene,0.9683,28162292
24695,patients,species,0.9653,28162292
24696,patients,species,0.988,28162292
24697,regorafenib,drug,0.951,28162292
24698,RRx-,drug,0.964,28162292
24699,irinotecan,drug,0.9985,28162292
24700,Regorafenib,drug,0.997,28162292
24701,irinotecan,drug,0.9985,28162292
24702,RRx,drug,0.746,28162292
24703,KRAS,gene,0.9385,28162292
24704,p53,DNA,0.7837,28162292
24705,p53,gene,0.998,28162292
24706,colorectal cancer,disease,1.0,28162292
24707,RAS,gene,0.9937,26220150
24708,epidermal growth factor,gene,0.9614,26220150
24709,patients,species,0.971,26220150
24710,RAS family proteins,gene,0.9746,26220150
24711,KRAS,DNA,0.6836,26220150
24712,KRAS,gene,0.9917,26220150
24713,NRAS,gene,0.99,26220150
24714,epidermal growth factor receptor,gene,0.9795,26220150
24715,EGFR,gene,0.9966,26220150
24716,RAS genes,DNA,0.892,26220150
24717,RAS genes,gene,0.992,26220150
24718,"exons 2, 3, and 4",DNA,0.8477,26220150
24719,RAS proteins,gene,0.9893,26220150
24720,KRAS exon 2,gene,0.99,26220150
24721,codon 12/13,DNA,0.6895,26220150
24722,anti-EGFR monoclonal antibodies cetuximab,gene,0.9355,26220150
24723,panitumumab,gene,0.7705,26220150
24724,patients,species,0.934,26220150
24725,metastatic colorectal cancer,disease,1.0,26220150
24726,mCRC,disease,1.0,26220150
24727,patients,species,0.985,26220150
24728,patients,species,0.978,26220150
24729,mCRC,disease,0.995,26220150
24730,tumors,disease,1.0,26220150
24731,RAS genes,gene,0.994,26220150
24732,RAS mutationsincluding,gene,0.9697,26220150
24733,"KRAS exon 2, 3, and 4",DNA,0.914,26220150
24734,"NRAS exons 2, 3",DNA,0.9,26220150
24735,NRAS exons 2,gene,0.868,26220150
24736,patient,species,0.981,26220150
24737,EGFR,gene,0.664,26220150
24738,RAS,gene,0.998,26220150
24739,patients,species,0.988,26220150
24740,RAS,DNA,0.8633,26220150
24741,RAS,gene,0.9897,26220150
24742,patients,species,0.991,26220150
24743,anti-EGFR,gene,0.9326,26220150
24744,Rectal Cancer,disease,1.0,26197754
24745,Portal Vein Tumor Thrombosis,disease,0.9985,26197754
24746,patient,species,0.9634,26197754
24747,man,species,0.8604,26197754
24748,progressive rectal cancer,disease,0.7944,26197754
24749,tumor thrombosis,disease,0.9224,26197754
24750,subileus,disease,1.0,26197754
24751,KRAS gene,gene,0.985,26197754
24752,wild-type gene,DNA,0.7773,26197754
24753,panitumumab,gene,0.913,26197754
24754,tumor,disease,0.9663,26197754
24755,capecitabine,drug,0.999,26197754
24756,panitumumab,gene,0.8286,26197754
24757,capecitabine,drug,0.998,26197754
24758,capecitabine,drug,0.9985,26197754
24759,rectal cancer,disease,1.0,26197754
24760,portal vein tumor thrombosis,disease,0.9995,26197754
24761,panitumumab,gene,0.868,26197754
24762,Panitumumab,gene,0.821,26194457
24763,oncologic,disease,0.7583,26194457
24764,patients,species,0.9653,26194457
24765,KRAS,gene,0.9883,26189770
24766,NRAS,DNA,0.506,26189770
24767,NRAS Mutations,gene,0.831,26189770
24768,Metastatic Colorectal Carcinoma,disease,1.0,26189770
24769,metastatic colorectal cancer,disease,1.0,26189770
24770,KRAS,gene,0.991,26189770
24771,NRAS,DNA,0.7383,26189770
24772,NRAS,gene,0.996,26189770
24773,panitumumab,gene,0.808,26189770
24774,cetuximab,gene,0.7754,26189770
24775,Cancer,disease,0.998,26189770
24776,metastatic colorectal carcinoma,disease,1.0,26189770
24777,patients,species,0.9937,26189770
24778,patients,species,0.99,26189770
24779,patients,species,0.988,26189770
24780,KRAS,gene,0.981,26189770
24781,NRAS,DNA,0.8584,26189770
24782,NRAS,gene,0.991,26189770
24783,NRAS exons 3 and 4,DNA,0.8325,26189770
24784,NRAS,gene,0.9976,26189770
24785,NRAS exon 3 at c.59,DNA,0.614,26189770
24786,NRAS exon 3,gene,0.8174,26189770
24787,NRAS exon 4,gene,0.96,26189770
24788,metastatic colorectal adenocarcinomas,disease,0.9995,26189770
24789,genes,DNA,0.576,26189770
24790,RAS,gene,0.9927,26189770
24791,human,species,0.9927,26187737
24792,sperm,cell_type,0.4507,26187737
24793,Sperm,cell_type,0.51,26187737
24794,sperm,cell_type,0.7964,26187737
24795,human sperm,cell_type,0.8394,26187737
24796,human,species,0.8325,26187737
24797,sperm,cell_type,0.6484,26187737
24798,human,species,0.996,26187737
24799,sperm,cell_type,0.3792,26187737
24800,sperm-,disease,0.9155,26187737
24801,human sperm,cell_type,0.6367,26187737
24802,human,species,0.994,26187737
24803,integrins,gene,0.988,26187737
24804,fibronectins,gene,0.987,26187737
24805,epidermal growth factor receptors,gene,0.996,26187737
24806,collagens,gene,0.9814,26187737
24807,tetraspanins protein families,gene,0.8257,26187737
24808,sperm,cell_type,0.762,26187737
24809,gefitinib,drug,0.999,26187737
24810,Iressa,drug,0.9854,26187737
24811,erlotinib hydrochloride,drug,0.9946,26187737
24812,Tarceva,drug,0.9956,26187737
24813,clingitide,drug,0.608,26187737
24814,cetuximab,gene,0.901,26187737
24815,Erbitux,gene,0.7715,26187737
24816,panitumumab,gene,0.833,26187737
24817,Vectibix,drug,0.991,26187737
24818,sperm,cell_type,0.6577,26187737
24819,human,species,0.992,26187737
24820,sperm,cell_type,0.4463,26187737
24821,sperm,cell_type,0.7056,26187737
24822,papulopustular rash,disease,1.0,26187661
24823,papulopustular rash,disease,0.9995,26187661
24824,PPR,disease,1.0,26187661
24825,patients,species,0.9897,26187661
24826,patients,species,0.9697,26187661
24827,cancer,disease,1.0,26187661
24828,cetuximab,gene,0.8447,26187661
24829,panitumumab,gene,0.886,26187661
24830,patients,species,0.9937,26187661
24831,patients,species,0.988,26187661
24832,rash,disease,0.9585,26187661
24833,rash,disease,0.9614,26187661
24834,rash,disease,0.992,26187661
24835,patients,species,0.9897,26187661
24836,patients,species,0.9873,26187661
24837,erythema,disease,1.0,26187661
24838,dry skin,disease,0.999,26187661
24839,patients,species,0.9917,26187661
24840,rash,disease,0.986,26187661
24841,patients,species,0.994,26187661
24842,rash,disease,0.995,26187661
24843,Patients,species,0.9854,26187661
24844,rash,disease,0.9873,26187661
24845,patient,species,0.9897,26187661
24846,acneiform skin rashes,disease,1.0,26184500
24847,epidermal growth factor receptor,gene,0.9956,26184500
24848,EGFR,gene,0.994,26184500
24849,metastatic colorectal cancer,disease,1.0,26184500
24850,mCRC,disease,1.0,26184500
24851,EGFR,gene,0.9946,26184500
24852,rashes,disease,0.6187,26184500
24853,rash,disease,0.982,26184500
24854,Patients,species,0.9756,26184500
24855,KRAS,gene,0.995,26184500
24856,mCRC,disease,0.957,26184500
24857,cetuximab,gene,0.6123,26184500
24858,panitumumab,gene,0.6353,26184500
24859,rash,disease,1.0,26184500
24860,patients,species,0.987,26184500
24861,cetuximab,gene,0.684,26184500
24862,panitumumab,gene,0.824,26184500
24863,EGFR,gene,0.991,26184500
24864,Rash,disease,0.933,26184500
24865,patients,species,0.975,26184500
24866,patients,species,0.9604,26184500
24867,patients,species,0.98,26184500
24868,steroid,drug,0.8706,26184500
24869,EGFR,gene,0.9956,26184500
24870,rashes,disease,0.901,26184500
24871,rash,disease,0.983,26184500
24872,mCRC,disease,0.9995,26184500
24873,locally advanced colon cancer,disease,0.969,26183044
24874,patients,species,0.9824,26183044
24875,patients,species,0.981,26183044
24876,colon cancer,disease,1.0,26183044
24877,T4,disease,,26183044
24878,peritoneal nodules,disease,0.9883,26183044
24879,patients,species,0.9927,26183044
24880,oxaliplatin,drug,1.0,26183044
24881,capecitabine,drug,0.9995,26183044
24882,"KRAS, BRAF and PIK3CA genes",DNA,0.689,26183044
24883,KRAS,gene,0.9697,26183044
24884,BRAF,gene,0.9976,26183044
24885,PIK3CA genes,gene,0.99,26183044
24886,panitumumab,gene,0.721,26183044
24887,tumour,disease,0.9995,26183044
24888,tumour,disease,0.998,26183044
24889,tumour,disease,0.818,26183044
24890,enlarged,disease,0.989,26183044
24891,patients,species,0.9746,26183044
24892,patients,species,0.993,26183044
24893,tumour,disease,0.978,26183044
24894,tumour,disease,0.4814,26183044
24895,cancer,disease,1.0,26168727
24896,indocyanine green,drug,0.999,26168727
24897,anti-epidermal growth factor receptor,gene,0.99,26168727
24898,EGFR,gene,0.9683,26168727
24899,panitumumab,gene,0.959,26168727
24900,Pan,gene,0.9272,26168727
24901,indocyanine green,drug,0.9985,26168727
24902,ICG,drug,1.0,26168727
24903,Sulfo-OSu,drug,0.854,26168727
24904,Pan-EG4-ICG,drug,0.896,26168727
24905,cancer,disease,0.945,26168727
24906,Pan-EG4,gene,0.6045,26168727
24907,ICG,drug,0.997,26168727
24908,EGFR,gene,0.9927,26168727
24909,EGFR-positive cells,cell_line,0.9224,26168727
24910,EGFR,gene,0.986,26168727
24911,-positive cells,cell_type,0.6655,26168727
24912,ICG,drug,0.993,26168727
24913,A431 tumor,disease,0.9863,26168727
24914,(EGFR++)-,cell_line,0.633,26168727
24915,EGFR,gene,0.8584,26168727
24916,mice,species,0.9834,26168727
24917,ICG,drug,0.995,26168727
24918,ICG,drug,0.9966,26168727
24919,A431,cell_line,0.921,26168727
24920,tumors,disease,0.99,26168727
24921,Pan,gene,0.9917,26168727
24922,EGFR,gene,0.994,26168727
24923,ICG,drug,0.9985,26168727
24924,panitumumab,gene,0.8745,26168727
24925,tumors,disease,1.0,26168727
24926,Gastrointestinal Cancers,disease,1.0,26167556
24927,patients,species,0.96,26166616
24928,metastatic colorectal cancer,disease,0.9995,26166616
24929,patients,species,0.995,26166616
24930,patients,species,0.9688,26166616
24931,metastatic colorectal cancer,disease,1.0,26166616
24932,patients,species,0.9893,26166616
24933,diarrhea,disease,0.9985,26160607
24934,mucositis,disease,0.9995,26160607
24935,colorectal cancer,disease,1.0,26160607
24936,anti-EGFR monoclonal antibodies,gene,0.833,26160607
24937,anti-Epidermal Growth Factor Receptor monoclonal antibodies,gene,0.898,26160607
24938,anti-EGFR MoAbs,gene,0.938,26160607
24939,wild type (WT) KRAS,disease,0.7236,26160607
24940,colorectal cancer,disease,0.8047,26160607
24941,diarrhoea,disease,1.0,26160607
24942,mucositis,disease,1.0,26160607
24943,colorectal cancer,disease,1.0,26160607
24944,WT-KRAS,gene,0.9917,26160607
24945,anti-EGFR,gene,0.8022,26160607
24946,colorectal cancer,disease,1.0,26160607
24947,diarrhoea,disease,1.0,26160607
24948,mucositis,disease,1.0,26160607
24949,anti-EGFR MoAbs,gene,0.774,26160607
24950,diarrhoea,disease,1.0,26160607
24951,mucositis,disease,1.0,26160607
24952,WT-KRAS,gene,0.9683,26160607
24953,EndoS,gene,0.9927,26156869
24954,EndoS2,gene,0.9844,26156869
24955,Fc-glycans,gene,0.7646,26156869
24956,mannose,drug,0.8975,26156869
24957,endoglycosidases,gene,0.8613,26156869
24958,Streptococcus pyogenes,species,0.982,26156869
24959,EndoS,gene,0.9907,26156869
24960,EndoS2,gene,0.982,26156869
24961,N,drug,0.816,26156869
24962,human immunoglobulin G,gene,0.9946,26156869
24963,EndoS,gene,0.9956,26156869
24964,EndoS2,gene,0.988,26156869
24965,monoclonal,gene,0.774,26156869
24966,cetuximab,gene,0.891,26156869
24967,adalimumab,gene,0.808,26156869
24968,panitumumab,gene,0.8477,26156869
24969,denosumab,gene,0.616,26156869
24970,EndoS,gene,0.9956,26156869
24971,EndoS2,gene,0.988,26156869
24972,EndoS2,gene,0.9917,26156869
24973,EndoS,gene,0.996,26156869
24974,cetuximab,gene,0.934,26156869
24975,EndoS,gene,0.9946,26156869
24976,EndoS2,gene,0.992,26156869
24977,EndoS2,gene,0.9956,26156869
24978,EndoS,gene,0.99,26156869
24979,IdeS protease,gene,0.9927,26156869
24980,mannose,drug,0.999,26156869
24981,Fc fragments,gene,0.9917,26156869
24982,EndoS,gene,0.993,26156869
24983,EndoS2,gene,0.975,26156869
24984,Fc-glycosylation site,gene,0.646,26156869
24985,mannose,drug,0.9946,26156869
24986,metastatic colorectal cancer,disease,0.997,26150735
24987,panitumumab,gene,0.9014,26150735
24988,metastatic colorectal cancer,disease,1.0,26150735
24989,mCRC,disease,1.0,26150735
24990,Panitumumab,gene,0.719,26150735
24991,humanized,species,0.6167,26150735
24992,immunoglobulin G2 monoclonal antibody,gene,0.934,26150735
24993,epidermal growth factor receptor,gene,0.997,26150735
24994,EGFR,gene,0.989,26150735
24995,mCRC,disease,0.9937,26150735
24996,Kirsten rat sarcoma,disease,0.5396,26150735
24997,KRAS,gene,0.541,26150735
24998,EGFR,gene,0.7764,26150735
24999,panitumumab,gene,0.9146,26150735
25000,mCRC,disease,0.9976,26150735
25001,panitumumab,gene,0.8574,26150735
25002,mCRC,disease,0.992,26150735
25003,Epidermal growth factor receptor,gene,0.998,26149458
25004,metastatic colorectal cancer,disease,0.972,26149458
25005,cancer,disease,1.0,26149458
25006,oncogenic drivers,DNA,0.668,26149458
25007,epidermal growth factor receptor,gene,0.9985,26149458
25008,solid tumours,disease,1.0,26149458
25009,epidermal growth factor receptor,gene,0.9985,26149458
25010,epidermal growth factor receptor,gene,0.998,26149458
25011,factor receptor,gene,0.741,26149458
25012,panitumumab,gene,0.895,26149458
25013,cetuximab,gene,0.8467,26149458
25014,colorectal cancer,disease,1.0,26149458
25015,epidermal growth factor receptor,gene,0.9985,26149458
25016,STAT1,gene,0.987,26141950
25017,Cisplatin,drug,0.9985,26141950
25018,EGFR,gene,0.983,26141950
25019,HNSCC Cells,cell_line,0.788,26141950
25020,HNSCC,disease,0.9995,26141950
25021,Cisplatin,drug,0.9995,26141950
25022,solid tumors,disease,1.0,26141950
25023,head and neck squamous cell carcinoma,disease,1.0,26141950
25024,HNSCC,disease,1.0,26141950
25025,EGF receptor,gene,0.998,26141950
25026,EGFR,gene,0.9985,26141950
25027,cisplatin,drug,0.999,26141950
25028,cisplatin,drug,0.9995,26141950
25029,EGFR,gene,0.993,26141950
25030,tumor,disease,1.0,26141950
25031,STAT1,gene,0.7983,26141950
25032,serine,drug,0.9937,26141950
25033,tyrosine,drug,0.998,26141950
25034,Cisplatin,drug,0.9995,26141950
25035,p-S727-STAT1,gene,0.9307,26141950
25036,STAT1,gene,0.998,26141950
25037,cisplatin,drug,0.9995,26141950
25038,EGFR,gene,0.992,26141950
25039,p-S727-STAT1,gene,0.959,26141950
25040,p-Y701-STAT1,gene,0.9546,26141950
25041,cell lines,cell_line,0.96,26141950
25042,EGFR,gene,0.99,26141950
25043,p-Y701-STAT1,gene,0.914,26141950
25044,EGFR,gene,0.992,26141950
25045,cisplatin,drug,0.9995,26141950
25046,cell lines,cell_line,0.956,26141950
25047,p-S727-STAT1,gene,0.9194,26141950
25048,cisplatin,drug,0.9995,26141950
25049,HNSCC,disease,1.0,26141950
25050,cisplatin,drug,0.999,26141950
25051,anti-EGFR antibody panitumumab,gene,0.914,26141950
25052,p-S727-STAT1,gene,0.977,26141950
25053,cisplatin,drug,0.9995,26141950
25054,STAT1,gene,0.991,26141950
25055,EGFR,gene,0.915,26141950
25056,cisplatin,drug,0.9995,26141950
25057,STAT1,gene,0.995,26141950
25058,HNSCC,disease,0.4817,26141950
25059,STRATEGIC,DNA,0.509,26141683
25060,GERCOR,DNA,0.501,26141683
25061,wild-type,disease,0.8276,26141683
25062,wild-type RAS,gene,0.9595,26141683
25063,metastatic colorectal cancer,disease,0.9976,26141683
25064,metastatic colorectal cancer,disease,0.9995,26141683
25065,mCRC,disease,1.0,26141683
25066,fluoropyrimidine,drug,0.9995,26141683
25067,oxaliplatin,drug,1.0,26141683
25068,irinotecan,drug,0.9995,26141683
25069,bevacizumab,gene,0.8843,26141683
25070,aflibercept,gene,0.9756,26141683
25071,regorafenib,drug,0.976,26141683
25072,epidermal growth factor receptor,gene,0.9985,26141683
25073,cetuximab,gene,0.7803,26141683
25074,panitumumab,gene,0.8555,26141683
25075,STRATEGIC,DNA,0.682,26141683
25076,RAS,DNA,0.565,26141683
25077,RAS wild,gene,0.8833,26141683
25078,mCRC,disease,0.964,26141683
25079,cetuximab,gene,0.9023,26141683
25080,oxaliplatin,drug,0.9995,26141683
25081,bevacizumab,gene,0.647,26141683
25082,bevacizumab,gene,0.7188,26141683
25083,irinotecan,drug,0.9985,26141683
25084,bevacizumab,gene,0.6636,26141683
25085,anti-,gene,0.7036,26141683
25086,epidermal growth factor receptor,gene,0.9204,26141683
25087,irinotecan,drug,0.9917,26141683
25088,STRATEGIC,DNA,0.5283,26141683
25089,RAS,gene,0.5454,26141683
25090,mCRC,disease,0.967,26141683
25091,STRATEGIC,DNA,0.55,26141683
25092,STRATEGIC,DNA,0.6655,26141683
25093,metastatic,disease,0.843,26113053
25094,colorectal cancer,disease,0.8594,26113053
25095,patients,species,0.984,26113053
25096,metastatic colorectal cancer,disease,1.0,26113053
25097,mCRC,disease,1.0,26113053
25098,patient,species,0.9873,26113053
25099,tumor,disease,1.0,26113053
25100,cetuximab,gene,0.566,26113053
25101,panitumumab,gene,0.584,26113053
25102,anti-EGFR monoclonal antibody,gene,0.8486,26113053
25103,patients,species,0.964,26113053
25104,RAS wild,cell_line,0.5166,26113053
25105,RAS wild-type tumors,disease,0.991,26113053
25106,RAS,gene,0.9897,26113053
25107,bevacizumab,gene,0.882,26113053
25108,patients,species,0.864,26113053
25109,CRC,disease,0.997,26113053
25110,mCRC,disease,0.9805,26113053
25111,bevacizumab,gene,0.882,26113053
25112,patients,species,0.9785,26113053
25113,mCRC,disease,0.9976,26113053
25114,aflibercept,gene,0.9854,26113053
25115,regorafenib,drug,0.961,26113053
25116,patients,species,0.971,26113053
25117,patients,species,0.969,26113053
25118,mCRC,disease,0.948,26113053
25119,KRAS,gene,0.989,26103891
25120,NRAS,DNA,0.758,26103891
25121,NRAS,gene,0.9946,26103891
25122,tumor,disease,1.0,26103891
25123,patient,species,0.991,26103891
25124,metastatic colorectal cancer,disease,0.998,26103891
25125,anti-EGFR,gene,0.9526,26103891
25126,Cetuximab,gene,0.9707,26103891
25127,Erbitux,gene,0.7485,26103891
25128,Panitumumab,gene,0.9683,26103891
25129,Vectibix,gene,0.7646,26103891
25130,exons 2-4,DNA,0.8335,26103891
25131,RAS genes,gene,0.99,26103891
25132,KRAS,DNA,0.8545,26103891
25133,KRAS,gene,0.8,26103891
25134,NRAS,gene,0.995,26103891
25135,colorectal cancers,disease,1.0,26103891
25136,RAS genes,DNA,0.9287,26103891
25137,RAS genes,gene,0.9937,26103891
25138,patients,species,0.9946,26103891
25139,KRAS,gene,0.987,26103891
25140,NRAS,DNA,0.8257,26103891
25141,NRAS,gene,0.992,26103891
25142,metastatic colorectal cancer,disease,0.9976,26103891
25143,RAS genes,gene,0.995,26103891
25144,exon 2,DNA,0.5747,26103891
25145,"exon 3-117, 146",DNA,0.731,26103891
25146,exon 4,DNA,0.753,26103891
25147,Panitumumab,gene,0.911,26094080
25148,Pemetrexed,drug,0.9995,26094080
25149,Cisplatin,drug,0.9985,26094080
25150,Pemetrexed,drug,0.9995,26094080
25151,Cisplatin,drug,0.999,26094080
25152,Advanced-,disease,0.735,26094080
25153,KRAS,gene,0.8633,26094080
25154,panitumumab,gene,0.765,26094080
25155,antiepidermal growth factor receptor monoclonal antibody,gene,0.9595,26094080
25156,pemetrexed,drug,0.999,26094080
25157,cisplatin,drug,0.9995,26094080
25158,wild type,gene,0.75,26094080
25159,V-Ki,DNA,0.501,26094080
25160,V-Ki-ras2 Kirsten rat sarcoma viral,gene,0.8354,26094080
25161,Kirsten rat sarcoma viral,disease,0.587,26094080
25162,oncogene homolog,DNA,0.8965,26094080
25163,KRAS,gene,0.7656,26094080
25164,pemetrexed,drug,0.9995,26094080
25165,cisplatin,drug,1.0,26094080
25166,PATIENTS,species,0.94,26094080
25167,panitumumab,gene,0.6904,26094080
25168,pemetrexed,drug,0.9995,26094080
25169,cisplatin,drug,0.998,26094080
25170,pemetrexed,drug,0.9995,26094080
25171,cisplatin,drug,0.9995,26094080
25172,panitumumab,gene,0.8364,26094080
25173,pemetrexed,drug,0.9995,26094080
25174,cisplatin,drug,0.9995,26094080
25175,panitumumab,gene,0.9263,26094080
25176,cisplatin,drug,1.0,26094080
25177,pemetrexed,drug,0.9995,26094080
25178,panitumumab,gene,0.8438,26094080
25179,adenocarcinoma,disease,1.0,26094080
25180,KRAS,gene,0.8022,26094080
25181,pemetrexed,drug,0.9995,26094080
25182,cisplatin,drug,1.0,26094080
25183,anti-,gene,0.916,26088456
25184,EGFR monoclonal,gene,0.588,26088456
25185,anti-EGFR monoclonal antibodies,gene,0.8975,26088456
25186,RAS,gene,0.506,26088456
25187,metastatic colorectal cancer,disease,1.0,26088456
25188,mCRC,disease,0.999,26088456
25189,EGFR MoAbs,gene,0.6797,26088456
25190,cetuximab,gene,0.7275,26088456
25191,panitumumab,gene,0.888,26088456
25192,bevacizumab,gene,0.493,26088456
25193,RAS,DNA,0.6323,26088456
25194,RAS wild,gene,0.848,26088456
25195,RAS,gene,0.5503,26088456
25196,anti-EGFR,gene,0.837,26088456
25197,anti-EGFR,gene,0.682,26088456
25198,anti-EGFR MoAbs,gene,0.679,26088456
25199,oxaliplatin,drug,0.9995,26088456
25200,irinotecan,drug,0.9985,26088456
25201,anti-EGFR MoAb,gene,0.9067,26088456
25202,RAS,gene,0.622,26088456
25203,5-FU,drug,0.994,26088456
25204,Epidermal Growth Factor Receptor,gene,0.998,26077270
25205,Metastatic Colorectal Cancer,disease,1.0,26077270
25206,epidermal growth factor receptor,gene,0.998,26077270
25207,EGFR,gene,0.992,26077270
25208,colorectal cancer,disease,1.0,26077270
25209,CRC,disease,1.0,26077270
25210,metastatic CRC,disease,1.0,26077270
25211,mCRC,disease,1.0,26077270
25212,anti-,gene,0.869,26077270
25213,EGFR monoclonal,gene,0.663,26077270
25214,cetuximab,gene,0.4165,26077270
25215,panitumumab,gene,0.644,26077270
25216,Kirsten,RNA,0.4834,26077270
25217,Kirsten rat sarcoma viral,disease,0.96,26077270
25218,Kirsten rat sarcoma viral oncogene homolog,gene,0.5996,26077270
25219,KRAS,gene,0.99,26077270
25220,neuroblastoma,disease,0.708,26077270
25221,neuroblastoma RAS viral oncogene homolog,gene,0.7075,26077270
25222,NRAS,gene,0.994,26077270
25223,mCRC,disease,0.995,26077270
25224,mCRC,disease,0.998,26077270
25225,EGFR,gene,0.972,26077270
25226,KRAS,gene,0.4915,26077270
25227,mCRC,disease,0.9995,26077270
25228,EGFR,gene,0.871,26077270
25229,KRAS,gene,0.7275,26077270
25230,mCRC,disease,0.9976,26077270
25231,EGFR,gene,0.9873,26077270
25232,HER2,gene,0.9736,26077270
25233,MET proto-oncogene,gene,0.8955,26077270
25234,receptor tyrosine kinase,gene,0.998,26077270
25235,tyrosine,drug,0.9624,26077270
25236,MET,gene,0.994,26077270
25237,Cancer Cells,cell_type,0.8276,26075314
25238,Cancer,disease,0.9956,26075314
25239,epidermal growth factor receptor,gene,0.9966,26075314
25240,EGFR,gene,0.9966,26075314
25241,panitumumab,gene,0.7046,26075314
25242,cell lines,cell_line,0.9414,26075314
25243,wild-type Kirsten-Ras,gene,0.9966,26075314
25244,K-Ras,gene,0.9966,26075314
25245,Oncogenic K-Ras,gene,0.871,26075314
25246,EGFR,gene,0.922,26075314
25247,panitumumab,gene,0.953,26075314
25248,wild-type K-Ras,gene,0.998,26075314
25249,K,DNA,0.533,26075314
25250,K-Ras,gene,0.9985,26075314
25251,extracellular-signal-regulated kinase,gene,0.9966,26075314
25252,wild-type K-Ras,gene,0.997,26075314
25253,panitumumab,gene,0.8506,26075314
25254,panitumumab,gene,0.952,26075314
25255,cells,cell_type,0.4614,26075314
25256,K-Ras,gene,0.9976,26075314
25257,cell lines,cell_line,0.944,26075314
25258,Anti-EGFR Antibodies,gene,0.865,26071484
25259,EGF receptor,gene,0.997,26071484
25260,EGFR,gene,0.991,26071484
25261,tyrosine,drug,0.9224,26071484
25262,tyrosine kinase,gene,0.591,26071484
25263,cetuximab,gene,0.6265,26071484
25264,panitumumab,gene,0.6567,26071484
25265,patients,species,0.951,26071484
25266,head and neck,disease,0.845,26071484
25267,colorectal cancers,disease,1.0,26071484
25268,genomic,DNA,0.5454,26071484
25269,genomic abnormalities,disease,0.9995,26071484
25270,EGFR,gene,0.9907,26071484
25271,tumor,disease,1.0,26071484
25272,EGFR,gene,0.995,26071484
25273,normal tissue,cell_type,0.631,26071484
25274,EGFR,gene,0.9966,26071484
25275,acute inflammation,disease,0.9243,26071484
25276,chronic inflammation,disease,0.9946,26071484
25277,anti-EGFR antibodies,gene,0.92,26071484
25278,pruritus,disease,1.0,26070625
25279,cancer,disease,1.0,26070625
25280,patients,species,0.993,26070625
25281,Pruritus,disease,0.9995,26070625
25282,cancer,disease,1.0,26070625
25283,patients,species,0.9937,26070625
25284,patients,species,0.9844,26070625
25285,cancer,disease,1.0,26070625
25286,patients,species,0.988,26070625
25287,Non-small cell lung cancer,disease,1.0,26070625
25288,NSCLC,disease,1.0,26070625
25289,malignancies,disease,1.0,26070625
25290,pruritus,disease,0.999,26070625
25291,panitumumab,gene,0.8555,26070625
25292,gefitinib,drug,0.997,26070625
25293,erlotinib,drug,0.9985,26070625
25294,sunitinib,drug,0.9985,26070625
25295,pruritus,disease,0.9985,26070625
25296,gefitinib,drug,0.999,26070625
25297,pruritus,disease,0.9995,26070625
25298,pruritus,disease,0.9976,26070625
25299,panitumumab,gene,0.8257,26070625
25300,ipilimumab,gene,0.547,26070625
25301,pruritus,disease,0.993,26070625
25302,anti-EGFR mAbs,gene,0.979,26070625
25303,EGFR,gene,0.9883,26070625
25304,HER2,gene,0.9883,26070625
25305,cancer,disease,1.0,26070625
25306,patients,species,0.9927,26070625
25307,pruritus,disease,1.0,26070625
25308,pruritus,disease,1.0,26070625
25309,metastatic colorectal cancer,disease,0.9985,26066903
25310,EGFR,gene,0.9854,26066903
25311,vascular endothelial growth factor,gene,0.9985,26066903
25312,VEGF,gene,0.9966,26066903
25313,bevacizumab,gene,0.7046,26066903
25314,epidermal growth factor receptor,gene,0.9966,26066903
25315,EGFR,gene,0.994,26066903
25316,cetuximab,gene,0.741,26066903
25317,panitumumab,gene,0.8413,26066903
25318,RAS,gene,0.6333,26066903
25319,metastatic colorectal cancer,disease,0.9966,26066903
25320,EGFR,gene,0.9917,26066903
25321,colorectal cancer,disease,1.0,26066903
25322,cetuximab,gene,0.8813,26066903
25323,panitumumab,gene,0.928,26066903
25324,bevacizumab,gene,0.8477,26066903
25325,EGFR,gene,0.993,26066903
25326,VEGF,gene,0.9937,26066903
25327,RAS,gene,0.985,26066903
25328,EGFR,gene,0.9893,26066903
25329,VEGF,gene,0.5615,26066903
25330,EGFR,gene,0.991,26066903
25331,tumors,disease,1.0,26066903
25332,VEGF,gene,0.99,26066903
25333,tumors,disease,1.0,26066903
25334,L-Folinic,drug,0.836,26064730
25335,women,species,0.8994,26064730
25336,weight loss,disease,0.824,26064730
25337,anorexia,disease,1.0,26064730
25338,abdominal pain,disease,1.0,26064730
25339,sigmoid neoplasm,disease,1.0,26064730
25340,multiple bilobar liver metastases,disease,0.992,26064730
25341,patient,species,0.967,26064730
25342,FOLFOX,drug,0.515,26064730
25343,poorly differentiated invasive adenocarcinoma,disease,0.997,26064730
25344,K-RAS,gene,0.9985,26064730
25345,L-folinic acid,drug,0.9995,26064730
25346,5-fluorouracil,drug,0.9995,26064730
25347,5-FU,drug,0.999,26064730
25348,irinotecan,drug,0.989,26064730
25349,FOLFIRI,drug,0.991,26064730
25350,cetuximab,gene,0.5635,26064730
25351,CEA,gene,0.9854,26064730
25352,(FDG,drug,0.85,26064730
25353,cetuximab,gene,0.834,26064730
25354,lung lesions,disease,0.993,26064730
25355,pulmonary and local lymph node metastases,disease,0.859,26064730
25356,5-FU,drug,0.9985,26064730
25357,oxaliplatin,drug,0.9995,26064730
25358,FOLFOX,drug,0.995,26064730
25359,cetuximab,gene,0.653,26064730
25360,panitumumab,gene,0.6597,26064730
25361,patient,species,0.961,26064730
25362,stage IV,disease,0.995,26064730
25363,colorectal cancer,disease,0.9287,26064730
25364,5-FU,drug,0.9985,26064730
25365,CPT-11,drug,0.997,26064730
25366,EGFR,gene,0.9937,26064730
25367,LM,disease,,26064730
25368,IBC,disease,1.0,26063888
25369,Inflammatory breast cancer,disease,1.0,26063888
25370,IBC,disease,1.0,26063888
25371,invasive breast cancer,disease,1.0,26063888
25372,breast cancer,disease,1.0,26063888
25373,cancers,disease,1.0,26063888
25374,IBC,disease,0.9883,26063888
25375,IBC,disease,0.636,26063888
25376,HER2,gene,0.8896,26063888
25377,IBC,disease,0.996,26063888
25378,IBC,cell_line,0.576,26063888
25379,IBC,disease,0.958,26063888
25380,HER2,gene,0.9966,26063888
25381,trastuzumab,gene,0.964,26063888
25382,lapatinib,drug,0.994,26063888
25383,cancer,disease,0.9995,26065050
25384,patients,species,0.974,26065050
25385,patient,species,0.9883,26065050
25386,patient,species,0.9883,26065050
25387,CYP2D6,gene,0.8823,26065050
25388,tamoxifen,drug,0.9995,26065050
25389,breast cancer,disease,1.0,26065050
25390,KRAS,gene,0.983,26065050
25391,cetuximab,gene,0.877,26065050
25392,panitumumab,gene,0.8267,26065050
25393,colorectal cancer,disease,1.0,26065050
25394,BCR,gene,0.992,26065050
25395,-,DNA,0.871,26065050
25396,ABL1,gene,0.9985,26065050
25397,imatinib,drug,0.9917,26065050
25398,dasatinib,drug,0.997,26065050
25399,nilotinib,drug,0.9985,26065050
25400,chronic myeloid leukemia,disease,1.0,26065050
25401,Epidermal growth factor receptor,gene,0.9985,26059438
25402,panitumumab,gene,0.7393,26059438
25403,cetuximab,gene,0.7036,26059438
25404,gastrointestinal cancer,disease,1.0,26059438
25405,epidermal growth factor receptor,gene,0.999,26059438
25406,EGFR,gene,0.997,26059438
25407,gastrointestinal tumors,disease,1.0,26059438
25408,metastatic colorectal cancer,disease,1.0,26059438
25409,KRAS exon 2/3/4,DNA,0.8804,26059438
25410,KRAS exon 2,gene,0.8994,26059438
25411,NRAS exon 2/3/4,DNA,0.8745,26059438
25412,EGFR antibodies cetuximab,gene,0.831,26059438
25413,panitumumab,gene,0.846,26059438
25414,tumor,disease,0.678,26059438
25415,gastrointestinal cancer,disease,1.0,26059438
25416,EGFR antibodies,gene,0.9214,26059438
25417,tumor,disease,1.0,26059438
25418,EGFR exon 12,DNA,0.8574,26059438
25419,EGFR exon 12 mutation,gene,0.927,26059438
25420,tumors,disease,1.0,26059438
25421,panitumumab,gene,0.775,26059438
25422,EGFR G465R,gene,0.7925,26059438
25423,G465R,DNA,,26059438
25424,G465R,mutation,,26059438
25425,panitumumab,gene,0.974,26059438
25426,cetuximab,gene,0.979,26059438
25427,EGFR G465R-transfected Ba/F3 cells,cell_line,0.963,26059438
25428,EGFR G465R,gene,0.4663,26059438
25429,G465R,mutation,,26059438
25430,-transfected Ba/F3 cells,cell_type,0.516,26059438
25431,tumor DNA,DNA,0.4353,26059438
25432,panitumumab,gene,0.7783,26059438
25433,RAS,DNA,0.7197,26059438
25434,RAS mutations,gene,0.893,26059438
25435,panitumumab,gene,0.6655,26059438
25436,EGFR,gene,0.9917,26059438
25437,Panitumumab,gene,0.7754,26056353
25438,Gemcitabine,drug,0.999,26056353
25439,Locally Advanced Pancreatic Cancer,disease,0.999,26056353
25440,Epidermal growth factor receptor,gene,0.9976,26056353
25441,EGFR,gene,0.996,26056353
25442,gemcitabine,drug,0.9937,26056353
25443,gemcitabine,drug,0.999,26056353
25444,monoclonal EGFR antibody panitumumab,gene,0.7188,26056353
25445,panitumumab,gene,0.924,26056353
25446,gemcitabine,drug,0.9995,26056353
25447,locally advanced pancreatic cancer,disease,1.0,26056353
25448,LAPC,disease,1.0,26056353
25449,LAPC,disease,0.9995,26056353
25450,panitumumab,gene,0.8657,26056353
25451,gemcitabine,drug,0.9966,26056353
25452,gemcitabine,drug,0.9956,26056353
25453,gemcitabine,drug,0.9966,26056353
25454,panitumumab,gene,0.9263,26056353
25455,neutropenia,disease,1.0,26056353
25456,fatigue,disease,0.9976,26056353
25457,nausea,disease,0.999,26056353
25458,vomiting,disease,0.9976,26056353
25459,panitumumab,gene,0.8994,26056353
25460,gemcitabine,drug,0.999,26056353
25461,LAPC,disease,0.4788,26056353
25462,simvastatin,drug,0.9995,26053280
25463,panitumumab,gene,0.931,26053280
25464,Panitumumab,gene,0.9414,26053280
25465,patients,species,0.962,26053280
25466,metastatic or locally advanced colorectal cancer,disease,0.9995,26053280
25467,patients,species,0.9824,26053280
25468,KRAS,gene,0.9844,26053280
25469,tumour,disease,1.0,26053280
25470,Simvastatin,drug,0.9995,26053280
25471,mevalonate,drug,0.9937,26053280
25472,KRAS,DNA,0.831,26053280
25473,KRAS,gene,0.981,26053280
25474,RAS,gene,0.9956,26053280
25475,patients,species,0.981,26053280
25476,KRAS mutation,gene,0.972,26053280
25477,simvastatin,drug,0.9985,26053280
25478,panitumumab,gene,0.726,26053280
25479,tumours,disease,1.0,26053280
25480,wild-type KRAS,gene,0.9834,26053280
25481,simvastatin,drug,0.9995,26053280
25482,panitumumab,gene,0.9214,26053280
25483,colorectal,disease,0.999,26053280
25484,cancer,disease,0.9834,26053280
25485,patients,species,0.986,26053280
25486,KRAS,DNA,0.8325,26053280
25487,KRAS mutation,gene,0.9165,26053280
25488,fluoropyrimidine,drug,0.998,26053280
25489,oxaliplatin,drug,0.9995,26053280
25490,irinotecan,drug,0.9976,26053280
25491,patients,species,0.993,26053280
25492,panitumumab,gene,0.9067,26053280
25493,KRAS,gene,0.9907,26053280
25494,patients,species,0.9844,26053280
25495,patients,species,0.989,26053280
25496,KRAS,DNA,0.894,26053280
25497,KRAS,gene,0.9663,26053280
25498,patients,species,0.992,26053280
25499,mutant KRAS,gene,0.995,26053280
25500,simvastatin,drug,0.999,26053280
25501,RAS,gene,0.9966,26050230
25502,KRAS Exon 2,gene,0.887,26050230
25503,5-FU,drug,0.997,26050230
25504,metastatic colorectal cancer,disease,0.9966,26050230
25505,Epidermal growth factor receptor,gene,0.9985,26050230
25506,EGFR,gene,0.994,26050230
25507,tumors,disease,0.4363,26050230
25508,KRAS exon 2,DNA,0.7583,26050230
25509,KRAS exon 2 mutations,gene,0.972,26050230
25510,EGFR,gene,0.9873,26050230
25511,KRAS exon 2,DNA,0.7485,26050230
25512,KRAS exon 2 mutation,gene,0.961,26050230
25513,EGFR,gene,0.991,26050230
25514,RAS mutations,gene,0.959,26050230
25515,KRAS,DNA,0.68,26050230
25516,KRAS mutations,gene,0.906,26050230
25517,exons 3 and 4,DNA,0.8726,26050230
25518,NRAS,gene,0.6,26050230
25519,EGFR,gene,0.992,26050230
25520,RAS mutations,gene,0.736,26050230
25521,EGFR,gene,0.9927,26050230
25522,bevacizumab,gene,0.769,26050230
25523,EGFR,gene,0.9937,26050230
25524,RAS,gene,0.604,26050230
25525,EGFR,gene,0.9956,26050230
25526,EGFR,gene,0.991,26050230
25527,bevacizumab,gene,0.8306,26050230
25528,EGFR,gene,0.4824,26050230
25529,bevacizumab,gene,0.8247,26050230
25530,cetuximab,gene,0.8633,26050230
25531,panitumumab,gene,0.871,26050230
25532,RAS mutations,gene,0.6055,26049686
25533,metastatic colorectal cancer,disease,1.0,26049686
25534,epidermal growth factor receptor,gene,0.998,26049686
25535,metastatic colorectal cancer,disease,1.0,26049686
25536,mCRC,disease,1.0,26049686
25537,tumour wild type (WT) RAS mutation,DNA,0.549,26049686
25538,wild type,gene,0.566,26049686
25539,WT,gene,0.4954,26049686
25540,RAS,gene,0.8247,26049686
25541,exons 2/3/4,DNA,0.804,26049686
25542,KRAS,gene,0.668,26049686
25543,NRAS,gene,0.71,26049686
25544,RAS,DNA,0.717,26049686
25545,RAS mutation,gene,0.931,26049686
25546,mCRC,disease,0.9995,26049686
25547,panitumumab,gene,0.867,26049686
25548,mCRC,disease,0.9956,26049686
25549,RAS,gene,0.9966,26049686
25550,mCRC,disease,0.9976,26049686
25551,WT KRAS exon 2,gene,0.659,26049686
25552,RAS,gene,0.883,26049686
25553,RAS,gene,0.5444,26049686
25554,exons 2/3/4 KRAS,DNA,0.8784,26049686
25555,NRAS,gene,0.803,26049686
25556,mCRC,disease,0.9805,26049686
25557,RAS,DNA,0.749,26049686
25558,RAS mutation,gene,0.9565,26049686
25559,mCRC,disease,0.9937,26049686
25560,KRAS exon 2,gene,0.845,26049686
25561,KRAS exon 3,DNA,0.8667,26049686
25562,KRAS exon,gene,0.873,26049686
25563,KRAS exon 4,DNA,0.867,26049686
25564,NRAS exon 2,DNA,0.7646,26049686
25565,NRAS exon,gene,0.895,26049686
25566,NRAS exon 3,DNA,0.8716,26049686
25567,NRAS exon,gene,0.825,26049686
25568,NRAS exon 4,DNA,0.8643,26049686
25569,RAS,DNA,0.7095,26049686
25570,RAS mutation,gene,0.985,26049686
25571,RAS,DNA,0.7627,26049686
25572,RAS mutation,gene,0.9272,26049686
25573,mCRC,disease,0.999,26049686
25574,Panitumumab,gene,0.722,26045117
25575,cetuximab,gene,0.7847,26045117
25576,KRAS,gene,0.7026,26045117
25577,metastatic colorectal cancer,disease,0.998,26045117
25578,panitumumab,gene,0.811,26045117
25579,cetuximab,gene,0.954,26045117
25580,irinotecan,drug,0.998,26045117
25581,KRAS,gene,0.9966,26045117
25582,MCRC,disease,0.9985,26045117
25583,panitumumab,gene,0.617,26045117
25584,KRAS WT,gene,0.836,26045117
25585,MCRC,disease,0.9253,26045117
25586,panitumumab,gene,0.866,26045117
25587,cetuximab,gene,0.865,26045117
25588,cetuximab,gene,0.8955,26045117
25589,irinotecan,drug,0.9985,26045117
25590,oxaliplatin,drug,0.9995,26045117
25591,cetuximab,gene,0.706,26045117
25592,cetuximab,gene,0.714,26045117
25593,panitumumab,gene,0.7695,26045117
25594,cetuximab,gene,0.8115,26045117
25595,panitumumab,gene,0.8076,26045117
25596,anemia,disease,1.0,26045117
25597,neutropenia,disease,1.0,26045117
25598,thrombocytopenia,disease,0.9995,26045117
25599,dry skin,disease,0.9893,26045117
25600,rash,disease,0.9883,26045117
25601,nausea-vomiting,disease,0.995,26045117
25602,panitumumab,gene,0.82,26045117
25603,KRAS WT,gene,0.798,26045117
25604,MCRC,disease,0.9795,26045117
25605,cetuximab,gene,0.907,26045117
25606,humanized,species,0.775,26034219
25607,MEHD7945A,drug,0.8574,26034219
25608,HER3,gene,0.9937,26034219
25609,EGFR,gene,0.9834,26034219
25610,HER dimer,gene,0.989,26034219
25611,MEHD7945A,drug,0.9976,26034219
25612,Patients,species,0.9785,26034219
25613,epithelial tumors,disease,1.0,26034219
25614,MEHD7945A,drug,0.995,26034219
25615,Plasma samples,cell_type,0.4526,26034219
25616,tumor,disease,0.8804,26034219
25617,FDG,drug,0.9995,26034219
25618,EGFR,gene,0.9907,26034219
25619,HER3,gene,0.9893,26034219
25620,MEHD7945A,drug,0.9995,26034219
25621,diarrhea,disease,1.0,26034219
25622,nausea,disease,0.987,26034219
25623,patient,species,0.978,26034219
25624,patients,species,0.9663,26034219
25625,headache,disease,0.998,26034219
25626,fever,disease,0.958,26034219
25627,chills,disease,0.9263,26034219
25628,patients,species,0.987,26034219
25629,squamous cell carcinomas of head and neck,disease,1.0,26034219
25630,SCCHN,disease,1.0,26034219
25631,patients,species,0.97,26034219
25632,HER3 ligand,gene,0.9814,26034219
25633,heregulin,gene,0.971,26034219
25634,patients,species,0.987,26034219
25635,SCCHN,disease,1.0,26034219
25636,colorectal cancer,disease,1.0,26034219
25637,MEHD7945A,drug,0.999,26034219
25638,SCCHN,disease,0.9995,26034219
25639,SCCHN,disease,1.0,26034219
25640,colorectal cancer,disease,1.0,26034219
25641,EGFR,gene,0.994,26030179
25642,blood,cell_type,0.478,26030179
25643,colorectal cancer,disease,1.0,26030179
25644,Colorectal cancers,disease,1.0,26030179
25645,CRCs,disease,1.0,26030179
25646,CRC,disease,0.9995,26030179
25647,CRC,disease,1.0,26030179
25648,tumor,disease,1.0,26030179
25649,circulating tumor DNA,DNA,0.7817,26030179
25650,ctDNA,DNA,0.852,26030179
25651,colorectal tumors,disease,1.0,26030179
25652,epidermal growth factor receptor,gene,0.998,26030179
25653,EGFR,gene,0.993,26030179
25654,cetuximab,gene,0.927,26030179
25655,panitumumab,gene,0.9185,26030179
25656,ctDNA,DNA,0.6704,26030179
25657,patients,species,0.99,26030179
25658,EGFR,gene,0.9917,26030179
25659,KRAS,gene,0.958,26030179
25660,NRAS,DNA,0.844,26030179
25661,NRAS,gene,0.984,26030179
25662,MET,gene,0.992,26030179
25663,ERBB2,DNA,0.8457,26030179
25664,ERBB2,gene,0.9956,26030179
25665,FLT3,gene,0.9897,26030179
25666,EGFR,gene,0.9883,26030179
25667,MAP2K1,gene,0.9956,26030179
25668,Mutated,cell_line,0.6865,26030179
25669,KRAS,gene,0.7925,26030179
25670,EGFR,gene,0.9863,26030179
25671,EGFR-specific antibodies,gene,0.7974,26030179
25672,CRC cells,cell_line,0.9346,26030179
25673,CRC,disease,1.0,26030179
25674,cetuximab,gene,0.7954,26030179
25675,KRAS,DNA,0.5605,26030179
25676,KRAS clones,cell_line,0.6387,26030179
25677,KRAS,gene,0.996,26030179
25678,ctDNA,DNA,0.629,26030179
25679,ctDNA,RNA,0.5557,26030179
25680,anti-EGFR antibodies,gene,0.967,26030179
25681,mutant KRAS,gene,0.994,26030179
25682,CRC genome,DNA,0.8174,26030179
25683,CRC,disease,0.9873,26030179
25684,EGFR,gene,0.9883,26030179
25685,colorectal cancer,disease,1.0,26027741
25686,Colorectal cancer,disease,1.0,26027741
25687,CRC,disease,1.0,26027741
25688,malignancies,disease,1.0,26027741
25689,cancer,disease,1.0,26027741
25690,patient,species,0.9854,26027741
25691,anti-EGFR,gene,0.8633,26027741
25692,cetuximab,gene,0.8564,26027741
25693,panitumumab,gene,0.95,26027741
25694,bevacizumab,gene,0.875,26027741
25695,aflibercept,gene,0.9824,26027741
25696,regorafenib,drug,0.9473,26027741
25697,fluoropyrimidines,drug,0.9985,26027741
25698,genetic variants,DNA,0.5586,26027741
25699,CRC,disease,0.9985,26027741
25700,tumor,disease,0.819,26027741
25701,RAS,gene,0.9985,26027741
25702,RAF,gene,0.999,26027741
25703,MAPK,gene,0.9946,26027741
25704,PI3K,gene,0.994,26027741
25705,PTEN,gene,0.9956,26027741
25706,AKT,gene,0.998,26027741
25707,CRC,disease,0.999,26027741
25708,CRC,disease,0.999,26027741
25709,KRAS exon 2,gene,0.9893,26027741
25710,BRAF,gene,0.998,26027741
25711,p.V600,mutation,,26027741
25712,PI3KCA,DNA,0.636,26027741
25713,PI3KCA-,gene,0.9976,26027741
25714,-exon 9,DNA,0.5083,26027741
25715,PTEN,gene,0.9946,26027741
25716,EGFR,gene,0.747,26027741
25717,germline,DNA,0.6953,26027741
25718,ABC,gene,0.569,26027741
25719,SLC,gene,0.754,26027741
25720,CYP450,gene,0.9927,26027741
25721,GST,gene,0.995,26027741
25722,UGT,gene,0.994,26027741
25723,folate,drug,0.9995,26027741
25724,EGF,gene,0.9976,26027741
25725,VEGF,gene,0.9917,26027741
25726,tumor,disease,0.968,26027741
25727,CRC,disease,0.999,26027741
25728,patients,species,0.9883,26027741
25729,fluoropyrimidines,drug,0.998,26027741
25730,irinotecan,drug,0.9995,26027741
25731,oxaliplatin,drug,0.9995,26027741
25732,multiple host polymorphisms,DNA,0.4707,26027741
25733,tumor,disease,1.0,26027741
25734,CRC,disease,0.998,26027741
25735,CRC,disease,0.999,26027741
25736,panitumumab,gene,0.958,25999741
25737,bevacizumab,gene,0.867,25999741
25738,irinotecan,drug,0.999,25999741
25739,5-fluorouracil,drug,0.9995,25999741
25740,leucovorin,drug,0.998,25999741
25741,FOLFIRI,drug,0.9795,25999741
25742,FOLFIRI,drug,0.98,25999741
25743,metastatic colorectal cancer,disease,0.9995,25999741
25744,KRAS,DNA,0.7715,25999741
25745,KRAS mutation,gene,0.7837,25999741
25746,panitumumab,gene,0.965,25999741
25747,bevacizumab,gene,0.8325,25999741
25748,irinotecan,drug,0.9976,25999741
25749,5-fluorouracil,drug,0.9995,25999741
25750,leucovorin,drug,0.999,25999741
25751,FOLFIRI,drug,0.9316,25999741
25752,FOLFIRI,drug,0.962,25999741
25753,metastatic colorectal cancer,disease,1.0,25999741
25754,mCRC,disease,1.0,25999741
25755,V-Ki-ras2 Kirsten rat sarcoma viral oncogene,gene,0.893,25999741
25756,rat,species,0.408,25999741
25757,KRAS,gene,0.84,25999741
25758,mCRC,disease,0.9985,25999741
25759,KRAS,gene,0.797,25999741
25760,oxaliplatin,drug,0.9995,25999741
25761,panitumumab,gene,0.883,25999741
25762,bevacizumab,gene,0.672,25999741
25763,FOLFIRI,drug,0.9897,25999741
25764,FOLFIRI,drug,0.987,25999741
25765,panitumumab,gene,0.919,25999741
25766,bevacizumab,gene,0.7134,25999741
25767,FOLFIRI,drug,0.587,25999741
25768,panitumumab,gene,0.893,25999741
25769,bevacizumab,gene,0.688,25999741
25770,FOLFIRI,drug,0.774,25999741
25771,panitumumab,gene,0.9297,25999741
25772,bevacizumab,gene,0.6724,25999741
25773,FOLFIRI,drug,0.9805,25999741
25774,FOLFIRI,drug,0.9883,25999741
25775,WT KRAS,gene,0.9663,25999741
25776,panitumumab,gene,0.935,25999741
25777,bevacizumab,gene,0.729,25999741
25778,FOLFIRI,drug,0.66,25999741
25779,FOLFIRI,drug,0.9453,25999741
25780,panitumumab,gene,0.9546,25999741
25781,bevacizumab,gene,0.852,25999741
25782,FOLFIRI,drug,0.887,25999741
25783,FOLFIRI,drug,0.9404,25999741
25784,MU,cell_line,0.569,25999741
25785,KRAS,gene,0.446,25999741
25786,panitumumab,gene,0.8936,25999741
25787,bevacizumab,gene,0.4907,25999741
25788,FOLFIRI,drug,0.8096,25999741
25789,FOLFIRI,drug,0.882,25999741
25790,panitumumab,gene,0.945,25999741
25791,bevacizumab,gene,0.777,25999741
25792,FOLFIRI,drug,0.7183,25999741
25793,FOLFIRI,drug,0.9937,25999741
25794,panitumumab,gene,0.9404,25999741
25795,bevacizumab,gene,0.7944,25999741
25796,FOLFIRI,drug,0.891,25999741
25797,mCRC,disease,0.992,25999741
25798,panitumumab,gene,0.9233,25999741
25799,bevacizumab,gene,0.646,25999741
25800,FOLFIRI,drug,0.9814,25999741
25801,KRAS,gene,0.8374,25999741
25802,EGFR,gene,0.956,25993166
25803,Colorectal Cancer,disease,1.0,25993166
25804,epidermal growth factor receptor,gene,0.887,25993166
25805,EGFR,gene,0.9966,25993166
25806,colorectal cancer,disease,1.0,25993166
25807,CRC,disease,1.0,25993166
25808,RAS genes,gene,0.8823,25993166
25809,"KRAS/NRAS exons 2, 3, or 4",DNA,0.7544,25993166
25810,KRAS,gene,0.916,25993166
25811,NRAS,gene,0.985,25993166
25812,anti-EGFR monoclonal antibodies,gene,0.9507,25993166
25813,mitogen-activated protein kinase,gene,0.997,25993166
25814,MAPK,gene,0.997,25993166
25815,phosphoinositide 3-kinase,gene,0.9985,25993166
25816,PI3K,gene,0.995,25993166
25817,EGFR,gene,0.991,25993166
25818,BRAF,gene,0.586,25993166
25819,PIK3CA,gene,0.9897,25993166
25820,KRAS,gene,0.624,25993166
25821,ERBB2,gene,0.4849,25993166
25822,MET,gene,0.9883,25993166
25823,cetuximab,gene,0.8203,25993166
25824,panitumumab,gene,0.7783,25993166
25825,EGFR extracellular domain,gene,0.616,25993166
25826,receptor tyrosine kinases,gene,0.9956,25993166
25827,tyrosine,drug,0.759,25993166
25828,HER3,gene,0.7075,25993166
25829,MET,gene,0.995,25993166
25830,amphiregulin,gene,0.99,25993166
25831,transforming growth factor alpha,gene,0.9966,25993166
25832,heregulin,gene,0.943,25993166
25833,hepatocyte growth factor,gene,0.996,25993166
25834,tumor,disease,0.9956,25993166
25835,gene expression,DNA,0.652,25993166
25836,EGFR,gene,0.9917,25993166
25837,CRC,disease,0.488,25993166
25838,EGFR,gene,0.8853,25993166
25839,anti-EGFR,gene,0.979,25993166
25840,EGFR,gene,0.992,25993166
25841,tumor,disease,1.0,25993166
25842,Panitumumab,gene,0.888,25982297
25843,FOLFIRI,drug,0.992,25982297
25844,Bevacizumab,gene,0.7227,25982297
25845,FOLFIRI,drug,0.9917,25982297
25846,Wild Type KRAS,gene,0.569,25982297
25847,Metastatic Colorectal Cancer,disease,1.0,25982297
25848,anti-,gene,0.8555,25982297
25849,epidermal growth factor receptor,gene,0.907,25982297
25850,anti-,gene,0.8867,25982297
25851,vascular endothelial growth factor antibodies,gene,0.917,25982297
25852,wild type Kirsten,gene,0.801,25982297
25853,Kirsten,DNA,0.4805,25982297
25854,rat sarcoma viral oncogene homolog,gene,0.8564,25982297
25855,rat,species,0.9595,25982297
25856,KRAS,gene,0.793,25982297
25857,metastatic colorectal cancer,disease,1.0,25982297
25858,mCRC,disease,1.0,25982297
25859,mCRC,disease,0.996,25982297
25860,FOLFIRI,drug,0.901,25982297
25861,irinotecan,drug,0.9995,25982297
25862,5-fluorouracil,drug,0.9995,25982297
25863,leucovorin,drug,0.9985,25982297
25864,panitumumab,gene,0.9443,25982297
25865,bevacizumab,gene,0.744,25982297
25866,oxaliplatin,drug,0.9995,25982297
25867,PATIENTS,species,0.9346,25982297
25868,panitumumab,gene,0.854,25982297
25869,panitumumab,gene,0.9165,25982297
25870,bevacizumab,gene,0.909,25982297
25871,panitumumab,gene,0.914,25982297
25872,bevacizumab,gene,0.901,25982297
25873,panitumumab,gene,0.911,25982297
25874,bevacizumab,gene,0.925,25982297
25875,Skin disorders,disease,1.0,25982297
25876,diarrhea,disease,1.0,25982297
25877,hypomagnesemia,disease,1.0,25982297
25878,hypokalemia,disease,1.0,25982297
25879,dehydration,disease,1.0,25982297
25880,hypotension,disease,1.0,25982297
25881,panitumumab,gene,0.926,25982297
25882,Neutropenia,disease,0.9995,25982297
25883,bevacizumab,gene,0.9043,25982297
25884,Panitumumab,gene,0.8594,25982297
25885,bevacizumab,gene,0.8296,25982297
25886,FOLFIRI,drug,0.9404,25982297
25887,oxaliplatin,drug,1.0,25982297
25888,bevacizumab,gene,0.864,25982297
25889,BRAF-mutant colorectal tumors,cell_line,0.7007,25975986
25890,BRAF,gene,0.431,25975986
25891,colorectal tumors,disease,0.84,25975986
25892,colorectal cancer,disease,1.0,25975986
25893,BRAF-mutant,cell_line,0.5986,25975986
25894,BRAF-mutant tumor,disease,0.8447,25975986
25895,BRAF,gene,0.627,25975986
25896,BRAF-mutant colorectal cancer,disease,0.5903,25975986
25897,BRAF,gene,0.933,25975986
25898,anti-EGFR monoclonal antibodies,gene,0.8657,25975986
25899,BRAF,gene,0.9976,25975986
25900,BRAF,gene,0.66,25975986
25901,colorectal tumors,disease,1.0,25975986
25902,BRAF,gene,0.812,25975986
25903,colorectal tumors,disease,1.0,25975986
25904,BRAF,gene,0.977,25975986
25905,KRAS,gene,0.968,25975014
25906,metastatic colon carcinoma,disease,0.998,25975014
25907,anti-epidermal growth factor receptor antibody,gene,0.9536,25975014
25908,cetuximab,gene,0.911,25975014
25909,panitumumab,gene,0.9478,25975014
25910,KRAS,DNA,0.468,25975014
25911,KRAS-mutant tumors,disease,0.993,25975014
25912,KRAS,gene,0.98,25975014
25913,KRAS,DNA,0.826,25975014
25914,KRAS mutation,gene,0.8447,25975014
25915,cetuximab,gene,0.942,25975014
25916,panitumumab,gene,0.9097,25975014
25917,KRAS,DNA,0.8594,25975014
25918,KRAS mutation,gene,0.9556,25975014
25919,patients,species,0.965,25975014
25920,metastatic colorectal cancer,disease,1.0,25975014
25921,KRAS,DNA,0.857,25975014
25922,KRAS mutations,gene,0.935,25975014
25923,KRAS,gene,0.892,25975014
25924,panitumumab,gene,0.8438,25967287
25925,interstitial lung disease,disease,0.845,25967287
25926,ILD,disease,1.0,25967287
25927,Panitumumab,gene,0.8755,25967287
25928,ILD,disease,1.0,25967287
25929,panitumumab,gene,0.8716,25967287
25930,ILD,disease,0.9688,25967287
25931,ILD,disease,1.0,25967287
25932,colorectal cancer,disease,0.992,25967287
25933,patients,species,0.9854,25967287
25934,panitumumab,gene,0.838,25967287
25935,ILD,disease,1.0,25967287
25936,ILD,disease,1.0,25967287
25937,patients,species,0.991,25967287
25938,EGFR,gene,0.997,25967287
25939,panitumumab,gene,0.8853,25967287
25940,ILD,disease,1.0,25967287
25941,panitumumab,gene,0.7505,25967287
25942,ILD,disease,1.0,25967287
25943,alveolar damage,disease,0.6963,25967287
25944,EGFR,gene,0.96,25967287
25945,ILD,disease,1.0,25967287
25946,ILD,disease,1.0,25967287
25947,Panitumumab,gene,0.869,25967287
25948,ILD,disease,0.9956,25967287
25949,panitumumab,gene,0.9463,25963019
25950,patients,species,0.9697,25963019
25951,wild,DNA,0.689,25963019
25952,wild-type KRAS,gene,0.9375,25963019
25953,patients,species,0.9688,25963019
25954,metastatic colorectal cancer,disease,1.0,25963019
25955,mCRC,disease,1.0,25963019
25956,anti-,gene,0.8804,25963019
25957,epidermal growth factor,DNA,0.517,25963019
25958,epidermal growth factor receptor,gene,0.8926,25963019
25959,EGFR,gene,0.9917,25963019
25960,patients,species,0.9883,25963019
25961,PATIENTS,species,0.965,25963019
25962,patients,species,0.9487,25963019
25963,wild,gene,0.5254,25963019
25964,KRAS,gene,0.842,25963019
25965,exon 2,DNA,0.7227,25963019
25966,exon 2,gene,0.7393,25963019
25967,mCRC,disease,0.9956,25963019
25968,frailty,disease,0.779,25963019
25969,Patients,species,0.959,25963019
25970,panitumumab,gene,0.683,25963019
25971,patients,species,0.991,25963019
25972,KPC,disease,0.9976,25963019
25973,panitumumab,gene,0.915,25963019
25974,rash acneiform,disease,1.0,25963019
25975,RAS,gene,0.996,25963019
25976,WT RAS,gene,0.9814,25963019
25977,"WT exons 2, 3, and 4",DNA,0.8535,25963019
25978,KRAS,gene,0.973,25963019
25979,NRAS,DNA,0.779,25963019
25980,NRAS,gene,0.9927,25963019
25981,panitumumab,gene,0.9434,25963019
25982,patients,species,0.9673,25963019
25983,WT,cell_line,,25963019
25984,WT RAS tumours,disease,0.9556,25963019
25985,WT RAS,gene,0.9595,25963019
25986,Anti-EGFR Antibody,gene,0.971,25962717
25987,Tumor,disease,1.0,25962717
25988,EGFR,gene,0.989,25962717
25989,EGFR,gene,0.9927,25962717
25990,EGFR epitopes,gene,0.955,25962717
25991,Sym004,drug,0.938,25962717
25992,EGFR,gene,0.99,25962717
25993,skin toxicity,disease,0.9556,25962717
25994,hypomagnesemia,disease,1.0,25962717
25995,patients,species,0.941,25962717
25996,metastatic colorectal cancer,disease,1.0,25962717
25997,EGFR,gene,0.994,25962717
25998,patients,species,0.9893,25962717
25999,patients,species,0.989,25962717
26000,Sym004,drug,0.938,25962717
26001,EGFR,gene,0.985,25962717
26002,MET gene,gene,0.9883,25962717
26003,patient,species,0.9604,25962717
26004,Sym004,drug,0.924,25962717
26005,patient,species,0.9614,25962717
26006,EGFR(S492R) mutation,gene,0.873,25962717
26007,S492,mutation,,25962717
26008,cetuximab,gene,0.9424,25962717
26009,EGFR,gene,0.994,25962717
26010,patients,species,0.9707,25962717
26011,metastatic colorectal cancer,disease,1.0,25962717
26012,cetuximab,gene,0.9487,25962717
26013,panitumumab,gene,0.966,25962717
26014,tumors,disease,1.0,25962717
26015,EGFR,gene,0.994,25962717
26016,RAS,DNA,0.5254,25962717
26017,RAS,gene,0.994,25962717
26018,EGFR,gene,0.998,25962717
26019,tumour,disease,0.9985,25956209
26020,patients,species,0.9766,25956209
26021,Tumour,disease,0.98,25956209
26022,metastatic colorectal cancer,disease,1.0,25956209
26023,mCRC,disease,1.0,25956209
26024,tumour,disease,1.0,25956209
26025,patients,species,0.9897,25956209
26026,RAS wild-type (WT) tumours,disease,0.9985,25956209
26027,RAS,gene,0.986,25956209
26028,KRAS,gene,0.99,25956209
26029,/NRAS exons 2/3/4,DNA,0.781,25956209
26030,NRAS,gene,0.9956,25956209
26031,panitumumab,gene,0.928,25956209
26032,FOLFOX4,drug,0.8926,25956209
26033,FOLFOX4,drug,0.6494,25956209
26034,mCRC,disease,0.9043,25956209
26035,patients,species,0.9844,25956209
26036,Tumour,disease,0.989,25956209
26037,patients,species,0.9717,25956209
26038,RAS,DNA,0.7524,25956209
26039,RAS WT,gene,0.9976,25956209
26040,mCRC,disease,0.999,25956209
26041,patients,species,0.9873,25956209
26042,panitumumab,gene,0.9146,25956209
26043,FOLFOX4,drug,0.8945,25956209
26044,panitumumab,gene,0.9385,25956209
26045,FOLFOX4,drug,0.7925,25956209
26046,patients,species,0.963,25956209
26047,patients,species,0.963,25956209
26048,patients,species,0.965,25956209
26049,panitumumab,gene,0.9004,25956209
26050,FOLFOX4,drug,0.8457,25956209
26051,panitumumab,gene,0.837,25956209
26052,FOLFOX4,drug,0.983,25956209
26053,mCRC,disease,0.998,25956209
26054,RAS,gene,0.949,25944693
26055,metastatic colorectal cancer,disease,1.0,25944693
26056,EGFR,gene,0.6895,25944693
26057,metastatic colorectal cancer,disease,1.0,25944693
26058,mCRC,disease,1.0,25944693
26059,wild-type RAS gene,DNA,0.8867,25944693
26060,RAS mutation,gene,0.9805,25944693
26061,RAS,DNA,0.878,25944693
26062,RAS,gene,0.9414,25944693
26063,tumor DNA,DNA,0.783,25944693
26064,tumor,RNA,0.4727,25944693
26065,CRC,disease,1.0,25944693
26066,next generation sequencing panel,DNA,0.576,25944693
26067,CRC,disease,1.0,25944693
26068,KRAS,gene,0.982,25944693
26069,NRAS,DNA,0.787,25944693
26070,NRAS,gene,0.9834,25944693
26071,BRAF,gene,0.995,25944693
26072,RAS,DNA,0.8096,25944693
26073,RAS,gene,0.9976,25944693
26074,BRAF,gene,0.992,25944693
26075,hotspot regions,DNA,0.8105,25944693
26076,RAS,gene,0.997,25944693
26077,BRAF,DNA,0.813,25944693
26078,BRAF mutations,gene,0.9116,25944693
26079,RAS,DNA,0.4976,25944693
26080,BRAF,gene,0.9834,25944693
26081,RAS,DNA,0.7163,25944693
26082,RAS,gene,0.994,25944693
26083,BRAF mutations,gene,0.969,25944693
26084,colorectal cancer,disease,1.0,25943574
26085,patients,species,0.9907,25943574
26086,Colorectal cancer,disease,1.0,25943574
26087,patients,species,0.991,25943574
26088,CAIRO5,DNA,0.5767,25943574
26089,Colorectal cancer,disease,1.0,25943574
26090,patients,species,0.9927,25943574
26091,liver,disease,0.6333,25943574
26092,Tumours,disease,1.0,25943574
26093,patients,species,0.989,25943574
26094,RAS,DNA,0.669,25943574
26095,RAS mutation,gene,0.7476,25943574
26096,Patients,species,0.89,25943574
26097,RAS wild type tumours,cell_line,0.557,25943574
26098,RAS,disease,0.9507,25943574
26099,bevacizumab,gene,0.8096,25943574
26100,panitumumab,gene,0.9062,25943574
26101,patients,species,0.967,25943574
26102,RAS,DNA,0.4895,25943574
26103,RAS mutant tumours,disease,0.986,25943574
26104,RAS,gene,0.9893,25943574
26105,patients,species,0.9746,25943574
26106,colorectal cancer metastases,disease,0.971,25943574
26107,CAIRO 5,DNA,0.5757,25943574
26108,CAIRO,drug,0.6543,25943574
26109,CAIRO 5,DNA,0.4988,25943574
26110,CAIRO,drug,0.968,25943574
26111,KRAS,gene,0.9927,25936694
26112,BRAF,gene,0.998,25936694
26113,colon cancer,disease,1.0,25936694
26114,colon cancer,disease,1.0,25936694
26115,patients,species,0.9883,25936694
26116,KRAS,gene,0.99,25936694
26117,BRAF,DNA,0.7095,25936694
26118,BRAF mutations,gene,0.892,25936694
26119,epidermal growth factor receptor,gene,0.998,25936694
26120,EGFR,gene,0.9966,25936694
26121,antiEGFR antibodies,gene,0.9585,25936694
26122,cetuximab,gene,0.88,25936694
26123,panitumumab,gene,0.8877,25936694
26124,KRAS codon 13,DNA,0.6753,25936694
26125,KRAS codon 13 mutation,gene,0.901,25936694
26126,p.G13D,mutation,,25936694
26127,anti-EGFR antibodies,gene,0.963,25936694
26128,KRAS mutations,gene,0.987,25936694
26129,KRAS codon 12/13,DNA,0.6846,25936694
26130,KRAS codon,gene,0.971,25936694
26131,p.G13D,mutation,,25936694
26132,BRAF,DNA,0.5938,25936694
26133,BRAF mutation,gene,0.8296,25936694
26134,colon cancer,disease,1.0,25936694
26135,patients,species,0.988,25936694
26136,KRAS,gene,0.991,25936694
26137,BRAF,gene,0.9956,25936694
26138,KRAS mutation,gene,0.9844,25936694
26139,BRAF,gene,0.9917,25936694
26140,KRAS,DNA,0.689,25936694
26141,KRAS,gene,0.9805,25936694
26142,BRAF,gene,0.9976,25936694
26143,paclitaxel,drug,0.997,25928118
26144,carboplatin,drug,0.9985,25928118
26145,Women,species,0.7393,25928118
26146,metastatic triple negative breast cancer,disease,0.966,25928118
26147,TNBC,disease,1.0,25928118
26148,epidermal growth factor receptor,gene,0.998,25928118
26149,panitumumab,gene,0.608,25928118
26150,women,species,0.6597,25928118
26151,TNBC,disease,0.945,25928118
26152,paclitaxel,drug,0.998,25928118
26153,carboplatin,drug,0.9985,25928118
26154,panitumumab,gene,0.7593,25928118
26155,patients,species,0.9644,25928118
26156,TNBC,disease,0.997,25928118
26157,women,species,0.9478,25928118
26158,Hematologic,disease,0.8447,25928118
26159,neutropenia,disease,1.0,25928118
26160,thrombocytopenia,disease,1.0,25928118
26161,patients,species,0.9814,25928118
26162,tumors,disease,1.0,25928118
26163,basal-like subtype,cell_line,0.515,25928118
26164,carboplatin,drug,0.9995,25928118
26165,paclitaxel,drug,0.999,25928118
26166,panitumumab,gene,0.6353,25928118
26167,TNBC,disease,0.89,25928118
26168,cancer,disease,0.9995,25922090
26169,vascular endothelial growth factor,gene,0.8755,25922090
26170,VEGF,gene,0.998,25922090
26171,aflibercept,gene,0.99,25922090
26172,VEGF trap,gene,0.9316,25922090
26173,anti-VEGF receptor,gene,0.988,25922090
26174,VEGFR,gene,0.994,25922090
26175,tyrosine,drug,0.9507,25922090
26176,tyrosine kinase,gene,0.8887,25922090
26177,hypertension,disease,1.0,25922090
26178,proteinuria,disease,1.0,25922090
26179,human epidermal growth factor receptor,gene,0.9985,25922090
26180,human,species,0.7515,25922090
26181,HER,gene,0.99,25922090
26182,cetuximab,gene,0.6133,25922090
26183,panitumumab,gene,0.7153,25922090
26184,hypomagnesemia,disease,1.0,25922090
26185,hypokalemia,disease,1.0,25922090
26186,renal,cell_type,0.4731,25922090
26187,Cetuximab,gene,0.883,25922090
26188,renal tubular acidosis,disease,1.0,25922090
26189,imatinib,drug,0.9985,25922090
26190,dasatinib,drug,0.9966,25922090
26191,renal failure,disease,0.8657,25922090
26192,Rituximab,gene,0.694,25922090
26193,anti-CD20 monoclonal antibody,gene,0.9697,25922090
26194,acute,disease,0.7935,25922090
26195,renal failure,disease,0.767,25922090
26196,acute,disease,0.9663,25922090
26197,tumor lysis syndrome,disease,0.8804,25922090
26198,Everolimus,drug,0.999,25922090
26199,mammalian target,DNA,0.545,25922090
26200,mammalian target of rapamycin,gene,0.978,25922090
26201,rapamycin,drug,0.995,25922090
26202,mTOR,gene,0.999,25922090
26203,proteinuria,disease,1.0,25922090
26204,renal disease,disease,1.0,25922090
26205,locally advanced colon cancer,disease,0.986,25920359
26206,tumors,disease,1.0,25920359
26207,colon cancer,disease,1.0,25920359
26208,patients,species,0.986,25920359
26209,Patients,species,0.916,25920359
26210,colon cancer,disease,1.0,25920359
26211,adenocarcinoma,disease,1.0,25920359
26212,T4,cell_line,,25920359
26213,T4 tumor,disease,0.755,25920359
26214,Patients,species,0.906,25920359
26215,KRAS,gene,0.923,25920359
26216,BRAF,gene,0.9946,25920359
26217,PIK3CA,gene,0.993,25920359
26218,capecitabine,drug,0.998,25920359
26219,oxaliplatin,drug,0.9995,25920359
26220,patients,species,0.9907,25920359
26221,panitumumab,gene,0.709,25920359
26222,patients,species,0.9893,25920359
26223,patients,species,0.9883,25920359
26224,panitumumab,gene,0.9326,25920359
26225,Patients,species,0.9683,25920359
26226,patients,species,0.9946,25920359
26227,patients,species,0.9946,25920359
26228,patients,species,0.9917,25920359
26229,patients,species,0.991,25920359
26230,patients,species,0.99,25920359
26231,colon cancer,disease,1.0,25920359
26232,patients,species,0.979,25920359
26233,Endothelial growth factor receptor,gene,0.9976,25900280
26234,metastatic cancer of the head and neck,disease,0.9995,25900280
26235,squamous cell carcinoma of the head and neck,disease,1.0,25900280
26236,SCCHN,disease,1.0,25900280
26237,epidermal growth factor receptor,gene,0.998,25900280
26238,EGFR,gene,0.993,25900280
26239,EGFR,gene,0.9927,25900280
26240,anti-EGFR monoclonal antibodies,gene,0.9814,25900280
26241,EGFR tyrosine kinase,gene,0.844,25900280
26242,tyrosine,drug,0.986,25900280
26243,cetuximab,gene,0.8535,25900280
26244,EGFR,gene,0.9907,25900280
26245,SCCHN,disease,0.9375,25900280
26246,EGFR,gene,0.997,25899161
26247,panitumumab,gene,0.9683,25899161
26248,cetuximab,gene,0.948,25899161
26249,tumor,disease,1.0,25899161
26250,epidermal growth factor receptor,gene,0.9985,25899161
26251,EGFR,gene,0.99,25899161
26252,solid tumors,disease,1.0,25899161
26253,EGFR,gene,0.995,25899161
26254,cetuximab,gene,0.7866,25899161
26255,panitumumab,gene,0.837,25899161
26256,colorectal and head and neck cancer,disease,1.0,25899161
26257,single-chain fragment variable,gene,0.955,25899161
26258,scFv,gene,0.534,25899161
26259,cancer,disease,0.9985,25899161
26260,scFv,gene,0.9653,25899161
26261,EGFR,gene,0.994,25899161
26262,Pseudomonas exotoxin A,gene,0.976,25899161
26263,Pseudomonas,species,0.874,25899161
26264,ETA',gene,0.988,25899161
26265,solid tumor,disease,1.0,25899161
26266,rhabdomyosarcoma,disease,1.0,25899161
26267,"breast, prostate and pancreatic cancer",disease,1.0,25899161
26268,ITs,gene,0.515,25899161
26269,scFv2112,gene,0.9556,25899161
26270,ETA',gene,0.9497,25899161
26271,cetuximab,gene,0.9307,25899161
26272,scFv1711,gene,0.992,25899161
26273,ETA',gene,0.9585,25899161
26274,panitumumab,gene,0.916,25899161
26275,scFv,gene,0.9883,25899161
26276,ITs,drug,0.5103,25899161
26277,rhabdomyosarcoma,disease,1.0,25899161
26278,prostate and breast cancer,disease,1.0,25899161
26279,formalin,drug,0.7417,25899161
26280,target cells,cell_type,0.8633,25899161
26281,EGFR,gene,0.9893,25899161
26282,EGFR,gene,0.9863,25899161
26283,EGFR,gene,0.9937,25899161
26284,ETA,DNA,0.5176,25899161
26285,solid tumors,disease,1.0,25899161
26286,Panitumumab,gene,0.697,25895463
26287,Metastatic Colorectal Cancer,disease,1.0,25895463
26288,RAS,gene,0.543,25895463
26289,metastatic colorectal cancer,disease,1.0,25895463
26290,mCRC,disease,1.0,25895463
26291,epidermal growth factor,gene,0.9985,25895463
26292,EGFR,gene,0.996,25895463
26293,panitumumab,gene,0.895,25895463
26294,cetuximab,gene,0.826,25895463
26295,mCRC,disease,0.995,25895463
26296,EGFR,gene,0.9966,25895463
26297,KRAS exon 2,gene,0.526,25895463
26298,tumours,disease,0.4766,25895463
26299,KRAS,gene,0.823,25895463
26300,"NRAS exons 2, 3 and 4",gene,0.858,25895463
26301,RAS WT,gene,0.7515,25895463
26302,panitumumab,gene,0.717,25895463
26303,mCRC,disease,0.998,25895463
26304,RAS,gene,0.769,25895463
26305,Panitumumab,gene,0.8784,25895463
26306,RAS,DNA,0.5454,25895463
26307,epidermal growth factor receptor monoclonal antibodies,gene,0.8403,25892888
26308,metastatic colorectal cancer,disease,0.9995,25892888
26309,Kirsten rat sarcoma viral oncogene homolog,gene,0.784,25892888
26310,KRAS,gene,0.7695,25892888
26311,epidermal growth factor receptor,gene,0.974,25892888
26312,EGFR,gene,0.991,25892888
26313,metastatic colorectal cancer,disease,1.0,25892888
26314,mCRC,disease,1.0,25892888
26315,KRAS,DNA,0.8193,25892888
26316,KRAS mutation,gene,0.888,25892888
26317,mCRC,disease,0.9927,25892888
26318,anti-EGFR,gene,0.8125,25892888
26319,KRAS,gene,0.838,25892888
26320,wild,DNA,0.545,25892888
26321,wild-type KRAS,gene,0.9443,25892888
26322,Wild,gene,0.7144,25892888
26323,mCRC,disease,0.9927,25892888
26324,oxaliplatin,drug,0.9995,25892888
26325,mCRC,disease,0.9873,25892888
26326,anti-EGFR MoAbs,gene,0.9346,25892888
26327,fluorouracil,drug,0.9976,25892888
26328,anti-EGFR,gene,0.768,25892888
26329,wild,gene,0.519,25892888
26330,KRAS,gene,0.6787,25892888
26331,anti-,gene,0.8315,25892888
26332,EGFR MoAb,gene,0.548,25892888
26333,mCRC,disease,0.991,25892888
26334,cancer,disease,1.0,25879583
26335,cetuximab,gene,0.99,25879583
26336,panitumumab,gene,0.9546,25879583
26337,rituximab,gene,0.985,25879583
26338,Cetuximab,gene,0.9336,25879583
26339,EGFR-expressing H1975 tumor xenografts,cell_line,0.895,25879583
26340,EGFR,gene,0.993,25879583
26341,panitumumab,gene,0.818,25879583
26342,tumor,disease,1.0,25879583
26343,mouse,species,0.9824,25879583
26344,tumors,disease,1.0,25879583
26345,tumor,disease,1.0,25879583
26346,cetuximab,gene,0.9775,25879583
26347,VEGF,gene,0.594,25878330
26348,EGFR,gene,0.9966,25878330
26349,mTOR,gene,0.98,25878330
26350,anticancer,disease,0.9897,25878330
26351,tumor,disease,1.0,25878330
26352,peripheral blood mononuclear cells,cell_type,0.9106,25878330
26353,tumor,disease,1.0,25878330
26354,tumor,disease,1.0,25878330
26355,wound,disease,0.939,25878330
26356,granulation tissue,cell_type,0.5337,25878330
26357,bevacizumab,gene,0.778,25878330
26358,everolimus,drug,0.998,25878330
26359,erlotinib,drug,0.9976,25878330
26360,panitumumab,gene,0.838,25878330
26361,VEGFR2,gene,0.9966,25878330
26362,S6RP,gene,0.9956,25878330
26363,EGFR,gene,0.9785,25878330
26364,VEGF,gene,0.996,25878330
26365,VEGFR2,gene,0.979,25878330
26366,patients,species,0.975,25878330
26367,bevacizumab,gene,0.814,25878330
26368,everolimus,drug,0.998,25878330
26369,mTOR,gene,0.9976,25878330
26370,S6RP,gene,0.993,25878330
26371,patients,species,0.9873,25878330
26372,everolimus,drug,0.9956,25878330
26373,EGFR,gene,0.9927,25878330
26374,EGFR,gene,0.9873,25878330
26375,patients,species,0.966,25878330
26376,panitumumab,gene,0.903,25878330
26377,patients,species,0.982,25878330
26378,erlotinib,drug,0.9863,25878330
26379,MAGE,DNA,0.6533,25872923
26380,MAGE-A,gene,0.994,25872923
26381,head and neck cancer,disease,1.0,25872923
26382,head and neck squamous cell carcinoma,disease,1.0,25872923
26383,HNSCC,disease,1.0,25872923
26384,head and neck cancer,disease,1.0,25872923
26385,fetal keratinocytes,cell_type,0.8667,25872923
26386,melanoma-associated antigens-A,gene,0.992,25872923
26387,MAGE-A,gene,0.995,25872923
26388,malignancies,disease,1.0,25872923
26389,human squamous cell carcinoma cell lines,cell_line,0.9565,25872923
26390,human,species,0.98,25872923
26391,squamous cell carcinoma,disease,0.976,25872923
26392,cisplatin,drug,1.0,25872923
26393,5-fluorouracil,drug,0.9995,25872923
26394,paclitaxel,drug,0.9995,25872923
26395,docetaxel,drug,0.9995,25872923
26396,cetuximab,gene,0.638,25872923
26397,panitumumab,gene,0.5996,25872923
26398,MAGE-A subgroups,gene,0.9746,25872923
26399,MAGE-A1,gene,0.9985,25872923
26400,MAGE-A12,gene,0.9985,25872923
26401,pseudogene MAGE-A7,gene,0.92,25872923
26402,cell line,cell_line,0.919,25872923
26403,MAGE-A antigens,gene,0.991,25872923
26404,cell line,cell_line,0.912,25872923
26405,MAGE-A,DNA,0.8486,25872923
26406,MAGE-A,gene,0.993,25872923
26407,cell lines,cell_line,0.953,25872923
26408,MAGE-A4,gene,0.997,25872923
26409,MAGE,DNA,0.5024,25872923
26410,MAGE-A8,gene,0.9966,25872923
26411,"MAGE-A6, -A8, -A9 and -A10",gene,0.9956,25872923
26412,cell lines,cell_line,0.944,25872923
26413,MAGE,DNA,0.5645,25872923
26414,MAGE-A,gene,0.995,25872923
26415,MAGE,DNA,0.485,25872923
26416,MAGE-A,gene,0.983,25872923
26417,MAGE-A,gene,0.9917,25872923
26418,a MAGE-A,gene,0.9775,25872923
26419,antineoplastic,disease,0.6064,25872923
26420,MAGE-A,gene,0.991,25872923
26421,patients,species,0.99,25872923
26422,oxygen,drug,0.998,25862414
26423,phthalocyanine,drug,0.997,25862414
26424,IRDye,drug,0.9194,25862414
26425,IR-700,drug,0.8833,25862414
26426,panitumumab,gene,0.9165,25862414
26427,Pan,gene,0.9644,25862414
26428,mice,species,0.9614,25862414
26429,necrotic cell,cell_type,0.494,25862414
26430,tumor,disease,1.0,25862414
26431,oxygen,drug,0.9966,25862414
26432,oxygen,drug,0.999,25862414
26433,A431 cells,cell_line,0.9556,25862414
26434,oxygen,drug,0.9995,25862414
26435,Pan,drug,0.8525,25862414
26436,oxygen,drug,0.999,25862414
26437,PIT,drug,0.993,25862414
26438,tumor,disease,1.0,25862414
26439,mice,species,0.9717,25862414
26440,mice,species,0.969,25862414
26441,tumors,disease,0.9976,25862414
26442,oxygen,drug,0.999,25862414
26443,Sorafenib,drug,0.9985,25861837
26444,Cetuximab,gene,0.847,25861837
26445,EGFR,gene,0.997,25861837
26446,KRAS gene,gene,0.987,25861837
26447,epidermal growth factor receptor,gene,0.914,25861837
26448,EGFR,gene,0.9976,25861837
26449,cetuximab,gene,0.7134,25861837
26450,vascular endothelial growth factor (VEGF)-A,gene,0.9956,25861837
26451,EGFR,gene,0.889,25861837
26452,VEGF,gene,0.997,25861837
26453,RAS,gene,0.9946,25861837
26454,RAF,gene,0.998,25861837
26455,MEK,gene,0.998,25861837
26456,ERK,gene,0.995,25861837
26457,cetuximab,gene,0.8286,25861837
26458,PATIENTS,species,0.94,25861837
26459,patients,species,0.9697,25861837
26460,EGFR,gene,0.9985,25861837
26461,KRAS,gene,0.991,25861837
26462,metastatic colorectal cancer,disease,1.0,25861837
26463,mCRC,disease,1.0,25861837
26464,sorafenib,drug,0.9985,25861837
26465,cetuximab,gene,0.76,25861837
26466,zirconium 89,drug,0.9995,25861837
26467,panitumumab,gene,0.9717,25861837
26468,patients,species,0.9673,25861837
26469,patients,species,0.99,25861837
26470,rash,disease,1.0,25861837
26471,diarrhea,disease,1.0,25861837
26472,placental growth factor,gene,0.9966,25861837
26473,cetuximab,gene,0.945,25861837
26474,sorafenib,drug,0.999,25861837
26475,KRAS,gene,0.9766,25861837
26476,mCRC,disease,0.701,25861837
26477,EGFR,gene,0.993,25861837
26478,VEGF receptor,gene,0.996,25861837
26479,VEGFR,gene,0.9976,25861837
26480,patient,species,0.8887,25861837
26481,EGFR,gene,0.992,25861837
26482,VEGFR,gene,0.9907,25861837
26483,KRAS-mutated CRC,disease,0.8394,25861837
26484,KRAS,gene,0.977,25861837
26485,Panitumumab,gene,0.8364,25846092
26486,locally advanced head and neck squamous-cell carcinoma,disease,0.9326,25846092
26487,adenocarcinoma of the transverse colon,disease,1.0,25844680
26488,abdominal pain,disease,0.998,25844680
26489,intestinal obstruction,disease,0.999,25844680
26490,neoplasia,disease,1.0,25844680
26491,distended abdomen,disease,0.8984,25844680
26492,Tenderness,disease,0.5327,25844680
26493,circumferential mid-transverse tumor,disease,0.8994,25844680
26494,primary colorectal carcinoma,disease,0.928,25844680
26495,CRC,disease,1.0,25844680
26496,signet-ring cell type,cell_type,0.729,25844680
26497,hereditary nonpolyposis and hamartomatous colorectal cancer syndromes,disease,0.9976,25844680
26498,"p53,",DNA,0.8213,25844680
26499,p53,gene,0.999,25844680
26500,"BRAF, or K-RAS genes",DNA,0.7314,25844680
26501,BRAF,gene,0.998,25844680
26502,K-RAS genes,gene,0.9946,25844680
26503,neoplasm,disease,1.0,25844680
26504,Wnt,gene,0.9365,25844680
26505,-catenin protein,gene,0.858,25844680
26506,patient,species,0.958,25844680
26507,oxaliplatin,drug,0.998,25844680
26508,intra-abdominal tumor,disease,0.9937,25844680
26509,patient,species,0.9614,25844680
26510,Krukenberg tumors,disease,1.0,25844680
26511,metastatic retroperitoneal disease,disease,1.0,25844680
26512,hydronephrosis,disease,1.0,25844680
26513,patient,species,0.9873,25844680
26514,panitumumab,gene,0.6646,25844680
26515,CRC,disease,1.0,25844680
26516,cancer,disease,1.0,25844680
26517,Afatinib,drug,0.993,25842367
26518,Panitumumab,gene,0.7227,25842367
26519,Cetuximab,gene,0.6147,25834345
26520,panitumumab,gene,0.7314,25834345
26521,patient,species,0.9385,25834345
26522,colon cancer,disease,1.0,25834345
26523,epidermal growth factor receptor,gene,0.998,25834345
26524,EGFR,gene,0.9946,25834345
26525,advanced colorectal cancer,disease,0.9746,25834345
26526,patients,species,0.9717,25834345
26527,chronic dermatological,DNA,0.471,25834345
26528,chronic dermatological disease,disease,0.999,25834345
26529,EGFR,gene,0.9927,25834345
26530,psoriasis-related skin lesions,disease,0.9976,25834345
26531,patient,species,0.9463,25834345
26532,advanced colon cancer,disease,1.0,25834345
26533,psoriasis vulgaris,disease,1.0,25834345
26534,anti-EGFR antibody,gene,0.8354,25834345
26535,patient,species,0.995,25834345
26536,skin lesions,disease,0.9995,25834345
26537,anti-,gene,0.6094,25834345
26538,EGFR antibody,gene,0.6763,25834345
26539,patients,species,0.92,25834345
26540,psoriasis vulgaris,disease,1.0,25834345
26541,EGFR,gene,0.9937,25834345
26542,psoriasis,disease,1.0,25834345
26543,FOLFIRI,drug,0.9834,25831828
26544,cetuximab,gene,0.835,25831828
26545,panitumumab,gene,0.9565,25822327
26546,cetuximab,gene,0.899,25822327
26547,panitumumab,gene,0.8716,25822327
26548,FOLFOX,drug,0.965,25822327
26549,cetuximab,gene,0.78,25822327
26550,FOLFIRI,drug,0.952,25822327
26551,patients,species,0.982,25822327
26552,wild-type (WT),gene,0.902,25822327
26553,RAS,gene,0.628,25822327
26554,metastatic colorectal cancer,disease,1.0,25822327
26555,mCRC,disease,1.0,25822327
26556,panitumumab,gene,0.92,25822327
26557,cetuximab,gene,0.8486,25822327
26558,anti-EGFR,gene,0.974,25822327
26559,WT RAS,gene,0.977,25822327
26560,patient,species,0.992,25822327
26561,cetuximab,gene,0.948,25822327
26562,FOLFIRI,drug,0.9624,25822327
26563,WT RAS,gene,0.985,25822327
26564,mCRC,disease,0.9854,25822327
26565,patients,species,0.9863,25822327
26566,panitumumab,gene,0.945,25822327
26567,FOLFOX,drug,0.9907,25822327
26568,patient,species,0.9844,25822327
26569,panitumumab,gene,0.9277,25822327
26570,FOLFOX,drug,0.946,25822327
26571,cetuximab,gene,0.7993,25822327
26572,FOLFIRI,drug,0.945,25822327
26573,patient,species,0.983,25822327
26574,panitumumab,gene,0.8853,25822327
26575,FOLFOX,drug,0.913,25822327
26576,panitumumab,gene,0.869,25822327
26577,FOLFOX,drug,0.8623,25822327
26578,cetuximab,gene,0.683,25822327
26579,FOLFIRI,drug,0.8794,25822327
26580,WT,disease,,25822327
26581,RAS,gene,0.9243,25822327
26582,mCRC,disease,0.9917,25822327
26583,patients,species,0.9927,25822327
26584,EGFR,gene,0.9927,25819749
26585,tumor,disease,1.0,25819749
26586,IgG1,gene,0.991,25819749
26587,Fc-RIII,gene,0.9893,25819749
26588,natural killer (NK) cells,cell_type,0.9087,25819749
26589,EGFR,gene,0.9946,25819749
26590,panitumumab,gene,0.8286,25819749
26591,epidermal growth factor receptor,gene,0.998,25819749
26592,EGFR,gene,0.995,25819749
26593,target cells lines,cell_line,0.7285,25819749
26594,CAL166,cell_line,0.622,25819749
26595,A431,cell_line,0.9336,25819749
26596,HNO91,cell_line,0.871,25819749
26597,CAL27,cell_line,0.861,25819749
26598,effector cells,cell_type,0.741,25819749
26599,peripheral blood mononuclear cells,cell_type,0.8726,25819749
26600,natural killers,cell_type,0.5864,25819749
26601,NK,cell_type,0.7544,25819749
26602,target cells,cell_type,0.8247,25819749
26603,target cells,cell_type,0.766,25819749
26604,NK cells,cell_type,0.9004,25819749
26605,effector cells,cell_type,0.803,25819749
26606,ADCC,cell_type,0.484,25819749
26607,NK,cell_line,0.8145,25819749
26608,EGFR,gene,0.9893,25819749
26609,Mutant KRAS,gene,0.98,25815366
26610,KRAS oncogene,gene,0.9907,25815366
26611,colorectal cancer,disease,1.0,25815366
26612,CRC,disease,1.0,25815366
26613,cancer,disease,1.0,25815366
26614,tumor,disease,1.0,25815366
26615,KRAS,DNA,0.9272,25815366
26616,KRAS mutations,gene,0.898,25815366
26617,CRC,disease,0.9995,25815366
26618,KRAS-mutant tumors,disease,0.981,25815366
26619,KRAS,gene,0.9795,25815366
26620,epidermal growth factor receptor,gene,0.999,25815366
26621,EGFR,gene,0.9985,25815366
26622,cetuximab,gene,0.567,25815366
26623,panitumumab,gene,0.748,25815366
26624,EGFR,gene,0.9663,25815366
26625,KRAS-mutant tumor cells,cell_line,0.7285,25815366
26626,KRAS,gene,0.984,25815366
26627,tumor,disease,0.596,25815366
26628,mutant,DNA,0.6523,25815366
26629,mutant-KRAS,gene,0.996,25815366
26630,mutant,DNA,0.536,25815366
26631,mutant KRAS,gene,0.9946,25815366
26632,KRAS,DNA,0.571,25815366
26633,KRAS mutations,gene,0.9624,25815366
26634,CRC,disease,0.9966,25815366
26635,mutant KRAS,gene,0.996,25815366
26636,TAS-102,drug,0.998,25812794
26637,nucleoside,drug,0.6807,25812794
26638,trifluridine,drug,0.9985,25812794
26639,FTD,drug,0.995,25812794
26640,tipiracil,drug,0.997,25812794
26641,hydrochloride,drug,0.8525,25812794
26642,TPI,drug,0.997,25812794
26643,patients,species,0.9917,25812794
26644,colorectal cancer,disease,0.9985,25812794
26645,colorectal cancer,disease,1.0,25812794
26646,TAS-102,drug,0.9976,25812794
26647,bevacizumab,gene,0.8667,25812794
26648,cetuximab,gene,0.826,25812794
26649,panitumumab,gene,0.8657,25812794
26650,TAS-102,drug,0.9985,25812794
26651,bevacizumab,gene,0.839,25812794
26652,cetuximab,gene,0.892,25812794
26653,panitumumab,gene,0.8906,25812794
26654,TAS-102,drug,0.9976,25812794
26655,bevacizumab,gene,0.7954,25812794
26656,TAS-102,drug,0.9985,25812794
26657,bevacizumab,gene,0.77,25812794
26658,SW48,cell_line,0.8813,25812794
26659,HCT116,cell_line,0.948,25812794
26660,tumor models,cell_line,0.8013,25812794
26661,tumor,disease,1.0,25812794
26662,FTD,gene,0.616,25812794
26663,tumors,disease,1.0,25812794
26664,TAS-102,drug,0.999,25812794
26665,bevacizumab,gene,0.912,25812794
26666,TAS-102,drug,0.999,25812794
26667,TAS-102,drug,0.998,25812794
26668,cetuximab,gene,0.936,25812794
26669,panitumumab,gene,0.8867,25812794
26670,SW48 tumor model,cell_line,0.759,25812794
26671,tumor,disease,0.9624,25812794
26672,mice,species,0.9688,25812794
26673,TAS-102,drug,0.988,25812794
26674,TAS-102,drug,0.998,25812794
26675,bevacizumab,gene,0.899,25812794
26676,cetuximab,gene,0.9116,25812794
26677,panitumumab,gene,0.909,25812794
26678,colorectal cancer,disease,1.0,25812794
26679,EGFR,gene,0.992,25808440
26680,metastatic colorectal cancer,disease,1.0,25808440
26681,KRAS,gene,0.9536,25808440
26682,Patients,species,0.9585,25808440
26683,metastatic colorectal cancer,disease,1.0,25808440
26684,anti-,gene,0.9697,25808440
26685,EGFR receptor monoclonal antibodies,gene,0.787,25808440
26686,cetuximab,gene,0.501,25808440
26687,panitumumab,gene,0.7817,25808440
26688,patients,species,0.952,25808440
26689,type RAS,gene,0.806,25808440
26690,tumor,disease,1.0,25808440
26691,tumor,disease,0.998,25808440
26692,EGFR,gene,0.8306,25808440
26693,metastatic colorectal cancer,disease,0.9995,25808440
26694,patients,species,0.9697,25808438
26695,colorectal cancer,disease,1.0,25808438
26696,patients,species,0.9814,25808438
26697,colorectal cancer,disease,1.0,25808438
26698,CRC,disease,1.0,25808438
26699,patients,species,0.9746,25808438
26700,CRC,disease,0.9995,25808438
26701,CRC,disease,0.998,25808438
26702,CEA,gene,0.987,25808438
26703,gene signatures,DNA,0.7534,25808438
26704,patients,species,0.982,25808438
26705,KRAS,gene,0.987,25808438
26706,NRAS,gene,0.9946,25808438
26707,cetuximab,gene,0.8467,25808438
26708,panitumumab,gene,0.8525,25808438
26709,patients,species,0.9873,25808438
26710,dihydropyrimidine,drug,0.9995,25808438
26711,dihydropyrimidine dehydrogenase,gene,0.9834,25808438
26712,fluoropyrimidines,drug,0.9995,25808438
26713,uridine diphosphate,drug,0.9976,25808438
26714,uridine diphosphate glucuronosyltransferase*28,gene,0.9688,25808438
26715,UGT1A1*28,gene,0.988,25808438
26716,irinotecan,drug,0.998,25808438
26717,cancer,disease,1.0,25806286
26718,Non-small-cell lung cancer,disease,1.0,25806286
26719,NSCLC,disease,1.0,25806286
26720,lung cancers,disease,1.0,25806286
26721,platinum,drug,0.9995,25806286
26722,patients,species,0.972,25806286
26723,stage III NSCLC,disease,0.9253,25806286
26724,tumor,disease,0.967,25806286
26725,Bevacizumab,gene,0.8843,25806286
26726,epidermal growth factor receptor,gene,0.9985,25806286
26727,EGFR,gene,0.996,25806286
26728,cetuximab,gene,0.8115,25806286
26729,Panitumumab,gene,0.8657,25806286
26730,nimotuzumab,gene,0.7866,25806286
26731,Gefitinib,drug,0.9966,25806286
26732,stage III NSCLC,disease,0.962,25806286
26733,Erlotinib,drug,0.997,25806286
26734,m-TOR,gene,0.992,25806286
26735,bortezomib,drug,0.998,25806286
26736,heat shock protein 90,gene,0.9917,25806286
26737,Hsp90,gene,0.9976,25806286
26738,histone deacetylase,gene,0.9946,25806286
26739,HDACS,gene,0.993,25806286
26740,aurora kinases,gene,0.996,25806286
26741,mitogen activated protein kinases,gene,0.997,25806286
26742,MARK,gene,0.9927,25806286
26743,PARP,gene,0.9873,25806286
26744,RAS,gene,0.498,25800101
26745,KRAS,gene,0.783,25800101
26746,NRAS,gene,0.6313,25800101
26747,colorectal cancer,disease,1.0,25800101
26748,KRAS mutations,gene,0.667,25800101
26749,colorectal cancer,disease,1.0,25800101
26750,RAS,gene,0.5537,25800101
26751,KRAS,gene,0.741,25800101
26752,NRAS,gene,0.656,25800101
26753,anti-,gene,0.883,25800101
26754,epidermal growth factor receptor,gene,0.884,25800101
26755,EGFR,gene,0.9907,25800101
26756,RAS mutation,gene,0.672,25800101
26757,anti-,gene,0.622,25800101
26758,EGFR antibody,gene,0.6665,25800101
26759,EGFR,gene,0.9043,25800101
26760,tumor,disease,0.9995,25800101
26761,RAS,DNA,0.535,25800101
26762,RAS mutations,gene,0.8438,25800101
26763,KRAS exon 2 (,DNA,0.855,25800101
26764,KRAS exon 2,gene,0.9785,25800101
26765,codons 12 and 13,DNA,0.7817,25800101
26766,KRAS,gene,0.8677,25800101
26767,/NRAS mutations,DNA,0.5737,25800101
26768,NRAS,gene,0.996,25800101
26769,RAS,DNA,0.635,25800101
26770,RAS mutation,gene,0.9688,25800101
26771,RAS,DNA,0.7505,25800101
26772,RAS mutations,gene,0.881,25800101
26773,anti-,gene,0.8296,25800101
26774,EGFR antibody,gene,0.7886,25800101
26775,RAS,DNA,0.7075,25800101
26776,RAS mutation,gene,0.9463,25800101
26777,formalin,drug,0.982,25800101
26778,paraffin,drug,0.781,25800101
26779,RAS,DNA,0.669,25800101
26780,RAS mutation,gene,0.9795,25800101
26781,tumor cells,cell_type,0.862,25800101
26782,tumor,disease,0.9883,25800101
26783,RAS mutation,gene,0.683,25800101
26784,Tumor,disease,0.8613,25798804
26785,Cetuximab,gene,0.8784,25798804
26786,Panitumumab,gene,0.8066,25798804
26787,Cetuximab,gene,0.715,25798804
26788,panitumumab,gene,0.8047,25798804
26789,epidermal growth factor receptor,gene,0.9966,25798804
26790,EGFR,gene,0.99,25798804
26791,metastatic colorectal cancer,disease,0.999,25798804
26792,papulopustular rash,disease,0.999,25798804
26793,tumor,disease,1.0,25798804
26794,papulopustular rash,disease,1.0,25798804
26795,metastatic colorectal cancer,disease,1.0,25798804
26796,EGRF,gene,0.9272,25798804
26797,cetuximab,gene,0.7515,25798804
26798,panitumumab,gene,0.806,25798804
26799,papulopustular rash,disease,1.0,25798804
26800,EGFR,gene,0.989,25798804
26801,rash,disease,0.99,25798804
26802,rash reactions,disease,0.968,25798804
26803,tumor,disease,0.9995,25798804
26804,rash,disease,0.944,25798804
26805,rash,disease,0.899,25798804
26806,tumor,disease,1.0,25798804
26807,tumor,disease,1.0,25798804
26808,xerosis,disease,0.9995,25798804
26809,xerosis,disease,0.9985,25798804
26810,tumor,disease,1.0,25798804
26811,papulopustular rash,disease,1.0,25798804
26812,papulopustular rash,disease,1.0,25798804
26813,xerosis,disease,1.0,25798804
26814,EGFR,gene,0.9927,25798804
26815,papulopustular rash,disease,1.0,25798804
26816,anti-EGFR,gene,0.949,25798804
26817,bevacizumab,gene,0.8765,25785004
26818,cetuximab,gene,0.9297,25785004
26819,panitumumab,gene,0.9062,25785004
26820,metastatic colorectal cancer,disease,1.0,25785004
26821,mCRC,disease,1.0,25785004
26822,bevacizumab,gene,0.8145,25785004
26823,cetuximab,gene,0.9565,25785004
26824,panitumumab,gene,0.9585,25785004
26825,metastatic colorectal cancer,disease,1.0,25785004
26826,mCRC,disease,1.0,25785004
26827,bevacizumab,gene,0.86,25785004
26828,cetuximab,gene,0.904,25785004
26829,panitumumab,gene,0.92,25785004
26830,bevacizumab,gene,0.713,25785004
26831,cetuximab,gene,0.957,25785004
26832,bevacizumab,gene,0.9336,25785004
26833,cetuximab,gene,0.968,25785004
26834,panitumumab,gene,0.9263,25785004
26835,bevacizumab,gene,0.8965,25785004
26836,cetuximab,gene,0.939,25785004
26837,panitumumab,gene,0.847,25785004
26838,bevacizumab,gene,0.95,25785004
26839,cetuximab,gene,0.9624,25785004
26840,panitumumab,gene,0.943,25785004
26841,mCRC,disease,0.9766,25785004
26842,RAS,DNA,0.5923,25780283
26843,RAS wild,gene,0.801,25780283
26844,colorectal cancer,disease,0.9995,25780283
26845,patients,species,0.9727,25780283
26846,metastatic colorectal cancer,disease,1.0,25780283
26847,anti-epidermal growth factor receptor,gene,0.9785,25780283
26848,anti-,gene,0.8657,25780283
26849,EGFR),gene,0.9614,25780283
26850,anti-EGFR,gene,0.8896,25780283
26851,vascular endothelial growth factor,gene,0.929,25780283
26852,metastatic colorectal cancer,disease,1.0,25780283
26853,patients,species,0.992,25780283
26854,anti-EGFR,gene,0.671,25780283
26855,Bevacizumab,gene,0.684,25774477
26856,EGFR antibodies,gene,0.8423,25774477
26857,metastatic colorectal cancer,disease,1.0,25774477
26858,Motesanib,drug,0.997,25772756
26859,panitumumab,gene,0.9106,25772756
26860,FOLFIRI,drug,0.989,25772756
26861,FOLFOX,drug,0.9683,25772756
26862,motesanib,drug,0.9985,25772756
26863,panitumumab,gene,0.62,25772756
26864,FOLFIRI,drug,0.95,25772756
26865,FOLFOX,drug,0.865,25772756
26866,patients,species,0.9507,25772756
26867,metastatic colorectal cancer,disease,1.0,25772756
26868,mCRC,disease,1.0,25772756
26869,patients,species,0.9585,25772756
26870,mCRC,disease,0.9663,25772756
26871,motesanib,drug,0.996,25772756
26872,panitumumab,gene,0.9185,25772756
26873,motesanib,drug,0.997,25772756
26874,patients,species,0.9785,25772756
26875,motesanib,drug,0.9995,25772756
26876,panitumumab,gene,0.9727,25772756
26877,FOLFIRI,drug,0.8066,25772756
26878,panitumumab,gene,0.927,25772756
26879,motesanib,drug,0.999,25772756
26880,panitumumab,gene,0.8364,25772756
26881,motesanib,drug,0.997,25772756
26882,FOLFIRI,drug,0.8994,25772756
26883,FOLFOX,drug,0.62,25772756
26884,patients,species,0.9814,25772756
26885,patients,species,0.9727,25772756
26886,FOLFOX,drug,0.527,25772756
26887,FOLFIRI,drug,0.76,25772756
26888,FOLFOX,drug,0.668,25772756
26889,FOLFIRI,drug,0.732,25772756
26890,diarrhea,disease,1.0,25772756
26891,nausea,disease,0.9985,25772756
26892,fatigue,disease,0.999,25772756
26893,hypertension,disease,1.0,25772756
26894,cholecystitis,disease,1.0,25772756
26895,motesanib,drug,0.995,25772756
26896,VEGF,gene,0.9956,25772756
26897,Motesanib,drug,0.9985,25772756
26898,FOLFIRI,drug,0.864,25772756
26899,FOLFOX,drug,0.5586,25772756
26900,mCRC,disease,0.98,25772756
26901,appendix cancer,disease,1.0,25743145
26902,cancer of unknown primary origin,disease,0.981,25743145
26903,man,species,0.8833,25743145
26904,abdominal distension,disease,0.9976,25743145
26905,anorexia,disease,1.0,25743145
26906,ascites,disease,1.0,25743145
26907,peritoneal metastases,disease,0.9824,25743145
26908,fluorodeoxyglucose,drug,0.999,25743145
26909,FDG,drug,0.999,25743145
26910,patient,species,0.987,25743145
26911,adenocarcinoma,disease,1.0,25743145
26912,carboplatin,drug,0.9995,25743145
26913,paclitaxel,drug,1.0,25743145
26914,CBDCA,drug,0.9995,25743145
26915,PTX,drug,0.997,25743145
26916,gemcitabine,drug,0.9985,25743145
26917,intestinal obstruction,disease,1.0,25743145
26918,intestinal obstruction,disease,0.9854,25743145
26919,Appendix cancer,disease,1.0,25743145
26920,fluorouracil,drug,0.9995,25743145
26921,Leucovorin,drug,0.999,25743145
26922,oxaliplatin,drug,0.9995,25743145
26923,panitumumab,gene,0.944,25743145
26924,tumor,disease,0.985,25743145
26925,patient,species,0.992,25743145
26926,arrhythmia,disease,0.999,25743145
26927,patients,species,0.979,25743145
26928,cancer,disease,0.9995,25743145
26929,cetuximab,gene,0.9175,25743137
26930,panitumumab,gene,0.9097,25743137
26931,KRAS,gene,0.994,25743137
26932,cetuximab,gene,0.848,25743137
26933,panitumumab,gene,0.892,25743137
26934,patients,species,0.976,25743137
26935,KRAS,gene,0.9917,25743137
26936,metastatic colorectal cancer,disease,0.9995,25743137
26937,patients,species,0.9707,25743137
26938,patients,species,0.992,25743137
26939,skin toxicities,disease,0.9775,25743137
26940,patients,species,0.9917,25743137
26941,panitumumab,gene,0.9214,25743137
26942,interstitial lung disease,disease,0.846,25743137
26943,patient,species,0.988,25743137
26944,cetuximab,gene,0.8535,25743137
26945,patient,species,0.9907,25743137
26946,cetuximab,gene,0.932,25743137
26947,panitumumab,gene,0.91,25743137
26948,patients,species,0.9756,25743137
26949,patients,species,0.978,25743137
26950,metastatic colon cancer,disease,0.9995,25731422
26951,man,species,0.8433,25731422
26952,lower abdominal pain,disease,0.9556,25731422
26953,descending colon cancer,disease,1.0,25731422
26954,liver metastases,disease,0.9062,25731422
26955,colon cancer,disease,1.0,25731422
26956,capecitabine,drug,0.999,25731422
26957,oxaliplatin,drug,0.9995,25731422
26958,XELOX,drug,0.997,25731422
26959,bevacizumab,gene,0.593,25731422
26960,folinic acid,drug,0.9985,25731422
26961,fluorouracil,drug,0.9995,25731422
26962,irinotecan,drug,0.9976,25731422
26963,FOLFIRI,drug,0.9893,25731422
26964,bevacizumab,gene,0.736,25731422
26965,FOLFIRI,drug,0.976,25731422
26966,panitumumab,gene,0.945,25731422
26967,patient,species,0.9585,25731422
26968,tegafur,drug,0.9985,25731422
26969,uracil,drug,0.999,25731422
26970,Leucovorin,drug,0.9995,25731422
26971,UFT,drug,0.999,25731422
26972,UZEL,drug,0.9927,25731422
26973,FOLFIRI,drug,0.7256,25731422
26974,panitumumab,gene,0.932,25731422
26975,lung metastases,disease,0.7837,25731422
26976,patient,species,0.9697,25731422
26977,metastatic colorectal cancer,disease,1.0,25731325
26978,woman,species,0.9033,25731325
26979,liver metastases,disease,0.8086,25731325
26980,sigmoid,DNA,0.4895,25731325
26981,sigmoid colon tumor,disease,0.9985,25731325
26982,bevacizumab,gene,0.8965,25731325
26983,FOLFOX,drug,0.9907,25731325
26984,bevacizumab,gene,0.756,25731325
26985,FOLFIRI,drug,0.995,25731325
26986,S-1,drug,0.9536,25731325
26987,irinotecan,drug,0.997,25731325
26988,IRIS,drug,0.995,25731325
26989,panitumumab,gene,0.9795,25731325
26990,irinotecan,drug,0.997,25731325
26991,pulmonary metastases,disease,0.8857,25731325
26992,Cetuximab,gene,0.964,25731325
26993,irinotecan,drug,0.998,25731325
26994,tumor,disease,0.9087,25731325
26995,regorafenib,drug,0.993,25731325
26996,KRAS,gene,0.995,25731325
26997,metastatic colorectal cancer,disease,0.9995,25731325
26998,anti-epidermal growth factor receptor,gene,0.968,25731325
26999,EGFR,gene,0.9966,25731325
27000,tumor,disease,1.0,25731325
27001,stage IV,disease,0.9946,25731316
27002,rectal cancer,disease,0.7793,25731316
27003,woman,species,0.8755,25731316
27004,hematochezia,disease,1.0,25731316
27005,KRAS,gene,0.994,25731316
27006,liver,disease,0.9873,25731316
27007,patient,species,0.9893,25731316
27008,tumor,disease,0.9966,25731316
27009,5-fluorouracil,drug,0.9995,25731316
27010,Leucovorin,drug,0.9995,25731316
27011,oxaliplatin,drug,0.9995,25731316
27012,panitumumab,gene,0.86,25731316
27013,liver,disease,0.595,25731316
27014,patient,species,0.9814,25731316
27015,colon cancer,disease,0.946,25731301
27016,man,species,0.8833,25731301
27017,advanced sigmoid colon cancer,disease,1.0,25731301
27018,tumor,disease,0.9995,25731301
27019,KRAS,gene,0.9907,25731301
27020,patient,species,0.9834,25731301
27021,stenosis of,disease,0.9893,25731301
27022,patient,species,0.9727,25731301
27023,panitumumab,gene,0.98,25731301
27024,Pmab,gene,0.9814,25731301
27025,5-fluorouracil,drug,0.999,25731301
27026,5-FU,drug,0.999,25731301
27027,Leucovorin,drug,0.9995,25731301
27028,Pmab,gene,0.675,25731301
27029,anti-epidermal growth factor receptor,gene,0.9775,25731301
27030,EGFR,gene,0.997,25731301
27031,5-FU,drug,0.9976,25731301
27032,Pmab,gene,0.9375,25731301
27033,patient,species,0.992,25731301
27034,anti-EGFR antibody,gene,0.9014,25731301
27035,Hypersensitivity,disease,1.0,25721679
27036,tumor lysis syndrome,disease,1.0,25721679
27037,cetuximab,gene,0.885,25721679
27038,hypersensitivity reactions,disease,0.999,25721679
27039,cetuximab,gene,0.8433,25721679
27040,cetuximab,gene,0.9316,25721679
27041,panitumumab,gene,0.811,25721679
27042,hypersensitivity reactions,disease,0.975,25721679
27043,colon cancer,disease,1.0,25721679
27044,Tumor lysis syndrome,disease,1.0,25721679
27045,TLS,disease,1.0,25721679
27046,colorectal cancers,disease,1.0,25721679
27047,tumor,disease,0.719,25721679
27048,Tumor lysis syndrome,disease,1.0,25721679
27049,patient,species,0.8965,25721679
27050,bone and liver metastases,disease,0.979,25721679
27051,cetuximab,gene,0.7803,25721679
27052,irinotecan,drug,0.9883,25721679
27053,TLS,disease,0.8003,25721679
27054,patient,species,0.965,25721679
27055,cetuximab,gene,0.744,25721679
27056,anti-epidermal growth,disease,0.991,25707609
27057,Skin toxicity,disease,0.9873,25707609
27058,anti-epidermal growth,disease,0.9995,25707609
27059,EGFR,gene,0.997,25707609
27060,metastatic colorectal cancer,disease,1.0,25707609
27061,mCRC,disease,1.0,25707609
27062,anti-EGFR antibody,gene,0.855,25707609
27063,mCRC,disease,0.9976,25707609
27064,patients,species,0.9956,25707609
27065,KRAS,gene,0.9697,25707609
27066,patients,species,0.974,25707609
27067,anti-EGFR antibody,gene,0.7974,25707609
27068,KRAS WT,gene,0.9927,25707609
27069,patients,species,0.993,25707609
27070,patients,species,0.989,25707609
27071,epiregulin,gene,0.992,25707609
27072,EREG,gene,0.9966,25707609
27073,amphiregulin,gene,0.997,25707609
27074,AREG,gene,0.997,25707609
27075,hepatocyte growth factor,gene,0.994,25707609
27076,HGF,gene,0.997,25707609
27077,HGF,gene,0.9966,25707609
27078,EREG,gene,0.992,25707609
27079,AREG,gene,0.991,25707609
27080,HGF,gene,0.9985,25707609
27081,EREG,gene,0.995,25707609
27082,AREG,gene,0.994,25707609
27083,EGFR,gene,0.8076,25707609
27084,mCRC,disease,0.998,25707609
27085,patients,species,0.993,25707609
27086,gastric cancer,disease,1.0,25706252
27087,Gastric cancer,disease,1.0,25706252
27088,gastric cancer,disease,1.0,25706252
27089,patients,species,0.9907,25706252
27090,gastric cancer,disease,1.0,25706252
27091,patients,species,0.9937,25706252
27092,Trastuzumab,gene,0.837,25706252
27093,HER-2,gene,0.9956,25706252
27094,advanced gastric cancer,disease,1.0,25706252
27095,patients,species,0.9854,25706252
27096,HER-2,gene,0.9946,25706252
27097,tumor cells,cell_type,0.831,25706252
27098,tumor,disease,0.986,25706252
27099,VEGFR-2,gene,0.993,25706252
27100,EGFR,gene,0.995,25706252
27101,cetuximab,gene,0.9443,25706252
27102,panitumumab,gene,0.901,25706252
27103,VEGF-A,gene,0.998,25706252
27104,mTOR,gene,0.9883,25706252
27105,everolimus,drug,0.999,25706252
27106,c-MET,gene,0.9985,25706252
27107,HGF,gene,0.998,25706252
27108,gastric cancer,disease,1.0,25706252
27109,Circulating tumor cells,cell_type,0.8975,25704501
27110,patients,species,0.9775,25704501
27111,patients,species,0.9756,25704501
27112,RAS,gene,0.998,25704501
27113,BRAF,gene,0.9995,25704501
27114,colorectal cancer,disease,0.921,25704501
27115,CRC,disease,1.0,25704501
27116,antiepidermal growth factor receptor,gene,0.965,25704501
27117,EGFR,gene,0.969,25704501
27118,cetuximab,gene,0.5767,25704501
27119,panitumumab,gene,0.6724,25704501
27120,patient,species,0.978,25704501
27121,Circulating tumor cells,cell_type,0.9194,25704501
27122,CTCs,cell_type,0.846,25704501
27123,patients,species,0.9683,25704501
27124,RAS,gene,0.988,25704501
27125,BRAF,gene,0.9995,25704501
27126,cetuximab,gene,0.913,25704501
27127,irinotecan,drug,0.997,25704501
27128,panitumumab,gene,0.808,25704501
27129,CTC,cell_type,0.7393,25704501
27130,CTC,cell_type,0.7397,25704501
27131,CTC,cell_type,0.6846,25704501
27132,CTC,cell_type,0.719,25704501
27133,patients,species,0.9844,25704501
27134,CTC,cell_type,0.5864,25704501
27135,CTC,cell_type,0.5923,25704501
27136,CTC,cell_type,0.618,25704501
27137,CTC,cell_type,0.6333,25704501
27138,tumor,disease,0.9995,25704501
27139,patients,species,0.9805,25704501
27140,CTC,cell_type,0.546,25704501
27141,CTC,cell_type,0.6514,25704501
27142,CTC,cell_type,0.7266,25704501
27143,CTC,cell_type,0.709,25704501
27144,anti-EGFR monoclonal antibodies,gene,0.931,25704501
27145,panitumumab,gene,0.8696,25695537
27146,cetuximab,gene,0.935,25695537
27147,man,species,0.893,25695537
27148,wild-type KRAS,gene,0.949,25695537
27149,BRAF,gene,0.986,25695537
27150,colorectal adenocarcinoma,disease,0.9995,25695537
27151,patient,species,0.961,25695537
27152,FOLFOX,drug,0.9062,25695537
27153,bevacizumab,gene,0.7915,25695537
27154,hepatic,disease,0.5664,25695537
27155,FOLFIRI,drug,0.899,25695537
27156,anti-EGFR antibody cetuximab,gene,0.799,25695537
27157,FOLFIRI,drug,0.977,25695537
27158,anti-EGFR antibody,gene,0.9146,25695537
27159,patient,species,0.992,25695537
27160,lung,disease,0.662,25695537
27161,metastatic lesions,disease,1.0,25695537
27162,panitumumab,gene,0.9004,25695537
27163,cetuximab,gene,0.838,25695537
27164,patient,species,0.988,25695537
27165,pulmonary nodules,disease,0.956,25695537
27166,panitumumab,gene,0.857,25686117
27167,metastatic colorectal cancer,disease,1.0,25686117
27168,panitumumab,gene,0.9624,25686117
27169,Pmab,gene,0.9517,25686117
27170,skin toxicities,disease,0.873,25686117
27171,metastatic colorectal cancer,disease,1.0,25686117
27172,PATIENTS,species,0.631,25686117
27173,Pmab,gene,0.9106,25686117
27174,skin,disease,0.5645,25686117
27175,Pmab,drug,0.7993,25686117
27176,skin toxicities,disease,0.662,25686117
27177,metastatic colorectal cancer,disease,0.9995,25686117
27178,Panitumumab,gene,0.869,25679409
27179,epidermal growth factor receptor,gene,0.996,25679409
27180,EGFR,gene,0.982,25679409
27181,IgG2,gene,0.9966,25679409
27182,panitumumab,gene,0.912,25679409
27183,IgG1,gene,0.993,25679409
27184,engineered panitumumab,gene,0.839,25679409
27185,Pan,gene,0.9604,25679409
27186,antitumor,disease,0.9604,25679409
27187,Pan,gene,0.981,25679409
27188,Pan-P,gene,0.9893,25679409
27189,Pan,gene,0.985,25679409
27190,tumor,disease,0.7246,25679409
27191,Pan-P,gene,0.998,25679409
27192,Pan,gene,0.99,25679409
27193,Pan,gene,0.988,25679409
27194,Pan-P,gene,0.9956,25679409
27195,urokinase-type plasminogen activator,gene,0.999,25679409
27196,uPA,gene,0.996,25679409
27197,Pan-P,gene,0.98,25679409
27198,tumor,disease,0.9585,25679409
27199,colorectal cancer,disease,1.0,25679409
27200,CRC,disease,1.0,25679409
27201,patients,species,0.956,25679409
27202,tumor,disease,0.9956,25679409
27203,nude mice,species,0.66,25679409
27204,Pan-P,drug,0.993,25679409
27205,antitumor,disease,0.924,25679409
27206,antitumor,disease,0.8467,25679409
27207,Pan-P,drug,0.9966,25679409
27208,EGFR,gene,0.8716,25679409
27209,K-RAS,gene,0.7,25675084
27210,mucinous carcinoma,disease,1.0,25675084
27211,K-RAS locus,gene,0.845,25675084
27212,colon cancer cells,cell_line,0.635,25675084
27213,colon cancer,disease,1.0,25675084
27214,EGFR,gene,0.9873,25675084
27215,Ras,gene,0.9907,25675084
27216,colon cancer,disease,1.0,25675084
27217,K-RAS,DNA,0.576,25675084
27218,K-RAS mutations,gene,0.969,25675084
27219,codon 13,DNA,0.866,25675084
27220,13 (Gly to Asp,mutation,,25675084
27221,Gly,drug,0.5063,25675084
27222,Asp,drug,0.7764,25675084
27223,codon 19,DNA,0.8555,25675084
27224,19 (Leu to Phe,mutation,,25675084
27225,Leu,drug,0.877,25675084
27226,Phe,drug,0.9697,25675084
27227,alleles,DNA,0.67,25675084
27228,tumor cells,cell_type,0.8525,25675084
27229,tumor,disease,0.9946,25675084
27230,BRAF,DNA,0.7695,25673558
27231,BRAF mutations,gene,0.7983,25673558
27232,patients,species,0.9863,25673558
27233,advanced colorectal cancer,disease,1.0,25673558
27234,Wild,DNA,0.5244,25673558
27235,Wild type RAS,gene,0.997,25673558
27236,RAS-wt,gene,0.998,25673558
27237,epidermal growth factor receptor,gene,0.88,25673558
27238,EGFR,gene,0.986,25673558
27239,cetuximab,gene,0.589,25673558
27240,panitumumab,gene,0.864,25673558
27241,advanced colorectal cancer,disease,0.998,25673558
27242,CRC,disease,1.0,25673558
27243,patients,species,0.9873,25673558
27244,RAS,gene,0.997,25673558
27245,BRAF-mutant,gene,0.861,25673558
27246,BRAF-mut,gene,0.858,25673558
27247,C,drug,0.84,25673558
27248,C,drug,0.7407,25673558
27249,anti-EGFR,gene,0.6895,25673558
27250,RAS,gene,0.9946,25673558
27251,BRAF,gene,0.996,25673558
27252,patients,species,0.98,25673558
27253,RAS,gene,0.9956,25673558
27254,BRAF,gene,0.992,25673558
27255,CRC,disease,0.985,25673558
27256,patients,species,0.9893,25673558
27257,C or P,drug,0.7764,25673558
27258,BRAF,gene,0.996,25673558
27259,RAS,gene,0.996,25673558
27260,BRAF,gene,0.9927,25673558
27261,CRC,disease,0.95,25673558
27262,patients,species,0.9863,25673558
27263,BRAF,gene,0.986,25673558
27264,anti-EGFR monoclonal antibodies,gene,0.8447,25673558
27265,epidermal growth factor receptor,gene,0.9277,25666296
27266,vascular endothelial growth factor,gene,0.996,25666296
27267,advanced colorectal cancer,disease,0.999,25666296
27268,epidermal growth factor receptor,gene,0.9985,25666296
27269,EGFR,gene,0.991,25666296
27270,vascular endothelial growth factor,gene,0.9976,25666296
27271,VEGF,gene,0.993,25666296
27272,advanced colorectal cancer,disease,0.9995,25666296
27273,CRC,disease,1.0,25666296
27274,advanced CRC,disease,0.9937,25666296
27275,EGFR,gene,0.8228,25666296
27276,VEGF,gene,0.907,25666296
27277,KRAS,gene,0.9746,25666296
27278,KRAS,gene,0.8354,25666296
27279,CRC,disease,0.6646,25666296
27280,EGFR,gene,0.628,25666296
27281,VEGF,gene,0.747,25666296
27282,RAS,gene,0.485,25666296
27283,KRAS,gene,0.893,25666296
27284,-WT,DNA,0.4373,25666296
27285,RAS,DNA,0.7363,25666296
27286,RAS-WT,gene,0.9497,25666296
27287,EGFR,gene,0.5415,25666296
27288,VEGF,gene,0.612,25666296
27289,KRAS,gene,0.772,25666296
27290,RAS,DNA,0.626,25666296
27291,RAS-WT,gene,0.7593,25666296
27292,EGFR,gene,0.7017,25666296
27293,VEGF,gene,0.9453,25666296
27294,KRAS,gene,0.5527,25666296
27295,RAS,gene,0.9937,25666296
27296,advanced CRC,disease,0.997,25666296
27297,anti-EGFR monoclonal antibodies,gene,0.802,25666296
27298,VEGF,gene,0.9683,25666296
27299,advanced CRC,disease,0.998,25666296
27300,EGFR,gene,0.501,25663927
27301,advanced colorectal cancer,disease,1.0,25663927
27302,cetuximab,gene,0.733,25663927
27303,metastatic colorectal cancer,disease,1.0,25663927
27304,mCRC,disease,1.0,25663927
27305,anti-epidermal growth factor receptor,gene,0.9077,25663927
27306,EGFR,gene,0.986,25663927
27307,cetuximab,gene,0.6714,25663927
27308,CTX,gene,0.917,25663927
27309,panitumumab,gene,0.665,25663927
27310,wild,gene,0.6055,25663927
27311,RAS gene,gene,0.936,25663927
27312,RAS,gene,0.8433,25663927
27313,EGFR,gene,0.7275,25663927
27314,EGFR,gene,0.979,25663927
27315,EGFR,gene,0.581,25663927
27316,mCRC,disease,0.99,25663927
27317,mCRC,disease,0.9907,25663927
27318,Genomic DNA,DNA,0.598,25663927
27319,Genomic,RNA,0.4578,25663927
27320,tumoral,disease,1.0,25663927
27321,EGFR,gene,0.996,25663927
27322,"KRAS, BRAF and PIK3CA genes",DNA,0.877,25663927
27323,KRAS,gene,0.9478,25663927
27324,BRAF,gene,0.993,25663927
27325,PIK3CA genes,gene,0.98,25663927
27326,EGFR,gene,0.9893,25663927
27327,EGFR,gene,0.664,25663927
27328,EGFR,gene,0.9907,25663927
27329,EGFR,gene,0.9956,25663927
27330,KRAS,gene,0.894,25663927
27331,EGFR,gene,0.996,25663927
27332,BRAF,gene,0.9814,25663927
27333,EGFR,gene,0.9873,25663927
27334,EGFR,gene,0.671,25663927
27335,CTX,gene,0.663,25663927
27336,EGFR,gene,0.9966,25663927
27337,BRAF,gene,0.64,25663927
27338,PIK3CA mutations,gene,0.9077,25663927
27339,EGFRvIII,gene,0.743,25659577
27340,receptor tyrosine kinases,gene,0.993,25659577
27341,tyrosine,drug,0.972,25659577
27342,glioma,disease,1.0,25659577
27343,epidermal growth factor receptor,gene,0.998,25659577
27344,EGFRvIII,gene,0.991,25659577
27345,glioma,disease,1.0,25659577
27346,brain cancer,disease,1.0,25659577
27347,EGFRvIII,gene,0.519,25659577
27348,receptor tyrosine kinases,gene,0.995,25659577
27349,tyrosine,drug,0.9766,25659577
27350,RTKs,gene,0.976,25659577
27351,glioma,disease,1.0,25659577
27352,RTK MET,gene,0.9116,25659577
27353,MET,gene,0.996,25659577
27354,U87MG human glioma cells,cell_line,0.7505,25659577
27355,U87MG,disease,0.734,25659577
27356,EGFRvIII,gene,0.9937,25659577
27357,MET,gene,0.9937,25659577
27358,focal,DNA,0.565,25659577
27359,focal adhesion kinase,gene,0.9976,25659577
27360,FAK,gene,0.9985,25659577
27361,RTKs,gene,0.9927,25659577
27362,FAK,gene,0.995,25659577
27363,EGFRvIII,gene,0.8325,25659577
27364,panitumumab,gene,0.837,25659577
27365,RTKs,gene,0.9927,25659577
27366,motesanib,drug,0.995,25659577
27367,mouse,species,0.939,25659577
27368,glioma,disease,1.0,25659577
27369,RTKs,gene,0.9155,25659577
27370,EGFRvIII-expressing gliomas,disease,0.647,25659577
27371,EGFRvIII,gene,0.994,25659577
27372,EGFR Extracellular Mutations,gene,0.713,25623215
27373,Cetuximab,gene,0.8013,25623215
27374,Colorectal Cancer,disease,1.0,25623215
27375,colorectal cancer,disease,1.0,25623215
27376,anti-EGFR antibody cetuximab,gene,0.869,25623215
27377,resistant tumors,disease,0.9624,25623215
27378,EGFR,gene,0.995,25623215
27379,cetuximab,gene,0.64,25623215
27380,cellular models,cell_line,0.6743,25623215
27381,colorectal cancer,disease,1.0,25623215
27382,cetuximab,gene,0.8887,25623215
27383,Colorectal cancer cells,cell_type,0.607,25623215
27384,Colorectal cancer,disease,1.0,25623215
27385,cetuximab,gene,0.9146,25623215
27386,biopsies,cell_type,0.5815,25623215
27387,cell lines,cell_line,0.9604,25623215
27388,alleles,DNA,0.7085,25623215
27389,tumor specimens,cell_type,0.562,25623215
27390,tumor,disease,1.0,25623215
27391,cetuximab,gene,0.912,25623215
27392,EGFR,gene,0.796,25623215
27393,KRAS,gene,0.8057,25623215
27394,NRAS,gene,0.71,25623215
27395,"BRAF, and PIK3CA genes",DNA,0.6567,25623215
27396,BRAF,gene,0.995,25623215
27397,PIK3CA genes,gene,0.9883,25623215
27398,EGFR ectodomain,gene,0.9854,25623215
27399,R451C,DNA,,25623215
27400,R451C,mutation,,25623215
27401,K467T,mutation,,25623215
27402,cetuximab-resistant cells,cell_line,0.954,25623215
27403,cetuximab,gene,0.827,25623215
27404,-,cell_type,0.6196,25623215
27405,resistant cells,cell_type,0.6157,25623215
27406,EGFR alleles,gene,0.8125,25623215
27407,S464L,DNA,,25623215
27408,S464L,mutation,,25623215
27409,G465R,DNA,,25623215
27410,G465R,mutation,,25623215
27411,I491M,DNA,,25623215
27412,I491M,mutation,,25623215
27413,cetuximab-binding region,gene,0.751,25623215
27414,R451C,DNA,,25623215
27415,R451C,mutation,,25623215
27416,EGFR ectodomain,gene,0.986,25623215
27417,cetuximab,gene,0.873,25623215
27418,panitumumab,gene,0.84,25623215
27419,Colorectal tumors,disease,0.999,25623215
27420,EGFR,gene,0.9893,25623215
27421,colorectal cancer,disease,1.0,25623215
27422,anti-EGFR antibodies,gene,0.8335,25623215
27423,panitumumab,gene,0.815,25596691
27424,descending colon cancer,disease,1.0,25596691
27425,liver metastases,disease,0.7583,25596691
27426,descending colon cancer,disease,1.0,25596691
27427,liver metastases,disease,0.9062,25596691
27428,folinic acid,drug,0.9995,25596691
27429,5-fluorouracil,drug,0.9995,25596691
27430,oxaliplatin,drug,1.0,25596691
27431,panitumumab,gene,0.85,25596691
27432,panitumumab,gene,0.9175,25596691
27433,5-fluorouracil,drug,0.998,25596691
27434,Leucovorin,drug,0.997,25596691
27435,panitumumab,gene,0.7563,25596691
27436,liver tumors,disease,0.999,25596691
27437,tumor,disease,0.9937,25596691
27438,panitumumab,gene,0.926,25596691
27439,multiple,disease,0.582,25596691
27440,liver metastases,disease,0.8228,25596691
27441,colorectal cancer,disease,1.0,25596691
27442,panitumumab,gene,0.893,25596660
27443,squamous-cell carcinoma of the head and neck,disease,1.0,25596660
27444,Panitumumab,gene,0.8564,25596660
27445,EGFR,gene,0.992,25596660
27446,panitumumab,gene,0.826,25596660
27447,squamous-cell carcinoma of the head and neck,disease,1.0,25596660
27448,squamous-cell carcinoma of the head and neck,disease,0.999,25596660
27449,cisplatin,drug,0.998,25596660
27450,panitumumab,gene,0.792,25596660
27451,panitumumab,gene,0.94,25596660
27452,cisplatin,drug,0.989,25596660
27453,panitumumab,gene,0.914,25596660
27454,panitumumab,gene,0.9014,25596660
27455,panitumumab,gene,0.9634,25596660
27456,dysphagia,disease,1.0,25596660
27457,panitumumab,gene,0.957,25596660
27458,mucosal inflammation,disease,1.0,25596660
27459,radiation skin injury,disease,0.9995,25596660
27460,squamous-cell carcinoma of the head and neck,disease,0.9893,25596660
27461,panitumumab,gene,0.903,25596660
27462,cisplatin,drug,0.9995,25596660
27463,EGFR,gene,0.987,25596660
27464,Panitumumab,gene,0.9565,25596659
27465,squamous-cell carcinoma of the head and neck,disease,1.0,25596659
27466,panitumumab,gene,0.66,25596659
27467,EGFR,gene,0.991,25596659
27468,squamous-cell carcinoma,disease,1.0,25596659
27469,locally advanced squamous-cell carcinoma of the head and neck,disease,0.933,25596659
27470,cisplatin,drug,0.993,25596659
27471,panitumumab,gene,0.9434,25596659
27472,panitumumab,gene,0.8623,25596659
27473,gross tumour,disease,0.632,25596659
27474,panitumumab,gene,0.8774,25596659
27475,panitumumab,gene,0.95,25596659
27476,panitumumab,gene,0.972,25596659
27477,mucosal inflammation,disease,1.0,25596659
27478,panitumumab,gene,0.9727,25596659
27479,dysphagia,disease,1.0,25596659
27480,radiation skin,disease,0.8086,25596659
27481,panitumumab,gene,0.914,25596659
27482,Panitumumab,gene,0.791,25596659
27483,cisplatin,drug,0.996,25596659
27484,stage III-IVb,disease,0.8784,25596659
27485,squamous-cell carcinoma of the head and,disease,0.9917,25596659
27486,EGFR,gene,0.9927,25596659
27487,squamous-cell carcinoma of the head and neck,disease,0.9976,25596659
27488,EGFR,gene,0.9897,25594061
27489,VEGF,gene,0.918,25594061
27490,colorectal cancer,disease,1.0,25594061
27491,epidermal growth factor receptor,gene,0.998,25594061
27492,EGFR,gene,0.99,25594061
27493,EGFR,gene,0.928,25594061
27494,EGFR antibody,gene,0.8296,25594061
27495,erlotinib,drug,0.998,25594061
27496,cetuximab,gene,0.9014,25594061
27497,bevacizumab,gene,0.697,25594061
27498,metastatic colorectal cancer,disease,0.9995,25594061
27499,metastatic colorectal cancer,disease,0.9995,25594061
27500,rash,disease,0.9995,25594061
27501,hypomagnesemia,disease,1.0,25594061
27502,fatigue,disease,0.999,25594061
27503,bevacizumab,gene,0.878,25594061
27504,cetuximab,gene,0.7866,25594061
27505,bevacizumab,drug,0.95,25594061
27506,cetuximab,gene,0.7974,25594061
27507,bevacizumab,drug,0.9355,25594061
27508,cetuximab,gene,0.6875,25594061
27509,erlotinib,drug,0.9893,25594061
27510,panitumumab,gene,0.812,25594061
27511,bevacizumab,gene,0.9404,25594061
27512,cetuximab,gene,0.9136,25594061
27513,erlotinib,drug,0.9956,25594061
27514,metastatic colorectal cancer,disease,0.996,25594061
27515,epidermal growth factor receptor,gene,0.999,25592338
27516,KIT,gene,0.989,25592338
27517,BCR,gene,0.9375,25592338
27518,ABL,gene,0.991,25592338
27519,BRAF,gene,0.9956,25589621
27520,EGFR,gene,0.967,25589621
27521,BRAF,gene,0.5645,25589621
27522,metastatic colorectal cancer,disease,0.987,25589621
27523,BRAF,gene,0.4736,25589621
27524,metastatic colorectal cancer,disease,0.9995,25589621
27525,mCRC,disease,1.0,25589621
27526,colorectal cancer,disease,1.0,25589621
27527,RAF,gene,0.99,25589621
27528,EGFR,gene,0.9956,25589621
27529,colorectal tumor cells,cell_type,0.645,25589621
27530,colorectal tumor,disease,1.0,25589621
27531,RAF,gene,0.9976,25589621
27532,EGFR,gene,0.994,25589621
27533,RAF,gene,0.995,25589621
27534,EGFR,gene,0.983,25589621
27535,BRAF,cell_line,0.5146,25589621
27536,BRAF V600E,gene,0.965,25589621
27537,mCRC,disease,0.8647,25589621
27538,BRAF,gene,0.9956,25589621
27539,vemurafenib,drug,0.9893,25589621
27540,anti-,gene,0.944,25589621
27541,EGFR antibody,gene,0.7534,25589621
27542,panitumumab,gene,0.4426,25589621
27543,BRAF-mutant,disease,0.7915,25589621
27544,BRAF,gene,0.5957,25589621
27545,mCRC,disease,0.689,25589621
27546,panitumumab,gene,0.9033,25589621
27547,vemurafenib,drug,0.998,25589621
27548,fluoropyrimidine,drug,0.999,25589621
27549,oxaliplatin,drug,0.9995,25589621
27550,irinotecan,drug,0.998,25589621
27551,keratoacanthomas,disease,1.0,25589621
27552,squamous cell carcinomas,disease,1.0,25589621
27553,RAF,gene,0.996,25589621
27554,EGFR,gene,0.9873,25589621
27555,CRC,disease,0.997,25589621
27556,RAS,gene,0.9927,25584005
27557,patient,species,0.977,25584005
27558,colorectal cancer,disease,1.0,25580262
27559,Colorectal cancer,disease,1.0,25580262
27560,solid tumors,disease,1.0,25580262
27561,patient,species,0.983,25580262
27562,tumor,disease,0.9995,25580262
27563,tumors,disease,1.0,25580262
27564,rectal cancer,disease,1.0,25580262
27565,colon cancer,disease,1.0,25580262
27566,colorectal cancer,disease,1.0,25580262
27567,5-fluorouracil,drug,0.9995,25580262
27568,5-FU,drug,0.9995,25580262
27569,5-FU,drug,0.9995,25580262
27570,oxaliplatin,drug,0.9995,25580262
27571,irinotecan,drug,0.998,25580262
27572,anti-vascular endothelial growth factor-A,gene,0.9883,25580262
27573,anti-VEGF-A,gene,0.8857,25580262
27574,bevacizumab,gene,0.4504,25580262
27575,epidermal growth factor receptor,gene,0.997,25580262
27576,anti-EGFR,gene,0.944,25580262
27577,cetuximab,gene,0.4797,25580262
27578,panitumumab,gene,0.8374,25580262
27579,regorafenib,drug,0.9365,25580262
27580,aflibercept,gene,0.96,25580262
27581,Anti-,gene,0.682,25580262
27582,EGFR antibodies,gene,0.8057,25580262
27583,tumors,disease,1.0,25580262
27584,KRAS,gene,0.9834,25580262
27585,"NRAS exon 2, 3, 4",DNA,0.8877,25580262
27586,anti-EGFR,gene,0.8394,25580262
27587,VEGF,gene,0.6943,25580262
27588,patient,species,0.973,25580262
27589,Right-sided sporadic colon cancers,disease,0.9985,25580262
27590,microsatellite instability (MSI-H) tumors,disease,0.947,25580262
27591,hereditary non-polyposis colorectal cancer,disease,1.0,25580262
27592,colorectal cancer,disease,1.0,25580262
27593,colorectal cancer,disease,1.0,25579803
27594,CRC,disease,1.0,25579803
27595,5-fluorouracil,drug,0.9995,25579803
27596,5-FU,drug,0.9995,25579803
27597,5-FU,drug,0.999,25579803
27598,folate,drug,0.9995,25579803
27599,leucovorin,drug,0.8623,25579803
27600,topoisomerase I,gene,0.991,25579803
27601,irinotecan,drug,0.9917,25579803
27602,platinum,drug,1.0,25579803
27603,oxaliplatin,drug,0.9995,25579803
27604,5-FU,drug,0.9966,25579803
27605,prodrug,DNA,0.545,25579803
27606,capecitabine,drug,0.9985,25579803
27607,5-FU,drug,0.9995,25579803
27608,leucovorin,drug,0.9995,25579803
27609,oxaliplatin,drug,0.9995,25579803
27610,FOLFIRI,drug,0.6685,25579803
27611,5-FU,drug,0.9995,25579803
27612,leucovorin,drug,0.9995,25579803
27613,irinotecan,drug,0.999,25579803
27614,metastatic CRC,disease,0.7827,25579803
27615,FOLFOX,drug,0.958,25579803
27616,humanized,species,0.5366,25579803
27617,vascular endothelial growth factor,gene,0.9956,25579803
27618,cetuximab,gene,0.8135,25579803
27619,panitumumab,gene,0.9277,25579803
27620,epidermal growth factor receptor,gene,0.996,25579803
27621,cancer,disease,0.984,25579803
27622,5-FU,drug,0.998,25579803
27623,leucovorin,drug,0.9995,25579803
27624,patients,species,0.9604,25579803
27625,CRC,disease,0.999,25579803
27626,patients,species,0.985,25579664
27627,metastatic colorectal cancer,disease,0.9927,25579664
27628,patients,species,0.9805,25579664
27629,colorectal cancer,disease,1.0,25579664
27630,mCRC,disease,0.997,25579664
27631,VEGF,gene,0.6006,25579664
27632,bevacizumab,gene,0.9717,25579664
27633,aflibercept,gene,0.9946,25579664
27634,anti-EGFR antibodies,gene,0.9053,25579664
27635,panitumumab,gene,0.9526,25579664
27636,cetuximab,gene,0.9634,25579664
27637,regorafenib,drug,0.9854,25579664
27638,patients,species,0.973,25579664
27639,mCRC,disease,0.9907,25579664
27640,mCRC,disease,0.993,25579664
27641,malignancy,disease,0.9995,25542326
27642,metastatic colon cancer,disease,1.0,25542326
27643,obstructing sigmoid colon cancer,disease,1.0,25542326
27644,liver metastases,disease,0.993,25542326
27645,liver,disease,0.6606,25542326
27646,FOLFOX,drug,0.814,25542326
27647,5-fluorouracil,drug,0.9995,25542326
27648,5-FU,drug,0.9995,25542326
27649,leucovorin,drug,0.9985,25542326
27650,oxaliplatin,drug,0.9995,25542326
27651,bevacizumab,gene,0.7056,25542326
27652,5-FU,drug,0.9966,25542326
27653,bevacizumab,gene,0.762,25542326
27654,Oxaliplatin,drug,0.9995,25542326
27655,neuropathy,disease,0.998,25542326
27656,FOLFIRI,drug,0.9854,25542326
27657,5-FU,drug,0.9995,25542326
27658,leucovorin,drug,0.999,25542326
27659,irinotecan,drug,0.9985,25542326
27660,bevacizumab,gene,0.9097,25542326
27661,Kras,gene,0.9956,25542326
27662,irinotecan,drug,0.9907,25542326
27663,panitumumab,gene,0.6465,25542326
27664,yittrium-90,drug,0.8716,25542326
27665,irinotecan,drug,0.997,25542326
27666,portal hypertension,disease,1.0,25542326
27667,Electrolyte disorders,disease,1.0,25542231
27668,solid tumor,disease,1.0,25542231
27669,patients,species,0.978,25542231
27670,anti-EGFR,gene,0.964,25542231
27671,anti-epithelial growth factor receptor monoclonal antibodies,gene,0.995,25542231
27672,anti-EGFR MoAbs,gene,0.99,25542231
27673,electrolyte disorders,disease,0.952,25542231
27674,electrolyte disorder,disease,1.0,25542231
27675,patients,species,0.9927,25542231
27676,hypomagnesemia,disease,1.0,25542231
27677,anti-EGFR MoAbs,gene,0.93,25542231
27678,hypokalemia,disease,1.0,25542231
27679,hypocalcemia,disease,1.0,25542231
27680,colorectal cancer,disease,1.0,25542231
27681,cetuximab,gene,0.8306,25542231
27682,hypomagnesemia,disease,0.9956,25542231
27683,hypokalemia,disease,0.9976,25542231
27684,colorectal cancer,disease,1.0,25542231
27685,patients,species,0.987,25542231
27686,panitumumab,gene,0.964,25542231
27687,hypomagnesemia,disease,0.9995,25542231
27688,hypokalemia,disease,1.0,25542231
27689,anti-,gene,0.7295,25542231
27690,EGFR MoAbs,gene,0.685,25542231
27691,electrolyte disorders,disease,0.9966,25542231
27692,hypomagnesemia,disease,1.0,25542231
27693,hypomagnesemia,disease,1.0,25542231
27694,hypocalcemia,disease,1.0,25542231
27695,colorectal cancer,disease,1.0,25542231
27696,electrolyte disorders,disease,0.997,25542231
27697,mCRC,disease,0.9785,25531050
27698,VEGF,gene,0.9907,25531050
27699,bevacizumab,gene,0.8965,25531050
27700,EGFR,gene,0.996,25531050
27701,cetuximab,gene,0.905,25531050
27702,panitumumab,gene,0.903,25531050
27703,metastatic colorectal cancer,disease,1.0,25531050
27704,mCRC,disease,1.0,25531050
27705,mCRC,disease,0.9946,25531050
27706,mCRC,disease,0.998,25531050
27707,RAS,gene,0.467,25531050
27708,BRAF,gene,0.7324,25531050
27709,mCRC,disease,0.9365,25531050
27710,mCRC,disease,0.8677,25531050
27711,epidermal growth factor receptors,gene,0.9976,25496291
27712,penile cancer,disease,1.0,25496291
27713,Penile cancer,disease,1.0,25496291
27714,cancer,disease,0.999,25496291
27715,intraepithelial neoplasms,disease,1.0,25496291
27716,EGFR family,gene,0.9917,25496291
27717,penile cancer,disease,1.0,25496291
27718,HPV-positive and -negative tumors,disease,0.999,25496291
27719,EGFR,gene,0.835,25496291
27720,penile cancer,disease,1.0,25496291
27721,anti-EGFR monoclonal antibodies,gene,0.903,25496291
27722,MicroRNA-31-5p,gene,0.716,25472647
27723,EGFR,gene,0.817,25472647
27724,epidermal growth factor receptor,gene,0.996,25472647
27725,EGFR,gene,0.9893,25472647
27726,EGFR,gene,0.9766,25472647
27727,colorectal cancer,disease,1.0,25472647
27728,CRC,disease,1.0,25472647
27729,microRNA-31 (miR-31)-5p,RNA,0.6416,25472647
27730,BRAF,gene,0.993,25472647
27731,EGFR,gene,0.987,25472647
27732,CRC,disease,0.9995,25472647
27733,miR-31-5p,gene,0.8394,25472647
27734,EGFR,gene,0.9395,25472647
27735,CRC,disease,0.9995,25472647
27736,miR-31-5p,RNA,0.562,25472647
27737,miR-31-5p,gene,0.885,25472647
27738,KRAS,gene,0.99,25472647
27739,codon 61 or 146,DNA,0.755,25472647
27740,NRAS,gene,0.9897,25472647
27741,"codon 12, 13,",DNA,0.7905,25472647
27742,BRAF,DNA,0.6685,25472647
27743,BRAF (V600E,gene,0.814,25472647
27744,V600,mutation,,25472647
27745,EGFR,gene,0.996,25472647
27746,CRC,disease,0.999,25472647
27747,patients,species,0.986,25472647
27748,KRAS (codon 12 or 13),gene,0.8735,25472647
27749,EGFR,gene,0.9805,25472647
27750,KRAS,DNA,0.8076,25472647
27751,KRAS,gene,0.987,25472647
27752,codon 61 or 146,DNA,0.733,25472647
27753,NRAS,gene,0.973,25472647
27754,BRAF,DNA,0.7275,25472647
27755,BRAF mutations,gene,0.9316,25472647
27756,patients,species,0.991,25472647
27757,CRCs,disease,0.95,25472647
27758,CRCs,cell_line,0.7153,25472647
27759,CRCs,cell_type,0.6562,25472647
27760,CRCs,disease,0.9995,25472647
27761,wild-type genes,DNA,0.8896,25472647
27762,KRAS,gene,0.978,25472647
27763,NRAS,DNA,0.849,25472647
27764,NRAS,gene,0.9707,25472647
27765,BRAF,gene,0.979,25472647
27766,miR-31-5p,gene,0.942,25472647
27767,patients,species,0.981,25472647
27768,CRCs,disease,0.998,25472647
27769,wild-type genes,DNA,0.8135,25472647
27770,miR-31-,RNA,0.5176,25472647
27771,miR-31-5p,gene,0.9194,25472647
27772,miR-31-5p,gene,0.9194,25472647
27773,patients,species,0.9673,25472647
27774,CRC,disease,0.999,25472647
27775,EGFR,gene,0.8994,25472647
27776,CRCs,cell_line,0.809,25472647
27777,CRCs,cell_type,0.7246,25472647
27778,CRCs,disease,0.997,25472647
27779,wild-type genes,DNA,0.865,25472647
27780,miR-31,RNA,0.535,25472647
27781,miR-31-5p,gene,0.9326,25472647
27782,EGFR,gene,0.8433,25472647
27783,panitumumab,gene,0.9067,25459925
27784,natalizumab,gene,0.697,25459925
27785,cetuximab,gene,0.7407,25459925
27786,bevacizumab,gene,0.6963,25459925
27787,trastuzumab,gene,0.9346,25459925
27788,rituximab,gene,0.942,25459925
27789,palivizumab,gene,0.871,25459925
27790,adalimumab,gene,0.7983,25459925
27791,denosumab,gene,0.6763,25459925
27792,advanced colorectal cancer,disease,0.987,25458604
27793,Colorectal cancer,disease,1.0,25458604
27794,CRC,disease,1.0,25458604
27795,cancer,disease,1.0,25458604
27796,advanced CRC,disease,0.9995,25458604
27797,aCRC,disease,0.999,25458604
27798,aCRC,disease,0.996,25458604
27799,VEGF,gene,0.9966,25458604
27800,bevacizumab,gene,0.638,25458604
27801,aflibercept,gene,0.976,25458604
27802,VEGFR,gene,0.898,25458604
27803,regorafenib,drug,0.9766,25458604
27804,EGFR,gene,0.9873,25458604
27805,cetuximab,gene,0.612,25458604
27806,panitumumab,gene,0.6133,25458604
27807,patients,species,0.973,25458604
27808,aCRC,disease,0.991,25458604
27809,patient,species,0.9746,25456837
27810,pancreatic cancer,disease,0.9995,25456837
27811,patient,species,0.9756,25456837
27812,pancreatic cancer,disease,0.9893,25456837
27813,mice,species,0.9497,25456837
27814,F,gene,0.503,25456837
27815,fully-human anti-EGFR monoclonal antibody,gene,0.807,25456837
27816,human,species,0.875,25456837
27817,panitumumab,gene,0.859,25456837
27818,(64)Cu,drug,0.9985,25456837
27819,pancreatic cancers,disease,1.0,25456837
27820,EGFR,gene,0.9917,25456837
27821,F,gene,0.5347,25456837
27822,panitumumab IgG,gene,0.9897,25456837
27823,human IgG,gene,0.6772,25456837
27824,human,species,0.9854,25456837
27825,NOTA,drug,0.999,25456837
27826,(64)Cu,drug,0.9985,25456837
27827,Panitumumab IgG,gene,0.952,25456837
27828,Fab fragments,gene,0.7725,25456837
27829,(64)Cu,drug,0.9985,25456837
27830,EGFR,gene,0.991,25456837
27831,(64)Cu,drug,0.9995,25456837
27832,panitumumab IgG,gene,0.9565,25456837
27833,F(ab&#39;)2,gene,0.7837,25456837
27834,Fab,gene,0.9346,25456837
27835,non-tumor,cell_line,0.587,25456837
27836,mice,species,0.9404,25456837
27837,mice,species,0.7554,25456837
27838,patient,species,0.937,25456837
27839,OCIP23,cell_line,0.8584,25456837
27840,pancreatic tumors,disease,0.883,25456837
27841,NOD-scid,gene,0.7007,25456837
27842,PANC-1 human pancreatic cancer xenografts,cell_line,0.783,25456837
27843,human,species,0.9976,25456837
27844,pancreatic cancer,disease,0.8047,25456837
27845,Panitumumab F(ab&#39;)2 fragments,gene,0.9307,25456837
27846,NOTA,DNA,0.5034,25456837
27847,NOTA,drug,0.9976,25456837
27848,(64)Cu,drug,0.9985,25456837
27849,(64)Cu,drug,0.9995,25456837
27850,NOTA,drug,0.9717,25456837
27851,panitumumab F(ab&#39;)2,gene,0.9653,25456837
27852,OCIP23,cell_line,0.6836,25456837
27853,PANC-1 cells,cell_line,0.96,25456837
27854,panitumumab IgG,gene,0.997,25456837
27855,(64)Cu,drug,0.9995,25456837
27856,NOTA,drug,0.9688,25456837
27857,panitumumab F(ab&#39;)2,gene,0.92,25456837
27858,EGFR,gene,0.9863,25456837
27859,PANC-1 cells,cell_line,0.9434,25456837
27860,PANC-1 cells,cell_type,0.735,25456837
27861,F(ab,gene,0.736,25456837
27862,tumor,disease,1.0,25456837
27863,(64)Cu,drug,0.999,25456837
27864,panitumumab IgG,gene,0.9805,25456837
27865,Fab,gene,0.94,25456837
27866,(64)Cu-NOTA,drug,0.904,25456837
27867,panitumumab F(ab&#39;)2,gene,0.796,25456837
27868,PANC-1 xenografts,cell_line,0.875,25456837
27869,PANC,disease,0.96,25456837
27870,OCIP23,cell_line,0.909,25456837
27871,PANC,cell_type,0.4856,25456837
27872,PANC-1 tumors,disease,1.0,25456837
27873,(64)Cu-NOTA,drug,0.9067,25456837
27874,F(ab&,gene,0.7515,25456837
27875,OCIP23 xenografts,cell_line,0.8516,25456837
27876,(64)Cu,drug,0.9995,25456837
27877,panitumumab F(ab&#39;)2,gene,0.7656,25456837
27878,tumor xenografts,cell_line,0.553,25456837
27879,tumor,disease,1.0,25456837
27880,(64)Cu,drug,0.9995,25456837
27881,NOTA,drug,0.9946,25456837
27882,panitumumab F(ab,gene,0.837,25456837
27883,(64)Cu,drug,0.999,25456837
27884,panitumumab F(ab&,gene,0.884,25456837
27885,EGFR,gene,0.988,25456837
27886,pancreatic cancer cells,cell_type,0.706,25456837
27887,pancreatic cancer,disease,1.0,25456837
27888,patient-derived pancreatic cancer xenografts,cell_line,0.66,25456837
27889,patient,species,0.9326,25456837
27890,pancreatic cancer,disease,0.9985,25456837
27891,mice,species,0.974,25456837
27892,Panitumumab,gene,0.64,25437589
27893,Liver Metastases,disease,0.674,25437589
27894,man,species,0.863,25437589
27895,liver metastases,disease,0.977,25437589
27896,multiple colorectal cancers,disease,0.983,25437589
27897,familial adenomatous polyposis,disease,1.0,25437589
27898,panitumumab,gene,0.8223,25437589
27899,rectal cancer,disease,1.0,25437589
27900,sigmoid colon cancer,disease,1.0,25437589
27901,KRAS,gene,0.994,25437589
27902,liver metastases,disease,0.9985,25437589
27903,sigmoid colon cancer,disease,1.0,25437589
27904,liver,disease,0.954,25437589
27905,KRAS,DNA,0.525,25437589
27906,KRAS,gene,0.996,25437589
27907,rectal and sigmoid colon cancer,disease,1.0,25437589
27908,epidermal growth factor receptor,gene,0.997,25437589
27909,PTEN,gene,0.99,25437589
27910,rectal cancer,disease,1.0,25437589
27911,liver metastases,disease,0.6655,25437589
27912,sigmoid colon cancer,disease,1.0,25437589
27913,panitumumab,gene,0.8325,25437589
27914,PI3K,gene,0.9985,25437589
27915,AKT,gene,0.9873,25437589
27916,ErbB family,gene,0.9883,25435079
27917,lung and breast Overactivation,disease,1.0,25435079
27918,ErbB protein family,gene,0.9917,25435079
27919,receptor tyrosine kinase members,gene,0.991,25435079
27920,tyrosine,drug,0.948,25435079
27921,ErbB1,gene,0.9917,25435079
27922,epidermal growth factor receptor,gene,0.9043,25435079
27923,EGFR,gene,0.994,25435079
27924,HER1,gene,0.9985,25435079
27925,ErbB2,gene,0.9976,25435079
27926,HER2,gene,0.997,25435079
27927,ErbB3,gene,0.9966,25435079
27928,HER3,gene,0.9966,25435079
27929,ErbB4,gene,0.9976,25435079
27930,HER4,gene,0.9976,25435079
27931,malignancies,disease,0.9995,25435079
27932,"colorectal, head and neck,",disease,0.9976,25435079
27933,non-small cell lung cancers,disease,1.0,25435079
27934,NSCLCs,disease,1.0,25435079
27935,ErbB family,gene,0.9893,25435079
27936,cancer,disease,1.0,25435079
27937,EGFR tyrosine kinase,gene,0.928,25435079
27938,tyrosine,drug,0.848,25435079
27939,erlotinib,drug,0.9946,25435079
27940,gefitinib,drug,0.9966,25435079
27941,EGFR-targeting monoclonal antibodies,gene,0.917,25435079
27942,cetuximab,gene,0.642,25435079
27943,panitumumab,gene,0.8945,25435079
27944,HER2,gene,0.983,25435079
27945,monoclonal,gene,0.7275,25435079
27946,Lapatinib,drug,0.999,25435079
27947,EGFR,gene,0.9946,25435079
27948,HER2,gene,0.9844,25435079
27949,ErbB family,gene,0.99,25435079
27950,cancer,disease,1.0,25435079
27951,EGFR,gene,0.9976,25435079
27952,HER2,gene,0.994,25435079
27953,HER4,gene,0.991,25435079
27954,afatinib,drug,0.971,25435079
27955,dacomitinib,drug,0.9907,25435079
27956,neratinib,drug,0.9795,25435079
27957,NSCLC,disease,1.0,25435079
27958,breast cancer,disease,0.9995,25435079
27959,malignancies,disease,0.9995,25435079
27960,afatinib,drug,0.985,25435079
27961,EGFR,gene,0.994,25435079
27962,squamous NSCLC,disease,1.0,25435079
27963,dacomitinib,drug,0.997,25435079
27964,NSCLC,disease,1.0,25435079
27965,neratinib,drug,0.9824,25435079
27966,breast cancer,disease,1.0,25435079
27967,afatinib,drug,0.972,25435079
27968,head and neck cancer,disease,1.0,25435079
27969,solid tumor malignancies,disease,1.0,25435079
27970,panitumumab,gene,0.966,25431648
27971,panitumumab,gene,0.936,25431648
27972,epidermal growth factor receptor,gene,0.9966,25431648
27973,EGFR,gene,0.9946,25431648
27974,panitumumab,gene,0.9805,25431648
27975,tumors,disease,1.0,25431648
27976,mouse,species,0.9316,25431648
27977,EGFR,gene,0.9937,25431648
27978,Panitumumab,gene,0.902,25431648
27979,mice,species,0.897,25431648
27980,BT-474,cell_line,0.937,25431648
27981,MDA-MB-,cell_line,0.9224,25431648
27982,MDA-MB-468,cell_line,0.8525,25431648
27983,EGFR,gene,0.996,25431648
27984,panitumumab,gene,0.9727,25431648
27985,panitumumab,gene,0.956,25431648
27986,mouse,species,0.954,25431648
27987,EGFR,gene,0.9873,25431648
27988,tumor,disease,0.878,25431648
27989,panitumumab,gene,0.8833,25431648
27990,(89)Zr,drug,0.997,25431648
27991,tumor xenografts,cell_line,0.784,25431648
27992,tumor,disease,1.0,25431648
27993,EGFR,gene,0.9917,25431648
27994,panitumumab,gene,0.9536,25431648
27995,EGFR-expressing tumors,disease,0.9424,25431648
27996,EGFR,gene,0.996,25431648
27997,panitumumab,gene,0.866,25424399
27998,squamous cell head and neck cancer,disease,1.0,25424399
27999,target,DNA,0.502,25424399
28000,organs,DNA,0.5054,25424399
28001,GTVs,DNA,0.689,25424399
28002,CTVs,cell_type,0.5347,25424399
28003,PTVs,DNA,0.5044,25424399
28004,PTV,DNA,0.625,25424399
28005,OARs,DNA,0.539,25424399
28006,OARs,DNA,0.554,25424399
28007,CTV,DNA,0.522,25424399
28008,PTV,DNA,0.576,25424399
28009,EGFR,gene,0.6646,25412235
28010,TTAGGG tandem repeats,DNA,0.838,25412235
28011,chromosomal ends,DNA,0.7964,25412235
28012,telomerase,gene,0.987,25412235
28013,EGFR,gene,0.9927,25412235
28014,telomerase,gene,0.9795,25412235
28015,telomere,DNA,0.7056,25412235
28016,anti-epidermal growth factor receptor,gene,0.976,25412235
28017,EGFR,gene,0.993,25412235
28018,metastatic colorectal cancer,disease,1.0,25412235
28019,mCRC,disease,1.0,25412235
28020,Colorectal cancer cell lines,cell_line,0.8096,25412235
28021,Colorectal cancer,disease,1.0,25412235
28022,patients,species,0.9956,25412235
28023,EGFR,gene,0.844,25412235
28024,Telomere length,DNA,0.5996,25412235
28025,CRC cell lines,cell_line,0.958,25412235
28026,CRC,disease,0.9995,25412235
28027,cetuximab,gene,0.872,25412235
28028,patients,species,0.976,25412235
28029,KRas WT tumours,disease,0.9497,25412235
28030,KRas,gene,0.995,25412235
28031,mCRC,disease,0.999,25412235
28032,patients,species,0.9863,25412235
28033,EGFR,gene,0.665,25412235
28034,EGFR,gene,0.859,25412235
28035,EGFR,gene,0.995,25412235
28036,telomerase complex,gene,0.9175,25412235
28037,RAS,gene,0.9946,25410095
28038,colorectal cancer,disease,1.0,25410095
28039,CRC,disease,1.0,25410095
28040,RAS,DNA,0.8267,25410095
28041,RAS,gene,0.9917,25410095
28042,EGFR,gene,0.649,25410095
28043,RAS,gene,0.994,25410095
28044,metastatic CRC,disease,0.785,25410095
28045,KRAS exon 2,DNA,0.7876,25410095
28046,KRAS exon 2,gene,0.987,25410095
28047,RAS,DNA,0.5825,25410095
28048,KRAS,gene,0.9683,25410095
28049,cetuximab,gene,0.9214,25410095
28050,panitumumab,gene,0.8667,25410095
28051,patients,species,0.972,25410095
28052,metastatic CRC,disease,0.998,25410095
28053,RAS,DNA,0.882,25410095
28054,RAS,gene,0.994,25410095
28055,cetuximab,gene,0.4937,25410095
28056,KRAS,gene,0.9805,25410095
28057,RAS,DNA,0.84,25410095
28058,KRAS,gene,0.9614,25410095
28059,panitumumab,gene,0.828,25410095
28060,RAS,DNA,0.5522,25410095
28061,RAS,gene,0.993,25410095
28062,KRAS exon 2,gene,0.9907,25410095
28063,patients,species,0.9917,25410095
28064,RAS mutations,DNA,0.632,25410095
28065,RAS mutations,gene,0.9673,25410095
28066,exon 2,DNA,0.8584,25410095
28067,EGFR,gene,0.84,25410095
28068,EGFR,gene,0.9883,25400031
28069,colorectal cancer,disease,1.0,25400031
28070,Cetuximab,gene,0.9253,25400031
28071,Erbitux,gene,0.7646,25400031
28072,panitumumab,gene,0.932,25400031
28073,Vectibix,gene,0.697,25400031
28074,EGFR,gene,0.9907,25400031
28075,patients,species,0.9614,25400031
28076,wild,DNA,0.5425,25400031
28077,wild-type RAS,gene,0.9775,25400031
28078,metastatic colorectal cancer,disease,0.974,25400031
28079,skin (acneiform) rash,disease,1.0,25400031
28080,pruritus,disease,1.0,25400031
28081,EGFR,gene,0.7812,25400031
28082,metastatic colorectal cancer,disease,0.685,25384292
28083,metastatic colorectal cancer,disease,1.0,25384292
28084,mCRC,disease,1.0,25384292
28085,patients,species,0.9907,25384292
28086,patients,species,0.984,25384292
28087,mCRC,disease,0.9956,25384292
28088,mCRC,disease,0.965,25384292
28089,5-fluorouracil,drug,0.9995,25384292
28090,leucovorin,drug,0.999,25384292
28091,5-FU,drug,0.9995,25384292
28092,oxaliplatin,drug,0.999,25384292
28093,5-FU,drug,0.999,25384292
28094,irinotecan,drug,0.9966,25384292
28095,mCRC,disease,0.9795,25384292
28096,vascular endothelial growth factor,gene,0.997,25384292
28097,EGFR,gene,0.9976,25384292
28098,EGFR,gene,0.9956,25384292
28099,cetuximab,gene,0.7188,25384292
28100,panitumumab,gene,0.737,25384292
28101,wild,disease,0.7524,25384292
28102,wild-type KRAS,gene,0.868,25384292
28103,patients,species,0.9883,25384292
28104,mCRC,disease,0.999,25384292
28105,Solid Tumors,disease,0.982,25384292
28106,patient,species,0.985,25384292
28107,AIMS,cell_line,0.4377,25378536
28108,KRAS,gene,0.9795,25378536
28109,NRAS,DNA,0.831,25378536
28110,NRAS,gene,0.9766,25378536
28111,BRAF,gene,0.9883,25378536
28112,colorectal cancer,disease,1.0,25378536
28113,patients,species,0.9834,25378536
28114,cell lines,cell_line,0.957,25378536
28115,Ion Torrent panel,DNA,0.4902,25378536
28116,mutant alleles,DNA,0.7764,25378536
28117,cell lines,cell_line,0.9614,25378536
28118,BRAF gene,gene,0.994,25378536
28119,RAS genes,DNA,0.8643,25378536
28120,RAS genes,gene,0.992,25378536
28121,RAS mutant allele,gene,0.972,25378536
28122,KRAS,DNA,0.8887,25378536
28123,KRAS,gene,0.985,25378536
28124,NRAS,gene,0.982,25378536
28125,BRAF,DNA,0.862,25378536
28126,BRAF,gene,0.991,25378536
28127,Colon and Lung Cancer,disease,0.963,25378536
28128,patients,species,0.9844,25378536
28129,epidermal growth factor receptor,gene,0.8354,25378536
28130,EGFR,gene,0.9966,25378536
28131,metastatic colorectal cancer,disease,0.9165,25378536
28132,Panitumumab,gene,0.8574,25374966
28133,colon cancer,disease,1.0,25374966
28134,Panitumumab,gene,0.755,25374966
28135,human,species,0.8755,25374966
28136,epidermal growth factor receptor,gene,0.9966,25374966
28137,EGFR,gene,0.995,25374966
28138,colorectal cancer,disease,1.0,25374966
28139,CRC,disease,1.0,25374966
28140,CRC,disease,0.999,25374966
28141,panitumumab,gene,0.813,25374966
28142,EGFR,gene,0.6953,25374966
28143,Kirsten rat sarcoma viral oncogene,gene,0.9917,25374966
28144,KRAS,DNA,0.881,25374966
28145,KRAS,gene,0.991,25374966
28146,neuroblastoma RAS viral oncogene,gene,0.9937,25374966
28147,NRAS,DNA,0.885,25374966
28148,NRAS,gene,0.9956,25374966
28149,CRC,disease,1.0,25374966
28150,tumor,disease,1.0,25374966
28151,panitumumab,gene,0.8447,25374966
28152,CRC,disease,0.9995,25374966
28153,anti-epidermal growth factor,gene,0.9536,25369798
28154,Anti-epidermal growth factor receptor,gene,0.973,25369798
28155,EGFR,gene,0.978,25369798
28156,malignancies,disease,1.0,25369798
28157,anti-EGFR MoAbs,gene,0.9707,25369798
28158,cancer,disease,1.0,25369798
28159,patients,species,0.994,25369798
28160,patients,species,0.988,25369798
28161,anti-EGFR-MoAbs,gene,0.8564,25369798
28162,cancer,disease,1.0,25369798
28163,patients,species,0.9897,25369798
28164,anti-EGFR MoAbs,gene,0.9487,25369798
28165,tumor,disease,1.0,25369798
28166,anti-EGFR MoAbs,gene,0.9688,25369798
28167,cetuximab,gene,0.554,25369798
28168,panitumumab,gene,0.8716,25369798
28169,anti-EGFR MoAbs,gene,0.938,25369798
28170,cisplatin,drug,0.999,25369798
28171,irinotecan,drug,0.9985,25369798
28172,anti-EGFR,gene,0.8984,25369798
28173,sepsis,disease,0.988,25369798
28174,EGFR MoAbs,gene,0.7163,25369798
28175,cancer,disease,1.0,25369798
28176,patients,species,0.989,25369798
28177,tumor,disease,1.0,25369798
28178,cancer,disease,1.0,25369798
28179,patients,species,0.993,25369798
28180,recombinant monoclonal antibodies,gene,0.99,25359277
28181,silica,drug,1.0,25359277
28182,BEH300,DNA,0.6533,25359277
28183,ethylene,drug,0.998,25359277
28184,"immunoglobulin G1, G2, and G4 antibodies",gene,0.989,25359277
28185,panitumumab,gene,0.897,25359277
28186,natalizumab,gene,0.907,25359277
28187,cetuximab,gene,0.833,25359277
28188,bevacizumab,gene,0.8228,25359277
28189,trastuzumab,gene,0.924,25359277
28190,rituximab,gene,0.8896,25359277
28191,palivizumab,gene,0.884,25359277
28192,belimumab,gene,0.906,25359277
28193,adalimumab,gene,0.8174,25359277
28194,denosumab,gene,0.641,25359277
28195,human serum albumin,gene,0.9976,25359277
28196,human,species,0.961,25359277
28197,transferrin,gene,0.9893,25359277
28198,apoferritin,gene,0.989,25359277
28199,ovalbumin,gene,0.993,25359277
28200,Panitumumab,gene,0.9463,27202252
28201,Mfolfox,drug,0.978,27202252
28202,Bevacizumab,gene,0.8867,27202252
28203,Mfolfox,drug,0.986,27202252
28204,Metastatic Colorectal Cancer,disease,1.0,27202252
28205,Wild-Type Ras,gene,0.856,27202252
28206,Panitumumab,gene,0.924,27202247
28207,Mfolfox6,drug,0.959,27202247
28208,Bevacizumab,gene,0.8516,27202247
28209,Mfolfox6,drug,0.9717,27202247
28210,Wild-Type Ras,gene,0.8237,27202247
28211,metastatic colorectal cancer,disease,0.996,25326159
28212,metastatic colorectal cancer,disease,1.0,25326159
28213,mCRC,disease,1.0,25326159
28214,vascular endothelial growth factor,gene,0.9966,25326159
28215,VEGF,gene,0.995,25326159
28216,epidermal growth factor receptor,gene,0.998,25326159
28217,EGFR,gene,0.994,25326159
28218,aflibercept,gene,0.98,25326159
28219,regorafenib,drug,0.9683,25326159
28220,mCRC,disease,0.9404,25326159
28221,bevacizumab,gene,0.866,25326159
28222,fluoropyrimidine,drug,0.991,25326159
28223,VEGF,gene,0.9937,25326159
28224,aflibercept,gene,0.969,25326159
28225,regorafenib,drug,0.9487,25326159
28226,Cetuximab,gene,0.893,25326159
28227,fluoropyrimidine,drug,0.9985,25326159
28228,leucovorin,drug,0.999,25326159
28229,irinotecan,drug,0.9985,25326159
28230,FOLFIRI,drug,0.8955,25326159
28231,panitumumab,gene,0.8564,25326159
28232,oxaliplatin,drug,1.0,25326159
28233,fluoropyrimidine,drug,0.997,25326159
28234,anti-,gene,0.6294,25326159
28235,EGFR antibodies,gene,0.879,25326159
28236,tumors,disease,1.0,25326159
28237,Kirsten rat sarcoma,disease,1.0,25326159
28238,neuroblastoma,disease,0.505,25326159
28239,RAS,gene,0.4604,25326159
28240,anti-VEGF,gene,0.984,25326159
28241,anti- EGFR,gene,0.779,25326159
28242,gastric cancer,disease,1.0,25320512
28243,Trastuzumab,gene,0.963,25320512
28244,human epidermal growth factor receptor 2,gene,0.9985,25320512
28245,HER2,gene,0.9766,25320512
28246,gastric cancer,disease,1.0,25320512
28247,trastuzumab,gene,0.946,25320512
28248,gastric cancer,disease,1.0,25320512
28249,HER2 protein,gene,0.981,25320512
28250,bevacizumab,drug,0.608,25320512
28251,vascular endothelial growth factors,gene,0.998,25320512
28252,VEGF,gene,0.9927,25320512
28253,cetuximab,gene,0.7085,25320512
28254,panitumumab,gene,0.8027,25320512
28255,epidermal growth factors,gene,0.988,25320512
28256,colorectal cancer,disease,0.9985,25320512
28257,gastric cancer,disease,1.0,25320512
28258,VEGF receptor-2,gene,0.998,25320512
28259,gastric cancer,disease,0.8906,25320512
28260,gastric cancer,disease,1.0,25320512
28261,gastric cancer,disease,1.0,25320512
28262,light,DNA,0.477,25315245
28263,cancer,disease,1.0,25315245
28264,tumor,disease,0.9023,25315245
28265,cancer,disease,1.0,25315245
28266,cancer,disease,1.0,25315245
28267,luciferase-transfected breast cancer cell line,cell_line,0.956,25315245
28268,luciferase,gene,0.9673,25315245
28269,breast cancer,disease,0.9507,25315245
28270,2LMP-Luc,cell_line,0.863,25315245
28271,panitumumab,gene,0.97,25315245
28272,propidium iodide,drug,0.999,25315245
28273,tumors,disease,1.0,25315245
28274,epidermal growth factor receptor,gene,0.9863,25313182
28275,KRAS,gene,0.847,25313182
28276,anti-epidermal growth factor receptor,gene,0.9214,25313182
28277,EGFR,gene,0.6187,25313182
28278,metastatic colorectal cancer,disease,0.9995,25313182
28279,KRAS exon 2,gene,0.7207,25313182
28280,KRAS exon 2,gene,0.723,25313182
28281,KRAS wild-type tumors,cell_line,0.7266,25313182
28282,KRAS,gene,0.995,25313182
28283,cetuximab,gene,0.931,25313182
28284,panitumumab,gene,0.8965,25313182
28285,KRAS exon 2,gene,0.733,25313182
28286,EGFR,gene,0.839,25313182
28287,KRAS,DNA,0.824,25313182
28288,KRAS mutations,gene,0.766,25313182
28289,exon 2,DNA,0.9287,25313182
28290,RAS mutations,gene,0.965,25313182
28291,EGFR,gene,0.9897,25313182
28292,KRAS exon 2,gene,0.686,25313182
28293,exon 2,DNA,0.585,25313182
28294,KRAS,DNA,0.563,25313182
28295,KRAS mutations,gene,0.7236,25313182
28296,RAS,gene,0.99,25313182
28297,BRAF,gene,0.617,25313182
28298,Panitumumab,gene,0.798,25304881
28299,KRAS,gene,0.9956,25304881
28300,locally advanced rectal,disease,0.9897,25304881
28301,anti-epidermal growth factor receptor,gene,0.8916,25304881
28302,EGFR,gene,0.9946,25304881
28303,KRAS,gene,0.9927,25304881
28304,locally advanced rectal cancer,disease,0.9995,25304881
28305,LARC,disease,1.0,25304881
28306,panitumumab,gene,0.8506,25304881
28307,KRAS,DNA,0.7446,25304881
28308,KRAS,gene,0.995,25304881
28309,LARC,disease,0.998,25304881
28310,patients,species,0.988,25304881
28311,patients,species,0.98,25304881
28312,NRAS,gene,0.9624,25304881
28313,BRAF,DNA,0.761,25304881
28314,BRAF,gene,0.9966,25304881
28315,PI3KCA,gene,0.997,25304881
28316,patient,species,0.9736,25304881
28317,PTEN,gene,0.985,25304881
28318,EGFR,gene,0.9688,25304881
28319,plasma,gene,0.565,25304881
28320,TGF- and EGF,gene,0.9106,25304881
28321,panitumumab,gene,0.839,25304881
28322,patients,species,0.986,25304881
28323,TGF-,gene,0.702,25304881
28324,EGF,gene,0.8125,25304881
28325,panitumumab,gene,0.936,25304881
28326,KRAS,DNA,0.677,25304881
28327,KRAS,gene,0.9917,25304881
28328,LARC,disease,0.998,25304881
28329,pCR,DNA,0.5303,25304881
28330,panitumumab,gene,0.881,25304881
28331,KRAS,gene,0.996,25304881
28332,LARC,disease,0.995,25304881
28333,EGFR,gene,0.979,25293556
28334,colorectal cancer,disease,1.0,25293556
28335,EGFR,gene,0.9966,25293556
28336,cetuximab,gene,0.4792,25293556
28337,panitumumab,gene,0.7183,25293556
28338,metastatic,disease,0.5786,25293556
28339,colorectal cancers,disease,0.8394,25293556
28340,KRAS,gene,0.6772,25293556
28341,NRAS,gene,0.7783,25293556
28342,BRAF,gene,0.686,25293556
28343,ERBB2,gene,0.5938,25293556
28344,MET,gene,0.6494,25293556
28345,EGFR,gene,0.8784,25293556
28346,EGFR,gene,0.9893,25293556
28347,genes,DNA,0.601,25293556
28348,anti-EGFR antibodies,gene,0.857,25293556
28349,EGFR,gene,0.981,25293556
28350,metastatic colorectal cancer,disease,0.952,25293556
28351,cancer,disease,1.0,25288497
28352,anti-EGFR monoclonal antibodies,gene,0.9683,25288497
28353,cetuximab,gene,0.511,25288497
28354,panitumumab,gene,0.7974,25288497
28355,anti-EGFR monoclonal antibodies,gene,0.989,25288497
28356,cetuximab,gene,0.781,25288497
28357,panitumumab,gene,0.7583,25288497
28358,cancer,disease,1.0,25288497
28359,anti-EGFR mAbs,gene,0.9185,25288497
28360,PATIENTS,species,0.958,25288497
28361,cetuximab,gene,0.9165,25288497
28362,panitumumab,gene,0.93,25288497
28363,febrile neutropenia,disease,1.0,25288497
28364,FN,disease,0.9995,25288497
28365,anti-EGFR mAbs,gene,0.874,25288497
28366,FN,gene,0.985,25288497
28367,FN,disease,0.9946,25288497
28368,anti-EGFR mAbs,gene,0.9795,25288497
28369,anti-EGFR mAb,gene,0.9937,25288497
28370,tumor,disease,1.0,25288497
28371,colorectal cancer,disease,1.0,25288497
28372,non-small cell lung cancer,disease,1.0,25288497
28373,NSCLC,disease,1.0,25288497
28374,FN,disease,0.993,25288497
28375,cetuximab,gene,0.8896,25288497
28376,NSCLC,disease,0.9995,25288497
28377,anti-EGFR mAbs,gene,0.9395,25288497
28378,febrile neutropenia,disease,1.0,25288497
28379,ecthyma,disease,1.0,25266748
28380,epidermal growth factor receptor,gene,0.9976,25266748
28381,KRAS,DNA,0.818,26842186
28382,KRAS mutations,gene,0.9673,26842186
28383,metastatic colorectal cancer,disease,1.0,26842186
28384,tumor,disease,1.0,26842186
28385,colorectal cancers,disease,1.0,26842186
28386,CRCs,disease,1.0,26842186
28387,Kristen Rat Sarcoma (KRAS) gene,DNA,0.8677,26842186
28388,Kristen Rat Sarcoma,gene,0.9946,26842186
28389,KRAS,gene,0.9805,26842186
28390,KRAS,DNA,0.8154,26842186
28391,KRAS mutation,gene,0.7866,26842186
28392,Cetuximab,gene,0.858,26842186
28393,Panitumumab,gene,0.7754,26842186
28394,CRCs,disease,1.0,26842186
28395,Exon 2,DNA,0.8906,26842186
28396,KRAS gene,gene,0.9062,26842186
28397,CRC,disease,1.0,26842186
28398,tumors,disease,1.0,26842186
28399,Genomic DNA,DNA,0.5024,26842186
28400,tumor,disease,1.0,26842186
28401,Codons 12 and 13,DNA,0.762,26842186
28402,KRAS gene,gene,0.8853,26842186
28403,tumor,disease,0.9995,26842186
28404,tumor,disease,0.9995,26842186
28405,Codons 12 and 13,DNA,0.839,26842186
28406,tumors,disease,0.8247,26842186
28407,tumors,disease,0.949,26842186
28408,Codon 12,DNA,0.8003,26842186
28409,Codon 13,DNA,0.7754,26842186
28410,Glycine,drug,0.9995,26842186
28411,Arginine,drug,0.9976,26842186
28412,Glycine,drug,0.999,26842186
28413,Alanine,drug,0.9966,26842186
28414,KRAS,DNA,0.827,26842186
28415,KRAS mutation,gene,0.8906,26842186
28416,metastatic,disease,0.804,26842186
28417,CRC,disease,0.5366,26842186
28418,NRAS,gene,0.744,26842186
28419,v-raf murine sarcoma viral oncogene homolog B1,gene,0.7466,26842186
28420,murine,species,0.56,26842186
28421,epidermal growth factor receptor,gene,0.9927,26842186
28422,CRC,disease,0.999,26842186
28423,panitumumab,gene,0.971,25246275
28424,advanced colorectal cancer,disease,1.0,25246275
28425,advanced colorectal cancer,disease,1.0,25246275
28426,panitumumab,gene,0.765,25246275
28427,RAS,gene,0.5483,25246275
28428,KRAS,gene,0.7114,25246275
28429,NRAS,gene,0.478,25246275
28430,RAS,gene,0.5815,25246275
28431,tumors,disease,1.0,25246275
28432,KRAS mutations,gene,0.6665,25246275
28433,codons 12 to 13,DNA,0.8433,25246275
28434,panitumumab,gene,0.8916,25246275
28435,panitumumab,gene,0.8843,25246275
28436,KRAS,gene,0.854,25246275
28437,tumors,disease,1.0,25246275
28438,RAS,gene,0.548,25246275
28439,KRAS,gene,0.8086,25246275
28440,exons 3 to 4,DNA,0.8228,25246275
28441,NRAS exons 2 to 4,DNA,0.866,25246275
28442,NRAS,gene,0.99,25246275
28443,KRAS codon 61,DNA,0.7363,25246275
28444,KRAS,gene,0.9937,25246275
28445,codon 146,DNA,0.79,25246275
28446,NRAS,gene,0.852,25246275
28447,RAS,gene,0.6753,25246275
28448,RAS,DNA,0.4924,25246275
28449,RAS mutations,gene,0.8936,25246275
28450,codon 61,DNA,0.6846,25246275
28451,KRAS,gene,0.8315,25246275
28452,NRAS,gene,0.787,25246275
28453,codons 61,DNA,0.839,25246275
28454,RAS,gene,0.9966,25246275
28455,RAS,gene,0.5073,25246275
28456,codon 61,DNA,0.8687,25246275
28457,RAS,gene,0.587,25246275
28458,panitumumab,gene,0.8525,25246275
28459,tumor cells,cell_type,0.81,25245185
28460,tumor,disease,0.9995,25245185
28461,Panitumumab,gene,0.939,25245185
28462,Pan800QC,gene,0.7754,25245185
28463,IRDye,DNA,0.4392,25245185
28464,IRDye QC-,drug,0.6313,25245185
28465,epidermal growth factor receptor (EGFR)-expressing cells,cell_line,0.9395,25245185
28466,epidermal,cell_type,0.5356,25245185
28467,epidermal growth factor receptor,gene,0.9946,25245185
28468,EGFR,gene,0.971,25245185
28469,IRDye 800CW,drug,0.831,25245185
28470,IRDye,DNA,0.4077,25245185
28471,IRDye QC-1,drug,0.8203,25245185
28472,indocyanine green,drug,0.9985,25243604
28473,panitumumab,gene,0.9673,25243604
28474,Indocyanine green,drug,0.9995,25243604
28475,IC-Green,drug,0.9995,25243604
28476,IC-Green,drug,0.9688,25243604
28477,ICG,drug,0.9995,25243604
28478,sulfo-OSu,drug,0.9854,25243604
28479,ICG-sOSu,drug,0.9355,25243604
28480,ICG,drug,0.9985,25243604
28481,ICG,drug,0.998,25243604
28482,panitumumab,gene,0.9478,25243604
28483,ICG,drug,0.999,25243604
28484,ICG,drug,0.9995,25243604
28485,sOSu,gene,0.908,25243604
28486,panitumumab,gene,0.9844,25243604
28487,ICG,drug,0.9946,25243604
28488,sOSu,gene,0.8403,25243604
28489,panitumumab,gene,0.9897,25243604
28490,SDS,drug,0.773,25243604
28491,polyacrylamide,drug,0.9814,25243604
28492,panitumumab,gene,0.953,25243604
28493,ICG,drug,0.966,25243604
28494,ICG,drug,0.9985,25243604
28495,sOSu,gene,0.528,25243604
28496,panitumumab,gene,0.9785,25243604
28497,ethyl acetate,drug,0.9614,25243604
28498,nude mice,species,0.679,25243604
28499,HER1-expressing tumor xenografts,cell_line,0.648,25243604
28500,HER1,gene,0.997,25243604
28501,ICG,drug,0.999,25243604
28502,IC-Green,drug,0.995,25243604
28503,mAb,gene,0.7476,25243604
28504,lung cancer,disease,1.0,25238453
28505,EGFR,gene,0.99,25238453
28506,AvidinOX,gene,0.9946,25238453
28507,Cetuximab,gene,0.572,25238453
28508,Lung cancer,disease,1.0,25238453
28509,lung metastases,disease,0.818,25238453
28510,distal,disease,0.5576,25238453
28511,AvidinOX,gene,0.9854,25238453
28512,mice,species,0.698,25238453
28513,KRAS-mutated A549 metastatic lung cancer,disease,0.9814,25238453
28514,KRAS,gene,0.7056,25238453
28515,AvidinOX,gene,0.989,25238453
28516,Cetuximab,gene,0.7207,25238453
28517,tumor,disease,0.965,25238453
28518,AvidinOX,gene,0.997,25238453
28519,Cetuximab,gene,0.912,25238453
28520,Panitumumab,gene,0.883,25238453
28521,tumor cell lines,cell_line,0.655,25238453
28522,tumor cell,cell_type,0.8564,25238453
28523,tumor,disease,0.9995,25238453
28524,EGFR,gene,0.9937,25238453
28525,AvidinOX,gene,0.983,25238453
28526,panitumumab,gene,0.9297,25219451
28527,bevacizumab,gene,0.854,25219451
28528,wild-type,disease,0.724,25219451
28529,wild-type RAS,gene,0.766,25219451
28530,panitumumab,gene,0.9297,25219451
28531,oxaliplatin,drug,1.0,25219451
28532,5-fluorouracil,drug,0.9995,25219451
28533,leucovorin,drug,0.998,25219451
28534,bevacizumab,gene,0.8037,25219451
28535,wild,DNA,0.596,25219451
28536,wild-type RAS,gene,0.9717,25219451
28537,metastatic colorectal cancer,disease,1.0,25219451
28538,mCRC,disease,1.0,25219451
28539,panitumumab,gene,0.957,25219451
28540,bevacizumab,gene,0.7896,25219451
28541,mCRC,disease,0.999,25219451
28542,panitumumab,gene,0.7173,25219451
28543,wild,gene,0.8276,25219451
28544,mCRC,disease,0.9507,25219451
28545,panitumumab,gene,0.9326,25219451
28546,bevacizumab,gene,0.674,25219451
28547,panitumumab,gene,0.9404,25219451
28548,bevacizumab,gene,0.9214,25219451
28549,wild-type RAS,gene,0.8354,25219451
28550,mCRC,disease,0.9917,25219451
28551,metastatic colorectal cancer,disease,0.9985,25209093
28552,Colorectal cancer,disease,1.0,25209093
28553,CRC,disease,1.0,25209093
28554,cancers,disease,1.0,25209093
28555,metastatic CRC,disease,0.9985,25209093
28556,mCRC,disease,0.9995,25209093
28557,colon or rectal cancer,disease,1.0,25209093
28558,mCRC,disease,0.998,25209093
28559,5-fluorouracil,drug,0.9995,25209093
28560,5-FU,drug,0.999,25209093
28561,UFT,drug,0.9976,25209093
28562,capecitabine,drug,0.999,25209093
28563,tegafur,drug,0.999,25209093
28564,uracil,drug,0.9897,25209093
28565,tegafur,drug,0.9985,25209093
28566,"5-chloro-2,4-dihydroxypyridine",drug,0.9995,25209093
28567,oxonic acid,drug,0.9976,25209093
28568,panitumumab,gene,0.953,25209093
28569,KRAS,gene,0.6924,25209093
28570,tumors,disease,0.987,25209093
28571,KRAS mutant tumors,cell_line,0.6,25209093
28572,KRAS,gene,0.4492,25209093
28573,bevacizumab,gene,0.8594,25209093
28574,FOLFOX,drug,0.6865,25209093
28575,folinic acid,drug,0.9995,25209093
28576,5-FU,drug,0.9995,25209093
28577,oxaliplatin,drug,0.9995,25209093
28578,mCRC,disease,0.934,25209093
28579,MicroRNAs,RNA,0.6924,25206276
28580,colorectal cancer,disease,1.0,25206276
28581,Colorectal cancer,disease,1.0,25206276
28582,CRC,disease,1.0,25206276
28583,cancer,disease,1.0,25206276
28584,CRC,disease,0.9985,25206276
28585,cancer,disease,1.0,25206276
28586,5-fluorouracil,drug,0.999,25206276
28587,metastatic CRC,disease,0.9995,25206276
28588,mCRC,disease,0.9995,25206276
28589,oxaliplatin,drug,0.9995,25206276
28590,irinotecan,drug,0.999,25206276
28591,cetuximab,gene,0.79,25206276
28592,panitumumab,gene,0.9346,25206276
28593,bevacizumab,gene,0.8086,25206276
28594,bevacizumab,gene,0.629,25206276
28595,cetuximab,gene,0.9546,25206276
28596,panitumumab,gene,0.9663,25206276
28597,aflibercept,gene,0.9556,25206276
28598,regorafenib,drug,0.9907,25206276
28599,CRC,disease,0.998,25206276
28600,microRNAs,RNA,0.7227,25206276
28601,miRNAs,RNA,0.6455,25206276
28602,cancer,disease,1.0,25206276
28603,CRC,disease,0.997,25206276
28604,miRNAs,RNA,0.604,25206276
28605,CRCs,disease,0.5,25206276
28606,tumor,disease,1.0,25206276
28607,cancer,disease,0.986,25206276
28608,CRC,disease,0.999,25206276
28609,miRNAs,RNA,0.492,25206276
28610,CRC,disease,0.999,25206276
28611,panitumumab,gene,0.841,25195993
28612,esophageal cancer,disease,1.0,25195993
28613,esophageal cancer,disease,1.0,25195993
28614,epidermal growth factor receptor,gene,0.997,25195993
28615,EGFR,gene,0.994,25195993
28616,panitumumab,gene,0.614,25195993
28617,carboplatin,drug,0.998,25195993
28618,paclitaxel,drug,0.9995,25195993
28619,esophageal cancer,disease,1.0,25195993
28620,tumors,disease,0.723,25195993
28621,panitumumab,gene,0.8467,25195993
28622,carboplatin,drug,0.999,25195993
28623,paclitaxel,drug,0.998,25195993
28624,EGFR,gene,0.986,25195993
28625,HER 2,gene,0.9927,25195993
28626,P53,gene,0.9927,25195993
28627,adenocarcinoma,disease,1.0,25195993
28628,AC,disease,1.0,25195993
28629,AC,disease,1.0,25195993
28630,squamous cell carcinoma,disease,1.0,25195993
28631,rash,disease,0.999,25195993
28632,fatigue,disease,0.999,25195993
28633,nonfebrile neutropenia,disease,1.0,25195993
28634,panitumumab,gene,0.884,25195993
28635,carboplatin,drug,0.9995,25195993
28636,paclitaxel,drug,0.999,25195993
28637,cetuximab,gene,0.9346,25192874
28638,HNSCC,disease,0.5303,25192874
28639,AURKB,gene,0.9956,25192874
28640,DUSP proteins,gene,0.842,25192874
28641,cetuximab,gene,0.94,25192874
28642,head and neck squamous cell carcinoma,disease,1.0,25192874
28643,HNSCC,disease,1.0,25192874
28644,tumors,disease,1.0,25192874
28645,"""resistant"" cells",cell_line,0.6855,25192874
28646,RAS,gene,0.9976,25192874
28647,MAPK,gene,0.9966,25192874
28648,DUSP5,gene,0.9907,25192874
28649,DUSP6,gene,0.984,25192874
28650,ERK1/2,gene,0.994,25192874
28651,AURKB,gene,0.9976,25192874
28652,RAS,gene,0.9956,25192874
28653,MAPK,gene,0.991,25192874
28654,ERK1/2,gene,0.992,25192874
28655,apigenin,drug,0.999,25192874
28656,AURKB,gene,0.7515,25192874
28657,barasertib,drug,0.994,25192874
28658,cetuximab,gene,0.93,25192874
28659,HNSCC,disease,0.525,25192874
28660,let-7 microRNA-binding site polymorphism,gene,0.6694,25183481
28661,KRAS,gene,0.8906,25183481
28662,metastatic colorectal cancer,disease,1.0,25183481
28663,cetuximab,gene,0.9004,25183481
28664,panitumumab,gene,0.9136,25183481
28665,KRAS,gene,0.907,25183481
28666,LCS6,DNA,0.632,25183481
28667,LCS6-variant,gene,0.958,25183481
28668,variant or,mutation,,25183481
28669,rs61764370,gene,,25183481
28670,rs61764370,mutation,,25183481
28671,KRAS oncogene,gene,0.8945,25183481
28672,anti-EGFR monoclonal antibody,gene,0.9883,25183481
28673,metastatic colorectal cancer,disease,1.0,25183481
28674,LCS6,DNA,0.504,25183481
28675,LCS6-variant,gene,0.6475,25183481
28676,KRAS,gene,0.8105,25183481
28677,BRAF,gene,0.665,25183481
28678,metastatic colorectal cancer,disease,0.9995,25183481
28679,anti-EGFR mAb,gene,0.96,25183481
28680,colon cancer cell lines,cell_line,0.8867,25183481
28681,colon cancer,disease,1.0,25183481
28682,LCS6-variant allele,gene,0.8247,25183481
28683,metastatic colorectal cancer,disease,1.0,25183481
28684,LCS6,DNA,0.713,25183481
28685,LCS6-variant,gene,0.735,25183481
28686,BRAF,gene,0.5054,25183481
28687,LCS6,gene,0.8325,25183481
28688,anti-EGFR mAb,gene,0.8604,25183481
28689,KRAS,gene,0.7896,25183481
28690,BRAF,gene,0.643,25183481
28691,anti-,gene,0.956,25183481
28692,EGFR mAb,gene,0.7905,25183481
28693,LCS6,gene,0.6675,25183481
28694,Cell line,cell_line,0.5283,25183481
28695,LCS6-variant allele,gene,0.786,25183481
28696,anti-,gene,0.931,25183481
28697,EGFR mAb,gene,0.7812,25183481
28698,LCS6,gene,0.481,25183481
28699,colorectal cancer,disease,1.0,25183481
28700,anti-EGFR mAb,gene,0.907,25183481
28701,anti-EGFR mAb,gene,0.94,25183481
28702,metastatic colorectal cancer,disease,1.0,25183481
28703,metastatic colorectal cancer,disease,0.9995,25138900
28704,metastatic colorectal cancer,disease,0.9995,25138900
28705,bevacizumab,gene,0.822,25138900
28706,aflibercept,gene,0.982,25138900
28707,cetuximab,gene,0.954,25138900
28708,panitumumab,gene,0.949,25138900
28709,regorafenib,drug,0.978,25138900
28710,metastatic colorectal cancer,disease,0.997,25138900
28711,RAS,gene,0.968,25138900
28712,patients,species,0.992,25138900
28713,colorectal cancer,disease,1.0,25138900
28714,KRAS,gene,0.992,25137394
28715,circulating tumor cells,cell_type,0.8906,25137394
28716,patients,species,0.9766,25137394
28717,Circulating tumor cells,cell_type,0.878,25137394
28718,CTCs,cell_type,0.8354,25137394
28719,cancer cells,cell_type,0.672,25137394
28720,cancer,disease,1.0,25137394
28721,tumoral,disease,0.971,25137394
28722,KRAS,DNA,0.871,25137394
28723,KRAS mutations,gene,0.965,25137394
28724,CTCs,cell_type,0.7637,25137394
28725,patients,species,0.859,25137394
28726,metastatic colorectal cancer,disease,1.0,25137394
28727,mCRC,disease,1.0,25137394
28728,primary tumors,disease,0.961,25137394
28729,KRAS,DNA,0.808,25137394
28730,KRAS mutations,gene,0.961,25137394
28731,codons 12 and 13,DNA,0.707,25137394
28732,KRAS mutant cancer cells,cell_line,0.9434,25137394
28733,KRAS mutant cancer,disease,0.9463,25137394
28734,KRAS,gene,0.9717,25137394
28735,Epithelial,cell_type,0.4585,25137394
28736,KRAS mutations,gene,0.9688,25137394
28737,tumor cells,cell_type,0.848,25137394
28738,tumor,disease,0.997,25137394
28739,blood samples,cell_type,0.474,25137394
28740,patients,species,0.948,25137394
28741,mCRC,disease,0.9976,25137394
28742,patients,species,0.9683,25137394
28743,PIK3CA,DNA,0.6543,25137394
28744,PIK3CA,gene,0.994,25137394
28745,BRAF,gene,0.996,25137394
28746,primary,disease,0.9463,25137394
28747,tumors,disease,0.7812,25137394
28748,KRAS mutant tumors,disease,0.8867,25137394
28749,KRAS,gene,0.979,25137394
28750,CTCs,cell_line,0.6104,25137394
28751,CTCs,cell_type,0.835,25137394
28752,patients,species,0.988,25137394
28753,KRAS,DNA,0.8003,25137394
28754,KRAS mutation,gene,0.919,25137394
28755,CTC,cell_type,0.8047,25137394
28756,patients,species,0.99,25137394
28757,tumors,disease,0.9937,25137394
28758,CTCs,cell_type,0.8496,25137394
28759,KRAS,gene,0.991,25137394
28760,patient,species,0.9937,25137394
28761,CTCs,cell_line,0.6455,25137394
28762,CTCs,disease,0.6353,25137394
28763,KRAS,DNA,0.9326,25137394
28764,KRAS,gene,0.989,25137394
28765,CTCs,cell_type,0.836,25137394
28766,tumor cells,cell_type,0.7295,25137394
28767,tumor,disease,1.0,25137394
28768,KRAS,DNA,0.8633,25137394
28769,KRAS mutation,gene,0.947,25137394
28770,mCRC,disease,0.9985,25137394
28771,patients,species,0.9917,25137394
28772,advanced sigmoid colon cancer,disease,1.0,25131880
28773,liver metastases,disease,0.912,25131880
28774,patients,species,0.975,25131880
28775,advanced colorectal cancer,disease,1.0,25131880
28776,liver metastases,disease,0.988,25131880
28777,patients,species,0.9873,25131880
28778,liver dysfunction,disease,1.0,25131880
28779,advanced sigmoid colon cancer,disease,1.0,25131880
28780,icterus,disease,0.9507,25131880
28781,liver metastases,disease,0.9746,25131880
28782,cetuximab,gene,0.814,25131880
28783,man,species,0.9146,25131880
28784,tarry,disease,0.901,25131880
28785,abdominal distention,disease,0.996,25131880
28786,advanced sigmoid colon cancer,disease,1.0,25131880
28787,liver metastases,disease,0.968,25131880
28788,ascites,disease,0.9995,25131880
28789,patient,species,0.9805,25131880
28790,tumor,disease,0.578,25131880
28791,adenocarcinoma,disease,1.0,25131880
28792,KRAS,gene,0.9863,25131880
28793,advanced sigmoid colon cancer,disease,1.0,25131880
28794,hepatic metastases,disease,0.8276,25131880
28795,Cetuximab,gene,0.9287,25131880
28796,cetuximab,gene,0.9707,25131880
28797,liver metastases,disease,0.96,25131880
28798,5-fluorouracil,drug,0.9995,25131880
28799,Leucovorin,drug,0.9985,25131880
28800,oxaliplatin,drug,0.9995,25131880
28801,FOLFOX,drug,0.9434,25131880
28802,cetuximab,gene,0.8945,25131880
28803,rash,disease,0.995,25131880
28804,liver metastases,disease,0.991,25131880
28805,irinotecan,drug,0.994,25131880
28806,S-1,drug,0.9854,25131880
28807,IRIS,drug,0.991,25131880
28808,irinotecan,drug,0.9966,25131880
28809,panitumumab,gene,0.7534,25131880
28810,patient,species,0.9814,25131880
28811,panitumumab,gene,0.8857,25129084
28812,K-ras wild,DNA,0.679,25129084
28813,K-ras,gene,0.999,25129084
28814,Panitumumab,gene,0.862,25129084
28815,colorectal cancer,disease,1.0,25129084
28816,panitumumab,gene,0.9233,25129084
28817,K-ras,gene,0.9985,25129084
28818,colorectal cancers,disease,0.9995,25129084
28819,patients,species,0.99,25129084
28820,panitumumab,gene,0.7993,25129084
28821,patients,species,0.9897,25129084
28822,panitumumab,gene,0.8154,25129084
28823,patients,species,0.9917,25129084
28824,panitumumab,gene,0.9023,25129084
28825,skin disorders,disease,0.9995,25129084
28826,interstitial pneumonia,disease,1.0,25129084
28827,patient,species,0.985,25129084
28828,peripheral neuropathy,disease,1.0,25129084
28829,patient,species,0.968,25129084
28830,neutropenia,disease,1.0,25129084
28831,patient,species,0.946,25129084
28832,patients,species,0.985,25129084
28833,peripheral neuropathy,disease,1.0,25129084
28834,neutropenia,disease,1.0,25129084
28835,panitumumab,gene,0.9424,25129084
28836,panitumumab,gene,0.8696,25129084
28837,panitumumab,gene,0.8506,25117978
28838,trastuzumab,gene,0.8657,25117978
28839,MEK,gene,0.992,25117978
28840,Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations,DNA,0.734,25117978
28841,Kirsten rat sarcoma viral oncogene homolog,gene,0.996,25117978
28842,KRAS,gene,0.9873,25117978
28843,epidermal growth factor receptor,gene,0.997,25117978
28844,EGFR),gene,0.996,25117978
28845,pancreatic ductal adenocarcinoma,disease,1.0,25117978
28846,PDAC,disease,1.0,25117978
28847,PDAC,disease,0.9976,25117978
28848,mitogen-activated protein kinase-extracellular-signal-regulated kinase (ERK) kinase1/2,gene,0.954,25117978
28849,MEK1/2,gene,0.9985,25117978
28850,trametinib,drug,0.9966,25117978
28851,EGFR,gene,0.999,25117978
28852,human epidermal growth factor receptor 2,gene,0.998,25117978
28853,human,species,0.849,25117978
28854,HER2,gene,0.9985,25117978
28855,lapatinib,drug,0.9966,25117978
28856,panitumumab,gene,0.9014,25117978
28857,EGFR,gene,0.9883,25117978
28858,trastuzumab,gene,0.893,25117978
28859,HER2,gene,0.9937,25117978
28860,EGFR,gene,0.995,25117978
28861,HER2,gene,0.995,25117978
28862,patient-derived xenograft (PDX) tumors,cell_line,0.6304,25117978
28863,patient,species,0.971,25117978
28864,tumors,disease,0.646,25117978
28865,EGFR,gene,0.766,25117978
28866,HER2,gene,0.9146,25117978
28867,MEK1/2,gene,0.997,25117978
28868,trametinib,drug,0.9854,25117978
28869,PDX tumors,cell_line,0.661,25117978
28870,KRAS mutant xenograft groups,cell_line,0.6353,25117978
28871,KRAS,gene,0.9927,25117978
28872,trametinib,drug,0.995,25117978
28873,tumors,disease,0.952,25117978
28874,tumor,disease,0.734,25117978
28875,KRAS,DNA,0.7344,25117978
28876,KRAS wild-type xenografts,cell_line,0.743,25117978
28877,KRAS,gene,0.993,25117978
28878,tumor 738,disease,0.9814,25117978
28879,trametinib,drug,0.999,25117978
28880,tumor,disease,0.9995,25117978
28881,trametinib,drug,0.998,25117978
28882,lapatinib,drug,0.999,25117978
28883,EGFR,gene,0.991,25117978
28884,HER2,gene,0.9854,25117978
28885,pancreatic cancer,disease,1.0,25117978
28886,KRAS,gene,0.984,25117978
28887,fibrosarcoma,disease,1.0,25117978
28888,fibrosarcoma kinase,gene,0.9453,25117978
28889,RAF,gene,0.9995,25117978
28890,MEK,gene,0.9976,25117978
28891,ERK,gene,0.9976,25117978
28892,EGFR,gene,0.996,25117978
28893,HER2,gene,0.9976,25117978
28894,patients,species,0.9854,25117978
28895,metastatic colorectal carcinoma,disease,1.0,25115714
28896,Bevacizumab,gene,0.5864,25115714
28897,humanized monoclonal IgG antibody,gene,0.9253,25115714
28898,humanized,species,0.6953,25115714
28899,vascular endothelial growth factor,gene,0.9966,25115714
28900,VEGF,gene,0.995,25115714
28901,patients,species,0.9736,25115714
28902,metastatic colorectal cancer,disease,1.0,25115714
28903,mCRC,disease,1.0,25115714
28904,bevacizumab,gene,0.937,25115714
28905,mCRC,disease,0.99,25115714
28906,cancer,disease,1.0,25115714
28907,PATIENTS,species,0.942,25115714
28908,patients,species,0.993,25115714
28909,bevacizumab,gene,0.899,25115714
28910,tumor,disease,0.9824,25115714
28911,patients,species,0.9736,25115714
28912,patients,species,0.993,25115714
28913,patients,species,0.939,25115714
28914,PD,disease,,25115714
28915,patient,species,0.9854,25115714
28916,patients,species,0.986,25115714
28917,patients,species,0.9946,25115714
28918,patient,species,0.9746,25115714
28919,mCRC,disease,0.999,25115714
28920,bevacizumab,gene,0.869,25115714
28921,patient,species,0.987,25115714
28922,bevacizumab,gene,0.942,25115714
28923,cetuximab,gene,0.858,25115714
28924,panitumumab,gene,0.881,25115714
28925,patient,species,0.9805,25115714
28926,RAS mutations,gene,0.808,25115304
28927,anti-EGFR monoclonal antibody,gene,0.816,25115304
28928,epidermal growth factor receptor,gene,0.9976,25115304
28929,EGFR,gene,0.9946,25115304
28930,metastatic colorectal cancer,disease,1.0,25115304
28931,mCRC,disease,1.0,25115304
28932,Kirsten rat sarcoma,disease,0.9517,25115304
28933,Kirsten rat sarcoma viral oncogene,gene,0.996,25115304
28934,KRAS,gene,0.994,25115304
28935,tumors,disease,0.935,25115304
28936,RAS mutations,gene,0.933,25115304
28937,exons 3 and 4,DNA,0.8203,25115304
28938,KRAS,gene,0.979,25115304
28939,"exons 2, 3 and 4",DNA,0.845,25115304
28940,NRAS,gene,0.985,25115304
28941,anti-EGFR mAbs,gene,0.9614,25115304
28942,tumors,disease,1.0,25115304
28943,RAS mutations,DNA,0.6006,25115304
28944,RAS mutations,gene,0.961,25115304
28945,Tumors,disease,0.9946,25115304
28946,RAS,DNA,0.5913,25115304
28947,RAS mutations,gene,0.861,25115304
28948,tumors,disease,1.0,25115304
28949,RAS,gene,0.994,25115304
28950,tumors,disease,1.0,25115304
28951,KRAS exon 2,gene,0.969,25115304
28952,EGFR,gene,0.6772,25115304
28953,participants,species,0.9873,25115304
28954,KRAS exon 2,DNA,0.862,25115304
28955,KRAS exon 2,gene,0.9907,25115304
28956,RAS mutations,gene,0.963,25115304
28957,KRAS exon,cell_line,0.5625,25115304
28958,KRAS,cell_type,0.51,25115304
28959,KRAS exon 2,gene,0.8525,25115304
28960,RAS mutations,gene,0.986,25115304
28961,Tumors,disease,0.924,25115304
28962,RAS,gene,0.9976,25115304
28963,KRAS exon 2,DNA,0.8584,25115304
28964,KRAS exon 2,gene,0.989,25115304
28965,RAS mutations,gene,0.8003,25115304
28966,anti-EGFR mAb,gene,0.986,25115304
28967,tumors,disease,1.0,25115304
28968,RAS,DNA,0.614,25115304
28969,RAS mutations,gene,0.9243,25115304
28970,tumors,disease,1.0,25115304
28971,KRAS exon 2,gene,0.99,25115304
28972,tumors,disease,1.0,25115304
28973,RAS mutations,gene,0.797,25115304
28974,anti-EGFR,gene,0.757,25115304
28975,EGFR mAb,gene,0.7915,25115304
28976,tumors,cell_type,0.4712,25115304
28977,tumors,disease,1.0,25115304
28978,RAS,DNA,0.6357,25115304
28979,RAS mutations,gene,0.777,25115304
28980,anti-EGFR mAbs,gene,0.9604,25115304
28981,tumors,disease,1.0,25115304
28982,RAS,DNA,0.5005,25115304
28983,RAS mutation,gene,0.9575,25115304
28984,RAS mutations,gene,0.973,25115304
28985,anti-,gene,0.8926,25115304
28986,EGFR mAb,gene,0.8086,25115304
28987,mCRC,disease,0.996,25115304
28988,epidermal growth factor receptor,gene,0.999,25110417
28989,epidermal growth factor receptor,gene,0.998,25110417
28990,EGFR,gene,0.993,25110417
28991,cetuximab,gene,0.644,25110417
28992,panitumumab,gene,0.7354,25110417
28993,patients,species,0.9463,25110417
28994,metastatic colorectal cancer,disease,1.0,25110417
28995,mCRC,disease,1.0,25110417
28996,patients,species,0.991,25110417
28997,K-ras,DNA,0.698,25110417
28998,K-ras mutations,gene,0.961,25110417
28999,K-ras,gene,0.998,25110417
29000,EGFR mAb,gene,0.987,25110417
29001,mCRC,disease,0.9907,25110417
29002,Ras,gene,0.988,25110417
29003,BRAF,gene,0.996,25110417
29004,MEK,gene,0.9956,25110417
29005,AKT,gene,0.9946,25110417
29006,cancer,disease,1.0,25110417
29007,EGFR,gene,0.991,25110417
29008,EGFR mAb,gene,0.9736,25110417
29009,patients,species,0.9766,25110417
29010,mCRC,disease,0.973,25110417
29011,anti-,gene,0.5645,25110417
29012,EGFR,gene,0.7754,25110417
29013,cancer,disease,1.0,25110417
29014,genes,DNA,0.459,25110417
29015,EGFR,gene,0.9976,25110417
29016,Ras,gene,0.9976,25110417
29017,ERK,gene,0.9956,25110417
29018,PI3K,gene,0.995,25110417
29019,KRAS,gene,0.9414,25110411
29020,anti-EGFR monoclonal antibodies,gene,0.8916,25110411
29021,epidermal growth factor receptor,gene,0.9985,25110411
29022,EGFR,gene,0.997,25110411
29023,EGFR,gene,0.963,25110411
29024,patients,species,0.9746,25110411
29025,metastatic colorectal cancer,disease,0.9995,25110411
29026,patients,species,0.983,25110411
29027,cetuximab,gene,0.8525,25110411
29028,panitumumab,gene,0.7305,25110411
29029,EGFR,gene,0.6973,25110411
29030,KRAS,DNA,0.8403,25110411
29031,KRAS,gene,0.975,25110411
29032,BRAF,gene,0.991,25110411
29033,NRAS,DNA,0.825,25110411
29034,NRAS,gene,0.966,25110411
29035,PI3KCA,gene,0.9976,25110411
29036,PTEN,DNA,0.606,25110411
29037,PTEN,gene,0.995,25110411
29038,colorectal cancer,disease,1.0,25110411
29039,patients,species,0.9937,25110411
29040,panitumumab,gene,0.972,25091317
29041,patients,species,0.9526,25091317
29042,advanced cutaneous squamous cell carcinoma,disease,0.997,25091317
29043,CSCC,disease,1.0,25091317
29044,panitumumab,gene,0.9717,25091317
29045,patients,species,0.976,25091317
29046,CSCC,disease,0.9995,25091317
29047,PATIENTS,species,0.942,25091317
29048,patients,species,0.9575,25091317
29049,panitumumab,gene,0.908,25091317
29050,Solid Tumours,disease,0.981,25091317
29051,patients,species,0.9907,25091317
29052,patients,species,0.9883,25091317
29053,patients,species,0.983,25091317
29054,patients,species,0.9883,25091317
29055,patients,species,0.9844,25091317
29056,patients,species,0.9814,25091317
29057,skin toxicity,disease,0.83,25091317
29058,patient,species,0.964,25091317
29059,skin,disease,0.782,25091317
29060,patients,species,0.991,25091317
29061,patient,species,0.982,25091317
29062,panitumumab,gene,0.9487,25091317
29063,patients,species,0.9688,25091317
29064,advanced CSCC,disease,0.8574,25091317
29065,patients,species,0.987,25089105
29066,KRAS,DNA,0.6655,25089105
29067,KRAS wild,gene,0.8755,25089105
29068,patients,species,0.982,25089105
29069,metastatic colorectal cancer,disease,1.0,25089105
29070,mcrc,disease,1.0,25089105
29071,mcrc,disease,1.0,25089105
29072,folfiri,drug,0.964,25089105
29073,cetuximab,gene,0.77,25089105
29074,folfiri,drug,0.9404,25089105
29075,panitumumab,gene,0.6675,25089105
29076,folfiri,drug,0.97,25089105
29077,patients,species,0.969,25089105
29078,KRAS,gene,0.9976,25089105
29079,type mcrc,gene,0.8003,25089105
29080,mcrc,DNA,0.4922,25089105
29081,patient,species,0.9927,25089105
29082,care,cell_type,0.4001,25089105
29083,Cancer,disease,0.9565,25089105
29084,Patient,species,0.9946,25089105
29085,mcrc,disease,1.0,25089105
29086,patients,species,0.9863,25089105
29087,KRAS,gene,0.996,25089105
29088,bevacizumab,gene,0.8438,25089105
29089,folfiri,drug,0.9775,25089105
29090,bevacizumab,gene,0.812,25089105
29091,cetuximab,gene,0.791,25089105
29092,bevacizumab,gene,0.565,25089105
29093,folfiri,drug,0.9785,25089105
29094,patients,species,0.9556,25089105
29095,KRAS,DNA,0.704,25089105
29096,KRAS,gene,0.996,25089105
29097,mcrc,disease,0.9663,25089105
29098,panitumumab,gene,0.9507,25089105
29099,folfiri,drug,0.8477,25089105
29100,cetuximab,gene,0.946,25089105
29101,folfiri,drug,0.831,25089105
29102,cetuximab,gene,0.9336,25089105
29103,folfiri,drug,0.9014,25089105
29104,bevacizumab,gene,0.937,25089105
29105,folfiri,drug,0.9766,25089105
29106,"frozen, thaw-and-use cells",cell_line,0.6445,25086226
29107,primary effector cells,cell_line,0.8657,25086226
29108,human,species,0.88,25086226
29109,blood,cell_type,0.486,25086226
29110,engineered Jurkat stable cell line,cell_line,0.8667,25086226
29111,effector cells,cell_type,0.872,25086226
29112,engineered effector cells,cell_line,0.8936,25086226
29113,Jurkat effector cells,cell_line,0.9546,25086226
29114,Jurkat effector cells,cell_type,0.5527,25086226
29115,Fc,gene,,25086226
29116,fresh cells,cell_type,0.5874,25086226
29117,continuous,cell_line,0.4673,25086226
29118,hematopoietic or solid tumors,disease,1.0,25086226
29119,antibody IgG isotypes,gene,0.658,25086226
29120,anti-CD20,gene,0.995,25086226
29121,anti-EGFR,gene,0.996,25086226
29122,rituximab,gene,0.989,25086226
29123,trastuzumab,gene,0.969,25086226
29124,PBMC,cell_type,0.9023,25086226
29125,glyco-modified trastuzumab,gene,0.7295,25086226
29126,antibody Fc,gene,0.9873,25086226
29127,skin toxicities,disease,0.981,25085331
29128,panitumumab,gene,0.8506,25085331
29129,panitumumab,gene,0.692,25085331
29130,cancer,disease,1.0,25085331
29131,rash,disease,0.9937,25085331
29132,patient,species,0.986,25085331
29133,panitumumab,gene,0.914,25085331
29134,colorectal cancer,disease,1.0,25085331
29135,papulopustular rash,disease,1.0,25085331
29136,patients,species,0.967,25085331
29137,Patients,species,0.9824,25085331
29138,rash,disease,0.9995,25085331
29139,rash,disease,0.883,25085331
29140,patients,species,0.98,25085331
29141,Rash,disease,0.9526,25085331
29142,patients,species,0.992,25085331
29143,Dermatologic,disease,0.63,25085331
29144,panitumumab,gene,0.6826,25085331
29145,binding site,DNA,0.638,25084055
29146,binding site,DNA,0.8203,25084055
29147,binding site,DNA,0.767,25084055
29148,human carcinoma cell lines,cell_line,0.972,25084055
29149,human,species,0.96,25084055
29150,carcinoma,disease,0.985,25084055
29151,epidermal growth factor receptor,gene,0.997,25084055
29152,EGFR,gene,0.994,25084055
29153,EGF,gene,0.996,25084055
29154,transforming growth factor alpha,gene,0.9946,25084055
29155,TGF-,gene,0.9937,25084055
29156,anti-EGFR antibodies,gene,0.988,25084055
29157,cetuximab,gene,0.665,25084055
29158,panitumumab,gene,0.816,25084055
29159,EGFR domain,gene,0.983,25084055
29160,EGFR,gene,0.9893,25084055
29161,cetuximab,gene,0.837,25084055
29162,panitumumab,gene,0.8145,25084055
29163,"TGF-,",gene,0.9795,25084055
29164,EGF,gene,0.997,25084055
29165,binding site,DNA,0.648,25084055
29166,advanced colorectal cancer,disease,1.0,25083064
29167,advanced colorectal cancer,disease,0.999,25083064
29168,patient,species,0.988,25083064
29169,patient,species,0.9937,25083064
29170,patients,species,0.9766,25083064
29171,patients,species,0.9756,25083064
29172,epidermal growth factor receptor antibodies,gene,0.993,25083064
29173,cetuximab,gene,0.943,25083064
29174,panitumumab,gene,0.928,25083064
29175,vascular endothelial growth factor,gene,0.99,25083064
29176,bevacizumab,gene,0.9688,25083064
29177,aflibercept,gene,0.99,25083064
29178,bevacizumab,gene,0.7817,25083064
29179,advanced colorectal cancer,disease,0.9966,25083064
29180,anti-epidermal growth factor receptor antibodies,gene,0.9863,25074246
29181,anti-epidermal growth factor receptor,gene,0.998,25074246
29182,patients,species,0.9707,25074246
29183,metastatic colorectal cancer,disease,1.0,25074246
29184,mCRC,disease,1.0,25074246
29185,patients,species,0.9766,25074246
29186,mCRC,disease,0.97,25074246
29187,Patients,species,0.973,25074246
29188,mCRC,disease,0.9956,25074246
29189,EGFR,gene,0.9487,25074246
29190,KRAS,gene,0.9844,25074246
29191,patients,species,0.964,25074246
29192,colon primary tumors,disease,1.0,25074246
29193,EGFR,gene,0.7725,25074246
29194,anti-EGFR antibody,gene,0.946,25074246
29195,anti-EGFR antibodies,gene,0.7427,25074246
29196,patients,species,0.9707,25074246
29197,mCRC,disease,0.995,25074246
29198,patients,species,0.9785,25074246
29199,EGFR,gene,0.569,25074246
29200,BRAF,DNA,0.609,25069797
29201,BRAF mutations,gene,0.9634,25069797
29202,metastatic colorectal cancers,disease,1.0,25069797
29203,patients,species,0.986,25069797
29204,BRAF-mutant tumors,disease,0.9478,25069797
29205,BRAF,gene,0.993,25069797
29206,PATIENTS,species,0.9824,25069797
29207,patients,species,0.9766,25069797
29208,colorectal cancer,disease,1.0,25069797
29209,BRAF mutations,DNA,0.7847,25069797
29210,BRAF mutations,gene,0.924,25069797
29211,Patients,species,0.9746,25069797
29212,patients,species,0.9917,25069797
29213,BRAF,DNA,0.878,25069797
29214,BRAF mutations,gene,0.7705,25069797
29215,tumors,disease,1.0,25069797
29216,BRAF,DNA,0.8413,25069797
29217,BRAF mutations,gene,0.867,25069797
29218,patients,species,0.984,25069797
29219,patients,species,0.989,25069797
29220,patients,species,0.964,25069797
29221,patients,species,0.979,25069797
29222,oxaliplatin,drug,1.0,25069797
29223,irinotecan,drug,0.999,25069797
29224,patients,species,0.952,25069797
29225,BRAF,gene,0.996,25069797
29226,metastatic colorectal cancer,disease,0.9995,25069797
29227,patients,species,0.9814,25069797
29228,metastatic colorectal cancers,disease,0.9746,25065664
29229,metastatic colorectal cancer,disease,0.8247,25065664
29230,tyrosine,drug,0.9956,25065664
29231,tyrosine kinase,gene,0.9893,25065664
29232,EGF-receptor,gene,0.996,25065664
29233,cetuximab,gene,0.9253,25065664
29234,panitumumab,gene,0.905,25065664
29235,cutaneous toxicity,disease,0.9634,25065664
29236,bevacizumab,gene,0.9404,25065664
29237,aflibercept,gene,0.97,25065664
29238,regorafenib,drug,0.9814,25065664
29239,hypertension,disease,1.0,25065664
29240,gastrointestinal cancers,disease,1.0,25065664
29241,Metastatic colorectal cancer,disease,0.983,25065655
29242,kirsten rat sarcoma,disease,1.0,25065655
29243,kirsten rat,species,0.7266,25065655
29244,Cancer,disease,0.766,25065655
29245,Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) gene,DNA,0.889,25065655
29246,Kirsten Rat Sarcoma Viral Oncogene Homolog,gene,0.998,25065655
29247,KRAS,gene,0.983,25065655
29248,epidermal growth factor receptor,gene,0.9966,25065655
29249,metastatic colorectal cancer,disease,1.0,25065655
29250,mCRC,disease,1.0,25065655
29251,KRAS genotype,gene,0.9414,25065655
29252,patients,species,0.9844,25065655
29253,patients,species,0.976,25065655
29254,mCRC,disease,0.9644,25065655
29255,KRAS,DNA,0.871,25065655
29256,KRAS,gene,0.977,25065655
29257,Patient,species,0.9927,25065655
29258,KRAS genotype,gene,0.9414,25065655
29259,mCRC,disease,0.996,25065655
29260,patients,species,0.9897,25065655
29261,KRAS,DNA,0.841,25065655
29262,KRAS,gene,0.949,25065655
29263,patients,species,0.9927,25065655
29264,Bevacizumab,gene,0.8955,25065655
29265,KRAS,gene,0.957,25065655
29266,patients,species,0.9844,25065655
29267,patients,species,0.946,25065655
29268,patients,species,0.993,25065655
29269,KRAS,DNA,0.643,25065655
29270,KRAS mutant,gene,0.9595,25065655
29271,patients,species,0.9893,25065655
29272,KRAS,DNA,0.7944,25065655
29273,KRAS WT,gene,0.9897,25065655
29274,patients,species,0.991,25065655
29275,human papillomavirus,species,0.7188,25057165
29276,Squamous cell carcinoma of the head and neck,disease,1.0,25057165
29277,SCCHN,disease,1.0,25057165
29278,human papillomavirus,disease,0.9995,25057165
29279,HPV,disease,0.97,25057165
29280,HPV,species,0.7314,25057165
29281,oropharyngeal tumors,disease,1.0,25057165
29282,HPV,disease,0.8853,25057165
29283,OPC,disease,1.0,25057165
29284,HPV,species,0.736,25057165
29285,patients,species,0.981,25057165
29286,HPV-positive (HPV+),disease,0.8413,25057165
29287,SCCHN,disease,0.934,25057165
29288,HPV,species,0.6436,25057165
29289,OPC,cell_type,0.793,25057165
29290,LA disease,disease,1.0,25057165
29291,RM disease,disease,1.0,25057165
29292,HPV,species,0.7476,25057165
29293,LA disease,disease,0.999,25057165
29294,patients,species,0.9575,25057165
29295,HPV,species,0.562,25057165
29296,patients,species,0.9873,25057165
29297,HPV,species,0.755,25057165
29298,HPV,species,0.741,25057165
29299,RM disease,disease,1.0,25057165
29300,HPV,species,0.6357,25057165
29301,panitumumab,gene,0.955,25053599
29302,patients,species,0.9663,25053599
29303,panitumumab,gene,0.9106,25053599
29304,patients,species,0.962,25053599
29305,metastatic colorectal cancer,disease,1.0,25053599
29306,mCRC,disease,1.0,25053599
29307,patients,species,0.993,25053599
29308,patients,species,0.972,25053599
29309,wild-type KRAS,gene,0.8423,25053599
29310,patients,species,0.9854,25053599
29311,skin toxicity,disease,0.871,25053599
29312,infections,disease,0.76,25053599
29313,diarrhea,disease,1.0,25053599
29314,dehydration,disease,1.0,25053599
29315,mucositis,disease,1.0,25053599
29316,hypokalemia,disease,1.0,25053599
29317,fatigue,disease,0.9995,25053599
29318,hypomagnesemia,disease,1.0,25053599
29319,pulmonary embolism,disease,1.0,25053599
29320,paronychia,disease,1.0,25053599
29321,skin toxicity,disease,0.962,25053599
29322,diarrhea,disease,1.0,25053599
29323,infection,disease,0.7583,25053599
29324,hypokalemia,disease,1.0,25053599
29325,mucositis,disease,1.0,25053599
29326,mCRC,disease,0.9976,25053599
29327,patients,species,0.991,25053599
29328,wild,DNA,0.5083,25053599
29329,wild-type KRAS,gene,0.926,25053599
29330,metastatic colorectal cancer,disease,0.8916,25045279
29331,Metastatic colorectal cancer,disease,0.9985,25045279
29332,patient,species,0.976,25045279
29333,epidermal growth factor receptor,gene,0.996,25045279
29334,panitumumab,gene,0.941,25045279
29335,cetuximab,gene,0.76,25045279
29336,cetuximab,gene,0.662,25045279
29337,cetuximab,gene,0.933,25045279
29338,bevacizumab,gene,0.5903,25045279
29339,KRAS exon 2,gene,0.983,25045279
29340,codons 12 and 13,DNA,0.6484,25045279
29341,vascular endothelial growth factor,gene,0.995,25045279
29342,bevacizumab,gene,0.501,25045279
29343,bevacizumab,gene,0.5283,25045279
29344,bevacizumab,gene,0.8604,25045279
29345,capecitabine,drug,0.999,25045279
29346,erlotinib,drug,0.996,25045279
29347,aflibercept,gene,0.9927,25045279
29348,regorafenib,drug,0.966,25045279
29349,metastatic colorectal cancer,disease,1.0,25045279
29350,patients,species,0.972,25045279
29351,metastatic colorectal cancer,disease,0.9985,25045279
29352,folliculitis,disease,1.0,25040914
29353,impetiginization,disease,0.93,25040914
29354,woman,species,0.6626,25040914
29355,EGFR gene polymorphisms,DNA,0.727,25039761
29356,EGFR gene,gene,0.988,25039761
29357,skin rash,disease,1.0,25039761
29358,anti-EGFR Cetuximab,gene,0.704,25039761
29359,panitumumab,gene,0.7354,25039761
29360,epidermal growth factor receptor,gene,0.9976,25039761
29361,EGFR,gene,0.9976,25039761
29362,metastatic colorectal cancer,disease,0.997,25039761
29363,mCRC,disease,0.9985,25039761
29364,patients,species,0.9683,25039761
29365,papulopustular rash,disease,0.9995,25039761
29366,tumor,disease,1.0,25039761
29367,EGFR gene,gene,0.993,25039761
29368,tumor,disease,1.0,25039761
29369,skin rash,disease,1.0,25039761
29370,EGFR gene,DNA,0.8545,25039761
29371,EGFR gene,gene,0.9946,25039761
29372,papulopustular rash,disease,1.0,25039761
29373,EGFR polymorphisms,gene,0.7944,25039761
29374,-216,DNA,0.8613,25039761
29375,-191,DNA,0.762,25039761
29376,CA-SSR,DNA,0.885,25039761
29377,R521K,DNA,0.6304,25039761
29378,R521,mutation,,25039761
29379,patients,species,0.9653,25039761
29380,mCRC,disease,0.999,25039761
29381,EGFR,gene,0.5986,25039761
29382,cutaneous rash,disease,1.0,25039761
29383,tumor,disease,1.0,25039761
29384,SNP-216,DNA,0.6895,25039761
29385,tumor,disease,1.0,25039761
29386,tumor,disease,1.0,25039761
29387,patients,species,0.9893,25039761
29388,skin rash,disease,0.998,25039761
29389,SNP-216,DNA,0.5767,25039761
29390,SNP,gene,0.5,25039761
29391,EGFR gene,gene,0.9937,25039761
29392,tumor,disease,1.0,25039761
29393,skin rash,disease,1.0,25039761
29394,metastatic colon cancer,disease,0.993,25024813
29395,metastatic colon cancer,disease,0.992,25024813
29396,epidermal growth factor receptor,gene,0.997,25024813
29397,anti-EGFR monoclonal antibody,gene,0.8936,24997207
29398,monoclonal antibodies,gene,0.733,24997207
29399,mAb,gene,0.8003,24997207
29400,cetuximab,gene,0.7764,24997207
29401,panitumumab,gene,0.78,24997207
29402,human epidermal growth factor receptor,gene,0.999,24997207
29403,human,species,0.8613,24997207
29404,squamous cell carcinoma of the head and neck,disease,0.9995,24997207
29405,SCCHN,disease,1.0,24997207
29406,patients,species,0.9883,24997207
29407,patients,species,0.993,24997207
29408,TA,gene,,24997207
29409,SCCHN,disease,1.0,24997207
29410,patients,species,0.9966,24997207
29411,patient,species,0.95,24997207
29412,patients,species,0.988,24997207
29413,ASPECCT,DNA,0.486,24988928
29414,panitumumab,gene,0.9263,24988928
29415,cetuximab,gene,0.8945,24988928
29416,colorectal cancer,disease,1.0,24988928
29417,ASPECCT,DNA,0.516,24988927
29418,panitumumab,gene,0.9478,24988927
29419,cetuximab,gene,0.8896,24988927
29420,colorectal cancer,disease,1.0,24988927
29421,ASPECCT,DNA,0.516,24988926
29422,panitumumab,gene,0.9478,24988926
29423,cetuximab,gene,0.8896,24988926
29424,colorectal cancer,disease,1.0,24988926
29425,metastatic,disease,0.817,24985058
29426,colorectal cancer,disease,0.909,24985058
29427,Colorectal cancer,disease,1.0,24985058
29428,cancers,disease,1.0,24985058
29429,patients,species,0.985,24985058
29430,metastatic,disease,0.701,24985058
29431,Patients,species,0.984,24985058
29432,fluoropyrimidine,drug,0.9995,24985058
29433,irinotecan,drug,0.9995,24985058
29434,oxaliplatin,drug,0.9995,24985058
29435,cetuximab,gene,0.945,24985058
29436,panitumumab,gene,0.912,24985058
29437,bevacizumab,gene,0.845,24985058
29438,patient,species,0.9946,24985058
29439,EGFR-pathway oncogenes,gene,0.9316,24985058
29440,EGFR,gene,0.9795,24985058
29441,Patients,species,0.9507,24985058
29442,colorectal cancer,disease,1.0,24985058
29443,metastatic colorectal cancer,disease,0.9995,24971400
29444,patients,species,0.9707,24971400
29445,metastatic colorectal cancer,disease,1.0,24971400
29446,mCRC,disease,0.9985,24971400
29447,bevacizumab,gene,0.9136,24971400
29448,afibercept,gene,0.98,24971400
29449,epidermal growth factor receptor monoclonal antibodies,gene,0.9565,24971400
29450,cetuximab,gene,0.8975,24971400
29451,panitumumab,gene,0.902,24971400
29452,Cetuximab,gene,0.8667,24971400
29453,FOLFIRI,drug,0.9434,24971400
29454,irinotecan,drug,0.9995,24971400
29455,5-fuorouracil,drug,0.9985,24971400
29456,leucovorin,drug,0.9985,24971400
29457,patients,species,0.9863,24971400
29458,KRAS mutation-negative (wild-type) tumors,cell_line,0.721,24971400
29459,KRAS,gene,0.982,24971400
29460,tumors,disease,0.9946,24971400
29461,mCRC,disease,0.9834,24971400
29462,KRAS,DNA,0.888,24971400
29463,KRAS mutation,gene,0.9707,24971400
29464,KRAS,gene,0.9707,24971400
29465,mCRC,disease,0.996,24971400
29466,pathologists,cell_type,0.513,24971400
29467,KRAS,DNA,0.8774,24971400
29468,KRAS,gene,0.752,24971400
29469,KRAS,gene,0.98,24971400
29470,mCRC,disease,0.999,24971400
29471,KRAS,DNA,0.9043,24971400
29472,KRAS,gene,0.882,24971400
29473,patient,species,0.9897,24971400
29474,gemcitabine,drug,0.9995,24960403
29475,oxaliplatin,drug,0.9995,24960403
29476,panitumumab,gene,0.6055,24960403
29477,KRAS,gene,0.992,24960403
29478,platinum,drug,0.9995,24960403
29479,biliary tract cancer,disease,1.0,24960403
29480,EGFR,gene,0.9834,24960403
29481,gastrointestinal malignancies,disease,1.0,24960403
29482,KRAS,gene,0.991,24960403
29483,colon cancer,disease,1.0,24960403
29484,panitumumab,gene,0.8887,24960403
29485,gemcitabine,drug,0.9995,24960403
29486,GEM,drug,0.9917,24960403
29487,oxaliplatin,drug,0.9995,24960403
29488,KRAS,gene,0.996,24960403
29489,Patients,species,0.9585,24960403
29490,KRAS,DNA,0.561,24960403
29491,KRAS wild-type biliary tract or gallbladder adenocarcinoma,disease,0.9976,24960403
29492,KRAS,gene,0.989,24960403
29493,panitumumab,gene,0.887,24960403
29494,GEM,drug,0.9966,24960403
29495,OX,drug,,24960403
29496,patients,species,0.981,24960403
29497,anaemia,disease,1.0,24960403
29498,leukopenia,disease,1.0,24960403
29499,fatigue,disease,0.9995,24960403
29500,neuropathy,disease,1.0,24960403
29501,rash,disease,1.0,24960403
29502,gemcitabine,drug,0.9995,24960403
29503,oxaliplatin,drug,0.9995,24960403
29504,panitumumab,gene,0.8115,24960403
29505,KRAS,gene,0.9976,24960403
29506,metastatic biliary tract cancer,disease,1.0,24960403
29507,biliary tract cancer,disease,1.0,24960403
29508,KRAS,gene,0.829,24956256
29509,EGFR,gene,0.8926,24956256
29510,metastatic colorectal cancer,disease,0.9844,24956256
29511,metastatic colorectal cancer,disease,0.9995,24956256
29512,anti-,gene,0.5693,24956256
29513,EGFR,gene,0.5557,24956256
29514,KRAS codons 12 and 13,DNA,0.8066,24956256
29515,KRAS codons,gene,0.876,24956256
29516,anti-EGFR antibodies,gene,0.8965,24956256
29517,KRAS,gene,0.7734,24956256
29518,NRAS,gene,0.75,24956256
29519,RAS,gene,0.623,24956256
29520,anti-EGFR antibodies,gene,0.8013,24956256
29521,RAS,gene,0.592,24956256
29522,-,DNA,0.4946,24956256
29523,MAPK,gene,0.9976,24956256
29524,PI3K,gene,0.997,24956256
29525,-AKT pathways,DNA,0.481,24956256
29526,AKT,gene,0.997,24956256
29527,MET,gene,0.503,24956256
29528,HER,gene,0.986,24956256
29529,ErbB receptors,gene,0.9014,24956256
29530,EGFR,gene,0.996,24956256
29531,HER2,gene,0.994,24956256
29532,HER3,gene,0.994,24956256
29533,EGFR,gene,0.9966,24956256
29534,miRNAs,RNA,0.6475,24956256
29535,metastatic colorectal cancer,disease,0.988,24956256
29536,Hepatitis C virus,disease,0.987,24944464
29537,cancer,disease,1.0,24944464
29538,patients,species,0.984,24944464
29539,hepatitis C,disease,1.0,24944464
29540,cancer,disease,1.0,24944464
29541,patients,species,0.9873,24944464
29542,cancer,disease,1.0,24944464
29543,patients,species,0.9946,24944464
29544,Gastrointestinal Cancer,disease,0.998,24944464
29545,rituximab,gene,0.9033,24944464
29546,alemtuzumab,gene,0.7085,24944464
29547,brentuximab,gene,0.676,24944464
29548,hepatitis,disease,1.0,24944464
29549,hepatitis C,disease,1.0,24944464
29550,tyrosine,drug,0.9834,24944464
29551,tyrosine kinase,gene,0.991,24944464
29552,imatinib,drug,0.994,24944464
29553,mammalian target,DNA,0.564,24944464
29554,mammalian target of rapamycin,gene,0.869,24944464
29555,rapamycin,drug,0.9956,24944464
29556,mTOR,gene,0.9946,24944464
29557,everolimus,drug,0.998,24944464
29558,HER,gene,0.974,24944464
29559,trastuzumab,gene,0.932,24944464
29560,pertuzumab,gene,0.8784,24944464
29561,lapatinib,drug,0.995,24944464
29562,epidermal growth factor receptor,gene,0.995,24944464
29563,cetuximab,gene,0.7007,24944464
29564,panitumumab,gene,0.752,24944464
29565,rituximab,gene,0.967,24944464
29566,hepatitis C virus,disease,0.999,24944464
29567,hepatitis,species,0.5103,24944464
29568,HCV,species,0.7617,24944464
29569,patients,species,0.9526,24944464
29570,hepatic flare,disease,0.997,24944464
29571,HCV ribonucleic acid,RNA,0.7593,24944464
29572,HCV,species,0.8286,24944464
29573,HCV-RNA,RNA,0.722,24944464
29574,HCV,species,0.764,24944464
29575,patients,species,0.988,24944464
29576,chronic active hepatitis,disease,1.0,24944464
29577,cirrhosis,disease,1.0,24944464
29578,rituximab,gene,0.9233,24944464
29579,HCV,species,0.79,24944464
29580,HCV,species,0.7217,24944464
29581,alemtuzumab,gene,0.598,24944464
29582,HCV RNA,RNA,0.752,24944464
29583,HCV,species,0.6763,24944464
29584,Brentuximab,gene,0.726,24944464
29585,brentuximab,gene,0.8423,24944464
29586,HCV infected,disease,0.8535,24944464
29587,patients,species,0.9873,24944464
29588,hepatitis C,disease,1.0,24944464
29589,hepatitis C,disease,1.0,24944464
29590,imatinib,drug,0.9976,24944464
29591,hepatitis B,disease,1.0,24944464
29592,imatinib,drug,0.998,24944464
29593,hepatitis B,disease,1.0,24944464
29594,imatinib,drug,0.997,24944464
29595,imatinib,drug,0.9976,24944464
29596,imatinib,drug,0.9976,24944464
29597,HCV,species,0.6294,24944464
29598,human epidermal growth factor receptor 2,gene,0.997,24944464
29599,human,species,0.8584,24944464
29600,hepatic flare,disease,0.9897,24944464
29601,HCV infected,disease,0.901,24944464
29602,patients,species,0.9854,24944464
29603,mTOR,gene,0.99,24944464
29604,patients,species,0.9614,24944464
29605,hepatitis C,disease,0.994,24944464
29606,hepatic flare,disease,0.996,24944464
29607,Cetuximab,gene,0.924,24944464
29608,panitumumab,gene,0.8364,24944464
29609,HCV,disease,0.9194,24944464
29610,HCV infected,disease,0.999,24944464
29611,melanoma,disease,0.5815,24944464
29612,HCV,disease,0.908,24944464
29613,HCV,species,0.733,24944464
29614,hepatic flare,disease,0.8735,24944464
29615,HCV infected,disease,0.8794,24944464
29616,cancer,disease,0.9863,24944464
29617,patients,species,0.992,24944464
29618,rilotumumab,gene,0.4905,24919569
29619,ganitumab,gene,0.752,24919569
29620,panitumumab,gene,0.7583,24919569
29621,Panitumumab,gene,0.898,24919569
29622,fully human anti-epidermal growth factor receptor monoclonal antibody,gene,0.894,24919569
29623,human,species,0.834,24919569
29624,patients,species,0.96,24919569
29625,wild,DNA,0.5225,24919569
29626,wild-type KRAS,gene,0.8228,24919569
29627,metastatic colorectal cancer,disease,1.0,24919569
29628,mCRC,disease,1.0,24919569
29629,Rilotumumab,gene,0.506,24919569
29630,human,species,0.594,24919569
29631,hepatocyte growth factor,gene,0.9966,24919569
29632,HGF,gene,0.998,24919569
29633,scatter factor,gene,0.9893,24919569
29634,IGF1R,gene,0.9976,24919569
29635,ganitumab,gene,0.684,24919569
29636,panitumumab,gene,0.587,24919569
29637,patients,species,0.933,24919569
29638,wild-type KRAS,gene,0.8306,24919569
29639,mCRC,disease,0.9487,24919569
29640,panitumumab,gene,0.908,24919569
29641,panitumumab,gene,0.8403,24919569
29642,ganitumab,gene,0.607,24919569
29643,rilotumumab,gene,0.4907,24919569
29644,panitumumab,gene,0.9653,24919569
29645,rilotumumab,gene,0.5356,24919569
29646,panitumumab,gene,0.934,24919569
29647,ganitumab,gene,0.711,24919569
29648,panitumumab,gene,0.8984,24919569
29649,MET,gene,0.9937,24919569
29650,IGF-related protein,gene,0.922,24919569
29651,Panitumumab,gene,0.945,24919569
29652,rilotumumab,gene,0.5566,24919569
29653,ganitumab,gene,0.5376,24919569
29654,HGF,gene,0.9985,24919569
29655,rilotumumab,gene,0.81,24919569
29656,panitumumab,gene,0.5884,24919569
29657,patients,species,0.923,24919569
29658,mCRC,disease,0.976,24919569
29659,TGF,gene,0.9966,24916700
29660,amphiregulin,gene,0.997,24916700
29661,EGFR,gene,0.991,24916700
29662,EGFR,gene,0.9907,24916700
29663,mAbs cetuximab,gene,0.876,24916700
29664,panitumumab,gene,0.847,24916700
29665,RAS,gene,0.989,24916700
29666,EGFR,gene,0.9927,24916700
29667,KRAS,gene,0.9834,24916700
29668,patients,species,0.984,24916700
29669,resilient cells,cell_type,0.882,24916700
29670,KRAS,DNA,0.847,24916700
29671,KRAS mutations,gene,0.9756,24916700
29672,resistant subpopulation,cell_line,0.8667,24916700
29673,surrounding sensitive cells,cell_type,0.645,24916700
29674,three-dimensional cocultures,cell_line,0.689,24916700
29675,cetuximab-sensitive and -resistant cells,cell_type,0.8193,24916700
29676,cetuximab,gene,0.708,24916700
29677,EGFR ligands,gene,0.9253,24916700
29678,cells,cell_type,0.372,24916700
29679,cetuximab,gene,0.8657,24916700
29680,panitumumab,gene,0.7866,24916700
29681,EGFR ligands,gene,0.8447,24916700
29682,sensitive cells,cell_line,0.66,24916700
29683,sensitive cells,cell_type,0.798,24916700
29684,cetuximab,gene,0.7935,24916700
29685,EGFR,gene,0.995,24916700
29686,Colorectal cancer cells,cell_line,0.669,24916700
29687,Colorectal cancer,disease,1.0,24916700
29688,EGFR,gene,0.994,24916700
29689,cetuximab,gene,0.7607,24916700
29690,resistant,cell_line,0.5884,24916700
29691,resistant cells,cell_line,0.9434,24916700
29692,resistant cells,cell_type,0.6616,24916700
29693,sensitive parental cells,cell_type,0.756,24916700
29694,cetuximab,gene,0.897,24916700
29695,EGFR,gene,0.991,24916700
29696,TGF,gene,0.9956,24916700
29697,amphiregulin,gene,0.9907,24916700
29698,resistant cells,cell_line,0.929,24916700
29699,EGFR,gene,0.9946,24916700
29700,ERK,gene,0.9937,24916700
29701,sensitive cells,cell_type,0.8975,24916700
29702,Colorectal cancer cells,cell_line,0.8257,24916700
29703,Colorectal cancer,disease,1.0,24916700
29704,cetuximab,gene,0.8975,24916700
29705,panitumumab,gene,0.863,24916700
29706,TGF,gene,0.9976,24916700
29707,amphiregulin,gene,0.9863,24916700
29708,EGFR,gene,0.989,24916700
29709,Anti-EGFR,gene,0.8433,24916545
29710,colorectal cancer,disease,1.0,24916545
29711,Anti-epidermal growth-factor receptor,gene,0.986,24916545
29712,EGFR,gene,0.998,24916545
29713,colorectal cancer,disease,0.9966,24916545
29714,colorectal,disease,1.0,24916545
29715,patient,species,0.972,24916545
29716,EGFR,gene,0.858,24916545
29717,KRAS,DNA,0.8276,24916545
29718,KRAS mutation,gene,0.8564,24916545
29719,EGFR,gene,0.993,24916545
29720,EGFR,gene,0.5996,24916545
29721,tumor,disease,0.999,24916545
29722,anti-EGFR MoAb,gene,0.8623,24916545
29723,anti-EGFR,gene,0.932,24916545
29724,colorectal cancer,disease,0.9604,24916545
29725,folinic acid,drug,0.9995,24915899
29726,5-fluorouracil,drug,0.9995,24915899
29727,folinic acid,drug,0.999,24915899
29728,5-fluorouracil,drug,0.9995,24915899
29729,irinotecan,drug,0.998,24915899
29730,FOLFIRI,drug,0.978,24915899
29731,panitumumab,gene,0.9224,24915899
29732,bevacizumab,gene,0.601,24915899
29733,patients,species,0.9575,24915899
29734,metastatic colorectal cancer,disease,1.0,24915899
29735,mCRC,disease,1.0,24915899
29736,Patients,species,0.966,24915899
29737,mCRC,disease,0.9946,24915899
29738,oxaliplatin,drug,0.9995,24915899
29739,FOLFIRI,drug,0.971,24915899
29740,FOLFIRI,drug,0.978,24915899
29741,FOLFIRI,drug,0.953,24915899
29742,panitumumab,gene,0.9355,24915899
29743,bevacizumab,gene,0.683,24915899
29744,FOLFIRI,drug,0.99,24915899
29745,patients,species,0.976,24915899
29746,FOLFIRI,drug,0.9805,24915899
29747,FOLFIRI,drug,0.9414,24915899
29748,FOLFIRI,drug,0.992,24915899
29749,FOLFIRI,drug,0.984,24915899
29750,FOLFIRI,drug,0.9487,24915899
29751,FOLFIRI,drug,0.965,24915899
29752,FOLFIRI,drug,0.9775,24915899
29753,FOLFIRI,drug,0.9653,24915899
29754,FOLFIRI,drug,0.95,24915899
29755,panitumumab,gene,0.949,24915899
29756,bevacizumab,gene,0.6514,24915899
29757,FOLFIRI,drug,0.9634,24915899
29758,patients,species,0.931,24915899
29759,mCRC,disease,0.9697,24915899
29760,EGFR,gene,0.996,24913799
29761,colorectal cancer,disease,1.0,24913799
29762,Cetuximab,gene,0.6265,24913799
29763,panitumumab,gene,0.618,24913799
29764,anti-epidermal growth factor receptor,gene,0.9717,24913799
29765,anti-EGFR,gene,0.9873,24913799
29766,metastatic colorectal cancer,disease,1.0,24913799
29767,patients,species,0.994,24913799
29768,RAS,gene,0.9966,24913799
29769,patients,species,0.993,24913799
29770,EGFR,gene,0.996,24913799
29771,tumor cells,cell_type,0.8823,24913799
29772,tumor,disease,0.9956,24913799
29773,anti-,gene,0.8125,24913799
29774,EGFR,gene,0.737,24913799
29775,EGFR,gene,0.9966,24913799
29776,RAS,gene,0.998,24913799
29777,RAF,gene,0.999,24913799
29778,MEK,gene,0.998,24913799
29779,receptor tyrosine kinases,gene,0.9873,24913799
29780,tyrosine,drug,0.9893,24913799
29781,anti-EGFR antibodies,gene,0.824,24913799
29782,anti-EGFR,gene,0.7817,24913799
29783,MEK,gene,0.9976,24913799
29784,ERK,gene,0.996,24913799
29785,AKT,gene,0.9917,24913799
29786,Circulating tumor DNA,RNA,0.4668,24913799
29787,patient,cell_line,0.6406,24913799
29788,patient,species,0.5996,24913799
29789,patients,species,0.981,24913799
29790,EGFR,gene,0.996,24898788
29791,patients,species,0.977,24898788
29792,EGFR,gene,0.9956,24898788
29793,VEGF,gene,0.9893,24898788
29794,metastatic colorectal cancer,disease,0.9985,24898788
29795,VEGF,gene,0.9966,24898788
29796,bevacizumab,gene,0.7656,24898788
29797,anti-EGFR antibody cetuximab,gene,0.793,24898788
29798,EGFR,gene,0.995,24898788
29799,VEGF,gene,0.994,24898788
29800,patients,species,0.9673,24898788
29801,KRAS,gene,0.962,24898788
29802,NRAS,gene,0.9976,24898788
29803,EGFR,gene,0.8896,24898788
29804,EGFR,gene,0.8794,24898788
29805,VEGF,gene,0.815,24898788
29806,EGFR,gene,0.994,24898788
29807,EGFR,gene,0.9946,24898788
29808,metastatic colorectal cancer,disease,0.9976,24898788
29809,177Lu,drug,0.999,24889367
29810,cetuximab,gene,0.929,24889367
29811,panitumumab,gene,0.9355,24889367
29812,tumors,disease,1.0,24889367
29813,cetuximab,gene,0.94,24889367
29814,panitumumab,gene,0.9375,24889367
29815,epidermal growth factor receptor,gene,0.9976,24889367
29816,EGFR,gene,0.9897,24889367
29817,"1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacet acid",drug,0.9995,24889367
29818,"1,4,7-triazacyclononane-1,4,7-triacetic acid",drug,0.9995,24889367
29819,"3,6,9,15-tetraazabicyclo[9.3.1]-pentadeca-1(15),11 acid",drug,0.9976,24889367
29820,lutetium,drug,0.999,24889367
29821,EGFR-expressing cell lines,cell_line,0.9287,24889367
29822,EGFR,gene,0.459,24889367
29823,-expressing cell,cell_type,0.425,24889367
29824,target cells,cell_type,0.837,24889367
29825,cetuximab,gene,0.9453,24889367
29826,panitumumab,gene,0.876,24889367
29827,lutetium-177,drug,0.887,24889367
29828,EGFR,gene,0.9956,24889367
29829,lutetium,drug,0.9985,24889367
29830,cancer,disease,0.9995,24885589
29831,target,cell_type,0.515,24885589
29832,targeted cells,cell_type,0.816,24885589
29833,mAb,gene,0.816,24885589
29834,ATP,drug,0.9844,24885589
29835,luciferase-transfected MDA-MB-468luc cell line,cell_line,0.925,24885589
29836,luciferase,gene,0.92,24885589
29837,EGFR,gene,0.992,24885589
29838,luciferase,gene,0.988,24885589
29839,panitumumab,gene,0.976,24885589
29840,Pan,gene,0.8994,24885589
29841,MDA-MB-468luc,cell_line,0.945,24885589
29842,orthotopic breast cancer,disease,0.876,24885589
29843,cetuximab,gene,0.9326,24880984
29844,panitumumab,gene,0.904,24880984
29845,metastatic colorectal cancer,disease,1.0,24880984
29846,anti-EGFR,gene,0.966,24880984
29847,metastatic,disease,0.9897,30190967
29848,colorectal cancer,disease,0.76,30190967
29849,cetuximab,gene,0.9526,30190967
29850,panitumumab,gene,0.958,30190967
29851,bevacizumab,gene,0.898,30190967
29852,aflibercept,gene,0.969,30190967
29853,regorafenib,drug,0.925,30190967
29854,metastatic colorectal cancer,disease,1.0,30190967
29855,patient,species,0.956,30190967
29856,metastatic colorectal cancer,disease,0.999,30190967
29857,cetuximab,gene,0.93,24876815
29858,panitumumab,gene,0.865,24876815
29859,metastatic colorectal cancer,disease,0.9995,24876815
29860,anti-EGFR antibodies,gene,0.9014,24876815
29861,cetuximab,gene,0.8296,24876815
29862,panitumumab,gene,0.822,24876815
29863,mCRC,disease,0.962,24876815
29864,EGFR,gene,0.997,24876815
29865,malignant cells,cell_type,0.897,24876815
29866,malignant,disease,0.9985,24876815
29867,EGFR,gene,0.9937,24876815
29868,EGFR,gene,0.866,24876815
29869,mCRC,disease,0.9907,24876815
29870,cetuximab,gene,0.9116,24876815
29871,panitumab,gene,0.5815,24876815
29872,RAS,DNA,0.719,24876815
29873,RAS mutations,gene,0.879,24876815
29874,EGFR gene,gene,0.7705,24876815
29875,PI3KCA gene,gene,0.6978,24876815
29876,P53,gene,0.997,24876815
29877,PTEN,gene,0.9937,24876815
29878,EGFR,gene,0.986,24876815
29879,Cetuximab,gene,0.905,24876815
29880,IgG1 class antibody,gene,0.943,24876815
29881,neoplasm cells,cell_type,0.8975,24876815
29882,neoplasm,disease,0.989,24876815
29883,panitumumab,gene,0.8926,24876815
29884,IgG2 class antibody,gene,0.9478,24876815
29885,cetuximab,gene,0.9346,24876815
29886,receptor immunoglobulin Fc fragments,gene,0.9956,24876815
29887,FcRIIa,gene,0.9956,24876815
29888,FcRIII,gene,0.996,24876815
29889,HPV16,species,0.8794,24875798
29890,squamous cell cancers of the head and neck,disease,0.999,24875798
29891,anti-,gene,0.839,24839940
29892,EGFR antibodies,gene,0.802,24839940
29893,KRAS-mutated colon cancer,disease,0.986,24839940
29894,KRAS,gene,0.9663,24839940
29895,patients,species,0.99,24839940
29896,anti-EGFR monoclonal antibody,gene,0.9707,24839940
29897,metastatic colorectal cancer,disease,1.0,24839940
29898,mCRC,disease,1.0,24839940
29899,anti-EGFR MoAb,gene,0.8755,24839940
29900,anti-EGFR MoAb,gene,0.8623,24839940
29901,mCRC,disease,0.996,24839940
29902,patients,species,0.986,24839940
29903,KRAS,DNA,0.7456,24839940
29904,KRAS mutations,gene,0.897,24839940
29905,KRAS,DNA,0.6436,24839940
29906,KRAS mutational,gene,0.754,24839940
29907,BRAF,gene,0.9956,24839940
29908,PIK3CA,gene,0.9966,24839940
29909,PTEN,gene,0.8677,24839940
29910,MET,DNA,0.761,24839940
29911,MET,gene,0.99,24839940
29912,patients,species,0.9717,24839940
29913,KRAS-mutant tumors,cell_line,0.75,24839940
29914,KRAS,gene,0.99,24839940
29915,p.G13,mutation,,24839940
29916,p.G12,mutation,,24839940
29917,p.G12,mutation,,24839940
29918,G12C,DNA,0.5146,24839940
29919,G12,mutation,,24839940
29920,Patients,species,0.9907,24839940
29921,p,DNA,0.5015,24839940
29922,p.G13,mutation,,24839940
29923,patients,species,0.9956,24839940
29924,KRAS mutations,gene,0.929,24839940
29925,patients,species,0.989,24839940
29926,KRAS,DNA,0.7715,24839940
29927,KRAS mutations,gene,0.931,24839940
29928,Patients,species,0.954,24839940
29929,PTEN,gene,0.995,24839940
29930,PTEN,gene,0.994,24839940
29931,patients,species,0.9253,24839940
29932,KRAS,DNA,0.6436,24839940
29933,KRAS mutations,gene,0.871,24839940
29934,MET,gene,0.995,24839940
29935,MET,gene,0.9946,24839940
29936,patients,species,0.9688,24839940
29937,KRAS,DNA,0.6455,24839940
29938,KRAS mutations,gene,0.9165,24839940
29939,PTEN,gene,0.9893,24839940
29940,MET,gene,0.9927,24839940
29941,anti-EGFR MoAbs,gene,0.824,24839940
29942,mCRC,disease,0.9985,24839940
29943,patients,species,0.9727,24839940
29944,KRAS,DNA,0.721,24839940
29945,KRAS mutations,gene,0.9175,24839940
29946,KRAS p.G13D mutation,gene,0.8594,24839940
29947,p.G13,mutation,,24839940
29948,EGFR,gene,0.6597,24839940
29949,KRAS,DNA,0.7847,24839940
29950,KRAS mutations,gene,0.9316,24839940
29951,cisplatin,drug,1.0,24837597
29952,5-fluorouracil,drug,0.9995,24837597
29953,panitumumab,gene,0.82,24837597
29954,patients,species,0.9614,24837597
29955,cisplatin,drug,1.0,24837597
29956,5-fluorouracil,drug,0.9995,24837597
29957,cisplatin,drug,0.9995,24837597
29958,5-fluorouracil,drug,0.9985,24837597
29959,recurrent/metastatic squamous cell carcinoma of the head and neck,disease,0.9917,24837597
29960,cisplatin,drug,0.9995,24837597
29961,5-fluorouracil,drug,0.9976,24837597
29962,cisplatin,drug,0.998,24837597
29963,cisplatin,drug,1.0,24837597
29964,5-fluorouracil,drug,0.9995,24837597
29965,patients,species,0.9536,24837597
29966,panitumumab,gene,0.693,24837597
29967,cisplatin,drug,1.0,24837597
29968,5-fluorouracil,drug,0.9995,24837597
29969,cisplatin,drug,1.0,24837597
29970,5-fluorouracil,drug,0.9995,24837597
29971,patients,species,0.9536,24837597
29972,neutropenia,disease,1.0,24837597
29973,hypomagnesemia,disease,1.0,24837597
29974,stomatitis,disease,1.0,24837597
29975,hyponatremia,disease,1.0,24837597
29976,paronychia,disease,1.0,24837597
29977,febrile neutropenia,disease,0.995,24837597
29978,decreased appetite,disease,0.993,24837597
29979,hypokalemia,disease,1.0,24837597
29980,cisplatin,drug,0.9976,24837597
29981,5-fluorouracil,drug,0.999,24837597
29982,cisplatin,drug,0.998,24837597
29983,5-fluorouracil,drug,0.9985,24837597
29984,cisplatin,drug,1.0,24837597
29985,5-fluorouracil,drug,0.9995,24837597
29986,recurrent/metastatic squamous cell carcinoma of the head and neck,disease,0.993,24837597
29987,patients,species,0.981,24837597
29988,EGFR,gene,0.9966,24831079
29989,breast cancer,disease,1.0,24831079
29990,EGFR,gene,0.9927,24831079
29991,breast cancer,disease,0.9976,24831079
29992,EGFR,gene,0.995,24831079
29993,EGFR,gene,0.9927,24831079
29994,EGFR,gene,0.995,24831079
29995,breast cancer,disease,0.999,24831079
29996,platinum salts,drug,0.933,24831079
29997,tyrosine,drug,0.9536,24831079
29998,tyrosine kinase,gene,0.9917,24831079
29999,Gefitinib,drug,0.9995,24831079
30000,estrogen,drug,0.9995,24831079
30001,estrogen receptor,gene,0.9907,24831079
30002,breast cancer,disease,0.997,24831079
30003,patients,species,0.9917,24831079
30004,anti-EGFR,gene,0.8843,24831079
30005,BRCA-mutated breast cancer,disease,0.9985,24831079
30006,BRCA,gene,0.932,24831079
30007,patients,species,0.9834,24831079
30008,epidermal [corrected] growth factor receptor,gene,0.997,24830936
30009,anti-,gene,0.692,24830936
30010,EGFR antibodies,gene,0.7886,24830936
30011,colorectal cancer,disease,1.0,24830936
30012,CRC,disease,1.0,24830936
30013,EGFR,gene,0.993,24830936
30014,EGFR,gene,0.995,24830936
30015,anti-EGFR antibody,gene,0.8745,24830936
30016,formalin,drug,0.9556,24830936
30017,tumor,disease,1.0,24830936
30018,EGFR,gene,0.993,24830936
30019,KRAS,gene,0.9727,24830936
30020,BRAF,DNA,0.788,24830936
30021,BRAF,gene,0.9834,24830936
30022,PIK3CA,gene,0.994,24830936
30023,NRAS,DNA,0.8667,24830936
30024,NRAS,gene,0.9775,24830936
30025,patients,species,0.9927,24830936
30026,KRAS,gene,0.9897,24830936
30027,patients,species,0.957,24830936
30028,EGFR,gene,0.991,24830936
30029,EGFR,gene,0.994,24830936
30030,EGFR downstream gene mutations,DNA,0.7144,24830936
30031,EGFR,gene,0.9653,24830936
30032,EGFR,gene,0.9844,24830936
30033,KRAS codon 146,DNA,0.7266,24830936
30034,KRAS codon 146 mutation,gene,0.8433,24830936
30035,NRAS codon 61,gene,0.9697,24830936
30036,EGFR downstream gene,DNA,0.7505,24830936
30037,EGFR downstream,gene,0.7563,24830936
30038,anti-,gene,0.606,24830936
30039,EGFR antibodies,gene,0.815,24830936
30040,metastatic colorectal cancer,disease,1.0,24830936
30041,patients,species,0.987,24830936
30042,panitumumab,gene,0.7593,24827135
30043,Triple-negative breast cancer,disease,1.0,24827135
30044,TNBC,disease,1.0,24827135
30045,tumors,disease,1.0,24827135
30046,epithelial growth factor receptor,gene,0.9976,24827135
30047,EGFR,gene,0.9956,24827135
30048,anti-EGFR antibody,gene,0.954,24827135
30049,panitumumab,gene,0.8457,24827135
30050,anthracycline,drug,0.9995,24827135
30051,taxane,drug,0.9995,24827135
30052,patients,species,0.933,24827135
30053,TNBC,disease,0.999,24827135
30054,PATIENTS,species,0.9683,24827135
30055,panitumumab,gene,0.722,24827135
30056,5-fluorouracil,drug,0.9995,24827135
30057,epidoxorubicin,drug,0.9995,24827135
30058,cyclophosphamide,drug,0.9995,24827135
30059,docetaxel,drug,0.9966,24827135
30060,patients,species,0.986,24827135
30061,patients,species,0.9854,24827135
30062,tumor,disease,1.0,24827135
30063,anti-EGFR antibody,gene,0.8867,24827135
30064,patients,species,0.9697,24827135
30065,EGFR,gene,0.996,24827135
30066,cytokeratin 8/18,gene,0.9873,24827135
30067,tumor cells,cell_type,0.72,24827135
30068,tumor,disease,0.9995,24827135
30069,CD8+ tumor-infiltrating lymphocytes,cell_type,0.7124,24827135
30070,CD8+,gene,0.9165,24827135
30071,tumor,disease,0.7725,24827135
30072,Panitumumab,gene,0.9194,24827135
30073,docetaxel,drug,0.9736,24827135
30074,TNBC,disease,0.992,24827135
30075,patients,species,0.9614,24827135
30076,patients,species,0.9585,24827135
30077,TNBC,cell_type,0.4714,24827135
30078,TNBC,disease,0.999,24827135
30079,everolimus,drug,0.9976,24819684
30080,5-FU,drug,0.9985,24819684
30081,mTOR,gene,0.997,24819684
30082,everolimus,drug,0.9966,24819684
30083,5-fluorouracil,drug,0.999,24819684
30084,leucovorin,drug,0.998,24819684
30085,5-FU,drug,0.9995,24819684
30086,5-FU,drug,0.9995,24819684
30087,oxaliplatin,drug,0.9995,24819684
30088,panitumumab,gene,0.8384,24819684
30089,patients,species,0.974,24819684
30090,solid tumors,disease,1.0,24819684
30091,Patients,species,0.9814,24819684
30092,patient,species,0.9766,24819684
30093,everolimus,drug,0.9985,24819684
30094,5-FU,drug,0.999,24819684
30095,everolimus,drug,0.9966,24819684
30096,panitumumab,gene,0.672,24819684
30097,patients,species,0.972,24819684
30098,DLT,disease,0.65,24819684
30099,patients,species,0.9795,24819684
30100,patients,species,0.988,24819684
30101,patients,species,0.9873,24819684
30102,patients,species,0.972,24819684
30103,patients,species,0.971,24819684
30104,mucositis,disease,0.9966,24819684
30105,everolimus,drug,0.996,24819684
30106,panitumumab,gene,0.7993,24819684
30107,patients,species,0.9824,24819684
30108,metastatic colorectal cancer,disease,0.9995,24819684
30109,patients,species,0.9893,24819684
30110,everolimus,drug,0.9976,24819684
30111,5-FU,drug,0.9985,24819684
30112,panitumumab,gene,0.8774,24819684
30113,mTOR,gene,0.9873,24819684
30114,patients,species,0.94,24819684
30115,solid tumors,disease,1.0,24819684
30116,mCRC,disease,0.999,24819684
30117,EGFR,gene,0.9956,24811491
30118,colorectal cancer,disease,1.0,24811491
30119,metastatic colorectal cancer,disease,0.999,24811491
30120,tumor,disease,0.856,24811491
30121,anti-epidermal growth factor receptor,gene,0.9688,24811491
30122,EGFR,gene,0.9688,24811491
30123,cetuximab,gene,0.912,24811491
30124,panitumumab,gene,0.846,24811491
30125,tumors,disease,1.0,24811491
30126,anti-EGFR antibodies,gene,0.878,24811491
30127,advanced colorectal cancer,disease,1.0,24793846
30128,K-RAS,gene,0.684,24793846
30129,Colorectal cancer,disease,1.0,24793846
30130,CRC,disease,1.0,24793846
30131,cancer,disease,1.0,24793846
30132,CRC,disease,0.9995,24793846
30133,K-RAS gene,gene,0.8545,24793846
30134,metastatic colorectal cancer,disease,1.0,24793846
30135,mCRC,disease,1.0,24793846
30136,tumour,disease,0.97,24793846
30137,epidermal growth factor receptor,gene,0.995,24793846
30138,EGFR,gene,0.9546,24793846
30139,K-RAS,DNA,0.662,24793846
30140,K-RAS mutations,gene,0.926,24793846
30141,EGFR,gene,0.9824,24793846
30142,panitumumab,gene,0.783,24793846
30143,cetuximab,gene,0.653,24793846
30144,K-RAS,gene,0.6377,24793846
30145,EGFR,gene,0.9487,24793846
30146,K-RAS,gene,0.6836,24793846
30147,CRC,disease,0.9976,24793846
30148,K-RAS gene,gene,0.8374,24793846
30149,mCRC,disease,0.6133,24793846
30150,vascular endothelial growth factor,gene,0.999,24793846
30151,VEGF,gene,0.995,24793846
30152,anti-VEGF antibody,gene,0.7686,24793846
30153,bevacizumab,gene,0.4382,24793846
30154,mCRC,disease,0.999,24793846
30155,bevacizumab,gene,0.585,24793846
30156,K-RAS,gene,0.6714,24793846
30157,EGFR,gene,0.5054,24793846
30158,mCRC,disease,0.961,24793846
30159,K-RAS gene,gene,0.853,24793846
30160,mCRC,disease,0.9604,24793846
30161,bevacizumab,gene,0.848,24793617
30162,panitumumab,gene,0.905,24793617
30163,irinotecan,drug,0.999,24793617
30164,5-fluorouracil,drug,0.9995,24793617
30165,leucovorin,drug,0.999,24793617
30166,FOLFIRI,drug,0.904,24793617
30167,metastatic colorectal cancer,disease,0.999,24793617
30168,Bevacizumab,gene,0.854,24793617
30169,panitumumab,gene,0.9253,24793617
30170,vascular endothelial growth factor,gene,0.9976,24793617
30171,epidermal growth factor receptor,gene,0.996,24793617
30172,bevacizumab,gene,0.8784,24793617
30173,panitumumab,gene,0.9497,24793617
30174,fluorouracil,drug,0.999,24793617
30175,leucovorin,drug,0.998,24793617
30176,irinotecan,drug,0.9985,24793617
30177,FOLFIRI,drug,0.5454,24793617
30178,metastatic colorectal cancer,disease,1.0,24793617
30179,mCRC,disease,1.0,24793617
30180,mCRC,disease,0.987,24793617
30181,oxaliplatin,drug,0.9995,24793617
30182,bevacizumab,gene,0.8916,24793617
30183,panitumumab,gene,0.888,24793617
30184,FOLFIRI,drug,0.987,24793617
30185,bevacizumab,gene,0.913,24793617
30186,panitumumab,gene,0.965,24793617
30187,FOLFIRI,drug,0.867,24793617
30188,mCRC,disease,0.98,24793617
30189,metastatic colorectal cancer,disease,1.0,24787230
30190,imatinib,drug,0.9966,24787230
30191,panitumumab,gene,0.875,24787230
30192,imatinib,drug,0.9985,24787230
30193,panitumumab,gene,0.9053,24787230
30194,metastatic colorectal cancer,disease,1.0,24787230
30195,mCRC,disease,1.0,24787230
30196,imatinib,drug,0.999,24787230
30197,mCRC,disease,0.9995,24787230
30198,liver,disease,0.5483,24787230
30199,c-Kit,gene,0.9946,24787230
30200,PDGFR,gene,0.9976,24787230
30201,c-Abl,gene,0.9937,24787230
30202,imatinib,drug,0.9985,24787230
30203,panitumumab,gene,0.8203,24787230
30204,panitumumab,gene,0.936,24787230
30205,drug,DNA,0.4607,24787230
30206,drug,DNA,0.5244,24787230
30207,AKT,gene,0.998,24787230
30208,mTOR,gene,0.9927,24787230
30209,receptor tyrosine kinases,gene,0.961,24787230
30210,tyrosine,drug,0.985,24787230
30211,receptor tyrosine kinases,gene,0.992,24782606
30212,tyrosine,drug,0.956,24782606
30213,gastric cancer,disease,1.0,24782606
30214,receptor tyrosine kinases,gene,0.995,24782606
30215,tyrosine,drug,0.984,24782606
30216,RTKs,gene,0.9893,24782606
30217,gastric cancer,disease,1.0,24782606
30218,Trastuzumab,gene,0.941,24782606
30219,ERBB2,gene,0.9653,24782606
30220,gastric cancer,disease,1.0,24782606
30221,receptor tyrosine kinases,gene,0.993,24782606
30222,tyrosine,drug,0.969,24782606
30223,epidermal growth factor receptor,gene,0.997,24782606
30224,vascular endothelial growth factor,gene,0.9976,24782606
30225,platelet-derived growth factor receptor,gene,0.9985,24782606
30226,c-Met,gene,0.997,24782606
30227,IGF-1R,gene,0.9966,24782606
30228,fibroblast growth factor receptor 2,gene,0.998,24782606
30229,gastric cancer,disease,1.0,24782606
30230,trastuzumab,gene,0.98,24782606
30231,gastric cancer,disease,1.0,24782606
30232,trastuzumab,gene,0.988,24782606
30233,factor receptor 2,gene,0.9937,24782606
30234,bevacizumab,gene,0.9263,24782606
30235,gastric cancer,disease,1.0,24782606
30236,bevacizumab,gene,0.959,24782606
30237,RTKs,gene,0.981,24782606
30238,cetuximab,gene,0.856,24782606
30239,panitumumab,gene,0.8936,24782606
30240,gefitinib,drug,0.996,24782606
30241,erlotinib,drug,0.9956,24782606
30242,figitumumab,gene,0.6763,24782606
30243,sorafenib,drug,0.9995,24782606
30244,sunitinib,drug,0.9985,24782606
30245,lapatinib,drug,0.9985,24782606
30246,gastric cancer,disease,1.0,24782606
30247,advanced gastric cancer,disease,1.0,24782606
30248,epidermal growth factor receptor,gene,0.998,24780353
30249,cetuximab,gene,0.8853,24780353
30250,panitumumab,gene,0.7773,24780353
30251,head and neck carcinoma cells,cell_line,0.681,24780353
30252,head and neck carcinoma,disease,1.0,24780353
30253,epidermal growth factor receptor,gene,0.998,24780353
30254,EGFR,gene,0.9863,24780353
30255,EGFR,gene,0.9834,24780353
30256,epidermal growth factor,gene,0.996,24780353
30257,cetuximab,gene,0.955,24780353
30258,panitumumab,gene,0.8965,24780353
30259,EGFR,gene,0.972,24780353
30260,original cell lines,cell_line,0.801,24780353
30261,EGFR,gene,0.995,24780353
30262,EGFR,gene,0.989,24780353
30263,cell lines,cell_line,0.931,24780353
30264,cetuximab,gene,0.8013,24780353
30265,panitumumab,gene,0.8145,24780353
30266,cell lines,cell_line,0.9395,24780353
30267,cetuximab,gene,0.9272,24780353
30268,panitumumab,gene,0.824,24780353
30269,EGFR,gene,0.894,24780353
30270,EGFR,gene,0.991,24780353
30271,head and neck cancer cell lines,cell_line,0.825,24780353
30272,head and neck cancer,disease,1.0,24780353
30273,cetuximab,gene,0.8843,24780353
30274,panitumumab,gene,0.8086,24780353
30275,head and neck cancer,disease,1.0,24780353
30276,metastatic colorectal cancer,disease,0.9966,24768040
30277,metastatic colorectal cancer,disease,1.0,24768040
30278,mCRC,disease,1.0,24768040
30279,bevacizumab,gene,0.874,24768040
30280,ziv-aflibercept,gene,0.9863,24768040
30281,regorafenib,drug,0.988,24768040
30282,mCRC,disease,0.9946,24768040
30283,bevacizumab,gene,0.9062,24768040
30284,mCRC,disease,0.966,24768040
30285,FOLFOX,drug,0.7363,24768040
30286,folinic acid,drug,0.9995,24768040
30287,5-fluorouracil,drug,0.9995,24768040
30288,oxaliplatin,drug,0.9995,24768040
30289,folinic acid,drug,0.9995,24768040
30290,5-fluorouracil,drug,0.9995,24768040
30291,irinotecan,drug,0.9985,24768040
30292,epidermal growth factor receptor,gene,0.9966,24768040
30293,cetuximab,gene,0.905,24768040
30294,panitumumab,gene,0.925,24768040
30295,wild-type KRAS,gene,0.7847,24768040
30296,ziv-aflibercept,gene,0.9805,24768040
30297,FOLFIRI,drug,0.946,24768040
30298,mCRC,disease,0.917,24768040
30299,Regorafenib,drug,0.995,24768040
30300,mCRC,disease,0.999,24768040
30301,mCRC,disease,0.9624,24768040
30302,advanced colorectal cancer,disease,1.0,24766530
30303,advanced colorectal cancer,disease,0.9995,24766530
30304,CRC,disease,1.0,24766530
30305,bevacizumab,gene,0.9478,24766530
30306,cetuximab,gene,0.961,24766530
30307,panitumumab,gene,0.941,24766530
30308,advanced CRC,disease,0.9844,24766530
30309,bevacizumab,gene,0.727,24766530
30310,cetuximab,gene,0.7393,24766530
30311,advanced CRC,disease,0.997,24766530
30312,metastatic disease,disease,0.972,24766530
30313,Panitumumab,gene,0.9224,24766434
30314,colorectal cancer,disease,1.0,24766434
30315,Panitumumab,gene,0.6743,24766434
30316,human IgG2 mAb,gene,0.7803,24766434
30317,EGFR,gene,0.993,24766434
30318,tumor cell,cell_type,0.4917,24766434
30319,tumor,disease,1.0,24766434
30320,metastatic colorectal cancer,disease,0.999,24766434
30321,CRC,disease,1.0,24766434
30322,RAS genes,gene,0.91,24766434
30323,panitumumab,gene,0.889,24766434
30324,RAS,gene,0.516,24766434
30325,wt,disease,0.856,24766434
30326,panitumumab,gene,0.81,24766434
30327,CRC,disease,0.643,24766434
30328,K-RAS,gene,0.637,24766434
30329,RAS,gene,0.994,24766434
30330,acne-like skin rash,disease,1.0,24766434
30331,diarrhea,disease,1.0,24766434
30332,hypomagnesaemia,disease,1.0,24766434
30333,Panitumumab,gene,0.894,24766434
30334,metastatic CRC,disease,0.8784,24766434
30335,panitumumab,gene,0.8755,24766434
30336,Skin toxicity,disease,0.9204,24766434
30337,panitumumab,gene,0.8657,24766434
30338,diarrhea,disease,1.0,24766434
30339,hypomagnesaemia,disease,1.0,24766434
30340,EGFR,gene,0.8906,24764664
30341,VEGF,gene,0.8594,24764664
30342,colorectal liver,disease,0.995,24764664
30343,Colorectal liver metastasis,disease,1.0,24764664
30344,CLM,disease,1.0,24764664
30345,patients,species,0.9585,24764664
30346,CLM,disease,1.0,24764664
30347,anti-epidermal growth factor receptor,gene,0.9976,24764664
30348,anti-EGFR,gene,0.997,24764664
30349,anti-vascular endothelial growth factor,gene,0.947,24764664
30350,anti-VEGF,gene,0.9863,24764664
30351,Kirsten rat sarcoma viral oncogene,gene,0.995,24764664
30352,KRAS,DNA,0.8555,24764664
30353,KRAS,gene,0.9907,24764664
30354,anti-,gene,0.5264,24764664
30355,EGFR,gene,0.685,24764664
30356,CLM,disease,1.0,24764664
30357,patients,species,0.9785,24764664
30358,KRAS G13D mutation,gene,0.987,24764664
30359,G13,mutation,,24764664
30360,cetuximab,gene,0.712,24764664
30361,KRAS,DNA,0.8477,24764664
30362,KRAS G13D mutation,gene,0.855,24764664
30363,G13D,DNA,0.469,24764664
30364,G13,mutation,,24764664
30365,EGFR,gene,0.672,24764664
30366,RAS mutations,gene,0.9614,24764664
30367,neuroblastoma RAS viral (v-ras) oncogene homolog,DNA,0.8047,24764664
30368,neuroblastoma RAS viral (v-ras) oncogene homolog,gene,0.986,24764664
30369,NRAS,gene,0.9966,24764664
30370,exons 3 and 4,DNA,0.8423,24764664
30371,KRAS,gene,0.9414,24764664
30372,PRIME,DNA,0.501,24764664
30373,patients,species,0.9907,24764664
30374,KRAS exon 2,DNA,0.752,24764664
30375,KRAS exon,gene,0.9287,24764664
30376,RAS mutations,gene,0.891,24764664
30377,panitumumab,gene,0.9487,24764664
30378,fluorouracil,drug,0.9985,24764664
30379,leucovorin,drug,0.998,24764664
30380,oxaliplatin,drug,0.999,24764664
30381,FOLFOX,drug,0.842,24764664
30382,patients,species,0.988,24764664
30383,KRAS,DNA,0.6006,24764664
30384,KRAS mutations,gene,0.93,24764664
30385,exon 2,DNA,0.8564,24764664
30386,anti-,gene,0.6987,24764664
30387,EGFR,gene,0.708,24764664
30388,cetuximab,gene,0.951,24764664
30389,FOLFOX,drug,0.9795,24764664
30390,bevacizumab,gene,0.9556,24764664
30391,oxaliplatin,drug,0.9995,24764664
30392,NO16966,drug,0.5776,24764664
30393,cetuximab,gene,0.8896,24764664
30394,FOLFOX,drug,0.976,24764664
30395,bevacizumab,gene,0.947,24764664
30396,oxaliplatin,drug,0.9995,24764664
30397,bevacizumab,gene,0.91,24764664
30398,cetuximab,gene,0.906,24764664
30399,bevacizumab,gene,0.797,24764664
30400,FIRE,DNA,0.497,24764664
30401,CLM,disease,1.0,24764664
30402,CLM,disease,1.0,24764664
30403,erlotinib,drug,0.9976,24764664
30404,bevacizumab,gene,0.6577,24764664
30405,NRAS,DNA,0.8525,24758538
30406,NRAS Mutations,gene,0.942,24758538
30407,Colorectal Cancer,disease,1.0,24758538
30408,Patients,species,0.9937,24758538
30409,Colorectal cancer,disease,1.0,24758538
30410,CRC,disease,1.0,24758538
30411,cancers,disease,1.0,24758538
30412,CRC,disease,0.9985,24758538
30413,anti-Epidermal Growth Factor Receptor,gene,0.9106,24758538
30414,EGFR,gene,0.987,24758538
30415,EGFR,gene,0.993,24758538
30416,tyrosine,drug,0.5186,24758538
30417,tyrosine kinase,gene,0.952,24758538
30418,RAS,gene,0.9985,24758538
30419,RAF,gene,0.996,24758538
30420,PIK3CA,gene,0.9834,24758538
30421,Cetuximab,gene,0.837,24758538
30422,panitumumab,gene,0.7666,24758538
30423,EGFR,gene,0.9805,24758538
30424,oncogene Kirsten-RAS,gene,0.984,24758538
30425,KRAS,DNA,0.8496,24758538
30426,KRAS,gene,0.9927,24758538
30427,EGFR,gene,0.9165,24758538
30428,KRAS wild-type (WT) tumors,cell_line,0.7085,24758538
30429,KRAS wild-type (WT) tumors,disease,0.9624,24758538
30430,KRAS,gene,0.9556,24758538
30431,EGFR,gene,0.8853,24758538
30432,BRAF,gene,0.9976,24758538
30433,NRAS,DNA,0.805,24758538
30434,NRAS,gene,0.976,24758538
30435,PIK3CA,gene,0.995,24758538
30436,PTEN,gene,0.9937,24758538
30437,Neuroblastoma-RAS,DNA,0.5576,24758538
30438,Neuroblastoma,disease,0.7847,24758538
30439,Neuroblastoma-,gene,0.9917,24758538
30440,RAS,gene,0.6973,24758538
30441,NRAS,gene,0.9995,24758538
30442,metastatic CRC,disease,1.0,24758538
30443,mCRC,disease,0.9985,24758538
30444,patients,species,0.987,24758538
30445,pts,species,0.977,24758538
30446,EGFR,gene,0.686,24758538
30447,Vemurafenib,drug,0.9995,24755613
30448,panitumumab,gene,0.8286,24755613
30449,BRAF,gene,0.9966,24755613
30450,cancer,disease,1.0,24755613
30451,cancer,disease,1.0,24755613
30452,"KRAS,",DNA,0.833,24755613
30453,KRAS,gene,0.9707,24755613
30454,"BRAF, and PIK3CA genes",DNA,0.6885,24755613
30455,BRAF,gene,0.9946,24755613
30456,PIK3CA genes,gene,0.99,24755613
30457,EGFR,gene,0.994,24755613
30458,metastatic colorectal cancer,disease,1.0,24755613
30459,mCRC,disease,1.0,24755613
30460,mCRC,disease,0.999,24755613
30461,patient,species,0.992,24755613
30462,vemurafenib,drug,0.9995,24755613
30463,Zelboraf,drug,0.9995,24755613
30464,panitumumab,gene,0.794,24755613
30465,BRAF(V600E),gene,0.9277,24755613
30466,V600,mutation,,24755613
30467,EGFR,gene,0.9946,24755613
30468,WT KRAS,gene,0.7114,24755613
30469,PIK3CA,gene,0.8335,24755613
30470,HER2,gene,0.984,24755613
30471,vemurafenib,drug,0.9995,24755613
30472,panitumumab,gene,0.9824,24755613
30473,vemurafenib,drug,0.997,24755613
30474,anti-EGFR,gene,0.9937,24755613
30475,panitumumab,gene,0.9297,24755613
30476,BRAF,DNA,0.6104,24755613
30477,BRAF(V600E),gene,0.924,24755613
30478,V600,mutation,,24755613
30479,vemurafenib,drug,0.998,24755613
30480,mCRC,disease,0.998,24755613
30481,patient,species,0.9927,24755613
30482,FcRIIa,gene,0.9897,24752341
30483,tumor cells,cell_type,0.87,24752341
30484,tumor,disease,0.9644,24752341
30485,monoclonal,gene,0.662,24752341
30486,human Fc receptors,gene,0.998,24752341
30487,FcRs,gene,0.9927,24752341
30488,FcRIIIa,gene,0.994,24752341
30489,natural killer (NK) cells,cell_type,0.937,24752341
30490,IgG1-subclass mAbs,gene,0.932,24752341
30491,FcRIIa,gene,0.987,24752341
30492,FcRIIa,gene,0.9873,24752341
30493,myeloid effector cells,cell_line,0.847,24752341
30494,myeloid effector cells,cell_type,0.872,24752341
30495,neutrophils,cell_type,0.7856,24752341
30496,macrophages,cell_type,0.6074,24752341
30497,effector cells,cell_type,0.667,24752341
30498,FcRIIa-expressing effector cells,cell_line,0.8057,24752341
30499,FcRIIa,gene,0.985,24752341
30500,-expressing effector cells,cell_type,0.7217,24752341
30501,human FcRIIa-expressing reporter cell line,cell_line,0.983,24752341
30502,human,species,0.8936,24752341
30503,FcRIIa,gene,0.995,24752341
30504,reporter cell,cell_type,0.511,24752341
30505,FcRIIa,gene,0.99,24752341
30506,FcRIIa,gene,0.9956,24752341
30507,anti-CD20 mAb,gene,0.9937,24752341
30508,rituximab,gene,0.6255,24752341
30509,Fc,gene,,24752341
30510,anti-EGFR mAbs,gene,0.982,24752341
30511,IgG,gene,0.99,24752341
30512,cetuximab,gene,0.93,24752341
30513,IgG1,gene,0.9917,24752341
30514,panitumumab,gene,0.8857,24752341
30515,IgG2,gene,0.817,24752341
30516,FcRIIa,gene,0.9897,24752341
30517,EGFR,gene,0.965,24752341
30518,cetuximab,gene,0.8545,24752341
30519,FcRIIa reporter,gene,0.8096,24752341
30520,Fc-engineered mAbs,gene,0.9146,24752341
30521,IgG2-subclass mAbs,gene,0.9863,24752341
30522,acneiform eruptions,disease,1.0,24748906
30523,cetuximab,gene,0.5913,24748906
30524,epidermal growth factor receptor,gene,0.998,24748906
30525,cetuximab,gene,0.6465,24748906
30526,acne,disease,1.0,24748906
30527,acneiform lesions,disease,1.0,24748906
30528,cetuximab,gene,0.855,24748906
30529,patients,species,0.9536,24748906
30530,acneiform eruptions,disease,1.0,24748906
30531,cetuximab,gene,0.793,24748906
30532,PATIENTS,species,0.952,24748906
30533,patients,species,0.988,24748906
30534,epidermal growth factor receptor,gene,0.998,24748906
30535,patients,species,0.8496,24748906
30536,acneiform eruptions,disease,1.0,24748906
30537,patients,species,0.987,24748906
30538,tacrolimus,drug,0.9995,24748906
30539,ketoconazole,drug,0.997,24748906
30540,tetracycline,drug,0.999,24748906
30541,cyclooxygenase,gene,0.9897,24748906
30542,macrolide,drug,0.9834,24748906
30543,cetuximab,gene,0.546,24748906
30544,tetracycline,drug,0.9985,24748906
30545,Ketoconazole,drug,0.9966,24748906
30546,tetracycline,drug,0.9956,24748906
30547,ketoconazole,drug,0.994,24748906
30548,tetracyclin,drug,0.999,24748906
30549,ketokonazole,drug,0.997,24748906
30550,patients,species,0.9644,24748906
30551,acneiform eruptions,disease,0.994,24748906
30552,cetuximab,gene,0.899,24748906
30553,sigmoid colon cancer,disease,1.0,24743293
30554,panitumumab,gene,0.778,24743293
30555,man,species,0.903,24743293
30556,abdominal pain,disease,0.9346,24743293
30557,fever,disease,0.8896,24743293
30558,KRAS,gene,0.9946,24743293
30559,panitumumab,gene,0.764,24743293
30560,panitumumab,gene,0.888,24743293
30561,patients,species,0.9766,24743293
30562,KRAS,DNA,0.584,24743293
30563,KRAS wild-type colon cancer,disease,0.937,24743293
30564,KRAS wild,gene,0.8267,24743293
30565,patients,species,0.9946,24740231
30566,AIDS,disease,0.9995,24740231
30567,patients,species,0.9873,24740231
30568,patient,species,0.974,24740231
30569,epidermal growth factor receptor,gene,0.9976,24740231
30570,EGFR,gene,0.9956,24740231
30571,EGFR,gene,0.9907,24740231
30572,cancers,disease,1.0,24740231
30573,lung and colorectal cancers,disease,1.0,24740231
30574,cetuximab,gene,0.6685,24740231
30575,panitumumab,gene,0.592,24740231
30576,tyrosine,drug,0.986,24740231
30577,tyrosine kinase,gene,0.956,24740231
30578,erlotinib,drug,0.991,24740231
30579,gefitinib,drug,0.995,24740231
30580,tumor,disease,1.0,24740231
30581,oncogenes,DNA,0.921,24740231
30582,BRAF V600E,gene,0.886,24740231
30583,V600,mutation,,24740231
30584,KRAS G12/13,DNA,0.7935,24740231
30585,KRAS G12/13,gene,0.9634,24740231
30586,patient,species,0.9907,24740231
30587,Panitumumab,gene,0.602,24739896
30588,cetuximab,gene,0.504,24739896
30589,patients,species,0.992,24739896
30590,wild,DNA,0.4927,24739896
30591,wild-type KRAS,gene,0.8784,24739896
30592,anti-EGFR monoclonal antibodies,gene,0.811,24739896
30593,panitumumab,gene,0.414,24739896
30594,patients,species,0.98,24739896
30595,wild-,disease,0.962,24739896
30596,wild,gene,0.764,24739896
30597,metastatic colorectal cancer,disease,0.899,24739896
30598,panitumumab,gene,0.925,24739896
30599,cetuximab,gene,0.7627,24739896
30600,patients,species,0.985,24739896
30601,patients,species,0.988,24739896
30602,metastatic colorectal cancer,disease,0.998,24739896
30603,wild,DNA,0.7075,24739896
30604,wild-type KRAS exon 2,gene,0.94,24739896
30605,patients,species,0.964,24739896
30606,panitumumab,gene,0.853,24739896
30607,cetuximab,gene,0.619,24739896
30608,cetuximab,gene,0.7427,24739896
30609,cetuximab,gene,0.748,24739896
30610,patients,species,0.9897,24739896
30611,panitumumab,gene,0.9004,24739896
30612,cetuximab,gene,0.8306,24739896
30613,patients,species,0.9834,24739896
30614,panitumumab,gene,0.8906,24739896
30615,cetuximab,gene,0.7812,24739896
30616,panitumumab,gene,0.915,24739896
30617,cetuximab,gene,0.869,24739896
30618,panitumumab,gene,0.788,24739896
30619,cetuximab,gene,0.666,24739896
30620,Panitumumab,gene,0.901,24739896
30621,cetuximab,gene,0.854,24739896
30622,patients,species,0.9873,24739896
30623,panitumumab,gene,0.9214,24739896
30624,patients,species,0.9834,24739896
30625,cetuximab,gene,0.823,24739896
30626,panitumumab,gene,0.91,24739896
30627,cetuximab,gene,0.7905,24739896
30628,patient,species,0.9624,24739896
30629,patients,species,0.9043,24739896
30630,hypomagnesaemia,disease,0.9995,24739896
30631,panitumumab,gene,0.947,24739896
30632,lung infection,disease,1.0,24739896
30633,patient,species,0.9844,24739896
30634,cetuximab,gene,0.884,24739896
30635,panitumumab,gene,0.901,24739896
30636,cetuximab,gene,0.8535,24739896
30637,patients,species,0.9644,24739896
30638,EGFR,gene,0.6978,24739896
30639,EGFR,gene,0.993,24739895
30640,colorectal cancer,disease,1.0,24739895
30641,KRAS exon 2,gene,0.9746,24739895
30642,trastuzumab,gene,0.9917,24732154
30643,epidermal growth factor receptor,gene,0.998,24732154
30644,tumors,disease,1.0,24732154
30645,epidermal growth factor receptor,gene,0.9985,24732154
30646,EGFR,gene,0.996,24732154
30647,human epidermal,cell_type,0.685,24732154
30648,human,species,0.9575,24732154
30649,growth factor receptor 2,gene,0.9688,24732154
30650,trastuzumab,gene,0.967,24732154
30651,EGFR,gene,0.992,24732154
30652,EGFR,gene,0.9863,24732154
30653,trastuzumab,gene,0.9834,24732154
30654,EGFR,gene,0.991,24732154
30655,F(ab,gene,0.7236,24732154
30656,PaniF(ab&#39;)2,gene,0.8345,24732154
30657,anti-,gene,0.8076,24732154
30658,EGFR monoclonal antibody,gene,0.8857,24732154
30659,panitumumab,gene,0.5767,24732154
30660,PaniF(ab&#39,drug,0.836,24732154
30661,(68)Ga,drug,0.9985,24732154
30662,(68)Ga-PaniF(ab&,drug,0.9097,24732154
30663,HT-29 tumor,disease,0.99,24732154
30664,nude mice,species,0.7417,24732154
30665,trastuzumab,gene,0.976,24732154
30666,trastuzumab,gene,0.952,24732154
30667,HT-29 tumors,cell_line,0.912,24732154
30668,HT,cell_type,,24732154
30669,HT-29 tumors,disease,0.8945,24732154
30670,EGFR,gene,0.9927,24732154
30671,trastuzumab,gene,0.9414,24732154
30672,trastuzumab,gene,0.971,24732154
30673,(68)Ga-PaniF(,drug,0.985,24732154
30674,trastuzumab,gene,0.9897,24732154
30675,HT,cell_type,,24732154
30676,HT-29 tumors,disease,0.854,24732154
30677,(68)Ga-PaniF,drug,0.949,24732154
30678,EGFR,gene,0.9937,24732154
30679,trastuzumab,gene,0.91,24732154
30680,tumor,disease,1.0,24732154
30681,tumor,disease,1.0,24732154
30682,panitumumab,gene,0.9116,24718886
30683,Panitumumab,gene,0.86,24718886
30684,Metastatic colorectal cancer,disease,1.0,24718886
30685,panitumumab,gene,0.973,24718886
30686,FOLFOX4,drug,0.8,24718886
30687,FOLFOX4,drug,0.776,24718886
30688,wild,cell_line,0.6143,24718886
30689,WT) KRAS,gene,0.863,24718886
30690,KRAS,DNA,0.4692,24718886
30691,metastatic colorectal cancer,disease,1.0,24718886
30692,mCRC,disease,1.0,24718886
30693,PATIENTS,species,0.938,24718886
30694,Patients,species,0.9546,24718886
30695,panitumumab,gene,0.859,24718886
30696,FOLFOX4,drug,0.9194,24718886
30697,FOLFOX4,drug,0.858,24718886
30698,arm,DNA,0.7085,24718886
30699,patient,species,0.971,24718886
30700,patients,species,0.9844,24718886
30701,WT KRAS,gene,0.974,24718886
30702,mCRC,disease,0.9976,24718886
30703,WT KRAS,DNA,0.619,24718886
30704,WT KRAS,gene,0.9854,24718886
30705,mCRC,disease,0.999,24718886
30706,WT KRAS,gene,0.972,24718886
30707,mCRC,disease,0.9907,24718886
30708,WT KRAS,gene,0.9155,24718886
30709,mCRC,disease,0.8135,24718886
30710,panitumumab,gene,0.9146,24718886
30711,FOLFOX4,drug,0.8115,24718886
30712,patients,species,0.957,24718886
30713,WT KRAS,gene,0.884,24718886
30714,mCRC,disease,0.992,24718886
30715,panitumumab,gene,0.9233,24718886
30716,FOLFOX4,drug,0.608,24718886
30717,FOLFOX4,drug,0.8535,24718886
30718,panitumumab,gene,0.8457,24718886
30719,FOLFOX4,drug,0.7617,24718886
30720,patients,species,0.881,24718886
30721,WT,disease,,24718886
30722,WT KRAS,gene,0.8335,24718886
30723,KRAS,DNA,0.795,24718886
30724,KRAS,gene,0.9775,24718886
30725,patients,species,0.9863,24718886
30726,panitumumab,gene,0.8013,24718886
30727,indocyanine green,drug,0.9966,24706611
30728,phthalocyanine,drug,0.993,24706611
30729,tumor,disease,0.9976,24706611
30730,tumor,disease,0.9995,24706611
30731,Panitumumab,gene,0.9404,24706611
30732,epidermal growth factor receptor,gene,0.9995,24706611
30733,EGFR1,gene,0.9946,24706611
30734,EGFR-expressing A431 tumor cells,cell_line,0.933,24706611
30735,EGFR,gene,0.9946,24706611
30736,tumor,disease,0.7266,24706611
30737,xenografts,cell_line,0.461,24706611
30738,xenograft tumors,disease,0.998,24706611
30739,mice,species,0.964,24706611
30740,Indocyanine green,drug,0.999,24706611
30741,ICG,drug,0.997,24706611
30742,ICG,drug,0.847,24706611
30743,tumors,disease,1.0,24706611
30744,ICG,drug,0.831,24706611
30745,ICG,drug,0.9272,24706611
30746,tumors,disease,1.0,24706611
30747,ICG,drug,0.72,24706611
30748,tumors,disease,0.575,24706611
30749,Anti-,gene,0.614,24701207
30750,epidermal growth factor receptor monoclonal antibody,gene,0.823,24701207
30751,PIK3CA,DNA,0.5107,24701207
30752,PIK3CA mutations,gene,0.755,24701207
30753,exon 9,DNA,0.81,24701207
30754,exon 20,DNA,0.4563,24701207
30755,anti-epidermal growth factor receptor,gene,0.958,24701207
30756,EGFR,gene,0.962,24701207
30757,monoclonal antibodies,gene,0.6357,24701207
30758,KRAS,gene,0.995,24701207
30759,metastatic colorectal cancer,disease,0.881,24701207
30760,mCRC,disease,0.9995,24701207
30761,patients,species,0.989,24701207
30762,cancer,disease,1.0,24701207
30763,patients,species,0.991,24701207
30764,cetuximab,gene,0.864,24701207
30765,panitumumab,gene,0.8394,24701207
30766,cetuximab,gene,0.96,24701207
30767,panitumumab,gene,0.9487,24701207
30768,mCRC,disease,0.998,24701207
30769,patients,species,0.9907,24701207
30770,PIK3CA mutations,gene,0.8276,24701207
30771,KRAS,gene,0.9883,24701207
30772,mCRC,disease,0.991,24701207
30773,patients,species,0.978,24701207
30774,PIK3CA,gene,0.9937,24701207
30775,exon 20,RNA,0.499,24701207
30776,PIK3CA,DNA,0.661,24701207
30777,PIK3CA,gene,0.996,24701207
30778,anti-EGFR,gene,0.9434,24701207
30779,KRAS,gene,0.992,24701207
30780,mCRC,disease,0.9966,24701207
30781,patients,species,0.981,24701207
30782,PIK3CA exon 20,DNA,0.6665,24701207
30783,PIK3CA exon 20,gene,0.9736,24701207
30784,ALK gene,gene,0.9917,24691006
30785,EGFR,gene,0.8735,24691006
30786,cetuximab,gene,0.5103,24691006
30787,panitumumab,gene,0.594,24691006
30788,patients,species,0.909,24691006
30789,KRAS,DNA,0.7314,24691006
30790,KRAS,gene,0.989,24691006
30791,NRAS,gene,0.9985,24691006
30792,BRAF,DNA,0.4736,24691006
30793,BRAF,gene,0.999,24691006
30794,PI3KCA,gene,0.9976,24691006
30795,metastatic colorectal cancer,disease,0.9834,24691006
30796,molecularly enriched populations,cell_line,0.645,24691006
30797,PATIENTS,species,0.9023,24691006
30798,patients,species,0.9688,24691006
30799,advanced colorectal cancer,disease,1.0,24691006
30800,RAS,gene,0.986,24691006
30801,BRAF,DNA,0.763,24691006
30802,BRAF,gene,0.9946,24691006
30803,PI3KCA,gene,0.998,24691006
30804,ALK gene,DNA,0.582,24691006
30805,ALK gene,gene,0.987,24691006
30806,ALK gene,gene,0.996,24691006
30807,patients,species,0.9893,24691006
30808,cetuximab,gene,0.916,24691006
30809,irinotecan,drug,0.9946,24691006
30810,panitumumab,gene,0.7363,24691006
30811,ALK,gene,0.9976,24691006
30812,ALK gene,DNA,0.5815,24691006
30813,ALK gene,gene,0.9883,24691006
30814,tumors,disease,1.0,24691006
30815,patients,species,0.98,24691006
30816,ALK,gene,0.876,24691006
30817,ALK gene,gene,0.992,24691006
30818,mCRC,disease,0.998,24691006
30819,EGFR,gene,0.708,24691006
30820,panitumumab,gene,0.874,24687833
30821,panitumumab,gene,0.909,24687833
30822,fluorouracil,drug,0.993,24687833
30823,leucovorin,drug,0.9976,24687833
30824,oxaliplatin,drug,0.999,24687833
30825,bevacizumab,gene,0.819,24687833
30826,patients,species,0.9575,24687833
30827,wild,gene,0.836,24687833
30828,KRAS exon,gene,0.8716,24687833
30829,codons 12 and 13,DNA,0.7754,24687833
30830,metastatic colorectal cancer,disease,1.0,24687833
30831,mCRC,disease,1.0,24687833
30832,RAS,gene,0.981,24687833
30833,"exons 2, 3, and 4",DNA,0.7773,24687833
30834,KRAS,gene,0.9805,24687833
30835,NRAS,DNA,0.7705,24687833
30836,NRAS,gene,0.994,24687833
30837,PATIENTS,species,0.9526,24687833
30838,Patients,species,0.9653,24687833
30839,WT KRAS,cell_line,0.492,24687833
30840,WT,disease,,24687833
30841,WT KRAS exon 2,gene,0.767,24687833
30842,panitumumab,gene,0.894,24687833
30843,patients,species,0.98,24687833
30844,WT KRAS exon 2,DNA,0.751,24687833
30845,WT KRAS exon 2,gene,0.9844,24687833
30846,panitumumab,gene,0.939,24687833
30847,bevacizumab,gene,0.709,24687833
30848,WT RAS,gene,0.954,24687833
30849,"WT exons 2, 3, and 4",DNA,0.8555,24687833
30850,KRAS,gene,0.9707,24687833
30851,NRAS,DNA,0.7603,24687833
30852,NRAS,gene,0.989,24687833
30853,panitumumab,gene,0.847,24687833
30854,panitumumab,gene,0.9673,24687833
30855,bevacizumab,gene,0.7007,24687833
30856,panitumumab,gene,0.9087,24687833
30857,bevacizumab,gene,0.674,24687833
30858,patients,species,0.9404,24687833
30859,WT,cell_type,,24687833
30860,WT,disease,,24687833
30861,WT KRAS exon 2,gene,0.841,24687833
30862,Patients,species,0.942,24687833
30863,WT,cell_type,,24687833
30864,WT RAS tumors,disease,0.973,24687833
30865,WT RAS,gene,0.9097,24687833
30866,epidermal growth factor receptor,gene,0.979,24687833
30867,colorectal carcinoma,disease,1.0,24676216
30868,EGFR,gene,0.8677,24676216
30869,Epidermal Growth Factor Receptor,gene,0.998,24676216
30870,EGFR,gene,0.996,24676216
30871,cetuximab,gene,0.715,24676216
30872,panitumumab,gene,0.719,24676216
30873,metastatic colorectal cancer,disease,0.9683,24676216
30874,CRC,disease,1.0,24676216
30875,patients,species,0.987,24676216
30876,EGFR,gene,0.8315,24676216
30877,plasma DNA,RNA,0.617,24676216
30878,plasma,cell_type,0.4521,24676216
30879,patients,species,0.963,24676216
30880,EGFR,gene,0.8374,24676216
30881,KRAS,gene,0.9556,24676216
30882,BRAF,DNA,0.7905,24676216
30883,BRAF,gene,0.9863,24676216
30884,PIK3CA,gene,0.992,24676216
30885,EGFR,DNA,0.59,24676216
30886,EGFR,gene,0.995,24676216
30887,EGFR,gene,0.8955,24676216
30888,KRAS,gene,0.9507,24676216
30889,patients,species,0.983,24676216
30890,polysomy of 12p,disease,0.985,24676216
30891,EGFR,gene,0.945,24676216
30892,MET,DNA,0.773,24676216
30893,MET,gene,0.9946,24676216
30894,ERBB2,gene,0.988,24676216
30895,EGFR gene,DNA,0.903,24676216
30896,EGFR gene,gene,0.991,24676216
30897,EGFR,gene,0.8027,24676216
30898,EGFR,gene,0.702,24676216
30899,patients,species,0.9873,24676216
30900,KRAS,gene,0.971,24676216
30901,BRAF,DNA,0.789,24676216
30902,BRAF,gene,0.993,24676216
30903,PIK3CA,gene,0.995,24676216
30904,EGFR,DNA,0.6055,24676216
30905,EGFR,gene,0.9893,24676216
30906,mutant clones,cell_line,0.6396,24676216
30907,panitumumab,gene,0.726,24666666
30908,rectal adenocarcinoma,disease,0.9873,24666666
30909,low-lying rectal adenocarcinoma,disease,0.995,24666666
30910,panitumumab,gene,0.9243,24666666
30911,Pmab,gene,0.9683,24666666
30912,man,species,0.9097,24666666
30913,rectal adenocarcinoma,disease,0.917,24666666
30914,mFOLFOX6,drug,0.713,24666666
30915,Pmab,drug,0.6753,24666666
30916,rectal cancer,disease,1.0,24666666
30917,rectal tumor,disease,0.9976,24666666
30918,cancer,disease,1.0,24666666
30919,Pmab,drug,0.8,24666666
30920,advanced stage rectal cancer,disease,0.9995,24666666
30921,Pmab,drug,0.7227,24666666
30922,low-lying rectal adenocarcinoma,disease,0.998,24666666
30923,KRAS,gene,0.918,24666267
30924,NRAS,DNA,0.8267,24666267
30925,NRAS,gene,0.9595,24666267
30926,BRAF,gene,0.9814,24666267
30927,PIK3CA,DNA,0.7935,24666267
30928,PIK3CA,gene,0.9946,24666267
30929,PTEN,gene,0.9946,24666267
30930,EGFR,gene,0.8003,24666267
30931,metastatic colorectal cancer,disease,1.0,24666267
30932,KRAS,DNA,0.8135,24666267
30933,KRAS,gene,0.969,24666267
30934,exon 2,DNA,0.8936,24666267
30935,patients,species,0.99,24666267
30936,wild,cell_line,0.627,24666267
30937,tumors,disease,0.67,24666267
30938,anti-EGFR antibodies cetuximab,gene,0.858,24666267
30939,panitumumab,gene,0.7334,24666267
30940,RAS,gene,0.996,24666267
30941,RAF,gene,0.999,24666267
30942,MAPK,gene,0.997,24666267
30943,PI3K,gene,0.9854,24666267
30944,AKT,gene,0.9976,24666267
30945,mTOR,gene,0.9946,24666267
30946,colorectal cancer,disease,1.0,24666267
30947,KRAS,gene,0.9883,24666267
30948,exon 2,DNA,0.749,24666267
30949,NRAS,gene,0.9775,24666267
30950,BRAF,DNA,0.7065,24666267
30951,BRAF,gene,0.992,24666267
30952,PIK3CA,gene,0.9946,24666267
30953,PTEN,DNA,0.473,24666267
30954,PTEN,gene,0.993,24666267
30955,EGFR,gene,0.7476,24666267
30956,patients,species,0.992,24666267
30957,KRAS exons 3 and 4,DNA,0.848,24666267
30958,NRAS,gene,0.9873,24666267
30959,BRAF,DNA,0.8086,24666267
30960,BRAF,gene,0.9937,24666267
30961,PIK3CA,gene,0.9956,24666267
30962,PTEN,DNA,0.5513,24666267
30963,PTEN,gene,0.9946,24666267
30964,EGFR,gene,0.6855,24666267
30965,KRAS exons 3 and 4,DNA,0.811,24666267
30966,KRAS,gene,0.9907,24666267
30967,BRAF,gene,0.9946,24666267
30968,PIK3CA,DNA,0.6304,24666267
30969,PIK3CA,gene,0.996,24666267
30970,PTEN,gene,0.9834,24666267
30971,KRAS exons 3 and 4,DNA,0.7944,24666267
30972,NRAS,gene,0.9893,24666267
30973,BRAF,DNA,0.747,24666267
30974,BRAF,gene,0.9937,24666267
30975,PTEN,gene,0.911,24666267
30976,KRAS exons 3 and 4,DNA,0.806,24666267
30977,KRAS exons 3,gene,0.767,24666267
30978,NRAS,gene,0.9883,24666267
30979,BRAF,DNA,0.5767,24666267
30980,BRAF,gene,0.9917,24666267
30981,PIK3CA,gene,0.994,24666267
30982,PTEN,DNA,0.4946,24666267
30983,PTEN,gene,0.9863,24666267
30984,KRAS exons 3 and 4,DNA,0.7793,24666267
30985,KRAS,gene,0.9966,24666267
30986,NRAS,gene,0.9893,24666267
30987,BRAF,DNA,0.737,24666267
30988,BRAF,gene,0.996,24666267
30989,PIK3CA,gene,0.9966,24666267
30990,PTEN,gene,0.9946,24666267
30991,EGFR,gene,0.993,24666267
30992,KRAS exon 2,DNA,0.827,24666267
30993,KRAS exon 2,gene,0.9897,24666267
30994,anti-,gene,0.8267,24666267
30995,EGFR antibodies,gene,0.7314,24666267
30996,metastatic colorectal cancer,disease,0.9556,24666267
30997,EGFR gene,gene,0.981,24653627
30998,EGFR,gene,0.584,24653627
30999,epidermal growth factor receptor,gene,0.998,24653627
31000,EGFR,gene,0.997,24653627
31001,patients,species,0.97,24653627
31002,metastatic colorectal cancer,disease,1.0,24653627
31003,mCRC,disease,1.0,24653627
31004,patients,species,0.994,24653627
31005,EGFR gene,DNA,0.675,24653627
31006,EGFR gene,gene,0.8716,24653627
31007,anti-EGFR MoAbs,gene,0.7676,24653627
31008,mCRC,disease,0.996,24653627
31009,patients,species,0.975,24653627
31010,EGFR,gene,0.9946,24653627
31011,wild-type KRAS,gene,0.8237,24653627
31012,mCRC,disease,0.994,24653627
31013,patients,species,0.9893,24653627
31014,GCN,gene,0.8804,24653627
31015,wild,gene,0.705,24653627
31016,mCRC,disease,1.0,24653627
31017,patients,species,0.991,24653627
31018,EGFR,gene,0.994,24653627
31019,EGFR,gene,0.9946,24653627
31020,tumor,disease,0.986,24653627
31021,mCRC,disease,0.9995,24653627
31022,patients,species,0.987,24653627
31023,KRAS,gene,0.9775,24653627
31024,mCRC,disease,0.9995,24653627
31025,patients,species,0.9863,24653627
31026,EGFR,gene,0.9966,24653627
31027,cetuximab,gene,0.781,24653627
31028,panitumumab,gene,0.7124,24653627
31029,anti-EGFR monoclonal antibody,gene,0.9565,24621163
31030,skin rash,disease,0.998,24621163
31031,cancer,disease,1.0,24621163
31032,patients,species,0.993,24621163
31033,anti-epidermal growth factor receptor,gene,0.9727,24621163
31034,EGFR,gene,0.9233,24621163
31035,cancer,disease,1.0,24621163
31036,patients,species,0.992,24621163
31037,skin rash,disease,1.0,24621163
31038,acne-like skin rash,disease,1.0,24621163
31039,patients,species,0.9907,24621163
31040,rash,disease,0.537,24621163
31041,skin rash,disease,1.0,24621163
31042,acne,disease,1.0,24621163
31043,skin rash,disease,1.0,24621163
31044,Patients,species,0.9834,24621163
31045,skin rash,disease,1.0,24621163
31046,acne-like skin rash,disease,1.0,24621163
31047,skin rash,disease,1.0,24621163
31048,patients,species,0.9595,24621163
31049,advanced solid tumors,disease,1.0,24621163
31050,EGFR,gene,0.9946,24621163
31051,skin rash,disease,1.0,24621163
31052,acne-like skin rash,disease,1.0,24621163
31053,EGFR,gene,0.994,24621163
31054,metastatic colorectal cancer,disease,1.0,24616571
31055,Colorectal cancer,disease,1.0,24616571
31056,patients,species,0.985,24616571
31057,metastatic,disease,0.6416,24616571
31058,colorectal cancer,disease,0.885,24616571
31059,patient,species,0.94,24616571
31060,bevacizumab,gene,0.963,24616571
31061,cetuximab,gene,0.9653,24616571
31062,aflibercept,gene,0.988,24616571
31063,panitumumab,gene,0.936,24616571
31064,regorafenib,drug,0.9795,24616571
31065,FOLFOX,drug,0.9727,24616571
31066,XELOX,drug,0.7524,24616571
31067,FOLFIRI,drug,0.7837,24616571
31068,Metastatic colorectal cancer,disease,0.9995,24616571
31069,patients,species,0.9946,24616571
31070,metastatic colorectal cancer,disease,0.9946,24616571
31071,metastatic colorectal cancer,disease,1.0,24616571
31072,patients,species,0.991,24616571
31073,HER family members,gene,0.993,24609222
31074,patients,species,0.988,24609222
31075,Dukes&,disease,0.9985,24609222
31076,human epidermal growth factor receptor,gene,0.998,24609222
31077,human,species,0.795,24609222
31078,EGFR,gene,0.996,24609222
31079,patients,species,0.9585,24609222
31080,metastatic colorectal cancer,disease,1.0,24609222
31081,anti-EGFR antibodies,gene,0.8315,24609222
31082,cetuximab,gene,0.4834,24609222
31083,panitumumab,gene,0.818,24609222
31084,patients,species,0.9897,24609222
31085,patients,species,0.986,24609222
31086,EGFR,gene,0.995,24609222
31087,HER,gene,0.99,24609222
31088,Human epidermal receptor,gene,0.991,24609222
31089,Human,species,0.9487,24609222
31090,HER family,gene,0.9883,24609222
31091,colorectal cancer,disease,1.0,24609222
31092,patients,species,0.9946,24609222
31093,HER family,DNA,0.549,24609222
31094,HER family members,gene,0.9873,24609222
31095,tumour,disease,1.0,24609222
31096,patients,species,0.9707,24609222
31097,Dukes&,disease,0.9707,24609222
31098,tumour cells,cell_type,0.8174,24609222
31099,tumour,disease,0.9985,24609222
31100,EGFR,gene,0.9976,24609222
31101,HER-2,gene,0.9976,24609222
31102,HER-3,gene,0.997,24609222
31103,HER-4,gene,0.997,24609222
31104,EGFR,gene,0.997,24609222
31105,HER-2,gene,0.995,24609222
31106,EGFR,gene,0.993,24609222
31107,HER-3,gene,0.9976,24609222
31108,EGFR,gene,0.998,24609222
31109,HER-4,gene,0.9985,24609222
31110,HER family,gene,0.9937,24609222
31111,EGFR,gene,0.9966,24609222
31112,EGFR,gene,0.994,24609222
31113,HER-4,gene,0.994,24609222
31114,HER family,gene,0.9897,24609222
31115,colon cancer,disease,1.0,24609222
31116,EGFR mAbs,gene,0.979,24609222
31117,patients,species,0.985,24609222
31118,HER,gene,0.9917,24609222
31119,colorectal cancer,disease,1.0,24597358
31120,colorectal cancer,disease,1.0,24597358
31121,anti-VEGF antibody,gene,0.99,24597358
31122,cetuximab,gene,0.662,24597358
31123,panitumumab,gene,0.652,24597358
31124,anti-EGFR antibodies,gene,0.9766,24597358
31125,anti-VEGF antibody,gene,0.993,24597358
31126,anti-EGFR antibodies,gene,0.9766,24597358
31127,tumor,disease,1.0,24597358
31128,colorectal cancer,disease,1.0,24597356
31129,bevacizumab,gene,0.8657,24597356
31130,cetuximab,gene,0.9316,24597356
31131,panitumumab,gene,0.974,24597356
31132,regorafenib,drug,0.977,24597356
31133,patient,species,0.986,24597356
31134,tumor,disease,0.995,24597356
31135,patient,species,0.912,24597356
31136,cetuximab,gene,0.753,24597356
31137,patients,species,0.986,24597356
31138,5FU,drug,0.999,24597356
31139,UFT,drug,0.998,24597356
31140,capecitabine,drug,0.9995,24597356
31141,FOLFOX,drug,0.998,24597356
31142,CapeOX,drug,0.997,24597356
31143,S-1,drug,0.9927,24597356
31144,oxaliplatin,drug,0.9976,24597356
31145,patients,species,0.9883,24597356
31146,oxaliplatin,drug,0.9995,24597356
31147,cancer,disease,0.9956,24597345
31148,epidermal growth factor receptor,gene,0.9976,24597345
31149,EGFR,gene,0.9966,24597345
31150,receptor tyrosine kinase,gene,0.9946,24597345
31151,tyrosine,drug,0.9946,24597345
31152,RAS,gene,0.998,24597345
31153,RAF,gene,0.999,24597345
31154,MAPK,gene,0.997,24597345
31155,PI3K,gene,0.996,24597345
31156,AKT,gene,0.996,24597345
31157,JAK,gene,0.9937,24597345
31158,STAT,gene,0.972,24597345
31159,anti-EGFR monoclonal antibodies,gene,0.853,24597345
31160,cetuximab,gene,0.9053,24597345
31161,panitumumab,gene,0.83,24597345
31162,metastatic colorectal cancer,disease,0.9966,24597345
31163,KRAS,gene,0.992,24597345
31164,EGFR,gene,0.927,24597345
31165,KRAS,gene,0.5195,24597345
31166,EGFR,gene,0.9336,24597345
31167,colorectal cancer,disease,1.0,24597345
31168,NRAS,gene,0.977,24597345
31169,BRAF,gene,0.9893,24597345
31170,PIK3CA,gene,0.9966,24597345
31171,anti-EGFR monoclonal antibody,gene,0.9927,24597345
31172,pVEGF-A,gene,0.9844,24597345
31173,bevacizumab,gene,0.6143,24597345
31174,colorectal cancer,disease,1.0,24597345
31175,Panitumumab,gene,0.868,24593265
31176,metastatic colorectal cancer,disease,1.0,24593265
31177,metastatic colorectal cancer,disease,1.0,24593265
31178,mCRC,disease,1.0,24593265
31179,EGFR,gene,0.9927,24593265
31180,EGFR,gene,0.995,24593265
31181,K-,DNA,0.6343,24593265
31182,K-Ras mutation,gene,0.946,24593265
31183,Panitumumab,gene,0.904,24593265
31184,EGFR,gene,0.994,24593265
31185,mCRC,disease,0.991,24593265
31186,panitumumab,gene,0.832,24593265
31187,Ras,gene,0.995,24593265
31188,Ras,gene,0.9956,24593265
31189,panitumumab,gene,0.825,24593265
31190,EGFR,gene,0.994,24593265
31191,panitumumab,gene,0.7637,24593265
31192,FOLFIRI,drug,0.8164,32664046
31193,panitumumab,gene,0.777,32664046
31194,metastatic colorectal cancer,disease,0.9995,32664046
31195,metastatic colorectal cancer,disease,0.996,24574764
31196,metastatic colorectal cancer,disease,1.0,24574764
31197,mCRC,disease,1.0,24574764
31198,RAS,gene,0.798,24574764
31199,fluoropyrimidines,drug,0.9995,24574764
31200,irinotecan,drug,0.999,24574764
31201,oxaliplatin,drug,0.9995,24574764
31202,bevacizumab,gene,0.825,24574764
31203,epidermal growth factor receptor,gene,0.998,24574764
31204,EGFR,gene,0.987,24574764
31205,cetuximab,gene,0.641,24574764
31206,panitumumab,gene,0.775,24574764
31207,mCRC,disease,0.985,24574764
31208,fluoropyrimidines,drug,0.999,24574764
31209,oxaliplatin,drug,0.9995,24574764
31210,EGFR antibodies,gene,0.807,24574764
31211,EGFR,gene,0.993,24574764
31212,EGFR antibodies,gene,0.773,24574764
31213,RAS,gene,0.9873,24574764
31214,mCRC,disease,0.9688,24574764
31215,liver metastases,disease,0.9814,24570378
31216,colorectal carcinoma,disease,1.0,24570378
31217,colorectal liver metastases,disease,0.999,24570378
31218,perflubutane,drug,0.9033,24570378
31219,gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid,drug,0.961,24570378
31220,liver metastases,disease,0.999,24570378
31221,DLM,disease,0.9985,24570378
31222,tumors,disease,1.0,24570378
31223,DLMs,disease,0.9995,24570378
31224,DLMs,disease,1.0,24570378
31225,DLMs,disease,1.0,24570378
31226,DLMs,disease,1.0,24570378
31227,DLMs,disease,1.0,24570378
31228,DLMs,disease,0.9995,24570378
31229,adenocarcinoma,disease,1.0,24570378
31230,DLMs,disease,1.0,24570378
31231,DLMs,disease,1.0,24570378
31232,tumors,disease,1.0,24570378
31233,tumors,disease,1.0,24570378
31234,colorectal liver metastasis,disease,1.0,24570378
31235,cancer,disease,0.999,24569469
31236,Cancer,disease,1.0,24569469
31237,anti,disease,0.89,24569469
31238,cancer,disease,0.951,24569469
31239,cancer,disease,0.999,24569469
31240,CDF,DNA,0.549,24569469
31241,sorafenib,drug,0.998,24569469
31242,bevacizumab,gene,0.608,24569469
31243,sunitinib,drug,0.9985,24569469
31244,imatinib,drug,0.9937,24569469
31245,lapatinib,drug,0.999,24569469
31246,panitumumab,gene,0.853,24569469
31247,CDF,DNA,0.5176,24569469
31248,pazopanib,drug,0.9985,24569469
31249,cancer,disease,0.999,24569469
31250,docetaxel,drug,0.9985,24562448
31251,cisplatin,drug,0.9995,24562448
31252,panitumumab,gene,0.8843,24562448
31253,adenocarcinoma of the distal esophagus,disease,0.96,24562448
31254,adenocarcinoma of the esophagus,disease,1.0,24562448
31255,docetaxel,drug,0.999,24562448
31256,cisplatin,drug,0.9995,24562448
31257,PATIENTS,species,0.847,24562448
31258,distal esophageal adenocarcinoma,disease,1.0,24562448
31259,docetaxel,drug,0.999,24562448
31260,cisplatin,drug,0.9995,24562448
31261,panitumumab,gene,0.815,24562448
31262,tumor,disease,0.933,24562448
31263,cancer cells,cell_type,0.7466,24562448
31264,cancer,disease,0.991,24562448
31265,pCR,DNA,0.7334,24562448
31266,Lymphopenia,disease,1.0,24562448
31267,Adult respiratory distress syndrome,disease,1.0,24562448
31268,DCP,drug,0.9663,24562448
31269,KRAS,DNA,0.838,24558511
31270,KRAS G13D Mutation,gene,0.817,24558511
31271,G13D,DNA,,24558511
31272,G13D,mutation,,24558511
31273,Cetuximab,gene,0.738,24558511
31274,Panitumumab,gene,0.6177,24558511
31275,Colorectal Cancer Cell Line Model,cell_line,0.8364,24558511
31276,Colorectal Cancer,disease,1.0,24558511
31277,metastatic colorectal cancer,disease,1.0,24558511
31278,mCRC,disease,1.0,24558511
31279,epidermal growth factor receptor,gene,0.997,24558511
31280,EGFR,gene,0.992,24558511
31281,codon,DNA,0.558,24558511
31282,Kirsten rat sarcoma viral oncogene homolog (KRAS) gene,DNA,0.885,24558511
31283,Kirsten rat sarcoma viral oncogene homolog,gene,0.9956,24558511
31284,KRAS,gene,0.984,24558511
31285,EGFR,gene,0.996,24558511
31286,RAS,gene,0.928,24558511
31287,RAF,gene,0.9976,24558511
31288,MAPK,gene,0.993,24558511
31289,anti-EGFR monoclonal antibody,gene,0.939,24558511
31290,KRAS G13D mutation,gene,0.7017,24558511
31291,G13D,mutation,,24558511
31292,cetuximab,gene,0.7007,24558511
31293,panitumumab,gene,0.7734,24558511
31294,CRC cell lines,cell_line,0.958,24558511
31295,CRC,disease,1.0,24558511
31296,cetuximab,gene,0.799,24558511
31297,panitumumab,gene,0.855,24558511
31298,KRAS,DNA,0.8594,24558511
31299,KRAS mutational,gene,0.7856,24558511
31300,CRC cell lines,cell_line,0.9585,24558511
31301,CRC,disease,1.0,24558511
31302,cetuximab,gene,0.924,24558511
31303,panitumumab,gene,0.943,24558511
31304,CRC cell lines,cell_line,0.9453,24558511
31305,CRC,disease,1.0,24558511
31306,cetuximab,gene,0.916,24558511
31307,panitumumab,gene,0.9272,24558511
31308,cell lines,cell_line,0.831,24558511
31309,cetuximab,gene,0.959,24558511
31310,panitumumab,gene,0.9155,24558511
31311,KRAS G13D,DNA,0.568,24558511
31312,KRAS G13D mutant cell lines,cell_line,0.838,24558511
31313,KRAS G13D mutant,gene,0.958,24558511
31314,G13D,mutation,,24558511
31315,HCT-116,cell_line,0.886,24558511
31316,LoVo,cell_line,0.788,24558511
31317,T84,cell_line,0.9424,24558511
31318,KRAS G12V mutant cell line,cell_line,0.897,24558511
31319,KRAS G12V,gene,0.9165,24558511
31320,G12V,mutation,,24558511
31321,SW480,cell_line,0.557,24558511
31322,KRAS wild-type cell line LIM1215,cell_line,0.8926,24558511
31323,KRAS,gene,0.99,24558511
31324,G13D cell lines,cell_line,0.939,24558511
31325,G13D,gene,,24558511
31326,G13D,mutation,,24558511
31327,panitumumab,gene,0.8975,24558511
31328,cetuximab,gene,0.8223,24558511
31329,KRAS mutation,gene,0.66,24558511
31330,anti-EGFR monoclonal antibody,gene,0.933,24558511
31331,EGFR,gene,0.997,24553387
31332,MEK,gene,0.992,24553387
31333,EGFR,gene,0.968,24553387
31334,colorectal cancer,disease,1.0,24553387
31335,Colorectal cancers,disease,1.0,24553387
31336,CRCs,disease,1.0,24553387
31337,anti-epidermal growth factor receptor,gene,0.879,24553387
31338,EGFR,gene,0.957,24553387
31339,panitumumab,gene,0.682,24553387
31340,"KRAS,",DNA,0.8145,24553387
31341,KRAS,gene,0.9834,24553387
31342,"NRAS, and BRAF mutations",DNA,0.5693,24553387
31343,NRAS,gene,0.9814,24553387
31344,BRAF mutations,gene,0.8794,24553387
31345,CRC cells,cell_line,0.773,24553387
31346,CRC,disease,1.0,24553387
31347,EGFR,gene,0.989,24553387
31348,resistant cells,cell_line,0.854,24553387
31349,mitogen-activated protein kinase kinase,gene,0.999,24553387
31350,MEK,gene,0.9937,24553387
31351,extracellular signal-regulated kinase,gene,0.9907,24553387
31352,ERK,gene,0.9893,24553387
31353,EGFR,gene,0.9873,24553387
31354,MEK1/2,gene,0.987,24553387
31355,resistant cells,cell_line,0.851,24553387
31356,EGFR,gene,0.9927,24553387
31357,MEK1/2,gene,0.9844,24553387
31358,resistant cells,cell_line,0.8896,24553387
31359,MEK,gene,0.9917,24553387
31360,EGFR,gene,0.98,24553387
31361,ERK,gene,0.9937,24553387
31362,resistant tumor cells,cell_line,0.6187,24553387
31363,tumor cells,cell_type,0.753,24553387
31364,tumor,disease,1.0,24553387
31365,KRAS,gene,0.8345,24553387
31366,NRAS,gene,0.8716,24553387
31367,plasma samples,cell_type,0.5205,24553387
31368,anti-EGFR antibodies,gene,0.9717,24553387
31369,mouse xenotransplant,cell_line,0.6714,24553387
31370,mouse,species,0.83,24553387
31371,CRC,disease,0.999,24553387
31372,EGFR,gene,0.988,24553387
31373,MEK,gene,0.9766,24553387
31374,EGFR,gene,0.984,24553387
31375,EGFR,gene,0.9683,24553387
31376,ERK,gene,0.9917,24553387
31377,tumors,disease,1.0,24553387
31378,MEK,gene,0.9897,24553387
31379,cetuximab,gene,0.8184,24553387
31380,panitumumab,gene,0.817,24553387
31381,CRC,disease,0.9985,24553387
31382,EGFR,gene,0.9136,24553387
31383,metastatic colorectal cancer,disease,0.999,24534706
31384,fluoropyrimidines,drug,0.9995,24534706
31385,oxaliplatin,drug,0.9995,24534706
31386,irinotecan,drug,0.999,24534706
31387,metastatic colorectal cancer,disease,1.0,24534706
31388,mCRC,disease,1.0,24534706
31389,cetuximab,gene,0.954,24534706
31390,ziv-aflibercept,gene,0.988,24534706
31391,regorafenib,drug,0.9473,24534706
31392,fluoropyrimidine,drug,0.999,24534706
31393,oxaliplatin,drug,1.0,24534706
31394,irinotecan,drug,0.9985,24534706
31395,5-fluorouracil,drug,0.9995,24534706
31396,5-FU,drug,0.9995,24534706
31397,5-FU,drug,0.9966,24534706
31398,Capecitabine,drug,0.9995,24534706
31399,5-FU,drug,0.999,24534706
31400,oxaliplatin,drug,1.0,24534706
31401,irinotecan,drug,0.9995,24534706
31402,oxaliplatin,drug,0.9995,24534706
31403,irinotecan,drug,0.998,24534706
31404,bevacizumab,gene,0.8613,24534706
31405,ziv-aflibercept,gene,0.983,24534706
31406,epidermal growth factor receptor,gene,0.9985,24534706
31407,cetuximab,gene,0.63,24534706
31408,panitumumab,gene,0.86,24534706
31409,mCRC,disease,0.982,24534706
31410,KRAS,DNA,0.8223,24534706
31411,KRAS mutational,gene,0.773,24534706
31412,KRAS,DNA,0.8145,24534449
31413,KRAS mutations,gene,0.884,24534449
31414,Colorectal cancer,disease,1.0,24534449
31415,CRC,disease,1.0,24534449
31416,cancer,disease,1.0,24534449
31417,cancer,disease,1.0,24534449
31418,Cetuximab,gene,0.9116,24534449
31419,Panitumumab,gene,0.8066,24534449
31420,epidermal growth receptor,gene,0.9927,24534449
31421,EGFR,gene,0.9897,24534449
31422,KRAS,gene,0.685,24534449
31423,codon 12 and 13,DNA,0.7134,24534449
31424,EGFR,gene,0.643,24534449
31425,KRAS,gene,0.8984,24534449
31426,Panitumumab,gene,0.8843,24534449
31427,Cetuximab,gene,0.763,24534449
31428,metastatic CRC,disease,1.0,24534449
31429,mCRC,disease,1.0,24534449
31430,CRC,disease,0.9995,24534449
31431,KRAS,DNA,0.8574,24534449
31432,KRAS mutations,gene,0.9688,24534449
31433,KRAS,DNA,0.7183,24534449
31434,KRAS mutation,gene,0.823,24534449
31435,advanced CRC,disease,0.9995,24534449
31436,EGFR antibody,gene,0.8013,24534449
31437,KRAS,gene,0.8394,24534449
31438,KRAS,DNA,0.851,24534449
31439,KRAS mutation,gene,0.9653,24534449
31440,KRAS,DNA,0.8535,24534449
31441,KRAS mutation,gene,0.979,24534449
31442,Panitumumab,gene,0.8105,24526771
31443,patients,species,0.967,24526771
31444,colorectal cancer,disease,1.0,24526771
31445,Panitumumab,gene,0.885,24526771
31446,Kirsten rat sarcoma-2 virus,disease,0.9995,24526771
31447,oncogene,DNA,0.637,24526771
31448,colorectal cancer,disease,1.0,24526771
31449,panitumumab,gene,0.8335,24526771
31450,panitumumab,gene,0.9355,24526771
31451,patients,species,0.9883,24526771
31452,panitumumab,gene,0.8467,24526771
31453,patients,species,0.991,24526771
31454,panitumumab,gene,0.894,24526771
31455,patients,species,0.9775,24526771
31456,panitumumab,gene,0.837,24526771
31457,skin disorders,disease,0.998,24526771
31458,interstitial lung disease,disease,1.0,24526771
31459,electrolyte abnormalities,disease,1.0,24526771
31460,cardiac disorders,disease,1.0,24526771
31461,patients,species,0.987,24526771
31462,panitumumab,gene,0.952,24526771
31463,panitumumab,gene,0.841,24526771
31464,panitumumab,gene,0.8984,24526771
31465,patients,species,0.941,24526771
31466,colorectal cancer,disease,1.0,24526771
31467,anti-EGFR antibody,gene,0.9727,24517087
31468,skin disorder,disease,0.8574,24517087
31469,metastatic colon cancer,disease,1.0,24517087
31470,Panitumumab,gene,0.73,24517087
31471,human epidermal growth factor receptor,gene,0.909,24517087
31472,EGFR,gene,0.952,24517087
31473,metastatic colorectal cancer,disease,1.0,24517087
31474,anti-EGFR monoclonal antibody,gene,0.8804,24517087
31475,skin disorder,disease,1.0,24517087
31476,skin disorder,disease,1.0,24517087
31477,cancer,disease,1.0,24517087
31478,sigmoid colon cancer,disease,1.0,24517087
31479,lung metastasis,disease,0.9297,24517087
31480,panitumumab,gene,0.583,24517087
31481,anti-EGFR monoclonal antibody,gene,0.9673,24517087
31482,skin disorder,disease,1.0,24517087
31483,skin disorder,disease,1.0,24517087
31484,anti-EGFR antibody,gene,0.9663,24517087
31485,skin disorder,disease,0.997,24517087
31486,skin disorder,disease,1.0,24517087
31487,colorectal cancer,disease,1.0,24517087
31488,metastatic colorectal cancer,disease,1.0,24511107
31489,metastatic colorectal cancer,disease,1.0,24511107
31490,mCRC,disease,1.0,24511107
31491,mCRC,disease,0.9976,24511107
31492,fluoropyrimidine,drug,0.9995,24511107
31493,oxaliplatin,drug,0.9995,24511107
31494,bevacizumab,gene,0.925,24511107
31495,bevacizumab,gene,0.6265,24511107
31496,bevacizumab,gene,0.7354,24511107
31497,anti-EGFR monoclonal antibody,gene,0.9556,24511107
31498,cetuximab,gene,0.6504,24511107
31499,panitumumab,gene,0.5586,24511107
31500,anti-EGFR antibody,gene,0.989,24511107
31501,Anti-,gene,0.8594,24511107
31502,EGFR antibody,gene,0.6826,24511107
31503,KRAS,gene,0.9897,24511107
31504,mCRC,disease,0.9995,24511107
31505,bevacizumab,gene,0.636,24511107
31506,anti-,gene,0.6597,24511107
31507,EGFR,gene,0.626,24511107
31508,epidermal growth factor receptor,gene,0.9956,24508062
31509,cancer,disease,1.0,24508062
31510,tumors,disease,1.0,24508062
31511,anti-EGFR monoclonal antibodies,gene,0.9897,24508062
31512,cetuximab,gene,0.9077,24508062
31513,panitumumab,gene,0.818,24508062
31514,EGFR,gene,0.6323,24508062
31515,tumor,disease,0.9985,24508062
31516,IR-,drug,0.531,24508062
31517,cetuximab,gene,0.948,24508062
31518,cet,gene,0.955,24508062
31519,panitumumab,gene,0.894,24508062
31520,pan,gene,0.872,24508062
31521,EGFR,gene,0.621,24508062
31522,A431,cell_line,0.4587,24508062
31523,MDAMB468-luc cells,cell_line,0.9,24508062
31524,A431 xenografts,cell_line,0.8643,24508062
31525,MDAMB468-luc,cell_line,0.895,24508062
31526,tumor,disease,0.931,24508062
31527,Cet,gene,0.8413,24508062
31528,3D-spheroid,cell_line,0.4968,24508062
31529,anti-,disease,0.648,24508062
31530,tumor,disease,0.674,24508062
31531,cet,DNA,0.515,24508062
31532,tumors,disease,1.0,24508062
31533,cet,gene,0.464,24508062
31534,tumor,disease,1.0,24508062
31535,cet,gene,0.4927,24508062
31536,mice,species,0.96,24508062
31537,tumor,disease,1.0,24508062
31538,MicroRNA,RNA,0.799,24503111
31539,metastatic colorectal cancer,disease,1.0,24503111
31540,anti-EGFR monoclonal antibodies,gene,0.95,24503111
31541,microRNAs,RNA,0.626,24503111
31542,anti-epidermal growth factor receptor,gene,0.944,24503111
31543,EGFR,gene,0.976,24503111
31544,metastatic colorectal cancer,disease,1.0,24503111
31545,mCRC,disease,1.0,24503111
31546,mCRC,disease,0.9985,24503111
31547,cetuximab,gene,0.8276,24503111
31548,panitumumab,gene,0.8115,24503111
31549,MiRNA,RNA,0.53,24503111
31550,Let-7c,gene,0.492,24503111
31551,miR-99a,gene,0.43,24503111
31552,miR-125b,gene,0.4104,24503111
31553,EGFR,gene,0.7275,24503111
31554,KRAS,gene,0.635,24503111
31555,KRAS,gene,0.572,24503111
31556,MiR,DNA,0.4878,24503111
31557,MiR-99a,gene,0.9443,24503111
31558,Let-7c,gene,0.981,24503111
31559,miR-125b,gene,0.9707,24503111
31560,KRAS,gene,0.6787,24503111
31561,mCRC,disease,0.982,24503111
31562,EGFR,gene,0.9463,24503111
31563,MET,gene,0.49,24500024
31564,EGFR,gene,0.969,24500024
31565,metastatic colorectal cancer,disease,0.9995,24500024
31566,wild,gene,0.639,24500024
31567,KRAS,DNA,0.7275,24500024
31568,KRAS mutation,gene,0.794,24500024
31569,metastatic colorectal cancer,disease,1.0,24500024
31570,mCRC,disease,1.0,24500024
31571,anti-epidermal growth factor receptor,gene,0.8867,24500024
31572,EGFR,gene,0.996,24500024
31573,anti-EGFR,gene,0.967,24500024
31574,mCRC,disease,0.993,24500024
31575,KRAS,gene,0.7563,24500024
31576,BRAF,gene,0.7207,24500024
31577,PIK3CA,gene,0.5815,24500024
31578,PTEN,gene,0.9893,24500024
31579,MET,gene,0.9917,24500024
31580,BRAF,gene,0.619,24500024
31581,PIK3CA,DNA,0.6953,24500024
31582,PIK3CA mutations,gene,0.7734,24500024
31583,MET,gene,0.9956,24500024
31584,MET,gene,0.995,24500024
31585,wild,cell_line,0.614,24500024
31586,wild-type KRAS tumors,disease,0.993,24500024
31587,wild-type KRAS,gene,0.731,24500024
31588,BRAF,gene,0.998,24500024
31589,PIK3CA,gene,0.5293,24500024
31590,MET,gene,0.6836,24500024
31591,EGFR,gene,0.8623,24500024
31592,MET,gene,0.5107,24500024
31593,BRAF,gene,0.702,24500024
31594,PIK3CA,DNA,0.4531,24500024
31595,PIK3CA mutations,gene,0.8584,24500024
31596,anti-EGFR MoAbs,gene,0.7964,24500024
31597,mCRC,disease,0.999,24500024
31598,KRAS,DNA,0.4207,24500024
31599,anti-EGFR,gene,0.65,24500024
31600,177Lu,drug,0.9976,24472064
31601,EGFR,gene,0.992,24472064
31602,Epidermal growth factor receptor,gene,0.9985,24472064
31603,EGFR,gene,0.9927,24472064
31604,cancer,disease,1.0,24472064
31605,EGFR,gene,0.9956,24472064
31606,panitumumab,gene,0.899,24472064
31607,cetuximab,gene,0.8237,24472064
31608,patients,species,0.9897,24472064
31609,patients,species,0.9917,24472064
31610,panitumumab,gene,0.9746,24472064
31611,cetuximab,gene,0.9556,24472064
31612,tumor,disease,0.994,24472064
31613,tumor,disease,1.0,24472064
31614,panitumumab,gene,0.9478,24472064
31615,cetuximab,gene,0.901,24472064
31616,"1,4,7,10-tetraazadodecane-N,N&#39;,N&quot;,N&",drug,0.9355,24472064
31617,DOTA,drug,0.9985,24472064
31618,(177)Lu,drug,0.999,24472064
31619,(177)Lu,drug,0.9995,24472064
31620,DOTA,drug,0.9966,24472064
31621,panitumumab,gene,0.856,24472064
31622,(177)Lu,drug,0.9995,24472064
31623,(177)Lu,drug,0.999,24472064
31624,DOTA,drug,0.998,24472064
31625,cetuximab,gene,0.941,24472064
31626,(177)Lu,drug,0.9995,24472064
31627,Cet,gene,0.889,24472064
31628,UM-SCC-22B,cell_line,0.891,24472064
31629,UM,disease,,24472064
31630,tumor,disease,0.9863,24472064
31631,(177)Lu,drug,0.999,24472064
31632,(177)Lu,drug,0.9985,24472064
31633,tumor,disease,0.879,24472064
31634,(177)Lu,drug,0.9985,24472064
31635,(177)Lu,drug,0.999,24472064
31636,(177)Lu,drug,0.9985,24472064
31637,(177)Lu,drug,0.9976,24472064
31638,tumor,disease,0.996,24472064
31639,177)Lu,drug,0.9985,24472064
31640,tumor,disease,0.9995,24472064
31641,panitumumab,gene,0.9424,24472064
31642,cetuximab,gene,0.9263,24472064
31643,tumor,disease,0.896,24472064
31644,EGFR,gene,0.9917,24472064
31645,tumors,disease,1.0,24472064
31646,(89) Zr,drug,0.9995,24448743
31647,panitumumab,gene,0.7114,24448743
31648,Panitumumab,gene,0.743,24448743
31649,human,species,0.8604,24448743
31650,EGFR,gene,0.9966,24448743
31651,colorectal cancer,disease,1.0,24448743
31652,panitumumab,gene,0.9106,24448743
31653,(89) Zr,drug,0.999,24448743
31654,EGFR positive cancers,disease,0.9937,24448743
31655,EGFR,gene,0.9907,24448743
31656,(89) Zr,drug,0.9995,24448743
31657,EGFR,gene,0.9946,24448743
31658,panitumumab,gene,0.8887,24448743
31659,desferrioxamine,drug,0.999,24448743
31660,(89) Zr,drug,0.999,24448743
31661,(89) Zr,drug,0.9995,24448743
31662,panitumumab,gene,0.8867,24448743
31663,human,species,0.9966,24448743
31664,(89) Zr,drug,0.9995,24448743
31665,panitumumab,gene,0.9087,24448743
31666,metastatic liver tumor,disease,1.0,24437272
31667,liver metastases,disease,0.987,24437272
31668,colorectal cancer,disease,1.0,24437272
31669,patients,species,0.977,24437272
31670,liver metastases,disease,0.999,24437272
31671,patients,species,0.9814,24437272
31672,patients,species,0.9644,24437272
31673,advanced colorectal liver metastases,disease,0.996,24437272
31674,panitumumab,gene,0.8345,24437272
31675,patients,species,0.9717,24437272
31676,liver metastases,disease,0.997,24437272
31677,patients,species,0.976,24437272
31678,liver metastases,disease,0.9995,24437272
31679,colorectal cancer,disease,1.0,24437272
31680,PNIPAAM-b-PAMPTMA,drug,0.986,24428614
31681,siRNA,RNA,0.717,24428614
31682,cancer,disease,1.0,24428614
31683,viral infections,disease,0.82,24428614
31684,siRNA,RNA,0.6797,24428614
31685,nucleic acids,DNA,0.5703,24428614
31686,cytosol,cell_type,0.689,24428614
31687,N-isopropylacrylamide,drug,0.9995,24428614
31688,(3-acrylamidopropyl)trimethylammonium chloride,drug,0.9995,24428614
31689,siRNAs,RNA,0.746,24428614
31690,human fibrosarcoma cell line,cell_line,0.9688,24428614
31691,human,species,0.9937,24428614
31692,fibrosarcoma,disease,0.8506,24428614
31693,siRNA,RNA,0.533,24428614
31694,siRNAs,RNA,0.603,24428614
31695,target gene,DNA,0.7515,24428614
31696,siRNA,RNA,0.7515,24428614
31697,N-isopropylacrylamide,drug,0.999,24428614
31698,siRNA,RNA,0.7524,24428614
31699,Colorectal cancer,disease,1.0,24424112
31700,CRC,disease,1.0,24424112
31701,cancer,disease,0.9995,24424112
31702,mCRC,disease,1.0,24424112
31703,epidermal growth factor receptor,gene,0.998,24424112
31704,EGFR,gene,0.995,24424112
31705,malignancies,disease,0.999,24424112
31706,mCRC,disease,0.9995,24424112
31707,EGFR,gene,0.9907,24424112
31708,PI3K,gene,0.997,24424112
31709,AKT,gene,0.996,24424112
31710,RAS,gene,0.964,24424112
31711,RAF,gene,0.998,24424112
31712,MAPK,gene,0.988,24424112
31713,oxaliplatin,drug,0.9995,24403498
31714,Oxaliplatin,drug,0.999,24403498
31715,fluoropyrimidines,drug,0.999,24403498
31716,advanced colorectal cancer,disease,1.0,24403498
31717,stage III colon cancer,disease,0.8794,24403498
31718,Oxaliplatin,drug,0.9995,24403498
31719,irinotecan,drug,0.9985,24403498
31720,vascular endothelial growth factor,gene,0.997,24403498
31721,VEGF,gene,0.998,24403498
31722,bevacizumab,gene,0.765,24403498
31723,aflibercept,gene,0.9683,24403498
31724,anti-,gene,0.6074,24403498
31725,epidermal growth factor receptor,gene,0.9062,24403498
31726,EGFR,gene,0.9956,24403498
31727,cetuximab,gene,0.8086,24403498
31728,panitumumab,gene,0.9033,24403498
31729,advanced colorectal cancer,disease,1.0,24403498
31730,patients,species,0.9893,24403498
31731,EGFR,gene,0.743,24403498
31732,KRAS,gene,0.9697,24403498
31733,oxaliplatin,drug,0.9995,24403498
31734,locally advanced colorectal cancer,disease,0.9624,24394002
31735,woman,species,0.902,24394002
31736,diarrhea,disease,1.0,24394002
31737,hematochezia,disease,0.9995,24394002
31738,rectal cancer,disease,1.0,24394002
31739,5-fluorouracil,drug,0.9995,24394002
31740,leucovorin,drug,0.999,24394002
31741,oxaliplatin,drug,0.9995,24394002
31742,panitumumab,gene,0.894,24394002
31743,mFOLFOX6,drug,0.7485,24394002
31744,man,species,0.894,24394002
31745,high fever,disease,0.9956,24394002
31746,abdominal pain,disease,0.9946,24394002
31747,rectal cancer,disease,1.0,24394002
31748,vesicorectal fistula,disease,0.994,24394002
31749,panitumumab,gene,0.744,24394002
31750,capecitabine,drug,0.9995,24394002
31751,oxaliplatin,drug,0.9995,24394002
31752,XELOX,drug,0.996,24394002
31753,colorectal cancer,disease,1.0,24394002
31754,panitumumab,gene,0.915,24394002
31755,locally advanced colorectal cancer,disease,0.9976,24394002
31756,rectal,cell_line,0.4836,24394001
31757,rectal endocrine cell carcinoma,disease,1.0,24394001
31758,patient,species,0.939,24394001
31759,anal dysfunction,disease,1.0,24394001
31760,anal pain,disease,0.9946,24394001
31761,lower rectal cancer,disease,0.998,24394001
31762,dentate,DNA,0.532,24394001
31763,endocrine cell carcinoma,disease,1.0,24394001
31764,pararectal and right inguinal lymph node,disease,0.9365,24394001
31765,Leucovorin,drug,0.9995,24394001
31766,5-fluorouracil,drug,0.9995,24394001
31767,oxaliplatin,drug,0.9995,24394001
31768,FOLFOX,drug,0.8433,24394001
31769,K-RAS,gene,0.997,24394001
31770,FOLFOX,drug,0.9683,24394001
31771,panitumumab,gene,0.861,24394001
31772,tumor,disease,0.989,24394001
31773,lymph node swelling,disease,0.9976,24394001
31774,endocrine cell carcinoma,disease,1.0,24394001
31775,hepatic metastases,disease,0.6553,24393993
31776,colon cancer,disease,1.0,24393993
31777,irinotecan,drug,0.9917,24393993
31778,patient,species,0.95,24393993
31779,man,species,0.8916,24393993
31780,liver metastases,disease,0.9873,24393993
31781,sigmoid colon cancer,disease,1.0,24393993
31782,sigmoid colon cancer,disease,1.0,24393993
31783,liver tumors,disease,0.995,24393993
31784,S-1,drug,0.9956,24393993
31785,oxaliplatin,drug,0.9995,24393993
31786,SOX,drug,0.9966,24393993
31787,colon cancer,disease,1.0,24393993
31788,SOX,drug,0.978,24393993
31789,bevacizumab,gene,0.783,24393993
31790,advanced metastatic colorectal cancer,disease,0.9937,24393993
31791,irinotecan,drug,0.998,24393993
31792,S-1,drug,0.972,24393993
31793,IRIS,drug,0.934,24393993
31794,panitumumab,gene,0.592,24393993
31795,patient,species,0.989,24393993
31796,IRIS,drug,0.725,24393993
31797,panitumumab,gene,0.899,24393993
31798,patient,species,0.9917,24393993
31799,patient,species,0.995,24393993
31800,advanced rectal cancer,disease,1.0,24393977
31801,leucovorin,drug,0.9995,24393977
31802,fluorouracil,drug,0.999,24393977
31803,woman,species,0.9062,24393977
31804,advanced rectal cancer,disease,1.0,24393977
31805,wild,DNA,0.6465,24393977
31806,wild-type K-RAS,gene,0.993,24393977
31807,space,disease,0.8687,24393977
31808,enlarged,disease,0.7593,24393977
31809,rectal cancer,disease,1.0,24393977
31810,patient,species,0.9736,24393977
31811,Leucovorin,drug,0.9995,24393977
31812,fluorouracil,drug,0.9995,24393977
31813,oxaliplatin,drug,0.9995,24393977
31814,panitumumab,gene,0.891,24393977
31815,Pmab,gene,0.883,24393977
31816,Leucovorin,drug,0.9976,24393977
31817,5-fluorouraci,drug,0.997,24393977
31818,Pmab,gene,0.9355,24393977
31819,Pmab,gene,0.8335,24393977
31820,locally advanced K-,disease,0.7954,24393977
31821,K-RAS,gene,0.99,24393977
31822,locally advanced rectal cancer,disease,1.0,24393975
31823,patient,species,0.992,24393975
31824,acute pan-peritonitis,disease,1.0,24393975
31825,locally advanced rectal cancer,disease,0.995,24393975
31826,man,species,0.917,24393975
31827,lower abdominal pain,disease,0.938,24393975
31828,tumor,disease,0.8296,24393975
31829,panperitonitis,disease,1.0,24393975
31830,locally advanced,disease,0.943,24393975
31831,rectal cancer,disease,0.765,24393975
31832,panitumumab,gene,0.94,24393975
31833,cancer cells,cell_type,0.78,24393975
31834,cancer,disease,0.998,24393975
31835,locally advanced rectal cancer,disease,0.9775,24393975
31836,BRAF V600E,gene,0.9404,24390240
31837,V600E,mutation,,24390240
31838,anti-EGFR monoclonal antibodies,gene,0.993,24390240
31839,Anti-EGFR monoclonal antibodies,gene,0.9756,24390240
31840,anti-EGFR MoAbs,gene,0.9937,24390240
31841,metastatic colorectal cancer,disease,1.0,24390240
31842,mCRC,disease,0.9985,24390240
31843,patients,species,0.995,24390240
31844,BRAF V600E,gene,0.8213,24390240
31845,V600E,mutation,,24390240
31846,anti-EGFR MoAbs,gene,0.734,24390240
31847,mCRC,disease,0.9766,24390240
31848,patients,species,0.993,24390240
31849,colorectal cancer,disease,1.0,24390240
31850,cetuximab,gene,0.7026,24390240
31851,panitumumab,gene,0.5776,24390240
31852,BRAF mutation,gene,0.9224,24390240
31853,BRAF,gene,0.9985,24390240
31854,mCRC,disease,0.9917,24390240
31855,patients,species,0.9785,24390240
31856,KRAS,gene,0.9927,24390240
31857,anti-EGFR,gene,0.8896,24390240
31858,patients,species,0.9883,24390240
31859,KRAS,gene,0.9937,24390240
31860,BRAF,DNA,0.5503,24390240
31861,BRAF mutation,gene,0.779,24390240
31862,cetuximab,gene,0.775,24390240
31863,BRAF,DNA,0.62,24390240
31864,BRAF mutation,gene,0.832,24390240
31865,anti-EGFR,gene,0.877,24390240
31866,patients,species,0.9487,24390240
31867,wild,gene,0.563,24390240
31868,patients,species,0.939,24390240
31869,BRAF,gene,0.9966,24390240
31870,anti-EGFR,gene,0.962,24390240
31871,KRAS,gene,0.9937,24390240
31872,patients,species,0.974,24390240
31873,BRAF,gene,0.9917,24390240
31874,tumor,disease,1.0,24390240
31875,patients,species,0.9766,24390240
31876,KRAS,gene,0.9824,24390240
31877,anti-EGFR MoAb,gene,0.9175,24390240
31878,patients,species,0.9893,24390240
31879,BRAF,gene,0.9976,24390240
31880,KRAS,gene,0.9907,24390240
31881,paclitaxel,drug,0.9995,24389433
31882,carboplatin,drug,0.9995,24389433
31883,panitumumab,gene,0.8345,24389433
31884,panitumumab,gene,0.8237,24389433
31885,human,species,0.7676,24389433
31886,anti-epidermal growth factor receptor monoclonal antibody,gene,0.959,24389433
31887,carboplatin,drug,0.9995,24389433
31888,paclitaxel,drug,0.9995,24389433
31889,patients,species,0.951,24389433
31890,advanced non-small-cell lung cancer,disease,0.999,24389433
31891,patients,species,0.977,24389433
31892,paclitaxel,drug,0.995,24389433
31893,carboplatin,drug,0.9985,24389433
31894,panitumumab,gene,0.922,24389433
31895,patients,species,0.976,24389433
31896,paclitaxel,drug,0.9995,24389433
31897,carboplatin,drug,1.0,24389433
31898,panitumumab,gene,0.9424,24389433
31899,patients,species,0.986,24389433
31900,fatigue,disease,0.999,24389433
31901,pain in extremity,disease,0.8467,24389433
31902,dyspepsia,disease,1.0,24389433
31903,rash,disease,0.9995,24389433
31904,panitumumab,gene,0.8926,24389433
31905,skin toxicity,disease,0.6885,24389433
31906,diarrhea,disease,1.0,24389433
31907,stomatitis,disease,1.0,24389433
31908,vomiting,disease,0.997,24389433
31909,dizziness,disease,1.0,24389433
31910,panitumumab,gene,0.9204,24389433
31911,paclitaxel,drug,0.9995,24389433
31912,carboplatin,drug,1.0,24389433
31913,patients,species,0.9517,24389433
31914,advanced non-small-cell lung cancer,disease,0.996,24389433
31915,tumour,disease,0.9326,24388410
31916,colorectal cancer,disease,1.0,24388410
31917,Panitumumab,gene,0.8843,24381645
31918,patients,species,0.9756,24381645
31919,KRAS,gene,0.9966,24381645
31920,metastatic colorectal,disease,0.7915,24381645
31921,patients,species,0.9805,24381645
31922,colorectal cancer,disease,1.0,24381645
31923,panitumumab,gene,0.779,24381645
31924,epidermal growth factor receptor,gene,0.998,24381645
31925,tumor cells,cell_type,0.865,24381645
31926,tumor,disease,1.0,24381645
31927,tumor,disease,1.0,24381645
31928,panitumumab,gene,0.843,24381645
31929,metastatic colorectal cancer,disease,0.9375,24381645
31930,panitumumab,gene,0.6167,24381645
31931,patients,species,0.966,24381645
31932,KRAS tumors,disease,0.773,24381645
31933,KRAS,gene,0.9287,24381645
31934,Rash,disease,0.9976,24381645
31935,panitumumab,gene,0.8594,24381645
31936,panitumumab,gene,0.877,24381645
31937,metastatic colorectal cancer,disease,1.0,24381645
31938,patient,species,0.9463,24381645
31939,BRAFV600E,gene,0.9976,24367680
31940,patients,species,0.9688,24367680
31941,metastatic colorectal cancer,disease,1.0,24367680
31942,mCRC,disease,1.0,24367680
31943,BRAFV600E,gene,0.998,24367680
31944,patients,species,0.9473,24367680
31945,metastatic Colorectal Cancer,disease,1.0,24367680
31946,mCRC,disease,1.0,24367680
31947,PATIENTS,species,0.9497,24367680
31948,mCRC,disease,0.9863,24367680
31949,patients,species,0.9927,24367680
31950,BRAF,DNA,0.852,24367680
31951,BRAF mutation,gene,0.79,24367680
31952,patients,species,0.989,24367680
31953,primary tumors,disease,0.775,24367680
31954,high,cell_type,0.5156,24367680
31955,Patients,species,0.9756,24367680
31956,BRAFV600E,gene,0.9956,24367680
31957,wild,cell_line,0.689,24367680
31958,BRAFV600E,DNA,0.825,24367680
31959,BRAFV600E mutation,gene,0.893,24367680
31960,patients,species,0.981,24367680
31961,cetuximab,gene,0.823,24367680
31962,panitumumab,gene,0.795,24367680
31963,BRAFV600E,DNA,0.8604,24367680
31964,BRAFV600E mutation,gene,0.968,24367680
31965,BRAFV600E,DNA,0.7856,24367680
31966,BRAFV600E-mutation,gene,0.8916,24367680
31967,mCRC,disease,0.9995,24367680
31968,patients,species,0.9653,24367680
31969,patients,species,0.933,24367680
31970,breast cancer,disease,0.995,24360117
31971,patient,species,0.989,24360117
31972,patients,species,0.9873,24360117
31973,tumor,disease,0.9995,24360117
31974,malignant,disease,0.877,24360117
31975,bevacizumab,gene,0.6655,24360117
31976,cetuximab,gene,0.913,24360117
31977,panitumumab,gene,0.9336,24360117
31978,trastuzumab,gene,0.956,24360117
31979,tocilizumab,gene,0.915,24360117
31980,human,species,0.9927,24360117
31981,breast cancer flank tumors,disease,0.995,24360117
31982,Tumor,disease,0.951,24360117
31983,tumor,disease,0.9966,24360117
31984,Tumor,disease,0.673,24360117
31985,tumor,disease,0.8496,24360117
31986,tumor cells,cell_type,0.8003,24360117
31987,tumor,disease,0.9976,24360117
31988,normal tissue,cell_type,0.511,24360117
31989,Human,species,0.9976,24360117
31990,breast cancer tumors,disease,0.9995,24360117
31991,malignancies,disease,0.9995,24360117
31992,Epidermal growth factor receptor,gene,0.9976,24357745
31993,epidermal growth factor,gene,0.9976,24357745
31994,EGFR,gene,0.9937,24357745
31995,solid tumors,disease,1.0,24357745
31996,"lung,",disease,0.955,24357745
31997,"pancreatic, colorectal, and head and neck cancers",disease,1.0,24357745
31998,EGFR,gene,0.9927,24357745
31999,HER1,gene,0.995,24357745
32000,solid tumors,disease,1.0,24357745
32001,monoclonal antibodies,gene,0.654,24357745
32002,cetuximab,gene,0.55,24357745
32003,panitumumab,gene,0.8726,24357745
32004,tyrosine,drug,0.997,24357745
32005,tyrosine kinase,gene,0.983,24357745
32006,gefitinib,drug,0.985,24357745
32007,erlotinib,drug,0.9976,24357745
32008,afatinib,drug,0.993,24357745
32009,tyrosine,drug,0.9946,24357745
32010,tyrosine kinase,gene,0.9956,24357745
32011,EGFR,gene,0.9805,24357745
32012,EGFR,gene,0.992,24357745
32013,tumors,disease,1.0,24357745
32014,tumors,disease,1.0,24357745
32015,EGFR,gene,0.993,24357745
32016,"metastatic lung, colorectal, and head and neck cancers",disease,0.9717,24357745
32017,daunorubicin,drug,0.9893,24356818
32018,mixed tumor,disease,0.998,24356818
32019,solid tumors,disease,1.0,24356818
32020,malignant cells,cell_type,0.8296,24356818
32021,cancer,disease,0.999,24356818
32022,tumor,disease,1.0,24356818
32023,tumor,disease,1.0,24356818
32024,epidermal growth factor receptor (EGFR)-positive A431 cells,cell_line,0.6904,24356818
32025,epidermal growth factor receptor,gene,0.9624,24356818
32026,EGFR,gene,0.8774,24356818
32027,EGFR-negative Balb3T3/DsRed cells,cell_line,0.952,24356818
32028,EGFR,gene,0.9565,24356818
32029,DsRed,gene,0.8228,24356818
32030,tumor,disease,0.9937,24356818
32031,cancer,disease,0.9805,24356818
32032,IR700,drug,0.8286,24356818
32033,EGFR-positive A431 cells,cell_line,0.9375,24356818
32034,EGFR,gene,0.988,24356818
32035,tumor,disease,0.8037,24356818
32036,EGFR-negative Balb/DsRed cells,cell_line,0.7954,24356818
32037,EGFR-negative,cell_type,0.4548,24356818
32038,EGFR,gene,0.938,24356818
32039,tumor,disease,0.951,24356818
32040,DaunoXome,drug,0.966,24356818
32041,daunorubicin,drug,0.9795,24356818
32042,daunorubicin,drug,0.998,24356818
32043,EGFR,gene,0.991,24356818
32044,EGFR-negative Balb3T3/,cell_line,0.939,24356818
32045,EGFR,gene,0.9214,24356818
32046,DsRed,gene,0.9854,24356818
32047,mice,species,0.9814,24356818
32048,panitumumab,gene,0.661,24356622
32049,panitumumab,gene,0.9717,24356622
32050,FOLFIRI,drug,0.9946,24356622
32051,FOLFIRI,drug,0.989,24356622
32052,WT,gene,0.515,24356622
32053,KRAS,gene,0.865,24356622
32054,metastatic colorectal cancer,disease,1.0,24356622
32055,mCRC,disease,1.0,24356622
32056,PATIENTS,species,0.953,24356622
32057,Patients,species,0.937,24356622
32058,mCRC,disease,0.9966,24356622
32059,panitumumab,gene,0.8784,24356622
32060,FOLFIRI,drug,0.95,24356622
32061,FOLFIRI,drug,0.988,24356622
32062,tumor KRAS,gene,0.7334,24356622
32063,KRAS,DNA,0.4854,24356622
32064,patients,species,0.937,24356622
32065,patients,species,0.9253,24356622
32066,WT,disease,,24356622
32067,WT KRAS,gene,0.8774,24356622
32068,panitumumab,gene,0.899,24356622
32069,FOLFIRI,drug,0.987,24356622
32070,FOLFIRI,drug,0.6104,24356622
32071,patients,species,0.9478,24356622
32072,oxaliplatin,drug,1.0,24356622
32073,bevacizumab,gene,0.962,24356622
32074,panitumumab,gene,0.9536,24356622
32075,FOLFIRI,drug,0.9756,24356622
32076,epidermal growth factor receptor,gene,0.9062,24356622
32077,panitumumab,gene,0.949,24356622
32078,FOLFIRI,drug,0.9683,24356622
32079,WT KRAS,gene,0.9424,24356622
32080,mCRC,disease,0.987,24356622
32081,Metastatic colorectal cancer,disease,0.9995,24348051
32082,bevacizumab,gene,0.8364,24348051
32083,Bevacizumab,gene,0.878,24348051
32084,metastatic colorectal cancer,disease,1.0,24348051
32085,mCRC,disease,1.0,24348051
32086,K-ras oncogene,gene,0.9985,24348051
32087,patients,species,0.9897,24348051
32088,cetuximab,gene,0.759,24348051
32089,panitumumab,gene,0.8687,24348051
32090,patients,species,0.9917,24348051
32091,bevacizumab,gene,0.715,24348051
32092,K-ras mutation,gene,0.967,24348051
32093,mCRC,disease,0.9966,24348051
32094,bevacizumab,gene,0.7676,24348051
32095,patients,species,0.9893,24348051
32096,K-ras,gene,0.998,24348051
32097,K-ras,gene,0.998,24348051
32098,patients,species,0.978,24348051
32099,wild-type (WT) K-ras,gene,0.9805,24348051
32100,mutated (MT) K-ras,gene,0.909,24348051
32101,WT K,DNA,0.902,24348051
32102,WT K-ras,gene,0.9897,24348051
32103,MT K,DNA,0.728,24348051
32104,MT K-ras,gene,0.909,24348051
32105,metastatic sites,DNA,0.7974,24348051
32106,WT K-ras,gene,0.9985,24348051
32107,MT K-ras,gene,0.9976,24348051
32108,liver metastases,disease,0.949,24348051
32109,extrahepatic disease,disease,0.997,24348051
32110,K-ras mutation,gene,0.973,24348051
32111,mCRC,disease,0.992,24348051
32112,patients,species,0.9927,24348051
32113,bevacizumab,gene,0.778,24348051
32114,dermatologic,disease,0.8413,24347989
32115,epidermal growth factor receptor,gene,0.998,24347989
32116,EGFRIs,gene,0.966,24347989
32117,cetuximab,gene,0.67,24347989
32118,panitumumab,gene,0.731,24347989
32119,patients,species,0.9585,24347989
32120,metastatic colorectal cancer,disease,1.0,24347989
32121,mCRC,disease,1.0,24347989
32122,patients,species,0.9937,24347989
32123,papulopustular skin rash,disease,1.0,24347989
32124,skin rash,disease,1.0,24347989
32125,anti-epidermal growth factor receptor,gene,0.993,24347989
32126,EGFR,gene,0.9263,24347989
32127,cetuximab,gene,0.7285,24347989
32128,panitumumab,gene,0.8203,24347989
32129,mCRC,disease,0.906,24347989
32130,anti-EGFR mAbs,gene,0.97,24347989
32131,rash,disease,0.833,24347989
32132,skin rash,disease,1.0,24347989
32133,mAb,gene,0.623,24347989
32134,EGFRIs,gene,0.4888,24347989
32135,patients,species,0.98,24347989
32136,EGFR,gene,0.8345,24347989
32137,Cancer Skin Toxicity,disease,0.8154,24347989
32138,doxycycline,drug,0.9985,24347989
32139,minocycline,drug,0.9976,24347989
32140,skin rash,disease,1.0,24347989
32141,cetuximab,gene,0.9443,24347989
32142,panitumumab,gene,0.8936,24347989
32143,patient,species,0.9927,24347989
32144,skin rash,disease,0.9966,24347989
32145,skin,disease,0.985,24347989
32146,EGFR,gene,0.631,24347989
32147,small bowel adenocarcinoma,disease,0.997,24335374
32148,A,drug,0.6157,24335374
32149,abdominal and back pain,disease,0.9893,24335374
32150,tumor of the jejunum,disease,0.9424,24335374
32151,adenocarcinoma,disease,0.9194,24335374
32152,irinotecan,drug,0.998,24335374
32153,cisplatin,drug,0.9995,24335374
32154,tumor,disease,1.0,24335374
32155,epidermal growth factor receptor,gene,0.998,24335374
32156,EGFR,gene,0.9946,24335374
32157,wild,DNA,0.5713,24335374
32158,wild-type KRAS,gene,0.906,24335374
32159,EGFR,gene,0.9893,24335374
32160,patient,species,0.98,24335374
32161,panitumumab,gene,0.874,24335374
32162,S,drug,0.5806,24335374
32163,Small bowel adenocarcinoma,disease,1.0,24335374
32164,circulating tumor cells,cell_type,0.903,24332356
32165,esophagogastric cancers,disease,1.0,24332356
32166,Circulating tumor cells,cell_type,0.9165,24332356
32167,CTCs,cell_type,0.822,24332356
32168,malignancies,disease,0.9995,24332356
32169,CTCs,cell_type,0.723,24332356
32170,esophagogastric adenocarcinoma,disease,1.0,24332356
32171,PATIENTS,species,0.9697,24332356
32172,CTCs,cell_type,0.712,24332356
32173,advanced esophageal or gastric adenocarcinoma,disease,1.0,24332356
32174,CTC,cell_type,0.729,24332356
32175,CTC,cell_type,0.511,24332356
32176,metastatic esophageal or gastric adenocarcinoma,disease,0.999,24332356
32177,epirubicin,drug,0.9995,24332356
32178,oxaliplatin,drug,0.9995,24332356
32179,capecitabine,drug,0.999,24332356
32180,panitumumab,gene,0.6475,24332356
32181,CTC,cell_type,0.7554,24332356
32182,CTCs,cell_type,0.8115,24332356
32183,CTCs,cell_type,0.5425,24332356
32184,CTCs,cell_type,0.573,24332356
32185,CTCs,cell_type,0.854,24332356
32186,CTCs,cell_type,0.8447,24332356
32187,CTCs,cell_type,0.752,24332356
32188,locally advanced,disease,0.6924,24332356
32189,esophagogastric cancer,disease,0.968,24332356
32190,CTCs,cell_type,0.7915,24332356
32191,esophagogastric cancer,disease,1.0,24332356
32192,BEV,drug,0.8516,24319792
32193,anti-EGFR,gene,0.888,24319792
32194,BEV,drug,0.728,24319792
32195,wild type K-ras colon cancer,disease,0.987,24319792
32196,wild type K-ras,gene,0.924,24319792
32197,epidermal growth factor receptor,gene,0.9985,24317328
32198,EGFR,gene,0.993,24317328
32199,tumors,disease,1.0,24317328
32200,colorectal cancer,disease,1.0,24317328
32201,CRC,disease,1.0,24317328
32202,EGFR,gene,0.9937,24317328
32203,RAS,gene,0.9897,24317328
32204,RAF,gene,0.999,24317328
32205,MAPK,gene,0.993,24317328
32206,STAT,gene,0.996,24317328
32207,PI3K,gene,0.9893,24317328
32208,AKT,gene,0.993,24317328
32209,Anti-,gene,0.95,24317328
32210,EGFR,gene,0.537,24317328
32211,cetuximab,gene,0.7075,24317328
32212,panitumumab,gene,0.7783,24317328
32213,CRC,disease,0.9897,24317328
32214,EGFR,gene,0.9893,24317328
32215,EGFR,gene,0.993,24317328
32216,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9316,24312376
32217,cancer,disease,1.0,24312376
32218,Anti-,gene,0.858,24312376
32219,epidermal growth factor receptor,gene,0.923,24312376
32220,EGFR,gene,0.988,24312376
32221,cetuximab,gene,0.838,24312376
32222,panitumumab,gene,0.8755,24312376
32223,cancer,disease,1.0,24312376
32224,cancer,disease,1.0,24312376
32225,solid tumors,disease,1.0,24312376
32226,FAEs,disease,0.9536,24312376
32227,cetuximab,gene,0.859,24312376
32228,panitumumab,gene,0.675,24312376
32229,FAEs,disease,0.992,24312376
32230,EGFR-MoAbs,gene,0.7188,24312376
32231,tumor,disease,1.0,24312376
32232,breast cancer,disease,1.0,24312376
32233,esophagus cancer,disease,1.0,24312376
32234,EGFR-MoAbs,gene,0.793,24312376
32235,advanced solid tumors,disease,0.9995,24312376
32236,Panitumumab,gene,0.8823,24311948
32237,cetuximab,gene,0.9385,24311948
32238,irinotecan,drug,0.994,24311948
32239,KRAS,gene,0.7676,24311948
32240,anti-,gene,0.519,24311948
32241,epidermal growth factor receptor,gene,0.9526,24311948
32242,egfr,gene,0.996,24311948
32243,irinotecan,drug,0.9814,24311948
32244,KRAS wildtype,gene,0.882,24311948
32245,metastatic colorectal cancer,disease,1.0,24311948
32246,mcrc,disease,1.0,24311948
32247,panitumumab,gene,0.8887,24311948
32248,cetuximab,gene,0.895,24311948
32249,irinotecan,drug,0.9985,24311948
32250,KRAS,gene,0.8057,24311948
32251,mcrc,gene,0.354,24311948
32252,irinotecan,drug,0.999,24311948
32253,oxaliplatin,drug,0.9995,24311948
32254,panitumumab,gene,0.8257,24311948
32255,cetuximab,gene,0.8506,24311948
32256,irinotecan,drug,0.997,24311948
32257,Cancer,disease,0.777,24311948
32258,egfr,gene,0.5576,24311948
32259,panitumumab,gene,0.8623,24311948
32260,cetuximab,gene,0.814,24311948
32261,irinotecan,drug,0.9985,24311948
32262,cetuximab,gene,0.963,24311948
32263,irinotecan,drug,0.9985,24311948
32264,panitumumab,gene,0.937,24311948
32265,panitumumab,gene,0.91,24311948
32266,cetuximab,gene,0.946,24311948
32267,irinotecan,drug,0.995,24311948
32268,panitumumab,gene,0.9326,24311948
32269,cetuximab,gene,0.8677,24311948
32270,irinotecan,drug,0.998,24311948
32271,mcrc,gene,0.971,24311948
32272,metastatic colorectal cancer,disease,0.9688,24273599
32273,metastatic colorectal cancer,disease,0.999,24273599
32274,bevacizumab,gene,0.8037,24273599
32275,cetuximab,gene,0.9062,24273599
32276,panitumumab,gene,0.8945,24273599
32277,tumor,disease,0.948,24273599
32278,aflibercept,gene,0.965,24273599
32279,regorafenib,drug,0.9688,24273599
32280,mTOR,gene,0.995,24273599
32281,TNF,gene,0.9897,24273599
32282,ErbB,gene,0.997,24269963
32283,HER,gene,0.995,24269963
32284,protein-tyrosine kinases,gene,0.991,24269963
32285,tyrosine,drug,0.9854,24269963
32286,cancer,disease,1.0,24269963
32287,human epidermal growth factor receptor,gene,0.995,24269963
32288,EGFR,gene,0.9805,24269963
32289,ErbB,gene,0.9893,24269963
32290,ErbB1-4,gene,0.9873,24269963
32291,carboxyterminal,drug,0.995,24269963
32292,EGFR,gene,0.994,24269963
32293,epidermal growth factor,gene,0.9907,24269963
32294,transforming growth factor ,gene,0.9946,24269963
32295,ErbB2,gene,0.99,24269963
32296,ErbB3,gene,0.984,24269963
32297,ErbB4,gene,0.9463,24269963
32298,ErbB proteins,gene,0.9775,24269963
32299,ErbB2,gene,0.9927,24269963
32300,ErbB3,gene,0.994,24269963
32301,ErbB family,gene,0.9917,24269963
32302,EGFR,gene,0.993,24269963
32303,ligand-EGFR complexes,gene,0.9717,24269963
32304,EGFR intracellular,gene,0.7744,24269963
32305,cyclin,gene,0.9976,24269963
32306,cyclin-dependent kinase,gene,0.9966,24269963
32307,carboxyterminal,drug,0.971,24269963
32308,amino,drug,0.9766,24269963
32309,receiver,gene,0.562,24269963
32310,ErbB,gene,0.9966,24269963
32311,phosphatidylinositol,drug,0.9995,24269963
32312,phosphatidylinositol 3-kinase,gene,0.9917,24269963
32313,Akt,gene,0.996,24269963
32314,PKB,gene,0.988,24269963
32315,Ras,gene,0.98,24269963
32316,Raf,gene,0.9966,24269963
32317,MEK,gene,0.995,24269963
32318,ERK1/2,gene,0.983,24269963
32319,phospholipase C,gene,0.9976,24269963
32320,PLC,gene,0.997,24269963
32321,malignancies,disease,1.0,24269963
32322,ErbB family,gene,0.9927,24269963
32323,pancreatic carcinomas,disease,1.0,24269963
32324,glioblastoma,disease,1.0,24269963
32325,brain tumor,disease,1.0,24269963
32326,Gefitinib,drug,0.9985,24269963
32327,erlotinib,drug,0.997,24269963
32328,afatinib,drug,0.9937,24269963
32329,quinazoline,drug,0.818,24269963
32330,ERBB1-mutant lung cancer,disease,1.0,24269963
32331,ERBB1,gene,0.98,24269963
32332,Lapatinib,drug,0.9985,24269963
32333,quinazoline,drug,0.995,24269963
32334,ErbB2-overexpressing breast cancer,disease,0.998,24269963
32335,ErbB2,gene,0.9917,24269963
32336,Trastuzumab,gene,0.939,24269963
32337,pertuzumab,gene,0.9307,24269963
32338,ado-trastuzumab emtansine,gene,0.8354,24269963
32339,ErbB2-positive breast cancer,disease,0.998,24269963
32340,ErbB2,gene,0.9756,24269963
32341,ado-trastuzumab emtansine,gene,0.688,24269963
32342,ErbB2,gene,0.989,24269963
32343,Cetuximab,gene,0.732,24269963
32344,panitumumab,gene,0.745,24269963
32345,ErbB1,gene,0.9863,24269963
32346,colorectal cancer,disease,1.0,24269963
32347,Cancers,disease,1.0,24269963
32348,panitumumab,gene,0.7275,24258455
32349,liver dysfunction,disease,1.0,24258455
32350,Panitumumab,gene,0.7334,24258455
32351,metastatic,disease,0.791,24258455
32352,RAS,gene,0.524,24258455
32353,mCRC,disease,1.0,24258455
32354,liver metastases,disease,0.9854,24258455
32355,liver dysfunction,disease,0.9995,24258455
32356,hepatic impairment,disease,1.0,24258455
32357,mCRC,disease,1.0,24258455
32358,liver dysfunction,disease,0.998,24258455
32359,KRAS,gene,0.996,24258455
32360,mCRC,disease,0.9946,24258455
32361,liver disease,disease,0.999,24258455
32362,panitumumab,gene,0.833,24258455
32363,panitumumab,gene,0.8823,24258455
32364,panitumumab,gene,0.9277,24258455
32365,panitumumab,gene,0.9424,24258455
32366,hepatic dysfunction,disease,1.0,24258455
32367,liver dysfunction,disease,1.0,24258455
32368,diarrhea,disease,1.0,24258455
32369,skin toxicity,disease,0.9487,24258455
32370,panitumumab,gene,0.922,24258455
32371,metastatic colorectal cancer,disease,1.0,24258455
32372,liver dysfunction,disease,1.0,24258455
32373,panitumumab,gene,0.9497,24258455
32374,KRAS,gene,0.7437,24258455
32375,mCRC,disease,0.853,24258455
32376,hepatic dysfunction,disease,1.0,24258455
32377,Panitumumab,gene,0.929,24246276
32378,metastasised colorectal cancer,disease,0.9756,24246276
32379,panitumumab,gene,0.9434,24246276
32380,metastatic colorectal cancer,disease,1.0,24246276
32381,mCRC,disease,1.0,24246276
32382,panitumumab,gene,0.918,24246276
32383,wild,cell_type,0.461,24246276
32384,wild-type KRAS tumours,disease,0.6216,24246276
32385,fluoropyrimidine,drug,0.9937,24246276
32386,irinotecan,drug,0.991,24246276
32387,epidermal growth factor receptor,gene,0.9966,24246276
32388,skin toxicities,disease,0.703,24246276
32389,mCRC,disease,0.9985,24246276
32390,capecitabine,drug,0.9995,24246276
32391,oxaliplatin,drug,0.9995,24246276
32392,bevacizumab,gene,0.8423,24246276
32393,panitumumab,gene,0.8516,24246276
32394,panitumumab,gene,0.9272,24246276
32395,Carcinoembryonic antigen,gene,0.993,24246276
32396,CEA,gene,0.979,24246276
32397,CEA,gene,0.983,24246276
32398,CEA,gene,0.95,24246276
32399,skin toxicities,disease,0.988,24246276
32400,gastrointestinal complaints,disease,0.9883,24246276
32401,skin and gastrointestinal complaints,disease,0.92,24246276
32402,Panitumumab,gene,0.922,24246276
32403,KRAS,DNA,0.4263,24246276
32404,mCRC,disease,0.952,24246276
32405,irinotecan,drug,0.992,24246276
32406,CEA,gene,0.995,24246276
32407,panitumumab,gene,0.569,24246276
32408,metastatic colorectal cancer,disease,0.9995,24245912
32409,Fluoropyrimidines,drug,0.9995,24245912
32410,oxaliplatin,drug,0.9995,24245912
32411,irinotecan,drug,0.999,24245912
32412,Bevacizumab,gene,0.8975,24245912
32413,Panitumumab,gene,0.944,24245912
32414,Cetuximab,gene,0.8906,24245912
32415,metastatic colorectal cancer,disease,1.0,24245912
32416,CRC,disease,1.0,24245912
32417,mCRC,disease,0.9985,24245912
32418,mCRC,disease,0.9873,24245912
32419,tumor suppressive genes,DNA,0.882,24245912
32420,tumors,disease,1.0,24245912
32421,tumor,disease,1.0,24245912
32422,mCRC,disease,0.985,24245912
32423,Epidermal growth factor receptor,gene,0.998,24238569
32424,squamous cell carcinoma of the penis,disease,1.0,24238569
32425,advanced refractory penile cancer,disease,0.8003,24238569
32426,epidermal growth factor receptor,gene,0.9976,24238569
32427,EGFR,gene,0.988,24238569
32428,advanced penile cancer,disease,1.0,24238569
32429,platinum,drug,0.9995,24238569
32430,EGFR,gene,0.994,24238569
32431,tumor,disease,1.0,24238569
32432,EGFR,gene,0.991,24238569
32433,messenger ribonucleic acid,RNA,0.717,24238569
32434,human papillomavirus deoxyribonucleic acid,RNA,0.622,24238569
32435,K-ras,gene,0.6816,24238569
32436,codon 12,DNA,0.789,24238569
32437,codon 13,DNA,0.7837,24238569
32438,cetuximab,gene,0.622,24238569
32439,panitumumab,gene,0.894,24238569
32440,EGFR,gene,0.9893,24238569
32441,EGFR,gene,0.987,24238569
32442,messenger ribonucleic acid,RNA,0.828,24238569
32443,K-,DNA,0.6484,24238569
32444,K-ras mutations,gene,0.917,24238569
32445,human papillomavirus deoxyribonucleic acid,RNA,0.666,24238569
32446,EGFR,gene,0.993,24238569
32447,platinum,drug,1.0,24238569
32448,penile cancer,disease,0.998,24238569
32449,EGFR,gene,0.992,24238569
32450,penile cancer,disease,1.0,24238569
32451,recurrent/metastatic head and neck cancer,disease,0.9585,24236791
32452,Cisplatin,drug,0.9995,24236791
32453,fluorouracil,drug,0.9985,24236791
32454,panitumumab,gene,0.895,24236791
32455,squamous-cell carcinoma of the head and neck,disease,0.999,24236791
32456,squamous cell carcinoma of the head and neck,disease,1.0,24236791
32457,SCCHN,disease,1.0,24236791
32458,HPV,disease,0.7915,24236791
32459,EGF receptor,gene,0.9985,24236791
32460,EGFR,gene,0.9927,24236791
32461,locally advanced SCCHN,disease,0.9937,24236791
32462,EGFR monoclonal antibodies,gene,0.9316,24236791
32463,cetuximab,gene,0.7783,24236791
32464,anti-EGFR monoclonal antibody,gene,0.979,24236791
32465,SCCHN,disease,1.0,24236791
32466,platinum,drug,0.9995,24236791
32467,tumor,disease,0.5396,24236791
32468,anti-EGFR,gene,0.8086,24236791
32469,SPECTRUM,DNA,0.6216,24236791
32470,epidermal growth factor receptor,gene,0.9976,24216225
32471,EGFR,gene,0.9985,24216225
32472,ErbB,gene,0.9185,24216225
32473,head and neck squamous cell carcinoma,disease,1.0,24216225
32474,HNSCC,disease,0.506,24216225
32475,epidermal growth factor receptor,gene,0.998,24216225
32476,EGFR,gene,0.9937,24216225
32477,head and neck squamous cell carcinomas,disease,1.0,24216225
32478,HNSCC,disease,1.0,24216225
32479,Cetuximab,gene,0.6904,24216225
32480,chimeric,gene,0.719,24216225
32481,anti-EGFR monoclonal antibody,gene,0.9004,24216225
32482,HNSCC,disease,0.997,24216225
32483,platinum,drug,1.0,24216225
32484,platinum,drug,0.9995,24216225
32485,5-fluorouracil,drug,0.9995,24216225
32486,cetuximab,gene,0.8423,24216225
32487,HNSCC,disease,0.9995,24216225
32488,human papillomavirus,disease,0.8525,24216225
32489,hypersensitivity reactions,disease,0.9985,24216225
32490,EGFR,gene,0.7905,24216225
32491,tyrosine,drug,0.975,24216225
32492,tyrosine kinase,gene,0.9937,24216225
32493,lapatinib,drug,0.999,24216225
32494,dacomitinib,drug,0.9976,24216225
32495,afatinib,drug,0.9883,24216225
32496,anti-EGFR mAbs,gene,0.8623,24216225
32497,nimotuzumab,gene,0.789,24216225
32498,panitumumab,gene,0.8853,24216225
32499,HNSCC,disease,0.9985,24216225
32500,anti-,gene,0.562,24216225
32501,EGFR,gene,0.8594,24216225
32502,erlotinib,drug,0.989,24216225
32503,cancer,disease,1.0,24216225
32504,HNSCC,disease,1.0,24216225
32505,anti-EGFR mAbs,gene,0.9697,24216225
32506,MEHD7945A,drug,0.955,24216225
32507,necitumumab,gene,0.8496,24216225
32508,RO5083945,drug,0.9985,24216225
32509,vandetanib,drug,0.999,24216225
32510,icotinib,drug,0.996,24216225
32511,CUDC-101,drug,0.9985,24216225
32512,EGFR antisense,DNA,0.658,24216225
32513,EGFR,gene,0.66,24216225
32514,bevacizumab,gene,0.62,24216225
32515,interleukin-,gene,0.967,24216225
32516,lenalidomide,drug,0.993,24216225
32517,alisertib,drug,0.9966,24216225
32518,VTX-2337,drug,0.999,24216225
32519,temsirolimus,drug,0.999,24216225
32520,everolimus,drug,0.9976,24216225
32521,OSI-906,drug,0.999,24216225
32522,dasatinib,drug,0.9966,24216225
32523,PX-866,drug,0.998,24216225
32524,EGFR,gene,0.9434,24216225
32525,EGFR,gene,0.895,24216225
32526,HNSCC,disease,0.9995,24216225
32527,vascular endothelial growth factor,gene,0.997,24215550
32528,epidermal growth factor receptor,gene,0.9966,24215550
32529,metastatic colorectal cancer,disease,0.826,24215550
32530,colorectal cancer,disease,0.9995,24215550
32531,wild type Kirsten ras,gene,0.7197,24215550
32532,Kirsten ras,DNA,0.6323,24215550
32533,metastatic,disease,0.9644,24215550
32534,colorectal cancer,disease,0.8945,24215550
32535,anti-EGFRs,gene,0.9785,24215550
32536,2L anti-EGFRs,gene,0.899,24215550
32537,anti-EGFRs,gene,0.9927,24215550
32538,bevazicumab,gene,0.8403,24215550
32539,anti-EGFRs,gene,0.9746,24215550
32540,anti-EGFR,gene,0.9785,24215550
32541,bevacizumab,gene,0.5903,24215550
32542,anti-EGFR,gene,0.992,24215550
32543,anti-EGFRs,gene,0.9893,24215550
32544,anti-EGFRs,gene,0.986,24215550
32545,anti-EGFRs,gene,0.892,24215550
32546,anti-EGFR 1L,gene,0.586,24215550
32547,Ginkgo biloba,species,0.908,24210304
32548,Panitumumab,gene,0.9194,24210304
32549,metastatic colorectal cancer,disease,0.9946,24204124
32550,metastatic colorectal cancer,disease,1.0,24204124
32551,mCRC,disease,1.0,24204124
32552,bevacizumab,gene,0.7334,24204124
32553,cancer cells,cell_type,0.753,24204124
32554,cancer,disease,0.999,24204124
32555,mCRC,disease,0.989,24204124
32556,mCRC,disease,0.9683,24204124
32557,mCRC,disease,0.984,24204124
32558,bevacizumab,gene,0.856,24204124
32559,cetuximab,gene,0.715,24204124
32560,Aflibercept,gene,0.946,24204124
32561,folinic acid,drug,0.9995,24204124
32562,leucovorin,drug,0.9995,24204124
32563,fluorouracil,drug,0.9995,24204124
32564,irinotecan,drug,0.9985,24204124
32565,FOLFIRI,drug,0.8687,24204124
32566,mCRC,disease,0.988,24204124
32567,mCRC,disease,0.994,24204124
32568,-,DNA,0.4158,24204124
32569,KRAS,DNA,0.571,24204124
32570,panitumumab,gene,0.812,24204124
32571,folinic acid,drug,0.9995,24204124
32572,leucovorin,drug,0.9995,24204124
32573,fluorouracil,drug,0.9995,24204124
32574,oxaliplatin,drug,0.9995,24204124
32575,FOLFOX,drug,0.9604,24204124
32576,FOLFIRI,drug,0.794,24204124
32577,regorafenib,drug,0.9956,24204124
32578,FOLFOX,drug,0.964,24204124
32579,FOLFIRI,drug,0.8315,24204124
32580,mCRC,disease,0.9395,24204124
32581,mCRC,disease,0.9526,24204124
32582,malignancies,disease,1.0,24204124
32583,colorectal cancer,disease,1.0,24178577
32584,colorectal cancer,disease,1.0,24178577
32585,CRC,disease,1.0,24178577
32586,CRCs,cell_line,0.654,24178577
32587,cetuximab,gene,0.8115,24178577
32588,panitumumab,gene,0.7935,24178577
32589,epidermal growth factor receptor,gene,0.9985,24178577
32590,CRC,disease,0.998,24178577
32591,solid tumors,disease,1.0,24164614
32592,cetuximab,gene,0.672,24164614
32593,Erbitux,gene,0.501,24164614
32594,squamous cell cancer of the head and neck,disease,0.994,24164614
32595,EGFR,gene,0.671,24164614
32596,trastuzumab,gene,0.9707,24164614
32597,panitumumab,gene,0.9253,24164614
32598,erlotinib,drug,0.9844,24164614
32599,cilengitide,drug,0.985,24164614
32600,bevacizumab,gene,0.825,24164614
32601,solid tumors,disease,1.0,24164614
32602,colorectal cancer,disease,1.0,24158967
32603,Metastatic colorectal cancer,disease,1.0,24158967
32604,mCRC,disease,1.0,24158967
32605,mCRC,disease,0.9683,24158967
32606,anti-,gene,0.7437,24158967
32607,vascular endothelial growth factor,gene,0.876,24158967
32608,VEGF,gene,0.9873,24158967
32609,bevacizumab,gene,0.4941,24158967
32610,anti-epidermal growth factor receptor,gene,0.8594,24158967
32611,EGFR,gene,0.992,24158967
32612,cetuximab,gene,0.7344,24158967
32613,panitumumab,gene,0.857,24158967
32614,bevacizumab,gene,0.767,24158967
32615,VEGF,gene,0.55,24158967
32616,anti-EGFR antibody,gene,0.8555,24158967
32617,ziv-aflibercept,gene,0.9707,24158967
32618,regorafenib,drug,0.9346,24158967
32619,mCRC,disease,0.977,24158967
32620,CRC,disease,0.9976,24158967
32621,CRC,disease,0.998,24158967
32622,tumor,disease,1.0,24157422
32623,ADCC,cell_type,0.5083,24157422
32624,dialysis,disease,0.977,24157422
32625,effector cells,cell_type,0.875,24157422
32626,isolated polymorphonuclear cells,cell_type,0.733,24157422
32627,PMN,cell_type,0.7646,24157422
32628,peripheral blood mononuclear cells,cell_type,0.654,24157422
32629,PBMC,cell_type,0.801,24157422
32630,epidermal growth factor receptor Ab cetuximab,gene,0.905,24157422
32631,panitumumab,gene,0.8657,24157422
32632,cetuximab,gene,0.953,24157422
32633,human IgG1,gene,0.985,24157422
32634,panitumumab,gene,0.9033,24157422
32635,human IgG2 isotype,gene,0.9575,24157422
32636,Fc receptors,gene,0.993,24157422
32637,effector cell,cell_type,0.635,24157422
32638,PMN,cell_type,0.84,24157422
32639,panitumumab,gene,0.922,24157422
32640,cetuximab,gene,0.935,24157422
32641,IgG2,gene,0.996,24157422
32642,PBMC,cell_type,0.883,24157422
32643,IgG2 Abs,gene,0.9897,24157422
32644,FcRIIa,gene,0.9966,24157422
32645,PBMC,cell_type,0.808,24157422
32646,monocytes,cell_type,0.736,24157422
32647,cytotoxic,cell_line,0.4924,24157422
32648,cytotoxic cells,cell_type,0.9087,24157422
32649,monocytes,cell_type,0.5967,24157422
32650,monocytes,cell_type,0.6353,24157422
32651,Fc receptor,gene,0.975,24157422
32652,monocytes,cell_type,0.82,24157422
32653,DP,disease,1.0,24157422
32654,human IgG2 Abs,gene,0.9727,24157422
32655,Epidermal growth factor receptor,gene,0.998,24151349
32656,metastatic colorectal cancer,disease,1.0,24151349
32657,Colorectal cancer,disease,1.0,24151349
32658,CRC,disease,1.0,24151349
32659,CRC,disease,0.9995,24151349
32660,cancer,disease,1.0,24151349
32661,5-fluorouracil,drug,0.9995,24151349
32662,leucovorin,drug,0.9995,24151349
32663,irinotecan,drug,0.9985,24151349
32664,oxaliplatin,drug,0.9995,24151349
32665,epidermal growth factor receptor,gene,0.998,24151349
32666,EGFR,gene,0.9854,24151349
32667,metastatic disease,disease,0.802,24151349
32668,mCRC,disease,0.9956,24151349
32669,Cetuximab,gene,0.9062,24151349
32670,panitumumab,gene,0.888,24151349
32671,mCRC,disease,0.979,24151349
32672,EGFR,gene,0.8115,24151349
32673,mCRC,disease,0.998,24151349
32674,appendiceal adenocarcinomas,disease,1.0,24149137
32675,Appendiceal adenocarcinomas,disease,1.0,24149137
32676,AAs,disease,1.0,24149137
32677,cyclooxygenase-2,gene,0.9927,24149137
32678,COX-2,gene,0.9907,24149137
32679,epidermal,DNA,0.51,24149137
32680,epidermal growth factor receptor,gene,0.9976,24149137
32681,EGFR,gene,0.993,24149137
32682,PATIENTS,species,0.9473,24149137
32683,AA,disease,0.9946,24149137
32684,KRAS,gene,0.8174,24149137
32685,BRAF,gene,0.835,24149137
32686,cKIT,gene,0.6826,24149137
32687,EGFR,gene,0.9917,24149137
32688,PI3K,gene,0.9976,24149137
32689,c-KIT,gene,0.9966,24149137
32690,COX-2,gene,0.995,24149137
32691,COX-2,gene,0.9917,24149137
32692,KRAS,DNA,0.8105,24149137
32693,KRAS mutations,gene,0.9126,24149137
32694,signet ring cells,cell_type,0.9126,24149137
32695,COX-2,gene,0.9907,24149137
32696,KRAS,gene,0.76,24149137
32697,PI3K,gene,0.9907,24149137
32698,BRAF mutations,gene,0.5825,24149137
32699,KRAS,gene,0.7446,24149137
32700,AA,disease,1.0,24149137
32701,COX-2,gene,0.9917,24149137
32702,KRAS,DNA,0.7866,24149137
32703,KRAS mutation,gene,0.9575,24149137
32704,celecoxib,drug,0.999,24149137
32705,tumors,disease,1.0,24149137
32706,COX-2,gene,0.9917,24149137
32707,cetuximab,gene,0.601,24149137
32708,panitumumab,gene,0.576,24149137
32709,KRAS,gene,0.7153,24149137
32710,COX-2,gene,0.9937,24149137
32711,KRAS,gene,0.7695,24149137
32712,COX-2,gene,0.997,24149137
32713,EGFR,gene,0.9824,24149137
32714,AA,disease,0.9985,24149137
32715,AA,disease,0.9985,24149137
32716,gemcitabine,drug,0.9995,24146220
32717,irinotecan,drug,0.999,24146220
32718,panitumumab,gene,0.856,24146220
32719,advanced cholangiocarcinoma,disease,0.9985,24146220
32720,biliary tract cancer,disease,1.0,24146220
32721,epidermal growth factor receptor,gene,0.9985,24146220
32722,EGFR,gene,0.9927,24146220
32723,tumor,disease,1.0,24146220
32724,panitumumab,gene,0.8286,24146220
32725,monoclonal anti-EGFR antibody,gene,0.8804,24146220
32726,gemcitabine,drug,0.9995,24146220
32727,irinotecan,drug,0.9985,24146220
32728,PATIENTS,species,0.983,24146220
32729,advanced (unresectable,disease,0.8765,24146220
32730,cholangiocarcinoma,disease,0.9683,24146220
32731,panitumumab,gene,0.871,24146220
32732,gemcitabine,drug,0.9985,24146220
32733,irinotecan,drug,0.996,24146220
32734,EGFR,gene,0.993,24146220
32735,KRAS,gene,0.809,24146220
32736,BRAF,gene,0.862,24146220
32737,neutropenia,disease,1.0,24146220
32738,thrombocytopenia,disease,1.0,24146220
32739,skin rash,disease,1.0,24146220
32740,dehydration,disease,0.9995,24146220
32741,EGFR,gene,0.9917,24146220
32742,BRAF,DNA,0.6816,24146220
32743,BRAF mutations,gene,0.835,24146220
32744,KRAS,DNA,0.712,24146220
32745,KRAS mutations,gene,0.891,24146220
32746,KRAS,gene,0.746,24146220
32747,Cancer,disease,0.9917,24146220
32748,squamous cell carcinoma of the skin,disease,1.0,24135559
32749,Non-melanoma skin cancer,disease,1.0,24135559
32750,NMSC,disease,1.0,24135559
32751,squamous cell carcinoma,disease,1.0,24135559
32752,SCC,disease,1.0,24135559
32753,basal cell carcinoma,disease,1.0,24135559
32754,BCC,disease,1.0,24135559
32755,malignancy,disease,1.0,24135559
32756,SCC,disease,0.9995,24135559
32757,EGFR,gene,0.9873,24135559
32758,patients,species,0.9873,24135559
32759,anti-EGFR mAbs,gene,0.879,24135559
32760,SCC,cell_line,0.701,24135559
32761,patients,species,0.989,24135559
32762,SCC,disease,0.99,24135559
32763,cetuximab,gene,0.708,24135559
32764,panitumumab,gene,0.7397,24135559
32765,patients,species,0.9907,24135559
32766,cetuximab,gene,0.6367,24135559
32767,SCC,disease,0.9976,24135559
32768,patients,species,0.99,24135559
32769,patient,species,0.977,24135559
32770,cetuximab,gene,0.9287,24135559
32771,patient,species,0.977,24135559
32772,loco-regional metastatic disease of the scalp and neck,disease,1.0,24135559
32773,cetuximab,gene,0.9634,24135559
32774,panitumumab,gene,0.814,24135559
32775,patients,species,0.807,24135559
32776,skin rash,disease,0.999,24135559
32777,erythromycin,drug,0.9976,24135559
32778,doxycyclin,drug,0.999,24135559
32779,Cetuximab,gene,0.8403,24135559
32780,patients,species,0.976,24135559
32781,EGFR,gene,0.7056,24135559
32782,patients,species,0.985,24135559
32783,EGFR-driven tumors,disease,0.998,24113593
32784,EGFR,gene,0.995,24113593
32785,epidermal growth factor receptor,gene,0.9985,24113593
32786,EGFR,gene,0.993,24113593
32787,tumor cells,cell_type,0.8174,24113593
32788,tumor,disease,1.0,24113593
32789,neoplasms,disease,0.4482,24113593
32790,cancer,disease,1.0,24113593
32791,EGFR,gene,0.9966,24113593
32792,cetuximab,gene,0.866,24113593
32793,panitumumab,gene,0.86,24113593
32794,tyrosine,drug,0.9624,24113593
32795,tyrosine kinase,gene,0.983,24113593
32796,erlotinib,drug,0.9966,24113593
32797,gefitinib,drug,0.9976,24113593
32798,tumor cells,cell_type,0.842,24113593
32799,tumor,disease,0.998,24113593
32800,EGFR,gene,0.9927,24113593
32801,breast cancer,disease,0.9995,24107821
32802,breast cancer,disease,1.0,24107821
32803,tumors,disease,0.4688,24107821
32804,breast cancer,disease,0.998,24107821
32805,bevacizumab,gene,0.8525,24102083
32806,cetuximab,gene,0.8867,24102083
32807,panitumumab,gene,0.9033,24102083
32808,Colorectal cancer,disease,1.0,24102083
32809,CRC,disease,1.0,24102083
32810,cancer,disease,1.0,24102083
32811,melanoma skin cancers,disease,1.0,24102083
32812,Bevacizumab,gene,0.494,24102083
32813,human vascular endothelial growth factor,gene,0.995,24102083
32814,human,species,0.9707,24102083
32815,KRAS,gene,0.9946,24102083
32816,patients,species,0.981,24102083
32817,epidermal growth factor,gene,0.8975,24102083
32818,cetuximab,gene,0.4773,24102083
32819,panitumumab,gene,0.5713,24102083
32820,patients,species,0.977,24102083
32821,fluoropyrimidine,drug,0.998,24102083
32822,bevacizumab,gene,0.83,24102083
32823,cetuximab,gene,0.866,24102083
32824,panitumumab,gene,0.9126,24102083
32825,KRAS,DNA,0.6357,24102083
32826,KRAS,gene,0.9956,24102083
32827,mCRC,disease,0.995,24102083
32828,patients,species,0.9907,24102083
32829,patient,species,0.9883,24102083
32830,bevacizumab,gene,0.9243,24102083
32831,bevacizumab,gene,0.915,24102083
32832,panitumumab,gene,0.926,24102083
32833,cetuximab,gene,0.6035,24102083
32834,bevacizumab,gene,0.93,24102083
32835,KRAS,gene,0.9956,24102083
32836,mCRC,disease,0.9785,24102083
32837,bevacizumab,gene,0.9014,24102083
32838,FBC,drug,0.9067,24102083
32839,panitumumab,gene,0.8833,24102083
32840,FBC,drug,0.882,24102083
32841,cetuximab,gene,0.5674,24102083
32842,FBC,cell_type,0.7466,24102083
32843,bevacizumab,gene,0.7173,24102083
32844,patient,species,0.97,24102083
32845,panitumumab,gene,0.899,24100437
32846,EGF,gene,0.99,24100437
32847,EGFR,gene,0.382,24100437
32848,EGFRvIII-,disease,0.706,24100437
32849,EGFRvIII,gene,0.9937,24100437
32850,epidermal growth factor receptor,gene,0.998,24100437
32851,EGFR,gene,0.9927,24100437
32852,cancers,disease,1.0,24100437
32853,EGFR variant III,gene,0.996,24100437
32854,EGFRvIII,gene,0.994,24100437
32855,exons 2-7,DNA,0.8647,24100437
32856,EGFR,gene,0.9966,24100437
32857,EGFRvIII,gene,0.6914,24100437
32858,EGFR,gene,0.997,24100437
32859,panitumumab,gene,0.894,24100437
32860,EGF,gene,0.9067,24100437
32861,Aff800,gene,0.853,24100437
32862,Pan800,gene,0.9204,24100437
32863,EGF800,gene,0.99,24100437
32864,rat glioma cell line F98 parental,cell_line,0.8926,24100437
32865,rat,species,0.98,24100437
32866,glioma,disease,0.9214,24100437
32867,F98-p,cell_line,0.8994,24100437
32868,EGFR,gene,0.989,24100437
32869,2 F98-derived transgenic cell lines,cell_line,0.9453,24100437
32870,EGFR,gene,0.947,24100437
32871,EGFRvIII,gene,0.985,24100437
32872,F98-EGFR,cell_line,0.655,24100437
32873,F98,cell_line,0.75,24100437
32874,F98,gene,0.891,24100437
32875,EGFR,gene,0.7676,24100437
32876,EGF800,gene,0.948,24100437
32877,Pan800,gene,0.9297,24100437
32878,Aff800,gene,0.951,24100437
32879,EGF800,gene,0.989,24100437
32880,F98,DNA,0.5806,24100437
32881,F98-vIII,gene,0.9766,24100437
32882,F98-p tumors,cell_line,0.856,24100437
32883,F98-EGFR tumors,cell_line,0.785,24100437
32884,EGFR,gene,0.9336,24100437
32885,F98,cell_line,0.627,24100437
32886,F98-vIII,gene,0.729,24100437
32887,Pan800,cell_line,0.4863,24100437
32888,F98-EGFR and F98-vIII tumors,cell_line,0.904,24100437
32889,EGFR,gene,0.6978,24100437
32890,vIII tumors,disease,0.7383,24100437
32891,Pan800,gene,0.769,24100437
32892,Aff800,gene,0.8057,24100437
32893,wild-type EGFR,gene,0.9976,24100437
32894,EGFRvIII,gene,0.995,24100437
32895,EGF800,gene,0.9653,24100437
32896,wild-type EGFR,gene,0.998,24100437
32897,miR,DNA,0.5146,24098024
32898,miR-181a,gene,0.876,24098024
32899,colorectal cancer,disease,1.0,24098024
32900,EGFR,gene,0.991,24098024
32901,miR,DNA,0.4556,24098024
32902,miR-181a,gene,0.874,24098024
32903,181a,DNA,0.3865,24098024
32904,cancer,disease,0.9995,24098024
32905,Wnt,gene,0.972,24098024
32906,-catenin,gene,0.9956,24098024
32907,colorectal cancer,disease,1.0,24098024
32908,CRC,disease,1.0,24098024
32909,miR-181,gene,0.5947,24098024
32910,miR,RNA,0.647,24098024
32911,miR-181a,gene,0.932,24098024
32912,181a,DNA,0.3704,24098024
32913,CRC,disease,0.9946,24098024
32914,epidermal growth factor receptor,gene,0.996,24098024
32915,EGFR,gene,0.986,24098024
32916,KRAS,gene,0.3586,24098024
32917,CRC,disease,0.9995,24098024
32918,EGFR,gene,0.9927,24098024
32919,panitumumab,gene,0.822,24098024
32920,metastatic CRC,disease,0.9565,24098024
32921,KRAS,gene,0.73,24098024
32922,miR,RNA,0.5464,24098024
32923,miR-181a,gene,0.868,24098024
32924,CRC tumour,disease,0.8145,24098024
32925,microRNA,RNA,0.813,24098024
32926,EGFR,gene,0.994,24098024
32927,miR,RNA,0.5356,24098024
32928,miR-181a,gene,0.9346,24098024
32929,181a,DNA,0.3647,24098024
32930,CRC,disease,0.9956,24098024
32931,miR,DNA,0.499,24098024
32932,miR-181a,gene,0.917,24098024
32933,181a,DNA,0.4329,24098024
32934,miR,RNA,0.544,24098024
32935,miR-181a,gene,0.913,24098024
32936,181a,DNA,0.4106,24098024
32937,miR,RNA,0.648,24098024
32938,miR-,gene,0.8477,24098024
32939,181a,gene,0.533,24098024
32940,CRC,disease,0.9985,24098024
32941,miR,RNA,0.4905,24098024
32942,miR-181a,gene,0.7817,24098024
32943,EGFR,gene,0.991,24098024
32944,KRAS,gene,0.7563,24051306
32945,codon 13,DNA,0.804,24051306
32946,colorectal cancer,disease,1.0,24051306
32947,tumors,disease,1.0,24051306
32948,KRAS,gene,0.6665,24051306
32949,codon 12 and 13,DNA,0.7144,24051306
32950,EGFR,gene,0.6187,24051306
32951,codons,DNA,0.548,24051306
32952,cetuximab,gene,0.892,24051306
32953,panitumumab,gene,0.8647,24051306
32954,codon 12,DNA,0.8564,24051306
32955,codon 13,DNA,0.838,24051306
32956,KRAS gene,gene,0.8906,24051306
32957,codon 13,DNA,0.884,24051306
32958,EGFR,gene,0.928,24051306
32959,anti-EGFR antibodies,gene,0.763,24051306
32960,KRAS,gene,0.708,24051306
32961,codon 13,DNA,0.8477,24051306
32962,EGFR,gene,0.994,24048704
32963,NOX4,gene,0.981,24048704
32964,HNSCC,disease,0.4766,24048704
32965,tumor,disease,1.0,24048704
32966,epidermal growth factor receptor,gene,0.996,24048704
32967,EGFR,gene,0.9893,24048704
32968,head and neck squamous cell carcinoma (HNSCC) cells,cell_line,0.708,24048704
32969,head and neck squamous cell carcinoma,disease,0.9995,24048704
32970,HNSCC,disease,0.72,24048704
32971,EGFR,gene,0.9907,24048704
32972,HNSCC,disease,1.0,24048704
32973,EGFR,gene,0.9937,24048704
32974,erlotinib,drug,0.998,24048704
32975,cetuximab,gene,0.744,24048704
32976,lapatinib,drug,0.997,24048704
32977,panitumumab,gene,0.7695,24048704
32978,interleukins,gene,0.885,24048704
32979,IL-2,gene,0.8867,24048704
32980,IL-4,gene,0.948,24048704
32981,IL-6,gene,0.95,24048704
32982,IL-8,gene,0.942,24048704
32983,granulocyte-macrophage colony-stimulating factor,gene,0.998,24048704
32984,TNF-,gene,0.977,24048704
32985,IFN-,gene,0.992,24048704
32986,IL-6,gene,0.9917,24048704
32987,erlotinib,drug,0.9966,24048704
32988,IL-6 mRNA,gene,0.8774,24048704
32989,IL-6,gene,0.9937,24048704
32990,HNSCC cells,cell_line,0.7847,24048704
32991,HNSCC,disease,0.9634,24048704
32992,erlotinib,drug,0.9917,24048704
32993,tocilizumab,gene,0.929,24048704
32994,IL-6 receptor,gene,0.9736,24048704
32995,erlotinib,drug,0.9775,24048704
32996,NF-B,gene,0.9243,24048704
32997,p38,gene,0.7085,24048704
32998,JNK,gene,0.96,24048704
32999,erlotinib,drug,0.999,24048704
33000,IL-6,gene,0.9907,24048704
33001,NF-B,gene,0.859,24048704
33002,IL-6,gene,0.9873,24048704
33003,NADPH,drug,0.9995,24048704
33004,NADPH oxidase 4,gene,0.9243,24048704
33005,NOX4,gene,0.9863,24048704
33006,erlotinib,drug,0.996,24048704
33007,EGFR,gene,0.992,24048704
33008,NOX4,gene,0.978,24048704
33009,EGFR,gene,0.9907,24048704
33010,NOX4,gene,0.991,24048704
33011,HNSCC,disease,0.504,24048704
33012,S492R,DNA,0.6606,24025416
33013,S492R EGFR ectodomain mutation,gene,0.763,24025416
33014,S492,mutation,,24025416
33015,KRAS,gene,0.992,24025416
33016,epidermal growth factor receptor,gene,0.9985,24025416
33017,EGFR,gene,0.9863,24025416
33018,cetuximab,gene,0.516,24025416
33019,panitumumab,gene,0.8604,24025416
33020,metastatic colorectal carcinoma,disease,1.0,24025416
33021,mCRC,disease,1.0,24025416
33022,S492,mutation,,24025416
33023,EGFR,gene,0.9956,24025416
33024,1476C,RNA,0.4849,24025416
33025,cetuximab,gene,0.9316,24025416
33026,panitumumab,gene,0.9243,24025416
33027,mCRC,disease,0.999,24025416
33028,cetuximab,gene,0.865,24025416
33029,EGFR monoclonal antibodies,gene,0.9717,24025416
33030,CRC,disease,0.993,24025416
33031,S492,mutation,,24025416
33032,KRAS,gene,0.996,24025416
33033,exon 2,DNA,0.8276,24025416
33034,CRC,disease,0.999,24025416
33035,patients,species,0.9897,24025416
33036,Genomic DNA,DNA,0.7646,24025416
33037,formalin,drug,0.982,24025416
33038,CRC,disease,0.9995,24025416
33039,patients,species,0.9927,24025416
33040,S492,mutation,,24025416
33041,plasmid,DNA,0.674,24025416
33042,1474A,cell_line,0.615,24025416
33043,mutant DNA,DNA,0.907,24025416
33044,wild-type DNA,DNA,0.9165,24025416
33045,S492R,DNA,0.557,24025416
33046,S492,mutation,,24025416
33047,CRC,disease,1.0,24025416
33048,S492R,DNA,0.4727,24025416
33049,S492,mutation,,24025416
33050,cetuximab,gene,0.8413,24025416
33051,CRC,disease,0.9995,24025416
33052,patients,species,0.979,24025416
33053,mCRC,disease,0.997,24025416
33054,cetuximab,gene,0.9297,24025416
33055,panitumumab,gene,0.9517,24025413
33056,KRAS,DNA,0.742,24025413
33057,KRAS wild,gene,0.855,24025413
33058,metastatic colorectal cancer,disease,0.843,24025413
33059,cetuximab,gene,0.9346,24025413
33060,panitumumab,gene,0.8057,24025413
33061,advanced colorectal cancer,disease,1.0,24025413
33062,cetuximab,gene,0.756,24025413
33063,PATIENTS,species,0.89,24025413
33064,KRAS,gene,0.8145,24025413
33065,colorectal cancer,disease,0.989,24025413
33066,cetuximab,gene,0.801,24025413
33067,cetuximab,gene,0.72,24025413
33068,panitumumab,gene,0.9517,24025413
33069,Panitumumab,gene,0.754,24025413
33070,BRAF,gene,0.7153,24025413
33071,NRAS,gene,0.4866,24025413
33072,PI3KCA,gene,0.3604,24025413
33073,KRAS,gene,0.6675,24025413
33074,tumors,disease,0.939,24025413
33075,panitumumab,gene,0.7837,24025413
33076,panitumumab,gene,0.91,24025413
33077,cetuximab,gene,0.916,24025413
33078,exon 2,DNA,0.4841,24024844
33079,RAS,DNA,0.56,24024844
33080,RAS mutations,gene,0.756,24024844
33081,colorectal cancer,disease,1.0,24024844
33082,Panitumumab,gene,0.905,24024839
33083,RAS,DNA,0.7817,24024839
33084,RAS mutations,gene,0.8726,24024839
33085,colorectal cancer,disease,1.0,24024839
33086,metastatic colorectal cancer,disease,1.0,24024839
33087,KRAS,DNA,0.6206,24024839
33088,KRAS mutations,gene,0.9536,24024839
33089,exon 2,DNA,0.478,24024839
33090,epidermal growth factor receptor,gene,0.991,24024839
33091,EGFR,gene,0.991,24024839
33092,RAS,DNA,0.4783,24024839
33093,RAS mutations,gene,0.859,24024839
33094,EGFR,gene,0.923,24024839
33095,panitumumab,gene,0.792,24024839
33096,oxaliplatin,drug,0.9995,24024839
33097,fluorouracil,drug,0.999,24024839
33098,leucovorin,drug,0.9976,24024839
33099,FOLFOX4,drug,0.7217,24024839
33100,FOLFOX4,drug,0.891,24024839
33101,RAS,gene,0.992,24024839
33102,KRAS,gene,0.798,24024839
33103,NRAS,gene,0.726,24024839
33104,BRAF,gene,0.7803,24024839
33105,metastatic colorectal cancer,disease,1.0,24024839
33106,KRAS,DNA,0.646,24024839
33107,KRAS mutations,gene,0.7983,24024839
33108,exon 2,DNA,0.811,24024839
33109,KRAS exon 3,gene,0.7764,24024839
33110,"NRAS exon 2, 3, or 4",DNA,0.905,24024839
33111,BRAF exon 15,gene,0.885,24024839
33112,RAS,gene,0.8223,24024839
33113,RAS,DNA,0.8184,24024839
33114,RAS mutations,gene,0.8916,24024839
33115,panitumumab,gene,0.8213,24024839
33116,FOLFOX4,drug,0.812,24024839
33117,FOLFOX4,drug,0.967,24024839
33118,panitumumab,gene,0.9556,24024839
33119,FOLFOX4,drug,0.8506,24024839
33120,KRAS exon 2,gene,0.867,24024839
33121,RAS mutations,gene,0.8296,24024839
33122,panitumumab,gene,0.9287,24024839
33123,KRAS mutations,gene,0.645,24024839
33124,exon 2,DNA,0.4365,24024839
33125,BRAF,DNA,0.733,24024839
33126,BRAF mutations,gene,0.774,24024839
33127,RAS mutations,gene,0.6104,24024839
33128,panitumumab,gene,0.907,24024839
33129,metastatic colorectal cancer,disease,1.0,24024839
33130,RAS,DNA,0.776,24024839
33131,RAS mutations,gene,0.8223,24024839
33132,panitumumab,gene,0.9014,24024839
33133,FOLFOX4,drug,0.526,24024839
33134,PRIME,DNA,0.5596,24024839
33135,S-1,drug,0.995,24023332
33136,oxaliplatin,drug,0.999,24023332
33137,SOX,drug,0.999,24023332
33138,colorectal liver metastases,disease,1.0,24023332
33139,liver metastases,disease,0.991,24023332
33140,colorectal cancer,disease,1.0,24023332
33141,PATIENTS,species,0.9214,24023332
33142,colorectal liver metastases,disease,0.999,24023332
33143,S-1,drug,0.9814,24023332
33144,oxaliplatin,drug,0.9995,24023332
33145,SOX,drug,0.9956,24023332
33146,SOX,drug,0.998,24023332
33147,SOX,drug,0.9985,24023332
33148,bevacizumab,gene,0.809,24023332
33149,cetuximab,gene,0.852,24023332
33150,panitumumab,gene,0.9077,24023332
33151,SOX,drug,0.9946,24023332
33152,liver metastases,disease,0.802,24023332
33153,malignant cells,cell_type,0.87,24023332
33154,liver metastases,disease,0.8745,24023332
33155,SOX,drug,0.999,24023332
33156,liver metastases,disease,0.9097,24023332
33157,malignant cells,cell_type,0.8813,24023332
33158,tumor,disease,0.9985,24023332
33159,tumor cells,cell_type,0.8477,24023332
33160,tumor,disease,0.9956,24023332
33161,tumor,disease,0.9995,24023332
33162,tumor,disease,1.0,24023332
33163,tumor,disease,0.999,24023332
33164,metastatic Metastatic colorectal cancer,disease,0.94,24011538
33165,mCRC,disease,1.0,24011538
33166,patients,species,0.983,24011538
33167,mCRC,disease,0.973,24011538
33168,mCRC,disease,0.9966,24011538
33169,bevacizumab,gene,0.6123,24011538
33170,cetuximab,gene,0.9473,24011538
33171,panitumumab,gene,0.898,24011538
33172,bevacizumab,gene,0.7295,24011538
33173,cetuximab,gene,0.772,24011538
33174,panitumumab,gene,0.87,24011538
33175,bevacizumab,gene,0.8936,24011538
33176,cetuximab,gene,0.923,24011538
33177,panitumumab,gene,0.9053,24011538
33178,patients,species,0.9565,24011538
33179,mCRC,disease,0.9956,24011538
33180,Kirsten ras oncogene,gene,0.9985,24011538
33181,KRAS,gene,0.9976,24011538
33182,cetuximab,gene,0.8247,24011538
33183,panitumumab,gene,0.831,24011538
33184,cetuximab,gene,0.93,24011538
33185,panitumumab,gene,0.9316,24011538
33186,regorafenib,drug,0.898,24011538
33187,aflibercept,gene,0.9604,24011538
33188,metastatic colorectal cancer,disease,1.0,24003339
33189,metastatic colorectal cancer,disease,1.0,24003339
33190,fluorouracil,drug,0.9985,24003339
33191,irinotecan,drug,0.9985,24003339
33192,oxaliplatin,drug,0.9995,24003339
33193,epidermal growth factor receptor,gene,0.995,24003339
33194,EGFR,gene,0.9956,24003339
33195,tumours,disease,1.0,24003339
33196,patient,species,0.9893,24003339
33197,KRAS,DNA,0.855,24003339
33198,KRAS mutations,gene,0.934,24003339
33199,anti-EGFR monoclonal antibodies,gene,0.5996,24003339
33200,cetuximab,gene,0.6636,24003339
33201,panitumumab,gene,0.7603,24003339
33202,patients,species,0.9937,24003339
33203,KRAS,gene,0.976,24003339
33204,EGFR,gene,0.69,24003339
33205,colorectal cancer,disease,1.0,24003339
33206,patients,species,0.986,24003339
33207,colorectal cancers,disease,1.0,23997943
33208,colorectal cancers,disease,1.0,23997943
33209,epidermal growth factor receptor,gene,0.998,23997943
33210,EGFR,gene,0.9927,23997943
33211,cetuximab,gene,0.7715,23997943
33212,panitumumab,gene,0.871,23997943
33213,regorafenib,drug,0.9688,23997943
33214,anticancer,disease,0.907,23997943
33215,EGFR,gene,0.9897,23997940
33216,metastatic colorectal cancer,disease,0.998,23997940
33217,Colorectal cancer,disease,1.0,23997940
33218,cancer,disease,1.0,23997940
33219,metastatic colorectal cancer,disease,0.9893,23997940
33220,epidermal growth factor,gene,0.997,23997940
33221,EGFR,gene,0.991,23997940
33222,KRAS,DNA,0.8604,23997940
33223,KRAS mutation,gene,0.948,23997940
33224,BRAF mutations,gene,0.686,23997940
33225,EGFR,gene,0.996,23997940
33226,PI3K,gene,0.9927,23997940
33227,c-MET,gene,0.998,23997940
33228,IGF-1R,gene,0.998,23997940
33229,EGFR,gene,0.9907,23997940
33230,cetuximab,gene,0.563,23997940
33231,5-fluorouracil,drug,0.9995,23997940
33232,leucovorin,drug,0.999,23997940
33233,oxaliplatin,drug,0.9995,23997940
33234,FOLFOX,drug,0.5723,23997940
33235,EGFR,gene,0.993,23997940
33236,vascular endothelial growth factor,gene,0.998,23997940
33237,VEGF,gene,0.995,23997940
33238,EGFR,gene,0.992,23997940
33239,minocycline,drug,0.999,23997940
33240,doxycycline,drug,0.998,23997940
33241,rash,disease,0.987,23997940
33242,lower GI cancers,disease,1.0,23996476
33243,gastrointestinal malignancies,disease,1.0,23996476
33244,dermatologic,disease,0.5044,23996476
33245,patients,species,0.9927,23996476
33246,rash,disease,0.999,23996476
33247,dermatologic AEs,disease,0.6245,23996476
33248,Patients,species,0.9907,23996476
33249,patients,species,0.9824,23996476
33250,patients,species,0.9854,23996476
33251,cetuximab,gene,0.9883,23990977
33252,panitumumab,gene,0.984,23990977
33253,serum EGFR extracellular domain,gene,0.8784,23990977
33254,cetuximab,gene,0.9165,23990977
33255,panitumumab,gene,0.9116,23990977
33256,Vectibix,gene,0.723,23990977
33257,growth factor receptor,gene,0.9688,23990977
33258,EGFR,gene,0.997,23990977
33259,EGFR extracellular domain,gene,0.9746,23990977
33260,ECD,gene,0.7607,23990977
33261,SOMAmer,gene,0.941,23990977
33262,EGFR ECD,gene,0.869,23990977
33263,EGFR ECD,gene,0.9893,23990977
33264,EGFR,gene,0.995,23990977
33265,ErbB proteins,gene,0.99,23990977
33266,ErbB2,gene,0.9907,23990977
33267,ErbB3,gene,0.986,23990977
33268,ErbB4,gene,0.975,23990977
33269,normal,cell_type,0.447,23990977
33270,cetuximab,gene,0.9033,23990977
33271,panitumumab,gene,0.827,23990977
33272,EGFR ECD,gene,0.9927,23990977
33273,EGFR,gene,0.989,23990977
33274,serum,cell_type,0.5215,23990977
33275,EGFR,gene,0.953,23990977
33276,patients,species,0.991,23990977
33277,cetuximab,gene,0.8774,23990977
33278,panitumumab,gene,0.8535,23990977
33279,Pruritus,disease,0.999,23981682
33280,patients,species,0.98,23981682
33281,cancer,disease,0.9995,23981682
33282,Pruritus,disease,0.999,23981682
33283,cancer,disease,0.9995,23981682
33284,pruritus,disease,1.0,23981682
33285,axitinib,drug,0.999,23981682
33286,dasatinib,drug,0.997,23981682
33287,erlotinib,drug,0.998,23981682
33288,everolimus,drug,0.9985,23981682
33289,gefitinib,drug,0.999,23981682
33290,imatinib,drug,0.998,23981682
33291,ipilimumab,drug,0.847,23981682
33292,lapatinib,drug,0.9995,23981682
33293,nilotinib,drug,0.9995,23981682
33294,panitumumab,gene,0.8535,23981682
33295,pazopanib,drug,0.9995,23981682
33296,rituximab,gene,0.8613,23981682
33297,sorafenib,drug,0.9995,23981682
33298,temsirolimus,drug,0.9985,23981682
33299,vandetanib,drug,0.9985,23981682
33300,vemurafenib,drug,0.999,23981682
33301,pruritus,disease,1.0,23981682
33302,pruritus,disease,1.0,23981682
33303,pruritus,disease,0.9985,23981682
33304,pruritus,disease,1.0,23981682
33305,malignancies,disease,1.0,23981682
33306,pruritus,disease,1.0,23981682
33307,patients,species,0.9854,23981682
33308,solid tumors,disease,1.0,23981682
33309,pruritus,disease,1.0,23981682
33310,pruritus,disease,1.0,23981682
33311,patients,species,0.9897,23981682
33312,patients,species,0.9834,23981682
33313,metastatic colorectal cancer,disease,0.997,23954144
33314,Colorectal cancer,disease,1.0,23954144
33315,cancer,disease,1.0,23954144
33316,metastatic lesions,disease,0.6055,23954144
33317,patients,species,0.9814,23954144
33318,metastatic,disease,0.8345,23954144
33319,colorectal cancer,disease,0.8823,23954144
33320,epidermal growth factor receptor,gene,0.9985,23954144
33321,EGFR,gene,0.995,23954144
33322,cetuximab,gene,0.7495,23954144
33323,panitumumab,gene,0.721,23954144
33324,patients,species,0.952,23954144
33325,KRAS,gene,0.9966,23954144
33326,patients,species,0.9897,23954144
33327,EGFR,gene,0.733,23954144
33328,regorafenib,drug,0.992,23954144
33329,patients,species,0.9873,23954144
33330,patients,species,0.9814,23954144
33331,patient,species,0.9497,23954144
33332,tumour,disease,1.0,23954144
33333,tumour,disease,1.0,23954144
33334,Epidermal growth factor receptor,gene,0.9985,23953842
33335,cancer,disease,1.0,23953842
33336,epidermal growth factor receptor,gene,0.9985,23953842
33337,EGFR,gene,0.996,23953842
33338,ErbB,gene,0.964,23953842
33339,tyrosine,drug,0.982,23953842
33340,tyrosine kinase,gene,0.995,23953842
33341,EGFR,gene,0.992,23953842
33342,tumors,disease,1.0,23953842
33343,EGFR,gene,0.9937,23953842
33344,cancer,disease,1.0,23953842
33345,EGFR,gene,0.993,23953842
33346,tyrosine,drug,0.9775,23953842
33347,EGFR,gene,0.9927,23953842
33348,cetuximab,gene,0.8457,23953842
33349,panitumumab,gene,0.859,23953842
33350,gefitinib,drug,0.997,23953842
33351,erlotinib,drug,0.9976,23953842
33352,lapatinib,drug,0.9985,23953842
33353,cancers,disease,1.0,23953842
33354,EGFR,gene,0.9917,23953842
33355,patients,species,0.9844,23953842
33356,EGFR,gene,0.703,23953842
33357,EGFR,gene,0.992,23953842
33358,EGFR,gene,0.9927,23953842
33359,cancer,disease,1.0,23953842
33360,EGFR,gene,0.994,23953842
33361,EGFR,gene,0.9927,23953842
33362,EGFR,gene,0.996,23953842
33363,irinotecan,drug,0.99,23953030
33364,irinotecan,drug,0.994,23953030
33365,advanced colorectal cancer,disease,1.0,23953030
33366,CRC,disease,1.0,23953030
33367,diarrhoea,disease,0.9937,23953030
33368,SN-38,drug,0.998,23953030
33369,intestinal carboxylesterase,gene,0.9863,23953030
33370,irinotecan,drug,0.997,23953030
33371,SN-38G,drug,0.999,23953030
33372,ABCC2,gene,0.9937,23953030
33373,MRP2,gene,0.9956,23953030
33374,ABCB1,gene,0.99,23953030
33375,MDR1,gene,0.99,23953030
33376,ciclosporin,drug,0.9976,23953030
33377,irinotecan,drug,0.999,23953030
33378,ciclosporin,drug,0.9995,23953030
33379,cancer,disease,0.9976,23953030
33380,irinotecan,drug,0.999,23953030
33381,patients,species,0.865,23953030
33382,CRC,disease,0.996,23953030
33383,fluoropyrimidine,drug,0.989,23953030
33384,irinotecan,drug,0.9917,23953030
33385,irinotecan,drug,0.972,23953030
33386,ciclosporin,drug,0.999,23953030
33387,irinotecan,drug,0.998,23953030
33388,patients,species,0.991,23953030
33389,diarrhoea,disease,0.999,23953030
33390,patients,species,0.989,23953030
33391,irinotecan,drug,0.9985,23953030
33392,irinotecan,drug,0.999,23953030
33393,ciclosporin,drug,0.9985,23953030
33394,irinotecan,drug,0.9985,23953030
33395,ciclosporin,drug,0.9995,23953030
33396,irinotecan,drug,0.9995,23953030
33397,patients,species,0.969,23953030
33398,diarrhoea,disease,0.9966,23953030
33399,irinotecan,drug,0.999,23953030
33400,irinotecan,drug,0.999,23953030
33401,ciclosporin,DNA,0.457,23953030
33402,ciclosporin,drug,0.999,23953030
33403,irinotecan,drug,0.997,23953030
33404,ciclosporin,drug,0.999,23953030
33405,irinotecan,drug,0.996,23953030
33406,advanced CRC,disease,0.9976,23953030
33407,Cancer,disease,0.9434,23953030
33408,tumor,disease,0.998,23943887
33409,tumors,disease,1.0,23943887
33410,nurses,cell_type,0.4316,23943887
33411,Tumor,disease,0.9995,23943887
33412,non-small-cell lung,disease,1.0,23943887
33413,melanoma,disease,1.0,23943887
33414,colorectal,disease,0.9287,23943887
33415,cetuximab,gene,0.94,23943887
33416,bevacizumab,gene,0.8877,23943887
33417,eribulin,gene,0.813,23943887
33418,panitumumab,gene,0.908,23943887
33419,trastuzumab,gene,0.9756,23943887
33420,KRAS mutation,gene,0.979,23917487
33421,patient,species,0.94,23917487
33422,non-small cell lung cancer,disease,1.0,23917487
33423,RTOG,DNA,0.729,23917487
33424,panitumumab,gene,0.5806,23917487
33425,NSCLC,disease,1.0,23917487
33426,panitumumab,gene,0.7896,23917487
33427,anti-epithelial growth factor receptor,gene,0.901,23917487
33428,EGFR,gene,0.9854,23917487
33429,metastatic colorectal cancer,disease,0.999,23917487
33430,mCRC,disease,0.999,23917487
33431,KRAS,gene,0.99,23917487
33432,EGFR,gene,0.6455,23917487
33433,mCRC,disease,0.9985,23917487
33434,NSCLC,disease,0.9966,23917487
33435,KRAS,gene,0.9927,23917487
33436,EGFR,gene,0.7144,23917487
33437,cancer,disease,1.0,23917487
33438,patient,species,0.976,23917487
33439,stage III NSCLC,disease,0.968,23917487
33440,KRAS G12D,DNA,0.5264,23917487
33441,KRAS G12D activating,gene,0.8335,23917487
33442,G12D,mutation,,23917487
33443,minor KRAS mutant clone,cell_line,0.645,23917487
33444,KRAS,gene,0.9937,23917487
33445,G12D KRAS lung cancer clones,cell_line,0.7915,23917487
33446,G12D KRAS,gene,0.9595,23917487
33447,G12D,mutation,,23917487
33448,lung cancer,disease,0.9375,23917487
33449,panitumumab,gene,0.8984,23917487
33450,panitumumab,gene,0.953,23904849
33451,metastatic rectal cancer,disease,1.0,23904849
33452,man,species,0.849,23904849
33453,rectal cancer,disease,1.0,23904849
33454,liver metastasis,disease,0.9995,23904849
33455,bevacizumab,gene,0.821,23904849
33456,tumors,disease,1.0,23904849
33457,cetuximab,gene,0.858,23904849
33458,CPT-11,drug,0.997,23904849
33459,patient,species,0.9766,23904849
33460,metastatic,disease,0.7373,23904849
33461,panitumumab,gene,0.929,23904849
33462,pulmonary lesions,disease,0.9995,23904849
33463,patient,species,0.9746,23904849
33464,anti-(epidermal growth factor receptor) IgG fragments,gene,0.976,23890417
33465,Fc region,gene,0.8384,23890417
33466,IgGs,gene,0.987,23890417
33467,single-chain variable fragment,gene,0.9917,23890417
33468,scFv,gene,0.977,23890417
33469,humanized anti-(epidermal growth factor receptor,gene,0.994,23890417
33470,humanized,species,0.7793,23890417
33471,) IgG 528,gene,0.8345,23890417
33472,h528,gene,0.99,23890417
33473,tumor,disease,1.0,23890417
33474,h528,DNA,0.5444,23890417
33475,h528 scFv multimers,gene,0.8687,23890417
33476,cancer,disease,1.0,23890417
33477,h528 scFv monomer,gene,0.9575,23890417
33478,h528 scFv trimers,gene,0.966,23890417
33479,antitumor,disease,0.987,23890417
33480,anti-(epidermal growth factor receptor) therapeutic IgG Cetuximab,gene,0.9277,23890417
33481,Panitumumab,gene,0.817,23890417
33482,h528,gene,0.9688,23890417
33483,h528 scFv multimers,gene,0.8994,23890417
33484,anti-(epidermal growth factor receptor) therapeutic IgG,gene,0.939,23890417
33485,EGFR,gene,0.993,23888072
33486,follicular dendritic cells,cell_type,0.922,23888072
33487,EGFR,gene,0.996,23888072
33488,follicular dendritic cell sarcoma,disease,1.0,23888072
33489,FDC-S,cell_line,0.8853,23888072
33490,FDC,cell_type,0.657,23888072
33491,FDC-S,disease,1.0,23888072
33492,EGFR,gene,0.9927,23888072
33493,EGFR,gene,0.9937,23888072
33494,primary FDC-S short,cell_line,0.834,23888072
33495,FDC,cell_type,0.56,23888072
33496,FDC-AM09,cell_line,0.9043,23888072
33497,EGFR,gene,0.9927,23888072
33498,cetuximab,gene,0.4607,23888072
33499,panitumumab,gene,0.738,23888072
33500,MEK,gene,0.9883,23888072
33501,UO126,drug,0.928,23888072
33502,FDC-S cells,cell_line,0.751,23888072
33503,FDC-AM09,cell_line,0.671,23888072
33504,FDC,cell_type,0.5977,23888072
33505,KRAS,gene,0.9717,23888072
33506,BRAF,DNA,0.804,23888072
33507,BRAF,gene,0.993,23888072
33508,PI3KCA,gene,0.998,23888072
33509,tumor DNA,DNA,0.8193,23888072
33510,tumor,disease,0.9946,23888072
33511,EGFR,gene,0.991,23888072
33512,dysplastic,disease,0.6704,23888072
33513,FDC-AM09,cell_line,0.82,23888072
33514,FDC,cell_type,0.5283,23888072
33515,EGFR,gene,0.88,23888072
33516,FDC-S cells,cell_line,0.9517,23888072
33517,FDC,cell_type,0.76,23888072
33518,-S cells,cell_type,0.4543,23888072
33519,MAPK,gene,0.948,23888072
33520,STAT,gene,0.989,23888072
33521,EGFR ligands,gene,0.849,23888072
33522,heparin-binding EGF-like growth factor,gene,0.9985,23888072
33523,TGF,gene,0.9854,23888072
33524,Betacellulin,gene,0.9824,23888072
33525,BTC,gene,0.995,23888072
33526,tumor,disease,0.999,23888072
33527,FDC-S,cell_line,0.9463,23888072
33528,FDC,cell_type,0.799,23888072
33529,-S,cell_type,,23888072
33530,RNA,RNA,0.6562,23888072
33531,BTC,gene,0.9893,23888072
33532,FDC-S cells,cell_line,0.9688,23888072
33533,stromal cells,cell_type,0.8384,23888072
33534,tumor-derived genomic DNA,DNA,0.832,23888072
33535,KRAS,gene,0.97,23888072
33536,NRAS,DNA,0.8164,23888072
33537,NRAS,gene,0.973,23888072
33538,BRAF,gene,0.994,23888072
33539,PI3KCA,DNA,0.632,23888072
33540,PI3KCA,gene,0.9985,23888072
33541,EGFR,gene,0.677,23888072
33542,cancer,disease,0.9976,23888072
33543,FDC-S,cell_line,0.908,23888072
33544,FDC,cell_type,0.892,23888072
33545,-S,cell_type,,23888072
33546,EGFR,gene,0.993,23888072
33547,tumor,disease,0.994,23888072
33548,FDC-S,cell_type,0.898,23888072
33549,neoplasm,disease,1.0,23888072
33550,Kras mutation,gene,0.9053,23885463
33551,metastatic colorectal cancer,disease,0.9985,23885463
33552,Cetuximab,gene,0.9316,23885463
33553,Panitumumab,gene,0.9014,23885463
33554,EGFR,gene,0.989,23885463
33555,K-ras gene,gene,0.9976,23885463
33556,Cetuximab,gene,0.774,23885463
33557,K-ras,gene,0.9985,23885463
33558,anti-,gene,0.6963,23885463
33559,EGFR,gene,0.7227,23885463
33560,Amphiregulin,gene,0.9746,23885463
33561,Epiregulin,gene,0.982,23885463
33562,Epidermal growth factors family,gene,0.9985,23885463
33563,EGF,gene,0.9946,23885463
33564,EGFR,gene,0.994,23885463
33565,malignancies,disease,1.0,23885463
33566,non-malignant pathologies,disease,0.8965,23885463
33567,colorectal malignancies,disease,1.0,23885463
33568,inflammatory bowel disease,disease,1.0,23885463
33569,mRNA,RNA,0.8296,23885463
33570,colorectal malignancy,disease,1.0,23885463
33571,wild,DNA,0.6426,23885463
33572,wild type K-ras,gene,0.99,23885463
33573,patients,species,0.986,23885463
33574,Cetuximab,gene,0.7407,23885463
33575,colorectal cancer,disease,1.0,23885463
33576,K-ras mutations,gene,0.9497,23885463
33577,EpireguLin,gene,0.9956,23885463
33578,Amphiregulin,gene,0.9927,23885463
33579,malignant tissue,cell_type,0.515,23885463
33580,malignant,disease,0.9805,23885463
33581,colon cancer,disease,1.0,23885463
33582,patients,species,0.9814,23885463
33583,K-ras mutation,gene,0.9927,23885463
33584,Epiregulin,gene,0.9946,23885463
33585,AmphireguLin,gene,0.992,23885463
33586,K-ras gene,gene,0.998,23885463
33587,AmphireguLin,gene,0.985,23885463
33588,Epiregulin,gene,0.9897,23885463
33589,K-ras mutation,gene,0.995,23885463
33590,Epiregulin,gene,0.9897,23885463
33591,Amphiregulin,gene,0.9917,23885463
33592,colon cancer,disease,1.0,23885463
33593,Panitumumab,gene,0.8433,23868516
33594,oxaliplatin,drug,0.9995,23868516
33595,capecitabine,drug,0.998,23868516
33596,patients,species,0.914,23868516
33597,colorectal cancer,disease,1.0,23868516
33598,liver metastases,disease,0.992,23868516
33599,capecitabine,drug,0.9995,23868516
33600,oxaliplatin,drug,0.9995,23868516
33601,XELOX,drug,0.9985,23868516
33602,panitumumab,gene,0.813,23868516
33603,patients,species,0.9473,23868516
33604,colon cancer,disease,0.938,23868516
33605,patients,species,0.98,23868516
33606,liver metastases,disease,0.998,23868516
33607,colon cancer,disease,1.0,23868516
33608,patients,species,0.944,23868516
33609,XELOX,drug,0.9307,23868516
33610,panitumumab,gene,0.795,23868516
33611,patients,species,0.981,23868516
33612,patients,species,0.983,23868516
33613,wild-type KRAS,gene,0.9736,23868516
33614,wtKRAS,gene,0.991,23868516
33615,patients,species,0.995,23868516
33616,patients,species,0.996,23868516
33617,KRAS,gene,0.99,23868516
33618,patients,species,0.982,23868516
33619,XELOX,drug,0.9487,23868516
33620,patients,species,0.9873,23868516
33621,wtKRAS,gene,0.98,23868516
33622,patients,species,0.9663,23868516
33623,patients,species,0.9736,23868516
33624,liver metastasis,disease,0.994,23868516
33625,Patients,species,0.984,23868516
33626,cutaneous,disease,0.9004,23868516
33627,XELOX,drug,0.7744,23868516
33628,patients,species,0.955,23868516
33629,metastatic colon cancer,disease,0.9995,23868516
33630,oxaliplatin,drug,1.0,23822592
33631,fluoropyrimidine,drug,0.9995,23822592
33632,patients,species,0.9966,23822592
33633,epidermal growth factor receptor,gene,0.9966,23822592
33634,EGFR,gene,0.994,23822592
33635,oxaliplatin,drug,1.0,23822592
33636,KRAS,gene,0.9966,23822592
33637,metastatic colorectal cancer,disease,0.9995,23822592
33638,mCRC,disease,1.0,23822592
33639,5-fluorouracil,drug,0.9995,23822592
33640,5-,drug,1.0,23822592
33641,oxaliplatin,drug,0.999,23822592
33642,EGFR mAbs,gene,0.936,23822592
33643,Oxaliplatin,drug,0.9995,23822592
33644,EGFR mAbs,gene,0.9585,23822592
33645,KRAS wild,DNA,0.6963,23822592
33646,KRAS,gene,0.9854,23822592
33647,mCRC,disease,1.0,23822592
33648,COIN,DNA,0.5156,23822592
33649,NORDIC,DNA,0.4885,23822592
33650,patients,species,0.9907,23822592
33651,KRAS wild,DNA,0.6377,23822592
33652,KRAS,gene,0.988,23822592
33653,patients,species,0.987,23822592
33654,patients,species,0.9897,23822592
33655,oxaliplatin,drug,0.9995,23822592
33656,patients,species,0.9175,23822592
33657,KRAS,gene,0.996,23822592
33658,mCRC,disease,0.96,23822592
33659,5-FU,drug,0.998,23822592
33660,capecitabine,drug,0.999,23822592
33661,5-FU,drug,0.999,23822592
33662,oxaliplatin,drug,0.9995,23822592
33663,cetuximab,gene,0.848,23822592
33664,panitumumab,gene,0.897,23822592
33665,EGFR mAbs,gene,0.749,23822592
33666,oxaliplatin,drug,0.9995,23822592
33667,5-FU,drug,0.9956,23822592
33668,KRAS,gene,0.997,23822592
33669,mCRC,disease,0.9966,23822592
33670,Danitumumab,gene,0.5854,23819169
33671,panitumumab,gene,0.8945,23819169
33672,MicroRNAs,RNA,0.503,23817698
33673,EGFR,gene,0.995,23817698
33674,colorectal cancer,disease,1.0,23817698
33675,MicroRNAs,RNA,0.644,23817698
33676,miRNAs,RNA,0.5903,23817698
33677,18-25,RNA,0.4683,23817698
33678,non-coding single-stranded RNAs,RNA,0.7085,23817698
33679,protein-,DNA,0.6133,23817698
33680,protein-encoding mRNAs,RNA,0.794,23817698
33681,miRNAs,RNA,0.512,23817698
33682,epidermal growth factor receptor,gene,0.9985,23817698
33683,EGFR,gene,0.9897,23817698
33684,colorectal cancer,disease,1.0,23817698
33685,CRC,disease,1.0,23817698
33686,EGFR,gene,0.994,23817698
33687,CRC,disease,0.9995,23817698
33688,cetuximab,gene,0.6685,23817698
33689,panitumumab,gene,0.847,23817698
33690,metastatic CRC,disease,0.9175,23817698
33691,miRNAs,RNA,0.542,23817698
33692,EGFR,gene,0.994,23817698
33693,EGFR,gene,0.949,23817698
33694,miRNAs,RNA,0.4854,23817698
33695,EGFR,gene,0.9927,23817698
33696,CRC,disease,0.996,23817698
33697,Irinotecan,drug,0.9976,27121781
33698,Panitumumab,gene,0.852,27121781
33699,panitumumab,gene,0.8193,27121781
33700,human,species,0.7324,27121781
33701,epidermal growth factor receptor,gene,0.996,27121781
33702,EGFR,gene,0.9927,27121781
33703,irinotecan,drug,0.9976,27121781
33704,patients,species,0.941,27121781
33705,metastatic colorectal cancer,disease,1.0,27121781
33706,mCRC,disease,1.0,27121781
33707,EGFR,gene,0.991,27121781
33708,patients,species,0.9443,27121781
33709,irinotecan,drug,0.9966,27121781
33710,panitumumab,gene,0.7744,27121781
33711,panitumumab,gene,0.925,27121781
33712,patients,species,0.9585,27121781
33713,panitumumab,gene,0.921,27121781
33714,irinotecan,drug,0.9917,27121781
33715,irinotecan,drug,0.9976,27121781
33716,irinotecan,drug,0.9976,27121781
33717,patients,species,0.9917,27121781
33718,irinotecan,drug,0.9976,27121781
33719,panitumumab,gene,0.915,27121781
33720,irinotecan,drug,0.998,27121781
33721,panitumumab,gene,0.897,27121781
33722,panitumumab,gene,0.7056,27121781
33723,irinotecan,drug,0.9976,27121781
33724,irinotecan,drug,0.999,27121781
33725,panitumumab,gene,0.9272,27121781
33726,EGFR,gene,0.9346,23806981
33727,metastatic colorectal,disease,1.0,23806981
33728,EGFR,gene,0.9956,23806981
33729,EGFR,gene,0.982,23806981
33730,Cetuximab,gene,0.943,23806981
33731,Panitumumab,gene,0.8726,23806981
33732,EGFR,gene,0.677,23806981
33733,K-ras,gene,0.9985,23806981
33734,B-raf,gene,0.998,23806981
33735,PI3K,gene,0.988,23806981
33736,mTOR,gene,0.997,23806981
33737,Akt,gene,0.996,23806981
33738,anti-EGFR,gene,0.8877,23806981
33739,microRNA,RNA,0.782,23806981
33740,IGF1,gene,0.999,23806981
33741,IGF1R,gene,0.993,23806981
33742,HGF,gene,0.999,23806981
33743,cMET,gene,0.9937,23806981
33744,EGFR,gene,0.989,23806981
33745,Panitumumab,gene,0.7637,23802848
33746,metastatic colorectal cancer,disease,1.0,23802848
33747,metastatic colorectal cancer,disease,0.991,23802848
33748,Panitumumab,gene,0.7256,23802848
33749,humanized,species,0.481,23802848
33750,EGF receptor,gene,0.9976,23802848
33751,tumor,disease,1.0,23802848
33752,Panitumumab,gene,0.854,23802848
33753,metastatic colorectal cancer,disease,1.0,23802848
33754,non,cell_type,0.4937,23802848
33755,non-mutated KRAS tumors,disease,0.6626,23802848
33756,KRAS,gene,0.7744,23802848
33757,panitumumab,gene,0.7603,23802848
33758,Rash,disease,0.9966,23802848
33759,panitumumab,gene,0.8657,23802848
33760,panitumumab,gene,0.884,23802848
33761,skin rash,disease,1.0,23801914
33762,EGFR,gene,0.9946,23801914
33763,epidermal growth factor receptor,gene,0.998,23801914
33764,EGFR,gene,0.987,23801914
33765,solid tumors,disease,1.0,23801914
33766,rash,disease,0.998,23801914
33767,EGFR,gene,0.993,23801914
33768,skin rash,disease,1.0,23801914
33769,rash,disease,0.9834,23801914
33770,EGFR,gene,0.991,23801914
33771,Vitamin K,drug,0.9995,23801914
33772,EGFR,gene,0.994,23801914
33773,rash,disease,0.9966,23801914
33774,vitamin K,drug,0.9995,23801914
33775,doxycycline,drug,0.9976,23801914
33776,KRAS,DNA,0.8604,23792572
33777,KRAS mutation,gene,0.96,23792572
33778,metastatic colon cancer,disease,1.0,23792572
33779,KRAS oncogene,gene,0.876,23792572
33780,colorectal cancers,disease,1.0,23792572
33781,EGFR,gene,0.993,23792572
33782,cetuximab,gene,0.8447,23792572
33783,panitumumab,gene,0.7085,23792572
33784,EGFR receptor,gene,0.9897,23792572
33785,Cetuximab,gene,0.6626,23792572
33786,KRAS,gene,0.5938,23792572
33787,EGFR,gene,0.9985,23792572
33788,metastatic colorectal cancer,disease,1.0,23792572
33789,FOLFIRI,drug,0.8516,23792572
33790,5-fluorouracil,drug,0.9995,23792572
33791,irinotecan,drug,0.9985,23792572
33792,leucovorin,drug,0.999,23792572
33793,metastatic colon cancer,disease,1.0,23792572
33794,KRAS oncogene,gene,0.894,23792572
33795,anti-EGFR,gene,0.9165,23792572
33796,cetuximab,gene,0.8286,23792572
33797,wild-type KRAS-containing tumor,disease,0.9985,23792572
33798,wild-type KRAS,gene,0.6147,23792572
33799,heterogeneous,disease,0.6587,23792572
33800,tumor,disease,0.591,23792572
33801,cetuximab,gene,0.934,23792568
33802,sorafenib,drug,0.999,23792568
33803,panitumumab,gene,0.829,23792568
33804,regorafenib,drug,0.9976,23792568
33805,V600E,cell_line,,23792568
33806,V600E BRAF,gene,0.9087,23792568
33807,V600E,mutation,,23792568
33808,Sorafenib,drug,0.997,23792568
33809,BRAF mutant melanoma,disease,0.6978,23792568
33810,BRAF,gene,0.4727,23792568
33811,liver cancer,disease,1.0,23792568
33812,"thyroid, lung and brain cancer",disease,1.0,23792568
33813,Colorectal cancer,disease,1.0,23792568
33814,V600E BRAF,DNA,0.6455,23792568
33815,V600E BRAF mutation,gene,0.9014,23792568
33816,V600E,mutation,,23792568
33817,vemurafenib,drug,0.993,23792568
33818,BRAF-mutant colorectal cancer,disease,0.968,23792568
33819,BRAF,gene,0.7056,23792568
33820,BRAF-mutant metastatic colon cancer,disease,0.962,23792568
33821,BRAF,gene,0.5522,23792568
33822,bevacizumab,gene,0.7324,23792568
33823,cetuximab,gene,0.7095,23792568
33824,BRAF,gene,0.996,23792568
33825,colorectal cancer,disease,1.0,23792568
33826,EGFR,gene,0.982,23792568
33827,sorafenib,drug,0.9995,23792568
33828,cetuximab,gene,0.807,23792568
33829,Sorafenib,drug,0.9995,23792568
33830,cetuximab,gene,0.904,23792568
33831,V600E,cell_line,,23792568
33832,V600E BRAF,gene,0.4883,23792568
33833,V600E,mutation,,23792568
33834,cetuximab,gene,0.9756,23792568
33835,sorafenib,drug,0.999,23792568
33836,regorafenib,drug,0.9805,23792568
33837,regorafenib,drug,0.9907,23792568
33838,regorafenib,drug,0.9956,23792568
33839,panitumumab,gene,0.9204,23792568
33840,regorafenib,drug,0.997,23792568
33841,BRAF,gene,0.521,23792568
33842,advanced colorectal cancer,disease,0.9365,23792568
33843,tumor,disease,0.995,23781283
33844,Tumors,disease,1.0,23781283
33845,tumor,disease,0.9985,23781283
33846,tumor,disease,0.9995,23781283
33847,cancer,disease,1.0,23781283
33848,panitumumab,gene,0.967,23781283
33849,Pan,gene,0.955,23781283
33850,basiliximab,gene,0.96,23781283
33851,Bas,gene,0.967,23781283
33852,phthalocyanine,drug,0.9946,23781283
33853,ATAC4 cells,cell_line,0.67,23781283
33854,human epidermal growth factor receptor,gene,0.998,23781283
33855,EGFR,gene,0.993,23781283
33856,interleukin-2 receptor-alpha,gene,0.998,23781283
33857,CD25,gene,0.986,23781283
33858,tumor,disease,0.988,23781283
33859,ATAC4 tumor,cell_line,0.835,23781283
33860,mice,species,0.8936,23781283
33861,hEGF,gene,0.9897,23748900
33862,EGFR dimers,gene,0.9917,23748900
33863,epidermal growth factor receptor,gene,0.999,23748900
33864,EGFR,gene,0.998,23748900
33865,tyrosine,drug,0.9976,23748900
33866,tyrosine kinase,gene,0.9385,23748900
33867,gefitinib,drug,0.9976,23748900
33868,ZD1839,drug,0.9985,23748900
33869,Iressa,drug,0.9194,23748900
33870,cancer,disease,1.0,23748900
33871,gefitinib,drug,0.9917,23748900
33872,human EGF,gene,0.9937,23748900
33873,hEGF,gene,0.996,23748900
33874,hEGF,gene,0.9946,23748900
33875,EGFR,gene,0.9937,23748900
33876,gefitinib,drug,0.9976,23748900
33877,EGFR,gene,0.9897,23748900
33878,EGFR-expressing tumor cells,cell_line,0.8105,23748900
33879,EGFR,gene,0.991,23748900
33880,tumor,disease,0.6694,23748900
33881,SCC-1,cell_line,0.937,23748900
33882,22B,cell_line,0.818,23748900
33883,A549,cell_line,0.92,23748900
33884,HT-29,cell_line,0.9385,23748900
33885,gefitinib,drug,0.993,23748900
33886,)I-hEGF,gene,0.983,23748900
33887,(125)I,drug,0.9946,23748900
33888,(,gene,0.734,23748900
33889,anti-EGFR monoclonal antibody,gene,0.985,23748900
33890,EGFR dimer,gene,0.994,23748900
33891,gefitinib-treated cells,cell_line,0.8784,23748900
33892,gefitinib,cell_type,0.4495,23748900
33893,gefitinib,drug,0.99,23748900
33894,-,cell_type,0.638,23748900
33895,treated cells,cell_type,0.623,23748900
33896,EGFR,gene,0.996,23748900
33897,EGFR,gene,0.9907,23748900
33898,gefitinib,drug,0.9976,23748900
33899,Gefitinib,drug,0.9995,23748900
33900,EGFR dimers,gene,0.995,23748900
33901,(125)I,drug,0.8726,23748900
33902,(125)I-hEGF,gene,0.9946,23748900
33903,gefitinib,drug,0.9976,23748900
33904,(125)I,drug,0.9995,23748900
33905,tumor cells,cell_type,0.8687,23748900
33906,tumor,disease,0.999,23748900
33907,EGFR,gene,0.992,23748900
33908,hEGF,gene,0.9863,23748900
33909,EGFR + tumors,cell_line,0.6577,23748900
33910,EGFR,disease,0.995,23748900
33911,gefitinib,drug,0.998,23748900
33912,hEGF,gene,0.9927,23748900
33913,gefitinib,drug,1.0,23748900
33914,EGFR dimers,gene,0.9663,23748900
33915,hEGF,gene,0.994,23748900
33916,EGFR,gene,0.9873,23748900
33917,gefitinib,drug,0.9966,23748900
33918,Cisplatin,drug,0.9985,23746666
33919,fluorouracil,drug,0.9985,23746666
33920,panitumumab,gene,0.7456,23746666
33921,patients,species,0.987,23746666
33922,anti-EGFR monoclonal antibodies,gene,0.925,23746666
33923,patients,species,0.9844,23746666
33924,squamous-cell carcinoma of the head and neck,disease,1.0,23746666
33925,SCCHN,disease,1.0,23746666
33926,panitumumab,gene,0.926,23746666
33927,cisplatin,drug,0.999,23746666
33928,fluorouracil,drug,0.9976,23746666
33929,patients,species,0.989,23746666
33930,patients,species,0.984,23746666
33931,SCCHN,disease,1.0,23746666
33932,Patients,species,0.935,23746666
33933,primary,DNA,0.4705,23746666
33934,primary tumour,disease,0.9307,23746666
33935,Patients,species,0.9556,23746666
33936,cisplatin,drug,0.998,23746666
33937,fluorouracil,drug,0.9937,23746666
33938,panitumumab,gene,0.9316,23746666
33939,Patients,species,0.9863,23746666
33940,panitumumab,gene,0.8325,23746666
33941,tumour human papillomavirus,disease,0.999,23746666
33942,human papillomavirus,species,0.4873,23746666
33943,p16,gene,0.999,23746666
33944,-,DNA,0.5127,23746666
33945,INK4A,gene,0.983,23746666
33946,p16,gene,0.9956,23746666
33947,Patients,species,0.9834,23746666
33948,p16,DNA,0.688,23746666
33949,p16,gene,0.997,23746666
33950,patients,species,0.984,23746666
33951,patients,species,0.9893,23746666
33952,panitumumab,gene,0.9126,23746666
33953,panitumumab,gene,0.935,23746666
33954,panitumumab,gene,0.907,23746666
33955,panitumumab,gene,0.9136,23746666
33956,diarrhoea,disease,1.0,23746666
33957,hypomagnesaemia,disease,1.0,23746666
33958,hypokalaemia,disease,1.0,23746666
33959,dehydration,disease,1.0,23746666
33960,patients,species,0.9907,23746666
33961,panitumumab,gene,0.958,23746666
33962,panitumumab,gene,0.9463,23746666
33963,p16,gene,0.9937,23746666
33964,patients,species,0.974,23746666
33965,p16,gene,0.995,23746666
33966,patients,species,0.9736,23746666
33967,p16-negative tumours,disease,0.9595,23746666
33968,p16,gene,0.993,23746666
33969,panitumumab,gene,0.838,23746666
33970,p16,gene,0.9956,23746666
33971,patients,species,0.989,23746666
33972,p16,cell_type,0.4316,23746666
33973,p16,gene,0.998,23746666
33974,patients,species,0.9697,23746666
33975,p16,cell_line,0.681,23746666
33976,p16,gene,0.994,23746666
33977,patients,species,0.9688,23746666
33978,panitumumab,gene,0.963,23746666
33979,patients,species,0.9707,23746666
33980,SCCHN,disease,0.928,23746666
33981,p16,DNA,0.74,23746666
33982,p16,gene,0.987,23746666
33983,patients,species,0.954,23746666
33984,panitumumab,gene,0.9136,23746666
33985,cetuximab,gene,0.902,23745159
33986,patients,species,0.9507,23745159
33987,metastatic colorectal cancer,disease,1.0,23745159
33988,colorectal cancer,disease,1.0,23745159
33989,CRC,disease,1.0,23745159
33990,5-fluorouracil,drug,0.9995,23745159
33991,leucovorin,drug,0.999,23745159
33992,irinotecan,drug,0.999,23745159
33993,FOLFIRI,drug,0.9946,23745159
33994,oxaliplatin,drug,0.9995,23745159
33995,FOLFOX,drug,0.9814,23745159
33996,epidermal growth factor receptor,gene,0.9966,23745159
33997,EGFR,gene,0.995,23745159
33998,anti-EGFR mAbs,gene,0.9805,23745159
33999,cetuximab,gene,0.918,23745159
34000,panitumumab,gene,0.865,23745159
34001,KRAS,gene,0.9834,23745159
34002,EGFR,gene,0.996,23745159
34003,EGFR mAbs,gene,0.981,23745159
34004,cetuximab,gene,0.7705,23745159
34005,panitumumab,gene,0.599,23745159
34006,patients,species,0.9927,23745159
34007,KRAS mutation,DNA,0.67,23745159
34008,KRAS mutation,gene,0.9116,23745159
34009,KRAS,gene,0.995,23745159
34010,panitumumab,gene,0.81,23745159
34011,cetuximab,gene,0.6733,23745159
34012,cetuximab,gene,0.975,23745159
34013,FOLFIRI,drug,0.732,23745159
34014,metastatic CRC,disease,0.988,23745159
34015,panitumumab,gene,0.806,23745159
34016,cetuximab,gene,0.7173,23745159
34017,cetuximab,gene,0.509,23745159
34018,cetuximab,gene,0.7314,23745159
34019,cetuximab,gene,0.8096,23745159
34020,patients,species,0.99,23745159
34021,cetuximab,gene,0.8535,23745159
34022,cetuximab,gene,0.81,23745159
34023,metastatic colorectal cancer,disease,1.0,23743737
34024,patients,species,0.9517,23743737
34025,metastatic colorectal cancer,disease,1.0,23743737
34026,mCRC,disease,1.0,23743737
34027,irinotecan,drug,0.9946,23743737
34028,oxaliplatin,drug,0.9995,23743737
34029,vascular endothelial growth factor,gene,0.9976,23743737
34030,VEGF,gene,0.999,23743737
34031,bevacizumab,gene,0.954,23743737
34032,aflibercept,gene,0.97,23743737
34033,epidermal growth factor receptor antibodies,gene,0.9707,23743737
34034,cetuximab,gene,0.9004,23743737
34035,panitumumab,gene,0.8076,23743737
34036,tyrosine,drug,0.9956,23743737
34037,tyrosine kinase,gene,0.9785,23743737
34038,vatalanib,drug,0.9985,23743737
34039,VEGF,gene,0.998,23743737
34040,aflibercept,gene,0.9883,23743737
34041,bevacizumab,gene,0.837,23743737
34042,bevacizumab,gene,0.849,23743737
34043,mCRC,disease,0.971,23743737
34044,patients,species,0.993,23743737
34045,patients,species,0.9795,23743737
34046,bevacizumab,gene,0.882,23743737
34047,mCRC,disease,0.975,23743737
34048,patient,species,0.9893,23743737
34049,liver metastasis,disease,0.989,23741223
34050,colorectal cancer,disease,1.0,23741223
34051,patient,species,0.928,23741223
34052,chronic renal failure,disease,1.0,23741223
34053,dilated cardiomyopathy,disease,1.0,23741223
34054,portal vein tumor thrombus,disease,0.997,23741223
34055,rectal cancer,disease,1.0,23741223
34056,metastatic liver cancer,disease,1.0,23741223
34057,portal vein tumor thrombosis,disease,1.0,23741223
34058,5-fluorouracil,drug,0.9995,23741223
34059,l-leucovorin,drug,0.9995,23741223
34060,CEA,gene,0.996,23741223
34061,VA19-9,gene,0.9805,23741223
34062,UFT,drug,0.9985,23741223
34063,UZEL,drug,0.9946,23741223
34064,panitumumab,gene,0.9067,23741223
34065,patient,species,0.9175,23741223
34066,patients,species,0.966,23741223
34067,liver metastasis of,disease,0.9966,23741223
34068,colorectal cancer,disease,0.9497,23741223
34069,portal vein tumor thrombosis,disease,1.0,23741223
34070,panitumumab,gene,0.911,23741223
34071,MET receptor,gene,0.9966,23729478
34072,EGFR,gene,0.937,23729478
34073,EGF receptor,gene,0.996,23729478
34074,EGFR,gene,0.996,23729478
34075,metastatic colorectal,disease,0.999,23729478
34076,cancers,disease,0.9976,23729478
34077,patients,species,0.983,23729478
34078,KRAS,DNA,0.8584,23729478
34079,KRAS mutations,gene,0.955,23729478
34080,MET proto-oncogene,gene,0.997,23729478
34081,tumors,disease,1.0,23729478
34082,KRAS mutations,gene,0.847,23729478
34083,EGFR,gene,0.723,23729478
34084,MET locus,DNA,0.894,23729478
34085,MET locus,gene,0.9937,23729478
34086,circulating tumor DNA,DNA,0.684,23729478
34087,circulating tumor,cell_type,0.5654,23729478
34088,MET,gene,0.9956,23729478
34089,EGFR,gene,0.976,23729478
34090,patient,species,0.9365,23729478
34091,colorectal cancer,disease,1.0,23729478
34092,MET,DNA,0.8413,23729478
34093,MET,gene,0.996,23729478
34094,EGFR,gene,0.991,23729478
34095,MET kinase,gene,0.952,23729478
34096,MET,gene,0.995,23729478
34097,EGFR,gene,0.988,23729478
34098,colorectal cancer,disease,1.0,23729478
34099,MET,DNA,0.497,23729478
34100,MET,gene,0.9956,23729478
34101,patients,species,0.948,23729478
34102,MET,gene,0.9907,23729478
34103,Panitumumab,gene,0.929,23725851
34104,irinotecan,drug,0.9976,23725851
34105,irinotecan,drug,0.9985,23725851
34106,KRAS,gene,0.608,23725851
34107,fluorouracil-resistant,disease,0.915,23725851
34108,fluorouracil,drug,0.3425,23725851
34109,advanced colorectal cancer,disease,0.9727,23725851
34110,EGFR,gene,0.993,23725851
34111,advanced colorectal cancer,disease,0.9365,23725851
34112,panitumumab,gene,0.9263,23725851
34113,irinotecan,drug,0.998,23725851
34114,advanced colorectal cancer,disease,1.0,23725851
34115,advanced colorectal cancer,disease,1.0,23725851
34116,fluoropyrimidine,drug,0.9985,23725851
34117,oxaliplatin,drug,0.9995,23725851
34118,irinotecan,drug,0.999,23725851
34119,irinotecan,drug,0.999,23725851
34120,ciclosporin,drug,0.999,23725851
34121,irinotecan,drug,0.9995,23725851
34122,panitumumab,gene,0.891,23725851
34123,IrPan,drug,0.873,23725851
34124,panitumumab,gene,0.6772,23725851
34125,KRAS,gene,0.816,23725851
34126,irinotcan,drug,0.831,23725851
34127,EGFR,gene,0.993,23725851
34128,oxaliplatin,drug,0.9995,23725851
34129,bevacizumab,gene,0.617,23725851
34130,irinotecan,drug,0.9976,23725851
34131,IrPan,drug,0.973,23725851
34132,irinotecan,drug,0.9927,23725851
34133,panitumumab,gene,0.9346,23725851
34134,KRAS,gene,0.7256,23725851
34135,EGFR,gene,0.9946,23725851
34136,Tumour,cell_type,0.5474,23725851
34137,KRASc.146,gene,0.6187,23725851
34138,BRAF,gene,0.7573,23725851
34139,NRAS,gene,0.686,23725851
34140,PIK3CA,DNA,0.518,23725851
34141,PIK3CA mutations,gene,0.931,23725851
34142,panitumumab,gene,0.84,23725851
34143,KRASc,gene,0.752,23725851
34144,tumours,disease,0.6797,23725851
34145,EGFR,gene,0.9897,23725851
34146,irinotecan,drug,0.997,23725851
34147,IrPan,drug,0.916,23725851
34148,irinotecan,drug,0.9995,23725851
34149,diarrhoea,disease,1.0,23725851
34150,skin toxicity,disease,0.9062,23725851
34151,lethargy,disease,0.9995,23725851
34152,IrPan,drug,0.9927,23725851
34153,irinotecan,drug,0.999,23725851
34154,irinotecan,drug,0.999,23725851
34155,panitumumab,gene,0.949,23725851
34156,irinotecan,drug,0.999,23725851
34157,wild,cell_line,0.74,23725851
34158,wild-type KRAS tumours,disease,0.999,23725851
34159,wild-type KRAS,gene,0.8594,23725851
34160,EGFR,gene,0.989,23725851
34161,Cancer,disease,0.99,23725851
34162,Panitumumab,gene,0.918,23716858
34163,acneiform rash,disease,1.0,23716858
34164,patient,species,0.9287,23716858
34165,metastatic colon,disease,1.0,23716858
34166,cetuximab,gene,0.9355,23715932
34167,panitumumab,gene,0.966,23715932
34168,head and neck cancer,disease,1.0,23715932
34169,anti-epidermal growth factor receptor,gene,0.993,23715932
34170,EGFR,gene,0.993,23715932
34171,head and neck squamous cell carcinoma,disease,1.0,23715932
34172,HNSCC,disease,1.0,23715932
34173,anti-EGFR antibodies,gene,0.9575,23715932
34174,mice,species,0.88,23715932
34175,HNSCC,disease,1.0,23715932
34176,OSC-19,cell_line,0.7812,23715932
34177,tongue tumors,disease,0.907,23715932
34178,cetuximab,gene,0.9683,23715932
34179,panitumumab,gene,0.913,23715932
34180,IgG,gene,0.9956,23715932
34181,Tumors,disease,0.781,23715932
34182,Panitumumab,gene,0.934,23715932
34183,cetuximab,gene,0.9487,23715932
34184,EGFR,gene,0.9897,23715932
34185,Panitumumab,gene,0.9707,23715932
34186,cetuximab,gene,0.9585,23715932
34187,IgG,gene,0.9907,23715932
34188,cell line,cell_line,0.921,23715932
34189,OSC-19,cell_line,0.8647,23715932
34190,SCC-1,gene,0.9814,23715932
34191,anti-EGFR monoclonal antibodies,gene,0.95,23715932
34192,HNSCC,disease,1.0,23715932
34193,cetuximab,gene,0.9756,23715932
34194,panitumumab,gene,0.9272,23715932
34195,HNSCC,disease,0.999,23715932
34196,cancer,disease,0.9966,23706012
34197,cancers,disease,1.0,23706012
34198,cancers,disease,1.0,23706012
34199,cancers,disease,1.0,23706012
34200,Bevacizumab,gene,0.823,23706012
34201,sorafenib,drug,0.999,23706012
34202,sunitinib,drug,0.999,23706012
34203,temsirolimus,drug,0.999,23706012
34204,Lapatinib,drug,0.9995,23706012
34205,panitumumab,gene,0.837,23706012
34206,Bevacizumab,gene,0.9385,23706012
34207,sorafenib,drug,0.9966,23706012
34208,HCC,disease,0.999,23706012
34209,metastatic colorectal cancer,disease,0.9995,23673655
34210,metastatic colorectal cancer,disease,1.0,23673655
34211,colorectal cancer,disease,1.0,23673655
34212,patients,species,0.9927,23673655
34213,patients,species,0.9937,23673655
34214,patients,species,0.984,23673655
34215,patients,species,0.9956,23673655
34216,bevacizumab,gene,0.7065,23673655
34217,cetuximab,gene,0.773,23673655
34218,bevacizumab,gene,0.922,23673655
34219,cetuximab,gene,0.846,23673655
34220,patients,species,0.9854,23673655
34221,cetuximab,gene,0.819,23673655
34222,patients,species,0.9766,23673655
34223,Bevacizumab,gene,0.906,23673655
34224,cetuximab,gene,0.867,23673655
34225,colorectal cancer,disease,1.0,23671647
34226,KRAS,gene,0.9585,23671647
34227,BRAF,DNA,0.599,23671647
34228,BRAF,gene,0.996,23671647
34229,PIK3CA mutations,gene,0.863,23671647
34230,colorectal cancer,disease,1.0,23671647
34231,CRC,disease,1.0,23671647
34232,KRAS,gene,0.986,23671647
34233,EGFR,gene,0.99,23671647
34234,cetuximab,gene,0.616,23671647
34235,panitumumab,gene,0.5605,23671647
34236,metastatic colorectal cancer,disease,1.0,23671647
34237,mCRC,disease,1.0,23671647
34238,oncologists,cell_type,0.413,23671647
34239,KRAS,DNA,0.7686,23671647
34240,KRAS,gene,0.976,23671647
34241,BRAF,gene,0.9966,23671647
34242,PI3KCA,DNA,0.5596,23671647
34243,PI3KCA,gene,0.998,23671647
34244,DNA,RNA,0.4343,23671647
34245,formalin,drug,0.887,23671647
34246,CRC,disease,1.0,23671647
34247,FFPE,cell_line,0.548,23671647
34248,FFPE,cell_line,0.5654,23671647
34249,KRAS,gene,0.9365,23671647
34250,PIK3CA,DNA,0.6675,23671647
34251,PIK3CA,gene,0.9956,23671647
34252,E542,mutation,,23671647
34253,E545,mutation,,23671647
34254,allele,DNA,0.6235,23671647
34255,DS,disease,,23671647
34256,FFPE,cell_line,0.548,23671647
34257,FOLFOXIRI,drug,0.551,23666916
34258,panitumumab,gene,0.6924,23666916
34259,FOLFOXIRI,drug,0.555,23666916
34260,FOLFIRI,drug,0.972,23666916
34261,metastatic colorectal cancer,disease,1.0,23666916
34262,mCRC,disease,1.0,23666916
34263,Panitumumab,gene,0.647,23666916
34264,patients,species,0.971,23666916
34265,KRAS codon 12-13 wild,DNA,0.806,23666916
34266,KRAS codon 12-13,gene,0.929,23666916
34267,mCRC,disease,0.998,23666916
34268,KRAS codon 61,DNA,0.7554,23666916
34269,KRAS codon,gene,0.9263,23666916
34270,HRAS,gene,0.9683,23666916
34271,NRAS,DNA,0.632,23666916
34272,NRAS,gene,0.978,23666916
34273,BRAF V600E,DNA,0.5845,23666916
34274,BRAF V600E mutations,gene,0.7974,23666916
34275,V600,mutation,,23666916
34276,anti-epidermal growth factor receptor antibodies,gene,0.9326,23666916
34277,PATIENTS,species,0.937,23666916
34278,panitumumab,gene,0.8364,23666916
34279,irinotecan,drug,0.9985,23666916
34280,oxaliplatin,drug,0.9995,23666916
34281,folinate,drug,0.9966,23666916
34282,fluorouracil,drug,0.996,23666916
34283,wild-type KRAS,gene,0.965,23666916
34284,HRAS,gene,0.9927,23666916
34285,NRAS,DNA,0.777,23666916
34286,NRAS,gene,0.993,23666916
34287,codon 12-13-61,DNA,0.7437,23666916
34288,BRAF,gene,0.9985,23666916
34289,mCRC,disease,0.999,23666916
34290,patients,species,0.99,23666916
34291,Fluorouracil,drug,0.999,23666916
34292,patients,species,0.972,23666916
34293,diarrhoea,disease,0.9946,23666916
34294,febrile neutropenia,disease,1.0,23666916
34295,panitumumab,gene,0.685,23666916
34296,fluorouracil,drug,0.9766,23666916
34297,folinate,drug,0.834,23666916
34298,patients,species,0.973,23666916
34299,patients,species,0.962,23666916
34300,patients,species,0.9834,23666916
34301,neutropenia,disease,1.0,23666916
34302,febrile neutropenia,disease,0.9995,23666916
34303,diarrhoea,disease,1.0,23666916
34304,asthenia,disease,1.0,23666916
34305,stomatitis,disease,1.0,23666916
34306,skin toxic,disease,0.8877,23666916
34307,panitumumab,gene,0.8804,23666916
34308,FOLFOXIRI,drug,0.676,23666916
34309,fluorouracil,drug,0.9976,23666916
34310,irinotecan,drug,0.9976,23666916
34311,diarrhoea,disease,0.9995,23666916
34312,Ras,gene,0.997,23666916
34313,BRAF,DNA,0.5376,23666916
34314,BRAF,gene,0.999,23666916
34315,patients,species,0.9746,23666916
34316,cancer,disease,1.0,23656699
34317,patients,species,0.941,23656699
34318,cancer,disease,1.0,23656699
34319,estrogen,drug,0.9995,23656699
34320,estrogen receptors,gene,0.9927,23656699
34321,HER2,gene,0.9893,23656699
34322,human epidermal growth factor receptor 2,gene,0.998,23656699
34323,breast cancer,disease,1.0,23656699
34324,v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,gene,0.9565,23656699
34325,rat,species,0.3777,23656699
34326,KRAS,gene,0.9985,23656699
34327,patients,species,0.987,23656699
34328,advanced colorectal cancer,disease,1.0,23656699
34329,epidermal growth factor receptor antibodies,gene,0.9233,23656699
34330,panitumumab,gene,0.4993,23656699
34331,epidermal growth factor receptor,gene,0.999,23656699
34332,EGFR,gene,0.9985,23656699
34333,patients,species,0.968,23656699
34334,small cell lung cancer,disease,0.9653,23656699
34335,NSCLC,disease,1.0,23656699
34336,tyrosine,drug,0.992,23656699
34337,tyrosine kinase,gene,0.979,23656699
34338,gefitinib,drug,0.999,23656699
34339,erlotinib,drug,0.9946,23656699
34340,v-raf murine sarcoma viral oncogene homolog B1,gene,0.9985,23656699
34341,murine,species,0.5674,23656699
34342,BRAF,gene,0.997,23656699
34343,patients,species,0.967,23656699
34344,advanced melanoma,disease,1.0,23656699
34345,BRAF,gene,0.985,23656699
34346,vemurafenib,drug,0.999,23656699
34347,dabrafenib,drug,0.9966,23656699
34348,anaplastic lymphoma,disease,1.0,23656699
34349,receptor tyrosine kinase (ALK) translocations,DNA,0.7407,23656699
34350,receptor tyrosine kinase,gene,0.9966,23656699
34351,ALK,gene,0.9946,23656699
34352,patients,species,0.9795,23656699
34353,NSCLC,disease,0.999,23656699
34354,crizotinib,drug,0.996,23656699
34355,cancer,disease,1.0,23656699
34356,metastatic colorectal cancer,disease,0.9814,23645285
34357,colorectal cancer,disease,1.0,23645285
34358,CRC,disease,1.0,23645285
34359,cancer,disease,1.0,23645285
34360,CRC,disease,0.999,23645285
34361,vascular endothelial growth factor,gene,0.9976,23645285
34362,VEGF,gene,0.9966,23645285
34363,epidermal growth factor receptor,gene,0.9956,23645285
34364,EGFR,gene,0.997,23645285
34365,bevacizumab,gene,0.4978,23645285
34366,VEGF,gene,0.987,23645285
34367,cetuximab,gene,0.739,23645285
34368,panitumumab,gene,0.6577,23645285
34369,EGFR,gene,0.989,23645285
34370,metastatic CRC,disease,0.9995,23645285
34371,mCRC,disease,1.0,23645285
34372,EGFR,gene,0.714,23645285
34373,VEGF,gene,0.6743,23645285
34374,Aflibercept,gene,0.9487,23645285
34375,regorafenib,drug,0.988,23645285
34376,patients,species,0.9404,23645285
34377,mCRC,disease,0.971,23645285
34378,anti-VEGF,gene,0.9673,23645285
34379,anti-EGFR,gene,0.8115,23645285
34380,CRC,disease,0.999,23645285
34381,patients,species,0.9927,23645285
34382,colorectal cancer,disease,1.0,23638747
34383,patients,species,0.9824,23638747
34384,colorectal cancer,disease,1.0,23638747
34385,rituximab,gene,0.926,23638747
34386,B,cell_type,0.654,23638747
34387,B-cell non-Hodgkin&#x27;s lymphoma,disease,1.0,23638747
34388,trastuzumab,gene,0.937,23638747
34389,breast cancer,disease,1.0,23638747
34390,cetuximab,gene,0.984,23638747
34391,bevacizumab,gene,0.958,23638747
34392,panitumumab,gene,0.9673,23638747
34393,colorectal cancer,disease,1.0,23638747
34394,tumor cells,cell_type,0.812,23638747
34395,tumor,disease,0.6177,23638747
34396,tumor-specific cytotoxic CD8,cell_type,0.8823,23638747
34397,tumor,disease,0.9473,23638747
34398,APCs,cell_type,0.8394,23638747
34399,hematopoietic cells,cell_type,0.9326,23638747
34400,cancer,disease,1.0,23638747
34401,colorectal cancer,disease,1.0,23638747
34402,panitumumab,gene,0.8745,23625191
34403,metastatic colorectal cancer,disease,0.999,23625191
34404,Panitumumab,gene,0.7725,23625191
34405,epidermal growth factor receptor,gene,0.9966,23625191
34406,panitumumab,gene,0.878,23625191
34407,panitumumab,gene,0.8706,23625191
34408,panitumumab,gene,0.8457,23625191
34409,wild,cell_line,0.4697,23625191
34410,wild-type,gene,0.693,23625191
34411,BSC,disease,0.999,23625191
34412,mutant (MT) KRAS,gene,0.7603,23625191
34413,BSC,drug,0.7515,23625191
34414,panitumumab,gene,0.897,23625191
34415,KRAS,gene,0.7715,23625191
34416,panitumumab,gene,0.666,23625191
34417,MT,cell_type,0.47,23625191
34418,MT KRAS tumors,disease,0.684,23625191
34419,MT KRAS,gene,0.554,23625191
34420,panitumumab,gene,0.759,23625191
34421,WT,cell_type,0.4543,23625191
34422,WT KRAS,gene,0.51,23625191
34423,necrotizing fasciitis,disease,0.882,23622891
34424,panitumumab,gene,0.7544,23622891
34425,colorectal cancer,disease,1.0,23617351
34426,colorectal cancer,disease,1.0,23617351
34427,CRC,disease,1.0,23617351
34428,oxaliplatin,drug,0.999,23617351
34429,fluoropyrimidine,drug,0.997,23617351
34430,capecitabine,drug,0.996,23617351
34431,5-,drug,0.9937,23617351
34432,bevacizumab,gene,0.8896,23617351
34433,cetuximab,gene,0.9385,23617351
34434,panitumumab,gene,0.9414,23617351
34435,metastatic CRC,disease,0.8955,23617351
34436,bevacizumab,gene,0.89,23617351
34437,EGF receptor,gene,0.993,23617351
34438,cetuximab,gene,0.8315,23617351
34439,panitumumab,gene,0.9243,23617351
34440,metastatic CRC,disease,0.9927,23617351
34441,CRC,disease,0.9995,23617351
34442,melanoma,disease,1.0,23616260
34443,melanoma,disease,0.9995,23616260
34444,cancer,disease,1.0,23616260
34445,Melanoma cell lines,cell_line,0.8857,23616260
34446,Melanoma,disease,1.0,23616260
34447,A375,cell_line,0.9165,23616260
34448,SKMEL5,cell_line,0.8486,23616260
34449,mice,species,0.8735,23616260
34450,Bevacizumab,gene,0.924,23616260
34451,panitumumab,gene,0.918,23616260
34452,tocilizumab,gene,0.885,23616260
34453,immunoglobin G,gene,0.998,23616260
34454,IgG,gene,0.9946,23616260
34455,tumors,disease,0.9985,23616260
34456,Mice,species,0.9746,23616260
34457,IRDye800CW,DNA,0.4724,23616260
34458,tumor,disease,0.9966,23616260
34459,tumor,disease,0.9956,23616260
34460,normal,cell_type,0.4646,23616260
34461,IgG,gene,0.992,23616260
34462,panitumumab,gene,0.878,23616260
34463,cell line,cell_line,0.9106,23616260
34464,FDA,drug,0.645,23616260
34465,melanoma,disease,1.0,23616260
34466,KRAS,gene,0.795,23606169
34467,BRAF,gene,0.7017,23606169
34468,colorectal adenocarcinoma,disease,1.0,23606169
34469,tumor cells,cell_type,0.8394,23606169
34470,tumor,disease,0.9985,23606169
34471,wild-type DNA,DNA,0.9106,23606169
34472,KRAS,DNA,0.765,23606169
34473,KRAS mutations,gene,0.791,23606169
34474,"codons 12, 13, and 61",DNA,0.789,23606169
34475,BRAF,gene,0.573,23606169
34476,codon 600,DNA,0.775,23606169
34477,EGFR,gene,0.9966,23606169
34478,colorectal cancer,disease,1.0,23606169
34479,KRAS,gene,0.753,23606169
34480,BRAF,DNA,0.806,23606169
34481,BRAF mutation,gene,0.852,23606169
34482,tumor cells,cell_type,0.8726,23606169
34483,tumor,disease,0.997,23606169
34484,tumor cells,cell_type,0.86,23606169
34485,tumor,disease,0.997,23606169
34486,tumor cells,cell_type,0.8477,23606169
34487,tumor,disease,0.983,23606169
34488,KRAS,DNA,0.7505,23606169
34489,KRAS G12D,gene,0.8076,23606169
34490,G12D,DNA,,23606169
34491,G12D,mutation,,23606169
34492,G13D,DNA,,23606169
34493,G13D,mutation,,23606169
34494,Q61L,DNA,,23606169
34495,Q61L,mutation,,23606169
34496,formalin,drug,0.952,23606169
34497,colorectal cancer,disease,1.0,23606169
34498,KRAS codon 61,gene,0.881,23606169
34499,BRAF codon 600,gene,0.8853,23606169
34500,cetuximab,gene,0.8887,23606169
34501,panitumumab,gene,0.837,23606169
34502,KRAS,gene,0.8906,23606169
34503,KRBR,DNA,0.4695,23606169
34504,KRAS,gene,0.799,23606169
34505,BRAF,gene,0.7646,23606169
34506,KRAS WT,gene,0.701,23606169
34507,EGFR,gene,0.4993,23606169
34508,KRAS G12C mutation,gene,0.7275,23606169
34509,G12C,mutation,,23606169
34510,tumor,disease,1.0,23606169
34511,PTC,disease,0.892,23606169
34512,Erlotinib,drug,0.999,23602600
34513,metastatic non-small cell lung cancer,disease,0.9995,23602600
34514,Skin toxicities,disease,0.9873,23602600
34515,epidermal growth factor receptor,gene,0.993,23602600
34516,erlotinib,drug,0.969,23602600
34517,erlotinib,drug,0.9976,23602600
34518,non-small cell lung cancer,disease,1.0,23602600
34519,skin disorders,disease,0.9976,23602600
34520,acneiform rash,disease,1.0,23602600
34521,xeroderma,disease,1.0,23602600
34522,dry skin,disease,0.998,23602600
34523,pruritus,disease,1.0,23602600
34524,paronychia,disease,1.0,23602600
34525,rash,disease,0.8794,23602600
34526,erlotinib,drug,0.9966,23602600
34527,advanced or metastatic non-small cell lung cancer,disease,0.8755,23602600
34528,epidermal growth factor receptor,gene,0.998,23602600
34529,skin disorders,disease,0.94,23602600
34530,erlotinib,drug,0.9976,23602600
34531,erlotinib,drug,0.9937,23602600
34532,erlotinib,drug,0.996,23602600
34533,advanced non-small cell lung cancer,disease,1.0,23602600
34534,skin disorders,disease,0.9995,23602600
34535,skin disorders,disease,1.0,23602600
34536,PEG,drug,1.0,23600922
34537,indocyanine green,drug,0.995,23600922
34538,indocyanine green,drug,0.9995,23600922
34539,mAb,gene,0.585,23600922
34540,ICG,drug,0.9985,23600922
34541,ICG,drug,0.9976,23600922
34542,ICG,drug,0.9995,23600922
34543,Sulfo-OSu,drug,0.9697,23600922
34544,ICG,drug,0.979,23600922
34545,Panitumumab,gene,0.961,23600922
34546,ICG,drug,0.973,23600922
34547,ICG,drug,0.997,23600922
34548,ICG-PEG4-Sulfo-,drug,0.9917,23600922
34549,OSu,drug,0.777,23600922
34550,ICG-PEG8-Sulfo-OSu,drug,0.999,23600922
34551,polyethylene glycol,drug,0.9995,23600922
34552,PEG,drug,0.9995,23600922
34553,ICG,drug,0.98,23600922
34554,PEG,drug,0.999,23600922
34555,Panitumumab,gene,0.9688,23600922
34556,ICG,drug,0.997,23600922
34557,PEG,drug,0.998,23600922
34558,human epidermal,cell_line,0.6934,23600922
34559,human epidermal growth factor receptor 1,gene,0.945,23600922
34560,EGFR,gene,0.997,23600922
34561,tumors,disease,0.661,23600922
34562,EGFR positive tumor,cell_line,0.5356,23600922
34563,EGFR,gene,0.995,23600922
34564,tumor,disease,0.4888,23600922
34565,tumor,disease,0.5073,23600922
34566,panitumumab,gene,0.964,23599789
34567,metastatic colorectal cancer,disease,1.0,23599789
34568,Panitumumab,gene,0.9355,23599789
34569,Pmab,gene,0.989,23599789
34570,cetuximab,gene,0.967,23599789
34571,Cmab,gene,0.9834,23599789
34572,metastatic colorectal cancer,disease,1.0,23599789
34573,mCRC,disease,1.0,23599789
34574,patients,species,0.982,23599789
34575,Pmab,drug,0.95,23599789
34576,Cmab,drug,0.9683,23599789
34577,Pmab,gene,0.6543,23599789
34578,Cmab,gene,0.6,23599789
34579,patients,species,0.8955,23599789
34580,mCRC,disease,0.9956,23599789
34581,mCRC,disease,0.997,23599789
34582,patients,species,0.992,23599789
34583,Pmab,gene,0.535,23599789
34584,Cmab,drug,0.5156,23599789
34585,patients,species,0.988,23599789
34586,Pmab,gene,0.968,23599789
34587,patients,species,0.991,23599789
34588,Pmab,gene,0.9824,23599789
34589,patients,species,0.991,23599789
34590,Pmab,drug,0.7563,23599789
34591,patients,species,0.9897,23599789
34592,patients,species,0.988,23599789
34593,patients,species,0.9883,23599789
34594,KRAS,gene,0.987,23599789
34595,patients,species,0.991,23599789
34596,wild-type KRAS,DNA,0.799,23599789
34597,wild-type KRAS,gene,0.908,23599789
34598,wild,DNA,0.6113,23599789
34599,wild-type KRAS,gene,0.969,23599789
34600,patients,species,0.9946,23599789
34601,Pmab,gene,0.699,23599789
34602,patients,species,0.923,23599789
34603,mCRC,disease,0.9844,23599789
34604,Cmab,drug,0.6016,23599789
34605,Epirubicin,drug,0.9995,23594787
34606,oxaliplatin,drug,0.9995,23594787
34607,capecitabine,drug,0.999,23594787
34608,panitumumab,gene,0.6665,23594787
34609,advanced oesophagogastric cancer,disease,1.0,23594787
34610,EGFR,gene,0.984,23594787
34611,oesophagogastric adenocarcinomas,disease,1.0,23594787
34612,anti-EGFR antibody,gene,0.956,23594787
34613,panitumumab,gene,0.3965,23594787
34614,epirubicin,drug,0.9995,23594787
34615,oxaliplatin,drug,0.9995,23594787
34616,capecitabine,drug,0.9995,23594787
34617,advanced oesophagogastric adenocarcinoma,disease,1.0,23594787
34618,"metastatic, or locally advanced oesophagogastric adenocarcinoma",disease,0.952,23594787
34619,epirubicin,drug,0.995,23594787
34620,oxaliplatin,drug,0.9995,23594787
34621,capecitabine,drug,0.9985,23594787
34622,panitumumab,gene,0.802,23594787
34623,epirubicin,drug,0.999,23594787
34624,oxaliplatin,drug,0.9995,23594787
34625,capecitabine,drug,0.999,23594787
34626,panitumumab,gene,0.7236,23594787
34627,panitumumab,gene,0.8877,23594787
34628,EOC,disease,0.9893,23594787
34629,mEOC,disease,0.5,23594787
34630,mEOC,cell_line,0.4949,23594787
34631,diarrhoea,disease,0.9927,23594787
34632,rash,disease,0.998,23594787
34633,mucositis,disease,1.0,23594787
34634,hypomagnesaemia,disease,1.0,23594787
34635,neutropenia,disease,0.9995,23594787
34636,panitumumab,gene,0.8984,23594787
34637,EOC,disease,0.9927,23594787
34638,advanced oesophagogastric adenocarcinoma,disease,0.997,23594787
34639,anti-,gene,0.5293,23588415
34640,EGFR,gene,0.5547,23588415
34641,colorectal adenocarcinomas,disease,1.0,23588415
34642,fascin,gene,0.985,23588415
34643,Colorectal adenocarcinoma,disease,1.0,23588415
34644,CRC,disease,1.0,23588415
34645,Fascin,gene,0.987,23588415
34646,CRCs,disease,0.71,23588415
34647,wild type K-RAS gene,gene,0.9175,23588415
34648,epidermal growth factor receptor,gene,0.967,23588415
34649,EGFR,gene,0.9966,23588415
34650,fascin,gene,0.9917,23588415
34651,K-RAS,gene,0.691,23588415
34652,CRCs,cell_line,0.7715,23588415
34653,EGFR,gene,0.9556,23588415
34654,fascin-expressing CRCs,cell_line,0.704,23588415
34655,fascin,gene,0.4438,23588415
34656,CRCs,disease,0.9604,23588415
34657,fascin,gene,0.987,23588415
34658,K-RAS,gene,0.7993,23588415
34659,metastatic colorectal carcinoma,disease,1.0,23588415
34660,fascin,gene,0.985,23588415
34661,tumor,disease,1.0,23588415
34662,fascin,gene,0.986,23588415
34663,p.G12R,mutation,,23588415
34664,G12C,RNA,,23588415
34665,G12C,mutation,,23588415
34666,c,RNA,0.5317,23588415
34667,c.34G > A,mutation,,23588415
34668,p.G12S,mutation,,23588415
34669,c,RNA,0.5186,23588415
34670,c.35G > A,mutation,,23588415
34671,p.G12D,mutation,,23588415
34672,c,RNA,0.551,23588415
34673,c.35G > T,mutation,,23588415
34674,p.G12V,mutation,,23588415
34675,c,RNA,0.4824,23588415
34676,c.35G > C,mutation,,23588415
34677,G12A,mutation,,23588415
34678,c.38G,RNA,0.4502,23588415
34679,c.38G > A,mutation,,23588415
34680,K-RAS gene,gene,0.8706,23588415
34681,fascin,gene,0.964,23588415
34682,K-RAS,gene,0.7188,23588415
34683,codon 12,DNA,0.81,23588415
34684,codon 13,DNA,0.8726,23588415
34685,fascin,gene,0.988,23588415
34686,K-RAS,DNA,0.6567,23588415
34687,K-RAS mutations,gene,0.9663,23588415
34688,fascin,gene,0.984,23588415
34689,K-RAS,DNA,0.649,23588415
34690,K-RAS mutations,gene,0.956,23588415
34691,tumor cell,cell_type,0.641,23588415
34692,tumor,disease,0.9995,23588415
34693,fascin,gene,0.9707,23588415
34694,K-RAS,DNA,0.7065,23588415
34695,K-RAS mutations,gene,0.954,23588415
34696,fascin-expressing CRCs,cell_line,0.517,23588415
34697,fascin,gene,0.992,23588415
34698,CRCs,disease,0.904,23588415
34699,K-RAS mutation,gene,0.628,23588415
34700,EGFR,gene,0.92,23588415
34701,colon cancer,disease,1.0,23575231
34702,Colorectal cancer,disease,1.0,23575231
34703,malignant disease,disease,1.0,23575231
34704,5-fluorouracil,drug,0.9995,23575231
34705,5-FU,drug,0.999,23575231
34706,metastatic colorectal cancer,disease,0.9775,23575231
34707,Irinotecan,drug,0.999,23575231
34708,oxaliplatin,drug,0.9995,23575231
34709,bevacizumab,gene,0.6685,23575231
34710,cetuximab,gene,0.861,23575231
34711,cancer cells,cell_type,0.873,23575231
34712,cancer,disease,0.9883,23575231
34713,metastatic colon cancer,disease,0.998,23575231
34714,Bevacizumab,gene,0.9395,23575231
34715,colorectal cancer,disease,1.0,23575231
34716,irinotecan,drug,0.998,23575231
34717,5-FU,drug,0.9956,23575231
34718,cetuximab,gene,0.877,23575231
34719,irinotecan,drug,0.9985,23575231
34720,5-FU,drug,0.9985,23575231
34721,irinotecan,drug,0.9995,23575231
34722,tumor,disease,1.0,23575231
34723,circulating tumor cells,cell_type,0.8833,23564832
34724,metastatic colorectal cancer,disease,0.906,23564832
34725,circulating tumor cells,cell_type,0.9077,23564832
34726,CTCs,cell_type,0.785,23564832
34727,metastatic,disease,0.6978,23564832
34728,colorectal cancer,disease,0.851,23564832
34729,PATIENTS,species,0.9233,23564832
34730,CTCs,cell_type,0.8354,23564832
34731,Kirsten rat sarcoma viral oncogene homolog,gene,0.742,23564832
34732,KRAS,gene,0.5337,23564832
34733,colorectal cancer,disease,1.0,23564832
34734,metastatic,disease,0.6997,23564832
34735,oxaliplatin,drug,0.9995,23564832
34736,S-1,drug,0.9424,23564832
34737,SOX,drug,0.9985,23564832
34738,panitumumab,gene,0.713,23564832
34739,CTCs,cell_type,0.7993,23564832
34740,liver metastases,disease,0.881,23564832
34741,cancer,disease,0.997,23564832
34742,CTCs,disease,0.5874,23564832
34743,CTCs,cell_type,0.774,23564832
34744,cancer,disease,1.0,23564832
34745,CTCs,cell_type,0.8296,23564832
34746,CTCs,cell_type,0.818,23564832
34747,CTCs,cell_type,0.805,23564832
34748,panitumumab,gene,0.796,23559877
34749,Panitumumab,gene,0.84,23559877
34750,human,species,0.8657,23559877
34751,epidermal growth factor receptor,gene,0.995,23559877
34752,metastatic colorectal cancer,disease,0.9404,23559877
34753,patients,species,0.9897,23559877
34754,KRAS,gene,0.996,23559877
34755,metastatic colorectal cancer,disease,0.993,23559877
34756,panitumumab,gene,0.6577,23559877
34757,patients,species,0.9883,23559877
34758,Tumour,disease,0.998,23559877
34759,panitumumab,gene,0.794,23559877
34760,panitumumab,gene,0.927,23559877
34761,skin toxicity,disease,0.949,23559877
34762,hypomagnesemia,disease,1.0,23559877
34763,panitumumab,gene,0.9575,23559877
34764,panitumumab,gene,0.8115,23559877
34765,Panitumumab,gene,0.8174,23548971
34766,interstitial lung disease,disease,0.9995,23548971
34767,metastatic colorectal cancer,disease,1.0,23548971
34768,panitumumab,gene,0.896,23548971
34769,panitumumab,gene,0.873,23548971
34770,interstitial lung disease,disease,0.999,23548971
34771,ILD,disease,1.0,23548971
34772,ILD,disease,1.0,23548971
34773,panitumumab,gene,0.907,23548971
34774,metastatic sigmoid colon cancer,disease,0.9995,23548971
34775,panitumumab,gene,0.924,23548971
34776,dyspnea,disease,1.0,23548971
34777,ILD,disease,1.0,23548971
34778,methylprednisolone,drug,0.9863,23548971
34779,ILD,disease,0.9995,23548971
34780,epidermal growth factor receptor,gene,0.997,23548971
34781,EGFR,gene,0.9985,23548971
34782,tyrosine,drug,0.864,23548971
34783,tyrosine kinase,gene,0.759,23548971
34784,anti-EGFR antibodies,gene,0.9272,23548971
34785,ILD,disease,1.0,23548971
34786,cetuximab,gene,0.925,23547747
34787,bevacizumab,gene,0.639,23547747
34788,oxaliplatin,drug,0.999,23547747
34789,panitumumab,gene,0.878,23547747
34790,metastatic colorectal cancer,disease,1.0,23547747
34791,Colorectal cancer,disease,1.0,23547747
34792,cancer,disease,1.0,23547747
34793,breast and lung cancer,disease,1.0,23547747
34794,epidermal growth factor receptor,gene,0.992,23547747
34795,EGFR,gene,0.997,23547747
34796,cetuximab,gene,0.8936,23547747
34797,panitumumab,gene,0.928,23547747
34798,vascular endothelial,cell_type,0.4683,23547747
34799,VEGF,gene,0.996,23547747
34800,bevacizumab,gene,0.743,23547747
34801,panitumumab,gene,0.9224,23547747
34802,cetuximab,gene,0.5557,23547747
34803,Kirsten rat sarcoma,disease,0.9634,23547747
34804,KRAS,gene,0.8604,23547747
34805,oxaliplatin,drug,0.9995,23547747
34806,metastatic colorectal cancer,disease,0.999,23547747
34807,cetuximab,gene,0.9146,23547747
34808,bevacizumab,gene,0.8516,23547747
34809,panitumumab,gene,0.867,23547747
34810,EGFR,gene,0.998,23547747
34811,metastatic colorectal cancer,disease,1.0,23547747
34812,KRAS,gene,0.8364,23547747
34813,cetuximab,gene,0.8994,23547747
34814,panitumumab,gene,0.93,23547747
34815,metastatic colorectal cancer,disease,0.891,23547747
34816,bevacizumab,gene,0.938,23547747
34817,bevacizumab,gene,0.85,23547747
34818,oxaliplatin,drug,0.999,23547747
34819,KRAS,gene,0.848,23547747
34820,KRAS,gene,0.81,23547747
34821,cetuximab,gene,0.9146,23547747
34822,panitumumab,gene,0.848,23547747
34823,KRAS,gene,0.8545,23547747
34824,KRAS,gene,0.69,23547747
34825,cetuximab,gene,0.672,23547747
34826,panitumumab,gene,0.851,23547747
34827,cetuximab,gene,0.8755,23547747
34828,irinotecan,drug,0.995,23547747
34829,bevacizumab,gene,0.852,23547747
34830,cetuximab,gene,0.8813,23547747
34831,cetuximab,gene,0.893,23547747
34832,irinotecan,drug,0.9976,23547747
34833,bevacizumab,gene,0.8257,23547747
34834,cetuximab,gene,0.94,23547747
34835,irinotecan,drug,0.9966,23547747
34836,cetuximab,gene,0.9087,23547747
34837,irinotecan,drug,0.996,23547747
34838,KRAS,gene,0.79,23547747
34839,cetuximab,gene,0.85,23547747
34840,panitumumab,gene,0.732,23547747
34841,KRAS,gene,0.7397,23547747
34842,KRAS WT,DNA,0.6934,23547747
34843,KRAS,gene,0.9907,23547747
34844,cetuximab,gene,0.7295,23547747
34845,irinotecan,drug,0.9946,23547747
34846,colorectal cancer,disease,1.0,23543121
34847,colorectal cancer,disease,1.0,23543121
34848,cetuximab,gene,0.922,23538180
34849,cetuximab,gene,0.9316,23538180
34850,irinotecan,drug,0.9966,23538180
34851,panitumumab,gene,0.87,23538180
34852,cetuximab,gene,0.9316,23538180
34853,cetuximab,gene,0.8633,23538180
34854,irinotecan,drug,0.996,23538180
34855,panitumumab,gene,0.9175,23538180
34856,patients,species,0.9707,23538180
34857,Kirsten rat sarcoma wild-type,disease,0.966,23538180
34858,metastatic colorectal cancer,disease,0.999,23538180
34859,cetuximab,gene,0.9663,23538180
34860,panitumumab,gene,0.9414,23538180
34861,cetuximab,gene,0.962,23538180
34862,irinotecan,drug,0.9966,23538180
34863,Patients,species,0.9805,23538180
34864,panitumumab,gene,0.8516,23538180
34865,cetuximab,gene,0.6543,23538180
34866,cetuximab,gene,0.9106,23538180
34867,irinotecan,drug,0.9976,23538180
34868,Panitumumab,gene,0.865,23538180
34869,cetuximab,gene,0.915,23538180
34870,cetuximab,gene,0.658,23538180
34871,panitumumab,gene,0.8633,23538180
34872,patients,species,0.9907,23538180
34873,cetuximab,gene,0.9507,23538180
34874,irinotecan,drug,0.9956,23538180
34875,patient,species,0.9673,23538180
34876,18F-FDG,drug,0.998,23536226
34877,cancer,disease,1.0,23536226
34878,IR700,drug,0.699,23536226
34879,phthalocyanine,drug,0.975,23536226
34880,tumor,disease,1.0,23536226
34881,tumor,disease,0.9985,23536226
34882,(18)F-FDG,drug,0.999,23536226
34883,mice,species,0.9014,23536226
34884,panitumumab,gene,0.9785,23536226
34885,anti-HER1,gene,0.83,23536226
34886,HER1-positive tumor cells,cell_line,0.7637,23536226
34887,HER1,gene,0.9883,23536226
34888,tumor,disease,0.5425,23536226
34889,A431,cell_line,0.927,23536226
34890,(18)F-FDG,drug,0.9995,23536226
34891,tumor,disease,0.9985,23536226
34892,(18)F-FDG,drug,0.9995,23536226
34893,(18)F-FDG,drug,1.0,23536226
34894,tumors,disease,0.995,23536226
34895,tumors,disease,1.0,23536226
34896,tumors,disease,1.0,23536226
34897,tumors,disease,1.0,23536226
34898,glucose,drug,0.9907,23536226
34899,(18)F-FDG,drug,0.9995,23536226
34900,tumor,disease,0.9927,23536226
34901,(18)F-FDG,drug,0.9995,23536226
34902,tumor,disease,0.9995,23536226
34903,panitumumab,gene,0.9824,23525846
34904,cutaneous head and neck cancer,disease,1.0,23525846
34905,mice,species,0.9844,23525846
34906,panitumumab,gene,0.899,23525846
34907,cutaneous squamous cell carcinoma,disease,1.0,23525846
34908,cSCC,disease,1.0,23525846
34909,mice,species,0.9575,23525846
34910,epidermal growth factor receptor,gene,0.997,23525846
34911,panitumumab,gene,0.9043,23525846
34912,IgG,gene,0.9736,23525846
34913,mice,species,0.9194,23525846
34914,cSCC cell line,cell_line,0.893,23525846
34915,cSCC,disease,0.9995,23525846
34916,SCC-13,cell_line,0.901,23525846
34917,SRB-12,cell_line,0.881,23525846
34918,STSGs,DNA,0.506,23525846
34919,tumor,disease,0.9995,23525846
34920,tumor,disease,0.9883,23525846
34921,Immunodeficient,disease,0.531,23525846
34922,mice,species,0.7153,23525846
34923,STSG,DNA,0.4736,23525846
34924,Tumor,disease,0.9897,23525846
34925,panitumumab,gene,0.99,23525846
34926,IgG,gene,0.9927,23525846
34927,tumor,disease,0.9995,23525846
34928,tumor,disease,1.0,23525846
34929,panitumumab,gene,0.983,23525846
34930,cSCC,disease,0.9995,23525846
34931,colorectal cancer,disease,1.0,23513885
34932,locally advanced sigmoid colon cancer,disease,1.0,23507607
34933,FOLFIRI,drug,0.889,23507607
34934,panitumumab,gene,0.8833,23507607
34935,abdominal pain,disease,0.9985,23507607
34936,high fever,disease,0.996,23507607
34937,KRAS,gene,0.6157,23507607
34938,pelvic abscess,disease,1.0,23507607
34939,FOLFIRI,drug,0.99,23507607
34940,FOLFIRI,drug,0.9917,23507607
34941,panitumumab,gene,0.8545,23507607
34942,panitumumab,gene,0.8633,23507607
34943,FOLFIRI,drug,0.9688,23507607
34944,panitumumab,gene,0.9165,23507607
34945,FOLFIRI,drug,0.962,23507607
34946,panitumumab,gene,0.906,23507607
34947,KRAS,gene,0.6777,23507607
34948,locally advanced colon cancer,disease,0.9336,23507607
34949,metastatic colorectal cancer,disease,0.8564,23504768
34950,cetuximab,gene,0.9106,23504768
34951,panitumumab,gene,0.877,23504768
34952,v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog,gene,0.688,23504768
34953,rat,species,0.407,23504768
34954,KRAS,gene,0.961,23504768
34955,antiepidermal growth factor receptor,gene,0.9863,23504768
34956,anti-EGFR,gene,0.966,23504768
34957,cetuximab,gene,0.7793,23504768
34958,KRAS G13D,DNA,0.637,23504768
34959,KRAS G13D mutation,gene,0.9766,23504768
34960,G13D,mutation,,23504768
34961,KRAS mutations,gene,0.705,23504768
34962,panitumumab,gene,0.4976,23504768
34963,KRAS G13D mutation,gene,0.622,23504768
34964,G13D,mutation,,23504768
34965,anti-EGFR monoclonal,gene,0.8867,23504768
34966,skin toxicity,disease,0.8735,23504768
34967,EGFR,gene,0.9937,23504768
34968,anti-EGFR antibodies,gene,0.8706,23504768
34969,anti-EGFR antibodies,gene,0.9443,23504768
34970,EGFR,gene,0.903,23504768
34971,decitabine,drug,0.994,23504398
34972,panitumumab,gene,0.7285,23504398
34973,wild-type,gene,0.7236,23504398
34974,KRAS,gene,0.633,23504398
34975,metastatic colorectal cancer,disease,0.979,23504398
34976,KRAS,gene,0.5806,23504398
34977,EGFR,gene,0.9814,23504398
34978,metastatic colorectal cancer,disease,1.0,23504398
34979,mCRC,disease,1.0,23504398
34980,wild,DNA,0.5283,23504398
34981,wild-type KRAS,gene,0.9814,23504398
34982,EGFR,gene,0.9927,23504398
34983,decitabine,drug,0.9883,23504398
34984,panitumumab,gene,0.658,23504398
34985,EGFR,gene,0.9644,23504398
34986,mCRC,disease,0.9956,23504398
34987,wild,DNA,0.656,23504398
34988,wild-type KRAS,gene,0.8374,23504398
34989,mCRC,disease,0.9985,23504398
34990,decitabine,drug,0.993,23504398
34991,panitumumab,gene,0.804,23504398
34992,peripheral-blood cells,cell_type,0.7266,23504398
34993,PBMCs,cell_type,0.886,23504398
34994,rash,disease,0.9995,23504398
34995,hypomagnesemia,disease,1.0,23504398
34996,neutropenia,disease,0.63,23504398
34997,neutropenic fever,disease,1.0,23504398
34998,cetuximab,gene,0.7993,23504398
34999,MAGE promoter,gene,0.9336,23504398
35000,PBMCs,cell_type,0.903,23504398
35001,decitabine,drug,0.9844,23504398
35002,panitumumab,gene,0.7715,23504398
35003,wild-type KRAS,gene,0.9766,23504398
35004,mCRC,disease,0.995,23504398
35005,cetuximab,gene,0.8975,23504398
35006,tumor,disease,1.0,23504398
35007,EGFR mAb,gene,0.953,23504398
35008,mCRC,disease,0.9453,23504398
35009,Panitumumab,gene,0.921,23490492
35010,trichomegaly,disease,0.9917,23490492
35011,oesophagogastric cancer,disease,1.0,23481512
35012,Advanced or Locally advanced oesophagogastric cancer,disease,0.9985,23481512
35013,panitumumab,gene,0.838,23481512
35014,epirubicin,drug,0.999,23481512
35015,oxaliplatin,drug,0.9995,23481512
35016,capecitabine,drug,0.999,23481512
35017,EOC,drug,0.9204,23481512
35018,advanced oesophagogastric adenocarcinoma,disease,1.0,23481512
35019,undifferentiated carcinoma,disease,1.0,23481512
35020,epirubicin,drug,0.9976,23481512
35021,cisplatin,drug,0.9995,23481512
35022,5-fluorouracil,drug,0.9985,23481512
35023,oesophagogastric adenocarcinoma,disease,1.0,23481512
35024,PATIENTS,species,0.932,23481512
35025,patients,species,0.908,23481512
35026,EOC,drug,0.741,23481512
35027,REAL3,drug,0.524,23481512
35028,KRAS,gene,0.9536,23481512
35029,BRAF,DNA,0.5625,23481512
35030,BRAF,gene,0.9966,23481512
35031,PIK3CA mutations,gene,0.9043,23481512
35032,PTEN,gene,0.9717,23481512
35033,MAGIC,disease,1.0,23481512
35034,patients,species,0.992,23481512
35035,mEOC,disease,0.6294,23481512
35036,EOC,disease,0.778,23481512
35037,KRAS,gene,0.9736,23481512
35038,BRAF,DNA,0.822,23481512
35039,BRAF,gene,0.9893,23481512
35040,PIK3CA,gene,0.994,23481512
35041,PTEN,DNA,0.528,23481512
35042,PTEN,gene,0.991,23481512
35043,MAGIC,disease,1.0,23481512
35044,KRAS,gene,0.969,23481512
35045,BRAF,DNA,0.7183,23481512
35046,BRAF,gene,0.9897,23481512
35047,PIK3CA,gene,0.9966,23481512
35048,PTEN,gene,0.9937,23481512
35049,phosphatase and tensin homolog,gene,0.996,23481512
35050,mEOC,disease,0.9272,23481512
35051,advanced colorectal cancer,disease,0.8677,23456402
35052,advanced colorectal cancer,disease,0.998,23456402
35053,advanced colorectal cancer,disease,0.995,23456402
35054,Fluorouracil,drug,0.9995,23456402
35055,leucovorin,drug,0.999,23456402
35056,fluorouracil,drug,1.0,23456402
35057,leucovorin,drug,0.999,23456402
35058,irinotecan,drug,0.999,23456402
35059,oxaliplatin,drug,0.9995,23456402
35060,capecitabine,drug,0.999,23456402
35061,oxaliplatin,drug,0.9995,23456402
35062,CapeOx,drug,0.9976,23456402
35063,FOLFOX,drug,0.841,23456402
35064,colorectal cancer,disease,0.9907,23456402
35065,bevacizumab,gene,0.82,23456402
35066,cetuximab,gene,0.887,23456402
35067,panitumumab,gene,0.9404,23456402
35068,colorectal cancer,disease,1.0,23456402
35069,CapeOx,drug,0.9995,23456402
35070,FOLFOX,drug,0.9146,23456402
35071,FOLFIRI,drug,0.7866,23456402
35072,Zirconium-89,drug,0.996,23454247
35073,panitumumab,gene,0.934,23454247
35074,HER1,gene,0.522,23454247
35075,carcinomas,disease,0.629,23454247
35076,Anti-HER1 monoclonal antibody,gene,0.9697,23454247
35077,panitumumab,gene,0.92,23454247
35078,epidermal growth factor,gene,0.996,23454247
35079,EGFR,gene,0.995,23454247
35080,HER1,gene,0.9937,23454247
35081,colorectal,cell_type,0.5,23454247
35082,colorectal cancers,disease,1.0,23454247
35083,panitumumab,gene,0.9146,23454247
35084,(89)Zr,drug,0.9995,23454247
35085,DFO,drug,0.9927,23454247
35086,panitumumab,gene,0.97,23454247
35087,HER1,gene,0.987,23454247
35088,Panitumumab,gene,0.8813,23454247
35089,(89)Zr,drug,0.999,23454247
35090,desferrioxamine,drug,0.9995,23454247
35091,DFO-Bz-NCS,drug,0.9995,23454247
35092,(111)In,drug,0.9995,23454247
35093,"CHX-A"" DTPA",drug,0.9946,23454247
35094,tumor,disease,0.9873,23454247
35095,nude mice,species,0.793,23454247
35096,(89)Zr,drug,0.9985,23454247
35097,DFO,drug,0.9893,23454247
35098,panitumumab,gene,0.8115,23454247
35099,(111)In,drug,0.999,23454247
35100,CHX,drug,0.93,23454247
35101,DTPA,drug,0.9995,23454247
35102,panitumumab,gene,0.9805,23454247
35103,nude mice,species,0.6973,23454247
35104,human breast,cell_type,0.5273,23454247
35105,breast cancer tumors,disease,0.9824,23454247
35106,HER1,gene,0.993,23454247
35107,BT-474,cell_line,0.9556,23454247
35108,MDA-MB-231,cell_line,0.9395,23454247
35109,MDA-MB-468,cell_line,0.949,23454247
35110,(89)Zr,drug,0.9995,23454247
35111,DFO,drug,0.9604,23454247
35112,panitumumab,gene,0.848,23454247
35113,(89)Zr,drug,0.9995,23454247
35114,Panitumumab,gene,0.868,23454247
35115,panitumumab,gene,0.8525,23454247
35116,(111)In,drug,0.9995,23454247
35117,panitumumab,gene,0.9556,23454247
35118,(89)Zr,drug,0.9995,23454247
35119,DFO,drug,0.967,23454247
35120,panitumumab,gene,0.899,23454247
35121,athymic non-tumor bearing nude,cell_line,0.62,23454247
35122,nude,species,0.855,23454247
35123,mice,species,0.963,23454247
35124,panitumumab,gene,0.9043,23454247
35125,(89)Zr,drug,0.9995,23454247
35126,panitumumab,gene,0.9487,23454247
35127,(111)In,drug,0.9995,23454247
35128,panitumumab,gene,0.94,23454247
35129,tumor,disease,1.0,23454247
35130,mice,species,0.9707,23454247
35131,(89)Zr,drug,0.9995,23454247
35132,DFO,drug,0.9844,23454247
35133,panitumumab,gene,0.9077,23454247
35134,(89)Zr,drug,0.9995,23454247
35135,DFO,drug,0.9834,23454247
35136,panitumumab,gene,0.955,23454247
35137,mice,species,0.88,23454247
35138,breast cancer,disease,1.0,23454247
35139,HER1,gene,0.9907,23454247
35140,MDA-MB-468,cell_line,0.772,23454247
35141,HER1,gene,0.801,23454247
35142,mice,species,0.937,23454247
35143,HER1,gene,0.99,23454247
35144,(89)Zr,drug,0.999,23454247
35145,DFO,drug,0.9395,23454247
35146,panitumumab,gene,0.8315,23454247
35147,(89)Zr,drug,0.9995,23454247
35148,DFO,drug,0.9575,23454247
35149,panitumumab,gene,0.855,23454247
35150,HER-1,gene,0.988,23454247
35151,(89)Zr,drug,0.9995,23454247
35152,DFO,drug,0.9697,23454247
35153,panitumumab,gene,0.863,23454247
35154,(89)Zr,drug,0.9995,23454247
35155,DFO,drug,0.9897,23454247
35156,panitumumab,gene,0.9414,23454247
35157,EGFR gene,gene,0.9634,23441167
35158,colorectal cancer,disease,1.0,23441167
35159,patients,species,0.9834,23441167
35160,epidermal growth factor receptor (EGFR) gene,DNA,0.7783,23441167
35161,epidermal growth factor receptor,gene,0.9995,23441167
35162,EGFR,gene,0.9976,23441167
35163,colorectal cancer,disease,1.0,23441167
35164,CRC,disease,1.0,23441167
35165,anti-EGFR monoclonal antibodies,gene,0.9556,23441167
35166,EGFR,gene,0.9824,23441167
35167,patients,species,0.963,23441167
35168,advanced CRC,disease,0.9995,23441167
35169,EGFR,gene,0.615,23441167
35170,mAbs,DNA,0.518,23441167
35171,EGFR,gene,0.9956,23441167
35172,GCN,DNA,0.5605,23441167
35173,patients,species,0.9546,23441167
35174,metastatic CRC,disease,1.0,23441167
35175,panitumumab,gene,0.7695,23441167
35176,cetuximab,gene,0.7285,23441167
35177,EGFR,gene,0.9834,23441167
35178,GCN,gene,0.6777,23441167
35179,patients,species,0.9946,23441167
35180,GCN,gene,0.995,23441167
35181,patients,species,0.993,23441167
35182,GCN,gene,0.994,23441167
35183,patients,species,0.991,23441167
35184,GCN,gene,0.996,23441167
35185,EGFR,gene,0.9937,23441167
35186,TTP,gene,0.8535,23441167
35187,EGFR,gene,0.996,23441167
35188,KRAS,DNA,0.7583,23441167
35189,KRAS,gene,0.978,23441167
35190,EGFR,gene,0.992,23441167
35191,patients,species,0.9795,23441167
35192,EGFR,gene,0.67,23441167
35193,patients,species,0.9893,23441167
35194,EGFR,gene,0.9937,23441167
35195,patients,species,0.992,23441167
35196,panitumumab,gene,0.924,23441127
35197,human tumor xenograft models,cell_line,0.6597,23441127
35198,tumor,disease,1.0,23441127
35199,Epidermal growth factor receptor,gene,0.998,23441127
35200,EGFR,gene,0.9946,23441127
35201,cancer,disease,1.0,23441127
35202,gene array profile,DNA,0.8013,23441127
35203,panitumumab,gene,0.7183,23441127
35204,EGFR-binding antibody,gene,0.8745,23441127
35205,cancer,disease,0.999,23441127
35206,Mice,species,0.815,23441127
35207,xenograft models,cell_line,0.64,23441127
35208,panitumumab,gene,0.861,23441127
35209,immunoglobulin G2,gene,0.9976,23441127
35210,panitumumab,gene,0.8022,23441127
35211,xenografts,cell_line,0.61,23441127
35212,gene sets,DNA,0.8267,23441127
35213,panitumumab,gene,0.7607,23441127
35214,xenograft models,cell_line,0.5024,23441127
35215,panitumumab,gene,0.9233,23441127
35216,xenograft models,cell_line,0.8267,23441127
35217,panitumumab,gene,0.9062,23441127
35218,13,DNA,0.542,23441127
35219,genes,DNA,0.541,23441127
35220,xenograft,cell_line,0.5664,23441127
35221,panitumumab,gene,0.832,23441127
35222,panitumumab,gene,0.801,23441127
35223,head and neck cancer,disease,1.0,23440867
35224,squamous cell carcinoma of the head and neck,disease,1.0,23440867
35225,SCCHN,disease,1.0,23440867
35226,human papillomavirus,disease,0.818,23440867
35227,HPV,disease,0.6855,23440867
35228,SCCHN,disease,1.0,23440867
35229,SCCHN,disease,1.0,23440867
35230,epidermal growth factor receptor,gene,0.9985,23440867
35231,EGFR,gene,0.9946,23440867
35232,cetuximab,gene,0.8784,23440867
35233,panitumumab,gene,0.9204,23440867
35234,zalutumumab,gene,0.586,23440867
35235,nimotuzumab,gene,0.7876,23440867
35236,EGFR,gene,0.986,23440867
35237,tyrosine,drug,0.9214,23440867
35238,tyrosine kinase,gene,0.9707,23440867
35239,gefitinib,drug,0.9995,23440867
35240,erlotinib,drug,0.999,23440867
35241,lapatinib,drug,0.9995,23440867
35242,afatanib,drug,0.999,23440867
35243,dacomitinib,drug,0.999,23440867
35244,vascular endothelial growth factor receptor,gene,0.998,23440867
35245,VEGFR,gene,0.9946,23440867
35246,sorafenib,drug,0.999,23440867
35247,sunitinib,drug,0.9985,23440867
35248,vandetanib,drug,0.9956,23440867
35249,phosphatidylinositol,drug,0.999,23440867
35250,phosphatidylinositol 3' kinase,gene,0.9927,23440867
35251,PI3K,gene,0.997,23440867
35252,AKT,gene,0.998,23440867
35253,mammalian target of,gene,0.9355,23440867
35254,rapamycin,drug,0.9985,23440867
35255,mTOR,gene,0.988,23440867
35256,MET,gene,0.6523,23440867
35257,insulin-like growth factor receptor,gene,0.999,23440867
35258,IGF-1R,gene,0.998,23440867
35259,SCCHN,disease,0.9995,23440867
35260,tumor tissue,cell_type,0.5415,23429431
35261,tumor,disease,0.9214,23429431
35262,EGFR,gene,0.9937,23429431
35263,metastatic colorectal cancer,disease,1.0,23429431
35264,EGFR,gene,0.8354,23429431
35265,metastatic colorectal cancer,disease,1.0,23429431
35266,mCRC,disease,0.9966,23429431
35267,cetuximab,gene,0.828,23429431
35268,panitumumab,gene,0.8525,23429431
35269,KRAS,DNA,0.871,23429431
35270,KRAS mutation,gene,0.9272,23429431
35271,KRAS,DNA,0.7036,23429431
35272,KRAS mutation,gene,0.9287,23429431
35273,BRAF V600E,gene,0.746,23429431
35274,V600E,mutation,,23429431
35275,BRAF V600E,gene,0.651,23429431
35276,V600E,mutation,,23429431
35277,EGFR,gene,0.993,23429431
35278,mCRC,disease,0.958,23429431
35279,tumors,disease,1.0,23429431
35280,KRAS,gene,0.885,23429431
35281,NRAS,gene,0.793,23429431
35282,PIK3CA,gene,0.5127,23429431
35283,PTEN,gene,0.997,23429431
35284,AKT proteins,gene,0.9346,23429431
35285,EGFR,gene,0.9893,23429431
35286,cetuximab,gene,0.855,23429431
35287,panitumumab,gene,0.791,23429431
35288,mCRC,disease,0.991,23429431
35289,tumors,disease,1.0,23429431
35290,EGFR,gene,0.9927,23429431
35291,anti-EGFR antibodies,gene,0.9526,23429431
35292,cetuximab,gene,0.8433,23429431
35293,panitumumab,gene,0.832,23429431
35294,KRAS,DNA,0.86,23429431
35295,KRAS mutation,gene,0.8306,23429431
35296,codons 12 and 13,DNA,0.753,23429431
35297,KRAS,DNA,0.7954,23429431
35298,KRAS mutations,gene,0.9233,23429431
35299,codon 61,DNA,0.867,23429431
35300,BRAF,DNA,0.8696,23429431
35301,BRAF V600E,gene,0.866,23429431
35302,V600E,DNA,,23429431
35303,V600E,mutation,,23429431
35304,NRAS,gene,0.8525,23429431
35305,PIK3CA,gene,0.677,23429431
35306,PTEN,gene,0.9844,23429431
35307,AKT,gene,0.914,23429431
35308,mCRC,disease,0.9985,23429431
35309,PTEN,gene,0.988,23429431
35310,AKT,gene,0.994,23429431
35311,KRAS,DNA,0.8433,23429431
35312,KRAS mutation,gene,0.7715,23429431
35313,EGFR,gene,0.7676,23429431
35314,BRAF V600E,gene,0.644,23429431
35315,V600E,mutation,,23429431
35316,EGFR,gene,0.8535,23429431
35317,NRAS,gene,0.8306,23429431
35318,PIK3CA,gene,0.821,23429431
35319,PTEN,gene,0.9604,23429431
35320,ATK proteins,gene,0.8,23429431
35321,EGFR,gene,0.7188,23429431
35322,KRAS mutation,gene,0.674,23429431
35323,BRAF V600E,gene,0.5757,23429431
35324,V600E,mutation,,23429431
35325,PTEN,gene,0.988,23429431
35326,mCRC,disease,0.999,23429431
35327,tumors,disease,1.0,23429431
35328,wild-type BRAF sequence,gene,0.89,23429431
35329,PTEN,gene,0.9917,23429431
35330,NRAS or PIK3CA variants,DNA,0.7515,23429431
35331,NRAS,gene,0.987,23429431
35332,PIK3CA variants,gene,0.956,23429431
35333,AKT protein,gene,0.8965,23429431
35334,CRC,disease,0.9966,23429431
35335,mCRC,disease,0.9995,23429431
35336,cancer,disease,1.0,23429431
35337,mCRC,disease,0.999,23429431
35338,panitumumab,gene,0.8096,23426888
35339,acinar cell carcinoma of the pancreas,disease,1.0,23426888
35340,acinar carcinoma of the pancreas,disease,0.998,23426888
35341,colon cancer,disease,1.0,23426888
35342,panitumumab,gene,0.876,23426888
35343,tumour,disease,1.0,23426888
35344,panitumumab,gene,0.8887,23426888
35345,acinar cell carcinoma of the pancreas,disease,1.0,23426888
35346,panitumumab,gene,0.813,23426888
35347,epidermal growth factor receptor,gene,0.998,23425099
35348,squamous cell carcinoma,disease,1.0,23425099
35349,Squamous cell carcinoma,disease,1.0,23425099
35350,SCC,disease,1.0,23425099
35351,SCC,disease,0.999,23425099
35352,epidermal growth factor receptor,gene,0.9985,23425099
35353,EGFR,gene,0.991,23425099
35354,advanced SCC,disease,0.7017,23425099
35355,EGFR,gene,0.9946,23425099
35356,skin cancer,disease,1.0,23425099
35357,EGFR,gene,0.8545,23425099
35358,EGFR,gene,0.941,23425099
35359,skin cancer,disease,1.0,23425099
35360,Promoter CpG island,DNA,0.593,23422094
35361,CpG,drug,0.808,23422094
35362,DNA repair enzyme,gene,0.9844,23422094
35363,MGMT,gene,0.7085,23422094
35364,dacarbazine,drug,0.999,23422094
35365,metastatic colorectal cancer,disease,1.0,23422094
35366,O(6)-methylguanine,drug,0.9893,23422094
35367,O(6)-methylguanine-DNA-methyltransferase,gene,0.9736,23422094
35368,MGMT,gene,0.989,23422094
35369,DNA repair protein,gene,0.9756,23422094
35370,O(6,drug,0.841,23422094
35371,guanine,drug,0.9927,23422094
35372,colorectal cancers,disease,1.0,23422094
35373,CRC,disease,1.0,23422094
35374,MGMT deficiency,disease,0.9995,23422094
35375,MGMT,gene,0.9775,23422094
35376,dacarbazine,drug,0.9976,23422094
35377,O(6),drug,0.8643,23422094
35378,guanine,drug,0.8545,23422094
35379,dacarbazine,drug,0.999,23422094
35380,CRCs,cell_line,0.7837,23422094
35381,MGMT,gene,0.986,23422094
35382,dacarbazine,drug,0.9995,23422094
35383,CRCs,disease,0.4824,23422094
35384,oxaliplatin,drug,1.0,23422094
35385,irinotecan,drug,0.9995,23422094
35386,fluoropyrimidines,drug,0.9995,23422094
35387,cetuximab,gene,0.662,23422094
35388,panitumumab,gene,0.776,23422094
35389,KRAS,gene,0.768,23422094
35390,tumor tissue,cell_type,0.5117,23422094
35391,tumor,disease,0.9985,23422094
35392,MGMT,gene,0.99,23422094
35393,dacarbazine,drug,0.999,23422094
35394,MGMT,gene,0.543,23422094
35395,dacarbazine,drug,0.999,23422094
35396,fatigue,disease,0.9985,23422094
35397,nausea,disease,0.989,23422094
35398,vomiting,disease,0.6333,23422094
35399,constipation,disease,0.9995,23422094
35400,platelet,cell_type,0.5312,23422094
35401,anemia,disease,1.0,23422094
35402,MGMT promoter,gene,0.6562,23422094
35403,tumors,disease,1.0,23422094
35404,dacarbazine,drug,0.999,23422094
35405,CRC,disease,0.999,23422094
35406,tumors,disease,1.0,23422094
35407,DNA repair enzyme,gene,0.982,23422094
35408,MGMT,gene,0.5576,23422094
35409,advanced colorectal cancer,disease,0.972,23413162
35410,advanced colorectal cancer,disease,0.9995,23413162
35411,patients,species,0.966,23413162
35412,advanced colorectal cancer,disease,0.9976,23413162
35413,Fluorouracil,drug,0.9995,23413162
35414,leucovorin,drug,0.999,23413162
35415,fluorouracil,drug,1.0,23413162
35416,leucovorin,drug,0.999,23413162
35417,irinotecan,drug,0.999,23413162
35418,oxaliplatin,drug,0.9995,23413162
35419,capecitabine,drug,0.999,23413162
35420,oxaliplatin,drug,0.9995,23413162
35421,CapeOx,drug,0.9985,23413162
35422,FOLFOX,drug,0.841,23413162
35423,colorectal cancer,disease,0.9907,23413162
35424,bevacizumab,gene,0.82,23413162
35425,cetuximab,gene,0.943,23413162
35426,panitumumab,gene,0.9404,23413162
35427,patients,species,0.972,23413162
35428,patients,species,0.9478,23413162
35429,advanced colorectal cancer,disease,0.97,23413162
35430,CapeOx,drug,0.9995,23413162
35431,FOLFOX,drug,0.9146,23413162
35432,FOLFIRI,drug,0.7866,23413162
35433,KRAS gene,gene,0.9937,23404247
35434,colorectal cancer,disease,1.0,23404247
35435,EGFR,gene,0.995,23404247
35436,KRAS mutations,gene,0.825,23404247
35437,colorectal cancer,disease,1.0,23404247
35438,CRC,disease,1.0,23404247
35439,anti,gene,0.8115,23404247
35440,epidermal growth factor receptor,gene,0.8755,23404247
35441,EGFR,gene,0.9966,23404247
35442,patients,species,0.9814,23404247
35443,KRAS,DNA,0.7373,23404247
35444,KRAS mutations,gene,0.8413,23404247
35445,KRAS,gene,0.9927,23404247
35446,EGFR,gene,0.985,23404247
35447,cetuximab,gene,0.573,23404247
35448,panitumumab,gene,0.6655,23404247
35449,KRAS,DNA,0.8794,23404247
35450,KRAS,gene,0.9927,23404247
35451,KRAS,DNA,0.7495,23404247
35452,KRAS mutations,gene,0.869,23404247
35453,CRC,disease,0.9995,23404247
35454,KRAS,gene,0.987,23404247
35455,CRC,disease,0.9995,23404247
35456,CRC,disease,1.0,23404247
35457,KRAS,DNA,0.8945,23404247
35458,KRAS,gene,0.965,23404247
35459,tumor,disease,1.0,23404247
35460,EGFR,gene,0.937,23404247
35461,KRAS,gene,0.978,23404247
35462,CRC,disease,0.9995,23404247
35463,cell lines,cell_line,0.9614,23404247
35464,KRAS,DNA,0.8335,23404247
35465,KRAS,gene,0.9937,23404247
35466,KRAS,gene,0.9907,23404247
35467,Tumors,disease,1.0,23404247
35468,cell lines,cell_line,0.931,23404247
35469,EGFR,gene,0.673,23404247
35470,KRAS,DNA,0.8403,23404247
35471,KRAS,gene,0.9897,23404247
35472,CRC,disease,0.9956,23404247
35473,patients,species,0.9697,23404247
35474,cetuximab,gene,0.905,23375534
35475,panitumumab,gene,0.865,23375534
35476,oral squamous cell carcinoma cell lines,cell_line,0.9375,23375534
35477,oral squamous cell carcinoma,disease,0.9995,23375534
35478,epidermal growth factor receptor,gene,0.9976,23375534
35479,EGFR,gene,0.9937,23375534
35480,epithelial,cell_type,0.4646,23375534
35481,epithelial tumours,disease,1.0,23375534
35482,melanoma-associated antigens,gene,0.9956,23375534
35483,MAGE,gene,0.985,23375534
35484,tumour,disease,0.987,23375534
35485,cell lines,cell_line,0.917,23375534
35486,human,species,0.9814,23375534
35487,squamous cell carcinomas,disease,1.0,23375534
35488,cetuximab,gene,0.9424,23375534
35489,panitumumab,gene,0.8877,23375534
35490,MAGE-A1,DNA,0.4978,23375534
35491,"MAGE-A1, -A5, -A8, -A9, -A11 and -A12",gene,0.99,23375534
35492,MAGE-A,gene,0.995,23375534
35493,tumour cell lines,cell_line,0.9536,23375534
35494,tumour,disease,1.0,23375534
35495,cell line,cell_line,0.9556,23375534
35496,cetuximab,gene,0.969,23375534
35497,panitumumab,gene,0.9434,23375534
35498,panitumumab,gene,0.6304,23375534
35499,MAGE,DNA,0.6553,23375534
35500,MAGE-A12,gene,0.992,23375534
35501,panitumumab,gene,0.808,23375534
35502,MAGE-A5 and -A8,gene,0.994,23375534
35503,panitumumab,gene,0.8423,23375534
35504,cetuximab,gene,0.731,23375534
35505,viable cells,cell_type,0.729,23375534
35506,MAGE,DNA,0.515,23375534
35507,MAGE-A,gene,0.9937,23375534
35508,EGFR,gene,0.978,23375534
35509,MAGE,cell_line,0.622,23375534
35510,MAGE-,cell_type,0.5063,23375534
35511,MAGE-A,gene,0.9253,23375534
35512,HNSCC,disease,0.9985,23375534
35513,MAGE-A,gene,0.9966,23375534
35514,tumour,disease,0.999,23375534
35515,MAGE,DNA,0.496,23375534
35516,MAGE-A,gene,0.995,23375534
35517,patient,species,0.981,23375534
35518,metastatic colorectal cancer,disease,1.0,23375249
35519,metastatic colorectal cancer,disease,1.0,23375249
35520,mCRC,disease,1.0,23375249
35521,patients,species,0.9775,23375249
35522,mCRC,disease,0.995,23375249
35523,KRAS,gene,0.9766,23375249
35524,epidermal growth factor receptor,gene,0.998,23375249
35525,EGFR,gene,0.9985,23375249
35526,panitumumab,gene,0.622,23375249
35527,cetuximab,gene,0.86,23375249
35528,patient,species,0.9883,23375249
35529,mCRC,disease,0.999,23375249
35530,patients,species,0.9956,23375249
35531,patients,species,0.9844,23375249
35532,KRAS,disease,0.796,23375249
35533,KRAS G13D,gene,0.8765,23375249
35534,G13,mutation,,23375249
35535,BRAF V600,gene,0.632,23375249
35536,EGFR,gene,0.9946,23375249
35537,tumour,disease,1.0,23375249
35538,KRAS,DNA,0.876,23375249
35539,KRAS,gene,0.9688,23375249
35540,bevacizumab,gene,0.6772,23375249
35541,mCRC,disease,0.993,23375249
35542,mCRC,disease,0.9976,23375249
35543,patients,species,0.9907,23375249
35544,Panitumumab,gene,0.9155,23359181
35545,irinotecan,drug,0.994,23359181
35546,panitumumab,gene,0.9463,23359181
35547,irinotecan,drug,0.997,23359181
35548,patients,species,0.9585,23359181
35549,K-RAS,gene,0.9673,23359181
35550,colorectal cancer,disease,0.8213,23359181
35551,CRC,disease,1.0,23359181
35552,patients,species,0.9688,23359181
35553,panitumumab,gene,0.8027,23359181
35554,irinotecan,drug,0.9917,23359181
35555,patients,species,0.982,23359181
35556,patients,species,0.9844,23359181
35557,5-fluorouracil,drug,0.999,23359181
35558,oxaliplatin,drug,0.9995,23359181
35559,irinotecan,drug,0.999,23359181
35560,Patients,species,0.9795,23359181
35561,panitumumab,gene,0.907,23359181
35562,irinotecan,drug,0.9985,23359181
35563,patients,species,0.9917,23359181
35564,patients,species,0.9907,23359181
35565,patient,species,0.984,23359181
35566,diarrhoea,disease,1.0,23359181
35567,skin rash,disease,1.0,23359181
35568,neutropenia,disease,1.0,23359181
35569,panitumumab,gene,0.9565,23359181
35570,irinotecan,drug,0.9946,23359181
35571,patients,species,0.9727,23359181
35572,WT,cell_line,,23359181
35573,WT K-RAS,gene,0.8394,23359181
35574,K,DNA,0.5186,23359181
35575,CRC,disease,0.9893,23359181
35576,intact monoclonal,cell_line,0.5435,23358675
35577,150 kDa,RNA,0.507,23358675
35578,silica,drug,0.9995,23358675
35579,poly(styrene-divinyl benzene),drug,0.9995,23358675
35580,IgG1,gene,0.9976,23358675
35581,IgG2 mAbs,gene,0.9404,23358675
35582,rituximab,gene,0.946,23358675
35583,panitumumab,gene,0.945,23358675
35584,bevacizumab,gene,0.718,23358675
35585,C18,drug,0.9995,23358675
35586,phenyl,drug,0.9995,23358675
35587,silica,drug,1.0,23358675
35588,silica,drug,0.999,23358675
35589,silica,drug,1.0,23358675
35590,Panitumumab,gene,0.8384,23353714
35591,cetuximab,gene,0.8843,23353714
35592,patients,species,0.982,23353714
35593,metastatic colorectal cancer,disease,1.0,23353714
35594,patients,species,0.9824,23353714
35595,panitumumab,gene,0.8125,23353714
35596,cetuximab,gene,0.8423,23353714
35597,patients,species,0.981,23353714
35598,epidermal growth factor receptor,gene,0.998,23353714
35599,patients,species,0.9805,23353714
35600,patients,species,0.99,23353714
35601,panitumumab,gene,0.931,23352031
35602,meningeal,disease,0.975,23352031
35603,89Zr,drug,0.9995,23348788
35604,panitumumab,gene,0.7495,23348788
35605,epidermal growth factor receptor,gene,0.997,23348788
35606,EGFR,gene,0.9946,23348788
35607,malignancies,disease,1.0,23348788
35608,Panitumumab,gene,0.605,23348788
35609,anti-EGFR monoclonal antibody,gene,0.9653,23348788
35610,EGFR,gene,0.9795,23348788
35611,EGFR,gene,0.9927,23348788
35612,panitumumab,gene,0.897,23348788
35613,EGFR,gene,0.9863,23348788
35614,cell lines,cell_line,0.9272,23348788
35615,Desferrioxamine-Bz-NCS,drug,0.9976,23348788
35616,DFO,drug,0.999,23348788
35617,panitumumab,gene,0.9487,23348788
35618,(89)Zr,drug,0.9995,23348788
35619,cell lines,cell_line,0.9326,23348788
35620,mouse,species,0.964,23348788
35621,cell lines,cell_line,0.954,23348788
35622,tumors,disease,1.0,23348788
35623,Panitumumab,gene,0.8545,23348788
35624,(89)Zr,drug,0.9995,23348788
35625,EGFR,gene,0.9883,23348788
35626,(89)Zr,drug,0.9995,23348788
35627,panitumumab,gene,0.8276,23348788
35628,A431,disease,0.995,23348788
35629,HCT 116 tumors,disease,0.9976,23348788
35630,EGFR-,disease,0.9946,23348788
35631,EGFR,gene,0.974,23348788
35632,(89)Zr,drug,0.9995,23348788
35633,panitumumab,gene,0.8853,23348788
35634,EGFR,cell_line,0.53,23348788
35635,EGFR,gene,0.9937,23348788
35636,EGFR,gene,0.9863,23348788
35637,HER2,DNA,0.877,23348520
35638,HER2 gene,gene,0.991,23348520
35639,anti-EGFR monoclonal,gene,0.8115,23348520
35640,metastatic colorectal cancer,disease,1.0,23348520
35641,mCRC,disease,1.0,23348520
35642,KRAS,gene,0.973,23348520
35643,patients,species,0.989,23348520
35644,epidermal growth factor receptor,gene,0.998,23348520
35645,EGFR,gene,0.9956,23348520
35646,HER2,gene,0.992,23348520
35647,EGFR,gene,0.9946,23348520
35648,HER2 gene,DNA,0.9214,23348520
35649,HER2 gene,gene,0.995,23348520
35650,KRAS,gene,0.993,23348520
35651,mCRC,disease,0.9873,23348520
35652,patients,species,0.9824,23348520
35653,cetuximab,gene,0.7935,23348520
35654,panitumumab,gene,0.761,23348520
35655,HER2 gene,DNA,0.858,23348520
35656,HER2 gene,gene,0.9946,23348520
35657,patients,species,0.986,23348520
35658,patients,species,0.977,23348520
35659,HER2 gene,gene,0.989,23348520
35660,HER2,DNA,0.7896,23348520
35661,HER2,gene,0.9883,23348520
35662,CEP17  2,gene,0.9385,23348520
35663,neoplastic cells,cell_type,0.9126,23348520
35664,neoplastic,disease,0.956,23348520
35665,HER2,gene,0.993,23348520
35666,patients,species,0.9814,23348520
35667,HER2,DNA,0.723,23348520
35668,HER2,gene,0.9946,23348520
35669,minor clones,cell_line,0.805,23348520
35670,HER2,gene,0.987,23348520
35671,patients,species,0.989,23348520
35672,HER2,DNA,0.893,23348520
35673,HER2,gene,0.9946,23348520
35674,HER2,gene,0.9834,23348520
35675,Patients,species,0.9614,23348520
35676,HER2,gene,0.997,23348520
35677,patients,species,0.971,23348520
35678,HER2,gene,0.9976,23348520
35679,patients,species,0.9507,23348520
35680,HER2,gene,0.9976,23348520
35681,HER2 gene,DNA,0.819,23348520
35682,HER2 gene,gene,0.9897,23348520
35683,EGFR,gene,0.8125,23348520
35684,mCRC,disease,0.9844,23348520
35685,patients,species,0.986,23348520
35686,Metastatic colorectal cancer,disease,1.0,23338963
35687,mCRC,disease,1.0,23338963
35688,patients,species,0.979,23338963
35689,mCRC,disease,0.997,23338963
35690,epidermal growth factor receptor,gene,0.9985,23338963
35691,EGFR,gene,0.988,23338963
35692,panitumumab,gene,0.5854,23338963
35693,patients,species,0.9585,23338963
35694,kirsten rat sarcoma viral oncogene homolog,gene,0.997,23338963
35695,KRAS,gene,0.842,23338963
35696,mCRC,disease,0.9985,23338963
35697,mCRC,disease,0.9985,23338963
35698,KRAS,DNA,0.8813,23338963
35699,KRAS mutations,gene,0.787,23338963
35700,EGFR antibodies,gene,0.8677,23338963
35701,uridine diphosphate,drug,0.994,23338963
35702,uridine diphosphate-glucuronyl transferase 1A1,gene,0.9927,23338963
35703,UGT1A1,gene,0.9976,23338963
35704,irinotecan,drug,0.998,23338963
35705,mCRC,disease,0.993,23338963
35706,patient,species,0.9644,23338963
35707,mCRC,disease,0.993,23338963
35708,epidermal growth factor receptor,gene,0.9985,23331666
35709,cisplatin,drug,0.996,23331666
35710,human papillomavirus-related head and neck cancer,disease,1.0,23331666
35711,Human papillomavirus (HPV),disease,0.9883,23331666
35712,head and neck cancer,disease,0.999,23331666
35713,epidermal,DNA,0.577,23331666
35714,epidermal growth factor receptor,gene,0.9985,23331666
35715,EGFR,gene,0.9956,23331666
35716,p16,gene,0.997,23331666
35717,HPV16 DNA,DNA,0.814,23331666
35718,HPV16,species,0.639,23331666
35719,stage III/IV,disease,0.99,23331666
35720,head and neck cancer,disease,0.8936,23331666
35721,EGFR,gene,0.9946,23331666
35722,RESULTS DNA,DNA,0.4395,23331666
35723,HPV16,species,0.8696,23331666
35724,tumors,disease,1.0,23331666
35725,p16,gene,0.593,23331666
35726,tumors,disease,1.0,23331666
35727,p16,gene,0.9976,23331666
35728,EGFR,gene,0.9946,23331666
35729,p16,gene,0.4756,23331666
35730,p16,gene,0.6704,23331666
35731,EGFR,gene,0.995,23331666
35732,Orthotopic pleural mesothelioma,disease,0.996,23329660
35733,mice,species,0.983,23329660
35734,HER1,gene,0.9927,23329660
35735,HER2,gene,0.993,23329660
35736,anti-human epidermal growth factor receptor (HER)1,gene,0.9917,23329660
35737,anti-HER2,gene,0.885,23329660
35738,malignant pleural mesothelioma,disease,1.0,23329660
35739,MPM,disease,1.0,23329660
35740,mouse,species,0.9326,23329660
35741,mice,species,0.9683,23329660
35742,HER1,gene,0.991,23329660
35743,HER2,gene,0.991,23329660
35744,NCI-H226,cell_line,0.972,23329660
35745,MSTO-211H mesothelioma cells,cell_line,0.8857,23329660
35746,MSTO-,cell_type,0.562,23329660
35747,mesothelioma,disease,0.978,23329660
35748,mice,species,0.959,23329660
35749,MPM tumors,disease,1.0,23329660
35750,HER1,gene,0.9824,23329660
35751,HER2,gene,0.9937,23329660
35752,indium 111,drug,0.99,23329660
35753,(111)In,drug,0.999,23329660
35754,iodine 125,drug,0.937,23329660
35755,((125)I,drug,0.914,23329660
35756,trastuzumab,gene,0.9653,23329660
35757,mice,species,0.9497,23329660
35758,orthotopic tumors,disease,0.9995,23329660
35759,tumor,disease,0.9966,23329660
35760,Orthotopic tumors,disease,0.9966,23329660
35761,pleural effusions,disease,0.999,23329660
35762,tumor cell,cell_line,0.52,23329660
35763,tumor,disease,0.9995,23329660
35764,(111)In,drug,0.9995,23329660
35765,panitumumab,gene,0.941,23329660
35766,(111)In,drug,0.9995,23329660
35767,trastuzumab,gene,0.577,23329660
35768,(125)I,drug,0.9995,23329660
35769,(111)In,drug,0.999,23329660
35770,panitumumab,gene,0.9395,23329660
35771,tumor,disease,0.993,23329660
35772,tumor,disease,0.9985,23329660
35773,anti-HER1 antibodies,gene,0.901,23329660
35774,MPM,disease,0.9995,23329660
35775,tumor multigene,DNA,0.5254,23325582
35776,panitumumab,gene,0.802,23325582
35777,metastatic colorectal cancer,disease,1.0,23325582
35778,EGF receptor,gene,0.999,23325582
35779,EGFR,gene,0.9976,23325582
35780,panitumumab,gene,0.8247,23325582
35781,anti-EGFR monoclonal antibody,gene,0.9863,23325582
35782,metastatic colorectal cancer,disease,1.0,23325582
35783,KRAS,gene,0.773,23325582
35784,NRAS,gene,0.8105,23325582
35785,BRAF,gene,0.6665,23325582
35786,PIK3CA,gene,0.683,23325582
35787,PTEN,gene,0.994,23325582
35788,TP53,gene,0.7266,23325582
35789,EGFR,gene,0.9824,23325582
35790,AKT1,gene,0.996,23325582
35791,CTNNB1,gene,0.8555,23325582
35792,wild-type KRAS,gene,0.796,23325582
35793,mutant KRAS,gene,0.5703,23325582
35794,codons 12/13,DNA,0.735,23325582
35795,mutant,RNA,0.512,23325582
35796,mutant KRAS,gene,0.5293,23325582
35797,codon 61,DNA,0.6084,23325582
35798,Q61H,DNA,,23325582
35799,Q61H,mutation,,23325582
35800,KRAS,DNA,0.508,23325582
35801,codons 12/13/61,DNA,0.6763,23325582
35802,NRAS,DNA,0.533,23325582
35803,NRAS mutations,gene,0.864,23325582
35804,BRAF,DNA,0.5054,23325582
35805,BRAF mutations,gene,0.804,23325582
35806,PIK3CA,gene,0.6255,23325582
35807,PTEN mutations,gene,0.802,23325582
35808,CTNNB1,gene,0.7563,23325582
35809,panitumumab,gene,0.7524,23325582
35810,Panitumumab,gene,0.8745,23325582
35811,wild-type KRAS,gene,0.9053,23325582
35812,KRAS,DNA,0.3806,23325582
35813,panitumumab,gene,0.8115,23325582
35814,wild,gene,0.5737,23325582
35815,wild-type BRAF,gene,0.9956,23325582
35816,mutant NRAS,gene,0.5415,23325582
35817,cetuximab,gene,0.921,23321777
35818,panitumumab,gene,0.8774,23321777
35819,colorectal cancer,disease,1.0,23321777
35820,Skin rash,disease,1.0,23321777
35821,anti-epidermal growth factor receptor monoclonal antibodies,gene,0.946,23321777
35822,skin rash,disease,0.9966,23321777
35823,advanced colorectal cancer,disease,1.0,23321777
35824,cetuximab,gene,0.9062,23321777
35825,panitumumab,gene,0.8965,23321777
35826,skin rash,disease,0.9995,23321777
35827,rash,disease,1.0,23321777
35828,skin,disease,0.8,23321777
35829,rash,disease,0.9966,23321777
35830,skin rash,disease,1.0,23321777
35831,cetuximab,gene,0.939,23321777
35832,panitumumab,gene,0.883,23321777
35833,triple-negative breast cancer,disease,1.0,23319610
35834,EGFR,gene,0.9614,23319610
35835,Breast tumors,disease,1.0,23319610
35836,human epidermal growth factor receptor 2,gene,0.999,23319610
35837,HER2,gene,0.988,23319610
35838,estrogen,drug,0.974,23319610
35839,progesterone,drug,0.999,23319610
35840,progesterone receptors,gene,0.9507,23319610
35841,TNBC,disease,0.4792,23319610
35842,TNBC,disease,0.576,23319610
35843,EGF receptor,gene,0.9985,23319610
35844,EGFR,gene,0.9956,23319610
35845,EGFR,gene,0.963,23319610
35846,tumor,disease,1.0,23319610
35847,TNBC,disease,0.691,23319610
35848,cetuximab,gene,0.953,23319610
35849,panitumumab,gene,0.9297,23319610
35850,TNBC,disease,0.6772,23319610
35851,EGFR,gene,0.984,23319610
35852,EGF,gene,0.9976,23319610
35853,EGFR,gene,0.9937,23319610
35854,EGFR,gene,0.992,23319610
35855,TNBC,disease,0.9985,23319610
35856,EGFR,gene,0.994,23319610
35857,EGFR,gene,0.995,23319610
35858,tumor,disease,1.0,23319610
35859,skin,disease,0.9146,23314653
35860,EGFR,gene,0.9355,23314653
35861,epidermal growth factor receptor,gene,0.9727,23314653
35862,EGFR,gene,0.9966,23314653
35863,erlotinib,drug,0.9976,23314653
35864,metastatic lung cancer,disease,1.0,23314653
35865,cetuximab,gene,0.9155,23314653
35866,panitumumab,gene,0.9062,23314653
35867,metastatic colorectal cancer,disease,1.0,23314653
35868,mCRC,disease,1.0,23314653
35869,panitumumab,gene,0.907,23314653
35870,mCRC,disease,0.9897,23314653
35871,panitumumab,gene,0.9155,23314653
35872,skin,disease,0.7056,23314653
35873,patients,species,0.9575,23314653
35874,EGFR,gene,0.604,23314653
35875,panitumumab,gene,0.605,23314653
35876,erlotinib,drug,0.992,23314653
35877,mCRC,disease,0.997,23314653
35878,metastatic lung cancer,disease,1.0,23314653
35879,lymecycline,drug,0.999,23314653
35880,patients,species,0.941,23314653
35881,mCRC,disease,0.998,23314653
35882,metastatic lung cancer,disease,1.0,23314653
35883,erlotinib,drug,0.998,23314653
35884,cetuximab,gene,0.9424,23314653
35885,panitumumab,gene,0.946,23314653
35886,patients,species,0.99,23314653
35887,anti-EGFR,gene,0.9365,23314653
35888,lymecycline,drug,0.9985,23314653
35889,patients,species,0.993,23314653
35890,skin toxicities,disease,0.974,23314653
35891,anti-EGFR,gene,0.9814,23314653
35892,patients,species,0.994,23314653
35893,panitumumab,gene,0.9214,23306920
35894,metastatic colorectal cancer,disease,1.0,23306920
35895,metastatic colorectal cancer,disease,1.0,23306920
35896,panitumumab,gene,0.8765,23306920
35897,panitumumab,gene,0.915,23306920
35898,panitumumab,gene,0.9033,23306920
35899,Skin,disease,0.7876,23306920
35900,magnesium,drug,0.9995,23306920
35901,panitumumab,gene,0.866,23306920
35902,metastatic colorectal cancer,disease,0.999,23306920
35903,colorectal cancer,disease,1.0,23306912
35904,regorafenib,drug,0.996,23306912
35905,aflibercept,gene,0.988,23306912
35906,bevacizumab,gene,0.9443,23306912
35907,cetuximab,gene,0.9556,23306912
35908,panitumumab,gene,0.948,23306912
35909,colorectal cancer,disease,1.0,23306912
35910,regorafenib,drug,0.986,23306912
35911,aflibercept,gene,0.931,23306912
35912,mCRC,disease,0.989,23306912
35913,Regorafenib,drug,0.9976,23306912
35914,oncogenic receptor tyrosine kinase,gene,0.799,23306912
35915,tyrosine,drug,0.9536,23306912
35916,RTK,gene,0.992,23306912
35917,Aflibercept,gene,0.9688,23306912
35918,vascular endothelial growth factor,gene,0.9873,23306912
35919,VEGF,gene,0.975,23306912
35920,human VEGF receptors 1 and 2,gene,0.972,23306912
35921,human IgG1 immunoglobulin,gene,0.9834,23306912
35922,bevacizumab,gene,0.534,23306912
35923,colorectal cancer,disease,1.0,23306912
35924,metastatic colorectal cancer,disease,1.0,23303214
35925,metastatic colorectal cancer,disease,1.0,23303214
35926,mCRC,disease,1.0,23303214
35927,mCRC,disease,0.998,23303214
35928,mCRC,disease,0.9985,23303214
35929,fluoropyrimidine,drug,0.993,23303214
35930,panitumumab,gene,0.9126,23303214
35931,cetuximab,gene,0.8984,23303214
35932,bevacizumab,gene,0.864,23303214
35933,aflibercept,gene,0.972,23303214
35934,anti-EGFR,gene,0.933,23303214
35935,mCRC,disease,0.997,23303214
35936,mCRC,disease,0.987,23303214
35937,gastrointestinal malignancies,disease,1.0,23302905
35938,Gastrointestinal (GI) cancers,disease,1.0,23302905
35939,tumors,disease,0.9995,23302905
35940,GI cancers,disease,1.0,23302905
35941,cancer,disease,1.0,23302905
35942,cancers,disease,1.0,23302905
35943,GI tumors,disease,0.9995,23302905
35944,"esophageal, gastroesophageal, gastric, hepatocellular, pancreatic, and colorectal cancers",disease,1.0,23302905
35945,colorectal cancer,disease,1.0,23302905
35946,solid cancers,disease,1.0,23302905
35947,melanoma,disease,1.0,23302905
35948,prostate cancer,disease,1.0,23302905
35949,GI malignancies,disease,1.0,23302905
35950,GI cancers,disease,1.0,23302905
35951,GI malignancies,disease,1.0,23302905
35952,GI malignancies,disease,1.0,23302905
35953,EGFR,gene,0.994,23300028
35954,non-small cell lung cancer,disease,1.0,23300028
35955,epidermal growth factor receptor,gene,0.9985,23300028
35956,EGFR,gene,0.9883,23300028
35957,non-small cell lung cancer,disease,1.0,23300028
35958,NSCLC,disease,1.0,23300028
35959,Cetuximab,gene,0.8374,23300028
35960,advanced NSCLC,disease,0.9707,23300028
35961,cisplatin,drug,0.9995,23300028
35962,vinorelbine,drug,0.999,23300028
35963,cetuximab,gene,0.825,23300028
35964,EGFR,gene,0.9854,23300028
35965,Cetuximab,gene,0.9497,23300028
35966,carboplatin,drug,0.9995,23300028
35967,paclitaxel,drug,0.9995,23300028
35968,BMS099,drug,0.533,23300028
35969,platinum,drug,0.9995,23300028
35970,cetuximab,gene,0.739,23300028
35971,EGFR,gene,0.9937,23300028
35972,tumor cells,cell_type,0.8677,23300028
35973,tumor,disease,0.996,23300028
35974,cetuximab,gene,0.6094,23300028
35975,KRAS,gene,0.7383,23300028
35976,EGFR,gene,0.994,23300028
35977,Matuzumab,gene,0.9165,23300028
35978,panitumumab,gene,0.8735,23300028
35979,Necitumumab,gene,0.8447,23300028
35980,advanced NSCLC,disease,0.836,23300028
35981,Cetuximab,gene,0.8784,23300028
35982,KRAS,gene,0.822,23299277
35983,primary colorectal cancer,disease,0.9297,23299277
35984,liver metastases,disease,0.8125,23299277
35985,KRAS,DNA,0.7153,23299277
35986,KRAS mutation,gene,0.8804,23299277
35987,anti-epidermal growth factor receptor antibodies,gene,0.9155,23299277
35988,cetuximab,gene,0.6567,23299277
35989,panitumumab,gene,0.6533,23299277
35990,KRAS,gene,0.8457,23299277
35991,colorectal cancer,disease,0.9736,23299277
35992,KRAS,gene,0.8223,23299277
35993,KRAS,gene,0.7163,23299277
35994,formalin,drug,0.998,23299277
35995,primary colorectal cancer,disease,0.8643,23299277
35996,liver metastases,disease,0.9697,23299277
35997,KRAS,gene,0.824,23299277
35998,primary,cell_type,0.4558,23299277
35999,primary tumors,disease,0.969,23299277
36000,KRAS,gene,0.6763,23299277
36001,primary tumors,disease,0.998,23299277
36002,KRAS,gene,0.864,23299277
36003,KRAS,gene,0.8374,23299277
36004,DNA samples,DNA,0.6567,23299277
36005,degraded DNA,DNA,0.588,23299277
36006,KRAS,gene,0.8413,23299277
36007,cutaneous squamous cell carcinoma,disease,1.0,23298904
36008,tumor,disease,0.9897,23298904
36009,cutaneous squamous cell carcinoma,disease,1.0,23298904
36010,cSCC,disease,1.0,23298904
36011,bevacizumab,gene,0.933,23298904
36012,panitumumab,gene,0.9595,23298904
36013,tocilizumab,gene,0.957,23298904
36014,mice,species,0.7935,23298904
36015,tumor cell lines,cell_line,0.939,23298904
36016,tumor,disease,0.9995,23298904
36017,SCC13,cell_line,0.8755,23298904
36018,cutaneous human tumor explants,cell_type,0.6553,23298904
36019,tumor,disease,1.0,23298904
36020,SCC13 xenografts,cell_line,0.8394,23298904
36021,IgG,gene,0.991,23298904
36022,99,drug,0.4548,23298904
36023,tumor,disease,1.0,23298904
36024,tumor,disease,0.961,23298904
36025,panitumumab,gene,0.9766,23298904
36026,cSCC,disease,0.665,23298904
36027,Magnesium,drug,1.0,23278401
36028,anti-epidermal growth factor receptor antibodies,gene,0.925,23278401
36029,cetuximab,gene,0.887,23278401
36030,panitumumab,gene,0.853,23278401
36031,hypomagnesemia,disease,1.0,23278401
36032,magnesium,drug,0.9995,23278401
36033,epidermal growth factor receptor,gene,0.997,23278401
36034,EGFR,gene,0.985,23278401
36035,hypomagnesemia,disease,1.0,23278401
36036,cetuximab,gene,0.8906,23278401
36037,panitumumab,gene,0.887,23278401
36038,magnesium,drug,0.9995,23278401
36039,EGFR,gene,0.9917,23278401
36040,magnesium,drug,0.999,23278401
36041,hypomagnesemia,disease,1.0,23278401
36042,hypomagnesemia,disease,1.0,23278401
36043,hypomagnesemia,disease,1.0,23278401
36044,magnesium,drug,0.9995,23278401
36045,magnesium,drug,0.9995,23278401
36046,EGFR,gene,0.993,23278401
36047,EGFR,gene,0.9917,23276940
36048,head and neck cancers,disease,1.0,23276940
36049,Receptor tyrosine kinases,gene,0.9956,23276940
36050,tyrosine,drug,0.9653,23276940
36051,RTK,gene,0.9907,23276940
36052,cancer,disease,1.0,23276940
36053,ATP,drug,0.9985,23276940
36054,ATP-dependent kinase domains,gene,0.9727,23276940
36055,monoclonal,gene,0.664,23276940
36056,epidermal growth factor receptor,gene,0.999,23276940
36057,EGFR,gene,0.9927,23276940
36058,SCCHN,disease,1.0,23276940
36059,EGFR,gene,0.9946,23276940
36060,SCCHN,disease,1.0,23276940
36061,RTKs,gene,0.9707,23276940
36062,HER,DNA,0.544,23276932
36063,HER family,gene,0.9927,23276932
36064,colorectal cancer,disease,1.0,23276932
36065,Colorectal cancer,disease,1.0,23276932
36066,cancer,disease,1.0,23276932
36067,anti-epidermal growth factor receptor,gene,0.945,23276932
36068,EGFR,gene,0.945,23276932
36069,cetuximab,gene,0.8647,23276932
36070,panitumumab,gene,0.8804,23276932
36071,anti-vascular endothelial growth factor,gene,0.989,23276932
36072,VEGF,gene,0.991,23276932
36073,mAb,gene,0.724,23276932
36074,bevacizumab,gene,0.735,23276932
36075,metastatic colorectal cancer,disease,0.999,23276932
36076,HER,gene,0.9795,23276932
36077,erbB,gene,0.9517,23276932
36078,HER,gene,0.9897,23276932
36079,colorectal cancer,disease,1.0,23276932
36080,HER receptors,gene,0.9937,23276932
36081,HER,gene,0.9272,23276932
36082,HER,gene,0.981,23276932
36083,metastatic colon cancer,disease,0.9985,23272659
36084,metastatic colorectal cancer,disease,0.998,23272659
36085,metastatic colon cancer,disease,1.0,23272659
36086,mCC,disease,1.0,23272659
36087,Cancer,disease,0.9917,23272659
36088,bevacizumab,gene,0.854,23272659
36089,capecitabine,drug,0.9985,23272659
36090,fluoropyridimidine,drug,0.9995,23272659
36091,panitumumab,gene,0.944,23272659
36092,cetuximab,gene,0.8677,23272659
36093,epidermal growth factor receptor antibody,gene,0.9946,23272659
36094,colon cancer,disease,1.0,23272659
36095,mCC,disease,0.9824,23272659
36096,capecitabine,drug,0.9985,23272659
36097,panitumumab,gene,0.651,23272659
36098,cetuximab,gene,0.7397,23272659
36099,Bevacizumab,gene,0.8823,23272659
36100,mCC,disease,1.0,23272659
36101,sigmoid colon cancer,disease,1.0,23268050
36102,sigmoid colon cancer,disease,1.0,23268050
36103,sigmoid colon cancer,disease,1.0,23268050
36104,pulmonary metastases,disease,0.7656,23268050
36105,renal dysfunction,disease,1.0,23268050
36106,nephrectomy,disease,0.8193,23268050
36107,irinotecan,drug,0.9995,23268050
36108,CPT-11,drug,0.999,23268050
36109,capecitabine,drug,0.999,23268050
36110,oxaliplatin,drug,0.9995,23268050
36111,CapeOx,drug,0.992,23268050
36112,CPT-11,drug,0.998,23268050
36113,panitumumab,gene,0.71,23268050
36114,advanced colon cancer,disease,1.0,23268027
36115,type 2 tumor in the cecum,disease,0.9946,23268027
36116,adenocarcinoma,disease,1.0,23268027
36117,tumor,disease,0.935,23268027
36118,primary cancer,disease,0.907,23268027
36119,KRAS,gene,0.9663,23264846
36120,"codons 12, 13, and 61",DNA,0.7373,23264846
36121,KRAS proto-oncogene,gene,0.993,23264846
36122,colorectal,disease,0.997,23264846
36123,non-small cell lung,disease,0.965,23264846
36124,thyroid cancers,disease,0.999,23264846
36125,KRAS,DNA,0.7236,23264846
36126,KRAS mutations,gene,0.7734,23264846
36127,epidermal growth factor receptor,gene,0.976,23264846
36128,EGFR,gene,0.9956,23264846
36129,panitumumab,gene,0.7993,23264846
36130,cetuximab,gene,0.4812,23264846
36131,metastatic colorectal carcinoma,disease,0.9976,23264846
36132,EGFR,gene,0.9956,23264846
36133,tyrosine,drug,0.991,23264846
36134,non-small cell lung cancers,disease,0.994,23264846
36135,EGFR,gene,0.784,23264846
36136,KRAS,DNA,0.886,23264846
36137,KRAS mutation,gene,0.927,23264846
36138,EGFR,gene,0.996,23264846
36139,malignancies,disease,1.0,23264846
36140,KRAS,DNA,0.694,23264846
36141,KRAS mutation,gene,0.915,23264846
36142,patient,species,0.994,23264846
36143,KRAS,DNA,0.7783,23264846
36144,KRAS mutation,gene,0.9365,23264846
36145,KRAS,gene,0.972,23264846
36146,patient,species,0.9873,23264846
36147,EGFR,gene,0.701,23259389
36148,colorectal cancer,disease,1.0,23259389
36149,epidermal growth factor receptor,gene,0.9985,23259389
36150,EGFR,gene,0.995,23259389
36151,RAS,gene,0.996,23259389
36152,RAF,gene,0.999,23259389
36153,MAPK,gene,0.9946,23259389
36154,PI3K,gene,0.9917,23259389
36155,AKT,gene,0.996,23259389
36156,EGFR,gene,0.993,23259389
36157,cetuximab,gene,0.891,23259389
36158,panitumumab,gene,0.852,23259389
36159,metastatic colorectal cancers,disease,0.8945,23259389
36160,EGFR,gene,0.995,23259389
36161,KRAS gene,DNA,0.7925,23259389
36162,KRAS gene mutation,gene,0.8496,23259389
36163,anti-,gene,0.792,23259389
36164,EGFR antibody,gene,0.787,23259389
36165,anti-,gene,0.838,23259389
36166,EGFR antibody,gene,0.7417,23259389
36167,colorectal cancers,disease,1.0,23259389
36168,patients,species,0.9873,23259389
36169,EGFR,gene,0.996,23259389
36170,head and neck cancer,disease,1.0,23235168
36171,anti-,gene,0.878,23235168
36172,epidermal growth factor receptor monoclonal,gene,0.884,23235168
36173,Cetuximab,gene,0.72,23235168
36174,anti-epidermal growth factor receptor,gene,0.9585,23235168
36175,EGFR,gene,0.9653,23235168
36176,advanced squamous cell carcinoma of the head and neck,disease,0.98,23235168
36177,LA-SCCHN,disease,0.9995,23235168
36178,platinum,drug,0.999,23235168
36179,recurrent/metastatic SCCHN,disease,0.963,23235168
36180,R/M-SCCHN,disease,0.8975,23235168
36181,panitumumab,gene,0.9043,23235168
36182,nimotuzumab,gene,0.7637,23235168
36183,SCCHN,disease,1.0,23235168
36184,Anti-EGFR monoclonal antibodies,gene,0.886,23235168
36185,EGFR,gene,0.9673,23235168
36186,anti-EGFR monoclonal antibodies,gene,0.9653,23235168
36187,metastatic colon cancer,disease,0.9897,23232984
36188,Colorectal cancer,disease,1.0,23232984
36189,CRC,disease,1.0,23232984
36190,cancer,disease,1.0,23232984
36191,cancer,disease,0.9995,23232984
36192,CRC,disease,0.9966,23232984
36193,oxaliplatin,drug,0.9995,23232984
36194,irinotecan,drug,0.9995,23232984
36195,bevacizumab,gene,0.8955,23232984
36196,cetuximab,gene,0.9165,23232984
36197,panitumumab,gene,0.93,23232984
36198,metastatic CRC,disease,0.998,23232984
36199,vesicular stomatitis,disease,0.998,23232984
36200,vesicular stomatitis virus,species,0.7896,23232984
36201,VSV,species,0.856,23232984
36202,cancer,disease,1.0,23232984
36203,CRC,disease,0.999,23232984
36204,rats,species,0.978,23232984
36205,multifocal liver metastases,disease,0.916,23232984
36206,multiple lung metastases,disease,0.8438,23232984
36207,CRC cell line,cell_line,0.905,23232984
36208,CRC,disease,1.0,23232984
36209,RCN-H4,cell_line,0.9424,23232984
36210,rats,species,0.938,23232984
36211,L289A,mutation,,23232984
36212,Newcastle disease,disease,0.883,23232984
36213,Newcastle disease virus fusion protein,gene,0.9663,23232984
36214,Newcastle,species,0.79,23232984
36215,NDV,species,0.613,23232984
36216,L289A,mutation,,23232984
36217,liver metastases,disease,0.9985,23232984
36218,lung metastases,disease,0.9976,23232984
36219,liver,disease,0.8096,23232984
36220,NDV,species,0.4517,23232984
36221,L289A,cell_line,,23232984
36222,L289A,mutation,,23232984
36223,rats,species,0.987,23232984
36224,L289A,mutation,,23232984
36225,rats,species,0.99,23232984
36226,rats,species,0.9937,23232984
36227,Liver tumors,disease,1.0,23232984
36228,NDV/F,gene,0.6562,23232984
36229,NDV,species,0.862,23232984
36230,L289A),cell_line,0.429,23232984
36231,L289A,mutation,,23232984
36232,rats,species,0.9863,23232984
36233,rats,species,0.9775,23232984
36234,CRC liver and lung metastases,disease,0.94,23232984
36235,epidermal growth factor receptor epitopes,gene,0.957,23226096
36236,panitumumab,gene,0.9307,23226096
36237,cetuximab,gene,0.913,23226096
36238,Cetuximab,gene,0.711,23226096
36239,panitumumab,gene,0.683,23226096
36240,epidermal growth factor receptor,gene,0.9927,23226096
36241,EGFR,gene,0.9917,23226096
36242,metastatic colorectal cancer,disease,0.999,23226096
36243,extracellular EGFR domain,gene,0.9155,23226096
36244,EGFR targeting antibodies,gene,0.7344,23226096
36245,panitumumab,gene,0.887,23226096
36246,epitope-mimicking consensus motifs,DNA,0.728,23226096
36247,panitumumab,gene,0.844,23226096
36248,EGFR,gene,0.9736,23226096
36249,epitope,DNA,0.512,23226096
36250,WPEXRT,DNA,0.4058,23226096
36251,panitumumab,gene,0.8345,23226096
36252,panitumumab epitope,gene,0.8906,23226096
36253,cetuximab epitope,gene,0.9316,23226096
36254,amino acid,drug,0.9985,23226096
36255,cetuximab,gene,0.9404,23226096
36256,panitumumab,gene,0.808,23226096
36257,R390,DNA,0.4644,23226096
36258,EGFR,gene,0.9946,23226096
36259,liver metastases,disease,0.998,23207946
36260,colorectal cancer,disease,1.0,23207946
36261,patients,species,0.981,23207946
36262,patients,species,0.98,23207946
36263,liver metastases,disease,0.9863,23207946
36264,liver metastases,disease,0.991,23207946
36265,patients,species,0.9873,23207946
36266,liver metastases,disease,0.997,23207946
36267,Panitumumab,gene,0.9062,23212286
36268,metastatic colorectal cancer,disease,1.0,23212286
36269,Panitumumab,gene,0.874,23211422
36270,doxorubicin,drug,0.951,23211422
36271,platinum-resistant epithelial ovarian cancer,disease,0.96,23211422
36272,platinum,drug,0.4375,23211422
36273,KRAS,DNA,0.7773,23211422
36274,KRAS wild,gene,0.781,23211422
36275,ovarian cancer,disease,1.0,23211422
36276,platinum,drug,1.0,23211422
36277,KRAS,gene,0.6265,23211422
36278,ovarian cancer,disease,1.0,23211422
36279,doxorubicin,drug,0.999,23211422
36280,panitumumab,gene,0.8584,23211422
36281,PATIENTS,species,0.966,23211422
36282,relapsed,disease,0.769,23211422
36283,ovarian/fallopian/peritoneal cancer,disease,0.992,23211422
36284,platinum,drug,1.0,23211422
36285,CA125,gene,0.9683,23211422
36286,KRAS,gene,0.8174,23211422
36287,panitumumab,gene,0.84,23211422
36288,PLD,drug,0.719,23211422
36289,skin toxicity,disease,0.93,23211422
36290,fatigue,disease,0.997,23211422
36291,vomiting,disease,0.9946,23211422
36292,PLD,gene,0.9536,23211422
36293,panitumumab,gene,0.885,23211422
36294,platinum,drug,0.9995,23211422
36295,patients,species,0.9844,23201298
36296,metastatic colorectal cancer,disease,0.8867,23201298
36297,alkaline phosphatase,gene,0.995,23201298
36298,white blood cells,cell_type,0.897,23201298
36299,patients,species,0.9785,23201298
36300,metastatic,disease,0.7646,23201298
36301,colorectal cancer,disease,0.9673,23201298
36302,patients,species,0.988,23201298
36303,patient,species,0.9956,23201298
36304,patients,species,0.986,23201298
36305,white blood cells,cell_type,0.887,23201298
36306,white blood cells,cell_type,0.9297,23201298
36307,Mutant KRAS codon 12 and 13 alleles,DNA,0.772,23182985
36308,Mutant KRAS codon 12 and 13,gene,0.859,23182985
36309,patients,species,0.9673,23182985
36310,metastatic colorectal cancer,disease,1.0,23182985
36311,Panitumumab,gene,0.7817,23182985
36312,human,species,0.655,23182985
36313,epidermal growth factor receptor,gene,0.9976,23182985
36314,EGFR,gene,0.988,23182985
36315,patients,species,0.9062,23182985
36316,wild-type KRAS,gene,0.8257,23182985
36317,metastatic colorectal cancer,disease,1.0,23182985
36318,mCRC,disease,1.0,23182985
36319,KRAS codons 12 and 13,DNA,0.8228,23182985
36320,KRAS codons,gene,0.755,23182985
36321,anti-EGFR antibody,gene,0.836,23182985
36322,mutant KRAS codon 12 and 13 alleles,gene,0.9487,23182985
36323,PATIENTS,species,0.9233,23182985
36324,Patients,species,0.974,23182985
36325,FOLFOX4,drug,0.737,23182985
36326,fluorouracil,drug,0.9995,23182985
36327,leucovorin,drug,0.9985,23182985
36328,oxaliplatin,drug,0.9995,23182985
36329,FOLFIRI,drug,0.853,23182985
36330,fluorouracil,drug,0.9995,23182985
36331,leucovorin,drug,0.9805,23182985
36332,irinotecan,drug,0.998,23182985
36333,panitumumab,gene,0.858,23182985
36334,patients,species,0.9707,23182985
36335,mutant KRAS codon 12 or 13 alleles,DNA,0.8003,23182985
36336,mutant KRAS codon 12,gene,0.985,23182985
36337,mutant KRAS allele,gene,0.8555,23182985
36338,patients,species,0.9854,23182985
36339,mutant KRAS allele,DNA,0.759,23182985
36340,mutant KRAS allele,gene,0.8906,23182985
36341,patients,species,0.9746,23182985
36342,panitumumab,gene,0.822,23182985
36343,mutant KRAS alleles,gene,0.984,23182985
36344,G13D,DNA,0.5254,23182985
36345,G13,mutation,,23182985
36346,G12V,DNA,0.533,23182985
36347,G12,mutation,,23182985
36348,panitumumab,gene,0.8623,23182985
36349,G12A,DNA,0.7065,23182985
36350,G12,mutation,,23182985
36351,patients,species,0.955,23182985
36352,mutant KRAS codon 12 or 13,gene,0.9644,23182985
36353,mCRC tumors,disease,1.0,23182985
36354,panitumumab,gene,0.8027,23182985
36355,panitumumab,gene,0.917,23182985
36356,patients,species,0.923,23182985
36357,wild,gene,0.6577,23182985
36358,mCRC,disease,0.997,23182985
36359,(111)In,drug,0.999,23166960
36360,anti-epidermal growth factor receptor human monoclonal antibody,gene,0.937,23166960
36361,human,species,0.954,23166960
36362,epidermal growth factor receptor,gene,0.9976,23166960
36363,EGFR,gene,0.991,23166960
36364,ErbB oncogene family,gene,0.995,23166960
36365,EGFR,gene,0.997,23166960
36366,EGFR1,gene,0.9893,23166960
36367,EGFR2,gene,0.993,23166960
36368,EGFR3,gene,0.9907,23166960
36369,EGFR4,gene,0.9897,23166960
36370,tyrosine,drug,0.8965,23166960
36371,tyrosine kinase,gene,0.9844,23166960
36372,EGFR receptors,gene,0.994,23166960
36373,cancers,disease,1.0,23166960
36374,humans,species,0.993,23166960
36375,EGFR1,gene,0.9873,23166960
36376,colorectal and head and neck cancers,disease,1.0,23166960
36377,cetuximab,gene,0.6562,23166960
36378,human,species,0.9536,23166960
36379,mouse,species,0.9844,23166960
36380,panitumumab,gene,0.6113,23166960
36381,human,species,0.9756,23166960
36382,neoplasms,disease,1.0,23166960
36383,cancers,disease,1.0,23166960
36384,mutant KRAS oncogene,gene,0.9907,23166960
36385,EGFR,gene,0.994,23166960
36386,human,species,0.99,23166960
36387,tumors,disease,1.0,23166960
36388,KRAS,DNA,0.7437,23166960
36389,KRAS mutation,gene,0.9673,23166960
36390,cetuximab,gene,0.7275,23166960
36391,EGFR,gene,0.9893,23166960
36392,cancerous,disease,0.9917,23166960
36393,patient,species,0.995,23166960
36394,patients,species,0.992,23166960
36395,anti-EGFR,gene,0.9,23166960
36396,human mAb clones,cell_line,0.891,23166960
36397,human,species,0.9707,23166960
36398,EGFR,gene,0.994,23166960
36399,phage-display mAb library,DNA,0.878,23166960
36400,mAb,gene,0.5923,23166960
36401,048,DNA,0.698,23166960
36402,tumor,disease,0.829,23166960
36403,A431 cell xenograft,cell_line,0.791,23166960
36404,A431,cell_type,0.467,23166960
36405,xenograft tumors,disease,0.743,23166960
36406,mice,species,0.939,23166960
36407,cetuximab,gene,0.9517,23166960
36408,patients,species,0.99,23166960
36409,cetuximab,gene,0.9287,23166960
36410,panitumumab,gene,0.928,23166960
36411,048-006,drug,0.997,23166960
36412,human cell lines,cell_line,0.9707,23166960
36413,human,species,0.92,23166960
36414,(111)In,drug,0.9985,23166960
36415,048-006,drug,0.9976,23166960
36416,nude mice,species,0.692,23166960
36417,xenograft tumors,disease,0.9805,23166960
36418,EGFR,gene,0.9844,23166960
36419,Epistaxis,disease,0.998,23155268
36420,panitumumab,gene,0.927,23155268
36421,patient,species,0.9155,23155268
36422,colon cancer,disease,1.0,23155268
36423,Epidermal growth factor receptor,gene,0.9985,23155268
36424,EGFRIs,gene,0.973,23155268
36425,solid malignancy,disease,1.0,23155268
36426,colorectal cancer,disease,1.0,23155268
36427,growth factor receptor,gene,0.963,23155268
36428,Epistaxis,disease,0.9995,23155268
36429,Vascular,disease,0.5806,23155268
36430,Vascular Endothelial Growth Factor,gene,0.9966,23155268
36431,EGFRIs,gene,0.981,23155268
36432,patient,species,0.96,23155268
36433,man,species,0.9136,23155268
36434,metastatic colon cancer,disease,1.0,23155268
36435,epistaxis,disease,0.996,23155268
36436,panitumumab,gene,0.937,23155268
36437,EGFRIs,gene,0.942,23155268
36438,epistaxis,disease,1.0,23155268
36439,mucosal bleeding,disease,0.9976,23155268
36440,epidermal growth factor receptor,gene,0.997,23151647
36441,Epidermal growth factor receptor,gene,0.9976,23151647
36442,EGFR,gene,0.998,23151647
36443,solid tumors,disease,1.0,23151647
36444,"non-small cell lung, colorectal, head and neck, breast, and pancreatic cancers",disease,1.0,23151647
36445,EGFR,gene,0.9927,23151647
36446,patients,species,0.984,23151647
36447,patients,species,0.991,23151647
36448,EGFR,gene,0.9854,23151647
36449,EGFR,gene,0.9927,23151647
36450,EGFR,gene,0.991,23151647
36451,EGFR,gene,0.9883,23151647
36452,patients,species,0.988,23151647
36453,erlotinib,drug,0.994,23151647
36454,patients,species,0.991,23151647
36455,EGFR,gene,0.9907,23151647
36456,dysfunctional tear syndrome,disease,1.0,23151647
36457,DTS,disease,1.0,23151647
36458,blepharitis,disease,1.0,23151647
36459,eyelash changes,disease,0.8735,23151647
36460,trichomegaly,disease,1.0,23151647
36461,trichiasis,disease,1.0,23151647
36462,patients,species,0.985,23151647
36463,epithelial defects,disease,1.0,23151647
36464,corneal abrasions,disease,1.0,23151647
36465,EGFR,gene,0.9956,23151647
36466,patients,species,0.9907,23151647
36467,DTS,disease,1.0,23151647
36468,patients,species,0.992,23151647
36469,EGFR,gene,0.987,23151647
36470,patients,species,0.983,23151647
36471,eye toxicities,disease,0.95,23151647
36472,patients,species,0.9805,23151647
36473,EGFR,gene,0.9844,23151647
36474,metastatic colorectal cancer,disease,1.0,23149819
36475,mCRC,disease,1.0,23149819
36476,VEGF-,gene,0.5728,23149819
36477,anti-EGF receptor,gene,0.9976,23149819
36478,EGFR,gene,0.9976,23149819
36479,mCRC,disease,0.871,23149819
36480,patients,species,0.978,23149819
36481,bevacizumab,gene,0.905,23149819
36482,patients,species,0.9824,23149819
36483,patients,species,0.9927,23149819
36484,cetuximab,gene,0.941,23149819
36485,panitumumab,gene,0.7783,23149819
36486,anti-VEGF,gene,0.9165,23149819
36487,EGFR,gene,0.738,23149819
36488,panitumumab,gene,0.839,23139259
36489,patients,species,0.9663,23139259
36490,EGFR,gene,0.994,23139259
36491,panitumumab,gene,0.618,23139259
36492,capecitabine,drug,0.998,23139259
36493,KRAS,gene,0.9907,23139259
36494,locally advanced rectal cancer,disease,1.0,23139259
36495,LARC,disease,1.0,23139259
36496,PATIENTS,species,0.935,23139259
36497,Patients,species,0.959,23139259
36498,wild,DNA,0.724,23139259
36499,LARC,disease,0.998,23139259
36500,patients,species,0.9766,23139259
36501,patients,species,0.9863,23139259
36502,patients,species,0.9746,23139259
36503,patients,species,0.9824,23139259
36504,pNCR,DNA,0.6895,23139259
36505,patients,species,0.979,23139259
36506,DC 3 cells,cell_line,0.9644,23139259
36507,diarrhea,disease,1.0,23139259
36508,anastomotic leakage,disease,0.996,23139259
36509,panitumumab,gene,0.937,23139259
36510,patients,species,0.9355,23139259
36511,KRAS,gene,0.9946,23139259
36512,LARC,disease,0.999,23139259
36513,panitumumab,gene,0.9067,23139259
36514,EGFR,gene,0.996,23099994
36515,KRAS,DNA,0.635,23099994
36516,KRAS mutation,gene,0.909,23099994
36517,anti-EGFR antibodies,gene,0.967,23099994
36518,metastatic colorectal cancer,disease,1.0,23099994
36519,mCRC,disease,1.0,23099994
36520,mCRC,disease,1.0,23099994
36521,patients,species,0.987,23099994
36522,KRAS,gene,0.996,23099994
36523,Anti-EGFR antibodies,gene,0.902,23099994
36524,EGFR,gene,0.998,23099994
36525,mCRC,disease,0.9995,23099994
36526,EGFR,gene,0.996,23099994
36527,mCRC,disease,0.9834,23099994
36528,anti-EGFR antibodies,gene,0.83,23099994
36529,anti-EGFR antibodies,gene,0.985,23099994
36530,EGFR,gene,0.9805,23099994
36531,mCRC,disease,0.999,23099994
36532,patients,species,0.992,23099994
36533,cetuximab,gene,0.8066,23099994
36534,panitumumab,gene,0.8447,23099994
36535,mCRC,disease,0.9995,23099994
36536,patients,species,0.993,23099994
36537,wild,gene,0.5625,23099994
36538,KRAS,DNA,0.7876,23099994
36539,EGFR ligands,gene,0.9326,23099994
36540,amphiregulin,gene,0.994,23099994
36541,AR,gene,0.9995,23099994
36542,heparin-binding epidermal growth factor,gene,0.997,23099994
36543,HB-EGF,gene,0.998,23099994
36544,transforming growth factor-,gene,0.993,23099994
36545,TGF,gene,0.986,23099994
36546,epiregulin,gene,0.988,23099994
36547,EREG,gene,0.996,23099994
36548,patients,species,0.99,23099994
36549,AR,gene,0.999,23099994
36550,HB-EGF,gene,0.9985,23099994
36551,TGF-,gene,0.99,23099994
36552,EREG,gene,0.9946,23099994
36553,patients,species,0.994,23099994
36554,EGFR ligands,gene,0.9478,23099994
36555,AR,gene,0.9985,23099994
36556,HB-EGF,gene,0.9985,23099994
36557,TGF-,gene,0.9907,23099994
36558,EREG,gene,0.993,23099994
36559,patient,species,0.8906,23099994
36560,cetuximab,gene,0.909,23099994
36561,panitumumab,gene,0.8833,23099994
36562,patients,species,0.9287,23099994
36563,mCRC,disease,0.993,23099994
36564,EGF receptor monoclonal antibodies,gene,0.9033,23098115
36565,tyrosine,drug,0.87,23098115
36566,tyrosine kinase,gene,0.933,23098115
36567,HNSCC,disease,1.0,23098115
36568,anti-EGF receptor,gene,0.923,23098115
36569,EGFR,gene,0.9927,23098115
36570,cetuximab,gene,0.717,23098115
36571,patients,species,0.9653,23098115
36572,EGFR,gene,0.9873,23098115
36573,panitumumab,gene,0.78,23098115
36574,ErbB family,gene,0.893,23098115
36575,tyrosine,drug,0.8193,23098115
36576,tyrosine kinase,gene,0.7334,23098115
36577,lapatinib,drug,0.9995,23098115
36578,afatinib,drug,0.996,23098115
36579,dacomitinib,drug,0.998,23098115
36580,EGFR,gene,0.8984,23098115
36581,HNSCC,disease,0.999,23098115
36582,anti-EGFR monoclonal antibodies,gene,0.947,23098115
36583,tyrosine,drug,0.9697,23098115
36584,tyrosine kinase,gene,0.8013,23098115
36585,HNSCC,disease,0.999,23098115
36586,human papillomavirus,disease,0.9873,23098115
36587,epidermal growth factor receptor,gene,0.9985,23097702
36588,Colorectal cancer,disease,1.0,23097702
36589,malignancy,disease,1.0,23097702
36590,men,species,0.9326,23097702
36591,women,species,0.9644,23097702
36592,5-FU,drug,0.999,23097702
36593,irinotecan,drug,0.999,23097702
36594,oxaliplatin,drug,0.9995,23097702
36595,cetuximab,gene,0.8135,23097702
36596,panitumumab,gene,0.874,23097702
36597,epidermal growth factor receptor,gene,0.997,23097702
36598,EGFR,gene,0.994,23097702
36599,vascular epithelial growth factor,gene,0.998,23097702
36600,VEGF,gene,0.9946,23097702
36601,patients,species,0.9653,23097702
36602,metastatic colorectal cancer,disease,0.999,23097702
36603,cancer,disease,1.0,23097702
36604,metastatic colorectal cancer,disease,0.955,23097702
36605,EGFR,gene,0.9893,23097702
36606,bevacizumab,gene,0.943,23073991
36607,Metastatic colorectal cancer,disease,1.0,23073991
36608,cancer,disease,1.0,23073991
36609,capecitabine,drug,0.9995,23073991
36610,irinotecan,drug,0.9995,23073991
36611,oxaliplatin,drug,0.9995,23073991
36612,bevacizumab,gene,0.8354,23073991
36613,cetuximab,gene,0.8716,23073991
36614,panitumumab,gene,0.9395,23073991
36615,aflibercept,gene,0.9497,23073991
36616,reforafenib,drug,0.9946,23073991
36617,patients,species,0.9785,23073991
36618,patients,species,0.9927,23073991
36619,patients,species,0.995,23073991
36620,bevacizumab,gene,0.751,23073991
36621,hepatic metastases,disease,0.967,23064076
36622,ascending colon cancer,disease,1.0,23064076
36623,panitumumab,gene,0.838,23064076
36624,FOLFIRI,drug,0.5903,23064076
36625,5-FU,drug,0.9966,23064076
36626,irinotecan,drug,0.9956,23064076
36627,ascending colon cancer,disease,1.0,23064076
36628,liver metastases,disease,0.683,23064076
36629,k-ras,gene,0.818,23064076
36630,cancer tissue,cell_type,0.532,23064076
36631,cancer,disease,0.541,23064076
36632,panitumumab,gene,0.9185,23064076
36633,5-FU,drug,0.998,23064076
36634,irinotecan,drug,0.9976,23064076
36635,ascending colon cancer,disease,1.0,23064076
36636,metastatic liver tumors,disease,1.0,23064076
36637,panitumumab,gene,0.8726,23064076
36638,FOLFIRI,drug,0.9463,23064076
36639,liver metastases,disease,0.947,23064076
36640,colon cancer,disease,1.0,23064076
36641,metastatic colorectal cancer,disease,1.0,23064074
36642,wild,DNA,0.565,23064074
36643,wild-type K-RAS,gene,0.92,23064074
36644,panitumumab,gene,0.803,23064074
36645,liver metastases,disease,0.9985,23064074
36646,advanced rectal cancer,disease,1.0,23064074
36647,sigmoid cancer,disease,1.0,23064074
36648,FOLFOX,drug,0.9727,23064074
36649,bevacizumab,gene,0.541,23064074
36650,FOLFIRI,drug,0.9795,23064074
36651,liver metastases,disease,0.9897,23064074
36652,K-RAS genes,gene,0.87,23064074
36653,sigmoid colon cancer,disease,1.0,23064074
36654,wild-type K,DNA,0.546,23064074
36655,wild-type K-RAS,gene,0.9985,23064074
36656,panitumumab,gene,0.8867,23064074
36657,liver metastases,disease,0.8843,23064074
36658,liver metastases,disease,0.9985,23064074
36659,advanced rectal cancer,disease,1.0,23064074
36660,XELOX,drug,0.9585,23064074
36661,IRIS,drug,0.977,23064074
36662,panitumumab,gene,0.9424,23064074
36663,liver metastases,disease,0.8413,23064074
36664,panitumumab,gene,0.906,23064074
36665,colorectal cancer,disease,0.9995,23064074
36666,metastatic colorectal cancer,disease,0.9995,23063374
36667,colorectal cancer,disease,1.0,23063374
36668,cancer,disease,1.0,23063374
36669,epidermal growth factor receptor,gene,0.9976,23063374
36670,cetuximab,gene,0.747,23063374
36671,panitumumab,gene,0.829,23063374
36672,metastatic colorectal cancer,disease,0.9814,23063374
36673,mCRC,disease,0.998,23063374
36674,panitumumab,gene,0.9272,23063374
36675,cetuximab,gene,0.893,23063374
36676,factor receptor,gene,0.5547,23063374
36677,mCRC,disease,0.4685,23063374
36678,wild,DNA,0.486,23063374
36679,wild-type,gene,0.8047,23063374
36680,Kirsten rat sarcoma viral oncogene homolog,gene,0.8267,23063374
36681,panitumumab,gene,0.921,23063374
36682,cetuximab,gene,0.856,23063374
36683,panitumumab,gene,0.877,23063374
36684,panitumumab,gene,0.8677,23063374
36685,cetuximab,gene,0.927,23063374
36686,mCRC,disease,0.9863,23063374
36687,Kirsten rat sarcoma viral oncogene homolog,gene,0.843,23063374
36688,Panitumumab,gene,0.9155,23041588
36689,irinotecan,drug,0.997,23041588
36690,KRAS,gene,0.7534,23041588
36691,panitumumab,gene,0.919,23041588
36692,irinotecan,drug,0.991,23041588
36693,KRAS,gene,0.6323,23041588
36694,oxaliplatin,drug,0.9995,23041588
36695,fluoropyrimidines,drug,1.0,23041588
36696,irinotecan,drug,0.998,23041588
36697,PATIENTS,species,0.975,23041588
36698,KRAS,gene,0.83,23041588
36699,KRAS,gene,0.8403,23041588
36700,rare KRAS,DNA,0.577,23041588
36701,KRAS,gene,0.768,23041588
36702,NRAS,gene,0.7754,23041588
36703,BRAF,gene,0.7266,23041588
36704,EGFR,gene,0.991,23041588
36705,panitumumab,gene,0.9146,23041588
36706,irinotecan,drug,0.9956,23041588
36707,diarrhea,disease,1.0,23041588
36708,neutropenia,disease,1.0,23041588
36709,KRAS,gene,0.726,23041588
36710,codon 12 or 13,DNA,0.5625,23041588
36711,NRAS,gene,0.702,23041588
36712,BRAF,gene,0.782,23041588
36713,KRAS,DNA,0.7236,23041588
36714,KRAS mutation,gene,0.7646,23041588
36715,tumor,disease,0.973,23041588
36716,Panitumumab,gene,0.9097,23041588
36717,irinotecan,drug,0.9976,23041588
36718,metastatic colorectal carcinoma,disease,1.0,23041354
36719,cetuximab,gene,0.925,23041354
36720,panitumumab,gene,0.905,23041354
36721,cetuximab,gene,0.9277,23041354
36722,panitumumab,gene,0.9033,23041354
36723,colorectal carcinoma,disease,1.0,23041354
36724,metastatic colorectal carcinoma,disease,0.9995,23041354
36725,panitumumab,gene,0.8755,23041354
36726,cetuximab,gene,0.8027,23041354
36727,epidermal growth factor receptor,gene,0.998,23041354
36728,PATIENTS,species,0.914,23041354
36729,metastatic colorectal carcinoma,disease,0.9985,23041354
36730,cetuximab,gene,0.863,23041354
36731,panitumumab,gene,0.793,23041354
36732,Solid Tumors,disease,0.724,23041354
36733,tumor,disease,1.0,23041354
36734,metastatic colorectal carcinoma,disease,1.0,23041354
36735,cetuximab,gene,0.8105,23041354
36736,panitumumab,gene,0.85,23041354
36737,head and neck cancers,disease,1.0,23036118
36738,Head and neck cancers,disease,1.0,23036118
36739,HNC,disease,1.0,23036118
36740,malignancies,disease,1.0,23036118
36741,tumors,disease,1.0,23036118
36742,epithelial tumors,disease,1.0,23036118
36743,squamous cell carcinomas,disease,1.0,23036118
36744,head and neck squamous cell carcinomas,disease,1.0,23036118
36745,HNSCC,disease,1.0,23036118
36746,HNC,disease,1.0,23036118
36747,cancer,disease,0.999,23036118
36748,EGFR,gene,0.9863,23036118
36749,HNSCC,disease,0.4927,23036118
36750,Cetuximab,gene,0.9346,23036118
36751,HNSCC,disease,0.999,23036118
36752,panitumumab,gene,0.9067,23036118
36753,sorafenib,drug,0.9995,23036118
36754,VEGFR,gene,0.9946,23036118
36755,PDGFR,gene,0.995,23036118
36756,c-Kit,gene,0.994,23036118
36757,afatinib,drug,0.995,23036118
36758,pan-HER,gene,0.9937,23036118
36759,tyrosine,drug,0.9644,23036118
36760,tyrosine kinase,gene,0.9224,23036118
36761,STAT3,gene,0.9966,23036118
36762,EGFRvIII,gene,0.563,23036118
36763,K-ras,gene,0.9756,23036118
36764,H-ras,gene,0.9976,23036118
36765,PTEN,gene,0.9927,23036118
36766,patients,species,0.927,23020584
36767,metastatic colorectal cancer,disease,1.0,23020584
36768,epidermal growth factor receptor,gene,0.997,23020584
36769,EGFR,gene,0.9976,23020584
36770,Panitumumab,gene,0.672,23020584
36771,human,species,0.855,23020584
36772,EGFR,gene,0.994,23020584
36773,patients,species,0.964,23020584
36774,metastatic colorectal cancer,disease,1.0,23020584
36775,KRAS,gene,0.662,23020584
36776,panitumumab,gene,0.9497,23020584
36777,FOLFIRI,drug,0.6157,23020584
36778,patients,species,0.906,23020584
36779,metastatic colorectal cancer,disease,0.9995,23020584
36780,Cancer,disease,0.897,23020584
36781,skin,disease,0.8374,23020584
36782,patients,species,0.97,23020584
36783,WT KRAS,gene,0.9917,23020584
36784,mutant KRAS,DNA,0.5005,23020584
36785,mutant KRAS,gene,0.9854,23020584
36786,rash,disease,1.0,23020584
36787,dry skin,disease,0.9995,23020584
36788,acne,disease,1.0,23020584
36789,patients,species,0.985,23020584
36790,EQ-5D,DNA,0.5767,23020584
36791,QLQ,DNA,0.4902,23020584
36792,skin,disease,0.8438,23020584
36793,panitumumab,gene,0.9736,23020584
36794,FOLFIRI,drug,0.953,23020584
36795,colon cancer,disease,1.0,23017669
36796,"oesophageal, gastric, and rectal cancers",disease,1.0,23017669
36797,tumour cell,cell_type,0.576,23017669
36798,tumour,disease,0.999,23017669
36799,colon cancer,disease,1.0,23017669
36800,tumours,disease,1.0,23017669
36801,OxMdG,drug,0.895,23017669
36802,oxaliplatin,drug,0.9995,23017669
36803,l-folinic acid,drug,0.999,23017669
36804,fluorouracil,drug,0.9985,23017669
36805,OxMdG,drug,0.9966,23017669
36806,OxMdG,drug,0.996,23017669
36807,KRAS wild-type tumours,disease,0.8765,23017669
36808,KRAS,gene,0.658,23017669
36809,panitumumab,gene,0.7524,23017669
36810,tumour,disease,1.0,23017669
36811,tumours,disease,1.0,23017669
36812,advanced,disease,0.8574,23017669
36813,tumours,disease,0.849,23017669
36814,resection,DNA,0.4966,23017669
36815,colon cancer,disease,0.9883,23017669
36816,Cancer,disease,0.9946,23017669
36817,KRAS p.G13D,DNA,0.6416,23015072
36818,KRAS p.G13D mutations,gene,0.932,23015072
36819,p.G13D,mutation,,23015072
36820,anti-,gene,0.8335,23015072
36821,EGFR antibody,gene,0.797,23015072
36822,colorectal cancer cell lines,cell_line,0.902,23015072
36823,colorectal cancer,disease,1.0,23015072
36824,anti-EGFR antibodies panitumumab,gene,0.8945,23015072
36825,Pmab,gene,0.931,23015072
36826,cetuximab,gene,0.9097,23015072
36827,Cmab,gene,0.922,23015072
36828,metastatic colorectal adenocarcinoma,disease,0.9995,23015072
36829,tumours,disease,0.9976,23015072
36830,KRAS,gene,0.8677,23015072
36831,tumours,disease,1.0,23015072
36832,codon 13,DNA,0.7803,23015072
36833,KRAS,gene,0.7666,23015072
36834,Cmab,drug,0.8833,23015072
36835,tumours,disease,1.0,23015072
36836,KRAS codon 12,gene,0.791,23015072
36837,KRAS,DNA,0.677,23015072
36838,KRAS mutations,gene,0.792,23015072
36839,EGFR,gene,0.9937,23015072
36840,KRAS,gene,0.7046,23015072
36841,colorectal carcinoma cell lines,cell_line,0.8857,23015072
36842,colorectal carcinoma,disease,1.0,23015072
36843,Cmab,gene,0.7686,23015072
36844,Pmab,gene,0.8623,23015072
36845,BRAF,gene,0.516,23015072
36846,PIK3CA,gene,0.995,23015072
36847,EGFR,gene,0.9917,23015072
36848,PTEN,gene,0.985,23015072
36849,KRAS,gene,0.585,23015072
36850,cell lines,cell_line,0.918,23015072
36851,p,DNA,0.5137,23015072
36852,p.G13D,mutation,,23015072
36853,Cmab,drug,0.759,23015072
36854,Pmab,gene,0.7324,23015072
36855,cell lines,cell_line,0.955,23015072
36856,KRAS,DNA,0.616,23015072
36857,KRAS mutation,gene,0.939,23015072
36858,codon 12 or 61,DNA,0.6636,23015072
36859,KRAS wild-type cell lines,cell_line,0.9697,23015072
36860,KRAS,gene,0.9746,23015072
36861,Cmab,drug,0.855,23015072
36862,cell lines,cell_line,0.932,23015072
36863,BRAF,gene,0.635,23015072
36864,EGFR,gene,0.985,23015072
36865,PTEN protein,gene,0.822,23015072
36866,KRAS,cell_line,0.4407,23015072
36867,KRAS p.G13D,gene,0.9814,23015072
36868,p.G13D,mutation,,23015072
36869,tumour,disease,0.8555,23015072
36870,EGFR,gene,0.9927,23015072
36871,KRAS mutations,gene,0.72,23015072
36872,KRAS wild-type tumour cells,cell_line,0.757,23015072
36873,KRAS,gene,0.9937,23015072
36874,tumour,disease,0.9194,23015072
36875,BRAF,gene,0.4854,23015072
36876,EGFR,gene,0.9897,23015072
36877,PTEN,gene,0.981,23015072
36878,EGFR,gene,0.9907,23015072
36879,Trichomegaly of the eyelashes,disease,1.0,23010833
36880,epidermal growth factor receptor,gene,0.997,23010833
36881,skin,disease,0.7007,23010833
36882,epidermal growth factor receptor,gene,0.999,23010833
36883,EGFR,gene,0.9956,23010833
36884,papulopustular rash,disease,1.0,23010833
36885,xerosis,disease,1.0,23010833
36886,fissures,disease,0.9985,23010833
36887,pruritus,disease,1.0,23010833
36888,mucositis,disease,1.0,23010833
36889,paronychia,disease,1.0,23010833
36890,hair,disease,0.776,23010833
36891,Trichomegaly of the eyelashes,disease,1.0,23010833
36892,EGFR,gene,0.9883,23010833
36893,trichomegaly,disease,1.0,23010833
36894,EGFR,gene,0.9893,23010833
36895,metastatic lung cancer,disease,1.0,22996782
36896,colon cancer,disease,1.0,22996782
36897,metastatic lung cancer,disease,1.0,22996782
36898,colon cancer,disease,1.0,22996782
36899,colon cancer,disease,1.0,22996782
36900,liver metastasis,disease,0.8574,22996782
36901,bevacizumab,gene,0.8857,22996782
36902,FOLFOX,drug,0.9307,22996782
36903,FOLFIRI,drug,0.807,22996782
36904,lung metastases,disease,0.9805,22996782
36905,Panitumumab,gene,0.901,22996782
36906,FOLFIRI,drug,0.7114,22996782
36907,lung metastasis,disease,0.954,22996782
36908,colorectal cancer,disease,1.0,22996782
36909,digestive cancers,disease,1.0,22978333
36910,anti-VEGF,gene,0.9844,22978333
36911,bevacizumab,gene,0.7285,22978333
36912,anti-EGFR,gene,0.958,22978333
36913,cetuximab,gene,0.7266,22978333
36914,metastatic colorectal cancer,disease,0.9995,22978333
36915,mCRC,disease,0.99,22978333
36916,Panitumumab,gene,0.705,22978333
36917,anti-EGFR1,gene,0.9756,22978333
36918,HER1,gene,0.988,22978333
36919,mCRC,disease,0.989,22978333
36920,tumor,disease,0.9995,22978333
36921,EGFR,gene,0.9883,22978333
36922,wild-type K-Ras,gene,0.9434,22978333
36923,K,DNA,0.3748,22978333
36924,Panitumumab,gene,0.8716,22978333
36925,mCRC,disease,0.964,22978333
36926,EGFR,gene,0.9946,22978333
36927,chimeric cetuximab,gene,0.7456,22978333
36928,oncologists,cell_type,0.4463,22978333
36929,colorectal cancer,disease,1.0,22973955
36930,Colorectal cancer,disease,1.0,22973955
36931,cancers,disease,1.0,22973955
36932,cancer,disease,1.0,22973955
36933,colorectal cancer,disease,1.0,22973955
36934,colorectal cancer,disease,1.0,22973955
36935,metastatic colorectal cancer,disease,0.979,22973955
36936,bevacizumab,gene,0.705,22973955
36937,cetuximab,gene,0.6855,22973955
36938,panitumumab,gene,0.757,22973955
36939,VEGF,gene,0.997,22973955
36940,EGFR,gene,0.993,22973955
36941,tumor,disease,1.0,22973955
36942,metastatic colorectal cancer,disease,0.9966,22973955
36943,Wnt,gene,0.8843,22973955
36944,HGF,gene,0.999,22973955
36945,Met,gene,0.9937,22973955
36946,colorectal cancer,disease,1.0,22973955
36947,tyrosine,drug,0.9946,22973955
36948,tyrosine kinase,gene,0.989,22973955
36949,colorectal cancer,disease,1.0,22973955
36950,EGF-responsive colon cancer cells,cell_line,0.742,22956286
36951,EGF,gene,0.966,22956286
36952,colon cancer,disease,0.954,22956286
36953,panitumumab,gene,0.7974,22956286
36954,epidermal growth factor receptor,gene,0.999,22956286
36955,EGFR,gene,0.996,22956286
36956,HER family receptors,gene,0.9927,22956286
36957,EGF,gene,0.96,22956286
36958,colon cancer,disease,1.0,22956286
36959,Panitumumab,gene,0.816,22956286
36960,pmAb,gene,0.8984,22956286
36961,EGFR,gene,0.992,22956286
36962,EGF,gene,0.9907,22956286
36963,colon cancer cells,cell_type,0.7544,22956286
36964,colon cancer,disease,1.0,22956286
36965,HCT-8,cell_line,0.934,22956286
36966,HT-29,cell_line,0.925,22956286
36967,DLD-1,cell_line,0.8745,22956286
36968,HCT-116,cell_line,0.9478,22956286
36969,HCT-1116,cell_line,0.885,22956286
36970,DLD-1 cells,cell_line,0.501,22956286
36971,EGF,gene,0.998,22956286
36972,HT-29,cell_line,0.9067,22956286
36973,HCT-8,cell_line,0.9507,22956286
36974,EGF,gene,0.997,22956286
36975,HCT-8 cells,cell_line,0.7417,22956286
36976,EGFR,gene,0.989,22956286
36977,EGF,gene,0.991,22956286
36978,EGF-responsive cells,cell_line,0.7754,22956286
36979,EGF,gene,0.9683,22956286
36980,HCT-8,cell_line,0.9365,22956286
36981,EGFR,gene,0.992,22956286
36982,focal adhesion kinase,gene,0.992,22956286
36983,FAK,gene,0.9854,22956286
36984,EGF,gene,0.994,22956286
36985,colon cancer cells,cell_line,0.6597,22956286
36986,colon cancer,disease,1.0,22956286
36987,colon cancer,disease,1.0,22956286
36988,pmAb,gene,0.7026,22956286
36989,EGF,gene,0.986,22956286
36990,membrane-type 1 metalloproteinase,gene,0.9946,22956286
36991,MT1-MMP,gene,0.993,22956286
36992,extracellular metalloproteinases inducer,gene,0.995,22956286
36993,EMMPRIN,gene,0.988,22956286
36994,urokinase plasminogen activator,gene,0.998,22956286
36995,uPA,gene,0.988,22956286
36996,syndecan,gene,0.933,22956286
36997,EGF,gene,0.997,22956286
36998,EGFR,gene,0.995,22956286
36999,colon cancer,disease,1.0,22956286
37000,cancer,disease,1.0,22956286
37001,metastatic colorectal cancer,disease,0.9995,22930641
37002,metastatic colorectal cancer,disease,1.0,22930641
37003,vascular endothelial growth factor A,gene,0.997,22930641
37004,panitumumab,gene,0.5444,22930641
37005,epidermal growth factor receptor,gene,0.996,22930641
37006,Hypertension,disease,1.0,22930641
37007,thromboembolic events,disease,1.0,22930641
37008,proteinuria,disease,1.0,22930641
37009,bleeding,disease,0.9624,22930641
37010,gastrointestinal perforation,disease,1.0,22930641
37011,bevacizumab,gene,0.8135,22930641
37012,dermatologic,disease,0.6953,22930641
37013,cetuximab,gene,0.861,22930641
37014,panitumumab,gene,0.85,22930641
37015,Hypersensitivity reactions,disease,0.9995,22930641
37016,hypomagnesemia,disease,1.0,22930641
37017,cetuximab,gene,0.9355,22930641
37018,panitumumab,gene,0.94,22930641
37019,metastatic colorectal cancer,disease,1.0,22930641
37020,breast cancer cells,cell_type,0.5737,22894603
37021,breast cancer,disease,1.0,22894603
37022,breast cancer,disease,0.9946,22894603
37023,normal tissue,cell_type,0.6616,22894603
37024,liposomes,cell_type,0.542,22894603
37025,technetium-99m,drug,0.9995,22894603
37026,(99m)Tc,drug,0.9995,22894603
37027,rhenium-186,drug,0.9766,22894603
37028,(186)Re,drug,0.9995,22894603
37029,rhenium-188,drug,0.964,22894603
37030,(188)Re,drug,0.999,22894603
37031,cancer,disease,1.0,22894603
37032,rat breast cancer xenograft,cell_line,0.694,22894603
37033,rat,species,0.9907,22894603
37034,breast cancer,disease,0.9834,22894603
37035,panitumumab,gene,0.9707,22894603
37036,anti-EGFR,gene,0.9966,22894603
37037,bevacizumab,gene,0.7236,22894603
37038,anti-VEGF,gene,0.996,22894603
37039,(99m)Tc,drug,0.9995,22894603
37040,nude rats,species,0.917,22894603
37041,(99m)Tc,drug,0.9995,22894603
37042,immunoliposomes,cell_type,0.5767,22894603
37043,(99m)Tc,drug,0.9995,22894603
37044,Panitumumab,gene,0.944,22894603
37045,bevacizumab,gene,0.9033,22894603
37046,panitumumab,gene,0.9834,22894603
37047,tumor,disease,0.99,22894603
37048,panitumumab,gene,0.9673,22894603
37049,bevacizumab,gene,0.946,22894603
37050,cancer cells,cell_type,0.8022,22894603
37051,cancer,disease,0.998,22894603
37052,cancer cell,cell_type,0.5483,22873679
37053,cancer,disease,1.0,22873679
37054,cancer,disease,1.0,22873679
37055,phthalocyanine,drug,0.996,22873679
37056,cancer,disease,0.979,22873679
37057,mAb,gene,0.846,22873679
37058,luciferase-transfected breast cancer cell,cell_line,0.9263,22873679
37059,luciferase,gene,0.9727,22873679
37060,breast cancer,disease,0.974,22873679
37061,epidermal growth factor receptor,gene,0.998,22873679
37062,breast cancer,disease,0.9995,22873679
37063,MDA-MB-468luc tumors,disease,0.9756,22873679
37064,mice,species,0.887,22873679
37065,panitumumab,gene,0.967,22873679
37066,tumor,disease,0.9937,22873679
37067,mice,species,0.9795,22873679
37068,tumors,disease,1.0,22873679
37069,tumor cells,cell_type,0.8037,22873679
37070,tumor,disease,0.99,22873679
37071,KRAS,gene,0.8545,22865324
37072,KRAS gene,gene,0.912,22865324
37073,epidermal growth factor receptor,gene,0.996,22865324
37074,metastatic colorectal cancer,disease,1.0,22865324
37075,anti-EGFR monoclonal antibodies,gene,0.905,22865324
37076,Cetuximab,gene,0.7407,22865324
37077,Panitumumab,gene,0.706,22865324
37078,KRAS,DNA,0.803,22865324
37079,KRAS mutations,gene,0.964,22865324
37080,colorectal cancers,disease,1.0,22865324
37081,mutated KRAS oncogene,DNA,0.7114,22865324
37082,mutated,gene,0.6514,22865324
37083,KRAS oncogene,gene,0.7656,22865324
37084,KRAS,gene,0.8413,22865324
37085,KRAS,gene,0.774,22865324
37086,codons 12 and 13,DNA,0.6606,22865324
37087,exon 2,DNA,0.5254,22865324
37088,formalin,drug,0.9736,22865324
37089,colorectal cancer,disease,1.0,22865324
37090,KRAS,gene,0.6533,22865324
37091,KRAS,gene,0.406,22865324
37092,KRAS mutations,gene,0.647,22865324
37093,KRAS,DNA,0.8315,22865324
37094,KRAS mutation,gene,0.8916,22865324
37095,FFPE tumor samples,cell_line,0.575,22865324
37096,FFPE,cell_type,0.5234,22865324
37097,tumor samples,cell_type,0.4233,22865324
37098,tumor,disease,0.9995,22865324
37099,KRAS Mutation,gene,0.605,22865324
37100,KRAS,gene,0.649,22865324
37101,murine,species,0.9766,22863361
37102,chimeric MoAB,gene,0.955,22863361
37103,humanized MoAB,gene,0.923,22863361
37104,humanized,species,0.5786,22863361
37105,human MoAB,gene,0.9883,22863361
37106,solid tumours,disease,1.0,22863361
37107,transmembrane tyrosine kinase receptors,gene,0.988,22863361
37108,tyrosine,drug,0.9634,22863361
37109,tumour cells,cell_type,0.8657,22863361
37110,tumour,disease,0.7583,22863361
37111,IGF1,gene,0.997,22863361
37112,endothelial cells,cell_type,0.627,22863361
37113,Bevacizumab,gene,0.988,22863361
37114,Bevacizumab,gene,0.853,22863361
37115,"advanced colorectal, non squamous lung, ovarian, metastatic breast cancers",disease,0.9995,22863361
37116,glioblastomas,disease,1.0,22863361
37117,EGFR,gene,0.995,22863361
37118,colorectal cancer,disease,1.0,22863361
37119,KRAS,gene,0.85,22863361
37120,cetuximab,gene,0.8877,22863361
37121,panitumumab,gene,0.8975,22863361
37122,head and neck carcinomas,disease,1.0,22863361
37123,squamous lung cancers,disease,1.0,22863361
37124,Anti-,gene,0.6074,22863361
37125,ERBB2,gene,0.8384,22863361
37126,ERBB2 positive breast cancers,disease,0.9976,22863361
37127,ERBB2,gene,0.9917,22863361
37128,tumour,disease,1.0,22863361
37129,stromal cells,cell_type,0.867,22863361
37130,anti-CTLA4,gene,0.9497,22863361
37131,CTLA4,DNA,0.3962,22863361
37132,melanoma,disease,1.0,22863361
37133,normal cells,cell_type,0.9155,22863361
37134,ipilimumab,gene,0.6157,22863361
37135,cancers,disease,0.9873,22863361
37136,colorectal carcinoma,disease,1.0,22855150
37137,CRC,disease,1.0,22855150
37138,CRC,disease,0.5723,22855150
37139,Oncotype,DNA,0.6377,22855150
37140,gene,DNA,0.628,22855150
37141,advanced CRC,disease,0.998,22855150
37142,KRAS,gene,0.815,22855150
37143,EGFR,gene,0.894,22855150
37144,cetuximab,gene,0.758,22855150
37145,panitumumab,gene,0.777,22855150
37146,BRAF,gene,0.66,22855150
37147,EGFR,gene,0.5825,22855150
37148,PI3K,gene,0.453,22855150
37149,PTEN,DNA,0.5264,22855150
37150,PTEN mutations,gene,0.9653,22855150
37151,EGFR,gene,0.993,22847744
37152,colorectal cancer,disease,1.0,22847744
37153,latent subclones,cell_line,0.7646,22847744
37154,KRAS,gene,0.885,22847744
37155,EGFR,gene,0.9927,22847744
37156,colorectal cancer,disease,1.0,22847744
37157,EGFR,gene,0.992,22847744
37158,tumor,disease,0.9956,22847744
37159,pharmacogenetic,DNA,0.474,22845480
37160,normal cell,cell_type,0.85,22845480
37161,BRAF,DNA,0.6353,22845480
37162,BRAF V600E,gene,0.889,22845480
37163,V600E,DNA,,22845480
37164,V600E,mutation,,22845480
37165,vemurafenib,drug,0.9985,22845480
37166,melanoma,disease,1.0,22845480
37167,EML4,gene,0.9937,22845480
37168,-,DNA,0.5063,22845480
37169,ALK,gene,0.996,22845480
37170,crizotinib,drug,0.9966,22845480
37171,EGFR,gene,0.9946,22845480
37172,erlotinib,drug,0.994,22845480
37173,gefitinib,drug,0.9966,22845480
37174,non-small-cell lung cancer,disease,1.0,22845480
37175,KRAS,gene,0.542,22845480
37176,cetuximab,gene,0.841,22845480
37177,panitumumab,gene,0.816,22845480
37178,colorectal cancer,disease,1.0,22845480
37179,ERBB2,gene,0.996,22845480
37180,HER2,gene,0.994,22845480
37181,neu,gene,0.524,22845480
37182,trastuzumab,gene,0.822,22845480
37183,breast cancer,disease,1.0,22845480
37184,BCR,gene,0.5474,22845480
37185,ABL,gene,0.4111,22845480
37186,tyrosine,drug,0.7534,22845480
37187,tyrosine kinase,gene,0.842,22845480
37188,chronic myeloid leukemia,disease,1.0,22845480
37189,PML,gene,0.997,22845480
37190,RAR,gene,0.9966,22845480
37191,all-trans,drug,0.795,22845480
37192,retinoic acid,drug,0.9995,22845480
37193,arsenic trioxide,drug,0.9995,22845480
37194,acute promyelocytic leukemia,disease,1.0,22845480
37195,EGFR,gene,0.993,22843870
37196,IGF-1R,gene,0.9985,22843870
37197,head and neck cancer,disease,1.0,22843870
37198,epidermal growth factor receptor,gene,0.9985,22843870
37199,EGFR,gene,0.9907,22843870
37200,head and neck tumors,disease,1.0,22843870
37201,HNSCC,disease,1.0,22843870
37202,EGFR,gene,0.99,22843870
37203,insulin-like growth factor-1 receptor,gene,0.9985,22843870
37204,IGF-1R,gene,0.997,22843870
37205,tumor,disease,0.9966,22843870
37206,Mice,species,0.8955,22843870
37207,FaDu tumor xenografts,cell_line,0.7803,22843870
37208,FaDu tumor,disease,0.9985,22843870
37209,ganitumab,gene,0.773,22843870
37210,AMG479,gene,0.8003,22843870
37211,anti-IGF-1R antibody,gene,0.9873,22843870
37212,panitumumab,gene,0.664,22843870
37213,anti-EGFR antibody,gene,0.9897,22843870
37214,Tumor,disease,0.998,22843870
37215,tumor,disease,0.9995,22843870
37216,tumor,disease,1.0,22843870
37217,ganitumab,gene,0.8975,22843870
37218,panitumumab,gene,0.885,22843870
37219,Tumor,disease,0.8057,22843870
37220,ganitumab,gene,0.9487,22843870
37221,panitumumab,gene,0.925,22843870
37222,ganitumab,gene,0.8853,22843870
37223,panitumumab,gene,0.9155,22843870
37224,HNSCC,disease,0.999,22843870
37225,epidermal growth factor receptor,gene,0.998,22830443
37226,panitumumab,gene,0.936,22830443
37227,solid tumors,disease,1.0,22830443
37228,tumor,disease,1.0,22830443
37229,panitumumab,gene,0.6953,22830443
37230,anti-epidermal growth factor,gene,0.967,22830443
37231,EGFR,gene,0.697,22830443
37232,tumor,disease,0.5215,22830443
37233,EGFR,gene,0.991,22830443
37234,A431 epidermoid carcinoma xenograft,cell_line,0.872,22830443
37235,human,species,0.991,22830443
37236,cancer,disease,0.9985,22830443
37237,panitumumab,gene,0.8945,22830443
37238,tumors,disease,1.0,22830443
37239,panitumumab,gene,0.77,22830443
37240,pEGFR,gene,0.9956,22830443
37241,Ki67,gene,0.912,22830443
37242,pMAPK,gene,0.895,22830443
37243,tumor,disease,1.0,22830443
37244,tumor,disease,1.0,22830443
37245,tumor,disease,1.0,22830443
37246,tumor,disease,1.0,22830443
37247,panitumumab,gene,0.721,22830443
37248,tumor,disease,0.985,22830443
37249,EGFR,gene,0.991,22830443
37250,MAPK,gene,0.988,22830443
37251,epidermal growth factor receptor,gene,0.998,22818908
37252,epithelial ovarian cancer,disease,1.0,22818908
37253,ovarian carcinoma,disease,1.0,22818908
37254,platinum,drug,0.9995,22818908
37255,epidermal growth factor receptor,gene,0.9985,22818908
37256,EGFR,gene,0.99,22818908
37257,epithelial ovarian carcinoma,disease,1.0,22818908
37258,EOC,disease,1.0,22818908
37259,EGFR,gene,0.99,22818908
37260,EOC,disease,0.997,22818908
37261,Anti-,gene,0.82,22818908
37262,EGFR monoclonal antibodies,gene,0.587,22818908
37263,cetuximab,gene,0.8613,22818908
37264,panitumumab,gene,0.8535,22818908
37265,tyrosine,drug,0.993,22818908
37266,tyrosine kinase,gene,0.7563,22818908
37267,erlotinib,drug,0.995,22818908
37268,gefitinib,drug,0.995,22818908
37269,platinum,drug,0.9995,22818908
37270,EOC,disease,0.999,22818908
37271,EGFR,gene,0.995,22818908
37272,EGFR,gene,0.994,22818908
37273,epithelial ovarian cancers,disease,1.0,22818908
37274,cancer,disease,0.909,22800710
37275,monoclonal,gene,0.6816,22800710
37276,phthalocyanine,drug,0.9956,22800710
37277,tumor,disease,0.9995,22800710
37278,epidermal growth factor receptor,gene,0.934,22800710
37279,EGFR,gene,0.9897,22800710
37280,panitumumab,gene,0.9233,22800710
37281,EGFR-expressing A431 tumor cells,cell_line,0.816,22800710
37282,EGFR,gene,0.9927,22800710
37283,-expressing A431 tumor cells,cell_type,0.632,22800710
37284,cell pellets,cell_line,0.816,22800710
37285,xenografted tumors,disease,0.6904,22800710
37286,mice,species,0.964,22800710
37287,A431 cells,cell_line,0.9727,22800710
37288,tumors,disease,1.0,22800710
37289,FLT,gene,0.9395,22800710
37290,tumor,disease,0.999,22800710
37291,macrophages,cell_type,0.6772,22800710
37292,FLT,drug,0.9614,22800710
37293,tumors,disease,0.986,22800710
37294,Oncogenic,DNA,0.5015,22797062
37295,Oncogenic RAS,gene,0.994,22797062
37296,anti-EGFR,gene,0.8145,22797062
37297,epidermal growth factor receptor,gene,0.9976,22797062
37298,EGFR,gene,0.995,22797062
37299,cancer,disease,1.0,22797062
37300,tumors,disease,1.0,22797062
37301,RAS mutations,gene,0.9907,22797062
37302,RAS,gene,0.989,22797062
37303,anti-EGFR antibodies,gene,0.9233,22797062
37304,cetuximab,gene,0.7466,22797062
37305,panitumumab,gene,0.7114,22797062
37306,cancer,disease,1.0,22797062
37307,cetuximab,gene,0.916,22797062
37308,panitumumab,gene,0.844,22797062
37309,Oncogenic RAS,gene,0.9937,22797062
37310,RAS,gene,0.9893,22797062
37311,BCL,DNA,0.55,22797062
37312,BCL-XL,gene,0.993,22797062
37313,cancer cell lines,cell_line,0.9565,22797062
37314,cancer,disease,0.999,22797062
37315,colorectal cancers,disease,0.9897,22797062
37316,BCL-XL,gene,0.997,22797062
37317,short hairpin RNA,RNA,0.6655,22797062
37318,BH3,gene,0.5117,22797062
37319,RAS,gene,0.992,22797062
37320,RAS-mutant tumors,disease,0.988,22797062
37321,RAS,gene,0.9863,22797062
37322,anti-EGFR antibody,gene,0.9893,22797062
37323,RAS,gene,0.995,22797062
37324,colorectal liver metastases,disease,0.9995,22794325
37325,liver metastases,disease,0.6626,22794325
37326,colorectal cancer,disease,1.0,22794325
37327,CLMs,disease,0.9995,22794325
37328,CLMs,disease,0.9995,22794325
37329,patients,species,0.9775,22794325
37330,cetuximab,gene,0.94,22794325
37331,panitumumab,gene,0.9326,22794325
37332,bevacizumab,gene,0.8394,22794325
37333,CLMs,disease,1.0,22794325
37334,CLMs,disease,0.9995,22794325
37335,CLMs,disease,0.9995,22794325
37336,patients,species,0.9873,22794325
37337,CLMs,disease,0.999,22794325
37338,advanced mucinous adenocarcinoma of the transverse colon,disease,0.9995,22790058
37339,woman,species,0.887,22790058
37340,abdominal distention,disease,0.994,22790058
37341,vomiting,disease,0.922,22790058
37342,perforative peritonitis,disease,1.0,22790058
37343,patient,species,0.9893,22790058
37344,transverse colon cancer,disease,1.0,22790058
37345,mucinous adenocarcinoma,disease,1.0,22790058
37346,wild-type Kras gene,gene,0.9927,22790058
37347,FOLFOX4,drug,0.9062,22790058
37348,panitumumab,gene,0.7896,22790058
37349,neutropenia,disease,0.9663,22790058
37350,skin symptoms,disease,0.9985,22790058
37351,CEA,gene,0.746,22790058
37352,transverse colon cancer,disease,1.0,22790058
37353,panitumumab,gene,0.5874,22790058
37354,patients,species,0.964,22790058
37355,mucinous adenocarcinoma of the colon,disease,1.0,22790058
37356,Panitumumab,gene,0.9106,22790057
37357,liver metastases,disease,0.937,22790057
37358,panitumumab,gene,0.573,22790057
37359,man,species,0.9062,22790057
37360,rectal cancer,disease,1.0,22790057
37361,liver metastases,disease,0.9707,22790057
37362,FOLFOX6,drug,0.6914,22790057
37363,liver metastases,disease,0.849,22790057
37364,tumor,disease,0.781,22790057
37365,panitumumab,gene,0.934,22790057
37366,tumor,disease,0.9556,22790057
37367,liver,disease,0.807,22790057
37368,panitumumab,gene,0.929,22790057
37369,liver metastases,disease,0.992,22790057
37370,liver metastases,disease,0.9795,22790057
37371,colorectal cancer,disease,1.0,22790057
37372,Alexa Fluor680,drug,0.99,22787692
37373,panitumumab,gene,0.9775,22787692
37374,indocyanine green,drug,0.9966,22787692
37375,Alexa Fluor680,drug,0.989,22787692
37376,Alexa680,drug,0.983,22787692
37377,panitumumab,gene,0.98,22787692
37378,Pan,gene,0.945,22787692
37379,indocyanine green,drug,0.999,22787692
37380,ICG,drug,0.9995,22787692
37381,trastuzumab,gene,0.991,22787692
37382,Tra,gene,0.9683,22787692
37383,Alexa680,drug,0.818,22787692
37384,ICG,drug,0.704,22787692
37385,breast cancer,disease,0.999,22787692
37386,tumors,disease,0.64,22787692
37387,amino acids,drug,0.999,22787692
37388,ICG,drug,0.9824,22787692
37389,lysine,drug,0.9307,22787692
37390,PeT,drug,0.6934,22787692
37391,PeT,gene,0.702,22787692
37392,targeted cells,cell_type,0.91,22787692
37393,target cells,cell_type,0.8267,22787692
37394,Pan,gene,0.98,22787692
37395,Tra,gene,0.973,22787692
37396,Alexa680,drug,0.9966,22787692
37397,ICG,drug,0.963,22787692
37398,Pan,gene,0.9272,22787692
37399,human,species,0.881,22787692
37400,IgG2 mAb,gene,0.744,22787692
37401,human epidermal growth factor receptor,gene,0.9893,22787692
37402,human,species,0.9453,22787692
37403,EGFR,gene,0.9956,22787692
37404,HER1,gene,0.995,22787692
37405,Tra,gene,0.8813,22787692
37406,humanized,species,0.5464,22787692
37407,human EGFR type 2,gene,0.9927,22787692
37408,human,species,0.9883,22787692
37409,HER2,gene,0.9976,22787692
37410,Alexa680,drug,0.9844,22787692
37411,ICG,drug,0.964,22787692
37412,mice,species,0.88,22787692
37413,tumor,disease,1.0,22787692
37414,head and neck cancer,disease,1.0,22745915
37415,epidermal growth factor receptor,gene,0.998,22745915
37416,EGFR,gene,0.9946,22745915
37417,squamous cell carcinoma of the head and neck,disease,1.0,22745915
37418,SCCHN,disease,1.0,22745915
37419,EGFR,gene,0.9937,22745915
37420,Cetuximab,gene,0.8,22745915
37421,chimeric human/murine IgG1 antibody,gene,0.889,22745915
37422,murine,species,0.659,22745915
37423,EGFR,gene,0.9907,22745915
37424,SCCHN,disease,1.0,22745915
37425,EGFR,gene,0.9966,22745915
37426,panitumumab,gene,0.838,22745915
37427,cetuximab,gene,0.8574,22745915
37428,EGFR,gene,0.9966,22745915
37429,tyrosine,drug,0.9004,22745915
37430,tyrosine kinase,gene,0.9277,22745915
37431,SCCHN,disease,1.0,22745915
37432,ErbB family,gene,0.9814,22745915
37433,vascular endothelial growth factor,gene,0.9985,22745915
37434,VEGF,gene,0.9937,22745915
37435,VEGFR,gene,0.9854,22745915
37436,insulin-like growth factor 1 receptor,gene,0.998,22745915
37437,IGF-1R,gene,0.998,22745915
37438,insulin receptor,gene,0.9956,22745915
37439,IR,gene,0.99,22745915
37440,histone deacetylases,gene,0.9917,22745915
37441,HDAC,gene,0.988,22745915
37442,rapamycin,drug,0.999,22745915
37443,mTOR,gene,0.991,22745915
37444,platelet-derived growth factor receptor,gene,0.9985,22745915
37445,PDGFR,gene,0.991,22745915
37446,heat-shock protein 90,gene,0.996,22745915
37447,HSP90,gene,0.998,22745915
37448,nuclear factor-kappa B,gene,0.9893,22745915
37449,NF-B,gene,0.985,22745915
37450,aurora A or B,gene,0.995,22745915
37451,phosphatidylinositol,drug,0.9956,22745915
37452,phosphatidylinositol 3-kinase,gene,0.988,22745915
37453,PIK3CA,gene,0.991,22745915
37454,(111)In,drug,0.999,22741182
37455,(86)Y,drug,0.999,22741182
37456,F(ab,gene,0.7627,22741182
37457,panitumumab,gene,0.7314,22741182
37458,human,species,0.8203,22741182
37459,Panitumumab,gene,0.6523,22741182
37460,human,species,0.98,22741182
37461,anti-epidermal growth factor receptor,gene,0.9785,22741182
37462,EGFR,gene,0.8325,22741182
37463,150,RNA,0.678,22741182
37464,metastatic colorectal cancers,disease,0.996,22741182
37465,EGFR,gene,0.9946,22741182
37466,EGFR,gene,0.99,22741182
37467,panitumumab,gene,0.8457,22741182
37468,human,species,0.86,22741182
37469,patients,species,0.9893,22741182
37470,[(111)In,drug,0.9126,22741182
37471,panitumumab,gene,0.6094,22741182
37472,[(111)In,drug,0.961,22741182
37473,EGFR,gene,0.9854,22741182
37474,patients,species,0.9775,22741182
37475,(64)Cu,drug,0.9995,22741182
37476,panitumumab,gene,0.8374,22741182
37477,head and neck squamous cell carcinoma,disease,0.999,22741182
37478,tumors,disease,1.0,22741182
37479,EGFR,gene,0.991,22741182
37480,mice,species,0.969,22741182
37481,tumors,disease,1.0,22741182
37482,(86)Y,drug,0.9995,22741182
37483,panitumumab,gene,0.784,22741182
37484,HER1,gene,0.996,22741182
37485,tumors,disease,0.765,22741182
37486,mice,species,0.9756,22741182
37487,[(86)Y,drug,0.77,22741182
37488,HER1,gene,0.993,22741182
37489,malignant mesothelioma,disease,1.0,22741182
37490,mice,species,0.9146,22741182
37491,[(86)Y],drug,0.927,22741182
37492,[,gene,0.752,22741182
37493,solid tumors,disease,1.0,22741182
37494,tumor,disease,0.53,22741182
37495,patient,species,0.9917,22741182
37496,mAbs,gene,0.775,22741182
37497,Fc,gene,,22741182
37498,F(ab&,gene,0.9395,22741182
37499,110 kD,RNA,0.6157,22741182
37500,F(ab&,gene,0.967,22741182
37501,F(ab,gene,0.8145,22741182
37502,tumor,disease,0.753,22741182
37503,F(ab,gene,0.7974,22741182
37504,panitumumab,gene,0.7646,22741182
37505,111)In,drug,0.995,22741182
37506,(86)Y (7),drug,0.957,22741182
37507,[(111)In,drug,0.89,22741182
37508,(86)Y,drug,0.7656,22741182
37509,nude mice,species,0.6284,22741182
37510,HER1,gene,0.996,22741182
37511,(111)In,drug,0.999,22741182
37512,(86)Y,drug,0.9985,22741182
37513,tumors,disease,1.0,22741182
37514,(111)In,drug,0.999,22741180
37515,panitumumab,gene,0.773,22741180
37516,human,species,0.7915,22741180
37517,Panitumumab,gene,0.9673,22741180
37518,human,species,0.97,22741180
37519,anti-epidermal factor receptor,gene,0.9785,22741180
37520,EGFR,gene,0.9956,22741180
37521,metastatic colorectal cancers,disease,0.9795,22741180
37522,EGFR,gene,0.9883,22741180
37523,EGFR,gene,0.99,22741180
37524,panitumumab,gene,0.8457,22741180
37525,human,species,0.6055,22741180
37526,patients,species,0.9863,22741180
37527,[(111)In],drug,0.9497,22741180
37528,panitumumab,gene,0.711,22741180
37529,[(111)In],drug,0.977,22741180
37530,EGFR,gene,0.9897,22741180
37531,patients,species,0.9844,22741180
37532,(111)In,drug,0.999,22741180
37533,(111)In,drug,0.864,22741180
37534,mice,species,0.9507,22741180
37535,xenograft tumors,disease,0.8916,22741180
37536,A431,cell_line,0.9385,22741180
37537,HT-29,cell_line,0.8774,22741180
37538,LS-174T,cell_line,0.811,22741180
37539,SHAW,cell_line,0.9067,22741180
37540,Cancer,disease,0.8535,22741180
37541,SKOV-3 cell,cell_line,0.9014,22741180
37542,mice,species,0.94,22741180
37543,xenograft tumors,disease,0.9966,22741180
37544,(89)Zr,drug,0.9995,22741179
37545,p-isothiocyanatobenzyl-desferrioxamine B,drug,0.999,22741179
37546,Df-Bz-NCS,drug,0.9995,22741179
37547,Panitumumab,gene,0.944,22741179
37548,human,species,0.987,22741179
37549,anti-epidermal factor receptor 1,gene,0.9824,22741179
37550,HER1,gene,0.9346,22741179
37551,metastatic colorectal,disease,0.9976,22741179
37552,cancers,disease,1.0,22741179
37553,EGFR,gene,0.9937,22741179
37554,HER1,gene,0.9805,22741179
37555,panitumumab,gene,0.82,22741179
37556,human,species,0.86,22741179
37557,patients,species,0.9893,22741179
37558,(111)In,drug,0.9995,22741179
37559,panitumumab,gene,0.777,22741179
37560,HER1,gene,0.9956,22741179
37561,patients,species,0.977,22741179
37562,(64)Cu,drug,0.9985,22741179
37563,panitumumab,gene,0.948,22741179
37564,head and neck squamous cell carcinoma xenograft tumors,disease,0.9844,22741179
37565,tumors,disease,1.0,22741179
37566,HER1,gene,0.989,22741179
37567,mice,species,0.9414,22741179
37568,tumors,disease,1.0,22741179
37569,HER family,gene,0.979,22741179
37570,cancerous lesions,disease,1.0,22741179
37571,HER1,gene,0.757,22741179
37572,HER1,gene,0.9893,22741179
37573,cancerous lesions,disease,1.0,22741179
37574,(86)Y,drug,0.999,22741179
37575,panitumumab,gene,0.8057,22741179
37576,[(86)Y],drug,0.946,22741179
37577,HER1,gene,0.995,22741179
37578,tumors,disease,1.0,22741179
37579,mice,species,0.9785,22741179
37580,HER1,gene,0.9873,22741179
37581,malignant mesothelioma,disease,1.0,22741179
37582,mice,species,0.9624,22741179
37583,(64)Cu,drug,0.999,22741179
37584,(86)Y,drug,0.999,22741179
37585,tumors,disease,1.0,22741179
37586,HER1,gene,0.9893,22741179
37587,(89)Zr,drug,0.999,22741179
37588,(64)Cu,drug,0.9995,22741179
37589,(86)Y,drug,0.9995,22741179
37590,HER1,gene,0.987,22741179
37591,tumors,disease,1.0,22741179
37592,(89)Zr,drug,0.999,22741179
37593,(89)Zr,drug,0.999,22741179
37594,trastuzumab,gene,0.8657,22741179
37595,HER2,gene,0.9966,22741179
37596,metastatic breast cancer,disease,0.995,22741179
37597,(111)In,drug,0.999,22741179
37598,trastuzumab,gene,0.4827,22741179
37599,(89)Zr,drug,0.9995,22741179
37600,panitumumab,gene,0.895,22741179
37601,mice,species,0.911,22741179
37602,LS,disease,,22741179
37603,-174T cell tumors,cell_line,0.4768,22741179
37604,human colorectal adenocarcinoma cells,cell_type,0.457,22741179
37605,human,species,0.9917,22741179
37606,colorectal adenocarcinoma,disease,0.996,22741179
37607,HER1,gene,0.9893,22741179
37608,HER1,gene,0.997,22741179
37609,metastatic cancer,disease,1.0,22741179
37610,Cancer,disease,1.0,22739312
37611,tumours,disease,1.0,22738821
37612,breast cancer,disease,0.993,22738821
37613,colorectal cancer,disease,1.0,22738821
37614,Epidermal Growth Factor receptor,gene,0.9985,22738821
37615,Cetuximab,gene,0.8706,22738821
37616,Panitumumab,gene,0.7954,22738821
37617,FOLFOX,drug,0.944,22738821
37618,FOLFIRI,drug,0.91,22738821
37619,liver metastasis,disease,0.9995,22738821
37620,Endothelin receptor,gene,0.999,22738821
37621,Endothelin A,DNA,0.4958,22738821
37622,Endothelin A receptor,gene,0.998,22738821
37623,KRAS mutation,gene,0.747,22735045
37624,metastatic colorectal cancer,disease,1.0,22735045
37625,panitumumab,gene,0.764,22735045
37626,KRAS,gene,0.6978,22735045
37627,metastatic colorectal,disease,0.9995,22735045
37628,anti-Epidermal Growth Factor Receptor,gene,0.885,22735045
37629,EGFR,gene,0.9854,22735045
37630,panitumumab,gene,0.8657,22735045
37631,KRAS,DNA,0.7524,22735045
37632,KRAS mutations,gene,0.792,22735045
37633,KRAS,gene,0.8755,22735045
37634,KRAS,gene,0.8687,22735045
37635,KRAS,gene,0.8193,22735045
37636,panitumumab,gene,0.8613,22735045
37637,KRAS,gene,0.872,22735045
37638,KRAS,gene,0.8613,22735045
37639,panitumumab,gene,0.9233,22735045
37640,KRAS,gene,0.76,22735045
37641,tumor,disease,0.879,22735045
37642,KRAS,gene,0.814,22735045
37643,cancer,disease,1.0,22735045
37644,KRAS,gene,0.837,22735045
37645,mice,species,0.9497,22723098
37646,panitumumab,gene,0.9155,22723098
37647,mice,species,0.8394,22723098
37648,mice,species,0.944,22723098
37649,EGFR,gene,0.996,22722843
37650,colorectal cancers,disease,1.0,22722843
37651,Colorectal tumours,disease,1.0,22722843
37652,KRAS,gene,0.755,22722843
37653,EGFR,gene,0.9863,22722843
37654,anti-EGFR antibodies,gene,0.894,22722843
37655,ABL,gene,0.998,22722843
37656,EGFR,gene,0.997,22722843
37657,BRAF,gene,0.998,22722843
37658,MEK,gene,0.995,22722843
37659,genes,DNA,0.6704,22722843
37660,tumours,disease,1.0,22722843
37661,EGFR,gene,0.9907,22722843
37662,rare cells,cell_type,0.895,22722843
37663,KRAS,DNA,0.7466,22722843
37664,KRAS mutations,gene,0.929,22722843
37665,tumours,disease,1.0,22722843
37666,wild-type KRAS genes,gene,0.9106,22722843
37667,mutant KRAS DNA,DNA,0.877,22722843
37668,panitumumab,gene,0.6885,22722843
37669,anti-EGFR,gene,0.9956,22722843
37670,tumours,disease,1.0,22722843
37671,KRAS,gene,0.773,22722843
37672,KRAS,gene,0.885,22722843
37673,KRAS mutations,gene,0.67,22722843
37674,expanded subclones,cell_line,0.4917,22722843
37675,panitumumab,gene,0.8706,22722843
37676,KRAS,DNA,0.8716,22722843
37677,KRAS mutations,gene,0.75,22722843
37678,EGFR,gene,0.988,22722843
37679,solid,cell_type,0.4553,22722843
37680,solid tumours,disease,1.0,22722843
37681,KRAS mutations,gene,0.7,22722830
37682,EGFR,gene,0.965,22722830
37683,colorectal cancer,disease,1.0,22722830
37684,epidermal growth factor receptor,gene,0.992,22722830
37685,EGFR,gene,0.992,22722830
37686,KRAS,gene,0.674,22722830
37687,colorectal cancers,disease,1.0,22722830
37688,cetuximab,gene,0.826,22722830
37689,colorectal cancer,disease,1.0,22722830
37690,KRAS,gene,0.9043,22722830
37691,EGFR,gene,0.8394,22722830
37692,colorectal cancers,disease,1.0,22722830
37693,mutant KRAS,gene,0.9956,22722830
37694,endogenous gene promoter,DNA,0.8745,22722830
37695,cetuximab,gene,0.8887,22722830
37696,resistant cells,cell_line,0.846,22722830
37697,EGFR,gene,0.983,22722830
37698,mitogen-activated protein-kinase kinase,gene,0.999,22722830
37699,MEK,gene,0.9937,22722830
37700,cetuximab,gene,0.778,22722830
37701,panitumumab,gene,0.7983,22722830
37702,KRAS,gene,0.91,22722830
37703,KRAS,DNA,0.779,22722830
37704,KRAS mutations,gene,0.9165,22722830
37705,KRAS mutant alleles,gene,0.7104,22722830
37706,cetuximab,gene,0.8237,22722830
37707,KRAS,gene,0.851,22722830
37708,cetuximab,gene,0.606,22722830
37709,colorectal cancers,disease,1.0,22722830
37710,KRAS mutant clones,cell_line,0.4995,22722830
37711,KRAS,gene,0.979,22722830
37712,MEK,gene,0.9976,22722830
37713,monoclonal Recent,cell_line,0.4924,22715092
37714,IgG1,gene,0.9966,22715092
37715,IgG2 antibodies,gene,0.868,22715092
37716,rituximab,gene,0.9316,22715092
37717,panitumumab,gene,0.948,22715092
37718,bevacizumab,gene,0.705,22715092
37719,antigene,DNA,0.5576,22715092
37720,hydrogen,drug,0.932,22715092
37721,Aeris,DNA,0.5356,22715092
37722,C4,cell_line,,22715092
37723,biomolecules,DNA,0.4753,22715092
37724,n-butanol,drug,0.999,22715092
37725,hydroxyl,drug,0.9937,22715092
37726,n-butanol,drug,0.999,22715092
37727,silanol,drug,0.9814,22715092
37728,silanols,drug,0.9883,22715092
37729,cetuximab,gene,0.597,22706026
37730,BRAF and KRAS mutant tumors,disease,0.9575,22706026
37731,BRAF,gene,0.3481,22706026
37732,KRAS,gene,0.859,22706026
37733,EGFR,gene,0.986,22706026
37734,epidermal growth factor receptor,gene,0.998,22706026
37735,EGFR,gene,0.991,22706026
37736,epithelial cancers,disease,1.0,22706026
37737,cancer,disease,1.0,22706026
37738,EGFR,gene,0.9956,22706026
37739,cetuximab,gene,0.823,22706026
37740,panitumumab,gene,0.79,22706026
37741,EGFR,gene,0.9937,22706026
37742,raf,gene,0.9966,22706026
37743,ras effector proteins,gene,0.7104,22706026
37744,EGFR,gene,0.9873,22706026
37745,cetuximab,gene,0.9785,22706026
37746,fibronectin domain,gene,0.899,22706026
37747,EGFR,gene,0.9766,22706026
37748,EGFR,gene,0.984,22706026
37749,EGFR,gene,0.991,22706026
37750,tumor,disease,0.9995,22706026
37751,xenograft models,cell_line,0.6177,22706026
37752,cetuximab-resistant BRAF and KRAS mutant,cell_line,0.689,22706026
37753,cetuximab,gene,0.952,22706026
37754,BRAF,gene,0.982,22706026
37755,KRAS mutant,gene,0.8794,22706026
37756,cancers,disease,0.9976,22706026
37757,triepitopic constructs,DNA,0.889,22706026
37758,EGFR,gene,0.997,22706026
37759,panitumumab,gene,0.9053,22705694
37760,liver metastases,disease,0.9917,22705694
37761,portal venal tumor embolus,disease,0.9897,22705694
37762,rectal cancer,disease,1.0,22705694
37763,rectal cancer,disease,1.0,22705694
37764,liver metastases,disease,0.9927,22705694
37765,tumor embolus,disease,0.9595,22705694
37766,bevacizumab,gene,0.613,22705694
37767,liver metastases,disease,0.998,22705694
37768,panitumumab,gene,0.9453,22705694
37769,FOLFIRI,drug,0.942,22705694
37770,tumor,disease,0.888,22705694
37771,liver metastases,disease,0.9795,22705694
37772,panitumumab,gene,0.932,22705694
37773,recurrent rectal cancer,disease,0.9507,22705694
37774,Azithromycin,drug,0.997,22699716
37775,epidermal growth factor receptor,gene,0.997,22699716
37776,papulopustular eruption,disease,0.999,22699716
37777,tetracyclines,drug,0.999,22699716
37778,Papulopustular eruption,disease,1.0,22699716
37779,PPE,disease,1.0,22699716
37780,epidermal growth factor receptor,gene,0.9976,22699716
37781,EGFRIs,gene,0.978,22699716
37782,azithromycin,drug,0.9907,22699716
37783,EGFRI,gene,0.9487,22699716
37784,PPE,disease,0.9976,22699716
37785,EGFRIs,gene,0.933,22699716
37786,PPE,disease,0.998,22699716
37787,tetracyclines,drug,0.999,22699716
37788,azithromycin,drug,0.9785,22699716
37789,azithromycin,drug,0.9707,22699716
37790,rash,disease,0.882,22699716
37791,azithromycin,drug,0.991,22699716
37792,panitumumab,gene,0.9814,22669455
37793,head and neck cancer,disease,1.0,22669455
37794,head and neck squamous cell carcinoma,disease,0.9966,22669455
37795,HNSCC,disease,1.0,22669455
37796,epidermal growth factor receptor,gene,0.998,22669455
37797,EGFR,gene,0.992,22669455
37798,panitumumab,gene,0.915,22669455
37799,IgG,gene,0.9453,22669455
37800,HNSCC,disease,1.0,22669455
37801,SCC-1,cell_line,0.839,22669455
37802,FADU,cell_line,0.852,22669455
37803,OSC19,cell_line,0.8755,22669455
37804,xenografts,cell_line,0.469,22669455
37805,panitumumab,gene,0.976,22669455
37806,IgG,gene,0.987,22669455
37807,primary,disease,0.5713,22669455
37808,panitumumab,gene,0.9873,22669455
37809,IgG,gene,0.993,22669455
37810,malignancy,disease,0.5864,22669455
37811,Panitumumab,gene,0.8887,22669455
37812,HNSCC,disease,0.9995,22669455
37813,epidermal growth factor receptor,gene,0.997,22647972
37814,colorectal cancer,disease,1.0,22647972
37815,KRAS,DNA,0.8047,22647972
37816,KRAS mutations,gene,0.9004,22647972
37817,epidermal growth factor receptor,gene,0.9985,22647972
37818,EGFR,gene,0.997,22647972
37819,cetuximab,gene,0.753,22647972
37820,panitumumab,gene,0.8145,22647972
37821,metastatic colorectal cancer,disease,0.9917,22647972
37822,CRC,disease,1.0,22647972
37823,EGFR,gene,0.9966,22647972
37824,EGFR,gene,0.9956,22647972
37825,KRAS,gene,0.6836,22647972
37826,anti-EGFR mAbs,gene,0.909,22647972
37827,metastatic CRC,disease,0.9717,22647972
37828,EGFR,gene,0.992,22647972
37829,KRAS-mutated tumours,disease,0.6416,22647972
37830,KRAS,gene,0.4592,22647972
37831,cetuximab,gene,0.874,22647972
37832,panitumumab,gene,0.8457,22647972
37833,EGFR,gene,0.9946,22647972
37834,KRAS,gene,0.8267,22647972
37835,EGFR gene,gene,0.5586,22647972
37836,"BRAF,",DNA,0.7466,22647972
37837,BRAF,gene,0.959,22647972
37838,"NRAS, PIK3CA",DNA,0.504,22647972
37839,NRAS,gene,0.975,22647972
37840,PIK3CA,gene,0.9873,22647972
37841,PTEN,gene,0.9883,22647972
37842,anti-EGFR mAbs,gene,0.868,22647972
37843,EGFR,gene,0.995,22647972
37844,CRC,disease,0.9995,22647972
37845,bevacizumab,gene,0.886,22638798
37846,everolimus,drug,0.9985,22638798
37847,panitumumab,gene,0.881,22638798
37848,advanced solid tumors,disease,0.997,22638798
37849,VEGF,gene,0.9976,22638798
37850,mTOR,gene,0.9575,22638798
37851,EGFR,gene,0.992,22638798
37852,bevacizumab,gene,0.955,22638798
37853,everolimus,drug,0.9976,22638798
37854,panitumumab,gene,0.952,22638798
37855,advanced solid,disease,0.9893,22638798
37856,tumors,disease,0.994,22638798
37857,everolimus,drug,0.997,22638798
37858,panitumumab,gene,0.9194,22638798
37859,tumor,disease,0.8896,22638798
37860,everolimus,drug,0.998,22638798
37861,mucositis,disease,0.9995,22638798
37862,skin rash,disease,1.0,22638798
37863,thrombocytopenia,disease,1.0,22638798
37864,everolimus,drug,0.9976,22638798
37865,skin rash,disease,1.0,22638798
37866,pruritus,disease,0.9976,22638798
37867,mucositis,disease,1.0,22638798
37868,stomatitis,disease,1.0,22638798
37869,hypomagnesemia,disease,1.0,22638798
37870,hypocalcemia,disease,1.0,22638798
37871,hypokalemia,disease,1.0,22638798
37872,ovarian cancer,disease,1.0,22638798
37873,endometrial cancer,disease,1.0,22638798
37874,is,drug,0.989,22638798
37875,everolimus,drug,0.507,22638798
37876,panitumumab,gene,0.9253,22638798
37877,bevacizumab,gene,0.629,22638798
37878,refractory,disease,0.972,22638798
37879,tumors,disease,0.8403,22638798
37880,KRAS,gene,0.758,22638623
37881,BRAF,gene,0.597,22638623
37882,PIK3CA,DNA,0.4177,22638623
37883,PIK3CA mutations,gene,0.9155,22638623
37884,cetuximab,gene,0.8496,22638623
37885,irinotecan,drug,0.999,22638623
37886,oxaliplatin,drug,0.999,22638623
37887,metastatic colorectal cancer,disease,1.0,22638623
37888,Anti-,gene,0.57,22638623
37889,epidermal growth factor receptor,gene,0.919,22638623
37890,EGFR,gene,0.965,22638623
37891,cetuximab,gene,0.64,22638623
37892,panitumumab,gene,0.7007,22638623
37893,metastatic colorectal cancer,disease,1.0,22638623
37894,mCRC,disease,1.0,22638623
37895,EGFR,gene,0.9927,22638623
37896,KRAS,DNA,0.7573,22638623
37897,KRAS mutation,gene,0.9404,22638623
37898,CRC,disease,0.999,22638623
37899,EGFR antibody,gene,0.7725,22638623
37900,mCRC,disease,0.9956,22638623
37901,cetuximab,gene,0.627,22638623
37902,cetuximab,gene,0.923,22638623
37903,irinotecan,drug,0.997,22638623
37904,KRAS,gene,0.8047,22638623
37905,BRAF,gene,0.766,22638623
37906,PIK3CA,gene,0.597,22638623
37907,tumors,disease,0.5356,22638623
37908,tumors,disease,0.4312,22638623
37909,KRAS,gene,0.7695,22638623
37910,BRAF,gene,0.7295,22638623
37911,PIK3CA,DNA,0.4531,22638623
37912,PIK3CA mutations,gene,0.855,22638623
37913,tumors,disease,1.0,22638623
37914,wild,DNA,0.6587,22638623
37915,wild-type KRAS,gene,0.9956,22638623
37916,mutant KRAS,gene,0.59,22638623
37917,tumors,disease,0.4187,22638623
37918,KRAS,gene,0.8315,22638623
37919,BRAF,gene,0.8516,22638623
37920,PIK3CA,gene,0.7153,22638623
37921,KRAS,gene,0.7256,22638623
37922,BRAF,gene,0.72,22638623
37923,PIK3CA,gene,0.671,22638623
37924,wild-type KRAS,gene,0.9478,22638623
37925,KRAS,gene,0.8306,22638623
37926,cetuximab,gene,0.62,22638623
37927,BRAF and PIK3CA genes,DNA,0.8716,22638623
37928,BRAF,gene,0.9927,22638623
37929,PIK3CA genes,gene,0.983,22638623
37930,wild-type KRAS,gene,0.6836,22638623
37931,anti-EGFR antibody,gene,0.885,22638623
37932,solid cancers,disease,1.0,22584792
37933,cancer,disease,1.0,22584792
37934,cancer,disease,0.9995,22584792
37935,cancer,disease,1.0,22584792
37936,colorectal cancer,disease,1.0,22584792
37937,carcinoembryonic antigen,gene,0.9966,22584792
37938,patients,species,0.9453,22584792
37939,colorectal cancer,disease,1.0,22584792
37940,both -fetoprotein,gene,0.981,22584792
37941,human chorionic gonadotrophin,gene,0.9966,22584792
37942,human,species,0.869,22584792
37943,patients,species,0.9526,22584792
37944,non-seminomatous germ cell tumors,disease,1.0,22584792
37945,CA 125,gene,0.968,22584792
37946,patients,species,0.9087,22584792
37947,ovarian cancer,disease,1.0,22584792
37948,estrogen,drug,0.9995,22584792
37949,estrogen receptors,gene,0.9907,22584792
37950,breast cancer,disease,1.0,22584792
37951,human epidermal growth factor receptor 2,gene,0.9976,22584792
37952,human,species,0.5425,22584792
37953,women,species,0.763,22584792
37954,breast cancer,disease,1.0,22584792
37955,trastuzumab,gene,0.961,22584792
37956,KRAS,gene,0.9663,22584792
37957,patients,species,0.9727,22584792
37958,advanced colorectal cancer,disease,1.0,22584792
37959,anti-epidermal growth factor receptor antibodies,gene,0.942,22584792
37960,cetuximab,gene,0.799,22584792
37961,panitumumab,gene,0.7876,22584792
37962,prostate-specific antigen,gene,0.996,22584792
37963,prostate cancer,disease,1.0,22584792
37964,liver metastases,disease,0.99,22584346
37965,FOLFOX,drug,0.836,22584346
37966,FOLFIRI,drug,0.9224,22584346
37967,colorectal cancer,disease,1.0,22584346
37968,bevacizumab,gene,0.7056,22584346
37969,cetuximab,gene,0.8926,22584346
37970,Cmab,gene,0.8916,22584346
37971,K-ras,DNA,0.585,22584346
37972,K-ras wild,gene,0.902,22584346
37973,panitumumab,gene,0.9585,22584346
37974,Pmab,gene,0.9756,22584346
37975,K-ras wild,gene,0.9043,22584346
37976,CPT-11,drug,0.998,22584346
37977,Cmab,gene,0.9893,22584346
37978,K-ras wild-type,gene,0.923,22584346
37979,Cmab,gene,0.988,22584346
37980,Pmab,gene,0.9907,22584346
37981,Cmab,gene,0.9873,22584346
37982,S-1,gene,0.938,22584346
37983,liver metastases,disease,0.9897,22584346
37984,rectal cancer,disease,1.0,22584346
37985,K-ras,gene,0.9985,22584346
37986,5-FU,drug,0.998,22584346
37987,L-OHP,drug,0.9966,22584346
37988,CPT,drug,0.998,22584346
37989,liver,disease,0.507,22584346
37990,epidermal growth factor,gene,0.9956,22584020
37991,epidermal growth factor receptor,gene,0.9985,22584020
37992,EGFR,gene,0.9917,22584020
37993,panitumumab,gene,0.63,22584020
37994,erlotinib,drug,0.97,22584020
37995,PARTICIPANTS,species,0.595,22584020
37996,patients,species,0.98,22584020
37997,EGFR,gene,0.994,22584020
37998,patients,species,0.98,22584020
37999,erlotinib,drug,0.9854,22584020
38000,end-stage lung carcinoma,disease,1.0,22584020
38001,patient,species,0.972,22584020
38002,colorectal cancer,disease,1.0,22584020
38003,systemic disease,disease,0.9873,22584020
38004,epithelial defects,disease,1.0,22584020
38005,corneal melting,disease,0.99,22584020
38006,patients,species,0.9673,22584020
38007,patient,species,0.9824,22584020
38008,lower lid ectropion,disease,0.9824,22584020
38009,patients,species,0.9863,22584020
38010,corneal perforation,disease,1.0,22584020
38011,corneal perforation,disease,1.0,22584020
38012,EGFR,gene,0.995,22584020
38013,panitumumab,gene,0.6445,22584020
38014,erlotinib,drug,0.9897,22584020
38015,cancer,disease,0.9995,22576569
38016,anti-CCR4 antibody,gene,0.983,22576569
38017,cancer,disease,0.9873,22576569
38018,cancer,disease,0.998,22576569
38019,rituximab,gene,0.9775,22576569
38020,trastuzumab,gene,0.9575,22576569
38021,cetuximab,gene,0.8623,22576569
38022,bevacizumab,gene,0.7563,22576569
38023,cancers,disease,1.0,22576569
38024,cancer,disease,1.0,22576569
38025,cancer,disease,0.994,22576569
38026,cancer,disease,1.0,22576569
38027,patient,species,0.995,22576569
38028,cancer,disease,0.985,22576569
38029,VEGF,gene,0.9443,22570554
38030,bevacizumab,gene,0.96,22570554
38031,aflibercept,gene,0.977,22570554
38032,metastatic colorectal cancer,disease,1.0,22570554
38033,mCRC,disease,1.0,22570554
38034,advanced solid tumors,disease,0.9995,22570554
38035,patients,species,0.9595,22570554
38036,mCRC,disease,0.901,22570554
38037,antivascular endothelial growth factor,gene,0.994,22570554
38038,anti-VEGF,gene,0.9805,22570554
38039,bevacizumab,gene,0.894,22570554
38040,aflibercept,gene,0.9727,22570554
38041,antiendothelial cell growth factor receptor,gene,0.934,22570554
38042,anti-EGFR,gene,0.9478,22570554
38043,cetuximab,gene,0.8047,22570554
38044,panitumumab,gene,0.7524,22570554
38045,Aflibercept,gene,0.9546,22570554
38046,mCRC,disease,0.9946,22570554
38047,aflibercept,gene,0.974,22570554
38048,anti-VEGF,gene,0.7285,22570554
38049,bevacizumab,gene,0.8545,22570554
38050,aflibercept,gene,0.9795,22570554
38051,VEGF,gene,0.959,22570554
38052,mCRC,disease,0.992,22570554
38053,Erythrodermic psoriasis,disease,1.0,22565356
38054,panitumumab,gene,0.902,22565356
38055,bevacizumab,gene,0.8154,22565356
38056,FDG,drug,0.9995,22562987
38057,anti-EGFR antibody,gene,0.981,22562987
38058,Panitumumab,gene,0.5986,22562987
38059,anti-EGF receptor,gene,0.991,22562987
38060,EGFR,gene,0.9917,22562987
38061,colorectal cancers,disease,1.0,22562987
38062,K-RAS,gene,0.9976,22562987
38063,patient,species,0.9893,22562987
38064,(18)F-fluorodeoxyglucose,drug,0.999,22562987
38065,FDG,drug,0.9995,22562987
38066,panitumumab,gene,0.7344,22562987
38067,Solid Tumors,disease,1.0,22562987
38068,carcinoembryonic antigen,gene,0.9175,22562987
38069,FDG,drug,0.9956,22562987
38070,anti-,gene,0.681,22562987
38071,EGFR antibody,gene,0.821,22562987
38072,colorectal cancer,disease,1.0,22562987
38073,KRAS,gene,0.83,22549179
38074,miRNA-143,gene,0.8584,22549179
38075,EGFR,gene,0.994,22549179
38076,colorectal cancer,disease,1.0,22549179
38077,MicroRNA,RNA,0.5684,22549179
38078,MicroRNA-143,gene,0.9746,22549179
38079,miRNA-143,gene,0.981,22549179
38080,colorectal cancer,disease,1.0,22549179
38081,CRC,disease,1.0,22549179
38082,CRC,disease,0.5107,22549179
38083,5-fluorouracil,drug,0.9985,22549179
38084,mRNA,RNA,0.88,22549179
38085,KRAS oncogene,gene,0.922,22549179
38086,miRNA-143,gene,0.9756,22549179
38087,miRNA,RNA,0.6235,22549179
38088,miRNA-143,gene,0.9834,22549179
38089,epidermal growth factor receptor,gene,0.9985,22549179
38090,EGFR,gene,0.998,22549179
38091,CRC,disease,0.9995,22549179
38092,wild-type KRAS,gene,0.7563,22549179
38093,EGFR,gene,0.991,22549179
38094,cetuximab,gene,0.676,22549179
38095,panitumumab,gene,0.9526,22549179
38096,MicroRNA,RNA,0.574,22549179
38097,MicroRNA-143,gene,0.9795,22549179
38098,CRC,disease,1.0,22549179
38099,cancer,disease,0.999,22549179
38100,EGFR,gene,0.991,22549179
38101,miRNA,RNA,0.639,22549179
38102,miRNA-143,gene,0.8555,22549179
38103,tumours,disease,1.0,22549179
38104,miRNA,RNA,0.6387,22549179
38105,miRNA-143,gene,0.985,22549179
38106,EGFR,gene,0.9897,22549179
38107,miRNA,RNA,0.616,22549179
38108,miRNA-143,gene,0.9585,22549179
38109,CRC,disease,0.9985,22549179
38110,KRAS,gene,0.606,22549179
38111,miRNA,RNA,0.662,22549179
38112,miRNA-143,gene,0.9644,22549179
38113,EGFR,gene,0.9927,22549179
38114,miRNA-143,gene,0.944,22549179
38115,CRC,disease,0.999,22549179
38116,production cell lines,cell_line,0.908,22531442
38117,antigenic,DNA,0.521,22531442
38118,nimotuzumab,gene,0.697,22531442
38119,abciximab,gene,0.948,22531442
38120,rituximab,gene,0.865,22531442
38121,basiliximab,gene,0.9272,22531442
38122,palivizumab,gene,0.924,22531442
38123,infliximab,gene,0.9297,22531442
38124,trastuzumab,gene,0.84,22531442
38125,alemtuzumab,gene,0.8223,22531442
38126,adalimumab,gene,0.8525,22531442
38127,tositumomab-I131,gene,0.9062,22531442
38128,cetuximab,gene,0.837,22531442
38129,ibrituximab,gene,0.8213,22531442
38130,tiuxetan,drug,0.937,22531442
38131,omalizumab,gene,0.83,22531442
38132,natalizumab,gene,0.738,22531442
38133,ranibizumab,gene,0.5234,22531442
38134,panitumumab,gene,0.795,22531442
38135,eculizumab,gene,0.796,22531442
38136,certolizumab pegol,gene,0.8804,22531442
38137,golimumab,gene,0.8022,22531442
38138,catumaxomab,gene,0.574,22531442
38139,tocilizumab,gene,0.707,22531442
38140,belimumab,gene,0.9077,22531442
38141,ipilimumab,gene,0.7017,22531442
38142,brentuximab,gene,0.8467,22531442
38143,muromonab-CD3,gene,0.985,22531442
38144,nebacumab,gene,0.762,22531442
38145,edrecolomab,gene,0.6694,22531442
38146,daclizumab,gene,0.543,22531442
38147,gemtuzumab ozogamicin,gene,0.603,22531442
38148,efalizumab,gene,0.8643,22531442
38149,Panitumumab,gene,0.8384,22515440
38150,colorectal cancer,disease,1.0,22515440
38151,Panitumumab,gene,0.7544,22515440
38152,EGF receptor,gene,0.9976,22515440
38153,KRAS,gene,0.989,22515440
38154,metastatic colorectal carcinoma,disease,0.936,22515440
38155,panitumumab,gene,0.8687,22515440
38156,Panitumumab,gene,0.8755,22515440
38157,EGF receptor,gene,0.9976,22515440
38158,panitumumab,gene,0.816,22515440
38159,metastatic colorectal cancer,disease,1.0,22515440
38160,breast cancer,disease,0.9995,22510481
38161,cancer cells,cell_type,0.8184,22510481
38162,cancer,disease,0.9985,22510481
38163,cancer cells,cell_type,0.819,22510481
38164,cancer,disease,0.9907,22510481
38165,tumor,disease,1.0,22510481
38166,AlexaFluor680,drug,0.9985,22510481
38167,Alexa680,drug,0.997,22510481
38168,panitumumab,gene,0.9775,22510481
38169,Pan,gene,0.9497,22510481
38170,human epidermal growth factor receptor,gene,0.9966,22510481
38171,EGFR,gene,0.993,22510481
38172,Indocyanine Green,drug,0.995,22510481
38173,ICG,drug,0.999,22510481
38174,trastuzumab,gene,0.995,22510481
38175,Tra,gene,0.957,22510481
38176,human epidermal growth factor receptor type 2,gene,0.9985,22510481
38177,HER2,gene,0.9927,22510481
38178,Tra-ICG,drug,0.988,22510481
38179,breast cancer,disease,0.996,22510481
38180,mouse,species,0.961,22510481
38181,Alexa680,drug,0.751,22510481
38182,ICG,drug,0.533,22510481
38183,MDA-MB-468,cell_line,0.936,22510481
38184,EGFR,gene,0.996,22510481
38185,HER2,gene,0.9946,22510481
38186,3T3/HER2 cells,cell_line,0.891,22510481
38187,HER2,gene,0.9277,22510481
38188,EGFR,gene,0.9844,22510481
38189,HER2,gene,0.9956,22510481
38190,Tra-ICG,gene,0.689,22510481
38191,ICG,drug,0.5254,22510481
38192,mice,species,0.964,22510481
38193,MDA-MB-468,cell_line,0.9375,22510481
38194,HER2 tumors,disease,0.868,22510481
38195,HER2,gene,0.9653,22510481
38196,breast tumor,disease,0.9937,22510481
38197,breast cancer,disease,0.9995,22510481
38198,breast tumor,disease,0.9966,22510481
38199,ganitumab,gene,0.941,22510349
38200,AMG 479,gene,0.7646,22510349
38201,sorafenib,drug,0.999,22510349
38202,panitumumab,gene,0.8716,22510349
38203,erlotinib,drug,0.996,22510349
38204,gemcitabine,drug,0.999,22510349
38205,advanced solid tumors,disease,0.9995,22510349
38206,ganitumab,gene,0.8145,22510349
38207,insulin-like growth factor 1 (IGF1) receptor,gene,0.975,22510349
38208,advanced solid tumors,disease,1.0,22510349
38209,advanced solid tumors,disease,1.0,22510349
38210,ganitumab,gene,0.963,22510349
38211,sorafenib,drug,0.997,22510349
38212,panitumumab,gene,0.8496,22510349
38213,erlotinib,drug,0.994,22510349
38214,gemcitabine,drug,0.999,22510349
38215,ganitumab,gene,0.9365,22510349
38216,Ganitumab,gene,0.7607,22510349
38217,sorafenib,drug,0.9985,22510349
38218,panitumumab,gene,0.8823,22510349
38219,erlotinib,drug,0.9927,22510349
38220,gemcitabine,drug,0.9995,22510349
38221,fatigue,disease,0.9985,22510349
38222,nausea,disease,0.9956,22510349
38223,vomiting,disease,0.9897,22510349
38224,chills,disease,0.989,22510349
38225,hyperglycemia,disease,1.0,22510349
38226,ganitumab,gene,0.9663,22510349
38227,panitumumab,gene,0.9517,22510349
38228,neutropenia,disease,0.9995,22510349
38229,ganitumab,gene,0.9585,22510349
38230,gemcitabine,drug,0.9995,22510349
38231,thrombocytopenia,disease,0.9985,22510349
38232,ganitumab,gene,0.8965,22510349
38233,erlotinib,drug,0.9985,22510349
38234,Ganitumab-binding,gene,0.7383,22510349
38235,panitumumab-binding antibodies,gene,0.9653,22510349
38236,ganitumab,gene,0.9204,22510349
38237,IGF1,gene,0.998,22510349
38238,IGF binding protein 3,gene,0.998,22510349
38239,sorafenib,drug,0.9995,22510349
38240,panitumumab,gene,0.8687,22510349
38241,erlotinib,drug,0.9976,22510349
38242,gemcitabine,drug,0.9995,22510349
38243,Ganitumab,gene,0.7085,22510349
38244,squamous cell carcinoma of the head and neck,disease,1.0,22498572
38245,platinum,drug,0.9995,22498572
38246,locally advanced squamous cell carcinoma of the head and neck,disease,0.923,22498572
38247,platinum,drug,0.9995,22498572
38248,epidermal growth factor receptor,gene,0.996,22498572
38249,cetuximab,gene,0.924,22498572
38250,panitumumab,gene,0.872,22498572
38251,platinum,drug,1.0,22498572
38252,pan-human epidermal receptor,gene,0.943,22498572
38253,pan-HER,gene,0.867,22498572
38254,platinum,drug,1.0,22498572
38255,platinum,drug,0.9995,22498572
38256,platinum,drug,0.9995,22498572
38257,tumor,disease,0.998,22498572
38258,platinum,drug,1.0,22498572
38259,cell lines,cell_line,0.9556,22497959
38260,cell lines,cell_line,0.956,22497959
38261,epidermal growth factor receptor,gene,0.997,22497959
38262,EGFR,gene,0.987,22497959
38263,A431,cell_line,0.9194,22497959
38264,HaCaT,cell_line,0.8564,22497959
38265,HCT116,cell_line,0.949,22497959
38266,HepG2,cell_line,0.954,22497959
38267,EGFR,gene,0.9893,22497959
38268,[,gene,0.6865,22497959
38269,[,gene,0.663,22497959
38270,seeded cells,cell_line,0.7173,22497959
38271,seeded,cell_type,0.617,22497959
38272,cells,cell_type,0.4006,22497959
38273,cell lines,cell_line,0.9346,22497959
38274,cell lines,cell_line,0.9126,22497959
38275,A431,cell_line,0.878,22497959
38276,HaCaT,cell_line,0.89,22497959
38277,HCT116,cell_line,0.4802,22497959
38278,HepG2,cell_line,0.8926,22497959
38279,EGFR,gene,0.9893,22497959
38280,cell lines,cell_line,0.8945,22497959
38281,cetuximab,gene,0.9497,22489288
38282,bevacizumab,gene,0.845,22489288
38283,panitumumab,gene,0.889,22489288
38284,metastatic colorectal cancer,disease,0.9995,22489288
38285,IgG2 antibody,gene,0.9883,22477029
38286,IgG2 antibody,gene,0.9883,22477029
38287,IgG2,gene,0.9956,22477029
38288,IgG2,gene,0.998,22477029
38289,tumors,disease,1.0,22469241
38290,technetium 99m,drug,0.998,22469241
38291,(99m)Tc,drug,0.999,22469241
38292,tricarbonyl,drug,0.9985,22469241
38293,CO,drug,0.9814,22469241
38294,His,drug,0.979,22469241
38295,annexin A5,gene,0.831,22469241
38296,His,drug,0.9995,22469241
38297,His-ann A5,gene,0.848,22469241
38298,Colo205,cell_line,0.8535,22469241
38299,mice,species,0.9307,22469241
38300,5-fluorouracil,drug,0.9995,22469241
38301,5-FU,drug,0.999,22469241
38302,irinotecan,drug,0.999,22469241
38303,oxaliplatin,drug,0.9995,22469241
38304,bevacizumab,gene,0.91,22469241
38305,panitumumab,gene,0.877,22469241
38306,(99m)Tc-(CO) His-ann A5,drug,0.979,22469241
38307,caspase-3,gene,0.995,22469241
38308,survivin,gene,0.996,22469241
38309,LC3-II,gene,0.996,22469241
38310,(99m)Tc-(CO) His,drug,0.9985,22469241
38311,colorectal cancer,disease,1.0,22469241
38312,5-FU,drug,0.9995,22469241
38313,irinotecan,drug,0.9995,22469241
38314,oxaliplatin,drug,1.0,22469241
38315,Bevacizumab,gene,0.9434,22469241
38316,mice,species,0.9795,22469241
38317,(99m)Tc-(CO) His,drug,0.9985,22469241
38318,panitumumab,gene,0.877,22469241
38319,mice,species,0.9805,22469241
38320,caspase-3,gene,0.9883,22469241
38321,irinotecan,drug,0.9995,22469241
38322,oxaliplatin,drug,0.999,22469241
38323,tumors,disease,0.933,22469241
38324,caspase-3,gene,0.991,22469241
38325,5-FU,drug,0.999,22469241
38326,panitumumab,gene,0.9717,22469241
38327,mice,species,0.983,22469241
38328,annexin A5,gene,0.959,22469241
38329,Colo205 model,cell_line,0.696,22469241
38330,cancer,disease,1.0,22432839
38331,solid tumors,disease,1.0,22432839
38332,solid tumors,disease,1.0,22432839
38333,tumor,disease,0.9995,22432839
38334,cancer,disease,1.0,22432839
38335,tumor,disease,0.9995,22432839
38336,trastuzumab,gene,0.9683,22432839
38337,cetuximab,gene,0.927,22432839
38338,panitumumab,gene,0.9277,22432839
38339,bevacizumab,gene,0.82,22432839
38340,catumaxomab,gene,0.7036,22432839
38341,ipilimumab,gene,0.619,22432839
38342,denosumab,gene,0.518,22432839
38343,solid tumor,disease,1.0,22432839
38344,"breast, colorectal, head and neck, non-small cell lung cancers",disease,1.0,22432839
38345,melanomas,disease,1.0,22432839
38346,oropharyngeal squamous cell carcinoma,disease,1.0,22425872
38347,oropharyngeal squamous cell carcinoma,disease,1.0,22425872
38348,OPSCC,disease,1.0,22425872
38349,OPSCC,disease,0.9995,22425872
38350,OPSCC,disease,0.9995,22425872
38351,FFDM,disease,0.952,22425872
38352,metastatic,disease,0.7256,22423266
38353,colorectal cancer,disease,0.977,22423266
38354,colorectal cancer,disease,1.0,22423266
38355,tumor,disease,0.991,22423266
38356,colon cancer,disease,1.0,22423266
38357,tumor,disease,0.994,22423266
38358,metastatic,disease,0.7754,22423266
38359,colorectal cancer,disease,0.811,22423266
38360,cancer,disease,1.0,22423266
38361,serum lactate dehydrogenase,gene,0.856,22423266
38362,lactate,drug,0.9946,22423266
38363,Kirsten rat sarcoma viral oncogene homolog,gene,0.8276,22423266
38364,KRAS,gene,0.736,22423266
38365,metastatic colorectal cancer,disease,1.0,22423266
38366,fluoropyrimidine,drug,0.9995,22423266
38367,oxaliplatin,drug,1.0,22423266
38368,irinotecan,drug,0.9995,22423266
38369,bevacizumab,gene,0.7964,22423266
38370,epidermal growth factor,gene,0.9897,22423266
38371,cetuximab,gene,0.753,22423266
38372,panitumumab,gene,0.8076,22423266
38373,metastatic colorectal cancer,disease,0.9985,22408376
38374,panitumumab,gene,0.9077,22408376
38375,Colorectal cancer,disease,1.0,22408376
38376,cancer,disease,1.0,22408376
38377,patients,species,0.9893,22408376
38378,EGFR,gene,0.7217,22408376
38379,panitumumab,gene,0.7344,22408376
38380,human,species,0.8403,22408376
38381,Patient,species,0.988,22385512
38382,anti-EGFR monoclonal antibodies,gene,0.9463,22385512
38383,patient,species,0.984,22385512
38384,patient,species,0.988,22385512
38385,tumor,disease,0.999,22385512
38386,cancer,disease,0.9995,22385512
38387,anti-epidermal growth factor receptor,gene,0.8945,22385512
38388,EGFR,gene,0.9946,22385512
38389,metastatic colorectal cancer,disease,1.0,22385512
38390,mCRC,disease,1.0,22385512
38391,tumor,disease,1.0,22385512
38392,patient,species,0.974,22385512
38393,EGFR,gene,0.988,22385512
38394,Cetuximab,gene,0.901,22385512
38395,chimeric mouse human IgG1 mAb,gene,0.8823,22385512
38396,mouse,species,0.976,22385512
38397,human,species,0.971,22385512
38398,panitumumab,gene,0.824,22385512
38399,human,species,0.9844,22385512
38400,anti-EGFR mAbs,gene,0.8755,22385512
38401,wild,cell_line,0.484,22385512
38402,wild-type (WT,gene,0.775,22385512
38403,mCRC,disease,0.983,22385512
38404,microRNAs,RNA,0.5713,22385512
38405,miRNAs,RNA,0.7207,22385512
38406,CRC,disease,0.9995,22385512
38407,head and neck cancer,disease,1.0,22373581
38408,Head and neck squamous cell carcinoma,disease,1.0,22373581
38409,HNSCC,disease,1.0,22373581
38410,HNSCC,disease,0.9995,22373581
38411,HNSCC,disease,0.999,22373581
38412,HNSCC,disease,0.9995,22373581
38413,tumor,disease,1.0,22373581
38414,tumor,disease,0.9976,22373581
38415,HNSCC,disease,0.999,22373581
38416,EGFR,gene,0.9834,22373581
38417,Cetuximab,gene,0.9014,22373581
38418,Panitumumab,gene,0.823,22373581
38419,Zalutumumab,gene,0.665,22373581
38420,EGFR,gene,0.9927,22373581
38421,tyrosine,drug,0.9165,22373581
38422,Gefitinib,drug,0.999,22373581
38423,Erloitinib,drug,0.996,22373581
38424,VEGFR,gene,0.9907,22373581
38425,Bevacizumab,gene,0.753,22373581
38426,Vandetanib,drug,0.9756,22373581
38427,Src-family kinase,gene,0.992,22373581
38428,PARP,gene,0.98,22373581
38429,mTOR,gene,0.9937,22373581
38430,COX,gene,0.9834,22373581
38431,heat shock protein,gene,0.983,22373581
38432,cancer,disease,1.0,22373581
38433,patients,species,0.989,22373581
38434,tumor,disease,1.0,22369484
38435,phthalocyanine,drug,0.98,22369484
38436,IR700,drug,0.962,22369484
38437,tumor cell,cell_type,0.71,22369484
38438,tumor,disease,0.999,22369484
38439,mice,species,0.9644,22369484
38440,panitumumab,gene,0.791,22369484
38441,tumor,disease,0.9995,22369484
38442,HER1,gene,0.9976,22369484
38443,tumor,disease,0.5425,22369484
38444,A431,cell_line,0.5283,22369484
38445,panitumumab,gene,0.974,22369484
38446,tumor,disease,1.0,22369484
38447,tumor,disease,0.893,22369484
38448,A431 tumors,disease,0.9985,22369484
38449,tumor,disease,0.9985,22369484
38450,panitumumab,gene,0.8765,22367707
38451,KRAS,DNA,0.7456,22367707
38452,KRAS wild,gene,0.796,22367707
38453,biliary tract cancer,disease,1.0,22367707
38454,panitumumab,gene,0.888,22367707
38455,KRAS,gene,0.9966,22367707
38456,biliary tract cancer,disease,0.9927,22367707
38457,PATIENTS,species,0.93,22367707
38458,Patients,species,0.9756,22367707
38459,gemcitabine,drug,0.9995,22367707
38460,oxaliplatin,drug,0.9995,22367707
38461,panitumumab,gene,0.816,22367707
38462,capecitabine,drug,0.998,22367707
38463,patients,species,0.987,22367707
38464,patients,species,0.976,22367707
38465,epidermal growth factor receptor,gene,0.9985,22367707
38466,patient,species,0.9526,22367707
38467,biliary tract cancer,disease,1.0,22367707
38468,panitumumab,gene,0.7524,22367707
38469,patients,species,0.9814,22367707
38470,KRAS,gene,0.993,22367707
38471,EGFR,gene,0.973,22358385
38472,patients,species,0.9883,22358385
38473,KRAS wild,gene,0.8193,22358385
38474,Cetuximab,gene,0.7383,22358385
38475,panitumumab,gene,0.6875,22358385
38476,KRAS,gene,0.995,22358385
38477,metastatic colorectal cancer,disease,1.0,22358385
38478,mCRC,disease,1.0,22358385
38479,patients,species,0.9834,22358385
38480,mCRC,disease,0.997,22358385
38481,patients,species,0.9863,22358385
38482,KRAS,gene,0.9976,22358385
38483,KRAS,gene,0.9956,22358385
38484,patients,species,0.966,22358385
38485,C or,drug,0.9663,22358385
38486,patients,species,0.8315,22358385
38487,mCRC,disease,0.968,22358385
38488,liver-limited disease,disease,0.951,22358385
38489,KRAS,gene,0.994,22358385
38490,patients,species,0.982,22358385
38491,liver metastases,disease,0.9985,22358385
38492,cancer,disease,1.0,22342917
38493,Panitumumab,gene,0.72,22342917
38494,EGF-receptor,gene,0.999,22342917
38495,colorectal carcinoma,disease,1.0,22342917
38496,CRC,disease,1.0,22342917
38497,tumor,disease,1.0,22342917
38498,CRC,disease,0.9995,22342917
38499,mAbs,gene,0.7007,22342917
38500,Trastuzumab,gene,0.599,22342917
38501,Panitumumab,gene,0.9585,22342917
38502,heat,cell_line,0.6206,22342917
38503,protein A,gene,0.9893,22342917
38504,protein G,gene,0.995,22342917
38505,patient-derived CRC cell lines,cell_line,0.9624,22342917
38506,patient,species,0.9517,22342917
38507,CRC,disease,0.9443,22342917
38508,human lymphocytes,cell_type,0.76,22342917
38509,human,species,0.838,22342917
38510,effector cells,cell_type,0.5522,22342917
38511,long-term stimulated lymphocyte cultures,cell_line,0.959,22342917
38512,NK-cell-like cytolytic effectors,cell_type,0.83,22342917
38513,CRC target cells,cell_type,0.7954,22342917
38514,CRC,disease,0.9995,22342917
38515,NK cell target K562,cell_line,0.647,22342917
38516,tumor,disease,1.0,22342917
38517,circulating NK cells,cell_type,0.683,22342917
38518,CRC,disease,0.999,22342917
38519,NK cells,cell_type,0.947,22342917
38520,cancer,disease,1.0,22342917
38521,advanced gastric cancer,disease,1.0,22334453
38522,Gastric cancer,disease,1.0,22334453
38523,cancer,disease,1.0,22334453
38524,advanced gastric cancer,disease,1.0,22334453
38525,AGC,disease,1.0,22334453
38526,patients,species,0.9897,22334453
38527,AGC,disease,1.0,22334453
38528,patients,species,0.9956,22334453
38529,human epidermal growth factor receptor,gene,0.999,22334453
38530,human,species,0.733,22334453
38531,HER,gene,0.9976,22334453
38532,phosphatidylinositol,drug,0.9956,22334453
38533,phosphatidylinositol-3-kinase,gene,0.9966,22334453
38534,PI3K,gene,0.998,22334453
38535,Akt,gene,0.998,22334453
38536,rapamycin,drug,0.9995,22334453
38537,AGC,disease,1.0,22334453
38538,patients,species,0.996,22334453
38539,Trastuzumab,gene,0.9756,22334453
38540,Gastric Cancer,disease,0.9995,22334453
38541,trastuzumab,gene,0.983,22334453
38542,patients,species,0.9033,22334453
38543,HER,gene,0.709,22334453
38544,Avastin,gene,0.719,22334453
38545,Gastric Cancer,disease,0.9995,22334453
38546,bevacizumab,gene,0.901,22334453
38547,patients,species,0.976,22334453
38548,bevacizumab,gene,0.946,22334453
38549,cetuximab,gene,0.906,22334453
38550,panitumumab,gene,0.923,22334453
38551,lapatinib,drug,0.999,22334453
38552,everolimus,drug,0.9985,22334453
38553,AGC,disease,1.0,22334453
38554,AGC,disease,1.0,22334453
38555,patients,species,0.9946,22334453
38556,patient,species,0.9004,22334453
38557,rectal cancer,disease,0.9795,22333651
38558,rectal cancer,disease,1.0,22333651
38559,tumor,disease,0.5005,22333651
38560,panitumumab,gene,0.643,22333651
38561,endothelial growth factor receptor,gene,0.998,22333651
38562,EGFR,gene,0.997,22333651
38563,man,species,0.931,22333651
38564,Stage IV,disease,0.9907,22333651
38565,rectal cancer,disease,0.9937,22333651
38566,panitumumab,gene,0.7207,22333651
38567,FOLFOX,drug,0.6406,22333651
38568,FOLFOX,drug,0.768,22333651
38569,panitumumab,gene,0.8154,22333651
38570,FOLFIRI,drug,0.9453,22333651
38571,panitumumab,gene,0.784,22333651
38572,peripheral neuropathy,disease,0.999,22333651
38573,panitumumab,gene,0.8633,22333651
38574,primary,disease,0.5454,22333651
38575,lung metastasis,disease,0.8384,22333651
38576,tumor-like lesion,disease,0.9995,22333651
38577,tumor cells,cell_type,0.8115,22333651
38578,tumor,disease,0.9614,22333651
38579,patient,species,0.9927,22333651
38580,EGFR receptor antibody,gene,0.804,22333651
38581,cancer,disease,0.7173,22333651
38582,colorectal cancer,disease,1.0,22333651
38583,KRAS gene,gene,0.989,22333651
38584,tumors,disease,1.0,22333651
38585,EGFR antibody,gene,0.783,22333651
38586,irinotecan,drug,0.998,22333650
38587,panitumumab,gene,0.9614,22333650
38588,interstitial pneumonia,disease,0.999,22333650
38589,man,species,0.8105,22333650
38590,advanced colon cancer,disease,1.0,22333650
38591,liver metastases,disease,0.997,22333650
38592,bevacizumab,gene,0.8286,22333650
38593,bevacizumab,gene,0.9263,22333650
38594,CEA,gene,0.9937,22333650
38595,CA19-,gene,0.9814,22333650
38596,FOLFIRI,drug,0.525,22333650
38597,panitumumab,gene,0.9263,22333650
38598,dyspnea,disease,0.9995,22333650
38599,ground-glass opacities,disease,0.9995,22333650
38600,traction bronchiectasis,disease,1.0,22333650
38601,interstitial pneumonitis,disease,1.0,22333650
38602,irinotecan,drug,0.9985,22333650
38603,panitumumab,gene,0.907,22333650
38604,methyl- prednisolone,drug,0.996,22333650
38605,respiratory failure,disease,1.0,22333650
38606,EGFR tyrosine kinase,gene,0.973,22333650
38607,tyrosine,drug,0.5293,22333650
38608,interstitial pneumonitis,disease,1.0,22333650
38609,irinotecan,drug,0.996,22333650
38610,KRAS gene,gene,0.9937,22329297
38611,colorectal cancer,disease,1.0,22329297
38612,KRAS oncogene,DNA,0.9204,22329297
38613,KRAS oncogene,gene,0.992,22329297
38614,KRAS,DNA,0.724,22329297
38615,KRAS mutations,gene,0.9043,22329297
38616,patients,species,0.9756,22329297
38617,colorectal cancer,disease,1.0,22329297
38618,CRC,disease,1.0,22329297
38619,anti-epidermal growth factor receptor,gene,0.9336,22329297
38620,EGFR,gene,0.9976,22329297
38621,cetuximab,gene,0.6323,22329297
38622,panitumumab,gene,0.784,22329297
38623,metastatic,disease,0.5093,22329297
38624,CRC,disease,0.588,22329297
38625,patients,species,0.9824,22329297
38626,KRAS,gene,0.991,22329297
38627,codons 12 and 13,DNA,0.565,22329297
38628,metastatic CRC,disease,0.998,22329297
38629,EGFR,gene,0.783,22329297
38630,KRAS,gene,0.9917,22329297
38631,codons 12 or 13,DNA,0.6694,22329297
38632,CRC,disease,1.0,22329297
38633,paraffin,drug,0.697,22329297
38634,tumor,disease,1.0,22329297
38635,KRAS,DNA,0.807,22329297
38636,KRAS mutations,gene,0.88,22329297
38637,tumor samples,cell_type,0.4805,22329297
38638,tumor,disease,1.0,22329297
38639,patients,species,0.9917,22329297
38640,Gly12Val,DNA,0.6406,22329297
38641,Gly12Va,mutation,,22329297
38642,Gly12Asp,DNA,0.6587,22329297
38643,Gly12As,mutation,,22329297
38644,patients,species,0.993,22329297
38645,Gly13Asp,DNA,0.541,22329297
38646,Gly13As,mutation,,22329297
38647,patient,species,0.989,22329297
38648,Gly12Ser,DNA,0.607,22329297
38649,Gly12Se,mutation,,22329297
38650,Gly12Cys,DNA,0.6387,22329297
38651,Gly12Cy,mutation,,22329297
38652,tumor,disease,1.0,22329297
38653,KRAS,gene,0.9897,22329297
38654,CRC,disease,1.0,22329297
38655,KRAS,DNA,0.88,22329297
38656,KRAS,gene,0.9844,22329297
38657,EGFR,gene,0.9927,22329297
38658,patients,species,0.969,22329297
38659,CRC,disease,0.999,22329297
38660,circulating tumor cells,cell_type,0.743,22328299
38661,colorectal,disease,0.9985,22328299
38662,circulating tumor cells,cell_type,0.885,22328299
38663,CTCs,cell_type,0.8145,22328299
38664,patients,species,0.973,22328299
38665,metastatic,disease,0.8413,22328299
38666,colorectal cancer,disease,0.9604,22328299
38667,CTCs,cell_type,0.6704,22328299
38668,patients,species,0.977,22328299
38669,K-ras,gene,0.998,22328299
38670,colorectal cancer,disease,0.957,22328299
38671,metastatic lesions,disease,0.9604,22328299
38672,SOX,drug,0.997,22328299
38673,TS-1,drug,0.9873,22328299
38674,L-OHP,drug,0.9985,22328299
38675,panitumumab,gene,0.6665,22328299
38676,patients,species,0.991,22328299
38677,CTCs,cell_type,0.791,22328299
38678,patients,species,0.98,22328299
38679,CTCs,disease,0.92,22328299
38680,serum,gene,0.6035,22328299
38681,carcinoembryonic antigen,gene,0.849,22328299
38682,CEA,gene,0.9873,22328299
38683,patients,species,0.9883,22328299
38684,CTCs,disease,0.635,22328299
38685,CTCs,cell_type,0.622,22328299
38686,CEA,gene,0.809,22328299
38687,patients,species,0.995,22328299
38688,CTCs,cell_type,0.5415,22328299
38689,CTCs,cell_type,0.6587,22328299
38690,patients,species,0.9873,22328299
38691,cancer,disease,1.0,22328299
38692,patients,species,0.994,22328299
38693,CTCs,disease,0.6265,22328299
38694,CTCs,cell_type,0.69,22328299
38695,patients,species,0.9556,22328299
38696,metastatic,disease,0.934,22328299
38697,colorectal cancer,disease,0.853,22328299
38698,biliary tract cancers,disease,1.0,22318523
38699,Biliary tract cancers,disease,1.0,22318523
38700,BTCs,disease,1.0,22318523
38701,malignancies,disease,0.984,22318523
38702,patients,species,0.971,22318523
38703,tumors,disease,1.0,22318523
38704,gemcitabine,drug,0.999,22318523
38705,cisplatin,drug,0.999,22318523
38706,BTC,disease,1.0,22318523
38707,BTC,disease,1.0,22318523
38708,epidermal growth factor receptor,gene,0.9966,22318523
38709,mitogen-activated protein kinase,gene,0.995,22318523
38710,monoclonal antibody,gene,0.7544,22299770
38711,mAb,gene,0.8936,22299770
38712,metastatic colorectal cancer,disease,1.0,22299770
38713,mCRC,disease,1.0,22299770
38714,mCRC,disease,0.9956,22299770
38715,patients,species,0.9927,22299770
38716,cetuximab,gene,0.8613,22299770
38717,panitumumab,gene,0.7905,22299770
38718,bevacizumab,gene,0.832,22299770
38719,IRs,DNA,0.485,22299770
38720,patients,species,0.9814,22299770
38721,cetuximab,gene,0.921,22299770
38722,patients,species,0.9893,22299770
38723,IRs,cell_type,0.459,22299770
38724,cetuximab,gene,0.815,22299770
38725,bevacizumab,gene,0.894,22299770
38726,panitumumab,gene,0.941,22299770
38727,IRs,DNA,0.6094,22299770
38728,cetuximab,gene,0.93,22299770
38729,PTEN gene,gene,0.996,22285706
38730,PIK3CA gene,gene,0.997,22285706
38731,epidermal growth factor receptor,gene,0.997,22285706
38732,patients,species,0.9585,22285706
38733,metastatic colorectal cancer,disease,0.9927,22285706
38734,PATIENTS,species,0.93,22285706
38735,patients,species,0.982,22285706
38736,cetuximab,gene,0.8237,22285706
38737,panitumumab,gene,0.8086,22285706
38738,tumor,disease,0.999,22285706
38739,Tumor,disease,0.998,22285706
38740,"KRAS, BRAF, PIK3CA, PIK3R1, AKT1, and PTEN genes",DNA,0.8145,22285706
38741,KRAS,gene,0.9805,22285706
38742,BRAF,gene,0.996,22285706
38743,PIK3CA,gene,0.9937,22285706
38744,PIK3R1,gene,0.99,22285706
38745,AKT1,gene,0.9893,22285706
38746,PTEN genes,gene,0.958,22285706
38747,PTEN promoter,gene,0.9873,22285706
38748,patients,species,0.9863,22285706
38749,KRAS gene,DNA,0.8228,22285706
38750,KRAS gene,gene,0.9883,22285706
38751,patients,species,0.9604,22285706
38752,PTEN,gene,0.9917,22285706
38753,PIK3CA,gene,0.9976,22285706
38754,PTEN,gene,0.9873,22285706
38755,PIK3CA,DNA,0.5776,22285706
38756,PIK3CA-,gene,0.996,22285706
38757,tumors,disease,0.561,22285706
38758,PTEN,gene,0.989,22285706
38759,PTEN gene,DNA,0.8877,22285706
38760,PTEN gene,gene,0.994,22285706
38761,KRAS,gene,0.981,22285706
38762,PTEN,gene,0.9854,22285706
38763,PIK3CA,DNA,0.8164,22285706
38764,PIK3CA,gene,0.9956,22285706
38765,EGFR,gene,0.917,22285706
38766,metastatic colorectal cancer,disease,0.927,22285706
38767,PTEN promoter,gene,0.9844,22285706
38768,PTEN,gene,0.992,22285706
38769,EGFR,gene,0.9966,22285706
38770,Epidermal Growth Antibodies,gene,0.9937,22270724
38771,epidermal growth factor receptor,gene,0.9976,22270724
38772,EGFR,gene,0.997,22270724
38773,cetuximab,gene,0.9346,22270724
38774,panitumumab,gene,0.8306,22270724
38775,colorectal cancer,disease,1.0,22270724
38776,patients,species,0.9883,22270724
38777,EGFR,DNA,0.53,22270724
38778,EGFR ectodomain,gene,0.993,22270724
38779,S492,mutation,,22270724
38780,cetuximab,gene,0.9424,22270724
38781,cetuximab,gene,0.7983,22270724
38782,panitumumab,gene,0.891,22270724
38783,cetuximab,gene,0.9165,22270724
38784,cetuximab,gene,0.9634,22270724
38785,S492,mutation,,22270724
38786,panitumumab,gene,0.937,22270724
38787,cetuximab,gene,0.9546,22264223
38788,colorectal cancer,disease,1.0,22264223
38789,CRC,disease,0.9995,22264223
38790,tumor,disease,1.0,22264223
38791,cancer,disease,1.0,22264223
38792,KRAS,DNA,0.8,22264223
38793,KRAS mutations,gene,0.7715,22264223
38794,metastatic-CRC,disease,0.992,22264223
38795,cetuximab,gene,0.8164,22264223
38796,panitumumab,gene,0.6465,22264223
38797,KRAS,gene,0.9795,22264223
38798,patients,species,0.9717,22264223
38799,BRAF,DNA,0.7124,22264223
38800,BRAF,gene,0.998,22264223
38801,NRAS,gene,0.9976,22264223
38802,PIK3CA,DNA,0.5435,22264223
38803,PIK3CA,gene,0.998,22264223
38804,PTEN,gene,0.998,22264223
38805,cetuximab,gene,0.9106,22264223
38806,cetuximab,gene,0.8984,22264223
38807,cetuximab,gene,0.82,22264223
38808,cetuximab,gene,0.9575,22264223
38809,irinotecan,drug,0.999,22264223
38810,Cetuximab,gene,0.891,22264223
38811,bevacizumab,gene,0.886,22264223
38812,cetuximab,gene,0.9575,22264223
38813,irinotecan,drug,0.999,22264223
38814,KRAS,gene,0.99,22264223
38815,KRAS,gene,0.963,22264223
38816,patients,species,0.9697,22264223
38817,cetuximab,gene,0.7095,22264223
38818,tumors,disease,1.0,22264223
38819,Cetuximab,gene,0.883,22264223
38820,CRC,disease,0.9995,22264223
38821,cetuximab,gene,0.885,22264223
38822,EGFR,gene,0.9883,22252310
38823,squamous,disease,0.617,22252310
38824,squamous cell carcinoma of the head and,disease,1.0,22252310
38825,SCCHN,disease,1.0,22252310
38826,SCCHN,disease,1.0,22252310
38827,epidermal growth factor receptor,gene,0.999,22252310
38828,EGFR,gene,0.9985,22252310
38829,ErbB,gene,0.9956,22252310
38830,EGFR,gene,0.996,22252310
38831,tyrosine,drug,0.975,22252310
38832,tyrosine kinase,gene,0.7363,22252310
38833,SCCHN,disease,1.0,22252310
38834,EGFR,gene,0.998,22252310
38835,cetuximab,gene,0.5894,22252310
38836,locally advanced SCCHN,disease,0.996,22252310
38837,SCCHN,disease,1.0,22252310
38838,platinum,drug,0.9995,22252310
38839,5-fluorouracil,drug,0.998,22252310
38840,SCCHN,disease,0.9995,22252310
38841,platinum,drug,0.9995,22252310
38842,EGFR,gene,0.998,22252310
38843,panitumumab,gene,0.865,22252310
38844,nimotuzumab,gene,0.815,22252310
38845,SCCHN,disease,1.0,22252310
38846,tyrosine,drug,0.902,22252310
38847,tyrosine kinase domain,gene,0.9756,22252310
38848,EGFR,gene,0.974,22252310
38849,SCCHN,disease,1.0,22252310
38850,gefitinib,drug,0.994,22252310
38851,erlotinib,drug,0.9917,22252310
38852,SCCHN,disease,1.0,22252310
38853,EGFR,gene,0.9946,22252310
38854,ErbB receptors,gene,0.9907,22252310
38855,lapatinib,drug,0.9956,22252310
38856,ErbB family receptors,gene,0.9927,22252310
38857,afatinib,drug,0.994,22252310
38858,PF-00299804,drug,0.999,22252310
38859,SCCHN,disease,1.0,22252310
38860,SCCHN,disease,0.9995,22252310
38861,venous and arterial thromboembolic events,disease,1.0,22241897
38862,EGFR,gene,0.799,22241897
38863,epidermal growth factor receptor,gene,0.8813,22241897
38864,EGFR,gene,0.994,22241897
38865,tyrosine,drug,0.986,22241897
38866,tyrosine kinase,gene,0.981,22241897
38867,advanced cancers,disease,1.0,22241897
38868,Arterial and venous thromboembolic events,disease,0.9595,22241897
38869,ATEs,disease,0.9995,22241897
38870,VTEs,disease,0.998,22241897
38871,PATIENTS,species,0.96,22241897
38872,VTEs,disease,0.993,22241897
38873,ATEs,disease,0.999,22241897
38874,patients,species,0.9917,22241897
38875,VTEs,disease,0.7964,22241897
38876,patients,species,0.985,22241897
38877,ATEs,disease,0.9443,22241897
38878,patients,species,0.9766,22241897
38879,patients,species,0.9897,22241897
38880,EGFR,gene,0.9814,22241897
38881,VTEs,disease,0.9697,22241897
38882,cetuximab,gene,0.8857,22241897
38883,panitumumab,gene,0.8496,22241897
38884,mutant EGFRs,gene,0.995,22232519
38885,glioblastoma multiforme,disease,1.0,22232519
38886,epidermal growth factor receptor,gene,0.998,22232519
38887,EGFR,gene,0.998,22232519
38888,ErbB1,gene,0.996,22232519
38889,glioblastoma multiforme,disease,1.0,22232519
38890,GBM,disease,1.0,22232519
38891,primary brain tumor,disease,1.0,22232519
38892,wild-type,gene,0.8276,22232519
38893,GBMs,disease,1.0,22232519
38894,EGFR,gene,0.994,22232519
38895,intact cells,cell_type,0.913,22232519
38896,EGFRvIII,gene,0.995,22232519
38897,EGFRc958 mutants,gene,0.9917,22232519
38898,EGFR mutants,gene,0.985,22232519
38899,GBMs,disease,1.0,22232519
38900,phospho,drug,0.511,22232519
38901,phospho-EGFR,gene,0.9805,22232519
38902,EGFRwt,gene,0.9985,22232519
38903,EGFRvIII,gene,0.997,22232519
38904,GBM,disease,1.0,22232519
38905,cell line,cell_line,0.7256,22232519
38906,EGFR,gene,0.799,22232519
38907,cetuximab,gene,0.894,22232519
38908,matuzumab,gene,0.9146,22232519
38909,panitumumab,gene,0.8413,22232519
38910,EGFRwt,gene,0.9873,22232519
38911,EGFRvIII homodimers,gene,0.969,22232519
38912,EGFRwt,gene,0.996,22232519
38913,EGFRvIII,gene,0.998,22232519
38914,EGFRvIII,gene,0.999,22232519
38915,EGFRc958,gene,0.992,22232519
38916,EGFRvIII,gene,0.9897,22232519
38917,matuzumab,gene,0.913,22232519
38918,EGFR monoclonal antibodies,gene,0.99,22232519
38919,mutant EGFR dimer,gene,0.982,22232519
38920,GBMs,disease,1.0,22232519
38921,EGFR,gene,0.7085,22232519
38922,KRAS,gene,0.9316,22214007
38923,BRAF,DNA,0.7207,22214007
38924,BRAF,gene,0.9517,22214007
38925,PIK3CA,gene,0.9883,22214007
38926,anti-EGFR antibody,gene,0.918,22214007
38927,metastatic peritoneal and pulmonary colorectal cancer,disease,1.0,22213822
38928,mice,species,0.968,22213822
38929,Human epidermal growth factor receptor 1,gene,0.9976,22213822
38930,Human,species,0.8354,22213822
38931,HER1,gene,0.989,22213822
38932,colorectal cancer,disease,1.0,22213822
38933,Panitumumab,gene,0.63,22213822
38934,anti-HER1 monoclonal antibody,gene,0.977,22213822
38935,colorectal cancer,disease,1.0,22213822
38936,HER1,gene,0.9937,22213822
38937,panitumumab,gene,0.89,22213822
38938,(89)Zr,drug,0.9995,22213822
38939,HER1,gene,0.9917,22213822
38940,HER1-expressing LS-174T,cell_line,0.669,22213822
38941,HER1,gene,0.9966,22213822
38942,LS,cell_type,,22213822
38943,HER1,gene,0.8774,22213822
38944,tumor,disease,0.934,22213822
38945,intraperitoneal and pulmonary metastases,disease,0.992,22213822
38946,(89)Zr,drug,0.9995,22213822
38947,panitumumab,gene,0.8857,22213822
38948,HER1,gene,0.9956,22213822
38949,HER1-expressing models,cell_line,0.842,22213822
38950,HER1,gene,0.9805,22213822
38951,LS-174T,cell_line,0.865,22213822
38952,A375,cell_line,0.8726,22213822
38953,A375,cell_type,0.4648,22213822
38954,LS-174T,cell_line,0.7686,22213822
38955,LS-174T,cell_line,0.8706,22213822
38956,mice,species,0.961,22213822
38957,panitumumab,gene,0.7827,22213822
38958,mice,species,0.96,22213822
38959,tumor,disease,0.994,22213822
38960,mice,species,0.9873,22213822
38961,tumor,disease,0.993,22213822
38962,HER1,gene,0.9927,22213822
38963,LS-174T tumor models,cell_line,0.787,22213822
38964,LS,cell_type,,22213822
38965,LS-174T tumor,disease,0.9463,22213822
38966,subcutaneous tumor,disease,0.999,22213822
38967,thoracic tumors,disease,1.0,22213822
38968,intraperitoneal tumors,disease,1.0,22213822
38969,(89)Zr,drug,0.9995,22213822
38970,panitumumab,gene,0.843,22213822
38971,HER1,gene,0.99,22213822
38972,(89)Zr,drug,0.999,22213822
38973,panitumumab,gene,0.951,22213822
38974,patient,species,0.966,22213822
38975,patients,species,0.9473,22210091
38976,KRAS,gene,0.9863,22210091
38977,Cetuximab,gene,0.8535,22210091
38978,panitumumab,gene,0.7715,22210091
38979,epidermal growth factor receptor,gene,0.997,22210091
38980,EGFR,gene,0.995,22210091
38981,patients,species,0.9883,22210091
38982,KRAS,gene,0.996,22210091
38983,meta-static colorectal cancer,disease,0.989,22210091
38984,panitumumab,gene,0.862,22210091
38985,patients,species,0.992,22210091
38986,cetuximab,gene,0.855,22210091
38987,panitumumab,gene,0.8525,22210091
38988,patients,species,0.9688,22210091
38989,KRAS,DNA,0.7295,22210091
38990,KRAS,gene,0.994,22210091
38991,metastatic colorectal cancer,disease,0.9604,22210091
38992,cetuximab,gene,0.886,22210091
38993,PATIENTS,species,0.93,22210091
38994,patients,species,0.98,22210091
38995,panitumumab,gene,0.859,22210091
38996,panitumumab,gene,0.931,22210091
38997,patients,species,0.9775,22210091
38998,patients,species,0.974,22210091
38999,anti-cetuximab,gene,0.997,22210091
39000,anti-panitumumab antibodies,gene,0.987,22210091
39001,patients,species,0.9834,22210091
39002,patients,species,0.963,22210091
39003,Panitumumab,gene,0.8247,22210091
39004,patients,species,0.994,22210091
39005,dry skin,disease,0.845,22210091
39006,rash,disease,0.938,22210091
39007,patients,species,0.9883,22210091
39008,hyperglycemia,disease,1.0,22210091
39009,hyperbilirubinemia,disease,1.0,22210091
39010,hypokalemia,disease,1.0,22210091
39011,patients,species,0.9673,22210091
39012,anti-cetuximab antibodies,gene,0.995,22210091
39013,patient,species,0.9556,22210091
39014,anti-panitumumab antibodies,gene,0.9824,22210091
39015,Panitumumab,gene,0.7715,22210091
39016,patients,species,0.9775,22210091
39017,KRAS,gene,0.996,22210091
39018,cetuximab,gene,0.798,22210091
39019,cetuximab,gene,0.9517,22210091
39020,panitumumab,gene,0.847,22210091
39021,EGFR,gene,0.991,22210091
39022,Cetuximab,gene,0.8784,22210091
39023,murine,species,0.958,22210091
39024,panitumumab,gene,0.758,22210091
39025,human,species,0.9966,22210091
39026,hypersensitivity reactions,disease,0.971,22210091
39027,cetuximab,gene,0.761,22210091
39028,panitumumab,gene,0.732,22210091
39029,panitumumab,gene,0.934,22210091
39030,patients,species,0.992,22210091
39031,cetuximab,gene,0.863,22210091
39032,KRAS,DNA,0.748,22210091
39033,KRAS,gene,0.998,22210091
39034,metastatic colorectal cancer,disease,1.0,22210091
39035,patients,species,0.979,22210091
39036,cetuximab,gene,0.909,22210091
39037,irinotecan,drug,0.991,22210091
39038,panitumumab,gene,0.8037,22210091
39039,panitumumab,gene,0.815,22210091
39040,patients,species,0.979,22210091
39041,cetuximab,gene,0.934,22210091
39042,irinotecan,drug,0.9956,22210091
39043,patients,species,0.981,22210091
39044,patients,species,0.9673,22210091
39045,anti-cetuximab antibodies,gene,0.99,22210091
39046,patients,species,0.9854,22210091
39047,cetuximab,gene,0.779,22210091
39048,cetuximab,gene,0.8984,22210091
39049,panitumumab,gene,0.812,22210091
39050,carcinoembryonic antigen,gene,0.9985,22210091
39051,CEA,gene,0.994,22210091
39052,cetuximab,gene,0.757,22210091
39053,patients,species,0.982,22210091
39054,panitumumab,gene,0.889,22210091
39055,cetuximab,gene,0.837,22210091
39056,panitumumab,gene,0.8716,22210091
39057,patients,species,0.984,22210091
39058,cetuximab,gene,0.813,22210091
39059,KRAS,gene,0.9907,22208484
39060,EGFR,gene,0.705,22208484
39061,patients,species,0.975,22208484
39062,KRAS,DNA,0.7866,22208484
39063,KRAS,gene,0.986,22208484
39064,patient,species,0.954,22208484
39065,EGFR antibodies,gene,0.6797,22208484
39066,cetuximab,gene,0.9077,22208484
39067,panitumumab,gene,0.8354,22208484
39068,metastatic colorectal carcinoma,disease,0.9946,22208484
39069,KRAS,DNA,0.838,22208484
39070,KRAS mutations,gene,0.9585,22208484
39071,KRAS,DNA,0.844,22208484
39072,KRAS mutations,gene,0.975,22208484
39073,KRAS,gene,0.9814,22208484
39074,KRAS,DNA,0.8867,22208484
39075,KRAS mutation,gene,0.837,22208484
39076,metastatic colon carcinoma,disease,1.0,22208484
39077,KRAS,DNA,0.8916,22208484
39078,KRAS mutation,gene,0.9287,22208484
39079,KRAS,gene,0.9834,22208484
39080,ovarian metastasis,disease,0.984,22202357
39081,colon cancer,disease,0.9995,22202357
39082,sigmoid colon cancer,disease,1.0,22202357
39083,bilateral ovarian tumors,disease,0.938,22202357
39084,colon cancer,disease,1.0,22202357
39085,gastric cancer,disease,1.0,22202357
39086,capecitabine,drug,0.9985,22202357
39087,para-aortic lymph node,disease,0.9863,22202357
39088,FOLFIRI,drug,0.976,22202357
39089,panitumumab,gene,0.9478,22202357
39090,CK20,gene,0.996,22202357
39091,CK7,DNA,0.554,22202357
39092,CK7,gene,0.998,22202357
39093,Ovarian tumors,disease,0.9995,22202357
39094,colon cancer,disease,1.0,22202357
39095,colon cancer,disease,1.0,22202357
39096,colorectal cancer,disease,1.0,22202344
39097,patient,species,0.9824,22202344
39098,multiple liver metastases,disease,0.9014,22202344
39099,colorectal cancer,disease,0.9995,22202344
39100,-FU,drug,0.8164,22202344
39101,IRIS,disease,0.998,22202344
39102,S-1,drug,0.985,22202344
39103,CPT-11,drug,0.9956,22202344
39104,5-FU,drug,0.996,22202344
39105,panitumumab,gene,0.896,22202344
39106,Panitumumab,gene,0.937,22202344
39107,5-FU,drug,0.997,22202344
39108,tumor,disease,0.996,22202344
39109,FOLFIRI,drug,0.9507,22202344
39110,FOLFIRI,drug,0.8613,22202344
39111,colorectal cancer,disease,1.0,22202344
39112,IRIS,drug,0.856,22202344
39113,FOLFIRI,drug,0.756,22202344
39114,liver metastases,disease,0.9985,22202344
39115,colorectal cancer,disease,1.0,22202344
39116,panitumumab,gene,0.937,22202344
39117,IRIS,disease,0.999,22202344
39118,patients,species,0.997,22202343
39119,anti-EGFR antibody,gene,0.976,22202343
39120,patients,species,0.9966,22202343
39121,anti-EGFR antibody,gene,0.9717,22202343
39122,metastatic colorectal cancer,disease,0.9927,22202343
39123,woman,species,0.9097,22202343
39124,cetuximab,gene,0.622,22202343
39125,rectal cancer,disease,1.0,22202343
39126,liver and lung metastases,disease,0.9795,22202343
39127,CEA,gene,0.991,22202343
39128,CA19-9,gene,0.9097,22202343
39129,rectal tumor,disease,0.9995,22202343
39130,woman,species,0.918,22202343
39131,cetuximab,gene,0.65,22202343
39132,peritoneal metastases,disease,0.976,22202343
39133,CEA,gene,0.993,22202343
39134,CA19-9,gene,0.9175,22202343
39135,tumor,disease,0.9683,22202343
39136,man,species,0.8916,22202343
39137,panitumumab,gene,0.6274,22202343
39138,"lung, liver and para-aortic lymph node metastases",disease,0.9375,22202343
39139,descending colectomy,disease,0.9956,22202343
39140,CEA,gene,0.992,22202343
39141,CA19-9,gene,0.917,22202343
39142,tumor,disease,0.998,22202343
39143,Elders,species,0.695,22202343
39144,acneiform skin rash,disease,1.0,22202343
39145,paronychia,disease,1.0,22202343
39146,desquamation,disease,1.0,22202343
39147,dry skin,disease,1.0,22202343
39148,pruritis,disease,1.0,22202343
39149,skin rash,disease,1.0,22202343
39150,EGFR,gene,0.9565,22201852
39151,colorectal carcinoma,disease,1.0,22201852
39152,epidermal growth factor receptor,gene,0.9976,22201852
39153,EGFR,gene,0.9956,22201852
39154,cancer,disease,1.0,22201852
39155,tumours,disease,1.0,22201852
39156,Cetuximab,gene,0.747,22201852
39157,panitumumab,gene,0.637,22201852
39158,EGFR,gene,0.994,22201852
39159,metastatic colorectal cancer,disease,1.0,22201852
39160,patients,species,0.989,22201852
39161,EGFR,gene,0.9897,22201852
39162,patients,species,0.9917,22201852
39163,K-Ras,gene,0.998,22201852
39164,RAS family,gene,0.993,22201852
39165,EGFR,gene,0.995,22201852
39166,Patients,species,0.9736,22201852
39167,wild-type K-Ras,gene,0.998,22201852
39168,patients,species,0.978,22201852
39169,K-Ras,gene,0.997,22201852
39170,metastatic colorectal cancer,disease,0.999,22192364
39171,metastatic colorectal cancer,disease,1.0,22192364
39172,mCRC,disease,1.0,22192364
39173,irinotecan,drug,0.9995,22192364
39174,oxaliplatin,drug,0.9995,22192364
39175,5-fluorouracil,drug,0.9995,22192364
39176,5-FU,drug,0.9995,22192364
39177,capecitabine,drug,0.9995,22192364
39178,bevacizumab,gene,0.9316,22192364
39179,cetuximab,gene,0.8633,22192364
39180,panitumumab,gene,0.909,22192364
39181,bevacizumab,gene,0.5977,22192364
39182,anti-endothelial growth factor,gene,0.9497,22192364
39183,EGFR,gene,0.821,22192364
39184,monoclonal,gene,0.4375,22192364
39185,EGFR,gene,0.9683,22192364
39186,FOLFIRI,drug,0.9062,22192364
39187,5-fluorouracil,drug,0.9995,22192364
39188,leucovorin,drug,0.9985,22192364
39189,folinic acid,drug,0.999,22192364
39190,irinotecan,drug,0.9985,22192364
39191,FOLFOX,drug,0.873,22192364
39192,5-,drug,1.0,22192364
39193,fluorouracil,drug,0.9927,22192364
39194,leucovorin,drug,0.9995,22192364
39195,folinic acid,drug,0.999,22192364
39196,oxaliplatin,drug,0.9995,22192364
39197,patients,species,0.9863,22192364
39198,tumors,disease,1.0,22192364
39199,wild-type KRAS,gene,0.9966,22192364
39200,cetuximab,gene,0.906,22192364
39201,patients,species,0.979,22192364
39202,patients,species,0.9883,22192364
39203,tumor,disease,0.998,22192364
39204,patient,species,0.9927,22192364
39205,patients,species,0.987,22192364
39206,Cancer,disease,0.878,22192364
39207,KRAS,gene,0.98,22192364
39208,mCRC,disease,0.957,22192364
39209,EGFR,gene,0.6255,22192364
39210,cancer,disease,1.0,22188921
39211,cetuximab,gene,0.8745,22188921
39212,trastuzumab,gene,0.9663,22188921
39213,panitumumab,gene,0.9683,22188921
39214,nimotuzumab,gene,0.8804,22188921
39215,sunitinib,drug,0.9995,22188921
39216,sorafenib,drug,0.9995,22188921
39217,lapatinib,drug,1.0,22188921
39218,gefitinib,drug,0.9995,22188921
39219,erlotinib,drug,0.9995,22188921
39220,thalidomide,drug,0.9995,22188921
39221,lenalidomide,drug,0.9995,22188921
39222,erythropoietin,gene,0.9917,22188921
39223,hypo-,disease,0.9995,22188921
39224,dermatologic adverse,disease,0.77,22184762
39225,dermatologic toxicities,disease,0.806,22184762
39226,patients,species,0.9844,22184762
39227,PATIENTS,species,0.832,22184762
39228,cancer,disease,1.0,22184762
39229,patient,species,0.9854,22184762
39230,patients,species,0.9907,22184762
39231,patient,species,0.9897,22184762
39232,Sorafenib,drug,0.999,22184762
39233,patient,species,0.9663,22184762
39234,patient,species,0.8633,22184762
39235,imatinib,drug,0.9976,22184762
39236,patient,species,0.983,22184762
39237,patient,species,0.9785,22184762
39238,dT,DNA,,22184762
39239,hand/foot skin reaction,disease,1.0,22184762
39240,sorafenib,drug,0.999,22184762
39241,patient,species,0.977,22184762
39242,panitumumab,gene,0.8726,22184762
39243,acneiform eruption,disease,1.0,22184762
39244,patient,species,0.9814,22184762
39245,dTs,disease,0.745,22184762
39246,cancer,disease,1.0,22184762
39247,dTs,disease,0.6934,22184762
39248,metastatic colorectal cancer,disease,1.0,22181051
39249,metastatic colorectal cancer,disease,1.0,22181051
39250,bevacizumab,gene,0.888,22181051
39251,cetuximab,gene,0.9194,22181051
39252,panitumumab,gene,0.948,22181051
39253,ICD,DNA,0.5605,22181051
39254,bevacizumab,gene,0.655,22181051
39255,hypertension,disease,1.0,22181051
39256,arterial thrombosis,disease,1.0,22181051
39257,hemorrhage,disease,1.0,22181051
39258,gastrointestinal (GI) perforation,disease,1.0,22181051
39259,fistula,disease,1.0,22181051
39260,wound-healing complications,disease,0.898,22181051
39261,cetuximab,gene,0.9463,22181051
39262,panitumumab,gene,0.897,22181051
39263,skin rash,disease,1.0,22181051
39264,hypomagnesemia,disease,1.0,22181051
39265,infusion reactions,disease,0.6177,22181051
39266,GI perforation,disease,0.9995,22181051
39267,fistula,disease,0.999,22181051
39268,arterial thrombosis,disease,1.0,22181051
39269,hypomagnesemia,disease,1.0,22181051
39270,skin rash,disease,1.0,22181051
39271,skin rash,disease,1.0,22181051
39272,wound,disease,0.5176,22181051
39273,(86)Y-CHX-A&#x27;&#x27;-diethylenetriamine pentaacetic acid,drug,0.8745,22171389
39274,panitumumab,gene,0.958,22171389
39275,Epidermal growth factor,gene,0.996,22171389
39276,EGF,gene,0.994,22171389
39277,amino,drug,0.963,22171389
39278,ectodermic cells,cell_type,0.8975,22171389
39279,monocytes,cell_type,0.847,22171389
39280,EGF,gene,0.994,22171389
39281,epidermal,cell_line,0.5415,22171389
39282,epidermal and epithelial cells,cell_type,0.8745,22171389
39283,EGF,gene,0.9937,22171389
39284,EGF receptor,gene,0.998,22171389
39285,EGFR,gene,0.992,22171389
39286,EGFR,gene,0.996,22171389
39287,HER1,gene,0.9985,22171389
39288,erbB-1,gene,0.998,22171389
39289,HER2,gene,0.994,22171389
39290,erbB-2,gene,0.998,22171389
39291,neu),gene,0.994,22171389
39292,HER3,gene,0.9966,22171389
39293,erbB-3,gene,0.9976,22171389
39294,HER4,gene,0.9956,22171389
39295,erbB-4,gene,0.997,22171389
39296,HER1,gene,0.994,22171389
39297,HER3,gene,0.9897,22171389
39298,HER4,gene,0.9873,22171389
39299,cytoplasmic tyrosine kinase domain,gene,0.903,22171389
39300,tyrosine,drug,0.9663,22171389
39301,HER2,gene,0.994,22171389
39302,HER2,gene,0.9927,22171389
39303,HER receptors,gene,0.992,22171389
39304,HER1,gene,0.989,22171389
39305,HER2,gene,0.993,22171389
39306,solid tumor cells,cell_type,0.728,22171389
39307,solid tumor,disease,0.998,22171389
39308,"breast, nonsmall-cell lung, head and neck, and colon cancers",disease,1.0,22171389
39309,HER1,gene,0.995,22171389
39310,HER2,gene,0.991,22171389
39311,cancer cells,cell_type,0.848,22171389
39312,cancer,disease,0.9976,22171389
39313,Trastuzumab,gene,0.796,22171389
39314,humanized immunoglobulin G(1),gene,0.98,22171389
39315,humanized,species,0.765,22171389
39316,IgG(1),gene,0.9375,22171389
39317,recombinant HER2,gene,0.993,22171389
39318,(111)In,drug,0.9995,22171389
39319,C225 mAb,gene,0.9756,22171389
39320,"anti-EGFR,",gene,0.981,22171389
39321,"mouse-human chimeric, monoclonal IgG(1) antibody",gene,0.939,22171389
39322,mouse,species,0.98,22171389
39323,human,species,0.8926,22171389
39324,cetuximab,gene,0.8022,22171389
39325,99m)Tc-,drug,0.998,22171389
39326,EC-C225,drug,0.824,22171389
39327,EGFR,gene,0.986,22171389
39328,solid tumors,disease,1.0,22171389
39329,(64)Cu,drug,0.9985,22171389
39330,cetuximab,gene,0.988,22171389
39331,Panitumumab,gene,0.832,22171389
39332,EGFR,gene,0.9927,22171389
39333,colorectal carcinoma,disease,0.6484,22171389
39334,(64)Cu,drug,0.999,22171389
39335,panitumumab,gene,0.886,22171389
39336,"1,4,7,10-tetraazacyclododecane-N,N&#x27;,N&#x27;&# acid",drug,0.997,22171389
39337,DOTA,drug,0.9995,22171389
39338,(64)Cu,drug,0.9995,22171389
39339,panitumumab,gene,0.9497,22171389
39340,(64)Cu,drug,0.999,22171389
39341,panitumumab,gene,0.9746,22171389
39342,nude mice,species,0.544,22171389
39343,human,species,0.9937,22171389
39344,head and neck squamous cell carcinoma,disease,0.9995,22171389
39345,tumors,disease,0.99,22171389
39346,EGFR,gene,0.988,22171389
39347,(86)Y-CHX-A&#x27;&#x27;-diethylenetriamine pentaacetic acid,drug,0.995,22171389
39348,DTPA,drug,0.9995,22171389
39349,panitumumab,gene,0.707,22171389
39350,(86)Y,drug,0.9985,22171389
39351,HER1,gene,0.9917,22171389
39352,carcinoma,disease,1.0,22171389
39353,(86)Y,drug,0.9966,22171389
39354,(90)Y,drug,0.987,22171389
39355,anti-epidermal growth factor receptor,gene,0.9683,22169039
39356,EGFR,gene,0.996,22169039
39357,Monoclonal antibodies,gene,0.8916,22168282
39358,cell,cell_type,0.4434,22168282
39359,abciximab,gene,0.956,22168282
39360,alemtuzumab,gene,0.82,22168282
39361,basiliximab,gene,0.9395,22168282
39362,cetuximab,gene,0.919,22168282
39363,daclizumab,gene,0.5884,22168282
39364,efalizumab,gene,0.5674,22168282
39365,muromonab,gene,0.761,22168282
39366,natalizumab,gene,0.8,22168282
39367,panitumumab,gene,0.892,22168282
39368,rituximab,gene,0.926,22168282
39369,tocilizumab,gene,0.9116,22168282
39370,trastuzumab,gene,0.905,22168282
39371,mAbs,gene,0.5273,22168282
39372,human,species,0.9917,22168282
39373,mice,species,0.985,22168282
39374,human,species,0.791,22168282
39375,human,species,0.996,22168282
39376,human,species,0.9917,22168282
39377,mice,species,0.9873,22168282
39378,human,species,0.9937,22168282
39379,NHPs,cell_type,0.4734,22168282
39380,EGFR,gene,0.993,22158333
39381,skin rash,disease,0.999,22158333
39382,epidermal growth factor receptor,gene,0.9966,22158333
39383,EGFR,gene,0.9966,22158333
39384,cancer,disease,1.0,22158333
39385,patients,species,0.982,22158333
39386,EGFR,gene,0.9805,22158333
39387,functional EGFR polymorphisms,DNA,0.5786,22158333
39388,patients,species,0.977,22158333
39389,patients,species,0.9927,22158333
39390,skin rash,disease,0.9697,22158333
39391,EGFR,gene,0.9873,22158333
39392,497G,RNA,0.4602,22158333
39393,promoter variants,DNA,0.8203,22158333
39394,EGFR-216G/T,gene,0.9214,22158333
39395,skin rash,disease,1.0,22158333
39396,PIK3CA gene,DNA,0.9062,22158333
39397,PIK3CA gene,gene,0.9917,22158333
39398,skin rash,disease,1.0,22158333
39399,EGFR gene,gene,0.9917,22158333
39400,PIK3CA,gene,0.996,22158333
39401,EGFR,gene,0.992,22158333
39402,skin rash,disease,0.988,22158333
39403,Nephrotoxicity,disease,0.9463,22145268
39404,glomerular or tubular dysfunction,disease,1.0,22145268
39405,hypertension,disease,1.0,22145268
39406,disturbance,disease,0.6963,22145268
39407,chronic kidney disease,disease,1.0,22145268
39408,cancer,disease,1.0,22145268
39409,patient,species,0.9907,22145268
39410,anticancer,disease,0.6226,22145268
39411,cisplatin,drug,1.0,22145268
39412,methotrexate,drug,0.9995,22145268
39413,ifosfamide,drug,0.999,22145268
39414,citumixab,drug,0.9,22145268
39415,panitumumab,gene,0.8486,22145268
39416,mitocin C,drug,0.997,22145268
39417,gemcitabine,drug,0.9995,22145268
39418,EGFR,gene,0.9897,22145213
39419,metastatic colorectal,disease,1.0,22145213
39420,cetuximab,gene,0.7417,22145213
39421,epidermal growth factor receptor,gene,0.9966,22145213
39422,EGFR,gene,0.9976,22145213
39423,metastatic colorectal cancer,disease,1.0,22145213
39424,patients,species,0.99,22145213
39425,EGFR,gene,0.994,22145213
39426,EGFR,gene,0.9937,22145213
39427,EGFR,gene,0.996,22145213
39428,"KRAS, BRAF, or PIK3CA oncogenes",DNA,0.924,22145213
39429,KRAS,gene,0.977,22145213
39430,BRAF,gene,0.933,22145213
39431,PIK3CA oncogenes,gene,0.9624,22145213
39432,PTEN tumor supressor gene,gene,0.988,22145213
39433,tumor,disease,0.518,22145213
39434,colorectal cancer,disease,1.0,22145213
39435,KRAS,DNA,0.603,22145213
39436,patients,species,0.9194,22145213
39437,colorectal cancer,disease,1.0,22145213
39438,cetuximab,gene,0.95,22145213
39439,panitumumab,gene,0.9336,22145213
39440,tumors,disease,1.0,22145213
39441,wild,gene,0.849,22145213
39442,BRAF,gene,0.992,22145213
39443,PIK3CA,gene,0.9976,22145213
39444,PTEN,gene,0.9805,22145213
39445,anti-EGFR monoclonal antibody,gene,0.939,22145213
39446,EGFR ligands,gene,0.856,22145213
39447,tumor,disease,1.0,22145213
39448,cetuximab,gene,0.9585,22145213
39449,panitumumab,gene,0.912,22145213
39450,epidermal growth factor receptor,gene,0.983,22127113
39451,cancer,disease,1.0,22127113
39452,epidermal growth factor receptor,gene,0.999,22127113
39453,EGFR,gene,0.996,22127113
39454,EGFR family,gene,0.993,22127113
39455,receptor tyrosine kinases,gene,0.9927,22127113
39456,tyrosine,drug,0.985,22127113
39457,RTKs,gene,0.9863,22127113
39458,EGFR,gene,0.9937,22127113
39459,EGFR,gene,0.9893,22127113
39460,epithelial cancers,disease,1.0,22127113
39461,head and neck squamous cell carcinoma,disease,1.0,22127113
39462,HNSCC,disease,1.0,22127113
39463,non-small cell lung cancer,disease,1.0,22127113
39464,NSCLC,disease,1.0,22127113
39465,colorectal cancer,disease,1.0,22127113
39466,CRC,disease,1.0,22127113
39467,breast cancer,disease,1.0,22127113
39468,pancreatic cancer,disease,1.0,22127113
39469,brain cancer,disease,1.0,22127113
39470,EGFR,gene,0.9893,22127113
39471,cetuximab,gene,0.846,22127113
39472,panitumumab,gene,0.881,22127113
39473,tyrosine,drug,0.9014,22127113
39474,tyrosine kinase domain,gene,0.6313,22127113
39475,erlotinib,drug,0.999,22127113
39476,gefitinib,drug,0.9985,22127113
39477,lapatinib,drug,0.999,22127113
39478,EGFR,gene,0.647,22127113
39479,EGFR,gene,0.9863,22127113
39480,nuclear EGFR,gene,0.6953,22127113
39481,cancer,disease,1.0,22127113
39482,epidermal growth factor receptor,gene,0.9966,22123060
39483,epidermal growth factor receptor,gene,0.9985,22123060
39484,EGFR,gene,0.9937,22123060
39485,malignancies,disease,1.0,22123060
39486,cancer,disease,1.0,22123060
39487,anti-EGFR antibodies,gene,0.921,22123060
39488,cetuximab,gene,0.879,22123060
39489,panitumumab,gene,0.858,22123060
39490,epitopes,DNA,0.5234,22123060
39491,human cancer cells,cell_type,0.84,22123060
39492,cancer,disease,0.6353,22123060
39493,anti-EGFR antibody,gene,0.912,22123060
39494,Sym004,drug,0.847,22123060
39495,anti-EGFR antibodies,gene,0.96,22123060
39496,cancer cells,cell_type,0.876,22123060
39497,cancer,disease,0.998,22123060
39498,tumor,disease,1.0,22123060
39499,EGFR dependent cancer cells,cell_line,0.842,22123060
39500,EGFR,gene,0.5864,22123060
39501,cancer cells,cell_type,0.7036,22123060
39502,cancer,disease,0.9883,22123060
39503,EGFR,gene,0.986,22123060
39504,EGFR,gene,0.994,22100458
39505,skin,disease,0.7173,22100458
39506,Epidermal growth factor receptor,gene,0.9985,22100458
39507,EGFR,gene,0.9937,22100458
39508,cetuximab,gene,0.4724,22100458
39509,panitumumab,gene,0.859,22100458
39510,cancer,disease,0.9995,22100458
39511,EGFR,gene,0.992,22100458
39512,tumor,disease,0.999,22100458
39513,skin,disease,0.696,22100458
39514,tumor,disease,0.981,22100458
39515,EGFR,gene,0.9907,22100458
39516,EGFR,gene,0.992,22100458
39517,EGFR,gene,0.9946,22100458
39518,skin,disease,0.71,22100458
39519,nail,disease,0.5947,22088429
39520,epidermal growth factor receptor,gene,0.995,22088429
39521,nail changes,disease,0.9688,22088429
39522,epidermal growth factor receptor,gene,0.9966,22088429
39523,EGFRIs,gene,0.9517,22088429
39524,nail toxicity,disease,0.982,22088429
39525,EGFRIs,gene,0.9497,22088429
39526,nail toxicity,disease,0.977,22088429
39527,nail toxicity,disease,0.874,22088429
39528,nail toxicity,disease,0.95,22088429
39529,nail,disease,0.7944,22088429
39530,cancer,disease,1.0,22088429
39531,EGFRIs,gene,0.9614,22088429
39532,EGFRI,gene,0.996,22088429
39533,epidermal growth factor receptor,gene,0.994,22085444
39534,epidermal growth factor receptor,gene,0.9985,22085444
39535,EGFR,gene,0.9897,22085444
39536,mAb,gene,0.867,22085444
39537,EGFR,gene,0.9883,22085444
39538,matuzumab,gene,0.979,22085444
39539,cetuximab,gene,0.9575,22085444
39540,panitumumab,gene,0.9097,22085444
39541,extracellular soluble form,RNA,0.63,22085444
39542,ecEGFR,gene,0.4873,22085444
39543,ecEGFR,gene,0.9863,22085444
39544,ecEGFR molecules,gene,0.966,22085444
39545,cetuximab,gene,0.978,22085444
39546,matuzumab,gene,0.954,22085444
39547,panitumumab,gene,0.748,22085444
39548,anti-EGFR antibodies,gene,0.991,22085444
39549,KRAS,DNA,0.7344,22083191
39550,KRAS mutations,gene,0.868,22083191
39551,codons 12 and 13,DNA,0.7007,22083191
39552,formalin,drug,0.966,22083191
39553,metastatic colorectal cancer,disease,1.0,22083191
39554,anti-EGFR monoclonal antibodies,gene,0.9863,22083191
39555,cetuximab,gene,0.667,22083191
39556,panitumumab,gene,0.6753,22083191
39557,metastatic colorectal cancer,disease,1.0,22083191
39558,mCRC,disease,1.0,22083191
39559,KRAS,DNA,0.807,22083191
39560,KRAS mutations,gene,0.825,22083191
39561,KRAS mutation,gene,0.662,22083191
39562,EGFR,gene,0.931,22083191
39563,mCRC,disease,0.9453,22083191
39564,KRAS,DNA,0.833,22083191
39565,KRAS mutation,gene,0.8096,22083191
39566,KRAS,DNA,0.804,22083191
39567,KRAS mutations,gene,0.905,22083191
39568,KRAS,DNA,0.7983,22083191
39569,KRAS mutations,gene,0.758,22083191
39570,plasmid DNAs,DNA,0.8223,22083191
39571,mutant KRAS genes,gene,0.897,22083191
39572,formalin,drug,0.991,22083191
39573,mCRC,disease,1.0,22083191
39574,KRAS,gene,0.849,22083191
39575,paraffin,cell_line,0.5044,22083191
39576,mCRC,disease,0.998,22083191
39577,KRAS,DNA,0.724,22083191
39578,KRAS mutation,gene,0.872,22083191
39579,Skin,disease,0.644,22083182
39580,skin,disease,0.5684,22083182
39581,skin disorder,disease,1.0,22083182
39582,epidermal growth factor receptor,gene,0.998,22083182
39583,EGFR,gene,0.99,22083182
39584,cetuximab,gene,0.747,22083182
39585,panitumumab,gene,0.809,22083182
39586,erlotinib,drug,0.9897,22083182
39587,EGFR,gene,0.9927,22083182
39588,hand-foot syndrome,disease,1.0,22083182
39589,fluorinated pyrimidine,drug,0.9966,22083182
39590,capecitabine,drug,0.9976,22083182
39591,S-1,drug,0.994,22083182
39592,Pulmonary,disease,0.9214,22076388
39593,Pulmonary,disease,0.647,22076388
39594,endothelial growth factor receptor,gene,0.9985,22076388
39595,EGFR,gene,0.996,22076388
39596,tyrosine,drug,0.9688,22076388
39597,tyrosine kinase,gene,0.8604,22076388
39598,gefitinib,drug,0.9985,22076388
39599,erlotinib,drug,0.9937,22076388
39600,interstitial lung disease,disease,1.0,22076388
39601,ILD,disease,1.0,22076388
39602,BCR,gene,0.998,22076388
39603,ABL,gene,0.997,22076388
39604,tyrosine,drug,0.798,22076388
39605,imatinib,drug,0.991,22076388
39606,dasatinib,drug,0.981,22076388
39607,pleural effusions,disease,1.0,22076388
39608,EGFR,gene,0.727,22076388
39609,cetuximab,gene,0.829,22076388
39610,panitumumab,gene,0.897,22076388
39611,bronchiolitis,disease,1.0,22076388
39612,pulmonary fibrosis,disease,1.0,22076388
39613,mammalian target of rapamycin,gene,0.9795,22076388
39614,rapamycin,drug,0.997,22076388
39615,mTOR,gene,0.995,22076388
39616,interstitial pneumonitis,disease,1.0,22076388
39617,Bevacizumab,drug,0.6226,22076388
39618,vascular endothelial growth factor,gene,0.9893,22076388
39619,VEGF,gene,0.996,22076388
39620,hemoptysis,disease,0.99,22076388
39621,pulmonary embolism,disease,1.0,22076388
39622,squamous cell lung cancer,disease,1.0,22076388
39623,acute respiratory distress syndrome,disease,1.0,22076388
39624,ARDS,disease,1.0,22076388
39625,interstitial pneumonitis,disease,1.0,22076388
39626,rituximab,gene,0.542,22076388
39627,alemtuzumab,gene,0.775,22076388
39628,pulmonary and cardiovascular co-morbidities,disease,0.9976,22076388
39629,panitumumab,gene,0.7876,22070868
39630,Panitumumab,gene,0.7324,22070868
39631,epidermal growth factor receptor,gene,0.997,22070868
39632,metastatic colorectal cancer,disease,1.0,22070868
39633,mCRC,disease,1.0,22070868
39634,panitumumab,gene,0.702,22070868
39635,anti-panitumumab antibodies,gene,0.9727,22070868
39636,mCRC,disease,0.9917,22070868
39637,panitumumab,gene,0.661,22070868
39638,oxaliplatin,drug,0.9995,22070868
39639,irinotecan,drug,0.9966,22070868
39640,anti-panitumumab antibodies,gene,0.982,22070868
39641,panitumumab,gene,0.8325,22070868
39642,anti-panitumumab antibodies,gene,0.9424,22070868
39643,panitumumab,gene,0.5557,22070868
39644,oxaliplatin,drug,0.9995,22070868
39645,irinotecan,drug,0.997,22070868
39646,anti-panitumumab antibodies,gene,0.9287,22070868
39647,tumors,disease,1.0,22070868
39648,mutant KRAS,gene,0.7607,22070868
39649,oxaliplatin,drug,0.9995,22070868
39650,irinotecan,drug,0.995,22070868
39651,anti-panitumumab antibodies,gene,0.9795,22070868
39652,panitumumab,gene,0.7363,22070868
39653,Panitumumab,gene,0.908,22070868
39654,panitumumab,gene,0.863,22070868
39655,Liver,disease,0.725,22044204
39656,colorectal cancer,disease,1.0,22044204
39657,Colorectal liver metastases,disease,1.0,22044204
39658,CLM,disease,1.0,22044204
39659,CLM,disease,1.0,22044204
39660,CLM,disease,0.9995,22044204
39661,PIK3CA exon 20,gene,0.617,22039088
39662,anti-EGFR monoclonal antibodies,gene,0.909,22039088
39663,KRAS,gene,0.4924,22039088
39664,metastatic colorectal cancer,disease,0.9985,22039088
39665,PIK3CA,gene,0.5566,22039088
39666,anti-,gene,0.7607,22039088
39667,epidermal growth factor receptor,gene,0.878,22039088
39668,EGFR,gene,0.994,22039088
39669,PIK3CA exon,gene,0.817,22039088
39670,metastatic colorectal cancer,disease,1.0,22039088
39671,mCRC,disease,1.0,22039088
39672,PIK3CA,gene,0.994,22039088
39673,mCRC,disease,0.995,22039088
39674,anti-EGFR,gene,0.7485,22039088
39675,mCRC,disease,0.9917,22039088
39676,KRAS,gene,0.541,22039088
39677,mCRC,disease,0.9907,22039088
39678,PIK3CA exon 20,DNA,0.7363,22039088
39679,PIK3CA exon 20 mutations,gene,0.931,22039088
39680,PIK3CA exon,gene,0.9165,22039088
39681,PIK3CA exon 20,gene,0.7583,22039088
39682,KRAS,gene,0.7876,22039088
39683,mCRC,disease,0.9985,22039088
39684,anti-EGFR,gene,0.7847,22039088
39685,MoAbs,gene,0.687,22039088
39686,exon 20,DNA,0.5537,22039088
39687,exon 9,DNA,0.4836,22039088
39688,PIK3CA exon 20,gene,0.603,22039088
39689,anti-EGFR MoAbs,gene,0.784,22039088
39690,KRAS,gene,0.99,22039088
39691,mCRC,disease,0.9873,22039088
39692,Phytomenadione,drug,0.9883,22035385
39693,EGFR,gene,0.995,22035385
39694,folliculitis,disease,0.998,22035385
39695,epidermal growth factor receptor,gene,0.997,22035385
39696,Acneiform eruptions,disease,1.0,22035385
39697,skin toxicities,disease,0.999,22035385
39698,patients,species,0.9956,22035385
39699,phytomenadione,drug,0.998,22035385
39700,vitamin K1,drug,0.9995,22035385
39701,acne-like follicular rash,disease,1.0,22035385
39702,epidermal growth factor receptor,gene,0.996,22035385
39703,patients,species,0.979,22035385
39704,colorectal cancer,disease,1.0,22035385
39705,head and neck cancer,disease,1.0,22035385
39706,phytomenadione,drug,0.999,22035385
39707,patients,species,0.9526,22035385
39708,patients,species,0.9883,22035385
39709,cetuximab,gene,0.9185,22035385
39710,panitumumab,gene,0.931,22035385
39711,folliculitis,disease,0.8784,22035385
39712,phytomenadione,drug,0.9995,22035385
39713,patients,species,0.9795,22035385
39714,phytomenadione,drug,0.9844,22035385
39715,acneiform eruptions,disease,1.0,22035385
39716,patients,species,0.9917,22035385
39717,rash,disease,0.852,22035385
39718,patients,species,0.9937,22035385
39719,phytomenadione,drug,0.9995,22035385
39720,patients,species,0.9917,22035385
39721,phytomenadione,drug,0.9995,22035385
39722,phytomenadione,drug,0.9985,22035385
39723,abnormalities in blood coagulation,disease,0.949,22035385
39724,phytomenadione,drug,0.9937,22035385
39725,epidermal growth factor,gene,0.996,22035385
39726,acneiform eruptions,disease,1.0,22035385
39727,panitumumab,gene,0.8154,22000810
39728,FOLFIRI,drug,0.974,22000810
39729,Panitumumab,gene,0.8003,22000810
39730,human,species,0.654,22000810
39731,epidermal growth factor receptor,gene,0.997,22000810
39732,EGFR,gene,0.9927,22000810
39733,metastatic colorectal cancer,disease,0.999,22000810
39734,mCRC,disease,1.0,22000810
39735,patients,species,0.9385,22000810
39736,wild,gene,0.565,22000810
39737,KRAS,gene,0.6143,22000810
39738,skin toxicities,disease,0.9937,22000810
39739,EGFR,gene,0.9883,22000810
39740,KRAS,gene,0.994,22000810
39741,tumor,disease,0.9985,22000810
39742,PATIENTS,species,0.9707,22000810
39743,patients,species,0.982,22000810
39744,mCRC,disease,0.9897,22000810
39745,fluoropyrimidine,drug,0.999,22000810
39746,oxaliplatin,drug,0.9995,22000810
39747,Patients,species,0.9463,22000810
39748,skin toxicity,disease,0.7607,22000810
39749,Patients,species,0.9717,22000810
39750,panitumumab,gene,0.91,22000810
39751,FOLFIRI,drug,0.9805,22000810
39752,panitumumab,gene,0.8447,22000810
39753,irinotecan,drug,0.9937,22000810
39754,KRAS,DNA,0.758,22000810
39755,KRAS,gene,0.9917,22000810
39756,tumor,disease,0.9556,22000810
39757,patients,species,0.974,22000810
39758,KRAS,gene,0.9907,22000810
39759,patients,species,0.9697,22000810
39760,patients,species,0.9873,22000810
39761,mutant (MT) KRAS tumors,cell_line,0.6367,22000810
39762,mutant (MT,disease,0.9463,22000810
39763,mutant (MT) KRAS,gene,0.893,22000810
39764,patients,species,0.9727,22000810
39765,MT KRAS tumors,disease,0.8564,22000810
39766,MT KRAS,gene,0.667,22000810
39767,patients,species,0.981,22000810
39768,MT KRAS tumors,cell_line,0.5513,22000810
39769,MT KRAS,gene,0.6685,22000810
39770,KRAS,DNA,0.3782,22000810
39771,KRAS tumors,disease,0.5767,22000810
39772,KRAS,gene,0.9937,22000810
39773,tumor,disease,0.858,22000810
39774,dermatitis acneiform,disease,1.0,22000810
39775,pruritus,disease,1.0,22000810
39776,Panitumumab,gene,0.905,22000810
39777,irinotecan,drug,0.998,22000810
39778,mCRC,disease,0.966,22000810
39779,patients,species,0.9883,22000810
39780,WT,disease,,22000810
39781,WT KRAS,gene,0.9575,22000810
39782,EGF receptor,gene,0.9956,21999128
39783,colorectal cancer,disease,1.0,21999128
39784,EGF receptor,gene,0.998,21999128
39785,EGFR,gene,0.995,21999128
39786,cetuximab,gene,0.803,21999128
39787,panitumumab,gene,0.852,21999128
39788,EGFR,gene,0.9927,21999128
39789,advanced colorectal cancer,disease,1.0,21999128
39790,anti-EGFR,gene,0.96,21999128
39791,anti-EGFR,gene,0.9077,21999128
39792,tumor,disease,0.998,21999128
39793,patients,species,0.964,21989186
39794,metastatic colorectal cancer,disease,1.0,21989186
39795,Panitumumab,gene,0.871,21989186
39796,metastatic colorectal cancer,disease,1.0,21989186
39797,mCRC,disease,1.0,21989186
39798,patients,species,0.9893,21989186
39799,panitumumab,gene,0.841,21989186
39800,Patients,species,0.8857,21989186
39801,mCRC,disease,0.9634,21989186
39802,FOLFOX,drug,0.689,21989186
39803,FOLFIRI,drug,0.6416,21989186
39804,panitumumab,gene,0.8994,21989186
39805,Patients,species,0.935,21989186
39806,wild,gene,0.7974,21989186
39807,mCRC,disease,0.998,21989186
39808,patients,species,0.9746,21989186
39809,wild,DNA,0.4878,21989186
39810,wild-type KRAS,gene,0.761,21989186
39811,mCRC,disease,0.9897,21989186
39812,panitumumab,gene,0.9517,21989186
39813,FOLFOX4,drug,0.8813,21989186
39814,FOLFOX4,drug,0.887,21989186
39815,patients,species,0.98,21989186
39816,wild,DNA,0.559,21989186
39817,wild-type KRAS,gene,0.78,21989186
39818,mCRC,disease,0.9917,21989186
39819,panitumumab,gene,0.9526,21989186
39820,FOLFIRI,drug,0.9907,21989186
39821,FOLFIRI,drug,0.9683,21989186
39822,EQ,DNA,,21989186
39823,panitumumab,gene,0.8804,21989186
39824,FOLFOX4,drug,0.9287,21989186
39825,FOLFIRI,drug,0.737,21989186
39826,mCRC,disease,0.957,21989186
39827,colorectal liver metastases,disease,0.9995,21975333
39828,Colorectal cancer,disease,1.0,21975333
39829,CRC,disease,1.0,21975333
39830,cancer,disease,1.0,21975333
39831,colorectal liver metastases,disease,1.0,21975333
39832,CLM,disease,0.9976,21975333
39833,CLM,disease,1.0,21975333
39834,CLM,disease,1.0,21975333
39835,CLM,disease,0.9985,21975333
39836,CLM,disease,1.0,21975333
39837,oxaliplatin,drug,0.9995,21975333
39838,CLM,disease,0.9995,21975333
39839,CLM,disease,1.0,21975333
39840,KRAS,gene,0.8457,21975333
39841,k,cell_line,0.573,21975333
39842,k-ras,gene,0.543,21975333
39843,bevacizumab,gene,0.637,21975333
39844,k-ras,gene,0.5635,21975333
39845,cetuximab,gene,0.8975,21975333
39846,FOLFIRI,drug,0.7,21975333
39847,FOLFOX,drug,0.536,21975333
39848,panitumumab,gene,0.854,21975333
39849,FOLFOX,drug,0.9766,21975333
39850,Bevacizumab,gene,0.646,21975333
39851,KRAS,gene,0.8916,21975333
39852,KRAS,DNA,0.853,21962894
39853,KRAS mutation,gene,0.7974,21962894
39854,metastatic colorectal cancer,disease,1.0,21962894
39855,Cetuximab,gene,0.802,21962894
39856,panitumumab,gene,0.721,21962894
39857,epidermal growth factor receptor,gene,0.997,21962894
39858,metastatic colorectal cancer,disease,0.9893,21962894
39859,KRAS,gene,0.8105,21962894
39860,epidermal growth factor receptor,gene,0.992,21962894
39861,KRAS,gene,0.795,21962894
39862,cetuximab,gene,0.9434,21962894
39863,panitumumab,gene,0.923,21962894
39864,KRAS,DNA,0.7764,21962894
39865,KRAS mutation,gene,0.9785,21962894
39866,metastatic colorectal cancer,disease,1.0,21962894
39867,188,drug,0.5938,21962894
39868,KRAS codon 12 and 13,gene,0.859,21962894
39869,consensus mutations,DNA,0.706,21962894
39870,panitumumab,gene,0.928,21960318
39871,irinotecan,drug,0.999,21960318
39872,5-fluorouracil,drug,0.9995,21960318
39873,leucovorin,drug,0.9995,21960318
39874,metastatic colorectal cancer,disease,0.9995,21960318
39875,Panitumumab,gene,0.8135,21960318
39876,KRAS,gene,0.993,21960318
39877,metastatic colorectal cancer,disease,1.0,21960318
39878,mCRC,disease,1.0,21960318
39879,panitumumab,gene,0.9185,21960318
39880,FOLFIRI,drug,0.73,21960318
39881,mCRC,disease,0.9634,21960318
39882,panitumumab,gene,0.8604,21960318
39883,FOLFIRI,drug,0.9653,21960318
39884,irinotecan,drug,0.9976,21960318
39885,leucovorin,drug,0.999,21960318
39886,KRAS,gene,0.6875,21960318
39887,KRAS,gene,0.7954,21960318
39888,KRAS WT,gene,0.607,21960318
39889,KRAS,gene,0.84,21960318
39890,diarrhoea,disease,1.0,21960318
39891,stomatitis,disease,1.0,21960318
39892,oral mucositis,disease,1.0,21960318
39893,KRAS,gene,0.7295,21960318
39894,MT tumours,disease,0.4414,21960318
39895,panitumumab,gene,0.803,21960318
39896,FOLFIRI,drug,0.9517,21960318
39897,EGFR,gene,0.9893,21928052
39898,nurses,cell_type,0.431,21928052
39899,Panitumumab,gene,0.6963,21925954
39900,human,species,0.8794,21925954
39901,anti-epidermal growth factor receptor,gene,0.9893,21925954
39902,EGFR,gene,0.993,21925954
39903,panitumumab,gene,0.6284,21925954
39904,patients,species,0.9595,21925954
39905,metastatic colorectal cancer,disease,1.0,21925954
39906,mCRC,disease,1.0,21925954
39907,panitumumab,gene,0.8984,21925954
39908,5-fluorouracil,drug,0.9995,21925954
39909,leucovorin,drug,0.9985,21925954
39910,oxaliplatin,drug,0.9995,21925954
39911,FOLFOX,drug,0.967,21925954
39912,mCRC,disease,0.854,21925954
39913,5-fluorouracil,drug,0.9995,21925954
39914,leucovorin,drug,0.9985,21925954
39915,irinotecan,drug,0.9985,21925954
39916,FOLFIRI,drug,0.97,21925954
39917,mCRC,disease,0.9644,21925954
39918,panitumumab,gene,0.8696,21925954
39919,FOLFOX,drug,0.9824,21925954
39920,FOLFIRI,drug,0.9165,21925954
39921,FOLFOX,drug,0.9893,21925954
39922,FOLFIRI,drug,0.9824,21925954
39923,panitumumab,gene,0.9053,21925954
39924,FOLFIRI,drug,0.993,21925954
39925,panitumumab,gene,0.835,21925954
39926,patients,species,0.9443,21925954
39927,wild,disease,0.582,21925954
39928,wild-type KRAS,gene,0.8037,21925954
39929,KRAS,gene,0.9956,21925954
39930,mCRC,disease,0.9995,21925954
39931,KRAS,gene,0.99,21925954
39932,mCRC,disease,0.999,21925954
39933,patients,species,0.979,21925954
39934,anti-EGFR monoclonal antibodies,gene,0.892,21925954
39935,panitumumab,gene,0.9253,21925954
39936,FOLFOX,drug,0.9937,21925954
39937,FOLFIRI,drug,0.9683,21925954
39938,skin toxicities,disease,0.9346,21925954
39939,gastrointestinal toxicities,disease,0.7446,21925954
39940,patients,species,0.9805,21925954
39941,panitumumab,gene,0.749,21925954
39942,FOLFOX,drug,0.9297,21925954
39943,FOLFIRI,drug,0.7173,21925954
39944,patients,species,0.9346,21925954
39945,mCRC,disease,0.9937,21925954
39946,wild,gene,0.809,21925954
39947,sigmoid colon cancer,disease,1.0,21918357
39948,liver and ovarian metastases,disease,0.734,21918357
39949,panitumumab,gene,0.8555,21918357
39950,abdominal fullness,disease,0.966,21918357
39951,liver,disease,0.978,21918357
39952,ovarian tumor,disease,0.991,21918357
39953,advanced cancer,disease,0.9976,21918357
39954,liver and ovarian metastases,disease,0.9414,21918357
39955,advanced sigmoid colon cancer,disease,1.0,21918357
39956,FOLFOX,drug,0.8496,21918357
39957,FOLFOX,drug,0.8257,21918357
39958,liver and ovarian metastases,disease,0.986,21918357
39959,sensorimotor neuropathic symptoms,disease,0.826,21918357
39960,oxaliplatin,drug,0.9995,21918357
39961,FOLFOX,drug,0.9927,21918357
39962,FOLFIRI,drug,0.994,21918357
39963,FOLFIRI,drug,0.9814,21918357
39964,liver and ovarian metastases,disease,0.996,21918357
39965,oxaliplatin,drug,1.0,21918357
39966,FOLFOX,drug,0.9683,21918357
39967,K-RAS genes,gene,0.87,21918357
39968,sigmoid colon cancer,disease,1.0,21918357
39969,wild-type K,DNA,0.546,21918357
39970,wild-type K-RAS,gene,0.9985,21918357
39971,panitumumab,gene,0.915,21918357
39972,FOLFOX,drug,0.994,21918357
39973,liver and ovarian metastases,disease,0.9395,21918357
39974,Panitumumab,gene,0.8984,21918357
39975,colorectal cancer,disease,0.9966,21918357
39976,metastatic colorectal cancer,disease,1.0,21899955
39977,metastatic colorectal cancer,disease,1.0,21899955
39978,mCRC,disease,1.0,21899955
39979,vascular endothelial growth factor A,gene,0.9985,21899955
39980,factor,DNA,0.469,21899955
39981,mCRC,disease,0.909,21899955
39982,KRAS,gene,0.827,21899955
39983,BRAF,gene,0.805,21899955
39984,mCRC,disease,0.998,21899955
39985,KRAS,gene,0.8276,21898389
39986,metastatic colorectal cancer,disease,1.0,21898389
39987,KRAS,gene,0.8535,21898389
39988,EGFR,gene,0.991,21898389
39989,cetuximab,gene,0.565,21898389
39990,panitumumab,gene,0.628,21898389
39991,metastatic colorectal cancer,disease,1.0,21898389
39992,mCRC,disease,1.0,21898389
39993,mCRC,disease,0.994,21898389
39994,KRAS,gene,0.8022,21898389
39995,EGFR,gene,0.9927,21898389
39996,cetuximab,gene,0.9355,21898389
39997,irinotecan,drug,0.9985,21898389
39998,FOLFIRI,drug,0.98,21898389
39999,cetuximab,gene,0.904,21898389
40000,panitumumab,gene,0.922,21898389
40001,KRAS,gene,0.8203,21898389
40002,KRAS,gene,0.532,21898389
40003,irinotecan,drug,0.998,21898389
40004,KRAS,gene,0.668,21898389
40005,cetuximab,gene,0.856,21898389
40006,KRAS,gene,0.88,21898389
40007,panitumumab,gene,0.7637,21898389
40008,KRAS,gene,0.873,21898389
40009,KRAS,DNA,0.833,21898389
40010,KRAS mutations,gene,0.9785,21898389
40011,KRAS,gene,0.8584,21898389
40012,EGFR,gene,0.9897,21898389
40013,cystamine,drug,1.0,21882823
40014,cystamine,drug,0.9995,21882823
40015,Gd-DOTA,drug,0.9985,21882823
40016,F(ab')(2) fragment,gene,0.762,21882823
40017,monoclonal,gene,0.55,21882823
40018,mAb,gene,0.4995,21882823
40019,panitumumab,gene,0.922,21882823
40020,maleimide,drug,0.999,21882823
40021,Ab-(G4S15),gene,0.9844,21882823
40022,Ab-(G5S29),gene,0.984,21882823
40023,Ab-(G4S15)(4,gene,0.7173,21882823
40024,Magnevist,drug,0.89,21882823
40025,Gd(3+),drug,1.0,21882823
40026,Gd(3+),drug,0.9995,21882823
40027,SMCC,drug,0.9946,21882823
40028,cysteine,drug,0.9985,21882823
40029,KRAS,gene,0.819,21874108
40030,colorectal cancer,disease,1.0,21874108
40031,epidermal growth factor receptor,gene,0.9985,21874108
40032,anti-egfr,gene,0.9756,21874108
40033,metastatic colorectal cancer,disease,0.993,21874108
40034,tumours,disease,1.0,21874108
40035,KRAS mutation,gene,0.5835,21874108
40036,codon 12 or 13,DNA,0.6626,21874108
40037,anti-egfr antibodies,gene,0.8516,21874108
40038,KRAS,DNA,0.8486,21874108
40039,KRAS mutation,gene,0.7847,21874108
40040,metastatic colorectal cancer,disease,0.9995,21874108
40041,KRAS,gene,0.7803,21874108
40042,KRAS,gene,0.8945,21874108
40043,colon cancer,disease,1.0,21863510
40044,T1,cell_line,0.5146,21863510
40045,T1 tumours,disease,0.9985,21863510
40046,tumour,disease,1.0,21863510
40047,UICC,cell_line,0.5586,21863510
40048,T4,DNA,0.4507,21863510
40049,T4 tumour,disease,0.995,21863510
40050,tumour,disease,0.9995,21863510
40051,5-FU,drug,0.9985,21863510
40052,FOLFOX,drug,0.9746,21863510
40053,tumour,disease,0.9995,21863510
40054,irinotecan,drug,0.996,21863510
40055,5-FU,drug,0.998,21863510
40056,capecitabine,drug,0.9927,21863510
40057,primary tumour,disease,0.9785,21863510
40058,liver metastases,disease,0.9536,21863510
40059,cetuximab,gene,0.6616,21863510
40060,tumour,disease,0.9995,21863510
40061,colon cancer,disease,0.9937,21863510
40062,5-FU,drug,0.9946,21863510
40063,MSI,DNA,0.6567,21863510
40064,tumour tissue,cell_type,0.474,21863510
40065,tumour,disease,0.9995,21863510
40066,FOLFOX,drug,0.9766,21863510
40067,MSI,DNA,0.7427,21863510
40068,tumour,disease,1.0,21863510
40069,cetuximab,gene,0.726,21863510
40070,panitumumab,gene,0.7983,21863510
40071,KRAS,gene,0.832,21863510
40072,epithelial growth factor receptor,gene,0.9966,21863510
40073,EGFR,gene,0.9927,21863510
40074,tumours,disease,1.0,21863510
40075,KRAS,DNA,0.68,21863510
40076,KRAS wild,gene,0.9043,21863510
40077,panitumumab,gene,0.8887,21855038
40078,FOLFIRI,drug,0.962,21855038
40079,metastatic colorectal cancer,disease,0.9995,21855038
40080,panitumumab,gene,0.9204,21855038
40081,folinic acid,drug,0.998,21855038
40082,5-fluorouracil,drug,0.999,21855038
40083,irinotecan,drug,0.9976,21855038
40084,FOLFIRI,drug,0.739,21855038
40085,metastatic colorectal cancer,disease,1.0,21855038
40086,mCRC,disease,1.0,21855038
40087,oxaliplatin,drug,1.0,21855038
40088,bevacizumab,gene,0.6553,21855038
40089,panitumumab,gene,0.832,21855038
40090,FOLFIRI,drug,0.9727,21855038
40091,KRAS,gene,0.7544,21855038
40092,tumor,disease,0.9995,21855038
40093,tumor KRAS,gene,0.8833,21855038
40094,tumor KRAS,gene,0.7676,21855038
40095,KRAS,gene,0.9126,21855038
40096,mutant KRAS,gene,0.978,21855038
40097,wild,DNA,0.613,21855038
40098,wild-type KRAS,gene,0.9824,21855038
40099,mutant KRAS,gene,0.657,21855038
40100,wild-type KRAS,gene,0.637,21855038
40101,mutant KRAS,gene,0.5796,21855038
40102,mutant KRAS strata,DNA,0.4875,21855038
40103,mutant KRAS,gene,0.992,21855038
40104,diarrhea,disease,1.0,21855038
40105,Panitumumab,gene,0.878,21855038
40106,FOLFIRI,drug,0.9673,21855038
40107,wild,disease,0.658,21855038
40108,wild-type KRAS,gene,0.7285,21855038
40109,panitumumab,gene,0.9478,21855038
40110,FOLFIRI,drug,0.9062,21855038
40111,metastatic colorectal cancer,disease,1.0,21854190
40112,metastatic colorectal cancer,disease,1.0,21854190
40113,mCRC,disease,1.0,21854190
40114,bevacizumab,gene,0.8135,21854190
40115,cetuximab,gene,0.8726,21854190
40116,panitumumab,gene,0.812,21854190
40117,mCRC,disease,0.9995,21854190
40118,CRC,disease,0.9995,21854190
40119,mCRC,disease,0.993,21854190
40120,mCRC,disease,0.999,21854190
40121,stroke,disease,1.0,21854190
40122,arterial thromboembolism,disease,1.0,21854190
40123,ATE,disease,1.0,21854190
40124,wound-healing complications,disease,0.9985,21854190
40125,WHC,disease,0.999,21854190
40126,acute myocardial infarction,disease,1.0,21854190
40127,AMI,disease,1.0,21854190
40128,congestive heart failure,disease,1.0,21854190
40129,CHF,disease,1.0,21854190
40130,neutropenia,disease,1.0,21854190
40131,stroke,disease,1.0,21854190
40132,ATE,disease,0.9995,21854190
40133,mCRC,disease,0.9995,21854190
40134,mCRC,disease,0.9985,21854190
40135,metastatic colorectal cancer,disease,0.992,21848897
40136,metastatic colorectal cancer,disease,1.0,21848897
40137,mCRC,disease,1.0,21848897
40138,mCRC,disease,0.9863,21848897
40139,mCRC,disease,0.53,21848897
40140,mCRC,disease,0.999,21848897
40141,cetuximab,gene,0.8613,21848897
40142,panitumumab,gene,0.79,21848897
40143,wild,gene,0.4927,21848897
40144,mCRC,disease,0.9224,21848897
40145,F(ab')(2) Fragment,gene,0.9526,21845232
40146,Panitumumab,gene,0.788,21845232
40147,HER1,gene,0.9966,21845232
40148,Cancers,disease,1.0,21845232
40149,F(ab')(2) fragment,gene,0.889,21845232
40150,panitumumab,gene,0.531,21845232
40151,panitumumab F(ab')(2),gene,0.954,21845232
40152,pepsin,gene,0.9956,21845232
40153,F(ab')(2),gene,0.881,21845232
40154,tumor,disease,0.9927,21845232
40155,panitumumab F(ab')(2),gene,0.952,21845232
40156,panitumumab F(ab')(2),gene,0.88,21845232
40157,F(ab')(2),gene,0.818,21845232
40158,"CHX-A""-DTPA",drug,0.9985,21845232
40159,(111)In,drug,0.9985,21845232
40160,(86)Y,drug,0.999,21845232
40161,tumor,disease,0.888,21845232
40162,tumor,disease,0.767,21845232
40163,tumor,disease,0.9976,21845232
40164,panitumumab F(ab')(2),gene,0.9346,21845232
40165,HER1,gene,0.9956,21845232
40166,anti-EGFR monoclonal antibody,gene,0.93,21843103
40167,hypomagnesemia,disease,1.0,21843103
40168,anti-epidermal growth factor receptor,gene,0.895,21843103
40169,EGFR,gene,0.958,21843103
40170,panitumumab,gene,0.817,21843103
40171,cetuximab,gene,0.8,21843103
40172,cutaneous maculopapular rash,disease,0.997,21843103
40173,hypomagnesemia,disease,1.0,21843103
40174,hypomagnesemia,disease,1.0,21843103
40175,cetuximab,gene,0.9224,21843103
40176,panitumumab,gene,0.8706,21843103
40177,cetuximab,gene,0.878,21843103
40178,panitumumab,gene,0.93,21843103
40179,anti,disease,0.661,21843103
40180,hypomagnesemia,disease,1.0,21843103
40181,hypomagnesemia,disease,1.0,21843103
40182,cetuximab,gene,0.896,21843103
40183,panitumumab,gene,0.826,21843103
40184,anti-EGFR monoclonal antibodies,gene,0.9307,21843103
40185,hypomagnesemia,disease,1.0,21843103
40186,panitumumab,gene,0.809,21843103
40187,diarrhea,disease,1.0,21843103
40188,dehydration,disease,1.0,21843103
40189,Hypomagnesemia,disease,1.0,21843103
40190,human cancer cells,cell_type,0.7827,21842425
40191,cancer,disease,0.9604,21842425
40192,KRAS,gene,0.809,21842425
40193,Panitumumab,gene,0.7896,21842425
40194,epidermal growth factor receptor,gene,0.9976,21842425
40195,KRAS,gene,0.5312,21842425
40196,KRAS,gene,0.8623,21842425
40197,Panitumumab,gene,0.8438,21842425
40198,cancer cells,cell_type,0.783,21842425
40199,cancer,disease,1.0,21842425
40200,HT-29,cell_line,0.9087,21842425
40201,KRAS,gene,0.9907,21842425
40202,A549,cell_line,0.909,21842425
40203,KRAS mutant,gene,0.9053,21842425
40204,Panitumumab,gene,0.8267,21842425
40205,H2AX,gene,0.9956,21842425
40206,Panitumumab,gene,0.874,21842425
40207,KRAS-mutated cell line A549,cell_line,0.888,21842425
40208,KRAS,gene,0.9854,21842425
40209,BrdU,drug,0.8994,21842425
40210,Panitumumab,gene,0.837,21842425
40211,Panitumumab,gene,0.8726,21842425
40212,LDH,gene,0.9844,21842425
40213,KRAS wild-type cells,cell_line,0.6753,21842425
40214,KRAS,gene,0.973,21842425
40215,HT-29,cell_line,0.5293,21842425
40216,Panitumumab,gene,0.7837,21842425
40217,KRAS,gene,0.8486,21842425
40218,epidermal growth factor receptor,gene,0.9917,21837660
40219,nonsmall cell lung cancer,disease,1.0,21837660
40220,NSCLC,disease,1.0,21837660
40221,colorectal cancer,disease,1.0,21837660
40222,CRC,disease,1.0,21837660
40223,epidermal growth factor receptor,gene,0.997,21837660
40224,EGFR,gene,0.979,21837660
40225,EGFR,gene,0.994,21837660
40226,KRAS gene,DNA,0.8164,21837660
40227,KRAS gene mutation,gene,0.8647,21837660
40228,NSCLC,disease,0.9995,21837660
40229,CRC,disease,0.9995,21837660
40230,cytological samples,cell_type,0.5444,21837660
40231,cytological samples,cell_type,0.54,21837660
40232,NSCLC,disease,1.0,21837660
40233,CRC,disease,0.9995,21837660
40234,anti-,gene,0.529,21837660
40235,EGFR,gene,0.6904,21837660
40236,gene,DNA,0.5137,21837660
40237,cytological samples,cell_type,0.574,21837660
40238,cytopathologist,cell_type,0.413,21837660
40239,Colorectal cancer,disease,1.0,21829061
40240,colorectal cancer,disease,1.0,21829061
40241,colorectal cancer,disease,1.0,21829061
40242,colorectal cancer,disease,1.0,21829061
40243,Rectal cancer,disease,1.0,21829061
40244,liver metastases,disease,0.982,21829061
40245,liver metastasis,disease,0.997,21829061
40246,liver metastasis,disease,0.9995,21829061
40247,oxaliplatin,drug,0.9995,21829061
40248,irinotecan,drug,0.999,21829061
40249,bevacizumab,gene,0.847,21829061
40250,cetuximab,gene,0.9,21829061
40251,panitumumab,gene,0.9316,21829061
40252,tumors,disease,0.9756,21829061
40253,primary advanced rectal cancer,disease,0.994,21829061
40254,rectal cancer,disease,0.791,21829061
40255,oxaliplatin,drug,1.0,21829061
40256,irinotecan,drug,0.9985,21829061
40257,colorectal cancer,disease,1.0,21829061
40258,ErbB receptors,gene,0.992,21827413
40259,high-grade glioma,disease,1.0,21827413
40260,High-grade gliomas,disease,1.0,21827413
40261,glioblastoma,disease,1.0,21827413
40262,neoplasms,disease,0.905,21827413
40263,tumors,disease,1.0,21827413
40264,cancer,disease,0.9995,21827413
40265,ErbB growth factor receptors,gene,0.997,21827413
40266,tumors,disease,1.0,21827413
40267,ErbB receptor family,gene,0.992,21827413
40268,tyrosine,drug,0.85,21827413
40269,tyrosine kinases,gene,0.9946,21827413
40270,epidermal growth factor receptor,gene,0.997,21827413
40271,EGFR,gene,0.998,21827413
40272,ErbB1,gene,0.9985,21827413
40273,HER1,gene,0.9956,21827413
40274,ErbB2,gene,0.9956,21827413
40275,HER2,gene,0.999,21827413
40276,neu,gene,0.9966,21827413
40277,ErbB3,gene,0.9966,21827413
40278,HER3,gene,0.9976,21827413
40279,ErbB4,gene,0.997,21827413
40280,HER4,gene,0.996,21827413
40281,mutant EGFR,gene,0.983,21827413
40282,EGFRvIII,gene,0.9946,21827413
40283,GBM,disease,1.0,21827413
40284,ErbB,gene,0.937,21827413
40285,EGFR,gene,0.9697,21827413
40286,ErbB,gene,0.8955,21827413
40287,cetuximab,gene,0.862,21827413
40288,panitumumab,gene,0.8516,21827413
40289,Tyrosine,drug,0.9775,21827413
40290,Tyrosine kinase,gene,0.9517,21827413
40291,gefitinib,drug,0.999,21827413
40292,erlotinib,drug,0.9985,21827413
40293,lapatinib,drug,0.999,21827413
40294,ErbB receptors,gene,0.9883,21827413
40295,high-grade gliomas,disease,1.0,21827413
40296,ErbB,gene,0.9927,21827413
40297,gliomas,disease,1.0,21827413
40298,bevacizumab,gene,0.96,21795432
40299,everolimus,drug,0.997,21795432
40300,metastatic colorectal cancer,disease,0.9995,21795432
40301,metastatic colorectal cancer,disease,1.0,21795432
40302,mCRC,disease,1.0,21795432
40303,5-fluorouracil,drug,0.9995,21795432
40304,oxaliplatin,drug,0.9995,21795432
40305,irinotecan,drug,0.999,21795432
40306,bevacizumab,gene,0.877,21795432
40307,cetuximab,gene,0.845,21795432
40308,panitumumab,gene,0.902,21795432
40309,vascular endothelial growth factor,gene,0.9976,21795432
40310,mammalian target,gene,0.7866,21795432
40311,rapamycin,drug,0.9985,21795432
40312,antitumor,disease,0.6772,21795432
40313,bevacizumab,gene,0.9746,21795432
40314,everolimus,drug,0.997,21795432
40315,mCRC,disease,0.9976,21795432
40316,mCRC,disease,0.968,21795432
40317,bevacizumab,gene,0.844,21795432
40318,everolimus,drug,0.995,21795432
40319,bevacizumab,gene,0.824,21795432
40320,bevacizumab,gene,0.685,21795432
40321,mucositis,disease,1.0,21795432
40322,hyperlipidemia,disease,1.0,21795432
40323,hypertension,disease,1.0,21795432
40324,fistula,disease,0.9917,21795432
40325,abscess,disease,0.979,21795432
40326,mucositis,disease,1.0,21795432
40327,hemorrhage,disease,0.9966,21795432
40328,Bevacizumab,gene,0.899,21795432
40329,everolimus,drug,0.9985,21795432
40330,mucosal,disease,0.9087,21795432
40331,Bevacizumab,gene,0.9766,21795432
40332,everolimus,drug,0.998,21795432
40333,mCRC,disease,0.994,21795432
40334,anti-EGFR monoclonal,gene,0.8267,21772090
40335,colorectal cancer,disease,1.0,21772090
40336,epidermal growth factor receptor,gene,0.9985,21772090
40337,EGFR,gene,0.9956,21772090
40338,receptor tyrosine kinase,gene,0.996,21772090
40339,tyrosine,drug,0.983,21772090
40340,RAS,gene,0.989,21772090
40341,RAF,gene,0.9976,21772090
40342,MAPK,gene,0.9595,21772090
40343,PI3K,gene,0.9946,21772090
40344,AKT,gene,0.9946,21772090
40345,EGFR,gene,0.9927,21772090
40346,solid tumors,disease,1.0,21772090
40347,EGFR,gene,0.992,21772090
40348,cetuximab,gene,0.81,21772090
40349,panitumumab,gene,0.771,21772090
40350,metastatic colorectal cancer,disease,1.0,21772090
40351,mCRC,disease,1.0,21772090
40352,EGFR,gene,0.9937,21772090
40353,KRAS,DNA,0.7705,21772090
40354,KRAS mutation,gene,0.948,21772090
40355,mCRC,disease,0.9927,21772090
40356,anti-,gene,0.6514,21772090
40357,EGFR antibody,gene,0.806,21772090
40358,anti-,gene,0.953,21772090
40359,EGFR antibody,gene,0.726,21772090
40360,wild,disease,0.64,21772090
40361,EGFR,gene,0.996,21772090
40362,"BRAF, PIK3CA, PTENgenes",DNA,0.8774,21772090
40363,BRAF,gene,0.9883,21772090
40364,PIK3CA,gene,0.9814,21772090
40365,PTENgenes,gene,0.97,21772090
40366,Cetuximab,gene,0.777,21772090
40367,chimeric immunoglobulin 1,gene,0.977,21772090
40368,IgG1,gene,0.7437,21772090
40369,FCrR1 a-,gene,0.656,21772090
40370,H131R and,DNA,0.5156,21772090
40371,H131R,mutation,,21772090
40372,FC7RIKa-,gene,0.53,21772090
40373,V158F polymorphisms,DNA,0.4375,21772090
40374,V158F,mutation,,21772090
40375,"BRAF, PIK3CA, PTEN and FcqR genes",DNA,0.75,21772090
40376,BRAF,gene,0.9956,21772090
40377,PIK3CA,gene,0.992,21772090
40378,PTEN,gene,0.989,21772090
40379,FcqR genes,gene,0.988,21772090
40380,KRAS,gene,0.546,21772090
40381,anti-,gene,0.9546,21772090
40382,EGFR antibody,gene,0.7485,21772090
40383,metastatic colorectal cancer,disease,0.995,21752724
40384,metastatic colorectal cancer,disease,0.9995,21752724
40385,mCRC,disease,1.0,21752724
40386,bevacizumab,gene,0.8335,21752724
40387,cetuximab,gene,0.949,21752724
40388,panitumumab,gene,0.9653,21752724
40389,mCRC,disease,0.977,21752724
40390,aflibercept,gene,0.977,21752724
40391,receptor tyrosine kinase,gene,0.9443,21752724
40392,tyrosine,drug,0.9463,21752724
40393,regorafenib,drug,0.9897,21752724
40394,brivanib,drug,0.9937,21752724
40395,Akt,gene,0.9927,21752724
40396,perifosine,drug,0.966,21752724
40397,mCRC,disease,0.992,21752724
40398,mCRC,disease,0.9575,21752724
40399,colorectal cancer,disease,1.0,21751717
40400,KRAS,DNA,0.725,21751504
40401,KRAS mutation,gene,0.837,21751504
40402,metastatic colorectal carcinoma,disease,0.999,21751504
40403,malignant tumors,disease,1.0,21751504
40404,Colorectal carcinomas,disease,1.0,21751504
40405,anti-EGFR antibodies,gene,0.9253,21751504
40406,cetuximab,gene,0.8564,21751504
40407,panitumumab,gene,0.852,21751504
40408,codons 12 and 13,DNA,0.6104,21751504
40409,exon 2,DNA,0.554,21751504
40410,KRAS gene,gene,0.844,21751504
40411,EGFR,gene,0.7256,21751504
40412,metastatic colorectal cancer,disease,0.999,21751504
40413,KRAS gene,gene,0.9062,21751504
40414,KRAS,gene,0.87,21751504
40415,KRAS,DNA,0.9,21751504
40416,metastatic colorectal tumors,disease,0.998,21751504
40417,KRAS,gene,0.828,21751504
40418,KRAS,gene,0.765,21742054
40419,BRAF mutations,gene,0.529,21742054
40420,advanced colorectal cancers,disease,0.9995,21742054
40421,KRAS,DNA,0.83,21742054
40422,KRAS mutations,gene,0.829,21742054
40423,epidermal growth factor receptor,gene,0.9907,21742054
40424,metastatic colorectal cancers,disease,0.9404,21742054
40425,KRAS,gene,0.763,21742054
40426,cetuximab,gene,0.86,21742054
40427,panitumumab,gene,0.829,21742054
40428,BRAF,gene,0.736,21742054
40429,KRAS,gene,0.819,21742054
40430,BRAF,gene,0.7505,21742054
40431,KRAS codons 12 and 13,DNA,0.83,21742054
40432,KRAS codons,gene,0.9385,21742054
40433,BRAF,gene,0.7305,21742054
40434,codon 600,DNA,0.803,21742054
40435,formalin,drug,0.9907,21742054
40436,paraffin,drug,0.8184,21742054
40437,KRAS,gene,0.7393,21742054
40438,BRAF codon 600,gene,0.7183,21742054
40439,KRAS,gene,0.7183,21737577
40440,colorectal cancer,disease,1.0,21737577
40441,advanced colorectal cancer,disease,1.0,21737577
40442,CRC,disease,1.0,21737577
40443,anti-epidermal growth factor receptor antibodies,gene,0.928,21737577
40444,cetuximab,gene,0.668,21737577
40445,panitumumab,gene,0.748,21737577
40446,tumors,disease,0.4424,21737577
40447,KRAS,gene,0.772,21737577
40448,KRAS,gene,0.8804,21737577
40449,KRAS,gene,0.8584,21737577
40450,advanced/metastatic CRC,disease,0.9966,21737577
40451,KRAS,gene,0.878,21737577
40452,advanced CRC,disease,0.998,21737577
40453,metastatic colorectal cancer,disease,0.961,21729675
40454,Colorectal cancer,disease,1.0,21729675
40455,CRC,disease,1.0,21729675
40456,cancer,disease,1.0,21729675
40457,CRC,disease,0.9976,21729675
40458,metastatic CRC,disease,0.997,21729675
40459,mCRC,disease,0.9995,21729675
40460,mCRC,disease,0.8423,21729675
40461,mCRC,disease,0.9565,21729675
40462,bevacizumab,gene,0.85,21729675
40463,cetuximab,gene,0.9126,21729675
40464,panitumumab,gene,0.9204,21729675
40465,mCRC,disease,0.9614,21729675
40466,mCRC,disease,0.8687,21729675
40467,Erlotinib,drug,0.998,21725209
40468,tumors,disease,1.0,21725209
40469,cetuximab,gene,0.825,21725209
40470,epidermal growth factor receptor,gene,0.999,21725209
40471,EGFR,gene,0.994,21725209
40472,receptor tyrosine kinase,gene,0.998,21725209
40473,tyrosine,drug,0.9756,21725209
40474,RTK,gene,0.9893,21725209
40475,tumors,disease,0.575,21725209
40476,EGFR,gene,0.979,21725209
40477,panitumumab,gene,0.8237,21725209
40478,cetuximab,gene,0.842,21725209
40479,tyrosine,drug,0.9937,21725209
40480,tyrosine kinase,gene,0.886,21725209
40481,erlotinib,drug,0.9976,21725209
40482,gefitinib,drug,0.997,21725209
40483,lapatinib,drug,0.999,21725209
40484,EGFR,gene,0.993,21725209
40485,tumors,disease,1.0,21725209
40486,cetuximab,gene,0.8247,21725209
40487,cetuximab-resistant clones,cell_line,0.889,21725209
40488,cetuximab,gene,0.822,21725209
40489,NCI-H226 NSCLC cell line,cell_line,0.952,21725209
40490,NSCLC,disease,0.72,21725209
40491,cetuximab,gene,0.882,21725209
40492,Cetuximab-resistant clones,cell_line,0.7993,21725209
40493,Cetuximab,gene,0.9375,21725209
40494,EGFR,gene,0.996,21725209
40495,HER2,gene,0.9917,21725209
40496,HER3 receptors,gene,0.9897,21725209
40497,MAPK,gene,0.6543,21725209
40498,AKT,gene,0.996,21725209
40499,cetuximab-resistant clones,cell_line,0.859,21725209
40500,cetuximab,gene,0.848,21725209
40501,EGFR,gene,0.996,21725209
40502,cetuximab,gene,0.8325,21725209
40503,EGFR,gene,0.9956,21725209
40504,erlotinib,drug,0.913,21725209
40505,erlotinib,drug,0.996,21725209
40506,EGFR,gene,0.993,21725209
40507,erlotinib,drug,0.991,21725209
40508,cetuximab-resistant NCI-H226 mouse xenografts,cell_line,0.7407,21725209
40509,cetuximab,gene,0.972,21725209
40510,mouse,species,0.9204,21725209
40511,erlotinib,drug,0.991,21725209
40512,Mice,species,0.904,21725209
40513,cetuximab,gene,0.9854,21725209
40514,erlotinib,drug,0.9927,21725209
40515,tumor,disease,0.9863,21725209
40516,erlotinib,drug,0.9976,21725209
40517,tumors,disease,1.0,21725209
40518,cetuximab,gene,0.7725,21725209
40519,EGFR,gene,0.994,21725209
40520,tumors,disease,1.0,21725209
40521,cetuximab,gene,0.7456,21725209
40522,erlotinib,drug,0.9883,21725209
40523,cetuximab,gene,0.9453,21725209
40524,Natural killer,cell_type,0.6753,21717064
40525,NK,cell_type,0.4983,21717064
40526,dendritic cell,cell_type,0.8413,21717064
40527,DC,cell_type,0.749,21717064
40528,tumor,disease,0.9365,21717064
40529,Tumor,DNA,0.517,21717064
40530,trastuzumab,gene,0.9434,21717064
40531,cetuximab,gene,0.897,21717064
40532,panitumumab,gene,0.927,21717064
40533,rituximab,gene,0.7427,21717064
40534,metastatic colorectal cancer,disease,0.939,21717064
40535,head and neck cancer,disease,1.0,21717064
40536,breast cancer,disease,1.0,21717064
40537,follicular lymphoma,disease,1.0,21717064
40538,immune cells,cell_type,0.9224,21717064
40539,NK cells,cell_type,0.916,21717064
40540,dendritic cells,cell_type,0.8633,21717064
40541,DCs,cell_type,0.793,21717064
40542,DC,cell_type,0.7437,21717064
40543,maturing,cell_line,0.533,21717064
40544,maturing DC,cell_type,0.647,21717064
40545,NK cells,cell_type,0.922,21717064
40546,DC,cell_type,0.7744,21717064
40547,tumor,disease,1.0,21717064
40548,NK cells,cell_type,0.939,21717064
40549,DC,cell_type,0.7783,21717064
40550,tumor,disease,1.0,21717064
40551,EGFR,gene,0.998,21684835
40552,HER1,gene,0.9956,21684835
40553,EGFR,gene,0.989,21684835
40554,tyrosine,drug,0.9663,21684835
40555,tyrosine kinase,gene,0.6494,21684835
40556,tumors,disease,1.0,21684835
40557,colorectal cancer,disease,1.0,21684835
40558,lung cancer,disease,1.0,21684835
40559,pancreatic cancer,disease,1.0,21684835
40560,head and neck cancer,disease,1.0,21684835
40561,EGFR,gene,0.9653,21684835
40562,cancer,disease,0.996,21678641
40563,colorectal cancer,disease,1.0,21678641
40564,K,DNA,0.6533,21678641
40565,K-ras,gene,0.998,21678641
40566,colorectal cancer,disease,1.0,21678641
40567,CRC,disease,1.0,21678641
40568,epidermal,cell_type,0.669,21678641
40569,growth factor receptor--EGFR,gene,0.839,21678641
40570,cetuximab,gene,0.828,21678641
40571,panitumumab,gene,0.778,21678641
40572,EGFR monoclonal antibodies,gene,0.9434,21678641
40573,colorectal cancer,disease,1.0,21678641
40574,oncogene K-ras,gene,0.881,21678641
40575,K-ras mutations,gene,0.695,21678641
40576,cetuximab,gene,0.851,21678641
40577,CRC,disease,0.9985,21678641
40578,K-ras,gene,0.6616,21678641
40579,K-ras mutations,gene,0.7236,21678641
40580,CRC,disease,0.505,21678641
40581,KRAS,gene,0.695,21656377
40582,KRAS,gene,0.636,21656377
40583,EGFR,gene,0.992,21656377
40584,cetuximab,gene,0.82,21656377
40585,panitumumab,gene,0.829,21656377
40586,KRAS,gene,0.8184,21656377
40587,KRAS,DNA,0.8716,21656377
40588,KRAS mutation,gene,0.845,21656377
40589,KRAS,DNA,0.8374,21656377
40590,KRAS mutation,gene,0.952,21656377
40591,Eyelash trichomegaly,disease,0.674,21655160
40592,panitumumab,gene,0.9053,21655160
40593,KRAS,DNA,0.858,21632860
40594,KRAS mutations,gene,0.8877,21632860
40595,anti-EGFR monoclonal antibody,gene,0.9443,21632860
40596,metastatic colorectal cancer,disease,1.0,21632860
40597,KRAS,DNA,0.609,21632860
40598,KRAS mutations,gene,0.72,21632860
40599,anti-epidermal growth factor receptor,gene,0.941,21632860
40600,EGFR,gene,0.989,21632860
40601,metastatic colorectal cancer,disease,1.0,21632860
40602,mCRC,disease,1.0,21632860
40603,KRAS,gene,0.874,21632860
40604,anti-EGFR MoAbs,gene,0.8735,21632860
40605,tumor,disease,0.9873,21632860
40606,mCRC,disease,0.9956,21632860
40607,cetuximab,gene,0.9023,21632860
40608,panitumumab,gene,0.824,21632860
40609,KRAS codons 12 and 13,DNA,0.8623,21632860
40610,KRAS codons,gene,0.865,21632860
40611,KRAS codon 61,gene,0.8105,21632860
40612,BRAF,gene,0.815,21632860
40613,PIK3CA,gene,0.7593,21632860
40614,PTEN,gene,0.989,21632860
40615,codons 12 and 13,DNA,0.742,21632860
40616,KRAS,gene,0.8037,21632860
40617,BRAF,gene,0.4875,21632860
40618,KRAS mutations,gene,0.703,21632860
40619,PIK3CA,gene,0.902,21632860
40620,PTEN,gene,0.994,21632860
40621,PI3K,gene,0.996,21632860
40622,KRAS,DNA,0.867,21632860
40623,KRAS mutations,gene,0.802,21632860
40624,mCRC,disease,0.9966,21632860
40625,anti-EGFR MoAbs,gene,0.9175,21632860
40626,epidermal growth factor receptor,gene,0.9766,21632506
40627,squamous cell carcinoma of the penis,disease,1.0,21632506
40628,human colorectal tumour cell lines,cell_line,0.953,21617858
40629,colorectal tumour,disease,0.9014,21617858
40630,afatinib,drug,0.9805,21617858
40631,BIBW2992,drug,0.999,21617858
40632,erbB family,gene,0.9893,21617858
40633,HER family,gene,0.985,21617858
40634,anti-,gene,0.875,21617858
40635,epidermal growth factor receptor,gene,0.9014,21617858
40636,EGFR,gene,0.9507,21617858
40637,cetuximab,gene,0.8125,21617858
40638,panitumumab,gene,0.87,21617858
40639,colorectal cancer,disease,1.0,21617858
40640,afatinib,drug,0.982,21617858
40641,erbB family,gene,0.9897,21617858
40642,irinotecan,drug,0.9995,21617858
40643,oxaliplatin,drug,0.9995,21617858
40644,mAb ICR62,gene,0.9775,21617858
40645,human colorectal tumour cell lines,cell_line,0.964,21617858
40646,colorectal tumour,disease,0.861,21617858
40647,EGFR family,DNA,0.5635,21617858
40648,EGFR family members,gene,0.905,21617858
40649,EGFR-overexpressing DiFi cells,cell_line,0.968,21617858
40650,EGFR-overexpressing,cell_type,0.4272,21617858
40651,EGFR,gene,0.9697,21617858
40652,afatinib,drug,0.9883,21617858
40653,ICR62,drug,0.9985,21617858
40654,Afatinib,drug,0.997,21617858
40655,tumour cell lines,cell_line,0.9565,21617858
40656,tumour,disease,0.508,21617858
40657,CCL-221,cell_line,0.936,21617858
40658,HCT-116,cell_line,0.9424,21617858
40659,HCT,cell_type,0.5737,21617858
40660,EGFR,gene,0.9907,21617858
40661,human epidermal growth factor receptor (HER)-2,gene,0.997,21617858
40662,HER-3,gene,0.9956,21617858
40663,afatinib,drug,0.9937,21617858
40664,afatinib,drug,0.997,21617858
40665,afatinib,drug,0.9927,21617858
40666,colorectal tumour cells,cell_type,0.603,21617858
40667,colorectal tumour,disease,1.0,21617858
40668,HER family members,gene,0.9907,21617858
40669,erbB,gene,0.9766,21617858
40670,cancer,disease,1.0,21617858
40671,erbB,gene,0.9814,21617858
40672,panitumumab,gene,0.7188,21610704
40673,wild-type KRAS,gene,0.8384,21610704
40674,metastatic colorectal cancer,disease,1.0,21610704
40675,Panitumumab,gene,0.877,21610704
40676,KRAS,gene,0.6665,21610704
40677,metastatic colorectal cancer,disease,1.0,21610704
40678,mCRC,disease,1.0,21610704
40679,panitumumab,gene,0.717,21610704
40680,EuroQoL 5-dimensions,DNA,0.4856,21610704
40681,panitumumab,gene,0.9395,21610704
40682,BSC,cell_type,0.4924,21610704
40683,wild,gene,0.5757,21610704
40684,mCRC,disease,0.973,21610704
40685,panitumumab,gene,0.8086,21610704
40686,BSC,drug,0.978,21610704
40687,BSC,drug,0.8076,21610704
40688,KRAS,gene,0.8276,21609938
40689,advanced colorectal cancer,disease,1.0,21609938
40690,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9204,21609938
40691,KRAS,gene,0.7744,21609938
40692,advanced colorectal cancer,disease,1.0,21609938
40693,anti-epidermal growth factor receptor antibody,gene,0.982,21609938
40694,EGFR,gene,0.721,21609938
40695,PATIENTS,species,0.9717,21609938
40696,metastatic colorectal cancer,disease,0.9995,21609938
40697,EGFR,gene,0.891,21609938
40698,wild,DNA,0.617,21609938
40699,wild-type KRAS,gene,0.9844,21609938
40700,tumor,disease,0.528,21609938
40701,KRAS,DNA,0.5903,21609938
40702,KRAS mutation,gene,0.9746,21609938
40703,EGFR,gene,0.9136,21609938
40704,KRAS,DNA,0.8306,21609938
40705,KRAS mutation,gene,0.896,21609938
40706,EGFR,gene,0.8477,21609938
40707,advanced colorectal cancer,disease,1.0,21609938
40708,EGFR,gene,0.881,21609938
40709,mutant KRAS,gene,0.9746,21609938
40710,KRAS gene,gene,0.7593,21609938
40711,EGFR,gene,0.621,21609938
40712,Panitumumab,gene,0.8486,21596817
40713,vectibix,gene,0.5215,21596817
40714,Panitumumab,gene,0.838,21596817
40715,EGFR,gene,0.9136,21596817
40716,metastatic colorectal carcinoma,disease,0.9985,21596817
40717,fluoropyrimidine,drug,0.994,21596817
40718,oxaliplatin,drug,0.9995,21596817
40719,irinotecan,drug,0.999,21596817
40720,panitumumab,gene,0.9507,21586659
40721,bevacizumab,gene,0.6445,21586659
40722,metastatic gallbladder carcinoma,disease,0.998,21586659
40723,KRAS,gene,0.804,21575616
40724,colorectal cancer,disease,1.0,21575616
40725,gene chip,DNA,0.4644,21575616
40726,epidermal growth factor receptor,gene,0.9985,21575616
40727,EGFR,gene,0.9897,21575616
40728,KRAS,gene,0.806,21575616
40729,RAF,gene,0.998,21575616
40730,MAPK,gene,0.994,21575616
40731,PI3K,gene,0.9897,21575616
40732,EGFR,gene,0.9883,21575616
40733,codons 12 and 13,DNA,0.7397,21575616
40734,KRAS,gene,0.7646,21575616
40735,EGFR,gene,0.988,21575616
40736,cetuximab,gene,0.7163,21575616
40737,panitumumab,gene,0.767,21575616
40738,colorectal cancer,disease,1.0,21575616
40739,KRAS,DNA,0.843,21575616
40740,KRAS mutation,gene,0.936,21575616
40741,colorectal cancers,disease,1.0,21575616
40742,colorectal tumor,disease,1.0,21575616
40743,KRAS,DNA,0.825,21575616
40744,KRAS mutations,gene,0.94,21575616
40745,motesanib,drug,0.998,21559248
40746,panitumumab,gene,0.6772,21559248
40747,motesanib,drug,0.9985,21559248
40748,vascular endothelial growth factor receptors 1,gene,0.998,21559248
40749,platelet-derived growth factor receptor,gene,0.999,21559248
40750,Kit,gene,0.9893,21559248
40751,panitumumab,gene,0.828,21559248
40752,gemcitabine,drug,0.999,21559248
40753,cisplatin,drug,0.9995,21559248
40754,patients,species,0.9805,21559248
40755,advanced solid tumors,disease,1.0,21559248
40756,gemcitabine,drug,0.9995,21559248
40757,cisplatin,drug,1.0,21559248
40758,Patients,species,0.9585,21559248
40759,motesanib,drug,0.998,21559248
40760,panitumumab,gene,0.913,21559248
40761,gemcitabine,drug,0.999,21559248
40762,cisplatin,drug,0.999,21559248
40763,patients,species,0.981,21559248
40764,patients,species,0.9883,21559248
40765,patients,species,0.979,21559248
40766,patients,species,0.9873,21559248
40767,patients,species,0.9946,21559248
40768,motesanib,drug,0.9966,21559248
40769,motesanib,drug,0.997,21559248
40770,patients,species,0.9863,21559248
40771,motesanib,drug,0.9985,21559248
40772,patients,species,0.983,21559248
40773,motesanib,drug,0.999,21559248
40774,venous thromboembolic events,disease,0.931,21559248
40775,motesanib,drug,0.999,21559248
40776,arterial thromboembolic events,disease,0.9976,21559248
40777,patient,species,0.985,21559248
40778,motesanib,drug,0.9985,21559248
40779,panitumumab,gene,0.7627,21559248
40780,gemcitabine,drug,0.9995,21559248
40781,cisplatin,drug,1.0,21559248
40782,Panitumumab,gene,0.8125,21542198
40783,mCRC,disease,0.981,21542198
40784,wild,DNA,0.523,21542198
40785,wild-type KRAS,gene,0.911,21542198
40786,epidermal growth factor receptor,gene,0.992,21537180
40787,epidermal growth factor receptor,gene,0.9966,21537180
40788,EGFRIs,gene,0.9697,21537180
40789,gefitinib,drug,0.9956,21537180
40790,erlotinib,drug,0.9966,21537180
40791,cetuximab,gene,0.8374,21537180
40792,lapatinib,drug,0.9966,21537180
40793,panitumumab,gene,0.8413,21537180
40794,EGFRIs,gene,0.965,21537180
40795,dermatologic,disease,0.7466,21537180
40796,epidermal growth factor receptor,gene,0.997,21537180
40797,papulopustular rash,disease,1.0,21537180
40798,xerosis,disease,1.0,21537180
40799,pruritus,disease,1.0,21537180
40800,dermatologic,disease,0.958,21537180
40801,EGFRIs,gene,0.976,21537180
40802,EGFRIs,gene,0.9517,21537180
40803,dermatologic,disease,0.5923,21537180
40804,K-ras,gene,0.845,21532493
40805,colorectal cancer,disease,1.0,21532493
40806,K-ras,gene,0.653,21532493
40807,colorectal cancer,disease,1.0,21532493
40808,epidermal growth factor receptor,gene,0.997,21532493
40809,cetuximab,gene,0.9004,21532493
40810,panitumumab,gene,0.9253,21532493
40811,K-ras,gene,0.667,21532493
40812,restriction fragment length polymorphism,DNA,0.88,21532493
40813,RFLP,DNA,0.8657,21532493
40814,RFLP,DNA,0.659,21532493
40815,RFLP,DNA,0.5894,21532493
40816,K-ras,DNA,0.796,21532493
40817,K-ras mutation,gene,0.942,21532493
40818,tumor cells,cell_type,0.8696,21532493
40819,tumor,disease,0.9966,21532493
40820,wild-type K-ras,gene,0.816,21532493
40821,tumor,disease,1.0,21532493
40822,genomes,DNA,0.661,23662107
40823,cancer,disease,1.0,23662107
40824,genome,DNA,0.5083,23662107
40825,cancer,disease,1.0,23662107
40826,cancer,disease,1.0,23662107
40827,colorectal cancer,disease,0.9155,23662107
40828,colorectal cancer,disease,1.0,23662107
40829,cancer genome DNA,DNA,0.84,23662107
40830,cancer,disease,0.9966,23662107
40831,colorectal cancer,disease,1.0,23662107
40832,cancer,disease,0.98,21514211
40833,cancer,disease,0.9956,21514211
40834,mucositis,disease,1.0,21514211
40835,stomatitis,disease,1.0,21514211
40836,dysphagia,disease,1.0,21514211
40837,xerostomia,disease,1.0,21514211
40838,pharyngitis,disease,1.0,21514211
40839,taste alterations,disease,0.9824,21514211
40840,EGFRI,gene,0.9976,21514211
40841,VEGF,gene,0.996,21514211
40842,mTOR,gene,0.991,21514211
40843,cetuximab,gene,0.846,21514211
40844,panitumumab,gene,0.9243,21514211
40845,erlotinib,drug,0.9985,21514211
40846,sorafenib,drug,0.9995,21514211
40847,sunitinib malate,drug,0.999,21514211
40848,imatinib mesylate,drug,0.9985,21514211
40849,bevacizumab,gene,0.765,21514211
40850,trastuzumab,gene,0.951,21514211
40851,lapatinib,drug,0.9985,21514211
40852,mTORs,gene,0.9956,21514211
40853,cancer,disease,1.0,21514211
40854,egfr,gene,0.704,21505590
40855,epidermal growth factor receptor,gene,0.999,21505590
40856,egfris,DNA,0.4878,21505590
40857,embase,gene,0.4514,21505590
40858,egfris,gene,0.982,21505590
40859,cetuximab,gene,0.939,21505590
40860,panitumumab,gene,0.917,21505590
40861,egfri,gene,0.9946,21505590
40862,rash,disease,1.0,21505590
40863,rash,disease,0.9995,21505590
40864,rash,disease,0.9995,21505590
40865,rash,disease,0.9824,21505590
40866,rash,disease,0.988,21505590
40867,rash,disease,0.861,21505590
40868,rash,disease,0.7056,21505590
40869,panitumumab,gene,0.9214,21498734
40870,metastatic colorectal cancer,disease,0.996,21498734
40871,metastatic colorectal cancer,disease,1.0,21498734
40872,mCRC,disease,1.0,21498734
40873,Panitumumab,gene,0.6733,21498734
40874,epidermal growth factor receptor,gene,0.998,21498734
40875,EGFR,gene,0.999,21498734
40876,Kirsten (K)-RAS,gene,0.7026,21498734
40877,metastatic colorectal cancer,disease,0.9995,21498734
40878,fluoropyrimidine,drug,0.9985,21498734
40879,oxaliplatin,drug,0.999,21498734
40880,irinotecan,drug,0.9976,21498734
40881,panitumumab,gene,0.941,21498734
40882,bevacizumab,gene,0.8022,21498734
40883,mCRC,disease,0.993,21498734
40884,tumour,disease,0.9834,21498734
40885,K,disease,0.583,21498734
40886,K-RAS,gene,0.546,21498734
40887,bevacizumab,gene,0.876,21498734
40888,panitumumab,gene,0.945,21498734
40889,Panitumumab,gene,0.846,21498734
40890,panitumumab,gene,0.9414,21498734
40891,panitumumab,gene,0.9604,21498734
40892,mCRC,disease,0.953,21498734
40893,bevacizumab,gene,0.855,21498734
40894,Epidermal growth factor receptor,gene,0.998,21485758
40895,solid tumours,disease,1.0,21485758
40896,epithelial cancers,disease,1.0,21485758
40897,epidermal growth factor receptor,gene,0.9985,21485758
40898,EGFR,gene,0.997,21485758
40899,EGFR,gene,0.993,21485758
40900,anti-EGFR monoclonal antibodies,gene,0.957,21485758
40901,cetuximab,gene,0.8027,21485758
40902,panitumumab,gene,0.825,21485758
40903,EGFR tyrosine kinase,gene,0.927,21485758
40904,tyrosine,drug,0.8843,21485758
40905,erlotinib,drug,0.988,21485758
40906,gefitinib,drug,0.996,21485758
40907,EGFR,gene,0.9243,21485758
40908,metastatic nonsmall-cell lung cancer,disease,0.9985,21485758
40909,colorectal cancer,disease,1.0,21485758
40910,squamous-cell carcinoma of the,disease,1.0,21485758
40911,"head and neck, and pancreatic cancer",disease,1.0,21485758
40912,EGFR,gene,0.8667,21485758
40913,cancer,disease,1.0,21485758
40914,EGFR,gene,0.922,21485758
40915,KRAS,DNA,0.6377,21472513
40916,KRAS,gene,0.978,21472513
40917,metastatic colorectal cancer,disease,1.0,21472513
40918,mcrc,disease,1.0,21472513
40919,5-fluorouracil,drug,0.999,21472513
40920,FOLFOX,drug,0.9766,21472513
40921,FOLFIRI,drug,0.933,21472513
40922,Bevacizumab,gene,0.8765,21472513
40923,FOLFOX,drug,0.972,21472513
40924,irinotecan,drug,0.993,21472513
40925,FOLFIRI,drug,0.8584,21472513
40926,FOLFIRI,drug,0.95,21472513
40927,BEV,drug,0.9873,21472513
40928,FOLFOX,drug,0.647,21472513
40929,metastatic colorectal cancer,disease,1.0,21472513
40930,tumor,disease,0.9897,21472513
40931,KRAS,DNA,0.7207,21472513
40932,KRAS mutation,gene,0.857,21472513
40933,exon 2,DNA,0.5615,21472513
40934,tumor,disease,1.0,21472513
40935,KRAS,gene,0.804,21472513
40936,cetuximab,gene,0.8086,21472513
40937,panitumumab,gene,0.819,21472513
40938,irinotecan,drug,0.9946,21472513
40939,tumors,disease,1.0,21472513
40940,cetuximab,gene,0.8813,21472513
40941,panitumumab,gene,0.8633,21472513
40942,cetuximab,gene,0.949,21472513
40943,panitumumab,gene,0.8945,21472513
40944,tumors,disease,0.4429,21472513
40945,KRAS,DNA,0.742,21472513
40946,KRAS mutant,gene,0.885,21472513
40947,oxaliplatin,drug,1.0,21472513
40948,irinotecan,drug,0.9985,21472513
40949,KRAS wild type and mutant tumors,disease,0.5776,21472513
40950,KRAS,gene,0.9727,21472513
40951,mcrc,gene,0.88,21472513
40952,tumor,disease,0.9995,21472513
40953,human EGFR family,gene,0.9785,21468131
40954,esophagogastric cancer,disease,1.0,21468131
40955,Esophagogastric cancer,disease,1.0,21468131
40956,EGFR,gene,0.9946,21468131
40957,HER2,gene,0.988,21468131
40958,HER2,gene,0.9907,21468131
40959,trastuzumab,gene,0.5605,21468131
40960,HER2,gene,0.983,21468131
40961,HER2 gene,gene,0.8457,21468131
40962,HER2-positive breast cancer,disease,0.9673,21468131
40963,HER2,gene,0.991,21468131
40964,advanced-stage gastric or esophagogastric-junction adenocarcinomas,disease,0.9775,21468131
40965,trastuzumab,gene,0.986,21468131
40966,cisplatin,drug,0.9995,21468131
40967,fluoropyrimidine,drug,0.9946,21468131
40968,HER2,gene,0.9907,21468131
40969,Cetuximab,gene,0.5186,21468131
40970,panitumumab,gene,0.6006,21468131
40971,EGFR,gene,0.9946,21468131
40972,EGFR,gene,0.9985,21468131
40973,HER2,gene,0.997,21468131
40974,tyrosine,drug,0.976,21468131
40975,tyrosine kinase,gene,0.779,21468131
40976,lapatinib,drug,0.9897,21468131
40977,esophagogastric cancer,disease,1.0,21468131
40978,human EGFRs,gene,0.906,21468131
40979,esophagogastric cancer,disease,1.0,21468131
40980,tyrosine,drug,0.984,21467916
40981,tyrosine kinase,gene,0.8906,21467916
40982,cancers,disease,1.0,21467916
40983,lapatinib,drug,0.999,21467916
40984,trastuzumab,gene,0.9883,21467916
40985,bevacizumab,drug,0.546,21467916
40986,trastuzumab,gene,0.9893,21467916
40987,HER2-positive metastatic breast cancer,disease,0.9995,21467916
40988,HER2,gene,0.9883,21467916
40989,cetuximab,gene,0.924,21467916
40990,panitumumab,gene,0.9224,21467916
40991,bevacizumab,gene,0.7803,21467916
40992,metastatic/advanced colorectal cancer,disease,1.0,21467916
40993,HER1,gene,0.9956,21464917
40994,86Y,drug,0.9985,21464917
40995,panitumumab,gene,0.685,21464917
40996,86Y,drug,0.9966,21464917
40997,cetuximab,gene,0.7227,21464917
40998,malignant mesothelioma tumors,disease,1.0,21464917
40999,Malignant mesothelioma,disease,1.0,21464917
41000,MM,disease,1.0,21464917
41001,cancer,disease,1.0,21464917
41002,Asbestos,drug,0.8516,21464917
41003,HER1,gene,0.9834,21464917
41004,HER1,gene,0.9854,21464917
41005,MM,disease,0.999,21464917
41006,HER1,gene,0.997,21464917
41007,chimeric IgG(1),gene,0.935,21464917
41008,cetuximab,gene,0.938,21464917
41009,human IgG(2),gene,0.9873,21464917
41010,panitumumab,gene,0.9194,21464917
41011,(86)Y,drug,0.999,21464917
41012,MM,disease,0.9995,21464917
41013,cetuximab,gene,0.9375,21464917
41014,panitumumab,gene,0.9424,21464917
41015,CHX-A''-DTPA,drug,0.999,21464917
41016,(86)Y,drug,0.9985,21464917
41017,HER1,gene,0.9893,21464917
41018,NCI-H226,cell_line,0.949,21464917
41019,NCI-H2052,cell_line,0.856,21464917
41020,NCI-H2452,cell_line,0.9077,21464917
41021,MSTO-211H human mesothelioma cells,cell_line,0.8657,21464917
41022,human mesothelioma cells,cell_type,0.683,21464917
41023,mesothelioma,disease,0.8403,21464917
41024,tumor,disease,0.999,21464917
41025,mice,species,0.886,21464917
41026,HER1,gene,0.9927,21464917
41027,tumor,disease,0.6406,21464917
41028,mice,species,0.9805,21464917
41029,tumor,disease,0.999,21464917
41030,(86)Y,drug,0.9985,21464917
41031,cetuximab,gene,0.641,21464917
41032,86,drug,0.5483,21464917
41033,),drug,0.4875,21464917
41034,(86)Y,drug,0.9995,21464917
41035,panitumumab,gene,0.8374,21464917
41036,(86)Y,drug,0.999,21464917
41037,orthotopic tumors,disease,0.8813,21464917
41038,HER1,gene,0.9927,21464917
41039,(86)Y,drug,0.9995,21464917
41040,panitumumab,gene,0.682,21464917
41041,(86)Y,drug,0.999,21464917
41042,HER1,gene,0.9937,21464917
41043,MM,disease,0.992,21464917
41044,panitumumab,gene,0.9614,21464917
41045,cetuximab,gene,0.972,21464917
41046,metastatic colon cancer,disease,0.999,21464866
41047,metastatic colorectal cancer,disease,0.9966,21464866
41048,bevacizumab,gene,0.885,21464866
41049,cetuximab,gene,0.946,21464866
41050,panitumumab,gene,0.9717,21464866
41051,metastatic colorectal cancer,disease,0.9995,21464866
41052,metastatic colorectal cancer,disease,0.9995,21464866
41053,cancer,disease,1.0,21464866
41054,colorectal cancer,disease,1.0,21464866
41055,colorectal cancer,disease,1.0,21428886
41056,metastatic colorectal cancer,disease,1.0,21428886
41057,mCRC,disease,1.0,21428886
41058,epidermal growth factor receptor,gene,0.998,21428886
41059,EGFR,gene,0.9907,21428886
41060,vascular endothelial growth factor,gene,0.997,21428886
41061,VEGF,gene,0.994,21428886
41062,anti-EGFR monoclonal antibodies,gene,0.9614,21428886
41063,cetuximab,gene,0.9375,21428886
41064,panitumumab,gene,0.936,21428886
41065,anti-VEGF mAb,gene,0.974,21428886
41066,bevacizumab,gene,0.573,21428886
41067,anti-,gene,0.5293,21428886
41068,EGFR,gene,0.5337,21428886
41069,VEGF,gene,0.807,21428886
41070,mCRC,disease,0.982,21428886
41071,Anti-,gene,0.8247,21427284
41072,EGFR,gene,0.858,21427284
41073,colorectal cancers,disease,1.0,21427284
41074,cetuximab,gene,0.8667,21427284
41075,panitumumab,gene,0.822,21427284
41076,anti-,gene,0.7695,21427284
41077,epidermal growth factor receptor,gene,0.9526,21427284
41078,EGFR,gene,0.985,21427284
41079,metastatic colorectal cancer,disease,0.9917,21427284
41080,CRC,disease,1.0,21427284
41081,Cetuximab,gene,0.9287,21427284
41082,panitumumab,gene,0.8237,21427284
41083,bevacizumab,gene,0.864,21427284
41084,panitumumab,gene,0.936,21385884
41085,oxaliplatin,drug,0.9995,21385884
41086,5-fluorouracil,drug,0.9995,21385884
41087,locally advanced rectal cancer,disease,0.9736,21385884
41088,STAR,DNA,0.4846,21385884
41089,panitumumab,gene,0.6777,21385884
41090,oxaliplatin,drug,1.0,21385884
41091,5-fluorouracil,drug,0.9995,21385884
41092,locally advanced rectal cancer,disease,1.0,21385884
41093,PATIENTS,species,0.9634,21385884
41094,rectal adenocarcinoma,disease,1.0,21385884
41095,Panitumumab,gene,0.851,21385884
41096,5-fluorouracil,drug,0.9995,21385884
41097,oxaliplatin,drug,0.9995,21385884
41098,diarrhea,disease,1.0,21385884
41099,cutaneous reactions,disease,0.9956,21385884
41100,nausea,disease,0.9985,21385884
41101,asthenia,disease,1.0,21385884
41102,anorexia,disease,1.0,21385884
41103,neutropenia,disease,1.0,21385884
41104,diarrhea,disease,1.0,21385884
41105,panitumumab,gene,0.9224,21385884
41106,diarrhea,disease,0.9995,21385884
41107,rectal cancer,disease,0.999,21385884
41108,anti-epidermal growth factor receptor monoclonal antibodies,gene,0.8853,21385884
41109,cancer cell subpopulations,cell_type,0.8325,21380628
41110,cancer,disease,0.9224,21380628
41111,colorectal tumors,disease,0.999,21380628
41112,cancer cells,cell_type,0.86,21380628
41113,cancer,disease,0.971,21380628
41114,tumor,disease,0.974,21380628
41115,chromosome,DNA,0.5483,21380628
41116,solid tumors,disease,1.0,21380628
41117,APC,gene,0.826,21380628
41118,TP53,gene,0.8457,21380628
41119,KRAS,gene,0.799,21380628
41120,colorectal cancer,disease,1.0,21380628
41121,colorectal cancer,disease,1.0,21380628
41122,primary tumor,disease,0.7876,21380628
41123,primary,disease,0.797,21380628
41124,tumor,disease,0.8765,21380628
41125,KRAS mutation-negative subpopulations,cell_line,0.508,21380628
41126,KRAS,gene,0.7456,21380628
41127,metastatic tumors,disease,0.9946,21380628
41128,KRAS,gene,0.823,21380628
41129,cetuximab,gene,0.839,21380628
41130,panitumumab,gene,0.881,21380628
41131,cetuximab,gene,0.866,21380628
41132,panitumumab,gene,0.882,21380628
41133,metastatic tumors,disease,0.908,21380628
41134,head and neck cancer,disease,1.0,21372717
41135,cancer,disease,0.998,21372717
41136,head and neck cancer,disease,1.0,21372717
41137,HNC,disease,1.0,21372717
41138,HNC,disease,1.0,21372717
41139,epithelial growth factor receptors,gene,0.998,21372717
41140,EGFRs,gene,0.991,21372717
41141,Human papilloma virus,disease,1.0,21372717
41142,Human papilloma,species,0.7236,21372717
41143,tumors,disease,0.928,21372717
41144,Cetuximab,gene,0.9326,21372717
41145,panitumumab,gene,0.8345,21372717
41146,EGFR,gene,0.992,21372717
41147,vascular endothelial cell growth factor receptor,gene,0.997,21372717
41148,vascular endoinsulin-like growth factor 1 receptor,gene,0.9946,21372717
41149,MET,gene,0.6343,21372717
41150,PI3KA,gene,0.9946,21372717
41151,mammalian target,gene,0.672,21372717
41152,rapamycin,drug,0.9976,21372717
41153,HNC,disease,1.0,21372717
41154,Metastatic Colorectal Cancer,disease,1.0,21358960
41155,metastatic colorectal cancer,disease,1.0,21358960
41156,mCRC,disease,1.0,21358960
41157,mCRC,disease,0.992,21358960
41158,fluorouracil,drug,0.998,21358960
41159,leucovorin,drug,0.999,21358960
41160,oxaliplatin,drug,0.9956,21358960
41161,FOLFOX,drug,0.9624,21358960
41162,FOLFOX,drug,0.733,21358960
41163,bevacizumab,gene,0.739,21358960
41164,fluorouracil,drug,1.0,21358960
41165,leucovorin,drug,0.998,21358960
41166,irinotecan,drug,0.9985,21358960
41167,FOLFIRI,drug,0.9546,21358960
41168,FOLFIRI,drug,0.854,21358960
41169,bevacizumab,gene,0.882,21358960
41170,bevacizumab,gene,0.7705,21358960
41171,cetuximab,gene,0.744,21358960
41172,panitumumab,gene,0.738,21358960
41173,bevacizumab,gene,0.762,21358960
41174,bevacizumab,gene,0.774,21358960
41175,mCRC,disease,0.9917,21358960
41176,FOLFOX,drug,0.902,21358960
41177,FOLFIRI,drug,0.8804,21358960
41178,Bevacizumab,gene,0.9224,21358960
41179,bevacizumab,gene,0.709,21358960
41180,epidermal growth factor receptor,gene,0.998,21356164
41181,colorectal cancer,disease,1.0,21356164
41182,epidermal growth factor receptor,gene,0.9985,21356164
41183,receptor tyrosine kinase family,gene,0.9966,21356164
41184,tyrosine,drug,0.9814,21356164
41185,EGFR,gene,0.992,21356164
41186,colon cancer,disease,1.0,21356164
41187,colon cancer,disease,1.0,21356164
41188,EGFR,gene,0.992,21356164
41189,EGFR monoclonal antibodies,gene,0.966,21356164
41190,tyrosine,drug,0.9604,21356164
41191,tyrosine kinase,gene,0.9424,21356164
41192,EGFR,gene,0.9907,21356164
41193,colon cancer,disease,1.0,21356164
41194,EGFR,gene,0.996,21356164
41195,colon cancer,disease,1.0,21356164
41196,anti-EGFR monoclonal antibodies,gene,0.9824,21356164
41197,EGFR,gene,0.995,21356164
41198,KRAS,gene,0.893,21356164
41199,BRAF,gene,0.8574,21356164
41200,anti-EGFR MAbs,gene,0.8535,21356164
41201,cetuximab,gene,0.841,21356164
41202,panitumumab,gene,0.808,21356164
41203,KRAS,gene,0.8213,21356164
41204,anti-EGFR monoclonal,gene,0.826,21356164
41205,colon cancer,disease,1.0,21356164
41206,cancer,disease,0.9995,21356164
41207,Cancer,disease,0.9995,21355777
41208,Cancer,disease,0.9995,21355777
41209,cancer,disease,1.0,21355777
41210,levamisole,drug,0.999,21355777
41211,interferon-,gene,0.9507,21355777
41212,interleukin-2,gene,0.9795,21355777
41213,rituximab,gene,0.9126,21355777
41214,ofatumumab,gene,0.662,21355777
41215,alemtuzumab,gene,0.8706,21355777
41216,trastuzumab,gene,0.916,21355777
41217,bevacizumab,gene,0.9175,21355777
41218,cetuximab,gene,0.9355,21355777
41219,panitumumab,gene,0.956,21355777
41220,Y-90,drug,0.989,21355777
41221,I-131 tositumomab,gene,0.7793,21355777
41222,denileukin diftitox,gene,0.6387,21355777
41223,gemtuzumab ozogamicin,gene,0.8267,21355777
41224,lymphocyte,cell_type,0.4087,21355777
41225,prostate cancer,disease,1.0,21355777
41226,sipuleucel-T,gene,0.736,21355777
41227,B- and T-cell malignancies,disease,1.0,21355777
41228,solid tumors,disease,1.0,21355777
41229,melanoma,disease,0.661,21355777
41230,glioblastoma,disease,1.0,21355777
41231,lymphoma,disease,1.0,21355777
41232,melanoma,disease,1.0,21355777
41233,anti-CTLA-4 monoclonal antibody,gene,0.9624,21355777
41234,regulatory T-cells,cell_type,0.933,21355777
41235,melanoma,disease,1.0,21355777
41236,cancer,disease,1.0,21355777
41237,rectal cancer,disease,1.0,21346551
41238,epidermal growth factor receptor,gene,0.9985,21346551
41239,EGFR,gene,0.989,21346551
41240,solid tumours,disease,1.0,21346551
41241,EGFR,gene,0.9937,21346551
41242,cancer,disease,1.0,21346551
41243,EGFR,gene,0.994,21346551
41244,cetuximab,gene,0.8276,21346551
41245,head and neck cancer,disease,1.0,21346551
41246,metastatic colorectal cancer,disease,0.9863,21346551
41247,cetuximab,gene,0.961,21346551
41248,panitumumab,gene,0.852,21346551
41249,EGFR,gene,0.997,21346551
41250,locally advanced rectal cancer,disease,0.9995,21346551
41251,EGFR,gene,0.9927,21346551
41252,anti-,gene,0.5093,21346551
41253,VEGF antibodies,gene,0.752,21346551
41254,rectal cancer,disease,1.0,21346551
41255,EGFR,gene,0.984,21346551
41256,EGFR,gene,0.9937,21346551
41257,rectal cancer,disease,1.0,21346551
41258,EGFR,gene,0.983,21346551
41259,fluoropyrimidine,drug,0.9966,21346551
41260,cetuximab,gene,0.938,21346551
41261,cetuximab,gene,0.9844,21346551
41262,gastrointestinal toxicity,disease,0.876,21346551
41263,diarrhoea,disease,1.0,21346551
41264,anti-EGFR,gene,0.8447,21345141
41265,oxaliplatin,drug,0.999,21345141
41266,metastatic colorectal cancer,disease,0.9995,21345141
41267,EGF receptor,gene,0.9976,21345141
41268,EGFR,gene,0.9956,21345141
41269,wild-type KRAS,gene,0.8345,21345141
41270,metastatic colorectal cancer,disease,0.99,21345141
41271,Panitumumab,gene,0.7007,21345141
41272,EGFRs,gene,0.996,21345141
41273,tumor,disease,0.9985,21345141
41274,colorectal cancer,disease,1.0,21345141
41275,Panitumumab,gene,0.923,21345141
41276,Metastatic Colorectal Cancer,disease,0.9995,21345141
41277,fluoroucil,drug,0.9966,21345141
41278,leucovorin,drug,0.9985,21345141
41279,oxaliplatin,drug,0.9995,21345141
41280,panitumumab,gene,0.7554,21345141
41281,metastatic colorectal cancer,disease,0.9995,21345141
41282,PRIME,DNA,0.5254,21345141
41283,EGFR,gene,0.993,21345141
41284,cetuximab,gene,0.7354,21345141
41285,oxaliplatin,drug,0.9995,21345141
41286,metastatic colorectal cancer,disease,0.899,21345141
41287,gemcitabine,drug,0.999,21312086
41288,cisplatin,drug,0.9995,21312086
41289,EGF receptor antibody,gene,0.863,21312086
41290,panitumumab,gene,0.607,21312086
41291,GemCisP,drug,0.998,21312086
41292,GemCis,drug,0.9985,21312086
41293,locally advanced/metastatic urothelial carcinoma,disease,0.9995,21312086
41294,HRAS,gene,0.5254,21312086
41295,- PURO,DNA,0.3838,21312086
41296,PURO,gene,0.8926,21312086
41297,KRAS,DNA,0.831,21299161
41298,KRAS mutation,gene,0.899,21299161
41299,EGFR,gene,0.993,21299161
41300,colorectal cancer,disease,1.0,21299161
41301,metastatic colorectal cancer,disease,1.0,21299161
41302,KRAS,DNA,0.74,21299161
41303,KRAS mutation,gene,0.7905,21299161
41304,anti-EGFR antibodies,gene,0.8755,21299161
41305,KRAS,DNA,0.838,21299161
41306,KRAS mutation,gene,0.9043,21299161
41307,KRAS mutations,gene,0.7754,21299161
41308,paraffin,drug,0.5273,21299161
41309,Pathologists,cell_type,0.4465,21299161
41310,tumoral,disease,1.0,21299161
41311,KRAS,DNA,0.8237,21299161
41312,KRAS mutation,gene,0.971,21299161
41313,KRAS,DNA,0.773,21299161
41314,KRAS mutation,gene,0.978,21299161
41315,viable,cell_type,0.498,21299161
41316,tumour cells,cell_type,0.7847,21299161
41317,tumour,disease,0.998,21299161
41318,Pathologists,cell_type,0.4182,21299161
41319,invasive carcinoma,disease,0.9995,21299161
41320,neoplastic,disease,0.582,21299161
41321,nontumoural,DNA,0.57,21299161
41322,nontumoural elements,cell_type,0.542,21299161
41323,tumour cells,cell_type,0.7876,21299161
41324,tumour,disease,1.0,21299161
41325,KRAS,DNA,0.8486,21299161
41326,KRAS mutation,gene,0.971,21299161
41327,Cetuximab,gene,0.827,21286919
41328,panitumumab,gene,0.7534,21286919
41329,KRAS,gene,0.9927,21286919
41330,epidermal growth factor receptor monoclonal,gene,0.8696,21286919
41331,panitumumab,gene,0.899,21286919
41332,cetuximab,gene,0.658,21286919
41333,KRAS,DNA,0.6533,21286919
41334,KRAS wild,gene,0.7534,21286919
41335,patients,species,0.988,21286919
41336,advanced colorectal cancer,disease,1.0,21286919
41337,KRAS,gene,0.992,21286919
41338,patients,species,0.9697,21286919
41339,PATIENTS,species,0.967,21286919
41340,KRAS,DNA,0.724,21286919
41341,KRAS,gene,0.9946,21286919
41342,patients,species,0.966,21286919
41343,patients,species,0.9873,21286919
41344,tumor,disease,1.0,21286919
41345,patients,species,0.983,21286919
41346,anti-,gene,0.7603,21286919
41347,EGFR monoclonal antibodies,gene,0.771,21286919
41348,KRAS,gene,0.9927,21286919
41349,colorectal cancer,disease,0.84,21286919
41350,patients,species,0.991,21286919
41351,metastatic colorectal carcinoma,disease,0.9653,21277276
41352,metastatic colorectal cancer,disease,1.0,21277276
41353,mCRC,disease,1.0,21277276
41354,VEGF,gene,0.997,21277276
41355,epidermal growth factor,gene,0.9077,21277276
41356,EGFR,gene,0.994,21277276
41357,bevacizumab,gene,0.733,21277276
41358,VEGF,gene,0.9966,21277276
41359,KRAS oncogen,gene,0.995,21277276
41360,EGFR,gene,0.9834,21277276
41361,patients,species,0.9736,21277276
41362,tumors,disease,1.0,21277276
41363,wild type KRAS oncogen,DNA,0.8276,21277276
41364,wild type KRAS oncogen,gene,0.995,21277276
41365,tumor,disease,1.0,21277276
41366,mCRC,disease,0.875,21277276
41367,chimeric EGFR,gene,0.6855,21239398
41368,cetuximab,gene,0.8257,21239398
41369,panitumumab,gene,0.93,21233587
41370,KRAS,gene,0.7764,21229361
41371,KRAS,DNA,0.794,21229361
41372,KRAS mutation,gene,0.8975,21229361
41373,panitumumab,gene,0.7515,21229361
41374,metastatic colorectal cancer,disease,0.9995,21229361
41375,metastatic colon cancer,disease,1.0,21222364
41376,cardiac arrest,disease,1.0,21222364
41377,irinotecan,drug,0.9976,21222364
41378,panitumumab,gene,0.9395,21222364
41379,Panitumumab,gene,0.721,21222364
41380,recombinant human Immunoglobulin G antibody,gene,0.98,21222364
41381,Irinotecan,drug,0.998,21222364
41382,S,DNA,0.4902,21222364
41383,S-phase cell cycle,cell_line,0.627,21222364
41384,Panitumumab,gene,0.9346,21222364
41385,metastatic colon cancer,disease,1.0,21222364
41386,Panitumumab,gene,0.9404,21222364
41387,Irinotecan,drug,0.9707,21222364
41388,cardiac arrest,disease,1.0,21222364
41389,Panitumumab,gene,0.798,21222364
41390,Irinotecan,drug,0.9946,21222364
41391,cardiac arrest,disease,1.0,21222364
41392,cardiac arrest,disease,1.0,21222364
41393,Irinotecan,drug,0.999,21222364
41394,Panitumumab,gene,0.879,21222364
41395,Cancer,disease,0.9805,21222364
41396,Panitumumab,gene,0.89,21222364
41397,metastatic colon,disease,0.999,21222364
41398,cancer,disease,1.0,21222364
41399,panitumumab,gene,0.8525,21221853
41400,metastatic colorectal cancer,disease,1.0,21221853
41401,wild,DNA,0.7173,21221853
41402,wild-type KRAS,gene,0.8486,21221853
41403,Panitumumab,gene,0.644,21221853
41404,anti-epidermal growth factor receptor,gene,0.983,21221853
41405,EGFR,gene,0.9844,21221853
41406,metastatic colorectal cancer,disease,1.0,21221853
41407,mCRC,disease,1.0,21221853
41408,wild-type (WT) KRAS gene,DNA,0.9287,21221853
41409,panitumumab,gene,0.97,21221853
41410,mCRC,disease,0.9766,21221853
41411,KRAS,gene,0.8823,21221853
41412,tumor KRAS,gene,0.7993,21221853
41413,KRAS,DNA,0.4292,21221853
41414,anti-EGFR,gene,0.7144,21221853
41415,WT KRAS,gene,0.9497,21221853
41416,mCRC,disease,0.9927,21221853
41417,panitumumab,gene,0.9316,21208847
41418,cetuximab,gene,0.8887,21208847
41419,Cetuximab,gene,0.9224,21208847
41420,cetuximab,gene,0.9004,21208847
41421,hypersensitivity reactions,disease,1.0,21208847
41422,HSRs,disease,0.993,21208847
41423,HSRs,disease,0.9985,21208847
41424,cetuximab,gene,0.7305,21208847
41425,cetuximab,gene,0.946,21208847
41426,HSRs,disease,0.5137,21208847
41427,panitumumab,gene,0.8857,21208847
41428,panitumumab,gene,0.934,21208847
41429,metastatic colorectal cancer,disease,1.0,21208847
41430,mCRC,disease,1.0,21208847
41431,panitumumab,gene,0.9375,21208847
41432,cetuximab,gene,0.9355,21208847
41433,PATIENTS,species,0.9604,21208847
41434,mCRC,disease,0.989,21208847
41435,panitumumab,gene,0.8623,21208847
41436,cetuximab,gene,0.881,21208847
41437,Cancer,disease,0.7515,21208847
41438,Cancer,disease,0.6113,21208847
41439,KRAS,gene,0.781,21208847
41440,tumor tissue,cell_type,0.4712,21208847
41441,tumor,disease,0.998,21208847
41442,panitumumab,gene,0.775,21208847
41443,panitumumab,gene,0.858,21208847
41444,carcinoembryonic antigen,gene,0.9927,21208847
41445,CEA,gene,0.961,21208847
41446,CEA,gene,0.9824,21208847
41447,panitumumab,gene,0.8013,21208847
41448,hypersensitivity reactions,disease,0.9995,21208847
41449,skin rash,disease,0.9995,21208847
41450,asthenia,disease,1.0,21208847
41451,skin rash,disease,0.9995,21208847
41452,paronychia,disease,1.0,21208847
41453,hypomagnesemia,disease,1.0,21208847
41454,fatigue,disease,0.995,21208847
41455,wild-type KRAS,DNA,0.6265,21208847
41456,wild,gene,0.6353,21208847
41457,CEA,gene,0.961,21208847
41458,mutant KRAS,gene,0.6733,21208847
41459,mutant KRAS,gene,0.6807,21208847
41460,Panitumumab,gene,0.796,21208847
41461,mCRC,disease,0.9873,21208847
41462,cetuximab,gene,0.9067,21208847
41463,cetuximab,gene,0.958,21208847
41464,panitumumab,gene,0.9375,21208847
41465,epidermal growth factor receptor,gene,0.9946,21200037
41466,KRAS,DNA,0.873,21200037
41467,KRAS mutations,gene,0.8657,21200037
41468,advanced colorectal cancer,disease,1.0,21200037
41469,KRAS,DNA,0.7363,21200037
41470,KRAS mutations,gene,0.8706,21200037
41471,advanced colorectal cancer,disease,1.0,21200037
41472,anti-,gene,0.642,21200037
41473,epidermal growth factor receptor,gene,0.899,21200037
41474,EGFR,gene,0.9854,21200037
41475,panitumumab,gene,0.7754,21200037
41476,KRAS,gene,0.7705,21200037
41477,EGFR,gene,0.9478,21200037
41478,advanced colorectal cancer,disease,1.0,21200037
41479,KRAS,gene,0.7383,21200037
41480,KRAS mutations,gene,0.699,21200037
41481,EGFR,gene,0.6143,21200037
41482,metastatic colorectal cancer,disease,1.0,21200037
41483,EGFR,gene,0.583,21200037
41484,EGFR,gene,0.561,21200037
41485,KRAS,gene,0.975,21200037
41486,EGFR,gene,0.8877,21200037
41487,KRAS,gene,0.7256,21200037
41488,KRAS,gene,0.864,21200037
41489,anti-EGFR antibodies,gene,0.77,21200037
41490,KRAS mutations,gene,0.814,21200037
41491,KRAS,gene,0.756,21200037
41492,advanced,disease,0.559,21200037
41493,colorectal cancer,disease,1.0,21200037
41494,anti-,gene,0.705,21200037
41495,EGFR antibodies,gene,0.7817,21200037
41496,colorectal cancer,disease,0.9683,21197743
41497,metastatic colorectal cancer,disease,0.9775,21197743
41498,irinotecan,drug,0.9985,21197743
41499,oxaliplatin,drug,0.9995,21197743
41500,5FU,drug,0.9976,21197743
41501,leucovorin,drug,0.999,21197743
41502,bevacizumab,gene,0.695,21197743
41503,VEGF,gene,0.9907,21197743
41504,cetuximab,gene,0.567,21197743
41505,panitumumab,gene,0.834,21197743
41506,EGF receptor,gene,0.9966,21197743
41507,advanced colorectal cancer,disease,0.9995,21197743
41508,cancer,disease,1.0,21197742
41509,colorectal cancer,disease,1.0,21197742
41510,colorectal cancer,disease,1.0,21197741
41511,cancer,disease,0.9995,21197741
41512,EGFR,gene,0.986,21197741
41513,colorectal cancer,disease,1.0,21197741
41514,Bevacizumab,gene,0.9185,21197741
41515,cetuximab,gene,0.926,21197741
41516,panitumumab,gene,0.9326,21197741
41517,KRAS gene,gene,0.9097,21197741
41518,anti-EGFR,gene,0.804,21197741
41519,5FU,drug,0.9927,21197741
41520,advanced colorectal cancer,disease,0.9995,21197741
41521,EGFR,gene,0.991,21196389
41522,head and neck cancer,disease,1.0,21196389
41523,EGFR,gene,0.993,21196389
41524,tyrosine,drug,0.988,21196389
41525,tyrosine-kinase,gene,0.981,21196389
41526,head and neck cancer,disease,0.968,21196389
41527,Cetuximab,gene,0.946,21196389
41528,platinum,drug,0.9985,21196389
41529,fluorouracil,drug,0.9927,21196389
41530,Cetuximab,gene,0.8496,21196389
41531,EGFR,gene,0.9634,21196389
41532,skin rash,disease,1.0,21196389
41533,EGFR,gene,0.911,21196389
41534,EGFR,gene,0.991,21196353
41535,bilio-pancreatic and liver carcinoma,disease,1.0,21196353
41536,epidermal growth factor receptor,gene,0.9976,21196353
41537,EGFR,gene,0.9907,21196353
41538,cancer,disease,1.0,21196353
41539,EGFR,gene,0.996,21196353
41540,cetuximab,gene,0.9185,21196353
41541,panitumumab,gene,0.8667,21196353
41542,tyrosine,drug,0.9937,21196353
41543,tyrosine kinase,gene,0.9736,21196353
41544,gefitinib,drug,0.9927,21196353
41545,erlotinib,drug,0.9897,21196353
41546,EGFR,gene,0.7085,21196353
41547,non-colorectal digestive cancer,disease,1.0,21196353
41548,Anti-,gene,0.923,21196277
41549,EGFR monoclonal,gene,0.6235,21196277
41550,cancer,disease,0.9995,21196277
41551,EGFR,gene,0.993,21196277
41552,EGFR,gene,0.99,21196277
41553,tyrosine,drug,0.923,21196277
41554,tyrosine kinase,gene,0.9717,21196277
41555,EGFR,gene,0.9844,21196277
41556,EGFR tyrosine kinase,gene,0.907,21196277
41557,tyrosine,drug,0.9927,21196277
41558,EGFR,gene,0.998,21196277
41559,cancer cells,cell_type,0.8516,21196277
41560,cancer,disease,0.9995,21196277
41561,anti-EGFR monoclonal antibodies,gene,0.8574,21196277
41562,solid tumors,disease,1.0,21196277
41563,EGFR,gene,0.993,21196277
41564,tumor,disease,1.0,21196277
41565,colorectal cancer,disease,1.0,21190026
41566,patients,species,0.9785,21190026
41567,Panitumumab,gene,0.937,21190026
41568,wild,gene,0.715,21190026
41569,metastatic colorectal cancer,disease,0.9966,21190026
41570,mCRC,disease,0.9985,21190026
41571,Patient,species,0.9727,21190026
41572,patient,species,0.9507,21190026
41573,patients,species,0.91,21190026
41574,mCRC,disease,0.985,21190026
41575,panitumumab,gene,0.911,21190026
41576,BSC,drug,0.993,21190026
41577,BSC,drug,0.9663,21190026
41578,Patient,species,0.992,21190026
41579,CRC,disease,0.9375,21190026
41580,KRAS,gene,0.992,21190026
41581,tumor,disease,0.9595,21190026
41582,KRAS,DNA,0.8,21190026
41583,KRAS,gene,0.9946,21190026
41584,tumor,disease,0.9775,21190026
41585,patient,species,0.996,21190026
41586,patients,species,0.9775,21190026
41587,panitumumab,gene,0.5703,21190026
41588,patients,species,0.944,21190026
41589,wild-type KRAS,gene,0.8315,21190026
41590,mCRC,disease,0.995,21190026
41591,panitumumab,gene,0.8364,21190026
41592,patients,species,0.979,21190026
41593,wild-type KRAS,gene,0.8867,21190026
41594,mCRC,disease,0.994,21190026
41595,patients,species,0.9893,21190026
41596,mutant KRAS,gene,0.9697,21190026
41597,mCRC,disease,0.987,21190026
41598,Panitumumab,gene,0.95,21190026
41599,patients,species,0.946,21190026
41600,wild,gene,0.7705,21190026
41601,mCRC,disease,0.9976,21190026
41602,CRC,disease,0.999,21190026
41603,panitumumab,gene,0.8613,21190026
41604,metastatic colorectal cancer,disease,0.868,21180382
41605,colorectal cancer,disease,1.0,21180382
41606,metastatic colorectal cancer,disease,1.0,21180382
41607,fluorouracil,drug,0.999,21180382
41608,folinic acid,drug,0.9985,21180382
41609,oxaliplatin,drug,0.9995,21180382
41610,irinotecan,drug,0.999,21180382
41611,fluorouracil,drug,0.9995,21180382
41612,fluorouracil,drug,0.999,21180382
41613,Folfox,drug,0.995,21180382
41614,Folfiri,drug,0.992,21180382
41615,Folfiri,drug,0.679,21180382
41616,Folfoxiri,drug,0.7837,21180382
41617,fluorouracil,drug,0.9995,21180382
41618,oxaliplatin,drug,0.9995,21180382
41619,irinotecan,drug,0.9985,21180382
41620,Folfoxiri,drug,0.964,21180382
41621,capecitabine,drug,0.9995,21180382
41622,tegafur,drug,0.996,21180382
41623,fluorouracil,drug,0.9995,21180382
41624,Pemetrexed,drug,0.9995,21180382
41625,Bevacizumab,gene,0.9224,21180382
41626,panitumumab,gene,0.9336,21180382
41627,cetuximab,gene,0.9336,21180382
41628,fluorouracil,drug,0.999,21180382
41629,capecitabine,drug,0.999,21180382
41630,oxaliplatin,drug,0.9995,21180382
41631,irinotecan,drug,0.9985,21180382
41632,tumours,disease,1.0,21180382
41633,wild-type KRAS gene,gene,0.922,21180382
41634,cetuximab,gene,0.869,21180382
41635,Cetuximab,gene,0.842,21180382
41636,anti-EGFR antibody,gene,0.9204,21180382
41637,panitumumab,gene,0.8735,21180382
41638,cetuximab,gene,0.8613,21180382
41639,bevacizumab,gene,0.6436,21180382
41640,Folfox,drug,0.999,21180382
41641,fluorouracil,drug,1.0,21180382
41642,oxaliplatin,drug,0.9995,21180382
41643,Folfox,drug,0.8335,21180382
41644,fluorouracil,drug,1.0,21180382
41645,irinotecan,drug,0.998,21180382
41646,Folfiri,drug,0.7783,21180382
41647,panitumumab,gene,0.9585,21180382
41648,cetuximab,gene,0.9414,21180382
41649,wild-type KRAS gene,gene,0.924,21180382
41650,KRAS,DNA,0.7007,21180382
41651,KRAS mutations,gene,0.881,21180382
41652,metastatic colorectal cancer,disease,1.0,21180382
41653,fluorouracil,drug,1.0,21180382
41654,folinic acid,drug,0.9985,21180382
41655,oxaliplatin,drug,0.9995,21180382
41656,irinotecan,drug,0.9985,21180382
41657,fluorouracil,drug,0.9976,21180382
41658,folinic acid,drug,0.9985,21180382
41659,capecitabine,drug,0.9995,21180382
41660,colorectal cancer,disease,1.0,21180382
41661,KRAS wild,cell_line,0.563,21180382
41662,KRAS,gene,0.5093,21180382
41663,IgG,gene,0.996,21178280
41664,EGFR,gene,0.994,21178280
41665,cetuximab,gene,0.8247,21178280
41666,cetuximab,gene,0.4946,21178280
41667,anti-epidermal growth factor receptor,gene,0.9844,21178280
41668,EGFR,gene,0.634,21178280
41669,human Fc receptors,gene,0.9946,21178280
41670,tumor cell lines,cell_line,0.95,21178280
41671,tumor,disease,0.9756,21178280
41672,peripheral blood mononuclear cells,cell_type,0.7812,21178280
41673,NK cells,cell_type,0.9,21178280
41674,lactate,drug,0.998,21178280
41675,lactate dehydrogenase,gene,0.995,21178280
41676,Cetuximab,gene,0.92,21178280
41677,cetuximab,gene,0.9604,21178280
41678,panitumumab,gene,0.8516,21178280
41679,anti-EGFR IgG2,gene,0.9917,21178280
41680,Cetuximab,gene,0.8677,21178280
41681,FcRI,gene,0.9966,21178280
41682,FcRIIIa,gene,0.9956,21178280
41683,tumor cell lines,cell_line,0.891,21178280
41684,tumor cell,cell_type,0.4524,21178280
41685,tumor,disease,1.0,21178280
41686,Panitumumab,gene,0.838,21178280
41687,FcRI,gene,0.998,21178280
41688,FcRIIIa,gene,0.9976,21178280
41689,effector-target cell,cell_type,0.6313,21178280
41690,EGFR,gene,0.9956,21178280
41691,cetuximab,gene,0.913,21178280
41692,panitumumab,gene,0.851,21178280
41693,cetuximab,gene,0.958,21178280
41694,EGFR,gene,0.991,21178280
41695,tumor cells,cell_type,0.8906,21178280
41696,tumor,disease,0.996,21178280
41697,tumor cells,cell_type,0.8193,21178280
41698,tumor,disease,1.0,21178280
41699,IgG1 isotype,gene,0.866,21178280
41700,tumor-cell,cell_type,0.797,21178280
41701,tumor,disease,0.7827,21178280
41702,EGFR,gene,0.9067,21178280
41703,cetuximab,gene,0.8047,21178280
41704,KRAS,gene,0.8857,21174626
41705,cetuximab,gene,0.6597,21174626
41706,panitumumab,gene,0.677,21174626
41707,EGFR,gene,0.9937,21174626
41708,gefitinib,drug,0.997,21174626
41709,CYP2D6,gene,0.9937,21174626
41710,tamoxifen,drug,0.9995,21174626
41711,TPMT,DNA,0.5483,21174626
41712,TPMT,gene,0.98,21174626
41713,azathioprine,drug,0.9995,21174626
41714,6-mercaptopurine,drug,0.999,21174626
41715,VKORC1,gene,0.9946,21174626
41716,CYP2C9,gene,0.9985,21174626
41717,warfarin,drug,1.0,21174626
41718,CYP2C19,DNA,0.516,21174626
41719,CYP2C19,gene,0.991,21174626
41720,clopidogrel,drug,0.9995,21174626
41721,HLA-B*5701,gene,0.992,21174626
41722,abacavir,drug,0.9995,21174626
41723,HLA-B*5701,gene,0.993,21174626
41724,flucloxacillin,drug,0.999,21174626
41725,SLCO1B1,gene,0.9727,21174626
41726,statins,drug,0.9995,21174626
41727,CYP3A5,gene,0.988,21174626
41728,tacrolimus,drug,0.9995,21174626
41729,Tumor KRAS,gene,0.821,21169348
41730,KRAS,DNA,0.426,21169348
41731,panitumumab,gene,0.613,21169348
41732,patients,species,0.9077,21169348
41733,KRAS gene,gene,0.9937,21169348
41734,tumors,disease,1.0,21169348
41735,anti-,gene,0.652,21169348
41736,epidermal growth factor receptor antibody,gene,0.936,21169348
41737,patients,species,0.9478,21169348
41738,metastatic colorectal cancer,disease,0.997,21169348
41739,human,species,0.9155,21169348
41740,anti-epidermal growth factor receptor antibody panitumumab,gene,0.91,21169348
41741,KRAS,DNA,0.827,21169348
41742,KRAS,gene,0.9736,21169348
41743,metastatic colorectal,disease,1.0,21169348
41744,cancer,disease,1.0,21169348
41745,patients,species,0.989,21169348
41746,KRAS,gene,0.948,21169348
41747,patients,species,0.9824,21169348
41748,tumor,disease,1.0,21169348
41749,KRAS,DNA,0.8223,21169348
41750,KRAS,gene,0.982,21169348
41751,solid tumors,disease,1.0,21169348
41752,Tumor samples,cell_type,0.523,21169348
41753,KRAS,gene,0.994,21169348
41754,metastatic colorectal cancer,disease,1.0,21169348
41755,patients,species,0.9927,21169348
41756,patients,species,0.9907,21169348
41757,patients,species,0.993,21169348
41758,wild,disease,0.8013,21169348
41759,patients,species,0.9927,21169348
41760,mutated KRAS,gene,0.7773,21169348
41761,tumors,disease,0.6665,21169348
41762,patients,species,0.9814,21169348
41763,tumors,disease,1.0,21169348
41764,wild,DNA,0.641,21169348
41765,wild-type KRAS,gene,0.982,21169348
41766,patients,species,0.9565,21169348
41767,wild-type KRAS,gene,0.9795,21169348
41768,patients,species,0.979,21169348
41769,tumors,disease,1.0,21169348
41770,patient,species,0.968,21169348
41771,KRAS,DNA,0.859,21169348
41772,KRAS,gene,0.9834,21169348
41773,tumors,disease,0.999,21169348
41774,patients,species,0.9316,21169348
41775,metastatic colorectal cancer,disease,1.0,21169348
41776,panitumumab,gene,0.928,21169348
41777,colorectal cancer,disease,1.0,21163770
41778,Colon cancer,disease,1.0,21163770
41779,cancer,disease,1.0,21163770
41780,metastatic colon cancer,disease,0.9995,21163770
41781,anti-EGFR,gene,0.752,21163770
41782,cetuximab,gene,0.8955,21163770
41783,panitumumab,gene,0.8887,21163770
41784,liver metastases,disease,0.995,21163770
41785,EGFR,gene,0.738,21163770
41786,anti-EGFR,gene,0.8057,21163770
41787,colorectal cancer,disease,1.0,21163770
41788,anti-VEGF antibody,gene,0.8413,21163770
41789,EGFR,gene,0.7544,21163770
41790,EGFR,gene,0.9873,21163770
41791,KRAS,gene,0.6895,21163770
41792,BRAF,gene,0.664,21163770
41793,PIK3CA,DNA,0.4912,21163770
41794,PIK3CA mutations,gene,0.885,21163770
41795,formalin,drug,0.9893,21163770
41796,paraffin,cell_line,0.4583,21163770
41797,KRAS,DNA,0.843,21163770
41798,KRAS mutations,gene,0.774,21163770
41799,KRAS mutant tumors,disease,0.8315,21163770
41800,KRAS,gene,0.62,21163770
41801,EGFR,gene,0.6333,21163770
41802,cetuximab,gene,0.9473,21163770
41803,KRAS mutant tumors,disease,0.636,21163770
41804,KRAS,gene,0.465,21163770
41805,BRAF mutant tumor,disease,0.7007,21163770
41806,BRAF,gene,0.494,21163770
41807,tumor,disease,1.0,21163770
41808,cetuximab,gene,0.8247,21163770
41809,KRAS,gene,0.6724,21163770
41810,BRAF,DNA,0.609,21163770
41811,BRAF mutations,gene,0.9546,21163770
41812,KRAS,gene,0.8394,21163770
41813,primary tumor,disease,0.7417,21163770
41814,PIK3CA,DNA,0.718,21163770
41815,PIK3CA mutations,gene,0.8794,21163770
41816,tumor samples,cell_type,0.4836,21163770
41817,tumor,disease,1.0,21163770
41818,PIK3CA,gene,0.554,21163770
41819,primary,disease,0.979,21163770
41820,tumor,disease,0.8115,21163770
41821,KRAS,gene,0.6934,21163770
41822,BRAF,gene,0.85,21163770
41823,EGFR,gene,0.7295,21163770
41824,PIK3CA,gene,0.482,21163770
41825,circulating tumor cells,cell_type,0.9,21163770
41826,egfr,gene,0.6553,21151408
41827,metastatic colorectal cancer,disease,0.9966,21151408
41828,colorectal cancer,disease,1.0,21151408
41829,crc,disease,1.0,21151408
41830,epidermal growth factor receptor,gene,0.9985,21151408
41831,egfr,gene,0.996,21151408
41832,metastatic crc,disease,0.9756,21151408
41833,mcrc,disease,1.0,21151408
41834,KRAS,gene,0.8374,21151408
41835,tumour,disease,1.0,21151408
41836,egfr,gene,0.7485,21151408
41837,egfr,gene,0.9946,21151408
41838,tumours,disease,1.0,21151408
41839,mutated KRAS,gene,0.6787,21151408
41840,KRAS,DNA,0.5044,21151408
41841,wild-type KRAS,gene,0.6636,21151408
41842,mcrc,disease,0.543,21151408
41843,fluoropyrimidine,drug,0.999,21151408
41844,irinotecan,drug,0.999,21151408
41845,oxaliplatin,drug,0.9995,21151408
41846,egfr,gene,0.5854,21151408
41847,Cetuximab,gene,0.864,21151408
41848,cetuximab,gene,0.9004,21151408
41849,irinotecan,drug,0.997,21151408
41850,panitumumab,gene,0.788,21151408
41851,wild,DNA,0.6304,21151408
41852,wild-type KRAS,gene,0.8135,21151408
41853,KRAS,gene,0.815,21142908
41854,panitumumab,gene,0.9243,21142908
41855,HLA,DNA,0.569,21142908
41856,HLA-B*5701,gene,0.9907,21142908
41857,abacavir,drug,0.9976,21142908
41858,panitumumab,gene,0.7275,21142906
41859,warfarin,drug,0.9995,21142906
41860,clopidogrel,drug,0.999,21142906
41861,PGx,DNA,0.4814,21142906
41862,PGx,DNA,0.4717,21142906
41863,colorectal cancer,disease,1.0,21129611
41864,KRAS,gene,0.6494,21129611
41865,BRAF,gene,0.547,21129611
41866,EGFR,gene,0.8423,21129611
41867,metastatic CRC,disease,0.985,21129611
41868,epidermal growth factor receptor,gene,0.9976,21129611
41869,EGFR,gene,0.9917,21129611
41870,anti-EGFR monoclonal antibodies,gene,0.9463,21129611
41871,cetuximab,gene,0.8037,21129611
41872,panitumumab,gene,0.7495,21129611
41873,EGFR,gene,0.9937,21129611
41874,EGFR,gene,0.994,21129611
41875,anti-EGFR antibodies,gene,0.8613,21129611
41876,KRAS,gene,0.823,21129611
41877,panitumumab,gene,0.8115,21129611
41878,cetuximab,gene,0.746,21129611
41879,tumors,disease,1.0,21129611
41880,KRAS,DNA,0.842,21129611
41881,KRAS mutations,gene,0.8696,21129611
41882,EGFR,gene,0.9966,21129611
41883,B-RAF,DNA,0.532,21129611
41884,B-RAF mutations,gene,0.8784,21129611
41885,KRAS,DNA,0.85,21129611
41886,KRAS mutations,gene,0.7656,21129611
41887,anti-EGFR mAbs,gene,0.9478,21129611
41888,BRAF,gene,0.7803,21129611
41889,anti-EGFR Abs,gene,0.933,21129611
41890,metastatic colorectal cancer,disease,0.995,21129603
41891,Metastatic colorectal cancer,disease,1.0,21129603
41892,mCRC,disease,1.0,21129603
41893,KRAS,gene,0.592,21129603
41894,epidermal growth factor receptor,gene,0.9985,21129603
41895,EGFR,gene,0.9966,21129603
41896,cetuximab,gene,0.512,21129603
41897,KRAS,gene,0.859,21129603
41898,mCRC,disease,0.9976,21129603
41899,EGFR,gene,0.993,21129603
41900,5-fluorouracil,drug,0.999,21129603
41901,oxaliplatin,drug,0.9985,21129603
41902,irinotecan,drug,0.997,21129603
41903,EGFR,gene,0.9917,21129603
41904,KRAS wild,cell_line,0.5767,21129603
41905,KRAS wild-type cancer,disease,0.9995,21129603
41906,KRAS,gene,0.971,21129603
41907,KRAS mutant disease,disease,0.996,21129603
41908,KRAS,gene,0.4849,21129603
41909,KRAS,gene,0.7725,21129603
41910,BRAF,gene,0.551,21129603
41911,PIK3CA exon 20 mutations,gene,0.9033,21129603
41912,EGFR,gene,0.9883,21129603
41913,mCRC,disease,0.997,21129603
41914,tumor,disease,1.0,21129603
41915,mCRC,disease,0.9937,21129603
41916,KRAS,gene,0.8604,21129603
41917,MEK1/2,gene,0.9624,21118963
41918,AS703026,drug,0.9976,21118963
41919,AZD6244,drug,0.999,21118963
41920,KRAS mutated,disease,0.8975,21118963
41921,KRAS,gene,0.9785,21118963
41922,colorectal cancer,disease,0.977,21118963
41923,EGFR monoclonal antibody,gene,0.9277,21118963
41924,Epidermal growth factor receptor,gene,0.999,21118963
41925,EGFR,gene,0.9966,21118963
41926,metastatic colorectal cancer,disease,1.0,21118963
41927,mCRC,disease,1.0,21118963
41928,K-ras mutation,gene,0.6475,21118963
41929,EGFR mAbs,gene,0.9824,21118963
41930,cetuximab,gene,0.897,21118963
41931,Erbitux,gene,0.503,21118963
41932,panitumumab,gene,0.895,21118963
41933,K-ras,gene,0.6494,21118963
41934,EGFR mAb,gene,0.9814,21118963
41935,MEK,gene,0.9897,21118963
41936,AS703026,drug,0.997,21118963
41937,AZD6244,drug,0.9995,21118963
41938,K-ras mutated,disease,0.786,21118963
41939,K-ras,gene,0.9927,21118963
41940,colorectal cancers,disease,0.856,21118963
41941,EGFR mAb,gene,0.9507,21118963
41942,AS703026,drug,0.999,21118963
41943,AZD6244,drug,0.9995,21118963
41944,isogenic human colorectal tumor cell lines,cell_line,0.961,21118963
41945,K-Ras,gene,0.9966,21118963
41946,EGFR mAb cetuximab,gene,0.8413,21118963
41947,Ras,gene,0.9956,21118963
41948,ERK,gene,0.9956,21118963
41949,D-WT cells,cell_line,0.953,21118963
41950,D-MUT cells,cell_line,0.6514,21118963
41951,D,gene,0.743,21118963
41952,AS703026,drug,0.997,21118963
41953,AZD6244,drug,0.999,21118963
41954,D-MUT cells,cell_line,0.5684,21118963
41955,MEK,gene,0.998,21118963
41956,ERK,gene,0.9873,21118963
41957,MEK,gene,0.9863,21118963
41958,AS703026,drug,0.995,21118963
41959,AZD6244,drug,0.999,21118963
41960,cetuximab-resistant colorectal cancer cells,cell_line,0.887,21118963
41961,cetuximab,gene,0.4578,21118963
41962,-resistant,cell_type,0.4272,21118963
41963,colorectal cancer cells,cell_type,0.618,21118963
41964,colorectal cancer,disease,0.9995,21118963
41965,K-ras,gene,0.615,21118963
41966,MEK,gene,0.9937,21118963
41967,K,cell_line,0.4915,21118963
41968,K-ras,gene,0.643,21118963
41969,CRC,disease,0.9175,21118963
41970,Ras,gene,0.9844,21115922
41971,EGFR,gene,0.99,21115922
41972,colorectal carcinoma,disease,1.0,21115922
41973,epidermal growth factor receptor,gene,0.9985,21115922
41974,EGFR,gene,0.9946,21115922
41975,tumours,disease,1.0,21115922
41976,colorectal cancer,disease,1.0,21115922
41977,CRC,disease,1.0,21115922
41978,EGFR,gene,0.9927,21115922
41979,EGFR,gene,0.9937,21115922
41980,Ras,gene,0.9897,21115922
41981,"codons 12, 13 and 61",DNA,0.708,21115922
41982,CRC,disease,0.9995,21115922
41983,GTPase,gene,0.9688,21115922
41984,ras proteins,gene,0.982,21115922
41985,tumour cells,cell_type,0.815,21115922
41986,tumour,disease,1.0,21115922
41987,EGFR,gene,0.9956,21115922
41988,cetuximab,gene,0.821,21115922
41989,panitumumab,gene,0.7686,21115922
41990,EGFR,gene,0.9927,21115922
41991,metastatic CRC,disease,0.9976,21115922
41992,cetuximab,gene,0.5225,21115922
41993,wild,cell_line,0.7285,21115922
41994,wild-type K-ras tumours,disease,0.951,21115922
41995,wild-type K-ras,gene,0.9507,21115922
41996,K-ras,gene,0.695,21115922
41997,cetuximab,gene,0.869,21115922
41998,panitumumab,gene,0.813,21115922
41999,CRC,disease,0.9976,21115922
42000,K-ras,gene,0.567,21115922
42001,CRC,disease,0.9995,21115922
42002,K-ras mutations,gene,0.6865,21115922
42003,CRC,disease,0.9897,21115922
42004,pancreatic cancer,disease,1.0,21115922
42005,K-ras,gene,0.665,21115922
42006,cetuximab,gene,0.7505,21115922
42007,panitumumab,gene,0.6313,21115922
42008,CRC,disease,0.9995,21115922
42009,EGFR,gene,0.9897,21109448
42010,non-small cell lung cancer,disease,1.0,21109448
42011,epidermal growth factor receptor,gene,0.9985,21109448
42012,EGFR,gene,0.9897,21109448
42013,non-small cell lung cancer,disease,1.0,21109448
42014,chimeric,gene,0.776,21109448
42015,anti-EGFR monoclonal antibody,gene,0.905,21109448
42016,advanced NSCLC,disease,0.9946,21109448
42017,cetuximab,gene,0.9624,21109448
42018,cisplatin,drug,0.9995,21109448
42019,vinorelbine,drug,0.9995,21109448
42020,EGFR-,disease,0.8223,21109448
42021,EGFR,gene,0.9917,21109448
42022,cetuximab,gene,0.9185,21109448
42023,carboplatin,drug,0.999,21109448
42024,paclitaxed,drug,0.9966,21109448
42025,cetuximab,gene,0.841,21109448
42026,cetuximab,gene,0.9414,21109448
42027,platinum,drug,0.999,21109448
42028,advanced NSCLC,disease,0.92,21109448
42029,Matuzumab,gene,0.924,21109448
42030,panitumumab,gene,0.88,21109448
42031,Necitumumab,gene,0.865,21109448
42032,Lung adenocarcinoma,disease,1.0,21105123
42033,Lung cancer,disease,0.9995,21105123
42034,cancer,disease,1.0,21105123
42035,cancer,disease,1.0,21105123
42036,Cancer,disease,0.8013,21105123
42037,lung cancer,disease,1.0,21105123
42038,lung cancer,disease,1.0,21105123
42039,lung cancer,disease,1.0,21105123
42040,lung adenocarcinoma,disease,1.0,21105123
42041,lung adenocarcinoma,disease,1.0,21105123
42042,epidermal growth factor receptor,gene,0.998,21105123
42043,epidermal growth factor receptor,gene,0.9976,21105123
42044,lung adenocarcinoma,disease,1.0,21105123
42045,oncogene,DNA,0.913,21105123
42046,epidermal growth factor receptor,gene,0.9956,21105123
42047,epidermal growth factor,gene,0.9985,21105123
42048,metastatic chemoresistant lung cancer,disease,0.962,21105123
42049,lung adenocarcinoma,disease,1.0,21105123
42050,fibronectin,gene,0.9956,21099371
42051,epidermal growth factor receptor,gene,0.9966,21099371
42052,insulin-like growth factor-I receptor,gene,0.9985,21099371
42053,human fibronectin,gene,0.9463,21099371
42054,Adnectins,gene,0.953,21099371
42055,Adnectin,gene,0.933,21099371
42056,epidermal growth factor receptor,gene,0.997,21099371
42057,EGFR,gene,0.9897,21099371
42058,insulin-like growth factor-I receptor,gene,0.9985,21099371
42059,IGF-IR,gene,0.9976,21099371
42060,cancer,disease,1.0,21099371
42061,Single-domain Adnectins,gene,0.94,21099371
42062,EGFR,gene,0.994,21099371
42063,IGF-IR,gene,0.997,21099371
42064,mRNA,RNA,0.8467,21099371
42065,Adnectin variants,gene,0.975,21099371
42066,mRNA,RNA,0.8047,21099371
42067,Adnectin,gene,0.992,21099371
42068,EGFR,gene,0.991,21099371
42069,parental clone,cell_line,0.8765,21099371
42070,Adnectins,gene,0.9937,21099371
42071,EGFR,gene,0.9946,21099371
42072,IGF-IR,gene,0.9985,21099371
42073,EI-Tandem Adnectin,gene,0.913,21099371
42074,EGFR,gene,0.9927,21099371
42075,IGF-IR,gene,0.996,21099371
42076,human cancer cell lines,cell_line,0.7354,21099371
42077,human cancer cell,cell_type,0.77,21099371
42078,cancer,disease,0.6753,21099371
42079,A431,cell_line,0.9434,21099371
42080,H292,cell_line,0.9185,21099371
42081,BxPC3,cell_line,0.8745,21099371
42082,RH41,cell_line,0.901,21099371
42083,Adnectins,gene,0.9546,21099371
42084,EGFR,gene,0.9893,21099371
42085,anti-EGFR antibodies,gene,0.9893,21099371
42086,cetuximab,gene,0.619,21099371
42087,panitumumab,gene,0.842,21099371
42088,nimotuzumab,gene,0.7812,21099371
42089,anti-EGFR,gene,0.995,21099371
42090,Adnectins,gene,0.9214,21099371
42091,EGF,gene,0.9946,21099371
42092,EGFR,gene,0.985,21099371
42093,EI,gene,0.531,21099371
42094,EGFR,gene,0.9893,21099371
42095,IGF-IR,gene,0.9976,21099371
42096,tumor,disease,0.996,21099371
42097,EGFR,gene,0.992,21099371
42098,EGFR,gene,0.9854,21099371
42099,tumors,disease,1.0,21099371
42100,Adnectins,gene,0.9644,21099371
42101,tumor,disease,1.0,21099371
42102,cancer,disease,0.9995,21099371
42103,matrix metalloproteinase-7,gene,0.997,21099348
42104,MMP-7,gene,0.9937,21099348
42105,phosphorylated insulin growth factor receptor I,gene,0.8916,21099348
42106,pIGF-1R,gene,0.993,21099348
42107,wild-type KRAS,gene,0.7188,21099348
42108,cetuximab,gene,0.8047,21099348
42109,panitumumab,gene,0.7046,21099348
42110,GEMCAD,DNA,0.5854,21099348
42111,insulin growth factor receptor I,gene,0.9976,21099348
42112,IGF-1R,gene,0.9966,21099348
42113,epidermal growth factor receptor,gene,0.998,21099348
42114,EGFR,gene,0.99,21099348
42115,MMP-7,gene,0.9927,21099348
42116,colorectal cancer cells,cell_line,0.725,21099348
42117,colorectal cancer,disease,1.0,21099348
42118,IGF-1R,gene,0.998,21099348
42119,IGFBP-3,gene,0.9966,21099348
42120,IGF-I,gene,0.998,21099348
42121,pts,species,0.969,21099348
42122,advanced colorectal cancer,disease,1.0,21099348
42123,CRC,disease,1.0,21099348
42124,cetuximab,gene,0.8945,21099348
42125,panitumumab,gene,0.901,21099348
42126,IGF-1R,gene,0.998,21099348
42127,p-IGF-1R,gene,0.992,21099348
42128,MMP-7,gene,0.99,21099348
42129,KRAS,gene,0.6987,21099348
42130,BRAF,gene,0.7646,21099348
42131,CRC,disease,0.9995,21099348
42132,IGF-1R,gene,0.976,21099348
42133,MMP-7,gene,0.9863,21099348
42134,pts,species,0.8135,21099348
42135,MMP-7,gene,0.9966,21099348
42136,pIGF-1R,gene,0.996,21099348
42137,pts,species,0.9556,21099348
42138,KRAS,gene,0.794,21099348
42139,BRAF,gene,0.706,21099348
42140,Pts,species,0.9507,21099348
42141,DP,disease,0.788,21099348
42142,EGFR,gene,0.705,21099348
42143,pts,species,0.8906,21099348
42144,KRAS,gene,0.4846,21099348
42145,pts,species,0.958,21099348
42146,MMP-7,gene,0.9937,21099348
42147,p-IGF-1R,gene,0.996,21099348
42148,WT KRAS,gene,0.934,21099348
42149,pts,species,0.791,21099348
42150,anti-EGFR,gene,0.9106,21099348
42151,indocyanine green,drug,0.886,21073171
42152,Panitumumab,gene,0.9663,21073171
42153,anti-HER1 antibody,gene,0.992,21073171
42154,cancer,disease,0.9844,21073171
42155,amine,drug,0.9985,21073171
42156,indocyanine green,drug,0.999,21073171
42157,anti-HER1,gene,0.9946,21073171
42158,panitumumab,gene,0.873,21073171
42159,indocyanine green,drug,0.996,21073171
42160,HER1-expressing A431 cells,cell_line,0.779,21073171
42161,HER1,gene,0.513,21073171
42162,-expressing A431 cells,cell_type,0.588,21073171
42163,HER1,gene,0.997,21073171
42164,-expressing tumors,cell_type,0.448,21073171
42165,Aclidinium bromide,drug,0.999,21069103
42166,AE,drug,0.568,21069103
42167,AMA1-C1,gene,0.873,21069103
42168,ISA 720,drug,0.7515,21069103
42169,Amlodipine besylate,drug,0.998,21069103
42170,atorvastatin calcium,drug,0.8296,21069103
42171,Arachidonic acid,drug,0.9985,21069103
42172,Arbaclofen placarbil,drug,0.9985,21069103
42173,Aripiprazole,drug,0.9985,21069103
42174,ARQ-621,drug,0.9995,21069103
42175,Azelnidipine,drug,0.9985,21069103
42176,Azilsartan medoxomil potassium,drug,0.9946,21069103
42177,Bortezomib,drug,0.9995,21069103
42178,Choriogonadotropin alfa,gene,0.9946,21069103
42179,CTS-1027,drug,0.9966,21069103
42180,Dapagliflozin,drug,0.9995,21069103
42181,Dasatinib,drug,0.9995,21069103
42182,Deforolimus,drug,0.998,21069103
42183,Degarelix acetate,drug,0.998,21069103
42184,Denufosol tetrasodium,drug,0.9976,21069103
42185,Desvenlafaxine succinate,drug,0.999,21069103
42186,Dronedarone hydrochloride,drug,0.998,21069103
42187,Duloxetine hydrochloride,drug,0.9985,21069103
42188,Dutasteride,drug,0.998,21069103
42189,Entecavir,drug,0.99,21069103
42190,Etaracizumab,gene,0.6406,21069103
42191,Everolimus,drug,0.995,21069103
42192,Exenatide,gene,0.808,21069103
42193,Ezetimibe,drug,0.9976,21069103
42194,Ferric carboxymaltose,drug,0.9995,21069103
42195,Fludarabine,drug,0.999,21069103
42196,Foretinib,drug,0.9976,21069103
42197,Gefitinib,drug,0.999,21069103
42198,GFT-505,drug,0.9995,21069103
42199,GSK-256066,drug,0.999,21069103
42200,HPV,species,0.504,21069103
42201,HuM195,cell_line,0.6514,21069103
42202,HyperAcute-Lung cancer,disease,1.0,21069103
42203,Imatinib mesylate,drug,0.9985,21069103
42204,Insulin,gene,0.985,21069103
42205,Insulin glargine,gene,0.686,21069103
42206,Ivabradine hydrochloride,drug,0.9883,21069103
42207,Lacosamide,drug,0.998,21069103
42208,Lapatinib ditosylate,drug,0.999,21069103
42209,Lenalidomide,drug,0.999,21069103
42210,Lidocaine,drug,0.999,21069103
42211,prilocaine,drug,0.999,21069103
42212,Liposomal,drug,0.92,21069103
42213,vincristine,drug,0.823,21069103
42214,Liraglutide,gene,0.6567,21069103
42215,Lixivaptan,drug,0.979,21069103
42216,diphtheria,species,0.4844,21069103
42217,Methoxy polyethylene glycol,drug,0.9937,21069103
42218,epoetin-,gene,0.973,21069103
42219,Mirabegron,drug,0.9863,21069103
42220,Morphine,drug,0.996,21069103
42221,oxycodone,drug,0.9976,21069103
42222,MSC-1936369B,drug,0.999,21069103
42223,Mycophenolic acid sodium salt,drug,0.9976,21069103
42224,Narlaprevir,drug,0.9995,21069103
42225,N-Desmethylclozapine,drug,0.999,21069103
42226,Ocriplasmin,drug,0.994,21069103
42227,Olaparib,drug,0.998,21069103
42228,Olmesartan medoxomil,drug,0.999,21069103
42229,Olmesartan medoxomil,drug,0.999,21069103
42230,azelnidipine,drug,0.9976,21069103
42231,ONO-5334,drug,0.9976,21069103
42232,ONO-8539,drug,0.9985,21069103
42233,Palifermin,drug,0.9883,21069103
42234,Panitumumab,gene,0.7603,21069103
42235,Pardoprunox hydrochloride,drug,0.998,21069103
42236,Peginterferon alfa-2a,gene,0.9976,21069103
42237,Peginterferon alfa-2b,gene,0.9976,21069103
42238,Pemetrexed disodium,drug,0.999,21069103
42239,Pexelizumab,gene,0.5854,21069103
42240,PF-337210,drug,0.9995,21069103
42241,Pitavastatin calcium,drug,0.9307,21069103
42242,Raltegravir potassium,drug,0.923,21069103
42243,interleukin-7,gene,0.981,21069103
42244,Regadenoson,drug,0.5317,21069103
42245,Reniale,drug,0.9854,21069103
42246,Roflumilast,drug,0.9995,21069103
42247,Rosuvastatin calcium,drug,0.9385,21069103
42248,Safinamide mesilate,drug,0.998,21069103
42249,SB-1518,drug,0.998,21069103
42250,SCH-527123,drug,0.9985,21069103
42251,Selumetinib,drug,0.999,21069103
42252,Solifenacin succinate,drug,0.9985,21069103
42253,Sorafenib,drug,0.9976,21069103
42254,Sunitinib malate,drug,0.998,21069103
42255,Tadalafil,drug,0.9956,21069103
42256,Talaporfin sodium,drug,0.998,21069103
42257,Tanespimycin,drug,0.999,21069103
42258,Insulin,gene,0.694,21069103
42259,Telaprevir,drug,0.9937,21069103
42260,Telatinib,drug,0.9956,21069103
42261,Telcagepant,drug,0.992,21069103
42262,Telmisartan,drug,0.999,21069103
42263,hydrochlorothiazide,drug,0.9995,21069103
42264,Teriparatide,drug,0.8228,21069103
42265,Testosterone,drug,0.9995,21069103
42266,TH-302,drug,0.99,21069103
42267,Tiotropium bromide,drug,0.9985,21069103
42268,Tocilizumab,gene,0.705,21069103
42269,Tremelimumab,gene,0.4482,21069103
42270,Valsartan,drug,0.998,21069103
42271,amlodipine besylate,drug,0.9453,21069103
42272,Vernakalant hydrochloride,drug,0.905,21069103
42273,Visilizumab,gene,0.752,21069103
42274,Voreloxin,drug,0.995,21069103
42275,Vorinostat,drug,0.9976,21069103
42276,Panitumumab,gene,0.8296,21042543
42277,metastatic colorectal cancer,disease,0.9995,21042543
42278,Panitumumab,gene,0.8086,21042543
42279,Epidermal Growth Factor Receptor,gene,0.9927,21042543
42280,EGFR,gene,0.9907,21042543
42281,solid tumors,disease,1.0,21042543
42282,tumor,disease,0.6655,21042543
42283,panitumumab,gene,0.889,21042543
42284,tumor,disease,0.9995,21042543
42285,cancer,disease,1.0,21042543
42286,colorectal,disease,0.906,21042543
42287,CRC,disease,0.9946,21042543
42288,panitumumab,gene,0.8228,21042543
42289,metastatic colorectal cancer,disease,1.0,21042543
42290,mCRC,disease,1.0,21042543
42291,panitumumab,gene,0.915,21042543
42292,epidermal growth factor receptor,gene,0.9985,21042543
42293,mCRC,disease,0.9907,21042543
42294,fluoropyrimidine,drug,0.998,21042543
42295,oxaliplatin,drug,0.9995,21042543
42296,irinotecan,drug,0.9976,21042543
42297,panitumumab,gene,0.925,21042543
42298,K,DNA,0.3926,21042543
42299,mutant K-RAS,gene,0.5547,21042543
42300,K-RAS,gene,0.85,21042543
42301,EGFR,gene,0.9897,21042543
42302,wild-type K-RAS,gene,0.753,21042543
42303,panitumumab,gene,0.9263,21042543
42304,panitumumab,gene,0.839,21042543
42305,metastatic colorectal cancer,disease,0.9985,21042543
42306,anti-EGFR monoclonal antibodies,gene,0.9873,20974572
42307,liver metastasis,disease,0.9985,20974572
42308,colorectal adenocarcinoma,disease,1.0,20974572
42309,hypersensitivity reaction,disease,0.991,20974572
42310,cetuximab,gene,0.8223,20974572
42311,skin toxicity,disease,0.935,20974572
42312,cetuximab,gene,0.9604,20974572
42313,panitumumab,gene,0.6533,20974572
42314,skin rash,disease,1.0,20974572
42315,panitumumab,gene,0.817,20974572
42316,anti-epidermal growth factor receptor,gene,0.977,20974572
42317,BRAF,DNA,0.708,20972475
42318,BRAF p.Val600Glu,gene,0.6787,20972475
42319,p.Val600Glu,mutation,,20972475
42320,Val600Glu,DNA,0.4001,20972475
42321,V600E,mutation,,20972475
42322,Metastatic Colorectal Cancer,disease,1.0,20972475
42323,Colon and rectal cancer,disease,1.0,20972475
42324,CRC,disease,1.0,20972475
42325,cancer,disease,1.0,20972475
42326,anti-,gene,0.801,20972475
42327,epidermal growth factor receptor,gene,0.9287,20972475
42328,EGFR,gene,0.992,20972475
42329,cetuximab,gene,0.672,20972475
42330,Erbitux,gene,0.56,20972475
42331,panitumumab,gene,0.9624,20972475
42332,CRC,disease,0.999,20972475
42333,p,RNA,0.464,20972475
42334,p.Val600Glu,mutation,,20972475
42335,V600E,mutation,,20972475
42336,BRAF gene,gene,0.9097,20972475
42337,anti-EGFR monoclonal antibodies,gene,0.981,20972475
42338,metastatic colorectal cancer,disease,0.9995,20954331
42339,colorectal cancer,disease,1.0,20954331
42340,metastatic,disease,0.5034,20954331
42341,colorectal disease,disease,0.9346,20954331
42342,irinotecan,drug,0.999,20954331
42343,oxaliplatin,drug,0.9995,20954331
42344,5-fluorouracil,drug,0.999,20954331
42345,bevacizumab,gene,0.884,20954331
42346,FOLFOX,drug,0.9644,20954331
42347,NO16966,drug,0.9995,20954331
42348,anti-EGFR monoclonal antibody,gene,0.8813,20954331
42349,FOLFOX,drug,0.9414,20954331
42350,FOLFIRI,drug,0.9414,20954331
42351,"(64)Cu-1,4,7,10-Tetraazacyclododecane-N,N&#x27;,N& acid",drug,0.985,20945561
42352,panitumumab,gene,0.8843,20945561
42353,Epidermal growth factor,gene,0.996,20945561
42354,EGF,gene,0.994,20945561
42355,amino,drug,0.963,20945561
42356,ectodermic cells,cell_type,0.8975,20945561
42357,monocytes,cell_type,0.847,20945561
42358,EGF,gene,0.994,20945561
42359,epidermal,cell_line,0.5415,20945561
42360,epidermal and epithelial cells,cell_type,0.8745,20945561
42361,EGF,gene,0.9937,20945561
42362,EGF receptor,gene,0.998,20945561
42363,EGFR,gene,0.992,20945561
42364,EGFR,gene,0.996,20945561
42365,HER1,gene,0.9985,20945561
42366,erbB-1,gene,0.998,20945561
42367,HER2,gene,0.994,20945561
42368,erbB-2,gene,0.998,20945561
42369,neu),gene,0.994,20945561
42370,HER3,gene,0.9966,20945561
42371,erbB-3,gene,0.9976,20945561
42372,HER4,gene,0.9956,20945561
42373,erbB-4,gene,0.997,20945561
42374,HER1,gene,0.994,20945561
42375,HER3,gene,0.9897,20945561
42376,HER4,gene,0.9873,20945561
42377,cytoplasmic tyrosine kinase domain,gene,0.903,20945561
42378,tyrosine,drug,0.9663,20945561
42379,HER2,gene,0.994,20945561
42380,HER2,gene,0.9927,20945561
42381,HER receptors,gene,0.992,20945561
42382,HER1,gene,0.9883,20945561
42383,HER2,gene,0.9937,20945561
42384,solid tumor cells,cell_type,0.72,20945561
42385,solid tumor,disease,0.9995,20945561
42386,"breast, nonsmall-cell lung, head and neck, and colon cancers",disease,1.0,20945561
42387,HER1,gene,0.995,20945561
42388,HER2,gene,0.991,20945561
42389,cancer cells,cell_type,0.848,20945561
42390,cancer,disease,0.9976,20945561
42391,Trastuzumab,gene,0.9,20945561
42392,humanized immunoglobulin G(1),gene,0.979,20945561
42393,humanized,species,0.8003,20945561
42394,IgG(1),gene,0.9634,20945561
42395,recombinant HER2,gene,0.989,20945561
42396,(111)In,drug,0.999,20945561
42397,C225,gene,0.777,20945561
42398,anti-EGFR,gene,0.9873,20945561
42399,"mouse-human chimeric, monoclonal IgG(1) antibody",gene,0.943,20945561
42400,mouse,species,0.981,20945561
42401,human,species,0.9116,20945561
42402,cetuximab,gene,0.6885,20945561
42403,(99m),drug,0.991,20945561
42404,Tc-EC-C225,drug,0.9844,20945561
42405,EGFR,gene,0.9883,20945561
42406,solid tumors,disease,1.0,20945561
42407,(64)Cu,drug,0.998,20945561
42408,cetuximab,gene,0.9736,20945561
42409,EGFR,gene,0.996,20945561
42410,metastatic,disease,0.8906,20945561
42411,colorectal carcinoma,disease,0.961,20945561
42412,(64)Cu,drug,0.9995,20945561
42413,panitumumab,gene,0.83,20945561
42414,"1,4,7,10-tetraazacyclododecane-N,N",drug,0.998,20945561
42415,DOTA,drug,0.997,20945561
42416,(64)Cu,drug,0.9995,20945561
42417,DOTA,drug,0.945,20945561
42418,panitumumab,gene,0.9565,20945561
42419,nude mice,species,0.5996,20945561
42420,human,species,0.9956,20945561
42421,head and neck squamous cell carcinoma (HNSCC) tumors,disease,0.9937,20945561
42422,EGFR,gene,0.9907,20945561
42423,EGFR,gene,0.9897,20945561
42424,tumors,disease,1.0,20945561
42425,VEGF,gene,0.995,20943606
42426,Bevacizumab,gene,0.7446,20943606
42427,bevacizumab,gene,0.942,20943606
42428,fluoropyrimidies,drug,0.999,20943606
42429,5-FU,drug,0.998,20943606
42430,capecitabine,drug,0.999,20943606
42431,5-FU,drug,0.998,20943606
42432,FOLFOX,drug,0.805,20943606
42433,EGF receptor antibodies,gene,0.9497,20943606
42434,cetuximab,gene,0.4873,20943606
42435,panitumumab,gene,0.8154,20943606
42436,k-ras,DNA,0.629,20943606
42437,k-ras wt,gene,0.885,20943606
42438,tumors,disease,0.969,20943606
42439,FOLFIRI,drug,0.989,20943606
42440,FOLFOX,drug,0.972,20943606
42441,tumor,disease,0.9897,20943606
42442,tumors,disease,0.7017,20943606
42443,EGFR antibody,gene,0.753,20943606
42444,tumor,disease,0.9854,20943606
42445,tumor,disease,0.5977,20943606
42446,5-FU,drug,0.998,20943606
42447,capecitabine,drug,0.9985,20943606
42448,bevacizumab,gene,0.7266,20943606
42449,k-ras,gene,0.6494,20943606
42450,tumors,disease,0.7593,20943606
42451,FOLFOX,drug,0.994,20943606
42452,EGFR antibody,gene,0.8804,20943606
42453,k,disease,0.535,20943606
42454,k-ras,gene,0.994,20943606
42455,EGFR,gene,0.9956,20943606
42456,VEGF antibodies,gene,0.788,20943606
42457,EGFR,gene,0.9497,20939111
42458,metastatic colorectal cancer,disease,1.0,20939111
42459,tumor,disease,1.0,20939111
42460,K-RAS,gene,0.715,20939111
42461,epidermal growth factor receptor,gene,0.9766,20939111
42462,metastatic colorectal cancer,disease,1.0,20939111
42463,mCRC,disease,1.0,20939111
42464,mCRC,disease,1.0,20939111
42465,cetuximab,gene,0.9106,20939111
42466,panitumumab,gene,0.887,20939111
42467,Solid Tumors,disease,0.761,20939111
42468,Tumor,disease,0.6436,20939111
42469,pan-cytokeratin,gene,0.939,20939111
42470,K-RAS,gene,0.7593,20939111
42471,K-RAS,gene,0.7407,20939111
42472,tumor,disease,0.9907,20939111
42473,K-RAS,gene,0.7075,20939111
42474,tumor,disease,0.6523,20939111
42475,K-RAS,gene,0.6616,20939111
42476,tumor,disease,1.0,20939111
42477,tumor,disease,1.0,20939111
42478,K-RAS,gene,0.703,20939111
42479,panitumumab,gene,0.7554,20923247
42480,Panitumumab,gene,0.716,20923247
42481,epidermal growth factor receptor,gene,0.997,20923247
42482,EGFR,gene,0.993,20923247
42483,EGFR,gene,0.9966,20923247
42484,metastatic colorectal cancer,disease,0.999,20923247
42485,Panitumumab,gene,0.6484,20923247
42486,EGFR,gene,0.9946,20923247
42487,cells,cell_type,0.412,20923247
42488,Panitumumab,gene,0.6167,20923247
42489,endogenous immunoglobulins,gene,0.816,20923247
42490,panitumumab,gene,0.9263,20923247
42491,panitumumab,gene,0.869,20923247
42492,Panitumumab,gene,0.703,20923247
42493,tumour,disease,1.0,20923247
42494,EGFR,gene,0.9907,20923247
42495,tumour,disease,0.9995,20923247
42496,tumour KRAS mutation,gene,0.744,20923247
42497,renal or hepatic dysfunction,disease,1.0,20923247
42498,irinotecan,drug,0.999,20923247
42499,paclitaxel,drug,0.9995,20923247
42500,carboplatin,drug,0.9995,20923247
42501,panitumumab,gene,0.9053,20923247
42502,panitumumab,gene,0.8774,20923247
42503,panitumumab,gene,0.8384,20923247
42504,skin rash,disease,0.996,20923247
42505,EGFR,gene,0.9893,20923247
42506,EGFR,gene,0.9844,20923247
42507,Anti-panitumumab antibody,gene,0.9805,20923247
42508,panitumumab,gene,0.783,20923247
42509,panitumumab,gene,0.894,20921465
42510,fluorouracil,drug,0.998,20921465
42511,leucovorin,drug,0.997,20921465
42512,oxaliplatin,drug,0.999,20921465
42513,FOLFOX4,drug,0.8735,20921465
42514,FOLFOX4,drug,0.864,20921465
42515,metastatic colorectal cancer,disease,0.9976,20921465
42516,Panitumumab,gene,0.5596,20921465
42517,anti-epidermal growth factor receptor,gene,0.97,20921465
42518,EGFR,gene,0.963,20921465
42519,metastatic colorectal cancer,disease,0.999,20921465
42520,mCRC,disease,1.0,20921465
42521,Panitumumab,gene,0.701,20921465
42522,Metastatic Colorectal Cancer,disease,1.0,20921465
42523,panitumumab,gene,0.8574,20921465
42524,leucovorin,drug,0.994,20921465
42525,oxaliplatin,drug,0.9985,20921465
42526,FOLFOX4,drug,0.952,20921465
42527,FOLFOX4,drug,0.969,20921465
42528,mCRC,disease,0.9688,20921465
42529,PATIENTS,species,0.9707,20921465
42530,mCRC,disease,0.9766,20921465
42531,panitumumab,gene,0.9067,20921465
42532,FOLFOX4,drug,0.5703,20921465
42533,FOLFOX4,drug,0.5166,20921465
42534,KRAS,DNA,0.516,20921465
42535,KRAS,gene,0.731,20921465
42536,KRAS,gene,0.411,20921465
42537,panitumumab,gene,0.929,20921465
42538,FOLFOX4,drug,0.8296,20921465
42539,FOLFOX4,drug,0.865,20921465
42540,panitumumab,gene,0.9497,20921465
42541,mutant KRAS,gene,0.52,20921465
42542,panitumumab,gene,0.928,20921465
42543,FOLFOX4,drug,0.578,20921465
42544,anti-,gene,0.515,20921465
42545,EGFR,gene,0.559,20921465
42546,panitumumab,gene,0.8853,20921465
42547,FOLFOX4,drug,0.7637,20921465
42548,WT KRAS,gene,0.7373,20921465
42549,KRAS,gene,0.7905,20921465
42550,mCRC,disease,0.995,20921465
42551,panitumumab,gene,0.9014,20921462
42552,fluorouracil,drug,0.9995,20921462
42553,leucovorin,drug,0.9976,20921462
42554,irinotecan,drug,0.999,20921462
42555,FOLFIRI,drug,0.9746,20921462
42556,FOLFIRI,drug,0.944,20921462
42557,metastatic colorectal cancer,disease,0.974,20921462
42558,Panitumumab,gene,0.68,20921462
42559,anti-epidermal growth factor receptor,gene,0.964,20921462
42560,EGFR,gene,0.979,20921462
42561,metastatic colorectal cancer,disease,1.0,20921462
42562,mCRC,disease,1.0,20921462
42563,panitumumab,gene,0.9453,20921462
42564,fluorouracil,drug,0.9995,20921462
42565,leucovorin,drug,0.998,20921462
42566,irinotecan,drug,0.9985,20921462
42567,FOLFIRI,drug,0.828,20921462
42568,FOLFIRI,drug,0.709,20921462
42569,mCRC,disease,0.951,20921462
42570,tumor KRAS,gene,0.6577,20921462
42571,KRAS,DNA,0.4539,20921462
42572,PATIENTS,species,0.945,20921462
42573,mCRC,disease,0.9966,20921462
42574,mCRC,disease,0.9883,20921462
42575,tumor,disease,0.9463,20921462
42576,panitumumab,gene,0.882,20921462
42577,FOLFIRI,drug,0.9746,20921462
42578,FOLFIRI,drug,0.9604,20921462
42579,KRAS,gene,0.841,20921462
42580,KRAS,gene,0.7163,20921462
42581,wild-type (WT) KRAS tumors,disease,0.746,20921462
42582,wild,gene,0.8394,20921462
42583,KRAS,gene,0.4854,20921462
42584,mutant (MT) KRAS tumors,disease,0.642,20921462
42585,mutant (MT) KRAS,gene,0.847,20921462
42586,WT KRAS,gene,0.8584,20921462
42587,panitumumab,gene,0.853,20921462
42588,panitumumab,gene,0.9355,20921462
42589,FOLFIRI,drug,0.934,20921462
42590,panitumumab,gene,0.9575,20921462
42591,MT KRAS,gene,0.78,20921462
42592,EGFR,gene,0.7983,20921462
42593,Panitumumab,gene,0.8687,20921462
42594,FOLFIRI,drug,0.933,20921462
42595,WT KRAS,gene,0.521,20921462
42596,mCRC,disease,0.998,20921462
42597,EGFR antibodies,gene,0.8193,20921457
42598,colorectal cancer,disease,1.0,20921457
42599,Colorectal cancer,disease,1.0,20921207
42600,colorectal cancer,disease,1.0,20921207
42601,colorectal cancers,disease,1.0,20921207
42602,cetuximab,gene,0.6177,20921207
42603,panitumumab,gene,0.6743,20921207
42604,epidermal growth factor receptor,gene,0.998,20921207
42605,colorectal cancer,disease,1.0,20921207
42606,microRNA,DNA,0.5254,20881268
42607,microRNA transcriptome,RNA,0.7383,20881268
42608,microRNA,RNA,0.7354,20881268
42609,colorectal cancer,disease,1.0,20881268
42610,CRC,disease,1.0,20881268
42611,667,RNA,0.741,20881268
42612,miRNAs,RNA,0.4744,20881268
42613,human CRC cell lines,cell_line,0.9463,20881268
42614,human,species,0.992,20881268
42615,CRC,disease,0.992,20881268
42616,cetuximab,gene,0.864,20881268
42617,Caco-2,cell_line,0.8887,20881268
42618,HCT-116,cell_line,0.9346,20881268
42619,HCT,cell_type,0.53,20881268
42620,Caco-2,cell_line,0.8364,20881268
42621,Caco,cell_type,0.4695,20881268
42622,HCT-116,cell_line,0.9517,20881268
42623,HCT,cell_type,0.5737,20881268
42624,miRNAs,RNA,0.855,20881268
42625,miRNAs,RNA,0.6646,20881268
42626,Caco-2,cell_line,0.8843,20881268
42627,HCT-116,cell_line,0.9575,20881268
42628,miRNAs,RNA,0.57,20881268
42629,CRC,disease,1.0,20881268
42630,patients,species,0.995,20881268
42631,miR,RNA,0.5503,20881268
42632,miR-146b-3p,gene,0.966,20881268
42633,miR-486-5p,gene,0.889,20881268
42634,K-ras,gene,0.9985,20881268
42635,wild-type ones,cell_line,0.6816,20881268
42636,miRNAs,RNA,0.509,20881268
42637,cancer,disease,1.0,20881268
42638,CRC,disease,0.9995,20881268
42639,cetuximab,gene,0.962,20881268
42640,CRC,disease,1.0,20881268
42641,miRNAs,RNA,0.717,20881268
42642,CRC,disease,0.9995,20881268
42643,let-7b,gene,0.9683,20881268
42644,let,RNA,0.4778,20881268
42645,let-7e,gene,0.978,20881268
42646,K-ras,gene,0.997,20881268
42647,miR-17,DNA,0.5996,20881268
42648,miR-17*,gene,0.975,20881268
42649,CRC,disease,1.0,20881268
42650,cetuximab,gene,0.8745,20881268
42651,cancer,disease,1.0,20881268
42652,ubiquitin,gene,0.9976,20881268
42653,miRNAs,RNA,0.6855,20881268
42654,patients,species,0.99,20881268
42655,human,species,0.797,20845811
42656,panitumumab,gene,0.7085,20845811
42657,panitumumab,gene,0.8086,20845811
42658,patients,species,0.9907,20845811
42659,cetuximab antibody,gene,0.946,20845811
42660,woman,species,0.8115,20845811
42661,metastatic colorectal cancer,disease,0.9995,20845811
42662,cetuximab,gene,0.856,20845811
42663,corticosteroids,drug,0.6694,20845811
42664,Cetuximab,gene,0.891,20845811
42665,panitumumab,gene,0.9414,20845811
42666,panitumumab,gene,0.9043,20845811
42667,patients,species,0.981,20845811
42668,metastatic colorectal cancer,disease,1.0,20845811
42669,panitumumab,gene,0.8438,20845811
42670,patients,species,0.9805,20845811
42671,cetuximab,gene,0.8696,20845811
42672,KRAS,gene,0.978,20817364
42673,KRAS oncogene,DNA,0.864,20817364
42674,KRAS oncogene,gene,0.9893,20817364
42675,anti-epidermal growth factor,gene,0.9863,20817364
42676,EGFR,gene,0.95,20817364
42677,cetuximab,gene,0.7534,20817364
42678,panitumumab,gene,0.8013,20817364
42679,patients,species,0.99,20817364
42680,metastatic colorectal cancer,disease,1.0,20817364
42681,wild-type,gene,0.906,20817364
42682,KRAS,DNA,0.8027,20817364
42683,KRAS genotype,gene,0.7705,20817364
42684,KRAS,gene,0.9775,20817364
42685,KRAS,DNA,0.869,20817364
42686,KRAS,gene,0.9897,20817364
42687,EGFR,gene,0.916,20817364
42688,metastatic colorectal cancer,disease,0.965,20817364
42689,KRAS,gene,0.911,20817364
42690,patient,species,0.991,20817364
42691,KRAS,DNA,0.8735,20817364
42692,KRAS,gene,0.9756,20817364
42693,KRAS,gene,0.9375,20817364
42694,KRAS,DNA,0.7476,20817364
42695,KRAS,gene,0.9834,20817364
42696,tumor,disease,1.0,20817364
42697,human,species,0.9976,20811384
42698,human,species,0.8623,20811384
42699,monoclonal antibodies,gene,0.6484,20811384
42700,mice,species,0.877,20811384
42701,yeast,species,0.899,20811384
42702,human,species,0.9707,20811384
42703,adalimumab,gene,0.951,20811384
42704,human,species,0.9175,20811384
42705,human,species,0.6855,20811384
42706,panitumumab,gene,0.887,20811384
42707,golimumab,gene,0.9473,20811384
42708,canakinumab,gene,0.5923,20811384
42709,ustekinumab,gene,0.58,20811384
42710,denosumab,gene,0.4907,20811384
42711,belimumab,gene,0.8696,20811384
42712,human,species,0.9604,20811384
42713,Panitumumab,gene,0.9233,20740189
42714,Metastatic Colorectal Carcinoma,disease,0.956,20740189
42715,metastatic colorectal cancer,disease,1.0,20740189
42716,metastatic,disease,0.984,20740189
42717,KRAS,gene,0.5825,20740189
42718,panitumumab,gene,0.8237,20740189
42719,5-fluorouracil,drug,0.999,20740189
42720,irinotecan,drug,0.9995,20740189
42721,oxaliplatin,drug,0.9995,20740189
42722,bevacizumab,gene,0.705,20740189
42723,tumor,disease,0.923,20740189
42724,carcinoembryonic antigen,gene,0.992,20740189
42725,Panitumumab,gene,0.931,20740189
42726,metastatic colorectal cancer,disease,1.0,20740189
42727,KRAS,gene,0.625,20740189
42728,panitumumab,gene,0.927,20740189
42729,BRAF,gene,0.7383,20733556
42730,advanced colorectal cancer,disease,0.9727,20733556
42731,KRAS mutant colorectal tumors,disease,0.871,20733556
42732,KRAS,gene,0.5576,20733556
42733,anti-EGFR monoclonal antibodies,gene,0.9673,20733556
42734,cetuximab,gene,0.604,20733556
42735,panitumumab,gene,0.6597,20733556
42736,colorectal cancer,disease,1.0,20733556
42737,KRAS,gene,0.8564,20733556
42738,BRAF,gene,0.86,20733556
42739,KRAS,gene,0.733,20733556
42740,BRAF,gene,0.7607,20733556
42741,metastatic colorectal carcinoma,disease,0.883,20733556
42742,BRAF,DNA,0.705,20733556
42743,BRAF mutations,gene,0.9253,20733556
42744,tumors,disease,0.4346,20733556
42745,KRAS,gene,0.8037,20733556
42746,BRAF,gene,0.8345,20733556
42747,metastatic colorectal cancer,disease,1.0,20733556
42748,rash,disease,0.97,20732960
42749,human epidermal growth factor receptor 1,gene,0.9985,20732960
42750,HER1,gene,0.989,20732960
42751,HER1,gene,0.837,20732960
42752,cancer,disease,1.0,20732960
42753,Human epidermal growth factor receptor (HER) 1,gene,0.9946,20732960
42754,HER 1/2,gene,0.8013,20732960
42755,solid tumors,disease,1.0,20732960
42756,rash,disease,0.993,20732960
42757,rash,disease,0.997,20732960
42758,lapatinib,drug,0.9976,20732960
42759,HER1/2,gene,0.9897,20732960
42760,HER1/2i,gene,0.958,20732960
42761,HER1,gene,0.995,20732960
42762,HER1i,gene,0.943,20732960
42763,cetuximab,gene,0.693,20732960
42764,erlotinib,drug,0.9937,20732960
42765,panitumumab,gene,0.7354,20732960
42766,rash,disease,1.0,20732960
42767,pAKT,gene,0.992,20732960
42768,K16,gene,0.7725,20732960
42769,p27,gene,0.4858,20732960
42770,HER1/2i,gene,0.9697,20732960
42771,HER1i,gene,0.9927,20732960
42772,epidermal atrophy,disease,1.0,20732960
42773,follicular neutrophilic,cell_type,0.543,20732960
42774,HER1/2i,gene,0.98,20732960
42775,HER1i,gene,0.995,20732960
42776,HER1/2i,gene,0.966,20732960
42777,rash,disease,0.9897,20732960
42778,HER,gene,0.9834,20732960
42779,skin toxicity,disease,0.774,20732960
42780,HER1,DNA,0.6265,20732960
42781,HER1/,gene,0.9937,20732960
42782,lapatinib,drug,0.9995,20732960
42783,HER1,gene,0.994,20732960
42784,cetuximab,gene,0.544,20732960
42785,erlotinib,drug,0.9536,20732960
42786,panitumumab,gene,0.741,20732960
42787,KRAS gene,gene,0.903,20732413
42788,wild-type alleles,DNA,0.8125,20732413
42789,codons 12 and 13,DNA,0.606,20732413
42790,KRAS gene,gene,0.857,20732413
42791,EGFR,gene,0.9927,20732413
42792,panitumumab,gene,0.8877,20732413
42793,metastatic colorectal carcinoma,disease,1.0,20732413
42794,mCRC,disease,1.0,20732413
42795,tumor,disease,0.989,20732413
42796,KRAS,DNA,0.8535,20732413
42797,KRAS mutation,gene,0.864,20732413
42798,rare mutated cells,cell_type,0.8203,20732413
42799,wild-type cells,cell_line,0.871,20732413
42800,KRAS,DNA,0.775,20732413
42801,KRAS mutations,gene,0.9478,20732413
42802,wild-type KRAS alleles,gene,0.8877,20732413
42803,mutated KRAS alleles,gene,0.7417,20732413
42804,mutated KRAS,gene,0.847,20732413
42805,HCT-116,cell_line,0.966,20732413
42806,HCT,cell_type,0.577,20732413
42807,WTB,DNA,0.5107,20732413
42808,mutated alleles,DNA,0.553,20732413
42809,wild-type alleles,DNA,0.895,20732413
42810,KRAS mutations,gene,0.757,20732413
42811,mCRC,disease,0.993,20732413
42812,synonymous mutated codons 13,DNA,0.6313,20732413
42813,c,RNA,0.575,20732413
42814,c.39C > T,mutation,,20732413
42815,missense mutated codons 14,DNA,0.689,20732413
42816,c,RNA,0.53,20732413
42817,c.40G > A,mutation,,20732413
42818,WTB,DNA,0.695,20732413
42819,WTB,DNA,0.5015,20732413
42820,mutated KRAS gene,gene,0.8955,20732413
42821,Cetuximab,gene,0.8193,20726623
42822,eyelash trichomegaly,disease,1.0,20726623
42823,epidermal growth factor receptor,gene,0.996,20726623
42824,Eyelash trichomegaly,disease,1.0,20726623
42825,epidermal growth factor receptor,gene,0.998,20726623
42826,EGFR,gene,0.995,20726623
42827,Elongation of the eyelashes,disease,0.983,20726623
42828,oncology,disease,0.5957,20726623
42829,colorectal or lung cancer,disease,1.0,20726623
42830,cetuximab,gene,0.9087,20726623
42831,erlotinib,drug,0.995,20726623
42832,gefitinib,drug,0.9946,20726623
42833,panitumumab,gene,0.7676,20726623
42834,cetuximab,gene,0.932,20726623
42835,eyelash trichomegaly,disease,0.9976,20726623
42836,metastatic rectal carcinoma,disease,1.0,20726623
42837,EGFR,gene,0.9927,20726623
42838,eyelash trichomegaly,disease,1.0,20726623
42839,EGFR,gene,0.9795,20726623
42840,nonmelanoma skin cancer,disease,1.0,20725548
42841,Basal cell carcinoma,disease,1.0,20725548
42842,squamous cell carcinoma,disease,1.0,20725548
42843,cancer,disease,1.0,20725548
42844,nonmelanoma skin cancers,disease,1.0,20725548
42845,retinoids,drug,0.999,20725548
42846,carcinomas,disease,1.0,20725548
42847,perillyl alcohol,drug,0.9985,20725548
42848,T4 endonuclease 5,gene,0.991,20725548
42849,DL-alpha-tocopherol,drug,0.9995,20725548
42850,alpha-difluoromethylornithine,drug,0.997,20725548
42851,interferon,gene,0.9966,20725548
42852,imiquimod,drug,0.994,20725548
42853,retinoids,drug,0.9976,20725548
42854,5-fluorouracil,drug,0.999,20725548
42855,superficial nonmelanoma skin cancers,disease,0.999,20725548
42856,premalignant lesions,disease,1.0,20725548
42857,actinic keratosis,disease,1.0,20725548
42858,nonmelanoma skin cancers,disease,1.0,20725548
42859,ingenol mebutate,drug,0.961,20725548
42860,cyclooxygenase-2,gene,0.9927,20725548
42861,betulinic acid,drug,0.918,20725548
42862,hedgehog,gene,0.7354,20725548
42863,cyclopamine,drug,0.9956,20725548
42864,GDC-0449,drug,0.994,20725548
42865,epidermal growth factor receptor,gene,0.997,20725548
42866,gefitinib,drug,0.9873,20725548
42867,erlotinib,drug,0.9893,20725548
42868,anti-epidermal growth factor receptor monoclonal,gene,0.8296,20725548
42869,cetuximab,gene,0.9346,20725548
42870,panitumumab,gene,0.927,20725548
42871,5-fluorouracil,drug,0.9995,20725548
42872,capecitabine,drug,0.9956,20725548
42873,colorectal cancer,disease,1.0,20719530
42874,Colorectal cancer,disease,1.0,20719530
42875,CRC,disease,1.0,20719530
42876,fluoropyrimidines,drug,1.0,20719530
42877,oxaliplatin,drug,1.0,20719530
42878,irinotecan,drug,0.999,20719530
42879,bevacizumab,gene,0.7056,20719530
42880,cetuximab,gene,0.9346,20719530
42881,panitumumab,gene,0.935,20719530
42882,CRC,disease,0.9995,20719530
42883,CRC,disease,0.999,20719530
42884,EGFR,gene,0.9937,20718704
42885,RAS,gene,0.9966,20718704
42886,PI3K,gene,0.989,20718704
42887,K-Ras,gene,0.996,20718704
42888,colon tumours,disease,1.0,20718704
42889,EGFR,gene,0.99,20718704
42890,cetuximab,gene,0.72,20718704
42891,panitumumab,gene,0.7734,20718704
42892,K-Ras,gene,0.9985,20718704
42893,K-Ras mutant,gene,0.93,20718704
42894,Farnesyltransferase,gene,0.884,20718704
42895,K-Ras,gene,0.995,20718704
42896,MAPK,gene,0.9854,20718704
42897,PI3K,gene,0.995,20718704
42898,mutant K-Ras,gene,0.998,20718704
42899,K,DNA,0.5464,20718704
42900,K-Ras,gene,0.9985,20718704
42901,EGFR,gene,0.9937,20718704
42902,tumour,disease,1.0,20718704
42903,EGFR,gene,0.995,20718704
42904,colon cancer,disease,1.0,20718704
42905,Her,gene,0.9873,20718704
42906,c-Met,gene,0.998,20718704
42907,IGFR,gene,0.9893,20718704
42908,Src,gene,0.9927,20718704
42909,VEGF,gene,0.9883,20718704
42910,EGFR,gene,0.994,20718704
42911,insulin-like growth factor-1 receptor,gene,0.9995,20713879
42912,IMC-A12,drug,0.996,20713879
42913,cetuximab,gene,0.8184,20713879
42914,cetuximab,gene,0.914,20713879
42915,panitumumab-refractory metastatic colorectal cancer,disease,0.845,20713879
42916,panitumumab,gene,0.7456,20713879
42917,IMC-A12,gene,0.9136,20713879
42918,insulin-like growth factor receptor-1,gene,0.997,20713879
42919,IGF-1R,gene,0.997,20713879
42920,cetuximab,gene,0.623,20713879
42921,anti-epidermal growth factor receptor,gene,0.98,20713879
42922,EGFR,gene,0.9346,20713879
42923,colorectal cancer,disease,1.0,20713879
42924,IMC-A12,drug,0.999,20713879
42925,IMC-A12,drug,0.998,20713879
42926,cetuximab,gene,0.699,20713879
42927,anti-EGFR mAb,gene,0.9644,20713879
42928,KRAS,DNA,0.5747,20713879
42929,tumor,disease,1.0,20713879
42930,KRAS,gene,0.6255,20713879
42931,PIK3CA,gene,0.558,20713879
42932,BRAF,gene,0.666,20713879
42933,pAKT,gene,0.9795,20713879
42934,IGF-1R,gene,0.9985,20713879
42935,IMC-A12,drug,0.9995,20713879
42936,IMC-A12,drug,0.998,20713879
42937,cetuximab,gene,0.8164,20713879
42938,KRAS,gene,0.866,20713879
42939,KRAS,gene,0.8267,20713879
42940,IMC-A12,drug,0.9995,20713879
42941,thrombocytopenia,disease,1.0,20713879
42942,hyperglycemia,disease,0.9775,20713879
42943,pyrexia,disease,0.9995,20713879
42944,IMC-A12,drug,0.998,20713879
42945,cetuximab,gene,0.826,20713879
42946,colorectal cancer,disease,1.0,20713879
42947,EGFR,gene,0.993,20713879
42948,Papulopustular eruption,disease,1.0,20713838
42949,panitumumab,gene,0.8,20713838
42950,metastatic colorectal cancer,disease,1.0,20711244
42951,Colorectal cancer,disease,1.0,20711244
42952,CRC,disease,1.0,20711244
42953,cancer,disease,1.0,20711244
42954,advanced cancer,disease,1.0,20711244
42955,FOLFOX,drug,0.5146,20711244
42956,FOLFIRI,drug,0.6416,20711244
42957,metastatic colorectal cancer,disease,0.9966,20711244
42958,mCRC,disease,0.997,20711244
42959,metastatic disease,disease,0.9995,20711244
42960,panitumumab,gene,0.816,20711244
42961,epidermal growth factor receptor,gene,0.998,20711244
42962,cancer,disease,1.0,20711244
42963,EGFR,gene,0.9966,20709812
42964,epidermal growth factor receptor,gene,0.956,20709812
42965,cetuximab,gene,0.7983,20709812
42966,panitumumab,gene,0.8276,20709812
42967,epidermal growth factor receptor,gene,0.996,20709812
42968,EGFR,gene,0.9917,20709812
42969,tyrosine,drug,0.97,20709812
42970,tyrosine kinase,gene,0.9966,20709812
42971,erlotinib,drug,0.9976,20709812
42972,gefitinib,drug,0.998,20709812
42973,tumor,disease,1.0,20709812
42974,EGFR,gene,0.9897,20709812
42975,skin reactions,disease,0.725,20709812
42976,anti-EGFR,gene,0.681,20709812
42977,skin reactions,disease,0.9336,20709812
42978,EGFR,gene,0.9946,20709812
42979,EGFR,gene,0.994,20709812
42980,skin reactions,disease,0.824,20709812
42981,EGFR,gene,0.9937,20709812
42982,skin reactions,disease,0.852,20709812
42983,EGFR,gene,0.9907,20709812
42984,cancer,disease,1.0,20685042
42985,tumors,disease,1.0,20685042
42986,estrogen,drug,0.9995,20685042
42987,estrogen and progesterone receptors,gene,0.878,20685042
42988,progesterone,drug,0.981,20685042
42989,breast cancers,disease,1.0,20685042
42990,HER-2,gene,0.9907,20685042
42991,breast cancer,disease,1.0,20685042
42992,trastuzumab,gene,0.9346,20685042
42993,K-RAS mutations,gene,0.676,20685042
42994,advanced colorectal cancer,disease,0.9897,20685042
42995,cetuximab,gene,0.8657,20685042
42996,panitumumab,gene,0.83,20685042
42997,EGFR mutations,gene,0.982,20685042
42998,advanced non-small-cell lung cancer,disease,0.997,20685042
42999,tyrosine,drug,0.9937,20685042
43000,tyrosine kinase,gene,0.9927,20685042
43001,gefitinib,drug,0.983,20685042
43002,erlotinib,drug,0.9775,20685042
43003,cancer,disease,1.0,20685042
43004,Epidermal growth factor receptor,gene,0.998,20682654
43005,head and neck cancer,disease,1.0,20682654
43006,90Y,drug,0.9917,20682654
43007,panitumumab,gene,0.4707,20682654
43008,Panitumumab,gene,0.875,20682654
43009,ABX-EGF,gene,0.9766,20682654
43010,Vectibix,gene,0.5166,20682654
43011,epidermal growth factor receptor,gene,0.9956,20682654
43012,EGFR,gene,0.989,20682654
43013,metastatic colorectal cancer,disease,0.9976,20682654
43014,EGFR,gene,0.9907,20682654
43015,nude,species,0.6997,20682654
43016,mouse,species,0.4814,20682654
43017,(90)Y,drug,0.998,20682654
43018,panitumumab,gene,0.674,20682654
43019,(111)In,drug,0.9995,20682654
43020,DOTA,drug,0.676,20682654
43021,panitumumab,gene,0.918,20682654
43022,(90)Y,drug,0.9985,20682654
43023,DOTA,drug,0.994,20682654
43024,panitumumab,gene,0.918,20682654
43025,UM-SCC-22B,cell_line,0.9004,20682654
43026,tumor,disease,0.993,20682654
43027,CD31,gene,0.9785,20682654
43028,Ki67,gene,0.86,20682654
43029,terminal deoxynucleotidyl transferase,gene,0.994,20682654
43030,dUTP,drug,0.997,20682654
43031,UM-SCC-22B,cell_line,0.9272,20682654
43032,UM-SCC-,disease,0.732,20682654
43033,tumor,disease,0.9956,20682654
43034,(111)In,drug,0.9995,20682654
43035,DOTA,drug,0.9775,20682654
43036,panitumumab,gene,0.9634,20682654
43037,UM-SCC-22B,cell_line,0.876,20682654
43038,tumor,disease,0.9673,20682654
43039,nude mice,species,0.675,20682654
43040,panitumumab,gene,0.9854,20682654
43041,antitumor,disease,0.595,20682654
43042,(90)Y,drug,0.9995,20682654
43043,DOTA,drug,0.8647,20682654
43044,panitumumab,gene,0.9585,20682654
43045,UM-SCC-,cell_line,0.849,20682654
43046,UM-SCC,disease,0.8735,20682654
43047,22B tumor model,cell_line,0.586,20682654
43048,tumor,disease,0.971,20682654
43049,(90)Y,drug,0.9995,20682654
43050,DOTA,drug,0.881,20682654
43051,panitumumab,gene,0.933,20682654
43052,tumors,disease,1.0,20682654
43053,(90)Y,drug,0.999,20682654
43054,DOTA,drug,0.8267,20682654
43055,panitumumab,gene,0.904,20682654
43056,(90)Y,drug,0.9995,20682654
43057,DOTA,drug,0.9956,20682654
43058,panitumumab,gene,0.858,20682654
43059,EGFR,gene,0.4658,20682654
43060,solid tumors,disease,0.9897,20682654
43061,KRAS,gene,0.7476,20680106
43062,metastatic colorectal cancer,disease,0.9995,20680106
43063,EGFR,gene,0.9526,20680106
43064,metastatic CRC,disease,1.0,20680106
43065,mCRC,disease,0.9995,20680106
43066,epidermal growth factor receptor,gene,0.997,20680106
43067,EGFR,gene,0.991,20680106
43068,cetuximab,gene,0.8623,20680106
43069,panitumumab,gene,0.793,20680106
43070,mCRC,disease,0.8604,20680106
43071,KRAS oncogene,gene,0.914,20680106
43072,cetuximab,gene,0.7944,20680106
43073,panitumumab,gene,0.7637,20680106
43074,KRAS,gene,0.8584,20680106
43075,EGFR,gene,0.933,20680106
43076,EGFR,gene,0.9043,20680105
43077,metastatic colorectal cancer,disease,0.895,20680105
43078,anti-,gene,0.941,20680105
43079,epidermal growth factor receptor,gene,0.892,20680105
43080,EGFR,gene,0.9946,20680105
43081,metastatic colorectal cancer,disease,1.0,20680105
43082,mCRC,disease,1.0,20680105
43083,mouse,species,0.9873,20680105
43084,panitumumab,gene,0.9175,20680105
43085,anti-EGFR monoclonal antibodies cetuximab,gene,0.858,20680105
43086,panitumumab,gene,0.6963,20680105
43087,mCRC,disease,0.993,20680105
43088,cetuximab,gene,0.9756,20680105
43089,panitumumab,gene,0.934,20680105
43090,mCRC,disease,0.9766,20680105
43091,KRAS,DNA,0.5747,20680105
43092,cetuximab,gene,0.949,20680105
43093,irinotecan,drug,0.9976,20680105
43094,cetuximab,gene,0.8286,20680105
43095,panitumumab,gene,0.655,20680105
43096,irinotecan,drug,0.997,20680105
43097,EGFR,gene,0.9375,20680104
43098,metastatic colorectal cancer,disease,0.9985,20680104
43099,epidermal growth factor receptor,gene,0.999,20680104
43100,EGFR,gene,0.99,20680104
43101,ErbB family,gene,0.986,20680104
43102,receptor tyrosine kinases,gene,0.9526,20680104
43103,tyrosine,drug,0.9644,20680104
43104,neoplastic cell,cell_type,0.57,20680104
43105,neoplastic,disease,0.988,20680104
43106,EGFR,gene,0.9917,20680104
43107,tumors,disease,0.995,20680104
43108,colorectal cancer,disease,1.0,20680104
43109,CRC,disease,1.0,20680104
43110,EGFR,gene,0.987,20680104
43111,metastatic CRC,disease,1.0,20680104
43112,mCRC,disease,1.0,20680104
43113,EGFR,gene,0.6826,20680104
43114,anti-EGFR monoclonal antibodies,gene,0.9326,20680104
43115,cetuximab,gene,0.497,20680104
43116,panitumumab,gene,0.8174,20680104
43117,mCRC,disease,0.9746,20680104
43118,Epirubicin,drug,0.9995,20679619
43119,oxaliplatin,drug,0.9995,20679619
43120,capecitabine,drug,0.9995,20679619
43121,panitumumab,gene,0.7886,20679619
43122,advanced esophagogastric cancer,disease,1.0,20679619
43123,REAL,DNA,0.4573,20679619
43124,Epirubicin,drug,0.9995,20679619
43125,oxaliplatin,drug,0.9995,20679619
43126,capecitabine,drug,0.9995,20679619
43127,advanced esophagogastric cancer,disease,0.9966,20679619
43128,Panitumumab,gene,0.907,20679619
43129,immunoglobulin G2 monoclonal antibody,gene,0.9697,20679619
43130,epidermal growth factor receptor,gene,0.9976,20679619
43131,Panitumumab,gene,0.903,20679619
43132,Advanced and Locally Advanced Esophagogastric Cancer,disease,1.0,20679619
43133,advanced esophagogastric adenocarcinoma,disease,0.9937,20679619
43134,undifferentiated carcinoma,disease,1.0,20679619
43135,PATIENTS,species,0.9033,20679619
43136,REAL,DNA,0.5234,20679619
43137,P DL-1,drug,0.986,20679619
43138,epirubicin,drug,0.999,20679619
43139,oxaliplatin130,drug,0.999,20679619
43140,capecitabine,drug,0.9985,20679619
43141,EOC,drug,0.6533,20679619
43142,diarrhea,disease,0.999,20679619
43143,diarrhea,disease,0.989,20679619
43144,is epirubicin,drug,0.9526,20679619
43145,oxaliplatin,drug,0.9995,20679619
43146,capecitabine,drug,0.9995,20679619
43147,REAL,DNA,0.5244,20679619
43148,[C]RAC,drug,0.9995,20664824
43149,(18)F-Fluoromisonidazole,drug,0.9995,20664824
43150,89-12,drug,0.998,20664824
43151,9-[F],drug,0.9966,20664824
43152,Fluoropropyl-(+)-dihydrotetrabenazine,drug,0.9995,20664824
43153,Adalimumab,gene,0.9097,20664824
43154,Adecatumumab,gene,0.6963,20664824
43155,ADXS-11-001,gene,0.7637,20664824
43156,Aflibercept,gene,0.951,20664824
43157,Agatolimod sodium,drug,0.991,20664824
43158,AGS-004,drug,0.8184,20664824
43159,Alglucosidase,gene,0.6777,20664824
43160,Aliskiren fumarate,drug,0.999,20664824
43161,Alvocidib hydrochloride,drug,0.998,20664824
43162,AMG-108,drug,0.9966,20664824
43163,AMG-853,drug,0.998,20664824
43164,Apixaban,drug,0.999,20664824
43165,Aripiprazole,drug,0.9956,20664824
43166,Armodafinil,drug,0.997,20664824
43167,Atazanavir sulfate,drug,0.992,20664824
43168,Atomoxetine hydrochloride,drug,0.994,20664824
43169,Bevacizumab,gene,0.594,20664824
43170,insulin aspart,gene,0.7856,20664824
43171,Bortezomib,drug,0.9995,20664824
43172,Bosentan,drug,0.998,20664824
43173,Caspofungin acetate,drug,0.998,20664824
43174,Cediranib,drug,0.9995,20664824
43175,Cetuximab,gene,0.865,20664824
43176,Choriogonadotropin alfa,gene,0.995,20664824
43177,Cinacalcet hydrochloride,drug,0.989,20664824
43178,Cizolirtine citrate,drug,0.9985,20664824
43179,Clofarabine,drug,0.998,20664824
43180,Cocaine,drug,0.9995,20664824
43181,CX,drug,0.664,20664824
43182,Darbepoetin alfa,gene,0.9536,20664824
43183,Dasatinib,drug,0.9966,20664824
43184,Decitabine,drug,0.9976,20664824
43185,Denosumab,gene,0.4993,20664824
43186,Desvenlafaxine succinate,drug,0.9966,20664824
43187,Dexamethasone sodium phosphate,drug,0.9985,20664824
43188,Dienogest,drug,0.9985,20664824
43189,Diphencyprone,drug,0.999,20664824
43190,Doripenem,drug,0.998,20664824
43191,Dutasteride,drug,0.9966,20664824
43192,E-7010,drug,0.9937,20664824
43193,Ecallantide,drug,0.936,20664824
43194,Ecstasy,drug,0.999,20664824
43195,Eicosapentaenoic acid,drug,0.9995,20664824
43196,docosahexaenoic acid,drug,0.9995,20664824
43197,Emtricitabine,drug,1.0,20664824
43198,Enfuvirtide,drug,0.782,20664824
43199,Erlotinib hydrochloride,drug,0.993,20664824
43200,Eszopiclone,drug,0.9995,20664824
43201,Etonogestrel,drug,0.999,20664824
43202,ethinyl estradiol,drug,0.9995,20664824
43203,Etoricoxib,drug,0.9995,20664824
43204,Everolimus,drug,0.999,20664824
43205,Everolimus,drug,0.999,20664824
43206,coronary stent,DNA,0.4998,20664824
43207,EVT,DNA,0.528,20664824
43208,Ezetimibe,drug,0.9985,20664824
43209,Ezetimibe,drug,0.999,20664824
43210,simvastatin,drug,0.998,20664824
43211,Ferumoxytol,drug,0.9995,20664824
43212,Fesoterodine fumavate,drug,0.999,20664824
43213,Filgrastim,gene,0.803,20664824
43214,Fingolimod hydrochloride,drug,0.965,20664824
43215,Fluticasone furoate,drug,0.999,20664824
43216,Fluval P,drug,0.9824,20664824
43217,Fluzone,drug,0.9956,20664824
43218,Fondaparinux sodium,drug,0.9565,20664824
43219,Fulvestrant,drug,0.9985,20664824
43220,Fungichromin,drug,0.995,20664824
43221,Gamma-hydroxybutyrate sodium,drug,0.9976,20664824
43222,Gefitinib,drug,0.9985,20664824
43223,GHB-01L1,drug,0.999,20664824
43224,GLY-230,drug,0.998,20664824
43225,GSK-1349572,drug,0.9976,20664824
43226,Hydrocodone bitartrate,drug,0.999,20664824
43227,IC-51,drug,0.9976,20664824
43228,Icatibant acetate,drug,0.996,20664824
43229,Imatinib mesylate,drug,0.998,20664824
43230,Immunoglobulin,gene,0.9937,20664824
43231,Indetanib,drug,0.997,20664824
43232,human insulin,gene,0.7314,20664824
43233,Insulin glargine,gene,0.8984,20664824
43234,Insulin glulisine,gene,0.9375,20664824
43235,Interferon-beta,gene,0.991,20664824
43236,Ispinesib mesylate,drug,0.9946,20664824
43237,Ixabepilone,drug,0.999,20664824
43238,Laromustine,drug,0.9985,20664824
43239,Latanoprost,drug,0.95,20664824
43240,timolol maleate,drug,0.9937,20664824
43241,L-Citrulline,drug,0.998,20664824
43242,Lenalidomide,drug,0.9976,20664824
43243,Linezolid,drug,0.9995,20664824
43244,Lopinavir,drug,0.9995,20664824
43245,ritonavir,drug,0.998,20664824
43246,Lutropin alfa,gene,0.992,20664824
43247,MDX-,gene,0.4954,20664824
43248,MDX-1388,gene,0.6147,20664824
43249,Methoxy polyethylene glycol,drug,0.998,20664824
43250,epoetin-beta,gene,0.9585,20664824
43251,Metreleptin,drug,0.9985,20664824
43252,Micafungin sodium,drug,0.9956,20664824
43253,Mometasone furoate,drug,0.999,20664824
43254,oxymetazoline hydrochloride,drug,0.9976,20664824
43255,Mycophenolic acid sodium salt,drug,0.983,20664824
43256,Nabiximols,drug,0.996,20664824
43257,Natalizumab,gene,0.558,20664824
43258,Nemonoxacin,drug,0.998,20664824
43259,Norelgestromin,drug,0.999,20664824
43260,ethinyl estradiol,drug,0.9976,20664824
43261,Oblimersen sodium,drug,0.976,20664824
43262,Ocriplasmin,drug,0.7036,20664824
43263,Olmesartan medoxomil,drug,0.999,20664824
43264,Omacetaxine mepesuccinate,drug,0.999,20664824
43265,Paclitaxel,drug,0.999,20664824
43266,Pagoclone,drug,0.9966,20664824
43267,Paliperidone,drug,0.9985,20664824
43268,Panitumumab,gene,0.878,20664824
43269,Pazopanib hydrochloride,drug,0.9985,20664824
43270,PCV7,drug,0.8594,20664824
43271,Pegaptanib octasodium,drug,0.9985,20664824
43272,Peginterferon alfa-2a,gene,0.9966,20664824
43273,Peginterferon alfa-2b,gene,0.99,20664824
43274,ribavirin,drug,0.999,20664824
43275,Pegvisomant,drug,0.999,20664824
43276,Pemetrexed disodium,drug,0.9966,20664824
43277,Perifosine,drug,0.999,20664824
43278,Pimecrolimus,drug,0.9995,20664824
43279,Pitavastatin calcium,drug,0.9893,20664824
43280,Plerixafor hydrochloride,drug,0.996,20664824
43281,Plitidepsin,drug,0.9985,20664824
43282,Posaconazole,drug,0.9966,20664824
43283,Pregabalin,drug,0.9995,20664824
43284,Progesterone capriate,drug,0.999,20664824
43285,Raltegravir potassium,drug,0.9863,20664824
43286,Ranelic acid distrontium salt,drug,0.737,20664824
43287,Rasburicase,gene,0.9546,20664824
43288,Recombinant Bet V1,gene,0.9927,20664824
43289,Recombinant human insulin,gene,0.9917,20664824
43290,rhFSH,gene,0.9927,20664824
43291,Rolofylline,drug,0.999,20664824
43292,Romidepsin,drug,0.9966,20664824
43293,Romiplostim,drug,0.8657,20664824
43294,Rosuvastatin,drug,0.9976,20664824
43295,calcium,drug,0.81,20664824
43296,Sapacitabine,drug,0.9995,20664824
43297,Sevelamer carbonate,drug,0.998,20664824
43298,Sinecatechins,drug,0.9995,20664824
43299,Sirolimus,drug,0.4421,20664824
43300,Sitagliptin phosphate monohydrate,drug,0.9995,20664824
43301,SN-29244,drug,0.998,20664824
43302,Sorafenib,drug,0.9966,20664824
43303,Sugammadex sodium,drug,0.941,20664824
43304,Sunitinib malate,drug,0.9985,20664824
43305,Tadalafil,drug,0.9775,20664824
43306,Tafenoquine,drug,0.9985,20664824
43307,Talnetant,drug,0.998,20664824
43308,Tapentadol hydrochloride,drug,0.998,20664824
43309,Tasocitinib citrate,drug,0.999,20664824
43310,Insulin,gene,0.943,20664824
43311,Telcagepant,drug,0.9604,20664824
43312,Tenofovir disoproxil fumarate,drug,0.9985,20664824
43313,Ticagrelor,drug,0.996,20664824
43314,Tigecycline,drug,0.998,20664824
43315,Tiotropium bromide,drug,0.999,20664824
43316,Tipifarnib,drug,0.9976,20664824
43317,TS,drug,0.518,20664824
43318,Ulipristal acetate,drug,0.9946,20664824
43319,Ustekinumab,gene,0.5137,20664824
43320,Vandetanib,drug,0.9995,20664824
43321,Varenicline tartrate,drug,0.9985,20664824
43322,Vicriviroc,drug,0.999,20664824
43323,Voriconazole,drug,0.9995,20664824
43324,Vorinostat,drug,0.9995,20664824
43325,Zoledronic acid monohydrate,drug,0.9956,20664824
43326,N-glycolylneuraminic acid,drug,0.9995,20657583
43327,nonhuman mammalian cell lines,cell_line,0.9683,20657583
43328,sialic acid,drug,0.961,20657583
43329,N-glycolylneuraminic acid,drug,0.997,20657583
43330,Neu5Gc,drug,0.999,20657583
43331,Neu5Gc,drug,0.9946,20657583
43332,Neu5Gc,drug,0.7744,20657583
43333,Neu5Gc-specific antibodies,gene,0.9854,20657583
43334,Neu5Gc,drug,0.9917,20657583
43335,cetuximab,gene,0.947,20657583
43336,panitumumab,gene,0.904,20657583
43337,Anti-Neu5Gc antibodies,gene,0.997,20657583
43338,cetuximab,gene,0.9023,20657583
43339,Neu5Gc,drug,0.999,20657583
43340,Mice,species,0.936,20657583
43341,Neu5Gc,drug,0.5117,20657583
43342,cetuximab,gene,0.756,20657583
43343,anti-Neu5Gc antibodies,gene,0.984,20657583
43344,Neu5Gc,drug,0.9995,20657583
43345,cultured human and nonhuman cell lines,cell_line,0.9536,20657583
43346,[(99m)Tc/,drug,0.993,20641461
43347,"(90)Y]-1,4,7,10 Tetraazacyclododecane-N,N,N,N-tetraacetic",drug,0.985,20641461
43348,epidermal growth factor receptor,gene,0.9976,20641461
43349,EGFR,gene,0.9946,20641461
43350,tyrosine,drug,0.984,20641461
43351,tyrosine kinase,gene,0.996,20641461
43352,TK,gene,0.8545,20641461
43353,cells,cell_type,0.4639,20641461
43354,cancers,disease,1.0,20641461
43355,tumors,disease,1.0,20641461
43356,patient,species,0.9766,20641461
43357,EGFR-associated TK,gene,0.849,20641461
43358,EGFR,gene,0.9785,20641461
43359,cancers,disease,1.0,20641461
43360,cetuximab,gene,0.933,20641461
43361,panitumumab,gene,0.902,20641461
43362,malignant tumors,disease,1.0,20641461
43363,cancer,disease,1.0,20641461
43364,patient,species,0.9854,20641461
43365,Cetuximab,gene,0.9404,20641461
43366,cancerous tumors,disease,1.0,20641461
43367,EGFR,gene,0.991,20641461
43368,humans,species,0.9917,20641461
43369,anti-EGFR antibody,gene,0.9766,20641461
43370,cancer,disease,1.0,20641461
43371,patients,species,0.9927,20641461
43372,humanized,species,0.753,20641461
43373,h-R3,gene,0.966,20641461
43374,murine,species,0.928,20641461
43375,ior egf/r3,gene,0.7363,20641461
43376,(99m)Tc,drug,0.9995,20641461
43377,humans,species,0.9834,20641461
43378,patients,species,0.974,20641461
43379,(99m)Tc,drug,0.9995,20641461
43380,ior egf/r3,gene,0.9883,20641461
43381,phenylalanine,drug,0.998,20641461
43382,"1,4,7,10-tetraazacyclododecane-N,N,N,N-tetraacetic acid",drug,0.9995,20641461
43383,DOTA-Ph-Al,drug,0.9995,20641461
43384,(99m)Tc,drug,0.9995,20641461
43385,[(99m)Tc]Ph-Al-ior egf/r3,drug,0.994,20641461
43386,(90)Y,drug,0.999,20641461
43387,[(90)Y]Ph-Al-ior egf/r3,drug,0.984,20641461
43388,mice,species,0.9077,20641461
43389,Ehrlich ascites (EA) tumors,disease,1.0,20641461
43390,mice,species,0.7974,20641461
43391,U-87MG cell,cell_line,0.9688,20641461
43392,human,species,0.985,20641461
43393,malignant glioma,disease,0.999,20641461
43394,xenograft tumors,disease,0.96,20641461
43395,KRAS,gene,0.7056,20645028
43396,BRAF mutations,gene,0.8994,20645028
43397,colorectal cancer,disease,1.0,20645028
43398,EGFR,gene,0.9165,20645028
43399,colorectal cancer,disease,1.0,20645028
43400,KRAS gene,gene,0.907,20645028
43401,EGFR,gene,0.995,20645028
43402,KRAS,DNA,0.7563,20645028
43403,KRAS wild-type,gene,0.7383,20645028
43404,KRAS,gene,0.518,20645028
43405,wild-type BRAF,gene,0.9414,20645028
43406,BRAF,DNA,0.4165,20645028
43407,wt-BRAF,gene,0.4766,20645028
43408,panitumumab,gene,0.844,20645028
43409,cetuximab,gene,0.7686,20645028
43410,BRAF,gene,0.7344,20645028
43411,KRAS,gene,0.6973,20645028
43412,EGFR,gene,0.6274,20645028
43413,metastatic colorectal cancer,disease,1.0,20645028
43414,KRAS gene,gene,0.935,20645028
43415,V600E,mutation,,20645028
43416,BRAF gene,gene,0.9136,20645028
43417,wt-KRAS genotype,gene,0.7725,20645028
43418,KRAS,DNA,0.5063,20645028
43419,KRAS,DNA,0.5303,20645028
43420,KRAS mutants,gene,0.989,20645028
43421,V600E,DNA,,20645028
43422,V600E,mutation,,20645028
43423,BRAF gene,gene,0.9004,20645028
43424,V600E,RNA,,20645028
43425,V600E,mutation,,20645028
43426,BRAF,gene,0.745,20645028
43427,wt-KRAS,gene,0.957,20645028
43428,KRAS,gene,0.8174,20645028
43429,BRAF,gene,0.7026,20645028
43430,tumor,disease,0.387,20645028
43431,KRAS,gene,0.7363,20645028
43432,V600E,mutation,,20645028
43433,BRAF,gene,0.512,20645028
43434,KRAS,DNA,0.564,20645028
43435,KRAS mutations,gene,0.959,20645028
43436,codons 12 and 13,DNA,0.6494,20645028
43437,V600E,mutation,,20645028
43438,BRAF gene,gene,0.8433,20645028
43439,KRAS,gene,0.595,20645028
43440,BRAF,DNA,0.4988,20645028
43441,BRAF mutation,gene,0.7944,20645028
43442,anti-EGFR,gene,0.761,20645028
43443,colorectal cancers,disease,1.0,20637356
43444,Colorectal cancer,disease,1.0,20637356
43445,CCR,disease,1.0,20637356
43446,cancer,disease,1.0,20637356
43447,tumor,disease,1.0,20637356
43448,genetic polymorphisms,DNA,0.4763,20637356
43449,DPD,gene,0.9683,20637356
43450,UGT1A1,gene,0.932,20637356
43451,5-FU,drug,0.999,20637356
43452,irinotecan,drug,0.998,20637356
43453,oxaliplatin,drug,0.9995,20637356
43454,GSTpi,gene,0.9907,20637356
43455,KRAS,DNA,0.717,20637356
43456,KRAS mutation,gene,0.8623,20637356
43457,anti-EGFR monoclonal antibody,gene,0.971,20637356
43458,cetuximab,gene,0.861,20637356
43459,panitumumab,gene,0.8877,20637356
43460,drug target,DNA,0.5156,20637356
43461,epidermal growth factor receptor,gene,0.9976,20635913
43462,epidermal growth factor receptor,gene,0.9966,20635913
43463,EGFR,gene,0.9917,20635913
43464,cancer,disease,0.989,20635913
43465,tumor,disease,1.0,20635913
43466,EGFR,gene,0.9927,20635913
43467,Cetuximab,gene,0.926,20635913
43468,panitumumab,gene,0.9185,20635913
43469,cetuximab,gene,0.9614,20635913
43470,metastatic colorectal cancer,disease,1.0,20635913
43471,locally advanced and metastatic squamous cell cancer of the head and neck,disease,0.9844,20635913
43472,panitumumab,gene,0.78,20635913
43473,metastatic colorectal cancer,disease,0.9834,20635913
43474,EGFR,gene,0.9946,20635913
43475,EGFR,gene,0.9893,20635913
43476,advanced colorectal cancer,disease,0.9966,20631611
43477,Colorectal cancer,disease,1.0,20631611
43478,CRC,disease,1.0,20631611
43479,malignancy,disease,1.0,20631611
43480,cancer,disease,1.0,20631611
43481,advanced CRC,disease,0.957,20631611
43482,cetuximab,gene,0.914,20631611
43483,type KRAS gene,gene,0.6953,20631611
43484,KRAS and BRAF genes,DNA,0.848,20631611
43485,KRAS,gene,0.982,20631611
43486,BRAF genes,gene,0.9756,20631611
43487,Panitumumab,gene,0.874,20631611
43488,wild-type KRAS,gene,0.91,20631611
43489,anti-vascular endothelial growth factor,gene,0.981,20631611
43490,anti-,gene,0.5938,20631611
43491,epidermal growth factor,gene,0.836,20631611
43492,bevacizumab,gene,0.842,20631611
43493,advanced CRC,disease,0.7544,20631611
43494,tumour,disease,1.0,20631611
43495,advanced CRC,disease,0.77,20631611
43496,epidermal growth factor receptor,gene,0.9966,20630850
43497,colorectal cancer,disease,1.0,20630850
43498,Epidermal growth factor receptor,gene,0.9985,20630850
43499,EGFR,gene,0.9907,20630850
43500,metastatic colorectal cancer,disease,1.0,20630850
43501,mCRC,disease,1.0,20630850
43502,KRAS,DNA,0.847,20630850
43503,KRAS mutation,gene,0.8945,20630850
43504,EGFR,gene,0.6284,20630850
43505,EGFR,gene,0.9956,20630850
43506,cetuximab,gene,0.4363,20630850
43507,panitumumab,gene,0.7764,20630850
43508,mCRC,disease,0.9946,20630850
43509,KRAS,gene,0.8447,20630850
43510,EGFR,gene,0.992,20630850
43511,colorectal cancer,disease,1.0,20630848
43512,metastatic colorectal cancer,disease,0.9985,20630848
43513,CRC,disease,1.0,20630848
43514,bevacizumab,gene,0.8296,20630848
43515,cetuximab,gene,0.915,20630848
43516,panitumumab,gene,0.9272,20630848
43517,CRC,disease,0.993,20630848
43518,CRC,disease,0.999,20630848
43519,bevacizumab,gene,0.9214,20630848
43520,solid cancers,disease,1.0,20630848
43521,CRC,disease,0.9863,20630848
43522,CRC,disease,0.9873,20630848
43523,epidermal growth factor receptor,gene,0.997,20628713
43524,epidermal growth factor receptor,gene,0.9976,20628713
43525,EGFR,gene,0.988,20628713
43526,erlotinib,drug,0.9966,20628713
43527,gefitinib,drug,0.998,20628713
43528,cetuximab,gene,0.853,20628713
43529,panitumumab,gene,0.8545,20628713
43530,solid tumors,disease,0.9995,20628713
43531,cancer,disease,0.9805,20628713
43532,papulo-pustular rash,disease,1.0,20628713
43533,paronychia,disease,0.828,20628713
43534,xerosis cutis,disease,1.0,20628713
43535,pruritus,disease,1.0,20628713
43536,alopecia,disease,1.0,20628713
43537,alterations of the hair structure,disease,0.9937,20628713
43538,EGFR,gene,0.9917,20628713
43539,panitumumab,gene,0.8804,20623992
43540,metastatic colorectal cancer,disease,1.0,20623992
43541,Panitumumab,gene,0.783,20623992
43542,IgG2,gene,0.8984,20623992
43543,anti-epidermal growth factor receptor,gene,0.9653,20623992
43544,EGFR,gene,0.9883,20623992
43545,panitumumab,gene,0.9272,20623992
43546,metastatic colorectal cancer,disease,0.9995,20623992
43547,metastatic,disease,1.0,20623992
43548,colorectal cancer,disease,0.875,20623992
43549,Panitumumab,gene,0.6387,20623992
43550,wild,cell_line,0.5845,20623992
43551,wild-type rather than mutant KRAS tumors,disease,0.9966,20623992
43552,panitumumab,gene,0.9434,20623992
43553,metastatic colorectal cancer,disease,0.999,20623992
43554,panitumumab,gene,0.925,20623992
43555,wild,cell_line,0.6865,20623992
43556,wild-type KRAS tumors,disease,0.9194,20623992
43557,mutant,cell_type,0.4631,20623992
43558,mutant KRAS tumors,disease,0.6685,20623992
43559,mutant KRAS,gene,0.9233,20623992
43560,panitumumab,gene,0.826,20623992
43561,oxaliplatin,drug,0.9995,20623992
43562,FOLFOX4,drug,0.8813,20623992
43563,FOLFOX4,drug,0.768,20623992
43564,panitumumab,gene,0.936,20623992
43565,irinotecan,drug,0.998,20623992
43566,FOLFIRI,drug,0.95,20623992
43567,FOLFIRI,drug,0.966,20623992
43568,metastatic colorectal cancer,disease,1.0,20623992
43569,panitumumab,gene,0.952,20623992
43570,wild,cell_line,0.4775,20623992
43571,wild-type KRAS tumors,disease,1.0,20623992
43572,wild-type KRAS,gene,0.84,20623992
43573,mutant KRAS tumors,disease,0.6025,20623992
43574,mutant KRAS,gene,0.926,20623992
43575,panitumumab,gene,0.891,20623992
43576,EGFR,gene,0.99,20623992
43577,wild,gene,0.4905,20623992
43578,panitumumab,gene,0.6924,20623992
43579,metastatic colorectal cancer,disease,1.0,20623992
43580,metastatic colorectal cancer,disease,1.0,20623992
43581,KRAS,gene,0.7603,20619739
43582,BRAF,gene,0.5957,20619739
43583,NRAS,gene,0.536,20619739
43584,PIK3CA mutations,gene,0.9,20619739
43585,cetuximab,gene,0.8853,20619739
43586,metastatic colorectal cancer,disease,0.998,20619739
43587,mutant KRAS,gene,0.5854,20619739
43588,anti-,gene,0.899,20619739
43589,epidermal growth factor receptor,gene,0.9175,20619739
43590,EGFR,gene,0.9565,20619739
43591,tumours,disease,1.0,20619739
43592,metastatic colorectal,disease,0.9995,20619739
43593,cancer,disease,0.9717,20619739
43594,KRAS,DNA,0.844,20619739
43595,KRAS mutations,gene,0.928,20619739
43596,cetuximab,gene,0.5483,20619739
43597,panitumumab,gene,0.63,20619739
43598,KRAS,gene,0.6104,20619739
43599,cetuximab,gene,0.865,20619739
43600,metastatic colorectal cancer,disease,1.0,20619739
43601,cetuximab,gene,0.8477,20619739
43602,KRAS,gene,0.819,20619739
43603,tumour DNA samples,DNA,0.7983,20619739
43604,tumour,disease,0.9995,20619739
43605,cetuximab,gene,0.693,20619739
43606,tumour,disease,1.0,20619739
43607,DNA,RNA,0.4624,20619739
43608,tumour samples,cell_type,0.429,20619739
43609,tumour,disease,0.9863,20619739
43610,KRAS,gene,0.822,20619739
43611,BRAF,gene,0.7974,20619739
43612,NRAS,gene,0.8154,20619739
43613,PIK3CA,gene,0.7666,20619739
43614,cetuximab,gene,0.8354,20619739
43615,tumours,disease,1.0,20619739
43616,KRAS mutation,gene,0.6714,20619739
43617,PIK3CA,DNA,0.586,20619739
43618,PIK3CA mutation,gene,0.9863,20619739
43619,exon 9,DNA,0.4675,20619739
43620,exon 20,DNA,0.6475,20619739
43621,BRAF,DNA,0.696,20619739
43622,BRAF mutation,gene,0.9326,20619739
43623,NRAS mutation,gene,0.6226,20619739
43624,KRAS,DNA,0.7227,20619739
43625,KRAS mutants,gene,0.9854,20619739
43626,wild types,cell_type,0.4905,20619739
43627,KRAS,gene,0.558,20619739
43628,BRAF,gene,0.551,20619739
43629,NRAS mutations,gene,0.4724,20619739
43630,BRAF,gene,0.994,20619739
43631,NRAS,gene,0.991,20619739
43632,BRAF mutations,gene,0.734,20619739
43633,BRAF,DNA,0.5366,20619739
43634,BRAF wild types,gene,0.883,20619739
43635,NRAS,DNA,0.81,20619739
43636,NRAS mutations,gene,0.9126,20619739
43637,NRAS,DNA,0.617,20619739
43638,NRAS wild types,gene,0.9062,20619739
43639,PIK3CA,gene,0.994,20619739
43640,exon 20,DNA,0.5254,20619739
43641,KRAS,gene,0.5728,20619739
43642,BRAF,gene,0.6924,20619739
43643,NRAS,gene,0.816,20619739
43644,PIK3CA exon 20,gene,0.6226,20619739
43645,KRAS,gene,0.741,20619739
43646,KRAS,gene,0.508,20619739
43647,BRAF,gene,0.4775,20619739
43648,NRAS,gene,0.49,20619739
43649,PIK3CA,gene,0.9976,20619739
43650,exon 20,DNA,0.537,20619739
43651,KRAS,DNA,0.5493,20619739
43652,KRAS mutations,gene,0.886,20619739
43653,cetuximab,gene,0.877,20619739
43654,BRAF,gene,0.6616,20619739
43655,NRAS,gene,0.7607,20619739
43656,PIK3CA exon 20,DNA,0.65,20619739
43657,PIK3CA exon,gene,0.801,20619739
43658,BRAF,gene,0.747,20619739
43659,NRAS,gene,0.7563,20619739
43660,PIK3CA exon 20,DNA,0.5854,20619739
43661,PIK3CA exon 20 mutations,gene,0.769,20619739
43662,KRAS,gene,0.4883,20619739
43663,Cancer,disease,0.9995,20619739
43664,KRAS,gene,0.811,20607679
43665,colo-rectal carcinoma,disease,1.0,20607679
43666,Anti-,gene,0.844,20607679
43667,EGFR monoclonal,gene,0.7314,20607679
43668,cetuximab,gene,0.7446,20607679
43669,panitumumab,gene,0.742,20607679
43670,advanced colo-rectal cancer,disease,1.0,20607679
43671,CRC,disease,1.0,20607679
43672,KRAS gene,gene,0.9043,20607679
43673,KRAS,gene,0.8745,20607679
43674,KRAS,gene,0.868,20607679
43675,cytological samples,cell_type,0.565,20607679
43676,colon tumour,disease,1.0,20607679
43677,CRC,disease,1.0,20607679
43678,CRC,disease,1.0,20607679
43679,malignant cell,cell_type,0.8403,20607679
43680,Exon 2 KRAS gene,gene,0.8154,20607679
43681,KRAS,DNA,0.772,20607679
43682,KRAS Mutation,gene,0.9175,20607679
43683,KRAS,gene,0.749,20607679
43684,colon cancer,disease,1.0,20607679
43685,KRAS Mutation,gene,0.6587,20607679
43686,KRAS,gene,0.7397,20607679
43687,anti-epidermal growth factor receptor monoclonal antibodies,gene,0.9824,20585089
43688,EGFR,gene,0.958,20580896
43689,metastatic colorectal cancer,disease,0.9995,20580896
43690,anti-epidermal growth factor receptor,gene,0.9644,20580896
43691,EGFR,gene,0.9785,20580896
43692,panitumumab,gene,0.7544,20580896
43693,metastatic colorectal cancer,disease,1.0,20580896
43694,cetuximab,gene,0.7363,20580896
43695,panitumumab,gene,0.778,20580896
43696,EGFR,gene,0.994,20580896
43697,metastatic colorectal cancer,disease,1.0,20580896
43698,cetuximab,gene,0.63,20580896
43699,myelosuppression,disease,1.0,20580896
43700,mucositis,disease,1.0,20580896
43701,nausea and vomiting,disease,0.974,20580896
43702,anti-EGFR,gene,0.651,20580896
43703,diarrhoea,disease,1.0,20580896
43704,ocular toxicities,disease,0.9893,20580896
43705,cetuximab,gene,0.47,20580896
43706,EGFR,gene,0.8,20580896
43707,alemtuzumab,gene,0.8955,20569773
43708,bevacizumab,gene,0.8857,20569773
43709,cetuximab,gene,0.85,20569773
43710,gemtuzumab,gene,0.8257,20569773
43711,ozogamycin,drug,0.6978,20569773
43712,panitumumab,gene,0.9204,20569773
43713,rituximab,gene,0.9697,20569773
43714,trastuzumab,gene,0.976,20569773
43715,antibody-specific library,DNA,0.791,20569773
43716,Epidermal growth factor receptor,gene,0.998,20567625
43717,stages III and IV,disease,0.9956,20567625
43718,head and neck cancer,disease,0.9526,20567625
43719,anti-,gene,0.527,20567625
43720,epidermal growth factor receptor,gene,0.944,20567625
43721,EGFR,gene,0.651,20567625
43722,squamous cell carcinoma of the head and,disease,0.9995,20567625
43723,HNSCC,disease,1.0,20567625
43724,EGFR,gene,0.9756,20567625
43725,cetuximab,gene,0.592,20567625
43726,gefitinib,drug,0.9893,20567625
43727,lapatinib,drug,0.997,20567625
43728,erlotinib,drug,0.9907,20567625
43729,panitumumab,gene,0.6914,20567625
43730,Head-and-neck cancer,disease,1.0,20567625
43731,malignant tumours,disease,1.0,20567625
43732,squamous cell carcinoma,disease,1.0,20567625
43733,HNSCC,disease,1.0,20567625
43734,neoplasm,disease,1.0,20567625
43735,HNSCC,disease,1.0,20567625
43736,HNSCC,disease,1.0,20567625
43737,platinum,drug,0.9995,20567625
43738,Cetuximab,gene,0.9033,20567625
43739,HNSCC,disease,0.9907,20567625
43740,platinum,drug,0.9995,20567625
43741,EGFR,gene,0.9116,20567625
43742,HNSCC,disease,0.9497,20567625
43743,Head and Neck Cancer,disease,0.9995,20567625
43744,Cancer,disease,0.9443,20567625
43745,tumour,disease,1.0,20567625
43746,EGFR,gene,0.9155,20567625
43747,Head and Neck Cancer,disease,1.0,20567625
43748,HNSCC,disease,0.9854,20567625
43749,HNSCC,disease,1.0,20567625
43750,platinum,drug,0.9995,20567625
43751,HNSCC,disease,0.9927,20567625
43752,platinum,drug,0.999,20567625
43753,HNSCC,disease,0.9966,20567625
43754,Platinum,drug,0.9995,20567625
43755,HNSCC,disease,0.985,20567625
43756,platinum,drug,0.9995,20567625
43757,cetuximab,gene,0.92,20567625
43758,Cetuximab,gene,0.915,20567625
43759,platinum,drug,0.9995,20567625
43760,HNSCC,disease,0.999,20567625
43761,EGFR,gene,0.9507,20567625
43762,HNSCC,disease,1.0,20567625
43763,HNSCC,disease,0.928,20567625
43764,cetuximab,gene,0.911,20567625
43765,cetuximab,gene,0.95,20567625
43766,EGFR,gene,0.9927,20567625
43767,cetuximab,gene,0.9,20567625
43768,HNSCC,disease,0.961,20567625
43769,platinum,drug,0.9995,20567625
43770,gefitinib,drug,0.9956,20567625
43771,methotrexate,drug,0.9985,20567625
43772,methotrexate,drug,0.998,20567625
43773,methotrexate,drug,0.998,20567625
43774,methotrexate,drug,0.999,20567625
43775,methotrexate,drug,0.9995,20567625
43776,gefitinib,drug,0.9985,20567625
43777,tumour hemorrhage,disease,1.0,20567625
43778,methotrexate,drug,0.998,20567625
43779,Cancer,disease,1.0,20567101
43780,advanced cancer,disease,1.0,20567101
43781,hyperkalemia,disease,1.0,20567101
43782,hypercalcemia,disease,1.0,20567101
43783,hyponatremia,disease,1.0,20567101
43784,Hyperkalemia,disease,1.0,20567101
43785,malignant tumors,disease,1.0,20567101
43786,tumor lysis syndrome,disease,1.0,20567101
43787,Hypercalcemia,disease,1.0,20567101
43788,hyponatremia,disease,1.0,20567101
43789,breast cancer,disease,1.0,20567101
43790,renal cancer,disease,1.0,20567101
43791,prostate cancer,disease,1.0,20567101
43792,paraneoplastic syndrome,disease,0.994,20567101
43793,hypercalcemia,disease,1.0,20567101
43794,osteolysis,disease,1.0,20567101
43795,parathyroid hormone-related protein,gene,0.998,20567101
43796,hyponatremia,disease,1.0,20567101
43797,antidiuretic hormone-producing tumor,disease,0.9995,20567101
43798,antidiuretic hormone,gene,0.57,20567101
43799,encephalopathy,disease,1.0,20567101
43800,arrhythmia,disease,1.0,20567101
43801,epidermal growth factor receptors,gene,0.9956,20567101
43802,cetuximab,gene,0.912,20567101
43803,panitumumab,gene,0.917,20567101
43804,hypomagnesia,disease,1.0,20567101
43805,m,DNA,0.5425,20567101
43806,m-TORinhibitors,gene,0.996,20567101
43807,ABL,gene,0.9956,20567101
43808,hypomagnesia,disease,1.0,20567101
43809,hypophosphatemia,disease,1.0,20567101
43810,magnesium,drug,1.0,20567101
43811,phosphate,drug,0.9937,20567101
43812,EGFR,gene,0.9956,20551942
43813,EGFR,gene,0.9897,20551942
43814,tyrosine,drug,0.9688,20551942
43815,tyrosine kinase,gene,0.985,20551942
43816,EGFR,gene,0.994,20551942
43817,EGFR,gene,0.9917,20551942
43818,human,species,0.975,20551942
43819,epithelial malignancies,disease,1.0,20551942
43820,"cancers of the colon, head and neck, lung, and pancreas",disease,1.0,20551942
43821,EGFR,gene,0.9927,20551942
43822,cancer,disease,1.0,20551942
43823,EGFR,gene,0.9946,20551942
43824,EGFR,gene,0.992,20551942
43825,EGFR,gene,0.994,20551942
43826,EGFR,gene,0.9946,20551942
43827,cancer,disease,1.0,20551942
43828,Immunoglobulin G fragment C receptor,gene,0.9956,20550522
43829,KRAS,DNA,0.813,20550522
43830,KRAS mutations,gene,0.8037,20550522
43831,KRAS,DNA,0.66,20550522
43832,KRAS mutations,gene,0.828,20550522
43833,anti-epidermal growth factor receptor,gene,0.8975,20550522
43834,EGFR,gene,0.997,20550522
43835,EGFR,gene,0.994,20550522
43836,anti-EGFR monoclonal antibodies,gene,0.973,20550522
43837,antibody fragment C portion,gene,0.9253,20550522
43838,Fc,gene,0.998,20550522
43839,Fc receptors,gene,0.989,20550522
43840,FcRs,gene,0.993,20550522
43841,immune effectors cells,cell_type,0.9014,20550522
43842,FcR,gene,0.995,20550522
43843,KRAS mutation,gene,0.908,20550522
43844,metastatic colorectal cancer,disease,1.0,20550522
43845,mCRC,disease,1.0,20550522
43846,patients,species,0.977,20550522
43847,anti-EGFR antibodies,gene,0.8613,20550522
43848,FcRIIa,DNA,0.549,20550522
43849,FcRIIa-,gene,0.995,20550522
43850,H131R,DNA,0.4404,20550522
43851,H131,mutation,,20550522
43852,FcRIIIa-,DNA,0.525,20550522
43853,FcRIIIa-V158F,gene,0.8403,20550522
43854,V158F,DNA,0.4614,20550522
43855,V158,mutation,,20550522
43856,genomic DNA,DNA,0.823,20550522
43857,Tumor tissues,cell_type,0.5854,20550522
43858,Tumor,disease,0.9956,20550522
43859,KRAS,DNA,0.79,20550522
43860,KRAS mutations,gene,0.871,20550522
43861,KRAS,gene,0.9814,20550522
43862,FcRIIa-,DNA,0.672,20550522
43863,FcRIIa-,gene,0.9976,20550522
43864,H131R,DNA,0.465,20550522
43865,H131,mutation,,20550522
43866,FcRIIIa-,DNA,0.627,20550522
43867,FcRIIIa-V158F,gene,0.761,20550522
43868,V158F,DNA,0.501,20550522
43869,V158,mutation,,20550522
43870,polymorphisms,DNA,0.3484,20550522
43871,KRAS,gene,0.98,20550522
43872,KRAS,DNA,0.816,20550522
43873,KRAS,gene,0.984,20550522
43874,FcRIIa,gene,0.997,20550522
43875,FcRIIIa,gene,0.997,20550522
43876,mCRC,disease,1.0,20550522
43877,patients,species,0.9907,20550522
43878,Cancer,disease,0.93,20550522
43879,KRAS,DNA,0.8423,20550522
43880,KRAS,gene,0.9727,20550522
43881,patients,species,0.9893,20550522
43882,EGFR,gene,0.7017,20550522
43883,metastatic colorectal cancer,disease,0.9995,20535969
43884,colorectal cancer,disease,1.0,20535969
43885,CRC,disease,1.0,20535969
43886,cancer,disease,1.0,20535969
43887,5-fluorouracil,drug,0.999,20535969
43888,leucovorin,drug,0.999,20535969
43889,CRC,disease,0.9985,20535969
43890,anticancer,disease,0.907,20535969
43891,irinotecan,drug,0.9995,20535969
43892,oxaliplatin,drug,0.9995,20535969
43893,bevacizumab,gene,0.631,20535969
43894,anti-EGFR antibodies,gene,0.9844,20535969
43895,cetuximab,gene,0.869,20535969
43896,panitumumab,gene,0.5854,20535969
43897,metastatic CRC,disease,0.973,20535969
43898,patient,species,0.982,20535969
43899,cancer,disease,0.9985,20535960
43900,cancer,disease,1.0,20535960
43901,rituximab,gene,0.961,20535960
43902,bevacizumab,gene,0.9097,20535960
43903,cetuximab,gene,0.886,20535960
43904,Panitumumab,gene,0.804,20535960
43905,epithelial growth factor receptor,gene,0.998,20535960
43906,EGFR,gene,0.9937,20535960
43907,colorectal cancer,disease,1.0,20535960
43908,KRAS,DNA,0.773,20535960
43909,KRAS mutation,gene,0.92,20535960
43910,anti-EGFR MoAbs,gene,0.8784,20535960
43911,bevacizumab,gene,0.535,20535960
43912,bevacizumab,gene,0.84,20535960
43913,nonsmall cell lung carcinoma,disease,1.0,20535960
43914,patients,species,0.9946,20535960
43915,cancer,disease,1.0,20535960
43916,cancer,disease,0.996,20535960
43917,epidermal growth factor receptor,gene,0.996,20526101
43918,colorectal cancer,disease,1.0,20526101
43919,CRC,disease,1.0,20526101
43920,Epidermal growth factor receptor,gene,0.998,20526101
43921,cancer,disease,1.0,20526101
43922,Cetuximab,gene,0.929,20526101
43923,panitumumab,gene,0.9146,20526101
43924,metastatic CRC,disease,0.874,20526101
43925,epidermal growth factor receptor,gene,0.996,20526101
43926,CRC,disease,0.998,20526101
43927,panitumumab,gene,0.9507,20508254
43928,panitumumab,gene,0.907,20508254
43929,human epidermal growth factor (EGF) receptor,gene,0.9976,20508254
43930,tyrosine,drug,0.9937,20508254
43931,epidermal growth factor receptor,gene,0.9966,20508254
43932,EGFR,gene,0.993,20508254
43933,STAT-1,gene,0.994,20508254
43934,human epidermoid carcinoma cell line A431,cell_line,0.943,20508254
43935,epidermoid carcinoma,disease,0.9272,20508254
43936,A431 cells,cell_line,0.9526,20508254
43937,recombinant human EGF,gene,0.9985,20508254
43938,panitumumab,gene,0.917,20508254
43939,EGF,gene,0.997,20508254
43940,rabbit,species,0.952,20508254
43941,Panitumumab,gene,0.94,20508254
43942,EGF,gene,0.9927,20508254
43943,panitumumab,gene,0.9707,20508254
43944,STAT-1,gene,0.9956,20508254
43945,EGFR,gene,0.991,20508254
43946,EGFR,gene,0.994,20508254
43947,anti EGFR antibody,gene,0.943,20495310
43948,colorectal cancer,disease,1.0,20495310
43949,Cancer of the Colon and Rectum,disease,0.9946,20495310
43950,Bevacizumab,gene,0.8364,20495310
43951,cetuximab,gene,0.87,20495310
43952,capecitabine,drug,0.9985,20495310
43953,advanced,disease,0.9995,20495310
43954,colorectal cancer,disease,0.926,20495310
43955,capecitabine,drug,0.9995,20495310
43956,Oxaliplatin,drug,0.9995,20495310
43957,CapeOx,drug,0.996,20495310
43958,XELOX,drug,0.9717,20495310
43959,panitumumab,gene,0.908,20495310
43960,KRAS,gene,0.832,20495310
43961,cetuximab,gene,0.698,20495310
43962,KRAS,gene,0.668,20495310
43963,Cetuximab,gene,0.867,20495310
43964,KRAS,gene,0.833,20495310
43965,anti EGFR antibody,gene,0.9463,20495310
43966,Anti-epidermal growth factor receptor monoclonal antibodies,gene,0.949,20495307
43967,Cetuximab,gene,0.6636,20495307
43968,panitumumab,gene,0.633,20495307
43969,anti-epidermal growth factor receptor,gene,0.946,20495307
43970,EGFR,gene,0.9175,20495307
43971,colorectal cancer,disease,1.0,20495307
43972,anti-EGFR MAbs,gene,0.8003,20495307
43973,infusion,disease,0.5093,20495307
43974,skin toxicity,disease,0.8457,20495307
43975,lung toxicity,disease,0.9053,20495307
43976,hypomagnesemia,disease,1.0,20495307
43977,anti-,gene,0.8535,20495307
43978,EGFR MAbs,gene,0.6016,20495307
43979,anti-,gene,0.7783,20495305
43980,EGFR antibodies,gene,0.8164,20495305
43981,cetuximab,gene,0.7007,20495305
43982,mouse chimeric immunoglobulin G1 monoclonal antibody,gene,0.972,20495305
43983,mouse,species,0.9814,20495305
43984,epidermal growth factor receptor,gene,0.9233,20495305
43985,EGFR,gene,0.9917,20495305
43986,metastatic colorectal cancer,disease,0.9595,20495305
43987,panitumumab,gene,0.898,20495305
43988,matuzumab,gene,0.9263,20495305
43989,nimotuzumab,gene,0.7964,20495305
43990,EGFR,gene,0.9917,20495305
43991,Cetuximab,gene,0.762,20495305
43992,anti-EGFR antibody,gene,0.929,20495305
43993,mouse,species,0.8877,20495305
43994,mouse,species,0.9775,20495305
43995,mouse,species,0.966,20495305
43996,cetuximab,gene,0.9624,20495305
43997,matuzumab,gene,0.95,20495305
43998,nimotuzumab,gene,0.833,20495305
43999,humanized,species,0.613,20495305
44000,panitumumab,gene,0.953,20495305
44001,zalutumumab,gene,0.4927,20495305
44002,anti-EGFR antibodies,gene,0.9697,20495305
44003,human anti-HER1 monoclonal antibody,gene,0.826,20484421
44004,panitumumab,gene,0.516,20484421
44005,86Y,drug,0.9883,20484421
44006,carcinoma,disease,1.0,20484421
44007,Panitumumab,gene,0.7407,20484421
44008,epidermal growth factor receptor,gene,0.996,20484421
44009,HER1,gene,0.9756,20484421
44010,HER1,gene,0.996,20484421
44011,(86)Y-CHX-A''-diethylenetriaminepentaacetic acid,drug,0.9937,20484421
44012,DTPA,drug,0.999,20484421
44013,panitumumab,gene,0.8677,20484421
44014,HER1,gene,0.557,20484421
44015,Panitumumab,gene,0.823,20484421
44016,CHX-A''-DTPA,drug,0.9995,20484421
44017,(86)Y,drug,0.9985,20484421
44018,mice,species,0.9453,20484421
44019,HER1,gene,0.996,20484421
44020,colorectal,disease,0.96,20484421
44021,panitumumab,gene,0.784,20484421
44022,(86)Y-CHX-A''-DTPA,drug,0.995,20484421
44023,HER1,gene,0.9937,20484421
44024,tumor,disease,0.9697,20484421
44025,mice,species,0.81,20484421
44026,LS-174T,disease,1.0,20484421
44027,PC-3,disease,0.997,20484421
44028,A431 tumors,disease,0.9995,20484421
44029,mice,species,0.952,20484421
44030,panitumumab,gene,0.8667,20484421
44031,tumor,disease,0.998,20484421
44032,LS,cell_type,0.499,20484421
44033,LS-174T tumor,disease,0.712,20484421
44034,tumors,disease,1.0,20484421
44035,(86)Y-CHX-A''-DTPA,drug,0.971,20484421
44036,panitumumab,gene,0.879,20484421
44037,HER1,gene,0.9946,20484421
44038,Panitumumab,gene,0.6895,20481659
44039,metastatic colorectal cancer,disease,1.0,20481659
44040,Panitumumab,gene,0.788,20481659
44041,IgG2,gene,0.933,20481659
44042,anti-epidermal growth factor receptor,gene,0.94,20481659
44043,EGFR,gene,0.9893,20481659
44044,panitumumab,gene,0.9375,20481659
44045,metastatic colorectal cancer,disease,0.9995,20481659
44046,metastatic colorectal cancer,disease,0.9116,20481659
44047,Panitumumab,gene,0.644,20481659
44048,wild,cell_line,0.6113,20481659
44049,wild-type rather than mutant KRAS tumours,disease,0.9995,20481659
44050,panitumumab,gene,0.9443,20481659
44051,metastatic colorectal cancer,disease,0.999,20481659
44052,panitumumab,gene,0.925,20481659
44053,wild-type KRAS tumours,disease,0.6216,20481659
44054,wild,gene,0.6294,20481659
44055,mutant,cell_type,0.4575,20481659
44056,mutant KRAS tumours,disease,0.6646,20481659
44057,mutant KRAS,gene,0.9077,20481659
44058,panitumumab,gene,0.801,20481659
44059,oxaliplatin,drug,0.9995,20481659
44060,oxaliplatin,drug,0.9995,20481659
44061,panitumumab,gene,0.936,20481659
44062,irinotecan,drug,0.998,20481659
44063,FOLFIRI,drug,0.95,20481659
44064,FOLFIRI,drug,0.966,20481659
44065,metastatic colorectal cancer,disease,1.0,20481659
44066,panitumumab,gene,0.952,20481659
44067,wild,cell_line,0.5435,20481659
44068,wild-type KRAS tumours,disease,1.0,20481659
44069,mutant KRAS tumours,disease,0.549,20481659
44070,mutant KRAS,gene,0.7812,20481659
44071,Panitumumab,gene,0.7856,20481659
44072,EGFR,gene,0.99,20481659
44073,wild,cell_line,0.6616,20481659
44074,wild-type KRAS tumours,disease,0.9873,20481659
44075,panitumumab,gene,0.6724,20481659
44076,metastatic colorectal cancer,disease,1.0,20481659
44077,metastatic colorectal cancer,disease,1.0,20481659
44078,cetuximab,gene,0.918,20464886
44079,Cetuximab,gene,0.736,20464886
44080,anti-epidermal growth factor receptor,gene,0.954,20464886
44081,EGFR,gene,0.99,20464886
44082,colorectal,disease,1.0,20464886
44083,CRC,disease,0.999,20464886
44084,head and neck (H&N) cancers,disease,1.0,20464886
44085,Hypersensitivity-infusion reactions,disease,1.0,20464886
44086,HIRs,disease,0.999,20464886
44087,HIRs,disease,1.0,20464886
44088,cetuximab,gene,0.8823,20464886
44089,CRC,disease,0.999,20464886
44090,H&N,disease,0.9995,20464886
44091,cetuximab,gene,0.726,20464886
44092,HIRs,disease,0.999,20464886
44093,HIR,disease,0.959,20464886
44094,cetuximab,gene,0.8545,20464886
44095,allergy,disease,0.776,20464886
44096,HIRs,disease,0.9995,20464886
44097,HIR,disease,0.9995,20464886
44098,HIR,disease,0.8755,20464886
44099,cetuximab,gene,0.98,20464886
44100,anti-EGFR MoAb,gene,0.8027,20464886
44101,HIR,disease,0.9927,20464886
44102,cetuximab,gene,0.907,20464886
44103,panitumumab,gene,0.8535,20464886
44104,cetuximab,gene,0.974,20464886
44105,CRC,disease,0.999,20464886
44106,KRAS,DNA,0.6074,20460490
44107,KRAS mutant,gene,0.7715,20460490
44108,metastatic colorectal cancer,disease,0.9854,20460490
44109,metastatic colorectal cancer,disease,0.996,20460490
44110,CRC,disease,1.0,20460490
44111,anti-epidermal growth factor receptor,gene,0.954,20460490
44112,EGFR,gene,0.932,20460490
44113,cetuximab,gene,0.853,20460490
44114,panitumumab,gene,0.833,20460490
44115,KRAS,gene,0.817,20460490
44116,anti-EGFR antibodies,gene,0.8906,20460490
44117,KRAS,gene,0.8687,20460490
44118,tumor,disease,1.0,20460490
44119,KRAS mutant tumors,cell_line,0.65,20460490
44120,KRAS mutant,disease,0.7266,20460490
44121,KRAS,gene,0.4412,20460490
44122,tumors,disease,0.581,20460490
44123,KRAS,gene,0.771,20460490
44124,KRAS,DNA,0.697,20460490
44125,KRAS wild,gene,0.8794,20460490
44126,KRAS,DNA,0.8438,20460490
44127,KRAS mutations,gene,0.9595,20460490
44128,KRAS,gene,0.6763,20460490
44129,metastatic CRC,disease,0.9854,20460490
44130,EGFR,gene,0.9917,20446909
44131,epidermal growth factor receptor,gene,0.9976,20446909
44132,epidermal growth factor receptor,gene,0.9976,20446909
44133,EGFR,gene,0.988,20446909
44134,anticancer,disease,0.589,20446909
44135,EGFR,gene,0.992,20446909
44136,EGFR,gene,0.989,20446909
44137,malignancy,disease,0.9517,20446909
44138,EGFR,gene,0.9946,20446909
44139,cancer,disease,1.0,20446909
44140,EGFR,gene,0.9937,20446909
44141,cetuximab,gene,0.8994,20446909
44142,panitumumab,gene,0.912,20446909
44143,EGFR,gene,0.994,20446909
44144,cardiac toxicity,disease,0.993,20446909
44145,cetuximab,gene,0.7256,20446909
44146,EGFR mAbs,gene,0.9067,20446909
44147,EGFR,gene,0.941,20446909
44148,cancer,disease,1.0,20446909
44149,EGFR,gene,0.9956,20437117
44150,rash,disease,0.967,20437117
44151,mitomycin C,drug,0.9976,20433364
44152,metastatic colorectal cancer,disease,0.999,20433364
44153,Fluoropyrimidines,drug,0.999,20433364
44154,oxaliplatin,drug,1.0,20433364
44155,irinotecan,drug,0.999,20433364
44156,bevacizumab,gene,0.8823,20433364
44157,cetuximab,gene,0.8447,20433364
44158,panitumumab,gene,0.827,20433364
44159,colorectal cancer,disease,0.9995,20433364
44160,mCRC,disease,0.9976,20433364
44161,Mitomycin C,drug,0.999,20433364
44162,capecitabine,drug,0.999,20433364
44163,irinotecan,drug,0.998,20433364
44164,mitomycin C,drug,0.9995,20433364
44165,fluorouracil,drug,1.0,20433364
44166,capecitabine,drug,0.9995,20433364
44167,irinotecan,drug,0.9995,20433364
44168,oxaliplatin,drug,1.0,20433364
44169,colorectal cancer,disease,1.0,20433364
44170,mitomycin C,drug,0.998,20433364
44171,mitomycin,drug,0.999,20433364
44172,metastatic colorectal cancer,disease,1.0,20433364
44173,Mitomycin C,drug,0.9985,20433364
44174,colorectal cancer,disease,1.0,20433364
44175,colorectal cancer,disease,1.0,20433364
44176,Panitumumab,gene,0.9243,20432075
44177,advanced colorectal cancer,disease,0.9995,20432075
44178,Panitumumab,gene,0.791,20432075
44179,anti-EGFR monoclonal antibody,gene,0.9277,20432075
44180,tumors,disease,0.4504,20432075
44181,wild-type RAS,gene,0.9644,20432075
44182,RAS,gene,0.512,20432075
44183,KRAS,gene,0.7783,20425075
44184,colorectal cancer,disease,1.0,20425075
44185,Cetuximab,gene,0.715,20425075
44186,panitumumab,gene,0.767,20425075
44187,metastatic colorectal cancer,disease,1.0,20425075
44188,mCRC,disease,1.0,20425075
44189,epidermal growth factor receptor,gene,0.9985,20425075
44190,EGFR,gene,0.992,20425075
44191,codons 12/13,DNA,0.7793,20425075
44192,exon 2,DNA,0.869,20425075
44193,KRAS gene,gene,0.8853,20425075
44194,Cancer,disease,0.638,20425075
44195,KRAS,DNA,0.8296,20425075
44196,KRAS mutation,gene,0.9077,20425075
44197,mCRC,disease,0.9893,20425075
44198,pathologist,cell_type,0.4075,20425075
44199,tumor,disease,1.0,20425075
44200,KRAS mutation,gene,0.72,20425075
44201,EGFR,gene,0.7134,20425075
44202,wild,cell_line,0.699,20425075
44203,wild-type KRAS,gene,0.918,20425075
44204,advanced colorectal cancer,disease,0.999,20423677
44205,advanced colorectal cancer,disease,1.0,20423677
44206,ACC,disease,1.0,20423677
44207,fluoropyrimidines,drug,0.999,20423677
44208,irinotecan,drug,0.9985,20423677
44209,oxaliplatin,drug,0.9995,20423677
44210,ACC,disease,1.0,20423677
44211,bevacizumab,gene,0.516,20423677
44212,vascular endothelial growth factor,gene,0.9976,20423677
44213,VEGF,gene,0.996,20423677
44214,panitumumab,gene,0.61,20423677
44215,epidermal growth factor receptor,gene,0.998,20423677
44216,EGFR,gene,0.991,20423677
44217,ACC,disease,0.4927,20423677
44218,EGFR,gene,0.9873,20415599
44219,head and neck squamous cell carcinoma,disease,1.0,20415599
44220,Head and neck cancer,disease,1.0,20415599
44221,cancer,disease,1.0,20415599
44222,EGFR,gene,0.9956,20415599
44223,cetuximab,gene,0.811,20415599
44224,Erbitux,gene,0.4983,20415599
44225,locally advanced head and neck squamous cell carcinoma,disease,0.9683,20415599
44226,HNSCC,disease,1.0,20415599
44227,HNSCC,disease,0.8765,20415599
44228,EGFR,gene,0.9937,20415599
44229,HNSCC,disease,0.9995,20415599
44230,head and neck cancer,disease,1.0,20415599
44231,EGFR,gene,0.9956,20415599
44232,cetuximab,gene,0.92,20415599
44233,panitumumab,gene,0.903,20415599
44234,zalutumumab,gene,0.54,20415599
44235,nimotuzumab,gene,0.798,20415599
44236,erlotinib,drug,0.9995,20415599
44237,gefitinib,drug,0.999,20415599
44238,lapatinib,drug,0.9995,20415599
44239,HNSCC,disease,1.0,20415599
44240,EGFR,gene,0.992,20415599
44241,HNSCC,disease,0.999,20415599
44242,Cetuximab,gene,0.702,20415599
44243,HNSCC,disease,0.8096,20415599
44244,EGFR,gene,0.9946,20415599
44245,HNSCC,disease,0.999,20415599
44246,solid tumours,disease,1.0,20406174
44247,solid tumours,disease,1.0,20406174
44248,trastuzumab,gene,0.9688,20406174
44249,cetuximab,gene,0.9507,20406174
44250,panitumumab,gene,0.9546,20406174
44251,bevacizumab,gene,0.8574,20406174
44252,catumaxomab,gene,0.746,20406174
44253,solid tumour,disease,1.0,20406174
44254,"breast, colorectal, and",disease,0.974,20406174
44255,non-small cell lung cancers,disease,1.0,20406174
44256,solid tumours,disease,1.0,20406174
44257,metastatic colorectal cancer,disease,0.8135,20399983
44258,vascular endothelial growth factor (VEGF) receptor,gene,0.925,20399983
44259,epidermal growth factor receptor,gene,0.9976,20399983
44260,EGFR,gene,0.986,20399983
44261,metastatic colorectal cancer,disease,1.0,20399983
44262,mCRC,disease,1.0,20399983
44263,anti-VEGF antibody bevacizumab,gene,0.9,20399983
44264,anti-EGFR antibodies,gene,0.9116,20399983
44265,cetuximab,gene,0.5312,20399983
44266,panitumumab,gene,0.765,20399983
44267,anti-VEGF,gene,0.885,20399983
44268,EGFR,gene,0.5923,20399983
44269,mCRC,disease,0.994,20399983
44270,KRAS mutation,gene,0.733,20399983
44271,anti-,gene,0.6865,20399983
44272,EGFR antibodies,gene,0.6963,20399983
44273,mCRC,disease,0.998,20399983
44274,colorectal neoplasms,disease,1.0,20399983
44275,bevacizumab,gene,0.6724,20399983
44276,cetuximab,gene,0.8125,20399983
44277,panitumumab,gene,0.863,20399983
44278,KRAS mutation,gene,0.742,20399983
44279,KRAS,gene,0.8345,20399983
44280,anti-EGFR antibodies,gene,0.829,20399983
44281,bevacizumab,gene,0.919,20399983
44282,mCRC,disease,0.9946,20399983
44283,bevacizumab,gene,0.872,20399983
44284,cetuximab,gene,0.911,20399983
44285,panitumumab,gene,0.7695,20399983
44286,mCRC,disease,0.9844,20399983
44287,cetuximab,gene,0.939,20399983
44288,panitumumab,gene,0.9385,20399983
44289,EGFR,gene,0.619,20399983
44290,KRAS,gene,0.472,20399983
44291,anti-EGFR,gene,0.7915,20399983
44292,VEGF,gene,0.924,20399983
44293,anti-EGFR antibody,gene,0.9824,20399983
44294,VEGF antibody,gene,0.7524,20399983
44295,bevacizumab,gene,0.4883,20399983
44296,anti-EGFR antibody,gene,0.8286,20399983
44297,anti-VEGF antibody bevacizumab,gene,0.851,20399983
44298,anti-EGFR antibodies cetuximab,gene,0.857,20399983
44299,panitumumab,gene,0.858,20399983
44300,mCRC,disease,0.75,20399983
44301,anti-,gene,0.754,20399983
44302,EGFR antibodies,gene,0.7817,20399983
44303,KRAS,gene,0.603,20399983
44304,anti-VEGF,gene,0.958,20399983
44305,anti-,gene,0.82,20399983
44306,EGFR antibodies,gene,0.6743,20399983
44307,epidermal growth factor receptor,gene,0.9946,20399639
44308,EGFR,gene,0.988,20399639
44309,colon cancer cells,cell_type,0.7114,20399639
44310,colon cancer,disease,1.0,20399639
44311,EGFR,gene,0.993,20399639
44312,Cetuximab,gene,0.7534,20399639
44313,human-murine chimeric IgG1 monoclonal antibody,gene,0.938,20399639
44314,murine,species,0.574,20399639
44315,epidermal growth factor-receptor,gene,0.9976,20399639
44316,EGFR,gene,0.9893,20399639
44317,"colon, head and neck and non-small cell lung cancer",disease,1.0,20399639
44318,Cetuximab,gene,0.7866,20399639
44319,EGFR,gene,0.994,20399639
44320,cancer,disease,0.925,20399639
44321,human IgG1,gene,0.9404,20399639
44322,colon cancer cells,cell_line,0.7344,20399639
44323,colon cancer,disease,0.9995,20399639
44324,cetuximab,gene,0.987,20399639
44325,activated killer,cell_type,0.5293,20399639
44326,LAK,cell_line,0.424,20399639
44327,colon cancer cell lines,cell_line,0.9287,20399639
44328,colon cancer,disease,1.0,20399639
44329,k-ras,gene,0.7896,20399639
44330,EGFR,gene,0.9946,20399639
44331,cetuximab,gene,0.9927,20399639
44332,5-flurouracil,drug,0.9995,20399639
44333,5-FU,drug,0.9995,20399639
44334,gemcitabine,drug,0.9995,20399639
44335,Gem,drug,0.9995,20399639
44336,irinotecan,drug,0.999,20399639
44337,EGFR,gene,0.982,20399639
44338,colon cancer cell lines,cell_line,0.9043,20399639
44339,colon,cell_type,0.4736,20399639
44340,colon cancer,disease,1.0,20399639
44341,Gem,drug,0.9995,20399639
44342,Iri,drug,0.9966,20399639
44343,Levofolinic acid,drug,0.9995,20399639
44344,5-FU,drug,0.998,20399639
44345,LAK cells,cell_type,0.8706,20399639
44346,cetuximab,gene,0.9863,20399639
44347,colon cancer cell lines,cell_line,0.8574,20399639
44348,colon cancer,disease,1.0,20399639
44349,-,DNA,0.4766,20399639
44350,ras,gene,0.8687,20399639
44351,cetuximab,gene,0.975,20399639
44352,Panitumumab,gene,0.8438,20397915
44353,metastatic colorectal cancer,disease,0.999,20397915
44354,Panitumumab,gene,0.7847,20397915
44355,monoclonal IgG(2) antibody,gene,0.853,20397915
44356,EGF receptor,gene,0.9966,20397915
44357,EGFR,gene,0.9937,20397915
44358,Panitumumab,gene,0.5894,20397915
44359,EGFR,gene,0.994,20397915
44360,EGFR,gene,0.998,20397915
44361,metastatic colorectal carcinoma,disease,1.0,20397915
44362,wild-type,gene,0.806,20397915
44363,KRAS,gene,0.8643,20397915
44364,fluoropyrimidine,drug,0.9985,20397915
44365,oxaliplatin,drug,0.9995,20397915
44366,irinotecan,drug,0.998,20397915
44367,skin rashes,disease,0.9995,20397915
44368,diarrhea,disease,1.0,20397915
44369,panitumumab,gene,0.7944,20397915
44370,hypersensitivity reaction,disease,0.977,20397915
44371,cetuximab,gene,0.8945,20397915
44372,Panitumumab,gene,0.901,20397915
44373,metastatic colorectal carcinoma,disease,0.9985,20397915
44374,anti-EGFR monoclonal antibody,gene,0.93,20397915
44375,metastatic colorectal carcinoma,disease,1.0,20397915
44376,KRAS gene,gene,0.91,20392785
44377,colorectal cancer,disease,1.0,20392785
44378,cetuximab,gene,0.7065,20392785
44379,panitumumab,gene,0.6694,20392785
44380,trastuzumab,gene,0.94,20392785
44381,breast cancer,disease,1.0,20392785
44382,HER2,gene,0.995,20392785
44383,EGFR,gene,0.9937,20392785
44384,tyrosine,drug,0.816,20392785
44385,tyrosine kinase,gene,0.97,20392785
44386,lung cancer,disease,1.0,20392785
44387,breast cancer,disease,1.0,20392785
44388,advanced and/or metastatic colorectal cancer,disease,0.999,20385517
44389,bevacizumab,gene,0.826,20385517
44390,oxaliplatin,drug,0.9995,20385517
44391,Folfox7,drug,0.8936,20385517
44392,tumor,disease,1.0,20385517
44393,advanced colorectal cancer,disease,1.0,20385517
44394,cetuximab,gene,0.8145,20385517
44395,panitumumab,gene,0.885,20385517
44396,anti epidermal growth factor receptor,gene,0.881,20385517
44397,vascular endothelial growth factor,gene,0.9976,20385517
44398,PATIENTS,species,0.962,20385517
44399,oxaliplatin,drug,0.9995,20385517
44400,Folfox7,drug,0.784,20385517
44401,metastatic colorectal cancer,disease,0.999,20385517
44402,tumor,disease,0.5386,20385517
44403,vascular endothelial growth factor,gene,0.9976,20385517
44404,tumor,disease,0.999,20385517
44405,tumours,disease,1.0,20385517
44406,vascular endothelial growth factor,gene,0.9985,20385517
44407,bevacizumab,gene,0.619,20385517
44408,vascular endothelial growth factor,gene,0.9976,20385517
44409,colorectal cancers,disease,0.9995,20385517
44410,bevacizumab,gene,0.8994,20385517
44411,advanced colorectal cancer,disease,0.945,20385517
44412,epidermal growth factor receptor,gene,0.999,20383783
44413,EGFR,gene,0.997,20383783
44414,EGFR,gene,0.9937,20383783
44415,metastatic colorectal cancer,disease,0.999,20383783
44416,KRAS,gene,0.848,20383783
44417,epidermal growth factor receptor,gene,0.9985,20383783
44418,EGFR,gene,0.9985,20383783
44419,cetuximab,gene,0.749,20383783
44420,metastatic colorectal cancer,disease,0.9995,20383783
44421,cancer,disease,0.919,20383783
44422,metastatic colorectal cancer,disease,0.9834,20383783
44423,EGFR,gene,0.9897,20383783
44424,KRAS-mutated tumors,disease,0.632,20383783
44425,KRAS,gene,0.9795,20383783
44426,cetuximab,gene,0.9253,20383783
44427,panitumumab,gene,0.8843,20383783
44428,anti-,gene,0.699,20383783
44429,EGFR antibody,gene,0.7075,20383783
44430,oncogenic,DNA,0.5176,20383783
44431,EGFR,gene,0.9937,20383783
44432,EGFR monoclonal antibodies,gene,0.927,20383783
44433,colorectal cancer,disease,1.0,20383783
44434,KRAS,gene,0.866,20383783
44435,BRAF,gene,0.7295,20383783
44436,PIK3CA,gene,0.49,20383783
44437,PTEN,gene,0.9907,20383783
44438,EGFR,gene,0.9844,20383783
44439,EGFR gene,gene,0.7646,20383783
44440,EGFR,gene,0.994,20383783
44441,colorectal cancer,disease,1.0,20383189
44442,anti-,gene,0.9165,20383189
44443,epidermal growth factor receptor,gene,0.8843,20383189
44444,anti-EGFR,gene,0.973,20383189
44445,cetuximab,gene,0.561,20383189
44446,panitumumab,gene,0.8037,20383189
44447,metastatic colorectal cancer,disease,0.9995,20383189
44448,mCRC,disease,0.9985,20383189
44449,EGFR,gene,0.9927,20383189
44450,colorectal cancers,disease,1.0,20383189
44451,tumour,disease,0.843,20383189
44452,tumour KRAS mutations,gene,0.797,20383189
44453,KRAS,DNA,0.4917,20383189
44454,cetuximab,gene,0.8945,20383189
44455,panitumumab,gene,0.8516,20383189
44456,mCRC,disease,0.9985,20383189
44457,BRAF,gene,0.6045,20383189
44458,PIK3CA mutations,gene,0.916,20383189
44459,PTEN,gene,0.9434,20383189
44460,anti-EGFR monoclonal,gene,0.759,20383189
44461,anti-EGFR antibodies,gene,0.982,20383189
44462,tumours,disease,1.0,20383189
44463,anti-EGFR,gene,0.9395,20383189
44464,colorectal cancer,disease,1.0,20375894
44465,vascular endothelial growth factor,gene,0.9995,20375894
44466,VEGF,gene,0.993,20375894
44467,tumor,disease,0.924,20375894
44468,colorectal cancer,disease,1.0,20375894
44469,CRC,disease,0.9985,20375894
44470,Bevacizumab,gene,0.884,20375894
44471,VEGF,gene,0.997,20375894
44472,CRC,disease,0.998,20375894
44473,VEGF,gene,0.997,20375894
44474,bevacizumab,gene,0.733,20375894
44475,metastatic CRC,disease,1.0,20375894
44476,mCRC,disease,1.0,20375894
44477,VEGF,gene,0.996,20375894
44478,epidermal growth factor,gene,0.997,20375894
44479,mCRC,disease,0.9927,20375894
44480,Tyrosine,drug,0.8506,20375894
44481,Tyrosine kinase,gene,0.781,20375894
44482,mCRC,disease,0.9844,20375894
44483,VEGF,gene,0.992,20375894
44484,bevacizumab,gene,0.803,20375894
44485,CRC,disease,0.999,20375894
44486,bevacizumab,gene,0.863,20375894
44487,epidermal growth factor,gene,0.6475,20375894
44488,cetuximab,gene,0.812,20375894
44489,panitumumab,gene,0.92,20375894
44490,mCRC,disease,0.996,20375894
44491,tyrosine,drug,0.918,20375894
44492,tyrosine kinase,gene,0.9893,20375894
44493,CRC,disease,0.999,20375894
44494,Panitumumab,gene,0.874,20351681
44495,colorectal cancer,disease,1.0,20351681
44496,Erlotinib,drug,0.998,20332457
44497,paclitaxel,drug,0.9897,20332457
44498,poorly-differentiated thyroid carcinoma cells,cell_line,0.7324,20332457
44499,poorly-differentiated thyroid carcinoma,disease,0.997,20332457
44500,EGFR,gene,0.993,20332457
44501,thyroid malignancies,disease,1.0,20332457
44502,EGF,gene,0.994,20332457
44503,thyroid cancers,disease,1.0,20332457
44504,EGFR,gene,0.9917,20332457
44505,erlotinib,drug,0.996,20332457
44506,cetuximab,gene,0.8564,20332457
44507,panitumumab,gene,0.8823,20332457
44508,tumor cell lines,cell_line,0.9116,20332457
44509,tumor cell,cell_type,0.4712,20332457
44510,tumor,disease,1.0,20332457
44511,Erlotinib,drug,0.999,20332457
44512,EGF,gene,0.9946,20332457
44513,AKT,gene,0.9883,20332457
44514,ERK1/2,gene,0.951,20332457
44515,poorly-differentiated thyroid carcinoma FRO cells,cell_line,0.86,20332457
44516,poorly-,cell_type,0.574,20332457
44517,poorly-differentiated thyroid carcinoma,disease,0.999,20332457
44518,anti-EGFR monoclonal antibodies,gene,0.947,20332457
44519,erlotinib,drug,0.994,20332457
44520,doxorubicin,drug,0.9995,20332457
44521,paclitaxel,drug,0.9995,20332457
44522,paclitaxel,drug,0.998,20332457
44523,poorly-differentiated thyroid carcinoma cells,cell_line,0.738,20332457
44524,poorly-differentiated thyroid carcinoma,disease,0.998,20332457
44525,EGFR,gene,0.9707,20332457
44526,poorly-differentiated thyroid carcinoma cells,cell_line,0.6494,20332457
44527,poorly-differentiated thyroid carcinoma,disease,0.965,20332457
44528,EGFR tyrosine kinase,gene,0.9683,20332457
44529,tyrosine,drug,0.9937,20332457
44530,epidermal growth factor receptor,gene,0.998,20332321
44531,Panitumumab,gene,0.8467,20332321
44532,metastatic colorectal cancer,disease,0.998,20332321
44533,Panitumumab,gene,0.6533,20332321
44534,anti-epidermal growth factor receptor,gene,0.975,20332321
44535,EGFR,gene,0.9673,20332321
44536,metastatic colorectal cancer,disease,0.9976,20332321
44537,EGFR,gene,0.7476,20332321
44538,metastatic colorectal cancer,disease,0.9985,20332321
44539,tumors,disease,0.4353,20332321
44540,EGFR,gene,0.9624,20332321
44541,EGFR,gene,0.9316,20332321
44542,EGFR,gene,0.9927,20332321
44543,panitumumab,gene,0.672,20332321
44544,solid tumors,disease,0.9995,20332321
44545,EGFR,gene,0.9575,20332321
44546,EGFR,gene,0.9263,20332321
44547,EGFR,gene,0.9863,20332321
44548,EGFR,gene,0.982,20332321
44549,EGFR,gene,0.993,20332321
44550,wild,DNA,0.5527,20332321
44551,wild-type KRAS,gene,0.988,20332321
44552,mutant KRAS,gene,0.6074,20332321
44553,tumor,cell_type,0.5146,20332321
44554,EGFR,gene,0.7324,20332321
44555,EGFR antibody,gene,0.9814,20332321
44556,EGFR antibody,gene,0.9375,20332321
44557,tumors,disease,0.4766,20332321
44558,wild-type KRAS,gene,0.658,20332321
44559,epidermal growth factor receptor,gene,0.997,20305131
44560,metastatic colorectal cancer,disease,1.0,20305131
44561,RANKL,gene,0.9873,20215062
44562,tumor,disease,0.7246,20215062
44563,EGFR,gene,0.9907,20215062
44564,panitumumab,gene,0.3987,20215062
44565,bone metastasis,disease,0.9937,20215062
44566,Bone metastases,disease,0.999,20215062
44567,skeletal complications,disease,0.927,20215062
44568,osteoclast,cell_type,0.8174,20215062
44569,RANKL,gene,0.9937,20215062
44570,osteoclast,cell_type,0.7603,20215062
44571,tumor,disease,1.0,20215062
44572,osteolysis,disease,1.0,20215062
44573,RANKL,gene,0.9863,20215062
44574,osteoprotegerin,gene,0.9707,20215062
44575,OPG,gene,0.9946,20215062
44576,tumor,disease,1.0,20215062
44577,osteolysis,disease,0.996,20215062
44578,tumor,disease,0.9937,20215062
44579,osteoclast,cell_type,0.8257,20215062
44580,tumor,disease,1.0,20215062
44581,osteoclast,cell_type,0.801,20215062
44582,tumor,disease,1.0,20215062
44583,tumor,disease,0.985,20215062
44584,epidermal growth factor receptor,gene,0.999,20215062
44585,EGFR,gene,0.9917,20215062
44586,EGFR,gene,0.9194,20215062
44587,tumor,disease,1.0,20215062
44588,osteolysis,disease,0.9995,20215062
44589,RANKL,gene,0.982,20215062
44590,tumor,disease,0.98,20215062
44591,anti-EGFR antibody,gene,0.989,20215062
44592,panitumumab,gene,0.735,20215062
44593,A431 epidermoid carcinoma,cell_line,0.6494,20215062
44594,A431,disease,0.9478,20215062
44595,epidermoid carcinoma,disease,0.9966,20215062
44596,bone metastasis,disease,0.8076,20215062
44597,tumor,disease,0.984,20215062
44598,RANKL,gene,0.977,20215062
44599,OPG-Fc,gene,0.874,20215062
44600,tumor,disease,1.0,20215062
44601,OPG,gene,0.9873,20215062
44602,Fc,gene,0.637,20215062
44603,tumor,disease,1.0,20215062
44604,osteolysis,disease,0.9727,20215062
44605,RANKL,gene,0.9907,20215062
44606,RANKL,gene,0.989,20215062
44607,tumor,disease,0.9316,20215062
44608,anti-EGFR antibody,gene,0.973,20215062
44609,tumor,disease,1.0,20215062
44610,tumor,disease,0.898,20215062
44611,RANKL,gene,0.991,20215062
44612,tumor,disease,0.902,20215062
44613,panitumumab,gene,0.6235,20215062
44614,anti-EGFR antibody,gene,0.9624,20215062
44615,Panitumumab,gene,0.8784,20189055
44616,metastatic colorectal cancer,disease,1.0,20189055
44617,wild,gene,0.4912,20189055
44618,metastatic colorectal cancer,disease,0.84,20189054
44619,panitumumab,gene,0.886,20189054
44620,epidermal growth factor receptor,gene,0.996,20189054
44621,chimeric,gene,0.5537,20189054
44622,panitumumab,gene,0.5645,20189054
44623,colorectal cancer,disease,1.0,20189054
44624,panitumumab,gene,0.9297,20189054
44625,abdominal pain,disease,0.995,20189054
44626,fever,disease,0.996,20189054
44627,tumour lesion,disease,0.9985,20189054
44628,poorly differentiated necrotic carcinoma of the sigmoid colon,disease,0.993,20189054
44629,tubular adenomas,disease,1.0,20189054
44630,tumour,disease,0.997,20189054
44631,Carcinoembryonic antigen,gene,0.9927,20189054
44632,CEA,gene,0.987,20189054
44633,irinotecan,drug,0.999,20189054
44634,5-fluorouracil,drug,0.9995,20189054
44635,leucovorin,drug,0.999,20189054
44636,FOLFOX4,drug,0.5938,20189054
44637,oxaliplatin,drug,1.0,20189054
44638,leucovorin,drug,0.999,20189054
44639,5-fluorouracil,drug,0.9995,20189054
44640,vascular endothelial growth factor,gene,0.9976,20189054
44641,PTK787,drug,0.9985,20189054
44642,ZK 222584,drug,0.9946,20189054
44643,valatinib,drug,0.9995,20189054
44644,panitumumab,gene,0.8745,20189054
44645,CEA,gene,0.994,20189054
44646,panitumumab,gene,0.8457,20189054
44647,non,DNA,0.5503,20189054
44648,KRAS,gene,0.873,20189054
44649,diarrhoea,disease,0.9995,20189054
44650,folliculitis,disease,1.0,20189054
44651,acne-like rash,disease,1.0,20189054
44652,panitumumab,gene,0.8955,20189054
44653,metastatic colorectal cancer,disease,0.9834,20189054
44654,skin toxicities,disease,0.907,20189054
44655,anti-,gene,0.7144,20189053
44656,epidermal growth factor receptor monoclonal antibody,gene,0.9023,20189053
44657,metastatic colorectal cancer,disease,0.863,20189053
44658,irinotecan,drug,0.999,20189053
44659,capecitabine,drug,0.999,20189053
44660,oxaliplatin,drug,0.9995,20189053
44661,metastatic colorectal cancer,disease,1.0,20189053
44662,mCRC,disease,1.0,20189053
44663,anti-epidermal growth factor receptor,gene,0.986,20189053
44664,EGFR,gene,0.9956,20189053
44665,panitumumab,gene,0.5205,20189053
44666,cetuximab,gene,0.93,20189053
44667,EGFR,gene,0.9966,20189053
44668,mCRC,disease,0.995,20189053
44669,tumours,disease,0.9604,20189053
44670,KRAS,gene,0.9004,20189053
44671,Cetuximab,gene,0.9033,20189053
44672,mCRC,disease,0.974,20189053
44673,panitumumab,gene,0.9424,20189053
44674,cetuximab,gene,0.8003,20189053
44675,BSC,drug,0.73,20189053
44676,mCRC,disease,0.9927,20189053
44677,panitumumab,gene,0.9316,20189053
44678,tumours,disease,1.0,20189053
44679,wild-type KRAS,gene,0.9873,20189053
44680,anti-,gene,0.787,20189053
44681,EGFR mAb,gene,0.8022,20189053
44682,tumours,disease,0.4302,20189053
44683,wild-type KRAS,gene,0.642,20189053
44684,anti-EGFR mAb,gene,0.9565,20189053
44685,skin rash,disease,0.999,20189053
44686,BRAF,gene,0.5713,20189053
44687,PTEN,gene,0.995,20189053
44688,PI3K,gene,0.995,20189053
44689,colorectal cancer,disease,1.0,20200482
44690,solid tumors,disease,1.0,20200482
44691,cancers,disease,1.0,20200482
44692,solid tumors,disease,1.0,20200482
44693,hematological malignancies,disease,1.0,20200482
44694,metastatic colorectal cancer,disease,0.9995,20200482
44695,cetuximab,gene,0.9404,20200482
44696,panitumumab,gene,0.95,20200482
44697,bevacizumab,gene,0.794,20200482
44698,colorectal cancer,disease,1.0,20200482
44699,Colorectal Cancer,disease,0.971,20189976
44700,metastatic colorectal cancer,disease,1.0,20189976
44701,mCRC,disease,0.9995,20189976
44702,mCRC,disease,1.0,20189976
44703,mCRC,disease,1.0,20189976
44704,EQ-5D,DNA,0.532,20189976
44705,EGFR,gene,0.838,22993543
44706,cancer,disease,1.0,22993543
44707,blood,cell_type,0.4521,22993543
44708,anti-epidermal growth factor receptor,gene,0.9927,22993543
44709,EGFR,gene,0.9756,22993543
44710,cetuximab,gene,0.892,22993543
44711,panitumumab,gene,0.82,22993543
44712,cetuximab,gene,0.775,22993543
44713,panitumumab,gene,0.7974,22993543
44714,Cetuximab,gene,0.8706,22993543
44715,hypomagnesemia,disease,1.0,22993543
44716,panitumumab,gene,0.8145,22993543
44717,hypomagnesemia,disease,1.0,22993543
44718,magnesium,drug,0.9995,22993543
44719,anti-EGFR,gene,0.9136,22993543
44720,magnesium,drug,0.9995,22993543
44721,electrolyte depletion,disease,0.843,22993543
44722,magnesium,drug,1.0,22993543
44723,magnesium,drug,1.0,22993543
44724,magnesium,drug,1.0,22993543
44725,magnesium,drug,1.0,22993543
44726,albumin,gene,0.9507,22993543
44727,anti-EGFR,gene,0.758,22993543
44728,albumin,gene,0.9956,22993543
44729,acutely ill,disease,0.7285,22993543
44730,hypoalbuminemia,disease,1.0,22993543
44731,albumin,gene,0.726,22993543
44732,Cetuximab,gene,0.916,20180626
44733,rectal cancer,disease,1.0,20180626
44734,epidermal growth factor receptor,gene,0.999,20180626
44735,EGFR,gene,0.995,20180626
44736,cetuximab,gene,0.59,20180626
44737,head and neck cancer,disease,1.0,20180626
44738,colorectal cancer,disease,1.0,20180626
44739,cetuximab,gene,0.8706,20180626
44740,panitumumab,gene,0.778,20180626
44741,EGFR,gene,0.9893,20180626
44742,fluoropyrimidine,drug,0.9946,20180626
44743,rectal adenocarcinoma,disease,1.0,20180626
44744,cetuximab,gene,0.932,20180626
44745,rectal cancer,disease,1.0,20180626
44746,cetuximab,gene,0.7,20180626
44747,5-fluorouracil,drug,0.9985,20180626
44748,capecitabine,drug,0.998,20180626
44749,irinotecan,drug,0.999,20180626
44750,oxaliplatin,drug,0.9995,20180626
44751,panitumumab,gene,0.9272,20180626
44752,gefinitib,gene,0.694,20180626
44753,pCR,DNA,0.6104,20180626
44754,cetuximab,gene,0.9775,20180626
44755,gastrointestinal toxicity,disease,0.8413,20180626
44756,diarrhoea,disease,1.0,20180626
44757,EGFR,gene,0.987,20180626
44758,fluoropyrimidine,drug,0.9834,20180626
44759,adenocarcinoma,disease,0.9976,20180626
44760,5FU,drug,0.9985,20180626
44761,oxaliplatin,drug,0.9995,20180626
44762,Cetuximab,gene,0.835,20180626
44763,fluoropyrimidine,drug,0.9917,20180626
44764,Perifollicular,cell_type,0.472,20169314
44765,Perifollicular xanthomas,disease,1.0,20169314
44766,epidermal growth factor receptor,gene,0.997,20169314
44767,metastatic colorectal cancer,disease,1.0,20167564
44768,colorectal cancer,disease,1.0,20167564
44769,hepatic metastasis,disease,0.893,20167564
44770,hepatic lesions,disease,0.996,20167564
44771,colorectal cancer,disease,1.0,20167564
44772,hepatic lesions,disease,0.9995,20167564
44773,hepatic steatosis,disease,1.0,20167564
44774,steatosis,disease,1.0,20167564
44775,Steatohepatitis,disease,1.0,20167564
44776,irinotecan,drug,0.9985,20167564
44777,Sinusoidal obstruction syndrome,disease,1.0,20167564
44778,vascular hepatic lesion,disease,1.0,20167564
44779,oxaliplatin,drug,0.9995,20167564
44780,Bevacizumab,gene,0.89,20167564
44781,oxaliplatin,drug,0.9995,20167564
44782,vascular hepatic lesions,disease,0.9272,20167564
44783,bevacizumab,gene,0.7856,20167564
44784,anti-EGF-R antibody,gene,0.9644,20167564
44785,irinotecan,drug,0.994,20167564
44786,hepatic failure,disease,1.0,20167564
44787,oxaliplatine,drug,0.9995,20167564
44788,hepatic,disease,0.84,20167564
44789,colorectal cancer,disease,1.0,20167564
44790,panitumumab,gene,0.8135,20142600
44791,skin,disease,0.649,20142600
44792,metastatic colorectal cancer,disease,0.9995,20142600
44793,Panitumumab,gene,0.5117,20142600
44794,epidermal growth factor receptor,gene,0.996,20142600
44795,EGFR,gene,0.9873,20142600
44796,metastatic colorectal cancer,disease,1.0,20142600
44797,mCRC,disease,1.0,20142600
44798,Skin toxicities,disease,0.996,20142600
44799,EGFR,gene,0.987,20142600
44800,mCRC,disease,0.999,20142600
44801,EGFR,gene,0.9917,20142600
44802,PATIENTS,species,0.9536,20142600
44803,panitumumab,gene,0.815,20142600
44804,doxycycline,drug,0.9966,20142600
44805,pre,DNA,0.4807,20142600
44806,EGFR,gene,0.9946,20130423
44807,human epidermal growth factor receptor,gene,0.999,20130423
44808,ErbB,gene,0.995,20130423
44809,HER,gene,0.9956,20130423
44810,tumor,disease,1.0,20130423
44811,malignancies,disease,1.0,20130423
44812,cancer,disease,1.0,20130423
44813,ErbB,gene,0.9873,20130423
44814,cardiovascular and neurodegenerative diseases,disease,1.0,20130423
44815,ErbB,gene,0.9917,20130423
44816,tyrosine,drug,0.9688,20130423
44817,tyrosine kinase,gene,0.8594,20130423
44818,ErbB receptor family,gene,0.993,20130423
44819,EGFR,gene,0.997,20130423
44820,HER-2,gene,0.9946,20130423
44821,cancer,disease,0.9604,20130423
44822,anti-,gene,0.7896,20130423
44823,ErbB,gene,0.539,20130423
44824,cetuximab,gene,0.942,20130423
44825,panitumumab,gene,0.9424,20130423
44826,trastuzumab,gene,0.9805,20130423
44827,gefitinib,drug,0.999,20130423
44828,erlotinib,drug,0.9985,20130423
44829,lapatinib,drug,0.998,20130423
44830,advanced colorectal cancer,disease,1.0,20130423
44831,squamous cell carcinoma of the head and neck,disease,1.0,20130423
44832,advanced,disease,0.8364,20130423
44833,non-small-cell lung cancer,disease,0.9814,20130423
44834,pancreatic and breast cancer,disease,1.0,20130423
44835,EGFR,gene,0.991,20101558
44836,Epidermal growth factor receptor,gene,0.998,20101558
44837,EGFR,gene,0.9917,20101558
44838,cetuximab,gene,0.7197,20101558
44839,erlotinib,drug,0.993,20101558
44840,panitumumab,gene,0.6777,20101558
44841,gefitinib,drug,0.9897,20101558
44842,recurrent tumours,disease,1.0,20101558
44843,colorectal carcinoma,disease,1.0,20101558
44844,non-small cell lung cancer,disease,1.0,20101558
44845,NSCLC,disease,1.0,20101558
44846,squamous cell carcinoma of the head and neck,disease,1.0,20101558
44847,SCCHN,disease,1.0,20101558
44848,pancreatic cancer,disease,1.0,20101558
44849,EGFR,gene,0.989,20101558
44850,EGFR,gene,0.994,20101558
44851,acneiform rash,disease,1.0,20101558
44852,acne,disease,1.0,20101558
44853,rosacea,disease,1.0,20101558
44854,paronychia,disease,1.0,20101558
44855,EGFR,gene,0.993,20101558
44856,cetuximab,gene,0.9717,20101065
44857,panitumumab,gene,0.9434,20101065
44858,polyvinyl chloride,drug,0.9834,20101065
44859,cetuximab,gene,0.964,20101065
44860,panitumumab,gene,0.9297,20101065
44861,polyvinyl chloride,drug,0.996,20101065
44862,PVC,drug,0.999,20101065
44863,cetuximab,gene,0.901,20101065
44864,PVC,drug,0.9946,20101065
44865,panitumumab,gene,0.9263,20101065
44866,sodium chloride,drug,0.99,20101065
44867,PVC,drug,0.9707,20101065
44868,Cetuximab,gene,0.9473,20101065
44869,panitumumab,gene,0.905,20101065
44870,cetuximab,gene,0.968,20101065
44871,panitumumab,gene,0.958,20101065
44872,Cetuximab,gene,0.7603,20101065
44873,PVC,drug,0.648,20101065
44874,Panitumumab,gene,0.8853,20101065
44875,sodium chloride,drug,0.99,20101065
44876,cetuximab,gene,0.928,20100961
44877,panitumumab,gene,0.835,20100961
44878,colorectal cancer,disease,1.0,20100961
44879,cancer,disease,1.0,20100961
44880,colorectal tumors,disease,1.0,20100961
44881,epidermal growth factor receptor,gene,0.9985,20100961
44882,EGFR,gene,0.998,20100961
44883,cetuximab,gene,0.6416,20100961
44884,panitumumab,gene,0.8423,20100961
44885,metastatic colorectal cancer,disease,1.0,20100961
44886,mCRC,disease,0.99,20100961
44887,mCRCs,cell_line,0.778,20100961
44888,EGFR,gene,0.9893,20100961
44889,tumor,disease,0.6147,20100961
44890,cetuximab,gene,0.96,20100961
44891,panitumumab,gene,0.944,20100961
44892,mCRCs,disease,0.989,20100961
44893,EGFR,gene,0.9966,20100961
44894,KRAS,gene,0.689,20100961
44895,BRAF,gene,0.5195,20100961
44896,PIK3CA,gene,0.9956,20100961
44897,PTEN,gene,0.9927,20100961
44898,CRCs,disease,0.7715,20100961
44899,EGFR,gene,0.9453,20100961
44900,EGFR,gene,0.9956,20100961
44901,capecitabine,drug,0.999,20100686
44902,colorectal cancer,disease,1.0,20100686
44903,Fluoropyrimidines,drug,0.9985,20100686
44904,metastatic colorectal cancer,disease,1.0,20100686
44905,mCRC,disease,1.0,20100686
44906,irinotecan,drug,0.9995,20100686
44907,oxaliplatin,drug,0.9995,20100686
44908,bevacizumab,gene,0.868,20100686
44909,cetuximab,gene,0.917,20100686
44910,panitumumab,gene,0.937,20100686
44911,5-fluorouracil,drug,0.9995,20100686
44912,5-FU,drug,0.9995,20100686
44913,fluoropyrimidine,drug,0.998,20100686
44914,Capecitabine,drug,0.998,20100686
44915,fluoropyrimidine carbamate,drug,0.9995,20100686
44916,5-FU,drug,0.999,20100686
44917,tumor,disease,0.9995,20100686
44918,capecitabine,drug,0.999,20100686
44919,mCRC,disease,0.9043,20100686
44920,oxaliplatin,drug,0.9995,20100686
44921,capecitabine,drug,0.9985,20100686
44922,comorbid illnesses,disease,0.9766,20100686
44923,capecitabine,drug,0.998,20100686
44924,fluoropyrimidine,drug,0.9917,20100686
44925,mCRC,disease,0.9937,20100686
44926,KRAS,gene,0.8257,20100685
44927,colorectal cancer,disease,1.0,20100685
44928,KRAS,gene,0.801,20100685
44929,epidermal growth factor receptor,gene,0.9976,20100685
44930,EGFR,gene,0.997,20100685
44931,metastatic colorectal cancer,disease,0.9995,20100685
44932,wild-type KRAS,gene,0.669,20100685
44933,cetuximab,gene,0.6626,20100685
44934,panitumumab,gene,0.8545,20100685
44935,KRAS-mutant tumors,disease,0.762,20100685
44936,KRAS,gene,0.4937,20100685
44937,EGFR,gene,0.9717,20100685
44938,KRAS,DNA,0.8066,20100685
44939,KRAS mutation,gene,0.7793,20100685
44940,KRAS,gene,0.716,20100685
44941,tumor,disease,1.0,20100685
44942,anti-EGFR monoclonal antibody,gene,0.977,20100685
44943,anti-,gene,0.501,20100685
44944,EGFR,gene,0.64,20100685
44945,paraffin,drug,0.8423,20100685
44946,KRAS,gene,0.866,20100685
44947,Colorectal Cancer,disease,0.9014,20100683
44948,Colorectal Tumour,disease,0.98,20100683
44949,metastatic colorectal cancer,disease,1.0,20100683
44950,mCRC,disease,1.0,20100683
44951,bevacizumab,gene,0.683,20100683
44952,cetuximab,gene,0.908,20100683
44953,panitumumab,gene,0.894,20100683
44954,mCRC,disease,0.9766,20100683
44955,bevacizumab,gene,0.8193,20100683
44956,epidermal growth factor receptor,gene,0.9976,20100683
44957,cetuximab,gene,0.8125,20100683
44958,panitumumab,gene,0.913,20100683
44959,mCRC,disease,0.981,20100683
44960,mCRC,disease,0.8384,20100683
44961,mCRC,disease,0.9946,20100683
44962,EGFR,gene,0.9307,20088793
44963,colorectal cancer,disease,1.0,20088793
44964,colorectal cancer,disease,1.0,20088793
44965,CRC,disease,1.0,20088793
44966,epidermal,cell_type,0.463,20088793
44967,EGFR,gene,0.995,20088793
44968,vascular endothelial growth factor,gene,0.9966,20088793
44969,VEGF,gene,0.9917,20088793
44970,metastatic CRC,disease,1.0,20088793
44971,mCRC,disease,1.0,20088793
44972,cancer,disease,0.9995,20088793
44973,CRC,disease,0.9995,20088793
44974,RAS,gene,0.9937,20088793
44975,RAF,gene,0.9976,20088793
44976,MAPK,gene,0.9897,20088793
44977,KRAS and BRAF genes,DNA,0.8926,20088793
44978,KRAS,gene,0.9595,20088793
44979,BRAF genes,gene,0.98,20088793
44980,anti-EGFR,gene,0.7734,20088793
44981,EGFR,gene,0.9956,20088793
44982,PI3K,gene,0.9976,20088793
44983,PTEN,gene,0.9956,20088793
44984,Akt,gene,0.994,20088793
44985,JAK,gene,0.9844,20088793
44986,STAT,gene,0.9844,20088793
44987,EGFR,gene,0.989,20088793
44988,mAb Panitumumab,gene,0.59,20088793
44989,Cetuximab,gene,0.8403,20088793
44990,mCRC,disease,0.9854,20088793
44991,codon 12 and 13,DNA,0.763,20088793
44992,KRAS gene,gene,0.888,20088793
44993,KRAS,DNA,0.8433,20088793
44994,KRAS mutations,gene,0.869,20088793
44995,CRC,disease,0.9985,20088793
44996,EGFR,gene,0.8774,20088793
44997,EGFR,gene,0.9956,20088793
44998,KRAS,gene,0.7734,20088793
44999,gastrointestinal cancers,disease,1.0,20084161
45000,gastrointestinal cancers,disease,1.0,20084161
45001,cancer,disease,0.9995,20084161
45002,comorbidities,disease,0.774,20084161
45003,impaired liver and renal function,disease,0.9976,20084161
45004,tumor,disease,1.0,20084161
45005,digestive system tumors,disease,1.0,20084161
45006,5-fluorouracil,drug,0.9995,20084161
45007,oxaliplatin,drug,1.0,20084161
45008,cisplatin,drug,1.0,20084161
45009,irinotecan,drug,0.9995,20084161
45010,gemcitabine,drug,0.9995,20084161
45011,bevacizumab,gene,0.665,20084161
45012,cetuximab,gene,0.8657,20084161
45013,panitumumab,gene,0.8145,20084161
45014,erlotinib,drug,0.993,20084161
45015,UDP,drug,0.518,20084161
45016,UDP-glucuronosyltransferase 1A1,gene,0.893,20084161
45017,irinotecan,drug,0.997,20084161
45018,tumors,disease,1.0,20084161
45019,KRAS,DNA,0.809,20071308
45020,KRAS mutation,gene,0.919,20071308
45021,colorectal cancer,disease,1.0,20071308
45022,KRAS,gene,0.8574,20071308
45023,anti-EGFR monoclonal antibodies,gene,0.873,20071308
45024,advanced and/or metastatic colorectal cancer,disease,0.9966,20071308
45025,KRAS,DNA,0.811,20071308
45026,KRAS mutations,gene,0.9634,20071308
45027,KRAS,gene,0.9023,20071308
45028,colorectal cancer,disease,1.0,20067946
45029,metastatic colorectal cancer,disease,1.0,20067946
45030,mCRC,disease,1.0,20067946
45031,vascular endothelial,DNA,0.5337,20067946
45032,vascular endothelial growth factor ligand,gene,0.996,20067946
45033,bevacizumab,gene,0.809,20067946
45034,Cetuximab,gene,0.5815,20067946
45035,epidermal growth factor receptor,gene,0.9956,20067946
45036,EGFR,gene,0.9897,20067946
45037,irinotecan,drug,0.999,20067946
45038,irinotecan,drug,0.9995,20067946
45039,oxaliplatin,drug,0.9995,20067946
45040,Panitumumab,gene,0.669,20067946
45041,EGFR mAb,gene,0.85,20067946
45042,mCRC,disease,0.9526,20067946
45043,EGFR,gene,0.991,20067946
45044,wild,cell_line,0.5684,20067946
45045,wild-type K-RAS tumors,disease,0.95,20067946
45046,wild-type K-RAS,gene,0.849,20067946
45047,B-RAF,DNA,0.76,20067946
45048,B-RAF mutation,gene,0.955,20067946
45049,EGFR,gene,0.6445,20067946
45050,EGFR,gene,0.918,20067946
45051,colon cancer,disease,0.995,20067946
45052,molecular,DNA,0.4807,20067946
45053,mCRC,disease,0.946,20067946
45054,HER family,gene,0.967,20064507
45055,epidermal growth factor,gene,0.997,20064507
45056,EGF,gene,0.874,20064507
45057,receptor tyrosine kinases,gene,0.9917,20064507
45058,tyrosine,drug,0.571,20064507
45059,EGFR,gene,0.9966,20064507
45060,HER1,gene,0.998,20064507
45061,ErbB1,gene,0.997,20064507
45062,HER2,gene,0.996,20064507
45063,neu,gene,0.997,20064507
45064,ErbB2,gene,0.998,20064507
45065,HER3,gene,0.996,20064507
45066,ErbB3,gene,0.997,20064507
45067,HER4,gene,0.536,20064507
45068,ErbB4,gene,0.995,20064507
45069,EGFR,gene,0.9946,20064507
45070,HER2,gene,0.991,20064507
45071,epithelial cancers,disease,1.0,20064507
45072,head and neck squamous cell carcinoma,disease,1.0,20064507
45073,HNSCC,disease,1.0,20064507
45074,non-small cell lung cancer,disease,1.0,20064507
45075,NSCLC,disease,1.0,20064507
45076,colorectal cancer,disease,1.0,20064507
45077,CRC,disease,1.0,20064507
45078,breast cancer,disease,1.0,20064507
45079,EGFR,gene,0.995,20064507
45080,HER2,gene,0.991,20064507
45081,cetuximab,gene,0.6807,20064507
45082,panitumumab,gene,0.7734,20064507
45083,trastuzumab,gene,0.82,20064507
45084,tyrosine,drug,0.987,20064507
45085,tyrosine kinase domains,gene,0.9907,20064507
45086,erlotinib,drug,0.9985,20064507
45087,gefitinib,drug,0.998,20064507
45088,lapatinib,drug,0.998,20064507
45089,tyrosine,drug,0.923,20064507
45090,tyrosine kinase,gene,0.9893,20064507
45091,EGFR,gene,0.9946,20064507
45092,HER2,gene,0.985,20064507
45093,HER family,gene,0.689,20064507
45094,EGFR,gene,0.9976,20049837
45095,KRAS,gene,0.7734,20049837
45096,anti-,gene,0.8384,20049837
45097,EGFR antibodies,gene,0.788,20049837
45098,colorectal cancer,disease,1.0,20049837
45099,KRAS,DNA,0.7246,20049837
45100,KRAS mutations,gene,0.803,20049837
45101,anti-,gene,0.8877,20049837
45102,epidermal growth factor receptor,gene,0.896,20049837
45103,EGFR,gene,0.909,20049837
45104,advanced colorectal cancer,disease,1.0,20049837
45105,CRC,disease,1.0,20049837
45106,wild-type (WT) KRAS,gene,0.7534,20049837
45107,EGFR,gene,0.9956,20049837
45108,advanced CRC,disease,1.0,20049837
45109,cetuximab,gene,0.8447,20049837
45110,panitumumab,gene,0.8374,20049837
45111,KRAS,gene,0.838,20049837
45112,EGFR,gene,0.992,20049837
45113,RAS,gene,0.9893,20049837
45114,MAPK,gene,0.987,20049837
45115,PI3K,gene,0.987,20049837
45116,AKT,gene,0.995,20049837
45117,pERK1/2,gene,0.9883,20049837
45118,pMEK1,gene,0.989,20049837
45119,pAKT,gene,0.988,20049837
45120,pP70S6K,gene,0.988,20049837
45121,pGSK3beta,gene,0.963,20049837
45122,Plex,DNA,0.536,20049837
45123,KRAS mutated tumors,disease,0.9766,20049837
45124,KRAS,gene,0.523,20049837
45125,WT tumors,disease,0.573,20049837
45126,pP70S6K,gene,0.9917,20049837
45127,pMEK1,gene,0.996,20049837
45128,pP70S6K,gene,0.985,20049837
45129,pP70S6K,gene,0.995,20049837
45130,pMEK1,gene,0.9976,20049837
45131,pP70S6K,gene,0.987,20049837
45132,KRAS,gene,0.8047,20049837
45133,pP70S6K,gene,0.996,20049837
45134,WT KRAS,gene,0.526,20049837
45135,pP70S6K,gene,0.9937,20049837
45136,EGFR,gene,0.9966,20049837
45137,KRAS,gene,0.815,20049837
45138,panitumumab,gene,0.767,20044619
45139,colon cancer,disease,1.0,20044619
45140,Panitumumab,gene,0.6963,20044619
45141,epidermal growth factor receptor,gene,0.997,20044619
45142,EGFR,gene,0.985,20044619
45143,EGFR,gene,0.9976,20044619
45144,metastatic colorectal carcinoma,disease,1.0,20044619
45145,mCRC,disease,1.0,20044619
45146,panitumumab,gene,0.6606,20044619
45147,wild-type KRAS,DNA,0.6836,20044619
45148,wild,gene,0.8003,20044619
45149,panitumumab,gene,0.7876,20044619
45150,colon cancer cells,cell_line,0.6562,20044619
45151,colon cancer,disease,1.0,20044619
45152,panitumumab,gene,0.807,20044619
45153,cell lines,cell_line,0.9214,20044619
45154,Caco-2,cell_line,0.8623,20044619
45155,DLD-1,cell_line,0.8643,20044619
45156,HT,cell_line,0.8857,20044619
45157,-29,cell_line,0.721,20044619
45158,EGFR,gene,0.987,20044619
45159,HER-2,gene,0.988,20044619
45160,methyl tetrazolium,drug,0.986,20044619
45161,MTT,drug,1.0,20044619
45162,propidium iodide,drug,0.9985,20044619
45163,propidium iodide,drug,0.9995,20044619
45164,glutathione,drug,0.998,20044619
45165,GSH,drug,0.999,20044619
45166,KRAS sequence,gene,0.8926,20044619
45167,Panitumumab,gene,0.8687,20044619
45168,DLD-1 cells,cell_line,0.607,20044619
45169,mutated KRAS,gene,0.72,20044619
45170,cell line,cell_line,0.8877,20044619
45171,panitumumab,gene,0.8984,20044619
45172,DLD-1,cell_line,0.5083,20044619
45173,panitumumab,gene,0.5894,20044619
45174,beclin-1,gene,0.983,20044619
45175,GSH,drug,0.9307,20044619
45176,panitumumab,gene,0.9326,20044619
45177,Panitumumab,gene,0.5576,20044619
45178,colon cancer,disease,1.0,20044619
45179,KRAS,gene,0.835,20044619
45180,EGFR protein,gene,0.942,20044619
45181,EGFR,gene,0.9927,29783375
45182,tumor,disease,1.0,29783375
45183,EGF receptor,gene,0.9976,29783375
45184,non-small-cell lung cancer,disease,1.0,29783375
45185,colorectal cancer,disease,1.0,29783375
45186,EGF receptor,gene,0.9937,20034874
45187,EGFR receptor,gene,0.975,20034874
45188,solid tumors,disease,1.0,20034874
45189,EGF receptor,gene,0.996,20034874
45190,KRAS,gene,0.8066,20034870
45191,colorectal cancer,disease,1.0,20034870
45192,EGF receptor,gene,0.9985,20034870
45193,KRAS,gene,0.5093,20034870
45194,cetuximab,gene,0.9165,20034870
45195,panitumumab,gene,0.7676,20034870
45196,KRAS wild,cell_line,0.5864,20034870
45197,KRAS wild-type tumours,disease,0.993,20034870
45198,KRAS,gene,0.4595,20034870
45199,KRAS,gene,0.7554,20034870
45200,EGFR,gene,0.9854,20034870
45201,KRAS mutations,gene,0.692,20034870
45202,tumour,disease,1.0,20034870
45203,KRAS,gene,0.8696,20034870
45204,cell line DNAs,DNA,0.888,20034870
45205,DNAs,DNA,0.575,20034870
45206,paraffin,cell_type,0.492,20034870
45207,KRAS,gene,0.8823,20034870
45208,KRAS,gene,0.791,20034870
45209,solid tumour,disease,1.0,20034870
45210,tumour,disease,1.0,20034870
45211,KRAS,gene,0.867,20034869
45212,colorectal cancer,disease,1.0,20034869
45213,Colorectal cancer,disease,1.0,20034869
45214,cancer,disease,1.0,20034869
45215,metastatic colorectal cancers,disease,0.9097,20034869
45216,oxaliplatin,drug,0.9995,20034869
45217,irinotecan,drug,0.9985,20034869
45218,5-fluorouracil,drug,0.9995,20034869
45219,capecitabine,drug,0.999,20034869
45220,UFT,drug,0.9976,20034869
45221,metastatic colorectal cancer,disease,0.9937,20034869
45222,bevacizumab,gene,0.579,20034869
45223,vascular endothelial growth factor,gene,0.9985,20034869
45224,VEGF,gene,0.5234,20034869
45225,epidermal growth factor receptor,gene,0.998,20034869
45226,EGFR,gene,0.9805,20034869
45227,cetuximab,gene,0.9014,20034869
45228,panitumumab,gene,0.8433,20034869
45229,KRAS,gene,0.8813,20034869
45230,colorectal cancer,disease,1.0,20034869
45231,anti-,gene,0.877,20034868
45232,EGFR antibodies,gene,0.8013,20034868
45233,cetuximab,gene,0.793,20034868
45234,panitumumab,gene,0.765,20034868
45235,metastatic colorectal cancer,disease,0.9995,20034868
45236,KRAS,gene,0.633,20034868
45237,Cetuximab,gene,0.603,20034868
45238,panitumumab,gene,0.646,20034868
45239,anti-EGF receptor antibodies,gene,0.9507,20034868
45240,colorectal cancer,disease,1.0,20034868
45241,5-fluorouracil,drug,0.9995,20034868
45242,folinic acid,drug,0.9995,20034868
45243,oxaliplatin,drug,0.9995,20034868
45244,Folfox,drug,0.9883,20034868
45245,irinot,drug,0.506,20034868
45246,Cetuximab,gene,0.959,20034868
45247,irinot,drug,0.812,20034868
45248,cetuximab,gene,0.9766,20034868
45249,irinot,drug,0.799,20034868
45250,cetuximab,gene,0.9277,20034868
45251,KRAS,gene,0.8267,20034868
45252,EGFR antibodies,gene,0.8853,20034868
45253,KRAS,gene,0.798,20034868
45254,cetuximab,gene,0.9365,20034868
45255,KRAS,gene,0.638,20034868
45256,metastatic colorectal cancer,disease,0.9995,20034868
45257,panitumumab,gene,0.787,20034868
45258,KRAS,gene,0.8066,20034866
45259,colorectal cancer,disease,1.0,20034866
45260,KRAS,gene,0.7236,20034866
45261,metastatic colorectal,disease,0.9995,20034866
45262,anti-,gene,0.8115,20034866
45263,EGFR,gene,0.5874,20034866
45264,epidermal growth factor receptor,gene,0.993,20034866
45265,panitumumab,gene,0.9683,20034866
45266,KRAS,DNA,0.788,20034866
45267,KRAS mutations,gene,0.8433,20034866
45268,KRAS,gene,0.8677,20034866
45269,tumor,disease,1.0,20034866
45270,KRAS mutations,gene,0.6606,20034866
45271,KRAS,gene,0.887,20034866
45272,KRAS,DNA,0.7925,20032635
45273,KRAS mutation,gene,0.816,20032635
45274,cancers,disease,1.0,20032635
45275,antiepidermal growth factor receptor,gene,0.9634,20032635
45276,EGFR,gene,0.996,20032635
45277,metastatic colorectal cancer,disease,1.0,20032635
45278,mCRC,disease,1.0,20032635
45279,wild,cell_line,0.606,20032635
45280,wild-type KRAS,gene,0.841,20032635
45281,anti-EGFR monoclonal antibodies panitumumab,gene,0.718,20032635
45282,cetuximab,gene,0.576,20032635
45283,mCRC,disease,0.9937,20032635
45284,KRAS codons 12 or 13,DNA,0.835,20032635
45285,KRAS codons,gene,0.847,20032635
45286,panitumumab,gene,0.8267,20032635
45287,mCRC,disease,0.9863,20032635
45288,wild,DNA,0.556,20032635
45289,wild-type KRAS,gene,0.9106,20032635
45290,KRAS,gene,0.854,20032635
45291,mCRC,disease,0.991,20032635
45292,KRAS,gene,0.832,20032635
45293,Pathologists,cell_type,0.4797,20032635
45294,tumor,disease,0.4783,20032635
45295,KRAS,gene,0.8,20032635
45296,KRAS,gene,0.845,20032635
45297,KRAS,gene,0.8755,20032635
45298,motesanib,drug,0.9985,20028752
45299,carboplatin,drug,1.0,20028752
45300,paclitaxel,drug,0.9995,20028752
45301,panitumumab,gene,0.8003,20028752
45302,advanced non-small cell,disease,0.992,20028752
45303,lung cancer,disease,1.0,20028752
45304,Motesanib,drug,0.9985,20028752
45305,"vascular endothelial growth factor receptor 1, 2, and 3",gene,0.9976,20028752
45306,platelet-derived growth factor receptor,gene,0.9985,20028752
45307,Kit,gene,0.99,20028752
45308,motesanib,drug,0.9985,20028752
45309,carboplatin,drug,0.9995,20028752
45310,paclitaxel,drug,0.9995,20028752
45311,anti-epidermal growth factor receptor monoclonal antibody panitumumab,gene,0.8916,20028752
45312,advanced non-small cell lung cancer,disease,0.999,20028752
45313,NSCLC,disease,1.0,20028752
45314,NSCLC,disease,0.9976,20028752
45315,motesanib,drug,0.9985,20028752
45316,carboplatin,drug,0.9995,20028752
45317,paclitaxel,drug,0.9985,20028752
45318,panitumumab,gene,0.871,20028752
45319,carboplatin,drug,0.9995,20028752
45320,paclitaxel,drug,0.999,20028752
45321,panitumumab,gene,0.7305,20028752
45322,motesanib,drug,0.9976,20028752
45323,pulmonary embolism,disease,1.0,20028752
45324,deep vein thrombosis,disease,1.0,20028752
45325,MTD,DNA,0.5005,20028752
45326,motesanib,drug,0.999,20028752
45327,fatigue,disease,0.9995,20028752
45328,diarrhea,disease,1.0,20028752
45329,hypertension,disease,1.0,20028752
45330,anorexia,disease,1.0,20028752
45331,nausea,disease,0.9966,20028752
45332,cholecystitis,disease,1.0,20028752
45333,motesanib,drug,0.9985,20028752
45334,carboplatin,drug,1.0,20028752
45335,paclitaxel,drug,0.9995,20028752
45336,paclitaxel,drug,0.9966,20028752
45337,motesanib,drug,0.9956,20028752
45338,carboplatin,drug,0.9995,20028752
45339,paclitaxel,drug,0.9995,20028752
45340,panitumumab,gene,0.8936,20028752
45341,motesanib,drug,0.9985,20028752
45342,NSCLC,disease,0.9995,20028752
45343,Vascular Endothelial Growth Factor,gene,0.9976,20016807
45344,Epidermal Growth Factor Receptor,gene,0.9976,20016807
45345,Metastatic Colorectal Cancer,disease,1.0,20016807
45346,metastatic colorectal cancer,disease,0.9995,20016807
45347,mCRC,disease,1.0,20016807
45348,anti-epidermal growth factor receptor,gene,0.925,20016807
45349,EGFR,gene,0.9478,20016807
45350,panitumumab,gene,0.497,20016807
45351,cetuximab,gene,0.809,20016807
45352,anti-,gene,0.881,20016807
45353,vascular endothelial growth factor,gene,0.9,20016807
45354,VEGF,gene,0.909,20016807
45355,mCRC,disease,0.6963,20016807
45356,bevacizumab,gene,0.8877,20016807
45357,panitumumab,gene,0.936,20016807
45358,cetuximab,gene,0.8335,20016807
45359,mCRC,disease,0.956,20016807
45360,cetuximab,gene,0.957,20016807
45361,bevacizumab,gene,0.9023,20016807
45362,mCRC,disease,0.89,20016807
45363,mCRC,disease,0.708,20016807
45364,Panitumumab,gene,0.7275,20016807
45365,Colorectal Cancer,disease,0.8564,20016807
45366,oxaliplatin,drug,0.9995,20016807
45367,irinotecan,drug,0.9976,20016807
45368,bevacizumab,gene,0.759,20016807
45369,panitumumab,gene,0.911,20016807
45370,capecitabine,drug,0.9995,20016807
45371,oxaliplatin,drug,0.9995,20016807
45372,bevacizumab,gene,0.6934,20016807
45373,cetuximab,gene,0.775,20016807
45374,bevacizumab,gene,0.7876,20016807
45375,EGFR-specific antibody,gene,0.758,20016807
45376,mCRC,disease,0.8965,20016807
45377,mCRC,disease,0.973,20016807
45378,colorectal cancer,disease,1.0,20010514
45379,colorectal cancer,disease,1.0,20010514
45380,colorectal cancer,disease,1.0,20010514
45381,tyrosine,drug,0.9854,20010514
45382,tyrosine kinase,gene,0.9966,20010514
45383,bevacizumab,gene,0.8745,20010514
45384,EGFR,gene,0.9927,20010514
45385,cetuximab,gene,0.8364,20010514
45386,panitumumab,gene,0.788,20010514
45387,colorectal cancer,disease,1.0,20010514
45388,bevacizumab,gene,0.8184,20010514
45389,EGFR,gene,0.991,20010514
45390,tumor,disease,1.0,20010514
45391,Epidermal Growth Factor Receptor Monoclonal Antibodies,gene,0.9746,20008849
45392,Metastatic Colorectal Cancer,disease,1.0,20008849
45393,cancers,disease,1.0,20008849
45394,breast cancer,disease,1.0,20008849
45395,hematologic malignancies,disease,1.0,20008849
45396,colorectal cancer,disease,1.0,20008849
45397,CRC,disease,1.0,20008849
45398,cancers,disease,1.0,20008849
45399,metastatic CRC,disease,0.9946,20008849
45400,epidermal growth factor receptor,gene,0.9985,20008849
45401,EGFR,gene,0.99,20008849
45402,cetuximab,gene,0.844,20008849
45403,panitumumab,gene,0.9067,20008849
45404,KRAS,gene,0.8228,20008849
45405,EGFR,gene,0.995,20008849
45406,EGFR antibodies,gene,0.973,20008849
45407,tumors,disease,1.0,20008849
45408,EGFR antibodies,gene,0.9326,20008849
45409,CRC,disease,0.999,20008849
45410,KRAS,gene,0.825,20008849
45411,EGFR,gene,0.9946,20008849
45412,EGFR,gene,0.994,20008849
45413,EGFR,gene,0.983,20008849
45414,CRC,disease,0.998,20008849
45415,colorectal cancer,disease,1.0,19957085
45416,colorectal cancer,disease,1.0,19957085
45417,colorectal carcinomas,disease,1.0,19957085
45418,KRAS,DNA,0.8076,19957085
45419,KRAS mutation,gene,0.95,19957085
45420,EGFR,gene,0.995,19957085
45421,mismatch-repair deficiency,disease,1.0,19957085
45422,5-FU,drug,0.9985,19957085
45423,Colorectal carcinomas,disease,1.0,19957085
45424,medullary carcinoma,disease,1.0,19957085
45425,carcinomas,disease,1.0,19957085
45426,epidermal growth factor receptor antibodies,gene,0.9756,19954416
45427,metastatic colorectal cancer,disease,0.984,19954416
45428,epidermal growth factor receptor,gene,0.9985,19954416
45429,EGFR,gene,0.991,19954416
45430,EGFR,gene,0.994,19954416
45431,tyrosine,drug,0.956,19954416
45432,colorectal cancer,disease,1.0,19954416
45433,colorectal cancer,disease,1.0,19954416
45434,EGFR,gene,0.8643,19954416
45435,cetuximab,gene,0.5967,19954416
45436,panitumumab,gene,0.8027,19954416
45437,skin rash,disease,0.998,19954416
45438,EGFR,gene,0.9883,19954416
45439,KRAS,gene,0.762,19954416
45440,anti-EGFR monoclonal antibodies,gene,0.9873,19954416
45441,colorectal malignant disease,disease,1.0,19954416
45442,EGFR,gene,0.9585,19954416
45443,metastatic colorectal cancer,disease,0.9985,19954416
45444,KRAS,gene,0.737,19954416
45445,PTEN,gene,0.9873,19954416
45446,germinal gene polymorphisms,DNA,0.772,19954416
45447,HLA-A*0201,gene,0.902,19952953
45448,epidermal growth factor receptor,gene,0.956,19952953
45449,head and neck cancer,disease,1.0,19952953
45450,epidermal growth factor receptor,gene,0.9985,19952953
45451,EGFR,gene,0.991,19952953
45452,colorectal and head and neck squamous cell carcinoma,disease,1.0,19952953
45453,SCCHN,disease,1.0,19952953
45454,cetuximab,gene,0.9365,19952953
45455,panitumumab,gene,0.927,19952953
45456,Fcgamma receptor genotypes,gene,0.968,19952953
45457,cetuximab-resistant tumor cells,cell_line,0.809,19952953
45458,cetuximab,gene,0.917,19952953
45459,-,cell_type,0.397,19952953
45460,tumor cells,cell_type,0.5327,19952953
45461,tumor,disease,0.992,19952953
45462,EGFR,gene,0.9927,19952953
45463,tumor,disease,0.859,19952953
45464,cytotoxic T lymphocyte,cell_type,0.813,19952953
45465,CTL,cell_type,0.474,19952953
45466,EGFR,gene,0.995,19952953
45467,EGFR,gene,0.997,19952953
45468,EGFR853-861,gene,0.544,19952953
45469,anchor,DNA,0.5063,19952953
45470,HLA-A*0201,gene,0.872,19952953
45471,-A*0201,DNA,0.542,19952953
45472,cross-reactive anti-wild-type EGFR853-861-specific CTL,cell_line,0.5913,19952953
45473,anti-wild-type EGFR853,gene,0.82,19952953
45474,HER2861,drug,0.625,19952953
45475,HER2861-869,gene,0.5117,19952953
45476,EGFR853,DNA,0.5854,19952953
45477,EGFR853-861,gene,0.877,19952953
45478,SCCHN cells,cell_line,0.6323,19952953
45479,SCCHN,disease,1.0,19952953
45480,tumor cells,cell_type,0.8174,19952953
45481,cetuximab,gene,0.9033,19952953
45482,EGFR,gene,0.9893,19952953
45483,EGFR853-861-specific CTLs,cell_line,0.8364,19952953
45484,EGFR853-,cell_type,0.4504,19952953
45485,EGFR853,gene,0.9927,19952953
45486,SCCHN,disease,1.0,19952953
45487,healthy control peripheral blood mononuclear cells,cell_type,0.741,19952953
45488,EGFR-encoded CTL epitope,gene,0.8306,19952953
45489,EGFR,gene,0.992,19952953
45490,cancer,disease,0.9995,19952953
45491,Human IgG2 antibodies,gene,0.7993,19949082
45492,epidermal growth factor receptor,gene,0.997,19949082
45493,IgG1,gene,0.9946,19949082
45494,myeloid lineage,cell_type,0.8184,19949082
45495,human IgG1,gene,0.974,19949082
45496,IgG2 Abs,gene,0.9873,19949082
45497,epidermal growth factor receptor,gene,0.999,19949082
45498,EGF-R,gene,0.949,19949082
45499,panitumumab,gene,0.6255,19949082
45500,human IgG2 Ab,gene,0.95,19949082
45501,EGF-R,gene,0.9966,19949082
45502,panitumumab,gene,0.646,19949082
45503,EGF-R Ab,gene,0.948,19949082
45504,human IgG1 isotype,gene,0.899,19949082
45505,panitumumab,gene,0.9194,19949082
45506,zalutumumab,gene,0.59,19949082
45507,myeloid effector cells,cell_type,0.866,19949082
45508,neutrophils,cell_type,0.733,19949082
45509,monocytes,cell_type,0.649,19949082
45510,NK cell,cell_line,0.8237,19949082
45511,IgG1 Ab,gene,0.9893,19949082
45512,Neutrophil,cell_type,0.7764,19949082
45513,tumor,disease,1.0,19949082
45514,myeloid growth factors,gene,0.985,19949082
45515,FcgammaRIIa,gene,0.988,19949082
45516,Panitumumab,gene,0.929,19949082
45517,FcgammaRIIa-,DNA,0.6934,19949082
45518,FcgammaRIIa-R131H,gene,0.854,19949082
45519,R131H polymorphism,DNA,0.4626,19949082
45520,R131H,mutation,,19949082
45521,neutrophils,cell_type,0.894,19949082
45522,FcgammaRIIa-131H,gene,0.9507,19949082
45523,neutrophil,cell_type,0.8867,19949082
45524,IgG1 Ab,gene,0.98,19949082
45525,zalutumumab,gene,0.4194,19949082
45526,effector cell,cell_type,0.564,19949082
45527,Zalutumumab,gene,0.552,19949082
45528,panitumumab,gene,0.8306,19949082
45529,EGF-R,gene,0.9985,19949082
45530,zalutumumab,gene,0.6904,19949082
45531,panitumumab,gene,0.8374,19949082
45532,tumor,disease,0.9995,19949082
45533,myeloid cell,cell_type,0.8003,19949082
45534,EGF-R,gene,0.9976,19949082
45535,metastatic colorectal cancer,disease,0.982,19942926
45536,VEGF,gene,0.994,19942926
45537,bevacizumab,gene,0.758,19942926
45538,EGFR,gene,0.9854,19942926
45539,cetuximab,gene,0.775,19942926
45540,panitumumab,gene,0.806,19942926
45541,metastatic colorectal cancer,disease,0.999,19942926
45542,anti-VEGF,gene,0.752,19942926
45543,EGFR,gene,0.764,19942926
45544,anti-EGFR antibody,gene,0.902,19942926
45545,bevacizumab,gene,0.747,19942926
45546,Colon cancer,disease,1.0,19942166
45547,GI disease,disease,0.9956,19942166
45548,Colorectal cancer,disease,1.0,19942166
45549,tumours,disease,1.0,19942166
45550,neoplasm,disease,1.0,19942166
45551,mismatch repair gene,gene,0.853,19942166
45552,colorectal cancer,disease,1.0,19942166
45553,colorectal adenomas,disease,1.0,19942166
45554,cancer,disease,1.0,19942166
45555,altered DNA,DNA,0.7485,19942166
45556,adenomas,disease,1.0,19942166
45557,cancer,disease,1.0,19942166
45558,colorectal cancer,disease,1.0,19942166
45559,metastatic colorectal cancer,disease,0.996,19942166
45560,5-fluorouracil,drug,0.9995,19942166
45561,5-fluorouracil,drug,0.9995,19942166
45562,capecitabine,drug,0.9985,19942166
45563,irinotecan,drug,0.995,19942166
45564,oxaliplatin,drug,0.9995,19942166
45565,anti-vascular endothelial growth factor Moab,gene,0.9775,19942166
45566,cetuximab,gene,0.7603,19942166
45567,panitumumab,gene,0.8867,19942166
45568,anti-epidermal growth factor,gene,0.9106,19942166
45569,oxaliplatin,drug,1.0,19942166
45570,5-fluorouracil,drug,0.999,19942166
45571,stage II and stage III colon cancer,disease,0.9736,19942166
45572,KRAS,gene,0.799,19936839
45573,colon cancer,disease,1.0,19936839
45574,EGFR,gene,0.993,19936839
45575,epidermal growth factor receptor,gene,0.9976,19936839
45576,EGFR,gene,0.981,19936839
45577,metastatic colorectal cancer,disease,0.995,19936839
45578,mCRC,disease,0.9985,19936839
45579,EGFR,gene,0.9946,19936839
45580,mCRC,disease,0.9497,19936839
45581,mouse,species,0.993,19936839
45582,cetuximab,gene,0.629,19936839
45583,KRAS oncogene,gene,0.9087,19936839
45584,mCRC,disease,0.99,19936839
45585,EGFR,gene,0.991,19936839
45586,EGFR,gene,0.9927,19936839
45587,tumors,disease,1.0,19936839
45588,wild-type KRAS gene,gene,0.918,19936839
45589,KRAS,gene,0.7773,19936839
45590,KRAS,gene,0.8145,19936839
45591,CRC,disease,0.997,19936839
45592,KRAS gene,gene,0.717,19936839
45593,KRAS,gene,0.8574,19936839
45594,EGFR-,gene,0.991,19936839
45595,EGFR-,gene,0.995,19936839
45596,EGFR-,gene,0.993,19936839
45597,mCRC,disease,0.9966,19936839
45598,KRAS,DNA,0.8335,19936839
45599,KRAS mutation,gene,0.938,19936839
45600,KRAS,gene,0.796,19934290
45601,stage III colon cancer,disease,0.872,19934290
45602,RAS,gene,0.998,19934290
45603,RAF,gene,0.998,19934290
45604,KRAS,gene,0.777,19934290
45605,metastatic colorectal cancer,disease,1.0,19934290
45606,anti-epidermal growth factor receptor,gene,0.8804,19934290
45607,EGFR,gene,0.9966,19934290
45608,cetuximab,gene,0.669,19934290
45609,panitumumab,gene,0.785,19934290
45610,KRAS,gene,0.833,19934290
45611,colon cancer,disease,1.0,19934290
45612,EGFR,gene,0.7397,19934290
45613,stage III colon cancer,disease,0.986,19934290
45614,5-fluorouracil,drug,0.999,19934290
45615,leucovorin,drug,0.999,19934290
45616,irinotecan,drug,0.995,19934290
45617,KRAS,DNA,0.755,19934290
45618,KRAS mutations,gene,0.873,19934290
45619,tumors,disease,1.0,19934290
45620,KRAS,DNA,0.8433,19934290
45621,KRAS mutation,gene,0.905,19934290
45622,tumor,disease,0.9897,19934290
45623,KRAS-wild-type tumors,disease,0.587,19934290
45624,KRAS,gene,0.506,19934290
45625,KRAS-,DNA,0.619,19934290
45626,KRAS,gene,0.997,19934290
45627,tumors,disease,0.793,19934290
45628,KRAS,gene,0.9746,19934290
45629,KRAS,gene,0.973,19934290
45630,KRAS,DNA,0.8247,19934290
45631,KRAS mutation,gene,0.9453,19934290
45632,KRAS,gene,0.8364,19934290
45633,stage III colon cancer,disease,0.9717,19934290
45634,KRAS,DNA,0.8296,19934290
45635,KRAS mutational,gene,0.9136,19934290
45636,Kras,DNA,0.7515,19923311
45637,Kras mutations,gene,0.772,19923311
45638,epidermal growth factor receptor,gene,0.997,19923311
45639,Kras,gene,0.6597,19923311
45640,cetuximab,gene,0.7344,19923311
45641,panitumumab,gene,0.683,19923311
45642,Epidermal growth factor receptor,gene,0.998,19923311
45643,EGFR,gene,0.995,19923311
45644,cetuximab,gene,0.844,19923311
45645,panitumumab,gene,0.7944,19923311
45646,metastatic colorectal cancer,disease,0.9995,19923311
45647,Cetuximab,gene,0.9478,19923311
45648,irinotecan,drug,0.9976,19923311
45649,panitumumab,gene,0.918,19923311
45650,EGFR,gene,0.9937,19923311
45651,Kras oncogene,gene,0.841,19923311
45652,RAS protein,gene,0.9897,19923311
45653,EGFR,gene,0.995,19923311
45654,EGFR,gene,0.9863,19923311
45655,Kras,gene,0.55,19923311
45656,metastatic colorectal cancers,disease,0.9995,19923311
45657,EGFR,gene,0.9893,19923311
45658,Kras,gene,0.7695,19923311
45659,metastatic colorectal cancer,disease,1.0,19923311
45660,EGFR,gene,0.9883,19923311
45661,Kras oncogene,gene,0.8975,19923311
45662,EGFR,gene,0.9805,19923311
45663,metastatic colorectal cancer,disease,0.999,19923311
45664,Kras,gene,0.788,19923311
45665,EGFR,gene,0.9927,19923311
45666,Kras,gene,0.9233,19923311
45667,Epidermal growth factor receptor,gene,0.998,19922468
45668,tumor,disease,1.0,19922468
45669,EGFR,gene,0.994,19922468
45670,epidermal growth factor receptor,gene,0.9985,19922468
45671,EGFR,gene,0.989,19922468
45672,EGFR,gene,0.9966,19922468
45673,cetuximab,gene,0.8916,19922468
45674,panitumumab,gene,0.8545,19922468
45675,EGFR,gene,0.996,19922468
45676,tyrosine,drug,0.946,19922468
45677,tyrosine kinase,gene,0.989,19922468
45678,gefitinib,drug,0.9976,19922468
45679,erlotinib,drug,0.9927,19922468
45680,intracellular,gene,0.7485,19922468
45681,tyrosine,drug,0.8315,19922468
45682,tyrosine kinase domain,gene,0.8833,19922468
45683,EGFR,gene,0.995,19922468
45684,EGFR,gene,0.9946,19922468
45685,EGFR,gene,0.9253,19922468
45686,cancer,disease,1.0,19919110
45687,radiolabeled probe,DNA,0.5757,19919110
45688,panitumumab,gene,0.916,19919110
45689,anti-HER1,gene,0.9897,19919110
45690,trastuzumab,gene,0.9463,19919110
45691,anti-HER2,gene,0.9595,19919110
45692,111In,drug,0.991,19919110
45693,HER1,gene,0.994,19919110
45694,HER2,gene,0.992,19919110
45695,tumor,disease,0.6973,19919110
45696,mice,species,0.9707,19919110
45697,ICG,drug,0.9956,19919110
45698,panitumumab,gene,0.986,19919110
45699,ICG,drug,0.8677,19919110
45700,trastuzumab,gene,0.984,19919110
45701,ICG,drug,0.924,19919110
45702,target cells,cell_type,0.82,19919110
45703,tumor,disease,0.9995,19919110
45704,EGFR,gene,0.973,19917537
45705,KRAS,gene,0.653,19917537
45706,metastatic colorectal cancer,disease,0.9995,19917537
45707,anti-EGFR monoclonal antibodies,gene,0.881,19917537
45708,cetuximab,gene,0.7583,19917537
45709,panitumumab,gene,0.882,19917537
45710,oxaliplatin,drug,0.9995,19917537
45711,CPT-11,drug,0.996,19917537
45712,cetuximab,gene,0.8477,19917537
45713,panitumumab,gene,0.7207,19917537
45714,KRAS wild-type (KRAS-wt) colorectal tumours,disease,0.9985,19917537
45715,KRAS,gene,0.9834,19917537
45716,KRAS,gene,0.7935,19917537
45717,KRAS-mutated tumours,disease,0.5264,19917537
45718,KRAS,gene,0.4534,19917537
45719,colorectal tumours,disease,1.0,19917537
45720,KRAS-wt tumours,disease,0.502,19917537
45721,KRAS,gene,0.9805,19917537
45722,EGFR,gene,0.9517,19917537
45723,EGFR,gene,0.943,19917537
45724,KRASwt,gene,0.6484,19917537
45725,colorectal tumours,disease,0.9995,19917537
45726,EGFR,gene,0.996,19917537
45727,EGFR,gene,0.993,19917537
45728,EGFR,gene,0.9937,19917537
45729,KRAS,gene,0.585,19917537
45730,B-,gene,0.8315,19917537
45731,RAF,gene,0.987,19917537
45732,PIK3CA,gene,0.9985,19917537
45733,PTEN,gene,0.997,19917537
45734,AKT,gene,0.996,19917537
45735,JAK,gene,0.995,19917537
45736,STAT,gene,0.9893,19917537
45737,EGFR,gene,0.9277,19917537
45738,tumour,disease,1.0,19917537
45739,EGFR,gene,0.9375,19917537
45740,epidermal growth factor receptor,gene,0.996,19906103
45741,metastatic colorectal cancer,disease,0.9995,19906103
45742,anti-epidermal growth factor receptor,gene,0.9736,19906103
45743,EGFR,gene,0.994,19906103
45744,metastatic colorectal cancer,disease,1.0,19906103
45745,mCRC,disease,1.0,19906103
45746,anti-EGFR monoclonal antibody,gene,0.8687,19906103
45747,anti-EGFR monoclonal,gene,0.832,19906103
45748,mCRC,disease,0.983,19906103
45749,anti-EGFR,gene,0.942,19906103
45750,diarrhea,disease,1.0,19906103
45751,skin toxicity,disease,0.993,19906103
45752,hypomagnesemia,disease,1.0,19906103
45753,EGFR,gene,0.988,19906103
45754,paclitaxel,drug,0.999,19892746
45755,panitumumab,gene,0.9106,19892746
45756,carboplatin,drug,0.9985,19892746
45757,Panitumumab,gene,0.9062,19892746
45758,squamous cell carcinoma of the head and neck,disease,1.0,19892746
45759,SCCHN,disease,1.0,19892746
45760,PATIENTS,species,0.974,19892746
45761,paclitaxel,drug,0.9995,19892746
45762,Taxol,drug,0.999,19892746
45763,panitumumab,gene,0.9253,19892746
45764,carboplatin,drug,0.9995,19892746
45765,SCCHN,disease,0.9097,19892746
45766,panitumumab,gene,0.9194,19892746
45767,carboplatin,drug,0.9995,19892746
45768,paclitaxel,drug,0.9937,19892746
45769,paclitaxel,drug,0.9653,19892746
45770,mucositis,disease,0.9995,19892746
45771,Oral pain,disease,0.999,19892746
45772,xerostomia,disease,1.0,19892746
45773,dysphagia,disease,1.0,19892746
45774,weight loss,disease,0.9995,19892746
45775,dermatitis,disease,1.0,19892746
45776,nausea,disease,1.0,19892746
45777,acneiform rash,disease,1.0,19892746
45778,Panitumumab,gene,0.69,19892746
45779,carboplatin,drug,0.999,19892746
45780,paclitaxel,drug,0.998,19892746
45781,SCCHN,disease,1.0,19892746
45782,SCCHN,disease,0.9995,19892746
45783,KRAS,gene,0.861,21789120
45784,epidermal growth factor receptor,gene,0.9976,21789120
45785,metastatic colorectal cancer,disease,1.0,21789120
45786,cetuximab,gene,0.5786,21789120
45787,panitumumab,gene,0.8804,21789120
45788,epidermal growth factor receptor,gene,0.997,21789120
45789,EGFR,gene,0.9946,21789120
45790,KRAS,gene,0.64,21789120
45791,metastatic colorectal cancer,disease,0.9062,21789120
45792,mCRC,disease,0.997,21789120
45793,tumors,disease,0.457,21789120
45794,KRAS,gene,0.8335,21789120
45795,v-Ki-,gene,0.993,21789120
45796,ras2,DNA,0.7876,21789120
45797,ras2 Kirsten rat sarcoma viral oncogene homolog),gene,0.946,21789120
45798,Kirsten rat sarcoma viral oncogene homolog),DNA,0.7363,21789120
45799,EGFR,gene,0.9927,21789120
45800,KRAS,gene,0.821,21789120
45801,KRAS,gene,0.98,21789120
45802,EGFR,gene,0.9927,21789120
45803,anti-EGFRs,gene,0.943,21789120
45804,colorectal cancer,disease,1.0,21789120
45805,EGFR,gene,0.991,21789120
45806,Cetuximab,gene,0.8994,19875336
45807,panitumumab,gene,0.9204,19875336
45808,Panitumumab,gene,0.7886,19843050
45809,Epidermal growth factor receptor,gene,0.997,19826350
45810,cancer,disease,1.0,19826350
45811,epidermal growth factor receptor,gene,0.999,19826350
45812,EGFR,gene,0.9966,19826350
45813,epithelial cancers,disease,1.0,19826350
45814,EGFR,gene,0.995,19826350
45815,non-small-cell lung cancer,disease,1.0,19826350
45816,gefitinib,drug,0.999,19826350
45817,erlotinib,drug,0.998,19826350
45818,metastatic colorectal cancer,disease,1.0,19826350
45819,cetuximab,gene,0.79,19826350
45820,panitumumab,gene,0.8193,19826350
45821,head and neck,disease,0.996,19826350
45822,cetuximab,gene,0.771,19826350
45823,pancreatic cancer,disease,1.0,19826350
45824,erlotinib,drug,0.9985,19826350
45825,breast (lapatinib) cancer,disease,0.968,19826350
45826,lapatinib,drug,0.993,19826350
45827,EGFR mutation,gene,0.8516,19826350
45828,KRAS,DNA,0.8364,19826350
45829,KRAS mutations,gene,0.8267,19826350
45830,non-small-cell lung cancer,disease,1.0,19826350
45831,colon cancer,disease,1.0,19826350
45832,anti-EGFR monoclonal antibodies cetuximab,gene,0.9062,19826350
45833,panitumumab,gene,0.8125,19826350
45834,EGFR tyrosine kinase,gene,0.9307,19826350
45835,tyrosine,drug,0.81,19826350
45836,gefitinib,drug,0.993,19826350
45837,erlotinib,drug,0.9893,19826350
45838,EGFR,gene,0.9927,19826350
45839,EGFR,gene,0.9805,19826350
45840,EGFR,gene,0.9917,19826350
45841,EGFR,gene,0.9917,19826350
45842,cancer,disease,1.0,19826350
45843,EGFR,gene,0.993,19826350
45844,metastatic,disease,0.813,19821033
45845,colorectal cancer,disease,0.891,19821033
45846,Metastatic colorectal cancer,disease,0.999,19821033
45847,CRC,disease,1.0,19821033
45848,cancer,disease,1.0,19821033
45849,CRC,disease,0.9976,19821033
45850,metastatic CRC,disease,0.9116,19821033
45851,myelosuppression,disease,1.0,19821033
45852,EGFR,gene,0.9946,19806185
45853,colorectal cancer,disease,1.0,19806185
45854,KRAS,DNA,0.7656,19806185
45855,KRAS mutations,gene,0.8145,19806185
45856,metastatic colorectal cancers,disease,0.9995,19806185
45857,mCRC,disease,1.0,19806185
45858,EGFR,gene,0.989,19806185
45859,cetuximab,gene,0.7305,19806185
45860,panitumumab,gene,0.7183,19806185
45861,wild,cell_line,0.7236,19806185
45862,wild-type KRAS,gene,0.688,19806185
45863,EGFR,gene,0.996,19806185
45864,BRAF,gene,0.99,19806185
45865,PIK3CA,gene,0.9976,19806185
45866,PTEN,gene,0.995,19806185
45867,KRAS,gene,0.707,19806185
45868,BRAF,gene,0.579,19806185
45869,PIK3CA,DNA,0.4517,19806185
45870,PIK3CA mutations,gene,0.754,19806185
45871,PTEN,gene,0.989,19806185
45872,mCRC,disease,0.999,19806185
45873,cetuximab,gene,0.7983,19806185
45874,panitumumab,gene,0.7485,19806185
45875,KRAS,gene,0.808,19806185
45876,BRAF,gene,0.777,19806185
45877,PIK3CA,gene,0.6553,19806185
45878,PTEN,gene,0.9956,19806185
45879,tumors,disease,1.0,19806185
45880,cetuximab,gene,0.851,19806185
45881,panitumumab,gene,0.847,19806185
45882,mCRC,disease,1.0,19806185
45883,tumors,disease,1.0,19806185
45884,tumors,disease,0.4182,19806185
45885,PTEN,gene,0.987,19806185
45886,KRAS,gene,0.79,19806185
45887,BRAF,gene,0.8057,19806185
45888,PIK3CA,gene,0.6753,19806185
45889,mCRC,disease,0.996,19806185
45890,EGFR,gene,0.9287,19806185
45891,CRCs,disease,0.637,19806185
45892,KRAS,gene,0.829,19806185
45893,BRAF,gene,0.8257,19806185
45894,PTEN,gene,0.5527,19806185
45895,PIK3CA,gene,0.6816,19806185
45896,EGFR,gene,0.9966,19806185
45897,mCRC,disease,0.997,19806185
45898,cetuximab,gene,0.8555,19806185
45899,panitumumab,gene,0.857,19806185
45900,colonic cancer,disease,0.9795,19802936
45901,5-Fluorouramcil,drug,0.9956,19802936
45902,metastatic,disease,0.887,19802936
45903,colonic cancer,disease,0.828,19802936
45904,irinotecan,drug,0.9995,19802936
45905,oxaliplatin,drug,0.9995,19802936
45906,capecitabine,drug,0.9995,19802936
45907,bevacizumab,gene,0.8384,19802936
45908,cetuximab,gene,0.878,19802936
45909,Panitumumab,gene,0.7397,19802936
45910,metastatic colorectal cancer,disease,1.0,19793687
45911,mCRC,disease,1.0,19793687
45912,metastatic colorectal cancer,disease,1.0,19793687
45913,mCRC,disease,1.0,19793687
45914,fluorouracil,drug,1.0,19793687
45915,folinic acid,drug,0.999,19793687
45916,oxaliplatin,drug,0.9995,19793687
45917,irinotecan,drug,0.9985,19793687
45918,bevacizumab,gene,0.9204,19793687
45919,cetuximab,gene,0.926,19793687
45920,panitumumab,gene,0.932,19793687
45921,mCRC,disease,0.8525,19793687
45922,KRAS,DNA,0.8394,19792050
45923,KRAS mutation,gene,0.971,19792050
45924,metastatic colorectal cancer,disease,0.9937,19792050
45925,KRAS,DNA,0.7246,19792050
45926,KRAS mutations,gene,0.962,19792050
45927,colorectal cancer,disease,1.0,19792050
45928,KRAS,gene,0.7,19792050
45929,codons 12 or 13,DNA,0.573,19792050
45930,metastatic tumors,disease,1.0,19792050
45931,epidermal growth factor receptor,gene,0.9956,19792050
45932,cetuximab,gene,0.8574,19792050
45933,panitumumab,gene,0.8984,19792050
45934,KRAS mutation,gene,0.6763,19792050
45935,metastatic colorectal cancer,disease,1.0,19792050
45936,Cancer,disease,0.9985,19792050
45937,KRAS,gene,0.866,19792050
45938,KRAS,DNA,0.8687,19792050
45939,KRAS mutations,gene,0.9316,19792050
45940,colorectal tumors,disease,1.0,19792050
45941,cetuximab,gene,0.9185,19792050
45942,panitumumab,gene,0.876,19792050
45943,KRAS,gene,0.8076,19792050
45944,metastatic colorectal cancer,disease,0.999,19792050
45945,Neratinib,drug,0.9985,19780706
45946,EGFR,gene,0.998,19780706
45947,HER2,gene,0.995,19780706
45948,breast and non-small cell lung cancer,disease,1.0,19780706
45949,imatinib,drug,0.9956,19780706
45950,BCR,gene,0.998,19780706
45951,ABL,gene,0.9976,19780706
45952,tyrosine,drug,0.5215,19780706
45953,chronic myelogenous leukemia,disease,1.0,19780706
45954,cancer,disease,1.0,19780706
45955,erythroblastic leukemia viral oncogene homolog family,gene,0.998,19780706
45956,receptor,gene,0.51,19780706
45957,EGFR,gene,0.996,19780706
45958,HER1,gene,0.995,19780706
45959,human epidermal growth factor receptor 2,gene,0.9775,19780706
45960,HER2,gene,0.9824,19780706
45961,neu,gene,0.9937,19780706
45962,cancers,disease,1.0,19780706
45963,neratinib,drug,0.9917,19780706
45964,HKI-272,drug,0.9995,19780706
45965,EGFR,gene,0.9907,19780706
45966,HER2,gene,0.9863,19780706
45967,neratinib,drug,0.998,19780706
45968,HKI-272,drug,0.9995,19780706
45969,EGFR,gene,0.99,19780706
45970,HER2,gene,0.9907,19780706
45971,lapatinib,drug,0.998,19780706
45972,trastuzumab,gene,0.8433,19780706
45973,erlotinib,drug,0.9976,19780706
45974,gefitinib,drug,0.995,19780706
45975,cetuximab,gene,0.8975,19780706
45976,panitumumab,gene,0.902,19780706
45977,Breast Cancer,disease,0.9917,19780706
45978,neratinib,drug,0.9976,19780706
45979,advanced breast cancer,disease,0.9995,19780706
45980,NSCLC,disease,1.0,19780706
45981,KRAS,gene,0.8506,19775645
45982,skin toxicities,disease,0.76,19755624
45983,epidermal growth factor receptor,gene,0.9966,19755624
45984,epidermal growth factor receptor,gene,0.998,19755624
45985,EGFRI,gene,0.991,19755624
45986,epidermal growth factor receptor,gene,0.999,19755624
45987,cetuximab,gene,0.7466,19755624
45988,erlotinib,drug,0.9985,19755624
45989,gefitinib,drug,0.997,19755624
45990,EGFRI,gene,0.9956,19755624
45991,skin toxicities,disease,0.991,19755624
45992,EGFRI,gene,0.996,19755624
45993,skin toxicities,disease,0.898,19755624
45994,EGFRI,gene,0.9956,19755624
45995,skin toxicities,disease,0.9404,19755624
45996,corticosteroids,drug,0.566,19755624
45997,retinoids,drug,0.9976,19755624
45998,EGFRI,gene,0.998,19755624
45999,skin rash,disease,1.0,19755624
46000,EGFRI,gene,0.996,19755624
46001,epidermal growth factor receptor,gene,0.998,19747140
46002,solid tumors,disease,1.0,19747140
46003,tumors,disease,0.4346,19747140
46004,epidermal growth factor receptor,gene,0.9985,19747140
46005,EGFR,gene,0.992,19747140
46006,HER family,gene,0.9863,19747140
46007,receptor tyrosine kinases,gene,0.984,19747140
46008,tyrosine,drug,0.971,19747140
46009,cancer,disease,1.0,19747140
46010,EGFR,gene,0.9946,19747140
46011,EGFR,gene,0.989,19747140
46012,cancer,disease,0.996,19747140
46013,solid tumors,disease,1.0,19747140
46014,colorectal,disease,0.979,19747140
46015,EGFR,gene,0.9927,19747140
46016,EGFR,gene,0.9897,19747140
46017,tyrosine,drug,0.9565,19747140
46018,tyrosine kinase,gene,0.9644,19747140
46019,extracellular domain,DNA,0.4968,19747140
46020,EGFR,gene,0.995,19747140
46021,erbB1,gene,0.9805,19747140
46022,cetuximab,gene,0.86,19747140
46023,panitumumab,gene,0.8477,19747140
46024,Cetuximab,gene,0.7856,19747140
46025,chimeric IgG1 anti-EGFR monoclonal antibody,gene,0.8867,19747140
46026,panitumumab,gene,0.6436,19747140
46027,IgG2 anti-EGFR monoclonal antibody,gene,0.891,19747140
46028,EGFR,gene,0.9897,19747140
46029,epidermal growth factor receptor,gene,0.9976,19738166
46030,metastatic colorectal cancer,disease,1.0,19738166
46031,panitumumab,gene,0.4702,19738166
46032,cetuximab,gene,0.7876,19738166
46033,epidermal growth factor receptor,gene,0.997,19738166
46034,EGFR,gene,0.9927,19738166
46035,metastatic colorectal cancer,disease,0.945,19738166
46036,EGFR,gene,0.9966,19738166
46037,chemotherapy-refractory tumors,disease,0.9624,19738166
46038,EGFR,gene,0.996,19738166
46039,EGFR,gene,0.996,19738166
46040,EGFR,gene,0.9966,19738166
46041,"KRAS, BRAF, or PIK3CA oncogenes",DNA,0.93,19738166
46042,KRAS,gene,0.9766,19738166
46043,BRAF,gene,0.9336,19738166
46044,PIK3CA oncogenes,gene,0.9556,19738166
46045,PTEN tumor,disease,0.571,19738166
46046,PTEN tumor suppressor gene,gene,0.792,19738166
46047,colorectal cancer,disease,1.0,19738166
46048,KRAS,DNA,0.542,19738166
46049,colorectal cancer,disease,1.0,19738166
46050,panitumumab,gene,0.9116,19738166
46051,cetuximab,gene,0.884,19738166
46052,colorectal tumors,disease,1.0,19738166
46053,KRAS,DNA,0.5024,19738166
46054,BRAF,gene,0.996,19738166
46055,PIK3CA,gene,0.629,19738166
46056,PTEN,gene,0.9106,19738166
46057,EGFR,gene,0.992,19738166
46058,EGFR,gene,0.994,19738166
46059,KRAS,gene,0.8115,19738166
46060,anti-EGFR monoclonal antibody,gene,0.9204,19738166
46061,panitumumab,gene,0.8774,19738166
46062,cetuximab,gene,0.7876,19738166
46063,metastatic colorectal cancer,disease,0.9946,19738166
46064,epidermal growth factor receptor monoclonal,gene,0.9204,19737224
46065,cancer,disease,1.0,19737224
46066,epidermal growth factor receptor,gene,0.999,19737224
46067,EGFR,gene,0.993,19737224
46068,transmembrane tyrosine kinase receptor,gene,0.9756,19737224
46069,tyrosine,drug,0.9614,19737224
46070,cancer cells,cell_type,0.8633,19737224
46071,cancer,disease,1.0,19737224
46072,EGFR,gene,0.989,19737224
46073,cancer,disease,1.0,19737224
46074,EGFR,gene,0.9966,19737224
46075,cancer,disease,1.0,19737224
46076,EGFR,gene,0.9946,19737224
46077,cancer,disease,1.0,19737224
46078,EGFR,gene,0.993,19737224
46079,tumour,disease,0.982,19737224
46080,cetuximab,gene,0.933,19737224
46081,panitumumab,gene,0.839,19737224
46082,metastatic colorectal and head and neck cancer,disease,0.9985,19737224
46083,EGFR,gene,0.995,19737224
46084,Gastrointestinal Cancers,disease,1.0,19736659
46085,rashes,disease,0.9814,19731583
46086,EGFR,gene,0.7344,19731583
46087,panitumumab,gene,0.7954,19723673
46088,advanced solid tumors,disease,0.9995,19723673
46089,Panitumumab,gene,0.747,19723673
46090,human epidermal growth factor receptor,gene,0.996,19723673
46091,EGFR,gene,0.992,19723673
46092,panitumumab,gene,0.7256,19723673
46093,advanced solid tumors,disease,0.9995,19723673
46094,panitumumab,gene,0.767,19723673
46095,colorectal cancer,disease,1.0,19723673
46096,cancer,disease,1.0,19723673
46097,panitumumab,gene,0.797,19723673
46098,panitumumab,gene,0.895,19723673
46099,paclitaxel,drug,0.999,19723673
46100,carboplatin,drug,0.9995,19723673
46101,tumor,cell_type,0.5044,19723673
46102,EGFR,gene,0.6973,19723673
46103,panitumumab,gene,0.857,19723673
46104,antipanitumumab antibodies,gene,0.903,19723673
46105,panitumumab,gene,0.864,19723673
46106,panitumumab,gene,0.7803,19723673
46107,panitumumab,gene,0.949,19723673
46108,colorectal cancer,disease,1.0,19717258
46109,metastatic colorectal cancers,disease,0.983,19717258
46110,CRC,disease,1.0,19717258
46111,5-fluorouracil,drug,0.999,19717258
46112,folinic acid,drug,0.998,19717258
46113,oxaliplatin,drug,0.9995,19717258
46114,irinotecan,drug,0.998,19717258
46115,CRC,disease,0.819,19717258
46116,Bevacizumab,gene,0.67,19717258
46117,anti-VEGF antibody,gene,0.9736,19717258
46118,irinotecan,drug,0.995,19717258
46119,bevacizumab,gene,0.9014,19717258
46120,oxaliplatin,drug,1.0,19717258
46121,FOLFOX,drug,0.695,19717258
46122,5-,drug,0.992,19717258
46123,fluorouracil,drug,0.999,19717258
46124,bevacizumab,gene,0.9297,19717258
46125,FOLFIRI,drug,0.976,19717258
46126,FOLFOX,drug,0.952,19717258
46127,XELOX,drug,0.8267,19717258
46128,Cetuximab,gene,0.9546,19717258
46129,panitumumab,gene,0.9253,19717258
46130,cetuximab,gene,0.953,19717258
46131,panitumumab,gene,0.946,19717258
46132,irinotecan,drug,0.996,19717258
46133,cetuximab,gene,0.948,19717258
46134,cetuximab,gene,0.8237,19717258
46135,FOLFIRI,drug,0.882,19717258
46136,FOLFOX,drug,0.8506,19717258
46137,epithelial growth factor receptors,gene,0.998,19717258
46138,EGFR,gene,0.994,19717258
46139,cetuximab,gene,0.8745,19717258
46140,panitumumab,gene,0.8594,19717258
46141,tumors,disease,1.0,19717258
46142,oncogene KRAS,gene,0.836,19717258
46143,anti-EGFR,gene,0.8213,19717258
46144,KRAS,gene,0.7983,19717258
46145,panitumumab,gene,0.9126,19717258
46146,cetuximab,gene,0.7534,19717258
46147,anti-EGFR,gene,0.9673,19717258
46148,KRAS tumors,disease,0.9546,19717258
46149,KRAS,gene,0.4695,19717258
46150,metastatic CRC,disease,0.915,19717258
46151,KRAS,gene,0.452,19717258
46152,advanced colorectal cancer,disease,0.97,21789113
46153,advanced colorectal cancer,disease,0.9985,21789113
46154,CRC,disease,1.0,21789113
46155,oxaliplatin,drug,1.0,21789113
46156,irinotecan,drug,0.999,21789113
46157,bevacizumab,gene,0.885,21789113
46158,epidermal growth factor receptor,gene,0.9985,21789113
46159,EGFR,gene,0.9243,21789113
46160,cetuximab,gene,0.845,21789113
46161,panitumumab,gene,0.878,21789113
46162,metastatic CRC,disease,0.838,21789113
46163,CRC,disease,0.999,21789113
46164,advanced CRC,disease,0.824,21789113
46165,bevacizumab,gene,0.8906,21789113
46166,bevacizumab,gene,0.86,21789113
46167,metastatic CRC,disease,0.973,21789113
46168,bevacizumab,gene,0.863,21789113
46169,bevacizumab,gene,0.683,21789113
46170,Cetuximab,gene,0.9404,21789113
46171,panitumumab,gene,0.908,21789113
46172,bevacizumab,gene,0.882,21789113
46173,EGFR antibodies,gene,0.915,21789113
46174,tumor,disease,0.9985,21789113
46175,EGFR antibodies,gene,0.8867,21789113
46176,CRC,disease,0.4934,21789113
46177,KRAS,gene,0.692,21789113
46178,BRAF,gene,0.944,21789113
46179,EGFR antibodies,gene,0.972,21789113
46180,CRC,disease,1.0,21789113
46181,cetuximab,gene,0.938,21789113
46182,panitumumab,gene,0.9106,21789113
46183,CRC,disease,0.997,21789113
46184,mitomycin C,drug,0.997,19707832
46185,oxaliplatin,drug,0.999,19707832
46186,colorectal carcinomatosis,disease,1.0,19707832
46187,colorectal carcinomatosis,disease,1.0,19707832
46188,mitomycin C,drug,0.9995,19707832
46189,oxaliplatin,drug,1.0,19707832
46190,mouse,species,0.889,19707832
46191,mice,species,0.8857,19707832
46192,HT-29 colorectal cancer cells,cell_line,0.63,19707832
46193,HT,disease,0.809,19707832
46194,oxaliplatin,drug,1.0,19707832
46195,mitomycin C,drug,0.9995,19707832
46196,panitumumab,gene,0.9126,19707832
46197,erlotinib,drug,0.9976,19707832
46198,cetuximab,gene,0.8735,19707832
46199,irinotecan,drug,0.998,19707832
46200,mitomycin C,drug,0.9995,19707832
46201,panitumumab,gene,0.9087,19707832
46202,irinotecan,drug,0.9985,19707832
46203,5-fluorouracil,drug,0.9995,19707832
46204,leucovorin,drug,0.999,19707832
46205,irinotecan,drug,0.997,19707832
46206,FOLFIRI,drug,0.9517,19707832
46207,mice,species,0.97,19707832
46208,irinotecan,drug,0.9995,19707832
46209,mitomycin C,drug,0.999,19707832
46210,mice,species,0.9785,19707832
46211,FOLFIRI,drug,0.964,19707832
46212,mice,species,0.986,19707832
46213,irinotecan,drug,0.996,19707832
46214,mitomycin C,drug,0.998,19707832
46215,mice,species,0.9863,19707832
46216,FOLFIRI,drug,0.981,19707832
46217,mitomycin C,drug,0.999,19707832
46218,irinotecan,drug,0.996,19707832
46219,panitumumab,gene,0.9346,19707832
46220,mitomycin C,drug,0.9995,19707832
46221,irinotecan,drug,0.998,19707832
46222,irinotecan,drug,0.999,19707832
46223,mitomycin C,drug,0.999,19707832
46224,panitumumab,gene,0.912,19707832
46225,mitomycin C,drug,0.9985,19707832
46226,irinotecan,drug,0.996,19707832
46227,FOLFIRI,drug,0.975,19707832
46228,mitomycin C,drug,0.9985,19707832
46229,panitumumab,gene,0.912,19707832
46230,irinotecan,drug,0.9956,19707832
46231,panitumumab,gene,0.867,19705240
46232,advanced solid tumors,disease,0.9995,19705240
46233,Panitumumab,gene,0.8735,19705240
46234,epidermal growth factor receptor,gene,0.9966,19705240
46235,solid tumors,disease,1.0,19705240
46236,panitumumab,gene,0.8843,19705240
46237,skin toxicities,disease,0.95,19705240
46238,panitumumab,gene,0.8613,19705240
46239,advanced solid tumors,disease,0.9995,19705240
46240,panitumumab,gene,0.9443,19705240
46241,panitumumab,gene,0.659,19705240
46242,anti-panitumumab antibodies,gene,0.987,19705240
46243,panitumumab,gene,0.8457,19705240
46244,fatigue,disease,0.999,19705240
46245,anorexia,disease,1.0,19705240
46246,skin toxicities,disease,0.8413,19705240
46247,rash,disease,1.0,19705240
46248,acneiform dermatitis,disease,1.0,19705240
46249,anti-panitumumab antibodies,gene,0.9736,19705240
46250,Panitumumab,gene,0.9204,19705240
46251,colorectal cancer,disease,1.0,19705240
46252,solid tumors,disease,1.0,19705240
46253,panitumumab,gene,0.8887,19705240
46254,colorectal cancer,disease,1.0,19705240
46255,metastatic colorectal cancer,disease,0.9995,19701148
46256,advanced colorectal cancer,disease,0.998,19700342
46257,Panitumumab,gene,0.871,19700342
46258,cetuximab,gene,0.883,19700342
46259,Colorectal cancer,disease,1.0,19700342
46260,advanced colorectal cancer,disease,1.0,19700342
46261,fluoropyrimidines,drug,1.0,19700342
46262,irinotecan,drug,0.999,19700342
46263,oxaliplatin,drug,0.9995,19700342
46264,bevacizumab,gene,0.869,19700342
46265,cetuximab,gene,0.8647,19700342
46266,advanced colorectal cancer,disease,0.999,19700342
46267,panitumumab,gene,0.7793,19700342
46268,anti-EGFR monoclonal antibody,gene,0.9717,19700342
46269,panitumumab,gene,0.858,19700342
46270,metastatic colorectal cancer,disease,1.0,19700342
46271,panitumumab,gene,0.9126,19700342
46272,colorectal cancer,disease,1.0,19694362
46273,colon cancer,disease,1.0,19694362
46274,irinotecan,drug,0.9946,19694362
46275,oxaliplatin,drug,0.9995,19694362
46276,epidermal growth factor receptor,gene,0.998,19694362
46277,EGFR,gene,0.991,19694362
46278,panitumumab,gene,0.803,19694362
46279,tumor,disease,1.0,19694362
46280,wild type (non mutated),DNA,0.7275,19694362
46281,KRAS gene,gene,0.7295,19694362
46282,EGFR,gene,0.731,19694362
46283,colorectal cancer,disease,1.0,19694362
46284,KRAS gene,gene,0.906,19694362
46285,Pathologists,cell_type,0.5034,19694362
46286,epidermal growth factor receptor,gene,0.997,19681874
46287,(111)In,drug,0.999,19681874
46288,CHX,drug,0.92,19681874
46289,panitumumab,gene,0.9004,19681874
46290,human carcinoma cell lines,cell_line,0.9536,19681874
46291,carcinoma,disease,0.9824,19681874
46292,epidermal growth factor receptors,gene,0.998,19681874
46293,Panitumumab,gene,0.9043,19681874
46294,CHX-A''-DTPA,drug,0.9995,19681874
46295,diethylenetriamine-pentaacetic acid,drug,0.9995,19681874
46296,(111)In,drug,0.9956,19681874
46297,CHX-A''-DTPA,drug,0.9976,19681874
46298,panitumumab,gene,0.9585,19681874
46299,(111)In,drug,0.9995,19681874
46300,CHX-A''-DTPA,drug,0.961,19681874
46301,panitumumab,gene,0.964,19681874
46302,tumour,disease,0.9985,19681874
46303,human tumour cell lines,cell_line,0.964,19681874
46304,tumour,disease,0.9785,19681874
46305,epidermal growth factor receptors,gene,0.9985,19681874
46306,panitumumab,gene,0.9067,19681874
46307,CHX-A''-DTPA,drug,0.999,19681874
46308,(111)In,drug,0.998,19681874
46309,(111)In,drug,0.997,19681874
46310,panitumumab,gene,0.8,19681874
46311,A431 cells,cell_line,0.7676,19681874
46312,(111)In,drug,0.9985,19681874
46313,panitumumab,gene,0.7925,19681874
46314,mice,species,0.867,19681874
46315,A431,cell_line,0.944,19681874
46316,HT-29,cell_line,0.9375,19681874
46317,LS-174T,cell_line,0.904,19681874
46318,SHAW,cell_line,0.873,19681874
46319,SKOV-3,cell_line,0.9263,19681874
46320,s,cell_line,0.748,19681874
46321,normal,cell_type,0.4487,19681874
46322,(111)In,drug,0.999,19681874
46323,panitumumab,gene,0.9272,19681874
46324,tumour,disease,0.992,19681874
46325,mice,species,0.9497,19681874
46326,(111)In,drug,0.9985,19681874
46327,panitumumab,gene,0.819,19681874
46328,A431 tumour,disease,0.6543,19681874
46329,mice,species,0.9272,19681874
46330,Panitumumab,gene,0.827,19681874
46331,(111)In,drug,0.9956,19681874
46332,tumour,disease,0.9976,19681874
46333,panitumumab,gene,0.9287,19681874
46334,EGFR,gene,0.971,19663767
46335,colorectal cancer,disease,1.0,19663767
46336,anti-,gene,0.9443,19663767
46337,epidermal growth factor receptor monoclonal antibodies,gene,0.8804,19663767
46338,cetuximab,gene,0.4773,19663767
46339,panitumumab,gene,0.7505,19663767
46340,advanced colorectal cancer,disease,0.985,19663767
46341,KRAS gene,gene,0.922,19663767
46342,cetuximab,gene,0.833,19663767
46343,panitumumab,gene,0.763,19663767
46344,KRAS,gene,0.821,19663767
46345,EGFR,gene,0.9873,19663767
46346,EGFR gene,gene,0.7427,19663767
46347,EGFR,gene,0.994,19663767
46348,PI3K,gene,0.9785,19663767
46349,PTEN,gene,0.9907,19663767
46350,AKT,gene,0.998,19663767
46351,mTOR,gene,0.9956,19663767
46352,JAK,gene,0.9907,19663767
46353,STAT,gene,0.983,19663767
46354,EGFR antibody,gene,0.9614,19663767
46355,BRAF,gene,0.7573,19663767
46356,mRNA,RNA,0.762,19663767
46357,EGFR-,gene,0.998,19663767
46358,Epiregulin,gene,0.8867,19663767
46359,Amphiregulin,gene,0.9863,19663767
46360,cetuximab,gene,0.7915,19663767
46361,K-ras,gene,0.691,19661358
46362,colorectal cancer,disease,1.0,19661358
46363,K-ras oncogene,gene,0.854,19661358
46364,codons 12,DNA,0.5693,19661358
46365,K-,gene,0.9863,19661358
46366,ras,gene,0.9585,19661358
46367,panitumumab,gene,0.7656,19661358
46368,cetuximab,gene,0.7324,19661358
46369,K-ras,gene,0.766,19661358
46370,paraffin,drug,0.4785,19661358
46371,tumor,disease,1.0,19661358
46372,Exons 1 and 2,DNA,0.7837,19661358
46373,K-ras,DNA,0.731,19661358
46374,K-ras mutation,gene,0.977,19661358
46375,codon 22,DNA,0.825,19661358
46376,Gln22Stop,DNA,0.6733,19661358
46377,metastatic colorectal cancer,disease,1.0,19661358
46378,BRAF,gene,0.6567,19661358
46379,p53,gene,0.997,19661358
46380,anti-EGFR MAb,gene,0.8906,19661358
46381,K-,cell_line,0.4456,19661358
46382,ras,DNA,0.6523,19661358
46383,ras truncating,gene,0.852,19661358
46384,metastatic colorectal cancer,disease,1.0,19661358
46385,colorectal cancer,disease,1.0,19642458
46386,ctuximab,gene,0.9106,19642458
46387,panitumumab,gene,0.9404,19642458
46388,bevacizumab,gene,0.6226,19642458
46389,Colorectal cancer,disease,1.0,19642458
46390,cancer,disease,1.0,19642458
46391,metastatic colorectal cancer,disease,0.898,19642458
46392,anti-EGFR,gene,0.975,19642458
46393,anti-VEGFR,gene,0.9614,19642458
46394,anti-EGFR antibodies,gene,0.901,19642458
46395,ctuximab,gene,0.932,19642458
46396,panitumumab,gene,0.8843,19642458
46397,FOLFIRI,drug,0.5923,19642458
46398,wild type K-ras,gene,0.806,19642458
46399,VEGFR,gene,0.928,19642458
46400,bevacizumab,gene,0.797,19642458
46401,metastatic colorectal cancer,disease,0.9985,19642458
46402,irinotecan,drug,0.9985,19642458
46403,large intestinal and rectal carcinomas,disease,1.0,19642320
46404,colorectal cancer,disease,1.0,19642320
46405,oxaliplatin,drug,1.0,19642320
46406,irinotecan,drug,0.9995,19642320
46407,capecitabine,drug,0.9995,19642320
46408,CRC,disease,0.9976,19642320
46409,bevacizumab,gene,0.4993,19642320
46410,antiVEGF antibody,gene,0.9873,19642320
46411,cetuximab,gene,0.618,19642320
46412,anti EGFR antibodies,gene,0.9463,19642320
46413,cancer,disease,0.9995,19642320
46414,K ras,gene,0.704,19642320
46415,oxaliplatin,drug,1.0,19642320
46416,fluorouracil,drug,0.9995,19642320
46417,leukovorin,drug,0.9985,19642320
46418,colorectal cancer,disease,1.0,19642320
46419,FUFA,drug,0.9985,19642320
46420,FOLFOX,drug,0.9966,19642320
46421,FOLFIRI,drug,0.9956,19642320
46422,XELOX,drug,0.9907,19642320
46423,XELIRI,drug,0.987,19642320
46424,bevacizumab,gene,0.786,19642320
46425,cetuximab,gene,0.796,19642320
46426,panitumumab,gene,0.9126,19642320
46427,colorectal cancer,disease,1.0,19642320
46428,KRAS,gene,0.808,19636327
46429,EGFR,gene,0.993,19636327
46430,metastatic CRC,disease,0.987,19636327
46431,EGFR,gene,0.995,19636327
46432,cancer-cell,cell_type,0.631,19636327
46433,cancer,disease,0.5234,19636327
46434,tumor,disease,0.999,19636327
46435,cancers,disease,1.0,19636327
46436,colorectal cancer,disease,0.9995,19636327
46437,mCRC,disease,0.9976,19636327
46438,anti-EGFR monoclonal antibodies,gene,0.8345,19636327
46439,cetuximab,gene,0.5996,19636327
46440,panitumumab,gene,0.7676,19636327
46441,mCRC,disease,0.981,19636327
46442,EGFR,gene,0.9907,19636327
46443,mCRC,disease,0.9956,19636327
46444,anti-,gene,0.531,19636327
46445,EGFR antibodies,gene,0.7617,19636327
46446,EGFR,gene,0.9917,19636327
46447,mCRC,disease,0.996,19636327
46448,KRAS,gene,0.865,19636327
46449,anti-EGFR monoclonal antibodies,gene,0.8887,19636327
46450,KRAS,gene,0.8374,19636327
46451,EGFR,gene,0.9937,19636327
46452,mCRC,disease,0.9976,19636327
46453,codons 12 and 13,DNA,0.846,19636327
46454,exon 2,DNA,0.4746,19636327
46455,KRAS,gene,0.8223,19636327
46456,cetuximab,gene,0.7085,19636327
46457,panitumumab,gene,0.6025,19636327
46458,mCRC,disease,0.9976,19636327
46459,EGFR,gene,0.996,19636327
46460,RAS,gene,0.996,19636327
46461,EGFR,gene,0.981,19636327
46462,KRAS,gene,0.8345,19636327
46463,mCRC,disease,0.9717,19636327
46464,anti-EGFR monoclonal antibodies,gene,0.831,19636327
46465,KRAS,gene,0.8003,19632927
46466,metastatic colorectal cancer,disease,0.9985,19632927
46467,Colorectal cancer,disease,1.0,19632927
46468,vascular endothelial growth factor,gene,0.997,19632927
46469,bevacizumab,gene,0.7666,19632927
46470,epidermal growth factor,gene,0.996,19632927
46471,cetuximab,gene,0.9517,19632927
46472,panitumumab,gene,0.955,19632927
46473,KRAS,DNA,0.7153,19632927
46474,KRAS mutations,gene,0.877,19632927
46475,colorectal cancer,disease,1.0,19632927
46476,KRAS,gene,0.7944,19632927
46477,EGFR,gene,0.994,19632927
46478,EGFR,gene,0.9883,19632927
46479,KRAS,gene,0.8433,19632927
46480,anti-EGFR antibodies,gene,0.8867,19632927
46481,cetuximab,gene,0.744,19632927
46482,panitumumab,gene,0.7715,19632927
46483,KRAS,DNA,0.743,19632927
46484,KRAS mutation,gene,0.975,19632927
46485,tumors,disease,1.0,19632927
46486,EGFR,gene,0.9717,19632927
46487,metastatic CRC,disease,0.9272,19632927
46488,panitumumab,gene,0.8467,19616446
46489,colorectal cancer,disease,1.0,19616446
46490,metastatic colorectal cancer,disease,1.0,19616446
46491,mCRC,disease,1.0,19616446
46492,Panitumumab,gene,0.702,19616446
46493,IgG2,gene,0.8037,19616446
46494,epidermal growth factor receptor,gene,0.996,19616446
46495,EGFR,gene,0.9917,19616446
46496,panitumumab,gene,0.9355,19616446
46497,mCRC,disease,0.996,19616446
46498,panitumumab,gene,0.9614,19616446
46499,BSC,drug,0.8364,19616446
46500,BSC,drug,0.5713,19616446
46501,panitumumab,gene,0.8203,19616446
46502,Skin toxicities,disease,0.9995,19616446
46503,hypomagnesemia,disease,1.0,19616446
46504,diarrhea,disease,1.0,19616446
46505,anti-EGFR,gene,0.674,19616446
46506,KRAS,gene,0.7744,19616446
46507,skin rash,disease,1.0,19616446
46508,panitumumab,gene,0.9463,19616446
46509,panitumumab,gene,0.826,19616446
46510,mCRC,disease,0.998,19616446
46511,panitumumab,gene,0.926,19581184
46512,Panitumumab,gene,0.932,19581179
46513,metastatic colorectal cancer,disease,0.9995,19581179
46514,metastatic colorectal cancer,disease,1.0,19581179
46515,panitumumab,gene,0.8667,19581179
46516,Panitumumab,gene,0.6865,19581179
46517,epidermal growth factor receptor,gene,0.998,19581179
46518,EGFR,gene,0.9897,19581179
46519,KRAS,gene,0.803,19581179
46520,RAS oncogene,gene,0.898,19581179
46521,panitumumab,gene,0.76,19581179
46522,KRAS,gene,0.994,19581179
46523,KRAS,gene,0.4963,19581179
46524,panitumumab,gene,0.606,19581179
46525,panitumumab,gene,0.9033,19581179
46526,EGFR,gene,0.996,19581179
46527,metastatic colorectal carcinoma,disease,1.0,19581179
46528,wild-type,gene,0.901,19581179
46529,KRAS,gene,0.8574,19581179
46530,fluoropyrimidine,drug,0.9985,19581179
46531,oxaliplatin,drug,0.9995,19581179
46532,irinotecan,drug,0.998,19581179
46533,EGFR,gene,0.9897,19581179
46534,skin symptoms,disease,1.0,19581179
46535,rash,disease,1.0,19581179
46536,lung infiltrates,disease,1.0,19581179
46537,diarrhoea,disease,1.0,19581179
46538,ion abnormalities,disease,0.999,19581179
46539,EGFR,gene,0.9756,19562083
46540,Non-Small Cell Lung Cancer,disease,1.0,19562083
46541,Epidermal growth factor receptor,gene,0.9985,19562083
46542,EGFR,gene,0.9927,19562083
46543,non-small cell lung cancer,disease,1.0,19562083
46544,NSCLC,disease,1.0,19562083
46545,tumors,disease,1.0,19562083
46546,EGFR,gene,0.99,19562083
46547,adenocarcinoma,disease,1.0,19562083
46548,EGFR,gene,0.994,19562083
46549,tyrosine,drug,0.9536,19562083
46550,tyrosine kinase,gene,0.979,19562083
46551,erlotinib,drug,0.9976,19562083
46552,gefitinib,drug,0.998,19562083
46553,lapatinib,drug,0.9985,19562083
46554,tyrosine,drug,0.9385,19562083
46555,tyrosine kinase domain,gene,0.6094,19562083
46556,cetuximab,gene,0.842,19562083
46557,panitumumab,gene,0.8413,19562083
46558,EGFR,gene,0.9897,19562083
46559,metastatic NSCLC,disease,0.923,19562083
46560,anti-EGFR mAb,gene,0.952,19562083
46561,cetuximab,gene,0.595,19562083
46562,NSCLC,disease,0.471,19562083
46563,EGFR,gene,0.988,19562083
46564,receptor tyrosine kinases,gene,0.991,19562083
46565,tyrosine,drug,0.9707,19562083
46566,EGFR,gene,0.996,19562083
46567,colorectal cancer,disease,1.0,19546597
46568,tumour,disease,0.512,19546597
46569,KRAS,gene,0.494,19546597
46570,BRAF,gene,0.355,19546597
46571,epidermal growth factor receptor,gene,0.999,19546597
46572,EGFR,gene,0.9907,19546597
46573,cetuximab,gene,0.814,19546597
46574,panitumumab,gene,0.855,19546597
46575,KRAS,DNA,0.826,19546597
46576,KRAS mutation,gene,0.9424,19546597
46577,BRAF,gene,0.827,19546597
46578,bevacizumab,gene,0.717,19546597
46579,KRAS,gene,0.7637,19546597
46580,BRAF,DNA,0.5967,19546597
46581,BRAF wild,gene,0.843,19546597
46582,irinotecan,drug,0.999,19546597
46583,cetuximab,gene,0.913,19546597
46584,KRAS,gene,0.8135,19546608
46585,colorectal cancer,disease,1.0,19546608
46586,colorectal cancer,disease,1.0,19546608
46587,cancer,disease,1.0,19546608
46588,metastatic colon cancer,disease,0.9985,19546608
46589,colon cancer,disease,1.0,19546608
46590,epidermal growth factor receptor,gene,0.998,19546608
46591,EGFR,gene,0.9907,19546608
46592,metastatic colorectal carcinoma,disease,0.9985,19546608
46593,anti-,gene,0.8823,19546608
46594,EGFR,gene,0.588,19546608
46595,cetuximab,gene,0.93,19546608
46596,panitumumab,gene,0.8755,19546608
46597,metastatic colorectal carcinoma,disease,0.8726,19546608
46598,tumors,disease,0.442,19546608
46599,codons 12 and 13,DNA,0.7544,19546608
46600,exon 2,DNA,0.804,19546608
46601,KRAS gene,gene,0.882,19546608
46602,Cancer,disease,0.834,19546608
46603,KRAS,DNA,0.8594,19546608
46604,KRAS mutation,gene,0.917,19546608
46605,colorectal cancer,disease,1.0,19546608
46606,EGFR,gene,0.877,19546608
46607,KRAS,DNA,0.8574,19546608
46608,KRAS mutations,gene,0.9214,19546608
46609,KRAS,gene,0.851,19546608
46610,colorectal cancer,disease,1.0,19546608
46611,solid malignancies,disease,1.0,19534378
46612,cancers,disease,1.0,19534378
46613,Trastuzumab,gene,0.9556,19534378
46614,human epidermal receptor 2 (Her2) positive breast cancers,disease,0.5723,19534378
46615,human epidermal receptor 2,gene,0.971,19534378
46616,Her2,gene,0.9214,19534378
46617,vascular growth factor receptor,gene,0.9976,19534378
46618,VEGF,gene,0.9937,19534378
46619,bevacizumab,gene,0.563,19534378
46620,cetuximab,gene,0.705,19534378
46621,epidermal growth factor receptor,gene,0.996,19534378
46622,EGFR,gene,0.989,19534378
46623,cancers,disease,1.0,19534378
46624,colorectal cancer,disease,1.0,19534378
46625,Sorafenib,drug,0.9946,19534378
46626,sunitinib,drug,0.9966,19534378
46627,renal carcinoma,disease,1.0,19534378
46628,Sorafenib,drug,0.9995,19534378
46629,sorafenib,drug,0.999,19534378
46630,advanced hepatocellular carcinoma,disease,1.0,19534378
46631,gastrointestinal tumors,disease,1.0,19534378
46632,imatinib,drug,0.998,19534378
46633,sunitinib,drug,0.997,19534378
46634,EGFR antibody,gene,0.8936,19525473
46635,head and neck squamous cell carcinoma,disease,1.0,19525473
46636,Epidermal growth factor receptor,gene,0.999,19525473
46637,EGFR,gene,0.995,19525473
46638,protooncogene,DNA,0.9033,19525473
46639,tumor,disease,1.0,19525473
46640,solid cancers,disease,1.0,19525473
46641,EGFR,gene,0.995,19525473
46642,cetuximab,gene,0.5986,19525473
46643,panitumumab,gene,0.609,19525473
46644,EGFR,gene,0.9834,19525473
46645,(64)Cu,drug,0.999,19525473
46646,panitumumab,gene,0.936,19525473
46647,xenografts,cell_line,0.589,19525473
46648,cell lines,cell_line,0.9224,19525473
46649,head and neck squamous cell carcinoma,disease,0.988,19525473
46650,HNSCC,disease,1.0,19525473
46651,HNSCC tumors,disease,0.999,19525473
46652,EGFR,gene,0.9893,19525473
46653,"(64)Cu-1,4,7,10-tetraazacyclododecane-N,N',N'',",drug,0.9995,19525473
46654,N'' acid,drug,0.965,19525473
46655,DOTA,drug,0.9863,19525473
46656,panitumumab,gene,0.8906,19525473
46657,tumors,disease,1.0,19525473
46658,panitumumab,gene,0.9736,19525473
46659,fluorescein 5(6)-isothiocyanate,drug,0.9995,19525473
46660,FITC,drug,0.9956,19525473
46661,CD31,gene,0.9897,19525473
46662,tumor,disease,0.9995,19525473
46663,UM-SCC-22B,cell_line,0.949,19525473
46664,tumors,disease,0.98,19525473
46665,EGFR,gene,0.9946,19525473
46666,(64)Cu-DOTA,drug,0.943,19525473
46667,panitumumab,gene,0.978,19525473
46668,SQB20 tumors,cell_line,0.818,19525473
46669,EGFR,gene,0.9897,19525473
46670,(64)Cu,drug,0.9995,19525473
46671,DOTA,drug,0.7324,19525473
46672,panitumumab,gene,0.97,19525473
46673,SQB20 cells,cell_line,0.9595,19525473
46674,EGFR,gene,0.99,19525473
46675,tumors,disease,1.0,19525473
46676,nude,species,0.5747,19525473
46677,mice,species,0.468,19525473
46678,(64)Cu,drug,0.9995,19525473
46679,DOTA,drug,0.972,19525473
46680,panitumumab,gene,0.9375,19525473
46681,SQB20 tumors,cell_line,0.929,19525473
46682,tumors,disease,0.7124,19525473
46683,EGFR,gene,0.991,19525473
46684,CD31,gene,0.995,19525473
46685,binding site,DNA,0.57,19525473
46686,EGFR-expressing SQB20 tumors,cell_line,0.693,19525473
46687,EGFR,gene,0.9927,19525473
46688,SQB20 tumors,disease,0.4536,19525473
46689,cetuximab,gene,0.871,19525473
46690,panitumumab,gene,0.813,19525473
46691,EGFR,gene,0.9937,19525473
46692,EGFR mAb,gene,0.8003,19525473
46693,HNSCC,disease,0.999,19525473
46694,malignancies,disease,1.0,19525473
46695,panitumumab,gene,0.7964,19509246
46696,non-small cell lung carcinoma cell lines,cell_line,0.8345,19509246
46697,non-small cell lung carcinoma,disease,1.0,19509246
46698,mutant epidermal growth factor receptor,gene,0.996,19509246
46699,Epidermal,DNA,0.5117,19509246
46700,Epidermal growth factor receptor,gene,0.9985,19509246
46701,EGFR,gene,0.9927,19509246
46702,hypersensitivity,disease,0.857,19509246
46703,tyrosine,drug,0.992,19509246
46704,tyrosine kinase,gene,0.9927,19509246
46705,EGFR,gene,0.99,19509246
46706,panitumumab,gene,0.7905,19509246
46707,mutant EGFR-expressing non,cell_line,0.799,19509246
46708,mutant EGFR,gene,0.767,19509246
46709,NSCLC) cells,cell_line,0.712,19509246
46710,NSCLC,disease,1.0,19509246
46711,Mutant EGFR-expressing NSCLC cells,cell_line,0.614,19509246
46712,Mutant EGFR,gene,0.941,19509246
46713,NSCLC,disease,0.8247,19509246
46714,NCI-H1975,cell_line,0.9185,19509246
46715,L858R,DNA,,19509246
46716,L858R,mutation,,19509246
46717,T790M,mutation,,19509246
46718,NCI-H1650,cell_line,0.913,19509246
46719,Delta746-750,DNA,0.695,19509246
46720,CHO cells,cell_line,0.495,19509246
46721,panitumumab,gene,0.8193,19509246
46722,EGF,gene,0.996,19509246
46723,EGFR,gene,0.9907,19509246
46724,tumors,disease,1.0,19509246
46725,panitumumab,gene,0.9146,19509246
46726,mouse,species,0.721,19509246
46727,docetaxel,drug,0.9976,19509246
46728,cisplatin,drug,0.999,19509246
46729,mutant EGFR-expressing CHO,cell_line,0.857,19509246
46730,mutant EGFR,gene,0.991,19509246
46731,NSCLC cells,cell_type,0.776,19509246
46732,NSCLC,disease,0.997,19509246
46733,panitumumab,gene,0.5835,19509246
46734,NCI-H1975,cell_line,0.9473,19509246
46735,NCI-H1650 xenografts,cell_line,0.794,19509246
46736,panitumumab,gene,0.8926,19509246
46737,cisplatin,drug,0.9976,19509246
46738,tumor,disease,0.5283,19509246
46739,panitumumab,gene,0.941,19509246
46740,docetaxel,drug,0.999,19509246
46741,xenografts,cell_line,0.55,19509246
46742,panitumumab,gene,0.906,19509246
46743,Panitumumab,gene,0.6885,19509246
46744,Ki-67,gene,0.9873,19509246
46745,phospho- mitogen-activated protein kinase,gene,0.9873,19509246
46746,pMAPK,gene,0.985,19509246
46747,xenografts,cell_line,0.4565,19509246
46748,Docetaxel,drug,0.9985,19509246
46749,panitumumab,gene,0.9175,19509246
46750,NCI-H1650 xenografts,cell_line,0.82,19509246
46751,Ki-67,gene,0.993,19509246
46752,pMAPK,gene,0.9297,19509246
46753,Panitumumab,gene,0.642,19509246
46754,EGFR,gene,0.995,19509246
46755,tumor,disease,0.9434,19509246
46756,docetaxel,drug,0.998,19509246
46757,NSCLC cell lines,cell_line,0.9614,19509246
46758,NSCLC,disease,0.9473,19509246
46759,EGFR kinase domain,gene,0.9893,19509246
46760,tyrosine,drug,0.8833,19509246
46761,tyrosine kinase,gene,0.9507,19509246
46762,T790M,DNA,,19509246
46763,T790M,mutation,,19509246
46764,Cetuximab,gene,0.7183,19482958
46765,anti-epidermal growth factor receptor monoclonal antibodies,gene,0.896,19482958
46766,non-small cell lung cancer,disease,1.0,19482958
46767,Non-small cell lung cancer,disease,1.0,19482958
46768,NSCLC,disease,1.0,19482958
46769,lung cancer,disease,1.0,19482958
46770,NSCLC,disease,0.999,19482958
46771,NSCLC,disease,0.997,19482958
46772,tumor,disease,0.9995,19482958
46773,epidermal growth factor receptor,gene,0.9985,19482958
46774,EGFR,gene,0.9937,19482958
46775,ErbB family,gene,0.989,19482958
46776,NSCLC,disease,1.0,19482958
46777,EGFR,gene,0.99,19482958
46778,NSCLC,disease,0.999,19482958
46779,tumor,disease,0.9995,19482958
46780,EGFR,gene,0.9863,19482958
46781,tyrosine kinase,gene,0.832,19482958
46782,NSCLC,disease,0.9995,19482958
46783,anti-EGFR monoclonal antibodies,gene,0.9136,19482958
46784,advanced NSCLC,disease,0.9927,19482958
46785,cetuximab,gene,0.908,19482958
46786,anti-EGFR monoclonal antibodies,gene,0.7812,19482958
46787,panitumumab,gene,0.8687,19482958
46788,matuzumab,gene,0.9014,19482958
46789,nimotuzumab,gene,0.791,19482958
46790,advanced NSCLC,disease,0.7705,19482958
46791,colorectal carcinoma,disease,1.0,19471640
46792,KRAS,DNA,0.872,19471640
46793,KRAS mutation,gene,0.945,19471640
46794,EGFR,gene,0.9937,19471640
46795,epidermal growth factor receptor,gene,0.998,19471640
46796,EGFR,gene,0.9897,19471640
46797,metastatic colorectal carcinoma,disease,1.0,19471640
46798,mCRC,disease,1.0,19471640
46799,anti-EGFR antibodies,gene,0.875,19471640
46800,tumor,disease,1.0,19471640
46801,KRAS protein,gene,0.9883,19471640
46802,EGFR,gene,0.9907,19471640
46803,KRAS,DNA,0.769,19471640
46804,KRAS mutation,gene,0.9243,19471640
46805,colorectal carcinomas,disease,1.0,19471640
46806,KRAS gene,gene,0.9116,19471640
46807,EGFR,gene,0.9604,19471640
46808,KRAS gene,gene,0.9067,19471640
46809,EGFR antibodies cetuximab,gene,0.793,19471640
46810,panitumumab,gene,0.639,19471640
46811,KRAS gene,gene,0.914,19471640
46812,cetuximab,gene,0.7686,19471640
46813,panitumumab,gene,0.717,19471640
46814,EGFR,gene,0.943,19471640
46815,metastatic colorectal carcinoma,disease,0.999,19471640
46816,KRAS gene,gene,0.9233,19471640
46817,wild-type KRAS gene,DNA,0.8813,19471640
46818,panitumumab,gene,0.8823,19468688
46819,cetuximab,gene,0.938,19468688
46820,epidermal growth factor receptor,gene,0.9976,19468688
46821,EGFR,gene,0.9873,19468688
46822,metastatic colorectal cancer,disease,1.0,19468688
46823,mCRC,disease,1.0,19468688
46824,KRAS,gene,0.726,19468688
46825,cetuximab,gene,0.9097,19468688
46826,Cmab,gene,0.8623,19468688
46827,IgG1 chimeric molecule,gene,0.892,19468688
46828,Panitumumab,gene,0.9146,19468688
46829,Pmab,gene,0.9614,19468688
46830,humanized,species,0.6655,19468688
46831,mCRC,disease,0.997,19468688
46832,Pmab,gene,0.7603,19468688
46833,EGFR antibody,gene,0.7847,19468688
46834,Cmab,gene,0.623,19468688
46835,mCRC,disease,0.998,19468688
46836,Pmab,gene,0.94,19468688
46837,Cmab,gene,0.7393,19468688
46838,Cmab,drug,0.9414,19468688
46839,HSR,disease,0.9062,19468688
46840,Pmab,gene,0.542,19468688
46841,Cmab,drug,0.871,19468688
46842,mCRC,disease,0.9863,19468688
46843,Pmab,drug,0.977,19468688
46844,Cmab,drug,0.99,19468688
46845,cetuximab,gene,0.9185,19415280
46846,panitumumab,gene,0.875,19415280
46847,metastatic colorectal cancer,disease,1.0,19415280
46848,Cetuximab,gene,0.8457,19415280
46849,panitumumab,gene,0.851,19415280
46850,epidermal growth factor receptor,gene,0.998,19415280
46851,metastatic colorectal cancer,disease,1.0,19415280
46852,mCRC,disease,1.0,19415280
46853,cetuximab,gene,0.8315,19415280
46854,panitumumab,gene,0.8086,19415280
46855,panitumumab,gene,0.8413,19415280
46856,cetuximab,gene,0.894,19415280
46857,cetuximab,gene,0.961,19415280
46858,panitumumab,gene,0.946,19415280
46859,cetuximab,gene,0.8457,19415280
46860,panitumumab,gene,0.902,19415280
46861,PATIENTS,species,0.9443,19415280
46862,mCRC,disease,0.9976,19415280
46863,panitumumab,gene,0.702,19415280
46864,chest tightness,disease,0.9966,19415280
46865,shortness of breath,disease,0.9995,19415280
46866,SOB,disease,0.9976,19415280
46867,panitumumab,gene,0.953,19415280
46868,mCRC,disease,0.997,19415280
46869,back pain,disease,0.9844,19415280
46870,SOB,disease,0.945,19415280
46871,tachycardia,disease,0.999,19415280
46872,hypotension,disease,0.9985,19415280
46873,panitumumab,gene,0.734,19415280
46874,irinotecan,drug,0.9956,19415280
46875,cetuximab,gene,0.729,19415280
46876,cetuximab,gene,0.745,19415280
46877,acniform rash,disease,1.0,19415280
46878,panitumumab,gene,0.91,19415280
46879,cetuximab,gene,0.9375,19415280
46880,panitumumab,gene,0.84,19415280
46881,cetuximab,gene,0.9067,19415280
46882,panitumumab,gene,0.7583,19415280
46883,cetuximab,gene,0.821,19415280
46884,hypersensitivity,disease,0.982,19415280
46885,anti-epidermal growth factor receptor antibodies,gene,0.996,19415280
46886,oncogene,DNA,0.6777,19412429
46887,receptor tyrosine kinases,gene,0.99,19412429
46888,tyrosine,drug,0.964,19412429
46889,epidermal growth factor receptor,gene,0.9985,19412429
46890,EGFR,gene,0.9917,19412429
46891,glioblastoma multiforme,disease,1.0,19412429
46892,GBM,disease,1.0,19412429
46893,de2-7 EGFR,gene,0.9897,19412429
46894,EGFRvIII,gene,0.696,19412429
46895,Hepatocyte growth factor,gene,0.9946,19412429
46896,HGF,gene,0.996,19412429
46897,receptor tyrosine kinase,gene,0.9976,19412429
46898,tyrosine,drug,0.9453,19412429
46899,RTK,gene,0.995,19412429
46900,c-Met,gene,0.994,19412429
46901,GBM,disease,1.0,19412429
46902,HGF,gene,0.999,19412429
46903,c-Met,gene,0.997,19412429
46904,de2,DNA,0.53,19412429
46905,de2-7 EGFR,gene,0.993,19412429
46906,GBM,disease,1.0,19412429
46907,phosphatidylinositol,drug,0.999,19412429
46908,phosphatidylinositol-3 kinase,gene,0.994,19412429
46909,pAkt,gene,0.991,19412429
46910,RTK,gene,0.9673,19412429
46911,de2-7 EGFR,gene,0.98,19412429
46912,U87MG GBM cells,cell_line,0.696,19412429
46913,U87MG GBM,disease,0.8687,19412429
46914,RTKs,gene,0.9624,19412429
46915,platelet-derived growth factor receptor beta,gene,0.9873,19412429
46916,c-Met,gene,0.996,19412429
46917,HGF,gene,0.9873,19412429
46918,AMG102,gene,0.7944,19412429
46919,EGFR,gene,0.981,19412429
46920,c-Met,gene,0.9946,19412429
46921,U87MG xenografts,cell_line,0.7646,19412429
46922,AMG,drug,0.811,19412429
46923,U87MG.Delta 2-7 xenografts,cell_line,0.9175,19412429
46924,U87MG.Delta 2-7 xenografts,cell_line,0.9097,19412429
46925,anti-EGFR antibody,gene,0.934,19412429
46926,tumor,disease,0.647,19412429
46927,HGF,gene,0.9976,19412429
46928,c-Met,gene,0.9937,19412429
46929,panitumumab,gene,0.9272,19412429
46930,tumor,disease,1.0,19412429
46931,panitumumab,gene,0.939,19412429
46932,AMG,drug,0.5728,19412429
46933,GBM,disease,1.0,19412429
46934,GBM cells,cell_line,0.792,19412429
46935,GBM,disease,0.999,19412429
46936,RTK,gene,0.8315,19412429
46937,oncogene,DNA,0.7886,19412429
46938,RTK,gene,0.9595,19412429
46939,dominant oncogene,DNA,0.9307,19412429
46940,RTKs,gene,0.9795,19412429
46941,metastatic colorectal cancer,disease,0.9487,19411318
46942,cancer cells,cell_type,0.8706,19411318
46943,cancer,disease,0.991,19411318
46944,colon cancer,disease,1.0,19411318
46945,bevacizumab,gene,0.8516,19411318
46946,cetuximab,gene,0.865,19411318
46947,panitumumab,gene,0.899,19411318
46948,metastatic colorectal cancer,disease,0.9883,19411318
46949,mCRC,disease,0.9966,19411318
46950,Bevacizumab,gene,0.9453,19411318
46951,irinotecan,drug,0.998,19411318
46952,5-fluorouracil,drug,0.988,19411318
46953,cetuximab,gene,0.915,19411318
46954,irinotecan,drug,0.997,19411318
46955,5-fluorouracil,drug,0.9414,19411318
46956,irinotecan,drug,0.999,19411318
46957,Cetuximab,gene,0.788,19411318
46958,panitumumab,gene,0.57,19411318
46959,mCRC,disease,0.9976,19411318
46960,wild,DNA,0.502,19411318
46961,wild-type KRAS,gene,0.8286,19411318
46962,tyrosine,drug,0.9194,19411318
46963,tyrosine kinase,gene,0.996,19411318
46964,erlotinib,drug,0.9966,19411318
46965,gefitinib,drug,0.997,19411318
46966,sunitinib,drug,0.998,19411318
46967,vatalanib,drug,0.9976,19411318
46968,PTK787,drug,0.9976,19411318
46969,ZK 222584,drug,0.998,19411318
46970,colorectal cancer,disease,1.0,19408743
46971,KRAS,DNA,0.819,19390304
46972,KRAS mutations,gene,0.751,19390304
46973,cetuximab,gene,0.8286,19390304
46974,panitumumab,gene,0.671,19390304
46975,colorectal cancer,disease,1.0,19390304
46976,advanced colorectal cancer,disease,1.0,19390304
46977,patients,species,0.9937,19390304
46978,tumors,disease,1.0,19390304
46979,KRAS gene,gene,0.9883,19390304
46980,epidermal growth factor receptor,gene,0.998,19390304
46981,cetuximab,gene,0.621,19390304
46982,panitumumab,gene,0.7354,19390304
46983,anticancer,disease,0.7515,19390304
46984,colorectal cancer,disease,1.0,19390304
46985,patient,species,0.988,19384694
46986,cancer,disease,1.0,19384694
46987,patients,species,0.9946,19384694
46988,tumor,disease,1.0,19384694
46989,patient,species,0.972,19384694
46990,patient,species,0.9214,19384694
46991,patient,species,0.985,19384694
46992,colorectal cancer,disease,1.0,19381027
46993,advanced colorectal cancer,disease,1.0,19381027
46994,bevacizumab,gene,0.9004,19381027
46995,cetuximab,gene,0.835,19381027
46996,advanced colorectal cancer,disease,1.0,19381027
46997,patients,species,0.9917,19381027
46998,colorectal cancer,disease,1.0,19381027
46999,cetuximab,gene,0.8647,19381027
47000,panitumumab,gene,0.817,19381027
47001,KRAS,gene,0.9893,19381027
47002,EGFR,gene,0.9937,19379120
47003,tumours,disease,1.0,19379120
47004,EGFR,gene,0.9883,19379120
47005,cancer,disease,1.0,19379120
47006,EGFR,gene,0.993,19379120
47007,anti-EGFR monoclonal antibodies,gene,0.9956,19379120
47008,tyrosine,drug,0.988,19379120
47009,tyrosine kinase,gene,0.9946,19379120
47010,Cetuximab,gene,0.8486,19379120
47011,panitumumab,gene,0.8604,19379120
47012,anti-EGFR monoclonal antibodies,gene,0.972,19379120
47013,Zalutumumab,gene,0.4822,19379120
47014,IgG1 completely human anti-EGFR monoclonal antibody,gene,0.914,19379120
47015,human,species,0.789,19379120
47016,EGFR,gene,0.9873,19379120
47017,neoplastic,disease,0.9478,19379120
47018,Zalutumumab,gene,0.528,19379120
47019,squamous cell cancer of head and neck,disease,1.0,19379120
47020,NSCLC,disease,1.0,19379120
47021,colorectal cancer,disease,1.0,19379120
47022,KRAS,gene,0.988,19378369
47023,metastatic colorectal cancer,disease,1.0,19378369
47024,EGFR,gene,0.7783,19378369
47025,malignancies,disease,0.999,19378369
47026,colorectal cancer,disease,1.0,19378369
47027,KRAS,DNA,0.839,19378369
47028,KRAS,gene,0.9785,19378369
47029,colorectal cancer,disease,1.0,19378369
47030,patients,species,0.9883,19378369
47031,mutant KRAS,gene,0.9854,19378369
47032,epidermal growth factor,gene,0.997,19378369
47033,patients,species,0.962,19378369
47034,metastatic colorectal cancer,disease,0.999,19378369
47035,KRAS,DNA,0.8965,19378369
47036,KRAS,gene,0.966,19378369
47037,patients,species,0.987,19378369
47038,KRAS,DNA,0.795,19368524
47039,KRAS mutations,gene,0.824,19368524
47040,anti-EGFR monoclonal antibodies,gene,0.929,19368524
47041,metastatic colorectal carcinoma,disease,0.9995,19368524
47042,Cetuximab,gene,0.693,19368524
47043,panitumumab,gene,0.689,19368524
47044,EGFR,gene,0.9946,19368524
47045,metastatic colorectal carcinoma,disease,1.0,19368524
47046,mCRC,disease,1.0,19368524
47047,tumors,disease,0.9995,19368524
47048,EGFR,gene,0.9883,19368524
47049,KRAS,gene,0.8267,19368524
47050,human homolog,DNA,0.5503,19368524
47051,human homolog of the Kirsten rat sarcoma-2 virus oncogene,gene,0.873,19368524
47052,Kirsten rat sarcoma-2 virus oncogene,DNA,0.7764,19368524
47053,small G-protein,gene,0.9966,19368524
47054,EGFR,gene,0.9917,19368524
47055,KRAS,gene,0.8438,19368524
47056,anti-EGFR mAbs,gene,0.889,19368524
47057,wild type KRAS,gene,0.673,19368524
47058,tumors,disease,0.4768,19368524
47059,KRAS,DNA,0.854,19368524
47060,KRAS mutations,gene,0.745,19368524
47061,cetuximab,gene,0.8716,19368524
47062,panitumumab,gene,0.8228,19368524
47063,EGFR,gene,0.9927,19368524
47064,RAS,gene,0.9966,19368524
47065,RAF,gene,0.998,19368524
47066,MAPK,gene,0.992,19368524
47067,mCRC,disease,0.9844,19368524
47068,epidermal growth factor receptor,gene,0.9976,19362943
47069,non-small-cell lung cancer,disease,1.0,19362943
47070,epidermal growth factor receptor,gene,0.9985,19362943
47071,EGFR,gene,0.986,19362943
47072,epithelial malignancies,disease,1.0,19362943
47073,EGFR tyrosine kinase,gene,0.985,19362943
47074,tyrosine,drug,0.871,19362943
47075,advanced non-small-cell lung cancer,disease,0.9927,19362943
47076,NSCLC,disease,1.0,19362943
47077,EGFR,gene,0.9834,19362943
47078,EGFR,gene,0.986,19362943
47079,EGFR,gene,0.9927,19362943
47080,NSCLC,disease,0.9976,19362943
47081,cetuximab,gene,0.6963,19362943
47082,EGFR,gene,0.9834,19361406
47083,cell membrane growth factor receptors,gene,0.715,19361406
47084,epidermal growth factor receptor,gene,0.998,19361406
47085,EGFR,gene,0.993,19361406
47086,epithelial cancers,disease,1.0,19361406
47087,EGFR,gene,0.992,19361406
47088,human cancer cells,cell_line,0.8096,19361406
47089,cancer,disease,0.922,19361406
47090,EGFR,gene,0.997,19361406
47091,Akt,gene,0.9897,19361406
47092,KRAS,gene,0.8267,19361406
47093,mammalian target of,gene,0.952,19361406
47094,rapamycin,drug,0.9976,19361406
47095,mTOR,gene,0.984,19361406
47096,EGFR,gene,0.993,19361406
47097,mTOR,gene,0.9873,19361406
47098,tumour,disease,1.0,19361406
47099,mTOR,gene,0.9966,19361406
47100,EGFR,gene,0.993,19361406
47101,EGFR,gene,0.9897,19361406
47102,Colorectal cancers,disease,1.0,19357016
47103,5-fluorouracil,drug,0.999,19357016
47104,colorectal cancer,disease,1.0,19357016
47105,oxaliplatin,drug,0.9995,19357016
47106,irinotecan,drug,0.9995,19357016
47107,capecitabine,drug,0.999,19357016
47108,cetuximab,gene,0.7627,19357016
47109,bevacizumab,gene,0.6587,19357016
47110,colorectal cancer,disease,1.0,19357016
47111,KRAS,DNA,0.7617,19352138
47112,KRAS mutational,gene,0.795,19352138
47113,epidermal growth factor receptor,gene,0.997,19352138
47114,colorectal cancer,disease,1.0,19352138
47115,epidermal growth factor receptor,gene,0.9976,19352138
47116,EGFR,gene,0.9893,19352138
47117,advanced colorectal cancer,disease,0.985,19352138
47118,EGFR,gene,0.9907,19352138
47119,KRAS,gene,0.803,19352138
47120,RAS family,gene,0.9937,19352138
47121,EGFR,gene,0.9956,19352138
47122,KRAS,DNA,0.843,19352138
47123,KRAS mutations,gene,0.943,19352138
47124,metastatic colorectal cancer,disease,1.0,19352138
47125,codons 12 and 13,DNA,0.7124,19352138
47126,KRAS,gene,0.827,19352138
47127,anti-EGFR monoclonal antibodies panitumumab,gene,0.9336,19352138
47128,cetuximab,gene,0.673,19352138
47129,wild-type KRAS,gene,0.804,19352138
47130,KRAS,DNA,0.817,19352138
47131,KRAS mutations,gene,0.854,19352138
47132,KRAS,gene,0.8296,19352138
47133,EGFR,gene,0.9937,19352138
47134,colorectal tumors,disease,1.0,19352138
47135,KRAS,DNA,0.796,19352138
47136,KRAS mutations,gene,0.851,19352138
47137,EGFR,gene,0.82,19352138
47138,Colorectal Cancer,disease,1.0,19343143
47139,EGFR,gene,0.9946,19343143
47140,VEGF,gene,0.994,19343143
47141,colorectal cancer,disease,1.0,19343143
47142,cetuximab,gene,0.921,19343143
47143,bevacizumab,gene,0.8887,19343143
47144,panitumumab,gene,0.9453,19343143
47145,colorectal cancer,disease,1.0,19343143
47146,KRAS,gene,0.7085,19343143
47147,EGFR,gene,0.9937,19343143
47148,cytotoxic T lymphocyte antigen 4,gene,0.9985,19343143
47149,anti-CTLA4] monoclonal antibodies,gene,0.947,19343143
47150,insulin-like growth factor 1 receptor,gene,0.999,19343143
47151,IGF1R,gene,0.997,19343143
47152,IGF1R monoclonal antibodies,gene,0.988,19343143
47153,mammalian target of,gene,0.919,19343143
47154,rapamycin,drug,0.9995,19343143
47155,mTOR,gene,0.9907,19343143
47156,mTOR kinase,gene,0.974,19343143
47157,colorectal cancer,disease,0.9976,19343143
47158,colorectal cancer,disease,1.0,19337429
47159,anti-,gene,0.8193,19337429
47160,epidermal growth factor receptor antibodies,gene,0.9263,19337429
47161,panitumumab,gene,0.7373,19337429
47162,Panitumumab,gene,0.658,19337429
47163,humanized,species,0.6475,19337429
47164,epidermal growth factor receptor,gene,0.996,19337429
47165,metastatic colorectal cancer,disease,0.9995,19337429
47166,rash,disease,0.999,19337429
47167,metastatic colorectal cancer,disease,0.9995,19337429
47168,panitumumab,gene,0.9297,19337429
47169,KRAS,gene,0.8135,19337429
47170,tumors,disease,0.996,19337429
47171,KRAS,DNA,0.6885,19337429
47172,KRAS mutation,gene,0.878,19337429
47173,panitumumab,gene,0.7812,19337429
47174,panitumumab,gene,0.765,19337429
47175,panitumumab,gene,0.926,19337429
47176,advanced colorectal cancer,disease,0.9995,19337429
47177,advanced,disease,0.675,19336009
47178,colorectal cancer,disease,0.871,19336009
47179,advanced colorectal cancer,disease,1.0,19336009
47180,ACC,disease,1.0,19336009
47181,cancer,disease,1.0,19336009
47182,ACC,disease,0.9995,19336009
47183,ACC,disease,0.9995,19336009
47184,colorectal cancer,disease,1.0,19333227
47185,metastatic colorectal cancer,disease,0.9985,19333227
47186,oxaliplatin,drug,1.0,19333227
47187,irinotecan,drug,0.9995,19333227
47188,5-fluorouracil,drug,0.9995,19333227
47189,capecitabine,drug,0.9995,19333227
47190,acute and chronic neuropathy,disease,0.992,19333227
47191,hypersensitivity reactions,disease,0.9995,19333227
47192,diarrhea,disease,1.0,19333227
47193,neutropenia,disease,1.0,19333227
47194,hand-foot syndrome,disease,1.0,19333227
47195,hypertension,disease,1.0,19333227
47196,EGFR,gene,0.98,19333227
47197,hypersensitivity,disease,1.0,19333227
47198,paronychial infections,disease,1.0,19333227
47199,dermatologic rash,disease,1.0,19333227
47200,EGFR,gene,0.918,19333227
47201,rash,disease,0.9995,19333227
47202,colorectal cancer,disease,1.0,19333227
47203,metastatic colorectal cancer,disease,0.9995,19333227
47204,KRAS,gene,0.8486,19309232
47205,metastatic colorectal cancer,disease,1.0,19309232
47206,Colorectal carcinoma,disease,1.0,19309232
47207,CRC,disease,1.0,19309232
47208,CRC,disease,1.0,19309232
47209,Colorectal cancer,disease,1.0,19309232
47210,CRC,disease,0.998,19309232
47211,EGFR,gene,0.993,19309232
47212,CRC,disease,0.999,19309232
47213,Ras protein,gene,0.9033,19309232
47214,KRAS oncogene,gene,0.9004,19309232
47215,cancers,disease,1.0,19309232
47216,"colorectal, pancreatic, billiary tract and lung tumors",disease,1.0,19309232
47217,KRAS,DNA,0.8105,19309232
47218,KRAS mutations,gene,0.9414,19309232
47219,metastatic colorectal cancer,disease,1.0,19309232
47220,epidemal growth factor receptor,gene,0.999,19309232
47221,EGFR,gene,0.9966,19309232
47222,Panitumumab,gene,0.8794,19309232
47223,Cetuximab,gene,0.9204,19309232
47224,KRAS,DNA,0.8584,19309232
47225,KRAS mutations,gene,0.8477,19309232
47226,CRC,disease,0.9995,19309232
47227,KRAS,gene,0.5117,19309232
47228,tumors,disease,0.999,19309232
47229,KRAS,gene,0.8438,19309232
47230,formalin fixed paraffin embedded (FFPE) tissues DNA,DNA,0.554,19309232
47231,KRAS Mutation,gene,0.5903,19309232
47232,FFPE,cell_line,0.6084,19309232
47233,codon 12 and 13,DNA,0.7666,19309232
47234,KRAS gene,gene,0.8804,19309232
47235,tumor,disease,0.9976,19309232
47236,KRAS mutations,gene,0.6533,19309232
47237,KRAS,DNA,0.743,19309232
47238,KRAS mutations,gene,0.8936,19309232
47239,FFPE,cell_line,0.5806,19309232
47240,200bp amplicons,DNA,0.8486,19309232
47241,solid tumors,disease,1.0,19305491
47242,solid tumors,disease,1.0,19305491
47243,solid tumors,disease,1.0,19305491
47244,human epidermal receptor 2,gene,0.9966,19305491
47245,HER2,gene,0.978,19305491
47246,epidermal growth factor receptor,gene,0.997,19305491
47247,EGFR,gene,0.9883,19305491
47248,vascular endothelial growth factor,gene,0.998,19305491
47249,VEGF,gene,0.992,19305491
47250,solid tumors,disease,1.0,19305491
47251,head and neck,disease,0.8276,19305491
47252,gynecologic cancers,disease,1.0,19305491
47253,Trastuzumab,gene,0.9775,19305491
47254,bevacizumab,gene,0.88,19305491
47255,cetuximab,gene,0.91,19305491
47256,panitumumab,gene,0.935,19305491
47257,EGFR,gene,0.993,19293803
47258,colorectal cancer,disease,0.998,19293803
47259,Cetuximab,gene,0.7876,19293803
47260,panitumumab,gene,0.7334,19293803
47261,metastatic colorectal cancer,disease,1.0,19293803
47262,mCRC,disease,1.0,19293803
47263,EGFR gene,gene,0.831,19293803
47264,primary tumour,disease,0.997,19293803
47265,EGFR,gene,0.995,19293803
47266,primary,disease,0.7583,19293803
47267,tumour,disease,0.888,19293803
47268,mCRC,disease,1.0,19293803
47269,cetuximab,gene,0.91,19293803
47270,panitumumab,gene,0.957,19293803
47271,EGFR gene,gene,0.7324,19293803
47272,K-Ras,gene,0.9985,19293803
47273,BRAF,gene,0.5195,19293803
47274,PTEN,gene,0.993,19293803
47275,EGFR gene,gene,0.985,19293803
47276,primary tumours,disease,0.9995,19293803
47277,K-Ras,gene,0.999,19293803
47278,cancers,disease,1.0,19293803
47279,BRAF,DNA,0.6587,19293803
47280,BRAF mutations,gene,0.773,19293803
47281,cancers,disease,1.0,19293803
47282,PTEN,gene,0.984,19293803
47283,cancers,disease,1.0,19293803
47284,primary,disease,0.897,19293803
47285,colorectal cancer,disease,0.892,19293803
47286,EGFR,gene,0.991,19293803
47287,cetuximab,gene,0.947,19293803
47288,panitumumab,gene,0.8945,19293803
47289,EGFR,gene,0.7983,19293803
47290,mCRC,disease,0.9863,19293803
47291,panitumumab,gene,0.939,19287023
47292,metastatic colorectal cancer,disease,0.9995,19287023
47293,Panitumumab,gene,0.907,19287023
47294,epidermal growth factor receptor,gene,0.9966,19287023
47295,EGFR,gene,0.9863,19287023
47296,metastatic colorectal cancer,disease,0.997,19287023
47297,mCRC,disease,0.997,19287023
47298,panitumumab,gene,0.8716,19287023
47299,mCRC,disease,0.992,19287023
47300,fluoropyrimidine,drug,0.999,19287023
47301,irinotecan,drug,0.9995,19287023
47302,oxaliplatin,drug,0.9995,19287023
47303,colorectal adenocarcinoma,disease,1.0,19287023
47304,EGFR,gene,0.992,19287023
47305,tumor cells,cell_type,0.8525,19287023
47306,tumor,disease,0.954,19287023
47307,panitumumab,gene,0.724,19287023
47308,panitumumab,gene,0.8916,19287023
47309,Panitumumab,gene,0.722,19287023
47310,acne,disease,1.0,19287023
47311,dry skin,disease,0.9995,19287023
47312,rash,disease,1.0,19287023
47313,paronychia,disease,1.0,19287023
47314,pruritus,disease,1.0,19287023
47315,hypomagnesemia,disease,1.0,19287023
47316,Panitumumab,gene,0.871,19287023
47317,mCRC,disease,0.994,19287023
47318,panitumumab,gene,0.9634,19282350
47319,metastatic colorectal cancer,disease,0.9985,19282350
47320,panitumumab,gene,0.9287,19282350
47321,epidermal growth,disease,0.887,19282350
47322,factor,gene,0.5635,19282350
47323,metastatic colorectal carcinoma,disease,0.9897,19282350
47324,fluoropyrimidine,drug,0.9956,19282350
47325,oxaliplatin,drug,0.9985,19282350
47326,irinotecan,drug,0.9937,19282350
47327,panitumumab,gene,0.885,19282350
47328,bevacizumab,gene,0.8203,19282350
47329,panitumumab,gene,0.8125,19282350
47330,metastatic colorectal cancer,disease,0.988,19282350
47331,panitumumab,gene,0.887,19282350
47332,bevacizumab,gene,0.852,19282350
47333,bevacizumab,gene,0.828,19282350
47334,panitumumab,gene,0.9385,19282350
47335,panitumumab,gene,0.9146,19282350
47336,rash,disease,1.0,19282350
47337,acneiform dermatitis,disease,1.0,19282350
47338,diarrhea,disease,1.0,19282350
47339,dehydration,disease,0.9995,19282350
47340,diarrhea,disease,1.0,19282350
47341,hypokalemia,disease,1.0,19282350
47342,stomatitis,disease,1.0,19282350
47343,mucositis,disease,1.0,19282350
47344,pulmonary embolism,disease,1.0,19282350
47345,panitumumab,gene,0.916,19282350
47346,bevacizumab,gene,0.932,19282350
47347,metastatic colorectal cancer,disease,1.0,19282350
47348,bevacizumab,gene,0.825,19282350
47349,panitumumab,gene,0.848,19282350
47350,KRAS,gene,0.7363,19282104
47351,BRAF,gene,0.5947,19282104
47352,renal cell carcinoma,disease,1.0,19282104
47353,epidermal growth factor receptor monoclonal,gene,0.9214,19269105
47354,cancer,disease,1.0,19269105
47355,cancer,disease,1.0,19269105
47356,cancer,disease,1.0,19269105
47357,cancer,disease,1.0,19269105
47358,epidermal growth factor receptor,gene,0.9985,19269105
47359,EGFR,gene,0.9937,19269105
47360,EGFR,gene,0.9937,19269105
47361,EGFR,gene,0.9927,19269105
47362,EGFR,gene,0.97,19269105
47363,EGFR,gene,0.987,19269105
47364,tumor,disease,1.0,19269105
47365,panitumumab,gene,0.925,19254943
47366,hypersensitivity reactions,disease,0.998,19254943
47367,cetuximab,gene,0.82,19254943
47368,colorectal cancer,disease,1.0,29788610
47369,anti-EGFR monoclonal antibodies,gene,0.856,29788610
47370,Anti-EGF receptor,gene,0.875,29788610
47371,EGFR,gene,0.9795,29788610
47372,cetuximab,gene,0.8613,29788610
47373,panitumumab,gene,0.894,29788610
47374,metastatic colorectal cancer,disease,0.9966,29788610
47375,KRAS,DNA,0.765,29788610
47376,KRAS mutations,gene,0.876,29788610
47377,EGFR,gene,0.943,29788610
47378,EGF,gene,0.9907,29788610
47379,anti-tumor,disease,0.7437,29788610
47380,EGFR,gene,0.9365,29788610
47381,KRAS,gene,0.898,20856723
47382,Cetuximab,gene,0.846,20856723
47383,Panitumumab,gene,0.7744,20856723
47384,Colorectal Cancer,disease,1.0,20856723
47385,oncologists,cell_type,0.4321,20856723
47386,cetuximab,gene,0.79,20856723
47387,panitumumab,gene,0.6655,20856723
47388,KRAS,gene,0.7095,20856723
47389,codon 12 or 13,DNA,0.6646,20856723
47390,colorectal cancer,disease,1.0,20856723
47391,advanced colorectal cancer,disease,0.999,19238551
47392,metastatic colorectal cancer,disease,1.0,19238551
47393,MCRC,disease,1.0,19238551
47394,vascular endothelial growth factor,gene,0.999,19238551
47395,VEGF,gene,0.9956,19238551
47396,epidermal growth factor receptor,gene,0.999,19238551
47397,EGFR,gene,0.9956,19238551
47398,MCRC,disease,0.9766,19238551
47399,anti-VEGF monoclonal antibody,gene,0.9863,19238551
47400,bevacizumab,gene,0.842,19238551
47401,anti-EGFR monoclonal antibodies,gene,0.9756,19238551
47402,cetuximab,gene,0.866,19238551
47403,panitumumab,gene,0.892,19238551
47404,MCRC,cell_line,0.6997,19238551
47405,KRAS,gene,0.897,19238551
47406,EGFR,gene,0.9443,19238551
47407,metastatic colorectal cancer,disease,0.999,19231039
47408,Colorectal cancer,disease,1.0,19231039
47409,cancer,disease,1.0,19231039
47410,bevacizumab,gene,0.562,19231039
47411,VEGF,gene,0.9956,19231039
47412,EGFR,gene,0.9927,19231039
47413,cetuximab,gene,0.7363,19231039
47414,panitumumab,gene,0.786,19231039
47415,metastatic colorectal cancer,disease,0.994,19231039
47416,skin rash,disease,0.9985,19229368
47417,EGFR,gene,0.995,19229368
47418,gastrointestinal malignancies,disease,1.0,19229368
47419,epidermal growth factor receptor,gene,0.999,19229368
47420,EGFR,gene,0.9937,19229368
47421,solid tumours,disease,1.0,19229368
47422,gastrointestinal (GI) malignancies,disease,1.0,19229368
47423,EGFR,gene,0.996,19229368
47424,"advanced lung, head-and-neck, and colorectal",disease,0.9995,19229368
47425,carcinoma,disease,0.8926,19229368
47426,EGFR,gene,0.989,19229368
47427,tyrosine,drug,0.9126,19229368
47428,tyrosine kinase,gene,0.9736,19229368
47429,erlotinib,drug,0.985,19229368
47430,gefitinib,drug,0.9937,19229368
47431,panitumumab,gene,0.845,19229368
47432,cetuximab,gene,0.906,19229368
47433,EGFRIS,gene,0.7544,19229368
47434,malignancies,disease,0.9995,19229368
47435,skin rash,disease,1.0,19229368
47436,skin rash,disease,1.0,19229368
47437,EGFRI,gene,0.9946,19229368
47438,EGFR,gene,0.9966,19229368
47439,gi malignancy,disease,0.9995,19229368
47440,skin rash,disease,1.0,19229368
47441,skin rash,disease,1.0,19229368
47442,PIK3CA,gene,0.9927,19223544
47443,colorectal cancer,disease,1.0,19223544
47444,EGFR,gene,0.9937,19223544
47445,panitumumab,gene,0.847,19223544
47446,cetuximab,gene,0.814,19223544
47447,epidermal growth factor receptor,gene,0.9966,19223544
47448,EGFR,gene,0.993,19223544
47449,metastatic colorectal cancer,disease,0.9526,19223544
47450,mCRC,disease,0.9985,19223544
47451,EGFR,gene,0.996,19223544
47452,KRAS,gene,0.7095,19223544
47453,BRAF,gene,0.5596,19223544
47454,mitogen-activated protein kinases,gene,0.977,19223544
47455,PIK3CA,gene,0.937,19223544
47456,PTEN,gene,0.994,19223544
47457,AKT1,gene,0.997,19223544
47458,KRAS,gene,0.9946,19223544
47459,mCRC,disease,0.9995,19223544
47460,KRAS,DNA,0.622,19223544
47461,KRAS mutations,gene,0.833,19223544
47462,panitumumab,gene,0.842,19223544
47463,cetuximab,gene,0.6387,19223544
47464,PIK3CA,gene,0.99,19223544
47465,EGFR,gene,0.994,19223544
47466,PIK3CA,gene,0.822,19223544
47467,KRAS,gene,0.824,19223544
47468,PTEN protein,gene,0.8096,19223544
47469,mCRC,disease,0.9985,19223544
47470,EGFR moAbs,gene,0.945,19223544
47471,PIK3CA,gene,0.732,19223544
47472,KRAS,DNA,0.826,19223544
47473,KRAS mutations,gene,0.963,19223544
47474,PIK3CA,gene,0.994,19223544
47475,panitumumab,gene,0.8193,19223544
47476,cetuximab,gene,0.7437,19223544
47477,KRAS,gene,0.658,19223544
47478,tumors,disease,0.859,19223544
47479,PIK3CA,DNA,0.725,19223544
47480,PIK3CA mutations,gene,0.83,19223544
47481,PIK3CA,DNA,0.6562,19223544
47482,PIK3CA mutations,gene,0.7793,19223544
47483,panitumumab,gene,0.838,19223544
47484,cetuximab,gene,0.702,19223544
47485,mCRC,disease,0.998,19223544
47486,PIK3CA,gene,0.9946,19223544
47487,PTEN,gene,0.993,19223544
47488,KRAS,gene,0.812,19223544
47489,mCRC,disease,0.9966,19223544
47490,EGFR moAbs,gene,0.9424,19223544
47491,KRAS,gene,0.8223,19204679
47492,Panitumumab,gene,0.8936,19203897
47493,metastatic colorectal cancer,disease,1.0,19203897
47494,cetuximab,gene,0.883,19203897
47495,epidermal growth factor receptor,gene,0.998,19203897
47496,metastatic colorectal cancer,disease,1.0,19203897
47497,mCRC,disease,1.0,19203897
47498,cetuximab,gene,0.655,19203897
47499,panitumumab,gene,0.583,19203897
47500,panitumumab,gene,0.834,19203897
47501,mCRC,disease,0.9937,19203897
47502,cetuximab,gene,0.7725,19203897
47503,panitumumab,gene,0.8438,19203897
47504,PATIENTS,species,0.837,19203897
47505,fluoropyrimidine,drug,0.998,19203897
47506,oxaliplatin,drug,0.9995,19203897
47507,irinotecan,drug,0.996,19203897
47508,cetuximab,gene,0.8276,19203897
47509,panitumumab,gene,0.896,19203897
47510,bevacizumab,gene,0.759,19203897
47511,cetuximab,gene,0.8955,19203897
47512,cetuximab,gene,0.8877,19203897
47513,cetuximab,gene,0.8516,19203897
47514,panitumumab,gene,0.901,19203897
47515,Panitumumab,gene,0.8535,19203897
47516,panitumumab,gene,0.8975,19203897
47517,panitumumab,gene,0.954,19203897
47518,mCRC,disease,0.999,19203897
47519,cetuximab,gene,0.839,19203897
47520,panitumumab,gene,0.924,19203897
47521,panitumumab,gene,0.8467,19203894
47522,solid tumors,disease,1.0,19203894
47523,panitumumab,gene,0.851,19203894
47524,advanced solid malignancies,disease,0.9995,19203894
47525,PATIENTS,species,0.911,19203894
47526,advanced solid tumors,disease,1.0,19203894
47527,panitumumab,gene,0.759,19203894
47528,panitumumab,gene,0.8604,19203894
47529,antipanitumumab antibody,gene,0.897,19203894
47530,panitumumab,gene,0.7812,19203894
47531,panitumumab,gene,0.7173,19203894
47532,Panitumumab,gene,0.9116,19203894
47533,"colon, rectal, esophageal, and bladder cancers",disease,1.0,19203894
47534,panitumumab,gene,0.842,19203894
47535,KRAS,gene,0.8545,19189371
47536,panitumumab,gene,0.9365,19189371
47537,skin toxicity,disease,0.997,19189371
47538,ST,disease,0.9766,19189371
47539,ST,disease,0.871,19189371
47540,panitumumab,gene,0.801,19189371
47541,antiepidermal growth factor receptor antibody,gene,0.8975,19189371
47542,metastatic colorectal cancer,disease,1.0,19189371
47543,CRC,disease,1.0,19189371
47544,panitumumab,gene,0.79,19189371
47545,CRC,disease,0.9995,19189371
47546,KRAS,DNA,0.7817,19189371
47547,KRAS mutational,gene,0.886,19189371
47548,BSC,disease,0.967,19189371
47549,Panitumumab,gene,0.883,19189371
47550,ST,disease,0.9536,19189371
47551,KRAS,gene,0.791,19189371
47552,KRAS,gene,0.788,19189371
47553,ST,disease,0.635,19189371
47554,wild,cell_line,0.4924,19189371
47555,wild-type (WT) KRAS,gene,0.7554,19189371
47556,mutant,cell_line,0.559,19189371
47557,mutant KRAS tumors,disease,0.849,19189371
47558,mutant KRAS,gene,0.942,19189371
47559,ST,disease,0.9985,19189371
47560,CRC,disease,1.0,19189371
47561,panitumumab,gene,0.9053,19189371
47562,WT,disease,0.5146,19189371
47563,WT KRAS,gene,0.853,19189371
47564,KRAS gene,DNA,0.8516,19188670
47565,KRAS gene mutations,gene,0.8306,19188670
47566,metastatic colorectal carcinoma,disease,1.0,19188670
47567,epidermal growth factor receptor,gene,0.975,19188670
47568,KRAS gene,gene,0.8774,19188670
47569,metastatic colorectal carcinoma,disease,1.0,19188670
47570,anti-epidermal growth factor receptor,gene,0.9556,19188670
47571,anti-EGFR,gene,0.977,19188670
47572,cetuximab,gene,0.8755,19188670
47573,panitumumab,gene,0.9116,19188670
47574,metastatic colorectal cancer,disease,0.997,19188670
47575,EGFR,gene,0.9854,19188670
47576,KRAS,DNA,0.832,19188670
47577,KRAS mutations,gene,0.968,19188670
47578,codon 12 or 13,DNA,0.7627,19188670
47579,cetuximab,gene,0.8315,19188670
47580,panitumumab,gene,0.77,19188670
47581,metastatic colorectal carcinoma,disease,1.0,19188670
47582,KRAS,gene,0.824,19188670
47583,tumor,disease,0.9805,19188670
47584,KRAS,gene,0.806,19188670
47585,metastatic colorectal carcinoma,disease,0.9995,19188670
47586,anti-EGFR antibody,gene,0.9097,19188670
47587,tumor,disease,0.995,19188670
47588,KRAS,DNA,0.83,19188670
47589,KRAS mutations,gene,0.798,19188670
47590,KRAS,gene,0.718,19188670
47591,codon 12 or 13,DNA,0.7065,19188670
47592,metastatic colorectal carcinoma,disease,1.0,19188670
47593,anti-EGFR antibody,gene,0.8413,19188670
47594,PCOs,cell_line,0.49,19188670
47595,PCOs,DNA,0.5303,19188670
47596,cancer,disease,1.0,19176373
47597,indocyanine green,drug,0.9976,19176373
47598,indocyanine green,drug,0.9995,19176373
47599,ICG,drug,0.996,19176373
47600,ICG,drug,0.986,19176373
47601,ICG,drug,0.9614,19176373
47602,daclizumab,gene,0.8267,19176373
47603,Dac,gene,0.9585,19176373
47604,trastuzumab,gene,0.966,19176373
47605,Tra,gene,0.958,19176373
47606,panitumumab,gene,0.965,19176373
47607,Pan,gene,0.961,19176373
47608,2-mercaptoethanol,drug,0.9995,19176373
47609,target cells,cell_type,0.9043,19176373
47610,mice,species,0.973,19176373
47611,CD25,gene,0.995,19176373
47612,Dac,drug,0.946,19176373
47613,ICG,drug,0.8745,19176373
47614,tumors,disease,1.0,19176373
47615,HER1,gene,0.9937,19176373
47616,HER2,gene,0.9917,19176373
47617,Pan-ICG,gene,0.807,19176373
47618,Tra,drug,0.5244,19176373
47619,Tra-ICG,gene,0.9126,19176373
47620,target cells,cell_type,0.807,19176373
47621,epidermal growth factor receptor,gene,0.997,19144681
47622,metastatic colorectal cancer,disease,0.997,19144681
47623,advanced colorectal cancer,disease,0.934,19144681
47624,CRC,disease,1.0,19144681
47625,epidermal growth factor receptor,gene,0.9966,19144681
47626,EGFR,gene,0.9873,19144681
47627,cetuximab,gene,0.7534,19144681
47628,mouse,species,0.9634,19144681
47629,advanced CRC,disease,0.997,19144681
47630,Cetuximab,gene,0.9243,19144681
47631,irinotecan,drug,0.998,19144681
47632,panitumumab,gene,0.9043,19144681
47633,cetuximab,gene,0.8965,19144681
47634,advanced CRC,disease,0.9985,19144681
47635,panitumumab,gene,0.9497,19144681
47636,cetuximab,gene,0.906,19144681
47637,KRAS gene,gene,0.7363,19144681
47638,CRC,disease,0.999,19144681
47639,EGFR,gene,0.7866,19144681
47640,EGFR,gene,0.9175,19144681
47641,advanced CRC,disease,1.0,19144681
47642,metastatic colorectal cancer,disease,0.989,19133603
47643,metastatic colorectal cancer,disease,1.0,19133603
47644,mCRC,disease,1.0,19133603
47645,fluorouracil,drug,0.999,19133603
47646,5-FU,drug,0.999,19133603
47647,mCRC,disease,0.999,19133603
47648,5-FU,drug,0.999,19133603
47649,leucovorin,drug,0.9995,19133603
47650,irinotecan,drug,0.9985,19133603
47651,oxaliplatin,drug,0.9995,19133603
47652,capecitabine,drug,0.999,19133603
47653,bevacizumab,gene,0.8965,19133603
47654,cetuximab,gene,0.8955,19133603
47655,panitumumab,gene,0.9062,19133603
47656,KRAS,DNA,0.8174,19124802
47657,KRAS mutations,gene,0.8525,19124802
47658,epidermal growth factor receptor,gene,0.9966,19124802
47659,colorectal cancer,disease,1.0,19124802
47660,advanced colorectal cancer,disease,1.0,19124802
47661,tumors,disease,1.0,19124802
47662,KRAS gene,gene,0.927,19124802
47663,epidermal growth factor receptor,gene,0.998,19124802
47664,cetuximab,gene,0.621,19124802
47665,panitumumab,gene,0.7354,19124802
47666,anticancer,disease,0.7515,19124802
47667,colorectal cancer,disease,1.0,19124802
47668,KRAS,DNA,0.8438,19124802
47669,KRAS mutation,gene,0.974,19124802
47670,colorectal cancer,disease,1.0,19124802
47671,EGF-R,gene,0.999,19124237
47672,erbB-1,gene,0.9966,19124237
47673,VEGF-R,gene,0.9976,19124237
47674,cancer,disease,1.0,19124237
47675,tumour,disease,1.0,19124237
47676,EGF-R,gene,0.9985,19124237
47677,VEGF,gene,0.998,19124237
47678,VEGF-R,gene,0.997,19124237
47679,neoplastic,disease,0.8296,19124237
47680,EGF-R,gene,0.999,19124237
47681,erbB-2,gene,0.992,19124237
47682,VEGF-R-2,gene,0.9966,19124237
47683,VEGF,gene,0.9956,19124237
47684,cancer,disease,1.0,19124237
47685,cancers,disease,1.0,19124237
47686,EGF-R,gene,0.998,19124237
47687,VEGF,gene,0.998,19124237
47688,VEGF-R,gene,0.9976,19124237
47689,bFGF,gene,0.9863,19124237
47690,MMP-9,gene,0.9854,19124237
47691,SDF-1alpha,gene,0.9927,19124237
47692,HIF,gene,0.9536,19124237
47693,bone marrow-derived CD45+ myeloid cells,cell_type,0.902,19124237
47694,EGF-R,gene,0.998,19124237
47695,tyrosine,drug,0.9697,19124237
47696,tyrosine kinase,gene,0.993,19124237
47697,EGF-R,gene,0.999,19124237
47698,c-MET,gene,0.997,19124237
47699,IGF-1R,gene,0.998,19124237
47700,PTEN,gene,0.995,19124237
47701,K-ras,gene,0.6865,19124237
47702,EGF-R mutations,gene,0.9834,19124237
47703,K-ras,DNA,0.6484,19124237
47704,K-ras mutations,gene,0.9385,19124237
47705,EGF-R,gene,0.998,19124237
47706,tyrosine,drug,0.734,19124237
47707,tyrosine kinase,gene,0.708,19124237
47708,NSCLC,disease,0.999,19124237
47709,cetuximab,gene,0.9395,19124237
47710,panitumumab,gene,0.904,19124237
47711,advanced colorectal cancer,disease,1.0,19124237
47712,cancers,disease,1.0,19124237
47713,EGFR,gene,0.9946,19117687
47714,KRAS,gene,0.77,19117687
47715,colorectal cancer,disease,1.0,19117687
47716,EGFR,gene,0.9897,19117687
47717,epidermal growth factor receptor,gene,0.9976,19117687
47718,EGFR,gene,0.9917,19117687
47719,tumor,disease,0.555,19117687
47720,colorectal cancer,disease,1.0,19117687
47721,CRC,disease,1.0,19117687
47722,EGFR,gene,0.994,19117687
47723,CRC,disease,0.96,19117687
47724,KRAS,gene,0.99,19117687
47725,EGFR,gene,0.9946,19117687
47726,activating,gene,0.5225,19117687
47727,KRAS mutations,gene,0.4658,19117687
47728,EGFR,gene,0.995,19117687
47729,cetuximab,gene,0.701,19117687
47730,panitumumab,gene,0.736,19117687
47731,tumors,disease,1.0,19117687
47732,KRAS gene,gene,0.9224,19117687
47733,EGFR,gene,0.996,19117687
47734,PTEN,gene,0.913,19117687
47735,BRAF,gene,0.779,19117687
47736,EGFR,gene,0.922,19117687
47737,EGFR,gene,0.782,19117687
47738,isoniazid,drug,0.9985,22461093
47739,succinylcholine,drug,0.999,22461093
47740,thiopurine,drug,0.995,22461093
47741,thiopurine methyl transferase,gene,0.9927,22461093
47742,uridine,drug,0.9985,22461093
47743,uridine 5&#x27;-diphosphoglucuronosyl-transferase 1A1 gene,gene,0.966,22461093
47744,mercaptopurine,drug,0.9995,22461093
47745,azathioprine,drug,0.999,22461093
47746,irinotecan,drug,0.999,22461093
47747,myelosuppression,disease,0.998,22461093
47748,cytochrome P450 gene,gene,0.993,22461093
47749,HLA-B*5701 allele,gene,0.9946,22461093
47750,hypersensitivity reactions,disease,0.9834,22461093
47751,abacavir,drug,0.996,22461093
47752,human epidermal growth factor receptor,gene,0.9946,22461093
47753,human,species,0.8613,22461093
47754,HER-2,gene,0.9976,22461093
47755,trastuzumab,gene,0.968,22461093
47756,breast cancer,disease,1.0,22461093
47757,KRAS,gene,0.979,22461093
47758,cetuximab,gene,0.837,22461093
47759,panitumumab,gene,0.729,22461093
47760,colorectal cancer,disease,1.0,22461093
47761,osteoarticular diseases,disease,1.0,22461093
47762,rheumatoid arthritis,disease,1.0,22461093
47763,osteoporosis,disease,1.0,22461093
47764,vitamin D,drug,0.9995,22461093
47765,estrogens,drug,0.9985,22461093
47766,genetic variants,DNA,0.7036,22461093
47767,genetic variants,DNA,0.8223,22461093
47768,cetuximab,gene,0.9507,21188126
47769,colorectal cancer,disease,1.0,21188126
47770,epidermal growth factor receptor,gene,0.9634,21188126
47771,EGFR,gene,0.997,21188126
47772,cetuximab,gene,0.572,21188126
47773,colorectal cancer,disease,1.0,21188126
47774,Cetuximab,gene,0.931,21188126
47775,cetuximab,gene,0.824,21188126
47776,metastatic colorectal cancer,disease,0.9966,21188126
47777,cetuximab,gene,0.688,21188126
47778,patients,species,0.983,21188126
47779,KRAS,gene,0.992,21188126
47780,panitumumab,gene,0.6807,21188126
47781,EGFR antibody,gene,0.8247,21188126
47782,tumors,disease,1.0,21188126
47783,KRAS wildtype genes,DNA,0.9023,21188126
47784,KRAS wildtype genes,gene,0.9907,21188126
47785,tumors,disease,1.0,21188126
47786,oncogenic KRAS,gene,0.998,21188126
47787,codons,DNA,0.4858,21188126
47788,EGFR,gene,0.994,21188126
47789,EGFR,gene,0.9917,21188126
47790,KRAS,gene,0.994,21188126
47791,cetuximab,gene,0.6777,21188126
47792,KRAS,DNA,0.8193,21188126
47793,KRAS,gene,0.985,21188126
47794,KRAS,gene,0.9854,21188126
47795,EGFR,gene,0.9795,21188126
47796,patients,species,0.977,21188126
47797,KRAS,DNA,0.528,21188126
47798,KRAS mutated tumors,disease,0.8267,21188126
47799,KRAS,gene,0.983,21188126
47800,colorectal cancer,disease,1.0,20616903
47801,anti-,gene,0.8193,20616903
47802,epidermal growth factor receptor antibodies,gene,0.9263,20616903
47803,panitumumab,gene,0.7373,20616903
47804,colorectal cancer,disease,1.0,20616903
47805,CRC,disease,1.0,20616903
47806,epidermal growth factor receptor,gene,0.9985,20616903
47807,EGFR,gene,0.9937,20616903
47808,EGFR,gene,0.9917,20616903
47809,CRCs,disease,0.508,20616903
47810,EGFR,gene,0.9946,20616903
47811,CRC,disease,0.633,20616903
47812,cetuximab,gene,0.7837,20616903
47813,panitumumab,gene,0.742,20616903
47814,Cetuximab,gene,0.785,20616903
47815,mouse,species,0.9116,20616903
47816,EGF-receptor,gene,0.9976,20616903
47817,panitumumab,gene,0.792,20616903
47818,humanized,species,0.767,20616903
47819,EGFR,gene,0.988,20616903
47820,humanized,species,0.863,20616903
47821,panitumumab,gene,0.9355,20616903
47822,mouse,species,0.976,20616903
47823,hypersensitivity,disease,0.9062,20616903
47824,panitumumab,gene,0.913,20616903
47825,Panitumumab,gene,0.897,20616903
47826,mCRC,disease,0.9365,20616903
47827,panitumumab,gene,0.916,20616903
47828,KRAS,gene,0.881,20616903
47829,panitumumab,gene,0.837,20616903
47830,cetuximab,gene,0.7046,20616903
47831,CRC,disease,0.999,20616903
47832,wild,gene,0.5854,20616903
47833,cancer,disease,0.9995,20616903
47834,EGFR,gene,0.9727,20432670
47835,KRAS,gene,0.751,20432670
47836,metastatic colorectal cancer,disease,0.9995,20432670
47837,metastasic colorectal cancer,disease,1.0,20432670
47838,antiEGFR monoclonal antibodies,gene,0.845,20432670
47839,cetuximab,gene,0.848,20432670
47840,panitumumab,gene,0.8994,20432670
47841,FOLFOX,drug,0.884,20432670
47842,FOLFIRI,drug,0.837,20432670
47843,cetuximab,gene,0.8257,20432670
47844,panitumumab,gene,0.65,20432670
47845,KRAS-wild type (KRAS-wt) colorectal tumors,disease,0.9946,20432670
47846,KRAS,gene,0.9854,20432670
47847,KRAS,gene,0.8345,20432670
47848,KRAS-,cell_line,0.546,20432670
47849,KRAS-mutated tumors,disease,0.999,20432670
47850,KRAS,gene,0.4675,20432670
47851,colorectal tumors,disease,1.0,20432670
47852,KRAS,gene,0.6113,20432670
47853,tumors,disease,0.511,20432670
47854,KRAS,gene,0.9946,20432670
47855,tumors,disease,0.575,20432670
47856,KRAS,DNA,0.6396,20432670
47857,KRAS-,gene,0.994,20432670
47858,colorectal tumors,disease,0.9976,20432670
47859,EGFR,gene,0.996,20432670
47860,EGFR,gene,0.994,20432670
47861,EGFR,gene,0.9937,20432670
47862,KRAS,gene,0.5156,20432670
47863,B-RAF,gene,0.9927,20432670
47864,PIK3CA,gene,0.997,20432670
47865,PTEN,gene,0.986,20432670
47866,AKT,gene,0.9893,20432670
47867,JAK,gene,0.9956,20432670
47868,STAT,gene,0.98,20432670
47869,anti-,gene,0.559,20130433
47870,EGFR,gene,0.6504,20130433
47871,metastatic colorectal carcinoma,disease,1.0,20130433
47872,KRAS,gene,0.774,20130433
47873,BRAF,gene,0.4736,20130433
47874,epidermal growth factor receptor,gene,0.9985,20130433
47875,EGFR,gene,0.9893,20130433
47876,metastatic colorectal carcinoma,disease,0.934,20130433
47877,KRAS gene,gene,0.9336,20130433
47878,tumor,disease,0.9995,20130433
47879,BRAF,gene,0.76,20130433
47880,EGFR,gene,0.9487,20130433
47881,colorectal carcinoma,disease,1.0,20130433
47882,KRAS,gene,0.8745,20130433
47883,cetuximab,gene,0.692,20130433
47884,panitumumab,gene,0.8657,20130433
47885,FOLFIRI,drug,0.813,20130433
47886,folinic acid,drug,0.999,20130433
47887,fluorouracil,drug,0.999,20130433
47888,irinotecan,drug,0.999,20130433
47889,cetuximab,gene,0.8574,20130433
47890,folinic acid,drug,0.9995,20130433
47891,fluorouracil,drug,0.9995,20130433
47892,oxaliplatin,drug,0.9995,20130433
47893,cetuximab,gene,0.8394,20130433
47894,cetuximab,gene,0.9595,20130433
47895,panitumumab,gene,0.869,20130433
47896,metastatic colorectal cancer,disease,1.0,20130433
47897,KRAS,DNA,0.5747,20130433
47898,KRAS,DNA,0.842,20130433
47899,KRAS mutations,gene,0.799,20130433
47900,cetuximab,gene,0.8354,20130433
47901,panitumumab,gene,0.83,20130433
47902,EGFR,gene,0.9897,20130433
47903,RAS,gene,0.9927,20130433
47904,RAF,gene,0.998,20130433
47905,MAPK,gene,0.991,20130433
47906,metastatic colorectal cancer,disease,0.967,20130433
47907,HER,gene,0.5117,19433372
47908,head and neck and thoracic cancers,disease,1.0,19433372
47909,Bronchial and head and neck (HN) cancers,disease,1.0,19433372
47910,HER,gene,0.996,19433372
47911,HER,gene,0.9917,19433372
47912,cetuximab,gene,0.8154,19433372
47913,tyrosine,drug,0.9917,19433372
47914,tyrosine kinase,gene,0.9927,19433372
47915,HER,gene,0.9897,19433372
47916,gefitinib,drug,0.9585,19433372
47917,erlotinib,drug,0.988,19433372
47918,HER,gene,0.9927,19433372
47919,VEGFR,gene,0.9927,19433372
47920,ZD6474,drug,0.9966,19433372
47921,cetuximab,gene,0.865,19433372
47922,HN cancers,disease,0.896,19433372
47923,erlotinib,drug,0.997,19433372
47924,gefitinib,drug,0.998,19433372
47925,non-small-cell lung cancer,disease,1.0,19433372
47926,NSCLC,disease,1.0,19433372
47927,trastuzumab,gene,0.937,19433372
47928,panitumumab,gene,0.9004,19433372
47929,matuzumab,gene,0.889,19433372
47930,lapatinib,drug,0.9995,19433372
47931,HKI 272,drug,0.999,19433372
47932,PKI 166,drug,0.9995,19433372
47933,EKB-569,drug,0.9995,19433372
47934,AEE-788,drug,0.999,19433372
47935,HER,gene,0.99,19433372
47936,EGFR gene,DNA,0.767,19433372
47937,EGFR gene mutations,gene,0.9165,19433372
47938,EGFR,gene,0.9834,19433372
47939,lung cancer,disease,1.0,19433372
47940,HER,gene,0.989,19433372
47941,HN,disease,1.0,19433372
47942,NSCLC,disease,0.9995,19433372
47943,bevacizumab,gene,0.7285,19114685
47944,panitumumab,gene,0.9204,19114685
47945,bevacizumab,gene,0.718,19114685
47946,metastatic colorectal cancer,disease,0.9995,19114685
47947,Panitumumab,gene,0.599,19114685
47948,epidermal growth factor receptor,gene,0.9976,19114685
47949,metastatic colorectal cancer,disease,1.0,19114685
47950,mCRC,disease,1.0,19114685
47951,panitumumab,gene,0.8833,19114685
47952,bevacizumab,gene,0.9126,19114685
47953,oxaliplatin,drug,0.9995,19114685
47954,irinotecan,drug,0.9976,19114685
47955,mCRC,disease,0.946,19114685
47956,PATIENTS,species,0.887,19114685
47957,bevacizumab,gene,0.9053,19114685
47958,panitumumab,gene,0.7573,19114685
47959,oxaliplatin,drug,0.9995,19114685
47960,oxaliplatin,drug,0.9995,19114685
47961,irinotecan,drug,0.998,19114685
47962,Panitumumab,gene,0.862,19114685
47963,oxaliplatin,drug,0.999,19114685
47964,panitumumab,gene,0.903,19114685
47965,panitumumab,gene,0.9497,19114685
47966,panitumumab,gene,0.861,19114685
47967,oxaliplatin,drug,0.9995,19114685
47968,panitumumab,gene,0.907,19114685
47969,diarrhea,disease,0.9995,19114685
47970,pulmonary embolism,disease,1.0,19114685
47971,panitumumab,gene,0.957,19114685
47972,irinotecan,drug,0.9985,19114685
47973,KRAS,gene,0.7637,19114685
47974,panitumumab,gene,0.8643,19114685
47975,panitumumab,gene,0.8647,19114685
47976,bevacizumab,gene,0.874,19114685
47977,oxaliplatin,drug,0.9995,19114685
47978,irinotecan,drug,0.995,19114685
47979,mCRC,disease,0.956,19114685
47980,metastatic colorectal cancer,disease,0.9985,19105712
47981,metastatic colorectal cancer,disease,1.0,19105712
47982,5-fluorouracil,drug,0.999,19105712
47983,5-FU,drug,0.999,19105712
47984,folinic acid,drug,0.999,19105712
47985,5-FU,drug,0.999,19105712
47986,oxaliplatin,drug,0.9995,19105712
47987,FOLFOX,drug,0.9854,19105712
47988,folinic acid,drug,0.9995,19105712
47989,5-FU,drug,0.999,19105712
47990,irinotecan,drug,0.998,19105712
47991,FOLFIRI,drug,0.9785,19105712
47992,bevacizumab,gene,0.5024,19105712
47993,VEGF-A,gene,0.9976,19105712
47994,panitumumab,gene,0.724,19105712
47995,EGF receptor,gene,0.9976,19105712
47996,metastatic colorectal cancer,disease,0.9995,19105712
47997,(+)-Dapoxetine hydrochloride,drug,0.9966,19088949
47998,(S)-Tenatoprazole sodium salt monohydrate,drug,0.9966,19088949
47999,Acotiamide,drug,0.998,19088949
48000,hydrochloride hydrate,drug,0.7974,19088949
48001,ADV-TK,gene,0.7153,19088949
48002,AE-37,gene,0.8164,19088949
48003,Aflibercept,gene,0.966,19088949
48004,Albinterferon alfa-2b,gene,0.998,19088949
48005,Aliskiren fumarate,drug,0.999,19088949
48006,Asenapine maleate,drug,0.998,19088949
48007,Axitinib,drug,0.99,19088949
48008,Becatecarin,drug,0.7183,19088949
48009,Calcipotriol,drug,0.9995,19088949
48010,betamethasone dipropionate,drug,0.999,19088949
48011,Casopitant mesylate,drug,0.9917,19088949
48012,Cediranib,drug,0.999,19088949
48013,CMD-193,drug,0.994,19088949
48014,Cositecan,drug,0.9976,19088949
48015,Darinaparsin,drug,0.995,19088949
48016,Denosumab,gene,0.498,19088949
48017,DP-b99,drug,0.9746,19088949
48018,Duloxetine hydrochloride,drug,0.993,19088949
48019,Elacytarabine,drug,0.978,19088949
48020,EMD-273063,drug,0.999,19088949
48021,Enzastaurin hydrochloride,drug,0.994,19088949
48022,Eplerenone,drug,0.999,19088949
48023,Eribulin mesilate,drug,0.994,19088949
48024,Esomeprazole magnesium,drug,0.924,19088949
48025,Etravirine,drug,0.9995,19088949
48026,Everolimus,drug,0.9976,19088949
48027,Ezetimibe,drug,0.9985,19088949
48028,Faropenem daloxate,drug,0.9927,19088949
48029,Febuxostat,drug,0.9985,19088949
48030,Fenretinide,drug,0.9985,19088949
48031,Ghrelin,gene,0.945,19088949
48032,I,drug,0.9375,19088949
48033,I-131-3F8,drug,0.793,19088949
48034,Iclaprim,drug,0.9985,19088949
48035,Iguratimod,drug,0.998,19088949
48036,Iloperidone,drug,0.998,19088949
48037,Imatinib mesylate,drug,0.999,19088949
48038,Inalimarev,drug,0.9976,19088949
48039,Falimarev,drug,0.998,19088949
48040,Indacaterol,drug,0.9976,19088949
48041,Ispinesib mesylate,drug,0.996,19088949
48042,Ixabepilone,drug,0.9976,19088949
48043,Lapatinib ditosylate,drug,0.999,19088949
48044,Laquinimod sodium,drug,0.997,19088949
48045,Larotaxel dehydrate,drug,0.995,19088949
48046,Linezolid,drug,0.9985,19088949
48047,LOR-2040,drug,0.999,19088949
48048,Mapatumumab,gene,0.6177,19088949
48049,MKC-1,drug,0.9976,19088949
48050,Motesanib diphosphate,drug,0.999,19088949
48051,Mycophenolic acid sodium salt,drug,0.997,19088949
48052,NK-012,drug,0.997,19088949
48053,Olanzapine pamoate,drug,0.9976,19088949
48054,Ortataxel,drug,0.7983,19088949
48055,Paclitaxel,drug,0.9995,19088949
48056,Paclitaxel poliglumex,drug,0.9478,19088949
48057,Paliperidone palmitate,drug,0.9985,19088949
48058,Panitumumab,gene,0.8804,19088949
48059,Patupilone,drug,0.996,19088949
48060,PCV-9,drug,0.9263,19088949
48061,Pegfilgrastim,gene,0.851,19088949
48062,Peginterferon alfa-2a,gene,0.993,19088949
48063,Peginterferon alfa-2b,gene,0.985,19088949
48064,Pertuzumab,gene,0.6445,19088949
48065,Picoplatin,drug,0.999,19088949
48066,Pimavanserin tartrate,drug,0.999,19088949
48067,Pimecrolimus,drug,0.9985,19088949
48068,Plerixafor,drug,0.997,19088949
48069,PM-02734,drug,0.991,19088949
48070,PR1,DNA,0.563,19088949
48071,Prasugrel,drug,0.995,19088949
48072,Pregabalin,drug,0.999,19088949
48073,Progesterone caproate,drug,0.9995,19088949
48074,Prucalopride,drug,0.999,19088949
48075,Pumosetrag hydrochloride,drug,0.973,19088949
48076,RAV-12,drug,0.999,19088949
48077,RB-007,drug,0.849,19088949
48078,Recombinant human erythropoietin alfa,gene,0.9976,19088949
48079,Rimonabant,drug,0.999,19088949
48080,Romidepsin,drug,0.9985,19088949
48081,SAR-109659,drug,0.999,19088949
48082,Satraplatin,drug,0.999,19088949
48083,Sodium butyrate,drug,0.9985,19088949
48084,Tadalafil,drug,0.9956,19088949
48085,Talampanel,drug,0.998,19088949
48086,Tanespimycin,drug,0.999,19088949
48087,Tarenflurbil,drug,0.999,19088949
48088,Tariquidar,drug,0.997,19088949
48089,Taurine,drug,0.9966,19088949
48090,Tecovirimat,drug,0.998,19088949
48091,Telatinib,drug,0.994,19088949
48092,Telavancin hydrochloride,drug,0.9946,19088949
48093,Telcagepant,drug,0.998,19088949
48094,Terameprocol,drug,0.9985,19088949
48095,Tesofensine,drug,0.9985,19088949
48096,Tetrodotoxin,drug,0.996,19088949
48097,Tezampanel,drug,0.997,19088949
48098,Tipifarnib,drug,0.9985,19088949
48099,TPI-287,drug,0.9985,19088949
48100,Valspodar,drug,0.9956,19088949
48101,Vatalanib succinate,drug,0.9976,19088949
48102,VCL-CB01,drug,0.9995,19088949
48103,vCP1452,drug,0.9976,19088949
48104,Vorinostat,drug,0.9985,19088949
48105,XL-228,drug,0.9956,19088949
48106,Ziprasidone hydrochloride,drug,0.998,19088949
48107,panitumumab,gene,0.9277,19086328
48108,metastatic colorectal cancer,disease,0.9917,19086328
48109,Panitumumab,gene,0.8535,19086328
48110,monoclonal IgG2 antibody,gene,0.716,19086328
48111,epidermal growth factor receptor,gene,0.997,19086328
48112,EGFR,gene,0.9907,19086328
48113,panitumumab,gene,0.8384,19086328
48114,metastatic colorectal cancer,disease,1.0,19086328
48115,mCRC,disease,1.0,19086328
48116,panitumumab,gene,0.916,19086328
48117,EGFR,gene,0.9927,19086328
48118,mCRC,disease,0.966,19086328
48119,panitumumab,gene,0.872,19086328
48120,panitumumab,gene,0.8037,19086328
48121,panitumumab,gene,0.7227,19086328
48122,tumours,disease,1.0,19086328
48123,wild-type KRAS,gene,0.526,19086328
48124,Panitumumab,gene,0.7344,19086328
48125,Panitumumab,gene,0.9014,19086328
48126,diarrhoea,disease,1.0,19086328
48127,anti-panitumumab antibodies,gene,0.948,19086328
48128,Panitumumab,gene,0.714,19086328
48129,EGFR,gene,0.3743,19086328
48130,mCRC,disease,0.6704,19086328
48131,wild,DNA,0.51,19086328
48132,wild-type KRAS,gene,0.928,19086328
48133,ErbB,gene,0.9814,19075865
48134,cancer,disease,0.9985,19075865
48135,ErbBs,gene,0.9766,19075865
48136,solid cancers,disease,1.0,19075865
48137,MAPK,gene,0.987,19075865
48138,PI3K,gene,0.9956,19075865
48139,ErbB,gene,0.993,19075865
48140,cancer,disease,1.0,19075865
48141,ATP,drug,0.9443,19075865
48142,tyrosine,drug,0.997,19075865
48143,tyrosine kinase domain,gene,0.9863,19075865
48144,cancer,disease,1.0,19075865
48145,Trastuzumab,gene,0.977,19075865
48146,Herceptin,gene,0.654,19075865
48147,HER2,gene,0.994,19075865
48148,breast cancer,disease,1.0,19075865
48149,Cetuximab,gene,0.935,19075865
48150,Panitumumab,gene,0.9487,19075865
48151,anti-EGFR antibodies,gene,0.8403,19075865
48152,colorectal cancer,disease,1.0,19075865
48153,cancer,disease,1.0,19075865
48154,ErbB members,gene,0.914,19075865
48155,ErbB,gene,0.945,19075865
48156,cancer,disease,1.0,19075865
48157,Gefitinib,drug,0.9995,19075865
48158,Iressa,drug,0.995,19075865
48159,Erlotinib,drug,0.999,19075865
48160,Tarceva,drug,0.997,19075865
48161,EGFR,gene,0.9937,19075865
48162,Lapatinib,drug,0.998,19075865
48163,Tykerb,drug,0.9897,19075865
48164,EGFR,gene,0.998,19075865
48165,HER2,gene,0.9956,19075865
48166,metastatic breast cancer,disease,1.0,19075865
48167,TK,DNA,0.4832,19075865
48168,TK domain,gene,0.7583,19075865
48169,ATP,drug,0.973,19075865
48170,cancer,disease,0.9995,19075865
48171,advanced colon cancer,disease,0.9995,19072376
48172,Colorectal cancer,disease,1.0,19072376
48173,CRC,disease,1.0,19072376
48174,malignancy,disease,1.0,19072376
48175,cancer,disease,0.999,19072376
48176,CRC,disease,0.996,19072376
48177,5-fluorouracil,drug,0.9995,19072376
48178,metastatic CRC,disease,0.8,19072376
48179,oxaliplatin,drug,0.9995,19072376
48180,irinotecan,drug,0.999,19072376
48181,epidermal growth factor receptor,gene,0.997,19072376
48182,cetuximab,gene,0.902,19072376
48183,panitumumab,gene,0.941,19072376
48184,VEGF,gene,0.984,19072376
48185,bevacizumab,gene,0.8384,19072376
48186,metastatic colon cancer,disease,0.9995,19072376
48187,K-ras,gene,0.8496,19064407
48188,epidermal growth factor receptor,gene,0.9966,19064407
48189,colorectal cancer,disease,1.0,19064407
48190,metastatic colorectal cancer,disease,1.0,19064407
48191,mCRC,disease,1.0,19064407
48192,irinotecan,drug,0.9995,19064407
48193,oxaliplatin,drug,0.9995,19064407
48194,bevacizumab,gene,0.6216,19064407
48195,5-fluorouracil,drug,0.9995,19064407
48196,leucovorin,drug,0.999,19064407
48197,mCRC,disease,0.9634,19064407
48198,tumor cells,cell_type,0.8633,19064407
48199,tumor,disease,0.975,19064407
48200,growth factor receptor,gene,0.9688,19064407
48201,EGFR,gene,0.9946,19064407
48202,EGFR,gene,0.9897,19064407
48203,G protein,gene,0.991,19064407
48204,K-Ras,gene,0.9155,19064407
48205,K-Ras oncoprotein,gene,0.9976,19064407
48206,guanosine diphosphate,drug,1.0,19064407
48207,guanosine triphosphate,drug,0.9995,19064407
48208,EGFR,gene,0.9917,19064407
48209,mCRC,disease,0.9824,19064407
48210,Cetuximab,gene,0.781,19064407
48211,panitumumab,gene,0.636,19064407
48212,EGFR,gene,0.992,19064407
48213,cetuximab,gene,0.8936,19064407
48214,panitumumab,gene,0.7285,19064407
48215,tumors,disease,1.0,19064407
48216,wild-type K-ras,gene,0.6787,19064407
48217,K-ras,gene,0.6807,19064407
48218,EGFR,gene,0.991,19064407
48219,gastric cancer,disease,1.0,19033703
48220,gastric or gastroesophageal carcinoma,disease,1.0,19033703
48221,MAGIC,DNA,0.59,19033703
48222,epirubicin,drug,0.9985,19033703
48223,cisplatin,drug,0.9995,19033703
48224,5-FU,drug,0.999,19033703
48225,capecitabine,drug,0.999,19033703
48226,5-FU,drug,0.998,19033703
48227,metastatic and locally advanced,disease,0.785,19033703
48228,esophageal and gastric carcinoma,disease,0.8867,19033703
48229,platinum,drug,0.9995,19033703
48230,Oxaliplatin,drug,0.9995,19033703
48231,cisplatin,drug,1.0,19033703
48232,Capecitabine,drug,0.999,19033703
48233,5-FU,drug,0.998,19033703
48234,docetaxel,drug,0.999,19033703
48235,platinum,drug,0.9995,19033703
48236,5-FU,drug,0.9985,19033703
48237,cetuximab,gene,0.9404,19033703
48238,panitumumab,gene,0.9355,19033703
48239,bevacizumab,gene,0.623,19033703
48240,Colorectal carcinoma,disease,1.0,19033696
48241,K,DNA,0.7583,19033696
48242,K-RAS,gene,0.998,19033696
48243,colorectal carcinoma,disease,1.0,19033696
48244,CRC,disease,1.0,19033696
48245,RAS protein,gene,0.9897,19033696
48246,EGFR,gene,0.9927,19033696
48247,CRC,disease,1.0,19033696
48248,mutated K-RAS gene,gene,0.784,19033696
48249,tumor,disease,1.0,19033696
48250,wild-type K-RAS gene,gene,0.9053,19033696
48251,tumor,disease,1.0,19033696
48252,K-RAS,gene,0.7007,19033696
48253,EGFR,gene,0.934,19033696
48254,K-RAS gene,gene,0.7935,19033696
48255,anti-EGFR antibodies cetuximab,gene,0.8594,19033696
48256,panitumumab,gene,0.6377,19033696
48257,VEGF antibody bevacizumab,gene,0.6953,19033696
48258,wild-type K-RAS,gene,0.6436,19033696
48259,mutated K-RAS,gene,0.5547,19033696
48260,anti-,gene,0.8384,18980550
48261,epidermal growth factor receptor monoclonal antibodies,gene,0.9204,18980550
48262,metastatic colorectal cancer,disease,0.995,18980550
48263,Cetuximab,gene,0.887,18980550
48264,panitumumab,gene,0.8706,18980550
48265,epidermal growth factor receptor,gene,0.997,18980550
48266,EGFR,gene,0.9893,18980550
48267,metastatic colorectal cancer,disease,0.9966,18980550
48268,anti-EGFR,gene,0.855,18980550
48269,anti-vascular endothelial growth factor monoclonal antibody,gene,0.9927,18980550
48270,EGFR,gene,0.742,18980550
48271,cetuximab,gene,0.944,18980550
48272,panitumumab,gene,0.8667,18980550
48273,EGFR,gene,0.9937,18980550
48274,skin rash,disease,1.0,18980550
48275,K-ras,DNA,0.7466,18980550
48276,K-ras mutation,gene,0.9917,18980550
48277,anti-EGFR monoclonal antibody,gene,0.917,18980550
48278,anti-EGFR monoclonal antibodies,gene,0.787,18980550
48279,metastatic colorectal cancer,disease,1.0,18980550
48280,colorectal cancer,disease,0.9146,18980548
48281,Cancer,disease,0.4053,18980548
48282,anti-,gene,0.614,18980548
48283,vascular endothelial growth factor,gene,0.9224,18980548
48284,epidermal growth factor receptor,gene,0.9897,18980548
48285,colorectal cancer,disease,1.0,18980548
48286,colorectal cancer,disease,1.0,18980548
48287,anti-vascular endothelial growth factor (VEGF) monoclonal antibody,gene,0.9443,18980548
48288,cetuximab,gene,0.534,18980548
48289,panitumumab,gene,0.8306,18980548
48290,anti-epidermal growth factor receptor,gene,0.953,18980548
48291,EGFR,gene,0.8765,18980548
48292,colon and rectal cancer,disease,1.0,18980548
48293,colorectal cancer,disease,1.0,18980548
48294,advanced or metastatic,disease,0.77,18980548
48295,colorectal cancer,disease,0.7983,18980548
48296,anti-VEGF,gene,0.833,18980548
48297,KRAS,gene,0.8594,19056857
48298,colorectal tumors,disease,1.0,19056857
48299,KRAS,gene,0.8506,19056857
48300,cetuximab,gene,0.695,19056857
48301,panitumumab,gene,0.514,19056857
48302,metastatic colorectal cancer,disease,1.0,19056857
48303,CRC,disease,1.0,19056857
48304,primaries,DNA,0.5127,19056857
48305,KRAS,gene,0.847,19056857
48306,PATIENTS,species,0.9556,19056857
48307,KRAS codon,gene,0.8467,19056857
48308,12 and 13,DNA,0.4636,19056857
48309,formalin,drug,0.9697,19056857
48310,CRC,disease,1.0,19056857
48311,tumor,disease,1.0,19056857
48312,KRAS,DNA,0.804,19056857
48313,KRAS mutation,gene,0.874,19056857
48314,tumors,disease,0.9985,19056857
48315,KRAS,DNA,0.8315,19056857
48316,KRAS mutations,gene,0.9443,19056857
48317,metastatic,disease,0.9863,19056857
48318,tumors,disease,0.676,19056857
48319,CRC,disease,0.9995,19056857
48320,cetuximab,gene,0.828,19056857
48321,panitumumab,gene,0.8667,19056857
48322,K,DNA,0.5366,19033564
48323,K-Ras,gene,0.998,19033564
48324,advanced colorectal cancer,disease,0.981,19033564
48325,locally advanced head and neck cancer,disease,0.9976,19010265
48326,Locally advanced squamous cell cancer of the head and neck,disease,0.994,19010265
48327,esophageal stenosis,disease,1.0,19010265
48328,xerostomia,disease,1.0,19010265
48329,dental decay,disease,0.9995,19010265
48330,osteoradionecrosis,disease,1.0,19010265
48331,taxane,drug,0.987,19010265
48332,docetaxel,drug,0.999,19010265
48333,Taxotere,drug,0.998,19010265
48334,cisplatin,drug,0.9985,19010265
48335,5FU,drug,0.997,19010265
48336,TPF,drug,0.725,19010265
48337,cisplatin,drug,0.9995,19010265
48338,5FU,drug,0.9985,19010265
48339,EGF-R,gene,0.999,19010265
48340,cetuximab,gene,0.634,19010265
48341,panitumumab,gene,0.72,19010265
48342,colorectal cancer,disease,1.0,19004722
48343,colorectal cancer,disease,1.0,19004722
48344,oxaliplatin,drug,1.0,19004722
48345,irinotecan,drug,0.999,19004722
48346,colorectal cancer,disease,1.0,19004722
48347,UGT1A1,gene,0.9736,19004722
48348,irinotecan,drug,0.9985,19004722
48349,KRAS,gene,0.8735,19004722
48350,panitumumab,gene,0.688,19004722
48351,EGFR,gene,0.996,19004722
48352,tumour,disease,1.0,19004722
48353,metastatic colorectal cancer,disease,0.999,19004722
48354,Wild-type BRAF,gene,0.9917,19001320
48355,panitumumab,gene,0.847,19001320
48356,cetuximab,gene,0.74,19001320
48357,metastatic colorectal cancer,disease,0.999,19001320
48358,Cetuximab,gene,0.8936,19001320
48359,panitumumab,gene,0.942,19001320
48360,metastatic colorectal cancer,disease,1.0,19001320
48361,CRC,disease,1.0,19001320
48362,KRAS,DNA,0.7554,19001320
48363,KRAS mutations,gene,0.8135,19001320
48364,. The,mutation,,19001320
48365,serine,drug,0.996,19001320
48366,serine-threonine kinase BRAF,gene,0.9043,19001320
48367,threonine,drug,0.978,19001320
48368,BRAF,DNA,0.4495,19001320
48369,KRAS,gene,0.7905,19001320
48370,KRAS,gene,0.5654,19001320
48371,BRAF,DNA,0.6597,19001320
48372,BRAF mutations,gene,0.747,19001320
48373,PATIENTS,species,0.8506,19001320
48374,tumor,disease,0.7207,19001320
48375,KRAS,gene,0.7944,19001320
48376,BRAF,gene,0.7495,19001320
48377,tumors,disease,0.391,19001320
48378,cetuximab,gene,0.9053,19001320
48379,panitumumab,gene,0.8867,19001320
48380,metastatic CRC,disease,1.0,19001320
48381,BRAF V600E,DNA,0.6865,19001320
48382,BRAF V600E mutation,gene,0.9385,19001320
48383,V600E,mutation,,19001320
48384,cetuximab,gene,0.7607,19001320
48385,panitumumab,gene,0.7173,19001320
48386,CRC,disease,1.0,19001320
48387,KRAS,DNA,0.78,19001320
48388,KRAS mutations,gene,0.8135,19001320
48389,cetuximab,gene,0.8423,19001320
48390,panitumumab,gene,0.856,19001320
48391,BRAF,DNA,0.7085,19001320
48392,BRAF V600E mutation,gene,0.9,19001320
48393,V600E,DNA,,19001320
48394,V600E,mutation,,19001320
48395,wild,gene,0.6577,19001320
48396,BRAF,gene,0.6807,19001320
48397,BRAF mutations,gene,0.65,19001320
48398,BRAF,gene,0.5757,19001320
48399,CRC cells,cell_line,0.762,19001320
48400,CRC,disease,1.0,19001320
48401,BRAF V600E allele,gene,0.8647,19001320
48402,V600E,mutation,,19001320
48403,cetuximab,gene,0.7964,19001320
48404,panitumumab,gene,0.8135,19001320
48405,BRAF,gene,0.996,19001320
48406,sorafenib,drug,0.96,19001320
48407,panitumumab,gene,0.872,19001320
48408,cetuximab,gene,0.8022,19001320
48409,CRC cells,cell_line,0.841,19001320
48410,CRC,disease,0.9995,19001320
48411,V600E allele,DNA,0.8374,19001320
48412,V600E,mutation,,19001320
48413,BRAF,gene,0.6934,19001320
48414,panitumumab,gene,0.841,19001320
48415,cetuximab,gene,0.786,19001320
48416,epidermal growth factor receptor,gene,0.999,19001320
48417,BRAF,gene,0.994,19001320
48418,CRC,disease,0.9995,19001320
48419,V600E,DNA,,19001320
48420,V600E,mutation,,19001320
48421,Panitumumab,gene,0.776,18998757
48422,metastatic colorectal cancer,disease,0.9995,18998757
48423,wild,DNA,0.632,18998757
48424,wild-type KRAS,gene,0.9355,18998757
48425,Panitumumab,gene,0.667,18998757
48426,IgG2 monoclonal antibody,gene,0.8438,18998757
48427,epidermal growth factor receptor,gene,0.9966,18998757
48428,EGFR,gene,0.9927,18998757
48429,colorectal cancers,disease,1.0,18998757
48430,panitumumab,gene,0.8843,18998757
48431,EGFR,gene,0.9883,18998757
48432,metastatic colorectal cancer,disease,0.999,18998757
48433,panitumumab,gene,0.948,18998757
48434,tumor,disease,0.987,18998757
48435,panitumumab,gene,0.91,18998757
48436,wild-type,gene,0.683,18998757
48437,mutant KRAS,gene,0.5254,18998757
48438,panitumumab,gene,0.91,18998757
48439,wild-type KRAS,gene,0.7437,18998757
48440,wild-type KRAS,gene,0.712,18998757
48441,KRAS,gene,0.871,18998757
48442,mutant KRAS,gene,0.6953,18998757
48443,panitumumab,gene,0.8687,18998757
48444,panitumumab,gene,0.904,18998757
48445,panitumumab,gene,0.88,18998757
48446,rashes,disease,0.9775,18988655
48447,epidermal growth factor receptor,gene,0.9956,18988655
48448,Rash,disease,0.996,18988655
48449,epidermal growth factor receptor,gene,0.9956,18988655
48450,cancer,disease,1.0,18988655
48451,cancer,disease,0.9995,18988655
48452,rash,disease,0.995,18988655
48453,cutaneous adverse,disease,0.565,18988655
48454,rashes,disease,0.9956,18988655
48455,epidermal growth factor receptor,gene,0.994,18988655
48456,epidermal growth factor receptor,gene,0.9976,18988655
48457,rash,disease,0.999,18988655
48458,cancer,disease,1.0,18988655
48459,rash,disease,0.995,18988655
48460,rash,disease,0.9995,18988655
48461,rash,disease,0.999,18988655
48462,cancer,disease,1.0,18988655
48463,rash,disease,0.762,18988655
48464,epidermal growth factor receptor,gene,0.997,18988655
48465,cancer,disease,1.0,18988655
48466,cancer,disease,1.0,18988655
48467,EGFR,gene,0.9927,18836658
48468,SCCHN,disease,1.0,18836658
48469,NSCLC,disease,1.0,18836658
48470,Cancers of the head and neck and of the lung,disease,1.0,18836658
48471,cancers,disease,1.0,18836658
48472,solid tumors,disease,1.0,18836658
48473,cancer,disease,1.0,18836658
48474,epidermal growth factor receptor,gene,0.998,18836658
48475,EGFR,gene,0.992,18836658
48476,EGFR,gene,0.994,18836658
48477,EGFR,gene,0.99,18836658
48478,cancer,disease,0.996,18836658
48479,colon cancer,disease,1.0,18810446
48480,VEGF,gene,0.995,18810446
48481,EGFR,gene,0.9917,18810446
48482,Colorectal cancer,disease,1.0,18810446
48483,CRC,disease,1.0,18810446
48484,cancer,disease,1.0,18810446
48485,CRC,disease,0.9995,18810446
48486,CRC,disease,0.999,18810446
48487,capecitabine,drug,0.9995,18810446
48488,oxaliplatin,drug,0.9995,18810446
48489,bevacizumab,gene,0.745,18810446
48490,panitumumab,gene,0.8784,18810446
48491,CRC,disease,0.996,18810446
48492,CRC,disease,0.9995,18810446
48493,CRC,disease,0.999,18810446
48494,KRAS,gene,0.6934,18810446
48495,tumors,disease,0.559,18810446
48496,panitumumab,gene,0.833,18810446
48497,tumors,disease,1.0,18810446
48498,KRAS,gene,0.8374,18810446
48499,CRC,disease,0.9995,18810446
48500,metastatic colorectal cancer,disease,0.971,18799899
48501,metastatic colorectal cancer,disease,0.9995,18799899
48502,mCRC,disease,1.0,18799899
48503,fluoropyrimidine,drug,0.9956,18799899
48504,5-fluorouracil,drug,0.999,18799899
48505,5-FU,drug,0.999,18799899
48506,mCRC,disease,0.9287,18799899
48507,5-FU,drug,0.997,18799899
48508,oxaliplatin,drug,1.0,18799899
48509,FOLFOX,drug,0.9946,18799899
48510,irinotecan,drug,0.999,18799899
48511,FOLFIRI,drug,0.9956,18799899
48512,tumor,disease,0.9795,18799899
48513,bevacizumab,gene,0.865,18799899
48514,cetuximab,gene,0.9165,18799899
48515,panitumumab,gene,0.9346,18799899
48516,mCRC,disease,0.9775,18799899
48517,mCRC,disease,0.997,18799899
48518,bevacizumab,gene,0.9595,18799899
48519,mCRC,disease,0.9976,18799899
48520,mCRC,disease,0.972,18799899
48521,advanced colorectal cancer,disease,0.9985,18794063
48522,Colorectal cancer,disease,1.0,18794063
48523,CRC,disease,1.0,18794063
48524,cancer,disease,1.0,18794063
48525,cancer,disease,1.0,18794063
48526,5-fluorouracil,drug,0.999,18794063
48527,irinotecan,drug,0.9966,18794063
48528,oxaliplatin,drug,0.9995,18794063
48529,bevacizumab,gene,0.826,18794063
48530,cetuximab,gene,0.919,18794063
48531,panitumumab,gene,0.9443,18794063
48532,metastatic CRC,disease,0.999,18794063
48533,epidermal growth factor receptor,gene,0.9375,18794062
48534,colorectal cancer,disease,1.0,18794062
48535,epidermal growth factor receptor,gene,0.9976,18794062
48536,cetuximab,gene,0.6157,18794062
48537,panitumumab,gene,0.7793,18794062
48538,colorectal cancer,disease,1.0,18794062
48539,CRC,disease,1.0,18794062
48540,cetuximab,gene,0.802,18794062
48541,panitumumab,gene,0.8486,18794062
48542,CRC,disease,1.0,18794062
48543,cetuximab,gene,0.9375,18794062
48544,CRC,disease,0.9995,18794062
48545,panitumumab,gene,0.946,18794062
48546,CRC,disease,0.9985,18794062
48547,cetuximab,gene,0.9385,18794062
48548,rash,disease,0.987,18794062
48549,panitumumab,gene,0.8623,18794062
48550,rash,disease,0.9883,18794062
48551,panitumumab,gene,0.7124,18794062
48552,panitumumab,gene,0.8823,18793955
48553,upper aerodigestive tract cancer,disease,1.0,18793955
48554,panitumumab,gene,0.842,18793955
48555,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9443,18793955
48556,head-and-neck squamous cell carcinoma,disease,0.999,18793955
48557,non-small-cell lung cancer cell lines,cell_line,0.685,18793955
48558,non-small-cell lung cancer,disease,1.0,18793955
48559,head-and-neck squamous cell carcinoma lines,cell_line,0.952,18793955
48560,head-and-neck squamous cell carcinoma,disease,0.986,18793955
48561,UM-SCC1,cell_line,0.871,18793955
48562,SCC-1483,cell_line,0.766,18793955
48563,non-small-cell lung cancer line H226,cell_line,0.934,18793955
48564,non-small-cell lung cancer,disease,0.9995,18793955
48565,Tumor xenografts,cell_line,0.599,18793955
48566,Tumor,disease,0.9966,18793955
48567,nude mice,species,0.723,18793955
48568,panitumumab,gene,0.8184,18793955
48569,panitumumab,gene,0.9263,18793955
48570,Panitumumab,gene,0.8013,18793955
48571,epidermal growth factor receptor,gene,0.9985,18793955
48572,mitogen-activated protein kinase,gene,0.998,18793955
48573,MAPK,gene,0.994,18793955
48574,signal transducer and activator of transcription 3,gene,0.9883,18793955
48575,STAT3,gene,0.995,18793955
48576,panitumumab,gene,0.782,18793955
48577,Panitumumab,gene,0.7217,18793955
48578,cell lines,cell_line,0.9443,18793955
48579,H(2)AX,gene,0.9907,18793955
48580,panitumumab,gene,0.827,18793955
48581,Annexin V,gene,0.9424,18793955
48582,fluorescein isothiocyanate,drug,0.9976,18793955
48583,panitumumab,gene,0.9526,18793955
48584,panitumumab,gene,0.9062,18793955
48585,H226 xenografts,cell_line,0.862,18793955
48586,SCC-1483 xenografts,cell_line,0.823,18793955
48587,panitumumab,gene,0.8213,18793955
48588,panitumumab,gene,0.7856,18793955
48589,upper aerodigestive tract tumor,disease,1.0,18793955
48590,panitumumab,gene,0.7876,18793955
48591,epithelial tumors,disease,1.0,18793955
48592,cetuximab,gene,0.636,18782080
48593,epidermal growth factor receptor monoclonal antibodies,gene,0.9717,18782080
48594,advanced,disease,0.5317,18782080
48595,non-small cell lung cancer,disease,0.9395,18782080
48596,Lung cancer,disease,1.0,18782080
48597,cancer,disease,1.0,18782080
48598,Non-small cell lung cancer,disease,1.0,18782080
48599,NSCLC,disease,1.0,18782080
48600,lung cancer,disease,1.0,18782080
48601,NSCLC,disease,0.998,18782080
48602,platinum,drug,0.996,18782080
48603,advanced NSCLC,disease,0.9907,18782080
48604,tumour,disease,0.9985,18782080
48605,NSCLC,disease,0.9995,18782080
48606,epidermal growth factor receptor,gene,0.9985,18782080
48607,EGFR,gene,0.989,18782080
48608,ErbB family,gene,0.9873,18782080
48609,NSCLC,disease,1.0,18782080
48610,EGFR,gene,0.9927,18782080
48611,cancer,disease,1.0,18782080
48612,tumor,disease,1.0,18782080
48613,EGFR,gene,0.987,18782080
48614,monoclonal antibodies,gene,0.595,18782080
48615,EGFR,gene,0.9775,18782080
48616,tyrosine,drug,0.8535,18782080
48617,tyrosine kinase,gene,0.8755,18782080
48618,cetuximab,gene,0.8735,18782080
48619,advanced NSCLC,disease,0.79,18782080
48620,panitumumab,gene,0.897,18781300
48621,hypersensitivity reactions,disease,0.9927,18781300
48622,cetuximab,gene,0.788,18781300
48623,epidermal growth factor receptor,gene,0.998,18781300
48624,EGFR,gene,0.987,18781300
48625,metastatic colorectal cancer,disease,1.0,18781300
48626,mCRC,disease,1.0,18781300
48627,Cetuximab,gene,0.909,18781300
48628,EGFR,gene,0.9893,18781300
48629,cetuximab,gene,0.901,18781300
48630,hypersensitivity reaction,disease,1.0,18781300
48631,HSR,disease,1.0,18781300
48632,HSR,disease,0.9956,18781300
48633,cetuximab,gene,0.6396,18781300
48634,anti-EGFR,gene,0.706,18781300
48635,Panitumumab,gene,0.744,18781300
48636,EGFR,gene,0.994,18781300
48637,CET,disease,0.537,18781300
48638,HSR,disease,0.9175,18781300
48639,panitumumab,gene,0.8716,18781300
48640,HSR,disease,0.987,18781300
48641,cetuximab,gene,0.8916,18781300
48642,GI cancers,disease,1.0,18781300
48643,panitumumab,gene,0.632,18781300
48644,cetuximab,gene,0.7197,18781300
48645,PATIENTS,species,0.851,18781300
48646,panitumumab,gene,0.682,18781300
48647,HSR,disease,0.7163,18781300
48648,cetuximab,gene,0.8945,18781300
48649,mCRC,disease,0.9956,18781300
48650,HSR,disease,0.9185,18781300
48651,cetuximab,gene,0.7817,18781300
48652,mCRC,disease,0.9976,18781300
48653,HSR,disease,0.885,18781300
48654,cetuximab,gene,0.7686,18781300
48655,pancreatic cancer,disease,1.0,18781300
48656,HSR,disease,0.542,18781300
48657,cetuximab,gene,0.774,18781300
48658,allergy,disease,0.99,18781300
48659,H1,gene,0.517,18781300
48660,drug allergy,disease,0.9995,18781300
48661,bee sting allergy,disease,1.0,18781300
48662,eczema,disease,1.0,18781300
48663,allergic reactive airways disease,disease,1.0,18781300
48664,food allergy,disease,0.9995,18781300
48665,panitumumab,gene,0.841,18781300
48666,cetuximab,gene,0.8833,18781300
48667,HSR,disease,0.9795,18781300
48668,hybridoma,cell_line,0.759,18781300
48669,mouse-specific protein sequences,DNA,0.863,18781300
48670,mouse,species,0.9736,18781300
48671,HSR,disease,0.9995,18781300
48672,panitumumab,gene,0.7593,18781300
48673,cetuximab,gene,0.7505,18781300
48674,Anti-,gene,0.6133,18759698
48675,EGFR,gene,0.9014,18759698
48676,metastatic colorectal cancer,disease,1.0,18759698
48677,metastatic colorectal cancer,disease,1.0,18759698
48678,MCRC,disease,1.0,18759698
48679,MCRC,disease,0.975,18759698
48680,anti-EGFR monoclonal antibodies,gene,0.8716,18759698
48681,MCRC,disease,0.885,18759698
48682,palifermin,drug,0.993,18708365
48683,head and neck and colorectal carcinoma,disease,1.0,18708365
48684,oral mucositis,disease,1.0,18708365
48685,cancer,disease,1.0,18708365
48686,palifermin,drug,0.986,18708365
48687,recombinant human keratinocyte growth factor,gene,0.9976,18708365
48688,KGF,gene,0.994,18708365
48689,oral mucositis,disease,0.9995,18708365
48690,hematopoietic stem cell,cell_type,0.909,18708365
48691,palifermin,drug,0.9683,18708365
48692,solid tumor,disease,1.0,18708365
48693,palifermin,drug,0.999,18708365
48694,FaDu,cell_line,0.868,18708365
48695,colorectal (HT29) carcinoma,disease,0.9995,18708365
48696,mice,species,0.665,18708365
48697,FaDu,cell_line,0.597,18708365
48698,HT29 cells,cell_line,0.5317,18708365
48699,KGF,gene,0.9976,18708365
48700,epithelial growth factor receptors,gene,0.997,18708365
48701,palifermin,drug,0.9976,18708365
48702,5-fluorouracil,drug,0.9995,18708365
48703,cisplatin,drug,0.9995,18708365
48704,bevacizumab,gene,0.941,18708365
48705,cetuximab,gene,0.9526,18708365
48706,panitumumab,gene,0.965,18708365
48707,Palifermin,drug,0.9976,18708365
48708,FaDu,cell_line,0.656,18708365
48709,HT29,cell_line,0.904,18708365
48710,Palifermin,drug,0.992,18708365
48711,5-fluorouracil,drug,0.9995,18708365
48712,cisplatin,drug,0.9995,18708365
48713,cetuximab,gene,0.944,18708365
48714,bevacizumab,gene,0.8774,18708365
48715,panitumumab,gene,0.8975,18708365
48716,palifermin,drug,0.995,18708365
48717,carcinoma cell lines,cell_line,0.941,18708365
48718,carcinoma,disease,0.9995,18708365
48719,KGF receptors,gene,0.9976,18708365
48720,tumor cells,cell_type,0.858,18708365
48721,tumor,disease,0.998,18708365
48722,epidermal growth factor,gene,0.995,18691458
48723,head and neck cancer,disease,1.0,18691458
48724,Epidermal growth factor receptor,gene,0.9985,18691458
48725,EGFR,gene,0.99,18691458
48726,head and neck cancers,disease,1.0,18691458
48727,head and neck cancer,disease,1.0,18691458
48728,EGFRs,gene,0.997,18691458
48729,EGFR tyrosine kinase,gene,0.936,18691458
48730,tyrosine,drug,0.974,18691458
48731,cetuximab,gene,0.9707,18691458
48732,squamous cell carcinoma of the head and neck,disease,0.999,18691458
48733,SCCHN,disease,1.0,18691458
48734,SCCHN,disease,0.991,18691458
48735,platinum,drug,0.9985,18691458
48736,EGFR,gene,0.994,18691458
48737,head and neck cancer,disease,1.0,18691458
48738,EGFR monoclonal antibodies,gene,0.9463,18691458
48739,tyrosine,drug,0.9126,18691458
48740,SCCHN,disease,1.0,18691458
48741,head and neck cancer,disease,1.0,18681486
48742,Head and neck cancer,disease,1.0,18681486
48743,HNC,disease,1.0,18681486
48744,cancer,disease,1.0,18681486
48745,HNC,disease,1.0,18681486
48746,malignancies,disease,1.0,18681486
48747,Squamous cell carcinoma,disease,1.0,18681486
48748,HNC,disease,1.0,18681486
48749,HNC,disease,1.0,18681486
48750,HNC,disease,1.0,18681486
48751,epidermal growth factor receptor,gene,0.998,18681486
48752,EGFR,gene,0.9844,18681486
48753,EGFR,gene,0.9956,18681486
48754,type I insulin-like growth factor,gene,0.9995,18681486
48755,mCRC,disease,0.9463,18650190
48756,RAS,gene,0.6055,18640895
48757,EGFR,gene,0.994,18640895
48758,colorectal cancer,disease,1.0,18640895
48759,colorectal cancer,disease,1.0,18640895
48760,K-RAS,gene,0.549,18640895
48761,B-RAF,gene,0.583,18640895
48762,adenomas,disease,1.0,18640895
48763,K,cell_line,0.539,18640895
48764,K-,disease,0.972,18640895
48765,K-RAS,gene,0.9976,18640895
48766,B,disease,0.929,18640895
48767,B-RAF mutant,gene,0.9277,18640895
48768,microsatellite,DNA,0.7896,18640895
48769,Colorectal cancers,disease,1.0,18640895
48770,EGFR,gene,0.9946,18640895
48771,chromosomal polysomy,disease,0.957,18640895
48772,colorectal cancer,disease,1.0,18640895
48773,anti-,gene,0.8867,18640895
48774,EGFR antibody,gene,0.6973,18640895
48775,EGFR,gene,0.9946,18640895
48776,tumor,disease,0.9995,18640895
48777,colorectal cancer,disease,1.0,18640895
48778,anti-EGFR antibodies,gene,0.9766,18640895
48779,colorectal cancers,disease,1.0,18640895
48780,EGFR,gene,0.988,18640895
48781,panitumumab,gene,0.845,18640895
48782,K,DNA,0.6387,18640895
48783,K-RAS mutant,gene,0.9785,18640895
48784,tumors,disease,1.0,18640895
48785,cetuximab,gene,0.8853,18640895
48786,K-RAS,gene,0.64,18640895
48787,K-RAS,DNA,0.5913,18640895
48788,K-RAS mutant,gene,0.9766,18640895
48789,colorectal cancer,disease,1.0,18640895
48790,EGFR,gene,0.993,18640895
48791,colorectal cancer,disease,1.0,18640895
48792,K-RAS,gene,0.6777,18640895
48793,colorectal cancer,disease,1.0,18640895
48794,panitumumab,gene,0.9233,18621639
48795,cetuximab,gene,0.8833,18621639
48796,metastatic colorectal cancer,disease,1.0,18621639
48797,cetuximab,gene,0.7603,18621639
48798,cetuximab,gene,0.824,18621639
48799,murine,species,0.985,18621639
48800,panitumumab,gene,0.7007,18621639
48801,K-ras,gene,0.603,18621636
48802,metastatic colorectal cancer,disease,1.0,18621636
48803,panitumumab,gene,0.847,18621636
48804,K-ras,gene,0.745,18621636
48805,BRAF,gene,0.604,18621636
48806,PIK3CA gene mutations,gene,0.935,18621636
48807,tumor,disease,1.0,18621636
48808,panitumumab,gene,0.835,18621636
48809,PATIENTS,species,0.9727,18621636
48810,panitumumab,gene,0.825,18621636
48811,metastatic colorectal cancer,disease,1.0,18621636
48812,mCRC,disease,1.0,18621636
48813,genomic DNA,DNA,0.856,18621636
48814,K-ras mutation,gene,0.71,18621636
48815,wild-type K-ras,gene,0.6816,18621636
48816,mutant K-ras,gene,0.613,18621636
48817,K-ras mutation,gene,0.692,18621636
48818,panitumumab,gene,0.719,18621636
48819,wild-type,gene,0.929,18621636
48820,mutant K-ras,gene,0.5625,18621636
48821,V600E BRAF,DNA,0.5146,18621636
48822,V600E BRAF mutation,gene,0.7,18621636
48823,V600E,mutation,,18621636
48824,PIK3CA,DNA,0.7554,18621636
48825,PIK3CA mutation,gene,0.824,18621636
48826,mCRC,disease,0.999,18621636
48827,K,DNA,0.453,18621636
48828,K-ras mutations,gene,0.9434,18621636
48829,panitumumab,gene,0.9336,18621636
48830,PIK3CA,gene,0.745,18621636
48831,BRAF mutations,gene,0.5483,18621636
48832,panitumumab,gene,0.759,18621636
48833,EGFR,gene,0.9575,18621632
48834,EGFR,gene,0.9907,18621632
48835,metastatic,disease,0.869,18616207
48836,colorectal cancer,disease,0.9424,18616207
48837,Colorectal cancer,disease,1.0,18616207
48838,cancer,disease,1.0,18616207
48839,irinotecan,drug,0.999,18616207
48840,oxaliplatin,drug,0.9995,18616207
48841,bevacizumab,gene,0.934,18616207
48842,cetuximab,gene,0.954,18616207
48843,panitumumab,gene,0.9526,18616207
48844,metastatic colorectal cancer,disease,1.0,18616207
48845,mCRC,disease,1.0,18616207
48846,metastatic disease,disease,0.753,18616207
48847,mouse,species,0.9165,18606226
48848,human immunoglobulin gene sequences,gene,0.9478,18606226
48849,rodent,species,0.466,18606226
48850,adalimumab,gene,0.9663,18606226
48851,panitumumab,gene,0.937,18606226
48852,adalimumab,gene,0.9644,18606226
48853,panitumumab,gene,0.9224,18606226
48854,mouse,species,0.9565,18606226
48855,mouse,species,0.9443,18606226
48856,tumor,disease,0.4968,18593896
48857,epidermal growth factor receptor antibodies,gene,0.994,18593896
48858,epidermal growth factor receptor,gene,0.9985,18593896
48859,EGFR,gene,0.985,18593896
48860,colon and head and neck cancer,disease,1.0,18593896
48861,solid cancers,disease,1.0,18593896
48862,EGFR,gene,0.987,18593896
48863,EGFR,gene,0.9883,18593896
48864,EGFR,gene,0.988,18593896
48865,tumor cells,cell_type,0.869,18593896
48866,tumor,disease,0.9995,18593896
48867,human IgG1 antibodies,gene,0.986,18593896
48868,EGFR antibodies,gene,0.919,18593896
48869,solid cancers,disease,1.0,18593896
48870,rituximab,gene,0.939,18586928
48871,alemtuzumab,gene,0.8745,18586928
48872,trastuzumab,gene,0.9067,18586928
48873,bevacizumab,gene,0.8545,18586928
48874,cetuximab,gene,0.849,18586928
48875,panitumumab,gene,0.919,18586928
48876,malignancies,disease,0.9995,18586928
48877,IgE,gene,0.986,18586928
48878,IgE,gene,0.993,18586928
48879,IgE,gene,0.569,18586928
48880,cetuximab,gene,0.877,18586928
48881,acetaminophen,drug,0.9995,18586928
48882,cetuximab,gene,0.786,18586928
48883,ErbB receptors,gene,0.9844,18585454
48884,ErbB1,gene,0.9927,18585454
48885,ErbB2,gene,0.9907,18585454
48886,tumor,disease,1.0,18585454
48887,tyrosine,drug,0.9673,18585454
48888,tyrosine kinase,gene,0.9624,18585454
48889,ErbB,gene,0.988,18585454
48890,ErbB,gene,0.9863,18585454
48891,ErbB therapeutic,gene,0.766,18585454
48892,Cancer,disease,0.999,21748051
48893,cancers,disease,1.0,21748051
48894,cancers,disease,1.0,21748051
48895,trastuzumab,gene,0.973,21748051
48896,breast cancer,disease,1.0,21748051
48897,rituximab,gene,0.8975,21748051
48898,indolent lymphoma,disease,1.0,21748051
48899,tyrosine,drug,0.87,21748051
48900,tyrosine kinase,gene,0.981,21748051
48901,imatinib,drug,0.998,21748051
48902,gastrointestinal stromal tumours,disease,0.534,21748051
48903,hepatocellular carcinoma,disease,1.0,21748051
48904,sorafenib,drug,0.999,21748051
48905,renal cell carcinoma,disease,1.0,21748051
48906,sunitinib,drug,0.9985,21748051
48907,sorafenib,drug,0.9995,21748051
48908,temsirolimus,drug,0.9995,21748051
48909,bevacizumab,gene,0.798,21748051
48910,cancers,disease,1.0,21748051
48911,colon cancer,disease,1.0,21748051
48912,bevacizumab,gene,0.7915,21748051
48913,panitumumab,gene,0.9272,21748051
48914,cetuximab,gene,0.7866,21748051
48915,pancreatic adenocarcinoma,disease,1.0,21748051
48916,erlotinib,drug,0.9927,21748051
48917,breast cancer,disease,1.0,21748051
48918,lapatinib,drug,0.9985,21748051
48919,chronic myeloid leukemia,disease,1.0,21748051
48920,dasatinib,drug,0.998,21748051
48921,cancer,disease,1.0,21748051
48922,oxaliplatin,drug,0.9995,21748051
48923,colon cancer,disease,1.0,21748051
48924,temozolamide,drug,0.9966,21748051
48925,glioblastoma,disease,1.0,21748051
48926,non-small cell lung cancer,disease,1.0,21748051
48927,colorectal cancer,disease,1.0,18499888
48928,cancer,disease,1.0,18499888
48929,colorectal cancer,disease,1.0,18499888
48930,epidermal growth factor receptor,gene,0.997,18499888
48931,EGFR,gene,0.991,18499888
48932,vascular endothelial growth factor,gene,0.9956,18499888
48933,VEGF,gene,0.9937,18499888
48934,cancer,disease,1.0,18499888
48935,mouse,species,0.857,18499888
48936,normal cells,cell_type,0.912,18499888
48937,tumor cells,cell_type,0.85,18499888
48938,tumor,disease,1.0,18499888
48939,colon cancer,disease,1.0,18499888
48940,EGFR,gene,0.9946,18499888
48941,colorectal tumors,disease,1.0,18499888
48942,EGFR,gene,0.992,18499888
48943,panitumumab,gene,0.6724,18499888
48944,EGFR,gene,0.991,18499888
48945,cetuximab,gene,0.9434,18499888
48946,colorectal cancer,disease,1.0,18499888
48947,VEGF,gene,0.988,18499888
48948,VEGF,gene,0.994,18499888
48949,endothelial cell,cell_type,0.864,18499888
48950,VEGF,gene,0.9893,18499888
48951,VEGF ligand,gene,0.9355,18499888
48952,colorectal cancer,disease,1.0,18499888
48953,metastatic colorectal cancer,disease,0.9995,18499885
48954,metastatic colorectal cancer,disease,0.999,18499885
48955,vascular endothelial growth factor,gene,0.998,18499885
48956,VEGF,gene,0.992,18499885
48957,epidermal growth factor receptor,gene,0.9946,18499885
48958,EGFR,gene,0.987,18499885
48959,metastatic colorectal cancer,disease,1.0,18499885
48960,fluorouracil,drug,0.9995,18499885
48961,leucovorin,drug,0.999,18499885
48962,oxaliplatin,drug,0.9995,18499885
48963,irinotecan,drug,0.9995,18499885
48964,VEGF,gene,0.9946,18499885
48965,bevacizumab,gene,0.58,18499885
48966,EGFR,gene,0.9897,18499885
48967,cetuximab,gene,0.7935,18499885
48968,panitumumab,gene,0.762,18499885
48969,phosphatidylinositol,drug,0.9995,18499885
48970,phosphatidylinositol 3-kinase,gene,0.994,18499885
48971,PI3K,gene,0.99,18499885
48972,Akt,gene,0.9946,18499885
48973,mammalian target,gene,0.977,18499885
48974,rapamycin,drug,0.999,18499885
48975,src kinases,gene,0.997,18499885
48976,insulin-like growth factor-1 receptor,gene,0.9985,18499885
48977,metastatic colorectal cancer,disease,1.0,18499885
48978,meta-static colorectal cancer,disease,1.0,18499885
48979,solid tumors,disease,1.0,18536557
48980,anticancer,disease,0.9517,18536557
48981,solid tumors,disease,1.0,18536557
48982,trastuzumab,gene,0.9756,18536557
48983,Herceptin,gene,0.713,18536557
48984,breast cancer,disease,1.0,18536557
48985,bevacizumab,gene,0.854,18536557
48986,colorectal cancer,disease,1.0,18536557
48987,non-small cell lung cancer,disease,1.0,18536557
48988,cetuximab,gene,0.966,18536557
48989,Erbitux,gene,0.5474,18536557
48990,colorectal cancer,disease,1.0,18536557
48991,head and neck cancer,disease,1.0,18536557
48992,panitumumab,gene,0.95,18536557
48993,colorectal cancer,disease,1.0,18536557
48994,anticancer,disease,0.959,18536557
48995,growth factor receptors,gene,0.993,18536557
48996,tumor cell,cell_type,0.739,18536557
48997,tumor,disease,0.999,18536557
48998,epidermal growth factor receptor,gene,0.9976,18515238
48999,colorectal cancer,disease,1.0,19707356
49000,human anti-EGFR monoclonocal antibodies,gene,0.8984,19707356
49001,panitumumab,gene,0.8545,19707356
49002,anti-epidermal growth factor receptor,gene,0.949,19707356
49003,EGFR,gene,0.974,19707356
49004,panitumumab,gene,0.828,19707356
49005,colorectal cancer,disease,1.0,19707356
49006,cancer,disease,0.9966,19707356
49007,Panitumumab,gene,0.9272,19707356
49008,cetuximab,gene,0.9585,19707356
49009,hypersensitivity reactions,disease,0.9946,19707356
49010,panitumumab,gene,0.932,19707356
49011,cetuximab,gene,0.9155,19707356
49012,colorectal cancer,disease,1.0,19707356
49013,panitumumab,gene,0.838,18506165
49014,EGFR-,gene,0.6436,18506165
49015,colorectal cancer,disease,1.0,18506165
49016,Colorectal cancer,disease,1.0,18506165
49017,CRC,disease,1.0,18506165
49018,cancer,disease,1.0,18506165
49019,CRC,disease,0.997,18506165
49020,metastatic CRC,disease,0.9365,18506165
49021,EGFR,gene,0.9937,18506165
49022,CRC,disease,0.9985,18506165
49023,EGFR,gene,0.994,18506165
49024,CRC,disease,0.998,18506165
49025,Panitumumab,gene,0.816,18506165
49026,metastatic CRC,disease,0.941,18506165
49027,panitumumab,gene,0.891,18506165
49028,panitumumab,gene,0.9136,18506165
49029,Epidermal growth factor receptor monoclonal,gene,0.914,18503402
49030,metastatic colorectal cancer,disease,0.892,18503402
49031,metastatic,disease,0.719,18503402
49032,colorectal disease,disease,0.9766,18503402
49033,epidermal growth factor receptor,gene,0.999,18503402
49034,EGFR,gene,0.9883,18503402
49035,cetuximab,gene,0.9395,18503402
49036,panitumumab,gene,0.9185,18503402
49037,EGFR,gene,0.9893,18503402
49038,epithelial tissues,cell_type,0.634,18503402
49039,tumor,disease,1.0,18503402
49040,Cetuximab,gene,0.949,18503402
49041,panitumumab,gene,0.8535,18503402
49042,metastatic colorectal cancer,disease,0.883,18503402
49043,Cetuximab,gene,0.9336,18503402
49044,irinotecan,drug,0.997,18503402
49045,cetuximab,gene,0.9224,18503402
49046,irinotecan,drug,0.9985,18503402
49047,Cetuximab,gene,0.9424,18503402
49048,panitumumab,gene,0.8833,18503402
49049,irinotecan,drug,0.998,18503402
49050,oxaliplatin,drug,0.9995,18503402
49051,Cetuximab,gene,0.918,18503402
49052,Irinotecan,drug,0.951,18503402
49053,Metastatic Colorectal Cancer,disease,1.0,18503402
49054,cetuximab,gene,0.8687,18503402
49055,leucovorin,drug,0.998,18503402
49056,fluorouracil,drug,0.9995,18503402
49057,irinotecan,drug,0.9985,18503402
49058,FOLFIRI,drug,0.9736,18503402
49059,FOLFIRI,drug,0.8574,18503402
49060,FOLFIRI,drug,0.5405,18503402
49061,Panitumumab,gene,0.9097,18503402
49062,Colorectal Cancer,disease,0.936,18503402
49063,folinic acid,drug,0.7925,18503402
49064,leucovorin,drug,0.9995,18503402
49065,fluorouracil,drug,0.9995,18503402
49066,oxaliplatin,drug,0.9995,18503402
49067,FOLFOX,drug,0.8687,18503402
49068,bevacizumab,gene,0.665,18503402
49069,panitumumab,gene,0.852,18503402
49070,EGFR,gene,0.9917,18503402
49071,rash,disease,0.988,18503402
49072,EGFR monoclonal antibody,gene,0.9355,18503402
49073,rash,disease,1.0,18503402
49074,diarrhea,disease,1.0,18503402
49075,hypomagnesemia,disease,1.0,18503402
49076,hypersensitivity reactions,disease,1.0,18503402
49077,pulmonary toxicity,disease,1.0,18503402
49078,EGFR monoclonal antibodies,gene,0.9136,18503402
49079,metastatic colorectal cancer,disease,0.9814,18503402
49080,metastatic colorectal cancer,disease,1.0,18503402
49081,rash,disease,0.976,18501075
49082,bevacizumab,gene,0.8086,18501075
49083,advanced colorectal cancer,disease,1.0,18501075
49084,Bevacizumab,gene,0.8677,18501075
49085,vascular endothelial growth factor,gene,0.998,18501075
49086,5-FU,drug,0.979,18501075
49087,metastatic colorectal cancer,disease,0.9897,18501075
49088,Bevacizumab,gene,0.8276,18501075
49089,hypertension,disease,0.9995,18501075
49090,proteinuria,disease,1.0,18501075
49091,bleeding,disease,0.9565,18501075
49092,gastrointestinal perforation,disease,1.0,18501075
49093,arterial thrombotic events,disease,1.0,18501075
49094,exfoliative dermatitis,disease,1.0,18501075
49095,skin rash,disease,0.9995,18501075
49096,bevacizumab,gene,0.865,18501075
49097,colon cancer,disease,1.0,18501075
49098,rash,disease,0.8877,18501075
49099,bevacizumab,gene,0.867,18501075
49100,rectal carcinoma,disease,0.999,18501075
49101,bevacizumab,gene,0.8013,18501075
49102,rash,disease,0.9756,18501075
49103,bevacizumab,gene,0.7144,18501075
49104,rash,disease,0.8643,18501075
49105,serum,gene,0.5586,18501075
49106,carcinoembryonic antigen,gene,0.7715,18501075
49107,FOLFOX,drug,0.9517,18501075
49108,bevacizumab,gene,0.9287,18501075
49109,rash,disease,0.908,18501075
49110,bevacizumab,gene,0.8706,18501075
49111,rash,disease,0.995,18501075
49112,bevacizumab,gene,0.906,18501075
49113,Skin rash,disease,0.999,18501075
49114,rash,disease,0.9326,18501075
49115,acneiform rash,disease,1.0,18501075
49116,cetuximab,gene,0.93,18501075
49117,panitumumab,gene,0.8633,18501075
49118,rash,disease,0.9985,18501075
49119,bevacizumab,gene,0.78,18501075
49120,Panitumumab,gene,0.875,18497243
49121,panitumumab,gene,0.91,18497243
49122,metastatic colorectal cancer,disease,0.995,18497243
49123,Panitumumab,gene,0.738,18497243
49124,EGFR-expressing tumours,disease,0.997,18497243
49125,EGFR,gene,0.996,18497243
49126,wild-type,gene,0.8877,18497243
49127,K-ras genes,gene,0.973,18497243
49128,panitumumab,gene,0.9204,18497243
49129,advanced colorectal cancer,disease,0.9985,18487907
49130,VEGF,gene,0.9985,18487907
49131,vascular endothelial growth factor,gene,0.998,18487907
49132,EGFR,gene,0.9927,18487907
49133,epidermal growth factor receptor,gene,0.9976,18487907
49134,malignant tumors,disease,0.5474,18487907
49135,Bevacizumab,gene,0.679,18487907
49136,VEGF,gene,0.994,18487907
49137,cetuximab,gene,0.6787,18487907
49138,panitumumab,gene,0.6924,18487907
49139,EGFR,gene,0.993,18487907
49140,bevacizumab,gene,0.897,18487907
49141,cetuximab,gene,0.94,18487907
49142,panitumumab,gene,0.895,18487907
49143,colorectal cancer,disease,1.0,18487907
49144,bevacizumab,gene,0.7666,18487907
49145,cetuximab,gene,0.8257,18487907
49146,panitumumab,gene,0.741,18487907
49147,metastatic,disease,0.986,18472617
49148,colorectal cancer,disease,0.788,18472617
49149,5-FU,drug,0.997,18472617
49150,Colorectal cancer,disease,1.0,18472617
49151,cancer,disease,1.0,18472617
49152,metastatic colorectal cancer,disease,0.9976,18472617
49153,irinotecan,drug,0.9995,18472617
49154,Camptosar,drug,0.998,18472617
49155,oxaliplatin,drug,1.0,18472617
49156,Eloxatin,drug,0.9966,18472617
49157,capecitabine,drug,0.9995,18472617
49158,Xeloda,drug,0.9985,18472617
49159,cancer,disease,1.0,18472617
49160,bevacizumab,gene,0.7275,18472617
49161,vascular endothelial growth factor,gene,0.9956,18472617
49162,cetuximab,gene,0.9165,18472617
49163,Erbitux,gene,0.4937,18472617
49164,panitumumab,gene,0.9116,18472617
49165,epidermal growth factor receptor,gene,0.996,18472617
49166,Bevacizumab,gene,0.926,18471041
49167,oxaliplatin,drug,0.9995,18471041
49168,metastatic colorectal cancer,disease,0.9995,18471041
49169,metastatic colorectal cancer,disease,1.0,18471041
49170,VEGF,gene,0.71,18471041
49171,VEGF,gene,0.996,18471041
49172,tumor,disease,0.999,18471041
49173,VEGF,gene,0.974,18471041
49174,oxaliplatin,drug,0.9995,18471041
49175,metastatic colorectal cancer,disease,0.9966,18471041
49176,metastatic colorectal cancer,disease,1.0,18471041
49177,FOLFOX4,drug,0.973,18471041
49178,VEGF,gene,0.995,18471041
49179,bevacizumab,gene,0.894,18471041
49180,hypertension,disease,0.9688,18471041
49181,gastrointestinal perforation,disease,0.9995,18471041
49182,bevacizumab,gene,0.921,18471041
49183,oxaliplatin,drug,0.9995,18471041
49184,metastatic colorectal cancer,disease,1.0,18471041
49185,NO16966,drug,0.736,18471041
49186,Panitumumab,gene,0.55,18471041
49187,Colorectal Cancer,disease,0.916,18471041
49188,bevacizumab,gene,0.519,18471041
49189,Vectibix,drug,0.9604,18464754
49190,KRAS,gene,0.8115,18431556
49191,metastasized colorectal cancer,disease,0.8916,18431556
49192,colorectal cancer,disease,1.0,18415895
49193,colorectal cancer,disease,1.0,18415895
49194,tumour,disease,0.995,18415895
49195,tumour,disease,0.9683,18415895
49196,cetuximab,gene,0.9546,18415895
49197,Erbitux,gene,0.398,18415895
49198,bevacizumab,gene,0.837,18415895
49199,Avastin,gene,0.385,18415895
49200,epidermal growth factor receptor,gene,0.9966,18415895
49201,EGFR,gene,0.991,18415895
49202,vascular epithelial growth,cell_type,0.5273,18415895
49203,VEGF,gene,0.995,18415895
49204,metastatic colorectal cancer,disease,1.0,18415895
49205,colorectal cancer,disease,1.0,18415895
49206,epidermal growth factor receptor,gene,0.9976,18361806
49207,metastatic colorectal cancer,disease,0.9985,18361806
49208,epidermal growth factor receptor,gene,0.998,18361806
49209,EGFR,gene,0.9907,18361806
49210,colorectal cancers,disease,1.0,18361806
49211,CRCs,disease,1.0,18361806
49212,tumors,disease,1.0,18361806
49213,EGFR,gene,0.986,18361806
49214,cetuximab,gene,0.8013,18361806
49215,panitumumab,gene,0.8345,18361806
49216,tyrosine,drug,0.9937,18361806
49217,tyrosine kinase protein,gene,0.991,18361806
49218,metastatic CRC,disease,0.9995,18361806
49219,mCRC,disease,1.0,18361806
49220,anti-EGFR monoclonal antibody,gene,0.6924,18361806
49221,cetuximab,gene,0.553,18361806
49222,irinotecan,drug,0.9995,18361806
49223,mCRC,disease,0.974,18361806
49224,BSC,drug,0.9897,18361806
49225,Panitumumab,gene,0.8657,18361806
49226,tyrosine,drug,0.956,18361806
49227,tyrosine kinase,gene,0.9917,18361806
49228,EGFR,gene,0.991,18361806
49229,mCRC,disease,0.9897,18361806
49230,EGFR,gene,0.982,18361806
49231,epidermal growth factor receptor,gene,0.9976,18361805
49232,capecitabine,drug,0.999,18361802
49233,colorectal cancer,disease,1.0,18361802
49234,Colorectal cancer,disease,1.0,18361802
49235,CRC,disease,1.0,18361802
49236,CRC,disease,0.908,18361802
49237,fluoropyrimidine,drug,0.998,18361802
49238,5-fluorouracil,drug,0.999,18361802
49239,5-FU,drug,0.999,18361802
49240,metastatic CRC,disease,0.9595,18361802
49241,topoisomerase I,gene,0.9927,18361802
49242,irinotecan,drug,0.9956,18361802
49243,platinum,drug,1.0,18361802
49244,oxaliplatin,drug,0.9995,18361802
49245,fluoropyrimidine,drug,0.996,18361802
49246,capecitabine,drug,0.992,18361802
49247,anti-epidermal growth factor receptor antibodies cetuximab,gene,0.9385,18361802
49248,panitumumab,gene,0.88,18361802
49249,anti-vascular endothelial growth factor bevacizumab,gene,0.8345,18361802
49250,fluoropyrimidine,drug,0.9995,18361802
49251,capecitabine,drug,0.999,18361802
49252,irinotecan,drug,0.9976,18361802
49253,CAPIRI,drug,0.9976,18361802
49254,oxaliplatin,drug,0.9995,18361802
49255,CAPOX,drug,0.9976,18361802
49256,CAPOX,drug,0.9976,18361802
49257,FOLFOX,drug,0.8843,18361802
49258,5-FU,drug,0.9995,18361802
49259,leucovorin,drug,0.999,18361802
49260,oxaliplatin,drug,0.9995,18361802
49261,capecitabine,drug,0.9995,18361802
49262,bevacizumab,gene,0.891,18361802
49263,cetuximab,gene,0.742,18361802
49264,capecitabine,drug,0.9985,18361802
49265,K,DNA,0.5635,18391915
49266,K-Ras,gene,0.9956,18391915
49267,EGFR,gene,0.9946,18391915
49268,metastatic colorectal cancer,disease,0.9956,18391915
49269,human epidermal growth factor receptor,gene,0.9624,18390464
49270,human epidermal growth factor receptor,gene,0.9795,18390464
49271,HER1,gene,0.9985,18390464
49272,EGFR,gene,0.9985,18390464
49273,erlotinib,drug,0.9956,18390464
49274,cetuximab,gene,0.8965,18390464
49275,panitumumab,gene,0.87,18390464
49276,HER1,gene,0.994,18390464
49277,EGFR,gene,0.996,18390464
49278,HER1,gene,0.996,18390464
49279,EGFR,gene,0.997,18390464
49280,HER1,gene,0.991,18390464
49281,EGFR,gene,0.9927,18390464
49282,ABT-263,drug,0.963,18389098
49283,Adalimumab,gene,0.7563,18389098
49284,AG-7352,drug,0.997,18389098
49285,Agatolimod sodium,drug,0.989,18389098
49286,Alfimeprase,gene,0.896,18389098
49287,Aliskiren fumarate,drug,0.9995,18389098
49288,Alvimopan hydrate,drug,0.9985,18389098
49289,Aminolevulinic acid hexyl ester,drug,0.999,18389098
49290,Ammonium tetrathiomolybdate,drug,0.998,18389098
49291,Anakinra,drug,0.517,18389098
49292,Aripiprazole,drug,0.9976,18389098
49293,AS-1404,drug,0.9956,18389098
49294,AT-9283,drug,0.996,18389098
49295,Atomoxetine hydrochloride,drug,0.9966,18389098
49296,AVE-1642,drug,0.9985,18389098
49297,AVE-9633,drug,0.998,18389098
49298,Axitinib,drug,0.991,18389098
49299,AZD-0530,drug,0.999,18389098
49300,Becocalcidiol,drug,0.9966,18389098
49301,Belotecan hydrochloride,drug,0.9614,18389098
49302,Bevacizumab,gene,0.723,18389098
49303,BG-9928,drug,0.9976,18389098
49304,BIBF-1120,drug,0.998,18389098
49305,BMS-275183,drug,0.9907,18389098
49306,Bortezomib,drug,0.9995,18389098
49307,Bosentan,drug,0.999,18389098
49308,Catumaxomab,drug,0.6367,18389098
49309,Cetuximab,gene,0.794,18389098
49310,CHR-2797,drug,0.985,18389098
49311,Ciclesonide,drug,0.998,18389098
49312,Clevidipine,drug,0.9995,18389098
49313,Cypher,drug,0.5264,18389098
49314,Cytarabine,drug,0.9995,18389098
49315,daunorubicin,drug,0.999,18389098
49316,Darifenacin hydrobromide,drug,0.999,18389098
49317,Darunavir,drug,0.999,18389098
49318,Denosumab,gene,0.649,18389098
49319,Desvenlafaxine succinate,drug,0.9976,18389098
49320,Disufenton sodium,drug,0.998,18389098
49321,Duloxetine hydrochloride,drug,0.999,18389098
49322,Dutasteride,drug,0.998,18389098
49323,Eculizumab,gene,0.7974,18389098
49324,Eicosapentaenoic acid,drug,0.9995,18389098
49325,docosahexaenoic acid,drug,0.999,18389098
49326,Eplerenone,drug,0.9985,18389098
49327,Epratuzumab,gene,0.5093,18389098
49328,Erlotinib hydrochloride,drug,0.9917,18389098
49329,Escitalopram oxalate,drug,0.9995,18389098
49330,Ethynylcytidine,drug,0.999,18389098
49331,Etravirine,drug,0.999,18389098
49332,Everolimus,drug,0.998,18389098
49333,Ezetimibe,drug,0.998,18389098
49334,Fulvestrant,drug,0.9985,18389098
49335,Garenoxacin mesilate,drug,0.9976,18389098
49336,Gefitinib,drug,0.999,18389098
49337,Gestodene,drug,0.9985,18389098
49338,HI-164,drug,0.9966,18389098
49339,Hydralazine hydrochloride,drug,0.9985,18389098
49340,isosorbide dinitrate,drug,0.999,18389098
49341,Icatibant acetate,drug,0.996,18389098
49342,ICX-RHY,drug,0.9966,18389098
49343,Idraparinux sodium,drug,0.996,18389098
49344,Indacaterol,drug,0.999,18389098
49345,Ispronicline,drug,0.9995,18389098
49346,Ivabradine hydrochloride,drug,0.991,18389098
49347,Ixabepilone,drug,0.999,18389098
49348,KB-2115,drug,0.999,18389098
49349,KW-2449,drug,0.9995,18389098
49350,L-791515,drug,0.999,18389098
49351,Lapatinib ditosylate,drug,0.9985,18389098
49352,LGD-4665,drug,0.999,18389098
49353,Licofelone,drug,0.999,18389098
49354,doxorubicin,drug,0.969,18389098
49355,Lisdexamfetamine mesilate,drug,0.9966,18389098
49356,Lumiracoxib,drug,0.9976,18389098
49357,Methoxy polyethylene glycol,drug,0.998,18389098
49358,epoetin-beta,gene,0.9775,18389098
49359,Miglustat,drug,0.9927,18389098
49360,Mipomersen sodium,drug,0.9956,18389098
49361,Mitumprotimut-T,drug,0.996,18389098
49362,MK-0822A,drug,0.998,18389098
49363,MK-0974,drug,0.9976,18389098
49364,Nelarabine,drug,0.998,18389098
49365,Obatoclax mesylate,drug,0.9995,18389098
49366,Olmesartan medoxomil,drug,0.999,18389098
49367,Olmesartan medoxomil,drug,0.999,18389098
49368,hydrochlorothiazide,drug,0.999,18389098
49369,Paliperidone,drug,0.999,18389098
49370,Palonosetron hydrochloride,drug,0.9976,18389098
49371,Panitumumab,gene,0.8853,18389098
49372,Pegfilgrastim,gene,0.8203,18389098
49373,Peginterferon alfa-2a,gene,0.9907,18389098
49374,Pemetrexed disodium,drug,0.9985,18389098
49375,Perospirone hydrochloride,drug,0.9966,18389098
49376,Pertuzumab,gene,0.8643,18389098
49377,Pimecrolimus,drug,0.9995,18389098
49378,Pitrakinra,drug,0.971,18389098
49379,Pixantrone maleate,drug,0.9985,18389098
49380,Posaconazole,drug,0.997,18389098
49381,Pregabalin,drug,0.9985,18389098
49382,Quercetin,drug,0.999,18389098
49383,RALGA,drug,0.997,18389098
49384,Raltegravir potassium,drug,0.98,18389098
49385,Ranelic acid distrontium salt,drug,0.996,18389098
49386,rhHistone 1,gene,0.9883,18389098
49387,Rimonabant,drug,0.999,18389098
49388,Rivaroxaban,drug,0.9985,18389098
49389,Rosuvastatin calcium,drug,0.9746,18389098
49390,Satraplatin,drug,0.9995,18389098
49391,SNDX-275,drug,0.999,18389098
49392,Sodium butyrate,drug,0.9985,18389098
49393,Solifenacin succinate,drug,0.999,18389098
49394,Sorafenib,drug,0.9966,18389098
49395,SU-14813,drug,0.9985,18389098
49396,Sunitinib malate,drug,0.9976,18389098
49397,Tadalafil,drug,0.9937,18389098
49398,Tafenoquine succinate,drug,0.9985,18389098
49399,Tamatinib fosdium,drug,0.9873,18389098
49400,Taxus,drug,0.9766,18389098
49401,Telbivudine,drug,0.9995,18389098
49402,Telmisartan,drug,0.9995,18389098
49403,hydrochlorothiazide,drug,0.9995,18389098
49404,Temsirolimus,drug,0.999,18389098
49405,Tiotropium bromide,drug,0.999,18389098
49406,Tipranavir,drug,0.999,18389098
49407,Trabectedin,drug,0.9995,18389098
49408,Tramadol hydrochloride,drug,0.999,18389098
49409,acetaminophen,drug,0.9995,18389098
49410,Ulipristal acetate,drug,0.9985,18389098
49411,Uracil,drug,0.999,18389098
49412,Ursodeoxycholyltaurine,drug,0.9995,18389098
49413,Valdecoxib,drug,0.999,18389098
49414,Vardenafil hydrochloride hydrate,drug,0.997,18389098
49415,Varenicline tartrate,drug,0.9995,18389098
49416,Vildagliptin,drug,0.999,18389098
49417,Vinflunine,drug,0.999,18389098
49418,Vitespen,drug,0.999,18389098
49419,Vorinostat,drug,0.9995,18389098
49420,ZK-EPO,drug,0.995,18389098
49421,Zoledronic acid monohydrate,drug,0.9985,18389098
49422,Panitumumab,gene,0.7695,18343240
49423,epidermal growth factor receptors,gene,0.998,18343240
49424,metastatic colorectal cancer,disease,0.9995,18343240
49425,Panitumumab,gene,0.859,18343240
49426,ABX-EGF,gene,0.99,18343240
49427,recombinant human immunoglobulin G2 monoclonal antibody,gene,0.9795,18343240
49428,epidermal growth factor receptor,gene,0.999,18343240
49429,metastatic colorectal cancer,disease,1.0,18343240
49430,mCRC,disease,1.0,18343240
49431,fluoropyrimidine,drug,0.998,18343240
49432,oxaliplatin,drug,0.9995,18343240
49433,irinotecan,drug,0.997,18343240
49434,panitumumab,gene,0.662,18343240
49435,colorectal cancer,disease,1.0,18343240
49436,panitumumab,gene,0.7935,18343240
49437,ABX-EGF,gene,0.9937,18343240
49438,EGFr,gene,0.9946,18343240
49439,colorectal cancer,disease,1.0,18343240
49440,Cancer,disease,0.9336,18343240
49441,Gastrointestinal Cancer,disease,0.9995,18343240
49442,panitumumab,gene,0.818,18343240
49443,mCRC,disease,0.982,18343240
49444,panitumumab,gene,0.864,18343240
49445,mCRC,disease,0.992,18343240
49446,panitumumab,gene,0.829,18343240
49447,panitumumab,gene,0.9233,18343240
49448,tumor,disease,0.999,18343240
49449,panitumumab,gene,0.942,18343240
49450,mCRC,disease,0.9062,18343240
49451,bevacizumab,gene,0.8745,18343240
49452,panitumumab,gene,0.907,18343240
49453,solid tumors,disease,1.0,18343240
49454,"lung, breast, ovarian, bladder, and head and neck cancers",disease,1.0,18343240
49455,Panitumumab,gene,0.7954,18343240
49456,mCRC,disease,0.99,18343240
49457,Wild-type KRAS,gene,0.9927,18316791
49458,panitumumab,gene,0.922,18316791
49459,metastatic colorectal cancer,disease,0.9995,18316791
49460,Panitumumab,gene,0.4473,18316791
49461,epidermal growth factor receptor,gene,0.997,18316791
49462,EGFR,gene,0.99,18316791
49463,metastatic colorectal cancer,disease,1.0,18316791
49464,mCRC,disease,1.0,18316791
49465,KRAS,gene,0.7515,18316791
49466,small G-protein,gene,0.9985,18316791
49467,EGFR,gene,0.9946,18316791
49468,anti-EGFR antibodies,gene,0.844,18316791
49469,mCRC,disease,0.9976,18316791
49470,PATIENTS,species,0.9795,18316791
49471,KRAS,DNA,0.7886,18316791
49472,KRAS mutations,gene,0.935,18316791
49473,tumor,disease,1.0,18316791
49474,mCRC,disease,0.994,18316791
49475,panitumumab,gene,0.9575,18316791
49476,panitumumab,gene,0.81,18316791
49477,KRAS,gene,0.762,18316791
49478,KRAS,gene,0.6797,18316791
49479,panitumumab,gene,0.8506,18316791
49480,KRAS,DNA,0.794,18316791
49481,KRAS mutations,gene,0.8765,18316791
49482,wild-type,gene,0.622,18316791
49483,KRAS,gene,0.5723,18316791
49484,WT KRAS,gene,0.5947,18316791
49485,panitumumab,gene,0.7886,18316791
49486,panitumumab,gene,0.949,18316791
49487,WT KRAS,gene,0.9756,18316791
49488,WT KRAS,gene,0.6533,18316791
49489,WT KRAS,gene,0.673,18316791
49490,Panitumumab,gene,0.806,18316791
49491,mCRC,disease,0.999,18316791
49492,WT KRAS,gene,0.6045,18316791
49493,tumors,disease,0.575,18316791
49494,KRAS,gene,0.8438,18316791
49495,mCRC,disease,0.985,18316791
49496,panitumumab,gene,0.889,18316791
49497,panitumumab,gene,0.881,18316547
49498,epidermal growth factor receptor,gene,0.998,18316547
49499,metastatic colorectal carcinoma,disease,0.999,18316547
49500,fluoropyrimidine,drug,0.9985,18316547
49501,oxaliplatin,drug,0.9995,18316547
49502,irinotecan,drug,0.998,18316547
49503,panitumumab,gene,0.8887,18316547
49504,epidermal growth factor,gene,0.998,18316547
49505,metastatic colorectal carcinoma,disease,1.0,18316547
49506,factor,DNA,0.4685,18316547
49507,factor receptor,gene,0.738,18316547
49508,metastatic colorectal cancer,disease,1.0,18316547
49509,fluoropyrimidine,drug,0.997,18316547
49510,oxaliplatin,drug,0.9995,18316547
49511,irinotecan,drug,0.999,18316547
49512,panitumumab,gene,0.8315,18316547
49513,panitumumab,gene,0.8135,18316547
49514,panitumumab,gene,0.8354,18316547
49515,panitumumab,gene,0.919,18316547
49516,cetuximab,gene,0.823,18297114
49517,HER,gene,0.9897,18297114
49518,ErbB,gene,0.9814,18297114
49519,epidermal growth factor receptor,gene,0.999,18297114
49520,EGFR,gene,0.994,18297114
49521,cancers,disease,1.0,18297114
49522,EGFR,gene,0.9917,18297114
49523,cetuximab,gene,0.744,18297114
49524,panitumumab,gene,0.74,18297114
49525,erlotinib,drug,0.992,18297114
49526,gefitinib,drug,0.997,18297114
49527,lapatinib,drug,0.998,18297114
49528,EGFR,gene,0.991,18297114
49529,tumor,disease,0.9995,18297114
49530,advanced cancer,disease,1.0,18297114
49531,tumors,disease,1.0,18297114
49532,EGFR monoclonal antibody cetuximab,gene,0.811,18297114
49533,receptor tyrosine kinases,gene,0.9863,18297114
49534,tyrosine,drug,0.9688,18297114
49535,resistant tumor cells,cell_line,0.6465,18297114
49536,tumor,disease,0.997,18297114
49537,cetuximab,gene,0.7188,18297114
49538,cetuximab,gene,0.8374,18297114
49539,EGFR,gene,0.9863,18297114
49540,cetuximab-resistant cells,cell_line,0.9043,18297114
49541,cetuximab,gene,0.4812,18297114
49542,-,cell_type,0.701,18297114
49543,resistant cells,cell_type,0.706,18297114
49544,HER2,gene,0.9956,18297114
49545,HER3,gene,0.99,18297114
49546,cMET,gene,0.6694,18297114
49547,EGFR,gene,0.995,18297114
49548,HER2,gene,0.995,18297114
49549,HER3,gene,0.9893,18297114
49550,EGFR,gene,0.9927,18297114
49551,HER2,gene,0.9937,18297114
49552,HER3,gene,0.989,18297114
49553,PI(3)K,gene,0.996,18297114
49554,Akt,gene,0.989,18297114
49555,cetuximab,gene,0.697,18297114
49556,EGFR,gene,0.9956,18297114
49557,EGFR,gene,0.997,18297114
49558,HER3,gene,0.9863,18297114
49559,HER,gene,0.904,18297114
49560,tumors,disease,1.0,18297114
49561,cetuximab,gene,0.878,18297114
49562,Tumor,disease,0.992,18283460
49563,erlotinib,drug,0.9985,18283460
49564,cetuximab,gene,0.9404,18283460
49565,epidermal growth factor receptors,gene,0.997,18283460
49566,EGFR,gene,0.991,18283460
49567,EGFR,gene,0.983,18283460
49568,tyrosine,drug,0.9126,18283460
49569,tyrosine kinase,gene,0.994,18283460
49570,gefitinib,drug,0.997,18283460
49571,erlotinib,drug,0.9917,18283460
49572,cetuximab,gene,0.906,18283460
49573,panitumumab,gene,0.884,18283460
49574,pancreatic cancer,disease,1.0,18283460
49575,EGFR,gene,0.9927,18283460
49576,erlotinib,drug,0.9673,18283460
49577,EGFR,gene,0.9956,18283460
49578,cetuximab,gene,0.489,18283460
49579,panitumumab,gene,0.82,18258571
49580,anti-EGFR,gene,0.808,18251285
49581,hypomagnesemia,disease,0.9995,18251285
49582,aspartyl,drug,0.995,18232715
49583,anti-epidermal growth factor receptor immunoglobulin gamma2 antibody,gene,0.972,18232715
49584,monoclonal immunoglobulin gamma2 (,gene,0.859,18232715
49585,IgG2,gene,0.5986,18232715
49586,panitumumab,gene,0.6177,18232715
49587,human epidermal growth factor receptor,gene,0.998,18232715
49588,EGFR,gene,0.986,18232715
49589,aspartate,drug,0.999,18232715
49590,phenylalanine,drug,0.9985,18232715
49591,histidine,drug,0.999,18232715
49592,extracellular EGFR molecules,gene,0.961,18232715
49593,Asp,drug,0.9487,18232715
49594,Asp,drug,0.9985,18232715
49595,32D cell line,cell_line,0.9365,18232715
49596,32D cell,cell_type,0.4915,18232715
49597,full,DNA,0.5244,18232715
49598,full-length human EGFR,gene,0.9966,18232715
49599,EGFR,gene,0.9946,18232715
49600,intact,gene,0.5527,18232715
49601,IgG1 antibody cetuximab,gene,0.735,18232715
49602,IgG1 antibody,gene,0.8174,18232715
49603,IgG2,gene,0.9927,18232715
49604,human EGFR,gene,0.9956,18232715
49605,EGFR,gene,0.7017,18230579
49606,colorectal cancer,disease,1.0,18230579
49607,metastatic colorectal cancer,disease,0.9985,18230579
49608,CRC,disease,1.0,18230579
49609,cetuximab,gene,0.688,18230579
49610,Epidermal Growth receptor,gene,0.9985,18230579
49611,EGFR,gene,0.9907,18230579
49612,irinotecan,drug,0.9995,18230579
49613,metastatic CRC,disease,0.9946,18230579
49614,EGFR,gene,0.99,18230579
49615,Panitumumab,gene,0.641,18230579
49616,humanized,species,0.6313,18230579
49617,cetuximab,gene,0.9116,18230579
49618,panitumumab,gene,0.903,18230579
49619,EGF,gene,0.9966,18230579
49620,KRAS,DNA,0.5273,18230579
49621,KRAS mutations,gene,0.77,18230579
49622,EGFR gene,gene,0.7114,18230579
49623,epiregulin,gene,0.981,18230579
49624,amphiregulin,gene,0.9907,18230579
49625,skin toxicity,disease,0.9995,18230579
49626,CRC,disease,0.9995,18230579
49627,panitumumab,gene,0.9277,18223225
49628,advanced solid malignancies,disease,0.9995,18223225
49629,panitumumab,gene,0.8267,18223225
49630,IgG2 monoclonal antibody,gene,0.9707,18223225
49631,epidermal growth factor receptor,gene,0.996,18223225
49632,epidermal growth factor receptor,gene,0.9985,18223225
49633,advanced solid tumors,disease,0.9995,18223225
49634,panitumumab,gene,0.7905,18223225
49635,panitumumab,gene,0.775,18223225
49636,Tumor,disease,0.8784,18223225
49637,colorectal cancer,disease,1.0,18223225
49638,prostate,disease,0.9966,18223225
49639,renal,disease,0.913,18223225
49640,non-small cell lung,disease,1.0,18223225
49641,pancreatic,disease,0.679,18223225
49642,human anti-panitumumab antibodies,gene,0.9175,18223225
49643,panitumumab,gene,0.9487,18223225
49644,panitumumab,gene,0.647,18223225
49645,colorectal cancer,disease,1.0,18223225
49646,colorectal cancer,disease,1.0,18223225
49647,Panitumumab,gene,0.6953,18223225
49648,Rash,disease,0.9995,18223225
49649,dry skin,disease,0.9985,18223225
49650,Panitumumab,gene,0.8896,18223225
49651,advanced colorectal cancer,disease,0.9985,18223225
49652,EGFR,gene,0.9937,18208787
49653,colon cancer,disease,1.0,18208787
49654,EGFR,gene,0.9946,18208787
49655,colon cancer,disease,1.0,18208787
49656,CC,disease,1.0,18208787
49657,tyrosine,drug,0.999,18208787
49658,tyrosine-kinase,gene,0.991,18208787
49659,Cetuximab,gene,0.955,18208787
49660,CC,disease,0.508,18208787
49661,irinotecan,drug,0.9995,18208787
49662,cetuximab,gene,0.938,18208787
49663,liver metastases,disease,0.998,18208787
49664,bevacizumab,gene,0.6475,18208787
49665,Panitumumab,gene,0.7305,18208787
49666,CC,disease,0.9995,18208787
49667,EGFR,gene,0.996,18208787
49668,K-Ras,gene,0.998,18208787
49669,ErbB,gene,0.9805,18201769
49670,ErbB family,gene,0.9834,18201769
49671,ErbB1,gene,0.9927,18201769
49672,ErbB2,gene,0.9844,18201769
49673,cancers,disease,1.0,18201769
49674,tumor,disease,0.9995,18201769
49675,trastuzumab,gene,0.9673,18201769
49676,solid tumors,disease,1.0,18201769
49677,liposomes,cell_type,0.4626,18201769
49678,ErbB1,gene,0.522,18201769
49679,ErbB2 positive cancers,disease,0.9077,18201769
49680,ErbB2,gene,0.985,18201769
49681,ErbB,gene,0.9775,18201769
49682,ErbB1,gene,0.978,18201769
49683,cetuximab,gene,0.7207,18201769
49684,panitumumab,gene,0.8037,18201769
49685,matuzumab,gene,0.8115,18201769
49686,nimotuzumab,gene,0.691,18201769
49687,ICR62,gene,0.6035,18201769
49688,mAb 528,gene,0.9307,18201769
49689,ch806,gene,0.5684,18201769
49690,MDX-447,gene,0.934,18201769
49691,ErbB2,gene,0.986,18201769
49692,trastuzumab,gene,0.8896,18201769
49693,pertuzumab,gene,0.7764,18201769
49694,MDX-H210,gene,0.9673,18201769
49695,2B1,gene,0.788,18201769
49696,C6,gene,0.9326,18201769
49697,FRP-5,drug,0.98,18201769
49698,trastuzumab,gene,0.973,18201769
49699,epidermal growth factor receptor,gene,0.997,19419924
49700,platinum,drug,0.999,19419924
49701,non-small-cell lung cancer,disease,1.0,19419924
49702,advanced non-small-cell lung cancer,disease,0.9985,19419924
49703,NSCLC,disease,1.0,19419924
49704,Epidermal growth factor receptor,gene,0.9985,19419924
49705,EGFR,gene,0.9883,19419924
49706,EGFR,gene,0.992,19419924
49707,tumors,disease,1.0,19419924
49708,EGFR,gene,0.9907,19419924
49709,tyrosine,drug,0.988,19419924
49710,tyrosine kinase,gene,0.9927,19419924
49711,EGFR,gene,0.996,19419924
49712,platinum,drug,0.999,19419924
49713,platinum,drug,0.9995,19419924
49714,cetuximab,gene,0.888,19419924
49715,advanced NSCLC,disease,0.894,19419924
49716,EGFR,gene,0.9956,19419924
49717,EGFRI,gene,0.998,18159648
49718,dermatologic toxicities,disease,0.876,18159648
49719,Epidermal growth factor receptor,gene,0.9985,18159648
49720,EGFRIs,gene,0.952,18159648
49721,non-small-cell lung cancer,disease,1.0,18159648
49722,pancreatic cancer,disease,1.0,18159648
49723,colorectal cancer,disease,1.0,18159648
49724,EGFRIs,gene,0.905,18159648
49725,dermatologic,disease,0.8916,18159648
49726,panitumumab,gene,0.8574,18159648
49727,dermatologic,disease,0.726,18159648
49728,panitumumab,gene,0.716,18159648
49729,skin,disease,0.973,18159648
49730,dermatologic toxicities,disease,0.8755,18159648
49731,Panitumumab,gene,0.847,18159648
49732,advanced solid tumors,disease,0.9814,18159648
49733,EGFRI,gene,0.996,18154212
49734,dermatologic toxicities,disease,0.848,18154212
49735,cutaneous toxicities,disease,0.8516,18154212
49736,EGFR,gene,0.9907,18154212
49737,papulopustular reactions,disease,1.0,18154212
49738,xerosis,disease,1.0,18154212
49739,pruritus,disease,1.0,18154212
49740,fissures,disease,1.0,18154212
49741,nail changes,disease,0.9746,18154212
49742,telangiectasias,disease,1.0,18154212
49743,hyperpigmentation,disease,1.0,18154212
49744,mucositis,disease,1.0,18154212
49745,Panitumumab,gene,0.863,18097777
49746,Matuzumab,gene,0.886,18097777
49747,Nimotuzumab,gene,0.8384,18097777
49748,Zalutumumab,gene,0.777,18097777
49749,EGFR,gene,0.993,18097777
49750,EGFR,gene,0.9893,18097777
49751,tumours,disease,1.0,18097777
49752,EGFR,gene,0.9907,18097777
49753,cancer,disease,1.0,18097777
49754,Cetuximab,gene,0.938,18097777
49755,EGFR monoclonal antibodies,gene,0.8555,18097777
49756,Panitumumab,gene,0.925,18097777
49757,colorectal cancer,disease,1.0,18097777
49758,Matuzumab,gene,0.8867,18097777
49759,Nimotuzumab,gene,0.8457,18097777
49760,Zalutumumab,gene,0.681,18097777
49761,epidermal growth factor receptor,gene,0.9985,18086972
49762,head and neck cancer,disease,1.0,18086972
49763,epidermal growth factor receptor,gene,0.9985,18086972
49764,EGFR,gene,0.991,18086972
49765,cetuximab,gene,0.8394,18086972
49766,panitumumab,gene,0.7773,18086972
49767,squamous cell carcinoma of the head and neck (SCCHN) cell lines,cell_line,0.8867,18086972
49768,squamous cell,cell_type,0.7583,18086972
49769,SCCHN,disease,0.9863,18086972
49770,Squamous cell carcinoma of the head,disease,1.0,18086972
49771,EGFR-specific mAbs,gene,0.7427,18086972
49772,cetuximab,gene,0.56,18086972
49773,panitumumab,gene,0.8564,18086972
49774,peripheral blood mononuclear,cell_type,0.8555,18086972
49775,Cetuximab,gene,0.762,18086972
49776,panitumumab,gene,0.807,18086972
49777,EGFR,gene,0.9956,18086972
49778,SCCHN cell lines,cell_line,0.9204,18086972
49779,SCCHN cell,cell_type,0.4238,18086972
49780,SCCHN,disease,0.999,18086972
49781,cetuximab,gene,0.8633,18086972
49782,panitumumab,gene,0.7617,18086972
49783,EGFR,gene,0.9917,18086972
49784,phospho-EGFR,gene,0.9683,18086972
49785,SCCHN cell lines,cell_line,0.89,18086972
49786,SCCHN,disease,1.0,18086972
49787,peripheral blood lymphocytes,cell_type,0.88,18086972
49788,antitumor,disease,0.702,18086972
49789,EGFR,gene,0.9907,18086972
49790,prostate cancer,disease,1.0,18071949
49791,prostate cancer,disease,1.0,18071949
49792,PCa,disease,1.0,18071949
49793,metastatic,disease,0.501,18071949
49794,prostate cancer cells,cell_type,0.716,18071949
49795,prostate cancer,disease,1.0,18071949
49796,PCa,disease,1.0,18071949
49797,tumors,disease,0.9604,18071949
49798,PCa,disease,0.9985,18071949
49799,solid tumors,disease,1.0,18071949
49800,anti-human epidermal growth factor receptor-2,gene,0.986,18071949
49801,HER2,gene,0.938,18071949
49802,trastuzumab,gene,0.549,18071949
49803,EGFR,gene,0.9106,18071949
49804,cetuximab,gene,0.5645,18071949
49805,panitumumab,gene,0.881,18071949
49806,antivascular endothelial growth factor,gene,0.8906,18071949
49807,VEGF,gene,0.899,18071949
49808,bevacizumab,gene,0.598,18071949
49809,PCa,disease,0.9995,18071949
49810,tumor,disease,0.9556,18071949
49811,normal tissues,cell_type,0.4502,18071949
49812,tumor,disease,1.0,18071949
49813,PCa,disease,0.999,18071949
49814,mice,species,0.955,18071942
49815,muromonomab-CD3,gene,0.9795,18071942
49816,mouse,species,0.9893,18071942
49817,T cell,cell_type,0.556,18071942
49818,T cell CD3epsilon antigen,gene,0.9033,18071942
49819,cancer,disease,1.0,18071942
49820,autoimmune,disease,0.9717,18071942
49821,infectious and cardiac diseases,disease,1.0,18071942
49822,mice,species,0.9785,18071942
49823,mouse,species,0.9443,18071942
49824,panitumumab,gene,0.8096,18071942
49825,epidermal growth factor receptor,gene,0.998,18071942
49826,mice,species,0.9507,18071942
49827,CDR,gene,0.7866,18071942
49828,mouse,species,0.958,18071942
49829,gastrointestinal cancer,disease,1.0,18070705
49830,metastatic colorectal cancer,disease,0.994,18070705
49831,metastatic colorectal cancer,disease,0.979,18070705
49832,CRC,disease,1.0,18070705
49833,metastatic colorectal cancer,disease,0.999,18070705
49834,CRC,disease,0.9844,18070705
49835,5-fluorouracil,drug,0.9995,18070705
49836,5-FU,drug,0.999,18070705
49837,irinotecan,drug,0.9995,18070705
49838,oxaliplatin,drug,0.9995,18070705
49839,capecitabine,drug,0.9995,18070705
49840,vascular endothelial growth factor,gene,0.997,18070705
49841,VEGF,gene,0.9907,18070705
49842,bevacizumab,gene,0.8647,18070705
49843,epidermal,cell_type,0.4978,18070705
49844,EGFR,gene,0.9946,18070705
49845,cetuximab,gene,0.6885,18070705
49846,panitumumab,gene,0.7905,18070705
49847,metastatic colorectal cancer,disease,0.9927,18070705
49848,gastrointestinal cancer,disease,1.0,18070698
49849,gastric cancer,disease,1.0,18070698
49850,gastric cancer,disease,1.0,18070698
49851,advanced gastric cancer,disease,1.0,18070698
49852,gastric cancer,disease,0.9995,18070698
49853,cisplatin,drug,0.998,18070698
49854,fluoropyrimidines,drug,0.9893,18070698
49855,docetaxel,drug,0.9995,18070698
49856,oxaliplatin,drug,1.0,18070698
49857,irinotecan,drug,0.9995,18070698
49858,cetuximab,gene,0.961,18070698
49859,bevacizumab,gene,0.9336,18070698
49860,panitumumab,gene,0.969,18070698
49861,advanced gastric cancer,disease,1.0,18070698
49862,gastric cancer,disease,1.0,18070698
49863,EGFR,gene,0.989,18061885
49864,VEGF,gene,0.9844,18061885
49865,solid tumours,disease,1.0,18061885
49866,epidermal growth factor receptor,gene,0.9966,18061885
49867,EGFR,gene,0.989,18061885
49868,vascular endothelial growth factor,gene,0.9976,18061885
49869,VEGF,gene,0.9946,18061885
49870,germ,DNA,0.6987,18061885
49871,cetuximab,gene,0.5386,18061885
49872,panitumumab,gene,0.9604,18061885
49873,bevacizumab,gene,0.817,18061885
49874,tumour,disease,0.8413,18061885
49875,epidermal growth factor receptor,gene,0.998,18021487
49876,colorectal cancer,disease,1.0,18021487
49877,epidermal growth factor receptor,gene,0.998,18021487
49878,EGFR,gene,0.9907,18021487
49879,advanced colorectal cancer,disease,0.7803,18021487
49880,CRC,disease,1.0,18021487
49881,EGFR,gene,0.993,18021487
49882,EGFR,gene,0.9946,18021487
49883,advanced CRC,disease,0.9995,18021487
49884,anti-,gene,0.6973,18021486
49885,epidermal growth factor receptor monoclonal antibodies,gene,0.871,18021486
49886,metastatic colorectal cancer,disease,0.992,18021486
49887,colorectal cancer,disease,1.0,18021486
49888,CRC,disease,1.0,18021486
49889,tumor,disease,1.0,18021486
49890,epidermal growth factor receptor,gene,0.998,18021486
49891,EGFR,gene,0.9897,18021486
49892,tumors,disease,1.0,18021486
49893,metastatic CRC,disease,0.9985,18021486
49894,Cetuximab,gene,0.8594,18021486
49895,panitumumab,gene,0.878,18021486
49896,advanced,disease,0.878,18021486
49897,CRC,disease,0.9995,18021486
49898,liver-limited disease,disease,0.911,18021486
49899,cetuximab,gene,0.8467,18021486
49900,oxaliplatin,drug,0.9995,18021486
49901,irinotecan,drug,0.997,18021486
49902,metastatic CRC,disease,0.989,18021486
49903,FOLFIRI,drug,0.6577,18021486
49904,5-fluorouracil,drug,0.9995,18021486
49905,leucovorin,drug,0.999,18021486
49906,irinotecan,drug,0.9976,18021486
49907,cetuximab,gene,0.909,18021486
49908,EGFR,gene,0.993,18045190
49909,epidermal growth factor receptor,gene,0.9985,18045190
49910,EGFR,gene,0.992,18045190
49911,tyrosine,drug,0.9736,18045190
49912,tyrosine kinase,gene,0.6533,18045190
49913,cancer,disease,0.999,18045190
49914,cetuximab,gene,0.8945,18045190
49915,panitumumab,gene,0.914,18045190
49916,erlotinib,drug,0.9917,18045190
49917,EGFR,gene,0.9937,18045190
49918,tumor cells,cell_type,0.812,18045190
49919,tumor,disease,1.0,18045190
49920,EGFR,gene,0.917,18045190
49921,tyrosine,drug,0.889,18045190
49922,tyrosine kinase receptors,gene,0.9976,18045190
49923,EGFR receptor kinase domain,gene,0.977,18045190
49924,cancer cells,cell_type,0.852,18045190
49925,cancer,disease,0.999,18045190
49926,EGFR,gene,0.985,18045190
49927,anti-EGFR,gene,0.979,18045190
49928,EGFR,gene,0.9937,18045190
49929,tumor,disease,1.0,18045190
49930,EGFR,gene,0.9946,18045190
49931,panitumumab,gene,0.877,18040272
49932,panitumumab,gene,0.912,18040272
49933,metastatic colorectal cancer,disease,1.0,18040272
49934,mCRC,disease,1.0,18040272
49935,CRC,disease,0.9995,18040272
49936,CRC,disease,0.9995,18040272
49937,panitumumab,gene,0.7603,18040272
49938,BSC,disease,1.0,18040272
49939,panitumumab,gene,0.7876,18040272
49940,panitumumab,gene,0.7866,18040272
49941,CRC,disease,0.999,18040272
49942,panitumumab,gene,0.8564,18040272
49943,tyrosine,drug,0.9824,18039422
49944,tyrosine kinase,gene,0.991,18039422
49945,advanced colorectal cancer,disease,0.9893,18039422
49946,Colorectal cancer,disease,1.0,18039422
49947,CRC,disease,1.0,18039422
49948,oxaliplatin,drug,1.0,18039422
49949,5-fluorouracil,drug,0.9995,18039422
49950,5-FU,drug,0.9995,18039422
49951,leucovorin,drug,0.999,18039422
49952,irinotecan,drug,0.9995,18039422
49953,5-FU,drug,0.9897,18039422
49954,epidermal growth factor receptor,gene,0.9985,18039422
49955,EGFR,gene,0.998,18039422
49956,vascular endothelial growth factor,gene,0.9985,18039422
49957,VEGF,gene,0.9985,18039422
49958,CRC,disease,0.812,18039422
49959,cetuximab,gene,0.9585,18039422
49960,panitumumab,gene,0.8887,18039422
49961,bevacizumab,gene,0.661,18039422
49962,EGFR tyrosine kinase,gene,0.9844,18039422
49963,tyrosine,drug,0.829,18039422
49964,gefitinib,drug,0.9907,18039422
49965,erlotinib,drug,0.9487,18039422
49966,EKB-569,drug,0.9995,18039422
49967,metastatic CRC,disease,0.999,18039422
49968,VEGF receptor,gene,0.995,18039422
49969,vatalanib,drug,0.9946,18039422
49970,FOLFOX,drug,0.763,18039422
49971,sorafenib,drug,0.999,18039422
49972,sunitinib,drug,0.997,18039422
49973,advanced CRC,disease,0.919,18039422
49974,early-stage colon cancer,disease,0.994,18006799
49975,advanced colorectal cancer,disease,0.9526,18006799
49976,epidermal growth factor receptor,gene,0.9985,18006799
49977,vascular endothelial growth factor,gene,0.9976,18006799
49978,colorectal cancer,disease,1.0,18006799
49979,epidermal growth factor receptor,gene,0.999,18006799
49980,vascular endothelial growth factor antibodies,gene,0.8984,18006799
49981,advanced colorectal cancer,disease,0.999,18006799
49982,early-stage colon cancer,disease,0.957,18006799
49983,epidermal growth factor receptor,gene,0.9985,18006328
49984,metastatic,disease,0.84,18006328
49985,colorectal cancer,disease,0.7886,18006328
49986,metastatic colorectal cancer,disease,0.9917,18006328
49987,CRC,disease,1.0,18006328
49988,epidermal growth factor receptor,gene,0.998,18006328
49989,EGFR,gene,0.9883,18006328
49990,EGFR,gene,0.995,18006328
49991,CRC,disease,0.9946,18006328
49992,cetuximab,gene,0.861,18006328
49993,panitumumab,gene,0.802,18006328
49994,CRC,disease,0.9995,18006328
49995,EGFR tyrosine kinase,gene,0.9243,18006328
49996,tyrosine,drug,0.898,18006328
49997,CRC,disease,0.999,18006328
49998,EGFR,gene,0.9956,18006328
49999,EGFR,gene,0.868,18006328
50000,Epidermal growth factor receptor,gene,0.9976,17990353
50001,colorectal cancer,disease,1.0,17990353
50002,Colorectal cancer,disease,1.0,17990353
50003,malignancies,disease,1.0,17990353
50004,cancer,disease,0.999,17990353
50005,metastatic colon cancer,disease,1.0,17990353
50006,fluoropyrimidines,drug,0.9995,17990353
50007,irinotecan,drug,0.999,17990353
50008,oxaliplatin,drug,0.9995,17990353
50009,fluoropyrimidines,drug,1.0,17990353
50010,irinotecan,drug,1.0,17990353
50011,oxaliplatin,drug,1.0,17990353
50012,bevacizumab,gene,0.931,17990353
50013,cetuximab,gene,0.9316,17990353
50014,epidermal growth factor receptor,gene,0.9976,17990353
50015,colorectal cancer,disease,1.0,17990353
50016,cetuximab,gene,0.6724,17990353
50017,panitumumab,gene,0.716,17990353
50018,erlotinib,drug,0.9937,17990353
50019,gefitinib,drug,0.9956,17990353
50020,12B75,drug,0.996,17982511
50021,274150,drug,0.949,17982511
50022,Abacavir sulfate,drug,0.997,17982511
50023,lamivudine,drug,0.9995,17982511
50024,HIF-1alpha,gene,0.994,17982511
50025,Adalimumab,gene,0.5483,17982511
50026,Adefovir,drug,0.9956,17982511
50027,Adefovir dipivoxil,drug,0.9985,17982511
50028,AGN-201904-Z,drug,0.9536,17982511
50029,Albinterferon alfa-2b,gene,0.997,17982511
50030,Alemtuzumab,gene,0.6016,17982511
50031,Aliskiren fumarate,drug,0.999,17982511
50032,Alvimopan hydrate,drug,0.9854,17982511
50033,Amlodipine besylate,drug,0.999,17982511
50034,atorvastatin,drug,0.9966,17982511
50035,calcium,drug,0.868,17982511
50036,Amlodipine besylate,drug,0.9985,17982511
50037,Olmesartan medoxomil,drug,0.9976,17982511
50038,Ammonium tetrathiomolybdate,drug,0.998,17982511
50039,Amodiaquine,drug,0.9985,17982511
50040,Apaziquone,drug,0.9985,17982511
50041,Aprepitant,drug,0.9995,17982511
50042,Arsenic trioxide,drug,0.9995,17982511
50043,Artesunate,drug,0.998,17982511
50044,Amodiaquine,drug,0.998,17982511
50045,Ascorbic acid,drug,0.999,17982511
50046,Atazanavir sulfate,drug,0.982,17982511
50047,Atazanavir,drug,0.999,17982511
50048,ritonavir,drug,0.9966,17982511
50049,Atomoxetine hydrochloride,drug,0.9927,17982511
50050,Atrigel,drug,0.512,17982511
50051,Leuprolide,drug,0.9126,17982511
50052,Axitinib,drug,0.994,17982511
50053,Bevacizumab,drug,0.5366,17982511
50054,Binodenoson,drug,0.993,17982511
50055,Bortezomib,drug,0.9995,17982511
50056,Bovine lactoferrin,gene,0.979,17982511
50057,Bovine,species,0.8296,17982511
50058,Calcipotriol,drug,0.9995,17982511
50059,betamethasone dipropionate,drug,0.997,17982511
50060,Carisbamate,drug,0.9995,17982511
50061,Certolizumab pegol,drug,0.963,17982511
50062,Ciclesonide,drug,0.998,17982511
50063,Conivaptan hydrochloride,drug,0.9707,17982511
50064,CP-690550,drug,0.9995,17982511
50065,CP-751871,drug,0.9995,17982511
50066,Cypher,drug,0.8823,17982511
50067,Dapivirine,drug,0.999,17982511
50068,Darbepoetin alfa,gene,0.9546,17982511
50069,Darunavir,drug,0.999,17982511
50070,Dasatinib,drug,0.9985,17982511
50071,del,DNA,0.4797,17982511
50072,Denosumab,gene,0.4993,17982511
50073,Desloratadine,drug,0.9966,17982511
50074,Dexlansoprazole,drug,0.9946,17982511
50075,Drospirenone,drug,0.9995,17982511
50076,ethinylestradiol,drug,0.9995,17982511
50077,Duloxetine hydrochloride,drug,0.9966,17982511
50078,Dutasteride,drug,0.998,17982511
50079,Eculizumab,gene,0.64,17982511
50080,Eldecalcitol,drug,0.9995,17982511
50081,Eletriptan,drug,0.9985,17982511
50082,Emtricitabine,drug,0.9995,17982511
50083,Entecavir,drug,0.998,17982511
50084,Eritoran tetrasodium,drug,0.988,17982511
50085,Ertapenem sodium,drug,0.9746,17982511
50086,Escitalopram oxalate,drug,0.999,17982511
50087,Eslicarbazepine acetate,drug,0.998,17982511
50088,Esomeprazole magnesium,drug,0.9614,17982511
50089,Estradiol acetate,drug,0.999,17982511
50090,Eszopiclone,drug,0.999,17982511
50091,Etoricoxib,drug,0.999,17982511
50092,Exenatide,gene,0.917,17982511
50093,Ezetimibe,drug,0.999,17982511
50094,Fluticasone furoate,drug,0.999,17982511
50095,Fosmidomycin,drug,0.9995,17982511
50096,Fosmidomycin,drug,0.9995,17982511
50097,clindamycin,drug,0.999,17982511
50098,Glutamine,drug,0.999,17982511
50099,Heat Shock Protein 10,gene,0.9927,17982511
50100,Hepatitis B hyperimmunoglobulin,gene,0.996,17982511
50101,HIV,disease,0.724,17982511
50102,Human Albumin,gene,0.983,17982511
50103,Immune globulin,gene,0.9956,17982511
50104,Interferon omega,gene,0.9966,17982511
50105,Japanese encephalitis virus,species,0.6934,17982511
50106,Latanoprost,drug,0.9575,17982511
50107,timolol maleate,drug,0.9844,17982511
50108,Lenalidomide,drug,0.995,17982511
50109,Linaclotide acetate,drug,0.994,17982511
50110,Lumiracoxib,drug,0.998,17982511
50111,LY-517717,drug,0.9995,17982511
50112,Malaria,disease,0.5522,17982511
50113,MAS,drug,0.6597,17982511
50114,Meningitis B,disease,0.9995,17982511
50115,Methylnaltrexone bromide,drug,0.999,17982511
50116,Micafungin sodium,drug,0.996,17982511
50117,MK-0822A,drug,0.999,17982511
50118,Morphine glucuronide,drug,0.9985,17982511
50119,Morphine hydrochloride,drug,0.9976,17982511
50120,Mycophenolic acid sodium salt,drug,0.969,17982511
50121,Natalizumab,gene,0.7803,17982511
50122,Norelgestromin,drug,0.998,17982511
50123,ethinyl estradiol,drug,0.998,17982511
50124,Oblimersen sodium,drug,0.9937,17982511
50125,Olmesartan medoxomil,drug,0.9995,17982511
50126,Olmesartan medoxomil,drug,0.999,17982511
50127,hydrochlorothiazide,drug,0.999,17982511
50128,Omalizumab,gene,0.8013,17982511
50129,Otamixaban,drug,0.9985,17982511
50130,Paclitaxel,drug,0.9995,17982511
50131,Panitumumab,gene,0.848,17982511
50132,Panobinostat,drug,0.9976,17982511
50133,Parathyroid hormone,gene,0.966,17982511
50134,human recombinant,gene,0.7114,17982511
50135,Parecoxib sodium,drug,0.9976,17982511
50136,Pegfilgrastim,gene,0.8496,17982511
50137,Peginterferon alfa-2a,gene,0.9917,17982511
50138,Peginterferon alfa-2b,gene,0.9937,17982511
50139,Pegvisomant,drug,0.86,17982511
50140,Pimecrolimus,drug,0.999,17982511
50141,Poloxamer-188,drug,0.999,17982511
50142,Prasugrel,drug,0.999,17982511
50143,Pregabalin,drug,0.999,17982511
50144,Prulifloxacin,drug,0.9966,17982511
50145,R-109339,drug,0.999,17982511
50146,Ramipril,drug,0.998,17982511
50147,amlodipine,drug,0.9976,17982511
50148,Ranolazine,drug,0.9985,17982511
50149,Rasburicase,gene,0.957,17982511
50150,rHA,gene,0.7144,17982511
50151,Ro-50-3821,drug,0.997,17982511
50152,Rosuvastatin calcium,drug,0.9507,17982511
50153,Rotavirus,species,0.748,17982511
50154,Rotigotine,drug,0.999,17982511
50155,Ruboxistaurin mesilate hydrate,drug,0.996,17982511
50156,Satavaptan,drug,0.9985,17982511
50157,SC-75416,drug,0.998,17982511
50158,Solifenacin succinate,drug,0.9985,17982511
50159,Sorafenib,drug,0.994,17982511
50160,Sugammadex sodium,drug,0.8794,17982511
50161,Sunitinib malate,drug,0.983,17982511
50162,estrogens,drug,0.9106,17982511
50163,Tadalafil,drug,0.998,17982511
50164,Talnetant,drug,0.9976,17982511
50165,Taxus,drug,0.9785,17982511
50166,Tegaserod maleate,drug,0.9937,17982511
50167,Telbivudine,drug,0.9985,17982511
50168,Temsirolimus,drug,0.9985,17982511
50169,Tenofovir disoproxil fumarate,drug,0.9985,17982511
50170,Tetomilast,drug,0.9985,17982511
50171,Tiotropium bromide,drug,0.9995,17982511
50172,Tipifarnib,drug,0.999,17982511
50173,Tofimilast,drug,0.975,17982511
50174,Trimethoprim,drug,0.999,17982511
50175,Udenafil,drug,0.9873,17982511
50176,Urocortin 2,gene,0.9707,17982511
50177,Valdecoxib,drug,0.9995,17982511
50178,Vernakalant hydrochloride,drug,0.9775,17982511
50179,XP-828L,drug,0.9946,17982511
50180,EGFR,gene,0.7944,17982400
50181,panitumumab,gene,0.735,17982400
50182,metastatic colorectal cancer,disease,0.943,17982400
50183,advanced colorectal cancer,disease,0.9995,17981431
50184,metastatic colorectal cancer,disease,0.992,17981431
50185,cancer,disease,1.0,17981431
50186,colorectal cancer,disease,1.0,17981431
50187,advanced colorectal cancer,disease,0.997,17981431
50188,colorectal cancer,disease,1.0,17965001
50189,EGF receptor,gene,0.9985,17965001
50190,EGFR,gene,0.996,17965001
50191,VEGF,gene,0.9937,17965001
50192,colorectal cancer,disease,1.0,17965001
50193,EGFR,gene,0.993,17965001
50194,EGFR,gene,0.98,17965001
50195,tyrosine,drug,0.974,17965001
50196,tyrosine kinase,gene,0.99,17965001
50197,anti-EGFR monoclonal antibody,gene,0.929,17965001
50198,cetuximab,gene,0.7124,17965001
50199,irinotecan,drug,0.997,17965001
50200,metastatic colorectal cancer,disease,0.9976,17965001
50201,panitumumab,gene,0.858,17965001
50202,EGFR,gene,0.9854,17965001
50203,VEGF,gene,0.9893,17965001
50204,anti-VEGF antibody,gene,0.973,17965001
50205,bevacizumab,gene,0.7573,17965001
50206,5FU,drug,0.9985,17965001
50207,folinic acid,drug,0.998,17965001
50208,tumors,disease,0.481,17965001
50209,EGF receptors,gene,0.995,17964993
50210,colorectal cancers,disease,1.0,17964993
50211,EGFR,gene,0.9736,17964993
50212,colorectal cancers,disease,1.0,17964993
50213,colorectal,disease,0.9185,17964993
50214,Anti-,gene,0.925,17964993
50215,EGFR,gene,0.5723,17964993
50216,cetuximab,gene,0.9023,17964993
50217,Erbitux,gene,0.5303,17964993
50218,panitumumab,gene,0.8237,17964993
50219,anti-EGFR antibodies,gene,0.906,17964993
50220,tyrosine,drug,0.99,17964993
50221,tyrosine kinase,gene,0.991,17964993
50222,epidermal growth factor receptor,gene,0.9976,17848286
50223,head and neck cancer,disease,1.0,17848286
50224,epidermal growth factor receptor,gene,0.9985,17848286
50225,EGFR,gene,0.9863,17848286
50226,cancer,disease,1.0,17848286
50227,cetuximab,gene,0.8564,17848286
50228,panitumumab,gene,0.907,17848286
50229,gefitinib,drug,0.997,17848286
50230,erlotinib,drug,0.9976,17848286
50231,EGFR,gene,0.9946,17848286
50232,cancer,disease,0.9976,17848286
50233,Epidermal growth factor receptor,gene,0.9976,17848286
50234,tyrosine,drug,0.8975,17848286
50235,tyrosine kinase,gene,0.971,17848286
50236,advanced head and neck cancer,disease,0.9995,17848286
50237,cetuximab,gene,0.9214,17848286
50238,EGFR,gene,0.9927,17848286
50239,cancer,disease,1.0,17848286
50240,EGFR,gene,0.97,17848286
50241,anti-EGFR,gene,0.9653,17937885
50242,anti-HER2 monoclonal antibodies,gene,0.8267,17937885
50243,pancreatic cancer,disease,1.0,17937885
50244,panitumumab,gene,0.9463,17921999
50245,mice,species,0.9043,17921999
50246,mouse sequences,DNA,0.782,17921999
50247,mouse,species,0.9824,17921999
50248,mice,species,0.9077,17921999
50249,humanized,species,0.8774,17921999
50250,mice,species,0.968,17921999
50251,human immunoglobulin loci,gene,0.9062,17921999
50252,mice,species,0.9927,17921999
50253,mouse,species,0.9917,17921999
50254,XenoMouse strains,cell_line,0.8096,17921999
50255,panitumumab,gene,0.8105,17921999
50256,epidermal growth factor receptor,gene,0.9976,17921999
50257,EGFR,gene,0.9897,17921999
50258,advanced colorectal cancer,disease,0.9653,17921999
50259,panitumumab,gene,0.94,17921999
50260,mice,species,0.95,17921999
50261,metastatic colorectal cancer,disease,0.997,17921724
50262,metastatic colorectal cancer,disease,0.9995,17921724
50263,mCRC,disease,1.0,17921724
50264,fluoropyrimidine,drug,0.997,17921724
50265,5-fluorouracil,drug,0.999,17921724
50266,5-FU,drug,0.999,17921724
50267,mCRC,disease,0.896,17921724
50268,5-FU,drug,0.997,17921724
50269,oxaliplatin,drug,1.0,17921724
50270,FOLFOX,drug,0.9946,17921724
50271,irinotecan,drug,0.999,17921724
50272,FOLFIRI,drug,0.9956,17921724
50273,tumor,disease,0.9795,17921724
50274,Capecitabine,drug,0.999,17921724
50275,fluoropyrimidine,drug,0.9985,17921724
50276,5-FU,drug,0.998,17921724
50277,oxaliplatin,drug,1.0,17921724
50278,vascular endothelial growth factor,gene,0.9976,17921724
50279,VEGF,gene,0.996,17921724
50280,epidermal growth factor receptor,gene,0.997,17921724
50281,EGFR,gene,0.992,17921724
50282,Bevacizumab,gene,0.7373,17921724
50283,VEGF-A,gene,0.998,17921724
50284,fluoropyrimidine,drug,0.9985,17921724
50285,oxaliplatin,drug,0.9995,17921724
50286,irinotecan,drug,0.9976,17921724
50287,mCRC,disease,0.9097,17921724
50288,Cetuximab,gene,0.8345,17921724
50289,panitumumab,gene,0.8286,17921724
50290,EGFR,gene,0.996,17921724
50291,mCRC,disease,0.9907,17921724
50292,cetuximab,gene,0.947,17921724
50293,mCRC,disease,0.967,17921724
50294,mCRC,disease,0.9663,17921724
50295,Panitumumab,gene,0.727,17591813
50296,cancer,disease,1.0,17591813
50297,epidermal growth factor receptor,gene,0.9985,17591813
50298,EGFR,gene,0.9927,17591813
50299,erbB family,gene,0.982,17591813
50300,solid tumors,disease,1.0,17591813
50301,cancer cells,cell_type,0.8174,17591813
50302,cancer,disease,0.9995,17591813
50303,EGFR,gene,0.993,17591813
50304,tumor,disease,1.0,17591813
50305,EGFR,gene,0.988,17591813
50306,panitumumab,gene,0.8296,17591813
50307,solid tumors,disease,1.0,17591813
50308,bevacizumab,gene,0.893,17591813
50309,cetuximab,gene,0.946,17591813
50310,colorectal cancer,disease,1.0,17591813
50311,panitumumab,gene,0.887,17591813
50312,Epidermal growth factor receptor,gene,0.9985,17827454
50313,EGFR,gene,0.99,17827454
50314,cancer,disease,0.9995,17827454
50315,cancer,disease,1.0,17827454
50316,EGFR,gene,0.9795,17827454
50317,tyrosine,drug,0.971,17827454
50318,tyrosine kinase,gene,0.9404,17827454
50319,EGFR,gene,0.994,17827454
50320,cancer,disease,1.0,17827454
50321,cetuximab,gene,0.6733,17827454
50322,panitumumab,gene,0.803,17827454
50323,gefitinib,drug,0.9966,17827454
50324,erlotinib,drug,0.9976,17827454
50325,lapatinib,drug,0.9985,17827454
50326,EGFR,gene,0.9897,17827454
50327,epithelial,cell_type,0.451,17827454
50328,epithelial malignancies,disease,1.0,17827454
50329,EGFR,gene,0.9937,17827454
50330,EGFR,gene,0.9946,17827454
50331,cancers,disease,1.0,17827454
50332,tumor,disease,0.895,17827454
50333,EGFR,gene,0.993,17827454
50334,cancer,disease,1.0,17827454
50335,tumors,disease,1.0,17827454
50336,EGFR,gene,0.9717,17827454
50337,metastatic colorectal cancer,disease,0.992,17786445
50338,colorectal cancer,disease,1.0,17786445
50339,irinotecan,drug,0.9985,17786445
50340,capecitabine,drug,0.999,17786445
50341,oxaliplatin,drug,0.9995,17786445
50342,bevacizumab,gene,0.8657,17786445
50343,cetuximab,gene,0.943,17786445
50344,panitumumab,gene,0.903,17786445
50345,metastatic colorectal cancer,disease,1.0,17786445
50346,MCRC,disease,1.0,17786445
50347,MCRC,disease,0.9634,17786445
50348,oxaliplatin,drug,0.9995,17786445
50349,5-fluorouracil,drug,0.9995,17786445
50350,5-FU,drug,0.9985,17786445
50351,irinotecan,drug,0.999,17786445
50352,5-FU,drug,0.9976,17786445
50353,cetuximab,gene,0.8022,17786445
50354,irinotecan,drug,0.9985,17786445
50355,advanced colorectal cancer,disease,0.9995,17786445
50356,MCRC,disease,0.9995,17786445
50357,panitumumab,gene,0.836,17785764
50358,metastatic colorectal cancer,disease,1.0,17785764
50359,panitumumab,gene,0.8325,17785764
50360,human monoclonal anti-epidermal growth factor receptor antibody,gene,0.9053,17785764
50361,BSC,disease,0.8257,17785764
50362,metastatic colorectal cancer,disease,0.9966,17785764
50363,PATIENTS,species,0.937,17785764
50364,panitumumab,gene,0.9297,17785764
50365,BSC,disease,1.0,17785764
50366,panitumumab,gene,0.746,17785764
50367,panitumumab,gene,0.959,17785764
50368,Panitumumab,gene,0.8247,17785764
50369,Anti-panitumumab antibodies,gene,0.8193,17785764
50370,panitumumab,gene,0.9346,17785764
50371,chemorefractory,disease,0.8315,17785764
50372,colorectal cancer,disease,0.995,17785764
50373,epidermal growth factor receptor,gene,0.9956,17762902
50374,epidermal growth factor receptor,gene,0.9985,17762902
50375,EGFR,gene,0.9927,17762902
50376,solid,cell_type,0.4915,17762902
50377,solid tumors,disease,1.0,17762902
50378,EGFR,gene,0.996,17762902
50379,"lung, pancreatic, head and neck, and colon carcinomas",disease,1.0,17762902
50380,EGFR,gene,0.992,17762902
50381,tyrosine,drug,0.967,17762902
50382,tyrosine kinase,gene,0.9785,17762902
50383,erlotinib,drug,0.989,17762902
50384,Tarceva,drug,0.995,17762902
50385,cetuximab,gene,0.882,17762902
50386,panitumumab,gene,0.874,17762902
50387,solid tumors,disease,1.0,17762902
50388,erlotinib,drug,0.995,17762902
50389,advanced,disease,0.723,17762902
50390,non-small cell lung carcinoma,disease,0.9253,17762902
50391,NSCLC,disease,1.0,17762902
50392,pancreatic cancer,disease,1.0,17762902
50393,gemcitabine,drug,0.999,17762902
50394,Gemzar,drug,0.999,17762902
50395,Cetuximab,gene,0.9062,17762902
50396,panitumumab,gene,0.9185,17762902
50397,Vectibix,gene,0.4092,17762902
50398,metastatic colorectal carcinoma,disease,0.997,17762902
50399,Cetuximab,gene,0.862,17762902
50400,head and neck squamous cell carcinoma,disease,1.0,17762902
50401,cancer,disease,0.991,17723181
50402,epidermal growth factor receptor,gene,0.9956,17723181
50403,epidermal growth factor receptor,gene,0.9976,17723181
50404,EGFR,gene,0.9897,17723181
50405,cancers,disease,1.0,17723181
50406,EGFR-expressing cancers,disease,0.961,17723181
50407,EGFR,gene,0.5464,17723181
50408,Monoclonal,gene,0.5576,17723181
50409,cancer,disease,0.9995,17723181
50410,anti-EGFR mAb,gene,0.952,17723181
50411,metastatic colorectal cancer,disease,1.0,17723181
50412,mCRC,disease,1.0,17723181
50413,squamous cell carcinomas of the head and neck,disease,1.0,17723181
50414,SCCHN,disease,1.0,17723181
50415,Cetuximab,gene,0.962,17723181
50416,Erbitux,gene,0.551,17723181
50417,IMC-C225,gene,0.96,17723181
50418,IgG1 mAb,gene,0.991,17723181
50419,mCRC,disease,0.9995,17723181
50420,SCCHN,disease,1.0,17723181
50421,Panitumumab,gene,0.8833,17723181
50422,IgG2 mAb,gene,0.992,17723181
50423,mCRC,disease,0.997,17723181
50424,tumor,disease,1.0,17723181
50425,Anti-,gene,0.841,17723181
50426,EGFR antibodies,gene,0.7227,17723181
50427,malignancies,disease,0.887,17723181
50428,Metastatic colorectal cancer,disease,0.993,17722954
50429,colorectal cancer,disease,1.0,17722954
50430,metastatic colorectal cancer,disease,0.999,17722954
50431,oxaliplatin,drug,1.0,17722954
50432,irinotecan,drug,0.9985,17722954
50433,fluorouracil,drug,0.999,17722954
50434,5-FU,drug,0.999,17722954
50435,colorectal cancer,disease,1.0,17722954
50436,5-FU,drug,0.994,17722954
50437,fluoropyrimidine,drug,0.994,17722954
50438,5-FU,drug,0.997,17722954
50439,colorectal cancer,disease,1.0,17722954
50440,irinotecan,drug,0.9995,17722954
50441,oxaliplatin,drug,0.9995,17722954
50442,bevacizumab,gene,0.8413,17722954
50443,cetuximab,gene,0.8433,17722954
50444,Bevacizumab,gene,0.9673,17722954
50445,colorectal cancer,disease,1.0,17722954
50446,cetuximab,gene,0.9307,17722954
50447,vatalanib,drug,0.9976,17722954
50448,panitumumab,gene,0.855,17722954
50449,epidermal growth factor receptor,gene,0.998,17715697
50450,colorectal cancer,disease,1.0,17715697
50451,epidermal growth factor receptor,gene,0.9985,17715697
50452,EGFR,gene,0.9907,17715697
50453,colorectal cancer,disease,1.0,17715697
50454,EGFR,gene,0.9937,17715697
50455,cetuximab,gene,0.8994,17715697
50456,panitumumab,gene,0.912,17715697
50457,cetuximab,gene,0.9253,17715697
50458,panitumumab,gene,0.847,17715697
50459,colorectal cancer,disease,1.0,17715697
50460,Panitumumab,gene,0.697,17699842
50461,anti epidermal growth factor receptor antibody,gene,0.938,17699842
50462,colorectal cancer,disease,1.0,17699842
50463,epidermal growth factor receptor,gene,0.9985,17666985
50464,colorectal carcinoma,disease,1.0,17666985
50465,Colorectal cancer,disease,1.0,17666985
50466,epidermal growth factor receptor,gene,0.9976,17666985
50467,tyrosine,drug,0.9033,17666985
50468,tyrosine kinase,gene,0.9624,17666985
50469,colorectal cancer,disease,1.0,17666985
50470,epidermal growth factor receptor,gene,0.997,17666985
50471,Panitumumab,gene,0.9,17671985
50472,metastatic colorectal cancer,disease,0.9966,17671985
50473,panitumumab,gene,0.5894,17671985
50474,metastatic colorectal cancer,disease,1.0,17671985
50475,panitumumab,gene,0.9043,17671985
50476,metastatic colorectal cancer,disease,1.0,17671985
50477,fluoropyrimidine,drug,0.999,17671985
50478,irinotecan,drug,0.999,17671985
50479,oxaliplatin,drug,0.9995,17671985
50480,tumors,disease,1.0,17671985
50481,epidermal growth factor receptor,gene,0.9976,17671985
50482,EGFr,gene,0.9956,17671985
50483,panitumumab,gene,0.914,17671985
50484,panitumumab,gene,0.707,17671985
50485,EGFr,gene,0.9946,17671985
50486,EGFr,gene,0.994,17671985
50487,antipanitumumab antibodies,gene,0.9863,17671985
50488,Panitumumab,gene,0.5845,17671985
50489,colorectal cancer,disease,1.0,17671985
50490,panitumumab,gene,0.923,17671985
50491,colorectal cancer,disease,1.0,17671985
50492,epidermal growth factor receptor,gene,0.998,17671148
50493,non small cell lung cancer,disease,1.0,17671148
50494,matuzumab,gene,0.8228,17671148
50495,panitumumab,gene,0.6973,17671148
50496,Matuzumab,gene,0.6323,17671148
50497,panitumumab,gene,0.6987,17671148
50498,epidermal growth factor receptor,gene,0.9985,17671148
50499,EGFR,gene,0.9917,17671148
50500,malignancies,disease,1.0,17671148
50501,non-small cell lung cancer,disease,1.0,17671148
50502,NSCLC,disease,1.0,17671148
50503,matuzumab,gene,0.9478,17671148
50504,EGFR-positive cancer,disease,1.0,17671148
50505,EGFR,gene,0.99,17671148
50506,esophageal squamous cell carcinoma,disease,1.0,17671148
50507,colorectal carcinoma,disease,1.0,17671148
50508,matuzumab,gene,0.9634,17671148
50509,paclitaxel,drug,0.9966,17671148
50510,EGFR,gene,0.9946,17671148
50511,advanced NSCLC,disease,0.995,17671148
50512,NSCLC,disease,0.999,17671148
50513,matuzumab,gene,0.894,17671148
50514,pemetrexed,drug,0.9985,17671148
50515,panitumumab,gene,0.9375,17671148
50516,EGFR-positive,cell_line,0.4878,17671148
50517,EGFR,gene,0.994,17671148
50518,solid tumors,disease,0.999,17671148
50519,lung cancer,disease,1.0,17671148
50520,colorectal cancers,disease,1.0,17671148
50521,carboplatin,drug,1.0,17671148
50522,paclitaxel,drug,0.9995,17671148
50523,panitumumab,gene,0.854,17671148
50524,panitumumab,gene,0.953,17671148
50525,NSCLC,disease,0.9976,17671148
50526,panitumumab,gene,0.815,17671148
50527,NSCLC,disease,1.0,17671148
50528,Epidermal growth factor receptor gene,gene,0.64,17664472
50529,metastatic colorectal cancer,disease,1.0,17664472
50530,panitumumab,gene,0.8057,17664472
50531,metastatic colorectal cancer,disease,1.0,17664472
50532,mCRC,disease,1.0,17664472
50533,anti-epidermal growth factor receptor,gene,0.952,17664472
50534,EGFR,gene,0.9956,17664472
50535,EGFR gene,gene,0.7285,17664472
50536,tumors,disease,1.0,17664472
50537,EGFR,gene,0.9927,17664472
50538,GCN,DNA,0.447,17664472
50539,panitumumab,gene,0.7075,17664472
50540,PATIENTS,species,0.932,17664472
50541,mCRC,disease,0.998,17664472
50542,panitumumab,gene,0.935,17664472
50543,BSC,cell_type,0.4998,17664472
50544,tumor,disease,0.9995,17664472
50545,panitumumab,gene,0.765,17664472
50546,EGFR,gene,0.992,17664472
50547,GCN,cell_line,0.4336,17664472
50548,tumor cells,cell_type,0.888,17664472
50549,tumor,disease,0.9644,17664472
50550,chromosome 7,DNA,0.8784,17664472
50551,tumor,disease,0.9995,17664472
50552,EGFR,gene,0.994,17664472
50553,tumor cells,cell_type,0.8784,17664472
50554,tumor,disease,0.9966,17664472
50555,chromosome 7,DNA,0.8003,17664472
50556,chromosome 7 polysomy,disease,0.8,17664472
50557,BSC,drug,0.9976,17664472
50558,EGFR,gene,0.9956,17664472
50559,GCN,gene,0.509,17664472
50560,chromosome 7,DNA,0.8564,17664472
50561,mCRC,disease,0.9995,17664472
50562,tumors,disease,1.0,17664472
50563,EGFR,gene,0.9946,17664472
50564,chromosome 7,DNA,0.914,17664472
50565,panitumumab,gene,0.9043,17664472
50566,Panitumumab,gene,0.7812,17627455
50567,colorectal cancer,disease,1.0,17627455
50568,metastatic colorectal cancer,disease,0.9604,17627455
50569,Panitumumab,gene,0.846,17627455
50570,ABX-EGF,gene,0.99,17627455
50571,human epidermal growth factor receptor,gene,0.9985,17627455
50572,EGFR,gene,0.9976,17627455
50573,HER-1,gene,0.996,17627455
50574,colorectal cancer,disease,1.0,17627455
50575,panitumumab,gene,0.938,17627455
50576,colorectal cancer,disease,1.0,17627455
50577,panitumumab,gene,0.9243,17627455
50578,metastatic colorectal cancer,disease,0.9995,17627455
50579,EGFR,gene,0.9917,17615536
50580,solid tumors,disease,1.0,17615536
50581,epidermal growth factor receptor,gene,0.9976,17615536
50582,EGFR,gene,0.992,17615536
50583,cancer,disease,1.0,17615536
50584,EGFR,gene,0.996,17615536
50585,cancer,disease,1.0,17615536
50586,Cetuximab,gene,0.8877,17615536
50587,anti-EGFR monoclonal antibody,gene,0.9487,17615536
50588,panitumumab,gene,0.878,17615536
50589,matuzumab,gene,0.918,17615536
50590,MDX-447,gene,0.8926,17615536
50591,nimutozumab,gene,0.5547,17615536
50592,mAb806,gene,0.955,17615536
50593,EGFR tyrosine kinase,gene,0.8457,17615536
50594,tyrosine,drug,0.6304,17615536
50595,erlotinib,drug,0.996,17615536
50596,gefitinib,drug,0.9966,17615536
50597,EKB-569,drug,0.999,17615536
50598,lapatinib,drug,0.9966,17615536
50599,GW572016,drug,0.9956,17615536
50600,PKI-166,drug,0.999,17615536
50601,canertinib,drug,0.997,17615536
50602,CI-1033,drug,0.9966,17615536
50603,"colorectal, lung, breast, pancreatic, renal, head and neck, gynecologic, and prostate cancer",disease,1.0,17615536
50604,cetuximab,gene,0.9546,17615536
50605,panitumumab,gene,0.9224,17615536
50606,metastatic colorectal cancer,disease,0.994,17615536
50607,cetuximab,gene,0.957,17615536
50608,head and neck cancer,disease,1.0,17615536
50609,Erlotinib,drug,0.9985,17615536
50610,advanced/metastatic lung cancer,disease,1.0,17615536
50611,Erlotinib,drug,0.998,17615536
50612,gemcitabine,drug,0.999,17615536
50613,advanced/metastatic pancreatic cancer,disease,1.0,17615536
50614,EGFR,gene,0.994,17615536
50615,cancer types,disease,0.904,17615536
50616,EGFR,gene,0.994,17615536
50617,EGFR,gene,0.9907,17615536
50618,advanced colorectal cancer,disease,1.0,19365574
50619,colorectal cancer,disease,1.0,19365574
50620,oxaliplatin,drug,1.0,19365574
50621,irinotecan,drug,0.9995,19365574
50622,capecitabine,drug,0.9995,19365574
50623,cetuximab,gene,0.9434,19365574
50624,bevacizumab,gene,0.9014,19365574
50625,panitumumab,gene,0.9663,19365574
50626,vascular endothelial growth factor,gene,0.9985,19365574
50627,metastatic colorectal cancer,disease,0.956,19365574
50628,bevacizumab,gene,0.8657,19365574
50629,Bevacizumab,gene,0.8794,19365574
50630,bevacizumab,gene,0.707,19365574
50631,tumor,disease,0.9995,19365574
50632,tumor,disease,1.0,19365574
50633,metastatic colorectal cancer,disease,1.0,19365574
50634,bevacizumab,gene,0.8887,19365574
50635,bevacizumab,gene,0.8413,19365574
50636,bevacizumab,gene,0.534,19365574
50637,epidermal growth factor receptor,gene,0.998,19365574
50638,EGFR,gene,0.9907,17566832
50639,colorectal cancer,disease,1.0,17566832
50640,colorectal cancer,disease,1.0,17566832
50641,pyrimidine,drug,0.999,17566832
50642,5-fluorouracil,drug,0.999,17566832
50643,platinum,drug,0.9995,17566832
50644,oxaliplatin,drug,0.9995,17566832
50645,topoisomerase,gene,0.9893,17566832
50646,irinotecan,drug,0.981,17566832
50647,malignancies,disease,1.0,17566832
50648,anticancer,disease,0.9585,17566832
50649,epidermal growth factor receptor,gene,0.9976,17566832
50650,colorectal cancer,disease,1.0,17566832
50651,epidermal growth factor receptor,gene,0.9976,17566832
50652,colorectal cancer,disease,1.0,17566832
50653,panitumumab,gene,0.8184,17553202
50654,cetuximab,gene,0.781,17553202
50655,metastatic colorectal cancer,disease,1.0,17553202
50656,epidermal growth factor receptor,gene,0.9985,17553202
50657,EGFR,gene,0.9907,17553202
50658,metastatic colorectal cancer,disease,0.989,17553202
50659,Cetuximab,gene,0.846,17553202
50660,murine,species,0.5586,17553202
50661,EGFR,gene,0.9927,17553202
50662,cetuximab,gene,0.9185,17553202
50663,cetuximab,gene,0.8965,17553202
50664,EGFR,gene,0.9927,17553202
50665,Panitumumab,gene,0.779,17553202
50666,EGFR,gene,0.995,17553202
50667,Panitumumab,gene,0.893,17553202
50668,panitumumab,gene,0.873,17553202
50669,cetuximab,gene,0.787,17553202
50670,panitumumab,gene,0.8105,17553202
50671,cetuximab,gene,0.8164,17553202
50672,Panitumumab,gene,0.8926,17531105
50673,irinotecan,drug,0.9995,17531105
50674,leucovorin,drug,0.9995,17531105
50675,5-fluorouracil,drug,0.9995,17531105
50676,metastatic colorectal cancer,disease,0.999,17531105
50677,Panitumumab,gene,0.608,17531105
50678,epidermal growth factor receptor,gene,0.997,17531105
50679,metastatic colorectal cancer,disease,1.0,17531105
50680,mCRC,disease,1.0,17531105
50681,panitumumab,gene,0.824,17531105
50682,irinotecan,drug,0.997,17531105
50683,mCRC,disease,0.994,17531105
50684,PATIENTS,species,0.936,17531105
50685,panitumumab,gene,0.839,17531105
50686,irinotecan,drug,0.997,17531105
50687,5-fluorouracil,drug,0.999,17531105
50688,5-FU,drug,0.999,17531105
50689,leucovorin,drug,0.9995,17531105
50690,5-FU,drug,0.9976,17531105
50691,5-FU,drug,0.998,17531105
50692,FOLFIRI,drug,0.9487,17531105
50693,diarrhea,disease,0.9985,17531105
50694,panitumumab,gene,0.898,17531105
50695,diarrhea,disease,0.9995,17531105
50696,mCRC,disease,0.9854,17531105
50697,panitumumab,gene,0.979,17531105
50698,IFL,gene,0.994,17531105
50699,Panitumumab,gene,0.9365,17531105
50700,FOLFIRI,drug,0.97,17531105
50701,metastatic colorectal cancer,disease,0.9946,17530020
50702,colorectal cancer,disease,1.0,17530020
50703,CRC,disease,1.0,17530020
50704,CRC,disease,0.99,17530020
50705,5-fluorouracil,drug,0.999,17530020
50706,folinic acid,drug,0.9326,17530020
50707,irinotecan,drug,0.9985,17530020
50708,oxaliplatin,drug,0.9995,17530020
50709,tumor,disease,1.0,17530020
50710,tumor,disease,0.988,17530020
50711,bevacizumab,gene,0.929,17530020
50712,cetuximab,gene,0.952,17530020
50713,panitumumab,gene,0.9546,17530020
50714,CRC,disease,0.9995,17530020
50715,CRC,disease,0.999,17530020
50716,CRC,disease,0.999,17530020
50717,hypersensitivity reactions,disease,0.999,17522249
50718,cancer,disease,0.9966,17522249
50719,hypersensitivity reactions,disease,0.994,17522249
50720,hypersensitivity reactions,disease,0.9995,17522249
50721,hypersensitivity reactions,disease,1.0,17522249
50722,cetuximab,gene,0.943,17522249
50723,rituximab,gene,0.963,17522249
50724,trastuzumab,gene,0.952,17522249
50725,panitumumab,gene,0.9517,17522249
50726,bevacizumab,gene,0.913,17522249
50727,platinum,drug,1.0,17522249
50728,carboplatin,drug,0.9995,17522249
50729,oxaliplatin,drug,1.0,17522249
50730,taxanes,drug,0.997,17522249
50731,paclitaxel,drug,0.999,17522249
50732,docetaxel,drug,0.9995,17522249
50733,hypersensitivity reaction,disease,1.0,17522249
50734,hypersensitivity reactions,disease,0.9854,17522249
50735,Hypersensitivity reactions,disease,0.999,17522249
50736,platinum,drug,0.995,17522249
50737,type 1 hypersensitivity,disease,0.834,17522249
50738,taxanes,drug,0.8916,17522249
50739,Hypersensitivity,disease,1.0,17522249
50740,platinum,drug,0.999,17522249
50741,taxanes,drug,0.997,17522249
50742,hypersensitivity reactions,disease,1.0,17522249
50743,panitumumab,gene,0.9526,17522246
50744,panitumumab,gene,0.9224,17522246
50745,epidermal growth factor receptor,gene,0.994,17522246
50746,EGFR,gene,0.9937,17522246
50747,metastatic colorectal carcinoma,disease,0.999,17522246
50748,fluoropyrimidine,drug,0.9966,17522246
50749,oxaliplatin,drug,0.999,17522246
50750,irinotecan,drug,0.996,17522246
50751,Panitumumab,gene,0.8726,17522246
50752,EGFR,gene,0.993,17522246
50753,tumor cells,cell_type,0.83,17522246
50754,tumor,disease,0.9575,17522246
50755,metastatic colorectal cancer,disease,0.999,17522246
50756,panitumumab,gene,0.8477,17522246
50757,BSC,disease,1.0,17522246
50758,panitumumab,gene,0.846,17522246
50759,colon cancer,disease,1.0,17522246
50760,panitumumab,gene,0.8633,17522246
50761,panitumumab,gene,0.78,17522246
50762,BSC,drug,0.595,17522246
50763,panitumumab,gene,0.8535,17522246
50764,panitumumab,gene,0.838,17522246
50765,skin rash,disease,1.0,17522246
50766,hypomagnesemia,disease,1.0,17522246
50767,paronychia,disease,1.0,17522246
50768,fatigue,disease,0.999,17522246
50769,abdominal pain,disease,0.999,17522246
50770,nausea,disease,0.999,17522246
50771,diarrhea,disease,1.0,17522246
50772,pulmonary fibrosis,disease,1.0,17522246
50773,dermatologic toxicity,disease,0.9834,17522246
50774,septic death,disease,1.0,17522246
50775,infusion reactions,disease,0.799,17522246
50776,abdominal pain,disease,0.9995,17522246
50777,hypomagnesemia,disease,1.0,17522246
50778,nausea,disease,0.999,17522246
50779,vomiting,disease,0.9917,17522246
50780,diarrhea,disease,1.0,17522246
50781,constipation,disease,1.0,17522246
50782,EGFR,gene,0.996,17520581
50783,epidermal growth factor receptor,gene,0.998,17520581
50784,EGFR,gene,0.9917,17520581
50785,tumors,disease,1.0,17520581
50786,EGFR,gene,0.996,17520581
50787,cancer,disease,0.987,17520581
50788,tumor,disease,1.0,17520581
50789,EGFR,gene,0.9956,17520581
50790,cancer,disease,0.9995,17520581
50791,EGFR,gene,0.9414,17520581
50792,receptor tyrosine kinases,gene,0.9673,17520581
50793,tyrosine,drug,0.9326,17520581
50794,cancer cell,cell_type,0.6016,17520581
50795,cancer,disease,0.9995,17520581
50796,EGFR,gene,0.989,17520581
50797,genes,DNA,0.717,17520581
50798,cancer cells,cell_type,0.8716,17520581
50799,cancer,disease,0.999,17520581
50800,EGFR,gene,0.9937,17520581
50801,antitumor,disease,0.9653,17520581
50802,epidermal growth factor,gene,0.9937,17520578
50803,malignant diseases,disease,1.0,17520578
50804,epidermal growth factor receptor,gene,0.997,17520578
50805,EGFR,gene,0.9873,17520578
50806,cancer,disease,0.9985,17520578
50807,cancer,disease,1.0,17520578
50808,EGFR,gene,0.9937,17520578
50809,EGFR,gene,0.8115,17520578
50810,receptor tyrosine kinase,gene,0.974,17520578
50811,adenosine triphosphate,drug,0.9985,17520578
50812,tyrosine,drug,0.975,17520578
50813,tyrosine kinase portion,gene,0.9087,17520578
50814,EGFR,gene,0.995,17520578
50815,Cetuximab,gene,0.8433,17520578
50816,receptor tyrosine kinase,gene,0.9795,17520578
50817,tyrosine,drug,0.9517,17520578
50818,gefitinib,drug,0.992,17520578
50819,erlotinib,drug,0.988,17520578
50820,cancer,disease,1.0,17520578
50821,EGFR,gene,0.99,17520578
50822,EGFR,gene,0.99,17520578
50823,panitumumab,gene,0.887,17513798
50824,panitumumab,gene,0.909,17513798
50825,colorectal cancer,disease,1.0,17513798
50826,anti-panitumumab Abs,gene,0.9956,17513798
50827,anti-panitumumab Ab,gene,0.994,17513798
50828,epidermal,DNA,0.4783,17513798
50829,epidermal growth factor receptor,gene,0.998,17513798
50830,Mouse,species,0.939,17513798
50831,Panitumumab,gene,0.7637,17491586
50832,metastatic colorectal cancer,disease,1.0,17491586
50833,EGFR antibody panitumumab,gene,0.755,17488734
50834,chimeric EGFR antibody,gene,0.7646,17488734
50835,cetuximab,gene,0.5596,17488734
50836,panitumumab,gene,0.9126,17470858
50837,metastatic colorectal cancer,disease,0.998,17470858
50838,Panitumumab,gene,0.855,17470858
50839,epidermal growth factor receptor,gene,0.9956,17470858
50840,EGFR,gene,0.9893,17470858
50841,panitumumab,gene,0.9443,17470858
50842,metastatic colorectal cancer,disease,1.0,17470858
50843,PATIENTS,species,0.948,17470858
50844,EGFR,gene,0.989,17470858
50845,tumor cell,cell_type,0.4893,17470858
50846,panitumumab,gene,0.836,17470858
50847,BSC,disease,1.0,17470858
50848,panitumumab,gene,0.885,17470858
50849,Panitumumab,gene,0.849,17470858
50850,panitumumab,gene,0.75,17470858
50851,panitumumab,gene,0.8447,17470858
50852,panitumumab,gene,0.8774,17470858
50853,panitumumab,gene,0.845,17470858
50854,BSC,DNA,0.382,17470858
50855,panitumumab,gene,0.8276,17470858
50856,BSC,disease,1.0,17470858
50857,Panitumumab,gene,0.8247,17470858
50858,Skin toxicities,disease,0.9995,17470858
50859,hypomagnesaemia,disease,1.0,17470858
50860,diarrhea,disease,1.0,17470858
50861,Panitumumab,gene,0.807,17470858
50862,colorectal cancer,disease,1.0,17470858
50863,Panitumumab,gene,0.9043,17450113
50864,metastatic colorectal cancer,disease,0.9985,17450113
50865,advanced colorectal cancer,disease,0.999,17438669
50866,anti-EGFR monoclonal antibodies,gene,0.7324,17438669
50867,metastatic colorectal cancer,disease,1.0,17438669
50868,mCRC,disease,1.0,17438669
50869,5- fluorouracil,drug,0.9995,17438669
50870,folinic acid,drug,0.998,17438669
50871,irinotecan,drug,0.9966,17438669
50872,oxaliplatin,drug,0.999,17438669
50873,Epidermal growth factor receptor,gene,0.998,17438669
50874,EGFR,gene,0.992,17438669
50875,colorectal cancers,disease,1.0,17438669
50876,CRC,disease,1.0,17438669
50877,EGFR,gene,0.991,17438669
50878,EGFR,gene,0.993,17438669
50879,Cetuximab,gene,0.8013,17438669
50880,chimeric immunoglobulin (Ig) G1,gene,0.957,17438669
50881,anti-EGFR monoclonal antibody,gene,0.8916,17438669
50882,cetuximab,gene,0.929,17438669
50883,irinotecan,drug,0.9917,17438669
50884,metastatic CRC,disease,0.997,17438669
50885,Cetuximab,gene,0.931,17438669
50886,5-fluorouracil,drug,0.9995,17438669
50887,leucovorin,drug,0.9995,17438669
50888,irinotecan,drug,0.999,17438669
50889,oxaliplatin,drug,0.9995,17438669
50890,mCRC,disease,0.9053,17438669
50891,cetuximab,gene,0.8555,17438669
50892,Panitumumab,gene,0.75,17438669
50893,IgG2 monoclonal antibody,gene,0.8174,17438669
50894,EGFR,gene,0.7583,17438669
50895,mCRC,disease,0.997,17438669
50896,Anti-EGFR,gene,0.822,17438669
50897,anti-EGFR,gene,0.9404,17438669
50898,acneform skin rash,disease,0.9976,17438669
50899,anti-,gene,0.894,17438669
50900,EGFR,gene,0.63,17438669
50901,mCRC,disease,0.9214,17438669
50902,cetuximab,gene,0.731,17438669
50903,panitumumab,gene,0.644,17438669
50904,Panitumumab,gene,0.8413,17402800
50905,metastatic colorectal cancer,disease,0.999,17402800
50906,EGFR,gene,0.9927,17367921
50907,cancer,disease,1.0,17367921
50908,EGFR,gene,0.9897,17367921
50909,trans-membrane receptor tyrosine kinase,gene,0.9873,17367921
50910,tyrosine,drug,0.8105,17367921
50911,HER family,gene,0.989,17367921
50912,EGFR family,gene,0.9937,17367921
50913,normal cells,cell_type,0.905,17367921
50914,EGFR,gene,0.9927,17367921
50915,tumor cells,cell_type,0.832,17367921
50916,tumor,disease,1.0,17367921
50917,EGFR,gene,0.9966,17367921
50918,EGFR,gene,0.99,17367921
50919,EGFR,gene,0.9956,17367921
50920,tyrosine,drug,0.9824,17367921
50921,tyrosine kinase,gene,0.882,17367921
50922,gefitinib,drug,0.9995,17367921
50923,erlotinib,drug,0.9985,17367921
50924,cetuximab,gene,0.894,17367921
50925,panitumumab,gene,0.8774,17367921
50926,EGFR,gene,0.9937,17367921
50927,cancers,disease,1.0,17367921
50928,irinotecan,drug,0.9937,17366800
50929,colorectal cancer,disease,1.0,17366800
50930,RAS,gene,0.9976,17363584
50931,RAF,gene,0.9966,17363584
50932,metastatic colorectal cancers,disease,0.999,17363584
50933,anti-,gene,0.845,17363584
50934,epidermal growth factor receptor antibody,gene,0.889,17363584
50935,epidermal growth factor receptor,gene,0.995,17363584
50936,EGFR,gene,0.9893,17363584
50937,metastatic colorectal cancer,disease,1.0,17363584
50938,mCRC,disease,1.0,17363584
50939,EGFR,gene,0.995,17363584
50940,anti-EGFR mAbs,gene,0.967,17363584
50941,EGFR,gene,0.9775,17363584
50942,RAS,gene,0.999,17363584
50943,RAF,gene,0.9956,17363584
50944,mCRC,disease,0.9985,17363584
50945,CRCs,disease,0.7046,17363584
50946,RAS,gene,0.9946,17363584
50947,activated K-RAS allele,DNA,0.753,17363584
50948,activated,gene,0.6772,17363584
50949,K-RAS allele,gene,0.9443,17363584
50950,Gly(12)Val,gene,0.7036,17363584
50951,anti-EGFR mAbs,gene,0.933,17363584
50952,cancer cells,cell_type,0.8516,17363584
50953,cancer,disease,0.9995,17363584
50954,RAS,gene,0.9795,17363584
50955,mitogen-activated protein kinase,gene,0.9976,17363584
50956,MAPK,gene,0.995,17363584
50957,EGFR,gene,0.8696,17363584
50958,mAbs,DNA,0.518,17363584
50959,EGFR,gene,0.734,17363584
50960,EGFR,gene,0.993,17363584
50961,RAS,gene,0.9966,17363584
50962,RAF,gene,0.998,17363584
50963,MAPK,gene,0.9883,17363584
50964,CRC,disease,0.9995,17363584
50965,Panitumumab,gene,0.789,17355997
50966,metastatic colorectal cancer,disease,0.998,17355997
50967,panitumumab,gene,0.831,17355997
50968,panitumumab,gene,0.8853,17355997
50969,ABX-EGF,gene,0.985,17355997
50970,E7,cell_line,0.4841,17355997
50971,E7.6,gene,0.5713,17355997
50972,colorectal neoplasm,disease,1.0,17355997
50973,epidermal growth factor receptor,gene,0.9976,17355997
50974,EGFr,gene,0.986,17355997
50975,epidermal growth factor receptor,gene,0.999,17355997
50976,Cancer,disease,0.6606,17355997
50977,panitumumab,gene,0.875,17355997
50978,solid tumors,disease,1.0,17355997
50979,metastatic colorectal cancer,disease,1.0,17355997
50980,vascular endothelial growth factor,gene,0.9956,17355997
50981,epidermal growth factor receptor,gene,0.998,17355997
50982,EGFr,gene,0.991,17355997
50983,Panitumumab,gene,0.799,17355997
50984,EGFr,gene,0.9907,17355997
50985,EGFr,gene,0.561,17355997
50986,metastatic colorectal cancer,disease,0.9517,17355997
50987,tumor,disease,1.0,17355997
50988,Panitumumab,gene,0.817,17355997
50989,acneiform rash,disease,1.0,17355997
50990,Panitumumab,gene,0.843,17355997
50991,metastatic colorectal cancer,disease,1.0,17355997
50992,colorectal cancer,disease,1.0,17354514
50993,colorectal cancer,disease,1.0,17354514
50994,anti-vascular endothelial growth factor,gene,0.923,17354514
50995,VEGF,gene,0.821,17354514
50996,bevacizumab,gene,0.7227,17354514
50997,Avastin,gene,0.534,17354514
50998,anti-epidermal growth factor receptor,gene,0.94,17354514
50999,EGFR,gene,0.9746,17354514
51000,colorectal cancer,disease,1.0,17354514
51001,myelosuppression,disease,1.0,17354514
51002,diarrhea,disease,1.0,17354514
51003,alopecia,disease,1.0,17354514
51004,anti- VEGF monoclonal antibody bevacizumab,gene,0.91,17354514
51005,EGFR,gene,0.808,17354514
51006,cetuximab,gene,0.775,17354514
51007,Erbitux,gene,0.502,17354514
51008,panitumumab,gene,0.9087,17354514
51009,Vectibix,gene,0.397,17354514
51010,metastatic colorectal cancer,disease,0.9995,17354513
51011,Colorectal cancer,disease,1.0,17354513
51012,CRC,disease,1.0,17354513
51013,cancer,disease,1.0,17354513
51014,cancer,disease,0.9995,17354513
51015,fluorouracil,drug,0.998,17354513
51016,metastatic CRC,disease,1.0,17354513
51017,mCRC,disease,1.0,17354513
51018,topoisomerase I,gene,0.9814,17354513
51019,irinotecan,drug,0.998,17354513
51020,Camptosar,drug,0.999,17354513
51021,platinum,drug,1.0,17354513
51022,oxaliplatin,drug,0.9995,17354513
51023,Eloxatin,drug,0.9966,17354513
51024,fluoropyrimidine,drug,0.9995,17354513
51025,capecitabine,drug,0.999,17354513
51026,Xeloda,drug,0.998,17354513
51027,mCRC,disease,0.9233,17354513
51028,bevacizumab,gene,0.8457,17354513
51029,cetuximab,gene,0.9507,17354513
51030,Erbitux,gene,0.564,17354513
51031,panitumumab,gene,0.961,17354513
51032,mCRC,disease,0.9917,17354513
51033,mCRC,disease,0.996,17354513
51034,mCRC,disease,0.9897,17354513
51035,vatalanib,drug,0.998,17354513
51036,mCRC,disease,0.929,17354513
51037,colorectal cancer,disease,1.0,17354284
51038,lung cancer,disease,1.0,17354284
51039,sitagliptin phosphate,drug,0.999,17338483
51040,telbivudine,drug,0.9995,17338483
51041,panitumumab,gene,0.7617,17338483
51042,colorectal cancer,disease,1.0,17311700
51043,colorectal cancer,disease,0.9854,17311700
51044,Bevacizumab,gene,0.6255,17311700
51045,Bevacizumab,gene,0.881,17311700
51046,Cetuximab,gene,0.7837,17311700
51047,epidermal growth factor receptor,gene,0.9976,17311700
51048,Panitumumab,gene,0.6997,17311700
51049,human immunoglobulin G2 antibody,gene,0.89,17311700
51050,epidermal growth factor receptor,gene,0.9966,17311700
51051,Metastatic colorectal cancer,disease,1.0,17262903
51052,cancer,disease,1.0,17250464
51053,tumor cell,cell_type,0.711,17250464
51054,tumor,disease,1.0,17250464
51055,tumor,disease,1.0,17250464
51056,epidermal growth factor receptor,gene,0.998,17250464
51057,vascular endothelial growth factor,gene,0.9927,17250464
51058,protein tyrosine kinase,gene,0.967,17250464
51059,tyrosine,drug,0.973,17250464
51060,panitumumab,gene,0.894,17250464
51061,lapatinib,drug,0.9995,17250464
51062,sunitinib,drug,0.9995,17250464
51063,sorafenib,drug,0.9995,17250464
51064,erlotinib,drug,0.9985,17250464
51065,bevacizumab,gene,0.7744,17250464
51066,cetuximab,gene,0.7217,17250464
51067,Rash,disease,0.928,17239291
51068,epidermal growth factor receptor,gene,0.996,17239291
51069,lung cancer,disease,1.0,17239291
51070,Rash,disease,0.9985,17239291
51071,tyrosine,drug,0.9976,17239291
51072,tyrosine kinase,gene,0.9893,17239291
51073,erlotinib,drug,0.995,17239291
51074,gefitinib,drug,0.996,17239291
51075,cetuximab,gene,0.802,17239291
51076,panitumumab,gene,0.8735,17239291
51077,epidermal growth factor receptor,gene,0.9985,17239291
51078,EGFR,gene,0.9927,17239291
51079,cancer,disease,1.0,17239291
51080,Rash,disease,0.987,17239291
51081,tumor,disease,1.0,17239291
51082,rash,disease,0.996,17239291
51083,EGFR,gene,0.9937,17239291
51084,rash,disease,0.9956,17239291
51085,non-small-cell lung carcinoma,disease,1.0,17239291
51086,rash,disease,0.996,17239291
51087,erlotinib,drug,0.992,17239291
51088,gefitinib,drug,0.9976,17239291
51089,rash,disease,0.9863,17239291
51090,EGFR,gene,0.986,17239291
51091,rash,disease,0.9893,17239291
51092,EGFR,gene,0.989,17239291
51093,lung cancer,disease,1.0,17239291
51094,rash,disease,0.9966,17239291
51095,rash,disease,0.997,17239291
51096,EGFR,gene,0.985,17239291
51097,rash,disease,0.978,17239291
51098,EGFR,gene,0.9927,17239291
51099,5-Methyltetrahydrofolate,drug,0.999,17235418
51100,9-aminocamptothecin,drug,0.997,17235418
51101,AE-37,drug,0.6636,17235418
51102,albumin interferon alfa,gene,0.9883,17235418
51103,alicaforsen sodium,drug,0.9976,17235418
51104,alvocidib hydrochloride,drug,0.999,17235418
51105,AMG-706,drug,0.9976,17235418
51106,arginine butyrate,drug,0.999,17235418
51107,avanafil,drug,0.993,17235418
51108,axitinib,drug,0.997,17235418
51109,azimilide hydrochloride,drug,0.9985,17235418
51110,BAY-579352,drug,0.9995,17235418
51111,belagenpumatucel,drug,0.8706,17235418
51112,lapachone,drug,0.9517,17235418
51113,BHT-3009,drug,0.9995,17235418
51114,BIBW-2992,drug,0.9995,17235418
51115,BX-471,drug,0.9883,17235418
51116,Casopitant mesylate,drug,0.99,17235418
51117,cediranib,drug,0.9956,17235418
51118,certolizumab,gene,0.534,17235418
51119,CH,drug,0.87,17235418
51120,clofazimine,drug,0.998,17235418
51121,CpG-7909,drug,0.9985,17235418
51122,curcumin,drug,0.999,17235418
51123,Dapoxetine hydrochloride,drug,0.997,17235418
51124,darusentan,drug,0.9976,17235418
51125,diflomotecan,drug,0.9985,17235418
51126,D-methionine,drug,0.9985,17235418
51127,dnaJP1,DNA,0.516,17235418
51128,D-serine,drug,0.999,17235418
51129,E-7010,drug,0.8887,17235418
51130,edodekin,drug,0.8413,17235418
51131,EGFRvlll peptide vaccine,DNA,0.509,17235418
51132,EGFRvlll peptide,gene,0.8525,17235418
51133,elcometrine,drug,0.994,17235418
51134,elcometrine,drug,0.9663,17235418
51135,ethinylestradiol,drug,0.9995,17235418
51136,elsilimomab,drug,0.954,17235418
51137,enrasentan,drug,0.995,17235418
51138,ertumaxomab,gene,0.4521,17235418
51139,etalocib sodium,drug,0.994,17235418
51140,exisulind,drug,0.924,17235418
51141,Fenretinide,drug,0.998,17235418
51142,fesoterodine,drug,0.9985,17235418
51143,fingolimod hydrochloride,drug,0.986,17235418
51144,fontolizumab,gene,0.5107,17235418
51145,Gefitinib,drug,0.999,17235418
51146,gemtuzumab,drug,0.7705,17235418
51147,ghrelin,gene,0.984,17235418
51148,HTU-PA,cell_line,0.8696,17235418
51149,human papillomavirus,species,0.744,17235418
51150,Indacaterol,drug,0.998,17235418
51151,interleukin-,gene,0.9507,17235418
51152,insulin,gene,0.9707,17235418
51153,irinotecan hydrochloride,drug,0.754,17235418
51154,floxuridine,drug,0.999,17235418
51155,ISIS-301012,drug,0.9985,17235418
51156,ispinesib mesylate,drug,0.993,17235418
51157,ixabepilone,drug,0.9976,17235418
51158,K562,cell_line,0.861,17235418
51159,GM-CSF,gene,0.995,17235418
51160,Lapatinib,drug,0.9985,17235418
51161,L-BLP,gene,0.7134,17235418
51162,linezolid,drug,0.9995,17235418
51163,paclitaxel,drug,0.9985,17235418
51164,LY-2124275,drug,0.9995,17235418
51165,MC,cell_line,0.7344,17235418
51166,MC-1,cell_line,0.5312,17235418
51167,lisinopril,drug,0.9976,17235418
51168,melanoma,disease,0.9995,17235418
51169,meningitis,disease,0.9976,17235418
51170,Nilotinib,drug,0.999,17235418
51171,nociceptin,gene,0.9834,17235418
51172,Oblimersen sodium,drug,0.9937,17235418
51173,orbofiban acetate,drug,0.987,17235418
51174,ospemifene,drug,0.9985,17235418
51175,Paliperidone,drug,0.998,17235418
51176,panitumumab,gene,0.8613,17235418
51177,PEG,drug,0.596,17235418
51178,PEG-filgrastim,gene,0.9834,17235418
51179,PEGylated interferon alfacon-1,gene,0.9946,17235418
51180,perflubutane,drug,0.9966,17235418
51181,pertuzumab,gene,0.9297,17235418
51182,phenserine tartrate,drug,0.998,17235418
51183,phVEGF-A165,gene,0.99,17235418
51184,pleconaril,drug,0.999,17235418
51185,prasugrel,drug,0.998,17235418
51186,prednisolone sodium metasulfobenzoate,drug,0.997,17235418
51187,R-411,drug,0.6753,17235418
51188,rhGM-CSF,gene,0.9966,17235418
51189,roflumilast,drug,0.9995,17235418
51190,romidepsin,drug,0.999,17235418
51191,ruboxistaurin mesilate hydrate,drug,0.992,17235418
51192,Sirolimus,drug,0.9995,17235418
51193,SR-4554,DNA,0.525,17235418
51194,John,species,0.6494,17235418
51195,Talabostat,drug,0.998,17235418
51196,TGN-255,drug,0.9985,17235418
51197,tifacogin,drug,0.996,17235418
51198,tiotropium bromide,drug,0.9995,17235418
51199,tolevamer sodium,drug,0.998,17235418
51200,trabectedin,drug,0.999,17235418
51201,tretinoin,drug,0.974,17235418
51202,Vatalanib succinate,drug,0.9976,17235418
51203,Yellow fever,disease,1.0,17235418
51204,Panitumumab,gene,0.789,17201026
51205,Panitumumab,gene,0.81,21221177
51206,metastatic colorectal cancer,disease,0.9995,21221177
51207,Colorectal cancer,disease,1.0,21221177
51208,malignant disease,disease,1.0,21221177
51209,metastatic colorectal cancer,disease,0.977,21221177
51210,Panitumumab,gene,0.883,21221177
51211,ABX-EGF,gene,0.987,21221177
51212,colorectal cancer,disease,1.0,21221177
51213,epidermal growth factor receptor,gene,0.99,21221177
51214,panitumumab,gene,0.758,21221177
51215,metastatic colorectal cancer,disease,0.9995,21221177
51216,panitumumab,gene,0.914,21221177
51217,colorectal cancer,disease,1.0,21221177
51218,metastatic colorectal cancer,disease,0.999,21221177
51219,panitumumab,gene,0.839,21221177
51220,colorectal cancer,disease,0.9985,21221177
51221,panitumumab,gene,0.8433,21221177
51222,Panitumumab,gene,0.883,21221177
51223,Panitumumab,gene,0.789,17171190
51224,Panitumumab,gene,0.8643,17171190
51225,ABX-EGF,gene,0.9927,17171190
51226,solid-tumor cancers,disease,1.0,17171190
51227,epidermal growth factor receptor,gene,0.9985,17171190
51228,EGFR,gene,0.9854,17171190
51229,cancer,disease,1.0,17171190
51230,tumors,disease,0.999,17171190
51231,colorectal cancer,disease,1.0,17171190
51232,metastatic colorectal cancer,disease,1.0,17171190
51233,oxaliplatin,drug,0.9995,17171190
51234,irinotecan,drug,0.996,17171190
51235,panitumumab,gene,0.9663,17171190
51236,panitumumab,gene,0.8643,17171190
51237,rash,disease,0.9634,17171190
51238,anti-EGFR antibody,gene,0.986,17171190
51239,cetuximab,gene,0.9233,17171190
51240,panitumumab,gene,0.8467,17171190
51241,EGFR,gene,0.988,17171190
51242,EGFR,gene,0.992,17171190
51243,rash,disease,0.617,17171190
51244,panitumumab,gene,0.8906,17171190
51245,metastatic colorectal cancer,disease,0.9995,17171190
51246,EGFR,gene,0.994,17171190
51247,panitumumab,gene,0.764,17171190
51248,tumor,disease,1.0,17171190
51249,colorectal cancer,disease,1.0,17171190
51250,rash,disease,0.998,17171190
51251,EGFR,gene,0.9946,17168718
51252,cancer,disease,1.0,17168718
51253,HER-2,gene,0.9976,17168718
51254,Neu,gene,0.995,17168718
51255,cancers,disease,1.0,17168718
51256,B-cell acute lymphoblastic leukemia,disease,0.9995,17168718
51257,B-ALL,disease,1.0,17168718
51258,breast cancer,disease,1.0,17168718
51259,lung cancer,disease,1.0,17168718
51260,multiple myeloma,disease,1.0,17168718
51261,malignant cells,cell_type,0.917,17168718
51262,malignant,disease,0.897,17168718
51263,epidermal growth factor receptors,gene,0.9976,17168718
51264,EGFR,gene,0.9927,17168718
51265,HB,DNA,0.5327,17168718
51266,HB-EGF,gene,0.998,17168718
51267,amphiregulin,gene,0.994,17168718
51268,growth-factor family,gene,0.948,17168718
51269,EGFR,gene,0.9956,17168718
51270,cancer,disease,1.0,17168718
51271,EGFR,gene,0.9956,17168718
51272,hematologic malignancies,disease,1.0,17168718
51273,lung cancer,disease,1.0,17168718
51274,breast cancer,disease,1.0,17168718
51275,EGFR,gene,0.994,17168718
51276,Lapatinib,drug,0.999,17168718
51277,Tykerb,drug,0.995,17168718
51278,GW572016,drug,0.9927,17168718
51279,Gefitinib,drug,0.999,17168718
51280,Iressa,drug,0.9976,17168718
51281,ZD1839,drug,0.998,17168718
51282,Erlotinib,drug,0.9985,17168718
51283,Tarceva,drug,0.996,17168718
51284,OSI-774,drug,0.9966,17168718
51285,Trastuzumab,gene,0.9893,17168718
51286,Herceptin,gene,0.8774,17168718
51287,Pertuzumab,gene,0.973,17168718
51288,Omnitarg,gene,0.878,17168718
51289,rhuMab-2C4,gene,0.9883,17168718
51290,Cetuximab,gene,0.9126,17168718
51291,Erbitux,gene,0.815,17168718
51292,IMC-C225,gene,0.952,17168718
51293,Panitumumab,gene,0.916,17168718
51294,Abenix,gene,0.8066,17168718
51295,ABX-EGF,gene,0.995,17168718
51296,ZD6474,drug,0.9614,17168718
51297,EGFR,gene,0.9956,17168718
51298,EGFR,gene,0.99,17168674
51299,head and neck cancer,disease,1.0,17168674
51300,epidermal growth factor,gene,0.9966,17168674
51301,EGF,gene,0.991,17168674
51302,solid tumors,disease,1.0,17168674
51303,EGFR,gene,0.992,17168674
51304,EGFR tyrosine kinase,gene,0.9707,17168674
51305,tyrosine,drug,0.99,17168674
51306,EGFR,gene,0.996,17168674
51307,head and neck squamous cell cancer,disease,1.0,17168674
51308,HNSCC,disease,1.0,17168674
51309,EGFR,gene,0.986,17168674
51310,cetuximab,gene,0.7705,17168674
51311,HNSCC,disease,0.9995,17168674
51312,cetuximab,gene,0.9565,17168674
51313,HNSCC,disease,0.998,17168674
51314,EGFR,gene,0.99,17168674
51315,EGFR,gene,0.961,17168674
51316,Panitumumab,gene,0.8774,17159497
51317,Panitumumab,gene,0.8745,17159497
51318,ABX-EGF,gene,0.992,17159497
51319,epidermal growth factor receptor,gene,0.993,17159497
51320,tumors,disease,0.573,17159497
51321,cetuximab,gene,0.9087,17159497
51322,normal and neoplastic cell types,cell_type,0.723,17159497
51323,epidermal growth factor receptor,gene,0.998,17159497
51324,panitumumab,gene,0.877,17159497
51325,epidermal growth factor receptor,gene,0.998,17159497
51326,rash,disease,0.9976,17159497
51327,tumor,disease,0.6655,17159497
51328,panitumumab,gene,0.889,17159497
51329,tumor,disease,0.9995,17159497
51330,cancer,disease,1.0,17159497
51331,colorectal cancer,disease,1.0,17159497
51332,Panitumumab,gene,0.761,17159497
51333,Advanced,disease,0.884,17159497
51334,Colorectal Cancer,disease,0.8267,17159497
51335,panitumumab,gene,0.8745,17159497
51336,colorectal cancer,disease,1.0,17159497
51337,panitumumab,gene,0.76,17159497
51338,(-)-Epigallocatechin gallate,drug,0.9995,17136234
51339,(-)-gossypol,drug,1.0,17136234
51340,2-deoxyglucose,drug,0.9995,17136234
51341,p53,gene,0.9785,17136234
51342,adalimumab,gene,0.7827,17136234
51343,adefovir dipivoxil,drug,0.998,17136234
51344,ADH-1,gene,0.994,17136234
51345,alemtuzumab,gene,0.663,17136234
51346,aliskiren fumarate,drug,0.9985,17136234
51347,alvocidib hydrochloride,drug,0.9985,17136234
51348,aminolevulinic acid hydrochloride,drug,0.996,17136234
51349,aminolevulinic acid methyl ester,drug,0.999,17136234
51350,amrubicin hydrochloride,drug,0.995,17136234
51351,AN-152,drug,0.8643,17136234
51352,anecortave acetate,drug,0.9937,17136234
51353,antiasthma,disease,0.962,17136234
51354,AP-12009,drug,0.998,17136234
51355,AP-23573,drug,0.9854,17136234
51356,apaziquone,drug,0.998,17136234
51357,aprinocarsen sodium,drug,0.9985,17136234
51358,AR-C126532,drug,0.999,17136234
51359,AR-H065522,drug,0.998,17136234
51360,aripiprazole,drug,0.9985,17136234
51361,armodafinil,drug,0.9985,17136234
51362,arzoxifene hydrochloride,drug,0.998,17136234
51363,atazanavir sulfate,drug,0.994,17136234
51364,atilmotin,drug,0.997,17136234
51365,atomoxetine hydrochloride,drug,0.998,17136234
51366,atorvastatin,drug,0.999,17136234
51367,avanafil,drug,0.998,17136234
51368,azimilide hydrochloride,drug,0.997,17136234
51369,Bevacizumab,gene,0.5264,17136234
51370,insulin aspart,gene,0.8037,17136234
51371,BMS-214662,drug,0.999,17136234
51372,BN-83495,drug,0.997,17136234
51373,bortezomib,drug,0.9995,17136234
51374,bosentan,drug,0.9985,17136234
51375,botulinum toxin type B,gene,0.985,17136234
51376,Caspofungin acetate,drug,0.995,17136234
51377,cetuximab,gene,0.745,17136234
51378,chrysin,drug,0.9995,17136234
51379,ciclesonide,drug,0.9863,17136234
51380,clevudine,drug,0.9976,17136234
51381,clofarabine,drug,0.9966,17136234
51382,clopidogrel,drug,0.998,17136234
51383,CNF-1010,drug,0.999,17136234
51384,CNTO-328,drug,0.999,17136234
51385,CP-751871,drug,0.9995,17136234
51386,CX-717,drug,0.999,17136234
51387,Cypher,drug,0.832,17136234
51388,Dapoxetine hydrochloride,drug,0.9966,17136234
51389,darifenacin hydrobromide,drug,0.9995,17136234
51390,dasatinib,drug,0.998,17136234
51391,deferasirox,drug,0.997,17136234
51392,dextofisopam,drug,0.9985,17136234
51393,dextromethorphan,drug,0.999,17136234
51394,quinidine sulfate,drug,0.996,17136234
51395,diclofenac,drug,0.998,17136234
51396,dronedarone hydrochloride,drug,0.9966,17136234
51397,duloxetine hydrochloride,drug,0.996,17136234
51398,dutasteride,drug,0.997,17136234
51399,Edaravone,drug,0.9995,17136234
51400,efaproxiral sodium,drug,0.999,17136234
51401,emtricitabine,drug,0.9995,17136234
51402,entecavir,drug,0.996,17136234
51403,eplerenone,drug,0.998,17136234
51404,erlotinib hydrochloride,drug,0.9985,17136234
51405,escitalopram oxalate,drug,0.9995,17136234
51406,etoricoxib,drug,0.9985,17136234
51407,ezetimibe,drug,0.9976,17136234
51408,ezetimibe,drug,0.9985,17136234
51409,simvastatin,drug,0.999,17136234
51410,Finrozole,drug,0.998,17136234
51411,fipamezole hydrochloride,drug,0.999,17136234
51412,fondaparinux sodium,drug,0.988,17136234
51413,fulvestrant,drug,0.9995,17136234
51414,Gabapentin enacarbil,drug,0.9995,17136234
51415,gaboxadol,drug,0.9995,17136234
51416,gefitinib,drug,0.999,17136234
51417,gestodene,drug,0.9966,17136234
51418,ghrelin,gene,0.971,17136234
51419,Human insulin,gene,0.988,17136234
51420,human papillomavirus,species,0.7646,17136234
51421,Imatinib mesylate,drug,0.998,17136234
51422,immunoglobulin,gene,0.9937,17136234
51423,insulin detemir,gene,0.9834,17136234
51424,insulin glargine,gene,0.974,17136234
51425,insulin glulisine,gene,0.9736,17136234
51426,insulin,gene,0.525,17136234
51427,istradefylline,drug,0.998,17136234
51428,i,gene,0.9473,17136234
51429,ivabradine hydrochloride,drug,0.9976,17136234
51430,ixabepilone,drug,0.9995,17136234
51431,LA-419,drug,0.9976,17136234
51432,lacosamide,drug,0.999,17136234
51433,landiolol,drug,0.999,17136234
51434,lanthanum carbonate,drug,0.9995,17136234
51435,lidocaine,drug,0.9985,17136234
51436,prilocaine,drug,0.999,17136234
51437,cisplatin,drug,0.9995,17136234
51438,lutropin alfa,gene,0.991,17136234
51439,Matuzumab,gene,0.752,17136234
51440,MBP(82-98),gene,0.9424,17136234
51441,mecasermin,drug,0.8706,17136234
51442,MGCD-0103,drug,0.9985,17136234
51443,MMR,drug,0.888,17136234
51444,morphine hydrochloride,drug,0.999,17136234
51445,mycophenolic acid,drug,0.999,17136234
51446,sodium salt,drug,0.8564,17136234
51447,Natalizumab,gene,0.675,17136234
51448,NCX-4016,drug,0.983,17136234
51449,neridronic acid,drug,0.9985,17136234
51450,nesiritide,drug,0.7363,17136234
51451,nilotinib,drug,0.9985,17136234
51452,NSC-330507,drug,0.9995,17136234
51453,O6-benzylguanine,drug,0.999,17136234
51454,olanzapine,drug,0.997,17136234
51455,fluoxetine,drug,0.9985,17136234
51456,hydrochloride,drug,0.85,17136234
51457,omalizumab,gene,0.913,17136234
51458,Panitumumab,gene,0.753,17136234
51459,parathyroid hormone,gene,0.9863,17136234
51460,human recombinant,gene,0.8755,17136234
51461,parecoxib sodium,drug,0.9985,17136234
51462,PEG,drug,0.9873,17136234
51463,PEG-filgrastim,gene,0.9336,17136234
51464,peginterferon alfa-2a,gene,0.996,17136234
51465,peginterferon alfa-2b,gene,0.9966,17136234
51466,pegvisomant,drug,0.8726,17136234
51467,pemetrexed disodium,drug,0.999,17136234
51468,perospirone hydrochloride,drug,0.998,17136234
51469,pexelizumab,gene,0.6987,17136234
51470,phorbol 12-myristate 13-acetate,drug,0.999,17136234
51471,posaconazole,drug,0.998,17136234
51472,pramiconazole,drug,0.999,17136234
51473,prasugrel,drug,0.999,17136234
51474,pregabalin,drug,0.999,17136234
51475,prilocaine,drug,0.999,17136234
51476,GAD65,gene,0.441,17136234
51477,raclopride,drug,0.999,17136234
51478,rasagiline mesilate,drug,0.9985,17136234
51479,retapamulin,drug,0.9297,17136234
51480,rosuvastatin calcium,drug,0.9907,17136234
51481,rotigotine,drug,0.999,17136234
51482,rufinamide,drug,0.9995,17136234
51483,SarCNU,drug,0.79,17136234
51484,SB-743921,drug,0.9995,17136234
51485,SHL-749,drug,0.9995,17136234
51486,sirolimus,drug,0.5327,17136234
51487,sitaxsentan sodium,drug,0.9985,17136234
51488,sorafenib,drug,0.9995,17136234
51489,TachoSil,drug,0.963,17136234
51490,tadalafil,drug,0.9966,17136234
51491,talampanel,drug,0.999,17136234
51492,Taxus,drug,0.7188,17136234
51493,tegaserod maleate,drug,0.9814,17136234
51494,telithromycin,drug,0.998,17136234
51495,telmisartan,drug,0.998,17136234
51496,hydrochlorothiazide,drug,0.999,17136234
51497,temsirolimus,drug,0.998,17136234
51498,tenatoprazole,drug,0.991,17136234
51499,teriflunomide,drug,0.998,17136234
51500,tetrathiomolybdate,drug,0.9985,17136234
51501,ticilimumab,drug,0.556,17136234
51502,timcodar dimesilate,drug,0.9956,17136234
51503,tipifarnib,drug,0.998,17136234
51504,tirapazamine,drug,0.999,17136234
51505,TPI,drug,0.978,17136234
51506,tramiprosate,drug,0.998,17136234
51507,trifluridine,drug,0.9995,17136234
51508,TPI,drug,0.8413,17136234
51509,trimethoprim,drug,0.9995,17136234
51510,Ularitide,drug,0.526,17136234
51511,Urocortin 2,gene,0.982,17136234
51512,Valdecoxib,drug,0.9995,17136234
51513,valganciclovir hydrochloride,drug,0.9976,17136234
51514,valproate magnesium,drug,0.999,17136234
51515,valspodar,drug,0.999,17136234
51516,vardenafil hydrochloride hydrate,drug,0.9976,17136234
51517,vitespen,drug,0.995,17136234
51518,vofopitant hydrochloride,drug,0.9927,17136234
51519,vorinostat,drug,0.998,17136234
51520,Yttrium 90,drug,0.985,17136234
51521,90Y,drug,0.96,17136234
51522,Ziprasidone,drug,0.998,17136234
51523,hydrochloride,drug,0.9985,17136234
51524,zotarolimus,drug,0.997,17136234
51525,zotarolimus,drug,0.999,17136234
51526,Panitumumab,gene,0.84,17100412
51527,metastatic colorectal cancer,disease,0.9995,17100412
51528,Panitumumab,gene,0.678,17100412
51529,human immunoglobulin G2 monoclonal antibody,gene,0.8867,17100412
51530,epidermal growth factor receptor,gene,0.996,17100412
51531,EGFR,gene,0.9917,17100412
51532,colorectal cancers,disease,1.0,17100412
51533,metastatic colorectal cancer,disease,1.0,17100412
51534,EGFR,gene,0.9907,17100412
51535,tumour,disease,0.992,17100412
51536,panitumumab,gene,0.876,17100412
51537,panitumumab,gene,0.897,17100412
51538,Panitumumab,gene,0.868,17100412
51539,metastatic colorectal cancer,disease,1.0,17100412
51540,panitumumab,gene,0.869,17100412
51541,fluorouracil,drug,0.999,17100412
51542,folinic acid,drug,0.9985,17100412
51543,irinotecan,drug,0.9946,17100412
51544,metastatic colorectal cancer,disease,0.974,17100412
51545,Panitumumab,gene,0.8423,17100412
51546,panitumumab,gene,0.955,17100412
51547,BSC,drug,0.592,17100412
51548,panitumumab,gene,0.8003,17100412
51549,Panitumumab,gene,0.797,17049019
51550,colon cancer,disease,1.0,17049019
51551,Panitumumab,gene,0.6235,17049019
51552,human epidermal growth factor receptor receptor,gene,0.9985,17049019
51553,EGFR,gene,0.996,17049019
51554,HER-1,gene,0.9927,17049019
51555,colorectal cancer,disease,1.0,17049019
51556,panitumumab,gene,0.9126,17049019
51557,panitumumab,gene,0.8926,17049019
51558,panitumumab,gene,0.9272,17049019
51559,metastatic colorectal cancer,disease,1.0,17049019
51560,oatmeal,species,0.8286,17034418
51561,acneform eruption,disease,0.9937,17034418
51562,epidermal growth factor receptor,gene,0.999,17034418
51563,tyrosine,drug,0.995,17034418
51564,tyrosine-kinase,gene,0.997,17034418
51565,epidermal growth factor (EGFR)-positive cancers,disease,0.9927,17034418
51566,epidermal growth factor,gene,0.995,17034418
51567,EGFR,gene,0.945,17034418
51568,tyrosine,drug,0.9976,17034418
51569,tyrosine-kinase,gene,0.993,17034418
51570,acneiform eruption,disease,1.0,17034418
51571,oatmeal,species,0.759,17034418
51572,arachidonic acid,drug,0.999,17034418
51573,cytosolic phospholipase A2,gene,0.997,17034418
51574,tumour necrosis factor-alpha,gene,0.9844,17034418
51575,oatmeal,species,0.7114,17034418
51576,rash,disease,0.9053,17034418
51577,cetuximab,gene,0.9043,17034418
51578,erlotinib,drug,0.9966,17034418
51579,panitumumab,gene,0.7754,17034418
51580,sorafenib,drug,0.999,17034418
51581,oatmeal,species,0.655,17034418
51582,rash,disease,0.99,17034418
51583,EGFR,gene,0.994,17034418
51584,antineoplastic,disease,0.6685,17034418
51585,epidermal growth factor receptor,gene,0.9966,17030643
51586,colorectal cancer,disease,1.0,17030643
51587,metastatic colorectal cancer,disease,1.0,17030643
51588,mCRC,disease,1.0,17030643
51589,epidermal growth factor receptor,gene,0.9985,17030643
51590,EGFR,gene,0.9917,17030643
51591,EGFR-expressing mCRC,cell_line,0.568,17030643
51592,EGFR,disease,0.447,17030643
51593,mCRC,disease,0.992,17030643
51594,irinotecan,drug,0.9966,17030643
51595,EGFR,gene,0.9946,17030643
51596,CRC,disease,0.996,17030643
51597,Cetuximab,gene,0.906,17030643
51598,panitumumab,gene,0.8555,17030643
51599,cetuximab,gene,0.9194,17030643
51600,irinotecan,drug,0.994,17030643
51601,EGFR,gene,0.9893,17030643
51602,mCRC,disease,0.882,17030643
51603,rash,disease,0.999,17030643
51604,rash,disease,0.9985,17030643
51605,EGFR,gene,0.9937,17030643
51606,tyrosine kinase,gene,0.802,17030643
51607,EGFR,gene,0.993,17030643
51608,mCRC,disease,0.999,17030643
51609,panitumumab,gene,0.858,16945167
51610,metastatic colorectal cancer,disease,0.995,16945167
51611,Panitumumab,gene,0.847,16945167
51612,ABX-EGF,gene,0.993,16945167
51613,epidermal growth factor receptor,gene,0.997,16945167
51614,Panitumumab,gene,0.8823,16945167
51615,cancer,disease,1.0,16945167
51616,non-small-cell lung cancer,disease,1.0,16945167
51617,"renal,",disease,0.9985,16945167
51618,colorectal cancer,disease,1.0,16945167
51619,CRC,disease,1.0,16945167
51620,cetuximab,gene,0.956,16945167
51621,panitumumab,gene,0.9536,16945167
51622,rash,disease,0.9956,16945167
51623,epidermal growth factor receptor,gene,0.9976,16945167
51624,metastatic CRC,disease,0.9966,16945167
51625,panitumumab,gene,0.907,16945167
51626,irinotecan,drug,0.9966,16945167
51627,fluorouracil,drug,0.9907,16945167
51628,panitumumab,gene,0.8667,16945167
51629,fluorouracil,drug,0.9995,16945167
51630,leucovorin,drug,0.9995,16945167
51631,oxaliplatin,drug,0.9995,16945167
51632,bevacizumab,gene,0.7876,16945167
51633,panitumumab,gene,0.9385,16945167
51634,CRC,disease,0.999,16945167
51635,rash,disease,0.9985,16945167
51636,Epidermal growth factor receptor,gene,0.9907,16857825
51637,epidermal growth factor receptor,gene,0.9966,16857825
51638,EGFR,gene,0.997,16857825
51639,erlotinib,drug,0.988,16857825
51640,gefitinib,drug,0.9917,16857825
51641,cetuximab,gene,0.659,16857825
51642,non-small cell lung cancer,disease,1.0,16857825
51643,solid tumors,disease,1.0,16857825
51644,panitumumab,gene,0.81,16857825
51645,matuzumab,gene,0.8853,16857825
51646,EGFR,gene,0.996,16857825
51647,vascular endothelial growth factor receptor,gene,0.9976,16857825
51648,ZD6474,drug,0.9883,16857825
51649,AEE788,drug,0.9907,16857825
51650,EGFR,DNA,0.524,16857825
51651,EGFR family members,gene,0.9814,16857825
51652,lapatinib,drug,0.994,16857825
51653,canertinib,drug,0.9834,16857825
51654,HKI272,drug,0.999,16857825
51655,tumors,disease,1.0,16857825
51656,erlotinib,drug,0.9946,16857825
51657,gefitinib,drug,0.9966,16857825
51658,ZD6474,drug,0.999,16857825
51659,ZD6474,drug,0.999,16857825
51660,patients,species,0.917,16857825
51661,non-small cell lung cancer,disease,1.0,16857825
51662,EGFR,gene,0.992,16857825
51663,EGFR,gene,0.9927,16857825
51664,patients,species,0.976,16857825
51665,EGFR,gene,0.983,16857825
51666,EGFR,gene,0.9683,16857825
51667,p53,gene,0.996,16845450
51668,adalimumab,gene,0.7266,16845450
51669,albumin interferon alfa,gene,0.974,16845450
51670,alemtuzumab,gene,0.694,16845450
51671,aliskiren fumarate,drug,0.998,16845450
51672,aminolevulinic acid methyl ester,drug,0.999,16845450
51673,AR-C126532,drug,0.9976,16845450
51674,atomoxetine hydrochloride,drug,0.9927,16845450
51675,Bevacizumab,gene,0.5415,16845450
51676,bosentan,drug,0.993,16845450
51677,botulinum toxin type B,gene,0.9854,16845450
51678,brimonidine tartrate,drug,0.999,16845450
51679,timolol maleate,drug,0.997,16845450
51680,Calcipotriol,drug,0.9995,16845450
51681,betamethasone dipropionate,drug,0.999,16845450
51682,cangrelor tetrasodium,drug,0.904,16845450
51683,cetuximab,gene,0.727,16845450
51684,ciclesonide,drug,0.996,16845450
51685,cinacalcet hydrochloride,drug,0.9966,16845450
51686,collagen,gene,0.7524,16845450
51687,PVP,drug,0.9995,16845450
51688,Darbepoetin alfa,gene,0.9443,16845450
51689,darusentan,drug,0.996,16845450
51690,dasatinib,drug,0.997,16845450
51691,desloratadine,drug,0.999,16845450
51692,lung cancer,disease,1.0,16845450
51693,dexrazoxane,drug,0.998,16845450
51694,dextromethorphan,drug,0.999,16845450
51695,quinidine sulfate,drug,0.999,16845450
51696,duloxetine hydrochloride,drug,0.985,16845450
51697,eel calcitonin,gene,0.985,16845450
51698,eel,species,0.684,16845450
51699,efalizumab,gene,0.9424,16845450
51700,entecavir,drug,0.996,16845450
51701,etoricoxib,drug,0.991,16845450
51702,Falciparum merozoite protein-1,gene,0.9736,16845450
51703,Falciparum,species,0.805,16845450
51704,AS02A,gene,0.99,16845450
51705,fenretinide,drug,0.9956,16845450
51706,fondaparinux sodium,drug,0.9917,16845450
51707,gamma-Hydroxybutyrate sodium,drug,0.9976,16845450
51708,gefitinib,drug,0.999,16845450
51709,ghrelin,gene,0.9814,16845450
51710,human,species,0.9897,16845450
51711,hLM609,drug,0.9087,16845450
51712,Icatibant acetate,drug,0.996,16845450
51713,imatinib mesylate,drug,0.9985,16845450
51714,ipsapirone,drug,0.9985,16845450
51715,irofulven,drug,0.998,16845450
51716,LBH-589,drug,0.9956,16845450
51717,LE-AON,drug,0.9897,16845450
51718,levocetirizine,drug,0.9995,16845450
51719,LY-450139,drug,0.9995,16845450
51720,Malaria,disease,0.7393,16845450
51721,motexafin,drug,0.998,16845450
51722,gadolinium,drug,0.805,16845450
51723,muraglitazar,drug,0.998,16845450
51724,mycophenolic acid sodium salt,drug,0.9946,16845450
51725,paclitaxel,drug,1.0,16845450
51726,nelarabine,drug,0.9985,16845450
51727,O6-Benzylguanine,drug,0.9985,16845450
51728,olmesartan medoxomil,drug,0.9995,16845450
51729,orbofiban acetate,drug,0.998,16845450
51730,Panitumumab,gene,0.863,16845450
51731,peginterferon alfa-2a,gene,0.9976,16845450
51732,peginterferon alfa-2b,gene,0.997,16845450
51733,pemetrexed disodium,drug,0.9995,16845450
51734,YY3-36,drug,0.9995,16845450
51735,pleconaril,drug,0.9995,16845450
51736,prasterone,drug,0.9985,16845450
51737,pregabalin,drug,0.9995,16845450
51738,Ranolazine,drug,0.9995,16845450
51739,rebimastat,drug,0.9985,16845450
51740,malaria,species,0.434,16845450
51741,rosuvastatin calcium,drug,0.9863,16845450
51742,SQN-400,drug,0.999,16845450
51743,Taxus,drug,0.9883,16845450
51744,tegaserod maleate,drug,0.983,16845450
51745,tenofovir disoproxil fumarate,drug,0.9995,16845450
51746,troxacitabine,drug,0.9995,16845450
51747,Valganciclovir hydrochloride,drug,0.9995,16845450
51748,Val-Tyr,drug,0.9976,16845450
51749,sardine,DNA,0.625,16845450
51750,sardine peptidase,gene,0.985,16845450
51751,VNP-40101M,drug,0.997,16845450
51752,vorinostat,drug,0.999,16845450
51753,panitumumab,gene,0.7573,16796788
51754,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9414,16796788
51755,metastatic colorectal cancer,disease,1.0,16796788
51756,epidermal growth factor receptor,gene,0.9985,16796788
51757,metastatic colorectal cancer,disease,0.998,16796788
51758,CRC,disease,1.0,16796788
51759,mCRC,disease,0.993,16796788
51760,CRC,disease,0.999,16796788
51761,murine,species,0.658,16796788
51762,cetuximab,gene,0.5415,16796788
51763,anti-epiderman growth factor receptor monoclonal antibody panitumumab,gene,0.923,16796788
51764,panitumumab,gene,0.925,16796788
51765,metastatic CRC,disease,0.9976,16796788
51766,Pantitumumab,gene,0.6064,16796788
51767,tumor,disease,0.972,16796788
51768,Rash,disease,0.884,16796788
51769,panitumumab,gene,0.848,16796788
51770,colon cancer,disease,1.0,16796788
51771,Panitumumab,gene,0.7544,16796785
51772,anti-EGFR antibody,gene,0.92,16796785
51773,advanced colorectal cancer,disease,1.0,16796785
51774,metastatic colorectal cancer,disease,0.8496,16761936
51775,colorectal cancer,disease,1.0,16761936
51776,cancer,disease,1.0,16761936
51777,cancer,disease,1.0,16761936
51778,lung cancer,disease,1.0,16761936
51779,colorectal cancer,disease,1.0,16761936
51780,metastatic colorectal cancer,disease,0.9863,16761936
51781,5-fluorouracil,drug,0.999,16761936
51782,oxaliplatin,drug,1.0,16761936
51783,irinotecan,drug,0.999,16761936
51784,vascular endothelial growth factor,gene,0.997,16761936
51785,bevacizumab,gene,0.735,16761936
51786,epidermal growth factor receptor,gene,0.9976,16761936
51787,cetuximab,gene,0.824,16761936
51788,panitumumab,gene,0.8726,16761936
51789,advanced colorectal cancer,disease,1.0,16761936
51790,colorectal-cancer,disease,1.0,16696165
51791,receptor,gene,0.634,16648969
51792,cancers,disease,1.0,16648969
51793,Tumor,disease,1.0,16648969
51794,cancer,disease,1.0,16648969
51795,trastuzumab,gene,0.977,16648969
51796,Herceptin,gene,0.8,16648969
51797,tumors,disease,0.4758,16648969
51798,epidermal growth factor,gene,0.997,16648969
51799,antibodie,gene,0.6606,16648969
51800,cancer,disease,0.9995,16648969
51801,bevacizumab,gene,0.9736,16648969
51802,Theragyn,drug,0.506,16648969
51803,pemtumomab,gene,0.842,16648969
51804,daclizumab,gene,0.831,16648969
51805,Zenapax,gene,0.4321,16648969
51806,MDX-210,gene,0.717,16648969
51807,Herceptin,gene,0.546,16648969
51808,trastuzumab,gene,0.985,16648969
51809,panitumumab,gene,0.954,16648969
51810,ABX-EGF,gene,0.991,16648969
51811,mastuzimab,gene,0.638,16648969
51812,EMD-72000,drug,0.965,16648969
51813,certuximab,gene,0.9497,16648969
51814,IMC225,gene,0.768,16648969
51815,STI571,drug,0.703,16648969
51816,alemtuizumab,gene,0.9126,16648969
51817,gemtuzumab,gene,0.7983,16648969
51818,ozogamicin,drug,0.98,16648969
51819,cancer,disease,1.0,16648969
51820,131I,drug,0.6143,16636723
51821,labetuzumab,gene,0.631,16636723
51822,Abacavir sulfate,drug,0.987,16636723
51823,adalimumab,gene,0.779,16636723
51824,ademetionine,drug,0.998,16636723
51825,alefacept,drug,0.5625,16636723
51826,alemtuzumab,gene,0.879,16636723
51827,amlodipine,drug,0.9995,16636723
51828,amphotericin B,drug,0.9995,16636723
51829,anakinra,drug,0.9883,16636723
51830,aripiprazole,drug,0.999,16636723
51831,aspirin,drug,0.998,16636723
51832,axitinib,drug,0.996,16636723
51833,Betamethasone dipropionate,drug,0.999,16636723
51834,bevacizumab,gene,0.6465,16636723
51835,insulin aspart,gene,0.7676,16636723
51836,bortezomib,drug,0.9995,16636723
51837,bosentan,drug,0.997,16636723
51838,botulinum toxin type,gene,0.878,16636723
51839,BQ-123,drug,0.9985,16636723
51840,Calcium folinate,drug,0.999,16636723
51841,canertinib dihydrochloride,drug,0.999,16636723
51842,carboplatin,drug,0.9995,16636723
51843,carmustine,drug,0.982,16636723
51844,cetirizine hydrochloride,drug,0.999,16636723
51845,cholecalciferol,drug,0.9995,16636723
51846,ciclesonide,drug,0.986,16636723
51847,ciclosporin,drug,0.9995,16636723
51848,cinacalcet hydrochloride,drug,0.9956,16636723
51849,cisplatin,drug,0.9995,16636723
51850,clarithromycin,drug,0.9995,16636723
51851,clofazimine,drug,0.998,16636723
51852,CpG-7909,drug,0.9473,16636723
51853,Darbepoetin alfa,gene,0.9326,16636723
51854,darifenacin hydrobromide,drug,0.9995,16636723
51855,DB-289,drug,0.9907,16636723
51856,desloratadine,drug,0.998,16636723
51857,Dexamet,drug,0.9814,16636723
51858,dicycloverine hydrochloride,drug,0.9995,16636723
51859,dimethyl fumarate,drug,0.999,16636723
51860,docetaxel,drug,0.9995,16636723
51861,dolastatin 10,drug,0.9985,16636723
51862,drospirenone,drug,0.9995,16636723
51863,drospirenone,drug,0.9995,16636723
51864,estradiol,drug,0.9995,16636723
51865,duloxetine hydrochloride,drug,0.996,16636723
51866,edotecarin,drug,0.9937,16636723
51867,efaproxiral sodium,drug,0.999,16636723
51868,enalapril maleate,drug,0.9985,16636723
51869,epoetin beta,gene,0.9907,16636723
51870,epoprostenol sodium,drug,0.9966,16636723
51871,erlotinib hydrochloride,drug,0.997,16636723
51872,escitalopram oxalate,drug,0.9995,16636723
51873,estradiol,drug,0.9995,16636723
51874,etanercept,gene,0.8364,16636723
51875,Fluconazole,drug,0.999,16636723
51876,fludarabine phosphate,drug,0.9995,16636723
51877,fluorouracil,drug,0.9995,16636723
51878,Gefitinib,drug,0.999,16636723
51879,gemcitabine,drug,0.9995,16636723
51880,Ghrelin,gene,0.9736,16636723
51881,glibenclamide,drug,0.998,16636723
51882,glimepiride,drug,0.9966,16636723
51883,GTI-2040,drug,0.9985,16636723
51884,Haloperidol,drug,0.9995,16636723
51885,human insulin,gene,0.985,16636723
51886,hydrocortisone probutate,drug,0.9995,16636723
51887,Imatinib mesylate,drug,0.999,16636723
51888,indisulam,drug,0.998,16636723
51889,insulin,gene,0.559,16636723
51890,insulin aspart,gene,0.9585,16636723
51891,insulin glulisine,gene,0.9805,16636723
51892,insulin lispro,gene,0.9214,16636723
51893,irinotecan,drug,0.9995,16636723
51894,ispronicline,drug,0.9985,16636723
51895,Lamivudine,drug,0.9995,16636723
51896,lamivudine,drug,0.9995,16636723
51897,zidovudine,drug,0.9995,16636723
51898,abacavir sulfate,drug,0.9,16636723
51899,lapatinib,drug,0.9995,16636723
51900,letrozole,drug,0.9985,16636723
51901,levocetirizine,drug,0.999,16636723
51902,lomustine,drug,0.9956,16636723
51903,lonafarnib,drug,0.9995,16636723
51904,lumiracoxib,drug,0.999,16636723
51905,Magnesium,drug,0.9995,16636723
51906,sulfate,drug,0.6006,16636723
51907,MD-1100,drug,0.9897,16636723
51908,melphalan,drug,0.9946,16636723
51909,metformin hydrochloride,drug,0.9976,16636723
51910,methotrexate,drug,1.0,16636723
51911,metoclopramide hydrochloride,drug,0.9976,16636723
51912,mitiglinide calcium hydrate,drug,0.996,16636723
51913,monophosphoryl lipid A,drug,0.7764,16636723
51914,montelukast sodium,drug,0.993,16636723
51915,motexafin gadolinium,drug,0.8013,16636723
51916,mycophenolate mofetil,drug,0.999,16636723
51917,mycophenolic acid sodium salt,drug,0.991,16636723
51918,Nitisinone,drug,0.9995,16636723
51919,Omalizumab,gene,0.8164,16636723
51920,omapatrilat,drug,0.987,16636723
51921,ONYX-015,drug,0.9985,16636723
51922,oxaliplatin,drug,0.9995,16636723
51923,Paclitaxel,drug,0.999,16636723
51924,paclitaxel,drug,0.9995,16636723
51925,panitumumab,gene,0.8745,16636723
51926,parathyroid hormone,gene,0.9897,16636723
51927,human recombinant,gene,0.772,16636723
51928,peginterferon alfa-2a,gene,0.997,16636723
51929,peginterferon alfa,gene,0.996,16636723
51930,peginterferon alfa-2b,gene,0.9844,16636723
51931,ribavirin,drug,0.999,16636723
51932,pertuzumab,gene,0.928,16636723
51933,phosphatidylcholine,drug,0.999,16636723
51934,pimecrolimus,drug,0.9995,16636723
51935,pioglitazone hydrochloride,drug,0.998,16636723
51936,pramlintide acetate,drug,0.993,16636723
51937,prasterone,drug,0.988,16636723
51938,Ranelic acid distrontium salt,drug,0.9946,16636723
51939,ranolazine,drug,0.9917,16636723
51940,rasagiline mesilate,drug,0.9985,16636723
51941,RFB4,gene,0.952,16636723
51942,dsFv,gene,0.933,16636723
51943,PE38,gene,0.9316,16636723
51944,ribavirin,drug,0.9985,16636723
51945,rifabutin,drug,0.999,16636723
51946,risperidone,drug,0.999,16636723
51947,rituximab,gene,0.7217,16636723
51948,rofecoxib,drug,0.9956,16636723
51949,rosiglitazone,drug,0.9985,16636723
51950,maleate,drug,0.564,16636723
51951,rosiglitazone maleate,drug,0.999,16636723
51952,metformin hydrochloride,drug,0.995,16636723
51953,rotavirus,species,0.8047,16636723
51954,S-236,drug,0.9976,16636723
51955,salmeterol xinafoate,drug,0.999,16636723
51956,sarizotan hydrochloride,drug,0.992,16636723
51957,sildenafil,drug,0.999,16636723
51958,sildenafil citrate,drug,0.999,16636723
51959,sunitinib malate,drug,0.9985,16636723
51960,Tadalafil,drug,0.9976,16636723
51961,tegaserod maleate,drug,0.9814,16636723
51962,temozolomide,drug,0.9995,16636723
51963,tenofovir disoproxil fumarate,drug,0.9995,16636723
51964,teriparatide,drug,0.5454,16636723
51965,tiotropium bromide,drug,0.9995,16636723
51966,tipifarnib,drug,0.999,16636723
51967,trabectedin,drug,0.9995,16636723
51968,treprostinil sodium,drug,0.9985,16636723
51969,Vandetanib,drug,0.9995,16636723
51970,vardenafil hydrochloride hydrate,drug,0.997,16636723
51971,vatalanib succinate,drug,0.9976,16636723
51972,vinflunine,drug,0.999,16636723
51973,voriconazole,drug,0.9995,16636723
51974,Zidovudine,drug,0.999,16636723
51975,bevacizumab,gene,0.795,16512997
51976,panitumumab,gene,0.875,16512997
51977,metastatic colorectal cancer,disease,0.9746,16512997
51978,anti-,gene,0.6523,16336753
51979,epidermal growth factor receptor antibodies,gene,0.9355,16336753
51980,irinotecan,drug,0.9893,16336753
51981,colon cancer,disease,1.0,16336753
51982,epidermal growth factor receptor,gene,0.998,16336753
51983,EGFR,gene,0.9937,16336753
51984,colorectal cancers,disease,1.0,16336753
51985,colorectal cancer,disease,1.0,16336753
51986,anti-EGFR monoclonal antibodies,gene,0.892,16336753
51987,cetuximab,gene,0.9365,16336753
51988,panitumumab,gene,0.901,16336753
51989,matuzumab,gene,0.951,16336753
51990,cetuximab,gene,0.9404,16336753
51991,irinotecan,drug,0.9995,16336753
51992,colorectal cancer,disease,0.973,16336753
51993,EGFR,gene,0.8433,16336753
51994,irinotecan,drug,0.979,16336753
51995,epidermal growth factor receptor,gene,0.997,16336752
51996,colorectal cancer,disease,1.0,16336752
51997,epidermal growth factor receptor,gene,0.999,16336752
51998,EGFR,gene,0.994,16336752
51999,colorectal cancers,disease,1.0,16336752
52000,EGFR,gene,0.9937,16336752
52001,EGFR molecule,gene,0.9385,16336752
52002,EGFR,gene,0.9927,16336752
52003,colorectal cancer,disease,1.0,16336752
52004,Cetuximab,gene,0.936,16336752
52005,EGFR,gene,0.9893,16336752
52006,metastatic colorectal cancer,disease,0.9976,16336752
52007,Panitumumab,gene,0.4607,16336752
52008,anti-EGFR antibody,gene,0.9785,16336752
52009,immunoglobulin molecules,gene,0.909,16336752
52010,tumor,disease,0.4778,16336752
52011,CD3e-expressing T cells,cell_line,0.7354,16336752
52012,CD3e,gene,0.9897,16336752
52013,CD16-expressing natural killer cells,cell_type,0.763,16336752
52014,CD16,gene,0.9688,16336752
52015,granulocytes,cell_type,0.7554,16336752
52016,cancer cells,cell_type,0.83,16336752
52017,cancer,disease,0.9995,16336752
52018,Tyrosine,drug,0.977,16336752
52019,Tyrosine kinase,gene,0.909,16336752
52020,quinazoline,drug,0.991,16336752
52021,tyrosine,drug,0.8804,16336752
52022,tyrosine kinase domain,gene,0.92,16336752
52023,EGFR,gene,0.9863,16336752
52024,Erb2,gene,0.99,16336752
52025,vascular endothelial growth factor receptor,gene,0.9985,16336752
52026,EGFR,gene,0.995,16336752
52027,skin rash,disease,1.0,16336752
52028,EGFR gene,gene,0.632,16336752
52029,EGFR,gene,0.8765,16336752
52030,Cancer,disease,0.9976,16320130
52031,Epidermal growth factor receptor,gene,0.9976,16320130
52032,(-)-Epigallocatechin gallate,drug,0.9995,16273137
52033,(Z)-4-hydroxytamoxifen,drug,0.9995,16273137
52034,muIFN-beta,gene,0.916,16273137
52035,adalimumab,gene,0.4988,16273137
52036,adefovir dipivoxil,drug,0.996,16273137
52037,agalsidase alfa,gene,0.9937,16273137
52038,alemtuzumab,gene,0.665,16273137
52039,almotriptan,drug,0.9976,16273137
52040,vCP1452,drug,0.962,16273137
52041,alvimopan hydrate,drug,0.98,16273137
52042,ambrisentan,drug,0.9985,16273137
52043,anti-IFN-,gene,0.947,16273137
52044,gamma MAb,gene,0.873,16273137
52045,Bimatoprost,drug,0.9775,16273137
52046,BMS-188797,drug,0.9995,16273137
52047,BMS-214662,drug,0.9995,16273137
52048,bortezomib,drug,0.9995,16273137
52049,bosentan,drug,0.999,16273137
52050,bovine lactoferrin,gene,0.994,16273137
52051,bovine,species,0.8633,16273137
52052,Caffeine,drug,0.999,16273137
52053,canertinib dihydrochloride,drug,0.9985,16273137
52054,canfosfamide hydrochloride,drug,0.9985,16273137
52055,cannabidiol,drug,0.9995,16273137
52056,caspofungin acetate,drug,0.9966,16273137
52057,cetuximab,gene,0.835,16273137
52058,ciclesonide,drug,0.9927,16273137
52059,cilansetron,drug,0.999,16273137
52060,cinacalcet hydrochloride,drug,0.9946,16273137
52061,clopidogrel,drug,0.9985,16273137
52062,CpG-7909,drug,0.9946,16273137
52063,Daptomycin,drug,0.9976,16273137
52064,darbepoetin alfa,gene,0.9683,16273137
52065,darifenacin hydrobromide,drug,0.9995,16273137
52066,decitabine,drug,0.9976,16273137
52067,denufosol tetrasodium,drug,0.9985,16273137
52068,Dexamet,drug,0.995,16273137
52069,diindolemethane,drug,0.999,16273137
52070,drotrecogin,drug,0.9917,16273137
52071,duloxetine hydrochloride,drug,0.993,16273137
52072,DX-9065a,drug,0.998,16273137
52073,E-7010,drug,0.998,16273137
52074,edaravone,drug,0.9995,16273137
52075,efalizumab,gene,0.726,16273137
52076,eicosapentaenoic acid,drug,0.9995,16273137
52077,docosahexaenoic acid,drug,0.9995,16273137
52078,elacridar,drug,0.992,16273137
52079,eletriptan,drug,0.9907,16273137
52080,emtricitabine,drug,0.999,16273137
52081,erlotinib hydrochloride,drug,0.9946,16273137
52082,ertapenem sodium,drug,0.9863,16273137
52083,eszopiclone,drug,0.9995,16273137
52084,everolimus,drug,0.9985,16273137
52085,ezetimibe,drug,0.9985,16273137
52086,Fludarabine,drug,0.999,16273137
52087,fondaparinux sodium,drug,0.995,16273137
52088,gamma-Hydroxybutyrate sodium,drug,0.9966,16273137
52089,gavestinel sodium,drug,0.997,16273137
52090,gefitinib,drug,0.9985,16273137
52091,granisetron,drug,0.9897,16273137
52092,Human Albumin,gene,0.989,16273137
52093,human insulin,gene,0.982,16273137
52094,Imatinib mesylate,drug,0.9985,16273137
52095,interleukin-2 XL,gene,0.99,16273137
52096,isatoribine,drug,0.9995,16273137
52097,ISS-1018,drug,0.9956,16273137
52098,gamma-globulin,gene,0.9893,16273137
52099,ivabradine hydrochloride,drug,0.9976,16273137
52100,ixabepilone,drug,0.9995,16273137
52101,Lanthanum carbonate,drug,0.999,16273137
52102,L-arginine hydrochloride,drug,0.999,16273137
52103,doxorubicin,drug,0.995,16273137
52104,LY-450139,drug,0.9995,16273137
52105,Magnesium sulfate,drug,0.9995,16273137
52106,melatonin,drug,0.9995,16273137
52107,motexafin,drug,0.9985,16273137
52108,gadolinium,drug,0.8975,16273137
52109,mycophenolic acid sodium salt,drug,0.9946,16273137
52110,Natalizumab,gene,0.769,16273137
52111,nesiritide,gene,0.529,16273137
52112,niacin,drug,0.9995,16273137
52113,lovastatin,drug,0.999,16273137
52114,OGX-011,drug,0.9883,16273137
52115,olmesartan medoxomil,drug,0.999,16273137
52116,omalizumab,gene,0.876,16273137
52117,ospemifene,drug,0.998,16273137
52118,PACAP38,drug,0.6157,16273137
52119,panitumumab,gene,0.876,16273137
52120,parathyroid hormone,gene,0.9805,16273137
52121,human recombinant,gene,0.733,16273137
52122,parecoxib sodium,drug,0.9985,16273137
52123,patupilone,drug,0.9985,16273137
52124,pegfilgrastim,gene,0.6533,16273137
52125,peginterferon alfa-2a,gene,0.994,16273137
52126,peginterferon alfa-2b,gene,0.997,16273137
52127,peginterferon alfa-2b,gene,0.991,16273137
52128,ribavirin,drug,0.999,16273137
52129,pemetrexed disodium,drug,0.999,16273137
52130,pimecrolimus,drug,0.9995,16273137
52131,pirfenidone,drug,0.9985,16273137
52132,posaconazole,drug,0.996,16273137
52133,prasterone,drug,0.996,16273137
52134,pregabalin,drug,0.9995,16273137
52135,R-112,drug,0.996,16273137
52136,ramelteon,drug,0.99,16273137
52137,ranolazine,drug,0.997,16273137
52138,rasagiline mesilate,drug,0.999,16273137
52139,rebimastat,drug,0.997,16273137
52140,roflumilast,drug,0.9995,16273137
52141,rosuvastatin calcium,drug,0.997,16273137
52142,rotigotine hydrochloride,drug,0.999,16273137
52143,rupatadine fumarate,drug,0.9985,16273137
52144,S-3013,drug,0.9946,16273137
52145,S-3304,drug,0.8438,16273137
52146,semustine,drug,0.984,16273137
52147,sitaxsentan sodium,drug,0.998,16273137
52148,John's Wort,disease,0.8057,16273137
52149,John,species,0.581,16273137
52150,Tadalafil,drug,0.994,16273137
52151,tamoxifen,drug,0.9985,16273137
52152,Tc-99m-EDDA-HYNIC-TOC,drug,0.998,16273137
52153,TH-9507,drug,0.999,16273137
52154,tiotropium bromide,drug,0.999,16273137
52155,tipifarnib,drug,0.9985,16273137
52156,tocilizumab,gene,0.892,16273137
52157,tolvaptan,drug,0.986,16273137
52158,torcetrapib,drug,0.993,16273137
52159,TR-14035,drug,0.996,16273137
52160,tramadol hydrochloride,drug,0.9985,16273137
52161,acetaminophen,drug,0.999,16273137
52162,treprostinil diethanolamine,drug,0.9634,16273137
52163,troglitazone,drug,0.9976,16273137
52164,troxacitabine,drug,0.999,16273137
52165,Valdecoxib,drug,0.999,16273137
52166,valganciclovir hydrochloride,drug,0.999,16273137
52167,vandetanib,drug,0.9985,16273137
52168,vardenafil hydrochloride hydrate,drug,0.991,16273137
52169,VAS-991,drug,0.999,16273137
52170,veglin,drug,0.9946,16273137
52171,vinflunine,drug,0.9995,16273137
52172,voriconazole,drug,0.999,16273137
52173,sweet,species,0.5034,16273137
52174,potato,species,0.4617,16273137
52175,Ximelagatran,drug,0.8477,16273137
52176,Epidermal growth factor,gene,0.9976,16120047
52177,solid tumours,disease,1.0,16120047
52178,epidermal growth factor receptor,gene,0.998,16120047
52179,EGFR,gene,0.9927,16120047
52180,malignancies,disease,0.9614,16120047
52181,EGFR,gene,0.9897,16120047
52182,EGFR tyrosine kinase,gene,0.975,16120047
52183,tyrosine,drug,0.9897,16120047
52184,cetuximab,gene,0.766,16120047
52185,monoclonal EGFR antibody,gene,0.941,16120047
52186,gefitinib,drug,0.997,16120047
52187,erlotinib,drug,0.997,16120047
52188,EGFR tyrosine kinase,gene,0.902,16120047
52189,tyrosine,drug,0.967,16120047
52190,malignancies,disease,0.984,16120047
52191,cancer,disease,1.0,16033478
52192,epidermal growth factor receptor,gene,0.9966,16033478
52193,epidermal growth factor receptor,gene,0.998,16033478
52194,EGFR,gene,0.994,16033478
52195,solid tumours,disease,1.0,16033478
52196,EGFR,gene,0.991,16033478
52197,monoclonal antibody cetuximab,gene,0.922,16033478
52198,tyrosine,drug,0.9756,16033478
52199,tyrosine kinase,gene,0.9844,16033478
52200,erlotinib,drug,0.966,16033478
52201,acneiform eruption,disease,0.9995,16033478
52202,xerosis,disease,1.0,16033478
52203,eczema,disease,1.0,16033478
52204,tumour,disease,0.997,16033478
52205,acne,disease,1.0,16033478
52206,xerosis,disease,1.0,16033478
52207,skin reactions,disease,0.965,16033478
52208,skin,disease,0.5986,16012181
52209,epidermal growth factor receptor,gene,0.996,16012181
52210,epidermal growth factor receptor,gene,0.9976,16012181
52211,EGFR,gene,0.991,16012181
52212,cancer,disease,0.9995,16012181
52213,EGFR,gene,0.9956,16012181
52214,cetuximab,gene,0.803,16012181
52215,panitumumab,gene,0.832,16012181
52216,EGFR tyrosine kinase,gene,0.9126,16012181
52217,tyrosine,drug,0.91,16012181
52218,gefitinib,drug,0.99,16012181
52219,erlotinib,drug,0.991,16012181
52220,EGFR,gene,0.9956,16012181
52221,acneiform eruption,disease,1.0,16012181
52222,xerosis,disease,1.0,16012181
52223,eczema,disease,1.0,16012181
52224,telangiectasia,disease,1.0,16012181
52225,hyperpigmentation,disease,1.0,16012181
52226,hair changes,disease,0.9478,16012181
52227,paronychia,disease,1.0,16012181
52228,pyogenic granuloma,disease,1.0,16012181
52229,EGFR,gene,0.9907,16012181
52230,acneiform eruption,disease,1.0,16012181
52231,anti-inflammatory,disease,0.9824,16012181
52232,acne,disease,0.5024,16012181
52233,tetracyclines,drug,0.999,16012181
52234,EGFR,gene,0.9883,16012181
52235,panitumumab,gene,0.8584,15929802
52236,ABX-EGF,gene,0.978,15929802
52237,anti-epidermal growth factor receptor antibody,gene,0.9624,15929802
52238,metastatic colorectal cancer,disease,0.994,15929802
52239,cancer,disease,0.9985,15883910
52240,cancer,disease,0.9995,15883910
52241,Epidermal growth factor receptor,gene,0.9976,15871762
52242,epidermal growth factor receptor,gene,0.998,15871762
52243,EGFR,gene,0.9937,15871762
52244,colorectal cancer,disease,1.0,15871762
52245,CRC,disease,1.0,15871762
52246,EGFR,gene,0.994,15871762
52247,EGFR,gene,0.9937,15871762
52248,anticancer,disease,0.749,15871762
52249,EGFR,gene,0.935,15871762
52250,tyrosine,drug,0.9937,15871762
52251,tyrosine kinase,gene,0.994,15871762
52252,cetuximab,gene,0.565,15871762
52253,EGFR,gene,0.9956,15871762
52254,metastatic CRC,disease,0.963,15871762
52255,cetuximab,gene,0.9404,15871762
52256,irinotecan,drug,0.9907,15871762
52257,metastatic CRC,disease,0.9795,15871762
52258,matuzumab,gene,0.945,15871762
52259,EMD 72000,drug,0.9277,15871762
52260,panitumumab,gene,0.93,15871762
52261,ABG-EGF,gene,0.9893,15871762
52262,EGFR-expressing CRC,cell_line,0.808,15871762
52263,EGFR,disease,0.4475,15871762
52264,EGFR TK,gene,0.9785,15871762
52265,erlotinib,drug,0.9917,15871762
52266,gefitinib,drug,0.996,15871762
52267,non-small-lung cancer,disease,1.0,15871762
52268,erlotinib,drug,0.999,15871762
52269,gefitinib,drug,0.9985,15871762
52270,EGFR,gene,0.9893,15871762
52271,anti-EGFR,gene,0.8794,15871762
52272,acneiform skin rash,disease,1.0,15871762
52273,EGFR,gene,0.995,15871762
52274,EGFR,gene,0.994,15871762
52275,EGFR,gene,0.6895,15871762
52276,epidermal growth factor receptor,gene,0.998,15863375
52277,EGFR,gene,0.995,15863375
52278,colorectal cancer,disease,1.0,15863375
52279,antiepidermal growth factor receptor,gene,0.988,15863375
52280,antiEGFR,gene,0.9604,15863375
52281,panitumumab,gene,0.834,15863375
52282,metastatic colorectal cancer,disease,0.9995,15863375
52283,Tumours,disease,0.988,15863375
52284,metastatic colorectal cancer,disease,1.0,15863375
52285,cetuximab,gene,0.825,15863375
52286,panitumumab,gene,0.773,15863375
52287,EGFR,gene,0.992,15863375
52288,EGFR,gene,0.9937,15863375
52289,EGFR catalytic domain,gene,0.957,15863375
52290,exons,DNA,0.7153,15863375
52291,KRAS,gene,0.66,15863375
52292,BRAF,gene,0.5522,15863375
52293,PIK3CA,gene,0.995,15863375
52294,EGFR,gene,0.9883,15863375
52295,EGFR,gene,0.9917,15863375
52296,EGFR catalytic domain,gene,0.9717,15863375
52297,PIK3CA,gene,0.991,15863375
52298,KRAS,gene,0.739,15863375
52299,BRAF,gene,0.6816,15863375
52300,colorectal-cancer cell lines,cell_line,0.883,15863375
52301,colorectal-cancer,disease,1.0,15863375
52302,cetuximab,gene,0.72,15863375
52303,EGFR,gene,0.997,15863375
52304,EGFR,gene,0.985,15863375
52305,EGFR,gene,0.9854,15863375
52306,colorectal cancers,disease,1.0,15855893
52307,solid organ malignancies,disease,1.0,15855893
52308,tumor,disease,1.0,15855893
52309,metastatic colorectal cancer,disease,1.0,15855893
52310,colorectal cancer,disease,1.0,15855893
52311,colorectal cancer,disease,0.9526,15855893
52312,vascular endothelial growth factor,gene,0.9956,15855893
52313,epidermal growth factor receptor,gene,0.9985,15855893
52314,irinotecan,drug,0.999,15855893
52315,colon cancer,disease,0.9517,15855893
52316,irinotecan,drug,0.999,15855893
52317,colorectal cancer,disease,1.0,15855893
52318,cancer,disease,1.0,15855893
52319,Epidermal growth factor receptor,gene,0.998,15846113
52320,anti,disease,0.885,15846113
52321,cancer,disease,0.757,15846113
52322,epidermal growth factor receptor,gene,0.9985,15846113
52323,EGFR,gene,0.9907,15846113
52324,EGFR,gene,0.9927,15846113
52325,solid tumors,disease,1.0,15846113
52326,EGFR,gene,0.9956,15846113
52327,extracellular EGFR domain,gene,0.8247,15846113
52328,cetuximab,gene,0.9062,15846113
52329,panitumumab,gene,0.921,15846113
52330,tyrosine,drug,0.933,15846113
52331,tyrosine kinase,gene,0.9854,15846113
52332,gefitinib,drug,0.999,15846113
52333,erlotinib,drug,0.9976,15846113
52334,EGFR,gene,0.9927,15846113
52335,rash,disease,0.824,15846113
52336,epidermal growth factor receptor,gene,0.9976,15726506
52337,colorectal cancer,disease,1.0,15726506
52338,epidermal growth factor receptor,gene,0.9985,15726506
52339,EGFR,gene,0.993,15726506
52340,erbB receptor family,gene,0.9917,15726506
52341,EGFR,gene,0.995,15726506
52342,tumors,disease,1.0,15726506
52343,colorectal cancer,disease,1.0,15726506
52344,EGFR,gene,0.994,15726506
52345,tumor,disease,1.0,15726506
52346,anticancer,disease,0.8867,15726506
52347,EGFR,gene,0.9917,15726506
52348,tumors,disease,1.0,15726506
52349,EGFR,gene,0.9336,15726506
52350,tyrosine,drug,0.917,15726506
52351,tyrosine kinase,gene,0.682,15726506
52352,EGFR,gene,0.9946,15726506
52353,colorectal cancer,disease,1.0,15726506
52354,EGFR,gene,0.9937,15726506
52355,epidermal growth factor receptor,gene,0.984,15717942
52356,epidermal growth factor receptor,gene,0.9976,15717942
52357,EGFR,gene,0.99,15717942
52358,EGFR,gene,0.9946,15717942
52359,malignant neoplasms,disease,1.0,15717942
52360,EGFR,gene,0.991,15717942
52361,EGFR,gene,0.9873,15717942
52362,malignant cell,cell_type,0.5156,15717942
52363,tumor,disease,1.0,15717942
52364,EGFR,gene,0.9907,15717942
52365,cetuximab,gene,0.74,15717942
52366,advanced colorectal cancer,disease,0.999,15717942
52367,EGFR,gene,0.991,15717942
52368,panitumumab,gene,0.939,15717942
52369,ABX-EGF,gene,0.993,15717942
52370,h-R3,gene,0.984,15717942
52371,EMD72000,drug,0.993,15717942
52372,Epidermal growth factor receptor,gene,0.9976,15613446
52373,cancer,disease,0.9995,15613446
52374,epidermal growth factor receptor,gene,0.9966,15613446
52375,EGFR,gene,0.9927,15613446
52376,EGFR,gene,0.994,15613446
52377,epithelial malignancies,disease,1.0,15613446
52378,EGFR,gene,0.993,15613446
52379,tumor,disease,1.0,15613446
52380,EGFR,gene,0.9956,15613446
52381,cancer,disease,1.0,15613446
52382,EGFR,gene,0.995,15613446
52383,EGFR,gene,0.956,15613446
52384,cetuximab,gene,0.9062,15613446
52385,Erbitux,gene,0.423,15613446
52386,tyrosine,drug,0.957,15613446
52387,tyrosine kinase,gene,0.9907,15613446
52388,EGFR,gene,0.9927,15613446
52389,gefitinib,drug,0.998,15613446
52390,Iressa,drug,0.9614,15613446
52391,erlotinib,drug,0.995,15613446
52392,Tarceva,drug,0.9873,15613446
52393,EGFR,gene,0.993,15613446
52394,anti-EGFR mAbs,gene,0.933,15613446
52395,cetuximab,gene,0.901,15613446
52396,gefitinib,drug,0.9946,15613446
52397,colorectal and lung cancer,disease,1.0,15613446
52398,EGFR,gene,0.9844,15613446
52399,lung cancer,disease,1.0,15613446
52400,EGFR,gene,0.863,15613446
52401,tumors,disease,1.0,15613446
52402,EGFR,gene,0.988,15613446
52403,EGFR catalytic domain,gene,0.971,15613446
52404,EGFR,gene,0.9536,15613446
52405,EGFR,gene,0.9966,15613446
52406,tumors,disease,1.0,15613446
52407,EGFR,gene,0.992,15613446
52408,EGFR,gene,0.9917,15613446
52409,lung cancer,disease,1.0,15613446
52410,EGFR,gene,0.995,15613446
52411,cancer,disease,1.0,15613446
52412,Abiraterone acetate,drug,0.9814,15605126
52413,p53,gene,0.9907,15605126
52414,adefovir dipivoxil,drug,0.9985,15605126
52415,AE-941,drug,0.9917,15605126
52416,ambrisentan,drug,0.999,15605126
52417,aripiprazole,drug,0.999,15605126
52418,atomoxetine hydrochloride,drug,0.9946,15605126
52419,atrasentan,drug,0.998,15605126
52420,BCH-10618,drug,0.9985,15605126
52421,bimatoprost,drug,0.8955,15605126
52422,BMS-184476,drug,0.9995,15605126
52423,BMS-275183,drug,0.9995,15605126
52424,BMS-387032,drug,0.9995,15605126
52425,botulinum toxin type B,gene,0.9907,15605126
52426,BR96-,drug,0.996,15605126
52427,Doxorubicin,drug,0.6763,15605126
52428,Capravirine,drug,0.9995,15605126
52429,caspofungin acetate,drug,0.999,15605126
52430,cinacalcet hydrochloride,drug,0.998,15605126
52431,Darbepoetin alfa,gene,0.9067,15605126
52432,desloratadine,drug,0.999,15605126
52433,dextrin sulfate,drug,0.715,15605126
52434,DJ-927,drug,0.9863,15605126
52435,duloxetine hydrochloride,drug,0.998,15605126
52436,Elacridar,drug,0.999,15605126
52437,emtricitabine,drug,0.9995,15605126
52438,eplerenone,drug,0.999,15605126
52439,ertapenem sodium,drug,0.9805,15605126
52440,escitalopram oxalate,drug,0.999,15605126
52441,ESP-24217,drug,0.9995,15605126
52442,etoricoxib,drug,0.995,15605126
52443,exenatide,gene,0.688,15605126
52444,ezetimibe,drug,0.9976,15605126
52445,Ferumoxtran,drug,0.976,15605126
52446,fondaparinux sodium,drug,0.988,15605126
52447,fosamprenavir calcium,drug,0.9824,15605126
52448,GW-5634,drug,0.995,15605126
52449,HMN-214,gene,0.9595,15605126
52450,human insulin,gene,0.9844,15605126
52451,IC-14,drug,0.9976,15605126
52452,imatinib mesylate,drug,0.999,15605126
52453,insulin glargine,gene,0.9644,15605126
52454,insulinotropin,gene,0.9814,15605126
52455,iseganan hydrochloride,drug,0.937,15605126
52456,Lanthanum carbonate,drug,0.9995,15605126
52457,L-Arginine hydrochloride,drug,0.9985,15605126
52458,LEA29Y,drug,0.9985,15605126
52459,lenalidomide,drug,0.98,15605126
52460,lestaurtinib,drug,0.9985,15605126
52461,L-MDAM,drug,0.9985,15605126
52462,lometrexol,drug,0.9995,15605126
52463,lopinavir,drug,0.9995,15605126
52464,lopinavir,drug,0.9995,15605126
52465,ritonavir,drug,0.996,15605126
52466,Magnesium sulfate,drug,0.9995,15605126
52467,maraviroc,drug,0.9976,15605126
52468,metreleptin,drug,0.5435,15605126
52469,milataxel,drug,0.984,15605126
52470,MNA-715,drug,0.9067,15605126
52471,morphine hydrochloride,drug,0.9995,15605126
52472,neutrophil-inhibitory factor,gene,0.996,15605126
52473,NK-911,drug,0.9966,15605126
52474,Olanzapine,drug,0.998,15605126
52475,fluoxetine,drug,0.999,15605126
52476,hydrochloride,drug,0.564,15605126
52477,olmesartan medoxomil,drug,0.9995,15605126
52478,omalizumab,gene,0.8027,15605126
52479,ortataxel,drug,0.98,15605126
52480,oxycodone hydrochloride,drug,0.9995,15605126
52481,ibuprofen,drug,0.9985,15605126
52482,Panitumumab,gene,0.8003,15605126
52483,patupilone,drug,0.988,15605126
52484,PD-MAGE-3 Vaccine,gene,0.9824,15605126
52485,peginterferon alfa-2a,gene,0.997,15605126
52486,peginterferon alfa-2b,gene,0.9966,15605126
52487,peginterferon alfa,gene,0.995,15605126
52488,ribavirin,drug,0.9995,15605126
52489,pemetrexed disodium,drug,0.9995,15605126
52490,pimecrolimus,drug,0.9995,15605126
52491,prasugrel,drug,0.998,15605126
52492,pregabalin,drug,0.9985,15605126
52493,PRO-2000,drug,0.9775,15605126
52494,Rosuvastatin,drug,0.9995,15605126
52495,calcium,drug,0.9995,15605126
52496,RPR-113090,drug,0.9985,15605126
52497,sabarubicin hydrochloride,drug,0.997,15605126
52498,safinamide mesilate,drug,0.9985,15605126
52499,SB-715992,drug,0.9995,15605126
52500,sitaxsentan sodium,drug,0.9956,15605126
52501,soblidotin,drug,0.9395,15605126
52502,synthadotin,drug,0.9707,15605126
52503,Tadalafil,drug,0.9976,15605126
52504,taltobulin,drug,0.762,15605126
52505,temsirolimus,drug,0.999,15605126
52506,tenofovir disoproxil fumarate,drug,0.9995,15605126
52507,tenofovir disoproxil fumarate,drug,0.9995,15605126
52508,emtricitabine,drug,0.999,15605126
52509,testosterone,drug,0.9463,15605126
52510,tigecycline,drug,0.9985,15605126
52511,tipranavir,drug,0.9976,15605126
52512,tirapazamine,drug,0.9995,15605126
52513,trabectedin,drug,0.998,15605126
52514,travoprost,drug,0.943,15605126
52515,UCN-01,drug,0.9946,15605126
52516,Vardenafil hydrochloride hydrate,drug,0.9966,15605126
52517,XB-947,drug,0.982,15605126
52518,Yttrium 90,drug,0.9893,15605126
52519,90Y,drug,0.987,15605126
52520,ABX-EGF,gene,0.9775,15210739
52521,anti-epidermal growth factor receptor monoclonal antibody,gene,0.946,15210739
52522,metastatic renal cell cancer,disease,1.0,15210739
52523,ABX-EGF,gene,0.9814,15210739
52524,epidermal growth factor receptor,gene,0.9966,15210739
52525,EGFr,gene,0.9814,15210739
52526,metastatic renal cell carcinoma,disease,1.0,15210739
52527,PATIENTS,species,0.969,15210739
52528,ABX,drug,0.558,15210739
52529,EGF,gene,0.946,15210739
52530,ABX,drug,0.538,15210739
52531,EGF,gene,0.9434,15210739
52532,EGFr,gene,0.986,15210739
52533,tumor,disease,1.0,15210739
52534,hemoglobin,gene,0.9976,15210739
52535,alkaline phosphatase,gene,0.9956,15210739
52536,acneiform rash,disease,1.0,15210739
52537,ABX,drug,0.6846,15210739
52538,EGF,gene,0.9297,15210739
52539,rash,disease,0.986,15210739
52540,ABX,gene,0.947,15210739
52541,EGFr,gene,0.9966,15210739
52542,ABX,gene,0.8535,15210739
52543,EGF,gene,0.9604,15210739
52544,ABX,drug,0.6577,15210739
52545,EGF,gene,0.983,15210739
52546,metastatic renal cell carcinoma,disease,0.9995,15210739
52547,skin rash,disease,0.9976,15210739
52548,EGFR,gene,0.981,15175668
52549,epidermal growth factor receptor,gene,0.998,15142631
52550,epidermal growth factor receptor,gene,0.9985,15142631
52551,EGFR,gene,0.993,15142631
52552,erbB family,gene,0.988,15142631
52553,tyrosine,drug,0.9785,15142631
52554,tyrosine kinase receptors,gene,0.9717,15142631
52555,EGFR,gene,0.9956,15142631
52556,receptor tyrosine kinase,gene,0.996,15142631
52557,tyrosine,drug,0.9756,15142631
52558,normal cells,cell_type,0.886,15142631
52559,EGFR,gene,0.9907,15142631
52560,tumor cell lines,cell_line,0.932,15142631
52561,tumor,disease,1.0,15142631
52562,EGFR,gene,0.9937,15142631
52563,tumor cells,cell_type,0.8086,15142631
52564,tumor,disease,1.0,15142631
52565,EGFR,gene,0.99,15142631
52566,EGFR,gene,0.9907,15142631
52567,tyrosine,drug,0.983,15142631
52568,tyrosine kinase,gene,0.994,15142631
52569,EGFR,gene,0.9946,15142631
52570,tumor,disease,1.0,15142631
52571,tumor,disease,1.0,15142631
52572,EGFR,gene,0.9917,15142631
52573,ABX-EGF,gene,0.986,14967460
52574,anti-epidermal growth factor receptor antibody,gene,0.9556,14967460
52575,epidermal growth factor receptor,gene,0.998,14967460
52576,EGFR,gene,0.9946,14967460
52577,tyrosine,drug,0.8813,14967460
52578,tyrosine kinase domain,gene,0.9014,14967460
52579,EGFR,gene,0.995,14967460
52580,tyrosine,drug,0.973,14967460
52581,EGFR,gene,0.992,14967460
52582,epithelial,cell_type,0.4404,14967460
52583,epithelial cancers,disease,1.0,14967460
52584,ABX-EGF,gene,0.9863,14967460
52585,fully human IgG2 monoclonal antibody,gene,0.776,14967460
52586,human EGFR,gene,0.9917,14967460
52587,ABX-EGF,gene,0.673,14967460
52588,EGFR,gene,0.9917,14967460
52589,EGF,gene,0.996,14967460
52590,transforming growth factor-alpha,gene,0.9946,14967460
52591,EGFR,gene,0.9937,14967460
52592,tyrosine,drug,0.9966,14967460
52593,tumor cell,cell_type,0.8003,14967460
52594,tumor,disease,1.0,14967460
52595,ABX,gene,0.79,14967460
52596,EGF,gene,0.933,14967460
52597,tumor,disease,0.993,14967460
52598,A431,cell_type,0.628,14967460
52599,A431 tumors,disease,0.678,14967460
52600,Tumor,disease,0.9893,14967460
52601,ABX,gene,0.5967,14967460
52602,EGF,gene,0.3806,14967460
52603,tumor,disease,1.0,14967460
52604,renal cell cancer,disease,1.0,14967460
52605,EGFR,gene,0.9927,14967460
52606,cancer,disease,0.9995,14967460
52607,ABX,DNA,0.687,14601524
52608,ABX-EGF,gene,0.955,14601524
52609,epidermal growth factor receptor,gene,0.997,14601524
52610,cancer,disease,0.9844,14601524
52611,ABX,gene,0.5483,14601524
52612,EGF,gene,0.681,14601524
52613,"renal, colorectal, prostate and non-small-cell lung cancers",disease,1.0,14601524
52614,gastrointestinal cancers,disease,1.0,12941199
52615,gastrointestinal (GI) cancers,disease,1.0,12941199
52616,cancer,disease,1.0,12941199
52617,cancer,disease,1.0,12941199
52618,epidermal growth factor receptor,gene,0.9985,12941199
52619,EGFR,gene,0.9917,12941199
52620,tumor,disease,1.0,12941199
52621,EGFR,gene,0.996,12941199
52622,GI cancers,disease,1.0,12941199
52623,EGFR,gene,0.9717,12941199
52624,C225,gene,0.831,12941199
52625,ABX-EGF,gene,0.9863,12941199
52626,tyrosine,drug,0.9336,12941199
52627,tyrosine kinase,gene,0.785,12941199
52628,ZD1839,drug,0.984,12941199
52629,OSI-774,drug,0.9775,12941199
52630,Ras,gene,0.9814,12941199
52631,farnesyl transferase,gene,0.9897,12941199
52632,R115777,drug,0.9985,12941199
52633,SCH66336,drug,0.999,12941199
52634,Ras,gene,0.988,12941199
52635,vascular growth factor receptor,gene,0.998,12941199
52636,bevacizumab,gene,0.6,12941199
52637,PTK787,drug,0.9854,12941199
52638,matrix metalloproteinase,gene,0.9893,12941199
52639,Cyclooxygenase-2,gene,0.9834,12941199
52640,colorectal cancer,disease,1.0,12941199
52641,STI571,drug,0.995,12941199
52642,GI stromal,cell_type,0.4897,12941199
52643,GI stromal tumors,disease,1.0,12941199
52644,GI cancers,disease,1.0,12941199
52645,GI malignancies,disease,1.0,12941199
52646,Epidermal growth factor receptors,gene,0.9976,12834777
52647,EGFR,gene,0.99,12834777
52648,Epidermal Growth Factor receptor,gene,0.9985,12834777
52649,EGFR,gene,0.993,12834777
52650,tumoral,disease,0.9995,12834777
52651,EGFR,gene,0.992,12834777
52652,monoclonal antibodies,gene,0.677,12834777
52653,anti-EGFR,gene,0.909,12834777
52654,EGFR tyrosine kinase,gene,0.9634,12834777
52655,tyrosine,drug,0.9927,12834777
52656,cancer,disease,0.9995,12834777
52657,epidermal growth factor receptor,gene,0.998,12813169
52658,cancer,disease,1.0,12813169
52659,cancer,disease,1.0,12813169
52660,cancer cells,cell_type,0.824,12813169
52661,cancer,disease,1.0,12813169
52662,cancer,disease,0.998,12813169
52663,epidermal growth factor receptor,gene,0.9985,12813169
52664,EGFR,gene,0.9893,12813169
52665,cancer cells,cell_type,0.832,12813169
52666,cancer,disease,0.9995,12813169
52667,EGFR,gene,0.991,12813169
52668,EGFR,gene,0.9883,12813169
52669,EGFR,gene,0.9917,12813169
52670,EGFR,gene,0.9336,12813169
52671,tyrosine,drug,0.857,12813169
52672,tyrosine kinase,gene,0.968,12813169
52673,EGFR,gene,0.9893,12813169
52674,pharmacogenomic,DNA,0.6045,12813169
52675,Epidermal growth factor receptor,gene,0.998,12620146
52676,colorectal cancer,disease,1.0,12620146
52677,epidermal growth factor receptor,gene,0.9976,12620146
52678,EGFR,gene,0.9927,12620146
52679,advanced colorectal cancers,disease,0.9985,12620146
52680,CRCs,disease,1.0,12620146
52681,EGFR,gene,0.9873,12620146
52682,EGFR,gene,0.989,12620146
52683,anti-EGFR monoclonal antibodies,gene,0.9917,12620146
52684,cetuximab,gene,0.851,12620146
52685,ABX-EGF,gene,0.986,12620146
52686,tyrosine,drug,0.9785,12620146
52687,tyrosine kinase,gene,0.998,12620146
52688,gefitinib,drug,0.998,12620146
52689,Iressa,drug,0.9795,12620146
52690,erlotinib,drug,0.9976,12620146
52691,OSI-774,drug,0.9976,12620146
52692,Tarceva,drug,0.977,12620146
52693,cetuximab,gene,0.858,12620146
52694,EGFR,gene,0.996,12620146
52695,CRC,disease,0.9985,12620146
52696,EGFR,gene,0.957,12620146
52697,prostate cancer,disease,1.0,12599585
52698,patients,species,0.979,12537933
52699,advanced cancer,disease,1.0,12537933
52700,Epidermal growth factor receptor,gene,0.9985,12422312
52701,non-small cell lung cancer,disease,1.0,12422312
52702,non-small cell lung cancers,disease,1.0,12422312
52703,NSCLCs,disease,1.0,12422312
52704,epidermal growth factor receptor,gene,0.998,12422312
52705,EGFR,gene,0.9917,12422312
52706,EGFR,gene,0.99,12422312
52707,preneoplastic bronchial lesions,disease,1.0,12422312
52708,EGFR,gene,0.992,12422312
52709,EGFR,gene,0.9946,12422312
52710,EGFR,gene,0.963,12422312
52711,receptor tyrosine kinase,gene,0.912,12422312
52712,tyrosine,drug,0.9346,12422312
52713,human NSCLC cell lines,cell_line,0.9673,12422312
52714,NSCLC,disease,0.9097,12422312
52715,MAP kinases,gene,0.9907,12422312
52716,AKT,gene,0.995,12422312
52717,NSCLC tumors,disease,1.0,12422312
52718,nude mice,species,0.6543,12422312
52719,Skin rash,disease,0.9995,12422312
52720,skin rash,disease,0.9995,12422312
52721,ABX-EGF,gene,0.975,11894013
52722,anti-epidermal growth factor receptor monoclonal antibody,gene,0.9272,11894013
52723,cancer,disease,1.0,11894013
52724,epidermal growth factor receptor,gene,0.998,11894013
52725,EGFR,gene,0.9917,11894013
52726,cancers,disease,0.999,11894013
52727,tumor cells,cell_type,0.853,11894013
52728,tumor,disease,0.9995,11894013
52729,EGFR,gene,0.994,11894013
52730,EGFR,gene,0.986,11894013
52731,ABX-EGF,gene,0.993,11894013
52732,ABX,gene,0.944,11894013
52733,EGF,gene,0.7764,11894013
52734,epidermal growth factor,gene,0.999,11894013
52735,transforming growth factor alpha,gene,0.9976,11894013
52736,EGFR,gene,0.9937,11894013
52737,tyrosine,drug,0.998,11894013
52738,EGFR,gene,0.9897,11894013
52739,ABX,gene,0.5015,11894013
52740,EGF,gene,0.9146,11894013
52741,human epidermoid carcinoma A431 xenografts,cell_line,0.9404,11894013
52742,epidermoid carcinoma,disease,0.73,11894013
52743,mice,species,0.9326,11894013
52744,tumors,disease,1.0,11894013
52745,tumor,disease,1.0,11894013
52746,ABX,drug,0.521,11894013
52747,EGF,gene,0.974,11894013
52748,solid tumors,disease,1.0,11894013
52749,EGFR,gene,0.9893,11894013
52750,ABX-EGF,gene,0.989,11255078
52751,anti-EGF receptor monoclonal antibody,gene,0.9307,11255078
52752,cancer,disease,1.0,11255078
52753,epidermal growth factor receptor,gene,0.9976,11255078
52754,EGFr,gene,0.986,11255078
52755,human tumors,cell_type,0.42,11255078
52756,tumors,disease,1.0,11255078
52757,EGFr,gene,0.9956,11255078
52758,tumor,disease,1.0,11255078
52759,tumor,disease,1.0,11255078
52760,ABX-EGF,gene,0.9883,11255078
52761,human IgG2 monoclonal antibody,gene,0.967,11255078
52762,human EGFr,gene,0.996,11255078
52763,ABX,gene,0.824,11255078
52764,EGF,gene,0.8213,11255078
52765,EGFr,gene,0.9917,11255078
52766,EGF,gene,0.993,11255078
52767,transforming growth factor-alpha,gene,0.9956,11255078
52768,TGF-alpha,gene,0.9956,11255078
52769,EGFr-expressing human carcinoma cell lines,cell_line,0.942,11255078
52770,EGFr,gene,0.983,11255078
52771,EGF,gene,0.986,11255078
52772,tumor,disease,0.4473,11255078
52773,EGFr,gene,0.991,11255078
52774,tyrosine,drug,0.9937,11255078
52775,ABX,gene,0.861,11255078
52776,EGF,gene,0.8315,11255078
52777,human epidermoid carcinoma A431 xenografts,cell_line,0.906,11255078
52778,epidermoid carcinoma,disease,0.8667,11255078
52779,mice,species,0.9614,11255078
52780,ABX,gene,0.6274,11255078
52781,EGF,gene,0.9785,11255078
52782,tumors,disease,1.0,11255078
52783,tumor,disease,1.0,11255078
52784,tumor cell,cell_type,0.5356,11255078
52785,tumor,disease,1.0,11255078
52786,"human pancreatic, renal, breast and prostate tumor xenografts",cell_line,0.63,11255078
52787,"pancreatic, renal, breast and prostate tumor",disease,0.9917,11255078
52788,EGFr,gene,0.9946,11255078
52789,ABX-,gene,0.9478,11255078
52790,EGF,gene,0.7065,11255078
52791,Tumor,disease,0.9824,11255078
52792,EGFr,gene,0.9814,11255078
52793,ABX-,gene,0.9077,11255078
52794,EGF,gene,0.6074,11255078
52795,EGF,gene,0.77,11255078
52796,EGFr-negative tumors,cell_line,0.771,11255078
52797,EGFr,gene,0.997,11255078
52798,tumors,disease,0.501,11255078
52799,ABX,gene,0.9243,11255078
52800,EGF,gene,0.9062,11255078
52801,tumors,disease,1.0,11255078
52802,EGFr,gene,0.989,11255078
52803,solid tumors,disease,1.0,11255078
52804,cancer,disease,1.0,11255078
52805,tumor,disease,1.0,11255078
52806,HER2 antibody,gene,0.9487,11255078
52807,HER2,gene,0.995,11255078
52808,metastatic breast cancer,disease,1.0,11255078
52809,ABX-EGF,gene,0.956,11255078
52810,tumor,disease,0.854,11255078
52811,ABX,gene,0.733,11255078
52812,EGF,gene,0.958,11255078
52813,solid tumors,disease,1.0,11255078
52814,EGFr,gene,0.9937,11255078
